PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ihara, M; Hamamoto, S; Miyanoiri, Y; Takeda, M; Kainosho, M; Yabe, I; Uozumi, N; Yamashita, A				Ihara, Makoto; Hamamoto, Shin; Miyanoiri, Yohei; Takeda, Mitsuhiro; Kainosho, Masatsune; Yabe, Isamu; Uozumi, Nobuyuki; Yamashita, Atsuko			Molecular Bases of Multimodal Regulation of a Fungal Transient Receptor Potential (TRP) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-EVOKED ACTIVATION; ION-CHANNEL; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; VACUOLAR MEMBRANE; CATION CHANNEL; COILED COILS; PATCH-CLAMP; YEAST; DOMAIN	Multimodal activation by various stimuli is a fundamental characteristic of TRP channels. We identified a fungal TRP channel, TRPGz, exhibiting activation by hyperosmolarity, temperature increase, cytosolic Ca2+ elevation, membrane potential, and H2O2 application, and thus it is expected to represent a prototypic multimodal TRP channel. TRPGz possesses a cytosolic C-terminal domain (CTD), primarily composed of intrinsically disordered regions with some regulatory modules, a putative coiled-coil region and a basic residue cluster. The CTD oligomerization mediated by the coiled-coil region is required for the hyperosmotic and temperature increase activations but not for the tetrameric channel formation or other activation modalities. In contrast, the basic cluster is responsible for general channel inhibition, by binding to phosphatidylinositol phosphates. The crystal structure of the presumed coiled-coil region revealed a tetrameric assembly in an offset spiral rather than a canonical coiled-coil. This structure underlies the observed moderate oligomerization affinity enabling the dynamic assembly and disassembly of the CTD during channel functions, which are compatible with the multimodal regulation mediated by each functional module.	[Ihara, Makoto; Yamashita, Atsuko] RIKEN SPring 8 Ctr, Struct Physiol Res Grp, Mol Signaling Res Team, Sayo, Hyogo 6795148, Japan; [Ihara, Makoto; Yamashita, Atsuko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Hamamoto, Shin; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Miyanoiri, Yohei; Takeda, Mitsuhiro; Kainosho, Masatsune] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Nagoya, Aichi 4648602, Japan; [Kainosho, Masatsune] Tokyo Metropolitan Univ, Ctr Prior Areas, Hachioji, Tokyo 1920397, Japan; [Yabe, Isamu] Tokyo Denki Univ, Dept Green & Sustainable Chem, Tokyo 1208551, Japan	RIKEN; Okayama University; Tohoku University; Nagoya University; Tokyo Metropolitan University; Tokyo Denki University	Yamashita, A (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	a_yama@pharm.okayama-u.ac.jp	Yamashita, Atsuko/H-5566-2017; Uozumi, Nobuyuki/AAG-3252-2019; Ihara, Makoto/Q-7204-2016	Yamashita, Atsuko/0000-0002-8001-4642; Miyanoiri, Yohei/0000-0001-6889-5160; Uozumi, Nobuyuki/0000-0003-4268-1126; Ihara, Makoto/0000-0002-6403-0781	Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP); Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; MEXT	Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS), the Council for Science and Technology Policy (CSTP) (to A. Y.), and the Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (to A. Y. and M. K.) and Grants-in-aid for Scientific Research from MEXT (to S. H. and N. U.).	Akada R, 2002, YEAST, V19, P17, DOI 10.1002/yea.797; Arbuzova A, 2000, BIOCHEMISTRY-US, V39, P10330, DOI 10.1021/bi001039j; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Batiza AF, 1996, J BIOL CHEM, V271, P23357, DOI 10.1074/jbc.271.38.23357; BERTL A, 1990, P NATL ACAD SCI USA, V87, P7824, DOI 10.1073/pnas.87.20.7824; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chang YM, 2010, FEBS LETT, V584, P2028, DOI 10.1016/j.febslet.2009.12.035; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Desjardins AE, 2003, ANNU REV PHYTOPATHOL, V41, P177, DOI 10.1146/annurev.phyto.41.011703.115501; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Drummond A. J., 2011, GENEIOUS VERSION 5 3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Guler AD, 2002, J NEUROSCI, V22, P6408; Hamamoto S, 2008, J BIOL CHEM, V283, P1911, DOI 10.1074/jbc.M708213200; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; Ihara M, 2011, ANAL BIOCHEM, V412, P217, DOI 10.1016/j.ab.2011.01.038; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; MILLHAUSER GL, 1988, P NATL ACAD SCI USA, V85, P1503, DOI 10.1073/pnas.85.5.1503; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Molland KL, 2012, BBA-PROTEINS PROTEOM, V1824, P413, DOI 10.1016/j.bbapap.2011.12.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakanishi Y, 2003, J BIOCHEM, V134, P615, DOI 10.1093/jb/mvg184; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Popa CV, 2010, FEBS J, V277, P4027, DOI 10.1111/j.1742-4658.2010.07794.x; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Saimi Y, 2007, CURR TOP MEMBR, V58, P311, DOI 10.1016/S1063-5823(06)58012-3; Schindl R, 2007, BIOCHEM SOC T, V35, P84, DOI 10.1042/BST0350084; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Su ZW, 2007, P NATL ACAD SCI USA, V104, P19607, DOI 10.1073/pnas.0708584104; Su ZW, 2009, J MEMBRANE BIOL, V227, P141, DOI 10.1007/s00232-009-9153-9; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WADA Y, 1987, J BIOL CHEM, V262, P17260; Walshaw J, 2003, J STRUCT BIOL, V144, P349, DOI 10.1016/j.jsb.2003.10.014; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yabe I, 1999, J BIOL CHEM, V274, P34903, DOI 10.1074/jbc.274.49.34903; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/nchembio.692, 10.1038/NCHEMBIO.692]; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou XL, 2005, EUR BIOPHYS J BIOPHY, V34, P413, DOI 10.1007/s00249-005-0465-0; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	77	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15303	15317		10.1074/jbc.M112.434795	http://dx.doi.org/10.1074/jbc.M112.434795			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23553631	Green Published, hybrid			2022-12-25	WOS:000319452100056
J	Ramer, MD; Suman, ES; Richter, H; Stanger, K; Spranger, M; Bieberstein, N; Duncker, BP				Ramer, Matthew D.; Suman, Evelyin S.; Richter, Hagen; Stanger, Karen; Spranger, Martina; Bieberstein, Nicole; Duncker, Bernard P.			Dbf4 and Cdc7 Proteins Promote DNA Replication through Interactions with Distinct Mcm2-7 Protein Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION; KINASE; HELICASE; COMPLEX; STRESS; OVEREXPRESSION; MAINTENANCE; RESISTANCE	The essential cell cycle target of the Dbf4/Cdc7 kinase (DDK) is the Mcm2-7 helicase complex. Although Mcm4 has been identified as the critical DDK phosphorylation target for DNA replication, it is not well understood which of the six Mcm2-7 subunits actually mediate(s) docking of this kinase complex. We systematically examined the interaction between each Mcm2-7 subunit with Dbf4 and Cdc7 through two-hybrid and co-immunoprecipitation analyses. Strikingly different binding patterns were observed, as Dbf4 interacted most strongly with Mcm2, whereas Cdc7 displayed association with both Mcm4 and Mcm5. We identified an N-terminal Mcm2 region required for interaction with Dbf4. Cells expressing either an Mcm2 mutant lacking this docking domain (Mcm2 Delta DDD) or an Mcm4 mutant lacking a previously identified DDK docking domain (Mcm4 Delta DDD) displayed modest DNA replication and growth defects. In contrast, combining these two mutations resulted in synthetic lethality, suggesting that Mcm2 and Mcm4 play overlapping roles in the association of DDK with MCM rings at replication origins. Consistent with this model, growth inhibition could be induced in Mcm4 Delta DDD cells through Mcm2 overexpression as a means of titrating the Dbf4-MCM ring interaction. This growth inhibition was exacerbated by exposing the cells to either hydroxyurea or methyl methanesulfonate, lending support for a DDK role in stabilizing or restarting replication forks under S phase checkpoint conditions. Finally, constitutive overexpression of each individual MCM subunit was examined, and genotoxic sensitivity was found to be specific to Mcm2 or Mcm4 overexpression, further pointing to the importance of the DDK-MCM ring interaction.	[Ramer, Matthew D.; Suman, Evelyin S.; Richter, Hagen; Stanger, Karen; Spranger, Martina; Bieberstein, Nicole; Duncker, Bernard P.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Duncker, BP (corresponding author), Univ Waterloo, Dept Biol, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.	bduncker@uwaterloo.ca	Bieberstein, Nicole/G-4406-2014	Duncker, Bernard/0000-0002-6055-9522	Natural Sciences and Engineering Research Council of Canada [RGPIN 238392]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN 238392.	Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Baker SP, 2010, NAT CELL BIOL, V12, P294, DOI 10.1038/ncb2030; Bonte D, 2008, NEOPLASIA, V10, P920, DOI 10.1593/neo.08216; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Gonzalez MA, 2005, NAT REV CANCER, V5, P135, DOI 10.1038/nrc1548; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Harkins V, 2009, GENETICS, V183, P1269, DOI 10.1534/genetics.109.110155; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Hoang ML, 2007, MOL CELL BIOL, V27, P7594, DOI 10.1128/MCB.00997-07; Jones DR, 2010, CELL CYCLE, V9, P2018, DOI 10.4161/cc.9.10.11752; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Liku ME, 2005, MOL BIOL CELL, V16, P5026, DOI 10.1091/mbc.E05-05-0412; Matthews LA, 2012, J BIOL CHEM, V287, P2378, DOI 10.1074/jbc.M111.233973; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Pasero P, 2000, CURR OPIN GENET DEV, V10, P178, DOI 10.1016/S0959-437X(00)00067-8; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Semple JW, 2004, BIOTECHNOL ADV, V22, P621, DOI 10.1016/j.biotechadv.2004.06.001; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Stead BE, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-36; Stead BE, 2011, NUCLEIC ACIDS RES, V39, P6998, DOI 10.1093/nar/gkr371; Stead BE, 2009, J MOL BIOL, V391, P301, DOI 10.1016/j.jmb.2009.06.038; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tsuji T, 2008, MOL CELL, V32, P862, DOI 10.1016/j.molcel.2008.12.005; Varrin AE, 2005, MOL CELL BIOL, V25, P7494, DOI 10.1128/MCB.25.17.7494-7504.2005; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108	38	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14926	14935		10.1074/jbc.M112.392910	http://dx.doi.org/10.1074/jbc.M112.392910			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23549044	Green Published, hybrid			2022-12-25	WOS:000319452100023
J	Kabuta, T; Mitsui, T; Takahashi, M; Fujiwara, Y; Kabuta, C; Konya, C; Tsuchiya, Y; Hatanaka, Y; Uchida, K; Hohjoh, H; Wada, K				Kabuta, Tomohiro; Mitsui, Takeshi; Takahashi, Masaki; Fujiwara, Yuuki; Kabuta, Chihana; Konya, Chiho; Tsuchiya, Yukihiro; Hatanaka, Yusuke; Uchida, Kenko; Hohjoh, Hirohiko; Wada, Keiji			Ubiquitin C-terminal Hydrolase L1 (UCH-L1) Acts as a Novel Potentiator of Cyclin-dependent Kinases to Enhance Cell Proliferation Independently of Its Hydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-PRODUCT 9.5; INSULIN-RECEPTOR SUBSTRATE-3; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MUTANT UCH-L1; UCHL1 GENE; EXPRESSION; PGP9.5; CANCER; NEURON	Dysregulation of cell proliferation and the cell cycle are associated with various diseases, such as cancer. Cyclin-dependent kinases (CDKs) play central roles in cell proliferation and the cell cycle. Ubiquitin C-terminal hydrolase L1 (UCH-L1) is expressed in a restricted range of tissues, including the brain and numerous types of cancer. However, the molecular functions of UCH-L1 remain elusive. In this study, we found that UCH-L1 physically interacts with CDK1, CDK4, and CDK5, enhancing their kinase activity. Using several mutants of UCH-L1, we showed that this enhancement is dependent upon interaction levels between UCH-L1 and CDKs but is independent of the known ubiquitin-related functions of UCH-L1. Gain-and loss-of-function studies revealed that UCH-L1 enhances proliferation of multiple cell types, including human cancer cells. Inhibition of the interaction between UCH-L1 and cell cycle-associated CDK resulted in the abolishment of UCH-L1-induced enhancement of cell proliferation. RNA interference of UCH-L1 reduced the growth of human xenograft tumors in mice. We concluded that UCH-L1 is a novel regulator of the kinase activities of CDKs. We believe that our findings from this study will significantly contribute to our understanding of cell cycle-associated diseases.	[Kabuta, Tomohiro; Mitsui, Takeshi; Fujiwara, Yuuki; Kabuta, Chihana; Konya, Chiho; Tsuchiya, Yukihiro; Hatanaka, Yusuke; Wada, Keiji] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 1878502, Japan; [Takahashi, Masaki; Hohjoh, Hirohiko] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Pharmacol, Kodaira, Tokyo 1878502, Japan; [Mitsui, Takeshi; Fujiwara, Yuuki; Uchida, Kenko] Waseda Univ, Dept Elect Engn & Biosci, Shinjuku Ku, Tokyo 1698555, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Waseda University	Kabuta, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	kabuta@ncnp.go.jp	Wada, Keiji/AAV-1500-2021; Kabuta, Tomohiro/B-2948-2015	Kabuta, Tomohiro/0000-0002-3058-2596; Takahashi, Masaki/0000-0003-1190-2213; Fujiwara, Yuuki/0000-0003-1032-7755	Ministry of Health, Labour, and Welfare of Japan; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan; National Institute of Biomedical Innovation (NIBIO), Japan; Ministry of Health, Labour, and Welfare, Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO), Japan(National Institute of Biomedical Innovation); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants-in-aid for scientific research on nervous and mental disorders from the Ministry of Health, Labour, and Welfare of Japan (to T. K.); by grants-in-aid for young scientists (to T. K.) and grants-in-aid for scientific research (to K. W.) of the Japan Society for the Promotion of Science; by a Research grant in priority area research of the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to K. W.); by grants-in-aid for scientific research of the Ministry of Health, Labour, and Welfare, Japan (to K. W.) and the by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan (to K. W.).	ALKATIB AM, 1995, CELL GROWTH DIFFER, V6, P211; Arendt T, 1996, NEUROREPORT, V7, P3047; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Busser J, 1998, J NEUROSCI, V18, P2801; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; GIAMBANCO I, 1991, FEBS LETT, V290, P131, DOI 10.1016/0014-5793(91)81242-Z; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hibi K, 1999, AM J PATHOL, V155, P711, DOI 10.1016/S0002-9440(10)65169-3; Higashi S, 2010, NEUROCHEM INT, V57, P906, DOI 10.1016/j.neuint.2010.09.010; Higashi S, 2010, J NEUROCHEM, V115, P423, DOI 10.1111/j.1471-4159.2010.06930.x; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Hoozemans JJM, 2002, J NEUROPATH EXP NEUR, V61, P678, DOI 10.1093/jnen/61.8.678; Howell VM, 2009, J CLIN ENDOCR METAB, V94, P434, DOI 10.1210/jc.2008-1740; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kabuta T, 2010, BIOCHEM BIOPH RES CO, V394, P697, DOI 10.1016/j.bbrc.2010.03.054; Kabuta T, 2009, BIOCHEM BIOPH RES CO, V387, P121, DOI 10.1016/j.bbrc.2009.06.138; Kabuta T, 2008, BIOCHEM BIOPH RES CO, V377, P741, DOI 10.1016/j.bbrc.2008.09.106; Kabuta T, 2008, AUTOPHAGY, V4, P827, DOI 10.4161/auto.6560; Kagara I, 2008, J UROLOGY, V180, P343, DOI 10.1016/j.juro.2008.02.044; Kaminosono S, 2008, J NEUROSCI, V28, P8747, DOI 10.1523/JNEUROSCI.0973-08.2008; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; Kwon J, 2004, BIOL REPROD, V71, P515, DOI 10.1095/biolreprod.104.027565; Kwon J, 2003, EXP ANIM TOKYO, V52, P1, DOI 10.1538/expanim.52.1; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Mann DA, 1996, J NEUROCHEM, V66, P35; McShea A, 1997, AM J PATHOL, V150, P1933; Miyoshi Y, 2006, CANCER SCI, V97, P523, DOI 10.1111/j.1349-7006.2006.00202.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nagy Z, 1997, ACTA NEUROPATHOL, V93, P294, DOI 10.1007/s004010050617; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nishikawa K, 2003, BIOCHEM BIOPH RES CO, V304, P176, DOI 10.1016/S0006-291X(03)00555-2; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Otsuki T, 2004, BRIT J HAEMATOL, V127, P292, DOI 10.1111/j.1365-2141.2004.05205.x; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Sekiguchi S, 2006, AM J PATHOL, V169, P1722, DOI 10.2353/ajpath.2006.060301; Setsuie R, 2007, NEUROCHEM INT, V50, P119, DOI 10.1016/j.neuint.2006.07.015; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Takase T, 2003, HEPATO-GASTROENTEROL, V50, P1278; Tezel E, 2000, CLIN CANCER RES, V6, P4764; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Yamazaki T, 2002, CLIN CANCER RES, V8, P192; Yang Y, 2003, J NEUROSCI, V23, P2557	57	29	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12615	12626		10.1074/jbc.M112.435701	http://dx.doi.org/10.1074/jbc.M112.435701			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23543736	hybrid, Green Published			2022-12-25	WOS:000318555100020
J	Fernandez-Juricic, E; Ojeda, A; Deisher, M; Burry, B; Baumhardt, P; Stark, A; Elmore, AG; Ensminger, AL				Fernandez-Juricic, Esteban; Ojeda, Agustin; Deisher, Marcella; Burry, Brianna; Baumhardt, Patrice; Stark, Amy; Elmore, Amanda G.; Ensminger, Amanda L.			Do Male and Female Cowbirds See Their World Differently? Implications for Sex Differences in the Sensory System of an Avian Brood Parasite	PLOS ONE			English	Article							BROWN-HEADED COWBIRDS; VISUAL ECOLOGY; COLOR-VISION; HIPPOCAMPUS SIZE; M-CONE; SONG; DISPLAYS; MOTION; BIRDS; SENSITIVITY	Background: Male and female avian brood parasites are subject to different selection pressures: males compete for mates but do not provide parental care or territories and only females locate hosts to lay eggs. This sex difference may affect brain architecture in some avian brood parasites, but relatively little is known about their sensory systems and behaviors used to obtain sensory information. Our goal was to study the visual resolution and visual information gathering behavior (i.e., scanning) of brown-headed cowbirds. Methodology/Principal Findings: We measured the density of single cone photoreceptors, associated with chromatic vision, and double cone photoreceptors, associated with motion detection and achromatic vision. We also measured head movement rates, as indicators of visual information gathering behavior, when exposed to an object. We found that females had significantly lower density of single and double cones than males around the fovea and in the periphery of the retina. Additionally, females had significantly higher head-movement rates than males. Conclusions: Overall, we suggest that female cowbirds have lower chromatic and achromatic visual resolution than males (without sex differences in visual contrast perception). Females might compensate for the lower visual resolution by gazing alternatively with both foveae in quicker succession than males, increasing their head movement rates. However, other physiological factors may have influenced the behavioral differences observed. Our results bring up relevant questions about the sensory basis of sex differences in behavior. One possibility is that female and male cowbirds differentially allocate costly sensory resources, as a recent study found that females actually have greater auditory resolution than males.	[Fernandez-Juricic, Esteban; Deisher, Marcella; Burry, Brianna; Baumhardt, Patrice; Stark, Amy; Elmore, Amanda G.; Ensminger, Amanda L.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Ojeda, Agustin] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; California State University System; California State University Long Beach	Fernandez-Juricic, E (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	efernan@purdue.edu	Ensminger, Amanda/M-6196-2013	Ensminger, Amanda/0000-0002-2913-6951	National Science Foundation [IOS-0641550/0937187]; Direct For Biological Sciences [1103725] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by the National Science Foundation (IOS-0641550/0937187). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOIMONOS J, 1987, INT J COMPUT VISION, V1, P333; Blackwell BF, 2009, ANIM BEHAV, V77, P673, DOI 10.1016/j.anbehav.2008.11.017; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Campenhausen MV, 1998, J COMP PHYSIOL A, V183, P1; Clotfelter ED, 1998, ANIM BEHAV, V55, P1181, DOI 10.1006/anbe.1997.0638; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; Cummings ME, 2008, J EXP BIOL, V211, P1203, DOI 10.1242/jeb.012963; Dangles O, 2009, Q REV BIOL, V84, P51, DOI 10.1086/596463; Dawkins MS, 2002, ANIM BEHAV, V63, P991, DOI [10.1006/anbe.2002.1999, 10.1006/anbe.2002.999]; Dawkins MS, 2000, NATURE, V403, P652, DOI 10.1038/35001064; DAWLEY EM, 1992, COPEIA, P113, DOI 10.2307/1446542; Day LB, 2008, BEHAV NEUROSCI, V122, P527, DOI 10.1037/0735-7044.122.3.527; Dolan T, 2010, BRAIN BEHAV EVOLUT, V75, P111, DOI 10.1159/000305025; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; Dowling J. E., 2012, RETINA APPROACHABLE; Evans JE, 2006, ANIM BEHAV, V72, P393, DOI 10.1016/j.anbehav.2005.10.031; Fernandez-Juricic E, 2012, BEHAV PROCESS, V89, P143, DOI 10.1016/j.beproc.2011.10.006; Fernandez-Juricic E, 2011, ANIM BEHAV, V82, P573, DOI 10.1016/j.anbehav.2011.06.014; Fernandez-Juricic E, 2011, ANIM BEHAV, V81, P705, DOI 10.1016/j.anbehav.2010.11.014; Gall MD, 2010, J COMP PHYSIOL A, V196, P559, DOI 10.1007/s00359-010-0543-3; Gloag R, 2012, P ROY SOC B-BIOL SCI, V279, P1831, DOI 10.1098/rspb.2011.2047; Goldsmith TH, 2005, J COMP PHYSIOL A, V191, P933, DOI 10.1007/s00359-005-0024-2; Gunther KL, 2002, VISION RES, V42, P1367, DOI 10.1016/S0042-6989(02)00043-3; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hart NS, 2006, J EXP BIOL, V209, P4776, DOI 10.1242/jeb.02568; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hart NS, 2000, CURR BIOL, V10, P115, DOI 10.1016/S0960-9822(00)00297-9; Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X; Hauber ME, 1999, BEHAV NEUROSCI, V113, P1095, DOI 10.1037/0735-7044.113.5.1095; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; JAEGER RG, 1991, J HERPETOL, V25, P370, DOI 10.2307/1564603; Jagle H, 2006, DOC OPHTHALMOL, V113, P105, DOI 10.1007/s10633-006-9019-8; Knudsen DP, 2010, BRAIN LANG, V115, P59, DOI 10.1016/j.bandl.2009.09.008; Kram YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008992; Land M., 2009, LOOKING ACTING VISIO; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lisney TJ, 2012, VISION RES, V62, P125, DOI 10.1016/j.visres.2012.04.002; Lowther PE, 1993, BIRDS N AM ONLINE; MALDONADO PE, 1988, BRAIN BEHAV EVOLUT, V32, P57, DOI 10.1159/000116532; Martin G.R., 2008, SENSES COMPREHENSIVE, V1, P25, DOI 10.1016/B978-012370880-9.00401-1; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; Martins EP, 2005, BEHAV ECOL SOCIOBIOL, V58, P351, DOI 10.1007/s00265-005-0954-2; Mcllwain JT, 1990, INTRO BIOL VISION; Meyer D.B., 1977, VISUAL SYSTEM VERTEB, V5, P550; Montgomerie R, 2006, BIRD COLORATION MECH; Muchlinski MN, 2011, ANAT REC, V294, P2179, DOI 10.1002/ar.21507; MULLER B, 1989, J COMP NEUROL, V282, P581, DOI 10.1002/cne.902820409; Nava SS, 2012, BEHAV ECOL SOCIOBIOL, V66, P1357, DOI 10.1007/s00265-012-1392-6; Nava SS, 2009, BIOL LETTERS, V5, P732, DOI 10.1098/rsbl.2009.0348; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; O'Loghlen AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036130; O'Loghlen AL, 2010, CONDOR, V112, P615, DOI 10.1525/cond.2010.090216; O'Loghlen AL, 2010, ANIM BEHAV, V79, P1285, DOI 10.1016/j.anbehav.2010.03.001; O'Loghlen AL, 2003, BEHAV ECOL SOCIOBIOL, V53, P102, DOI 10.1007/s00265-002-0551-6; Ohayon S, 2006, J COMP PHYSIOL A, V192, P927, DOI 10.1007/s00359-006-0130-9; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Osorio D, 1999, J EXP BIOL, V202, P2951; PETTIGREW JD, 1988, BRAIN BEHAV EVOLUT, V32, P39, DOI 10.1159/000116531; RAUSCHECKER JP, 1994, EUR J NEUROSCI, V6, P149, DOI 10.1111/j.1460-9568.1994.tb00256.x; Reboreda JC, 1996, NEUROREPORT, V7, P505, DOI 10.1097/00001756-199601310-00031; Rossi EA, 2010, NAT NEUROSCI, V13, P156, DOI 10.1038/nn.2465; Rothstein S.I., 1986, Current Ornithology, V3, P127; ROTHSTEIN SI, 1988, ANIM BEHAV, V36, P73, DOI 10.1016/S0003-3472(88)80251-3; Sabbah S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-133; SHERRY DF, 1993, P NATL ACAD SCI USA, V90, P7839, DOI 10.1073/pnas.90.16.7839; Tomasi D, 2008, NEUROSCIENCE, V151, P1006, DOI 10.1016/j.neuroscience.2007.08.040; Uchiyama M, 2008, TOHOKU J EXP MED, V216, P277, DOI 10.1620/tjem.216.277; Ullmann JFP, 2012, BRAIN BEHAV EVOLUT, V79, P26, DOI 10.1159/000332802; Vorobyev M, 2003, P ROY SOC B-BIOL SCI, V270, P1255, DOI 10.1098/rspb.2003.2381; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0; Wilczynski W, 2010, CURR OPIN NEUROBIOL, V20, P754, DOI 10.1016/j.conb.2010.08.021; WILLIAMS DR, 1987, J OPT SOC AM A, V4, P1514, DOI 10.1364/JOSAA.4.001514	74	17	17	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58985	10.1371/journal.pone.0058985	http://dx.doi.org/10.1371/journal.pone.0058985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544049	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700012
J	Vaidya, JG; Knutson, B; O'Leary, DS; Block, RI; Magnotta, V				Vaidya, Jatin G.; Knutson, Brian; O'Leary, Daniel S.; Block, Robert I.; Magnotta, Vincent			Neural Sensitivity to Absolute and Relative Anticipated Reward in Adolescents	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; DECISION-MAKING; NUCLEUS-ACCUMBENS; AGE-DIFFERENCES; BRAIN; BEHAVIOR; DOPAMINE; IMPULSIVITY; ACTIVATION; NEUROBIOLOGY	Adolescence is associated with a dramatic increase in risky and impulsive behaviors that have been attributed to developmental differences in neural processing of rewards. In the present study, we sought to identify age differences in anticipation of absolute and relative rewards. To do so, we modified a commonly used monetary incentive delay (MID) task in order to examine brain activity to relative anticipated reward value (neural sensitivity to the value of a reward as a function of other available rewards). This design also made it possible to examine developmental differences in brain activation to absolute anticipated reward magnitude (the degree to which neural activity increases with increasing reward magnitude). While undergoing fMRI, 18 adolescents and 18 adult participants were presented with cues associated with different reward magnitudes. After the cue, participants responded to a target to win money on that trial. Presentation of cues was blocked such that two reward cues associated with $.20, $1.00, or $5.00 were in play on a given block. Thus, the relative value of the $1.00 reward varied depending on whether it was paired with a smaller or larger reward. Reflecting age differences in neural responses to relative anticipated reward (i.e., reference dependent processing), adults, but not adolescents, demonstrated greater activity to a $1 reward when it was the larger of the two available rewards. Adults also demonstrated a more linear increase in ventral striatal activity as a function of increasing absolute reward magnitude compared to adolescents. Additionally, reduced ventral striatal sensitivity to absolute anticipated reward (i.e., the difference in activity to medium versus small rewards) correlated with higher levels of trait Impulsivity. Thus, ventral striatal activity in anticipation of absolute and relative rewards develops with age. Absolute reward processing is also linked to individual differences in Impulsivity.	[Vaidya, Jatin G.; O'Leary, Daniel S.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Knutson, Brian] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Block, Robert I.] Univ Iowa, Dept Radiol, Carver Coll Med, Iowa City, IA 52242 USA; [Magnotta, Vincent] Univ Iowa, Dept Anesthesia, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; Stanford University; University of Iowa; University of Iowa	Vaidya, JG (corresponding author), Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA.	jatin-vaidya@uiowa.edu		O'Leary, Daniel/0000-0003-1959-6521; Vaidya, Jatin/0000-0002-2375-816X; Block, Robert/0000-0003-4971-1981; Magnotta, Vincent/0000-0001-8639-5354; Knutson, Brian/0000-0002-7669-426X	National Institutes of Health [DA023442]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA023442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by an R03 grant from the National Institutes of Health (DA023442) to JGV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Andrews MM, 2011, BIOL PSYCHIAT, V69, P675, DOI 10.1016/j.biopsych.2010.09.049; ARNETT J, 1992, DEV REV, V12, P339, DOI 10.1016/0273-2297(92)90013-R; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Berns GS, 2007, ANN NY ACAD SCI, V1104, P301, DOI 10.1196/annals.1390.013; Bjork JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011440; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; Cohen JR, 2010, NAT NEUROSCI, V13, P669, DOI 10.1038/nn.2558; Cooper JC, 2009, SOC COGN AFFECT NEUR, V4, P409, DOI 10.1093/scan/nsp031; Costa P.T., 1992, NEO FFI PERSONALITY; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Martino B, 2008, J NEUROSCI, V28, P10746, DOI 10.1523/JNEUROSCI.2895-08.2008; De Martino B, 2009, J NEUROSCI, V29, P3833, DOI 10.1523/JNEUROSCI.4832-08.2009; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Elliott R, 2008, EUR J NEUROSCI, V27, P2213, DOI 10.1111/j.1460-9568.2008.06202.x; Gaillard WD, 2001, NEUROIMAGE, V13, P239, DOI 10.1006/nimg.2000.0681; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Geier CF, 2010, CEREB CORTEX, V20, P1613, DOI 10.1093/cercor/bhp225; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gray J. A., 1991, EXPLORATIONS TEMPERA, P105, DOI [DOI 10.1007/978-1-4899-0643-4_8, 10.1007/978-1-4899-0643-4_8, 10.1007/978-1-4899-0643-4]; Hahn T, 2009, NEUROIMAGE, V46, P1148, DOI 10.1016/j.neuroimage.2009.03.038; Jarcho JM, 2012, DEV COGN NEUROSCI; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kenny D. A., 1987, STAT SOCIAL BEHAV SC; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B., 2006, BIOL PERSONALITY IND, P116; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Lee B, 2009, J NEUROSCI, V29, P14734, DOI 10.1523/JNEUROSCI.3765-09.2009; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Luciana M, 2005, CHILD DEV, V76, P697, DOI 10.1111/j.1467-8624.2005.00872.x; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pfeifer JH, 2011, NEURON, V69, P1029, DOI 10.1016/j.neuron.2011.02.019; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Sacchet MD, 2013, NEUROIMAGE, V66, P270, DOI 10.1016/j.neuroimage.2012.10.056; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SEEMAN P, 1987, SYNAPSE, V1, P399, DOI 10.1002/syn.890010503; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SPEAR LP, 1983, DEV PSYCHOBIOL, V16, P83, DOI 10.1002/dev.420160203; Sripada CS, 2011, HUM BRAIN MAPP, V32, P1637, DOI 10.1002/hbm.21136; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Vaidya JG, 2010, PERS INDIV DIFFER, V48, P815, DOI 10.1016/j.paid.2010.02.002; Van Leijenhorst L, 2010, CEREB CORTEX, V20, P61, DOI 10.1093/cercor/bhp078; Volkow ND, 2011, MOL PSYCHIATR, V16, P1147, DOI 10.1038/mp.2010.97; Wahlstrom D, 2010, NEUROSCI BIOBEHAV R, V34, P631, DOI 10.1016/j.neubiorev.2009.12.007; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7	60	15	15	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58708	10.1371/journal.pone.0058708	http://dx.doi.org/10.1371/journal.pone.0058708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544046	Green Submitted, gold, Green Published			2022-12-25	WOS:000317480700009
J	Paquet, M; Covas, R; Chastel, O; Parenteau, C; Doutrelant, C				Paquet, Matthieu; Covas, Rita; Chastel, Olivier; Parenteau, Charline; Doutrelant, Claire			Maternal Effects in Relation to Helper Presence in the Cooperatively Breeding Sociable Weaver	PLOS ONE			English	Article							EGG SIZE; LIFE-HISTORY; REPRODUCTIVE SUCCESS; PHILETAIRUS-SOCIUS; INVESTMENT STRATEGIES; CORTICOSTERONE LEVELS; OFFSPRING SURVIVAL; STRESS HORMONES; YOLK ANDROGENS; SEX-RATIO	In egg laying species, breeding females may adjust the allocation of nutrients or other substances into eggs in order to maximise offspring or maternal fitness. Cooperatively breeding species offer a particularly interesting context in which to study maternal allocation because helpers create predictably improved conditions during offspring development. Some recent studies on cooperative species showed that females assisted by helpers produced smaller eggs, as the additional food brought by the helpers appeared to compensate for this reduction in egg size. However, it remains unclear how common this effect might be. Also currently unknown is whether females change egg composition when assisted by helpers. This effect is predicted by current maternal allocation theory, but has not been previously investigated. We studied egg mass and contents in sociable weavers (Philetairus socius). We found that egg mass decreased with group size, while fledgling mass did not vary, suggesting that helpers may compensate for the reduced investment in eggs. We found no differences in eggs' carotenoid contents, but females assisted by helpers produced eggs with lower hormonal content, specifically testosterone, androstenedione (A4) and corticosterone levels. Taken together, these results suggest that the environment created by helpers can influence maternal allocation and potentially offspring phenotypes.	[Paquet, Matthieu; Doutrelant, Claire] CEFE CNRS, Montpellier, France; [Covas, Rita] CIBIO, Res Ctr Biodivers & Genet Resources, Vairao, Portugal; [Covas, Rita] Univ Cape Town, Percy Fitzpatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa; [Covas, Rita] Univ Porto, Dept Biol, Fac Sci, P-4100 Oporto, Portugal; [Chastel, Olivier; Parenteau, Charline] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France	Universite de Montpellier; National Research Foundation - South Africa; University of Cape Town; Universidade do Porto; Centre National de la Recherche Scientifique (CNRS)	Paquet, M (corresponding author), CEFE CNRS, 1919 Route Mende, Montpellier, France.	matthieu.paquet@cefe.cnrs.fr	Covas, Rita/G-2242-2018; Paquet, Matthieu/H-5507-2019	Covas, Rita/0000-0001-7130-144X; Paquet, Matthieu/0000-0003-1182-2299	Department of Science and Technology/National Research Foundation Centre of Excellence at the Percy FitzPatrick Institute, University of Cape Town, South Africa; Portuguese Science and Technology Foundation [FCT PTDC/BIA-BEC/103818/2008]; French Agence Nationale de la Recherche [09-JCJC-0050-01]; French-Portuguese exchange programme PESSOA	Department of Science and Technology/National Research Foundation Centre of Excellence at the Percy FitzPatrick Institute, University of Cape Town, South Africa; Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); French Agence Nationale de la Recherche(French National Research Agency (ANR)); French-Portuguese exchange programme PESSOA	Funding was provided by the Department of Science and Technology/National Research Foundation Centre of Excellence at the Percy FitzPatrick Institute, University of Cape Town, South Africa, the Portuguese Science and Technology Foundation (FCT PTDC/BIA-BEC/103818/2008 to RC) and the French Agence Nationale de la Recherche (09-JCJC-0050-01 to CD). Additional funding during analyses and writing up was provided by the French-Portuguese exchange programme PESSOA to RC and CD and MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold KE, 1998, P ROY SOC B-BIOL SCI, V265, P739, DOI 10.1098/rspb.1998.0355; Badyaev AV, 2008, ANN NY ACAD SCI, V1133, P151, DOI 10.1196/annals.1438.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benton TG, 2005, P ROY SOC B-BIOL SCI, V272, P1351, DOI 10.1098/rspb.2005.3081; Bernardo J, 1996, AM ZOOL, V36, P216; Biard C, 2005, OECOLOGIA, V144, P32, DOI 10.1007/s00442-005-0048-x; Blount JD, 2000, TRENDS ECOL EVOL, V15, P47, DOI 10.1016/S0169-5347(99)01774-7; Blount JD, 2004, ARCH BIOCHEM BIOPHYS, V430, P10, DOI 10.1016/j.abb.2004.03.039; Canestrari D, 2011, J EVOLUTION BIOL, V24, P1870, DOI 10.1111/j.1420-9101.2011.02313.x; CAREY C, 1980, CONDOR, V82, P335, DOI 10.2307/1367405; Cariello MO, 2006, HORM BEHAV, V49, P654, DOI 10.1016/j.yhbeh.2005.12.007; Chastel O, 2005, GEN COMP ENDOCR, V140, P33, DOI 10.1016/j.ygcen.2004.10.012; Christians JK, 2002, BIOL REV, V77, P1, DOI 10.1017/S1464793101005784; Clutton-Brock T. H., 1988, REPROD SUCCESS; Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x; Covas R, 2006, BEHAV ECOL SOCIOBIOL, V60, P323, DOI 10.1007/s00265-006-0168-2; Covas R, 2004, AUK, V121, P1199, DOI 10.1642/0004-8038(2004)121[1199:JAASIT]2.0.CO;2; Covas R, 2002, P ROY SOC B-BIOL SCI, V269, P1905, DOI 10.1098/rspb.2002.2106; Covas R, 2002, LIFE HIST EVOLUTION; Covas R, 2008, BEHAV ECOL SOCIOBIOL, V63, P103, DOI 10.1007/s00265-008-0640-2; Covas R, 2011, ANIM BEHAV, V81, P121, DOI 10.1016/j.anbehav.2010.09.022; Crawley M. J, 2002, STAT COMPUTING INTRO; De Fraipont M, 2000, J ANIM ECOL, V69, P404, DOI 10.1046/j.1365-2656.2000.00405.x; Dean WRJ, 2001, J ARID ENVIRON, V47, P101, DOI 10.1006/jare.2000.0693; Deville AS, 2009, CONSEQUENCES REPROD; Doutrelant C, 2004, BEHAV ECOL SOCIOBIOL, V56, P149, DOI 10.1007/s00265-004-0756-y; Doutrelant C, 2007, ANIM BEHAV, V74, P739, DOI 10.1016/j.anbehav.2006.11.033; Eguchi K, 2002, J ANIM ECOL, V71, P123, DOI 10.1046/j.0021-8790.2001.00585.x; Emlen S.T., 1991, P301; Ewen JG, 2009, P NATL ACAD SCI USA, V106, P12798, DOI 10.1073/pnas.0902575106; Fox CW, 1997, AM NAT, V149, P149, DOI 10.1086/285983; Giesing ER, 2011, P ROY SOC B-BIOL SCI, V278, P1753, DOI 10.1098/rspb.2010.1819; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; Gil D, 2007, AM NAT, V169, P802, DOI 10.1086/516652; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Griesser M, 2008, BEHAV ECOL, V19, P317, DOI 10.1093/beheco/arm131; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hartley RC, 2004, TRENDS ECOL EVOL, V19, P353, DOI 10.1016/j.tree.2004.04.002; Hatchwell BJ, 1999, AM NAT, V154, P205, DOI 10.1086/303227; Hayward LS, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1026, DOI 10.1086/432854; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Henriksen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023824; KAPLAN RH, 1992, ECOLOGY, V73, P280, DOI 10.2307/1938739; Khan MZ, 2002, BEHAV ECOL SOCIOBIOL, V51, P336, DOI 10.1007/s00265-001-0441-3; Koenig WD, 2009, BEHAV ECOL SOCIOBIOL, V63, P1659, DOI 10.1007/s00265-009-0773-y; Komdeur J, 2006, ETHOLOGY, V112, P729, DOI 10.1111/j.1439-0310.2006.01243.x; Legge S, 2000, J ANIM ECOL, V69, P714, DOI 10.1046/j.1365-2656.2000.00429.x; MACLEAN G L, 1973, Ostrich, V44, P176, DOI 10.1080/00306525.1973.9639158; MACLEAN G L, 1973, Ostrich, V44, P254, DOI 10.1080/00306525.1973.9639162; Malueg AL, 2009, BEHAV ECOL SOCIOBIOL, V63, P687, DOI 10.1007/s00265-008-0702-5; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Mazuc J, 2003, ECOL LETT, V6, P1084, DOI 10.1046/j.1461-0248.2003.00535.x; McCormick MI, 1998, ECOLOGY, V79, P1873, DOI 10.1890/0012-9658(1998)079[1873:BIMSIA]2.0.CO;2; McDonald PG, 2009, ANIM BEHAV, V77, P369, DOI 10.1016/j.anbehav.2008.10.009; McGraw KJ, 2005, NATURWISSENSCHAFTEN, V92, P375, DOI 10.1007/s00114-005-0003-z; Mendelsohn J. M., 1997, ATLAS SO AFRICAN BIR, P534; Meylan S, 2005, HORM BEHAV, V48, P44, DOI 10.1016/j.yhbeh.2004.11.022; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Monaghan P, 1998, P ROY SOC B-BIOL SCI, V265, P1731, DOI 10.1098/rspb.1998.0495; Mugabo M, 2010, J EVOLUTION BIOL, V23, P1886, DOI 10.1111/j.1420-9101.2010.02052.x; Nager RG, 2001, J AVIAN BIOL, V32, P159, DOI 10.1034/j.1600-048X.2001.320209.x; Nilsson JA, 2001, OECOLOGIA, V128, P187, DOI 10.1007/s004420100653; Olsson M, 2008, J EXP BIOL, V211, P1257, DOI 10.1242/jeb.015065; REZNICK D, 1993, ECOLOGY, V74, P2011, DOI 10.2307/1940844; RICKLEFS RE, 1977, AUK, V94, P350; Rubolini D, 2005, HORM BEHAV, V47, P592, DOI 10.1016/j.yhbeh.2005.01.006; Ruiz X, 2000, J AVIAN BIOL, V31, P567, DOI 10.1034/j.1600-048X.2000.310416.x; Russell AF, 2008, P R SOC B, V275, P29, DOI 10.1098/rspb.2007.0821; Russell AF, 2007, SCIENCE, V317, P941, DOI 10.1126/science.1146037; Russell AF, 2009, PHILOS T R SOC B, V364, P1143, DOI 10.1098/rstb.2008.0298; Sachser N, 2011, NEUROSCI BIOBEHAV R, V35, P1518, DOI 10.1016/j.neubiorev.2010.09.002; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Sandell MI, 2007, J AVIAN BIOL, V38, P284, DOI 10.1111/j.2007.0908-8857.03640.x; Santos ESA, 2011, ETHOLOGY, V117, P547, DOI 10.1111/j.1439-0310.2011.01905.x; Schwabl H, 2012, AGE, V34, P87, DOI 10.1007/s11357-011-9222-8; Segers FHID, 2012, P ROY SOC B-BIOL SCI, V279, P1241, DOI 10.1098/rspb.2011.1290; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Smiseth PT, 2011, ANIM BEHAV, V81, P507, DOI 10.1016/j.anbehav.2010.11.029; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Spottiswoode CN, 2005, BEHAV ECOLOGY TROPIC; Stearns S.C., 1992, pi; Strand A, 1998, COMP BIOCHEM PHYS A, V119, P963, DOI 10.1016/S1095-6433(98)00011-7; Taborsky B, 2007, BEHAV ECOL, V18, P652, DOI 10.1093/beheco/arm026; Taborsky B, 2006, BIOL LETTERS, V2, P225, DOI 10.1098/rsbl.2005.0422; Tella JL, 1998, PHYSIOL ZOOL, V71, P708, DOI 10.1086/515991; Tobler M, 2007, BIOLOGY LETT, V3, P408, DOI 10.1098/rsbl.2007.0127; Tschirren B, 2007, AM NAT, V169, P87, DOI 10.1086/509945; van Dijk R, 2012, OECOLOGIA; Vezina F, 2002, PHYSIOL BIOCHEM ZOOL, V75, P377, DOI 10.1086/343137; Vijendravarma RK, 2010, BIOL LETTERS, V6, P238, DOI 10.1098/rsbl.2009.0754; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; WHITE FN, 1975, IBIS, V117, P171, DOI 10.1111/j.1474-919X.1975.tb04205.x; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x; Woxvold IA, 2005, J ANIM ECOL, V74, P1039, DOI 10.1111/j.1365-2656.2005.01001.x; [No title captured]	96	31	31	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59336	10.1371/journal.pone.0059336	http://dx.doi.org/10.1371/journal.pone.0059336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536872	Green Submitted, Green Published, gold			2022-12-25	WOS:000317397200020
J	Van Steenkiste, N; Tessens, B; Willems, W; Backeljau, T; Jondelius, U; Artois, T				Van Steenkiste, Niels; Tessens, Bart; Willems, Wim; Backeljau, Thierry; Jondelius, Ulf; Artois, Tom			A Comprehensive Molecular Phylogeny of Dalytyphloplanida (Platyhelminthes: Rhabdocoela) Reveals Multiple Escapes from the Marine Environment and Origins of Symbiotic Relationships	PLOS ONE			English	Article							ANCESTRAL CHARACTER STATES; ULTRASTRUCTURE; SPERM; INTERRELATIONSHIPS; SPERMIOGENESIS; TURBELLARIA; MORPHOLOGY; PARASITISM; FLATWORMS; ALIGNMENT	In this study we elaborate the phylogeny of Dalytyphloplanida based on complete 18S rDNA (156 sequences) and partial 28S rDNA (125 sequences), using a Maximum Likelihood and a Bayesian Inference approach, in order to investigate the origin of a limnic or limnoterrestrial and of a symbiotic lifestyle in this large group of rhabditophoran flatworms. The results of our phylogenetic analyses and ancestral state reconstructions indicate that dalytyphloplanids have their origin in the marine environment and that there was one highly successful invasion of the freshwater environment, leading to a large radiation of limnic and limnoterrestrial dalytyphloplanids. This monophyletic freshwater clade, Limnotyphloplanida, comprises the taxa Dalyelliidae, Temnocephalida, and most Typhloplanidae. Temnocephalida can be considered ectosymbiotic Dalyelliidae as they are embedded within this group. Secondary returns to brackish water and marine environments occurred relatively frequently in several dalyeliid and typhloplanid taxa. Our phylogenies also show that, apart from the Limnotyphloplanida, there have been only few independent invasions of the limnic environment, and apparently these were not followed by spectacular speciation events. The distinct phylogenetic positions of the symbiotic taxa also suggest multiple origins of commensal and parasitic life strategies within Dalytyphloplanida. The previously established higher-level dalytyphloplanid clades are confirmed in our topologies, but many of the traditional families are not monophyletic. Alternative hypothesis testing constraining the monophyly of these families in the topologies and using the approximately unbiased test, also statistically rejects their monophyly.	[Van Steenkiste, Niels; Tessens, Bart; Willems, Wim; Artois, Tom] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium; [Backeljau, Thierry] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Backeljau, Thierry] Royal Belgian Inst Nat Sci, Dept Invertebrates, Brussels, Belgium; [Backeljau, Thierry] Royal Belgian Inst Nat Sci, Joint Expt Mol Unit, Brussels, Belgium; [Jondelius, Ulf] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden	Hasselt University; University of Antwerp; Royal Belgian Institute of Natural Sciences; Royal Belgian Institute of Natural Sciences; Swedish Museum of Natural History	Van Steenkiste, N (corresponding author), Fisheries & Oceans Canada, Pacific Biol Stn, Dept Fisheries & Oceans, Nanaimo, BC V9R 5K6, Canada.	niels_van_steenkiste@hotmail.com	Jondelius, Ulf/AAF-7943-2020; Artois, Tom/O-7349-2017	Jondelius, Ulf/0000-0003-2847-2192; Artois, Tom/0000-0002-2491-7273	Flemish Research Foundation (FWO Vlaanderen); Special Research Foundation (BOF) grant of Hasselt University;  [G.08.208]	Flemish Research Foundation (FWO Vlaanderen)(FWO); Special Research Foundation (BOF) grant of Hasselt University; 	NVS and BT have been benefitting from a grant (aspirant) of the Flemish Research Foundation (FWO Vlaanderen). WW is supported by a Special Research Foundation (BOF) grant of Hasselt University. This paper is also a contribution to the Flemish Research Foundation (FWO) project G.08.208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ax P., 1957, Verh Deutsch Zool Ges Hamburg, V1956, P428; Ax P, 2008, AKAD WISSENSCHAFT MN, V1; Ax P, 1952, FAUNA MITT NORDDEUT, VI, P18; AX PETER, 1960, ZEITSCHR WISS ZOOL, V163, P210; Barbeitos MS, 2010, P NATL ACAD SCI USA, V107, P11877, DOI 10.1073/pnas.0914380107; Beklemishev VN, 1927, ZOOLOGISCHES JAHRBUC, V54, P87; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Cannon L.R.G., 1986, P15; CANNON LRG, 1982, ZOOL SCR, V11, P173, DOI 10.1111/j.1463-6409.1982.tb00530.x; Damborenea MC, 2001, BELG J ZOOL, V131, P167; Doignon G, 2006, BELG J ZOOL, V136, P101; Ehlers U., 1972, Mikrofauna Meeresbodens, VNo. 11, P3; Ehlers U., 1989, Microfauna Marina, V5, P189; Ehlers U, 1985, PHYLOGENETISCHE SYST; EHLERS U, 1981, MIKROFAUNA MEERERSBO, V83, P1; Ehlers Ulrich, 1993, Microfauna Marina, V8, P65; FINDENEGG INGO, 1930, ZOOL JAHRB ABT SYST OKOL U GEOGR TIERE, V59, P73; Hochberg R, 2003, RAFFLES B ZOOL, V51, P1; Hochberg Rick, 2002, Zootaxa, V44, P1; Iomini C, 1999, FOLIA PARASIT, V46, P199; JENNINGS JB, 1978, BIOL BULL, V155, P542, DOI 10.2307/1540789; Jennings JB, 1997, INT J PARASITOL, V27, P679, DOI 10.1016/S0020-7519(97)00010-6; Joffe BI, 1998, HYDROBIOLOGIA, V383, P263, DOI 10.1023/A:1003438321560; JONDELIUS U, 1992, ZOOL SCR, V21, P93, DOI 10.1111/j.1463-6409.1992.tb00312.x; JONDELIUS U, 1992, ZOOL SCR, V21, P223, DOI 10.1111/j.1463-6409.1992.tb00325.x; JONDELIUS U, 1993, CAN J ZOOL, V71, P298, DOI 10.1139/z93-042; Jondelius Ulf, 1997, P187; Karling T, 1974, FAUNA FENN HELSINKI, V27, P1; KARLING T G, 1972, Zoologica Scripta, V1, P251, DOI 10.1111/j.1463-6409.1972.tb00575.x; KARLING TG, 1986, ZOOL SCR, V15, P201, DOI 10.1111/j.1463-6409.1986.tb00223.x; KARLING TOR G., 1956, ARKIV ZOOL, V10, P331; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kolasa J, 1977, ACTA ZOOL FENN, V154, P82; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Littlewood DTJ, 2000, MOL PHYLOGENET EVOL, V16, P449, DOI 10.1006/mpev.2000.0802; Littlewood DTJ, 1999, BIOL J LINN SOC, V68, P257, DOI 10.1111/j.1095-8312.1999.tb01169.x; Littlewood DTJ, 1999, BIOL J LINN SOC, V66, P75, DOI 10.1111/j.1095-8312.1999.tb01918.x; LUTHER A, 1946, ACTA ZOOL FENN, V46, P3; Luther A, 1955, ACTA ZOOL FENN, V87, P1; Luther A., 1948, ACTA ZOOL FENN, V55, P3; LUTHER ALEX, 1962, FAUNA FENNICA, V12, P1; Marcus E, 1954, PAP AVULS DEP ZOOL S, V11, P419; Meixner J., 1938, TIERWELT NORD OSTSEE, V33, P1; MEIXNER JOSEF, 1926, ZEITSCH MORPH U OKOL TIERE, V5, P577, DOI 10.1007/BF00408292; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Noren M, 2002, ZOOL SCR, V31, P403, DOI 10.1046/j.1463-6409.2002.00082.x; Noren M, 1999, CLADISTICS, V15, P103, DOI 10.1111/j.1096-0031.1999.tb00252.x; Nylander JAA, 2011, BURNTREES V0 1 9 PER; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A, 2009, TRACER V1 5; Rieger R.M., 1974, BIOL TURBELLARIA, P23; Risen J. U., 1961, Archiv fuer Hydrobiologie, V57, P464; ROHDE K, 1993, INT J PARASITOL, V23, P705, DOI 10.1016/0020-7519(93)90067-9; Rohde K, 1997, INT J PARASITOL, V27, P739, DOI 10.1016/S0020-7519(97)00014-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salisbury BA, 2001, SYST BIOL, V50, P557, DOI 10.1080/106351501750435103; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHOCKAERT E. R., 1996, METHODS EXAMINATION, P221; Schockaert ER, 2008, HYDROBIOLOGIA, V595, P41, DOI 10.1007/s10750-007-9002-8; Schultz TR, 1999, SYST BIOL, V48, P651, DOI 10.1080/106351599260229; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SOPOTTEHLERS B, 1995, ZOOMORPHOLOGY, V115, P41, DOI 10.1007/BF00397933; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stamatakis A, 2006, P 20 IEEE INT PAR DI, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Therriault TW, 1999, ARCH HYDROBIOL, V144, P371; TOWNSHEND J. L., 1963, NEMATOLOGICA, V9, P106; Van Steenkiste N, 2010, ZOOL SCI, V27, P285, DOI 10.2108/zsj.27.285; WATSON NA, 1993, PARASITOL RES, V79, P322, DOI 10.1007/BF00932189; Watson Nikki A., 2001, Systematics Association Special Volume Series, V60, P217; Willems WR, 2006, ZOOL SCR, V35, P1, DOI 10.1111/j.1463-6409.2005.00216.x; Willems WR, 2005, NEW ZEAL J ZOOL, V32, P79, DOI 10.1080/03014223.2005.9518400; Willems WR, 2005, THESIS LIMBURGS U CE; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Zamparo D, 2001, ZOOL SCR, V30, P59, DOI 10.1046/j.1463-6409.2001.00050.x	82	41	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59917	10.1371/journal.pone.0059917	http://dx.doi.org/10.1371/journal.pone.0059917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536894	Green Published, Green Submitted, gold			2022-12-25	WOS:000317397200042
J	Li, T; Liu, H; Cai, K; Tian, MR; Wang, Q; Shi, J; Gao, X; Wang, H				Li, Tao; Liu, Hao; Cai, Kun; Tian, Maoren; Wang, Qin; Shi, Jing; Gao, Xiang; Wang, Hui			Hypersensitive Detection and Quantitation of BoNT/A by IgY Antibody against Substrate Linear-Peptide	PLOS ONE			English	Article							BOTULINUM TYPE-A; NEUROTOXIN TYPE-A; CLOSTRIDIUM-BOTULINUM; ENDOPEPTIDASE IMMUNOASSAYS; SEROTYPE-A; TOXIN-F; ASSAYS; TETANUS; RELEASE; SNAP-25	Botulinum neurotoxin A (BoNT/A), the most acutely poisonous substance to humans known, cleave its SNAP-25 substrate with high specificity. Based on the endopeptidase activity, different methods have been developed to detect BoNT/A, but most lack ideal reproducibility or sensitivity, or suffer from long-term or unwanted interferences. In this study, we developed a simple method to detect and quantitate trace amounts of botulinum neurotoxin A using the IgY antibody against a linear-peptide substrate. The effects of reaction buffer, time, and temperature were analyzed and optimized. When the optimized assay was used to detect BoNT/A, the limit of detection of the assay was 0.01 mouse LD50 (0.04 pg), and the limit of quantitation was 0.12 mouse LD50/ml (0.48 pg). The findings also showed favorable specificity of detecting BoNT/A. When used to detect BoNT/A in milk or human serum, the proposed assay exhibited good quantitative accuracy (88%, < recovery, < 111%; inter- and intra- assay CVs, < 18%). This method of detection took less than 3 h to complete, indicating that it can be a valuable method of detecting BoNT/A in food or clinical diagnosis.	[Li, Tao; Liu, Hao; Cai, Kun; Tian, Maoren; Wang, Qin; Shi, Jing; Gao, Xiang; Wang, Hui] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Wang, H (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China.	geno0109@vip.sina.com			National Natural Science Foundation of China [31201352]; Beijing Natural Science Foundation [7122134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work is supported by National Natural Science Foundation of China (No. 31201352) and Beijing Natural Science Foundation (No. 7122134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC International, 2001, OFFICIAL METHODS ANA; Barr JR, 2005, EMERG INFECT DIS, V11, P1578, DOI 10.3201/eid1110.041279; Ekong TAN, 1997, MICROBIOL-SGM, V143, P3337, DOI 10.1099/00221287-143-10-3337; EKONG TAN, 1995, J IMMUNOL METHODS, V180, P181, DOI 10.1016/0022-1759(94)00313-L; Gaines Das R E, 1999, Dev Biol Stand, V101, P267; Hallis B, 1996, J CLIN MICROBIOL, V34, P1934, DOI 10.1128/JCM.34.8.1934-1938.1996; Johnson EA, 2001, TOXICON, V39, P1703, DOI 10.1016/S0041-0101(01)00157-X; Jones RGA, 2008, J IMMUNOL METHODS, V329, P92, DOI 10.1016/j.jim.2007.09.014; Jones RGA, 2009, J IMMUNOL METHODS, V343, P21, DOI 10.1016/j.jim.2009.01.001; Joshi SG, 2012, J PHARMACOL TOX MET, V65, P8, DOI 10.1016/j.vascn.2011.11.002; Kalb SR, 2006, ANAL BIOCHEM, V351, P84, DOI 10.1016/j.ab.2006.01.027; Kautter DA, 1997, J ASS ANAL CHEM, V60, P541; Kovacs-Nolan J, 2004, AVIAN POULT BIOL REV, V15, P25, DOI 10.3184/147020604783637462; Liu ZJ, 2012, ANAL CHIM ACTA, V735, P23, DOI 10.1016/j.aca.2012.05.008; Min D, 2004, P NATL ACAD SCI USA, V101, P14701, DOI 10.1073/pnas.0404107101; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; OGUMA K, 1995, MICROBIOL IMMUNOL, V39, P161, DOI 10.1111/j.1348-0421.1995.tb02184.x; Peck MW, 2009, ADV MICROB PHYSIOL, V55, P183, DOI 10.1016/S0065-2911(09)05503-9; Rivera VR, 2006, ANAL BIOCHEM, V353, P248, DOI 10.1016/j.ab.2006.02.030; Ruge DR, 2011, ANAL BIOCHEM, V411, P200, DOI 10.1016/j.ab.2011.01.002; SCHANTZ EJ, 1978, J ASSOC OFF ANA CHEM, V61, P96; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Schmidt JJ, 1995, J PROTEIN CHEM, V14, P703, DOI 10.1007/BF01886909; Schmidt JJ, 2001, ANAL BIOCHEM, V296, P130, DOI 10.1006/abio.2001.5236; Shone C, 2006, NEUROTOX RES, V9, P205, DOI 10.1007/BF03033940; TSE CK, 1982, EUR J BIOCHEM, V122, P493; Wang DX, 2012, ANAL CHEM, V84, P4652, DOI 10.1021/ac3006439; Wang HH, 2010, APPL ENVIRON MICROB, V76, P6658, DOI 10.1128/AEM.00731-10; Wang Q, 2010, CAN J MICROBIOL, V56, P1003, DOI 10.1139/W10-087	30	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58908	10.1371/journal.pone.0058908	http://dx.doi.org/10.1371/journal.pone.0058908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555605	Green Submitted, Green Published, gold			2022-12-25	WOS:000316546400015
J	Hernandez-Cervantes, R; Quintanar-Stephano, A; Moreno-Mendoza, N; Lopez-Griego, L; Lopez-Salazar, V; Hernandez-Bello, R; Carrero, JC; Morales-Montor, J				Hernandez-Cervantes, Rosalia; Quintanar-Stephano, Andres; Moreno-Mendoza, Norma; Lopez-Griego, Lorena; Lopez-Salazar, Valeria; Hernandez-Bello, Romel; Cesar Carrero, Julio; Morales-Montor, Jorge			Regulation of Intestinal Immune Response by Selective Removal of the Anterior, Posterior, or Entire Pituitary Gland in Trichinella spiralis Infected Golden Hamsters	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM INFECTION; HUMAN MONONUCLEAR PHAGOCYTES; NECROSIS-FACTOR-ALPHA; GROWTH-HORMONE; ADRENAL AXIS; ARGININE-VASOPRESSIN; NEUROENDOCRINE REGULATION; HELMINTH INFECTION; PORCINE JEJUNUM; HUMAN MONOCYTES	The influence of anterior pituitary hormones on the gastrointestinal tract of humans and animals has been previously reported. Hypophysectomy (HYPOX) in the rat causes atrophy of the intestinal mucosa, and reduction of gastric secretion and intestinal absorption, as well as increased susceptibility to bacterial and viral infections. However, to our knowledge, no findings have been published concerning the immune response following HYPOX during worm infection, particularly that which is caused by the nematode Trichinella spiralis. The aim of this work was to analyze the effects of total or partial HYPOX on colonization of T. spiralis in the intestinal lumen, together with duodenal and splenic cytokine expression. Our results indicate that 5 days post infection, only neurointermediate pituitary lobectomy (NIL) reduces the number of intestinally recovered T. spiralis larvae. Using semiquantitative inmunofluorescent laser confocal microscopy, we observed that the mean intensity of all tested Th1 cytokines was markedly diminished, even in the duodenum of infected controls. In contrast, a high level of expression of these cytokines was noted in the NIL infected hamsters. Likewise, a significant decrease in the fluorescence intensity of Th2 cytokines (with the exception of IL-4) was apparent in the duodenum of control and sham infected hamsters, compared to animals with NIL surgeries, which showed an increase in the expression of IL-5 and IL-13. Histology of duodenal mucosa from NIL hamsters showed an exacerbated inflammatory infiltrate located along the lamina propria, which was related to the presence of the parasite. We conclude that hormones from each pituitary lobe affect the gastrointestinal immune responses to T. spiralis through various mechanisms.	[Hernandez-Cervantes, Rosalia; Lopez-Griego, Lorena; Lopez-Salazar, Valeria; Hernandez-Bello, Romel; Cesar Carrero, Julio; Morales-Montor, Jorge] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico; [Quintanar-Stephano, Andres] Univ Autonoma Aguascalientes, Ctr Ciencias Basicas, Dept Fisiol & Farmacol, Aguascalientes, Mexico; [Moreno-Mendoza, Norma] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular, Mexico City 04510, DF, Mexico; [Hernandez-Bello, Romel] Univ Autonoma Nuevo Leon, Fac Med, Dept Microbiol, Monterrey, Nuevo Leon, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Aguascalientes; Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Nuevo Leon	Morales-Montor, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico.	jmontor66@biomedicas.unam.mx	Montor, Jorge/B-1224-2012	Montor, Jorge/0000-0002-9461-610X; Carrero, Julio/0000-0003-1055-5774; Quintanar-Stephano, Andres/0000-0002-3688-080X	Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT) [IN 214011-3]; Direccion General de Asuntos del Personal Academico (DGAPA) [213108]; Universidad Nacional Autonoma de Mexico; Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF); Red Farmed, Consejo Nacional de Ciencia y Tecnologia (CONACyT); Sistema Nacional de Investigadoers (SNI)	Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT); Direccion General de Asuntos del Personal Academico (DGAPA); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF); Red Farmed, Consejo Nacional de Ciencia y Tecnologia (CONACyT); Sistema Nacional de Investigadoers (SNI)	Financial support was provided by grant IN 214011-3 from the Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Romel Hernandez-Bello was a Post Doctoral fellowship from the Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF). Rosalia Hernandez-Cervantes had a Bachelorete scholarship from PAPIIT, DGAPA (# 213108), from Sistema Nacional de Investigadoers (SNI) as a research helper, and from Red Farmed, Consejo Nacional de Ciencia y Tecnologia (CONACyT). Dr. Lilia Graue corrected the English version of the manuscript.	ALVAREZ-BUYLLA R, 1991, Boletin de Estudios Medicos y Biologicos Universidad Nacional Autonoma de Mexico, V39, P33; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; BARRABES A, 1979, CR SOC BIOL, V173, P153; BELL J, 1993, LIFE SCI, V52, P95, DOI 10.1016/0024-3205(93)90292-B; BENJONATHAN N, 1982, ENDOCRINOLOGY, V110, P1861, DOI 10.1210/endo-110-6-1861; BERCZI I, 1981, ACTA ENDOCRINOL-COP, V98, P506, DOI 10.1530/acta.0.0980506; BERCZI I, 1984, ARTHRITIS RHEUM, V27, P682, DOI 10.1002/art.1780270612; Berczi I, 2009, ANN NY ACAD SCI, V1153, P220, DOI 10.1111/j.1749-6632.2008.03975.x; Besedovsky HO, 2000, Z RHEUMATOL, V59, P26, DOI 10.1007/s003930070014; BIENENSTOCK J, 1992, ANN NY ACAD SCI, V664, P1, DOI 10.1111/j.1749-6632.1992.tb39743.x; BLOCK LH, 1981, J CLIN INVEST, V68, P374, DOI 10.1172/JCI110265; Campos-Rodriguez R, 2006, INFECT IMMUN, V74, P1883, DOI 10.1128/IAI.74.3.1883-1889.2006; Chikanza IC, 1998, BRIT J RHEUMATOL, V37, P131; Chikanza IC, 2000, ANN NY ACAD SCI, V917, P825; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Correa-De-Santana E, 2006, J NEUROIMMUNOL, V173, P12, DOI 10.1016/j.jneuroim.2005.08.015; Crofford LJ, 2002, ENDOCRIN METAB CLIN, V31, P1, DOI 10.1016/S0889-8529(01)00004-4; Damian RT, 1997, PARASITOLOGY, V115, pS169, DOI 10.1017/S0031182097002357; DICARLO R, 1993, LIFE SCI, V53, P981, DOI 10.1016/0024-3205(93)90120-R; Dupouy-Camet J, 2000, VET PARASITOL, V93, P191, DOI 10.1016/S0304-4017(00)00341-1; EDWARDS CK, 1991, ENDOCRINOLOGY, V128, P989, DOI 10.1210/endo-128-2-989; EDWARDS CK, 1992, INFECT IMMUN, V60, P2514, DOI 10.1128/IAI.60.6.2514-2521.1992; EDWARDS CK, 1992, CELL MOL NEUROBIOL, V12, P499, DOI 10.1007/BF00711550; EDWARDS CK, 1991, P NATL ACAD SCI USA, V88, P2274, DOI 10.1073/pnas.88.6.2274; ELANDS J, 1990, ENDOCRINOLOGY, V126, P2703, DOI 10.1210/endo-126-5-2703; Elenkov IJ, 1999, ANN NY ACAD SCI, V876, P1, DOI 10.1111/j.1749-6632.1999.tb07618.x; Escobedo G, 2005, TRENDS PARASITOL, V21, P588, DOI 10.1016/j.pt.2005.09.013; FERNANDEZREPOLLET E, 1983, J HISTOCHEM CYTOCHEM, V31, P956, DOI 10.1177/31.7.6854008; FIGALLOVA V, 1988, FOLIA PARASIT, V35, P59; GALA RR, 1991, P SOC EXP BIOL MED, V198, P513; Garside P, 2000, PARASITE IMMUNOL, V22, P605, DOI 10.1046/j.1365-3024.2000.00344.x; Green BT, 2003, J NEUROIMMUNOL, V141, P74, DOI 10.1016/S0165-5728(03)00225-X; GROSSMAN CJ, 1983, J STEROID BIOCHEM, V19, P461, DOI 10.1016/0022-4731(83)90204-2; HEIJNEN CJ, 1991, IMMUNOL REV, V119, P41, DOI 10.1111/j.1600-065X.1991.tb00577.x; Hernandez-Bello R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/625380; Hu SB, 2003, J NEUROIMMUNOL, V135, P72, DOI 10.1016/S0165-5728(02)00442-3; Ierna MX, 2009, INFECT IMMUN, V77, P3879, DOI 10.1128/IAI.01461-08; Imai S, 2004, CURR TOP MED CHEM, V4, P539, DOI 10.2174/1568026043451285; Karmanska Krystyna, 1997, Wiadomosci Parazytologiczne, V43, P245; Kelley KW, 2007, BRAIN BEHAV IMMUN, V21, P384, DOI 10.1016/j.bbi.2006.11.010; Khegai II, 2003, B EXP BIOL MED+, V136, P448, DOI 10.1023/B:BEBM.0000017089.28428.1c; Klein JR, 2003, AUTOIMMUNITY, V36, P417, DOI 10.1080/08916930310001603019; Kolodziej-Sobocinska M, 2007, PARASITOL RES, V101, P629, DOI 10.1007/s00436-007-0527-6; Kulkarni-Narla A, 1999, CELL TISSUE RES, V298, P275, DOI 10.1007/s004419900096; Lingnau A., 1993, Applied Parasitology, V34, P153; LOCHER R, 1983, J CLIN INVEST, V71, P884, DOI 10.1172/JCI110842; MADDEN KS, 1995, PHYSIOL REV, V75, P77, DOI 10.1152/physrev.1995.75.1.77; Cardenas-Jaramillo LM, 2012, ANN NY ACAD SCI, V1261, P72, DOI 10.1111/j.1749-6632.2012.06648.x; Meli R, 1996, IMMUNOPHARMACOLOGY, V34, P1, DOI 10.1016/0162-3109(95)00052-6; Mena F, 1996, ENDOCRINE, V5, P285, DOI 10.1007/BF02739061; Morales-Montor J, 2005, PARASITOLOGY, V131, P287, DOI 10.1017/S0031182005007894; MUNCK A, 1992, MOL CELL ENDOCRINOL, V90, pC1, DOI 10.1016/0303-7207(92)90091-J; NAGY E, 1991, ENDOCRINOLOGY, V128, P2776, DOI 10.1210/endo-128-6-2776; NAGY E, 1981, ALLERGY, V36, P429, DOI 10.1111/j.1398-9995.1981.tb01850.x; NAGY E, 1983, ACTA ENDOCRINOL-COP, V102, P351, DOI 10.1530/acta.0.1020351; Navolotskaya EV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P357, DOI 10.1023/A:1014844718799; Nunez GG, 2005, PARASITOLOGY, V131, P255, DOI 10.1017/S0031182005007468; Nunez GG, 2002, PARASITOL RES, V88, P661, DOI 10.1007/s00436-002-0599-2; OTTAWAY CA, 1991, GASTROENTEROL CLIN N, V20, P511; Quintanar-Stephano A, 2004, NEUROIMMUNOMODULAT, V11, P233, DOI 10.1159/000078441; Quintanar-Stephano A, 2010, J PHYSIOL BIOCHEM, V66, P7, DOI 10.1007/s13105-010-0004-z; Quintanar-Stephano A, 2012, NEUROIMMUNOMODULAT, V19, P148, DOI 10.1159/000330578; REDDINGTON JJ, 1981, J PARASITOL, V67, P548, DOI 10.2307/3280489; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; Remoue F, 2001, CLIN EXP IMMUNOL, V124, P62, DOI 10.1046/j.1365-2249.2001.01495.x; SANI BP, 1985, BIOCHEM J, V232, P577, DOI 10.1042/bj2320577; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SCHOBITZ B, 1994, CRIT REV NEUROBIOL, V8, P263; Shoheib Zeinab S., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P31; Silverman MN, 2005, VIRAL IMMUNOL, V18, P41, DOI 10.1089/vim.2005.18.41; Sternberg EM, 2001, J ENDOCRINOL, V169, P429, DOI 10.1677/joe.0.1690429; Torres BA, 1997, CHEM IMMUNOL, V69, P155; WARWICKDAVIES J, 1995, J IMMUNOL, V154, P1909; WARWICKDAVIES J, 1995, INFECT IMMUN, V63, P4312, DOI 10.1128/IAI.63.11.4312-4316.1995; Webster JI, 2004, J ENDOCRINOL, V181, P207, DOI 10.1677/joe.0.1810207; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Wiegers GJ, 1998, TRENDS PHARMACOL SCI, V19, P317, DOI 10.1016/S0165-6147(98)01229-2; ZAHNER H, 1989, TROP MED PARASITOL, V40, P322	78	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59486	10.1371/journal.pone.0059486	http://dx.doi.org/10.1371/journal.pone.0059486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555042	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000316409800098
J	Rhee, S; Guerrero-Zayas, MI; Wallingford, MC; Ortiz-Pineda, P; Mager, J; Tremblay, KD				Rhee, Siyeon; Guerrero-Zayas, Mara-Isel; Wallingford, Mary C.; Ortiz-Pineda, Pablo; Mager, Jesse; Tremblay, Kimberly D.			Visceral Endoderm Expression of Yin-Yang1 (YY1) Is Required for VEGFA Maintenance and Yolk Sac Development	PLOS ONE			English	Article							YIN YANG 1; NUCLEAR FACTOR 4-ALPHA; POLYCOMB GROUP GENE; VASCULAR DEVELOPMENT; SKELETAL-MUSCLE; MOUSE EMBRYO; MICE LACKING; TRANSCRIPTION; GROWTH; GASTRULATION	Mouse embryos lacking the polycomb group gene member Yin-Yang1 (YY1) die during the peri-implantation stage. To assess the post-gastrulation role of YY1, a conditional knock-out (cKO) strategy was used to delete YY1 from the visceral endoderm of the yolk sac and the definitive endoderm of the embryo. cKO embryos display profound yolk sac defects at 9.5 days post coitum (dpc), including disrupted angiogenesis in mesoderm derivatives and altered epithelial characteristics in the visceral endoderm. Significant changes in both cell death and proliferation were confined to the YY1-expressing yolk sac mesoderm indicating that loss of YY1 in the visceral endoderm causes defects in the adjacent yolk sac mesoderm. Production of Vascular Endothelial Growth Factor A (VEGFA) by the visceral endoderm is essential for normal growth and development of the yolk sac vasculature. Reduced levels of VEGFA are observed in the cKO yolk sac, suggesting a cause for the angiogenesis defects. Ex vivo culture with exogenous VEGF not only rescued angiogenesis and apoptosis in the cKO yolk sac mesoderm, but also restored the epithelial defects observed in the cKO visceral endoderm. Intriguingly, blocking the activity of the mesoderm-localized VEGF receptor, FLK1, recapitulates both the mesoderm and visceral endoderm defects observed in the cKO yolk sac. Taken together, these results demonstrate that YY1 is responsible for maintaining VEGF in the developing visceral endoderm and that a VEGF-responsive paracrine signal, originating in the yolk sac mesoderm, is required to promote normal visceral endoderm development.	[Rhee, Siyeon; Guerrero-Zayas, Mara-Isel; Wallingford, Mary C.; Ortiz-Pineda, Pablo; Mager, Jesse; Tremblay, Kimberly D.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Tremblay, KD (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	kdtrembl@vasci.umass.edu		Ortiz-Pineda, Pablo Andres/0000-0003-3945-2023; Tremblay, Kimberly/0000-0002-3059-9910	National Institutes of Health [R01DK87753]; University of Massachusetts, Amherst; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts, Amherst; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by a grant number R01DK87753 from National Institutes of Health and start-up funds from the University of Massachusetts, Amherst to KDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Angelo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040707; Atchison Michael, 2011, Critical Reviews in Oncogenesis, V16, P143; Barbacci E, 1999, DEVELOPMENT, V126, P4795; Blattler SM, 2012, MOL CELL BIOL, V32, P3333, DOI 10.1128/MCB.00337-12; Bohnsack BL, 2004, GENE DEV, V18, P1345, DOI 10.1101/gad.1184904; BREIER G, 1995, DEV DYNAM, V204, P228, DOI 10.1002/aja.1002040303; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Byrd N, 2002, DEVELOPMENT, V129, P361; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Damert A, 2002, DEVELOPMENT, V129, P1881; de Nigris F, 2010, P NATL ACAD SCI USA, V107, P14484, DOI 10.1073/pnas.1008256107; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Duncan SA, 1997, DEVELOPMENT, V124, P279; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Griffith GJ, 2011, BIOL REPROD, V84, P654, DOI 10.1095/biolreprod.110.087213; Hayhurst GP, 2008, J HEPATOL, V49, P384, DOI 10.1016/j.jhep.2008.04.024; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Jones EAV, 2008, DEVELOPMENT, V135, P2479, DOI 10.1242/dev.014902; Koike S, 2009, J BIOL CHEM, V284, P33561, DOI 10.1074/jbc.M109.012716; Kwon HJ, 2003, BIOCHEM BIOPH RES CO, V306, P1008, DOI 10.1016/S0006-291X(03)01071-4; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Nagy A., 2003, MANIPULATING MOUSE E; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Trask MC, 2012, DEV BIOL, V368, P273, DOI 10.1016/j.ydbio.2012.05.031; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Waller-Evans H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014047; Wu S, 2009, MOL CELL BIOL, V29, P6245, DOI 10.1128/MCB.00679-09	51	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58828	10.1371/journal.pone.0058828	http://dx.doi.org/10.1371/journal.pone.0058828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554936	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800034
J	Vaithilingam, V; Fung, C; Ratnapala, S; Foster, J; Vaghjiani, V; Manuelpillai, U; Tuch, BE				Vaithilingam, Vijayaganapathy; Fung, Cherry; Ratnapala, Sabina; Foster, Jayne; Vaghjiani, Vijesh; Manuelpillai, Ursula; Tuch, Bernard E.			Characterisation of the Xenogeneic Immune Response to Microencapsulated Fetal Pig Islet-Like Cell Clusters Transplanted into Immunocompetent C57BL/6 Mice	PLOS ONE			English	Article							NEONATAL PORCINE ISLETS; NATURAL-KILLER-CELL; BETA-CELLS; XENOGRAFT REJECTION; MACROPHAGE DEPLETION; PROLONGED SURVIVAL; DIABETIC-PATIENT; NUDE-MICE; DIFFERENTIATION; ACTIVATION	Xenotransplantation of microencapsulated fetal pig islet-like cell clusters (FP ICCs) offers a potential cellular therapy for type 1 diabetes. Although microcapsules prevent direct contact of the host immune system with the xenografted tissue, poor graft survival is still an issue. This study aimed to characterise the nature of the host immune cells present on the engrafted microcapsules and effects on encapsulated FP ICCs that were transplanted into immunocompetent mice. Encapsulated FP ICCs were transplanted into the peritoneal cavity of C57BL/6 mice. Grafts retrieved at days 1, 3, 7, 14 and 21 post-transplantation were analysed for pericapsular fibrotic overgrowth (PFO), cell viability, intragraft porcine gene expression, macrophages, myofibroblasts and intraperitoneal murine cytokines. Graft function was assessed ex vivo by insulin secretion studies. Xenogeneic immune response to encapsulated FP ICCs was associated with enhanced intragraft mRNA expression of porcine antigens MIP-1 alpha, IL-8, HMGB1 and HSP90 seen within the first two weeks post-transplantation. This was associated with the recruitment of host macrophages, infiltration of myofibroblasts and collagen deposition leading to PFO which was evident from day 7 post-transplantation. This was accompanied by a decrease in cell viability and loss of FP ICC architecture. The only pro-inflammatory cytokine detected in the murine peritoneal flushing was TNF-alpha with levels peaking at day 7 post transplantation. This correlated with the onset of PFO at day 7 implying activated macrophages as its source. The anti-inflammatory cytokines detected were IL-5 and IL-4 with levels peaking at days 1 and 7, respectively. Porcine C-peptide was undetectable at all time points post-transplantation. PFO was absent and murine intraperitoneal cytokines were undetectable when empty microcapsules were transplanted. In conclusion, this study demonstrated that the macrophages are direct effectors of the xenogeneic immune response to encapsulated FP ICCs leading to PFO mediated by a combination of both pro-and anti-inflammatory cytokines.	[Vaithilingam, Vijayaganapathy; Fung, Cherry; Ratnapala, Sabina; Foster, Jayne; Tuch, Bernard E.] Univ New S Wales, Sch Med Sci, Prince Wales Hosp, Diabet Transplant Unit, Randwick, NSW, Australia; [Vaghjiani, Vijesh; Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [Vaithilingam, Vijayaganapathy; Tuch, Bernard E.] Commonwealth Sci & Ind Res Org, Mat Sci & Engn, N Ryde, NSW, Australia	University of New South Wales Sydney; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Tuch, BE (corresponding author), Univ New S Wales, Sch Med Sci, Prince Wales Hosp, Diabet Transplant Unit, Randwick, NSW, Australia.	bernie.tuch@csiro.au	Tuch, Bernard E/D-8041-2013	Vaghjiani, Vijesh/0000-0001-8004-3876	National Health and Medical Research Council (NHMRC) of Australia [455241]; Ursula Manuelpillai [606473]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ursula Manuelpillai; Victorian Government's Operational Infrastructure Support Program	This research was supported by Project Grant 455241 from the National Health and Medical Research Council (NHMRC) of Australia and Ursula Manuelpillai by 606473. Vijesh Vaghjiani and Ursula Manuelpillai are supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga A, 2001, ENDOCRINOLOGY, V142, P4314, DOI 10.1210/en.142.10.4314; Bai L, 2004, XENOTRANSPLANTATION, V11, P426, DOI 10.1111/j.1399-3089.2004.00158.x; Bai LJ, 2002, TRANSPLANTATION, V73, P714, DOI 10.1097/00007890-200203150-00010; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bottino R, 1998, DIABETES, V47, P316, DOI 10.2337/diabetes.47.3.316; Bottino R, 2007, XENOTRANSPLANTATION, V14, P74, DOI 10.1111/j.1399-3089.2006.00374.X; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Candinas D, 1996, TRANSPLANTATION, V62, P1920, DOI 10.1097/00007890-199612270-00042; COLE DR, 1992, DIABETOLOGIA, V35, P231, DOI 10.1007/BF00400922; Duvivier-Kali VF, 2004, AM J TRANSPLANT, V4, P1991, DOI 10.1111/j.1600-6143.2004.00628.x; El-Ouaghlidi A, 1999, J MOL MED, V77, P115, DOI 10.1007/s001090050315; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Foster JL, 2007, TRANSPLANTATION, V83, P1440, DOI 10.1097/01.tp.0000264555.46417.7d; GROTH CG, 1994, LANCET, V344, P1402, DOI 10.1016/S0140-6736(94)90570-3; King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L; Kobayashi T, 2005, TRANSPLANTATION, V80, P821, DOI 10.1097/01.TP.0000173773.01811.88; Kobayashi T, 2006, XENOTRANSPLANTATION, V13, P547, DOI 10.1111/j.1399-3089.2006.00349.x; Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649; KORSGREN O, 1991, DIABETOLOGIA, V34, P379, DOI 10.1007/BF00403174; Koulmanda M, 2004, XENOTRANSPLANTATION, V11, P525, DOI 10.1111/j.1399-3089.2004.00174.x; Kovarik J, 1997, TRANSPL IMMUNOL, V5, P307, DOI 10.1016/S0966-3274(97)80014-7; Krook H, 2002, DIABETES, V51, P79, DOI 10.2337/diabetes.51.1.79; Lanza RP, 1999, TRANSPLANTATION, V67, P1105, DOI 10.1097/00007890-199904270-00004; Lin Y, 1997, J IMMUNOL, V158, P5658; MORRIS CF, 1995, J IMMUNOL, V154, P2470; Omer A, 2003, XENOTRANSPLANTATION, V10, P240, DOI 10.1034/j.1399-3089.2003.01150.x; Omer A, 2003, DIABETES, V52, P69, DOI 10.2337/diabetes.52.1.69; Rayat GR, 2000, TRANSPLANTATION, V69, P1084, DOI 10.1097/00007890-200003270-00011; Reinholt FP, 1998, XENOTRANSPLANTATION, V5, P222, DOI 10.1111/j.1399-3089.1998.tb00031.x; Siebers U, 1999, J MOL MED-JMM, V77, P215, DOI 10.1007/s001090050339; Simeonovic CJ, 1999, TRANSPLANTATION, V67, P963, DOI 10.1097/00007890-199904150-00006; Solomon MF, 2003, XENOTRANSPLANTATION, V10, P164, DOI 10.1034/j.1399-3089.2003.01146.x; Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929; Trivedi N, 2001, ENDOCRINOLOGY, V142, P2115, DOI 10.1210/en.142.5.2115; Tu J, 2004, CELL TRANSPLANT, V13, P525, DOI 10.3727/000000004783983693; Tuch BE, 2001, CELL TRANSPLANT, V10, P285, DOI 10.3727/000000001783986819; Vaithilingam V, 2011, J MICROENCAPSUL, V28, P499, DOI 10.3109/02652048.2011.586067; Vaithilingam Vijayaganapathy, 2010, Rev Diabet Stud, V7, P62, DOI 10.1900/RDS.2010.7.62; VILCEK J, 1986, J EXP MED, V163, P632, DOI 10.1084/jem.163.3.632; Vo L, 2001, TRANSPLANTATION, V71, P1671, DOI 10.1097/00007890-200106150-00029; WEBER CJ, 1990, TRANSPLANTATION, V49, P396, DOI 10.1097/00007890-199002000-00034; Weinhaus AJ, 2003, J CLIN ENDOCR METAB, V88, P2753, DOI 10.1210/jc.2002-021542; Zamorano J, 2003, IMMUNOLOGIA, V22, P215	43	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59120	10.1371/journal.pone.0059120	http://dx.doi.org/10.1371/journal.pone.0059120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554983	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800060
J	Yakob, L; Clements, ACA				Yakob, Laith; Clements, Archie C. A.			A Mathematical Model of Chikungunya Dynamics and Control: The Major Epidemic on Reunion Island	PLOS ONE			English	Article							VECTOR-BORNE DISEASES; VIRUS-INFECTION; INDIAN-OCEAN; AEDES-ALBOPICTUS; MALARIA CONTROL; DENGUE; FEVER; TRANSMISSION; SURVIVAL; NUMBER	Chikungunya is a re-emerging arboviral disease transmitted by Aedes spp. mosquitoes. Although principally endemic to Africa and Asia, recent outbreaks have occurred in Europe following introductions by returning travellers. A particularly large outbreak occurred on Reunion Island in 2006, the published data from which forms the basis of the current study. A simple, deterministic mathematical model of the transmission of the virus between humans and mosquitoes was constructed and parameterised with the up-to-date literature on infection biology. The model is fitted to the large Reunion epidemic, resulting in an estimate of 4.1 for the type reproduction number of chikungunya. Although simplistic, the model provided a close approximation of both the peak incidence of the outbreak and the final epidemic size. Sensitivity analysis using Monte Carlo simulation demonstrated the strong influence that both the latent period of infection in humans and the pre-patent period have on these two epidemiological outcomes. We show why separating these variables, which are epidemiologically distinct in chikungunya infections, is not only necessary for accurate model fitting but also important in informing control.	[Yakob, Laith; Clements, Archie C. A.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of Queensland	Yakob, L (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	laith.yakob@uq.edu.au	Yakob, Laith/AAD-4521-2019; Clements, Archie/D-9619-2013; Clements, Archie/ABD-1615-2020; Yakob, Laith/B-1059-2012	Yakob, Laith/0000-0001-8639-4511; 				Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9; Boelle PY, 2008, VECTOR-BORNE ZOONOT, V8, P207, DOI 10.1089/vbz.2006.0620; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; Chhabra M, 2008, INDIAN J MED MICROBI, V26, P5, DOI 10.4103/0255-0857.38850; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313; Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x; Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1; Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x; Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3; Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630; Renault P, 2007, AM J TROP MED HYG, V77, P727; Roberts MG, 2003, P ROY SOC B-BIOL SCI, V270, P1359, DOI 10.1098/rspb.2003.2339; Robillard PY, 2006, PRESSE MED, V35, P785, DOI 10.1016/S0755-4982(06)74690-5; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623; Yakob L, 2011, BIOL LETTERS, V7, P947, DOI 10.1098/rsbl.2011.0453; Yakob L, 2011, J R SOC INTERFACE, V8, P799, DOI 10.1098/rsif.2010.0537; Yakob L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006921; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	33	77	78	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57448	10.1371/journal.pone.0057448	http://dx.doi.org/10.1371/journal.pone.0057448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23554860	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000316936100026
J	Rapsinski, GJ; Newman, TN; Oppong, GO; van Putten, JPM; Tukel, C				Rapsinski, Glenn J.; Newman, Tiffanny N.; Oppong, Gertrude O.; van Putten, Jos P. M.; Tukel, Cagla			CD14 Protein Acts as an Adaptor Molecule for the Immune Recognition of Salmonella Curli Fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; AMYLOID-BETA-PEPTIDE; ENTERICA SEROTYPE TYPHIMURIUM; CONGO-RED-BINDING; ESCHERICHIA-COLI; FIBRONECTIN-BINDING; ALZHEIMERS-DISEASE; MYCOBACTERIUM-TUBERCULOSIS; AGGREGATIVE FIMBRIAE; BACTERIAL FLAGELLIN	Amyloids, protein aggregates with a cross beta-sheet structure, contribute to inflammation in debilitating disorders, including Alzheimer's disease. Enteric bacteria also produce amyloids, termed curli, contributing to inflammation during infection. It has been demonstrated that curli and beta-amyloid are recognized by the immune system via the Toll-like receptor (TLR) 2/TLR1 complex. Here we investigated the role of CD14 in the immune recognition of bacterial amyloids. We used HeLa 57A cells, a human cervical cancer cell line containing a luciferase reporter gene under the control of an NF-kappa B promoter. When HeLa 57A cells were transiently transfected with combinations of human expression vectors containing genes for TLR2, TLR1, and CD14, membrane-bound CD14 enhanced NF-kappa B activation through the TLR2/TLR1 complex stimulated with curli fibers or recombinant CsgA, the curli major subunit. Similarly, soluble CD14 augmented the TLR2/TLR1 response to curli fibers in the absence of membrane-bound CD14. We further revealed that IL-6 and nitric oxide production were significantly higher by wild-type (C57BL/6) bone marrow-derived macrophages compared with TLR2-deficient or CD14-deficient bone marrow-derived macrophages when stimulated with curli fibers, recombinant CsgA, or synthetic CsgA peptide, CsgA-R4-5. Binding assays demonstrated that recombinant TLR2, TLR1, and CD14 bound purified curli fibers. Interestingly, CD14-curli interaction was specific to the fibrillar form of the amyloid, as demonstrated by using synthetic CsgA peptides proficient and deficient in fiber formation, respectively. Activation of the TLR2/TLR1/CD14 trimolecular complex by amyloids provides novel insights for innate immunity with implications for amyloid-associated diseases.	[Rapsinski, Glenn J.; Newman, Tiffanny N.; Oppong, Gertrude O.; Tukel, Cagla] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Utrecht University	Tukel, C (corresponding author), Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA.	ctukel@temple.edu		van Putten, Jos/0000-0002-4126-8172; Newman, Tiffanny/0000-0003-4129-5186	American Heart Association Scientist Development Grant [0835248N]; Pennsylvania Department of Health	American Heart Association Scientist Development Grant(American Heart Association); Pennsylvania Department of Health	This work was supported by American Heart Association Scientist Development Grant 0835248N and by a grant from the Pennsylvania Department of Health (to G. J. R.).	Aigelsreiter A, 2007, PATHOBIOLOGY, V74, P145, DOI 10.1159/000103374; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Alteri CJ, 2007, P NATL ACAD SCI USA, V104, P5145, DOI 10.1073/pnas.0602304104; Anas A, 2010, CRIT CARE, V14, DOI 10.1186/cc8850; Antao EM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-22; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bate C, 2004, NEUROREPORT, V15, P1427, DOI 10.1097/01.wnr.0000132203.76836.16; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Bian Z, 2000, J INFECT DIS, V181, P602, DOI 10.1086/315233; Bian Z, 2001, J INFECT DIS, V183, P612, DOI 10.1086/318528; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Castillo GM, 2000, J NEUROSCI RES, V62, P451, DOI 10.1002/1097-4547(20001101)62:3<451::AID-JNR15>3.0.CO;2-F; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Collinson SK, 1996, J BACTERIOL, V178, P662, DOI 10.1128/jb.178.3.662-667.1996; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dueholm MS, 2011, BIOCHEMISTRY-US, V50, P8281, DOI 10.1021/bi200967c; Fassbender K, 2004, FASEB J, V18, P203, DOI 10.1096/fj.03-0364fje; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Goulter-Thorsen RM, 2011, APPL ENVIRON MICROB, V77, P7339, DOI 10.1128/AEM.00277-11; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hammer ND, 2012, J MOL BIOL, V422, P376, DOI 10.1016/j.jmb.2012.05.043; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HAZIOT A, 1988, J IMMUNOL, V141, P547; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hetherington CJ, 1999, J IMMUNOL, V162, P503; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Keestra AM, 2007, J IMMUNOL, V178, P7110, DOI 10.4049/jimmunol.178.11.7110; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Leonhardt RM, 2010, J BIOL CHEM, V285, P16166, DOI 10.1074/jbc.M109.097725; Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Liu Y, 2005, BRAIN, V128, P1778, DOI 10.1093/brain/awh531; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; Mauclaire L, 2010, COLLOID SURFACE B, V76, P104, DOI 10.1016/j.colsurfb.2009.10.021; Miura T, 2002, J RAMAN SPECTROSC, V33, P530, DOI 10.1002/jrs.869; Mok KH, 2007, BIOCHEM BIOPH RES CO, V354, P1, DOI 10.1016/j.bbrc.2006.12.167; Moreno C, 2004, MICROBES INFECT, V6, P990, DOI 10.1016/j.micinf.2004.05.010; MORROW JF, 1981, P NATL ACAD SCI-BIOL, V78, P4718, DOI 10.1073/pnas.78.8.4718; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; Nenninger AA, 2011, MOL MICROBIOL, V81, P486, DOI 10.1111/j.1365-2958.2011.07706.x; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; OLSEN A, 1993, MOL MICROBIOL, V7, P523, DOI 10.1111/j.1365-2958.1993.tb01143.x; Oppong GO, 2013, INFECT IMMUN, V81, P478, DOI 10.1128/IAI.00453-12; Pan Z, 2000, J BIOL CHEM, V275, P36430, DOI 10.1074/jbc.M003192200; Pfefferkorn CM, 2010, P NATL ACAD SCI USA, V107, P21447, DOI 10.1073/pnas.1006424107; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ranoa DRE, 2013, J BIOL CHEM, V288, P9729, DOI 10.1074/jbc.M113.453266; Reed-Geaghan EG, 2010, J NEUROSCI, V30, P15369, DOI 10.1523/JNEUROSCI.2637-10.2010; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Romling U, 2003, INT J MED MICROBIOL, V293, P273, DOI 10.1078/1438-4221-00268; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schromm AB, 2010, INNATE IMMUN-LONDON, V16, P213, DOI 10.1177/1753425909339232; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x; Shu Q, 2012, P NATL ACAD SCI USA, V109, P6502, DOI 10.1073/pnas.1204161109; SJOBRING U, 1994, MOL MICROBIOL, V14, P443, DOI 10.1111/j.1365-2958.1994.tb02179.x; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Tucker HM, 2000, J NEUROSCI, V20, P3937; Tukel C, 2009, CELL HOST MICROBE, V6, P45, DOI 10.1016/j.chom.2009.05.020; Tukel C, 2005, MOL MICROBIOL, V58, P289, DOI 10.1111/j.1365-2958.2005.04825.x; Tukel C, 2010, CELL MICROBIOL, V12, P1495, DOI 10.1111/j.1462-5822.2010.01485.x; Udan MLD, 2008, J NEUROCHEM, V104, P524, DOI 10.1111/j.1471-4159.2007.05001.x; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yu WM, 1998, J IMMUNOL, V161, P4244; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4	89	37	37	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14178	14188		10.1074/jbc.M112.447060	http://dx.doi.org/10.1074/jbc.M112.447060			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548899	Green Published, hybrid			2022-12-25	WOS:000319253500022
J	Billich, A; Baumruker, T; Beerli, C; Bigaud, M; Bruns, C; Calzascia, T; Isken, A; Kinzel, B; Loetscher, E; Metzler, B; Mueller, M; Nuesslein-Hildesheim, B; Kleylein-Sohn, B				Billich, Andreas; Baumruker, Thomas; Beerli, Christian; Bigaud, Marc; Bruns, Christian; Calzascia, Thomas; Isken, Andrea; Kinzel, Bernd; Loetscher, Erika; Metzler, Barbara; Mueller, Matthias; Nuesslein-Hildesheim, Barbara; Kleylein-Sohn, Bernadette			Partial Deficiency of Sphingosine-1-Phosphate Lyase Confers Protection in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; LYMPHOCYTE SEQUESTRATION; S1P LYASE; FTY720; INHIBITION; HOMEOSTASIS; DRUG	Background: Sphingosine-I-phosphate (SIP) regulates the egress of T cells from lymphoid organs; levels of SIP in the tissues are controlled by SIP lyase (Sgpl1). Hence, Sgpl1 offers a target to block T cell-dependent inflammatory processes. However, the involvement of Sgpl1 in models of disease has not been fully elucidated yet, since Sgpl1 KO mice have a short life-span. Methodology: We generated inducible Sgpl1 KO mice featuring partial reduction of Sgpl1 activity and analyzed them with respect to sphingolipid levels, T-cell distribution, and response in models of inflammation. Principal Findings:The partially Sgpl1 deficient mice are viable but feature profound reduction of peripheral T cells, similar to the constitutive KO mice. While thymic T cell development in these mice appears normal, mature T cells are retained in thymus and lymph nodes, leading to reduced T cell numbers in spleen and blood, with a skewing towards increased proportions of memory T cells and T regulatory cells. The therapeutic relevance of Sgpl1 is demonstrated by the fact that the inducible KO mice are protected in experimental autoimmune encephalomyelitis (EAE). T cell immigration into the CNS was found to be profoundly reduced. Since SIP levels in the brain of the animals are unchanged, we conclude that protection in EAE is due to the peripheral effect on T cells, leading to reduced CNS immigration, rather than on local effects in the CNS. Significance:The data suggest Sgpl1 as a novel therapeutic target for the treatment of multiple sclerosis.	[Billich, Andreas; Baumruker, Thomas; Beerli, Christian; Bigaud, Marc; Bruns, Christian; Calzascia, Thomas; Isken, Andrea; Kinzel, Bernd; Loetscher, Erika; Metzler, Barbara; Mueller, Matthias; Nuesslein-Hildesheim, Barbara; Kleylein-Sohn, Bernadette] Novartis Inst BioMed Res, Basel, Switzerland	Novartis	Billich, A (corresponding author), Novartis Inst BioMed Res, Basel, Switzerland.	andreas.billich@novartis.com		Calzascia, Thomas/0000-0001-8225-6744				Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Bagdanoff JT, 2010, J MED CHEM, V53, P8650, DOI 10.1021/jm101183p; Bagdanoff JT, 2009, J MED CHEM, V52, P3941, DOI 10.1021/jm900278w; Bandhuvula P, 2007, J LIPID RES, V48, P2769, DOI 10.1194/jlr.D700010-JLR200; Bandhuvula P, 2011, AM J PHYSIOL-HEART C, V300, pH1753, DOI 10.1152/ajpheart.00946.2010; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Bode C, 2010, J CELL BIOCHEM, V109, P1232, DOI 10.1002/jcb.22507; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Dickson MA, 2011, CLIN CANCER RES, V17, P2484, DOI 10.1158/1078-0432.CCR-10-2323; Ettmayer P, 2004, BIOORG MED CHEM LETT, V14, P1555, DOI 10.1016/j.bmcl.2003.12.099; Feil Susanne, 2009, V530, P343, DOI 10.1007/978-1-59745-471-1_18; Fleischmann R, 2012, CURR OPIN RHEUMATOL, V24, P335, DOI 10.1097/BOR.0b013e32835190ef; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Goodman WA, 2012, CRIT REV IMMUNOL, V32, P65, DOI 10.1615/CritRevImmunol.v32.i1.40; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Jagle U, 2007, GENESIS, V45, P659, DOI 10.1002/dvg.20342; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Metzler B, 2008, INT IMMUNOL, V20, P633, DOI 10.1093/intimm/dxn023; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Pitman MR, 2010, CURR CANCER DRUG TAR, V10, P354, DOI 10.2174/156800910791208599; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sabbadini RA, 2011, BRIT J PHARMACOL, V162, P1225, DOI 10.1111/j.1476-5381.2010.01118.x; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sehrawat S, 2008, J IMMUNOL, V180, P7636, DOI 10.4049/jimmunol.180.11.7636; Serra M, 2010, ADV ENZYME REGUL, V50, P349, DOI 10.1016/j.advenzreg.2009.10.024; Swan DJ, 2010, J CELL MOL MED, V14, P2211, DOI 10.1111/j.1582-4934.2010.01136.x; VANVELDHOVEN PP, 1993, ADV LIPID RES, V26, P69; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O; Youm JK, 2008, J DERMATOL SCI, V51, P89, DOI 10.1016/j.jdermsci.2008.03.002; Yu XQ, 2010, XENOBIOTICA, V40, P350, DOI 10.3109/00498251003611376; Zhao YT, 2011, AM J RESP CELL MOL, V45, P426, DOI 10.1165/rcmb.2010-0422OC	44	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59630	10.1371/journal.pone.0059630	http://dx.doi.org/10.1371/journal.pone.0059630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544080	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700040
J	Truchon, MH; Measures, L; L'Herault, V; Brethes, JC; Galbraith, PS; Harvey, M; Lessard, S; Starr, M; Lecomte, N				Truchon, Marie-Helene; Measures, Lena; L'Herault, Vincent; Brethes, Jean-Claude; Galbraith, Peter S.; Harvey, Michel; Lessard, Sylvie; Starr, Michel; Lecomte, Nicolas			Marine Mammal Strandings and Environmental Changes: A 15-Year Study in the St. Lawrence Ecosystem	PLOS ONE			English	Article							RECENT CLIMATE-CHANGE; SEA-ICE; ALEXANDRIUM-TAMARENSE; CETACEAN STRANDINGS; HUDSON-BAY; BAFFIN-BAY; VARIABILITY; ESTUARY; WHALES; CANADA	Understanding the effects of climatic variability on marine mammals is challenging due to the complexity of ecological interactions. We used general linear models to analyze a 15-year database documenting marine mammal strandings (1994 2008; n=1,193) and nine environmental parameters known to affect marine mammal survival, from regional (sea ice) to continental scales (North Atlantic Oscillation, NAO). Stranding events were more frequent during summer and fall than other seasons, and have increased since 1994. Poor ice conditions observed during the same period may have affected marine mammals either directly, by modulating the availability of habitat for feeding and breeding activities, or indirectly, through changes in water conditions and marine productivity (krill abundance). For most species (75%, n = 6 species), a low volume of ice was correlated with increasing frequency of stranding events (e.g. R-adj(2)=0.59, hooded seal, Cystophora cristata). This likely led to an increase in seal mortality during the breeding period, but also to increase habitat availability for seasonal migratory cetaceans using ice-free areas during winter. We also detected a high frequency of stranding events for mysticete species (minke whale, Balaenoptera acutorostrata) and resident species (beluga, Delphinapterus leucas), correlated with low krill abundance since 1994. Positive NAO indices were positively correlated with high frequencies of stranding events for resident and seasonal migratory cetaceans, as well as rare species (R-adj(2)=0.53, 0.81 and 0.34, respectively). This contrasts with seal mass stranding numbers, which were negatively correlated with a positive NAO index. In addition, an unusual multiple species mortality event (n=114, 62% of total annual mortality) in 2008 was caused by a harmful algal bloom. Our findings provide an empirical baseline in understanding marine mammal survival when faced with climatic variability. This is a promising step in integrating stranding records to monitor the consequences of environmental changes in marine ecosystems over long time scales.	[Truchon, Marie-Helene; L'Herault, Vincent; Lecomte, Nicolas] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Measures, Lena; Galbraith, Peter S.; Harvey, Michel; Lessard, Sylvie; Starr, Michel] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Dept Fisheriesand Oceans, Mont Joli, PQ G5H 3Z4, Canada; [Brethes, Jean-Claude] Univ Quebec, Inst Sci Mer, Rimouski, PQ G5L 3A1, Canada; [Lecomte, Nicolas] Govt Nunavut, Dept Environm, Igloolik, NU, Canada	University of Quebec; Fisheries & Oceans Canada; University of Quebec	Truchon, MH (corresponding author), Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada.	marie-helene_truchon@uqar.qc.ca; nlecomte@gov.nu.ca	Galbraith, Peter/B-3797-2012	Galbraith, Peter/0000-0002-5587-6881; Lecomte, Nicolas/0000-0002-8473-5375	Fisheries and Oceans Canada	Fisheries and Oceans Canada	This research was funded by Fisheries and Oceans Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, CONTRIBUTION WORKING; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Blasco D, 2003, SCI MAR, V67, P261, DOI 10.3989/scimar.2003.67n3261; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bowen W. Donald, 1999, P423; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cotte C, 2005, MAR ECOL PROG SER, V288, P199, DOI 10.3354/meps288199; Cyr F, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007359; DFO, 2003, DFO CAN SCI ADV SECR, V2003/031; DFO, 2007, REV IC COND POT IMP; Doniol-Valcroze T, 2007, MAR ECOL PROG SER, V335, P207, DOI 10.3354/meps335207; Doucette GJ, 2006, MAR ECOL PROG SER, V306, P303, DOI 10.3354/meps306303; Evans K, 2005, BIOL LETT-UK, V1, P147, DOI 10.1098/rsbl.2005.0313; Evans PGH, 2010, J MAR BIOL ASSOC UK, V90, P1483, DOI 10.1017/S0025315410001815; Fauchot J, 2005, J PHYCOL, V41, P263, DOI 10.1111/j.1529-8817.2005.03092.x; Ferguson SH, 2005, MAR MAMMAL SCI, V21, P121, DOI 10.1111/j.1748-7692.2005.tb01212.x; Ferguson SH, 2010, MAR ECOL PROG SER, V411, P285, DOI 10.3354/meps08652; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; Forchhammer MC, 2004, POPUL ECOL, V46, P1, DOI 10.1007/s10144-004-0176-x; Galbraith PS, 2012, DEEP-SEA RES PT II, V77-80, P10, DOI 10.1016/j.dsr2.2012.04.001; Galbraith PS, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003159; Galbraith PS, 2011, TECHNICAL REPORT; Geraci JR, 2005, MARINE MAMMALS ASHOR, P113; Gilbert DBP, 1997, CAN J FISH AQUAT S1, V54; Harvey M, 2008, TECHNICAL REPORT; Harvey M, 2009, PROG OCEANOGR, V80, P1, DOI 10.1016/j.pocean.2008.09.001; Hemery G, 2008, GLOBAL CHANGE BIOL, V14, P27, DOI 10.1111/j.1365-2486.2007.01471.x; Higdon JW, 2009, ECOL APPL, V19, P1365, DOI 10.1890/07-1941.1; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; IUCN, 2019, IUCN RED LIST THREAT; Johnston DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029158; Johnston DW, 2005, CLIM RES, V29, P209, DOI 10.3354/cr029209; Koutitonsky V.G., 1991, CAN SPEC PUBL FISH A, V113, P57; Le Boeuf B. J., 2000, Journal of Cetacean Research and Management, V2, P85; Leeney RH, 2008, BIODIVERS CONSERV, V17, P2323, DOI 10.1007/s10531-008-9377-5; Lesage V, 2007, TECHNICAL REPORT; MacLeod CD, 2005, BIOL CONSERV, V124, P477, DOI 10.1016/j.biocon.2005.02.004; Maldini Daniela, 2005, Pacific Science, V59, P55, DOI 10.1353/psc.2005.0009; Marchand C, 1999, CAN J FISH AQUAT SCI, V56, P1832, DOI 10.1139/cjfas-56-10-1832; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; Mitchell MR, 2002, CAN TEC REP HYDROG O, V23; Moore JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052770; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Murase H, 2002, POLAR BIOL, V25, P135, DOI 10.1007/s003000100321; Mysak LA, 1996, ATMOS OCEAN, V34, P313, DOI 10.1080/07055900.1996.9649567; Nemiroff L, 2010, CAN FIELD NAT, V124, P32, DOI 10.22621/cfn.v124i1.1027; Norman S. A., 2004, Journal of Cetacean Research and Management, V6, P87; Plourde S, 2011, J PLANKTON RES, V33, P703, DOI 10.1093/plankt/fbq144; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; R Core Team, 2022, R LANG ENV STAT COMP; Savenkoff C, 2007, ESTUAR COAST SHELF S, V73, P711, DOI 10.1016/j.ecss.2007.03.011; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Sears RJ, 1990, REPORT INT WHALING C, P335; Simard Y, 1999, CAN J FISH AQUAT SCI, V56, P1182, DOI 10.1139/cjfas-56-7-1182; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stern HL, 2003, POLAR RES, V22, P11, DOI 10.1111/j.1751-8369.2003.tb00090.x; Taylor M, 2003, HABITAT DEGRADATION, P12; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weise AM, 2002, CAN J FISH AQUAT SCI, V59, P464, DOI 10.1139/F02-024; Zar JH, 1999, BIOSTATISTICAL ANAL	63	25	27	1	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59311	10.1371/journal.pone.0059311	http://dx.doi.org/10.1371/journal.pone.0059311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544059	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700021
J	Kwak, K; Jiang, R; Jagu, S; Wang, JW; Wang, CG; Christensen, ND; Roden, RBS				Kwak, Kihyuck; Jiang, Rosie; Jagu, Subhashini; Wang, Joshua W.; Wang, Chenguang; Christensen, Neil D.; Roden, Richard B. S.			Multivalent Human Papillomavirus L1 DNA Vaccination Utilizing Electroporation	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; CAPSID PROTEIN EXPRESSION; IN-VIVO; ESCHERICHIA-COLI; SKELETAL-MUSCLE; TYPE-16 L1; L2; HPV; ANTIBODIES; NEUTRALIZATION	Objectives: Naked DNA vaccines can be manufactured simply and are stable at ambient temperature, but require improved delivery technologies to boost immunogenicity. Here we explore in vivo electroporation for multivalent codon-optimized human papillomavirus (HPV) L1 and L2 DNA vaccination. Methods: Balb/c mice were vaccinated three times at two week intervals with a fusion protein comprising L2 residues similar to 11-88 of 8 different HPV types (11-88x8) or its DNA expression vector, DNA constructs expressing L1 only or L1+L2 of a single HPV type, or as a mixture of several high-risk HPV types and administered utilizing electroporation, i.m. injection or gene gun. Serum was collected two weeks and 3 months after the last vaccination. Sera from immunized mice were tested for in-vitro neutralization titer, and protective efficacy upon passive transfer to naive mice and vaginal HPV challenge. Heterotypic interactions between L1 proteins of HPV6, HPV16 and HPV18 in 293TT cells were tested by co-precipitation using type-specific monoclonal antibodies. Results: Electroporation with L2 multimer DNA did not elicit detectable antibody titer, whereas DNA expressing L1 or L1+L2 induced L1-specific, type-restricted neutralizing antibodies, with titers approaching those induced by Gardasil. Co-expression of L2 neither augmented L1-specific responses nor induced L2-specific antibodies. Delivery of HPV L1 DNA via in vivo electroporation produces a stronger antibody response compared to i.m. injection or i.d. ballistic delivery via gene gun. Reduced neutralizing antibody titers were observed for certain types when vaccinating with a mixture of L1 (or L1+L2) vectors of multiple HPV types, likely resulting from heterotypic L1 interactions observed in co-immunoprecipitation studies. High titers were restored by vaccinating with individual constructs at different sites, or partially recovered by co-expression of L2, such that durable protective antibody titers were achieved for each type. Discussion: Multivalent vaccination via in vivo electroporation requires spatial separation of individual type L1 DNA vaccines.	[Kwak, Kihyuck; Jiang, Rosie; Jagu, Subhashini; Wang, Joshua W.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Wang, Chenguang] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Christensen, Neil D.] Penn State Univ, Dept Pathol, Hershey, PA USA; [Christensen, Neil D.] Penn State Univ, Dept Microbiol, Hershey, PA USA; [Christensen, Neil D.] Penn State Univ, Dept Immunol, Hershey, PA USA	Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.	roden@jhmi.edu	Kwak, Kihyuck/Y-4377-2018	Kwak, Kihyuck/0000-0002-7386-9589	US Public Health Service [CA118790, P50 CA098252]; Shantha Biotechnics Ltd.; Sanofi Pasteur; GlaxoSmithKline; NATIONAL CANCER INSTITUTE [R01CA118790, R01CA047622] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Shantha Biotechnics Ltd.; Sanofi Pasteur; GlaxoSmithKline(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by US Public Health Service grants CA118790 and P50 CA098252 (grants.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. Subhashini Jagu and Richard Roden are co-inventors on L2 patents (20090047301 Papillomavirus L2 N-Terminal Peptides for the Induction of Broadly Cross-Neutralizing Antibodies and 20100297144 MULTITYPE HPV PEPTIDE COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION) licensed to Shantha Biotechnics Ltd., GlaxoSmithKline, PaxVax, Inc. and Acambis, Inc and have received research funding from Shantha Biotechnics Ltd., Sanofi Pasteur and GlaxoSmithKline and Richard Roden is a founder of Papivax LLC. The terms of these arrangements are managed by Johns Hopkins University in accordance with its conflict of interest policies. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abdulhaqq SA, 2008, IMMUNOL RES, V42, P219, DOI 10.1007/s12026-008-8076-3; Bagarazzi ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004414; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; Bronnimann MP, 2013, J VIROL, V87, P464, DOI 10.1128/JVI.01539-12; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Buonamassa DT, 2002, VIROLOGY, V293, P335, DOI 10.1006/viro.2001.1289; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Campo MS, 1997, VIROLOGY, V234, P261, DOI 10.1006/viro.1997.8649; Chen HS, 2010, VIROLOGY, V405, P289, DOI 10.1016/j.virol.2010.05.019; Chen XJS, 2001, J MOL BIOL, V307, P173, DOI 10.1006/jmbi.2000.4464; Christensen ND, 1996, VIROLOGY, V224, P477, DOI 10.1006/viro.1996.0554; Christensen ND, 1996, VIROLOGY, V223, P174, DOI 10.1006/viro.1996.0466; Cristillo AD, 2011, J GEN VIROL, V92, P128, DOI 10.1099/vir.0.023242-0; Cukjati D, 2007, BIOELECTROCHEMISTRY, V70, P501, DOI 10.1016/j.bioelechem.2006.11.001; Day PM, 2010, CELL HOST MICROBE, V8, P260, DOI 10.1016/j.chom.2010.08.003; Dolter KE, 2011, VACCINE, V29, P795, DOI 10.1016/j.vaccine.2010.11.011; Donnelly JJ, 1996, J INFECT DIS, V173, P314, DOI 10.1093/infdis/173.2.314; Finnen RL, 2003, J VIROL, V77, P4818, DOI 10.1128/JVI.77.8.4818-4826.2003; Fleury MJJ, 2009, PROTEIN SCI, V18, P1425, DOI 10.1002/pro.156; Fuller DH, 2006, METHODS, V40, P86, DOI 10.1016/j.ymeth.2006.05.022; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gasparic M, 2007, VACCINE, V25, P4540, DOI 10.1016/j.vaccine.2007.04.001; Geraets D., 2012, J PATHOLOGY; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hitzeroth II, 2009, VACCINE, V27, P6432, DOI 10.1016/j.vaccine.2009.06.015; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jagu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055538; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kim D, 2008, VACCINE, V26, P351, DOI 10.1016/j.vaccine.2007.11.019; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Leder C, 2001, J VIROL, V75, P9201, DOI 10.1128/JVI.75.19.9201-9209.2001; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Li ML, 1997, J VIROL, V71, P2988, DOI 10.1128/JVI.71.4.2988-2995.1997; Liu WJ, 2001, VACCINE, V20, P862, DOI 10.1016/S0264-410X(01)00406-6; Longet S, 2011, J VIROL, V85, P13253, DOI 10.1128/JVI.06093-11; Low L, 2009, HUM GENE THER, V20, P1269, DOI 10.1089/hum.2009.067; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Luxembourg A, 2006, VACCINE, V24, P4490, DOI 10.1016/j.vaccine.2005.08.014; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Moscicki Anna-Barbara, 2010, Adolesc Med State Art Rev, V21, P347; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Nardelli-Haefliger D, 1999, J VIROL, V73, P9609, DOI 10.1128/JVI.73.11.9609-9613.1999; Nieto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039741; Okun MM, 2001, J VIROL, V75, P4332, DOI 10.1128/JVI.75.9.4332-4342.2001; Otten G, 2004, VACCINE, V22, P2489, DOI 10.1016/j.vaccine.2003.11.073; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Peng BW, 2005, BIOCHEM BIOPH RES CO, V338, P1490, DOI 10.1016/j.bbrc.2005.10.111; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; RODEN RBS, 1994, J VIROL, V68, P7570, DOI 10.1128/JVI.68.11.7570-7574.1994; Roden RBS, 1996, J VIROL, V70, P5875, DOI 10.1128/JVI.70.9.5875-5883.1996; Roden RBS, 1996, J VIROL, V70, P3298, DOI 10.1128/JVI.70.5.3298-3301.1996; ROSE RC, 1993, J VIROL, V67, P1936, DOI 10.1128/JVI.67.4.1936-1944.1993; ROSE RC, 1994, J GEN VIROL, V75, P2445, DOI 10.1099/0022-1317-75-9-2445; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Schadlich L, 2009, J VIROL, V83, P7690, DOI 10.1128/JVI.02588-08; Schadlicha L, 2009, VACCINE, V27, P1511, DOI 10.1016/j.vaccine.2009.01.014; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Schiller JT, 2009, J INFECT DIS, V200, P166, DOI 10.1086/599988; Senger T, 2009, J VIROL, V83, P12692, DOI 10.1128/JVI.01582-09; Smith JF, 2007, HUM VACCINES, V3, P109, DOI 10.4161/hv.3.4.4058; Steele KE, 2001, VET PATHOL, V38, P203, DOI 10.1354/vp.38-2-203; Sundaram P, 1998, VACCINE, V16, P613, DOI 10.1016/S0264-410X(97)84510-0; Trollet C, 2006, CURR GENE THER, V6, P561, DOI 10.2174/156652306778520656; Tumban E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023310; Ulmer JB, 1999, VACCINE, V18, P18, DOI 10.1016/S0264-410X(99)00151-6; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999	78	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60507	10.1371/journal.pone.0060507	http://dx.doi.org/10.1371/journal.pone.0060507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536912	gold, Green Published, Green Submitted			2022-12-25	WOS:000317397200060
J	Liu, C; Qi, X; Zhao, Q; Yu, JJ				Liu, Chen; Qi, Xin; Zhao, Qian; Yu, Jingjuan			Characterization and Functional Analysis of the Potato Pollen-Specific Microtubule-Associated Protein SBgLR in Tobacco	PLOS ONE			English	Article							ELONGATION FACTOR-1-ALPHA; CORTICAL MICROTUBULES; GENE; PROMOTERS; CLONING; GROWTH; DOMAIN; ALPHA; SHAPE; MOR1	Microtubule-associated proteins play a crucial role in the regulation of microtubule dynamics, and are very important for plant cell and organ development. SBgLR is a potato pollen-specific protein, with five imperfect V-V-E-K-K-N/E-E repetitive motifs that are responsible for microtubule binding activity. In present study, SBgLR showed typical microtubule-associated protein characteristics; it bound tubulin and microtubules, and colocalized with microtubules in vitro. We also found that SBgLR could form oligomers, and that both the SBgLR monomers and oligomers bundle microtubules in vitro. Constitutive expression of SBgLR in tobacco caused curving and right-handed twisting root growth, abnormal directional cell expansion and cell layer arrangement, and pollen abortion. Immunofluorescence staining assays revealed that microtubule organization is altered in root epidermal cells in SBgLR-overexpressing lines. These suggest that SBgLR functions as a microtubule-associated protein in pollen development. Our results indicate that normal organization of MTs may be crucial for pollen development.	[Liu, Chen; Qi, Xin; Zhao, Qian; Yu, Jingjuan] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Yu, JJ (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	yujj@cau.edu.cn			National Natural Science Foundation of China [30971555]; National Transgenic Major Program of China [2011ZX003-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Major Program of China	This work was supported by National Natural Science Foundation of China (Grant No. 30971555), National Transgenic Major Program of China (Grant no. 2011ZX003-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdrakhamanova A, 2003, PLANT CELL PHYSIOL, V44, P676, DOI 10.1093/pcp/pcg097; Burk DH, 2002, PLANT CELL, V14, P2145, DOI 10.1105/tpc.003947; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Clore AM, 1996, PLANT CELL, V8, P2003, DOI 10.2307/3870408; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; HARDHAM AR, 1978, J CELL BIOL, V77, P14, DOI 10.1083/jcb.77.1.14; Hashimoto T, 2003, CURR OPIN PLANT BIOL, V6, P568, DOI 10.1016/j.pbi.2003.09.011; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huang SL, 2007, PLANT J, V51, P406, DOI 10.1111/j.1365-313X.2007.03153.x; Ishida T, 2007, J PLANT RES, V120, P61, DOI 10.1007/s10265-006-0039-y; JIANG CJ, 1993, J CELL SCI, V105, P891; Kumagai F, 1995, BOT ACTA, V108, P467, DOI 10.1111/j.1438-8677.1995.tb00523.x; LANCELLE SA, 1986, PROTOPLASMA, V131, P153, DOI 10.1007/BF01285037; Lang ZH, 2004, PLANT SCI, V166, P1227, DOI 10.1016/j.plantsci.2003.12.036; Lang ZH, 2008, PLANTA, V227, P387, DOI 10.1007/s00425-007-0625-9; Liu JQ, 1997, PLANT MOL BIOL, V33, P291, DOI 10.1023/A:1005746713759; Lloyd C, 2004, NAT REV MOL CELL BIO, V5, P13, DOI 10.1038/nrm1277; Mathur J, 2002, CURR BIOL, V12, pR669, DOI 10.1016/S0960-9822(02)01164-8; Mayer U, 2002, CURR OPIN PLANT BIOL, V5, P494, DOI 10.1016/S1369-5266(02)00302-3; Mineyuki Y, 2007, J PLANT RES, V120, P45, DOI 10.1007/s10265-006-0063-y; Moore RC, 2000, CELL MOTIL CYTOSKEL, V45, P279, DOI 10.1002/(SICI)1097-0169(200004)45:4<279::AID-CM4>3.3.CO;2-W; Moore RC, 1998, CELL MOTIL CYTOSKEL, V41, P168, DOI 10.1002/(SICI)1097-0169(1998)41:2<168::AID-CM7>3.0.CO;2-A; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; Perrin RM, 2007, PLANT J, V49, P961, DOI 10.1111/j.1365-313X.2006.03015.x; Sedbrook JC, 2004, PLANT CELL, V16, P1506, DOI 10.1105/tpc.020644; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; Sivaguru M, 2003, PLANT CELL PHYSIOL, V44, P667, DOI 10.1093/pcp/pcg094; Smertenko AP, 2004, PLANT CELL, V16, P2035, DOI 10.1105/tpc.104.023937; Smith LG, 2003, CURR OPIN PLANT BIOL, V6, P63, DOI 10.1016/S1369-5266(02)00012-2; TWELL D, 1989, PLANT PHYSIOL, V91, P1270, DOI 10.1104/pp.91.4.1270; Twell D, 2002, NAT CELL BIOL, V4, P711, DOI 10.1038/ncb844; VANDERLEEDEPLEGT LM, 1992, PLANT CELL REP, V11, P20, DOI 10.1007/BF00231833; Wang X, 2007, PLANT CELL, V19, P877, DOI 10.1105/tpc.106.048579; Wasteneys GO, 2009, TRENDS CELL BIOL, V19, P62, DOI 10.1016/j.tcb.2008.11.004; Wasteneys GO, 2003, PLANT CELL PHYSIOL, V44, P653, DOI 10.1093/pcp/pcg103; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Wilkinson JE, 1997, J EXP BOT, V48, P265, DOI 10.1093/jxb/48.2.265; Wu YR, 2010, P NATL ACAD SCI USA, V107, P12810, DOI 10.1073/pnas.1004721107; Yao M, 2008, J CELL SCI, V121, P2372, DOI 10.1242/jcs.030221; Yasuhara H, 2002, PLANT CELL PHYSIOL, V43, P595, DOI 10.1093/pcp/pcf074; [赵倩 Zhao Qian], 2004, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V20, P275; Zhao Y, 2006, PLANTA, V224, P405, DOI 10.1007/s00425-006-0226-z	42	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60543	10.1371/journal.pone.0060543	http://dx.doi.org/10.1371/journal.pone.0060543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536914	Green Submitted, Green Published, gold			2022-12-25	WOS:000317397200062
J	Schwarzkopf, DS; Rees, G				Schwarzkopf, D. Samuel; Rees, Geraint			Subjective Size Perception Depends on Central Visual Cortical Magnification in Human V1	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; EBBINGHAUS ILLUSION; GABA CONCENTRATION; RECEPTIVE-FIELDS; SIMILARITY; FREQUENCY; REPRESENTATION; PREDICTS; AREAS	In the Ebbinghaus illusion, the context surrounding an object modulates its subjectively perceived size. Previous work implicates human primary visual cortex (V1) as the neural substrate mediating this contextual effect. Here we studied in healthy adult humans how two different types of context (large or small inducers) in this illusion affected size perception by comparing each to a reference stimulus without any context. We found that individual differences in the magnitudes of the illusion produced by either type of context were correlated with V1 area defined through retinotopic mapping using functional MRI. However, participants' objective ability to discriminate the size of objects presented in isolation was unrelated to illusion strength and did not correlate with V1 area. Control analyses showed no correlations between behavioral measures and the overall V1 area estimated probabilistically on the basis of neuroanatomy alone. Therefore, subjective size perception correlated with variability in central cortical magnification rather than the anatomical extent of primary visual cortex. We propose that such changes in subjective perception of size are mediated by mechanisms that scale with the extent to which an individual's V1 selectively represents the central visual field.	[Schwarzkopf, D. Samuel; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Schwarzkopf, D. Samuel; Rees, Geraint] UCL, Inst Cognit Neurosci, London, England; [Schwarzkopf, D. Samuel] UCL, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Schwarzkopf, DS (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	s.schwarzkopf@ucl.ac.uk	Rees, Geraint/C-1493-2008	Rees, Geraint/0000-0002-9623-7007	Wellcome Trust; Wellcome Trust [091593/Z/10/Z]; Wellcome Trust [100227/Z/12/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Senior Clinical Research Fellowship to GR. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Benson NC, 2012, CURR BIOL, V22, P2081, DOI 10.1016/j.cub.2012.09.014; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Choplin JM, 1999, PERCEPT PSYCHOPHYS, V61, P3, DOI 10.3758/BF03211944; COREN S, 1979, PERCEPTION, V8, P303, DOI 10.1068/p080303; COREN S, 1993, PERCEPT PSYCHOPHYS, V54, P579, DOI 10.3758/BF03211782; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delboeuf J., 1892, B ACAD ROYALE BELGIQ, V24, P545; Deni JR, 1997, PERCEPT MOTOR SKILL, V84, P1171, DOI 10.2466/pms.1997.84.3c.1171; Doherty MJ, 2010, DEVELOPMENTAL SCI, V13, P714, DOI 10.1111/j.1467-7687.2009.00931.x; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Ebbinghaus H, 1902, GRUNDZUUGE PSYCHOL L; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gaetz W, 2011, HUMAN BRAIN MAPPING; Harvey BM, 2011, J NEUROSCI, V31, P13604, DOI 10.1523/JNEUROSCI.2572-11.2011; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Hughes M, 2010, J VISION, V10, P954, DOI [DOI 10.1167/10.7.954, 10.1167/10.7.954]; Lee S, 2012, 42 ANN M SOC NEUR NE, V723.08; Muise JG, 1997, PERCEPT MOTOR SKILL, V85, P1203, DOI 10.2466/pms.1997.85.3f.1203; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Palmer CR, 2012, J NEUROPHYSIOL, V107, P1857, DOI 10.1152/jn.00117.2011; Pelt van S, 2012, 42 ANN M SOC NEUR NE, V570.20; Phillips WA, 2004, PERCEPTION, V33, P79, DOI 10.1068/p5110; Ress D., 2011, J VIS, V11, P1197, DOI DOI 10.1167/11.11.1197; Roberts B, 2005, PERCEPTION, V34, P847, DOI 10.1068/p5273; Rose D, 2002, SPATIAL VISION, V15, P191, DOI 10.1163/15685680252875165; Schwarzkopf DS, 2012, J NEUROSCI, V32, P1507, DOI 10.1523/JNEUROSCI.4771-11.2012; Schwarzkopf DS, 2011, NAT NEUROSCI, V14, P28, DOI 10.1038/nn.2706; Schwarzkopf DS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00200; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Silverstein SM, 2011, SCHIZOPHRENIA BULL, V37, P690, DOI 10.1093/schbul/sbr052; Song C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-27; Sperandio I, 2012, NAT NEUROSCI, V15, P540, DOI 10.1038/nn.3069; Sperandio I, 2012, J VISION, V12, DOI 10.1167/12.2.18; Thelen L., 2010, J VIS, V10, P487, DOI DOI 10.1167/10.7.487; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x; Zuiderbaan W, 2012, J VISION, V12, DOI 10.1167/12.3.10	43	53	56	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60550	10.1371/journal.pone.0060550	http://dx.doi.org/10.1371/journal.pone.0060550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536915	Green Published, gold, Green Submitted			2022-12-25	WOS:000317397200063
J	Sender, V; Lang, LD; Stamme, C				Sender, Vicky; Lang, Linda; Stamme, Cordula			Surfactant Protein-A Modulates LPS-Induced TLR4 Localization and Signaling via beta-Arrestin 2	PLOS ONE			English	Article							KAPPA-B-ALPHA; TOLL-LIKE RECEPTORS; ALVEOLAR MACROPHAGES; PULMONARY SURFACTANT; GOLGI-APPARATUS; INFLAMMATORY RESPONSE; CELLULAR-RESPONSE; LIPOPOLYSACCHARIDE; MICE; EXPRESSION	The soluble C-type lectin surfactant protein (SP)-A mediates lung immune responses partially via its direct effects on alveolar macrophages (AM), the main resident leukocytes exposed to antigens. SP-A modulates the AM threshold of lipopolysaccharide (LPS) activity towards an anti-inflammatory phenotype both in vitro and in vivo through various mechanisms. LPS responses are tightly regulated via distinct pathways including subcellular TLR4 localization and thus ligand sensing. The cytosolic scaffold and signaling protein beta-arrestin 2 acts as negative regulator of LPS-induced TLR4 activation. Here we show that SP-A neither increases TLR4 abundancy nor co-localizes with TLR4 in primary AM. SP-A significantly reduces the LPS-induced co-localization of TLR4 with the early endosome antigen (EEA) 1 by promoting the co-localization of TLR4 with the post-Golgi compartment marker Vti1b in freshly isolated AM from rats and wild-type (WT) mice, but not in beta-arrestin 2(-/-) AM. Compared to WT mice pulmonary LPS-induced TNF-alpha release in beta-arrestin 2(-/-) mice is accelerated and enhanced and exogenous SP-A fails to inhibit both lung LPS-induced TNF-alpha release and TLR4/EEA1 positioning. SP-A, but not LPS, enhances beta-arrestin 2 protein expression in a time-dependent manner in primary rat AM. The constitutive expression of beta-arrestin 2 in AM from SP-A(-/-) mice is significantly reduced compared to SP-A(+/+) mice and is rescued by SP-A. Prolonged endosome retention of LPS-induced TLR4 in AM from SP-A(-/-) mice is restored by exogenous SP-A, and is antagonized by beta-arrestin 2 blocking peptides. LPS induces beta-arrestin 2/TLR4 association in primary AM which is further enhanced by SP-A. The data demonstrate that SP-A modulates LPS-induced TLR4 trafficking and signaling in vitro and in vivo engaging beta-arrestin 2.	[Sender, Vicky; Lang, Linda; Stamme, Cordula] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Cellular Pneumol, Borstel, Germany; [Stamme, Cordula] Univ Hosp Lubeck, Dept Anesthesiol, Lubeck, Germany	Forschungszentrum Borstel; University of Lubeck	Stamme, C (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Cellular Pneumol, Borstel, Germany.	cstamme@fz-borstel.de		Sender, Vicky/0000-0003-2174-946X	German Research Council (DFG) [609/2-1]	German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Council (DFG, Grant 609/2-1 to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2004, AM J PHYSIOL-LUNG C, V286, pL129, DOI 10.1152/ajplung.00427.2002; [Anonymous], GLOB BURD DIS 2004 U; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; Crowther JE, 2006, AM J PHYSIOL-LUNG C, V290, pL334, DOI 10.1152/ajplung.00267.2005; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; Fan HK, 2007, MOL IMMUNOL, V44, P3092, DOI 10.1016/j.molimm.2007.02.009; Fan HK, 2010, IMMUNOLOGY, V130, P344, DOI 10.1111/j.1365-2567.2009.03185.x; GALANOS C, 1975, EUR J BIOCHEM, V54, P603, DOI 10.1111/j.1432-1033.1975.tb04172.x; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; George CLS, 2008, INFECT IMMUN, V76, P380, DOI 10.1128/IAI.01043-07; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Juarez E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-2; Kagan JC, 2010, IMMUNITY, V33, P578, DOI 10.1016/j.immuni.2010.10.003; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lattin JE, 2009, MOL IMMUNOL, V47, P340, DOI 10.1016/j.molimm.2009.09.012; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; LeVine AM, 2001, MICROBES INFECT, V3, P161, DOI 10.1016/S1286-4579(00)01363-0; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Li G, 2002, AM J RESP CELL MOL, V26, P277, DOI 10.1165/ajrcmb.26.3.4584; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Moulakakis C, 2007, J IMMUNOL, V179, P4480, DOI 10.4049/jimmunol.179.7.4480; Moulakakis C, 2009, AM J PHYSIOL-LUNG C, V296, pL430, DOI 10.1152/ajplung.90458.2008; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Porter KJ, 2010, J CELL PHYSIOL, V225, P406, DOI 10.1002/jcp.22289; Progida C, 2010, J CELL SCI, V123, P1480, DOI 10.1242/jcs.051474; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramadas RA, 2009, J IMMUNOL, V182, P1560, DOI 10.4049/jimmunol.182.3.1560; Sano H, 1999, J IMMUNOL, V163, P387; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Sender V, 2011, J IMMUNOL, V186, P2397, DOI 10.4049/jimmunol.1002446; Stamme C, 2002, AM J RESP CELL MOL, V27, P353, DOI 10.1165/rcmb.4812; Stamme C, 2000, AM J RESP CELL MOL, V23, P772, DOI 10.1165/ajrcmb.23.6.4083; Thieblemont N, 1999, J EXP MED, V190, P523, DOI 10.1084/jem.190.4.523; Thorley AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021827; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wang Y, 2007, BLOOD, V110, P952; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; WRIGHT JR, 1987, J BIOL CHEM, V262, P2888; Wu YD, 2004, AM J RESP CELL MOL, V31, P587, DOI 10.1165/rcmb.2004-0003OC; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Zhang MF, 2010, DEV BIOL, V339, P407, DOI 10.1016/j.ydbio.2009.12.042	52	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59896	10.1371/journal.pone.0059896	http://dx.doi.org/10.1371/journal.pone.0059896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536892	gold, Green Published, Green Submitted			2022-12-25	WOS:000317397200040
J	Feuth, T; Arends, JE; Fransen, JH; Nanlohy, NM; van Erpecum, KJ; Siersema, PD; Hoepelman, AIM; van Baarle, D				Feuth, Thijs; Arends, Joop E.; Fransen, Justin H.; Nanlohy, Nening M.; van Erpecum, Karel J.; Siersema, Peter D.; Hoepelman, Andy I. M.; van Baarle, Debbie			Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; CHRONIC VIRAL-INFECTION; TRANSCRIPTION FACTOR; MICROBIAL TRANSLOCATION; IMMUNE ACTIVATION; PERIPHERAL-BLOOD; EXPRESSION; RESPONSES	Objectives: To investigate whether T-cell activation and exhaustion is linked to HCV- and HIV disease parameters in HIV/HCV infected individuals, we studied T-cell characteristics in HIV/HCV coinfected patients and controls. Methods: 14 HIV/HCV coinfected, 19 HCV monoinfected, 10 HIV monoinfected patients and 15 healthy controls were included in this cross-sectional study. Differences in expression of activation and exhaustion markers (HLA-DR, CD38, PD-1, Tim-3 and Fas) and phenotypic markers on CD4(+) and CD8(+) T-cells were analysed by flow cytometry and were related to HCV disease parameters (HCV-viremia, ALT and liver fibrosis). Results: Frequencies of activated CD4(+) and CD8(+) T-cells were higher in HIV/HCV-coinfected compared to healthy controls and HCV or HIV mono-infected individuals. Coinfected patients also showed high expression of the exhaustion marker PD-1 and death receptor Fas. In contrast, the exhaustion marker Tim-3 was only elevated in HIV-monoinfected patients. T-cell activation and exhaustion were correlated with HCV-RNA, suggesting that viral antigen influences T-cell activation and exhaustion. Interestingly, increased percentages of effector CD8(+) T-cells were found in patients with severe (F3-F4) liver fibrosis compared to those with no to minimal fibrosis (F0-F2). Conclusions: HIV/HCV coinfected patients display a high level of T-cell activation and exhaustion in the peripheral blood. Our data suggest that T-cell activation and exhaustion are influenced by the level of HCV viremia. Furthermore, high percentages of cytotoxic/effector CD8(+) T-cells are associated with liver fibrosis in both HCV monoinfected and HIV/HCV coinfected patients.	[Feuth, Thijs; Arends, Joop E.; Fransen, Justin H.; Hoepelman, Andy I. M.; van Baarle, Debbie] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Fransen, Justin H.; Nanlohy, Nening M.; van Baarle, Debbie] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands; [van Erpecum, Karel J.; Siersema, Peter D.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Baarle, D (corresponding author), Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands.	dvanbaarle@umcutrecht.nl	Siersema, Peter/V-1636-2019; Feuth, Thijs/F-6264-2013	Feuth, Thijs/0000-0001-6691-556X				Al-Harthi L, 2006, J INFECT DIS, V193, P1202, DOI 10.1086/500843; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Ando K, 1997, J IMMUNOL, V158, P5283; Arends JE, 2011, APOPTOSIS, V16, P959, DOI 10.1007/s10495-011-0620-2; Arends JE, 2010, ANTIVIR RES, V87, P353, DOI 10.1016/j.antiviral.2010.06.002; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bonacini M, 1999, J VIRAL HEPATITIS, V6, P203, DOI 10.1046/j.1365-2893.1999.00153.x; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Capa L, 2007, J MED VIROL, V79, P503, DOI 10.1002/jmv.20856; Costantini A, 2003, J IMMUNOL METHODS, V278, P145, DOI 10.1016/S0022-1759(03)00202-3; Deeks Steven G, 2009, Top HIV Med, V17, P118; Dianzani U, 2003, CURR HIV RES, V1, P405, DOI 10.2174/1570162033485131; Dutoit V, 2005, EUR J IMMUNOL, V35, P3493, DOI 10.1002/eji.200535035; Fowke KR, 2000, J IMMUNOL METHODS, V244, P139, DOI 10.1016/S0022-1759(00)00263-5; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; He XS, 1999, P NATL ACAD SCI USA, V96, P5692, DOI 10.1073/pnas.96.10.5692; Heydtmann M, 2006, J IMMUNOL, V177, P729, DOI 10.4049/jimmunol.177.1.729; Hiroishi K, 1997, HEPATOLOGY, V25, P705, DOI 10.1002/hep.510250336; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Kang WZ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-102; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kaufmann GR, 2000, RAPID RESTORATION CD; Kim AY, 2006, PLOS MED, V3, P2324, DOI 10.1371/journal.pmed.0030492; Klenerman P, 2012, GUT, V61, P1226, DOI 10.1136/gutjnl-2011-300620; Kondo Y, 2009, J INFECT DIS, V199, P726, DOI 10.1086/596739; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Mehal W, 2010, SEMIN LIVER DIS, V30, P226, DOI 10.1055/s-0030-1255352; MINUTELLO MA, 1993, J EXP MED, V178, P17, DOI 10.1084/jem.178.1.17; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Neumann-Haefelin C, 2008, HEPATOLOGY, V47, P1824, DOI 10.1002/hep.22242; Nunez M, 2006, CLIN INFECT DIS, V43, P1209, DOI 10.1086/508355; Page EE, 2011, CURR OPIN HIV AIDS, V6, P472, DOI 10.1097/COH.0b013e32834bbc71; Rallon NI, 2011, JAIDS-J ACQ IMM DEF, V57, P1, DOI 10.1097/QAI.0b013e31821024e7; Rockstroh JK, 2004, LANCET INFECT DIS, V4, P437, DOI 10.1016/S1473-3099(04)01059-X; Roe B, 2009, VIRAL IMMUNOL, V22, P39, DOI 10.1089/vim.2008.0074; Sandberg JK, 2010, VIRULENCE, V1, P177, DOI 10.4161/viru.1.3.11206; SHERMAN KE, 1993, J CLIN MICROBIOL, V31, P2679, DOI 10.1128/JCM.31.10.2679-2682.1993; Sosner P, 2012, ATHEROSCLEROSIS, V222, P274, DOI 10.1016/j.atherosclerosis.2012.02.027; Spengler U, 2007, CLIN SCI, V112, P141, DOI 10.1042/CS20060171; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Valdez H, 2002, AIDS, V16, P1859, DOI 10.1097/00002030-200209270-00002; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; Vrisekoop N, 2008, J IMMUNOL, V181, P1573, DOI 10.4049/jimmunol.181.2.1573; Watanabe T, 2010, J VIRAL HEPATITIS, V17, P453, DOI 10.1111/j.1365-2893.2010.01313.x; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004	48	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59302	10.1371/journal.pone.0059302	http://dx.doi.org/10.1371/journal.pone.0059302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555014	Green Submitted, Green Published, gold			2022-12-25	WOS:000316409800082
J	Lilja, AM; Rojdner, J; Mustafiz, T; Thome, CM; Storelli, E; Gonzalez, D; Unger-Lithner, C; Greig, NH; Nordberg, A; Marutle, A				Lilja, Anna M.; Rojdner, Jennie; Mustafiz, Tamanna; Thome, Carina M.; Storelli, Elisa; Gonzalez, Daniel; Unger-Lithner, Christina; Greig, Nigel H.; Nordberg, Agneta; Marutle, Amelia			Age-Dependent Neuroplasticity Mechanisms in Alzheimer Tg2576 Mice Following Modulation of Brain Amyloid-beta Levels	PLOS ONE			English	Article							NEURAL STEM-CELLS; TRANSGENIC MICE; A-BETA; HIPPOCAMPAL NEUROGENESIS; NEUROTROPHIC-FACTOR; PRECURSOR PROTEIN; MOUSE MODEL; DISEASE; INFLAMMATION; PEPTIDE	The objective of this study was to investigate the effects of modulating brain amyloid-beta (A beta) levels at different stages of amyloid pathology on synaptic function, inflammatory cell changes and hippocampal neurogenesis, i.e. processes perturbed in Alzheimer's disease (AD). Young (4- to 6-month-old) and older (15- to 18-month-old) APP(SWE) transgenic (Tg2576) mice were treated with the AD candidate drug (+)-phenserine for 16 consecutive days. We found significant reductions in insoluble A beta 1-42 levels in the cortices of both young and older transgenic mice, while significant reductions in soluble A beta 1-42 levels and insoluble A beta 1-40 levels were only found in animals aged 15-18 months. Autoradiography binding with the amyloid ligand Pittsburgh Compound B (H-3-PIB) revealed a trend for reduced fibrillar A beta deposition in the brains of older phenserine-treated Tg2576 mice. Phenserine treatment increased cortical synaptophysin levels in younger mice, while decreased interleukin-1 beta and increased monocyte chemoattractant protein-1 and tumor necrosis factor-alpha levels were detected in the cortices of older mice. The reduction in A beta 1-42 levels was associated with an increased number of bromodeoxyuridine-positive proliferating cells in the hippocampi of both young and older Tg2576 mice. To determine whether the increased cell proliferation was accompanied by increased neuronal production, the endogenous early neuronal marker doublecortin (DCX) was examined in the dentate gyrus (DG) using immunohistochemical detection. Although no changes in the total number of DCX+-expressing neurons were detected in the DG in Tg2576 mice at either age following (+)-phenserine treatment, dendritic arborization was increased in differentiating neurons in young Tg2576 mice. Collectively, these findings indicate that reducing A beta 1-42 levels in Tg2576 mice at an early pathological stage affects synaptic function by modulating the maturation and plasticity of newborn neurons in the brain. In contrast, lowering A beta levels in Tg2576 mice when Ab plaque pathology is prominent mainly alters the levels of proinflammatory cytokines and chemokines.	[Lilja, Anna M.; Rojdner, Jennie; Mustafiz, Tamanna; Thome, Carina M.; Storelli, Elisa; Gonzalez, Daniel; Unger-Lithner, Christina; Nordberg, Agneta; Marutle, Amelia] Karolinska Inst, Alzheimer Neurobiol Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Rojdner, Jennie; Nordberg, Agneta] Karolinska Univ, Huddinge Hosp, Dept Geriatr Med, Stockholm, Sweden; [Greig, Nigel H.] NIA, Drug Design & Dev Sect, Neurosci Lab, Intramural Res Program,NIH, Baltimore, MD 21224 USA	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Marutle, A (corresponding author), Karolinska Inst, Alzheimer Neurobiol Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	amelia.marutle@ki.se	nordberg, agneta/ABD-2479-2021	Unger Lithner, Christina/0000-0001-9775-0411; Storelli, Elisa/0000-0002-5515-4803; Gonzalez, Daniel/0000-0002-3919-1380; Nordberg, Agneta/0000-0001-7345-5151	Swedish Medical Research Council [05817]; Stockholm County Council-Karolinska Institutet; Karolinska Institutet Strategic Neuroscience Program; Swedish Brain Power; Brain Foundation; European Union; Gun and Bertil Stohne's Foundation; Foundation for Old Servants; Magnus Bergvall's Foundation; Dementia Association; Lars Hierta Memorial Foundation; Olle Engkvist Byggmastare Foundation; Karolinska Institutet Foundations; Johnson & Johnson administered through the Karolinska Institutet; Alzheimer Association Sweden; Karolinska Institutet for Funding for new doctoral students at Karolinska Institutet (KID); Erik and Edith Fernstrom's Foundation; Intramural Research Program, National Institute on Aging, National Institutes of Health; Torrey pines Therapeutics; GSK; Wyeth; Novartis; Pfizer; GE Healthcare; Johnson Johnson; NATIONAL INSTITUTE ON AGING [ZIAAG000311] Funding Source: NIH RePORTER	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm County Council-Karolinska Institutet(Stockholm County Council); Karolinska Institutet Strategic Neuroscience Program; Swedish Brain Power; Brain Foundation; European Union(European Commission); Gun and Bertil Stohne's Foundation; Foundation for Old Servants; Magnus Bergvall's Foundation; Dementia Association; Lars Hierta Memorial Foundation; Olle Engkvist Byggmastare Foundation; Karolinska Institutet Foundations(Karolinska Institutet); Johnson & Johnson administered through the Karolinska Institutet; Alzheimer Association Sweden; Karolinska Institutet for Funding for new doctoral students at Karolinska Institutet (KID); Erik and Edith Fernstrom's Foundation; Intramural Research Program, National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Torrey pines Therapeutics; GSK(GlaxoSmithKline); Wyeth(Wyeth); Novartis(Novartis); Pfizer(Pfizer); GE Healthcare(General ElectricGE Healthcare); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Swedish Medical Research Council (Project no. 05817), the Stockholm County Council-Karolinska Institutet (ALF grant), the Karolinska Institutet Strategic Neuroscience Program, Swedish Brain Power, the Brain Foundation, the INMiND consortium (Imaging of Neuroinflammation in Neurodegenerative Diseases) under the Seventh Research Framework Program of the European Union, Gun and Bertil Stohne's Foundation, the Foundation for Old Servants, Magnus Bergvall's Foundation, The Dementia Association, The Lars Hierta Memorial Foundation, the Olle Engkvist Byggmastare Foundation, Karolinska Institutet Foundations, an academic grant from Johnson & Johnson administered through the Karolinska Institutet, and the Alzheimer Association Sweden. AML was supported by a long-term scholarship from the Karolinska Institutet for Funding for new doctoral students at Karolinska Institutet (KID), a grant from Erik and Edith Fernstrom's Foundation, and a stipend from Gun and Bertil Stohne's Foundation. NHG was supported by the Intramural Research Program, National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Agneta Nordberg is PI for clinical trials sponsored by Torrey pines Therapeutics, GSK, Wyeth, and has been a consultant for AstraZeneca, served on the advisory board for Elan, Pfizer, GSK, Novartis, Lundbeck AB, GE Health Care, and received honorarium for lectures from Novartis, Jansen-Cilag, Pfizer, Merck and received research grants from Novartis, Pfizer, GE Healthcare, Johnson & Johnson. The experimental Alzheimer drugs, (2)- phenserine and (+)phenserine, both derive from Nigel H. Greig's research and are covered in patents that have been assigned to the National Institutes of Health and Dr. Greig has no ownership of these patents. None of the other authors have any conflicts of interest and potential competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Battaglia F, 2007, BIOL PSYCHIAT, V62, P1405, DOI 10.1016/j.biopsych.2007.02.027; Biscaro B, 2009, J NEUROSCI, V29, P14108, DOI 10.1523/JNEUROSCI.2055-09.2009; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; Burger C, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00140; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Chohan MO, 2011, NEUROBIOL AGING, V32, P1420, DOI 10.1016/j.neurobiolaging.2009.08.008; Combs CK, 2001, J NEUROSCI, V21, P1179; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Greig Nigel H., 2005, Current Alzheimer Research, V2, P281, DOI 10.2174/1567205054367829; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; HATTORI A, 1993, J BIOL CHEM, V268, P2577; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Hellstrom-Lindahl E, 2004, EUR J NEUROSCI, V19, P2703, DOI 10.1111/j.1460-9568.2004.03377.x; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Johnson AE, 2009, J NEUROCHEM, V108, P1177, DOI 10.1111/j.1471-4159.2008.05861.x; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Kadir A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.015; Kaneko N, 2006, NEUROPSYCHOPHARMACOL, V31, P2619, DOI 10.1038/sj.npp.1301137; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kuhn HG, 2007, EUR ARCH PSY CLIN N, V257, P281, DOI 10.1007/s00406-007-0732-4; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lindberg C, 2005, J MOL NEUROSCI, V27, P1, DOI 10.1385/JMN:27:1:001; Lithner CU, 2011, CURR ALZHEIMER RES, V8, P818; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Maccecchini ML, 2012, J NEUROL NEUROSUR PS, V83, P894, DOI 10.1136/jnnp-2012-302589; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morrens J, 2012, GLIA, V60, P159, DOI 10.1002/glia.21247; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Perry EK, 2012, NEUROBIOL DIS, V47, P155, DOI 10.1016/j.nbd.2012.03.033; Poon WW, 2011, NEUROBIOL AGING, V32, P821, DOI 10.1016/j.neurobiolaging.2009.05.012; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rockenstein E, 2011, J ALZHEIMERS DIS, V27, P743, DOI 10.3233/JAD-2011-110914; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; Russo I, 2011, J NEUROCHEM, V116, P947, DOI 10.1111/j.1471-4159.2010.07168.x; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Zhang C, 2007, EXP NEUROL, V204, P77, DOI 10.1016/j.expneurol.2006.09.018; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	65	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58752	10.1371/journal.pone.0058752	http://dx.doi.org/10.1371/journal.pone.0058752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554921	gold, Green Published, Green Submitted			2022-12-25	WOS:000316409800027
J	Radziwon-Balicka, A; de la Rosa, CM; Zielnik, B; Doroszko, A; Jurasz, P				Radziwon-Balicka, Aneta; de la Rosa, Cesar Moncada; Zielnik, Barbara; Doroszko, Adrian; Jurasz, Paul			Temporal and Pharmacological Characterization of Angiostatin Release and Generation by Human Platelets: Implications for Endothelial Cell Migration	PLOS ONE			English	Article							GROWTH-FACTOR; ANGIOGENESIS INHIBITOR; ALPHA-GRANULES; PROTEINS; PROSTACYCLIN; PLASMINOGEN; ACTIVATION; ENDOSTATIN; APOPTOSIS; VEGF	Platelets play an important role in thrombosis and in neo-vascularisation as they release and produce factors that both promote and suppress angiogenesis. Amongst these factors is the angiogenesis inhibitor angiostatin, which is released during thrombus formation. The impact of anti-thrombotic agents and the kinetics of platelet angiostatin release are unknown. Hence, our objectives were to characterize platelet angiostatin release temporally and pharmacologically and to determine how angiostatin release influences endothelial cell migration, an early stage of angiogenesis. We hypothesized anti-platelet agents would suppress angiostatin release but not generation by platelets. Human platelets were aggregated and temporal angiostatin release was compared to vascular endothelial growth factor (VEGF). Immuno-gold electron microscopy and immunofluorescence microscopy identified a-granules as storage organelles of platelet angiostatin. Acetylsalicylic acid, MRS2395, GPIIb/IIIa blocking peptide, and aprotinin were used to characterize platelet angiostatin release and generation. An endothelial cell migration assay was performed under hypoxic conditions to determine the effects of pharmacological platelet and angiostatin inhibition. Compared to VEGF, angiostatin generation and release from a-granules occurred later temporally during platelet aggregation. Consequently, collagen-activated platelet releasates stimulated endothelial cell migration more potently than maximally-aggregated platelets. Platelet inhibitors prostacyclin, S-nitroso-glutathione, acetylsalicylic acid, and GPIIb/IIIa blocking peptide, but not a P2Y12 inhibitor, suppressed angiostatin release but not generation. Suppression of angiostatin generation in the presence of acetylsalicylic acid enhanced platelet-stimulated endothelial migration. Hence, the temporal and pharmacological modulation of platelet angiostatin release may have significant consequences for neo-vascularization following thrombus formation.	[Radziwon-Balicka, Aneta; de la Rosa, Cesar Moncada; Zielnik, Barbara; Jurasz, Paul] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada; [Jurasz, Paul] Univ Alberta, Dept Pharmacol, Fac Med & Dent, Edmonton, AB, Canada; [Radziwon-Balicka, Aneta; de la Rosa, Cesar Moncada; Jurasz, Paul] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Doroszko, Adrian] Wroclaw Med Univ, Dept Internal Med Occupat Dis & Hypertens, Wroclaw, Poland	University of Alberta; University of Alberta; University of Alberta; Wroclaw Medical University	Jurasz, P (corresponding author), Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.	Jurasz@ualberta.ca	Radziwon-Balicka, Aneta/AAA-3787-2021	Doroszko, Adrian/0000-0001-5472-028X; Radziwon-Balicka, Aneta/0000-0002-5123-5710	Heart and Stroke Foundation of Alberta; NWT; Nunavut; Canadian Institutes of Health Research [MOP-102948]; Alberta Cancer Foundation	Heart and Stroke Foundation of Alberta; NWT; Nunavut; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation	This work is supported by a grant-in aid from the Heart and Stroke Foundation of Alberta, NWT, and Nunavut and operating grant from the Canadian Institutes of Health Research [MOP-102948] to P.J. C. M. R. is supported by a studentship from the Alberta Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirkhosravi A, 1999, PLATELETS, V10, P285; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; Claesson-Welsh L, 1998, P NATL ACAD SCI USA, V95, P5579, DOI 10.1073/pnas.95.10.5579; Falcone DJ, 1998, J BIOL CHEM, V273, P31480, DOI 10.1074/jbc.273.47.31480; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Folkman J, 2008, ANGIOGENESIS INTEGRA; Gately S, 1996, CANCER RES, V56, P4887; Griscelli F, 1998, P NATL ACAD SCI USA, V95, P6367, DOI 10.1073/pnas.95.11.6367; Hagberg IA, 1999, PLATELETS, V10, P382; Hanford HA, 2003, CANCER RES, V63, P4275; Howell N, 2012, J THOR IN PRESS 0810; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Ji WDR, 1998, FASEB J, V12, P1731, DOI 10.1096/fasebj.12.15.1731; Jurasz P, 2006, J THROMB HAEMOST, V4, P1095, DOI 10.1111/j.1538-7836.2006.01878.x; Jurasz P, 2011, ANGIOGENESIS, V14, P199, DOI 10.1007/s10456-011-9204-6; Jurasz P, 2010, THROMB RES, V125, P53, DOI 10.1016/j.thromres.2009.04.005; Kamykowski J, 2011, BLOOD, V118, P1370, DOI 10.1182/blood-2011-01-330910; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; Ma L, 2001, P NATL ACAD SCI USA, V98, P6470, DOI 10.1073/pnas.111150798; MENTER DG, 1987, JNCI-J NATL CANCER I, V78, P961; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Radomski A, 2002, BRIT J PHARMACOL, V137, P1330, DOI 10.1038/sj.bjp.0704936; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P181, DOI 10.1111/j.1476-5381.1987.tb11310.x; Radziwon-Balicka A, 2012, VASC PHARM IN PRESS; Radziwon-Balicka A, 2012, CAN J PHYSIOL PHARM, V90, P679, DOI [10.1139/Y2012-036, 10.1139/y2012-036]; Sharma MR, 2004, J CELL BIOCHEM, V91, P398, DOI 10.1002/jcb.10762; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Veitonmaki N, 2004, CANCER RES, V64, P3679, DOI 10.1158/0008-5472.CAN-03-1754; Zhang C, 2012, BLOOD IN PRESS  0724	32	12	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59281	10.1371/journal.pone.0059281	http://dx.doi.org/10.1371/journal.pone.0059281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555012	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800080
J	Abromaitis, S; Nelson, CS; Previte, D; Yoon, KS; Clark, JM; DeRisi, JL; Koehler, JE				Abromaitis, Stephanie; Nelson, Christopher S.; Previte, Domenic; Yoon, Kyong S.; Clark, J. Marshall; DeRisi, Joseph L.; Koehler, Jane E.			Bartonella quintana Deploys Host and Vector Temperature-Specific Transcriptomes	PLOS ONE			English	Article							DNA MICROARRAY ANALYSIS; RICKETTSIA-QUINTANA; GENE-EXPRESSION; ESCHERICHIA-COLI; STATIONARY-PHASE; BODY LICE; VIRULENCE; SYSTEM; HENSELAE; FAMILY	The bacterial pathogen Bartonella quintana is passed between humans by body lice. B. quintana has adapted to both the human host and body louse vector niches, producing persistent infection with high titer bacterial loads in both the host (up to 10(5) colony-forming units [CFU]/ml) and vector (more than 10(8) CFU/ml). Using a novel custom microarray platform, we analyzed bacterial transcription at temperatures corresponding to the host (37 degrees C) and vector (28 degrees C), to probe for temperature-specific and growth phase-specific transcriptomes. We observed that transcription of 7% (93 genes) of the B. quintana genome is modified in response to change in growth phase, and that 5% (68 genes) of the genome is temperature-responsive. Among these transcriptional changes in response to temperature shift and growth phase was the induction of known B. quintana virulence genes and several previously unannotated genes. Hemin binding proteins, secretion systems, response regulators, and genes for invasion and cell attachment were prominent among the differentially-regulated B. quintana genes. This study represents the first analysis of global transcriptional responses by B. quintana. In addition, the in vivo experiments provide novel insight into the B. quintana transcriptional program within the body louse environment. These data and approaches will facilitate study of the adaptation mechanisms employed by Bartonella during the transition between human host and arthropod vector.	[Abromaitis, Stephanie; Koehler, Jane E.] Univ Calif San Francisco, Microbial Pathogenesis & Host Def Program, San Francisco, CA 94143 USA; [Abromaitis, Stephanie; Koehler, Jane E.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA; [Nelson, Christopher S.; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Nelson, Christopher S.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Previte, Domenic; Yoon, Kyong S.; Clark, J. Marshall] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [DeRisi, Joseph L.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Amherst; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Koehler, JE (corresponding author), Univ Calif San Francisco, Microbial Pathogenesis & Host Def Program, San Francisco, CA 94143 USA.	jkoehler@medicine.ucsf.edu		Nelson, Christopher/0000-0002-5608-2338; Yoon, Kyong/0000-0002-1866-1339	Grand Challenges Explorations Phase 1 grant; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; California HIV Research Program Award; National Institutes of Health (NIH) from the National Institute of Allergy and Infectious Diseases (NIAID) [R01AI52813]; NIH [T32A1007641];  [1R56AI081933-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052813, R56AI081933] Funding Source: NIH RePORTER	Grand Challenges Explorations Phase 1 grant; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); California HIV Research Program Award; National Institutes of Health (NIH) from the National Institute of Allergy and Infectious Diseases (NIAID); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JDR is a Howard Hughes Medical Institute Investigator (http://www.hhmi.org/research/investigators/).The work was funded in part by a Grand Challenges Explorations Phase 1 grant (http://www.grandchallenges.org/Explorations/Pages/Introduction.aspx) to JDR. JEK received funding support from a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research (http://www.bwfund.org/pages/177/Clinical-Scientist-Awards-in-TranslationalResearch/), a California HIV Research Program Award (http://www.californiaaidsresearch.org/), and National Institutes of Health (NIH) grant R01AI52813 from the National Institute of Allergy and Infectious Diseases (NIAID). SA was supported by NIH grant T32A1007641. JMC, KSY and DP were supported by 1R56AI081933-01A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audia JP, 2008, APPL ENVIRON MICROB, V74, P7809, DOI 10.1128/AEM.00896-08; Bachman MA, 2001, MOL MICROBIOL, V40, P1201, DOI 10.1046/j.1365-2958.2001.02465.x; Battisti JM, 2006, INFECT IMMUN, V74, P3251, DOI 10.1128/IAI.00245-06; BENZ I, 1992, MOL MICROBIOL, V6, P1539, DOI 10.1111/j.1365-2958.1992.tb00875.x; Bonilla DL, 2009, EMERG INFECT DIS, V15, P912, DOI 10.3201/eid1506.090054; CULPEPPER GH, 1946, J ECON ENTOMOL, V39, P472, DOI 10.1093/jee/39.4.472; Dreher-Lesnick SM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-61; Eicher SC, 2012, CELL MICROBIOL, V14, P1166, DOI 10.1111/j.1462-5822.2012.01806.x; Ellison DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005612; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Foucault C, 2002, CLIN INFECT DIS, V35, P684, DOI 10.1086/342065; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Gillaspie D, 2009, APPL ENVIRON MICROB, V75, P5434, DOI 10.1128/AEM.00949-09; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Greub G, 2004, EMERG INFECT DIS, V2, P35; Han YP, 2004, MICROBIOL IMMUNOL, V48, P791, DOI 10.1111/j.1348-0421.2004.tb03605.x; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; ITO S, 1965, J BACTERIOL, V89, P481, DOI 10.1002/path.1700890205; Knoten CA, 2011, J BACTERIOL, V193, P6567, DOI 10.1128/JB.05803-11; KOEHLER JE, 1992, NEW ENGL J MED, V327, P1625, DOI 10.1056/NEJM199212033272303; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; Lynch T, 2011, J CLIN MICROBIOL, V49, P1363, DOI 10.1128/JCM.02403-10; Maggi RG, 2005, J CLIN MICROBIOL, V43, P2651, DOI 10.1128/JCM.43.6.2651-2655.2005; Mangan MW, 2006, MOL MICROBIOL, V59, P1831, DOI 10.1111/j.1365-2958.2006.05062.x; Minnick MF, 2003, INFECT IMMUN, V71, P814, DOI 10.1128/IAI.71.2.814-821.2003; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; MYERS WF, 1972, J BACTERIOL, V109, P89, DOI 10.1128/JB.109.1.89-95.1972; MYERS WF, 1969, J BACTERIOL, V97, P663, DOI 10.1128/JB.97.2.663-666.1969; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; O'Rourke KP, 2010, J BACTERIOL, V192, P1433, DOI 10.1128/JB.01161-09; Pulliainen AT, 2012, FEMS MICROBIOL REV, V36, P563, DOI 10.1111/j.1574-6976.2012.00324.x; Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Riess T, 2008, APPL ENVIRON MICROB, V74, P5224, DOI 10.1128/AEM.00621-08; Roden JA, 2012, INFECT IMMUN; Sander A, 2000, FEMS MICROBIOL LETT, V189, P55, DOI 10.1111/j.1574-6968.2000.tb09205.x; Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x; Seki N, 2007, AM J TROP MED HYG, V77, P562, DOI 10.4269/ajtmh.2007.77.562; Sherlock O, 2006, J BACTERIOL, V188, P1798, DOI 10.1128/JB.188.5.1798-1807.2006; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946; VINSON JW, 1969, AM J TROP MED HYG, V18, P713, DOI 10.4269/ajtmh.1969.18.713; WIGGLESWORTH V. B., 1941, PARASITOLOGY, V33, P67, DOI 10.1017/S0031182000024288; WU JH, 1993, J BIOL CHEM, V268, P52; Yoon KS, 2006, PESTIC BIOCHEM PHYS, V86, P195, DOI 10.1016/j.pestbp.2006.04.001; Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101; Zhao HY, 2010, MICROBIOL-SGM, V156, P385, DOI 10.1099/mic.0.033548-0	51	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58773	10.1371/journal.pone.0058773	http://dx.doi.org/10.1371/journal.pone.0058773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554923	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500041
J	Monzen, S; Yoshino, H; Kasai-Eguchi, K; Kashiwakura, I				Monzen, Satoru; Yoshino, Hironori; Kasai-Eguchi, Kiyomi; Kashiwakura, Ikuo			Characteristics of Myeloid Differentiation and Maturation Pathway Derived from Human Hematopoietic Stem Cells Exposed to Different Linear Energy Transfer Radiation Types	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; IN-VITRO; MEGAKARYOCYTOPOIESIS; EXPRESSION; THROMBOPOIESIS; POPULATIONS; PROGENITOR; BASOPHILS; BIOLOGY; CD14	Exposure of hematopoietic stem/progenitor cells (HSPCs) to ionizing radiation causes a marked suppression of mature functional blood cell production in a linear energy transfer (LET)- and/or dose-dependent manner. However, little information about LET effects on the proliferation and differentiation of HSPCs has been reported. With the aim of characterizing the effects of different types of LET radiations on human myeloid hematopoiesis, in vitro hematopoiesis in Human CD34(+) cells exposed to carbon-ion beams or X-rays was compared. Highly purified CD34(+) cells exposed to each form of radiation were plated onto semi-solid culture for a myeloid progenitor assay. The surviving fractions of total myeloid progenitors, colony-forming cells (CFC), exposed to carbon-ion beams were significantly lower than of those exposed to Xrays, indicating that CFCs are more sensitive to carbon-ion beams (D-0 = 0.65) than to X-rays (D-0 = 1.07). Similar sensitivities were observed in granulocyte-macrophage and erythroid progenitors, respectively. However, the sensitivities of mixed-type progenitors to both radiation types were similar. In liquid culture for 14 days, no significant difference in total numbers of mononuclear cells was observed between non-irradiated control culture and cells exposed to 0.5 Gy X-rays, whereas 0.5 Gy carbon-ion beams suppressed cell proliferation to 4.9% of the control, a level similar to that for cells exposed to 1.5 Gy Xrays. Cell surface antigens associated with terminal maturation, such as CD13, CD14, and CD15, on harvest from the culture of X-ray-exposed cells were almost the same as those from the non-irradiated control culture. X-rays increased the CD235a(+) erythroid-related fraction, whereas carbon-ion beams increased the CD34(+)CD38(-) primitive cell fraction and the CD13(+)CD14(+/-)CD15(-) fraction. These results suggest that carbon-ion beams inflict severe damage on the clonal growth of myeloid HSPCs, although the intensity of cell surface antigen expression by mature myeloid cells derived from HSPCs exposed to each type of radiation was similar to that by controls.	[Monzen, Satoru; Yoshino, Hironori; Kashiwakura, Ikuo] Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiol Life Sci, Hirosaki, Aomori, Japan; [Kasai-Eguchi, Kiyomi] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Radiat Effect Mech Res Grp, Chiba 260, Japan	Hirosaki University; National Institutes for Quantum Science & Technology	Kashiwakura, I (corresponding author), Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiol Life Sci, Hirosaki, Aomori, Japan.	ikashi@cc.hirosaki-u.ac.jp	Yoshino, Hironori/E-7961-2013; Monzen, Satoru/AAF-9870-2021; monzen, satoru/F-1468-2013; Kashiwakura, Ikuo/F-2080-2013	Yoshino, Hironori/0000-0003-2705-9929; Monzen, Satoru/0000-0003-2436-8048; monzen, satoru/0000-0003-2436-8048; 	Ministry of Education, Culture, Sports, Science and Technology, Japan [23791382, 21390336]; Grant for Co-medical Education Program in Radiation Emergency Medicine by the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grant for Hirosaki University Institutional Research, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant for Co-medical Education Program in Radiation Emergency Medicine by the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grant for Hirosaki University Institutional Research, Japan	This work was supported by KAKENHI, Grant-in-Aid for Young Scientists (B) (No. 23791382 SM), Grant-in-Aid for Scientific Research (B; No. 21390336 IK), and Grant for Co-medical Education Program in Radiation Emergency Medicine by the Ministry of Education, Culture, Sports, Science and Technology, Japan (2011). This work also received support from a Grant for Hirosaki University Institutional Research, Japan (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arock M, 2002, J LEUKOCYTE BIOL, V71, P557; Edvardsson L, 2006, EXP HEMATOL, V34, P599, DOI 10.1016/j.exphem.2006.01.017; Gorczyca W, 2011, METHOD CELL BIOL, V103, P221, DOI 10.1016/B978-0-12-385493-3.00010-3; Goussetis E, 2000, J HEMATOTH STEM CELL, V9, P827, DOI 10.1089/152581600750062255; Gros A, 2012, CLIN CANCER RES, V18, P5212, DOI 10.1158/1078-0432.CCR-12-1108; Hirayama R, 2009, RADIAT RES, V171, P212, DOI 10.1667/RR1490.1; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Kadhim MA, 1998, ADV SPACE RES, V22, P587, DOI 10.1016/S0273-1177(98)00081-7; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Karnchanaphanurach P, 2009, J CLIN INVEST, V119, P788, DOI 10.1172/JCI36088; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Krause DS, 1996, BLOOD, V87, P1; Lee JCM, 2004, BLOOD, V103, P1912, DOI 10.1182/blood-2003-03-0928; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; Liu HC, 2007, J FORMOS MED ASSOC, V106, P365, DOI 10.1016/S0929-6646(09)60321-1; Monks TJ, 2006, DRUG METAB REV, V38, P755, DOI 10.1080/03602530600959649; Monzen S, 2011, RADIAT RES, V176, P716, DOI 10.1667/RR2725.1; Monzen S, 2011, RADIAT RES, V176, P8, DOI 10.1667/RR2392.1; Monzen S, 2009, J RADIAT RES, V50, P477, DOI 10.1269/jrr.09058; Nagayama H, 2002, BONE MARROW TRANSPL, V29, P197, DOI 10.1038/sj.bmt.1703356; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Petzer AL, 1996, P NATL ACAD SCI USA, V93, P1470, DOI 10.1073/pnas.93.4.1470; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Reimer JM, 2006, ALLERGY, V61, P1063, DOI 10.1111/j.1398-9995.2006.01149.x; Ricceri F, 2011, DNA REPAIR, V10, P1044, DOI 10.1016/j.dnarep.2011.08.003; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Schmidt-Ullrich RK, 2000, RADIAT RES, V153, P245, DOI 10.1667/0033-7587(2000)153[0245:STACRR]2.0.CO;2; SIMMONS DL, 1989, BLOOD, V73, P284; Stubbert LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-207; SUTHERLAND DR, 1993, STEM CELLS, V11, P50, DOI 10.1002/stem.5530110914; Takahashi K, 2007, RADIAT RES, V168, P545, DOI 10.1667/rr1008.1; Takahashi K, 2010, RADIAT RES, V173, P184, DOI 10.1667/RR1839.1; Terato Hiroaki, 2004, Biol Sci Space, V18, P206, DOI 10.2187/bss.18.206; Tobias F, 2010, MUTAT RES-REV MUTAT, V704, P54, DOI 10.1016/j.mrrev.2009.11.004; Traore K, 2007, J CELL BIOCHEM, V100, P1010, DOI 10.1002/jcb.21101; USUKI Y, 1986, INT J CELL CLONING, V4, P447; Vandersickel V, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-30; Winnicka B, 2010, J LEUKOCYTE BIOL, V88, P347, DOI 10.1189/jlb.0210065	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59385	10.1371/journal.pone.0059385	http://dx.doi.org/10.1371/journal.pone.0059385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555027	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500088
J	Pincus, D; Ryan, CJ; Smith, RD; Brent, R; Resnekov, O				Pincus, David; Ryan, Christopher J.; Smith, Richard D.; Brent, Roger; Resnekov, Orna			Assigning Quantitative Function to Post-Translational Modifications Reveals Multiple Sites of Phosphorylation That Tune Yeast Pheromone Signaling Output	PLOS ONE			English	Article							MAP KINASE; SACCHAROMYCES-CEREVISIAE; PROTEIN-PHOSPHORYLATION; INTRINSIC DISORDER; ADAPTER PROTEIN; GENE-EXPRESSION; PLASMA-MEMBRANE; TRANSDUCTION; SCAFFOLD; SWITCH	Cell signaling systems transmit information by post-translationally modifying signaling proteins, often via phosphorylation. While thousands of sites of phosphorylation have been identified in proteomic studies, the vast majority of sites have no known function. Assigning functional roles to the catalog of uncharacterized phosphorylation sites is a key research challenge. Here we present a general approach to address this challenge and apply it to a prototypical signaling pathway, the pheromone response pathway in Saccharomyces cerevisiae. The pheromone pathway includes a mitogen activated protein kinase (MAPK) cascade activated by a G-protein coupled receptor (GPCR). We used published mass spectrometry-based proteomics data to identify putative sites of phosphorylation on pheromone pathway components, and we used evolutionary conservation to assign priority to a list of candidate MAPK regulatory sites. We made targeted alterations in those sites, and measured the effects of the mutations on pheromone pathway output in single cells. Our work identified six new sites that quantitatively tuned system output. We developed simple computational models to find system architectures that recapitulated the quantitative phenotypes of the mutants. Our results identify a number of putative phosphorylation events that contribute to adjust the input-output relationship of this model eukaryotic signaling system. We believe this combined approach constitutes a general means not only to reveal modification sites required to turn a pathway on and off, but also those required for more subtle quantitative effects that tune pathway output. Our results suggest that relatively small quantitative influences from individual phosphorylation events endow signaling systems with plasticity that evolution may exploit to quantitatively tailor signaling outcomes.	[Pincus, David; Ryan, Christopher J.; Brent, Roger; Resnekov, Orna] Inst Mol Sci, Berkeley, CA 94704 USA; [Smith, Richard D.] Pacific NW Natl Lab, Richland, WA 99352 USA	The Molecular Sciences Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Resnekov, O (corresponding author), Inst Mol Sci, Berkeley, CA 94704 USA.	resnekov@molsci.org	Smith, Richard D/J-3664-2012	Smith, Richard D/0000-0002-2381-2349	National Human Genome Research Institute [P50 HG002370]; National Institute of General Medical Sciences [8P41 GM103493-10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493, R01GM097479] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was supported by grant number P50 HG002370 (PI, R. Brent) from National Human Genome Research Institute. R. D. Smith acknowledges additional funding from grant number 8P41 GM103493-10 (PI, R. D. Smith) from National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Brent R, 2009, FEBS LETT, V583, P4019, DOI 10.1016/j.febslet.2009.11.029; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Chernomoretz A., 2008, CURR PROTOC MOL BIOL; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; ERREDE B, 1993, NATURE, V362, P261, DOI 10.1038/362261a0; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Houser JR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.18; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; McCullagh E, 2010, NAT CELL BIOL, V12, P954, DOI 10.1038/ncb2097; Nagiec MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002437; NEIMAN AM, 1994, P NATL ACAD SCI USA, V91, P3398, DOI 10.1073/pnas.91.8.3398; Olson KA, 2000, MOL CELL BIOL, V20, P4199, DOI 10.1128/MCB.20.12.4199-4209.2000; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Pincus D, 2010, YEAST, V27, P423, DOI 10.1002/yea.1758; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Ramezani-Rad M, 2003, CURR GENET, V43, P161, DOI 10.1007/s00294-003-0383-6; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; Sneddon MW, 2011, NAT METHODS, V8, P177, DOI [10.1038/nmeth.1546, 10.1038/NMETH.1546]; Stark C, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap026; Stroud RM, 1991, CURR OPIN STRUC BIOL, V1, P826, DOI 10.1016/0959-440X(91)90186-W; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Thomson TM, 2011, P NATL ACAD SCI USA, V108, P20265, DOI 10.1073/pnas.1004042108; Truckses DM, 2006, MOL CELL BIOL, V26, P912, DOI 10.1128/MCB.26.3.912-928.2006; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425; Yamamoto K, 2010, MOL CELL, V40, P87, DOI 10.1016/j.molcel.2010.09.011; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; YUAN YLO, 1991, MOL CELL BIOL, V11, P5910, DOI 10.1128/MCB.11.12.5910	54	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e56544	10.1371/journal.pone.0056544	http://dx.doi.org/10.1371/journal.pone.0056544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554854	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500002
J	Fortin, J; Kumar, V; Zhou, X; Wang, Y; Auwerx, J; Schoonjans, K; Boehm, U; Boerboom, D; Bernard, DJ				Fortin, Jerome; Kumar, Vikas; Zhou, Xiang; Wang, Ying; Auwerx, Johan; Schoonjans, Kristina; Boehm, Ulrich; Boerboom, Derek; Bernard, Daniel J.			NR5A2 Regulates Lhb and Fshb Transcription in Gonadotrope-Like Cells In Vitro, but Is Dispensable for Gonadotropin Synthesis and Fertility In Vivo	PLOS ONE			English	Article							STEROIDOGENIC FACTOR-I; HORMONE BETA-SUBUNIT; ORPHAN NUCLEAR RECEPTOR; OVARIAN GRANULOSA-CELLS; LUTEINIZING-HORMONE; GENE-EXPRESSION; PROMOTER ACTIVITY; TRANSGENIC MICE; BINDING-SITES; PITUITARY	Successful mammalian reproduction depends on proper synthesis of the pituitary-derived glycoprotein hormones, luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Several transcription factors cooperate to activate cell-specific and hormone-regulated expression of the gonadotropin beta subunits (Lhb and Fshb). Among these, NR5A1 (steroidogenic factor 1; SF1) has been shown to directly bind to the Lhb promoter, mediate basal and gonadotropin-releasing hormone (GnRH)-stimulated Lhb transcription, and possibly directly regulate Fshb expression. Recently, the closely-related NR5A2 was shown to activate the rat Lhb promoter in vitro. Here, we further characterized the role of NR5A2 in regulating gonadotropin synthesis. Ectopically expressed NR5A2 directly activated the murine Lhb promoter in a manner identical to that of NR5A1, whereas neither factor activated the murine Fshb promoter. In L beta T2 gonadotrope-like cells, depletion of endogenous NR5A1 or NR5A2 impaired basal and GnRH-stimulated Lhb and Fshb transcription. To analyze the physiological role of NR5A2 in gonadotropes in vivo, we generated mice with a gonadotrope-specific deletion of Nr5a2. In contrast with our in vitro data, these mice had normal pituitary Lhb and Fshb expression and intact fertility. Together, our data establish that NR5A2 can act in a non-redundant manner to regulate Lhb and Fshb transcription in vitro, but is dispensable in vivo.	[Fortin, Jerome; Kumar, Vikas; Zhou, Xiang; Wang, Ying; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Kumar, Vikas; Boerboom, Derek] Univ Montreal, Dept Biomed Vet, Ste Hyacinthe, PQ, Canada; [Auwerx, Johan; Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Boehm, Ulrich] Univ Saarland, Sch Med, Dept Pharmacol & Toxicol, Homburg, Saarland, Germany	McGill University; Universite de Montreal; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Saarland University	Bernard, DJ (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	daniel.bernard@mcgill.ca	Auwerx, Johan/ABE-9307-2021	Bernard, Daniel/0000-0001-5365-5586; Auwerx, Johan/0000-0002-5065-5393; Schoonjans, Kristina/0000-0003-1247-4265	CIHR [MOP-89991, MOP-102508]; MELS Merit Scholarship; National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction and Infertility Research) [U54-HD28934]	CIHR(Canadian Institutes of Health Research (CIHR)); MELS Merit Scholarship; National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction and Infertility Research)	JF was supported by a Doctoral Research Award from CIHR. VK was supported by a MELS Merit Scholarship. This work was funded by CIHR operating grants MOP-89991 to DJB/DB and MOP-102508 to DB. DB is the Canada Research Chair in Ovarian Molecular Biology and Functional Genomics. DJB is a Chercheurboursier senior of the Fonds de la recherche en sante du Quebec. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction and Infertility Research) Grant U54-HD28934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarid ET, 1996, DEVELOPMENT, V122, P3319; BARNHART KM, 1994, MOL ENDOCRINOL, V8, P878, DOI 10.1210/me.8.7.878; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Bliss SP, 2009, MOL ENDOCRINOL, V23, P1092, DOI 10.1210/me.2009-0030; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; Dorn C, 1999, J BIOL CHEM, V274, P13870, DOI 10.1074/jbc.274.20.13870; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Duval DL, 1997, BIOL REPROD, V56, P160, DOI 10.1095/biolreprod56.1.160; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Fayard E, 2003, J BIOL CHEM, V278, P35725, DOI 10.1074/jbc.M302370200; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Fortin J, 2010, CELL SIGNAL, V22, P936, DOI 10.1016/j.cellsig.2010.01.019; Fortin J, 2009, MOL HUM REPROD, V15, P77, DOI 10.1093/molehr/gan079; Fowkes RC, 2003, MOL ENDOCRINOL, V17, P2177, DOI 10.1210/me.2002-0393; Galarneau L, 1996, MOL CELL BIOL, V16, P3853; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; Halvorson LM, 1996, J BIOL CHEM, V271, P6645, DOI 10.1074/jbc.271.12.6645; Halvorson LM, 1998, J BIOL CHEM, V273, P14712, DOI 10.1074/jbc.273.24.14712; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Jacobs SBR, 2003, MOL ENDOCRINOL, V17, P1470, DOI 10.1210/me.2002-0286; Jorgensen JS, 2004, ENDOCR REV, V25, P521, DOI 10.1210/er.2003-0029; Kaiser UB, 2000, MOL ENDOCRINOL, V14, P1235, DOI 10.1210/me.14.8.1235; Keri RA, 1996, J BIOL CHEM, V271, P10782, DOI 10.1074/jbc.271.18.10782; Lamba P, 2006, J MOL ENDOCRINOL, V36, P201, DOI 10.1677/jme.1.01961; Lamba P, 2008, ENDOCRINOLOGY, V149, P3095, DOI 10.1210/en.2007-0425; Lazarus KA, 2012, J STEROID BIOCHEM, V130, P138, DOI 10.1016/j.jsbmb.2011.12.017; Liu FJ, 2002, MOL ENDOCRINOL, V16, P419, DOI 10.1210/me.16.3.419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo A, 2011, J MOL ENDOCRINOL, V47, P45, DOI 10.1530/JME-10-0137; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; Pelusi C, 2008, BIOL REPROD, V79, P1074, DOI 10.1095/biolreprod.108.069435; Pincas H, 2001, MOL ENDOCRINOL, V15, P319, DOI 10.1210/me.15.2.319; Quirk CC, 2003, J BIOL CHEM, V278, P1680, DOI 10.1074/jbc.M209906200; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tran S, 2013, MOL ENDOCRINOL, V27, P407, DOI 10.1210/me.2012-1286; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; Wang Y, 2008, ENDOCRINOLOGY, V149, P5577, DOI 10.1210/en.2008-0220; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; Wen SP, 2010, P NATL ACAD SCI USA, V107, P16372, DOI 10.1073/pnas.1000423107; Yazawa T, 2010, MOL ENDOCRINOL, V24, P485, DOI 10.1210/me.2009-0352; Zhao LP, 2001, DEVELOPMENT, V128, P147; Zheng WM, 2007, J MOL ENDOCRINOL, V38, P207, DOI 10.1677/JME-06-0001	45	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59058	10.1371/journal.pone.0059058	http://dx.doi.org/10.1371/journal.pone.0059058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536856	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100117
J	Jiang, GY; Fan, CF; Zhang, XP; Dong, QZ; Wang, L; Liu, Y; Dai, SD; Yang, LH; Zhang, Y; Yu, JH; Wang, EH				Jiang, Guiyang; Fan, Chuifeng; Zhang, Xiupeng; Dong, Qianze; Wang, Liang; Liu, Yang; Dai, Shundong; Yang, Lianhe; Zhang, Yong; Yu, Juanhan; Wang, Enhua			Ascertaining an Appropriate Diagnostic Algorithm Using EGFR Mutation-Specific Antibodies to Detect EGFR Status in Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR-RECEPTOR MUTATIONS; KINASE INHIBITOR THERAPY; PULMONARY ADENOCARCINOMA; GEFITINIB; GENE; SENSITIVITY; EFFUSION; IMPACT	Background: Epidermal growth factor receptor (EGFR) mutation status is the most valuable indicator in the screening of non-small-cell lung cancer (NSCLC) patients for tyrosine kinase inhibitor (TKI) therapy. Accurate, rapid and economical methods of detecting EGFR mutations have become important. The use of two mutation-specific antibodies targeting the delE746-A750 mutation in exon 19 and L858R mutation in exon 21 makes this task possible, but the lack of consensually acceptable criteria for positive results limits the application of this antibody based mutation detection. Methods: We collected 399 specimens from NSCLC patients (145 resection specimens, 220 biopsy specimens, and 34 cytology specimens) whose EGFR mutation status had been detected by TaqMan PCR assay. Immunohistochemical (IHC) analyses using EGFR mutation-specific antibodies were employed for all samples. After staining and scoring, the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated in accordance with different levels of positive grades in comparison with the results of PCR-based assay. Results: In IHC-based analyses, 144 cases were scored 0, 104 cases were scored 1+, 103 cases were scored 2+, and 48 cases were scored 3+. With the molecular-based results were set as the "gold standard", the prevalence of mutation was 6.94% (10/144), 23.08% (24/104), 67.96% (70/103) and 100% (48/48), respectively, for samples with scores 0, 1+, 2+ and 3+. When score 3+ was considered positive, the specificity and PPV were 100%; if only score 0 was considered negative, 93.06% NPV was obtained. Conclusion: Patients with score 3+ have a perfect PPV (100%), and may accept TKI treatment directly without any molecular-based assays. Patients with score 0 had high NPV (93.06%), which could reach 97.22% when the detection of total EGFR was applied. However, samples with score 1+ or 2+ are unreliable and need further verification of EGFR mutation status by molecular-based assays.	[Wang, Enhua] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China; China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China	China Medical University; China Medical University	Wang, EH (corresponding author), China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China.	wangeh@hotmail.com	Wang, Liang/AAM-2378-2021	Wang, Liang/0000-0003-4015-9385	National Natural Science Foundation of China [81071905, 81272606]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81071905 and 81272606 to EHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini-Spaltro A, 2012, APPL IMMUNOHISTO M M, V20, P356, DOI 10.1097/PAI.0b013e31823e064b; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Dimou A, 2011, AM J PATHOL, V179, P580, DOI 10.1016/j.ajpath.2011.04.031; Endo K, 2005, LUNG CANCER, V50, P375, DOI 10.1016/j.lungcan.2005.08.009; Fukui T, 2008, CLIN CANCER RES, V14, P4751, DOI 10.1158/1078-0432.CCR-07-5207; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Kato Y, 2010, J THORAC ONCOL, V5, P1551, DOI 10.1097/JTO.0b013e3181e9da60; Kawahara A, 2012, LUNG CANCER, V78, P39, DOI 10.1016/j.lungcan.2012.07.002; Kawahara A, 2011, LUNG CANCER, V74, P35, DOI 10.1016/j.lungcan.2011.02.002; Kawahara A, 2010, CLIN CANCER RES, V16, P3163, DOI 10.1158/1078-0432.CCR-09-3239; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Kim KS, 2005, CLIN CANCER RES, V11, P2244, DOI 10.1158/1078-0432.CCR-04-2081; Kimura H, 2006, CANCER SCI, V97, P642, DOI 10.1111/j.1349-7006.2006.00216.x; Kitamura A, 2010, CLIN CANCER RES, V16, P3349, DOI 10.1158/1078-0432.CCR-10-0129; Kozu Y, 2011, LUNG CANCER, V73, P45, DOI 10.1016/j.lungcan.2010.11.003; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Pao W, 2007, CLIN CANCER RES, V13, P4954, DOI 10.1158/1078-0432.CCR-07-1387; Riely GJ, 2006, CLIN CANCER RES, V12, P7232, DOI 10.1158/1078-0432.CCR-06-0658; Simonetti S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-135; Wu SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023303; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739; Zhou CC, 2006, CANCER J, V12, P33, DOI 10.1097/00130404-200601000-00007	26	23	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59183	10.1371/journal.pone.0059183	http://dx.doi.org/10.1371/journal.pone.0059183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536868	gold, Green Submitted, Green Published			2022-12-25	WOS:000316251100127
J	Park, SO; Wamsley, HL; Bae, K; Hu, ZB; Li, XM; Choe, SW; Slayton, WB; Oh, SP; Wagner, KU; Sayeski, PP				Park, Sung O.; Wamsley, Heather L.; Bae, Kyungmi; Hu, Zhongbo; Li, Xiaomiao; Choe, Se-woon; Slayton, William B.; Oh, S. Paul; Wagner, Kay-Uwe; Sayeski, Peter P.			Conditional Deletion of Jak2 Reveals an Essential Role in Hematopoiesis throughout Mouse Ontogeny: Implications for Jak2 Inhibition in Humans	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASES; MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; MUTATION; MYELOFIBROSIS; MICE; RUXOLITINIB; DISORDERS; RECEPTOR; IDENTIFICATION	Germline deletion of Jak2 in mice results in embryonic lethality at E12.5 due to impaired hematopoiesis. However, the role that Jak2 might play in late gestation and postnatal life is unknown. To understand this, we utilized a conditional knockout approach that allowed for the deletion of Jak2 at various stages of prenatal and postnatal life. Specifically, Jak2 was deleted beginning at either mid/late gestation (E12.5), at postnatal day 4 (PN4), or at similar to 2 months of age. Deletion of Jak2 beginning at E12.5 resulted in embryonic death characterized by a lack of hematopoiesis. Deletion beginning at PN4 was also lethal due to a lack of erythropoiesis. Deletion of Jak2 in young adults was characterized by blood cytopenias, abnormal erythrocyte morphology, decreased marrow hematopoietic potential, and splenic atrophy. However, death was observed in only 20% of the mutants. Further analysis of these mice suggested that the increased survivability was due to an incomplete deletion of Jak2 and subsequent re-population of Jak2 expressing cells, as conditional deletion in mice having one floxed Jak2 allele and one null allele resulted in a more severe phenotype and subsequent death of all animals. We found that the deletion of Jak2 in the young adults had a differential effect on hematopoietic lineages; specifically, conditional Jak2 deletion in young adults severely impaired erythropoiesis and thrombopoiesis, modestly affected granulopoiesis and monocytopoiesis, and had no effect on lymphopoiesis. Interestingly, while the hematopoietic organs of these mutant animals were severely affected by the deletion of Jak2, we found that the hearts, kidneys, lungs, and brains of these same mice were histologically normal. From this, we conclude that Jak2 plays an essential and non-redundant role in hematopoiesis during both prenatal and postnatal life and this has direct implications regarding the inhibition of Jak2 in humans.	[Park, Sung O.; Choe, Se-woon; Oh, S. Paul; Sayeski, Peter P.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA; [Wamsley, Heather L.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [Bae, Kyungmi] Univ Florida, Coll Med, Dept Urol, Gainesville, FL USA; [Hu, Zhongbo; Li, Xiaomiao; Slayton, William B.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Sayeski, PP (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA.	psayeski@ufl.edu	Hu, Zhongbo/ABB-8527-2020	Hu, Zhongbo/0000-0002-8935-0626; Wagner, Kay-Uwe/0000-0002-5081-0226; Choe, Se-woon/0000-0002-7298-4147	NIH [R01-HL67277-09, R01-CA117930]; NATIONAL CANCER INSTITUTE [R01CA117930] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH awards R01-HL67277-09 (PPS) and R01-CA117930 (KUW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti V, 2004, J EXP MED, V199, P867, DOI 10.1084/jem.20031983; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Booz GW, 2002, J MOL CELL CARDIOL, V34, P1443, DOI 10.1006/jmcc.2002.2076; Corey SJ, 1999, BLOOD, V93, P1, DOI 10.1182/blood.V93.1.1; Frenzel K, 2006, EXP CELL RES, V312, P2735, DOI 10.1016/j.yexcr.2006.05.004; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; HARPUR AG, 1992, ONCOGENE, V7, P1347; Hart S, 2011, LEUKEMIA, V25, P1751, DOI 10.1038/leu.2011.148; Huang H, 2012, NAT NEUROSCI, V15, P1391, DOI 10.1038/nn.3207; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Karur VG, 2006, BLOOD, V108, P1524, DOI 10.1182/blood-2005-09-008243; Khwaja A, 2006, BRIT J HAEMATOL, V134, P366, DOI 10.1111/j.1365-2141.2006.06206.x; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krempler A, 2004, GENESIS, V40, P52, DOI 10.1002/gene.20063; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Lannutti BJ, 2006, ONCOGENE, V25, P3316, DOI 10.1038/sj.onc.1209351; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li XM, 2010, EXP HEMATOL, V38, P1251, DOI 10.1016/j.exphem.2010.08.005; Mascarenhas J, 2012, CLIN CANCER RES, V18, P3008, DOI 10.1158/1078-0432.CCR-11-3145; Mazharian A, 2010, BLOOD, V116, P793, DOI 10.1182/blood-2010-03-275990; Neria F, 2009, KIDNEY INT, V75, P227, DOI 10.1038/ki.2008.487; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Sandberg EM, 2004, CELL BIOCHEM BIOPHYS, V41, P207, DOI 10.1385/CBB:41:2:207; Sharma Y, 2007, EXP HEMATOL, V35, P214, DOI 10.1016/j.exphem.2006.10.001; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tefferi A, 2011, BLOOD REV, V25, P229, DOI 10.1016/j.blre.2011.06.002; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; Tefferi A, 2012, NEW ENGL J MED, V366, P844, DOI 10.1056/NEJMe1115119; Tefferi A, 2011, MAYO CLIN PROC, V86, P1188, DOI 10.4065/mcp.2011.0518; Tefferi A, 2011, NEW ENGL J MED, V365, P1455, DOI 10.1056/NEJMc1109555; TSYGANKOV AY, 1993, STEM CELLS, V11, P371, DOI 10.1002/stem.5530110504; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Xiao WB, 2008, J CLIN INVEST, V118, P924, DOI 10.1172/JCI34013; Yoon SY, 2001, HAEMATOLOGICA, V86, P52; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	38	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59675	10.1371/journal.pone.0059675	http://dx.doi.org/10.1371/journal.pone.0059675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544085	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700045
J	Tan, SY; Lu, L; Li, L; Liu, JX; Oksov, Y; Lu, H; Jiang, SB; Liu, SW				Tan, Suiyi; Lu, Lu; Li, Lin; Liu, Jixiang; Oksov, Yelena; Lu, Hong; Jiang, Shibo; Liu, Shuwen			Polyanionic Candidate Microbicides Accelerate the Formation of Semen-Derived Amyloid Fibrils to Enhance HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; POLY(SODIUM 4-STYRENE SULFONATE); CELLULOSE SULFATE; POLYSTYRENE SULFONATE; VAGINAL MICROBICIDES; RECTAL MICROBICIDES; SEMINAL PLASMA; DOUBLE-BLIND; IN-VITRO; PREVENTION	Polyanionic candidate microbicides, including cellulose sulfate, carrageenan, PRO 2000, were proven ineffective in preventing HIV-1 transmission and even cellulose sulfate showed increased risk of HIV acquisition in the Phase III efficacy trials. Semen plays critical roles in HIV-1 sexual transmission. Specifically, amyloid fibrils formed by fragments of prostatic acidic phosphatase (PAP) in semen termed semen-derived enhancer of virus infection (SEVI) could drastically enhance HIV-1 infection. Here we investigated the interaction between polyanions and PAP248-286, a prototype peptide of SEVI, to understand the possible cause of polyanionic candidate microbicides to fail in clinical trials. We found anionic polymers could efficiently promote SEVI fibril formation, most likely mediated by the natural electrostatic interaction between polyanions and PAP248-286, as revealed by acid native PAGE and Western blot The overall anti-HIV-1 activity of polyanions in the presence or absence of PAP248-286 or semen was evaluated. In the viral infection assay, the supernatants of polyanions/PAP248-286 or polyanions/semen mixtures containing the free, unbound polyanionic molecules showed a general reduction in antiviral efficacy, while the pellets containing amyloid fibrils formed by the polyanion-bound PAP248-286 showed aggravated enhancement of viral infection. Collectively, from the point of drug-host protein interaction, our study revealed that polyanions facilitate SEVI fibril formation to promote HIV-1 infection, thus highlighting a molecular mechanism underlying the failure of polyanions in clinical trials and the importance of drug-semen interaction in evaluating the anti-HIV-1 efficacy of candidate microbicides.	[Tan, Suiyi; Li, Lin; Jiang, Shibo; Liu, Shuwen] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Hlth, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Tan, Suiyi; Lu, Lu; Liu, Jixiang; Oksov, Yelena; Lu, Hong; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA	Southern Medical University - China; Fudan University; Fudan University; Fudan University; New York Blood Center	Jiang, SB (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.	shibojiang@fudan.edu.cn; liusw@smu.edu.cn	Li, Li/AEM-3636-2022; li, li/HII-4157-2022; Jiang, Shibo/L-4500-2014; lu, lu/HGA-0894-2022; lu, lu/HII-7530-2022; Lu, Lu/K-7070-2014; LI, LI/GVS-5344-2022	Jiang, Shibo/0000-0001-8283-7135; Lu, Lu/0000-0002-2255-0391; Liu, Shuwen/0000-0001-6346-5006	Natural Science Foundation of China [81102482, U0832001]; Natural Science Foundation of Guangdong Province [S2011020005207]; National 973 Program [2012CB519001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National 973 Program(National Basic Research Program of China)	This study was supported by grants from the Natural Science Foundation of China (81102482 to S.T. and U0832001 to S.L.), the Natural Science Foundation of Guangdong Province (S2011020005207) to S.L. and the National 973 Program (2012CB519001) to S.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belec L, 2011, FUTURE MICROBIOL, V6, P731, DOI [10.2217/FMB.11.64, 10.2217/fmb.11.64]; Bourgault S, 2011, BIOCHEMISTRY-US, V50, P1001, DOI 10.1021/bi101822y; Bourne N, 1999, J INFECT DIS, V180, P203, DOI 10.1086/314853; Bourne N, 2003, CLIN MICROBIOL INFEC, V9, P816, DOI 10.1046/j.1469-0691.2003.00659.x; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Castillo GM, 1997, J NEUROCHEM, V69, P2452; Christensen ND, 2001, ANTIMICROB AGENTS CH, V45, P3427, DOI 10.1128/AAC.45.12.3427-3432.2001; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Epstein EA, 2008, CELL MICROBIOL, V10, P1413, DOI 10.1111/j.1462-5822.2008.01148.x; Garg S, 2010, ANTIVIR RES, V88, pS19, DOI 10.1016/j.antiviral.2010.09.010; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; Herold BC, 2000, J INFECT DIS, V181, P770, DOI 10.1086/315228; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2010, FUTURE MICROBIOL, V5, P527, DOI [10.2217/fmb.10.29, 10.2217/FMB.10.29]; Kim KA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-55; Lacey CJ, 2010, INT J STD AIDS, V21, P714, DOI 10.1258/ijsa.2010.010215; Li L, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-37; Lu H, 2006, AIDS RES HUM RETROV, V22, P411, DOI 10.1089/aid.2006.22.411; Martellini JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016285; Martellini JA, 2009, FASEB J, V23, P3609, DOI 10.1096/fj.09-131961; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; McGowan I, 2008, SEX TRANSM INFECT, V84, P413, DOI 10.1136/sti.2008.031328; McGowan I, 2008, CURR OPIN HIV AIDS, V3, P593, DOI 10.1097/COH.0b013e32830891cf; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Monsellier E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011363; Morris GC, 2010, CURR OPIN INFECT DIS, V23, P57, DOI 10.1097/QCO.0b013e328334de6d; Motamedi-Shad N, 2009, J BIOCHEM, V146, P805, DOI 10.1093/jb/mvp128; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Neurath AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-150; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Patel S, 2007, J INFECT DIS, V196, P1394, DOI 10.1086/522606; Pendergrass PB, 2003, GYNECOL OBSTET INVES, V55, P110, DOI 10.1159/000070184; Pirrone V, 2011, ANTIVIR RES, V90, P168, DOI 10.1016/j.antiviral.2011.03.176; Ren RY, 2010, J BIOL CHEM, V285, P37672, DOI 10.1074/jbc.M110.149575; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Scordi-Bello IA, 2005, ANTIMICROB AGENTS CH, V49, P3607, DOI 10.1128/AAC.49.9.3607-3615.2005; Simoes JA, 2002, ANTIMICROB AGENTS CH, V46, P2692, DOI 10.1128/AAC.46.8.2692-2695.2002; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Solomon JP, 2011, BIOCHEMISTRY-US, V50, P2486, DOI 10.1021/bi101905n; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wood H, 2011, PRACTITIONER, V255, P3; Wood Hayley, 2011, Practitioner, V255, P25	51	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59777	10.1371/journal.pone.0059777	http://dx.doi.org/10.1371/journal.pone.0059777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544097	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700057
J	Bowen, CV; DeBay, D; Ewart, HS; Gallant, P; Gormley, S; Ilenchuk, TT; Iqbal, U; Lutes, T; Martina, M; Mealing, G; Merkley, N; Sperker, S; Moreno, MJ; Rice, C; Syvitski, RT; Stewart, JM				Bowen, Chris V.; DeBay, Drew; Ewart, H. Stephen; Gallant, Pamela; Gormley, Sean; Ilenchuk, T. Toney; Iqbal, Umar; Lutes, Tyler; Martina, Marzia; Mealing, Geoffrey; Merkley, Nadine; Sperker, Sandra; Moreno, Maria J.; Rice, Christopher; Syvitski, Raymond T.; Stewart, John M.			In Vivo Detection of Human TRPV6-Rich Tumors with Anti-Cancer Peptides Derived from Soricidin	PLOS ONE			English	Article							CALCIUM-CHANNEL TRPV6; PROSTATE-CANCER; CA2+ CHANNEL; ION-CHANNEL; EXPRESSION; RECEPTOR; GROWTH; MEMBRANE; CAT1; IRON	Soricidin is a 54-amino acid peptide found in the paralytic venom of the northern short-tailed shrew (Blarina brevicauda) and has been found to inhibit the transient receptor potential of vallinoid type 6 (TRPV6) calcium channels. We report that two shorter peptides, SOR-C13 and SOR-C27, derived from the C-terminus of soricidin, are high-affinity antagonists of human TRPV6 channels that are up-regulated in a number of cancers. Herein, we report molecular imaging methods that demonstrate the in vivo diagnostic potential of SOR-C13 and SOR-C27 to target tumor sites in mice bearing ovarian or prostate tumors. Our results suggest that these novel peptides may provide an avenue to deliver diagnostic and therapeutic reagents directly to TRPV6-rich tumors and, as such, have potential applications for a range of carcinomas including ovarian, breast, thyroid, prostate and colon, as well as certain leukemia's and lymphomas.	[Bowen, Chris V.; DeBay, Drew] Natl Res Council Canada, Inst Biodiagnost Atlantic, Neuroimaging Res Lab, Halifax, NS, Canada; [Ewart, H. Stephen; Gallant, Pamela; Merkley, Nadine; Sperker, Sandra; Syvitski, Raymond T.] Natl Res Council Canada, Inst Marine Biosci, Halifax, NS, Canada; [Gormley, Sean; Ilenchuk, T. Toney; Lutes, Tyler; Rice, Christopher; Stewart, John M.] Soricimed Biopharma Inc, Sackville, NB, Canada; [Iqbal, Umar; Martina, Marzia; Mealing, Geoffrey; Moreno, Maria J.] Natl Res Council Canada, Inst Biol Sci, Neurobiol Program, Ottawa, ON K1A 0R6, Canada	International Business Machines (IBM); National Research Council Canada; International Business Machines (IBM); National Research Council Canada; National Research Council Canada	Stewart, JM (corresponding author), Soricimed Biopharma Inc, Sackville, NB, Canada.	jstewart@soricimed.com		Stewart, John/0000-0003-3116-4174	National Research Council Industrial Research Assistance Program (IRAP); Atlantic Canada Opportunities Agency (ACOA)	National Research Council Industrial Research Assistance Program (IRAP); Atlantic Canada Opportunities Agency (ACOA)	This work was supported by the National Research Council Industrial Research Assistance Program (IRAP) program (http://www. nrc-cnrc. gc. ca/eng/ irap/index. html) and Atlantic Canada Opportunities Agency (ACOA) (http://www. acoa-apeca. gc. ca/eng/Pages/Home. aspx) of the Government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ansary D, 2010, FASEB J, V24, P425, DOI 10.1096/fj.09-141481; Bodding M, 2004, J BIOL CHEM, V279, P36546, DOI 10.1074/jbc.M404679200; Bodding M, 2002, J BIOL CHEM, V277, P36656, DOI 10.1074/jbc.M202822200; Bodding M, 2007, CELL SIGNAL, V19, P617, DOI 10.1016/j.cellsig.2006.08.012; Bolanz KA, 2008, MOL CANCER THER, V7, P271, DOI 10.1158/1535-7163.MCT-07-0478; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Clinchy B, 2000, BREAST CANCER RES TR, V61, P217, DOI 10.1023/A:1006494001861; Fixemer T, 2003, ONCOGENE, V22, P7858, DOI 10.1038/sj.onc.1206895; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Howlader N, 2012, SEER CANC STAT REV 1; KIM DG, 1992, MOL CELL BIOL, V12, P3636, DOI 10.1128/MCB.12.8.3636; Kovacs G, 2012, CELL CALCIUM, V52, P468, DOI 10.1016/j.ceca.2012.08.005; Landowski CP, 2011, PHARM RES-DORDR, V28, P322, DOI 10.1007/s11095-010-0249-9; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Mani V, 2006, MAGN RESON MED, V55, P126, DOI 10.1002/mrm.20739; Montell C, 2003, CELL CALCIUM, V33, P409, DOI 10.1016/S0143-4160(03)00053-8; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montell C, 2011, PFLUG ARCH EUR J PHY, V461, P499, DOI 10.1007/s00424-010-0920-3; Nijenhuis T, 2003, J AM SOC NEPHROL, V14, P2731, DOI 10.1097/01.ASN.0000094081.78893.E8; Nijenhuis T, 2003, PFLUG ARCH EUR J PHY, V446, P401, DOI 10.1007/s00424-003-1038-7; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Peng JB, 2000, BIOCHEM BIOPH RES CO, V278, P326, DOI 10.1006/bbrc.2000.3716; Peng JB, 2001, BIOCHEM BIOPH RES CO, V282, P729, DOI 10.1006/bbrc.2001.4638; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Peters AA, 2012, MOL CANCER THER, V11, P2158, DOI 10.1158/1535-7163.MCT-11-0965; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Rossing MA, 2010, J NATL CANCER I, V102, P222, DOI 10.1093/jnci/djp500; Santoni G, 2011, ADV EXP MED BIOL, V704, P947, DOI 10.1007/978-94-007-0265-3_49; Schwarz EC, 2006, CELL CALCIUM, V39, P163, DOI 10.1016/j.ceca.2005.10.006; Semenova SB, 2009, AM J PHYSIOL-CELL PH, V296, pC1098, DOI 10.1152/ajpcell.00435.2008; Stewart JM, 2006, USPTO. Pat, Patent No. [7,119,168, 7119168]; Stewart JM, 2011, USPTO. Appl, Patent No. [12/886397, 12886397]; Stuber M, 2007, MAGN RESON MED, V58, P1072, DOI 10.1002/mrm.21399; Wissenbach U, 2004, BIOCHEM BIOPH RES CO, V322, P1359, DOI 10.1016/j.bbrc.2004.08.042; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Zheng DH, 2010, ONCOL REP, V23, P717, DOI 10.3892/or_00000689; Zhuang LY, 2002, LAB INVEST, V82, P1755, DOI 10.1097/01.LAB.0000043910.41414.E7	40	66	70	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58866	10.1371/journal.pone.0058866	http://dx.doi.org/10.1371/journal.pone.0058866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554944	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800040
J	Dumas, P; Jimenez, H; Peignon, C; Wantiez, L; Adjeroud, M				Dumas, Pascal; Jimenez, Haizea; Peignon, Christophe; Wantiez, Laurent; Adjeroud, Mehdi			Small-Scale Habitat Structure Modulates the Effects of No-Take Marine Reserves for Coral Reef Macroinvertebrates	PLOS ONE			English	Article							SPATIAL-PATTERNS; FISH COMMUNITIES; PROTECTED AREAS; NEW-CALEDONIA; FISHERIES; SUSTAINABILITY; BIODIVERSITY; ASSEMBLAGES; RECRUITMENT; SURROGATES	No-take marine reserves are one of the oldest and most versatile tools used across the Pacific for the conservation of reef resources, in particular for invertebrates traditionally targeted by local fishers. Assessing their actual efficiency is still a challenge in complex ecosystems such as coral reefs, where reserve effects are likely to be obscured by high levels of environmental variability. The goal of this study was to investigate the potential interference of small-scale habitat structure on the efficiency of reserves. The spatial distribution of widely harvested macroinvertebrates was surveyed in a large set of protected vs. unprotected stations from eleven reefs located in New Caledonia. Abundance, density and individual size data were collected along random, small-scale (20 x 1 m) transects. Fine habitat typology was derived with a quantitative photographic method using 17 local habitat variables. Marine reserves substantially augmented the local density, size structure and biomass of the target species. Density of Trochus niloticus and Tridacna maxima doubled globally inside the reserve network; average size was greater by 10 to 20% for T. niloticus. We demonstrated that the apparent success of protection could be obscured by marked variations in population structure occurring over short distances, resulting from small-scale heterogeneity in the reef habitat. The efficiency of reserves appeared to be modulated by the availability of suitable habitats at the decimetric scale ("microhabitats") for the considered sessile/low-mobile macroinvertebrate species. Incorporating microhabitat distribution could significantly enhance the efficiency of habitat surrogacy, a valuable approach in the case of conservation targets focusing on endangered or emblematic macroinvertebrate or relatively sedentary fish species	[Dumas, Pascal] IRD, UR CoReUs 2 227, Fisheries Dept Vanuatu, Port Vila, Vanuatu; [Jimenez, Haizea; Peignon, Christophe; Adjeroud, Mehdi] IRD, UR CoReUs 2 227, Noumea, New Caledonia; [Jimenez, Haizea] Smithsonian Environm Res Ctr, Marine Invas Res Lab, Tiburon, CA USA; [Wantiez, Laurent] Univ Nouvelle Caledonie, LIVE, Noumea, New Caledonia	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Smithsonian Institution; Smithsonian Environmental Research Center; Universite Nouvelle Caledonie	Dumas, P (corresponding author), IRD, UR CoReUs 2 227, Fisheries Dept Vanuatu, Port Vila, Vanuatu.	pascal-paul.dumas@ird.fr	Adjeroud, Mehdi/J-6411-2016; Wantiez, Laurent/L-3343-2013	Adjeroud, Mehdi/0000-0002-6825-8759; Wantiez, Laurent/0000-0001-5024-2057; Dumas, Pascal/0000-0001-7369-8989	french PAMPA-LITEAU III programme; IRD (Institut de Recherche pour le developpement)	french PAMPA-LITEAU III programme; IRD (Institut de Recherche pour le developpement)	This study was funded by french PAMPA-LITEAU III programme (http://www.ifremer.fr/pampa) and IRD (Institut de Recherche pour le developpement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 1997, MAR ECOL PROG SER, V159, P105, DOI 10.3354/meps159105; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrefouet S, 2010, MAR POLLUT BULL, V61, P612, DOI 10.1016/j.marpolbul.2010.06.031; Andrefouet S, 2009, CORAL REEFS, V28, P691, DOI 10.1007/s00338-009-0503-y; Andrefouet S., 2004, ATLAS R CIFS CORALLI; Barott KL, 2012, TRENDS MICROBIOL, V20, P621, DOI 10.1016/j.tim.2012.08.004; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Black R, 2011, MAR FRESHWATER RES, V62, P1318, DOI 10.1071/MF11093; Bour W, 1989, BIOL ECOLOGIE EXPLOI; Bozec YM, 2005, J FISH BIOL, V66, P966, DOI 10.1111/j.0022-1112.2005.00652.x; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Castilla JC, 2001, REV FISH BIOL FISHER, V11, P1, DOI 10.1023/A:1014235924952; Ceccarelli DM, 2011, PACIFIC CONSERVATION, P17; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Cleary DFR, 2005, ESTUAR COAST SHELF S, V65, P557, DOI 10.1016/j.ecss.2005.06.025; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; David G, 2010, MAR POLLUT BULL, V61, P323, DOI 10.1016/j.marpolbul.2010.06.020; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dumas P, 2007, J EXP MAR BIOL ECOL, V344, P88, DOI 10.1016/j.jembe.2006.12.015; Dumas P, 2010, ENVIRON CONSERV, V37, P364, DOI 10.1017/S0376892910000536; Dumas P, 2009, J EXP MAR BIOL ECOL, V368, P161, DOI 10.1016/j.jembe.2008.10.002; Dumas P, 2011, BENITIERS NOUVELLE C; English S., 1997, SURVEY MANUAL TROPIC; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Garcia-Charton JA, 2000, ENVIRON CONSERV, V27, P159, DOI 10.1017/S0376892900000199; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gillet R, 2010, MARINE FISHERY RESOU; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Halpern BS, 2003, ECOL APPL, V13, pS117; Hamel MA, 2010, MAR POLLUT BULL, V60, P1397, DOI 10.1016/j.marpolbul.2010.07.002; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hill JJ, 2004, METHODS ECOLOGICAL M; Jimenez H, 2012, CORAL REEFS, V31, P89, DOI 10.1007/s00338-011-0820-9; Jimenez H, 2011, FISH RES, V108, P195, DOI 10.1016/j.fishres.2010.12.021; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Lawrence J.M., 2001, EDIBLE SEA URCHINS B; Lincoln-Smith MP, 2006, CAN J FISH AQUAT SCI, V63, P1251, DOI 10.1139/F06-033; Lubchenco J, 2003, ECOL APPL, V13, pS3; Lucas John S., 1994, Reviews in Fisheries Science, V2, P181; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; MCNEILL SE, 1994, BIODIVERS CONSERV, V3, P586, DOI 10.1007/BF00114203; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; Mellin C, 2009, MAR POLLUT BULL, V58, P11, DOI 10.1016/j.marpolbul.2008.10.010; Nash W. J., 1993, NEARSHORE MARINE RES, P451; Pakoa K, 2009, STATUS TROCHUS TROCH; Pante E, 2006, AQUAT LIVING RESOUR, V19, P207, DOI 10.1051/alr:2006021; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Perez-Ruzafa A, 2008, J NAT CONSERV, V16, P234, DOI 10.1016/j.jnc.2008.09.003; Pillans S, 2005, MAR ECOL PROG SER, V295, P201, DOI 10.3354/meps295201; Raymakers C, 2003, REV EXPLOITATION TRI; ROBERTS CM, 1993, AMBIO, V22, P363; Stoner AW, 1996, FISH B-NOAA, V94, P551; Turner RA, 2007, CORAL REEFS, V26, P997, DOI 10.1007/s00338-007-0238-6; Uthicke S, 2004, CONSERV BIOL, V18, P1395, DOI 10.1111/j.1523-1739.2004.00309.x; Uthicke S, 2001, CORAL REEFS, V19, P271; Wabnitz CCC, 2010, FRONT ECOL ENVIRON, V8, P124, DOI 10.1890/080109; Wantiez L, 2011, SUIVI TEMPOREL RECIF; Wantiez L, 2011, MODALITES TEMPORELLE; Wantiez L, 2008, REV ECOL-TERRE VIE, V63, P117; Wantiez L, 2006, J MAR BIOL ASSOC UK, V86, P1229, DOI 10.1017/S0025315406014238; Wilkinson C, 2008, STATUS CORAL REEFS W; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092; Zuschin M, 2001, CORAL REEFS, V20, P107, DOI 10.1007/s003380100140	66	21	23	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58998	10.1371/journal.pone.0058998	http://dx.doi.org/10.1371/journal.pone.0058998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554965	gold, Green Published, Green Submitted			2022-12-25	WOS:000316409800051
J	Bermudez-Brito, M; Munoz-Quezada, S; Gomez-Llorente, C; Matencio, E; Bernal, MJ; Romero, F; Gil, A				Bermudez-Brito, Miriam; Munoz-Quezada, Sergio; Gomez-Llorente, Carolina; Matencio, Esther; Bernal, Maria J.; Romero, Fernando; Gil, Angel			Cell-Free Culture Supernatant of Bifidobacterium breve CNCM I-4035 Decreases Pro-Inflammatory Cytokines in Human Dendritic Cells Challenged with Salmonella typhi through TLR Activation	PLOS ONE			English	Article							PROBIOTIC USE; EXPRESSION; LACTOBACILLI; IMMUNITY; TOLL-LIKE-RECEPTOR-2; INDUCTION; RESPONSES; EFFICACY; STRAINS; PROTEIN	Dendritic cells (DCs) constitute the first point of contact between gut commensals and our immune system. Despite growing evidence of the immunomodulatory effects of probiotics, the interactions between the cells of the intestinal immune system and bacteria remain largely unknown. Indeed,, the aim of this work was to determine whether the probiotic Bifidobacterium breve CNCM I-4035 and its cell-free culture supernatant (CFS) have immunomodulatory effects in human intestinal-like dendritic cells (DCs) and how they respond to the pathogenic bacterium Salmonella enterica serovar Typhi, and also to elucidate the molecular mechanisms involved in these interactions. Human DCs were directly challenged with B. breve/CFS, S. typhi or a combination of these stimuli for 4 h. The expression pattern of genes involved in Toll-like receptor (TLR) signaling pathway and cytokine secretion was analyzed. CFS decreased pro-inflammatory cytokines and chemokines in human intestinal DCs challenged with S. typhi. In contrast, the B. breve CNCM I-4035 probiotic strain was a potent inducer of the pro-inflammatory cytokines and chemokines tested, i.e., TNF-alpha, IL-8 and RANTES, as well as anti-inflammatory cytokines including IL-10. CFS restored TGF-beta levels in the presence of Salmonella. Live B. breve and its supernatant enhanced innate immune responses by the activation of TLR signaling pathway. These treatments upregulated TLR9 gene transcription. In addition, CFS was a more potent inducer of TLR9 expression than the probiotic bacteria in the presence of S. typhi. Expression levels of CASP8 and IRAK4 were also increased by CFS, and both treatments induced TOLLIP gene expression. Our results indicate that the probiotic strain B. breve CNCM I-4035 affects the intestinal immune response, whereas its supernatant exerts anti-inflammatory effects mediated by DCs. This supernatant may protect immune system from highly infectious agents such as Salmonella typhi and can down-regulate pro-inflammatory pathways.	[Bermudez-Brito, Miriam; Munoz-Quezada, Sergio; Gomez-Llorente, Carolina; Gil, Angel] Univ Granada, Dept Biochem & Mol Biol 2, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix, Granada, Spain; [Matencio, Esther; Bernal, Maria J.; Romero, Fernando] Hero Grp, Global Ctr Child Nutr Technol, Murcia, Spain	University of Granada	Gil, A (corresponding author), Univ Granada, Dept Biochem & Mol Biol 2, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix, Granada, Spain.	agil@ugr.es	Gil, Angel/ABA-7621-2020; Llorente, Carolina Gomez/K-7484-2015; Gil, Angel/L-2275-2014	Gil, Angel/0000-0001-7663-0939; Llorente, Carolina Gomez/0000-0003-3948-1473; Gil, Angel/0000-0001-7663-0939; Bermudez Brito, Miriam/0000-0003-4156-143X	Hero Spain S.A. [3143]; Fundacion General Universidad de Granada Empresa; CDTI project, a public entity of the Ministry of Economy and Competitiveness of the Spanish Government; Plan Propio of University of Granada	Hero Spain S.A.; Fundacion General Universidad de Granada Empresa; CDTI project, a public entity of the Ministry of Economy and Competitiveness of the Spanish Government; Plan Propio of University of Granada	This study was supported by Hero Spain S.A. through a number 3143 contract signed with the Fundacion General Universidad de Granada Empresa and co-sponsored by a CDTI project, a public entity of the Ministry of Economy and Competitiveness of the Spanish Government. CGLL is a recipient of a postdoctoral fellowship of Plan Propio of University of Granada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Ayehunie S, 2009, TOXICOLOGY, V264, P1, DOI 10.1016/j.tox.2009.07.021; Bermudez-Brito M, 2012, ANN NUTR METAB, V61, P160, DOI 10.1159/000342079; Bermudez-Brito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043197; Borchers AT, 2009, J GASTROENTEROL, V44, P26, DOI 10.1007/s00535-008-2296-0; Boyle RJ, 2006, AM J CLIN NUTR, V83, P1256, DOI 10.1093/ajcn/83.6.1256; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Collado MC, 2009, CURR DRUG METAB, V10, P68, DOI 10.2174/138920009787048437; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; Feng T, 2011, INT IMMUNOPHARMACOL, V11, P589, DOI 10.1016/j.intimp.2010.11.016; Ghadimi D, 2010, INFLAMM BOWEL DIS, V16, P410, DOI 10.1002/ibd.21057; Golowczyc MA, 2007, INT J FOOD MICROBIOL, V118, P264, DOI 10.1016/j.ijfoodmicro.2007.07.042; Gomez-Llorente C, 2010, P NUTR SOC, V69, P381, DOI 10.1017/S0029665110001527; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hansen J, 2010, CURR OPIN GASTROEN, V26, P564, DOI 10.1097/MOG.0b013e32833f1195; Hiramatsu Y, 2012, MICROBES INFECT; Hoarau C, 2006, J ALLERGY CLIN IMMUN, V117, P696, DOI 10.1016/j.jaci.2005.10.043; Hua MC, 2010, WORLD J GASTROENTERO, V16, P3529, DOI 10.3748/wjg.v16.i28.3529; Huang JS, 2002, DIGEST DIS SCI, V47, P2625, DOI 10.1023/A:1020501202369; Kaji R, 2010, J IMMUNOL, V184, P3505, DOI 10.4049/jimmunol.0901569; Karska-Wysocki B, 2010, MICROBIOL RES, V165, P674, DOI 10.1016/j.micres.2009.11.008; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; Kim YG, 2006, MICROBES INFECT, V8, P994, DOI 10.1016/j.micinf.2005.10.019; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Lavelle EC, 2010, MUCOSAL IMMUNOL, V3, P17, DOI 10.1038/mi.2009.124; Liong MT, 2008, NUTR REV, V66, P192, DOI 10.1111/j.1753-4887.2008.00024.x; Lopez P, 2010, INT J FOOD MICROBIOL, V138, P157, DOI 10.1016/j.ijfoodmicro.2009.12.023; Madsen K, 2006, J CLIN GASTROENTEROL, V40, P232, DOI 10.1097/00004836-200603000-00014; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Munoz-Quezada S, 2013, Br. J. Nutr., V109, pS51, Patent No. 090006; Munoz-Quezada S, 2013, BRIT J NUTR, V109, pS63, DOI 10.1017/S0007114512005600; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Pelletier X, 2001, EUR J CLIN NUTR, V55, P509, DOI 10.1038/sj.ejcn.1601169; Pinto MGV, 2009, INT J FOOD MICROBIOL, V133, P86, DOI 10.1016/j.ijfoodmicro.2009.05.013; Plantinga TS, 2011, CLIN VACCINE IMMUNOL, V18, P621, DOI 10.1128/CVI.00498-10; Rafter J, 2007, AM J CLIN NUTR, V85, P488, DOI 10.1093/ajcn/85.2.488; Rizzello V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/473097; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Strobl H, 1999, MICROBES INFECT, V1, P1283, DOI 10.1016/S1286-4579(99)00256-7; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Tsilingiri K, 2012, GUT, V61, P1007, DOI 10.1136/gutjnl-2011-300971; Turroni F, 2011, INT J FOOD MICROBIOL, V149, P37, DOI 10.1016/j.ijfoodmicro.2010.12.010; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Verbeek R, 2010, BENEF MICROBES, V1, P109, DOI 10.3920/BM2009.0026; Voltan S, 2007, CLIN VACCINE IMMUNOL, V14, P1138, DOI 10.1128/CVI.00079-07; Weiss G, 2011, CYTOKINE, V56, P520, DOI 10.1016/j.cyto.2011.07.024; Woodard GA, 2009, J GASTROINTEST SURG, V13, P1198, DOI 10.1007/s11605-009-0891-x; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	57	73	76	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59370	10.1371/journal.pone.0059370	http://dx.doi.org/10.1371/journal.pone.0059370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555025	Green Submitted, Green Published, gold			2022-12-25	WOS:000316252500086
J	Chiang, NJ; Lin, CI; Liou, JP; Kuo, CC; Chang, CY; Chen, LT; Chang, JY				Chiang, Nai-Jung; Lin, Ching-I; Liou, Jing-Ping; Kuo, Ching-Chuan; Chang, Chi-Yen; Chen, Li-Tzong; Chang, Jang-Yang			A Novel Synthetic Microtubule Inhibitor, MPT0B214 Exhibits Antitumor Activity in Human Tumor Cells through Mitochondria-Dependent Intrinsic Pathway	PLOS ONE			English	Article							HUMAN CANCER-CELLS; TUBULIN-BINDING AGENTS; ANTIMITOTIC ACTIVITY; ANTICANCER DRUGS; PROTEIN-KINASE; CDC25 PROTEIN; IN-VITRO; CYCLIN-B; APOPTOSIS; PHOSPHORYLATION	Agents that interfere with mitotic progression by disturbing microtubule dynamics are commonly used for cancer treatment. Previously, a series of aroylquinolone regioisomers as novel microtubule inhibitors were discovered. One of these new compounds, MPT0B214 inhibited tubulin polymerization through strongly binding to the tubulin's colchicine-binding site and had cytotoxic activity in a variety of human tumor cell lines. After treatment with MPT0B214, KB cells were arrested in the G(2)-M phase before cell death occurred, which were associated with upregulation of cyclin B1, dephosphorylation of Cdc2, phosphorylation of Cdc25C and elevated expression of the mitotic marker MPM-2. Furthermore, the compound induced apoptotic cell death through mitochondria/caspase 9-dependent pathway. Notably, several KB-derived multidrug-resistant cancer cell lines were also sensitive to MPT0B214 treatment. These findings showed that MPT0B214 is a potential compound in the treatment of various malignancies.	[Chiang, Nai-Jung; Lin, Ching-I; Kuo, Ching-Chuan; Chang, Chi-Yen; Chen, Li-Tzong; Chang, Jang-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chiang, Nai-Jung; Lin, Ching-I; Chen, Li-Tzong; Chang, Jang-Yang] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Hematol Oncol, Tainan 70428, Taiwan; [Lin, Ching-I] St Martin De Porres Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Liou, Jing-Ping] Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Taipei Medical University	Chang, JY (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	jychang@nhri.org.tw	Chen, Li-Tzong/D-2071-2010; Chang, Jang-Yang/D-2099-2010; Kuo, Ching-Chuan/C-1201-2010		National Science Council [NSC-101-2325-B-400-007]; Department of Health [DOH101-TD-C-111-004]; National Health Research Institutes, Taiwan, ROC [CA-101-PP-22]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; National Health Research Institutes, Taiwan, ROC(National Health Research Institutes - Taiwan)	This work was supported by grants from National Science Council (NSC-101-2325-B-400-007), Department of Health (DOH101-TD-C-111-004), and National Health Research Institutes (CA-101-PP-22), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos LA, 2000, CURR OPIN STRUC BIOL, V10, P236, DOI 10.1016/S0959-440X(00)00070-1; Attard G, 2006, PATHOL BIOL, V54, P72, DOI 10.1016/j.patbio.2005.03.003; BLAGOSKLONNY MV, 1995, CANCER RES, V55, P4623; BOLLAG DM, 1995, CANCER RES, V55, P2325; Chang JY, 2004, MOL PHARMACOL, V65, P77, DOI 10.1124/mol.65.1.77; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; FERGUSON PJ, 1988, CANCER RES, V48, P5956; FINLAY GJ, 1984, ANAL BIOCHEM, V139, P272, DOI 10.1016/0003-2697(84)90002-2; Gaj CL, 1998, BIOCHEM PHARMACOL, V55, P1199, DOI 10.1016/S0006-2952(97)00614-X; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; Haldar S, 1997, CANCER RES, V57, P229; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Hsieh CC, 2010, BIOCHEM PHARMACOL, V79, P1261, DOI 10.1016/j.bcp.2009.12.017; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liou JP, 2007, J PHARMACOL EXP THER, V323, P398, DOI 10.1124/jpet.107.126680; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nien CY, 2010, J MED CHEM, V53, P2309, DOI 10.1021/jm900685y; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Scatena CD, 1998, J BIOL CHEM, V273, P30777, DOI 10.1074/jbc.273.46.30777; Srivastava RK, 1998, MOL CELL BIOL, V18, P3509, DOI 10.1128/MCB.18.6.3509; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Tahir SK, 2001, CANCER RES, V61, P5480; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469	35	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58953	10.1371/journal.pone.0058953	http://dx.doi.org/10.1371/journal.pone.0058953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554962	gold, Green Published, Green Submitted			2022-12-25	WOS:000316252500059
J	Wijsman, LW; de Craen, AJM; Trompet, S; Gussekloo, J; Stott, DJ; Rodondi, N; Welsh, P; Jukema, JW; Westendorp, RGJ; Mooijaart, SP				Wijsman, Liselotte W.; de Craen, Anton J. M.; Trompet, Stella; Gussekloo, Jacobijn; Stott, David J.; Rodondi, Nicolas; Welsh, Paul; Jukema, J. Wouter; Westendorp, Rudi G. J.; Mooijaart, Simon P.			Subclinical Thyroid Dysfunction and Cognitive Decline in Old Age	PLOS ONE			English	Article							CARDIOVASCULAR RISK; ATRIAL-FIBRILLATION; THYROTROPIN CONCENTRATIONS; TOTAL CHOLESTEROL; HYPOTHYROIDISM; DISEASE; MORTALITY; HYPERTHYROIDISM; ASSOCIATION; GUIDELINES	Background: Subclinical thyroid dysfunction has been implicated as a risk factor for cognitive decline in old age, but results are inconsistent. We investigated the association between subclinical thyroid dysfunction and cognitive decline in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Methods: Prospective longitudinal study of men and women aged 70-82 years with pre-existing vascular disease or more than one risk factor to develop this condition (N = 5,154). Participants taking antithyroid medications, thyroid hormone supplementation and/or amiodarone were excluded. Thyroid function was measured at baseline: subclinical hyper- and hypothyroidism were defined as thyroid stimulating hormones (TSH),0.45 mU/L or.4.50 mU/L respectively, with normal levels of free thyroxine (FT4). Cognitive performance was tested at baseline and at four subsequent time points during a mean follow-up of 3 years, using five neuropsychological performance tests. Results: Subclinical hyperthyroidism and hypothyroidism were found in 65 and 161 participants, respectively. We found no consistent association of subclinical hyper-or hypothyroidism with altered cognitive performance compared to euthyroid participants on the individual cognitive tests. Similarly, there was no association with rate of cognitive decline during follow-up. Conclusion: We found no consistent evidence that subclinical hyper-or hypothyroidism contribute to cognitive impairment or decline in old age. Although our data are not in support of treatment of subclinical thyroid dysfunction to prevent cognitive dysfunction in later life, only large randomized controlled trials can provide definitive evidence.	[Wijsman, Liselotte W.; de Craen, Anton J. M.; Trompet, Stella; Westendorp, Rudi G. J.; Mooijaart, Simon P.] Leiden Univ Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ Med Ctr, Dept Cardiol, Leiden, Netherlands; [Gussekloo, Jacobijn] Leiden Univ Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Stott, David J.] Univ Glasgow, Fac Med, Acad Sect Geriatr Med, Glasgow, Lanark, Scotland; [Rodondi, Nicolas] Univ Bern, Inselhosp, Dept Gen Internal Med, Bern, Switzerland; [Welsh, Paul] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Mooijaart, Simon P.] Inst Evidence Based Med Old Age IEMO, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); University of Glasgow; University of Bern; University Hospital of Bern; University of Glasgow	Mooijaart, SP (corresponding author), Leiden Univ Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	s.p.mooijaart@lumc.nl	Gussekloo, Jacobijn/ABE-3879-2021; Jukema, J. Wouter/ABD-6503-2021; Mooijaart, Simon P./A-5306-2008; Welsh, Paul/H-5249-2019	Gussekloo, Jacobijn/0000-0001-7186-8278; Jukema, J. Wouter/0000-0002-3246-8359; Mooijaart, Simon P./0000-0003-3106-3568; Welsh, Paul/0000-0002-7970-3643; Rodondi, Nicolas/0000-0001-9083-6896	Bristol-Myers Squibb, USA; Swiss National Science Foundation [SNSF 320030-138267]; Netherlands Consortium for Healthy Ageing, The Netherlands	Bristol-Myers Squibb, USA(Bristol-Myers Squibb); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Netherlands Consortium for Healthy Ageing, The Netherlands(Netherlands Government)	The PROSPER (The Prospective Study of Pravastatin in the Elderly at Risk) study was supported by an investigator initiated grant from Bristol-Myers Squibb, USA, and by a grant from the Swiss National Science Foundation (SNSF 320030-138267, PI: NR). The investigators were financed by the Netherlands Consortium for Healthy Ageing, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer J, 2001, AM HEART J, V142, P838, DOI 10.1067/mhj.2001.119370; Bensenor IM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-298; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Casserly Ivan P, 2004, Discov Med, V4, P149; Ceresini G, 2009, J AM GERIATR SOC, V57, P89, DOI 10.1111/j.1532-5415.2008.02080.x; Diez JJ, 2005, J CLIN ENDOCR METAB, V90, P4124, DOI 10.1210/jc.2005-0375; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Hogervorst E, 2008, PSYCHONEUROENDOCRINO, V33, P1013, DOI 10.1016/j.psyneuen.2008.05.008; Houx PJ, 2002, J NEUROL NEUROSUR PS, V73, P385, DOI 10.1136/jnnp.73.4.385; Hueston WJ, 2004, ANN FAM MED, V2, P351, DOI 10.1370/afm.79; Jorde R, 2006, J CLIN ENDOCR METAB, V91, P145, DOI 10.1210/jc.2005-1775; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Kanaya AM, 2002, ARCH INTERN MED, V162, P773, DOI 10.1001/archinte.162.7.773; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Klubo-Gwiezdzinska J, 2009, ARCH INTERN MED, V169, P1949, DOI 10.1001/archinternmed.2009.415; Ladenson PW, 2000, ARCH INTERN MED, V160, P1573, DOI 10.1001/archinte.160.11.1573; Luboshitzky R, 2002, THYROID, V12, P421, DOI 10.1089/105072502760043512; Mooijaart SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023890; Nanchen D, 2012, J CLIN ENDOCR METAB, V97, P852, DOI 10.1210/jc.2011-1978; Packard CJ, 2005, CIRCULATION, V112, P3058, DOI 10.1161/CIRCULATIONAHA.104.526848; Parle J, 2010, J CLIN ENDOCR METAB, V95, P3623, DOI 10.1210/jc.2009-2571; Peeters RP, 2009, J CLIN ENDOCR METAB, V94, P4658, DOI 10.1210/jc.2009-2198; Pinchera A, 2005, THYROID, V15, P1, DOI 10.1089/thy.2005.15.1; Roberts LM, 2006, ANN INTERN MED, V145, P573, DOI 10.7326/0003-4819-145-8-200610170-00006; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0; Stabouli S, 2010, EXPERT REV CARDIOVAS, V8, P1559, DOI [10.1586/erc.10.141, 10.1586/ERC.10.141]; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; Trompet S, 2009, AM J EPIDEMIOL, V170, P1415, DOI 10.1093/aje/kwp294; van Bemmel T, 2006, J HYPERTENS, V24, P287, DOI 10.1097/01.hjh.0000200513.48441.8e; van Boxtel MPJ, 2004, PSYCHONEUROENDOCRINO, V29, P891, DOI 10.1016/j.psyneuen.2003.08.002; Waldemar G, 2007, EUR J NEUROL, V14, pE1, DOI 10.1111/j.1468-1331.2006.01605.x; Walsh JP, 2005, CLIN ENDOCRINOL, V63, P670, DOI 10.1111/j.1365-2265.2005.02399.x; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9	38	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59199	10.1371/journal.pone.0059199	http://dx.doi.org/10.1371/journal.pone.0059199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554996	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000316252500073
J	Geyer, BC; Larrimore, KE; Kilbourne, J; Kannan, L; Mor, TS				Geyer, Brian C.; Larrimore, Katherine E.; Kilbourne, Jacquelyn; Kannan, Latha; Mor, Tsafrir S.			Reversal of Succinylcholine Induced Apnea with an Organophosphate Scavenging Recombinant Butyrylcholinesterase	PLOS ONE			English	Article							RAPID-SEQUENCE INTUBATION; FRESH-FROZEN PLASMA; HUMAN-SERUM; PROLONGED APNEA; NEUROMUSCULAR BLOCKADE; CHOLINESTERASE; DEFICIENCY; COCAINE; ENZYME; ACETYLCHOLINESTERASE	Background: Concerns about the safety of paralytics such as succinylcholine to facilitate endotracheal intubation limit their use in prehospital and emergency department settings. The ability to rapidly reverse paralysis and restore respiratory drive would increase the safety margin of an agent, thus permitting the pursuit of alternative intubation strategies. In particular, patients who carry genetic or acquired deficiency of butyrylcholinesterase, the serum enzyme responsible for succinylcholine hydrolysis, are susceptible to succinylcholine-induced apnea, which manifests as paralysis, lasting hours beyond the normally brief half-life of succinylcholine. We hypothesized that intravenous administration of plant-derived recombinant BChE, which also prevents mortality in nerve agent poisoning, would rapidly reverse the effects of succinylcholine. Methods: Recombinant butyrylcholinesterase was produced in transgenic plants and purified. Further analysis involved murine and guinea pig models of succinylcholine toxicity. Animals were treated with lethal and sublethal doses of succinylcholine followed by administration of butyrylcholinesterase or vehicle. In both animal models vital signs and overall survival at specified intervals post succinylcholine administration were assessed. Results: Purified plant-derived recombinant human butyrylcholinesterase can hydrolyze succinylcholine in vitro. Challenge of mice with an LD100 of succinylcholine followed by BChE administration resulted in complete prevention of respiratory inhibition and concomitant mortality. Furthermore, experiments in symptomatic guinea pigs demonstrated extremely rapid succinylcholine detoxification with complete amelioration of symptoms and no apparent complications. Conclusions: Recombinant plant-derived butyrylcholinesterase was capable of counteracting and reversing apnea in two complementary models of lethal succinylcholine toxicity, completely preventing mortality. This study of a protein antidote validates the feasibility of protection and treatment of overdose from succinylcholine as well as other biologically active butyrylcholinesterase substrates.	[Mor, Tsafrir S.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA; Arizona State Univ, Biodesign Inst, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Mor, TS (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA.	tsafrir.mor@asu.edu			National Institutes of Health CounterACT Program through the National Institute of Neurological Disorders and Stroke [U-54-NSO58183-01];  [W81XWH-07-2-0023]	National Institutes of Health CounterACT Program through the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); 	This work was funded in part by the National Institutes of Health CounterACT Program through the National Institute of Neurological Disorders and Stroke under the U-54-NSO58183-01 award, a consortium grant awarded to USAMRICD and contracted to TM under the research cooperative agreement number W81XWH-07-2-0023. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Emergency Physicians (ACEP), 2011, Ann Emerg Med, V58, P113, DOI 10.1016/j.annemergmed.2011.05.005; Ashani Y, 2000, DRUG DEVELOP RES, V50, P298, DOI 10.1002/1098-2299(200007/08)50:3/4<298::AID-DDR13>3.3.CO;2-O; Barker I, 2003, ANAESTHESIA, V58, P1144, DOI 10.1046/j.1365-2044.2003.03516.x; BAULD HW, 1974, BRIT J ANAESTH, V46, P273, DOI 10.1093/bja/46.4.273; BAULD HW, 1983, CAN MED ASSOC J, V128, P894; BEVAN DR, 1983, CAN ANAESTH SOC J, V30, P536, DOI 10.1007/BF03007091; BODLEY PO, 1969, BRIT MED J, V3, P510, DOI 10.1136/bmj.3.5669.510; Bodur E, 2010, BIOCHIMIE, V92, P979, DOI 10.1016/j.biochi.2010.04.010; Brimijoin S, 2008, NEUROPSYCHOPHARMACOL, V33, P2715, DOI 10.1038/sj.npp.1301666; Buyel JF, 2013, BIOENGINEERED, V4, P21, DOI 10.4161/bioe.21671; CHRISPIN P, 1995, LANCET, V345, P1248, DOI 10.1016/S0140-6736(95)92036-6; Davis DP, 2008, CAN MED ASSOC J, V178, P1171, DOI 10.1503/cmaj.080234; Davis DP, 2003, J TRAUMA, V55, P713, DOI 10.1097/01.TA.0000037428.65987.12; Evron T, 2007, FASEB J, V21, P2961, DOI 10.1096/fj.07-8112com; FISHER DM, 1988, ANESTHESIOLOGY, V69, P757, DOI 10.1097/00000542-198811000-00020; FULLER BH, 1990, S AFR MED J, V78, P577; Gao Y, 2004, J PHARMACOL EXP THER, V310, P1046, DOI 10.1124/jpet.104.068122; Garello E, 1999, DIGEST DIS SCI, V44, P782, DOI 10.1023/A:1026678228967; GAULT DT, 1987, BURNS, V13, P208, DOI 10.1016/0305-4179(87)90168-9; GEORGE PM, 1988, CLIN BIOCHEM, V21, P159, DOI 10.1016/0009-9120(88)90003-3; Geyer BC, 2008, CHEM-BIOL INTERACT, V175, P376, DOI 10.1016/j.cbi.2008.04.012; Geyer BC, 2010, P NATL ACAD SCI USA, V107, P20251, DOI 10.1073/pnas.1009021107; Geyer BC, 2010, PLANT BIOTECHNOL J, V8, P873, DOI 10.1111/j.1467-7652.2010.00515.x; GILL RS, 1991, ANAESTHESIA, V46, P1036, DOI 10.1111/j.1365-2044.1991.tb09917.x; Gudzenko V, 2010, RESP CARE, V55, P1026; Hamamoto Yasushi, 2004, Radiat Med, V22, P316; Han TH, 2011, BRIT J ANAESTH, V106, P675, DOI 10.1093/bja/aer023; Harle CC, 2004, ANAESTHESIA, V59, P89, DOI 10.1111/j.1365-2044.2004.03585.x; Herbstritt A, 2012, EMERG MED J, V29, P256, DOI 10.1136/emermed-2012-201100.4; KAO YJ, 1989, ANESTHESIOLOGY, V70, P905, DOI 10.1097/00000542-198906000-00004; Koseoglu V, 1999, BONE MARROW TRANSPL, V24, P1367, DOI 10.1038/sj.bmt.1702097; KRAMER LP, 1982, CAN MED ASSOC J, V127, P1078; Lewis RJ, 1996, SAXS DANGEROUS PROPE; LOCKRIDGE O, 1990, PHARMACOL THERAPEUT, V47, P35, DOI 10.1016/0163-7258(90)90044-3; Lossius HM, 2011, CRIT CARE, V15, DOI 10.1186/cc9973; Lurie S, 2007, REPROD SCI, V14, P192, DOI 10.1177/1933719107299871; Lynch TJ, 1997, TOXICOL APPL PHARM, V145, P363, DOI 10.1006/taap.1997.8187; Mace SE, 2008, EMERG MED CLIN N AM, V26, P1043, DOI 10.1016/j.emc.2008.10.002; Mallon WK, 2009, J EMERG MED, V37, P183, DOI 10.1016/j.jemermed.2008.07.021; Manoharan I, 2007, CLIN CHIM ACTA, V378, P128, DOI 10.1016/j.cca.2006.11.005; Masson P, 1997, BIOCHEMISTRY-US, V36, P2266, DOI 10.1021/bi962484a; Masson P, 2009, PROTEIN PEPTIDE LETT, V16, P1215, DOI 10.2174/092986609789071207; MCGUIRE MC, 1989, P NATL ACAD SCI USA, V86, P953, DOI 10.1073/pnas.86.3.953; Merlin MA, 2010, PREHOSP DISASTER MED, V25, P341, DOI 10.1017/S1049023X00008311; METS B, 1990, S AFR MED J, V77, P311; Mollerup HM, 2011, ACTA ANAESTH SCAND, V55, P82, DOI 10.1111/j.1399-6576.2010.02316.x; Mor T.S., 2004, ENCY PLANT CROP SCI, P564; Niazi A, 2004, J CLIN ANESTH, V16, P40, DOI 10.1016/j.jclinane.2003.02.010; Norris JC, 2003, ANAESTHESIA, V58, P1137, DOI 10.1046/j.1365-2044.2003.03503.x; OSTERGAARD D, 1995, ANESTHESIOLOGY, V82, P1295, DOI 10.1097/00000542-199505000-00027; Perry JJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002788.pub2; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Ruskin K, 2011, ANESTHESIA EMERGENCI; Saxena A, 2006, J MOL NEUROSCI, V30, P145, DOI 10.1385/JMN:30:1:145; Soliday Flanna K, 2010, AANA J, V78, P313; Sorensen MK, 2012, BRIT J ANAESTH, V108, P682, DOI 10.1093/bja/aer503; Strayer RJ, 2010, J EMERG MED, V39, P345, DOI 10.1016/j.jemermed.2009.08.070; VIBYMOGENSEN J, 1978, ACTA ANAESTH SCAND, V22, P371, DOI 10.1111/j.1399-6576.1978.tb01313.x; Wang HE, 2006, PREHOSP EMERG CARE, V10, P261, DOI 10.1080/10903120500541506; Zelicof-Paul A, 2005, CURR OPIN PEDIATR, V17, P355, DOI 10.1097/01.mop.0000162365.64140.b7; Zencirci B, 2010, INT J GEN MED, V3, P375, DOI 10.2147/IJGM.S14365; Zimran A, 2011, BLOOD, V118, P5767, DOI 10.1182/blood-2011-07-366955	62	6	7	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59159	10.1371/journal.pone.0059159	http://dx.doi.org/10.1371/journal.pone.0059159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536865	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100124
J	Ducker, GS; Atreya, CE; Simko, JP; Hom, YK; Matli, MR; Benes, CH; Hann, B; Nakakura, EK; Bergsland, EK; Donner, DB; Settleman, J; Shokat, KM; Warren, RS				Ducker, G. S.; Atreya, C. E.; Simko, J. P.; Hom, Y. K.; Matli, M. R.; Benes, C. H.; Hann, B.; Nakakura, E. K.; Bergsland, E. K.; Donner, D. B.; Settleman, J.; Shokat, K. M.; Warren, R. S.			Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors	ONCOGENE			English	Article						mTOR; colon cancer; PIK3CA; KRAS; xenograft; PP242	RENAL-CELL CARCINOMA; COLORECTAL-CANCER; KINASE INHIBITORS; BINDING PARTNER; PIK3CA MUTATION; GROWTH-CONTROL; COLON-CANCER; LUNG-CANCER; IN-VITRO; RAPAMYCIN	The mammalian target of rapamycin (mTOR) regulates cell growth by integrating nutrient and growth factor signaling and is strongly implicated in cancer. But mTOR is not an oncogene, and which tumors will be resistant or sensitive to new adenosine triphosphate (ATP) competitive mTOR inhibitors now in clinical trials remains unknown. We screened a panel of over 600 human cancer cell lines to identify markers of resistance and sensitivity to the mTOR inhibitor PP242. RAS and phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) mutations were the most significant genetic markers for resistance and sensitivity to PP242, respectively; colon origin was the most significant marker for resistance based on tissue type. Among colon cancer cell lines, those with KRAS mutations were most resistant to PP242, whereas those without KRAS mutations most sensitive. Surprisingly, cell lines with co-mutation of PIK3CA and KRAS had intermediate sensitivity. Immunoblot analysis of the signaling targets downstream of mTOR revealed that the degree of cellular growth inhibition induced by PP242 was correlated with inhibition of phosphorylation of the translational repressor eIF4E-binding protein 1 (4E-BP1), but not ribosomal protein S6 (rpS6). In a tumor growth inhibition trial of PP242 in patient-derived colon cancer xenografts, resistance to PP242-induced inhibition of 4E-BP1 phosphorylation and xenograft growth was again observed in KRAS mutant tumors without PIK3CA co-mutation, compared with KRAS wild-type controls. We show that, in the absence of PIK3CA co-mutation, KRAS mutations are associated with resistance to PP242 and that this is specifically linked to changes in the level of phosphorylation of 4E-BP1.	[Ducker, G. S.; Shokat, K. M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Atreya, C. E.; Bergsland, E. K.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Simko, J. P.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Hom, Y. K.; Hann, B.] Univ Calif San Francisco, Preclin Therapeut Core, San Francisco, CA 94143 USA; [Hom, Y. K.; Matli, M. R.; Hann, B.; Nakakura, E. K.; Donner, D. B.; Shokat, K. M.; Warren, R. S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Matli, M. R.; Nakakura, E. K.; Donner, D. B.; Warren, R. S.] Univ Calif San Francisco, Dept Surg, Sect Surg Oncol, San Francisco, CA 94115 USA; [Benes, C. H.; Settleman, J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Shokat, K. M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Shokat, K. M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 600 E 16th St,MC 2280, San Francisco, CA 94158 USA.	shokat@cmp.ucsf.edu; robert.warren@ucsfmedctr.org		Ducker, Gregory/0000-0002-8651-6846	American Cancer Society Postdoctoral Fellowship [11-183-TBG]; Millennium Pharmaceuticals provided through the Alliance for Clinical Trials in Oncology Foundation; Littlefield Trust; Howard Hughes Medical Institute; Waxman Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER	American Cancer Society Postdoctoral Fellowship(American Cancer Society); Millennium Pharmaceuticals provided through the Alliance for Clinical Trials in Oncology Foundation; Littlefield Trust; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Waxman Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank Dan Moore for his critical assistance in the statistical analysis, Sandy Devries for FISH analysis, Katherine Pogue-Guile for permission to use the ColoCarta oligonucleotide primer design files and Morris Feldman, Jon Ostrem and Iana Serafimova for reagents. CEA is supported in part by American Cancer Society Postdoctoral Fellowship 11-183-TBG; she also acknowledges support Millennium Pharmaceuticals provided through the Alliance for Clinical Trials in Oncology Foundation. RSW is supported in part by a charitable donation from the Littlefield 2000 Trust. KMS is supported by the Howard Hughes Medical Institute and the Waxman Foundation.	Alain T, 2012, CANCER RES, V72, P6468, DOI 10.1158/0008-5472.CAN-12-2395; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Atreya CE, 2012, INVEST NEW DRUG, V30, P2219, DOI 10.1007/s10637-012-9793-y; Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Blaser B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-86; Bohanes P, 2011, SEMIN ONCOL, V38, P576, DOI 10.1053/j.seminoncol.2011.05.012; Brough R, 2011, CURR OPIN GENET DEV, V21, P34, DOI 10.1016/j.gde.2010.10.009; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; House MG, 2010, J AM COLL SURGEONS, V210, P744, DOI 10.1016/j.jamcollsurg.2009.12.040; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Le NT, 2012, CIRC RES, V110, P536, DOI 10.1161/CIRCRESAHA.111.254730; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Weigelt B, 2011, ONCOGENE, V30, P3222, DOI 10.1038/onc.2011.42; Zhang YJ, 2011, DRUG DISCOV TODAY, V16, P325, DOI 10.1016/j.drudis.2011.02.008; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014	56	60	61	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 20	2014	33	12					1590	1600		10.1038/onc.2013.92	http://dx.doi.org/10.1038/onc.2013.92			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD4TS	23542178	Green Submitted, Green Accepted			2022-12-25	WOS:000333244200012
J	Amiya, E; Watanabe, M; Takeda, N; Saito, T; Shiga, T; Hosoya, Y; Nakao, T; Imai, Y; Manabe, I; Nagai, R; Komuro, I; Maemura, K				Amiya, Eisuke; Watanabe, Masafumi; Takeda, Norihiko; Saito, Tetsuya; Shiga, Taro; Hosoya, Yumiko; Nakao, Tomoko; Imai, Yasushi; Manabe, Ichiro; Nagai, Ryozo; Komuro, Issei; Maemura, Koji			Angiotensin II Impairs Endothelial Nitric-oxide Synthase Bioavailability under Free Cholesterol-enriched Conditions via Intracellular Free Cholesterol-rich Membrane Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE-CELLS; HUMAN ATHEROSCLEROTIC LESIONS; LIPID RAFTS; IN-VITRO; DYSFUNCTION; ACTIVATION; CAVEOLIN-1; MICE; HYPERCHOLESTEROLEMIA	Vascular endothelial function is impaired in hypercholesterolemia partly because of injury by modified LDL. In addition to modified LDL, free cholesterol (FC) is thought to play an important role in the development of endothelial dysfunction, although the precise mechanisms remain to be elucidated. The aim of this study was to clarify the mechanisms of endothelial dysfunction induced by an FC-rich environment. Loading cultured human aortic endothelial cells with FC induced the formation of vesicular structures composed of FC-rich membranes. Raft proteins such as phospho-caveolin-1 (Tyr-14) and small GTPase Rac were accumulated toward FC-rich membranes around vesicular structures. In the presence of these vesicles, angiotensin II-induced production of reactive oxygen species (ROS) was considerably enhanced. This ROS shifted endothelial NOS(eNOS) toward vesicle membranes and vesicles with a FC-rich domain trafficked toward perinuclear late endosomes/lysosomes, which resulted in the deterioration of eNOS Ser-1177 phosphorylation and NO production. Angiotensin II-induced ROS decreased the bioavailability of eNOS under the FC-enriched condition.	[Amiya, Eisuke; Watanabe, Masafumi; Takeda, Norihiko; Saito, Tetsuya; Shiga, Taro; Hosoya, Yumiko; Nakao, Tomoko; Imai, Yasushi; Manabe, Ichiro; Nagai, Ryozo; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Nagai, Ryozo] Jichi Med Univ, Shimotsuke 3290498, Japan; [Komuro, Issei] Nagasaki Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka 5650871, Japan; [Maemura, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiovasc Med, Nagasaki 8528102, Japan	University of Tokyo; Jichi Medical University; Nagasaki University; Nagasaki University	Maemura, K (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiovasc Med, 1-7-1 Sakamoto, Nagasaki 8528102, Japan.	maemura@nagasaki-u.ac.jp	Amiya, Eisuke/O-4981-2019; Manabe, Ichiro/E-1529-2014; Manabe, Ichiro/AAE-5105-2021	Amiya, Eisuke/0000-0003-2810-8040; 	Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy; Ministry of Education, Science, and Culture, Japan [19590853]; Takeda Science Foundation; Mitsubishi Pharma Research Foundation	Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP)); Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation	This work was supported by grants from the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy. This work was also supported by Grant-in-Aid for Scientific Research 19590853 from the Ministry of Education, Science, and Culture, Japan (to K. M.) and by funds from the Takeda Science Foundation (to K. M.) and the Mitsubishi Pharma Research Foundation (to K. M.).	Blair A, 1999, J BIOL CHEM, V274, P32512, DOI 10.1074/jbc.274.45.32512; Bodary PF, 2005, CIRCULATION, V111, P629, DOI 10.1161/01.CIR.0000154550.15963.80; Brown AJ, 2000, J LIPID RES, V41, P226; CHAO FF, 1988, AM J PATHOL, V131, P73; Chen WG, 2010, BIOCHEMISTRY-US, V49, P3129, DOI 10.1021/bi9016632; CONRAD PA, 1995, J CELL BIOL, V131, P1421, DOI 10.1083/jcb.131.6.1421; Cox DA, 1996, PHARMACOL REV, V48, P3; Cuddy LK, 2012, J NEUROSCI, V32, P5573, DOI 10.1523/JNEUROSCI.5235-11.2012; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Fang Y, 2006, CIRC RES, V98, P1064, DOI 10.1161/01.RES.0000218776.87842.43; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fernandes R, 2011, AM J PHYSIOL-CELL PH, V300, pC927, DOI 10.1152/ajpcell.00140.2010; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Grosheva I, 2009, ARTERIOSCL THROM VAS, V29, P1615, DOI 10.1161/ATVBAHA.109.191882; Hakala JK, 2003, ARTERIOSCL THROM VAS, V23, P1430, DOI 10.1161/01.ATV.0000077207.49221.06; Heare T, 2007, J INHERIT METAB DIS, V30, P79, DOI 10.1007/s10545-006-0473-y; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Jin S, 2008, ARTERIOSCL THROM VAS, V28, P485, DOI 10.1161/ATVBAHA.107.159772; KIM JA, 1991, J LIPID RES, V32, P1125; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; KRUTH HS, 1984, ATHEROSCLEROSIS, V51, P281, DOI 10.1016/0021-9150(84)90175-8; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lobysheva I, 2011, ARTERIOSCL THROM VAS, V31, P2098, DOI 10.1161/ATVBAHA.111.230623; Maron BA, 2012, CIRC J, V76, P2497, DOI 10.1253/circj.CJ-12-1207; MCGOOKEY DJ, 1983, J CELL BIOL, V96, P1273, DOI 10.1083/jcb.96.5.1273; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Morikage N, 2006, CIRC RES, V99, P299, DOI 10.1161/01.RES.0000235877.33682.e9; Paragh G, 1999, J LIPID RES, V40, P1728; Pietiainen VM, 2005, ANN MED, V37, P394, DOI 10.1080/07853890510011976; Porto A, 2006, FASEB J, V20, P2565, DOI 10.1096/fj.06-5867fje; Presley T, 2008, AM J PHYSIOL-CELL PH, V295, pC1281, DOI 10.1152/ajpcell.00550.2007; Pritchard KA, 2002, FREE RADICAL BIO MED, V33, P52, DOI 10.1016/S0891-5849(02)00851-1; Qin CB, 2006, ARTERIOSCL THROM VAS, V26, P372, DOI 10.1161/01.ATV.0000197848.67999.e1; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Robinson JM, 2001, HISTOCHEM CELL BIOL, V116, P119; Rombach SM, 2010, MOL GENET METAB, V99, P99, DOI 10.1016/j.ymgme.2009.10.004; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Sanchez FA, 2009, P NATL ACAD SCI USA, V106, P6849, DOI 10.1073/pnas.0812694106; Simionescu M, 2002, VASC PHARMACOL, V38, P275, DOI 10.1016/S1537-1891(02)00252-5; SIMIONESCU N, 1986, AM J PATHOL, V123, P109; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Yang BH, 2006, FASEB J, V20, P1501, DOI 10.1096/fj.05-5359fje; Zhang C, 2010, FREE RADICAL RES, V44, P831, DOI 10.3109/10715762.2010.485994; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026; Zuo L, 2005, ARTERIOSCL THROM VAS, V25, P1824, DOI 10.1161/01.ATV.0000175295.09607.18	48	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14497	14509		10.1074/jbc.M112.448522	http://dx.doi.org/10.1074/jbc.M112.448522			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548909	Green Published, hybrid			2022-12-25	WOS:000319253500052
J	Lo, CY; Antonopoulos, A; Gupta, R; Qu, J; Dell, A; Haslam, SM; Neelamegham, S				Lo, Chi Y.; Antonopoulos, Aristotelis; Gupta, Rohitesh; Qu, Jun; Dell, Anne; Haslam, Stuart M.; Neelamegham, Sriram			Competition between Core-2 GlcNAc-transferase and ST6GalNAc-transferase Regulates the Synthesis of the Leukocyte Selectin Ligand on Human P-selectin Glycoprotein Ligand-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLYCAN BIOSYNTHESIS; PSGL-1 AMINO-TERMINUS; SIALYL-LEWIS-X; SUBSTRATE-SPECIFICITY; CELL-ADHESION; T-CELLS; BINDING; SIALYLTRANSFERASE; OLIGOSACCHARIDE; IDENTIFICATION	The binding of selectins to carbohydrate ligands expressed on leukocytes regulates immunity and inflammation. Among the human selectin ligands, the O-linked glycans at the N-terminus of the leukocyte cell-surface molecule P-selectin glycoprotein ligand-1 (PSGL-1, CD162) are important because they bind all selectins (L-, E-, and P-selectin) with high affinity under hydrodynamic shear conditions. Analysis of glycan microheterogeneity at this site is complicated by the presence of 72 additional potential O-linked glycosylation sites on this mucinous protein. To overcome this limitation, truncated forms of PSGL-1, called "PSGL-1 peptide probes," were developed. Ultra-high sensitivity mass spectrometry analysis of glycans released from such probes along with glycoproteomic analysis demonstrate the presence of both the sialyl Lewis-X (sLe(X)) and the di-sialylated T-antigen (NeuAc alpha 2,3Gal beta 1,3(NeuAc alpha 2,6)GalNAc) at the PSGL-1 N-terminus. Overexpression of glycoprotein-specific ST6GalNAc-transferases (ST6GalNAc1, -2, or -4) in human promyelocytic HL-60 cells altered glycan structures and cell adhesion properties. In particular, ST6GalNAc2 overexpression abrogated cell surface HECA-452/CLA expression, reduced the number of rolling leukocytes on P-and L-selectin-bearing substrates by similar to 85%, and increased median rolling velocity of remaining cells by 80-150%. Cell rolling on E-selectin was unaltered although the number of adherent cells was reduced by 60%. ST6GalNAc2 partially co-localizes in the Golgi with the core-2 beta (1,6)GlcNAc-transferase C2GnT-1. Overall, the data describe the glycan microheterogeneity at the PSGL-1 N-terminus. They suggest that a competition between ST6GalNAc2 and C2GnT-1 for the core-1/Gal beta 1,3GalNAc glycan may regulate leukocyte adhesion under fluid shear.	[Lo, Chi Y.; Gupta, Rohitesh; Neelamegham, Sriram] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Qu, Jun] SUNY Buffalo, Buffalo, NY 14260 USA; [Qu, Jun; Neelamegham, Sriram] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Antonopoulos, Aristotelis; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London SW7 2AZ, England	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Imperial College London	Neelamegham, S (corresponding author), SUNY Buffalo, 906 Furnas Hall, Buffalo, NY 14260 USA.	neel@buffalo.edu		Neelamegham, Sriram/0000-0002-1371-8500; gupta, rohitesh/0000-0001-8515-5869	National Institutes of Health [HL63014, HL103411]; American Heart pre-doctoral fellowship; Biotechnology and Biological Sciences Research Council [B19088, BBF0083091]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103411, R01HL063014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM099607] Funding Source: NIH RePORTER; BBSRC [BB/F008309/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F008309/1] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart pre-doctoral fellowship(American Heart Association); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63014 and HL103411 (to S. N.). This work was also supported by an American Heart pre-doctoral fellowship (to C. Y. L.) and Biotechnology and Biological Sciences Research Council Grants B19088 and BBF0083091 (to A. D. and S. M. H.).	Aeed PA, 1998, GLYCOCONJUGATE J, V15, P975, DOI 10.1023/A:1006985825141; Afshar-Kharghan V, 2001, BLOOD, V97, P3306, DOI 10.1182/blood.V97.10.3306; AMANO J, 1988, J BIOL CHEM, V263, P1157; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; Beauharnois ME, 2005, BIOCHEMISTRY-US, V44, P9507, DOI 10.1021/bi0507130; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buffone A, 2013, J BIOL CHEM, V288, P1620, DOI 10.1074/jbc.M112.400929; Carlow DA, 2009, IMMUNOL REV, V230, P75, DOI 10.1111/j.1600-065X.2009.00797.x; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Goetz DJ, 1997, J CELL BIOL, V137, P509, DOI 10.1083/jcb.137.2.509; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hirata T, 2004, J BIOL CHEM, V279, P51775, DOI 10.1074/jbc.M409868200; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Jayakumar D, 2009, CYTOM PART A, V75A, P866, DOI 10.1002/cyto.a.20773; Julien S, 2007, J IMMUNOL, V179, P5701, DOI 10.4049/jimmunol.179.9.5701; Kono M, 2000, BIOCHEM BIOPH RES CO, V272, P94, DOI 10.1006/bbrc.2000.2745; Leon B, 2008, BLOOD, V111, P3126, DOI 10.1182/blood-2007-07-100610; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Liu W, 1998, J BIOL CHEM, V273, P7078, DOI 10.1074/jbc.273.12.7078; Marathe DD, 2010, BLOOD, V115, P1303, DOI 10.1182/blood-2009-07-231480; Marathe DD, 2008, FASEB J, V22, P4154, DOI 10.1096/fj.07-104257; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; Meng FY, 2001, NAT BIOTECHNOL, V19, P952, DOI 10.1038/nbt1001-952; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; Orr SL, 2013, GLYCOBIOLOGY, V23, P363, DOI 10.1093/glycob/cws150; PATEL KD, 1995, J CLIN INVEST, V96, P1887, DOI 10.1172/JCI118234; Patil SA, 2012, ANAL BIOCHEM, V425, P135, DOI 10.1016/j.ab.2012.03.009; PAULSON JC, 1982, J BIOL CHEM, V257, P2734; PILLER F, 1988, J BIOL CHEM, V263, P15146; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Skrincosky D, 1997, J BIOL CHEM, V272, P22695, DOI 10.1074/jbc.272.36.22695; Snapp KR, 2001, BLOOD, V97, P3806, DOI 10.1182/blood.V97.12.3806; Tsuchida A, 2005, J BIOCHEM, V138, P237, DOI 10.1093/jb/mvi124; VACHINO G, 1995, J BIOL CHEM, V270, P21966, DOI 10.1074/jbc.270.37.21966; Veerman KM, 2007, NAT IMMUNOL, V8, P532, DOI 10.1038/ni1456; VELDMAN GM, 1995, J BIOL CHEM, V270, P16470, DOI 10.1074/jbc.270.27.16470; Wagers AJ, 1998, J IMMUNOL, V160, P5122; Walcheck B, 2002, BLOOD, V99, P4063, DOI 10.1182/blood-2001-12-0265; Whitehouse C, 1997, J CELL BIOL, V137, P1229, DOI 10.1083/jcb.137.6.1229; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; Xiao ZH, 2006, BIOPHYS J, V90, P2221, DOI 10.1529/biophysj.105.065789	49	33	34	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					13974	13987		10.1074/jbc.M113.463653	http://dx.doi.org/10.1074/jbc.M113.463653			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548905	Green Published, hybrid			2022-12-25	WOS:000319253500005
J	Ordonez, H; Shuman, S				Ordonez, Heather; Shuman, Stewart			Mycobacterium smegmatis Lhr Is a DNA-dependent ATPase and a 3 '-to-5 ' DNA Translocase and Helicase That Prefers to Unwind 3 '-Tailed RNA:DNA Hybrids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; C VIRUS NS3; DISPLACE STREPTAVIDIN; MOTOR-NUCLEASE; SUPERFAMILY-II; BREAK REPAIR; TUBERCULOSIS; PROTEIN; ADNAB; UVRD1	We are interested in the distinctive roster of helicases of Mycobacterium, a genus of the phylum Actinobacteria that includes the human pathogen Mycobacterium tuberculosis and its avirulent relative Mycobacterium smegmatis. Here, we identify and characterize M. smegmatis Lhr as the exemplar of a novel clade of superfamily II helicases, by virtue of its biochemical specificities and signature domain organization. Lhr is a 1507-amino acid monomeric nucleic acid-dependent ATPase that uses the energy of ATP hydrolysis to drive unidirectional 3'-to-5' translocation along single strand DNA and to unwind duplexes en route. The ATPase is more active in the presence of calcium than magnesium. ATP hydrolysis is triggered by either single strand DNA or single strand RNA, yet the apparent affinity for a DNA activator is 11-fold higher than for an RNA strand of identical size and nucleobase sequence. Lhr is 8-fold better at unwinding an RNA: DNA hybrid than it is at displacing a DNA: DNA duplex of identical nucleobase sequence. The truncated derivative Lhr-(1-856) is an autonomous ATPase, 3'-to-5' translocase, and RNA: DNA helicase. Lhr-(1-856) is 100-fold better RNA: DNA helicase than DNA: DNA helicase. Lhr homologs are found in bacteria representing eight different phyla, being especially prevalent in Actinobacteria (including M. tuberculosis) and Proteobacteria (including Escherichia coli).	[Ordonez, Heather; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA.	shuman@ski.mskcc.org			National Institutes of Health [AI64693]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI64693.	Balasingham SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036960; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Biswas T, 2009, BIOCHEMISTRY-US, V48, P2839, DOI 10.1021/bi8022416; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Curti E, 2007, J BACTERIOL, V189, P1542, DOI 10.1128/JB.01421-06; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Guthlein C, 2009, J BACTERIOL, V191, P555, DOI 10.1128/JB.00216-08; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; Houghton J, 2012, J BACTERIOL, V194, P2916, DOI 10.1128/JB.06654-11; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; MATSON SW, 1989, P NATL ACAD SCI USA, V86, P4430, DOI 10.1073/pnas.86.12.4430; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Morris PD, 2002, BIOCHEMISTRY-US, V41, P2372, DOI 10.1021/bi012058b; Olsen I, 2009, FEMS IMMUNOL MED MIC, V56, P151, DOI 10.1111/j.1574-695X.2009.00562.x; Ordonez H, 2012, NUCLEIC ACIDS RES, V40, P4604, DOI 10.1093/nar/gks046; Poterszman A, 1997, TRENDS BIOCHEM SCI, V22, P418, DOI 10.1016/S0968-0004(97)01124-9; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; REUVEN NB, 1995, J BACTERIOL, V177, P5393, DOI 10.1128/jb.177.19.5393-5400.1995; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sinha KM, 2008, BIOCHEMISTRY-US, V47, P9355, DOI 10.1021/bi800725q; Sinha KM, 2007, J BIOL CHEM, V282, P15114, DOI 10.1074/jbc.M701167200; Sinha KM, 2009, GENE DEV, V23, P1423, DOI 10.1101/gad.1805709; Sinha KM, 2009, BIOCHEMISTRY-US, V48, P4019, DOI 10.1021/bi900103d; Unciuleac MC, 2010, J BIOL CHEM, V285, P34319, DOI 10.1074/jbc.M110.162925; Unciuleac MC, 2010, J BIOL CHEM, V285, P2632, DOI 10.1074/jbc.M109.076133; Williams A, 2011, J BACTERIOL, V193, P4487, DOI 10.1128/JB.00302-11; Yakovleva L, 2012, NUCLEIC ACIDS RES, V40, P7465, DOI 10.1093/nar/gks417; Zegeye ED, 2012, MICROBIOL-SGM, V158, P1982, DOI 10.1099/mic.0.058693-0	29	16	17	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14125	14134		10.1074/jbc.M113.466854	http://dx.doi.org/10.1074/jbc.M113.466854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23549043	hybrid, Green Published			2022-12-25	WOS:000319253500017
J	Lan, XQ; Rai, P; Chandel, N; Cheng, K; Lederman, R; Saleem, MA; Mathieson, PW; Husain, M; Crosson, JT; Gupta, K; Malhotra, A; Singhal, PC				Lan, Xiqian; Rai, Partab; Chandel, Nirupama; Cheng, Kang; Lederman, Rivka; Saleem, Moin A.; Mathieson, Peter W.; Husain, Mohammad; Crosson, John T.; Gupta, Kalpna; Malhotra, Ashwani; Singhal, Pravin C.			Morphine Induces Albuminuria by Compromising Podocyte Integrity	PLOS ONE			English	Article							OXIDATIVE STRESS; NEPHRIN; PROTEIN; MACROPHAGES; EXPRESSION; APOPTOSIS; INJURY	Morphine has been reported to accelerate the progression of chronic kidney disease. However, whether morphine affects slit diaphragm (SD), the major constituent of glomerular filtration barrier, is still unclear. In the present study, we examined the effect of morphine on glomerular filtration barrier in general and podocyte integrity in particular. Mice were administered either normal saline or morphine for 72 h, then urine samples were collected and kidneys were subsequently isolated for immunohistochemical studies and Western blot. For in vitro studies, human podocytes were treated with morphine and then probed for the molecular markers of slit diaphragm. Morphine-receiving mice displayed a significant increase in albuminuria and showed effacement of podocyte foot processes. In both in vivo and in vitro studies, the expression of synaptopodin, a molecular marker for podocyte integrity, and the slit diaphragm constituting molecules (SDCM), such as nephrin, podocin, and CD2-associated protein (CD2AP), were decreased in morphine-treated podocytes. In vitro studies indicated that morphine modulated podocyte expression of SDCM through opiate mu (MOR) and kappa (KOR) receptors. Since morphine also enhanced podocyte oxidative stress, the latter seems to contribute to decreased SDCM expression. In addition, AKT, p38, and JNK pathways were involved in morphine-induced down regulation of SDCM in human podocytes. These findings demonstrate that morphine has the potential to alter the glomerular filtration barrier by compromising the integrity of podocytes.	[Lan, Xiqian; Rai, Partab; Chandel, Nirupama; Cheng, Kang; Lederman, Rivka; Husain, Mohammad; Malhotra, Ashwani; Singhal, Pravin C.] Hofstra North Shore LIJ Med Sch, Feinstein Inst Med Res, Renal Mol Res Lab, Great Neck, NY USA; [Saleem, Moin A.; Mathieson, Peter W.] Southmead Hosp, Acad Renal Unit, Bristol, Avon, England; [Crosson, John T.] Univ Minnesota, Sch Med, Hennepin Cty Med Ctr, Dept Lab Med Pathol, Minneapolis, MN 55455 USA; [Gupta, Kalpna] Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA	Hofstra University; Northwell Health; Southmead Hospital; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Singhal, PC (corresponding author), Hofstra North Shore LIJ Med Sch, Feinstein Inst Med Res, Renal Mol Res Lab, Great Neck, NY USA.	psinghal@nshs.edu		Husain, Mohammad/0000-0003-3876-8181; Saleem, Moin/0000-0002-9808-4518; Singhal, Pravin/0000-0002-6898-358X	National Institutes of Health, Bethesda, MD [RO1DK084910, RO1DK083931, HL68802, HL103773]; Medical Research Council [G0800200] Funding Source: researchfish; MRC [G0800200] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068802, R01HL103733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083931, R01DK084910] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants RO1DK084910, RO1DK083931 (PCS) and HL68802, HL103773 (KG) from National Institutes of Health, Bethesda, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; BOURGOIGNIE JJ, 1990, KIDNEY INT, V37, P1571, DOI 10.1038/ki.1990.151; Dasgupta N, 2006, DRUG ALCOHOL DEPEN, V82, P135, DOI 10.1016/j.drugalcdep.2005.08.019; Dzau VJ, 2001, HYPERTENSION, V37, P1047, DOI 10.1161/01.HYP.37.4.1047; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Hopfer CJ, 2000, J AM ACAD CHILD PSY, V39, P1316, DOI 10.1097/00004583-200010000-00021; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Husain M, 2009, J BIOL CHEM, V284, P16648, DOI 10.1074/jbc.M109.008482; Ikezumi Y, 2008, BIOCHEM BIOPH RES CO, V376, P706, DOI 10.1016/j.bbrc.2008.09.049; JOHNSON JE, 1987, DRUG ALCOHOL DEPEN, V19, P249, DOI 10.1016/0376-8716(87)90044-5; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Lim AKH, 2009, DIABETOLOGIA, V52, P347, DOI 10.1007/s00125-008-1215-5; Ma WY, 2001, EUR J NEUROSCI, V14, P1091, DOI 10.1046/j.0953-816x.2001.01731.x; MacPherson RD, 2000, PHARMACOL THERAPEUT, V88, P163, DOI 10.1016/S0163-7258(00)00090-5; Mao JH, 2006, PEDIATR NEPHROL, V21, P1666, DOI 10.1007/s00467-006-0218-z; Marshall SM, 2007, CURR PHARM DESIGN, V13, P2713, DOI 10.2174/138161207781662957; Mongia A, 2004, KIDNEY INT, V65, P860, DOI 10.1111/j.1523-1755.2004.00464.x; Nielsen DA, 2012, DRUG ALCOHOL DEPEN, V123, pS33, DOI 10.1016/j.drugalcdep.2012.03.026; Nistala R, 2008, ANTIOXID REDOX SIGN, V10, P2047, DOI 10.1089/ars.2008.2034; Patel J, 2003, AM J PHYSIOL-RENAL, V285, pF861, DOI 10.1152/ajprenal.00134.2003; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; RAO TKS, 1984, NEW ENGL J MED, V310, P669, DOI 10.1056/NEJM198403153101101; Salhan D, 2012, CELL SIGNAL, V24, P734, DOI 10.1016/j.cellsig.2011.11.007; SHARP BM, 1985, ENDOCRINOLOGY, V117, P793, DOI 10.1210/endo-117-2-793; Singhal PC, 1998, KIDNEY INT, V53, P350, DOI 10.1046/j.1523-1755.1998.00758.x; SINGHAL PC, 1994, INFLAMMATION, V18, P293, DOI 10.1007/BF01534270; Singhal PC, 1998, J INVEST MED, V46, P243; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Takano Y, 2007, FEBS LETT, V581, P421, DOI 10.1016/j.febslet.2006.12.051; Tojo A, 2007, EXPERT OPIN THER TAR, V11, P1011, DOI 10.1517/14728222.11.8.1011; Weber ML, 2008, AM J PHYSIOL-RENAL, V294, pF1388, DOI 10.1152/ajprenal.00389.2007; Wen HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021707; Xing Y, 2006, EXP BIOL MED, V231, P585	33	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e55748	10.1371/journal.pone.0055748	http://dx.doi.org/10.1371/journal.pone.0055748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555556	Green Published, Green Submitted, gold			2022-12-25	WOS:000317263900001
J	Tian, M; Zallocchi, M; Wang, WM; Chen, CK; Palczewski, K; Delimont, D; Cosgrove, D; Peng, YW				Tian, Mei; Zallocchi, Marisa; Wang, Weimin; Chen, Ching-Kang; Palczewski, Krzysztof; Delimont, Duane; Cosgrove, Dominic; Peng, You-Wei			Light-Induced Translocation of RGS9-1 and G beta 5L in Mouse Rod Photoreceptors	PLOS ONE			English	Article							GTPASE-ACCELERATING PROTEIN; BETA-SUBUNIT G-BETA-5; ECTOPIC SYNAPTOGENESIS; DARK-ADAPTATION; RETINAL RODS; MICE LACKING; PHOTOTRANSDUCTION; TRANSDUCIN; VERTEBRATE; COMPLEX	The transducin GTPase-accelerating protein complex, which determines the photoresponse duration of photoreceptors, is composed of RGS9-1, G beta 5L and R9AP. Here we report that RGS9-1 and G beta 5L change their distribution in rods during light/dark adaptation. Upon prolonged dark adaptation, RGS9-1 and Gb5L are primarily located in rod inner segments. But very dim-light exposure quickly translocates them to the outer segments. In contrast, their anchor protein R9AP remains in the outer segment at all times. In the dark, G beta 5L's interaction with R9AP decreases significantly and RGS9-1 is phosphorylated at S-475 to a significant degree. Dim light exposure leads to quick de-phosphorylation of RGS9-1. Furthermore, after prolonged dark adaptation, RGS9-1 and transducin G alpha are located in different cellular compartments. These results suggest a previously unappreciated mechanism by which prolonged dark adaptation leads to increased light sensitivity in rods by dissociating RGS9-1 from R9AP and redistributing it to rod inner segments.	[Tian, Mei; Zallocchi, Marisa; Wang, Weimin; Delimont, Duane; Cosgrove, Dominic; Peng, You-Wei] Boys Town Natl Res Hosp, Retinal Neurobiol Lab, Omaha, NE 68131 USA; [Tian, Mei] Chinese Ctr Dis Control & Prevent, Natl Inst Radiol Protect, Beijing, Peoples R China; [Chen, Ching-Kang] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Boys Town National Research Hospital; Chinese Center for Disease Control & Prevention; National Institute for Radiological Protection, Chinese Center for Disease Control & Prevention; Virginia Commonwealth University; Case Western Reserve University	Peng, YW (corresponding author), Boys Town Natl Res Hosp, Retinal Neurobiol Lab, Omaha, NE 68131 USA.	You-wei.peng@boystown.org	Zallocchi, Marisa/HHS-7445-2022		National Institutes of Health (NIH) [P20 RR018788, R01 013811, R01 EY008061, R01 DC04844, R01 DK55000]; tobacco settlement fund from the State of Nebraska; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013811, R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004844] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); tobacco settlement fund from the State of Nebraska; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) P20 RR018788 to YWP, NIH R01 013811 to CKC, NIH R01 EY008061 to KP, NIH R01 DC04844, and R01 DK55000 to DC and the tobacco settlement fund from the State of Nebraska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Balasubramanian N, 2001, BIOCHEMISTRY-US, V40, P12619, DOI 10.1021/bi015624b; BARLOW HB, 1964, VISION RES, V4, P47, DOI 10.1016/0042-6989(64)90031-8; Burns ME, 2010, PHYSIOLOGY, V25, P72, DOI 10.1152/physiol.00001.2010; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Calvert PD, 2002, J GEN PHYSIOL, V119, P129, DOI 10.1085/jgp.119.2.129; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2010, J PHYSIOL-LONDON, V588, P3231, DOI 10.1113/jphysiol.2010.191221; Chen CK, 2005, REV PHYSIOL BIOCH P, V154, P101, DOI 10.1007/s10254-005-0004-5; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Fain GL, 2011, MOL NEUROBIOL, V44, P374, DOI 10.1007/s12035-011-8205-1; FARBER DB, 1991, EXP EYE RES, V53, P781, DOI 10.1016/0014-4835(91)90114-T; Fischer T, 2000, P NATL ACAD SCI USA, V97, P4040, DOI 10.1073/pnas.97.8.4040; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hecht S, 1937, PHYSIOL REV, V17, P239, DOI 10.1152/physrev.1937.17.2.239; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Hu G, 2001, J BIOL CHEM, V276, P22287, DOI 10.1074/jbc.M011539200; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Krispel CM, 2003, J GEN PHYSIOL, V122, P703, DOI 10.1085/jgp.200308938; Krispel CM, 2003, J NEUROSCI, V23, P6965, DOI 10.1523/JNEUROSCI.23-18-06965.2003; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lishko PV, 2002, J BIOL CHEM, V277, P24376, DOI 10.1074/jbc.M203237200; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Martemyanov KA, 2003, NEURON, V38, P857, DOI 10.1016/S0896-6273(03)00320-9; Masuho I, 2011, J BIOL CHEM, V286, P21806, DOI 10.1074/jbc.M111.241513; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; ORGANISCIAK DT, 1991, EXP EYE RES, V53, P773, DOI 10.1016/0014-4835(91)90113-S; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Peng YW, 2011, INVEST OPHTH VIS SCI, V52, P6421, DOI 10.1167/iovs.10-6557; Peng YW, 2003, NEUROSCIENCE, V119, P813, DOI 10.1016/S0306-4522(03)00153-2; Peng YW, 2000, NAT NEUROSCI, V3, P1121, DOI 10.1038/80639; Sokal I, 2003, J BIOL CHEM, V278, P8316, DOI 10.1074/jbc.M211782200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154	43	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58832	10.1371/journal.pone.0058832	http://dx.doi.org/10.1371/journal.pone.0058832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555598	gold, Green Published			2022-12-25	WOS:000317262200006
J	Basile, LFH; Sato, JR; Alvarenga, MY; Henrique, N; Pasquini, HA; Alfenas, W; Machado, S; Velasques, B; Ribeiro, P; Piedade, R; Anghinah, R; Ramos, RT				Basile, Luis F. H.; Sato, Joao R.; Alvarenga, Milkes Y.; Henrique, Nelson, Jr.; Pasquini, Henrique A.; Alfenas, William; Machado, Sergio; Velasques, Bruna; Ribeiro, Pedro; Piedade, Roberto; Anghinah, Renato; Ramos, Renato T.			Lack of Systematic Topographic Difference between Attention and Reasoning Beta Correlates	PLOS ONE			English	Article							BAND OSCILLATIONS; EEG; GENERATION; NETWORK; VARIABILITY; AREAS	Based on previous evidence for individual-specific sets of cortical areas active during simple attention tasks, in this work we intended to perform within individual comparisons of task-induced beta oscillations between visual attention and a reasoning task. Since beta induced oscillations are not time-locked to task events and were first observed by Fourier transforms, in order to analyze the cortical topography of attention induced beta activity, we have previously computed corrected-latency averages based on spontaneous peaks of band-pass filtered epochs. We then used Independent Component Analysis (ICA) only to single out the significant portion of averaged data, above noise levels. In the present work ICA served as the main, exhaustive means for decomposing beta activity in both tasks, using 128-channel EEG data from 24 subjects. Given the previous observed similarity between tasks by visual inspection and by simple descriptive statistics, we now intended another approach: to quantify how much each ICA component obtained in one task could be explained by a linear combination of the topographic patterns from the other task in each individual. Our hypothesis was that the major psychological difference between tasks would not be reflected as important topographic differences within individuals. Results confirmed the high topographic similarity between attention and reasoning beta correlates in that few components in each individual were not satisfactorily explained by the complementary task, and if those could be considered "task-specific", their scalp distribution and estimated cortical sources were not common across subjects. These findings, along with those from fMRI studies preserving individual data and conventional neuropsychological and neurosurgical observations, are discussed in support of a new functional localization hypothesis: individuals use largely different sets of cortical association areas to perform a given task, but those individual sets do not change importantly across tasks that differ in major psychological processes.	[Basile, Luis F. H.; Henrique, Nelson, Jr.; Pasquini, Henrique A.; Ramos, Renato T.] UMESP, Fac Saude, Psychophysiol Lab, Sao Paulo, Brazil; [Basile, Luis F. H.; Alvarenga, Milkes Y.] Univ Sao Paulo, Sch Med, Div Neurosurg, Sao Paulo, Brazil; [Machado, Sergio; Velasques, Bruna; Ribeiro, Pedro; Piedade, Roberto] Univ Fed Rio de Janeiro, Dept Psychiat, Rio De Janeiro, Brazil; [Ramos, Renato T.] Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, Brazil; [Anghinah, Renato] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil; [Alvarenga, Milkes Y.; Alfenas, William] Univ Sao Judas Tadeu, Sao Paulo, Brazil; [Sato, Joao R.] Fed Univ ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil	Universidade Metodista de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Sao Judas Tadeu; Universidade Federal do ABC (UFABC)	Basile, LFH (corresponding author), UMESP, Fac Saude, Psychophysiol Lab, Sao Paulo, Brazil.	lbasile@usp.br	Machado, Sergio/M-9384-2013; Ramos, Renato T/G-1566-2013	Machado, Sergio/0000-0001-8946-8467; Sato, Joao Ricardo/0000-0002-7503-9781				Barbas H, 1992, Adv Neurol, V57, P91; BASILE LFH, 1994, ELECTROEN CLIN NEURO, V90, P157, DOI 10.1016/0013-4694(94)90007-8; Basile LFH, 2003, INT J PSYCHOPHYSIOL, V48, P55, DOI 10.1016/S0167-8760(03)00004-7; Basile LFH, 2002, INT J PSYCHOPHYSIOL, V45, P227, DOI 10.1016/S0167-8760(02)00014-4; Basile LFH, 1997, INT J PSYCHOPHYSIOL, V27, P29, DOI 10.1016/S0167-8760(97)00784-8; Basile LFH, 2007, INT J PSYCHOPHYSIOL, V65, P238, DOI 10.1016/j.ijpsycho.2007.05.001; Basile LFH, 2006, INT J PSYCHOPHYSIOL, V61, P149, DOI 10.1016/j.ijpsycho.2005.09.004; Basile LFH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015022; Bibbig A, 2002, LONG RANGE SYNCHRONI; Brannen JH, 2001, AM J NEURORADIOL, V22, P1711; Buchner H, 1997, ELECTROEN CLIN NEURO, V102, P267, DOI 10.1016/S0013-4694(96)95698-9; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; Duffau H, 2012, Adv Tech Stand Neurosurg, V38, P3, DOI 10.1007/978-3-7091-0676-1_1; Duffau H, 2012, CORTEX, V48, P120, DOI 10.1016/j.cortex.2011.04.029; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; Fuchs M, 1999, J CLIN NEUROPHYSIOL, V16, P267, DOI 10.1097/00004691-199905000-00006; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Herholz K, 1996, NEUROIMAGE, V3, P185, DOI 10.1006/nimg.1996.0020; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Hudson AJ, 2000, CAN J NEUROL SCI, V27, P2, DOI 10.1017/S0317167100051908; Kaminski J, 2012, INT J PSYCHOPHYSIOL, V85, P125, DOI 10.1016/j.ijpsycho.2011.11.006; Kopell N, 2000, GAMMA RHYTHMS BETA R; Laird AR, 2010, NEUROIMAGE, V51, P677, DOI 10.1016/j.neuroimage.2010.02.048; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Macko K A, 1985, Res Publ Assoc Res Nerv Ment Dis, V63, P73; Mazoyer, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Mechelli A, 2002, NEUROIMAGE, V17, P1459, DOI 10.1006/nimg.2002.1231; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Noppency U, 2004, J ANATOMY, V205, P6; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; Pandya D.N., 1988, P39; PANDYA DN, 1990, PROG BRAIN RES, V85, P63; Pfurtscheller G, 2001, VISION RES, V41, P1257, DOI 10.1016/S0042-6989(00)00235-2; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Ramirez PM, 2001, ANN NY ACAD SCI, V931, P342; Raven J.C., 1976, COLOURED PROGR MATRI; Santarosa LMC, 1983, EDUC REAL, V1, P7; Seghier ML, 2007, NEUROIMAGE, V36, P594, DOI 10.1016/j.neuroimage.2007.03.021; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59595	10.1371/journal.pone.0059595	http://dx.doi.org/10.1371/journal.pone.0059595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544076	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700036
J	Berglund, K; Birkner, E; Augustine, GJ; Hochgeschwender, U				Berglund, Ken; Birkner, Elisabeth; Augustine, George J.; Hochgeschwender, Ute			Light-Emitting Channelrhodopsins for Combined Optogenetic and Chemical-Genetic Control of Neurons	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSGENIC MICE; REMOTE-CONTROL; IN-VIVO; NEURAL ACTIVITY; HIPPOCAMPAL-NEURONS; OPTICAL ACTIVATION; GAUSSIA LUCIFERASE; ION CHANNELS; CELL-TYPE	Manipulation of neuronal activity through genetically targeted actuator molecules is a powerful approach for studying information flow in the brain. In these approaches the genetically targeted component, a receptor or a channel, is activated either by a small molecule (chemical genetics) or by light from a physical source (optogenetics). We developed a hybrid technology that allows control of the same neurons by both optogenetic and chemical genetic means. The approach is based on engineered chimeric fusions of a light-generating Protein (luciferase) to a light-activated ion channel (channelrhodopsin). Ionic currents then can be activated by bioluminescence upon activation of luciferase by its substrate, coelenterazine (CTZ), as well as by external light. In cell lines, expression of the fusion of Gaussia luciferase to Channelrhodopsin-2 yielded photocurrents in response to CTZ. Larger photocurrents were produced by fusing the luciferase to Volvox Channelrhodopsin-1. This version allowed chemical modulation of neuronal activity when expressed in cultured neurons: CTZ treatment shifted neuronal responses to injected currents and sensitized neurons to fire action potentials in response to subthreshold synaptic inputs. These luminescent channelrhodopsins - or luminopsins - preserve the advantages of light-activated ion channels, while extending their capabilities. Our proof-of-principle results suggest that his novel class of tools can be improved and extended in numerous ways.	[Berglund, Ken; Birkner, Elisabeth; Hochgeschwender, Ute] Duke Univ, Dept Neurobiol, Durham, NC 27706 USA; [Birkner, Elisabeth; Hochgeschwender, Ute] Duke Univ, NeuroTransgen Lab, Durham, NC USA; [Augustine, George J.] Duke NUS Grad Med Sch, Program Neurosci & Behav Disorders, Singapore, Singapore; A STAR Duke NUS Neurosci Res Partnership, Singapore, Singapore; [Augustine, George J.] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea	Duke University; Duke University; National University of Singapore; Korea Institute of Science & Technology (KIST)	Hochgeschwender, U (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27706 USA.	ute@neuro.duke.edu	Augustine, George James/J-9228-2013		US National Institutes of Health [P30NS061789]; Duke University; German National Academic Foundation; CRP grant from National Research Foundation of Singapore; World Class Institute (WCI) Program of the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology of Korea (MEST) (NRF) [WCI 2009-003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061789] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University; German National Academic Foundation; CRP grant from National Research Foundation of Singapore(National Research Foundation, Singapore); World Class Institute (WCI) Program of the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology of Korea (MEST) (NRF)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the US National Institutes of Health (P30NS061789), by Duke University, by a fellowship from the German National Academic Foundation to EB, and by a CRP grant from the National Research Foundation of Singapore and by the World Class Institute (WCI) Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology of Korea (MEST) (NRF Grant Number WCI 2009-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000431; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Couillard-Despres S, 2008, MOL IMAGING, V7, P28, DOI 10.2310/7290.2008.0004; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Foutz TJ, 2012, J NEUROPHYSIOL, V107, P3235, DOI 10.1152/jn.00501.2011; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grossman N, 2011, IEEE T BIO-MED ENG, V58, P1742, DOI 10.1109/TBME.2011.2114883; Guler AD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1749; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; HEGEMANN P, 1987, EMBO J, V6, P259, DOI 10.1002/j.1460-2075.1987.tb04748.x; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Kim SB, 2011, ANAL CHEM, V83, P8732, DOI 10.1021/ac2021882; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Mancuso JJ, 2011, EXP PHYSIOL, V96, P26, DOI 10.1113/expphysiol.2010.055731; Martin JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000275; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Miesenbock G, 2011, ANNU REV CELL DEV BI, V27, P301; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Naumann EA, 2010, NAT NEUROSCI, V13, P513, DOI 10.1038/nn.2518; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Reumers V, 2008, STEM CELLS, V26, P2382, DOI 10.1634/stemcells.2007-1062; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Rogers KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000974; Sasaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020360; SHIMOMURA O, 1990, BIOCHEM J, V270, P309, DOI 10.1042/bj2700309; Shimomura O., 1985, Symposia of the Society for Experimental Biology, P351; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Teranishi K, 1997, ANAL BIOCHEM, V249, P37, DOI 10.1006/abio.1997.2150; Tsunematsu T, 2011, J NEUROSCI, V31, P10529, DOI 10.1523/JNEUROSCI.0784-11.2011; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Welsh JP, 2009, BIOCHEM BIOPH RES CO, V389, P563, DOI 10.1016/j.bbrc.2009.09.006; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893; Yamagata M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00018; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao Hui, 2004, Mol Imaging, V3, P43, DOI 10.1162/153535004773861714; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	70	57	57	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59759	10.1371/journal.pone.0059759	http://dx.doi.org/10.1371/journal.pone.0059759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544095	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700055
J	Fukao, M; Oshima, K; Morita, H; Toh, H; Suda, W; Kim, SW; Suzuki, S; Yakabe, T; Hattori, M; Yajima, N				Fukao, Masanori; Oshima, Kenshiro; Morita, Hidetoshi; Toh, Hidehiro; Suda, Wataru; Kim, Seok-Won; Suzuki, Shigenori; Yakabe, Takafumi; Hattori, Masahira; Yajima, Nobuhiro			Genomic Analysis by Deep Sequencing of the Probiotic Lactobacillus brevis KB290 Harboring Nine Plasmids Reveals Genomic Stability	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; OXIDATIVE STRESS; THIOREDOXIN REDUCTASE; ANTIBIOTIC-RESISTANCE; MATHEMATICAL-MODELS; NUCLEOTIDE-SEQUENCE; IN-VITRO; PLANTARUM; GENE; AGGREGATION	We determined the complete genome sequence of Lactobacillus brevis KB290, a probiotic lactic acid bacterium isolated from a traditional Japanese fermented vegetable. The genome contained a 2,395,134-bp chromosome that housed 2,391 protein-coding genes and nine plasmids that together accounted for 191 protein-coding genes. KB290 contained no virulence factor genes, and several genes related to presumptive cell wall-associated polysaccharide biosynthesis and the stress response were present in L. brevis KB290 but not in the closely related L. brevis ATCC 367. Plasmid-curing experiments revealed that the presence of plasmid pKB290-1 was essential for the strain's gastrointestinal tract tolerance and tendency to aggregate. Using next-generation deep sequencing of current and 18-year-old stock strains to detect low frequency variants, we evaluated genome stability. Deep sequencing of four periodic KB290 culture stocks with more than 1,000-fold coverage revealed 3 mutation sites and 37 minority variation sites, indicating long-term stability and providing a useful method for assessing the stability of industrial bacteria at the nucleotide level.	[Fukao, Masanori; Suzuki, Shigenori; Yakabe, Takafumi; Yajima, Nobuhiro] KAGOME Co Ltd, Res Inst, Nasushiobara, Tochigi, Japan; [Oshima, Kenshiro; Suda, Wataru; Kim, Seok-Won; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Chuo Ku, Sagamihara, Kanagawa, Japan; [Toh, Hidehiro] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 812, Japan	Kagome Co., Ltd.; University of Tokyo; Azabu University; Kyushu University	Fukao, M (corresponding author), KAGOME Co Ltd, Res Inst, Nasushiobara, Tochigi, Japan.	Masanori_Fukao@kagome.co.jp	Suda, Wataru/AAF-4469-2019; Toh, Yosuke/F-4675-2019; Hattori, Masahira/AAD-3785-2019; Hattori, Masahira/C-6958-2016	Toh, Yosuke/0000-0002-2494-5557; Hattori, Masahira/0000-0001-9467-0344	KAGOME Co. Ltd	KAGOME Co. Ltd	The authors have the following interests. Masanori Fukao, Shigenori Suzuki, Takafumi Yakabe and Nobuhiro Yajima are employed by KAGOME Co. Ltd, the funder of this study and provider of the lactic acid bacteria strain. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Bujnakova D, 2002, J VET MED B, V49, P152, DOI 10.1046/j.1439-0450.2002.00526.x; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cesena C, 2001, J DAIRY SCI, V84, P1001, DOI 10.3168/jds.S0022-0302(01)74559-6; Chaillou S, 2005, NAT BIOTECHNOL, V23, P1527, DOI 10.1038/nbt1160; Charteris WP, 1998, J APPL MICROBIOL, V84, P759; Claesson MJ, 2006, P NATL ACAD SCI USA, V103, P6718, DOI 10.1073/pnas.0511060103; Cohen DPA, 2006, PROTEOMICS, V6, P6485, DOI 10.1002/pmic.200600361; Davis BM, 2009, NUCLEIC ACIDS RES, V37, P5757, DOI 10.1093/nar/gkp568; De Gelder L, 2004, GENETICS, V168, P1131, DOI 10.1534/genetics.104.033431; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Denou E, 2008, J BACTERIOL, V190, P5806, DOI 10.1128/JB.01802-07; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Dougherty BA, 1998, MOL MICROBIOL, V29, P1029, DOI 10.1046/j.1365-2958.1998.00988.x; Engelbrektson AL, 2006, FEMS MICROBIOL ECOL, V57, P239, DOI 10.1111/j.1574-6941.2006.00112.x; FAO/WHO (Food and Agriculture Organization of the United Nations/World Health Organization), 2002, GUID EV PRO IN PRESS; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; FRETER R, 1983, INFECT IMMUN, V39, P60, DOI 10.1128/IAI.39.1.60-84.1983; Fukao M, 2009, J FOOD PROTECT, V72, P1923, DOI 10.4315/0362-028X-72.9.1923; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Grzeskowiak L, 2011, BRIT J NUTR, V105, P887, DOI 10.1017/S0007114510004496; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jang SH, 2011, ARCH VIROL, V156, P319, DOI 10.1007/s00705-010-0841-7; Jones BV, 2010, GUT MICROBES, V1, P415, DOI 10.4161/gmic.1.6.14087; Kandler O., 1986, BERGEYS MANUAL SYSTE, V2, P1209; Karnezis T, 2002, J BACTERIOL, V184, P4114, DOI 10.1128/JB.184.15.4114-4123.2002; Kishi A, 1996, J AM COLL NUTR, V15, P408; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; Lebeer S, 2011, MICROB BIOTECHNOL, V4, P368, DOI 10.1111/j.1751-7915.2010.00199.x; Lieske JC, 2005, KIDNEY INT, V68, P1244, DOI 10.1111/j.1523-1755.2005.00520.x; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Linsalata M, 2004, HELICOBACTER, V9, P165, DOI 10.1111/j.1083-4389.2004.00214.x; Lorca GL, 2007, BBA-BIOMEMBRANES, V1768, P1342, DOI 10.1016/j.bbamem.2007.02.007; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Murakami K, 2012, BIOPSYCHOSOC MED, V6, DOI 10.1186/1751-0759-6-16; Nobuta Y., 2009, International Journal of Probiotics and Prebiotics, V4, P263; Noonpakdee W, 2004, INT J FOOD MICROBIOL, V95, P127, DOI 10.1016/j.ijfoodmicro.2004.01.020; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; RENIERO R, 1992, J GEN MICROBIOL, V138, P763, DOI 10.1099/00221287-138-4-763; Ronka E, 2003, INT J FOOD MICROBIOL, V83, P63, DOI 10.1016/S0168-1605(02)00315-X; Saarela M, 2002, INT J FOOD MICROBIOL, V78, P99, DOI 10.1016/S0168-1605(02)00235-0; Salminen S, 1993, LACTIC ACID BACTERIA; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; Schachtsiek M, 2004, APPL ENVIRON MICROB, V70, P7078, DOI 10.1128/AEM.70.12.7078-7085.2004; Serata M, 2012, MICROBIOL-SGM, V158, P953, DOI 10.1099/mic.0.053942-0; Serrano LM, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-29; Siezen R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-126; Siezen RJ, 2008, APPL ENVIRON MICROB, V74, P424, DOI 10.1128/AEM.01850-07; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Stasinopoulos SJ, 1999, GLYCOBIOLOGY, V9, P31, DOI 10.1093/glycob/9.1.31; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van Kranenburg R, 2005, APPL ENVIRON MICROB, V71, P1223, DOI 10.1128/AEM.71.3.1223-1230.2005; van Kranenburg R, 2000, PLASMID, V43, P130, DOI 10.1006/plas.1999.1453; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Ventura M, 2006, APPL ENVIRON MICROB, V72, P3130, DOI 10.1128/AEM.72.5.3130-3146.2006; Voltan S, 2007, CLIN VACCINE IMMUNOL, V14, P1138, DOI 10.1128/CVI.00079-07; Wada T, 2009, MICROBIOL-SGM, V155, P1726, DOI 10.1099/mic.0.022871-0; Wall T, 2007, APPL ENVIRON MICROB, V73, P3924, DOI 10.1128/AEM.01502-06; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Werning ML, 2006, J FOOD PROTECT, V69, P161, DOI 10.4315/0362-028X-69.1.161; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791	74	38	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60521	10.1371/journal.pone.0060521	http://dx.doi.org/10.1371/journal.pone.0060521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544154	Green Submitted, Green Published, gold			2022-12-25	WOS:000317480700113
J	Li, Q; Bai, HH; Liang, WJ; Xia, JY; Wan, SQ; van der Putten, WH				Li, Qi; Bai, Huahua; Liang, Wenju; Xia, Jianyang; Wan, Shiqiang; van der Putten, Wim H.			Nitrogen Addition and Warming Independently Influence the Belowground Micro-Food Web in a Temperate Steppe	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMUNITY STRUCTURE; SPECIES RICHNESS; SOIL NEMATODES; GLOBAL CHANGE; ELEVATED CO2; PLANT; DEPOSITION; DIVERSITY; CARBON	Climate warming and atmospheric nitrogen (N) deposition are known to influence ecosystem structure and functioning. However, our understanding of the interactive effect of these global changes on ecosystem functioning is relatively limited, especially when it concerns the responses of soils and soil organisms. We conducted a field experiment to study the interactive effects of warming and N addition on soil food web. The experiment was established in 2006 in a temperate steppe in northern China After three to four years (2009-2010), we found that N addition positively affected microbial biomass and negatively influenced trophic group and ecological indices of soil nematodes. However, the warming effects were less obvious, only fungal PLFA showed a decreasing trend under warming. Interestingly, the influence of N addition did not depend on warming. Structural equation modeling analysis suggested that the direct pathway between N addition and soil food web components were more important than the indirect connections through alterations in soil abiotic characters or plant growth. Nitrogen enrichment also affected the soil nematode community indirectly through changes in soil pH and PLFA. We conclude that experimental warming influenced soil food web components of the temperate steppe less than N addition, and there was little influence of warming on N addition effects under these experimental conditions.	[Li, Qi; Bai, Huahua; Liang, Wenju] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Xia, Jianyang; Wan, Shiqiang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Li, Qi; van der Putten, Wim H.] Netherlands Inst Ecol, Terr Ecol Dept, Wageningen, Netherlands; [Wan, Shiqiang] Henan Univ, State Key Lab Cotton Biol, Sch Life Sci, Henan Key Lab Stress Plant Biol, Kaifeng, Henan, Peoples R China; [van der Putten, Wim H.] Univ Wageningen & Res Ctr, Nematol Lab, Wageningen, Netherlands	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Henan University; Wageningen University & Research	Li, Q (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	liq@iae.ac.cn; liangw@iae.ac.cn	van der Putten, Wim H/C-3707-2011; Xia, Jianyang/S-9499-2019; LI, Qi/N-2673-2017; Wan, Shiqiang/B-5799-2009; Wan, Shiqiang/L-9166-2019; Xia, Jianyang/A-7886-2008; KNAW, NIOO-KNAW/A-4320-2012	van der Putten, Wim H/0000-0002-9341-4442; LI, Qi/0000-0002-8652-8396; Wan, Shiqiang/0000-0003-0631-1232; Wan, Shiqiang/0000-0003-0631-1232; KNAW, NIOO-KNAW/0000-0002-3835-159X	Natural Science Foundation of China [31170484, 30925009]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-QN403]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the Natural Science Foundation of China (31170484 and 30925009) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-QN403). The funders had no role in study desigh, data collection and analysis, decision to publsh, or preparation of the manuscript.	[Anonymous], 2002, CAUSE CORRELATION BI; Antoninka A, 2009, GLOBAL CHANGE BIOL, V15, P914, DOI 10.1111/j.1365-2486.2008.01760.x; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1007, DOI 10.1016/S0038-0717(99)00014-0; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Blankinship JC, 2011, OECOLOGIA, V165, P553, DOI 10.1007/s00442-011-1909-0; Bleeker A, 2011, ENVIRON POLLUT, V159, P2280, DOI 10.1016/j.envpol.2010.10.036; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Bradford MA, 2002, OIKOS, V99, P317, DOI 10.1034/j.1600-0706.2002.990212.x; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Contosta AR, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00133.1; Contosta AR, 2012, BIOGEOCHEMISTRY, DOI [10.1007/s10533-012-9749-6, DOI 10.1007/S10533-012-9749-6]; Cusack DF, 2010, GLOBAL CHANGE BIOL, V16, P2555, DOI 10.1111/j.1365-2486.2009.02131.x; De Boeck HJ, 2008, BIOGEOSCIENCES, V5, P585, DOI 10.5194/bg-5-585-2008; De Deyn GB, 2007, OIKOS, V116, P923, DOI [10.1111/j.2007.0030-1299.15761.x, 10.1111/j.0030-1299.2007.15761.x]; Denef K, 2001, SOIL BIOL BIOCHEM, V33, P1599, DOI 10.1016/S0038-0717(01)00076-1; Eisenhauer N, 2012, GLOBAL CHANGE BIOL, V18, P435, DOI 10.1111/j.1365-2486.2011.02555.x; Fenner N, 2007, ENVIRON SCI TECHNOL, V41, P3146, DOI 10.1021/es061765v; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Fujimura KE, 2008, ISME J, V2, P105, DOI 10.1038/ismej.2007.89; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Grace J.B., 2006, STRUCT EQ MOD NAT; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hattori T., 1988, Reports of the Institute for Agricultural Research, Tohoku University, V37, P23; Hoeksema JD, 2000, PEDOBIOLOGIA, V44, P725, DOI 10.1078/S0031-4056(04)70085-2; Hutchison JS, 2010, ECOSYSTEMS, V13, P661, DOI 10.1007/s10021-010-9344-3; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Liang WJ, 2009, SOIL BIOL BIOCHEM, V41, P883, DOI 10.1016/j.soilbio.2008.06.018; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Manning P, 2008, OECOLOGIA, V157, P661, DOI 10.1007/s00442-008-1104-0; Manning P, 2006, ECOL LETT, V9, P1015, DOI 10.1111/j.1461-0248.2006.00959.x; Maraldo K, 2010, PEDOBIOLOGIA, V53, P161, DOI 10.1016/j.pedobi.2009.10.003; Niu SL, 2008, ENVIRON EXP BOT, V63, P91, DOI 10.1016/j.envexpbot.2007.10.016; Oostenbrink M., 1960, NEMATOLOGY; Papanikolaou N, 2010, GLOBAL CHANGE BIOL, V16, P3120, DOI 10.1111/j.1365-2486.2010.02196.x; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schuur EAG, 2007, ECOSYSTEMS, V10, P280, DOI 10.1007/s10021-007-9024-0; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sowerby A, 2005, SOIL BIOL BIOCHEM, V37, P1805, DOI 10.1016/j.soilbio.2005.02.023; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; TOWNSHEND J. L., 1963, NEMATOLOGICA, V9, P106; Turner MM, 2010, OECOLOGIA, V162, P227, DOI 10.1007/s00442-009-1435-5; Veen GF, 2010, ECOLOGY, V91, P828, DOI 10.1890/09-0134.1; Verburg PSJ, 2009, GLOBAL CHANGE BIOL, V15, P888, DOI 10.1111/j.1365-2486.2008.01797.x; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 2003, OIKOS, V102, P45, DOI 10.1034/j.1600-0706.2003.12481.x; Wei CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043384; Weltzin JF, 2003, GLOBAL CHANGE BIOL, V9, P141, DOI 10.1046/j.1365-2486.2003.00571.x; Wu ZT, 2011, ECOSYSTEMS, V14, P1066, DOI 10.1007/s10021-011-9464-4; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Xia JY, 2010, SCI TOTAL ENVIRON, V408, P2807, DOI 10.1016/j.scitotenv.2010.03.016; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; YEATES GW, 1993, J NEMATOL, V25, P315; Yeates GW, 1999, AGR ECOSYST ENVIRON, V74, P113, DOI 10.1016/S0167-8809(99)00033-X; Zhang NL, 2008, PLANT SOIL, V311, P19, DOI 10.1007/s11104-008-9650-0; Zhang NL, 2011, SOIL BIOL BIOCHEM, V43, P2053, DOI 10.1016/j.soilbio.2011.06.001; Zhang Y, 2008, ATMOS ENVIRON, V42, P1035, DOI 10.1016/j.atmosenv.2007.12.015	72	66	78	19	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60441	10.1371/journal.pone.0060441	http://dx.doi.org/10.1371/journal.pone.0060441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544140	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700099
J	Sulzenbruck, S; Heuer, H				Suelzenbrueck, Sandra; Heuer, Herbert			Effective Part-Task Training as Evidence of Distinct Adaptive Processes with Different Time Scales	PLOS ONE			English	Article							INTERNAL-MODELS; INVERSE MODELS; MOTOR; ADAPTATION; TRANSFORMATION; APPROXIMATIONS; MECHANISMS; RESOURCE; MEMORY	For some types of visuo-motor transformations like large visuo-motor rotations or the complex transformation of a sliding first-order lever, distinct adaptive processes have been hypothesized that produce a rapid, discrete approximation of the transformation and a slow, graded fine tuning, respectively. Here we investigate whether part task training of only the second of these processes, namely the fine tuning, transfers to the subsequent performance in a condition with the full transformation of the sliding first-order lever. Therefore, we compared performance of three groups with different practice conditions during transfer to the full transformation. While two groups only practiced the fine tuning without the right left inversion of the lever prior to transfer, a third group practiced the full lever transformation. Our results show a positive, but less than perfect transfer of the isolated practice of the fine tuning on performance with the full transformation. For the fine tuning itself, transfer was not reliably different from being perfect. The observation that the fine tuning can be acquired separately and added to the later adaptation to the left-right inversion of the lever supports the notion that these slow and fast processes progress rather independently. The additional finding that the preceding acquisition of the fine tuning also facilitates the subsequent rapid process could be due to generalized learning-to-learn or to a more precise assignment of movement errors to the process from which they originate.	[Suelzenbrueck, Sandra; Heuer, Herbert] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Sulzenbruck, S (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	suelzenbrueck@ifado.de		Heuer, Herbert/0000-0002-0488-2878; Sulzenbruck, Sandra/0000-0001-9527-8344	Deutsche Forschungsgemeinschaft (DFG) [HE 1187/16-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by grant HE 1187/16-1 of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeele S, 2001, EXP BRAIN RES, V140, P407, DOI 10.1007/s002210100846; Anguera JA, 2012, BEHAV BRAIN RES, V228, P107, DOI 10.1016/j.bbr.2011.11.040; Anguera JA, 2011, J COGNITIVE NEUROSCI, V23, P11, DOI 10.1162/jocn.2010.21451; ATKINSON JW, 1957, PSYCHOL REV, V64, P359, DOI 10.1037/h0043445; Bock O, 2001, EXP BRAIN RES, V138, P359, DOI 10.1007/s002210100704; Bock O, 2005, EXP RES, V160, P259; Davidson PR, 2004, EXP BRAIN RES, V155, P334, DOI 10.1007/s00221-003-1730-z; Davidson PR, 2000, HUM MOVEMENT SCI, V19, P761, DOI 10.1016/S0167-9457(00)00022-1; Flanagan JR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0005.1999; Gallagher AG, 1998, ENDOSCOPY, V30, P617, DOI 10.1055/s-2007-1001366; Ghahramani Z, 1997, NATURE, V386, P392, DOI 10.1038/386392a0; Ghez C, 1997, EXP BRAIN RES, V115, P217, DOI 10.1007/PL00005692; Guadagnoli M, 2004, J MOTOR BEHAV, V36, P334; Heathcote A, 2000, PSYCHON B REV, V7, P185, DOI 10.3758/BF03212979; Heuer H, 2012, NEUROSCIENCE, V207, P137, DOI 10.1016/j.neuroscience.2012.01.035; Heuer H., 1983, BEWEGUNGSLERNEN; HEUER H, 2013, HDB PSYCHOL, V4, P320; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2012, HUM MOVEMENT SCI, V31, P1056, DOI 10.1016/j.humov.2012.01.004; Heuer H, 2012, ERGONOMICS, V55, P1157, DOI 10.1080/00140139.2012.703697; Heuer H, 2009, J EXP PSYCHOL HUMAN, V35, P375, DOI 10.1037/0096-1523.35.2.375; Huang FC, 2012, IEEE T HAPTICS, V5, P356, DOI [10.1109/TOH.2011.52, 10.1109/ToH.2011.52]; Jacobs RA, 1991, NEURAL COMPUT, V3, P79, DOI 10.1162/neco.1991.3.1.79; Jordan M. I., 1996, HDB PERCEPTION ACTIO, V2, P71, DOI DOI 10.1016/S1874-5822(06)80005-8; Keisler A, 2010, J NEUROSCI, V30, P14817, DOI 10.1523/JNEUROSCI.4160-10.2010; Lee FJ, 2001, COGNITIVE PSYCHOL, V42, P267, DOI 10.1006/cogp.2000.0747; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; Macmillan AIM, 1999, AM J SURG, V177, P274, DOI 10.1016/S0002-9610(99)00016-1; McNay EC, 1998, LEARN MEMORY, V4, P411, DOI 10.1101/lm.4.5.411; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; Nakano E, 2002, SYST COMPUT JPN, V33, P814; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Sulzenbruck S, 2012, EXP BRAIN RES, V218, P283, DOI 10.1007/s00221-012-3011-1; Sulzenbruck S, 2011, ERGONOMICS, V54, P34, DOI 10.1080/00140139.2010.535023; Sulzenbruck S, 2010, EXP BRAIN RES, V201, P549, DOI 10.1007/s00221-009-2071-3; Sulzenbruck S, 2009, EXP BRAIN RES, V195, P153, DOI 10.1007/s00221-009-1764-y; Werner S, 2010, HUM MOVEMENT SCI, V29, P172, DOI 10.1016/j.humov.2010.02.004; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	41	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60196	10.1371/journal.pone.0060196	http://dx.doi.org/10.1371/journal.pone.0060196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544133	Green Submitted, Green Published, gold			2022-12-25	WOS:000317480700092
J	Xiang, YQ; Cheng, Y; Li, XT; Li, QL; Xu, JW; Zhang, JY; Liu, Y; Xing, QH; Wang, L; He, L; Zhao, XZ				Xiang, Yuqian; Cheng, Yan; Li, Xiaotian; Li, Qiaoli; Xu, Jiawei; Zhang, Junyu; Liu, Yun; Xing, Qinghe; Wang, Lei; He, Lin; Zhao, Xinzhi			Up-Regulated Expression and Aberrant DNA Methylation of LEP and SH3PXD2A in Pre-Eclampsia	PLOS ONE			English	Article							GENE-EXPRESSION; PROMOTER HYPOMETHYLATION; EPIGENETIC MECHANISMS; PLACENTAL LEPTIN; BREAST-CANCER; FOLIC-ACID; PROTEIN; INVASION; HYPERTENSION; HOMOCYSTEINE	The primary mechanism underlying pre-eclampsia (PE) remains one of the most burning problems in the obstetrics and gynecology. In this study, we performed an expression profiling screen and detected 1312 genes that were differentially expressed (p<0.05 and fold change >1.5) in PE placentas, including LEP and SH3PXD2A. After validating the microarray results, we conducted the quantitative methylation analysis of LEP and SH3PXD2A in preeclamptic (n=16) versus normal placentas (n = 16) Our results showed that many CpG sites close to the transcriptional start site (TSS) of LEP gene were hypomethylated in placentas from pregnancies with PE compared with those of in controls, including the TSS position (p = 0.001), the binding sites of Sp1 (p = 1.57 x 10(-4)), LP1 (p=0.023) and CEBP alpha (p=0.031). Luciferase reporter analysis confirmed the aberrant methylation of LEP promoter and CEBP alpha co-transfection had a role in the regulation of gene expression. Our results indicated the aberrant LEP promoter methylation was involved in the development of PE. We did not find a significant methylation differences between groups in the promoter region of SH3PXD2A, however, a CGI region in the gene body (CGI34) presented a higher methylation in preeclamptic placentas (p = 1.57 x 10(-4)), which might promote the efficiency of gene transcription. We speculated that SH3PXD2A may take part in the pathogenesis of PE through its role in the regulation of trophoblast cell invasion in the period of placenta formation.	[Xiang, Yuqian; Li, Qiaoli; Xu, Jiawei; Zhang, Junyu; Liu, Yun; Xing, Qinghe; Wang, Lei; He, Lin; Zhao, Xinzhi] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Xiang, Yuqian; Li, Qiaoli; Xu, Jiawei; Zhang, Junyu; Liu, Yun; Xing, Qinghe; Wang, Lei; He, Lin; Zhao, Xinzhi] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Cheng, Yan; Li, Xiaotian] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [He, Lin] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University	He, L (corresponding author), Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China.	helin@bio-x.cn; xzzhao@fudan.edu.cn	Zhang, Junyu/AAF-6658-2019; xu, jiawei/GWM-9710-2022; Li, Xiaotian/ABI-3309-2020	Zhang, Junyu/0000-0003-0239-6670; Li, Xiaotian/0000-0002-2051-4581	973 Program [2009825606, 2010CB529600]; National Key Technology RD Program [2012BAI01B09]; National Natural Science Foundation of China [30800616, 81000256, 81121001]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; Shanghai Rising-Star Program [09QA1400500]; Mingdao Program of Medical Student [MDJH2012027]	973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology Program; Shanghai Rising-Star Program; Mingdao Program of Medical Student	This work was supported by the 973 Program (2009825606, 2010CB529600), the National Key Technology R&D Program (2012BAI01B09), the National Natural Science Foundation of China (30800616, 81000256, 81121001), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), the Shanghai Rising-Star Program (09QA1400500) and the Mingdao Program of Medical Student (MDJH2012027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Cervero A, 2005, REPROD BIOMED ONLINE, V10, P217, DOI 10.1016/S1472-6483(10)60943-1; Chelbi ST, 2007, HYPERTENSION, V49, P76, DOI 10.1161/01.HYP.0000250831.52876.cb; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Eiland E, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/586578; Enquobahrie DA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.020; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Guven MA, 2009, HYPERTENS PREGNANCY, V28, P190, DOI 10.1080/10641950802601179; Hennessy A, 1999, J IMMUNOL, V163, P3491; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jarvenpaa J, 2007, GYNECOL ENDOCRINOL, V23, P351, DOI 10.1080/09513590701350291; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kang JH, 2011, J HYPERTENS, V29, P928, DOI 10.1097/HJH.0b013e328344a82c; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Knox KS, 2007, MOL HUM REPROD, V13, P251, DOI 10.1093/molehr/gal116; Kulkarni A, 2011, DNA CELL BIOL, V30, P79, DOI 10.1089/dna.2010.1084; Levine RJ, 2004, AM J OBSTET GYNECOL, V190, P707, DOI 10.1016/j.ajog.2003.12.019; Louwen F, 2012, ONCOTARGET, V3, P759; Makedos Georgios, 2007, Archives of Gynecology and Obstetrics, V275, P121, DOI 10.1007/s00404-006-0223-2; Maymo JL, 2011, PLACENTA, V32, pS146, DOI 10.1016/j.placenta.2011.01.004; Maymo JL, 2010, ENDOCRINOLOGY, V151, P3738, DOI 10.1210/en.2010-0064; Maymo JL, 2009, ENDOCRINOLOGY, V150, P304, DOI 10.1210/en.2008-0522; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Melzner I, 2002, J BIOL CHEM, V277, P45420, DOI 10.1074/jbc.M208511200; Mousa AA, 2012, AM J PATHOL, V181, P1455, DOI 10.1016/j.ajpath.2012.06.019; Muller HM, 2004, CLIN CHEM, V50, P1065, DOI 10.1373/clinchem.2003.030387; Nakatsukasa H, 2008, ENDOCR J, V55, P565, DOI 10.1507/endocrj.K07E-136; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; O'Neil JS, 2001, MOL CELL ENDOCRINOL, V176, P67, DOI 10.1016/S0303-7207(01)00473-7; Patel A, 2012, EUR J CELL BIOL, V91, P171, DOI 10.1016/j.ejcb.2011.11.006; Ramma W, 2012, ANGIOGENESIS, V15, P333, DOI 10.1007/s10456-012-9261-5; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Richardson B, 2007, NAT CLIN PRACT RHEUM, V3, P521, DOI 10.1038/ncprheum0573; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Saito S, 2007, MOL ASPECTS MED, V28, P192, DOI 10.1016/j.mam.2007.02.006; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Singh Urmila, 2008, J Indian Med Assoc, V106, P503; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Stylli SS, 2012, J CLIN NEUROSCI, V19, P436, DOI 10.1016/j.jocn.2011.11.013; Toft JH, 2008, J MATERN-FETAL NEO M, V21, P267, DOI 10.1080/14767050801924118; Tsai S, 2011, PLACENTA, V32, P175, DOI 10.1016/j.placenta.2010.11.014; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Varkonyi T, 2011, PLACENTA, V32, pS21, DOI 10.1016/j.placenta.2010.04.014; Wang W, 2012, J CLIN ENDOCR METAB, V97, pE1051, DOI 10.1210/jc.2011-3131; Weaver AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.288pe56; Xiang Y, 2012, MOL HUM REP IN PRESS; Yuen RKC, 2010, EUR J HUM GENET, V18, P1006, DOI 10.1038/ejhg.2010.63; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao AM, 2011, MOL HUM REPROD, V17, P199, DOI 10.1093/molehr/gaq092	55	32	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59753	10.1371/journal.pone.0059753	http://dx.doi.org/10.1371/journal.pone.0059753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544093	Green Submitted, Green Published, gold			2022-12-25	WOS:000317480700053
J	Barrow, H; Tam, B; Duckworth, CA; Rhodes, JM; Yu, LG				Barrow, Hannah; Tam, Benjamin; Duckworth, Carrie A.; Rhodes, Jonathan M.; Yu, Lu-Gang			Suppression of Core 1 Gal-Transferase Is Associated with Reduction of TF and Reciprocal Increase of Tn, sialyl-Tn and Core 3 Glycans in Human Colon Cancer Cells	PLOS ONE			English	Article							FRIEDENREICH CARBOHYDRATE ANTIGEN; O-GLYCOSYLATION; BREAST-CANCER; ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; CIRCULATING GALECTIN-3; PROTEIN GLYCOSYLATION; COLORECTAL-CANCER; GOLGI-APPARATUS; CARCINOMA-CELLS; GENE FAMILY	It has long been presumed, though with surprisingly little evidence, a competition between Core 1 Gal-transferase (C1GalT), Core 3 GlcNAc-transferase (C3GnT) and sialyl-transferase (ST6GalNAc-T) for elongation of O-linked mucin-type glycans initiated with GalNAc alpha-Ser/Thr. This study tested this presumption by selective suppression of one of these glycosyltransferases and then analysed the expressions of the enzymatic products of the other three glycosyltransferases. It was found that siRNA suppression of C1GalT markedly reduced the expression of Gal beta 1,3GalNAc alpha- (Core 1) and in the meantime increased the expressions of sialyl-GalNAc alpha- (sialyl-Tn), GalNAc alpha- (Tn) and GlcNAc beta 1,3GalNAc alpha-(Core 3)-associated glycans in human colon cancer HT29 and SW620 cells. This supports a competitive modification of the GalNAc alpha-Ser/Thr between C1GalT, C3GnT and ST6GalNAc-T in O-glycan biosynthesis. As Tn, TF and sialyl-Tn are oncofetal antigens and are over-expressed in most human cancers, this information is useful for the development of glycosyltransferase-targeted therapeutic strategies for cancer treatment.	[Barrow, Hannah; Tam, Benjamin; Duckworth, Carrie A.; Rhodes, Jonathan M.; Yu, Lu-Gang] Univ Liverpool, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Yu, LG (corresponding author), Univ Liverpool, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England.	lgyu@liv.ac.uk	Duckworth, Carrie/AAC-8361-2020; Duckworth, Carrie A/K-7302-2014	Duckworth, Carrie/0000-0001-9992-7540; Duckworth, Carrie A/0000-0001-9992-7540	North West Cancer Research Fund [CR777]; University of PhD Studentship	North West Cancer Research Fund; University of PhD Studentship	This work was supported in part by a grant (CR777) from the North West Cancer Research Fund and a University of PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow H, 2011, CLIN CANCER RES, V17, P7035, DOI 10.1158/1078-0432.CCR-11-1462; Barrow H, 2011, INT J CANCER, V129, P1, DOI 10.1002/ijc.25945; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bieberich E, 2000, J NEUROCHEM, V74, P2359, DOI 10.1046/j.1471-4159.2000.0742359.x; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; Campbell B, 2001, SMITHSONIAN, V32, P18; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; Desai PR, 1995, J IMMUNOL METHODS, V188, P175, DOI 10.1016/0022-1759(95)00246-4; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Heimburg-Molinaro J, 2009, NEOPLASIA, V11, P780, DOI 10.1593/neo.09504; Hounsell EF, 1996, GLYCOCONJUGATE J, V13, P19, DOI 10.1007/BF01049675; HUET G, 1995, J CELL SCI, V108, P1275; IKEDA Y, 1993, CANCER RES, V53, P1706; ITZKOWITZ S, 1991, GASTROENTEROLOGY, V100, P1691, DOI 10.1016/0016-5085(91)90671-7; Iwai T, 2005, P NATL ACAD SCI USA, V102, P4572, DOI 10.1073/pnas.0407983102; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Julien S, 2006, GLYCOBIOLOGY, V16, P54, DOI 10.1093/glycob/cwj033; Kellokumpu S, 2002, FEBS LETT, V516, P217, DOI 10.1016/S0014-5793(02)02535-8; Marcos NT, 2004, CANCER RES, V64, P7050, DOI 10.1158/0008-5472.CAN-04-1921; Marcos Nuno T, 2011, Front Biosci (Elite Ed), V3, P1443; Nakagoe T, 2000, ONCOLOGY-BASEL, V59, P131, DOI 10.1159/000012150; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Rivinoja A, 2006, J CELL PHYSIOL, V208, P167, DOI 10.1002/jcp.20653; Rottger S, 1998, J CELL SCI, V111, P45; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Takeuchi H, 2002, EUR J BIOCHEM, V269, P6173, DOI 10.1046/j.1432-1033.2002.03334.x; Terasawa K, 1996, CANCER RES, V56, P2229; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Young WW, 2004, J MEMBRANE BIOL, V198, P1, DOI 10.1007/s00232-004-0656-5; Yu LG, 1997, INT J CANCER, V73, P424, DOI 10.1002/(SICI)1097-0215(19971104)73:3<424::AID-IJC18>3.3.CO;2-C; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	43	21	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59792	10.1371/journal.pone.0059792	http://dx.doi.org/10.1371/journal.pone.0059792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536887	gold, Green Published, Green Submitted			2022-12-25	WOS:000317397200035
J	Cropper, SJ; Kvansakul, JGS; Little, DR				Cropper, Simon J.; Kvansakul, Jessica G. S.; Little, Daniel R.			The Categorisation of Non-Categorical Colours: A Novel Paradigm in Colour Perception	PLOS ONE			English	Article							SPECTRAL SENSITIVITY; REFLECTANCE SPECTRA; EXEMPLAR-RETRIEVAL; RESPONSE SPECTRA; SIMILARITY; VISION; UNIQUE; IDENTIFICATION; GENICULATE; LANGUAGE	In this paper, we investigate a new paradigm for studying the development of the colour 'signal' by having observers discriminate and categorize the same set of controlled and calibrated cardinal coloured stimuli. Notably, in both tasks, each observer was free to decide whether two pairs of colors were the same or belonged to the same category. The use of the same stimulus set for both tasks provides, we argue, an incremental behavioural measure of colour processing from detection through discrimination to categorisation. The measured data spaces are different for the two tasks, and furthermore the categorisation data is unique to each observer. In addition, we develop a model which assumes that the principal difference between the tasks is the degree of similarity between the stimuli which has different constraints for the categorisation task compared to the discrimination task. This approach not only makes sense of the current (and associated) data but links the processes of discrimination and categorisation in a novel way and, by implication, expands upon the previous research linking categorisation to other tasks not limited to colour perception.	[Cropper, Simon J.; Kvansakul, Jessica G. S.; Little, Daniel R.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia	University of Melbourne	Cropper, SJ (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.	scropper@unimelb.edu.au	Little, Daniel/J-5034-2019	Little, Daniel/0000-0003-3607-5525; Cropper, Simon James/0000-0002-3574-6414; Kvansakul, Jessica/0000-0003-3019-1832	ARC [DP120103120]	ARC(Australian Research Council)	This work was supported by an ARC Discovery Project Grant DP120103120 to the third author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney WD, 1909, P R SOC LOND A-CONTA, V83, P120; Anstis SM, 1983, COLOUR VISION PHYSL, P154; ASHBY FG, 1991, J EXP PSYCHOL GEN, V120, P150, DOI 10.1037/0096-3445.120.2.150; Berlin B., 1969, BASIC COLOR TERMS TH; BORNSTEIN MH, 1973, PSYCHOL BULL, V80, P257, DOI 10.1037/h0034837; BOYNTON RM, 1988, ANNU REV PSYCHOL, V39, P69, DOI 10.1146/annurev.ps.39.020188.000441; Boynton RM, 1975, HDB PERCEPTION, P302; Boynton RM, 1978, HDB PERCEPTION; BURNS SA, 1984, VISION RES, V24, P479, DOI 10.1016/0042-6989(84)90045-2; CAVANAGH P, 1991, VISION RES, V31, P2109, DOI 10.1016/0042-6989(91)90169-6; Chichilnisky EJ, 1999, VISION RES, V39, P3444, DOI 10.1016/S0042-6989(99)00033-4; Cohen AL, 2000, J EXP PSYCHOL HUMAN, V26, P1549, DOI 10.1037/0096-1523.26.5.1549; Conway BR, 2009, NEUROSCIENTIST, V15, P274, DOI 10.1177/1073858408331369; Cottaris NP, 1998, NATURE, V395, P896, DOI 10.1038/27666; Cropper Simon J, 2005, Behav Cogn Neurosci Rev, V4, P192, DOI 10.1177/1534582305285120; Cropper SJ, 2006, VISION RES, V46, P724, DOI 10.1016/j.visres.2005.06.034; Cropper SJ, 2005, VISION RES, V45, P865, DOI 10.1016/j.visres.2004.09.043; Cropper SJ, 1996, VISION RES, V36, P2475, DOI 10.1016/0042-6989(95)00299-5; Cropper SJ, 2013, PLOS ONE UNPUB; Danilova MV, 2012, VISION RES, V62, P162, DOI 10.1016/j.visres.2012.04.006; Danilova MV, 2012, J OPT SOC AM A, V29, pA157, DOI 10.1364/JOSAA.29.00A157; Danilova MV, 2010, J VISION, V10, DOI 10.1167/10.1.4; Davidoff J, 1999, NATURE, V398, P203, DOI 10.1038/18335; DAVIDOFF J, 1986, PERCEPT PSYCHOPHYS, V40, P391, DOI 10.3758/BF03208198; Davidoff J, 2001, TRENDS COGN SCI, V5, P382, DOI 10.1016/S1364-6613(00)01726-5; Davidoff J, 2012, J COGN PSYCHOL, V24, P871, DOI 10.1080/20445911.2012.706603; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P512, DOI 10.1073/pnas.97.1.512; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; Eskew RT, 2009, VISION RES, V49, P2686, DOI 10.1016/j.visres.2009.07.005; Fific M, 2008, J EXP PSYCHOL HUMAN, V34, P356, DOI 10.1037/0096-1523.34.2.356; FINDLAY JM, 1978, PERCEPT PSYCHOPHYS, V23, P181, DOI 10.3758/BF03208300; Foster DH, 2011, VISION RES, V51, P674, DOI 10.1016/j.visres.2010.09.006; Garner W. R., 1974, PROCESSING INFORM ST; GARNER WR, 1970, COGNITIVE PSYCHOL, V1, P225, DOI 10.1016/0010-0285(70)90016-2; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; Goldstone R. L., 2010, INTERDISCIPLINARY RE, V1, P65; GOLDSTONE RL, 1994, COGNITION, V52, P125, DOI 10.1016/0010-0277(94)90065-5; Green DM, 1966, SIGNAL DETECTION THE; Guild J, 1932, PHILOS T R SOC LOND, V230, P149, DOI 10.1098/rsta.1932.0005; Hansen T, 2009, J VIS, V9, p26 21; Hansen T, 2007, J VISION, V7, DOI 10.1167/7.4.2; Harnad Stevan, 1987, CATEGORICAL PERCEPTI; Heit E, 2005, J EXP PSYCHOL GEN, V134, P596, DOI 10.1037/0096-3445.134.4.596; Heit E, 2012, PSYCHOL LEARNING MOT; Heit E, 2011, J EXP PSYCHOL GEN, V140, P76, DOI 10.1037/a0021488; Helmholtz H. v., 1925, HELMHOLTZS TREATISE; Hering E., 1878, LEHRE LICHTSINN; Hering E., 1964, OUTLINES THEORY LIGH; Hine TJ, 2012, LAB APPL COGNITIVE R, P175; HOOKE R, 1961, J ACM, V8, P212, DOI 10.1145/321062.321069; Horwitz GD, 2012, NAT NEUROSCI; HURVICH LEO M., 1955, TRANS NEW YORK ACAD SCI, V18, P33; HURVICH LM, 1957, PSYCHOL REV, V64, P384, DOI 10.1037/h0041403; Hv Helmholtz, 1896, HDB PHYSL OPTIK; INDOW T, 1988, PSYCHOL REV, V95, P456, DOI 10.1037/0033-295X.95.4.456; INDOW T, 1960, J EXP PSYCHOL, V59, P330, DOI 10.1037/h0044796; Indow T, 1972, COLOR METRICS; KRAUSKOPF J, 1986, VISION RES, V26, P23, DOI 10.1016/0042-6989(86)90068-4; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; KRAUSKOPF J, 1992, VISION RES, V32, P2165, DOI 10.1016/0042-6989(92)90077-V; KRAUSKOPF J, 1965, SCIENCE, V150, P1477, DOI 10.1126/science.150.3702.1477; Krauskopf J, 1999, COLOR VISION GENES P, P149; LENNIE P, 1990, J NEUROSCI, V10, P649; Little DR, J EXPT PSYCHOL LEARN; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Macmillan N. A., 1991, DETECTION THEORY USE; Maddox WT, 1996, J EXP PSYCHOL HUMAN, V22, P795, DOI 10.1037/0096-1523.22.4.795; Malkoc G, 2012, VISION RES, V62, P75, DOI 10.1016/j.visres.2012.03.018; Marr D., 1982, VISION COMPUTATIONAL; McDermott KC, 2012, J OPT SOC AM A, V29, pA182, DOI 10.1364/JOSAA.29.00A182; Munsell Albert, 1915, ATLAS MUNSELL COLOR; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; Nosofsky RM, 1997, PERCEPT PSYCHOPHYS, V59, P1027, DOI 10.3758/BF03205518; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; Nosofsky RM, 2012, P NATL ACAD SCI USA, V109, P333, DOI 10.1073/pnas.1111304109; Nosofsky RM, 2011, PSYCHOL REV, V118, P280, DOI 10.1037/a0022494; Ozgen E, 2004, CURR DIR PSYCHOL SCI, V13, P95, DOI 10.1111/j.0963-7214.2004.00282.x; Ozgen E, 2002, J EXP PSYCHOL GEN, V131, P477, DOI 10.1037//0096-3445.131.4.477; Pilling M, 2003, MEM COGNITION, V31, P538, DOI 10.3758/BF03196095; Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369; Romney AK, 2005, P NATL ACAD SCI USA, V102, P16512, DOI 10.1073/pnas.0508172102; Romney AK, 2005, P NATL ACAD SCI USA, V102, P9720, DOI 10.1073/pnas.0503887102; Saunders BAC, 1997, BEHAV BRAIN SCI, V20, P167, DOI 10.1017/S0140525X97001428; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seaborn M, 2005, PATTERN RECOGN, V38, P165, DOI 10.1016/j.patcog.2004.05.001; Shepard R.N., 1992, ADAPTED MIND EVOLUTI, P495; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Shevell SK, 2008, ANNU REV PSYCHOL, V59, P143, DOI 10.1146/annurev.psych.59.103006.093619; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; SMITH VC, 1972, VISION RES, V12, P2059, DOI 10.1016/0042-6989(72)90058-2; Smithson HE, 2006, VISUAL NEUROSCI, V23, P453, DOI 10.1017/S0952523806233388; Steels L, 2005, BEHAV BRAIN SCI, V28, P469, DOI 10.1017/S0140525X05000087; Travis D, 1991, EFFECTIVE COLOR DISP; Valberg A, 2001, VISION RES, V41, P1645, DOI 10.1016/S0042-6989(01)00041-4; WAGNER G, 1972, J OPT SOC AM, V62, P1508, DOI 10.1364/JOSA.62.001508; Wandell BA, 2012, NAT NEUROSCI, V15, P809, DOI 10.1038/nn.3124; Webster MA, 2000, J OPT SOC AM A, V17, P1545, DOI 10.1364/JOSAA.17.001545; Webster MA, 2000, J OPT SOC AM A, V17, P1535, DOI 10.1364/JOSAA.17.001535; WEBSTER MA, 1991, NATURE, V349, P235, DOI 10.1038/349235a0; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; WEBSTER MA, 1994, VISION RES, V34, P1993, DOI 10.1016/0042-6989(94)90028-0; Wright O, 2011, NEW DIRECTIONS IN COLOUR STUDIES, P265; Wright W.D., 1929, T OPTICAL SOC, V30, P141, DOI [10.1088/1475-4878/30/4/301, DOI 10.1088/1475-4878/30/4/301]; Wuerger SM, 2005, VISION RES, V45, P3210, DOI 10.1016/j.visres.2005.06.016; Wyszecki G., 1967, COLOR SCI	108	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59945	10.1371/journal.pone.0059945	http://dx.doi.org/10.1371/journal.pone.0059945			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123NP	23536899	Green Published, gold			2022-12-25	WOS:000317397200047
J	Zhang, XX; Tang, XX; Zhou, B; Wang, Y				Zhang, Xinxin; Tang, Xuexi; Zhou, Bin; Wang, You			Effects of Decabromodiphenyl Ether (BDE-209) on Inter-Specific Competition between Two Species of Marine Bloom-Forming Microalgae	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; BROMINATED FLAME RETARDANTS; HARMFUL ALGAL BLOOMS; POLYCHLORINATED-BIPHENYLS; CHLOROPLAST ULTRASTRUCTURE; PROROCENTRUM-DONGHAIENSE; DEVELOPMENTAL EXPOSURE; CHEMICAL INTERFERENCE; HETEROSIGMA-AKASHIWO; GROWTH-INHIBITION	Decabromodiphenyl ether (BDE-209), a new kind of persistent organic pollutants, was selected to investigate its influence on population growth and inter-specific competition between two species of marine bloom-forming microalgae, Heterosigma akashiwo and Karenia mikimotoi. (1) BDE-209 showed acute toxic effects on both microalgae and H. akashiwo was more sensitive from view of 96 h-EC50 and the ultrastructure variation. (2) The microalgal population growth patterns in mono-culture were density-dependent and the growth of both species in the normal co-culture was significantly depressed by competition (P<0.05) with different initial biomass ratios. BDE-209 exposure significantly changed the growth. (3) Lotka-Volterra competition model was used to simulate the interaction between the microalgae. BDE-209 exposure broke the competitive balance to make competition gradually shift in favor of H. akashiwo. Results suggested BDE-209 did have toxic effects on either microalgal growth or the inter-specific competition, which was quite different from previous reports. Further exploration of the mechanism is needed.	[Zhang, Xinxin; Tang, Xuexi; Zhou, Bin; Wang, You] Ocean Univ China, Dept Marine Ecol, Coll Marine Life Sci, Qingdao, Peoples R China	Ocean University of China	Wang, Y (corresponding author), Ocean Univ China, Dept Marine Ecol, Coll Marine Life Sci, Qingdao, Peoples R China.	wangyou@ouc.edu.cn			Natural Science Foundation of China [41076066, 31070458]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Natural Science Foundation of China (41076066 and 31070458), www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; APHA A, 1985, STANDARD METHODS EXA; ASPLUND L, 1999, ORGANOHALOGEN COMPD, V40, P351; Birnbaum LS, 2004, ENVIRON HEALTH PERSP, V112, P9, DOI 10.1289/ehp.6559; Bondada BR, 2000, J AM SOC HORTIC SCI, V125, P553, DOI 10.21273/JASHS.125.5.553; BSEF Bromine Science and Environmental Forum, 2003, MAJ BROM FLAM RET VO; Burreau S, 2004, CHEMOSPHERE, V55, P1043, DOI 10.1016/j.chemosphere.2003.12.018; [蔡恒江 Cai Hengjiang], 2005, [海洋环境科学, Marine Environmental Science], V24, P37; CARBALLEIRA A, 1988, J CHEM ECOL, V14, P1775, DOI 10.1007/BF01014643; Cavender-Bares KK, 2001, LIMNOL OCEANOGR, V46, P778, DOI 10.4319/lo.2001.46.4.0778; Chattopadhyay J, 1996, ECOL MODEL, V84, P287, DOI 10.1016/0304-3800(94)00134-0; Christensen JH, 2001, J ENVIRON MONITOR, V3, P543, DOI 10.1039/b105501c; Christensen JR, 2005, ENVIRON SCI TECHNOL, V39, P6952, DOI 10.1021/es050749f; Covaci A, 2008, ENVIRON SCI TECHNOL, V42, P8654, DOI 10.1021/es8016528; Darnerud PO, 2001, ENVIRON HEALTH PERSP, V109, P49, DOI 10.2307/3434846; European Commission, 2004, UPD RISK ASS BIS PEN; European Commission, 2003, DIPH ETH OCT DER; Gabara B, 2003, PLANT SCI, V164, P507, DOI 10.1016/S0168-9452(02)00447-8; Goodman JE, 2009, REGUL TOXICOL PHARM, V54, P91, DOI 10.1016/j.yrtph.2009.02.006; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; HAGER SW, 1968, PRACTICAL MANUAL USE; Hardy M.L., 2000, ORGANOHALOGEN COMPOU, V47, P237; Imai I, 1996, HARMFUL TOXIC ALGAL, P197; IWASA Y, 1998, SURI SEIBUTUGAKU NYU, P352; Johnson-Restrepo B, 2005, ENVIRON SCI TECHNOL, V39, P8243, DOI 10.1021/es051551y; JONES MN, 1984, WATER RES, V18, P643, DOI 10.1016/0043-1354(84)90215-X; Kallqvist T, 2006, ENVIRON TOXICOL CHEM, V25, P1657, DOI 10.1897/05-424R.1; Kuriyama SN, 2005, ENVIRON HEALTH PERSP, V113, P149, DOI 10.1289/ehp.7421; Law RJ, 2006, CHEMOSPHERE, V64, P187, DOI 10.1016/j.chemosphere.2005.12.007; Lebeuf M, 2006, ENVIRON SCI TECHNOL, V40, P3211, DOI 10.1021/es0521829; Lema SC, 2007, AQUAT TOXICOL, V82, P296, DOI 10.1016/j.aquatox.2007.03.002; Li A, 2006, ENVIRON SCI TECHNOL, V40, P7528, DOI 10.1021/es0609506; Litchman E, 2001, AM NAT, V157, P170, DOI 10.1086/318628; Madhu NV, 2011, INDIAN J GEO-MAR SCI, V40, P821; [孟范平 MENG Fanping], 2009, [生态环境学报, Ecology and Environmental Sciences], V18, P1659; Moller A, 2012, ATMOS ENVIRON, V46, P346, DOI 10.1016/j.atmosenv.2011.09.055; Moller A, 2011, ENVIRON POLLUT, V159, P1577, DOI 10.1016/j.envpol.2011.02.054; Moreno-Garrido I, 2000, ECOTOX ENVIRON SAFE, V47, P112, DOI 10.1006/eesa.2000.1953; Mulderij G, 2005, AQUAT ECOL, V39, P11, DOI 10.1007/s10452-004-1021-1; Nakamaru M, 2000, THEOR POPUL BIOL, V57, P131, DOI 10.1006/tpbi.1999.1448; ORIS JT, 1985, AQUAT TOXICOL, V6, P133, DOI 10.1016/0166-445X(85)90012-8; Peng Q, 2009, J RARE EARTH, V27, P304, DOI 10.1016/S1002-0721(08)60238-0; Roy S, 2006, B MATH BIOL, V68, P2303, DOI 10.1007/s11538-006-9109-5; Schecter Arnold, 2006, Toxicological and Environmental Chemistry, V88, P319, DOI 10.1080/02772240600605087; Sellner KG, 2003, J IND MICROBIOL BIOT, V30, P383, DOI 10.1007/s10295-003-0074-9; Sellstrom U, 1999, ORGANOHALOGEN COMPD, V40, P383; Sinkkonen A, 2003, PLANT SOIL, V250, P315, DOI 10.1023/A:1022841503476; Sinkkonen A, 2001, J CHEM ECOL, V27, P1513, DOI 10.1023/A:1010329612753; Sinkkonen Aki, 2005, Nonlinearity in Biology Toxicology and Medicine, V3, P225, DOI 10.2201/nonlin.003.02.004; *SIS, 1991, 028106 SS SIS, P17; Sole J, 2005, ECOL MODEL, V183, P373, DOI 10.1016/j.ecolmodel.2004.08.021; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sommer U, 2007, LIMNOECOLOGY, P89; Ter Schure AFH, 2004, ENVIRON SCI TECHNOL, V38, P1282, DOI 10.1021/es0348086; Twiner MJ, 2005, HARMFUL ALGAE, V4, P789, DOI 10.1016/j.hal.2004.12.006; Uchida T, 1999, J EXP MAR BIOL ECOL, V241, P285, DOI 10.1016/S0022-0981(99)00088-X; USEPA (United States Environmental Protection Agency), 2010, EXP ASS POL DIPH ETH, P378; Van den Steen E, 2007, ENVIRON POLLUT, V148, P648, DOI 10.1016/j.envpol.2006.11.017; Van der Ven LTM, 2008, TOXICOL LETT, V179, P6, DOI 10.1016/j.toxlet.2008.03.003; Wang Y, 2008, HARMFUL ALGAE, V7, P65, DOI 10.1016/j.hal.2007.05.005; Wang Y, 2006, J SEA RES, V56, P17, DOI 10.1016/j.seares.2006.04.002; WEIDENHAMER JD, 1989, J APPL ECOL, V26, P613, DOI 10.2307/2404086; *WHO, 1994, 162 WHO; Xie Zhi-hao, 2008, Marine Environmental Science, V27, P462; Xie ZY, 2011, ENVIRON SCI TECHNOL, V45, P1820, DOI 10.1021/es103803t; Yamane K, 2004, PLANT PROD SCI, V7, P435, DOI 10.1626/pps.7.435; Zhang MP, 2010, J PLANT PHYSIOL, V167, P277, DOI 10.1016/j.jplph.2009.09.017; Zhang XX, 2012, MAR ENV SCI IN PRESS; Zhao Xiao-Wei, 2009, Chinese Journal of Plant Ecology, V33, P958, DOI 10.3773/j.issn.1005-264x.2009.05.015; [董云伟 Zhong Yunwei], 2004, [中国海洋大学学报. 自然科学版, Journal of Ocean University of China], V34, P964; Zhou T, 2002, TOXICOL SCI, V66, P105, DOI 10.1093/toxsci/66.1.105; Zhu L. X, 1983, ELECT MICROSCOPY BIO, P38; Zou YN, 2010, HARMFUL ALGAE, V9, P367, DOI 10.1016/j.hal.2010.01.005	74	25	25	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e56084	10.1371/journal.pone.0056084	http://dx.doi.org/10.1371/journal.pone.0056084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555557	Green Published, Green Submitted, gold			2022-12-25	WOS:000316546400002
J	Andrews, KA; Modat, M; Macdonald, KE; Yeatman, T; Cardoso, MJ; Leung, KK; Barnes, J; Villemagne, VL; Rowe, CC; Fox, NC; Ourselin, S; Schott, JM				Andrews, K. Abigail; Modat, Marc; Macdonald, Kate E.; Yeatman, Tom; Cardoso, M. Jorge; Leung, Kelvin K.; Barnes, Josephine; Villemagne, Victor L.; Rowe, Christopher C.; Fox, Nick C.; Ourselin, Sebastien; Schott, Jonathan M.		Australian Imaging Biomarkers; Lifestyle Flagship Study Ageing	Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PITTSBURGH COMPOUND-B; BIOMARKER SIGNATURE; HIPPOCAMPAL ATROPHY; A-BETA; DISEASE; BRAIN; VOLUME; MRI; DEPOSITION	There is considerable interest in designing therapeutic studies of individuals at risk of Alzheimer disease (AD) to prevent the onset of symptoms. Cortical beta-amyloid plaques, the first stage of AD pathology, can be detected in vivo using positron emission tomography (PET), and several studies have shown that similar to 1/3 of healthy elderly have significant beta-amyloid deposition. Here we assessed whether asymptomatic amyloid-PET-positive controls have increased rates of brain atrophy, which could be harnessed as an outcome measure for AD prevention trials. We assessed 66 control subjects (age = 73.5 +/- 7.3 yrs; MMSE = 29 +/- 1.3) from the Australian Imaging Biomarkers & Lifestyle study who had a baseline Pittsburgh Compound B (PiB) PET scan and two 3T MRI scans similar to 18-months apart. We calculated PET standard uptake value ratios (SUVR), and classified individuals as amyloid-positive/negative. Baseline and 18-month MRI scans were registered, and brain, hippocampal, and ventricular volumes and annualized volume changes calculated. Increasing baseline PiB-PET measures of beta-amyloid load correlated with hippocampal atrophy rate independent of age (p = 0.014). Twenty-two (1/3) were PiB-positive (SUVR>1.40), the remaining 44 PiB-negative (SUVR <= 1.31). Compared to PiB-negatives, PiB-positive individuals were older (76.8 +/- 7.5 vs. 71.7 +/- 7.5, p<0.05) and more were APOE4 positive (63.6% vs. 19.2%, p<0.01) but there were no differences in baseline brain, ventricle or hippocampal volumes, either with or without correction for total intracranial volume, once age and gender were accounted for. The PiB-positive group had greater total hippocampal loss (0.06 +/- 0.08 vs. 0.02 +/- 0.05 ml/yr, p = 0.02), independent of age and gender, with non-significantly higher rates of whole brain (7.1 +/- 9.4 vs. 4.7 +/- 5.5 ml/yr) and ventricular (2.0 +/- 3.0 vs. 1.1 +/- 1.0 ml/yr) change. Based on the observed effect size, recruiting 384 (95% CI 195-1080) amyloid-positive subjects/arm will provide 80% power to detect 25% absolute slowing of hippocampal atrophy rate in an 18-month treatment trial. We conclude that hippocampal atrophy may be a feasible outcome measure for secondary prevention studies in asymptomatic amyloidosis.	[Andrews, K. Abigail; Modat, Marc; Macdonald, Kate E.; Yeatman, Tom; Cardoso, M. Jorge; Leung, Kelvin K.; Barnes, Josephine; Villemagne, Victor L.; Rowe, Christopher C.; Fox, Nick C.; Ourselin, Sebastien; Schott, Jonathan M.] UCL, DRC, London, England; [Andrews, K. Abigail; Modat, Marc; Cardoso, M. Jorge; Leung, Kelvin K.; Ourselin, Sebastien] UCL, CMIC, London, England; [Villemagne, Victor L.; Rowe, Christopher C.] Austin Hlth, Dept Nucl Med, Heidelberg, Vic, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Ctr PET, Heidelberg, Vic, Australia	University of London; University College London; University of London; University College London; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Andrews, KA (corresponding author), UCL, DRC, London, England.	a.andrews@ucl.ac.uk	Barnes, Josesphine/P-5698-2014; Villemagne, Victor/AAC-5406-2019; Schott, Jonathan M/A-9065-2011; Fox, Nick C/B-1319-2009; Fox, Nick C/AAE-1849-2021; Rowe, Christopher/AAX-8748-2021; Ourselin, Sebastien/K-6960-2015; Cardoso, M. Jorge/N-5511-2018	Villemagne, Victor/0000-0002-5832-9875; Schott, Jonathan M/0000-0003-2059-024X; Fox, Nick C/0000-0002-6660-657X; Fox, Nick C/0000-0002-6660-657X; Ourselin, Sebastien/0000-0002-5694-5340; Cardoso, M. Jorge/0000-0003-1284-2558; Modat, Marc/0000-0002-5277-8530; Barnes, Josephine/0000-0003-3178-025X	National Institute for Health Research (NIHR) Biomedical Research Unit in Dementia; ARUK; Commonwealth Scientific Industrial Research Organization (CSIRO) Flagship Collaboration Fund through the Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship study of Ageing; Austin Hospital Medical Research Foundation, Neurosciences Victoria; University of Melbourne; EPSRC; IXICO Ltd; UCLH/UCL NIHR CBRC grant [168]; EPSRC [EP/W046410/1]; MRC (UK) [G0601846 PI]; National Institute on Aging (NIH) USA; UK Alzheimer's Society; Midas image processing software licences; CSIRO; Bayer; Avid Radiopharmaceuticals; GE Healthcare; Astra Zeneca; NHMRC/ADDF; AVID Radiopharmaceuticals Inc; Henry Stewart talks; Alzheimers Research UK [ART-EG2010B-1, ARUK-Network2011-6-ICE] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H046410/1, 1031290] Funding Source: researchfish; Medical Research Council [G0601846] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10123] Funding Source: researchfish; EPSRC [EP/H046410/1] Funding Source: UKRI; MRC [G0601846] Funding Source: UKRI	National Institute for Health Research (NIHR) Biomedical Research Unit in Dementia(National Institute for Health Research (NIHR)); ARUK(Alzheimer's Research UK (ARUK)); Commonwealth Scientific Industrial Research Organization (CSIRO) Flagship Collaboration Fund through the Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship study of Ageing; Austin Hospital Medical Research Foundation, Neurosciences Victoria; University of Melbourne(University of Melbourne); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); IXICO Ltd; UCLH/UCL NIHR CBRC grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Aging (NIH) USA; UK Alzheimer's Society; Midas image processing software licences; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Bayer(Bayer AG); Avid Radiopharmaceuticals; GE Healthcare(General ElectricGE Healthcare); Astra Zeneca(AstraZeneca); NHMRC/ADDF(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AVID Radiopharmaceuticals Inc; Henry Stewart talks; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Institute for Health Research (NIHR) Biomedical Research Unit (http://www.nihr.ac.uk/infrastructure/Pages/infrastructure_biomedical_research_units.aspx) in Dementia based at University College London Hospitals (UCLH), University College London (UCL). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The Dementia Research Centre (DRC) is an Alzheimer's Research UK (ARUK) Coordinating Centre and has also received equipment funded by ARUK (www.alzheimersresearchuk.org). The authors thank the AIBL Study Group (www.aibl.csiro.au) for providing the data for this study, they are supported by the Commonwealth Scientific Industrial Research Organization (CSIRO) Flagship Collaboration Fund through the Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship study of Ageing, the Austin Hospital Medical Research Foundation, Neurosciences Victoria, and the University of Melbourne; KA is funded by an EPSRC (www.epsrc.ac.uk) industrial CASE PhD studentship (http://www.epsrc.ac.uk/skills/students/coll/icase/Pages/intro.aspx) co-sponsored by commercial partner IXICO Ltd (www.ixico.com). MM and SO are supported by the UCLH/UCL NIHR CBRC grant 168. MC is supported by EPSRC (EP/W046410/1); NF is an MRC (UK) (www.mrc.ac.uk) Senior Clinical Scientist (Senior Clinical Fellowship No: G0601846 PI), and an NIHR Senior Scientist and also holds grants from the National Institute on Aging (NIH) USA for work on ADNI. JS is a UK HEFCE (www.hefce.ac.uk) Clinical Senior Lecturer and receives grant funding from ARUK and the UK Alzheimer's Society (www.alzheimers.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KA is funded by an EPSRC (www.epsrc.ac.uk) industrial CASE PhD studentship (http://www.epsrc.ac.uk/skills/students/coll/icase/Pages/intro.aspx) co-sponsored by commercial partner IXICO Ltd (www.ixico.com). The DRC holds a patent for QA Box (automated quality assurance for scan acquisition parameters), which may accrue revenue in the future, and currently receives royalties from Midas image processing software licences. NF has provided consultancy to GE Healthcare, Janssen-Cilag, Janssen-Elan pharmaceuticals, AVID Radiopharmaceuticals Inc, Lilly Research Labs, Eisai Inc and Johnson & Johnson; CR holds grants from CSIRO, Bayer, Avid Radiopharmaceuticals, GE Healthcare and Astra Zeneca; VV has provided consultancy to Bayer Healthcare and holds a grant from NHMRC/ADDF; JS receives grant funding from AVID Radiopharmaceuticals Inc and receives royalties from Henry Stewart talks. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Barnes J, 2008, NEUROIMAGE, V40, P1655, DOI 10.1016/j.neuroimage.2008.01.012; Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59; Bourgeat P, 2010, NEUROLOGY, V74, P121, DOI 10.1212/WNL.0b013e3181c918b5; Boyes RG, 2008, NEUROIMAGE, V39, P1752, DOI 10.1016/j.neuroimage.2007.10.026; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cardoso MJ, 2011, NEUROIMAGE, V56, P1386, DOI 10.1016/j.neuroimage.2011.02.013; Cardoso MJ, 2013, MED IMAGE IN PRESS; Chetelat G, 2012, NEUROLOGY, V78, P477, DOI 10.1212/WNL.0b013e318246d67a; Chetelat G, 2010, BRAIN, V133, P3349, DOI 10.1093/brain/awq187; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Evans MC, 2010, EUR RADIOL, V20, P674, DOI 10.1007/s00330-009-1581-5; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fox NC, 2005, NEUROLOGY, V64, P1563, DOI 10.1212/01.WNL.0000159743.08996.99; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Herholz K, 2011, LANCET NEUROL, V10, P667, DOI 10.1016/S1474-4422(11)70123-5; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Knopman DS, 2012, NEUROLOGY, V78, P1576, DOI 10.1212/WNL.0b013e3182563bbe; Leung KK, 2011, NEUROIMAGE, V55, P1091, DOI 10.1016/j.neuroimage.2010.12.067; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Leung KK, 2010, NEUROIMAGE, V50, P516, DOI 10.1016/j.neuroimage.2009.12.059; Lewis EB, 2004, NEUROIMAGE, V23, P75, DOI 10.1016/j.neuroimage.2004.04.030; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Rodrigue KM, 2012, NEUROLOGY, V78, P387, DOI 10.1212/WNL.0b013e318245d295; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Schott JM, 2006, J NEUROL, V253, P1147, DOI 10.1007/s00415-006-0173-4; Schott JM, 2010, NEUROBIOL AGING, V31, P1452, DOI 10.1016/j.neurobiolaging.2010.04.011; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Strobel G, 2011, ANTIAMYLOID TREATMEN; Tosun D, 2011, BRAIN, V134, P1077, DOI 10.1093/brain/awr044; Vellas B, 2011, PROG NEUROBIOL, V95, P594, DOI 10.1016/j.pneurobio.2011.08.014; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	48	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58816	10.1371/journal.pone.0058816	http://dx.doi.org/10.1371/journal.pone.0058816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554933	Green Published, gold			2022-12-25	WOS:000316409800033
J	Huxley, RR; Lopez, FL; MacLehose, RF; Eckfeldt, JH; Couper, D; Leiendecker-Foster, C; Hoogeveen, RC; Chen, LY; Soliman, EZ; Agarwal, SK; Alonso, A				Huxley, Rachel R.; Lopez, Faye L.; MacLehose, Richard F.; Eckfeldt, John H.; Couper, David; Leiendecker-Foster, Catherine; Hoogeveen, Ron C.; Chen, Lin Yee; Soliman, Elsayed Z.; Agarwal, Sunil K.; Alonso, Alvaro			Novel Association between Plasma Matrix Metalloproteinase-9 and Risk of Incident Atrial Fibrillation in a Case-Cohort Study: The Atherosclerosis Risk in Communities Study	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; CORONARY-ARTERY-DISEASE; MATRIX METALLOPROTEINASES; MYOCARDIAL-INFARCTION; SERUM MATRIX-METALLOPROTEINASE-9; CIRCULATING LEVELS; TISSUE INHIBITORS; HEART-FAILURE; HYPERTENSION; VALIDATION	Background: Previous cross-sectional studies have suggested that biomarkers of extracellular matrix remodelling are associated with atrial fibrillation (AF), but no prospective data have yet been published. Hence, we examine whether plasma matrix metalloproteinases (MMP) and their inhibitors are related to increased risk of incident AF. Methods: We used a case-cohort design in the context of the prospective Atherosclerosis Risk in Communities (ARIC) study. From 13718 eligible men and women free from AF in 1990-92, we selected a stratified random sample of 500 individuals without and 580 with incident AF over a mean follow-up of 11.8 years. Using a weighted proportional hazards regression model, the relationships between MMP-1, MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinase (TIMP)-1, TIMP-2 and C-terminal propeptide of collagen type-I with incident AF were examined after adjusting for confounders. Results: In models adjusted for age, sex and race, all biomarkers were associated with AF, but only the relationship between plasma MMP-9 remained significant in the fully-adjusted model: each one standard deviation increase in MMP-9 was associated with 27% (95% Confidence Interval: 7% to 50%) increase in risk of AF with no evidence of an interaction with race or sex. Individuals with above mean levels of MMP-9 were more likely to be male, white and current smokers. Conclusions: The findings suggest that elevated levels of MMP-9 are independently associated with increased risk of AF. However, given the lack of specificity of MMP-9 to atrial tissue, it remains to be determined whether the observed relationship reflects the impact of atrial fibrosis or more generalized fibrosis on risk of incident AF.	[Huxley, Rachel R.; Lopez, Faye L.; MacLehose, Richard F.; Leiendecker-Foster, Catherine; Chen, Lin Yee; Alonso, Alvaro] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Eckfeldt, John H.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Couper, David; Agarwal, Sunil K.] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; [Hoogeveen, Ron C.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Soliman, Elsayed Z.] Wake Forest Univ, Bowman Gray Sch Med, Dept Epidemiol & Prevent, Epidemiol Cardiol Res Ctr, Winston Salem, NC USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Wake Forest University; Wake Forest Baptist Medical Center	Huxley, RR (corresponding author), Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	rhuxley@umn.edu	Huxley, Rachel R/J-4638-2013; Huxley, Rachel R/C-7032-2013; Alonso, Alvaro/A-4917-2010; Soliman, Elsayed Z/AAD-7135-2020; Norby, Faye/S-3729-2017	Huxley, Rachel R/0000-0002-2705-6616; Huxley, Rachel R/0000-0002-2705-6616; Alonso, Alvaro/0000-0002-2225-8323; Soliman, Elsayed Z/0000-0001-5632-8150; Chen, Lin/0000-0002-0700-814X; Norby, Faye/0000-0002-1975-0405; Hoogeveen, Ron/0000-0003-2399-4653; Couper, David/0000-0002-4313-9235	National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, RC1HL099452]; American Heart Association [09SDG2280087]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055021, N01HC055018, N01HC055019, N01HC055020, N01HC055022, N01HC055016] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099452] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. This work was additionally supported by the National Heart, Lung, and Blood Institute grant RC1HL099452 and American Heart Association grant 09SDG2280087. There are no relationships with industry to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; [Anonymous], 1989, AM J EPIDEMIOL, V129, P687; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; BROWN DL, 1995, CIRCULATION, V91, P2125, DOI 10.1161/01.CIR.91.8.2125; CASALE PN, 1987, CIRCULATION, V75, P565, DOI 10.1161/01.CIR.75.3.565; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Dominguez-Rodriguez A, 2008, ATHEROSCLEROSIS, V196, P365, DOI 10.1016/j.atherosclerosis.2006.11.012; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; ERIKSSON H, 1987, EUR HEART J, V8, P1007, DOI 10.1093/oxfordjournals.eurheartj.a062365; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gai XB, 2010, CLIN CHIM ACTA, V411, P719, DOI 10.1016/j.cca.2010.02.002; Galis ZS, 2002, CIRC RES, V91, P852, DOI 10.1161/01.RES.0000041036.86977.14; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Grodin JL, 2011, VASC MED, V16, P339, DOI 10.1177/1358863X11422110; Jung K, 2008, CLIN CHEM, V54, P772, DOI 10.1373/clinchem.2007.099937; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Kallergis EM, 2008, J AM COLL CARDIOL, V52, P211, DOI 10.1016/j.jacc.2008.03.045; Kalogeropoulos AS, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-77; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Lund AK, 2009, ARTERIOSCL THROM VAS, V29, P511, DOI 10.1161/ATVBAHA.108.176107; Mannello F, 2008, ARTERIOSCL THROM VAS, V28, P611, DOI 10.1161/ATVBAHA.107.159608; Nakano Y, 2004, J AM COLL CARDIOL, V43, P818, DOI 10.1016/j.jacc.2003.08.060; Nambi V, 2008, TEX HEART I J, V35, P388; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Selvin E, 2005, DIABETIC MED, V22, P1726, DOI 10.1111/j.1464-5491.2005.01705.x; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Tayebjee MH, 2004, AM J HYPERTENS, V17, P764, DOI 10.1016/j.amjhyper.2004.05.019; Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708; Velagaleti RS, 2010, ARTERIOSCL THROM VAS, V30, P2283, DOI 10.1161/ATVBAHA.110.208462; Welsh P, 2008, QJM-INT J MED, V101, P785, DOI 10.1093/qjmed/hcn088; Wilson WRW, 2006, CIRCULATION, V113, P438, DOI 10.1161/CIRCULATIONAHA.105.551572; Zeng B, 2005, INTERN MED J, V35, P331, DOI 10.1111/j.1445-5994.2005.00822.x	38	32	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59052	10.1371/journal.pone.0059052	http://dx.doi.org/10.1371/journal.pone.0059052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554968	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800052
J	Amos, W; Brooks-Pollock, E; Blackwell, R; Driscoll, E; Nelson-Flower, M; Conlan, AJK				Amos, William; Brooks-Pollock, Ellen; Blackwell, Ruth; Driscoll, Erin; Nelson-Flower, Martha; Conlan, Andrew J. K.			Genetic Predisposition to Pass the Standard SICCT Test for Bovine Tuberculosis in British Cattle	PLOS ONE			English	Article							IMMUNE-RESPONSE; MYCOBACTERIUM-BOVIS; CANADIAN HOLSTEINS; SUSCEPTIBILITY; INFECTION; POLYMORPHISMS; RESISTANCE; DISEASE; SKIN	Bovine tuberculosis (bTB) imposes an important financial burden on the British cattle industry, yet despite intense efforts to control its spread, incidence is currently rising. Surveillance for bTB is based on a skin test that measures an immunological response to tuberculin. Cattle that fail the test are classified as "reactors'' and slaughtered. Recent studies have identified genetic markers associated with the reaction of cattle to the tuberculin test. At marker INRA111 a relatively common '22' genotype occurs significantly more frequently in non-reactor cattle. Here we test the possibility that the putative protective '22' genotype does not confer resistance but instead causes cattle that carry it to react less strongly to the prescribed test, and hence avoid slaughter, potentially even though they are infected. We show that, after controlling for age and breed, '22' cattle react less strongly to the immunological challenge and may therefore be less likely to be classified as a reactor. These results highlight the potential discrepancy between infection and test status and imply that the effectiveness of the test-and-slaughter policy may be being compromised by selection for cattle that are genetically predisposed to react less strongly to tuberculin.	[Amos, William; Driscoll, Erin; Nelson-Flower, Martha] Univ Cambridge, Dept Zool, Cambridge, Cambs, England; [Brooks-Pollock, Ellen; Conlan, Andrew J. K.] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, Cambs, England; [Blackwell, Ruth] AHVLA, Addlestone, Surrey, England	University of Cambridge; University of Cambridge	Amos, W (corresponding author), Univ Cambridge, Dept Zool, Cambridge, Cambs, England.	w.amos@zoo.cam.ac.uk	Conlan, Andrew/Q-3861-2019	Conlan, Andrew/0000-0002-2593-6353; Nelson-Flower, Martha/0000-0001-6753-9252; Brooks-Pollock, Ellen/0000-0002-5984-4932	DEFRA [SE-3127]; EPSRC; EPSRC [EP/H027270/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H027270/1] Funding Source: researchfish	DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	AJKC is supported by DEFRA grant SE-3127. EBP is supported by an EPSRC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Amos W, 2011, P ROY SOC B-BIOL SCI, V278, P1183, DOI 10.1098/rspb.2010.1920; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Brotherstone S, 2010, J DAIRY SCI, V93, P1234, DOI 10.3168/jds.2009-2609; Bulat-Kardum L, 2006, SCAND J IMMUNOL, V63, P142, DOI 10.1111/j.1365-3083.2005.01694.x; Canty A, 2012, BOOT BOOTSTRAP R S P; Coad M, 2010, VET RES, V41, DOI 10.1051/vetres/2009062; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Davison AC, 1997, BOOTSTRAP METHODS TH; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; DEFRA, 2011, BOV TB ER PROGR ENGL; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; DOWLING D. F., 1955, AUSTRALIAN JOUR AGRIC RES, V6, P776, DOI 10.1071/AR9550776; DOWLING DF, 1964, J AGR SCI-CAMBRIDGE, V62, P307, DOI 10.1017/S0021859600042398; Driscoll EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018806; Gallagher J, 2000, RES VET SCI, V69, P203, DOI 10.1053/rvsc.2000.0422; Goodchild AV, 2001, TUBERCULOSIS, V81, P23, DOI 10.1054/tube.2000.0256; Goodchild T, 2008, MYCOBACTERIUM BOVIS; Green DM, 2007, P ROYAL SOC B, V275, P1001, DOI DOI 10.1098/RSPB.2007.1601; Hine BC, 2012, CAN J VET RES, V76, P149; Hosmer D.W., 2000, ASSESSING FIT MODEL; Jackman S., 2012, PSCL CLASSES METHODS; Jackson CH, 2008, AM STAT, V62, P340, DOI 10.1198/000313008X370843; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Karolemeas K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043217; Kleeberg H. H., 1960, Journal of the South African Veterinary Medical Association, V31, P213; Li HT, 2006, INT J TUBERC LUNG D, V10, P3; Mitchell AP, 2006, P SOC VET EP PREV ME, P70; R Development Core Team, 2009, R FDN STAT COMP; Ramirez-Villaescusa AM, 2010, PREV VET MED, V95, P224, DOI 10.1016/j.prevetmed.2010.03.009; Ramirez-Villaescusa AM, 2009, PREV VET MED, V92, P188, DOI 10.1016/j.prevetmed.2009.08.011; Reid JM, 2003, P ROY SOC B-BIOL SCI, V270, P2151, DOI 10.1098/rspb.2003.2480; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Thompson-Crispi KA, 2012, J DAIRY SCI, V95, P401, DOI 10.3168/jds.2011-4452; Velez DR, 2009, HUM GENET, V126, P643, DOI 10.1007/s00439-009-0713-y; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	43	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58245	10.1371/journal.pone.0058245	http://dx.doi.org/10.1371/journal.pone.0058245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23554880	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100095
J	Zhang, Y; Yan, W; Chen, X				Zhang, Y.; Yan, W.; Chen, X.			P63 regulates tubular formation via epithelial-to-mesenchymal transition	ONCOGENE			English	Article						p63; the p53 family; tubular formation; epithelial-to-mesenchymal transition; cell proliferation; migration and invasion	P53 HOMOLOG; MIR-200 FAMILY; CELL CARCINOMA; GENE-MUTATIONS; EEC-SYNDROME; E-CADHERIN; IN-VIVO; TARGET; KIDNEY; GROWTH	P63, a p53 family member, is expressed as Delta A and DN isoforms. Interestingly, both TAp63 and Delta Np63 are transcription factors, and regulate both common and distinct sets of target genes. p63 is required for survival of some epithelial cell lineages, and lack of p63 leads to loss of epidermis and other epithelia in humans and mice. Here, we explored the role of p63 isoforms in cell proliferation, migration and tubulogenesis by using Madin-Darby Canine Kidney (MDCK) tubular epithelial cells in two-or three-dimensional (2-D or 3-D) culture. We found that like downregulation of p53, downregulation of p63 and TAp63 decreases expression of growth-suppressing genes, including p21, PUMA and MIC-1, and consequently promotes cell proliferation and migration in 2-D culture. However, in 3-D culture, downregulation of p63, especially TAp63, but not p53, decapacitates MDCK cells to form a cyst structure through enhanced epithelial-to-mesenchymal transition (EMT). In contrast, downregulation of DNp63 inhibits MDCK cell proliferation and migration in 2-D culture, and delays but does not block MDCK cell cyst formation and tubulogenesis in 3-D culture. Consistent with this, downregulation of DNp63 markedly upregulates growth-suppressing genes, including p21, PUMA and MIC-1. Taken together, these data suggest that TAp63 is the major isoform required for tubulogenesis by maintaining an appropriate level of EMT, whereas DNp63 fine-tunes the rate of cyst formation and tubulogenesis by maintaining an appropriate expression level of genes involved in cell cycle arrest and apoptosis.	[Chen, X.] Univ Calif Davis, Ctr Comparat Oncol, Sch Med, Davis, CA 95616 USA; [Chen, X.] Univ Calif Davis, Ctr Comparat Oncol, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Chen, X (corresponding author), Univ Calif Davis, Ctr Comparat Oncol, Sch Med, 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [CA102188, CA108122, CA076069]; NATIONAL CANCER INSTITUTE [R01CA102188, R01CA076069, R29CA076069, R01CA123227, R01CA081237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health grants CA102188, CA108122 and CA076069. We thank Jin Zhang for helpful comments on this manuscript.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Allen LM, 2008, J ULTRAS MED, V27, P149, DOI 10.7863/jum.2008.27.1.149; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; Brunner HG, 2002, AM J MED GENET, V112, P284, DOI 10.1002/ajmg.10778; Cao Y, 2008, CANCER RES, V68, P8667, DOI 10.1158/0008-5472.CAN-08-2614; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Cook HT, 2010, AM J PATHOL, V176, P22, DOI 10.2353/ajpath.2010.090898; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Dressler GR, 2002, TRENDS CELL BIOL, V12, P390, DOI 10.1016/S0962-8924(02)02334-6; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Herfs M, 2010, AM J PATHOL, V176, P1941, DOI 10.2353/ajpath.2010.090804; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jia LW, 2011, MOL BIOL CELL, V22, P2031, DOI 10.1091/mbc.E11-01-0038; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; LEIGHTON J, 1970, CANCER-AM CANCER SOC, V26, P1022, DOI 10.1002/1097-0142(197011)26:5<1022::AID-CNCR2820260509>3.0.CO;2-M; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Lo Iacono M, 2006, CELL CYCLE, V5, P78; Massion PP, 2003, CANCER RES, V63, P7113; MCATEER JA, 1987, ANAT REC, V217, P229, DOI 10.1002/ar.1092170303; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; O'Brien LE, 2006, METHOD ENZYMOL, V406, P676, DOI 10.1016/S0076-6879(06)06053-8; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Park BJ, 2000, CANCER RES, V60, P3370; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; Prindull G, 2004, BLOOD, V103, P2892, DOI 10.1182/blood-2003-08-2807; Rinne T, 2006, AM J MED GENET A, V140A, P1396, DOI 10.1002/ajmg.a.31271; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; Saxen L., 1987, Developmental and Cell Biology Series, V19, P1; Sensen CW, 1998, EXTREMOPHILES, V2, P305, DOI 10.1007/s007920050073; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; Sniezek JC, 2004, LARYNGOSCOPE, V114, P2063, DOI 10.1097/01.mlg.0000149437.35855.4b; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; van Bokhoven H, 2001, AM J HUM GENET, V69, P481, DOI 10.1086/323123; Vanbokhoven H, 2011, J INVEST DERMATOL, V131, P1196, DOI 10.1038/jid.2011.84; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang J, 2009, MOL CANCER RES, V7, P67, DOI 10.1158/1541-7786.MCR-08-0347; Zhang YH, 2008, J BIOL CHEM, V283, P30689, DOI 10.1074/jbc.M801711200; Zhang YH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214585; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021; Zimmers TA, 2005, SHOCK, V23, P543, DOI 10.1097/01.shk.0000163393.55350.70	58	23	23	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 20	2014	33	12					1548	1557		10.1038/onc.2013.101	http://dx.doi.org/10.1038/onc.2013.101			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD4TS	23542170	Green Accepted			2022-12-25	WOS:000333244200008
J	Zhao, H; Chen, MS; Lo, YH; Waltz, SE; Wang, J; Ho, PC; Vasiliauskas, J; Plattner, R; Wang, YL; Wang, SC				Zhao, H.; Chen, M-S; Lo, Y-H; Waltz, S. E.; Wang, J.; Ho, P-C; Vasiliauskas, J.; Plattner, R.; Wang, Y-L; Wang, S-C			The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer	ONCOGENE			English	Article						PCNA; Ron; receptor tyrosine kinase; tyrosine phosphorylation; Y211; c-Abl	GROWTH-FACTOR RECEPTOR; TERMINAL REPEATED DOMAIN; DAMAGE-INDUCED APOPTOSIS; NUCLEAR ANTIGEN PCNA; DNA MISMATCH REPAIR; RNA-POLYMERASE-II; TUMOR-FORMATION; PROTEIN; REPLICATION; FAMILY	Multiple growth pathways lead to enhanced proliferation in malignant cells. However, how the core machinery of DNA replication is regulated by growth signaling remains largely unclear. The sliding clamp proliferating cell nuclear antigen (PCNA) is an indispensable component of the DNA machinery responsible for replicating the genome and maintaining genomic integrity. We previously reported that epidermal growth factor receptor (EGFR) triggered tyrosine 211 (Y211) phosphorylation of PCNA, which in turn stabilized PCNA on chromatin to promote cell proliferation. Here we show that the phosphorylation can also be catalyzed by the non-receptor tyrosine kinase c-Abl. We further demonstrate that, in the absence of EGFR, signaling to PCNA can be attained through the activation of the Ron receptor tyrosine kinase and the downstream non-receptor tyrosine kinase c-Abl. We show that Ron and c-Abl form a complex, and that activation of Ron by its ligand, hepatocyte growth factor-like protein (HGFL), stimulates c-Abl kinase activity, which in turn directly phosphorylates PCNA at Y211 and leads to an increased level of chromatin-associated PCNA. Correspondingly, HGFL-induced Ron activation resulted in Y211 phosphorylation of PCNA while silencing of c-Abl blocked this effect. We show that c-Abl and Y211 phosphorylation of PCNA is an important axis downstream of Ron, which is required for cell proliferation. Treatment with a specific peptide that inhibits Y211 phosphorylation of PCNA or with the c-Abl pharmacological inhibitor imatinib suppressed HGFL-induced cell proliferation. Our findings identify the pathway of Ron-c-Abl-PCNA as a mechanism of oncogene-induced cell proliferation, with potentially important implications for development of combination therapy of breast cancer.	[Zhao, H.; Chen, M-S; Lo, Y-H; Waltz, S. E.; Ho, P-C; Vasiliauskas, J.; Wang, Y-L; Wang, S-C] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45267 USA; [Waltz, S. E.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA; [Wang, J.] Univ Cincinnati Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH USA; [Plattner, R.] Univ Kentucky, Sch Med, Dept Mol & Biomed Pharmacol, Lexington, KY USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; University of Kentucky	Wang, SC (corresponding author), Univ Cincinnati, Coll Med, Vontz Ctr, Dept Canc Biol, 3125 Eden Ave,PO 670521, Cincinnati, OH 45267 USA.	wangsc@ucmail.uc.edu	Wang, Shao-Chun/P-9904-2019	Wang, Shao-Chun/0000-0002-5477-1682; Waltz, Susan/0000-0003-3572-4642	Susan G Komen Breast Cancer Research Award [KG080540]; Department of Defense Prostate Cancer Research Program New Investigator Award [PC073951]; Center for Clinical and Translational Science and Training (CCTST) of University of Cincinnati and Cincinnati Children's Hospital; Elsa Pardee Foundation; VA Merit Award [1001BX000803, R01 CA125379, R01 CA116784]; PHS [P30 DK078392]; NATIONAL CANCER INSTITUTE [R01CA125379, R01CA116784, R01CA100002, T32CA117846] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000803] Funding Source: NIH RePORTER	Susan G Komen Breast Cancer Research Award(Susan G. Komen Breast Cancer Foundation); Department of Defense Prostate Cancer Research Program New Investigator Award(United States Department of Defense); Center for Clinical and Translational Science and Training (CCTST) of University of Cincinnati and Cincinnati Children's Hospital; Elsa Pardee Foundation; VA Merit Award(US Department of Veterans Affairs); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Drs David Plas and Daniel Starczynowski for the help in discussion and reagents. We also like to thank Dr Belinda Peace and Glenn Doerman for assistance in editing the manuscript and preparing the graphics, and Jerylin Gray for technical assistance. This work was supported in part by the Susan G Komen Breast Cancer Research Award KG080540, the Department of Defense Prostate Cancer Research Program New Investigator Award PC073951, the Center for Clinical and Translational Science and Training (CCTST) of University of Cincinnati and Cincinnati Children's Hospital, and the Elsa Pardee Foundation (S-CW), the VA Merit Award 1001BX000803 and R01 CA125379 (SEW), and R01 CA116784 (RP). This project was also supported in part by PHS Grant P30 DK078392.	Agami R, 1999, NATURE, V399, P809; Andoniou CE, 1996, ONCOGENE, V12, P1981; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Baker MA, 2009, DEV BIOL, V333, P57, DOI 10.1016/j.ydbio.2009.06.022; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Baskaran R, 1999, CELL GROWTH DIFFER, V10, P387; DUYSTER J, 1995, P NATL ACAD SCI USA, V92, P1555, DOI 10.1073/pnas.92.5.1555; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Follenzi A, 2000, ONCOGENE, V19, P3041, DOI 10.1038/sj.onc.1203620; FURUKAWA T, 1991, J SURG ONCOL, V48, P188, DOI 10.1002/jso.2930480310; Gong JG, 1999, NATURE, V399, P806; Iwama A, 1996, EMBO J, V15, P5866, DOI 10.1002/j.1460-2075.1996.tb00973.x; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kharbanda S, 1998, ONCOGENE, V17, P3309, DOI 10.1038/sj.onc.1202571; Kim WJ, 2007, J BIOL CHEM, V282, P32021, DOI 10.1074/jbc.M701451200; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Komatsu K, 2000, ONCOGENE, V19, P5291, DOI 10.1038/sj.onc.1203901; Lee WY, 2005, CLIN CANCER RES, V11, P2222, DOI 10.1158/1078-0432.CCR-04-1761; Lehmann AR, 2006, EXP CELL RES, V312, P2673, DOI 10.1016/j.yexcr.2006.06.010; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Leonis Mike A, 2007, Future Oncol, V3, P441, DOI 10.2217/14796694.3.4.441; Levav-Cohen Y, 2005, BIOCHEM BIOPH RES CO, V331, P737, DOI 10.1016/j.bbrc.2005.03.152; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Lo YH, 2011, ANTICANCER RES, V31, P789; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Maggiora P, 1998, ONCOGENE, V16, P2927, DOI 10.1038/sj.onc.1201812; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; Matunis MJ, 2002, MOL CELL, V10, P441, DOI 10.1016/S1097-2765(02)00653-6; McClaine RJ, 2010, NEOPLASIA, V12, P650, DOI 10.1593/neo.10476; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nehme A, 1997, CANCER RES, V57, P3253; O'Toole JM, 2006, CANCER RES, V66, P9162, DOI 10.1158/0008-5472.CAN-06-0283; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; Peace BE, 2005, CANCER RES, V65, P1285, DOI 10.1158/0008-5472.CAN-03-3580; Peace BE, 2001, ONCOGENE, V20, P6142, DOI 10.1038/sj.onc.1204836; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Thobe MN, 2010, ONCOGENE, V29, P214, DOI 10.1038/onc.2009.331; Truong T, 2003, P NATL ACAD SCI USA, V100, P10281, DOI 10.1073/pnas.1635435100; Tsai KKC, 2003, CANCER RES, V63, P3418; Ulrich HD, 2004, CELL CYCLE, V3, P15; Wagh PK, 2008, ADV CANCER RES, V100, P1, DOI 10.1016/S0065-230X(08)00001-8; Wang JYJ, 2001, BIOCHEM SOC T, V29, P666, DOI 10.1042/0300-5127:0290666; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Welm AL, 2007, P NATL ACAD SCI USA, V104, P7570, DOI 10.1073/pnas.0702095104; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Yi W, 2006, CANCER RES, V66, P151, DOI 10.1158/0008-5472.CAN-05-3019; Yogalingam G, 2008, J BIOL CHEM, V283, P35941, DOI 10.1074/jbc.M804543200; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yuan ZM, 1997, P NATL ACAD SCI USA, V94, P1437, DOI 10.1073/pnas.94.4.1437; Yuan ZM, 1996, NATURE, V382, P272, DOI 10.1038/382272a0; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zhao HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029416; Zhao HJ, 2011, MOL CANCER THER, V10, P29, DOI 10.1158/1535-7163.MCT-10-0778; Zhao HJ, 2011, MOL CARCINOGEN, V50, P383, DOI 10.1002/mc.20721; Zhao HJ, 2010, NEOPLASIA, V12, P214, DOI 10.1593/neo.91576; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	72	36	41	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2014	33	11					1429	1437		10.1038/onc.2013.84	http://dx.doi.org/10.1038/onc.2013.84			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD0SD	23542172	Green Accepted			2022-12-25	WOS:000332943500010
J	Ashpole, NM; Chawla, AR; Martin, MP; Brustovetsky, T; Brustovetsky, N; Hudmon, A				Ashpole, Nicole M.; Chawla, Aarti R.; Martin, Matthew P.; Brustovetsky, Tatiana; Brustovetsky, Nickolay; Hudmon, Andy			Loss of Calcium/Calmodulin-dependent Protein Kinase II Activity in Cortical Astrocytes Decreases Glutamate Uptake and Induces Neurotoxic Release of ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITATORY AMINO-ACIDS; P2X(7) RECEPTORS; GLIAL-CELLS; HIPPOCAMPAL-NEURONS; P2Y(1) RECEPTOR; CALCIUM WAVES; RAT STRIATUM; EXPRESSION; ISCHEMIA; CAMKII	The extent of calcium/calmodulin-dependent protein kinase II (CaMKII) inactivation in the brain after ischemia correlates with the extent of damage. We have previously shown that a loss of CaMKII activity in neurons is detrimental to neuronal viability by inducing excitotoxic glutamate release. In the current study we extend these findings to show that the ability of astrocytes to buffer extracellular glutamate is reduced when CaMKII is inhibited. Furthermore, CaMKII inhibition in astrocytes is associated with the rapid onset of intracellular calcium oscillations. Surprisingly, this rapid calcium influx is blocked by the N-type calcium channel antagonist, omega-conotoxin. Although the function of N-type calcium channels within astrocytes is controversial, these voltage-gated calcium channels have been linked to calcium-dependent vesicular gliotransmitter release. When extracellular glutamate and ATP levels are measured after CaMKII inhibition within our enriched astrocyte cultures, no alterations in glutamate levels are observed, whereas ATP levels in the extracellular environment significantly increase. Extracellular ATP accumulation associated with CaMKII inhibition contributes both to calcium oscillations within astrocytes and ultimately cortical neuron toxicity. Thus, a loss of CaMKII signaling within astrocytes dysregulates glutamate uptake and supports ATP release, two processes that would compromise neuronal survival after ischemic/excitotoxic insults.	[Ashpole, Nicole M.; Chawla, Aarti R.; Martin, Matthew P.; Brustovetsky, Nickolay; Hudmon, Andy] Indiana Univ, Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Brustovetsky, Tatiana; Brustovetsky, Nickolay] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Hudmon, Andy] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Hudmon, A (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Stark Neurosci Res Inst, 950 W Walnut St,R2-480, Indianapolis, IN 46202 USA.	ahudmon@iupui.edu			National Institutes of Health [NS078171, NS078008]; Indiana State Department of Health, Spinal Cord Brain Injury [ISDH/A70-2-079607]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078008, R01NS078171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana State Department of Health, Spinal Cord Brain Injury; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS078171 (to A. H.) and NS078008 (N. B.). This work was also supported by the Indiana State Department of Health, Spinal Cord Brain Injury (ISDH/A70-2-079607) research grants (A. H.).	Anderson CM, 2000, GLIA, V32, P1; Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Arbeloa J, 2012, NEUROBIOL DIS, V45, P954, DOI 10.1016/j.nbd.2011.12.014; ARONOWSKI J, 1992, J NEUROCHEM, V58, P1743, DOI 10.1111/j.1471-4159.1992.tb10049.x; Ashpole NM, 2012, J BIOL CHEM, V287, P8495, DOI 10.1074/jbc.M111.323915; Ashpole NM, 2011, MOL CELL NEUROSCI, V46, P720, DOI 10.1016/j.mcn.2011.02.003; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BARRES BA, 1991, J NEUROSCI, V11, P3685; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Carter DS, 2006, J PHARMACOL EXP THER, V319, P1021, DOI 10.1124/jpet.106.110403; Centemeri C, 1997, BRIT J PHARMACOL, V121, P1700, DOI 10.1038/sj.bjp.0701293; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Cotrina ML, 2000, DEV BIOL, V228, P326, DOI 10.1006/dbio.2000.9948; Cotrina ML, 2000, J NEUROSCI, V20, P2835; D'ascenzo M, 2004, GLIA, V45, P354, DOI 10.1002/glia.10336; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fan DL, 1999, J NEUROSCI RES, V57, P557, DOI 10.1002/(SICI)1097-4547(19990815)57:4<557::AID-JNR16>3.0.CO;2-I; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Franke H, 2004, J NEUROPATH EXP NEUR, V63, P686, DOI 10.1093/jnen/63.7.686; Franke H, 2006, PHARMACOL THERAPEUT, V109, P297, DOI 10.1016/j.pharmthera.2005.06.002; Franke H, 2012, PURINERG SIGNAL, V8, P629, DOI 10.1007/s11302-012-9300-0; Gallagher CJ, 2003, J NEUROSCI, V23, P6728; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; HANSON SK, 1994, STROKE, V25, P466, DOI 10.1161/01.STR.25.2.466; Holtje M, 2008, J BIOL CHEM, V283, P9289, DOI 10.1074/jbc.M706499200; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Inoue K, 2007, J NEUROCHEM, V102, P1447, DOI 10.1111/j.1471-4159.2007.04824.x; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kajihara H, 2001, BRAIN RES, V909, P92, DOI 10.1016/S0006-8993(01)02640-3; Klug JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045323; Koles L, 2011, ADV PHARMACOL, V61, P441, DOI 10.1016/B978-0-12-385526-8.00014-X; KOLB SJ, 1995, J NEUROCHEM, V64, P2147; Kuboyama K, 2011, J CEREBR BLOOD F MET, V31, P1930, DOI 10.1038/jcbfm.2011.49; Lammer A, 2006, EUR J NEUROSCI, V23, P2824, DOI 10.1111/j.1460-9568.2006.04825.x; Lammer AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019983; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; Latour I, 2003, GLIA, V41, P347, DOI 10.1002/glia.10162; Leon D, 2006, EUR J NEUROSCI, V23, P2999, DOI 10.1111/j.1460-9568.2006.04832.x; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu T, 2011, J NEUROSCI, V31, P10593, DOI 10.1523/JNEUROSCI.6401-10.2011; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; Mamedova LK, 2006, BIOCHEM PHARMACOL, V72, P1031, DOI 10.1016/j.bcp.2006.07.017; Matos M, 2008, NEUROSCIENCE, V156, P898, DOI 10.1016/j.neuroscience.2008.08.022; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCCARTHY KD, 1991, NEUROSCIENCE, V41, P325, DOI 10.1016/0306-4522(91)90330-Q; MCGUINNESS TL, 1985, J BIOL CHEM, V260, P1696; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Perego C, 2000, J NEUROCHEM, V75, P1076, DOI 10.1046/j.1471-4159.2000.0751076.x; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Phillis JW, 2000, BRAIN RES, V880, P224, DOI 10.1016/S0006-8993(00)02755-4; PHILLIS JW, 1994, NEUROCHEM RES, V19, P1125, DOI 10.1007/BF00965145; Pryazhnikov E, 2008, GLIA, V56, P38, DOI 10.1002/glia.20590; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Ryu JK, 2002, NEUROREPORT, V13, P1611, DOI 10.1097/00001756-200209160-00008; SAKAGAMI H, 1992, MOL BRAIN RES, V16, P20, DOI 10.1016/0169-328X(92)90189-I; SALTER MW, 1994, J NEUROSCI, V14, P1563, DOI 10.1523/JNEUROSCI.14-03-01563.1994; Schmidt-Kastner R, 2005, BRAIN RES, V1052, P28, DOI 10.1016/j.brainres.2005.06.018; Schulze-Lohoff E, 1998, AM J PHYSIOL-RENAL, V275, pF962, DOI 10.1152/ajprenal.1998.275.6.F962; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Sellers LK, 2001, J BIOL CHEM, V276, P16379, DOI 10.1074/jbc.M006617200; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Takahashi S, 1997, DEV BRAIN RES, V104, P111, DOI 10.1016/S0165-3806(97)00175-2; Takeuchi Y, 2000, J NEUROCHEM, V74, P2557, DOI 10.1046/j.1471-4159.2000.0742557.x; Tang QB, 2012, J NEUROSCI, V32, P11737, DOI 10.1523/JNEUROSCI.0983-12.2012; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Volonte C, 2003, CNS NEUROL DISORD-DR, V2, P403, DOI 10.2174/1568007033482643; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Waxham MN, 1996, J CEREBR BLOOD F MET, V16, P1, DOI 10.1097/00004647-199601000-00001; Yaguchi T, 2010, J CELL PHYSIOL, V225, P512, DOI 10.1002/jcp.22231; Yasuda K, 2011, GLIA, V59, P143, DOI 10.1002/glia.21083; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhou BY, 2004, MOL CELL NEUROSCI, V27, P296, DOI 10.1016/j.mcn.2004.07.003; Zhou Y, 2010, NEUROCHEM RES, V35, P2124, DOI 10.1007/s11064-010-0325-x	98	30	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14599	14611		10.1074/jbc.M113.466235	http://dx.doi.org/10.1074/jbc.M113.466235			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543737	Green Published, hybrid			2022-12-25	WOS:000319253500060
J	Garcia-Arcos, I; Hiyama, Y; Drosatos, K; Bharadwaj, KG; Hu, YY; Son, NHP; O'Byrne, SM; Chang, CCL; Deckelbaum, RJ; Takahashi, M; Westerterp, M; Obunike, JC; Jiang, HF; Yagyu, H; Blaner, WS; Goldberg, IJ				Garcia-Arcos, Itsaso; Hiyama, Yaeko; Drosatos, Konstantinos; Bharadwaj, Kalyani G.; Hu, Yunying; Son, Ni Huiping; O'Byrne, Sheila M.; Chang, Chuchun L.; Deckelbaum, Richard J.; Takahashi, Manabu; Westerterp, Marit; Obunike, Joseph C.; Jiang, Hongfeng; Yagyu, Hiroaki; Blaner, William S.; Goldberg, Ira J.			Adipose-specific Lipoprotein Lipase Deficiency More Profoundly Affects Brown than White Fat Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; HIGH-DENSITY-LIPOPROTEIN; IN-VIVO; ACID COMPOSITION; SKELETAL-MUSCLE; GENE-EXPRESSION; TRANSGENIC MICE; PPAR-GAMMA; TISSUE; METABOLISM	Adipose fat storage is thought to require uptake of circulating triglyceride (TG)-derived fatty acids via lipoprotein lipase (LpL). To determine how LpL affects the biology of adipose tissue, we created adipose-specific LpL knock-out (ATLO) mice, and we compared them with whole body LpL knock-out mice rescued with muscle LpL expression (MCK/L0) and wild type (WT) mice. ATLO LpL mRNA and activity were reduced, respectively, 75 and 70% in gonadal adipose tissue (GAT), 90 and 80% in subcutaneous tissue, and 84 and 85% in brown adipose tissue (BAT). ATLO mice had increased plasma TG levels associated with reduced chylomicron TG uptake into BAT and lung. ATLO BAT, but not GAT, had altered TG composition. GAT from MCK/L0 was smaller and contained less polyunsaturated fatty acids in TG, although GAT from ATLO was normal unless LpL was overexpressed in muscle. High fat diet feeding led to less adipose in MCK/L0 mice but TG acyl composition in subcutaneous tissue and BAT reverted to that of WT. Therefore, adipocyte LpL in BAT modulates plasma lipoprotein clearance, and the greater metabolic activity of this depot makes its lipid composition more dependent on LpL-mediated uptake. Loss of adipose LpL reduces fat accumulation only if accompanied by greater LpL activity in muscle. These data support the role of LpL as the "gatekeeper" for tissue lipid distribution.	[Garcia-Arcos, Itsaso; Hiyama, Yaeko; Drosatos, Konstantinos; Bharadwaj, Kalyani G.; Hu, Yunying; Son, Ni Huiping; O'Byrne, Sheila M.; Westerterp, Marit; Jiang, Hongfeng; Blaner, William S.; Goldberg, Ira J.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Chang, Chuchun L.; Deckelbaum, Richard J.] Columbia Univ Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA; [Takahashi, Manabu; Yagyu, Hiroaki] Jichii Univ, Dept Med, Mibu, Tochigi 3290498, Japan; [Westerterp, Marit] Univ Amsterdam, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Obunike, Joseph C.] CUNY, New York City Coll Technol, Dept Biol Sci, Brooklyn, NY 11201 USA	Columbia University; Columbia University; University of Amsterdam; City University of New York (CUNY) System	Goldberg, IJ (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA.	ijg3@columbia.edu	jiang, hongfeng/I-6188-2013; Drosatos, Konstantinos/H-9153-2013	Drosatos, Konstantinos/0000-0003-0903-834X; Garcia-Arcos, Itsaso/0000-0002-4190-3252	National Institutes of Health Grant from NHLBI [HL45095]; Basque Government [BFI09.241]; NWO VENI-Grant from The Netherlands Organization of Sciences [916.11.072]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL112853, T32HL007343, R01HL045095, R01HL073029, R37HL045095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK068437, R01DK095684] Funding Source: NIH RePORTER	National Institutes of Health Grant from NHLBI; Basque Government(Basque Government); NWO VENI-Grant from The Netherlands Organization of Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL45095 from NHLBI (to I. J. G.).; Recipient of Postdoctoral Fellowship BFI09.241 from the Basque Government.; Supported by NWO VENI-Grant 916.11.072 from The Netherlands Organization of Sciences.	Augustus A, 2004, J BIOL CHEM, V279, P25050, DOI 10.1074/jbc.M401028200; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; BERGER GMB, 1986, METABOLISM, V35, P1054, DOI 10.1016/0026-0495(86)90043-0; Bharadwaj KG, 2010, J BIOL CHEM, V285, P37976, DOI 10.1074/jbc.M110.174458; BRUN LD, 1989, METABOLISM, V38, P1005, DOI 10.1016/0026-0495(89)90013-9; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chang CL, 2010, ARTERIOSCL THROM VAS, V30, P2510, DOI 10.1161/ATVBAHA.110.215848; Clugston RD, 2011, J LIPID RES, V52, P2021, DOI 10.1194/jlr.M017368; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Davies BSJ, 2008, MOL ENDOCRINOL, V22, P2496, DOI 10.1210/me.2008-0146; Drosatos K, 2007, J BIOL CHEM, V282, P19556, DOI 10.1074/jbc.M700986200; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Goldberg IJ, 1996, J LIPID RES, V37, P693; GREENWOOD MRC, 1985, INT J OBESITY, V9, P67; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Haugen BR, 2004, ENDOCRINOLOGY, V145, P3679, DOI 10.1210/en.2003-1401; Hocquette JF, 1998, COMP BIOCHEM PHYS B, V121, P201, DOI 10.1016/S0305-0491(98)10090-1; JACOBSEN BK, 1983, AM J CLIN NUTR, V38, P906, DOI 10.1093/ajcn/38.6.906; Jensen MD, 2007, HORM METAB RES, V39, P722, DOI 10.1055/s-2007-990274; Kratky D, 2005, J CLIN INVEST, V115, P161, DOI 10.1172/JCI200515972; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Liu L, 2011, J LIPID RES, V52, P732, DOI 10.1194/jlr.M011395; MacLaren R, 2008, J LIPID RES, V49, P308, DOI 10.1194/jlr.M700199-JLR200; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; NILSSONEHLE P, 1976, J LIPID RES, V17, P536; O'Byrne SM, 2010, AM J PHYSIOL-ENDOC M, V298, pE862, DOI 10.1152/ajpendo.00491.2009; Olafsen T, 2010, J BIOL CHEM, V285, P39239, DOI 10.1074/jbc.M110.171041; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Palmer WK, 1998, ATHEROSCLEROSIS, V136, P115, DOI 10.1016/S0021-9150(97)00193-7; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Swayne TC, 2009, METHODS MOL BIOL, V586, P171, DOI 10.1007/978-1-60761-376-3_9; Takahashi M, 2013, J LIPID RES, V54, P1124, DOI 10.1194/jlr.M035568; Tang QQ, 2004, BIOCHEM BIOPH RES CO, V318, P213, DOI 10.1016/j.bbrc.2004.04.017; Ullrich NFE, 2001, J INVEST MED, V49, P273; VANSTAVEREN WA, 1986, AM J EPIDEMIOL, V123, P455; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wagner EM, 2004, J LIPID RES, V45, P356, DOI 10.1194/jlr.M300293-JLR200; Wang H, 2009, DIABETES, V58, P116, DOI 10.2337/db07-1839; Wassef L, 2011, J BIOL CHEM, V286, P32198, DOI 10.1074/jbc.M111.253070; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000	46	48	49	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14046	14058		10.1074/jbc.M113.469270	http://dx.doi.org/10.1074/jbc.M113.469270			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23542081	hybrid, Green Published			2022-12-25	WOS:000319253500010
J	Bahar, B; O'Doherty, JV; O'Doherty, AM; Sweeney, T				Bahar, Bojlul; O'Doherty, John V.; O'Doherty, Alan M.; Sweeney, Torres			Chito-Oligosaccharide Inhibits the De-Methylation of a 'CpG' Island within the Leptin (LEP) Promoter during Adipogenesis of 3T3-L1 Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELL; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; DNA METHYLATION; OB GENE; OBESITY; REGULATOR	Chito-oligosaccharide (COS) is a natural bioactive compound, which has been shown to suppress lipid metabolic genes and lipid accumulation in differentiating adipocytes. Leptin has been identified as a key regulator of energy homeostasis and is known to be under epigenetic regulation during adipogenesis. Hence, the first objective of this experiment was to compare leptin gene (LEP) expression and leptin secretion during the different stages of adipogenesis and to investigate the effect of COS on, these processes. As COS inhibited LEP expression during adipogenesis, the second aim was to investigate the methylation dynamics of a 'CpG' island in the proximal region of the LEP promoter during adipogenesis and to determine the effect of COS on this process. Mouse 3T3-L1 cells were stimulated to differentiate in the absence or presence of COS and the levels of leptin mRNA and protein were evaluated on days 0, 2,4 and 6 post-induction of differentiation (PID). The extent of de-methylation of six CpG sites was evaluated. LEP mRNA transcript and protein could not be detected on either day OPID or 2PID. In contrast, both were detected on day 4PID (P<0.05) and 6PID (P<0.001) and both were inhibited by COS (P<0.001). Of the six CpG sites analyzed, CpG_52, CpG_62 and CpG_95 became 11.5, 5.0 and 5.0% de-methylated between day 2PID and 6PID, respectively. COS blocked this de-methylation event at CpG_52 (P<0.001), CpG_62 (P<0.01) and CpG_95 (P<0.01) on day 6PID. These data suggest that COS can have an epigenetic effect on differentiating adipocytes, a novel biological function of COS which has potential applications for the manipulation of leptin gene expression adipogenesis, and conditions within the metabolic syndrome spectrum.	[Bahar, Bojlul; O'Doherty, John V.; O'Doherty, Alan M.] Natl Univ Ireland Univ Coll Dublin, Sch Agr & Food Sci, Dublin 4, Ireland; [Bahar, Bojlul; Sweeney, Torres] Natl Univ Ireland Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland	University College Dublin; University College Dublin	Sweeney, T (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland.	torres.sweeney@ucd.ie	O'Doherty, John/AAS-7261-2021	O'Doherty, John/0000-0002-0906-4065; Sweeney, Torres/0000-0003-2639-395X; O'Doherty, Alan/0000-0001-5071-6793	Sea Change Strategy [MFFRI/07/01]; Marine Institute; Department of Agriculture, Food and the Marine	Sea Change Strategy; Marine Institute; Department of Agriculture, Food and the Marine	This project (Grant-Aid Agreement No. MFFRI/07/01) is carried out under the Sea Change Strategy with the support of the Marine Institute and the Department of Agriculture, Food and the Marine, funded under the National Development Plan 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Bahar B, 2011, BRIT J NUTR, V106, P1142, DOI 10.1017/S0007114511001486; Cases JA, 2001, DIABETES, V50, P348, DOI 10.2337/diabetes.50.2.348; Cho EJ, 2008, J MICROBIOL BIOTECHN, V18, P80; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Dave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030831; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Enriori PJ, 2006, OBESITY, V14, P254; Farooqi IS, 2009, AM J CLIN NUTR, V89, p980S, DOI 10.3945/ajcn.2008.26788C; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guo W, 2009, CELL RES, V19, P216, DOI 10.1038/cr.2008.319; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Hwang CS, 1997, ANNU REV CELL DEV BI, V13, P231, DOI 10.1146/annurev.cellbio.13.1.231; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; Kallen CB, 1996, P NATL ACAD SCI USA, V93, P5793, DOI 10.1073/pnas.93.12.5793; Kim KJ, 2010, LIFE SCI, V86, P791, DOI 10.1016/j.lfs.2010.03.010; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kim WK, 2008, ENDOCR J, V55, P827, DOI 10.1507/endocrj.K08E-115; Koh KK, 2008, CIRCULATION, V117, P3238, DOI 10.1161/CIRCULATIONAHA.107.741645; Lee HW, 2003, BIOL PHARM BULL, V26, P1100; Lee YH, 2004, J LIPID RES, V45, P1162, DOI 10.1194/jlr.D300028-JLR200; Li HX, 2010, J ZHEJIANG UNIV-SC B, V11, P784, DOI 10.1631/jzus.B0900401; Liu SH, 2010, J AGR FOOD CHEM, V58, P5795, DOI 10.1021/jf100662r; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Marroqui L, 2012, J MOL ENDOCRINOL, V49, pR9, DOI 10.1530/JME-12-0025; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; Melzner I, 2002, J BIOL CHEM, V277, P45420, DOI 10.1074/jbc.M208511200; Moskalev EA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr213; Nishio Kazuaki, 2008, J Cardiometab Syndr, V3, P200, DOI 10.1111/j.1559-4572.2008.00019.x; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; O'Doherty AM, 2011, DEV BIOL, V356, P411, DOI 10.1016/j.ydbio.2011.05.665; Reidy SP, 2000, COMP BIOCHEM PHYS A, V125, P285, DOI 10.1016/S1095-6433(00)00159-8; Salma N, 2006, J MOL ENDOCRINOL, V36, P139, DOI 10.1677/jme.1.01918; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Walsh AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053828; Wu Jing, 2004, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V29, P623; Yokomori N, 2002, DIABETOLOGIA, V45, P140, DOI 10.1007/s125-002-8255-4; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; Zhang PL, 2002, ENDOCRINOLOGY, V143, P99, DOI 10.1210/en.143.1.99	45	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60011	10.1371/journal.pone.0060011	http://dx.doi.org/10.1371/journal.pone.0060011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544120	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700079
J	Condemi, S; Mounier, A; Giunti, P; Lari, M; Caramelli, D; Longo, L				Condemi, Silvana; Mounier, Aurelien; Giunti, Paolo; Lari, Martina; Caramelli, David; Longo, Laura			Possible Interbreeding in Late Italian Neanderthals? New Data from the Mezzena Jaw (Monti Lessini, Verona, Italy)	PLOS ONE			English	Article							UPPER PALEOLITHIC TRANSITION; MODERN HUMANS; EUROPE; CHRONOLOGY; MIDDLE; MTDNA; SYSTEMATICS; MANDIBLES; ORNAMENTS; SEQUENCE	In this article we examine the mandible of Riparo Mezzena a Middle Paleolithic rockshelter in the Monti Lessini (NE Italy, Verona) found in 1957 in association with Charentian Mousterian lithic assemblages. Mitochondrial DNA analysis performed on this jaw and on other cranial fragments found at the same stratigraphic level has led to the identification of the only genetically typed Neanderthal of the Italian peninsula and has confirmed through direct dating that it belongs to a late Neanderthal. Our aim here is to re-evaluate the taxonomic affinities of the Mezzena mandible in a wide comparative framework using both comparative morphology and geometric morphometrics. The comparative sample includes mid-Pleistocene fossils, Neanderthals and anatomically modern humans. This study of the Mezzena jaw shows that the chin region is similar to that of other late Neanderthals which display a much more modern morphology with an incipient mental trigone (e.g. Spy 1, La Ferrassie, Saint-Cesaire). In our view, this change in morphology among late Neanderthals supports the hypothesis of anatomical change of late Neanderthals and the hypothesis of a certain degree of interbreeding with AMHs that, as the dating shows, was already present in the European territory. Our observations on the chin of the Mezzena mandible lead us to support a non abrupt phylogenetic transition for this period in Europe.	[Condemi, Silvana; Mounier, Aurelien] Aix Marseille Univ, Sect Nord, Fac Med,CNRS,UMR 7268, EFS ADES Anthropol Bioculturelle Droit Eth & Sant, Marseille, France; [Mounier, Aurelien] Univ Cambridge, Dept Archaeol & Anthropol, Anthropol Div, Leverhulme Ctr Human Evolutionary Studies Biol, Cambridge, England; [Giunti, Paolo] Ist Italiano Preistoria & Protostoria, Florence, Italy; [Lari, Martina; Caramelli, David] Univ Florence, Dipartimento Biol Evoluzionist, Lab Antropol, Unita Antropol Mol Paleogenet, Florence, Italy; [Longo, Laura] Musei Civici Fiorentini, Florence, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; University of Cambridge; University of Florence	Condemi, S (corresponding author), Aix Marseille Univ, Sect Nord, Fac Med,CNRS,UMR 7268, EFS ADES Anthropol Bioculturelle Droit Eth & Sant, Marseille, France.	silvana.condemi@univ-amu.fr; laura.longo@comune.fi.it	Condemi, Silvana/ABE-2701-2021; Lari, Martina/A-4085-2009	Condemi, Silvana/0000-0002-6516-0879; Caramelli, David/0000-0001-6468-1675; Mounier, Aurelien/0000-0001-9713-7246				Barroso Ruiz C, 2001, SITE MOUSSTERIEN GRO; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; BRAUER G, 1990, J HUM EVOL, V19, P789, DOI 10.1016/0047-2484(90)90021-3; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Camps M, 2012, J HUM EVOL, V62, P89, DOI 10.1016/j.jhevol.2011.10.010; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; Condemi S., 2001, NEANDERTHALIENS CHAI; Condemi S, 2012, CR PALEVOL, V11, P79, DOI 10.1016/j.crpv.2011.08.004; Cooper A, 2000, SCIENCE, V289, P1139; Corrain C, 1968, MEMORIE MUSEO CIVICO, V16, P97; CreedMiles M, 1996, J HUM EVOL, V30, P147, DOI 10.1006/jhev.1996.0011; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; Davies W., 2001, P PREHIST SOC, V67, P195, DOI [10.1017/S0079497X00001663, DOI 10.1017/S0079497X00001663]; Douka K, 2012, J HUM EVOL, V62, P286, DOI 10.1016/j.jhevol.2011.11.009; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P13956, DOI 10.1073/pnas.1200567109; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; FRAYER DW, 1992, PREHISTOIRE EUROPEEN, V2, P9; Giunti P, 2011, HUMAN EVOLUTION, P131; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Higham T, 2009, QUATERNARY SCI REV, V28, P1257, DOI 10.1016/j.quascirev.2008.12.018; Holliday TW, 2006, NEANDERTHALS REVISIT, P336; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P18743, DOI 10.1073/pnas.1212924109; Jankovic I, 2011, VERTEBR PALEOBIOL PA, P299, DOI 10.1007/978-94-007-0492-3_23; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Lari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010648; LEVEQUE F, 1980, CR ACAD SCI D NAT, V291, P187; Longo L, 2012, QUATERN INT, V259, P102, DOI 10.1016/j.quaint.2011.08.008; Maroto J, 2012, QUATERN INT, V247, P15, DOI 10.1016/j.quaint.2011.07.007; MARTIN R, 1957, LEHRBUCH ANTHR SYSTE; Mellars P, 2005, EVOL ANTHROPOL, V14, P12, DOI 10.1002/evan.20037; Mellars P., 1989, HUMAN REVOLUTION BEH; Mounier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018821; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; OHiggins P., 2006, TOOLS STAT SHAPE ANA; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Palma di Cesnola A, 1993, PALEOLITICO SUPERIOR; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; Sampietro ML, 2005, ANN HUM GENET, V69, P535, DOI 10.1111/j.1529-8817.2005.00194.x; Sanchez-Quinto F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047765; Schwartz JH, 2006, PERIOD BIOL, V108, P389; Schwartz JH, 2000, J HUM EVOL, V38, P367, DOI 10.1006/jhev.1999.0339; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; SMITH FH, 1989, YEARB PHYS ANTHROPOL, V32, P35; Stefan VH, 1998, J HUM EVOL, V34, P443, DOI 10.1006/jhev.1997.0210; Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Trinkaus E, 2011, VERTEBR PALEOBIOL PA, P315, DOI 10.1007/978-94-007-0492-3_24; Trinkaus E, 2011, P NATL ACAD SCI USA, V108, P1267, DOI 10.1073/pnas.1018700108; van Andel T. H., 2003, NEANDERTHALS MODERN; Walker MJ, 2012, QUATERN INT, V259, P7, DOI 10.1016/j.quaint.2011.03.034; Walker MJ, 2010, AM J PHYS ANTHROPOL, V142, P261, DOI 10.1002/ajpa.21223; Weaver TD, 2009, P NATL ACAD SCI USA, V106, P16028, DOI 10.1073/pnas.0903864106; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Wolpoff MH, 1999, SCIENCE, V284, P1774; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; Zilhao J, 2006, EVOL ANTHROPOL, V15, P183, DOI 10.1002/evan.20110; Zilhao J, 2012, DEV QUATER SCI, V16, P35, DOI 10.1016/B978-0-444-53821-5.00004-X	64	25	27	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59781	10.1371/journal.pone.0059781	http://dx.doi.org/10.1371/journal.pone.0059781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	124QO	23544098	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700058
J	Fu, M; Song, XX; Yu, ZM; Liu, Y				Fu, Mei; Song, Xiuxian; Yu, Zhiming; Liu, Yun			Responses of Phosphate Transporter Gene and Alkaline Phosphatase in Thalassiosira pseudonana to Phosphine	PLOS ONE			English	Article							MATRIX-BOUND PHOSPHINE; SUPEROXIDE-DISMUTASE; PHOSPHORUS; IDENTIFICATION; EXPRESSION; CLONING; DIATOM; CELLS; PHYTOPLANKTON; ENVIRONMENT	Phosphine, which is released continuously from sediment, can affect the eco-physiological strategies and molecular responses of phytoplankton. To examine the effects of phosphine on phosphorus uptake and utilization in Thalassiosira pseudonana we examined the transcriptional level of the phosphate transporter gene (TpPHO) and the activity of alkaline phosphatase (AKP) in relation to supplement of various concentrations of phosphine. TpPHO expression was markedly promoted by phosphine in both the phosphate-deficient and phosphate-4.1 mu M culture. However, high phosphine concentrations can inhibit TpPHO transcription in the declining growth phase. AKP activity was also higher in the phosphine treatment groups than that of the control. It increased with increasing phosphine concentration in the range of 0 to 0.056 mu M but was inhibited by higher levels of phosphine. These responses revealed that phosphine can affect phosphate uptake and utilization in T. pseudonana. This result was consistent with the effect of phosphine on algal growth, while TpPHO expression and AKP were even more sensitive to phosphine than algal growth. This work provides a basic understanding for further research about how phosphine affects phytoplankton.	[Fu, Mei; Song, Xiuxian; Yu, Zhiming; Liu, Yun] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Fu, Mei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Song, XX (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	songxx@qdio.ac.cn		Yu, Zhiming/0000-0003-0377-1129	National Natural Science Foundation of China [30970522]; Funds for Creative Research Groups of China [41121064]; State Key Development Program for Basic Research of China (973 program) [2010CB428706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for Creative Research Groups of China(Science Fund for Creative Research Groups); State Key Development Program for Basic Research of China (973 program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China)	This work was financially supported by the National Natural Science Foundation of China (30970522), the Funds for Creative Research Groups of China (41121064), and the State Key Development Program for Basic Research of China (973 program) (2010CB428706). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Munoz-Martin MA, 2011, ANAL BIOANAL CHEM, V400, P3573, DOI 10.1007/s00216-011-5017-0; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BOLTER CJ, 1990, PESTIC BIOCHEM PHYS, V36, P52, DOI 10.1016/0048-3575(90)90020-3; BOND EJ, 1969, J STORED PROD RES, V5, P289, DOI 10.1016/0022-474X(69)90002-2; Brunner E, 2009, ANGEW CHEM INT EDIT, V48, P9724, DOI 10.1002/anie.200905028; CHEFURKA W, 1976, PESTIC BIOCHEM PHYS, V6, P65, DOI 10.1016/0048-3575(76)90010-9; Chung CC, 2003, APPL ENVIRON MICROB, V69, P754, DOI 10.1128/AEM.69.2.754-759.2003; DEVAI I, 1988, NATURE, V333, P343, DOI 10.1038/333343a0; DEVAI I, 1995, ORG GEOCHEM, V23, P277, DOI 10.1016/0146-6380(95)00021-6; [牛晓君 Niu Xiaojun], 2003, [湖泊科学, Scientia Limnologica Sinica], V15, P263; Dong B, 1999, PLANT CELL ENVIRON, V22, P1455, DOI 10.1046/j.1365-3040.1999.00500.x; Feng ZH, 2008, MAR POLLUT BULL, V56, P1630, DOI 10.1016/j.marpolbul.2008.05.017; Feng ZH, 2008, CHEMOSPHERE, V73, P519, DOI 10.1016/j.chemosphere.2008.06.018; Franco-Zorrilla JM, 2004, J EXP BOT, V55, P285, DOI 10.1093/jxb/erh009; GASSMANN G, 1994, MAR CHEM, V45, P197, DOI 10.1016/0304-4203(94)90003-5; Geng JJ, 2010, INT J ENVIRON AN CH, V90, P737, DOI 10.1080/03067310903013230; Glindemann D, 2005, ECOL ENG, V24, P457, DOI 10.1016/j.ecoleng.2005.01.002; Gonzalez-Gil S, 1998, MAR ECOL PROG SER, V164, P21, DOI 10.3354/meps164021; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Hanrahan G, 2005, TALANTA, V66, P435, DOI 10.1016/j.talanta.2004.10.004; Hsu CH, 2000, FREE RADICAL BIO MED, V28, P636, DOI 10.1016/S0891-5849(99)00277-4; Huang AY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-337; Ivancic I, 2010, MAR ENVIRON RES, V69, P85, DOI 10.1016/j.marenvres.2009.08.004; JANSSON M, 1988, HYDROBIOLOGIA, V170, P177, DOI 10.1007/BF00024904; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Lil H, 1998, MAR ECOL PROG SER, V173, P107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu M, 2006, J BIOL CHEM, V281, P13620, DOI 10.1074/jbc.M600523200; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; Niu XJ, 2004, SCI TOTAL ENVIRON, V323, P169, DOI 10.1016/j.scitotenv.2003.10.017; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; PETTERSSON K, 1980, ARCH HYDROBIOL, V89, P54; PRICE NR, 1984, J STORED PROD RES, V20, P163, DOI 10.1016/0022-474X(84)90025-0; SINHA RN, 1967, J ECON ENTOMOL, V60, P125, DOI 10.1093/jee/60.1.125; Song XX, 2011, MAR POLLUT BULL, V62, P1744, DOI 10.1016/j.marpolbul.2011.05.025; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; VRBA J, 1993, WATER SCI TECHNOL, V28, P15, DOI 10.2166/wst.1993.0124; WILLSKY GR, 1973, J BACTERIOL, V113, P529, DOI 10.1128/JB.113.2.529-539.1973; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Yu ZM, 2003, CHINESE SCI BULL, V48, P31, DOI 10.1360/03tb9006; Zhang BY, 2010, J PHYCOL, V46, P290, DOI 10.1111/j.1529-8817.2009.00801.x	42	13	14	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59770	10.1371/journal.pone.0059770	http://dx.doi.org/10.1371/journal.pone.0059770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544096	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700056
J	Inacio, JM; Marques, S; Nakamura, T; Shinohara, K; Meno, C; Hamada, H; Belo, JA				Inacio, Jose Manuel; Marques, Sara; Nakamura, Tetsuya; Shinohara, Kyosuke; Meno, Chikara; Hamada, Hiroshi; Belo, Jose Antonio			The Dynamic Right-to-Left Translocation of Cerl2 Is Involved in the Regulation and Termination of Nodal Activity in the Mouse Node	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; VERTEBRATE EMBRYO; LATERAL PLATE; CERBERUS-LIKE; FLUID-FLOW; HEART; EXPRESSION; SYMMETRY; ROLES	The determination of left-right body asymmetry in mouse embryos depends on the interplay of molecules In a highly sensitive structure, the node. Here, we show that the localization of Cerl2 protein does not correlate to its mRNA expression pattern, from 3-somite stage onwards. Instead, Cerl2 protein displays a nodal flow-dependent dynamic behavior that controls the activity of Nodal in the node, and the transmission of the laterality information to the left lateral plate mesoderm (LPM). Our results indicate that Cerl2 initially localizes and prevents the activation of Nodal genetic circuitry on the right side of the embryo, and later its right-to-left translocation shutdowns Nodal activity in the node. The consequent prolonged Nodal activity in the node by the absence of Cerl2 affects local Nodal expression and prolongs its expression in the LPM. Simultaneous genetic removal of both Nodal node inhibitors, Cerl2 and Lefty1, sustains even longer and bilateral his LPM expression.	[Inacio, Jose Manuel; Marques, Sara; Belo, Jose Antonio] Univ Algarve, Dept Ciencias Biomed & Med, Regenerat Med Program, Faro, Portugal; [Inacio, Jose Manuel; Marques, Sara; Belo, Jose Antonio] Univ Algarve, IBB, Ctr Biomed Mol & Estrutural, Faro, Portugal; [Nakamura, Tetsuya; Shinohara, Kyosuke; Hamada, Hiroshi] Osaka Univ, Dev Genet Grp, Grad Sch Frontier Biosci, Osaka, Japan; [Nakamura, Tetsuya; Shinohara, Kyosuke; Hamada, Hiroshi] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Osaka, Japan; [Meno, Chikara] Kyushu Univ, Grad Sch Med Sci, Dept Dev Biol, Fukuoka 812, Japan	Universidade do Algarve; Universidade do Algarve; Osaka University; Japan Science & Technology Agency (JST); Kyushu University	Belo, JA (corresponding author), Univ Algarve, Dept Ciencias Biomed & Med, Regenerat Med Program, Faro, Portugal.	jbelo@ualg.pt	Shinohara, Kyosuke/AAU-2471-2020; Inacio, Jose M/O-1455-2018; Belo, José A. A/F-4444-2012; Hamada, Hiroshi/N-6374-2015	Shinohara, Kyosuke/0000-0002-6350-1684; Inacio, Jose M/0000-0002-9790-8335; Belo, José A. A/0000-0001-7384-0949; Hamada, Hiroshi/0000-0002-7196-5948; Marques, Sara/0000-0001-6784-5612	F.C.T.; IBB/CBME, LA	F.C.T.(Portuguese Foundation for Science and Technology); IBB/CBME, LA	This work was supported by research grants from F.C.T. and from IBB/CBME, LA to J. A. Belo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Belo JA, 2009, INT J DEV BIOL, V53, P1399, DOI 10.1387/ijdb.072297jb; Brennan J, 2002, GENE DEV, V16, P2339, DOI 10.1101/gad.1016202; Brueckner M, 2007, CIRCULATION, V115, P2793, DOI 10.1161/CIRCULATIONAHA.107.699256; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hojo M, 2007, DEV GROWTH DIFFER, V49, P395, DOI 10.1111/j.1440-169x.2007.00937.x; Kawasumi A, 2011, DEV BIOL, V353, P321, DOI 10.1016/j.ydbio.2011.03.009; Larkins CE, 2012, DEV BIOL, V367, P15, DOI 10.1016/j.ydbio.2012.04.011; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Marques S, 2004, GENE DEV, V18, P2342; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nakamura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2319; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Oki S, 2007, DEVELOPMENT, V134, P3893, DOI 10.1242/dev.009464; Oki S, 2009, DEVELOPMENT, V136, P3917, DOI 10.1242/dev.039305; Ramsdell AF, 2005, DEV BIOL, V288, P1, DOI 10.1016/j.ydbio.2005.07.038; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Saijoh Y, 2003, DEV BIOL, V256, P160, DOI 10.1016/S0012-1606(02)00121-5; Schweickert A, 2010, CURR BIOL, V20, P738, DOI 10.1016/j.cub.2010.02.061; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shinohara K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1624; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Tavares AT, 2007, DEVELOPMENT, V134, P2051, DOI 10.1242/dev.000901; Vonica A, 2007, DEV BIOL, V303, P281, DOI 10.1016/j.ydbio.2006.09.039; Wright C V, 2001, Dev Cell, V1, P179, DOI 10.1016/S1534-5807(01)00036-3; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002	33	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60406	10.1371/journal.pone.0060406	http://dx.doi.org/10.1371/journal.pone.0060406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544137	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700096
J	Kaparakis-Liaskos, M; Tate, MD; Price, JD; Pearse, M; Wijburg, OLC				Kaparakis-Liaskos, Maria; Tate, Michelle D.; Price, Jason D.; Pearse, Martin; Wijburg, Odilia L. C.			Increased Antigen Specific T Cell Numbers in the Absence of Altered Migration or Division Rates as a Result of Mucosal Cholera Toxin Administration	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; DENDRITIC CELLS; PRESENTING CELLS; B-SUBUNIT; INTRANASAL IMMUNIZATION; LYMPHOCYTE-RESPONSES; IMMUNE-RESPONSES; TRANSGENIC MICE; FLOW-CYTOMETRY; TH2 CELLS	Cholera toxin (CT) is a mucosal adjuvant capable of inducing strong immune responses to co-administered antigens following oral or intranasal immunization of mice. To date, the direct effect of CT on antigen-specific CD4(+) T cell migration and proliferation profiles in vivo is not well characterized. In this study, the effect of CT on the migration pattern and proliferative responses of adoptively transferred, CD4(+) TCR transgenic T cells in orally or intranasally vaccinated mice, was analyzed by flow cytometry. GFP-expressing or CFSE-labeled OT-II lymphocytes were adoptively transferred to naive C57BL/6 mice, and mice were subsequently vaccinated with OVA with or without CT via the oral or intranasal route. CT did not alter the migration pattern of antigen-specific T cells, regardless of the route of immunization, but increased the number of transgenic CD4(+) T cells in draining lymphoid tissue. This increase in the number of transgenic CD4(+) T cells was not due to cells undergoing more rounds of cellular division in vivo, suggesting that CT may exert an indirect adjuvant effect on CD4(+) T cells. The findings reported here suggest that CT functions as a mucosal adjuvant by increasing the number of antigen specific CD4(+) T cells independent of their migration pattern or kinetics of cellular division.	[Kaparakis-Liaskos, Maria; Price, Jason D.; Wijburg, Odilia L. C.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Kaparakis-Liaskos, Maria; Tate, Michelle D.] Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Pearse, Martin] CSL Ltd, Parkville, Vic, Australia	University of Melbourne; Monash University; CSL	Wijburg, OLC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	odilia@unimelb.edu.au	Kaparakis-Liaskos, Maria/I-6511-2013; Kaparakis-Liaskos, Maria/R-9321-2019	Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Tate, Michelle/0000-0002-0587-5514	National Health and Medical Research Council of Australia (NHMRC); R.D. Wright Career Development Award	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); R.D. Wright Career Development Award	Grant support was received from the National Health and Medical Research Council of Australia (NHMRC). OLW is a recipient of an R.D. Wright Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alderuccio F, 1995, AUTOIMMUNITY, V21, P215, DOI 10.3109/08916939509008018; Anjuere F, 2004, J IMMUNOL, V173, P5103, DOI 10.4049/jimmunol.173.8.5103; Asanuma H, 1997, J IMMUNOL METHODS, V202, P123, DOI 10.1016/S0022-1759(96)00243-8; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BOWEN JC, 1994, IMMUNOLOGY, V81, P338; Bradley LM, 1996, CURR OPIN IMMUNOL, V8, P312, DOI 10.1016/S0952-7915(96)80118-X; Braun MC, 1999, J EXP MED, V189, P541, DOI 10.1084/jem.189.3.541; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cong YZ, 1997, J IMMUNOL, V159, P5301; Corthesy-Theulaz IE, 1998, INFECT IMMUN, V66, P581; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; ELSON CO, 1984, J IMMUNOL, V132, P2736; Eriksson K, 2003, INFECT IMMUN, V71, P1740, DOI 10.1128/IAI.71.4.1740-1747.2003; Fahlen-Yrlid L, 2009, J IMMUNOL, V183, P5032, DOI 10.4049/jimmunol.0803992; FINKELSTEIN RA, 1974, J IMMUNOL, V113, P145; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; George-Chandy A, 2001, INFECT IMMUN, V69, P5716, DOI 10.1128/IAI.69.9.5716-5725.2001; Graziano M, 1998, EXP CELL RES, V240, P75, DOI 10.1006/excr.1997.3900; HOLMGREN J, 1981, NATURE, V292, P413, DOI 10.1038/292413a0; HOLMGREN J, 1974, J EXP MED, V139, P801, DOI 10.1084/jem.139.4.801; HORNQUIST E, 1993, EUR J IMMUNOL, V23, P2136, DOI 10.1002/eji.1830230914; HORNQVIST E, 1991, INFECT IMMUN, V59, P3630; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Jones HP, 2001, J IMMUNOL, V167, P4518, DOI 10.4049/jimmunol.167.8.4518; Kato H, 2001, J IMMUNOL, V166, P3114, DOI 10.4049/jimmunol.166.5.3114; Kawakami N, 1999, IMMUNOL LETT, V70, P165; Lavelle EC, 2003, J IMMUNOL, V171, P2384, DOI 10.4049/jimmunol.171.5.2384; Lavelle EC, 2004, J LEUKOCYTE BIOL, V75, P756, DOI 10.1189/jlb.1103534; LEVINE MM, 1983, MICROBIOL REV, V47, P510, DOI 10.1128/MMBR.47.4.510-550.1983; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; LYCKE N, 1986, IMMUNOLOGY, V59, P301; LYCKE N, 1991, SCAND J IMMUNOL, V33, P691, DOI 10.1111/j.1365-3083.1991.tb02542.x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MARINARO M, 1995, J IMMUNOL, V155, P4621; Martin M, 2001, INFECT IMMUN, V69, P4486, DOI 10.1128/IAI.69.7.4486-4492.2001; NORTHRUP RS, 1972, J INFECT DIS, V125, P672, DOI 10.1093/infdis/125.6.672; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Porgador A, 1998, INFECT IMMUN, V66, P5876, DOI 10.1128/IAI.66.12.5876-5881.1998; Raghavan S, 2010, INFECT IMMUN, V78, P4251, DOI 10.1128/IAI.00536-10; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003; Simmons CP, 1999, J IMMUNOL, V163, P6502; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; SYDORA BC, 1993, INT IMMUNOL, V5, P743, DOI 10.1093/intimm/5.7.743; Uren TK, 2003, J IMMUNOL, V170, P2531, DOI 10.4049/jimmunol.170.5.2531; Westermann J, 1996, IMMUNOL TODAY, V17, P278, DOI 10.1016/0167-5699(96)80545-7; WESTON SA, 1990, J IMMUNOL METHODS, V133, P87, DOI 10.1016/0022-1759(90)90322-M; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Wu HY, 1997, INFECT IMMUN, V65, P227, DOI 10.1128/IAI.65.1.227-235.1997; WU HY, 1993, INFECT IMMUN, V61, P314, DOI 10.1128/IAI.61.1.314-322.1993; XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309; Yamamoto M, 1999, J IMMUNOL, V162, P7015; Yamamoto M, 2000, J INFECT DIS, V182, P180, DOI 10.1086/315694; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267	55	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59934	10.1371/journal.pone.0059934	http://dx.doi.org/10.1371/journal.pone.0059934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544110	Green Published, gold			2022-12-25	WOS:000317480700070
J	Kumar, NP; Gopinath, V; Sridhar, R; Hanna, LE; Banurekha, VV; Jawahar, MS; Nutman, TB; Babu, S				Kumar, Nathella Pavan; Gopinath, Venugopal; Sridhar, Rathinam; Hanna, Luke E.; Banurekha, Vaithilingam V.; Jawahar, Mohideen S.; Nutman, Thomas B.; Babu, Subash			IL-10 Dependent Suppression of Type 1, Type 2 and Type 17 Cytokines in Active Pulmonary Tuberculosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; INTERFERON-GAMMA; INFECTION; IL-23; MACROPHAGES; EXPRESSION; CONTRIBUTE	Background: Although Type 1 cytokine responses are considered protective in pulmonary tuberculosis (PTB), their role as well as those of Type 2, 17 and immunoregulatory cytokines in tuberculous lymphadenitis (TBL) and latent tuberculosis (LTB) have not been well studied. Aim and Methods: To identify cytokine responses associated with pulmonary tuberculosis (TB), TB lymphadenitits and latent TB, we examined mycobacterial antigen-specific immune responses of PTB, TBL and LTB individuals. More specifically, we examined ESAT-6 and CFP-10 induced Type 1, Type 2 and Type 17 cytokine production and their regulation using multiplex ELISA. Results:PTB individuals exhibited a significantly lower baseline as well as antigen-specific production of Type 1 (IFN gamma, TNF alpha and IL-2); Type 2 (IL-4) and Type 17 (IL-17A and IL-17F) cytokines in comparison to both TBL and LTB individuals. TBL individuals exhibited significantly lower antigen-specific IFN gamma responses alone in comparison to LTB individuals. Although, IL-10 levels were not significantly higher, neutralization of IL-10 during antigen stimulation resulted in significantly enhanced production of IFN gamma, IL-4 and IL-17A in PTB individuals, indicating that IL-10 mediates (at least partially) the suppression of cytokine responses in PTB. Conclusion: Pulmonary TB is characterized by an IL-10 dependent antigen-specific suppression of Type 1, Type 2 and Type 17 cytokines, reflecting an important association of these cytokines in the pathogenesis of active TB.	[Kumar, Nathella Pavan; Gopinath, Venugopal; Babu, Subash] NIH, Int Ctr Excellence Res, Chennai, Tamil Nadu, India; [Kumar, Nathella Pavan; Gopinath, Venugopal; Hanna, Luke E.; Banurekha, Vaithilingam V.; Jawahar, Mohideen S.] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Sridhar, Rathinam] Govt Stanley Med Hosp, Chennai, Tamil Nadu, India; [Nutman, Thomas B.; Babu, Subash] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Babu, S (corresponding author), NIH, Int Ctr Excellence Res, Chennai, Tamil Nadu, India.	sbabu@mail.nih.gov	Babu, Subash/GXG-4746-2022; Kumar, Nathella Pavan/AAU-2328-2021		Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000197, ZIAAI001065] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dheda K, 2008, THORAX, V63, P566, DOI 10.1136/thx.2007.092205; Ellner JJ, 2010, CTS-CLIN TRANSL SCI, V3, P23, DOI 10.1111/j.1752-8062.2010.00180.x; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Handa U, 2012, J INFECT DEV COUNTR, V6, P6, DOI 10.3855/jidc.2090; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; Hirsch CS, 1997, P NATL ACAD SCI USA, V94, P3926, DOI 10.1073/pnas.94.8.3926; Holland SM, 2007, IMMUNOL RES, V38, P342, DOI 10.1007/s12026-007-0045-8; Jacobs M, 2007, EUR CYTOKINE NETW, V18, P5; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lalvani A, 2010, BRIT MED BULL, V93, P69, DOI 10.1093/bmb/ldp039; Pasquinelli V, 2009, J INFECT DIS, V199, P661, DOI 10.1086/596742; Peng MY, 2008, CELL MOL IMMUNOL, V5, P203, DOI 10.1038/cmi.2008.25; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; TOOSSI Z, 1995, J IMMUNOL, V154, P465; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wozniak TM, 2006, INFECT IMMUN, V74, P557, DOI 10.1128/IAI.74.1.557-565.2006; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	34	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59572	10.1371/journal.pone.0059572	http://dx.doi.org/10.1371/journal.pone.0059572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544075	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000317480700035
J	Kwan, A; Hubank, M; Rashid, A; Klein, N; Peters, MJ				Kwan, Antonia; Hubank, Mike; Rashid, Asrar; Klein, Nigel; Peters, Mark J.			Transcriptional Instability during Evolving Sepsis May Limit Biomarker Based Risk Stratification	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; EXPRESSION; THERAPY	Background: Sepsis causes extensive morbidity and mortality in children worldwide. Prompt recognition and timely treatment of sepsis is critical in reducing morbidity and mortality. Genomic approaches are used to discover novel pathways, therapeutic targets and biomarkers. These may facilitate diagnosis and risk stratification to tailor treatment strategies. Objective: To investigate the temporal gene expression during the evolution of sepsis induced multi-organ failure in response to a single organism, Neisseria meningitidis, in previously healthy children. Method: RNA was extracted from serial blood samples (6 time points over 48 hours from presentation) from five critically ill children with meningococcal sepsis. Extracted RNA was hybridized to Affymetrix arrays. The RNA underwent strict quality control and standardized quantitation. Gene expression results were analyzed using GeneSpring software and Ingenuity Pathway Analysis. Result: A marked variability in differential gene expression was observed between time points and between patients revealing dynamic expression changes during the evolution of sepsis. While there was evidence of time-dependent changes in expected gene networks including those involving immune responses and inflammatory pathways, temporal variation was also evident in specific "biomarkers" that have been proposed for diagnostic and risk stratification functions. The extent and nature of this variability was not readily explained by clinical phenotype. Conclusion: This is the first study of its kind detailing extensive expression changes in children during the evolution of sepsis. This highlights a limitation of static or single time point biomarker estimation. Serial estimations or more comprehensive network approaches may be required to optimize risk stratification in complex, time-critical conditions such as evolving sepsis.	[Kwan, Antonia; Klein, Nigel] UCL, Inst Child Hlth, London, England; [Kwan, Antonia] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Hubank, Mike] UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London, England; [Rashid, Asrar] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham, England; [Peters, Mark J.] UCL, Inst Child Hlth, Portex Unit Paediat Crit Care, London, England	University of London; University College London; University of California System; University of California San Francisco; University of London; University College London; Nottingham University Hospital NHS Trust; University of Nottingham; University of London; University College London	Peters, MJ (corresponding author), UCL, Inst Child Hlth, Portex Unit Paediat Crit Care, London, England.	mark.peters@ucl.ac.uk	Peters, Mark/AAD-7518-2019; Hubank, Michael JF/C-1837-2008	Peters, Mark/0000-0003-3653-4808; Hubank, Michael JF/0000-0002-2901-0742; Klein, Nigel/0000-0003-3925-9258; rashid, asrar/0000-0001-6108-9289	National Institute for Health Research (NIHR) Biomedical Research Centres (BRC); NIHR Academic Clinical Fellowship; Higher Education Funding Council for England; Great Ormond Street Children's Charity; For Lucie charity; National Institute for Health Research [ACF-2008-18-032] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centres (BRC)(National Institute for Health Research (NIHR)); NIHR Academic Clinical Fellowship; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Great Ormond Street Children's Charity; For Lucie charity; National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research (NIHR) Biomedical Research Centres (BRC) (http://www.nihr.ac.uk/infrastructure/Page/infrastructure_biomedical_research_centres.aspx), NIHR Academic Clinical Fellowship (http://www.nihrtcc.nhs.uk/intetacatrain/acfs), Higher Education Funding Council for England (http://www.hefce.ac.uk/), Great Ormond Street Children's Charity (http://www.gosh.org/gen/), and For Lucie charity (http://www.forlucie.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; Bion J, 2012, LANCET INFECT DIS, V12, P898, DOI 10.1016/S1473-3099(12)70263-3; Booy R, 2002, ARCH DIS CHILD, V87, P560, DOI 10.1136/adc.87.6.560-a; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cornell TT, 2010, PEDIATRICS, V125, P1248, DOI 10.1542/peds.2009-3274; Deasy A, 2010, CURR OPIN INFECT DIS, V23, P255, DOI 10.1097/QCO.0b013e32833939de; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; Osuchowski MF, 2009, CRIT CARE MED, V37, P1567, DOI 10.1097/CCM.0b013e31819df06b; Peters Mark J., 2001, Pediatr Crit Care Med, V2, P225, DOI 10.1097/00130478-200107000-00007; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Solan PD, 2012, CRIT CARE MED, V40, P379, DOI 10.1097/CCM.0b013e318232e404; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Tibby SM, 2002, ARCH DIS CHILD, V87, P559, DOI 10.1136/adc.87.6.559; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2010, CRIT CARE MED, V38, P1955, DOI 10.1097/CCM.0b013e3181eb924f; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08	19	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60501	10.1371/journal.pone.0060501	http://dx.doi.org/10.1371/journal.pone.0060501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544148	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700107
J	O'Hara, A; Howarth, A; Varro, A; Dimaline, R				O'Hara, Adrian; Howarth, Alice; Varro, Andrea; Dimaline, Rod			Role of Proteasome Beta Subunits in Gastrin-Mediated Transcription of Plasminogen Activator Inhibitor-2 and Regenerating Protein1	PLOS ONE			English	Article							VESICULAR MONOAMINE TRANSPORTER; PLASMINOGEN-ACTIVATOR INHIBITOR-2; MESSENGER-RNA ABUNDANCE; EPITHELIAL-CELLS; NUCLEAR-LOCALIZATION; RESPONSE ELEMENT; GENE-EXPRESSION; AGS CELLS; GASTRIN-CHOLECYSTOKININ(B) RECEPTOR; IN-VITRO	The hormone gastrin physiologically regulates gastric acid secretion and also contributes to maintaining gastric epithelial architecture by regulating expression of genes such as plasminogen activator inhibitor 2 (PAI-2) and regenerating protein 1(Reg1). Here we examine the role of proteasome subunit PSMB1 in the transcriptional regulation of PAI-2 and Reg1 by gastrin, and its subcellular distribution during gastrin stimulation. We used the gastric cancer cell line AGS, permanently transfected with the CCK2 receptor (AGS-GR) to study gastrin stimulated expression of PAI-2 and Reg1 reporter constructs when PSMB1 was knocked down by siRNA. Binding of PSMB1 to the PAI-2 and Reg1 promoters was assessed by chromatin immunoprecipitation (ChIP) assay. Subcellular distribution of PSMB1 was determined by immunocytochemistry and Western Blot. Gastrin robustly increased expression of PAI-2 and Reg1 in AGS-GR cells, but when PSMB1 was knocked down the responses were dramatically reduced. In ChIP assays, following immunoprecipitation of chromatin with a PSMB1 antibody there was a substantial enrichment of DNA from the gastrin responsive regions of the PAI-2 and Reg1 promoters compared with chromatin precipitated with control IgG. In AGS-GR cells stimulated with gastrin there was a significant increase in the ratio of nuclear:cytoplasmic PSMB1 over the same timescale as recruitment of PSMB1 to the PAI-2 and Reg1 promoters seen in ChIP assays. We conclude that PSMB1 is part of the transcriptional machinery required for gastrin stimulated expression of PAI-2 and Reg1, and that its change in subcellular distribution in response to gastrin is consistent with this role.	[O'Hara, Adrian; Howarth, Alice; Varro, Andrea; Dimaline, Rod] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Dimaline, R (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	r.dimaline@liv.ac.uk	Varro, Andras/M-2647-2016; O'Hara, Adrian/ABE-7987-2020	O'Hara, Adrian/0000-0003-1837-680X	Wellcome Trust [089059/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding was provided by Wellcome Trust (www.wellcome.ac.uk) grant number 089059/Z/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2005, MATRIX BIOL, V23, P499, DOI 10.1016/j.matbio.2004.10.002; Almeida-Vega S, 2009, AM J PHYSIOL-GASTR L, V296, pG414, DOI 10.1152/ajpgi.90340.2008; Ancha HR, 2007, INT J BIOCHEM CELL B, V39, P2143, DOI 10.1016/j.biocel.2007.06.003; Asahara M, 1996, GASTROENTEROLOGY, V111, P45, DOI 10.1053/gast.1996.v111.pm8698224; Ashcroft FJ, 2004, BIOCHEM J, V381, P397, DOI 10.1042/BJ20031793; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Blackmore CG, 2001, J PHYSIOL-LONDON, V531, P605, DOI 10.1111/j.1469-7793.2001.0605h.x; Catlow K, 2007, J BIOL CHEM, V282, P17069, DOI 10.1074/jbc.M611421200; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; Daulhac L, 1999, J BIOL CHEM, V274, P20657, DOI 10.1074/jbc.274.29.20657; DIMALINE R, 1993, J PHYSIOL-LONDON, V465, P449, DOI 10.1113/jphysiol.1993.sp019686; Dimaline R, 1996, J PHYSIOL-LONDON, V490, P249, DOI 10.1113/jphysiol.1996.sp021140; DIMALINE R, 1993, AM J PHYSIOL, V264, pG583, DOI 10.1152/ajpgi.1993.264.3.G583; Dimaline R, 2007, EXP PHYSIOL, V92, P591, DOI 10.1113/expphysiol.2006.036483; Dockray G, 2005, PFLUG ARCH EUR J PHY, V449, P344, DOI 10.1007/s00424-004-1347-5; Dockray GJ, 1996, PHYSIOL REV, V76, P767, DOI 10.1152/physrev.1996.76.3.767; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Fjeldbo CS, 2012, AM J PHYSIOL-GASTR L, V302, pG21, DOI 10.1152/ajpgi.00197.2011; Fukui H, 1998, GASTROENTEROLOGY, V115, P1483, DOI 10.1016/S0016-5085(98)70027-7; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Higham AD, 1999, GASTROENTEROLOGY, V116, P1310, DOI 10.1016/S0016-5085(99)70495-6; Inoue E, 2010, J BIOL CHEM, V285, P25545, DOI 10.1074/jbc.M109.079152; Kazumori H, 2000, GASTROENTEROLOGY, V119, P1610, DOI 10.1053/gast.2000.20262; Khan ZE, 2003, GASTROENTEROLOGY, V125, P510, DOI 10.1016/S0016-5085(03)00908-9; Kim HD, 1999, J CELL PHYSIOL, V180, P97, DOI 10.1002/(SICI)1097-4652(199907)180:1<97::AID-JCP11>3.0.CO;2-Y; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; KRUITHOF EKO, 1987, BLOOD, V69, P460; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Nakamura A, 2006, NEUROSCI LETT, V406, P43, DOI 10.1016/j.neulet.2006.07.050; Nederlof PM, 1995, P NATL ACAD SCI USA, V92, P12060, DOI 10.1073/pnas.92.26.12060; Noble PJM, 2003, AM J PHYSIOL-GASTR L, V284, pG75, DOI 10.1152/ajpgi.00300.2002; Ogiso Y, 2002, CANCER RES, V62, P5008; Pagliocca A, 2002, AM J PHYSIOL-GASTR L, V283, pG292, DOI 10.1152/ajpgi.00056.2002; Pagliocca A, 2008, EXP PHYSIOL, V93, P1174, DOI 10.1113/expphysiol.2008.042648; PALMER A, 1994, EUR J CELL BIOL, V64, P163; Raychowdhury R, 2002, MOL ENDOCRINOL, V16, P2802, DOI 10.1210/me.2001-0292; Raychowdhury R, 2002, BIOCHEM BIOPH RES CO, V297, P1089, DOI 10.1016/S0006-291X(02)02345-8; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Steele IA, 2007, AM J PHYSIOL-GASTR L, V293, pG347, DOI 10.1152/ajpgi.00076.2007; TANAKA K, 1990, FEBS LETT, V271, P41, DOI 10.1016/0014-5793(90)80367-R; Todisco A, 2001, AM J PHYSIOL-GASTR L, V280, pG298, DOI 10.1152/ajpgi.2001.280.2.G298; Varro A, 2004, CANCER RES, V64, P1695, DOI 10.1158/0008-5472.CAN-03-2399; Varro A, 2002, GASTROENTEROLOGY, V123, P271, DOI 10.1053/gast.2002.34162; Varro A, 2002, GUT, V50, P827, DOI 10.1136/gut.50.6.827; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Wang TC, 1996, J CLIN INVEST, V98, P1918, DOI 10.1172/JCI118993; Watson F, 2001, J BIOL CHEM, V276, P7661, DOI 10.1074/jbc.M006697200; WOHLWEND A, 1987, J EXP MED, V165, P320, DOI 10.1084/jem.165.2.320; Wroblewski LE, 2002, BIOCHEM J, V365, P873, DOI 10.1042/BJ20020068	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59913	10.1371/journal.pone.0059913	http://dx.doi.org/10.1371/journal.pone.0059913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544109	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000317480700069
J	Wang, JX; Bartolotti, J; Amaral, LAN; Booth, JR				Wang, Jane X.; Bartolotti, James; Amaral, Luis A. N.; Booth, James R.			Changes in Task-Related Functional Connectivity across Multiple Spatial Scales Are Related to Reading Performance	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; AGE-RELATED-CHANGES; BRAIN CONNECTIVITY; SMALL-WORLD; CHILDREN; FMRI; ORGANIZATION; ACTIVATION; METAANALYSIS; INFORMATION	Reading requires the interaction of a distributed set of cortical areas whose distinct patterns give rise to a wide range of individual skill. However, the nature of these neural interactions and their relation to reading performance are still poorly understood Functional connectivity analyses of fMRI data can be used to characterize the nature of interactivity of distributed brain networks, yet most previous studies have focused on connectivity during task-free (i.e., "resting state") conditions. Here, we report new methods for assessing task related functional connectivity using data-driven graph theoretical methods and describe how large-scale patterns of connectivity relate to individual variability in reading Performance among children. We found that connectivity Patterns of subjects Performing a reading task could be decomposed hierarchically into multiple sub-networks, and we observed stronger long-range interaction between sub-networks in subjects with higher task accuracy. Additionally, we found a network of hub regions known to be critical to reading that displays increased short-range synchronization in higher accuracy subjects. These individual differences in task-related functional connectivity reveal that increased interaction between distant regions, coupled with selective local integration within key regions, is associated with better reading performance. Importantly, we show that task-related neuroimaging data contains far more information than usually extracted via standard univariate analyses - information that can meaningfully relate neural connectivity patterns to cognition and task.	[Wang, Jane X.; Amaral, Luis A. N.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Wang, Jane X.; Bartolotti, James; Booth, James R.] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA; [Wang, Jane X.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Amaral, Luis A. N.] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL USA; [Amaral, Luis A. N.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Howard Hughes Medical Institute; Northwestern University	Wang, JX (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.	janewang@northwestern.edu	Amaral, LAN/A-4980-2008; Amaral, Luis N./C-5485-2009	Amaral, LAN/0000-0002-3762-789X; 	National Institute of Child Health and Human Development [HD042049]; W. M. Keck Foundation (LANA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042049] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD042049] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); W. M. Keck Foundation (LANA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institute of Child Health and Human Development (HD042049 to JRB) and the W. M. Keck Foundation (LANA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfanakis K, 2000, MAGN RESON IMAGING, V18, P921, DOI 10.1016/S0730-725X(00)00190-9; Baayen R. H, 1995, CELEX LEXICAL DATABA; Beaulieu C, 2005, NEUROIMAGE, V25, P1266, DOI 10.1016/j.neuroimage.2004.12.053; Bitan T, 2007, HUM BRAIN MAPP, V28, P880, DOI 10.1002/hbm.20313; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; Bonacich P, 2004, SOC NETWORKS, V26, P331, DOI 10.1016/j.socnet.2004.08.007; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Booth JR, 2003, HUM BRAIN MAPP, V19, P155, DOI 10.1002/hbm.10111; Booth JR, 2002, NEUROIMAGE, V16, P7, DOI 10.1006/nimg.2002.1081; Brown TT, 2005, CEREB CORTEX, V15, P275, DOI 10.1093/cercor/bhh129; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Cao F, 2008, BRAIN LANG, V107, P91, DOI 10.1016/j.bandl.2007.12.009; Cao F, 2010, BRAIN LANG, V114, P80, DOI 10.1016/j.bandl.2009.07.005; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Odegard TN, 2009, NEUROPSYCHOLOGIA, V47, P1972, DOI 10.1016/j.neuropsychologia.2009.03.009; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Shaywitz BA, 2007, ANN NEUROL, V61, P363, DOI 10.1002/ana.21093; Sheppard JP, 2012, J COGNITIVE NEUROSCI, V24, P1087, DOI 10.1162/jocn_a_00210; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van der Mark S, 2011, NEUROIMAGE, V54, P2426, DOI 10.1016/j.neuroimage.2010.10.002; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Wechsler D., 1999, WECHSLER ABBREVIATED; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T; Zeno S., 1996, ED WORD FREQUENCY GU	62	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59204	10.1371/journal.pone.0059204	http://dx.doi.org/10.1371/journal.pone.0059204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544057	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700019
J	Narumi, S; Matsuo, K; Ishii, T; Tanahashi, Y; Hasegawa, T				Narumi, Satoshi; Matsuo, Kumihiro; Ishii, Tomohiro; Tanahashi, Yusuke; Hasegawa, Tomonobu			Quantitative and Sensitive Detection of GNAS Mutations Causing McCune-Albright Syndrome with Next Generation Sequencing	PLOS ONE			English	Article							FIBROUS DYSPLASIA; DYSFUNCTION	Somatic activating GNAS mutations cause McCune-Albright syndrome (MAS). Owing to low mutation abundance, mutant-specific enrichment procedures, such as the peptide nucleic acid (PNA) method, are required to detect mutations in peripheral blood. Next generation sequencing (NGS) can analyze millions of PCR amplicons independently, thus it is expected to detect low-abundance GNAS mutations quantitatively. In the present study, we aimed to develop an NGS-based method to detect low-abundance somatic GNAS mutations. PCR amplicons encompassing exons 8 and 9 of GNAS, in which most activating mutations occur, were sequenced on the MiSeq instrument. As expected, our NGS-based method could sequence the GNAS locus with very high read depth (approximately 100,000) and low error rate. A serial dilution study with use of cloned mutant and wildtype DNA samples showed a linear correlation between dilution and measured mutation abundance, indicating the reliability of quantification of the mutation. Using the serially diluted samples, the detection limits of three mutation detection methods (the PNA method, NGS, and combinatory use of PNA and NGS [PNA-NGS]) were determined. The lowest detectable mutation abundance was 1% for the PNA method, 0.03% for NGS and 0.01% for PNA-NGS. Finally, we analyzed 16 MAS patient-derived leukocytic DNA samples with the three methods, and compared the mutation detection rate of them. Mutation detection rate of the PNA method, NGS and PNA-NGS in 16 patient-derived peripheral blood samples were 56%, 63% and 75%, respectively. In conclusion, NGS can detect somatic activating GNAS mutations quantitatively and sensitively from peripheral blood samples. At present, the PNA-NGS method is likely the most sensitive method to detect low-abundance GNAS mutation.	[Narumi, Satoshi; Ishii, Tomohiro; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Matsuo, Kumihiro; Tanahashi, Yusuke] Asahikawa Med Univ, Dept Pediat, Sapporo, Hokkaido, Japan	Keio University	Narumi, S (corresponding author), Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan.	sat_naru@hotmail.com	Hasegawa, Tomonobu/L-3331-2013; Ishii, Tomohiro/B-8711-2019	Ishii, Tomohiro/0000-0001-7360-2465	Japan Society for the Promotion of Science [24791087]; Health Science Research Grant for Research on Applying Health Technology from the Ministry of Health, Labour and Welfare, Japan [Jitsuyoka (Nanbyo)-Ippan-014]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Science Research Grant for Research on Applying Health Technology from the Ministry of Health, Labour and Welfare, Japan	This work was supported by the Grant-in-Aid for Young Scientists (B) (24791087) from the Japan Society for the Promotion of Science, and the Health Science Research Grant for Research on Applying Health Technology [Jitsuyoka (Nanbyo)-Ippan-014] from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright F, 1937, NEW ENGL J MED, V216, P727, DOI 10.1056/NEJM193704292161701; Bianco P, 2000, J BONE MINER RES, V15, P120, DOI 10.1359/jbmr.2000.15.1.120; Candeliere GA, 1997, BONE, V21, P201, DOI 10.1016/S8756-3282(97)00107-5; Hannon TS, 2003, J PEDIATR-US, V142, P532, DOI 10.1067/mpd.2003.153; Kalfa N, 2006, EUR J ENDOCRINOL, V155, P839, DOI 10.1530/eje.1.02301; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SE, 2012, HUM PATHOL, V43, P1234, DOI 10.1016/j.humpath.2011.09.012; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lumbroso S, 2004, J CLIN ENDOCR METAB, V89, P2107, DOI 10.1210/jc.2003-031225; McCune D, 1936, AM J DIS CHILD, V52, P743; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403	16	23	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60525	10.1371/journal.pone.0060525	http://dx.doi.org/10.1371/journal.pone.0060525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536913	gold, Green Published, Green Submitted			2022-12-25	WOS:000317397200061
J	Zhang, X; Xu, J; Xiao, WX				Zhang, Xue; Xu, Jin; Xiao, Wang-xin			A New Method for the Discovery of Essential Proteins	PLOS ONE			English	Article							IDENTIFYING ESSENTIAL PROTEINS; ESSENTIAL GENES; NETWORK TOPOLOGY; PPI NETWORK; CENTRALITY; GENOME; INTEGRATION; PREDICTION; IDENTIFICATION; MAP	Background: Experimental methods for the identification of essential proteins are always costly, time-consuming, and laborious. It is a challenging task to find protein essentiality only through experiments. With the development of high throughput technologies, a vast amount of protein-protein interactions are available, which enable the identification of essential proteins from the network level. Many computational methods for such task have been proposed based on the topological properties of protein-protein interaction (PPI) networks. However, the currently available PPI networks for each species are not complete, i.e. false negatives, and very noisy, i.e. high false positives, network topology-based centrality measures are often very sensitive to such noise. Therefore, exploring robust methods for identifying essential proteins would be of great value. Method: In this paper, a new essential protein discovery method, named CoEWC (Co-Expression Weighted by Clustering coefficient), has been proposed. CoEWC is based on the integration of the topological properties of PPI network and the co-expression of interacting proteins. The aim of CoEWC is to capture the common features of essential proteins in both date hubs and party hubs. The performance of CoEWC is validated based on the PPI network of Saccharomyces cerevisiae. Experimental results show that CoEWC significantly outperforms the classical centrality measures, and that it also outperforms PeC, a newly proposed essential protein discovery method which outperforms 15 other centrality measures on the PPI network of Saccharomyces cerevisiae. Especially, when predicting no more than 500 proteins, even more than 50% improvements are obtained by CoEWC over degree centrality (DC), a better centrality measure for identifying protein essentiality. Conclusions: We demonstrate that more robust essential protein discovery method can be developed by integrating the topological properties of PPI network and the co-expression of interacting proteins. The proposed centrality measure, CoEWC, is effective for the discovery of essential proteins.	[Zhang, Xue; Xu, Jin] Peking Univ, Key Lab High Confidence Software Technol, Minist Educ, Beijing 100871, Peoples R China; [Zhang, Xue; Xu, Jin] Peking Univ, Sch Elect Engn & Comp Sci, Beijing 100871, Peoples R China; [Xiao, Wang-xin] Highway Minist Transport, Res Inst, Beijing, Peoples R China	Peking University; Peking University; Ministry of Transport of the People's Republic of China	Zhang, X (corresponding author), Peking Univ, Key Lab High Confidence Software Technol, Minist Educ, Beijing 100871, Peoples R China.	lindajia03@126.com			National Natural Science Fund [61133010, 61127005]; National Natural Science Foundation of China [50708085, 50978127]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by the Key project of National Natural Science Fund (No. 61133010 and No. 61127005) and the National Natural Science Foundation of China (No. 50708085 and No. 50978127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acencio ML, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-290; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Estrada E, 2006, PROTEOMICS, V6, P35, DOI 10.1002/pmic.200500209; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; HOLLAND PW, 1971, COMP GROUP STUD, V2, P107, DOI 10.1177/104649647100200201; Holman AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-243; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Li M, 2011, COMPUT BIOL CHEM, V35, P143, DOI 10.1016/j.compbiolchem.2011.04.002; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Ning K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-505; Park K, 2009, PROTEOMICS, V9, P5143, DOI 10.1002/pmic.200900357; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Ren J, 2011, LECT N BIOINFORMAT, V6674, P12, DOI 10.1007/978-3-642-21260-4_6; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; Wang H, 2011, LECT N BIOINFORMAT, V6674, P87, DOI 10.1007/978-3-642-21260-4_12; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wuchty S, 2003, J THEOR BIOL, V223, P45, DOI 10.1016/S0022-5193(03)00071-7; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	39	64	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58763	10.1371/journal.pone.0058763	http://dx.doi.org/10.1371/journal.pone.0058763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555595	gold, Green Published, Green Submitted			2022-12-25	WOS:000316546400011
J	Adaixo, R; Harley, CA; Castro-Rodrigues, AF; Morais-Cabral, JH				Adaixo, Ricardo; Harley, Carol A.; Castro-Rodrigues, Artur F.; Morais-Cabral, Joao H.			Structural Properties of PAS Domains from the KCNH Potassium Channels	PLOS ONE			English	Article							N-TERMINAL DOMAIN; CRYSTAL-STRUCTURES; LIGAND-BINDING; HERG; MECHANISM; PROTEIN; EAG	KCNH channels form an important family of voltage gated potassium channels. These channels include a N-terminal Per-Arnt-Sim (PAS) domain with unknown function. In other proteins PAS domains are implicated in cellular responses to environmental queues through small molecule binding or involvement in signaling cascades. To better understand their role we characterized the structural properties of several channel PAS domains. We determined high resolution structures of PAS domains from the mouse EAG (mEAG), drosophila ELK (dELK) and human ERG (hERG) channels and also of the hERG domain without the first nine amino acids. We analyzed these structures for features connected to ligand binding and signaling in other PAS domains. In particular, we have found cavities in the hERG and mEAG structures that share similarities with the ligand binding sites from other PAS domains. These cavities are lined by polar and apolar chemical groups and display potential flexibility in their volume. We have also found that the hydrophobic patch on the domain beta-sheet is a conserved feature and appears to drive the formation of protein-protein contacts. In addition, the structures of the dELK domain and of the truncated hERG domain revealed the presence of N-terminal helices. These helices are equivalent to the helix described in the hERG NMR structures and are known to be important for channel function. Overall, these channel domains retain many of the PAS domain characteristics known to be important for cell signaling.	[Adaixo, Ricardo; Harley, Carol A.; Castro-Rodrigues, Artur F.; Morais-Cabral, Joao H.] Univ Porto, IBMC, P-4100 Oporto, Portugal	Universidade do Porto	Morais-Cabral, JH (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jcabral@ibmc.up.pt	Morais-Cabral, Joao H/J-4914-2013; Harley, Carol/J-5375-2013	Morais-Cabral, Joao H/0000-0002-4461-9716; Harley, Carol/0000-0003-3610-0604; Rodrigues, Artur/0000-0002-1630-3810	EMBO; FEDER funds through the Operational Competitiveness Program - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-Feder-007427/PTDC/QUI/66171/2006, FCOMP-01-0124-FEDER-0227, FCT Pest-C/SAU/LA0002/2011]; National Institutes of Health [1R01NS081320-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081320] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); FEDER funds through the Operational Competitiveness Program - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by EMBO (installation grant), by FEDER funds through the Operational Competitiveness Program - COMPETE and by National Funds through FCT - Fundacao para a Ciencia e a Tecnologia under the projects FCOMP-01-0124-Feder-007427/PTDC/QUI/66171/2006 and FCOMP-01-0124-FEDER-0227(ref: FCT Pest-C/SAU/LA0002/2011) and by National Institutes of Health (1R01NS081320-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaixo R, 2010, ACTA CRYSTALLOGR F, V66, P1056, DOI 10.1107/S1744309110027880; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; BORGSTAHL GEO, 1995, BIOCHEMISTRY-US, V34, P6278, DOI 10.1021/bi00019a004; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Card PB, 2005, J MOL BIOL, V353, P664, DOI 10.1016/j.jmb.2005.08.043; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harley CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032654; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pardo LA, 2008, EXPERT OPIN THER TAR, V12, P837, DOI [10.1517/14728222.12.7.837, 10.1517/14728222.12.7.837 ]; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; Sonavane S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000188; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	42	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59265	10.1371/journal.pone.0059265	http://dx.doi.org/10.1371/journal.pone.0059265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555008	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800077
J	Amali, AA; Sie, L; Winkler, C; Featherstone, M				Amali, Aseervatham Anusha; Sie, Lawrence; Winkler, Christoph; Featherstone, Mark			Zebrafish hoxd4a Acts Upstream of meis1.1 to Direct Vasculogenesis, Angiogenesis and Hematopoiesis	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; DEFINITIVE HEMATOPOIESIS; HOMEOTIC TRANSFORMATIONS; ENDOTHELIAL LINEAGES; BLOOD; PROTEINS; PBX; LEUKEMOGENESIS; ESTABLISHMENT	Mice lacking the 4th-group paralog Hoxd4 display malformations of the anterior vertebral column, but are viable and fertile. Here, we report that zebrafish embryos having decreased function of the orthologous hoxd4a gene manifest striking perturbations in vasculogenesis, angiogenesis and primitive and definitive hematopoiesis. These defects are preceded by reduced expression of the hemangioblast markers scl1, lmo2 and fli1 within the posterior lateral plate mesoderm (PLM) at 13 hours post fertilization (hpf). Epistasis analysis revealed that hoxd4a acts upstream of meis1.1 but downstream of cdx4 as early as the shield stage in ventral-most mesoderm fated to give rise to hemangioblasts, leading us to propose that loss of hoxd4a function disrupts hemangioblast specification. These findings place hoxd4a high in a genetic hierarchy directing hemangioblast formation downstream of cdx1/cdx4 and upstream of meis1.1. An additional consequence of impaired hoxd4a and meis1.1 expression is the deregulation of multiple Hox genes implicated in vasculogenesis and hematopoiesis which may further contribute to the defects described here. Our results add to evidence implicating key roles for Hox genes in their initial phase of expression early in gastrulation.	[Amali, Aseervatham Anusha; Sie, Lawrence; Featherstone, Mark] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Winkler, Christoph] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Featherstone, M (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	msfeatherstone@ntu.edu.sg	Winkler, Christoph/G-4822-2012; Featherstone, Mark/E-8057-2010	Featherstone, Mark/0000-0003-1576-046X; Sie, Lawrence/0000-0002-9690-5968; Winkler, Christoph/0000-0003-4688-6241	Ministry of Education, Singapore [T207B3107]; Biomedical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore [10/1/22/19/663]	Ministry of Education, Singapore(Ministry of Education, Singapore); Biomedical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This project was supported by an Academic Research Fund Tier-2 grant (T207B3107) from the Ministry of Education, Singapore, to CW, and a grant (10/1/22/19/663) from the Biomedical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore, to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 2005, ANN NY ACAD SCI, V1044, P109, DOI 10.1196/annals.1349.014; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Bahrami SB, 2011, CELL ADHES MIGR, V5, P133, DOI 10.4161/cam.5.2.14373; Bjornsson JM, 2003, MOL CELL BIOL, V23, P3872, DOI 10.1128/MCB.23.11.3872-3883.2003; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; Charboneau A., 2005, Angiogenesis, V8, P289; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; Ciau-Uitz A, 2010, INT J DEV BIOL, V54, P1139, DOI 10.1387/ijdb.093055ac; Cvejic A, 2011, HAEMATOL-HEMATOL J, V96, P190, DOI 10.3324/haematol.2010.027698; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; DESCHAMPS J, 1993, DEV BIOL, V156, P473, DOI 10.1006/dbio.1993.1093; Deschamps J, 1999, INT J DEV BIOL, V43, P635; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; diIorio P, 2007, DEV BIOL, V304, P221, DOI 10.1016/j.ydbio.2006.12.024; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Durston AJ, 2010, GENOMICS, V95, P250, DOI 10.1016/j.ygeno.2009.11.002; Eklund E. A., 2011, Critical Reviews in Oncogenesis, V16, P65; Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035; GAUNT SJ, 1994, DEV DYNAM, V199, P229, DOI 10.1002/aja.1001990307; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hoegg S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-317; HORAN GSB, 1995, DEV BIOL, V169, P359, DOI 10.1006/dbio.1995.1150; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; Iacovino M, 2009, STEM CELLS DEV, V18, P783, DOI 10.1089/scd.2008.0227; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Ko KH, 2007, EXP HEMATOL, V35, P465, DOI 10.1016/j.exphem.2006.10.014; Lafontaine CA, 2012, BIOCHEMISTRY; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Magnusson M, 2007, EXP HEMATOL, V35, P1421, DOI 10.1016/j.exphem.2007.05.011; Mamo A, 2006, BLOOD, V108, P622, DOI 10.1182/blood-2005-06-2244; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Minehata K, 2008, BIOCHEM BIOPH RES CO, V374, P647, DOI 10.1016/j.bbrc.2008.07.075; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Nolte C, 2006, DEV BIOL, V299, P582, DOI 10.1016/j.ydbio.2006.08.061; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Peterkin T, 2009, DEVELOPMENT, V136, P1465, DOI 10.1242/dev.032748; Pillay LM, 2010, DEV BIOL, V340, P306, DOI 10.1016/j.ydbio.2010.01.033; Prince VE, 1998, DEVELOPMENT, V125, P407; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; THISSE C, 1993, DEVELOPMENT, V119, P1203; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Wacker SA, 2004, DEV BIOL, V268, P207, DOI 10.1016/j.ydbio.2003.12.022; Wacker SA, 2004, DEV BIOL, V266, P123, DOI 10.1016/j.ydbio.2003.10.011; Wan XY, 2011, J BIOL CHEM, V286, P33345, DOI 10.1074/jbc.M111.253252; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Warga RM, 2009, DEV CELL, V16, P744, DOI 10.1016/j.devcel.2009.04.007; Waskiewicz AJ, 2001, DEVELOPMENT, V128, P4139; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Winkler C, 2003, GENOME RES, V13, P1067, DOI 10.1101/gr.1097503; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907	69	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58857	10.1371/journal.pone.0058857	http://dx.doi.org/10.1371/journal.pone.0058857			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554940	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800037
J	Beaslas, O; Metso, J; Nissila, E; Laurila, PP; Kaiharju, E; Batchu, KC; Kaipiainen, L; Mayranpaa, MI; Yan, D; Gylling, H; Jauhiainen, M; Olkkonen, VM				Beaslas, Olivier; Metso, Jari; Nissila, Eija; Laurila, Pirkka-Pekka; Kaiharju, Essi; Batchu, Krishna Chaithanya; Kaipiainen, Leena; Mayranpaa, Mikko I.; Yan, Daoguang; Gylling, Helena; Jauhiainen, Matti; Olkkonen, Vesa M.			Osbpl8 Deficiency in Mouse Causes an Elevation of High-Density Lipoproteins and Gender-Specific Alterations of Lipid Metabolism	PLOS ONE			English	Article							OXYSTEROL-BINDING PROTEIN; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; ABCA1; EXPRESSION; STEROLS; FAMILY; ER; HYPERCATABOLISM; PURIFICATION; BIOGENESIS	OSBP-related protein 8 (ORP8) encoded by Osbpl8 is an endoplasmic reticulum sterol sensor implicated in cellular lipid metabolism. We generated an Osbpl8(-/-) (KO) C57Bl/6 mouse strain. Wild-type and Osbpl8KO animals at the age of 13-weeks were fed for 5 weeks either chow or high-fat diet, and their plasma lipids/lipoproteins and hepatic lipids were analyzed. The chow-fed Osbpl8KO male mice showed a marked elevation of high-density lipoprotein (HDL) cholesterol (+79%) and phospholipids (+35%), while only minor increase of apolipoprotein A-I (apoA-I) was detected. In chow-fed female KO mice a less prominent increase of HDL cholesterol (+27%) was observed, while on western diet the HDL increment was prominent in both genders. The HDL increase was accompanied by an elevated level of HDL-associated apolipoprotein E in male, but not female KO animals. No differences between genotypes were observed in lecithin: cholesterol acyltransferase (LCAT) or hepatic lipase (HL) activity, or in the fractional catabolic rate of fluorescently labeled mouse HDL injected in chow-diet fed animals. The Osbpl8KO mice of both genders displayed reduced phospholipid transfer protein (PLTP) activity, but only on chow diet. These findings are consistent with a model in which Osbpl8 deficiency results in altered biosynthesis of HDL. Consistent with this hypothesis, ORP8 depleted mouse hepatocytes secreted an increased amount of nascent HDL into the culture medium. In addition to the HDL phenotype, distinct gender-specific alterations in lipid metabolism were detected: Female KO animals on chow diet showed reduced lipoprotein lipase (LPL) activity and increased plasma triglycerides, while the male KO mice displayed elevated plasma cholesterol biosynthetic markers cholestenol, desmosterol, and lathosterol. Moreover, modest gender-specific alterations in the hepatic expression of lipid homeostatic genes were observed. In conclusion, we report the first viable OsbplKO mouse model, demonstrating a HDL elevating effect of Osbpl8 knock-out and additional gender- and/or diet-dependent impacts on lipid metabolism.	[Beaslas, Olivier; Nissila, Eija; Olkkonen, Vesa M.] Minerva Fdn, Helsinki, Finland; [Metso, Jari; Laurila, Pirkka-Pekka; Kaiharju, Essi; Jauhiainen, Matti] Natl Inst Hlth & Welf, Publ Hlth Genom Res Unit, Dept Chron Dis Prevent, Helsinki, Finland; [Metso, Jari; Laurila, Pirkka-Pekka; Kaiharju, Essi; Jauhiainen, Matti] Inst Mol Med Finland FIMM, Helsinki, Finland; [Nissila, Eija; Olkkonen, Vesa M.] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Batchu, Krishna Chaithanya] Univ Helsinki, Inst Biomed, Dept Biochem & Dev Biol, Helsinki, Finland; [Kaipiainen, Leena; Gylling, Helena] Univ Helsinki, Div Internal Med, Dept Med, Helsinki, Finland; [Mayranpaa, Mikko I.] Univ Helsinki, Haartman Inst, Dept Pathol, Helsinki, Finland; [Mayranpaa, Mikko I.] Univ Helsinki, Cent Hosp, HUSLAB Div Pathol, Meilahti Labs Pathol, Helsinki, Finland; [Yan, Daoguang] Jinan Univ, Dept Biol, Guangzhou, Guangdong, Peoples R China	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Jinan University	Olkkonen, VM (corresponding author), Minerva Fdn, Helsinki, Finland.	vesa.olkkonen@helsinki.fi	Nissila, Eija/AEQ-3909-2022	Nissila, Eija/0000-0002-8089-1266; Olkkonen, Vesa/0000-0001-5553-7997; Mayranpaa, Mikko/0000-0002-0877-9640	Academy of Finland [121457, 132629]; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Liv och Halsa Foundation; Novo Nordisk Foundation; EU [202272]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Liv och Halsa Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); EU(European Commission)	This study was supported by the Academy of Finland (grants 121457 to VMO and 132629 to MJ) the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, the Magnus Ehrnrooth Foundation, the Liv och Halsa Foundation, the Novo Nordisk Foundation, and the EU FP7 (LipidomicNet, agreement no 202272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annema W, 2011, CURR ATHEROSCLER REP, V13, P257, DOI 10.1007/s11883-011-0175-2; Anniss AM, 2002, DNA CELL BIOL, V21, P571, DOI 10.1089/104454902320308942; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Calabresi L, 2010, TRENDS CARDIOVAS MED, V20, P50, DOI 10.1016/j.tcm.2010.03.007; DAMEN J, 1982, BIOCHIM BIOPHYS ACTA, V712, P444, DOI 10.1016/0005-2760(82)90271-5; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; de Vries Rindert, 2003, Clin Lab, V49, P601; Ehnholm C, 1986, Methods Enzymol, V129, P716; FOLCH J, 1957, J BIOL CHEM, V226, P497; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HUTTUNEN JK, 1975, CLIN CHIM ACTA, V63, P335, DOI 10.1016/0009-8981(75)90055-8; Hynynen R, 2009, J LIPID RES, V50, P1305, DOI 10.1194/jlr.M800661-JLR200; Jaari S, 2001, COMP BIOCHEM PHYS B, V128, P781, DOI 10.1016/S1096-4959(01)00297-4; Jauhiainen M, 2005, METHODS, V36, P97, DOI 10.1016/j.ymeth.2004.11.006; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; Jaworski CJ, 2001, GENOMICS, V78, P185, DOI 10.1006/geno.2001.6663; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kainu V, 2010, J LIPID RES, V51, P3533, DOI 10.1194/jlr.D009373; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Lehto M, 2001, J LIPID RES, V42, P1203; MIETTINEN TA, 1988, J LIPID RES, V29, P43; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Mousley Carl J, 2012, Subcell Biochem, V59, P271, DOI 10.1007/978-94-007-3015-1_9; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Qin SC, 2000, J LIPID RES, V41, P269; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Ridgway ND, 2010, SUBCELL BIOCHEM, V51, P159, DOI 10.1007/978-90-481-8622-8_6; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Simonen P, 2008, ATHEROSCLEROSIS, V197, P883, DOI 10.1016/j.atherosclerosis.2007.08.003; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Valacchi G, 2011, ANN NY ACAD SCI, V1229, pE1, DOI 10.1111/j.1749-6632.2011.06205.x; van Haperen R, 2000, ARTERIOSCL THROM VAS, V20, P1082, DOI 10.1161/01.ATV.20.4.1082; Vihervaara T, 2012, BIOCHIMIE; Vihervaara T, 2011, CHEM PHYS LIPIDS, V164, P443, DOI 10.1016/j.chemphyslip.2011.03.002; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yazdanyar A, 2011, CURR ATHEROSCLER REP, V13, P242, DOI 10.1007/s11883-011-0172-5; Yokoyama S, 2006, J ATHEROSCLER THROMB, V13, P1, DOI 10.5551/jat.13.1; Zhou TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021078	47	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58856	10.1371/journal.pone.0058856	http://dx.doi.org/10.1371/journal.pone.0058856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554939	Green Submitted, gold, Green Published			2022-12-25	WOS:000316409800036
J	Brown, AD; Sisneros, JA; Jurasin, T; Nguyen, C; Coffin, AB				Brown, Andrew D.; Sisneros, Joseph A.; Jurasin, Tyler; Nguyen, Chau; Coffin, Allison B.			Differences in Lateral Line Morphology between Hatchery- and Wild-Origin Steelhead	PLOS ONE			English	Article							SALMON; GROWTH; TROUT; REGENERATION; RECEPTION; OTOLITHS; SURVIVAL; FITNESS; ORGANS; WATER	Despite identification of multiple factors mediating salmon survival, significant disparities in survival-to-adulthood among hatchery-versus wild-origin juveniles persist. In the present report, we explore the hypothesis that hatchery-reared juveniles might exhibit morphological defects in vulnerable mechanosensory systems prior to release from the hatchery, potentiating reduced survival after release. Juvenile steelhead (Oncorhynchus mykiss) from two different hatcheries were compared to wild-origin juveniles on several morphological traits including lateral line structure, otolith composition (a proxy for auditory function), and brain weight. Wild juveniles were found to possess significantly more superficial lateral line neuromasts than hatchery-reared juveniles, although the number of hair cells within individual neuromasts was not significantly different across groups. Wild juveniles were also found to possess primarily normal, aragonite-containing otoliths, while hatchery-reared juveniles possessed a high proportion of crystallized (vaterite) otoliths. Finally, wild juveniles were found to have significantly larger brains than hatchery-reared juveniles. These differences together predict reduced sensitivity to biologically important hydrodynamic and acoustic signals from natural biotic (predator, prey, conspecific) and abiotic (turbulent flow, current) sources among hatchery-reared steelhead, in turn predicting reduced survival fitness after release. Physiological and behavioral studies are required to establish the functional significance of these morphological differences.	[Brown, Andrew D.] Washington State Univ, Dept Speech & Hearing Sci, Vancouver, WA USA; [Sisneros, Joseph A.] Washington State Univ, Dept Psychol, Vancouver, WA USA; [Sisneros, Joseph A.] Washington State Univ, Dept Biol, Vancouver, WA USA; [Jurasin, Tyler] Quinault Indian Nat, Dept Fisheries, Taholah, WA USA; [Nguyen, Chau; Coffin, Allison B.] Washington State Univ, Coll Arts & Sci, Vancouver, WA 98686 USA; [Coffin, Allison B.] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Vancouver, WA USA	Washington State University; Washington State University; Washington State University; Washington State University; Washington State University	Coffin, AB (corresponding author), Washington State Univ, Coll Arts & Sci, Vancouver, WA 98686 USA.	allison.coffin@wsu.edu	Sisneros, Joseph/AAU-9965-2020	Sisneros, Joseph/0000-0002-3114-773X	Virginia Merrill Bloedel Hearing Research Center; Washington State University Vancouver	Virginia Merrill Bloedel Hearing Research Center; Washington State University Vancouver	This work was supported by a grant from the Virginia Merrill Bloedel Hearing Research Center (http://depts.washington.edu/hearing/) to JAS and by start-up funds from Washington State University Vancouver (http://www.vancouver.wsu.edu/) to ABC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Bonneville Power Administration, 2012, BPA INV FISH WILDL; Bowen CA, 1999, T AM FISH SOC, V128, P929, DOI 10.1577/1548-8659(1999)128<0929:VSIWAS>2.0.CO;2; Brenkman SJ, 2008, NORTHWEST SCI, V82, P91, DOI 10.3955/0029-344X-82.S.I.91; Brown AD, 2011, HEARING RES, V272, P1, DOI 10.1016/j.heares.2010.10.014; Chittenden CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012261; Coombs S., 1988, P553; DeHart M, 2007, COMP SURVIVAL STUDY; Dufourcq P, 2006, MOL CELL NEUROSCI, V33, P180, DOI 10.1016/j.mcn.2006.07.005; Engelmann J, 2002, J COMP PHYSIOL A, V188, P513, DOI 10.1007/s00359-002-0326-6; GAULDIE RW, 1986, NEW ZEAL J MAR FRESH, V20, P209, DOI 10.1080/00288330.1986.9516145; Groot C., 1995, PHYSL ECOLOGY PACIFI; Haeseker S, 2012, COMP SURV STUD ANN M; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Heard WR, 1995, 154 NPAFC NMFS NOAA; Jonsson N, 2003, J APPL ECOL, V40, P900, DOI 10.1046/j.1365-2664.2003.00851.x; Jorgensen J. M., 1991, CIBA F SYMP, V160, P163; Kalmijn A.J., 1988, P83; Kihslinger RL, 2006, J EXP BIOL, V209, P504, DOI 10.1242/jeb.02019; Kindschi GA, 2009, N AM J AQUACULT, V71, P79, DOI 10.1577/A07-063.1; Kostow K, 2009, REV FISH BIOL FISHER, V19, P9, DOI 10.1007/s11160-008-9087-9; Kostow KE, 2004, CAN J FISH AQUAT SCI, V61, P577, DOI [10.1139/f04-019, 10.1139/F04-019]; Larsson S, 2011, ENVIRON BIOL FISH, V92, P361, DOI 10.1007/s10641-011-9846-7; Lu ZM, 1998, HEARING RES, V126, P47, DOI 10.1016/S0378-5955(98)00149-X; MONTGOMERY J, 1995, REV FISH BIOL FISHER, V5, P399, DOI 10.1007/BF01103813; Montgomery J, 2000, PHILOS T ROY SOC B, V355, P1325, DOI 10.1098/rstb.2000.0693; Montgomery JC, 2003, P ROY SOC B-BIOL SCI, V270, pS195, DOI 10.1098/rsbl.2003.0052; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Montgomery JC, 2002, BRAIN BEHAV EVOLUT, V59, P190, DOI 10.1159/000064906; Oxman DS, 2007, CAN J FISH AQUAT SCI, V64, P1469, DOI 10.1139/F07-106; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Ramcharitar J, 2010, J APPL TOXICOL, V30, P536, DOI 10.1002/jat.1523; RAYMOND H L, 1988, North American Journal of Fisheries Management, V8, P1, DOI 10.1577/1548-8675(1988)008<0001:EOHDAF>2.3.CO;2; SATOU M, 1994, J COMP PHYSIOL A, V174, P539; Schellart NAM, 1998, PHYSL FISHES; SIREGAR YI, 1994, ACTA ZOOL-STOCKHOLM, V75, P213, DOI 10.1111/j.1463-6395.1994.tb01209.x; Smith ME, 2006, J EXP BIOL, V209, P4193, DOI 10.1242/jeb.02490; Suli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029727; Sweeting RM, 2004, REV FISH BIOL FISHER, V14, P361, DOI 10.1007/s11160-005-3793-3; Vladykov V, 1926, LATERAL LINE SYSTE 1; Wark AR, 2010, J EXP BIOL, V213, P108, DOI 10.1242/jeb.031625; Washington Department of Fish and Wildlife, 2002, SALM STOCK INV; Webb J.F., 2008, SPRINGER HDB AUDITOR, V32; WEBER DD, 1976, J FISH BIOL, V9, P217, DOI 10.1111/j.1095-8649.1976.tb04675.x; Wiese FK, 2008, ECOL APPL, V18, P681, DOI 10.1890/06-1825.1	47	29	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59162	10.1371/journal.pone.0059162	http://dx.doi.org/10.1371/journal.pone.0059162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554988	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800063
J	Griffing, SM; Viana, GMR; Mixson-Hayden, T; Sridaran, S; Alam, MT; de Oliveira, AM; Barnwell, JW; Escalante, AA; Povoa, MM; Udhayakumar, V				Griffing, Sean M.; Rachid Viana, Giselle M.; Mixson-Hayden, Tonya; Sridaran, Sankar; Alam, Mohammad Tauqeer; de Oliveira, Alexandre Macedo; Barnwell, John W.; Escalante, Ananias A.; Povoa, Marinete Marins; Udhayakumar, Venkatachalam			Historical Shifts in Brazilian P. falciparum Population Structure and Drug Resistance Alleles	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM; SULFADOXINE-PYRIMETHAMINE; CHLOROQUINE RESISTANCE; AMAZON REGION; MICROSATELLITE MARKERS; MALARIA; MUTATIONS; DIVERSITY; FIXATION	Previous work suggests that Brazilian Plasmodium falciparum has limited genetic diversity and a history of bottlenecks, multiple reintroductions due to human migration, and clonal expansions. We hypothesized that Brazilian P. falciparum would exhibit clonal structure. We examined isolates collected across two decades from Amapa, Rondonia, and Para state (n = 190). By examining more microsatellites markers on more chromosomes than previous studies, we hoped to define the extent of low diversity, linkage disequilibrium, bottlenecks, population structure, and parasite migration within Brazil. We used retrospective genotyping of samples from the 1980s and 1990s to explore the population genetics of SP resistant dhfr and dhps alleles. We tested an existing hypothesis that the triple mutant dhfr mutations 50R/51I/108N and 51I/108N/164L developed in southern Amazon from a single origin of common or similar parasites. We found that Brazilian P. falciparum had limited genetic diversity and isolation by distance was rejected, which suggests it underwent bottlenecks followed by migration between sites. Unlike Peru, there appeared to be gene flow across the Brazilian Amazon basin. We were unable to divide parasite populations by clonal lineages and pairwise FST were common. Most parasite diversity was found within sites in the Brazilian Amazon, according to AMOVA. Our results challenge the hypothesis that triple mutant alleles arose from a single lineage in the Southern Amazon. SP resistance, at both the double and triple mutant stages, developed twice and potentially in different regions of the Brazilian Amazon. We would have required samples from before the 1980s to describe how SP resistance spread across the basin or describe the complex internal migration of Brazilian parasites after the colonization efforts of past decades. The Brazilian Amazon basin may have sufficient internal migration for drug resistance reported in any particular region to rapidly spread to other parts of basin under similar drug pressure.	[Griffing, Sean M.; Mixson-Hayden, Tonya; Sridaran, Sankar; Alam, Mohammad Tauqeer; de Oliveira, Alexandre Macedo; Barnwell, John W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Griffing, Sean M.; Mixson-Hayden, Tonya; Alam, Mohammad Tauqeer] Atlanta Res & Educ Fdn, Decatur, GA USA; [Sridaran, Sankar] Assoc Publ Hlth Labs, Silver Spring, MD USA; [Escalante, Ananias A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Centers for Disease Control & Prevention - USA; Arizona State University; Arizona State University-Tempe	Udhayakumar, V (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA 30333 USA.	vxu0@cdc.gov	alam, mohammed/GXH-3645-2022; Viana, Giselle/ABF-2920-2020; Povoa, Marinete Marins/C-7039-2017	Viana, Giselle/0000-0003-1771-7211; Povoa, Marinete Marins/0000-0003-3517-2227; Escalante, Ananias/0000-0002-1532-3430	Antimicrobial Drug Resistance Working Group, Centers for Disease Control and Prevention, Atlanta Research and Education Foundation, Atlanta VA Medical Center; U.S. Agency for International Development; National Science Foundation; Association of Public Health Laboratories; Atlanta Research and Education Foundation; National Institutes of Health [R01GM084320]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084320] Funding Source: NIH RePORTER	Antimicrobial Drug Resistance Working Group, Centers for Disease Control and Prevention, Atlanta Research and Education Foundation, Atlanta VA Medical Center; U.S. Agency for International Development(United States Agency for International Development (USAID)); National Science Foundation(National Science Foundation (NSF)); Association of Public Health Laboratories; Atlanta Research and Education Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported in part by the Antimicrobial Drug Resistance Working Group, Centers for Disease Control and Prevention, Atlanta Research and Education Foundation, Atlanta VA Medical Center, and the U.S. Agency for International Development-supported Amazon Malaria Initiative. S. Griffing was supported by a National Science Foundation Graduate Research Fellowship. Luke Syphard and Sankar Sridaran were supported by Emerging Infectious Diseases fellowships from the Association of Public Health Laboratories. Andrea M. McCollum, Tonya Mixson-Hayden, Sean Griffing, and Sumiti Vinayak were supported by the Atlanta Research and Education Foundation. A. A. Escalante is supported by grant R01GM084320 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2010, GENE, V453, P37, DOI 10.1016/j.gene.2010.01.001; Alecrim MG, 1982, REV INST MED TROP SP, V24, P44; Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Bacon DJ, 2009, ANTIMICROB AGENTS CH, V53, P2042, DOI 10.1128/AAC.01677-08; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barata R B, 1998, Rev Panam Salud Publica, V3, P102; Barata R C, 1995, Cad Saude Publica, V11, P128, DOI 10.1590/S0102-311X1995000100019; Conway DJ, 2001, MOL BIOCHEM PARASIT, V115, P145, DOI 10.1016/S0166-6851(01)00278-X; Cornuet JM, 1996, GENETICS, V144, P2001; Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Da Silveira LA, 1999, INFECT IMMUN, V67, P5906, DOI 10.1128/IAI.67.11.5906-5916.1999; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; DEANE LM, 1988, AM J TROP MED HYG, V38, P223, DOI 10.4269/ajtmh.1988.38.223; DESOUZA JM, 1992, MEM I OSWALDO CRUZ, V87, P343, DOI 10.1590/S0074-02761992000700058; Durand S, 2007, AM J TROP MED HYG, V76, P614, DOI 10.4269/ajtmh.2007.76.614; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferreira MU, 1998, AM J TROP MED HYG, V59, P474, DOI 10.4269/ajtmh.1998.59.474; Gadelha P., 1998, Parassitologia (Rome), V40, P159; Griffing S, 2010, ANTIMICROB AGENTS CH, V54, P1572, DOI 10.1128/AAC.01243-09; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Hochman G, 2008, CAN BULL MED HIST, V25, P161, DOI 10.3138/cbmh.25.1.161; Loiola Carlos Catão Prates, 2002, Rev Panam Salud Publica, V11, P235, DOI 10.1590/S1020-49892002000400005; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Marques A C, 1986, Rev Bras Malariol Doencas Trop, V38, P51; Marquino W, 2003, AM J TROP MED HYG, V68, P120, DOI 10.4269/ajtmh.2003.68.120; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McCollum AM, 2006, J INFECT DIS, V194, P189, DOI 10.1086/504687; Nair S, 2007, MOL BIOL EVOL, V24, P562, DOI 10.1093/molbev/msl185; Nash D, 2005, P ROY SOC B-BIOL SCI, V272, P1153, DOI 10.1098/rspb.2004.3026; Packard, 2016, HIST GLOBAL HLTH INT; PAYNE D, 1988, PARASITOL TODAY, V4, P112, DOI 10.1016/0169-4758(88)90042-7; SLATKIN M, 1995, GENETICS, V139, P457; Stepan Nancy Leys, 2003, DIS HIST MODERN LATI, P25; Takken W, 2005, WAG UR FRON, V9, P113; Vasconcelos KF, 2000, MEM I OSWALDO CRUZ, V95, P721, DOI 10.1590/S0074-02762000000500020; Vieira PP, 2004, J INFECT DIS, V190, P417, DOI 10.1086/422006; Webb JLA, 2009, STUD ENVIRON HIST, P1; WHO, 1991, CD35INF2 WHO ORG PAN; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Zhou ZY, 2008, ANTIMICROB AGENTS CH, V52, P739, DOI 10.1128/AAC.00975-07	43	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58984	10.1371/journal.pone.0058984	http://dx.doi.org/10.1371/journal.pone.0058984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554964	Green Submitted, Green Published, gold			2022-12-25	WOS:000316409800050
J	Khanicheh, E; Mitterhuber, M; Xu, LF; Haeuselmann, SP; Kuster, GM; Kaufmann, BA				Khanicheh, Elham; Mitterhuber, Martina; Xu, Lifen; Haeuselmann, Stephanie P.; Kuster, Gabriela M.; Kaufmann, Beat A.			Noninvasive Ultrasound Molecular Imaging of the Effect of Statins on Endothelial Inflammatory Phenotype in Early Atherosclerosis	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; FAMILIAL HYPERCHOLESTEROLEMIA; CHOLESTEROL LEVELS; P-SELECTIN; PREVENTION; CORONARY; LESIONS; EVENTS; MEN; ROSUVASTATIN	Background/Objectives: Inflammatory changes on the endothelium are responsible for leukocyte recruitment to plaques in atherosclerosis. Noninvasive assessment of treatment-effects on endothelial inflammation may be of use for managing medical therapy and developing novel therapies. We hypothesized that molecular imaging of vascular cell adhesion molecule-1 (VCAM-1) with contrast enhanced ultrasound (CEU) could assess treatment effects on endothelial phenotype in early atherosclerosis. Methods: Mice with atherosclerosis produced by gene deletion of the LDL-receptor and Apobec-1-editing protein were studied. At 12 weeks of age, mice received 8 weeks of regular chow or atorvastatin-enriched chow (10 mg/kg/day). At 20 weeks, CEU molecular imaging for aortic endothelial VCAM-1 expression was performed with VCAM-1-targeted (MBVCAM) and control microbubbles (MBCtr). Aortic wall thickness was assessed with high frequency ultrasound. Histology, immunohistology and Western blot were used to assess plaque burden and VCAM-1 expression. Results: Plaque burden was reduced on histology, and VCAM-1 was reduced on Western blot by atorvastatin, which corresponded to less endothelial expression of VCAM-1 on immunohistology. High frequency ultrasound did not detect differences in aortic wall thickness between groups. In contrast, CEU molecular imaging demonstrated selective signal enhancement for MBVCAM in non-treated animals (MBVCAM 2 +/- 0.3 vs MBCtr 0.7 +/- 0.2, p<0.01), but not in statin-treated animals (MBVCAM 0.8 +/- 0.2 vs MBCtr 1.0 +/- 0.2, p = ns; p<0.01 for the effect of statin on MBVCAM signal). Conclusions: Non-invasive CEU molecular imaging detects the effects of anti-inflammatory treatment on endothelial inflammation in early atherosclerosis. This easily accessible, low-cost technique may be useful in assessing treatment effects in preclinical research and in patients.	[Khanicheh, Elham; Mitterhuber, Martina; Xu, Lifen; Haeuselmann, Stephanie P.; Kuster, Gabriela M.; Kaufmann, Beat A.] Univ Basel, Dept Biomed, CH-4003 Basel, Switzerland; [Khanicheh, Elham; Mitterhuber, Martina; Xu, Lifen; Haeuselmann, Stephanie P.; Kuster, Gabriela M.; Kaufmann, Beat A.] Univ Basel Hosp, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Kaufmann, BA (corresponding author), Univ Basel, Dept Biomed, CH-4003 Basel, Switzerland.	kaufmannb@uhbs.ch	Kuster, Gabriela M/AAB-5478-2022; Kaufmann, Beat/AAB-7805-2022	Kuster, Gabriela M/0000-0002-8209-4631; Kaufmann, Beat/0000-0001-6295-3630	Swiss National Science Foundation [SNSF 32323B_123819, 3232B0-141603, SNSF 3232B-111352, 3200B-111353]; University Hospital Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University Hospital Basel	This study was supported by SCORE grants from the Swiss National Science Foundation to Dr. Kaufmann (SNSF 32323B_123819 and 3232B0-141603) and to Dr. Kuster (SNSF 3232B-111352 and 3200B-111353). Dr. Khanicheh is supported by an MD-PhD start up grant from the University Hospital Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bustos C, 1998, J AM COLL CARDIOL, V32, P2057, DOI 10.1016/S0735-1097(98)00487-2; Chyu KY, 2011, CARDIOL CLIN, V29, P123, DOI 10.1016/j.ccl.2010.10.003; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Foster FS, 2002, ULTRASOUND MED BIOL, V28, P1165, DOI 10.1016/S0301-5629(02)00567-7; Fujimoto S, 2008, J AM COLL CARDIOL, V52, P1847, DOI 10.1016/j.jacc.2008.08.048; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738; Kaufmann BA, 2010, ARTERIOSCL THROM VAS, V30, P54, DOI 10.1161/ATVBAHA.109.196386; Khanicheh E, 2012, J AM SOC ECHOCARDIOG, V25, P460, DOI 10.1016/j.echo.2011.12.016; Lindner JR, 2001, CIRCULATION, V104, P2107, DOI 10.1161/hc4201.097061; Meuwese MC, 2009, J LIPID RES, V50, P148, DOI 10.1194/jlr.P800025-JLR200; Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380; Powell-Braxton L, 1998, NAT MED, V4, P934, DOI 10.1038/nm0898-934; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Rasmussen LM, 2001, BIOCHEM J, V360, P363, DOI 10.1042/0264-6021:3600363; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sukhova GK, 2002, ARTERIOSCL THROM VAS, V22, P1452, DOI 10.1161/01.ATV.0000030360.72503.56; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	21	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58761	10.1371/journal.pone.0058761	http://dx.doi.org/10.1371/journal.pone.0058761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554922	gold, Green Published, Green Submitted			2022-12-25	WOS:000316409800028
J	Oravcova, M; Teska, M; Puta, F; Folk, P; Prevorovsky, M				Oravcova, Martina; Teska, Mikolas; Puta, Frantisek; Folk, Petr; Prevorovsky, Martin			Fission Yeast CSL Proteins Function as Transcription Factors	PLOS ONE			English	Article							RBP-J; NOTCH; SUPPRESSOR; HAIRLESS; BINDING; CELL; VECTORS; EXPRESSION; HOMOLOG; PATHWAY	Background: Transcription factors of the CSL (CBF1/RBP-Jk/Suppressor of Hairless/LAG-1) family are key regulators of metazoan development and function as the effector components of the Notch receptor signalling pathway implicated in various cell fate decisions. CSL proteins recognize specifically the GTG[G/A]AA sequence motif and several mutants compromised in their ability to bind DNA have been reported. In our previous studies we have identified a number of novel putative CSL family members in fungi, organisms lacking the Notch pathway. It is not clear whether these represent genuine CSL family members. Methodology/Principal Findings: Using a combination of in vitro and in vivo approaches we characterized the DNA binding properties of Cbf11 and Cbf12, the antagonistic CSL paralogs from the fission yeast, important for the proper coordination of cell cycle events and the regulation of cell adhesion. We have shown that a mutation of a conserved arginine residue abolishes DNA binding in both CSL paralogs, similar to the situation in mouse. We have also demonstrated the ability of Cbf11 and Cbf12 to activate gene expression in an autologous fission yeast reporter system. Conclusions/Significance: Our results indicate that the fission yeast CSL proteins are indeed genuine family members capable of functioning as transcription factors, and provide support for the ancient evolutionary origin of this important protein family.	[Oravcova, Martina; Teska, Mikolas; Puta, Frantisek; Folk, Petr; Prevorovsky, Martin] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic	Charles University Prague	Prevorovsky, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic.	prevorov@natur.cuni.cz	Půta, František/K-6731-2017; Folk, Petr/V-7545-2017; Převorovský, Martin/R-5191-2016	Půta, František/0000-0002-8313-878X; Folk, Petr/0000-0003-3813-7777; Převorovský, Martin/0000-0003-0277-8361	Czech Science Foundation [P305/12/P040]; Czech Ministry of Education, Youth and Sports [UNCE 204013, SVV 265211, MSM0021620858]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was funded in part by the Czech Science Foundation post-doctoral grant P305/12/P040, projects UNCE 204013 and SVV 265211, and grant number MSM0021620858 of the Czech Ministry of Education, Youth and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Christensen S, 1996, DEVELOPMENT, V122, P1373; CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Ehebauer Matthias, 2006, Sci STKE, V2006, pcm7, DOI 10.1126/stke.3642006cm7; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Gordan R, 2009, GENOME RES, V19, P2090, DOI 10.1101/gr.094144.109; Koelzer S, 2003, DEVELOPMENT, V130, P1973, DOI 10.1242/dev.00426; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lam LT, 1998, J BIOL CHEM, V273, P24223, DOI 10.1074/jbc.273.37.24223; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Moreno MB, 2000, YEAST, V16, P861; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Prevorovsky M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-233; Prevorovsky M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023650; Prevorovsky M, 2009, EXP CELL RES, V315, P1533, DOI 10.1016/j.yexcr.2008.12.001; Pursglove SE, 2005, INT J BIOCHEM CELL B, V37, P2472, DOI 10.1016/j.biocel.2005.06.013; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wells ML, 2012, MOL CELLULAR BIOL; Weng AP, 2004, CURR OPIN GENET DEV, V14, P48, DOI 10.1016/j.gde.2003.11.004	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59435	10.1371/journal.pone.0059435	http://dx.doi.org/10.1371/journal.pone.0059435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555033	Green Submitted, gold, Green Published			2022-12-25	WOS:000316409800090
J	Takashima, O; Tsuruta, F; Kigoshi, Y; Nakamura, S; Kim, J; Katoh, MC; Fukuda, T; Irie, K; Chiba, T				Takashima, Osamu; Tsuruta, Fuminori; Kigoshi, Yu; Nakamura, Shingo; Kim, Jaehyun; Katoh, Megumi C.; Fukuda, Tomomi; Irie, Kenji; Chiba, Tomoki			Brap2 Regulates Temporal Control of NF-kappa B Localization Mediated by Inflammatory Response	PLOS ONE			English	Article							E3 LIGASE COMPLEX; UBIQUITIN-LIGASE; MODIFIER NEDD8; PROTEIN; SYSTEM; CUL1; CONJUGATION; PATHWAY; ATHEROSCLEROSIS; IDENTIFICATION	Nuclear factor-kappaB (NF-kappa B) is critical for the expression of multiple genes involved in inflammatory responses and cellular survival. NF-kappa B is normally sequestered in the cytoplasm through interaction with an inhibitor of NF-kappa B (I kappa B), but inflammatory stimulation induces proteasomal degradation of I kappa B, followed by NF-kappa B nuclear translocation. The degradation of I kappa B is mediated by a SCF (Skp1-Cullin1-F-box protein)-type ubiquitin ligase complex that is post-translationaly modified by a ubiquitin-like molecule Nedd8. In this study, we report that BRCA1-associated protein 2 (Brap2) is a novel Nedd8-binding protein that interacts with SCF complex, and is involved in NF-kappa B translocation following TNF-alpha stimulation. We also found a putative neddylation site in Brap2 associated with NF-kB activity. Our findings suggest that Brap2 is a novel modulator that associates with SCF complex and controls TNF-alpha-induced NF-kappa B nuclear translocation.	[Takashima, Osamu; Tsuruta, Fuminori; Kigoshi, Yu; Nakamura, Shingo; Kim, Jaehyun; Katoh, Megumi C.; Fukuda, Tomomi; Chiba, Tomoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Irie, Kenji] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba	Chiba, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	tchiba@biol.tsukuba.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Yasuda Medical Foundation; Grants-in-Aid for Scientific Research [24111504, 23570221, 24570192] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yasuda Medical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid from Ministry of Education, Science, Sports and Culture of Japan (T.C.) and Yasuda Medical Foundation (T.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; Avery CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002322; Czyzyk J, 2008, J BIOL CHEM, V283, P23004, DOI 10.1074/jbc.M804084200; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hsia MM, 2010, J BIOL CHEM, V285, P37070, DOI 10.1074/jbc.M110.168021; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Koon JC, 2010, J BIOL CHEM, V285, P13437, DOI 10.1074/jbc.M110.107011; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Liao YC, 2011, MOL MED, V17, P1065, DOI 10.2119/molmed.2011.00043; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ohki Y, 2009, BIOCHEM BIOPH RES CO, V381, P443, DOI 10.1016/j.bbrc.2009.02.090; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Ozaki K, 2009, NAT GENET, V41, P329, DOI 10.1038/ng.326; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Saeki Y, 2004, GENES GENET SYST, V79, P77, DOI 10.1266/ggs.79.77; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0	38	15	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58911	10.1371/journal.pone.0058911	http://dx.doi.org/10.1371/journal.pone.0058911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554956	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800047
J	Aleksinskaya, MA; van Faassen, EEH; Nelissen, J; Janssen, BJA; De Mey, JGR; Hanemaaijer, R; Rabelink, T; van Zonneveld, AJ				Aleksinskaya, Marina A.; van Faassen, Ernst E. H.; Nelissen, Jelly; Janssen, Ben J. A.; De Mey, Jo G. R.; Hanemaaijer, Roeland; Rabelink, Ton; van Zonneveld, Anton Jan			Identification of Free Nitric Oxide Radicals in Rat Bone Marrow: Implications for Progenitor Cell Mobilization in Hypertension	PLOS ONE			English	Article							SYNTHASE ENHANCER AVE9488; DOCA-SALT; ENDOTHELIAL DYSFUNCTION; NO; ISOFORMS; STEM; EXPRESSION; BIOLOGY; BLOOD	Nitric oxide (NO) has been implicated in matrix metallopeptidase 9 (MMP9)-dependent mobilization of hematopoietic stem and progenitor cells from bone marrow (BM). However, direct measurement of NO in the BM remained elusive due to its low in situ concentration and short lifetime. Using NO spin trapping and electron paramagnetic resonance (EPR) spectroscopy we give the first experimental confirmation of free NO radicals in rodent BM. NO production was quantified and attributed to enzymatic activity of NO synthases (NOS). Although endothelial NOS (eNOS) accounts for most (66%) of basal NO, we identified a significant contribution (23%) from inducible NOS (iNOS). Basal NO levels closely correlate with MMP9 bioavailability in BM of both hypertensive and control rats. Our observations support the hypothesis that inadequate mobilization of BM-derived stem and progenitor cells in hypertension results from impaired NOS/NO/MMP9 signalling in BM, a condition that may be corrected with pharmacological intervention.	[Aleksinskaya, Marina A.; van Faassen, Ernst E. H.; Rabelink, Ton; van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Aleksinskaya, Marina A.; van Faassen, Ernst E. H.; Rabelink, Ton; van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Nelissen, Jelly; Janssen, Ben J. A.; De Mey, Jo G. R.] Maastricht Univ, Dept Pharmacol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Hanemaaijer, Roeland] TNO, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Netherlands Organization Applied Science Research	Aleksinskaya, MA (corresponding author), Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.	m.a.aleksinskaya@lumc.nl	Rabelink, Ton J./A-5316-2008; van Zonneveld, Anton Jan/D-8060-2018	Rabelink, Ton J./0000-0001-6780-5186; van Zonneveld, Anton Jan/0000-0002-1676-7738; De Mey, Jo G. R./0000-0001-6274-8071	Dutch Top Institute Pharma [T2-108]; Dutch government [FES0908]	Dutch Top Institute Pharma; Dutch government	This research was performed within the framework of project T2-108 of the Dutch Top Institute Pharma and a grant from the Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM, grant No. FES0908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2004, TRENDS MOL MED, V10, P421, DOI 10.1016/j.molmed.2004.07.007; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Aicher A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004879; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bae EH, 2009, REGUL PEPTIDES, V157, P76, DOI 10.1016/j.regpep.2009.04.015; Brooks VL, 2006, AM J PHYSIOL-REG I, V291, pR1825, DOI 10.1152/ajpregu.00068.2006; Butler AR, 2001, CHEM COMMUN, P1732, DOI 10.1039/b105460k; Case J, 2008, ANTIOXID REDOX SIGN, V10, P1895, DOI 10.1089/ars.2008.2118; Crabos M, 1997, J MOL CELL CARDIOL, V29, P55, DOI 10.1006/jmcc.1996.0251; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Ergun S, 2011, ANTIOXID REDOX SIGN, V15, P981, DOI 10.1089/ars.2010.3507; Everaert BR, 2010, INT J CARDIOL, V144, P350, DOI 10.1016/j.ijcard.2010.04.018; Fraccarollo D, 2008, CIRCULATION, V118, P818, DOI 10.1161/CIRCULATIONAHA.107.717702; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Hanemaaijer R, 1998, MATRIX BIOL, V17, P657, DOI 10.1016/S0945-053X(98)90116-0; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Helfrich MH, 1997, J BONE MINER RES, V12, P1108, DOI 10.1359/jbmr.1997.12.7.1108; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Iyer A, 2010, CURR CARDIOL REV, V6, P291, DOI 10.2174/157340310793566109; Johnson FK, 2004, AM J PHYSIOL-HEART C, V286, pH1681, DOI 10.1152/ajpheart.00409.2003; Kleschyov AL, 2007, J CHROMATOGR B, V851, P12, DOI 10.1016/j.jchromb.2006.10.006; Kumar S, 2010, CYTOM PART A, V77A, P467, DOI 10.1002/cyto.a.20852; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Mur LAJ, 2011, PLANT SCI, V181, P509, DOI 10.1016/j.plantsci.2011.04.003; Op den Buijs J, 2004, AM J PHYSIOL-HEART C, V287, pH2651, DOI 10.1152/ajpheart.00332.2004; Rosti V, 2007, HAEMATOLOGICA, V92, P1291, DOI 10.3324/haematol.11455; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; Sasaki K, 2006, P NATL ACAD SCI USA, V103, P14537, DOI 10.1073/pnas.0604144103; Saura M, 2010, THESCIENTIFICWORLDJO, V10, P624, DOI 10.1100/tsw.2010.58; Savoia C, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/281240; Suzuki Y, 1997, BBA-GEN SUBJECTS, V1335, P242, DOI 10.1016/S0304-4165(97)00027-5; Taddei S, 2002, J HYPERTENS, V20, P1671, DOI 10.1097/00004872-200209000-00001; van Faassen E., 2007, RADICALS LIFE VARIOU; van Faassen EE, 2008, NITRIC OXIDE-BIOL CH, V18, P279, DOI 10.1016/j.niox.2008.02.003; van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151; van Zonneveld AJ, 2006, CURR OPIN NEPHROL HY, V15, P167, DOI 10.1097/01.mnh.0000214774.42103.ec; Vanin AF, 2007, CELL MOL LIFE SCI, V64, P96, DOI 10.1007/s00018-006-6374-2; Vanin AF, 2007, NITRIC OXIDE-BIOL CH, V16, P71, DOI 10.1016/j.niox.2006.06.009; Vanin Anatoly F., 2007, P383, DOI 10.1016/B978-044452236-8/50018-6; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d	43	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57761	10.1371/journal.pone.0057761	http://dx.doi.org/10.1371/journal.pone.0057761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554866	Green Published, gold			2022-12-25	WOS:000316252500006
J	Allen, JE; Gallant, JN; Dicker, DT; Amin, S; Irby, RB; Sharma, AK; El-Deiry, WS				Allen, Joshua E.; Gallant, Jean-Nicolas; Dicker, David T.; Amin, Shantu; Irby, Rosalyn B.; Sharma, Arun K.; El-Deiry, Wafik S.			The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; ISOTHIOCYANATES; CELLS; ISOSELENOCYANATES; RESISTANCE; APOPTOSIS; MUTATIONS; THERAPY	Phenylbutyl isoselenocyanate (ISC-4) is an Akt inhibitor with demonstrated preclinical efficacy against melanoma and colon cancer. In this study, we sought to improve the clinical utility of ISC-4 by identifying a synergistic combination with FDA-approved anti-cancer therapies, a relevant and appropriate disease setting for testing, and biomarkers of response. We tested the activity of ISC-4 and 19 FDA-approved anticancer agents, alone or in combination, against the SW480 and RKO human colon cancer cell lines. A synergistic interaction with cetuximab was identified and validated in a panel of additional colon cancer cell lines, as well as the kinetics of synergy. ISC-4 in combination with cetuximab synergistically reduced the viability of human colon cancer cells with wild-type but not mutant KRAS genes. Further analysis revealed that the combination therapy cooperatively decreased cell cycle progression, increased caspase-dependent apoptosis, and decreased phospho-Akt in responsive tumor cells. The synergism between ISC-4 and cetuximab was retained independently of acquired resistance to 5-FU in human colon cancer cells. The combination demonstrated synergistic anti-tumor effects in vivo without toxicity and in the face of resistance to 5-FU. These results suggest that combining ISC-4 and cetuximab should be explored in patients with 5-FU-resistant colon cancer harboring wild-type KRAS.	[Allen, Joshua E.; Gallant, Jean-Nicolas; Dicker, David T.; El-Deiry, Wafik S.] Penn State Hershey Canc Inst, Dept Med Hematol Oncol, Lab Translat Oncol & Expt Canc Therapeut, Hershey, PA 17033 USA; [Amin, Shantu; Sharma, Arun K.] Penn State Hershey Canc Inst, Dept Pharmacol, Hershey, PA USA; [Irby, Rosalyn B.] Penn State Hershey Canc Inst, Dept Med Hematol Oncol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	El-Deiry, WS (corresponding author), Penn State Hershey Canc Inst, Dept Med Hematol Oncol, Lab Translat Oncol & Expt Canc Therapeut, Hershey, PA 17033 USA.	wafik.eldeiry@gmail.com	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266; Sharma, Arun/0000-0002-7679-7779; Gallant, Jean-Nicolas/0000-0003-4696-2013	Penn State Hershey Cancer Institute; NIH National Cancer Institute [R03-CA143999]; Lung Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R03CA143999] Funding Source: NIH RePORTER	Penn State Hershey Cancer Institute; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to W.S.E.-D. and funds from the Penn State Hershey Cancer Institute, NIH National Cancer Institute grant R03-CA143999 to A. K. S., and the Lung Cancer Research Foundation grant to A. K. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2010, CURR COLORECT CANC R, V6, P212, DOI 10.1007/s11888-010-0069-7; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Faltas B, 2011, J CLIN ONCOL, V29, P2946, DOI 10.1200/JCO.2011.36.6179; Festuccia C, 2008, PROSTATE, V68, P965, DOI 10.1002/pros.20757; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Keum YS, 2004, MUTAT RES-FUND MOL M, V555, P191, DOI 10.1016/j.mrfmmm.2004.05.024; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Nguyen N, 2011, CANCER PREV RES, V4, P248, DOI 10.1158/1940-6207.CAPR-10-0106; Prewett M, 2007, CLIN CANCER RES, V13, P7432, DOI 10.1158/1078-0432.CCR-07-1768; Sharma A, 2009, CLIN CANCER RES, V15, P1674, DOI 10.1158/1078-0432.CCR-08-2214; Sharma AK, 2011, CLIN CANCER RES, V17, P4474, DOI 10.1158/1078-0432.CCR-10-2370; Sharma AK, 2008, J MED CHEM, V51, P7820, DOI 10.1021/jm800993r; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Zhang YS, 2004, MUTAT RES-FUND MOL M, V555, P173, DOI 10.1016/j.mrfmmm.2004.04.017	18	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59380	10.1371/journal.pone.0059380	http://dx.doi.org/10.1371/journal.pone.0059380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555026	gold, Green Published			2022-12-25	WOS:000316252500087
J	Getahun, MN; Olsson, SB; Lavista-Llanos, S; Hansson, BS; Wicher, D				Getahun, Merid N.; Olsson, Shannon B.; Lavista-Llanos, Sofia; Hansson, Bill S.; Wicher, Dieter			Insect Odorant Response Sensitivity Is Tuned by Metabotropically Autoregulated Olfactory Receptors	PLOS ONE			English	Article							PHOSPHOLIPASE-C; DROSOPHILA; NEURONS; GENE; EXPRESSION; EVOLUTION; MECHANISMS; PROTEINS; MAP	Insects possess one of the most exquisitely sensitive olfactory systems in the animal kingdom, consisting of three different types of chemosensory receptors: ionotropic glutamate-like receptors (IRs), gustatory receptors (GRs) and odorant receptors (ORs). Both insect ORs and IRs are ligand-gated ion channels, but ORs possess a unique configuration composed of an odorant-specific protein OrX and a ubiquitous coreceptor (Orco). In addition, these two ionotropic receptors confer different tuning properties for the neurons in which they are expressed. Unlike IRs, neurons expressing ORs are more sensitive and can also be sensitized by sub-threshold concentrations of stimuli. What is the mechanistic basis for these differences in tuning? We show that intrinsic regulation of Orco enhances neuronal response to odorants and sensitizes the ORs. We also demonstrate that inhibition of metabotropic regulation prevents receptor sensitization. Our results indicate that Orco-mediated regulation of OR sensitivity provides tunable ionotropic receptors capable of detecting odors over a wider range of concentrations, providing broadened sensitivity over IRs themselves.	[Getahun, Merid N.; Olsson, Shannon B.; Lavista-Llanos, Sofia; Hansson, Bill S.; Wicher, Dieter] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany	Max Planck Society	Wicher, D (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany.	dwicher@ice.mpg.de	Hansson, Bill S/G-2774-2013; Getahun, Merid Negash/ACU-6437-2022	Hansson, Bill S/0000-0002-4811-1223; Getahun, Merid Negash/0000-0001-5902-9236; Olsson, Shannon/0000-0003-4126-7353	Max Planck Society; International Max Planck Research School; iChem (6th Programme of the EU)	Max Planck Society(Max Planck Society); International Max Planck Research School; iChem (6th Programme of the EU)	This study was supported by the Max Planck Society (SLL, BSH, DW), the International Max Planck Research School (MNG), and iChem (6th Programme of the EU; SBO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Chatterjee Abhishek, 2009, BMC Physiology, V9, P22, DOI 10.1186/1472-6793-9-22; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605; Dethier V.G, 1947, CHEM INSECT ATTRACTA; Edwards JS, 1997, BRAIN BEHAV EVOLUT, V50, P8, DOI 10.1159/000113317; Getahun MN, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00054; Gomez-Diaz C, 2006, BEHAV GENET, V36, P309, DOI 10.1007/s10519-005-9031-x; Gomez-Diaz C, 2004, BEHAV GENET, V34, P395, DOI 10.1023/B:BEGE.0000023645.02710.fe; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kain P, 2008, J NEUROSCI, V28, P4745, DOI 10.1523/JNEUROSCI.5306-07.2008; Kaissling KE, 2009, BIOL INSPIRED SIGNAL, P170; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Nordstrom KJV, 2011, MOL BIOL EVOL, V28, P2471, DOI 10.1093/molbev/msr061; Olsson SB, 2011, J NEUROSCI METH, V201, P385, DOI 10.1016/j.jneumeth.2011.08.015; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; RIESGOESCOVAR J, 1995, P NATL ACAD SCI USA, V92, P2864, DOI 10.1073/pnas.92.7.2864; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Silbering AF, 2010, EMBO REP, V11, P173, DOI 10.1038/embor.2010.8; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wicher D, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00048; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	41	53	56	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58889	10.1371/journal.pone.0058889	http://dx.doi.org/10.1371/journal.pone.0058889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554952	Green Submitted, Green Published, gold			2022-12-25	WOS:000316252500054
J	Kamlet, AS; Neumann, CN; Lee, E; Carlin, SM; Moseley, CK; Stephenson, N; Hooker, JM; Ritter, T				Kamlet, Adam S.; Neumann, Constanze N.; Lee, Eunsung; Carlin, Stephen M.; Moseley, Christian K.; Stephenson, Nickeisha; Hooker, Jacob M.; Ritter, Tobias			Application of Palladium-Mediated F-18-Fluorination to PET Radiotracer Development: Overcoming Hurdles to Translation	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RECEPTOR MESSENGER-RNA; REDUCTIVE ELIMINATION; CELLULAR-LOCALIZATION; TRANSPORTER BINDING; FLUORINE; LIGANDS; RADIOSYNTHESIS; CITALOPRAM; AGONIST	New chemistry methods for the synthesis of radiolabeled small molecules have the potential to impact clinical positron emission tomography (PET) imaging, if they can be successfully translated. However, progression of modern reactions from the stage of synthetic chemistry development to the preparation of radiotracer doses ready for use in human PET imaging is challenging and rare. Here we describe the process of and the successful translation of a modern palladium-mediated fluorination reaction to non-human primate (NHP) baboon PET imaging-an important milestone on the path to human PET imaging. The method, which transforms [F-18]fluoride into an electrophilic fluorination reagent, provides access to aryl-F-18 bonds that would be challenging to synthesize via conventional radiochemistry methods.	[Kamlet, Adam S.; Neumann, Constanze N.; Lee, Eunsung; Stephenson, Nickeisha; Ritter, Tobias] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Carlin, Stephen M.; Moseley, Christian K.; Hooker, Jacob M.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Carlin, Stephen M.; Moseley, Christian K.; Hooker, Jacob M.] Harvard Univ, Sch Med, Charlestown, MA USA; [Hooker, Jacob M.; Ritter, Tobias] Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital	Hooker, JM (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	hooker@nmr.mgh.harvard.edu; ritter@chemistry.harvard.edu	Neumann, Constanze/AAL-3918-2020; Ritter, Tobias/AAJ-8703-2021; Stephenson, Nickeisha/AAF-3881-2019; Hooker, Jacob M/P-5716-2018; Lee, Eunsung/F-5308-2013	Neumann, Constanze/0000-0003-1004-1140; Stephenson, Nickeisha/0000-0003-4227-5371; Hooker, Jacob M/0000-0002-9394-7708; Lee, Eunsung/0000-0002-1507-098X	National Institutes of Health (NIH) [GM088237, MH093874, EB013042, S10RR017208, S10RR022976]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022976, S10RR017208, S10RR023385, S10RR026666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH093874] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (NIH) (GM088237, MH093874, EB013042, S10RR017208, and S10RR022976). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426; Antoni Gunnar, 2008, V185, P177, DOI 10.1007/978-3-540-72718-7_9; Bergman J, 1997, NUCL MED BIOL, V24, P677, DOI 10.1016/S0969-8051(97)00078-4; Bergstrom M, 2003, EUR J CLIN PHARMACOL, V59, P357, DOI 10.1007/s00228-003-0643-x; Cabarcos OM, 1999, J CHEM PHYS, V110, P5, DOI 10.1063/1.478075; Cai LS, 2008, EUR J ORG CHEM, V2008, P2853, DOI 10.1002/ejoc.200800114; Centurion D, 2000, N-S ARCH PHARMACOL, V362, P169, DOI 10.1007/s002100000277; Charette AB, 1998, J AM CHEM SOC, V120, P11943, DOI 10.1021/ja982055v; Christianson JP, 2010, BIOL PSYCHIAT, V67, P339, DOI 10.1016/j.biopsych.2009.09.011; COENEN HH, 1988, EUR J NUCL MED, V14, P80; EMSLEY J, 1980, CHEM SOC REV, V9, P91, DOI 10.1039/cs9800900091; Fowler JS, 1997, ACCOUNTS CHEM RES, V30, P181, DOI 10.1021/ar960068c; FOWLER JS, 1982, J LABELLED COMPD RAD, V19, P1634; Furuya T, 2008, CURR OPIN DRUG DISC, V11, P803; Furuya T, 2008, J AM CHEM SOC, V130, P10060, DOI 10.1021/ja803187x; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Furuya T, 2008, ANGEW CHEM INT EDIT, V47, P5993, DOI 10.1002/anie.200802164; Furuya T, 2010, J AM CHEM SOC, V132, P3793, DOI 10.1021/ja909371t; Hinz R, 2008, J CEREBR BLOOD F MET, V28, P1478, DOI 10.1038/jcbfm.2008.41; Hughes G, 2003, J AM CHEM SOC, V125, P11253, DOI 10.1021/ja0351692; Hummer G, 1996, J PHYS CHEM-US, V100, P1206, DOI 10.1021/jp951011v; Jiang ZJ, 2011, J PHARMACEUT BIOMED, V54, P722, DOI 10.1016/j.jpba.2010.11.004; Knight AR, 2004, N-S ARCH PHARMACOL, V370, P114, DOI 10.1007/s00210-004-0951-4; Kozikowski AP, 2010, CHEMMEDCHEM, V5, P1221, DOI 10.1002/cmdc.201000186; Landvatter SW, 1998, SYNTHESIS AND APPLICATIONS OF ISOTOPICALLY LABELLED COMPOUNDS 1997, P99; Lee E, 2012, J AM CHEM SOC, V134, P17456, DOI 10.1021/ja3084797; Lee E, 2011, SCIENCE, V334, P639, DOI 10.1126/science.1212625; Lopez-Gimenez JF, 2001, SYNAPSE, V42, P12, DOI 10.1002/syn.1095; Luedtke AT, 2007, INORG CHEM, V46, P8496, DOI 10.1021/ic701504z; Miller PW, 2008, ANGEW CHEM INT EDIT, V47, P8998, DOI 10.1002/anie.200800222; Monck NJT, 2008, PROGR MED CHEM, V46, P281, DOI 10.1016/S0079-6468(07)00006-9; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; O'Neil PM, 2012, OBESITY, V20, P1426, DOI 10.1038/oby.2012.66; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; Pandey SC, 1996, ALCOHOL CLIN EXP RES, V20, P1038, DOI 10.1111/j.1530-0277.1996.tb01944.x; Pasqualetti M, 1999, NEUROSCIENCE, V92, P601, DOI 10.1016/S0306-4522(99)00011-1; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Pinborg LH, 2012, SYNAPSE, V66, P880, DOI 10.1002/syn.21579; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Saulin A, 2012, AMINO ACIDS, V42, P2039, DOI 10.1007/s00726-011-1078-9; Serdons K, 2009, METHODS, V48, P104, DOI 10.1016/j.ymeth.2009.03.010; Serdons K, 2009, J MED CHEM, V52, P1428, DOI 10.1021/jm8013376; Shao X, 2011, J LABELLED COMPD RAD, V54, P292, DOI 10.1002/jlcr.1865; Siuciak JA, 2007, NEUROPHARMACOLOGY, V52, P279, DOI 10.1016/j.neuropharm.2006.07.024; SUEHIRO M, 1991, NUCL MED BIOL, V18, P791; Teare H, 2007, CHEM COMMUN, P2330, DOI 10.1039/b701177f; Teare H, 2010, ANGEW CHEM INT EDIT, V49, P6821, DOI 10.1002/anie.201002310; Wang JL, 2005, CURR TOP MED CHEM, V5, P1053, DOI 10.2174/156802605774297056	49	62	67	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59187	10.1371/journal.pone.0059187	http://dx.doi.org/10.1371/journal.pone.0059187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554994	Green Submitted, Green Published, gold			2022-12-25	WOS:000316252500072
J	Webb, EA; O'Reilly, MA; Clayden, JD; Seunarine, KK; Dale, N; Salt, A; Clark, CA; Dattani, MT				Webb, Emma A.; O'Reilly, Michelle A.; Clayden, Jonathan D.; Seunarine, Kiran K.; Dale, Naomi; Salt, Alison; Clark, Chris A.; Dattani, Mehul T.			Reduced Ventral Cingulum Integrity and Increased Behavioral Problems in Children with Isolated Optic Nerve Hypoplasia and Mild to Moderate or No Visual Impairment	PLOS ONE			English	Article							DIFFUSION-TENSOR; WHITE-MATTER; SPATIAL STATISTICS; CORPUS-CALLOSUM; AUTISM; SPECTRUM; ABNORMALITIES; DISORDER; AXONS	Objectives: To assess the prevalence of behavioral problems in children with isolated optic nerve hypoplasia, mild to moderate or no visual impairment, and no developmental delay. To identify white matter abnormalities that may provide neural correlates for any behavioral abnormalities identified. Patients and Methods: Eleven children with isolated optic nerve hypoplasia (mean age 5.9 years) underwent behavioral assessment and brain diffusion tensor imaging, Twenty four controls with isolated short stature (mean age 6.4 years) underwent MRI, 11 of whom also completed behavioral assessments. Fractional anisotropy images were processed using tract-based spatial statistics. Partial correlation between ventral cingulum, corpus callosum and optic radiation fractional anisotropy, and child behavioral checklist scores (controlled for age at scan and sex) was performed. Results: Children with optic nerve hypoplasia had significantly higher scores on the child behavioral checklist (p<0.05) than controls (4 had scores in the clinically significant range). Ventral cingulum, corpus callosum and optic radiation fractional anisotropy were significantly reduced in children with optic nerve hypoplasia. Right ventral cingulum fractional anisotropy correlated with total and externalising child behavioral checklist scores (r = -0.52, p < 0.02, r = -0.46, p < 0.049 respectively). There were no significant correlations between left ventral cingulum, corpus callosum or optic radiation fractional anisotropy and behavioral scores. Conclusions: Our findings suggest that children with optic nerve hypoplasia and mild to moderate or no visual impairment require behavioral assessment to determine the presence of clinically significant behavioral problems. Reduced structural integrity of the ventral cingulum correlated with behavioral scores, suggesting that these white matter abnormalities may be clinically significant. The presence of reduced fractional anisotropy in the optic radiations of children with mild to moderate or no visual impairment raises questions as to the pathogenesis of these changes which will need to be addressed by future studies.	[Webb, Emma A.; Dattani, Mehul T.] Univ Coll London Inst Child Hlth, Clin & Mol Genet Unit, Dev Endocrinol Res Grp, London, England; [O'Reilly, Michelle A.; Dale, Naomi; Salt, Alison] UCL Inst Child Hlth, Neurosci Unit, London, England; [O'Reilly, Michelle A.; Dale, Naomi; Salt, Alison] Great Ormond St Childrens Hosp, Dev Vis Clin, London, England; [Clayden, Jonathan D.; Seunarine, Kiran K.; Clark, Chris A.] Univ Coll London Inst Child Hlth, Imaging & Biophys Unit, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Dattani, MT (corresponding author), Univ Coll London Inst Child Hlth, Clin & Mol Genet Unit, Dev Endocrinol Res Grp, London, England.	m.dattani@ucl.ac.uk	Clayden, Jonathan D/C-1894-2008	Clayden, Jonathan D/0000-0002-6608-0619; Dale, Naomi/0000-0003-2195-1430	Child Growth Foundation; Novo Nordisk Ltd.; Great Ormond Street Children's Charity; Great Ormond Street Hospital Childrens Charity [V1255] Funding Source: researchfish	Child Growth Foundation; Novo Nordisk Ltd.(Novo Nordisk); Great Ormond Street Children's Charity; Great Ormond Street Hospital Childrens Charity	This study was sponsored by The Child Growth Foundation and an unrestricted educational grant from Novo Nordisk Ltd. EAW and MOR are sponsored by The Child Growth Foundation and an unrestricted educational grant from Novo Nordisk Ltd. MTD is funded by Great Ormond Street Children's Charity. JC, KS, AS, ND and CC have nothing to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018652; Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Althoff RR, 2010, PSYCHOL ASSESSMENT, V22, P609, DOI 10.1037/a0019699; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Cannistraro PA, 2007, DEPRESS ANXIETY, V24, P440, DOI 10.1002/da.20246; Ek U, 2005, ACTA PAEDIATR, V94, P1421, DOI 10.1080/08035250510037290; Fontenelle Leonardo F, 2009, Top Magn Reson Imaging, V20, P291, DOI 10.1097/RMR.0b013e3181e8f22c; Garcia ML, 2006, J CHILD NEUROL, V21, P949, DOI 10.2310/7010.2006.00241; Hobson RP, 1999, J AUTISM DEV DISORD, V29, P45; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jan J.E., 1977, VISUAL IMPAIRMENT CH; Kelberman D, 2007, PITUITARY, V10, P393, DOI 10.1007/s11102-007-0055-5; KOESTER SE, 1994, J NEUROSCI, V14, P6608; Kumar A, 2009, CEREB CORTEX; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; MARGALITH D, 1984, DEV MED CHILD NEUROL, V26, P311, DOI 10.1111/j.1469-8749.1984.tb04447.x; Nakata Y, 2009, AM J NEURORADIOL, V30, P1142, DOI 10.3174/ajnr.A1527; Parr JR, 2010, DEV MED CHILD NEUROL, V52, P917, DOI 10.1111/j.1469-8749.2010.03664.x; Patel L, 2006, J PEDIATR-US, V148, P85, DOI 10.1016/j.jpeds.2005.07.031; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; Reef J, 2011, SOC PSYCH PSYCH EPID, V46, P1233, DOI 10.1007/s00127-010-0297-9; Reef J, 2010, J AM ACAD CHILD PSY, V49, P1117, DOI 10.1016/j.jaac.2010.08.002; Reynell J, 1979, MANUAL REYNELL ZINKI; Salmela MB, 2010, PEDIATR RADIOL, V40, P708, DOI 10.1007/s00247-009-1478-0; Schoth F, 2004, NEURORADIOLOGY, V46, P759, DOI 10.1007/s00234-004-1207-1; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sonksen PM, 2002, DEV MED CHILD NEUROL, V44, P782; Steinkuller PG, 1999, J AAPOS, V3, P26, DOI 10.1016/S1091-8531(99)70091-1; Sundaram SK, 2008, CEREB CORTEX, V18, P2659, DOI 10.1093/cercor/bhn031; Tadic V, 2010, J CHILD PSYCHOL PSYC, V51, P696, DOI 10.1111/j.1469-7610.2009.02200.x; Tirosh E, 1998, INT J REHABIL RES, V21, P63, DOI 10.1097/00004356-199803000-00006; Wang F, 2008, BRIT J PSYCHIAT, V193, P126, DOI 10.1192/bjp.bp.107.048793; Webb EA, 2012, BRAIN, V135, P216, DOI 10.1093/brain/awr305; Webb EA, 2010, EUR J HUM GENET, V18, P393, DOI 10.1038/ejhg.2009.125; Wechsler D., 2004, WISC 4 WECHSLER INTE, DOI 10.1037/t15174-000; Wechsler D., 2003, WECHSLER PRESCHOOL P, V4th ed	43	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59048	10.1371/journal.pone.0059048	http://dx.doi.org/10.1371/journal.pone.0059048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554967	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500062
J	Xie, X; Ma, YT; Yang, YN; Li, XM; Ma, X; Fu, ZY; Zheng, YY; Chen, BD; Liu, F				Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Zheng, Ying-Ying; Chen, Bang-Dang; Liu, Fen			CYP2C19 Phenotype, Stent Thrombosis, Myocardial Infarction, and Mortality in Patients with Coronary Stent Placement in a Chinese Population	PLOS ONE			English	Article							OF-FUNCTION POLYMORPHISM; CYTOCHROME-P450 2C19-ASTERISK-2 POLYMORPHISM; PLATELET REACTIVITY; CARDIOVASCULAR EVENTS; HEALTHY-SUBJECTS; ARTERY-DISEASE; ANTIPLATELET TREATMENT; CLOPIDOGREL TREATMENT; RESPONSE VARIABILITY; ACTIVE METABOLITE	Background: Several studies have indicated that CYP2C19 loss-of-function polymorphisms have a higher risk of stent thrombosis (ST) after percutaneous coronary interventions (PCIs). However, this association has not been investigated thoroughly in a Chinese population. In this study, we aimed to determine the effect of CYP2C19*2 and CYP2C19*3 loss-of-function polymorphisms on the occurrence of ST and other adverse clinical events in a Chinese population. Methods: We designed a cohort study among 1068 consecutive patients undergoing intracoronary stent implantation after preloading with 600 mg of clopidogrel. CYP2C19*2 and CYP2C19*3 were genotyped by using polymerase chain reaction-restriction fragment length polymorphism analysis. The adverse clinical events recorded were ST, death, myocardial infarction (MI), and bleeding events. The primary end point of the study was the incidence of cumulative ST within 1 year after PCI. The secondary end point was other adverse clinical outcomes 1 year after the procedure. Results: The cumulative 1-year incidence of ST was 0.88% in patients with extensive metabolizers (EMs) (CYP2C19*1/*1 genotype), 4.67% in patients with intermediate metabolizers (IMs) (CYP2C19*1/*2 or *1/*3 genotype), and 10.0% in patients with poor metabolizers (PMs) (CYP2C19*2/*2, *2/*3, or *3/*3 genotype) (P < 0.001). The one-year event-free survival was 97.8% in patients with EMs, 96.5% in patients with IMs, and 92.0% in patients with PMs (P = 0.014). Multivariate analysis confirmed the independent association of CYP2C19 loss-of-function allele carriage with ST (P = 0.009) and total mortality (P < 0.05). Conclusion: PM patients had an increased risk of ST, death, and MI after coronary stent placement in a Chinese population.	[Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Zheng, Ying-Ying] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Chen, Bang-Dang; Liu, Fen] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	myt-xj@163.com	xie, xiang/AAG-2128-2021		National Natural Science Foundation of China [81160017]; Urumqi City Science and Technology Projects [Y101310008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Urumqi City Science and Technology Projects	This study was funded by the National Natural Science Foundation of China (grant number 81160017) and the Urumqi City Science and Technology Projects (grant number Y101310008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bauer T, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4588; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Caraco Y, 2004, NEW ENGL J MED, V351, P2867, DOI 10.1056/NEJMe048278; Chen M, 2012, ATHEROSCLEROSIS, V220, P168, DOI 10.1016/j.atherosclerosis.2011.04.008; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Frere C, 2008, AM J CARDIOL, V101, P1088, DOI 10.1016/j.amjcard.2007.11.065; Fuchshuber-Moraes M, 2011, PHARMACOGENET GENOM, V21, P694, DOI 10.1097/FPC.0b013e328349daba; Galyavich AS, 2012, KARDIOLOGIYA, V52, P20; Giusti B, 2007, PHARMACOGENET GENOM, V17, P1057, DOI 10.1097/FPC.0b013e3282f1b2be; Harmsze AM, 2010, EUR HEART J, V31, P3046, DOI 10.1093/eurheartj/ehq321; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Luo Y, 2011, J INT MED RES, V39, P2012, DOI 10.1177/147323001103900548; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Montalescot G, 2009, EUR HEART J, V30, P2685, DOI 10.1093/eurheartj/ehp436; Ndrepepa G, 2012, CIRCULATION, V125, P1424, DOI 10.1161/CIRCULATIONAHA.111.060871; Oh IY, 2012, HEART, V98, P139, DOI 10.1136/hrt.2011.227272; Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Shi WX, 2004, WORLD J GASTROENTERO, V10, P1961, DOI 10.3748/wjg.v10.i13.463; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Tang Xiao-Fang, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P617; Tazaki J, 2012, J ATHEROSCLER THROMB, V19, P186, DOI 10.5551/jat.10009; Tello-Montoliu A, 2012, REV ESP CARDIOL, V65, P219, DOI [10.1016/j.rec.2011.07.012, 10.1016/j.recesp.2011.07.013]; Thygesen K, 2007, EUR HEART J, V28, P2525; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Umemura K, 2008, J THROMB HAEMOST, V6, P1439, DOI 10.1111/j.1538-7836.2008.03050.x; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055; Xie X, 2011, BLOOD PRESSURE, V20, P232, DOI 10.3109/08037051.2011.566244; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Yang YN, 2010, CLIN APPL THROMB-HEM, V16, P579, DOI 10.1177/1076029610364522; Yusuf S, 2001, NEW ENGL J MED, V345, P494	39	18	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59344	10.1371/journal.pone.0059344	http://dx.doi.org/10.1371/journal.pone.0059344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555019	Green Submitted, gold, Green Published			2022-12-25	WOS:000316252500082
J	Raymond, JA; Morgan-Kiss, R				Raymond, James A.; Morgan-Kiss, Rachael			Separate Origins of Ice-Binding Proteins in Antarctic Chlamydomonas Species	PLOS ONE			English	Article							SEA-ICE; GREEN-ALGA; LAKE	The green alga Chlamydomonas raudensis is an important primary producer in a number of ice-covered lakes and ponds in Antarctica. A C. raudensis isolate (UWO241) from Lake Bonney in the McMurdo Dry Valleys, like many other Antarctic algae, was found to secrete ice-binding proteins (IBPs), which appear to be essential for survival in icy environments. The IBPs of several Antarctic algae (diatoms, a prymesiophyte, and a prasinophyte) are similar to each other (here designated as type I IBPs) and have been proposed to have bacterial origins. Other IBPs (type II IBPs) that bear no resemblance to type I IBPs, have been found in the Antarctic Chlamydomonas sp. CCMP681, a putative snow alga, raising the possibility that chlamydomonad IBPs developed separately from the IBPs of other algae. To test this idea, we obtained the IBP sequences of C. raudensis UWO241 by sequencing the transcriptome. A large number of transcripts revealed no sequences resembling type II IBPs. Instead, many isoforms resembling type I IBPs were found, and these most closely matched a hypothetical protein from the bacterium Stigmatella aurantiaca. The sequences were confirmed to encode IBPs by the activity of a recombinant protein and by the matching of predicted and observed isoelectric points and molecular weights. Furthermore, a mesophilic sister species, C. raudensis SAG49.72, showed no ice-binding activity or PCR products from UWO241 IBP primers. These results confirm that algal IBPs are required for survival in icy habitats and demonstrate that they have diverse origins that are unrelated to the taxonomic positions of the algae. Last, we show that the C. raudensis UWO241 IBPs can change the structure of ice in a way that could increase the survivability of cells trapped in the ice.	[Raymond, James A.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Morgan-Kiss, Rachael] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University System of Ohio; Miami University	Raymond, JA (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	raymond@unlv.nevada.edu		Morgan-kiss, Rachael/0000-0003-4783-5358	University of Nevada Las Vegas; National Science Foundation Office of Polar Programs [0631659, 1056396]	University of Nevada Las Vegas; National Science Foundation Office of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was mainly funded with personal funds (JR) with laboratory resources provided by the University of Nevada Las Vegas. This work was supported in part by National Science Foundation Office of Polar Programs Grants 0631659 and 1056396 to RM-K. The funders other than the authors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer-Giraldi M, 2010, ENVIRON MICROBIOL, V12, P1041, DOI 10.1111/j.1462-2920.2009.02149.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Janech MG, 2006, J PHYCOL, V42, P410, DOI 10.1111/j.1529-8817.2006.00208.x; Koob DD, 1972, ANTARCTIC TERRESTRIA, P51; Krembs C, 2011, P NATL ACAD SCI USA, V108, P3653, DOI 10.1073/pnas.1100701108; Lambert JD, 2010, INTEGR COMP BIOL, V50, P768, DOI 10.1093/icb/icq121; MCKAY CP, 1985, NATURE, V313, P561, DOI 10.1038/313561a0; Morgan-Kiss R, 2002, BBA-BIOMEMBRANES, V1561, P251, DOI 10.1016/S0005-2736(02)00352-8; Morgan-Kiss RM, 2008, EXTREMOPHILES, V12, P701, DOI 10.1007/s00792-008-0176-4; Morgan-Kiss RM, 2005, J PHYCOL, V41, P791, DOI 10.1111/j.1529-8817.2005.04174.x; NEALE PJ, 1995, PLANT CELL PHYSIOL, V36, P253, DOI 10.1093/oxfordjournals.pcp.a078757; Pocock T, 2004, J PHYCOL, V40, P1138, DOI 10.1111/j.1529-8817.2004.04060.x; Pocock T, 2011, J EXP BOT, V62, P1169, DOI 10.1093/jxb/erq347; Priscu JC, 1998, SCIENCE, V280, P2095, DOI 10.1126/science.280.5372.2095; Raymond JA, 2001, CRYOBIOLOGY, V43, P63, DOI 10.1006/cryo.2001.2341; Raymond JA, 2000, ANTARCT SCI, V12, P418; Raymond JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035968; Raymond JA, 2009, J PHYCOL, V45, P130, DOI 10.1111/j.1529-8817.2008.00623.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang KW, 2009, P ROY SOC B-BIOL SCI, V276, P81, DOI 10.1098/rspb.2008.0598	21	19	21	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59186	10.1371/journal.pone.0059186	http://dx.doi.org/10.1371/journal.pone.0059186			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536869	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100128
J	Chambliss, AB; Wu, PH; Chen, WC; Sun, SX; Wirtz, D				Chambliss, Allison B.; Wu, Pei-Hsun; Chen, Wei-Chiang; Sun, Sean X.; Wirtz, Denis			Simultaneously defining cell phenotypes, cell cycle, and chromatin modifications at single-cell resolution	FASEB JOURNAL			English	Article						epigenetics; high-throughput; microscopy	HISTONE ACETYLATION; CANCER; EPIGENETICS; INHIBITORS; TUMOR	Heterogeneity of cellular phenotypes in asynchronous cell populations placed in the same biochemical and biophysical environment may depend on cell cycle and chromatin modifications; however, no current method can measure these properties at single-cell resolution simultaneously and in situ. Here, we develop, test, and validate a new microscopy assay that rapidly quantifies global acetylation on histone H3 and measures a wide range of cell and nuclear properties, including cell and nuclear morphology descriptors, cell-cycle phase, and F-actin content of thousands of cells simultaneously, without cell detachment from their substrate, at single-cell resolution. These measurements show that isogenic, isotypic cells of identical DNA content and the same cell-cycle phase can still display large variations in H3 acetylation and that these variations predict specific phenotypic variations, in particular, nuclear size and actin cytoskeleton content, but not cell shape. The dependence of cell and nuclear properties on cell-cycle phase is assessed without artifact-prone cell synchronization. To further demonstrate its versatility, this assay is used to quantify the complex interplay among cell cycle, epigenetic modifications, and phenotypic variations following pharmacological treatments affecting DNA integrity, cell cycle, and inhibiting chromatin-modifying enzymes.Chambliss, A. B., Wu, P.-H., Chen, W.-C., Sun, S. X., Wirtz, D. Simultaneously defining cell phenotypes, cell cycle, and chromatin modifications at single-cell resolution.	[Chambliss, Allison B.; Wu, Pei-Hsun; Chen, Wei-Chiang; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Chambliss, Allison B.; Wu, Pei-Hsun; Chen, Wei-Chiang; Sun, Sean X.; Wirtz, Denis] Johns Hopkins Univ, Phys Scioncol Ctr, Baltimore, MD 21218 USA; [Chambliss, Allison B.; Wu, Pei-Hsun; Chen, Wei-Chiang; Sun, Sean X.; Wirtz, Denis] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Sun, Sean X.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wirtz, D (corresponding author), Johns Hopkins Univ, 3400 N Charles St,NEB 116, Baltimore, MD 21218 USA.	wirtz@jhu.edu	Sun, Sean X/C-6755-2009; Sun, Sean/M-7208-2019	Sun, Sean X/0000-0002-9077-7088; Sun, Sean/0000-0002-9077-7088; Chambliss, Allison/0000-0002-0461-8137	U.S. National Institutes of Health [R01CA174388, U54CA143868]; Achievement Rewards for College Scientists (ARCS) Foundation fellowship; NATIONAL CANCER INSTITUTE [R01CA174388, U54CA143868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075305] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists (ARCS) Foundation fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Prof. Jonathan Licht (Northwestern University, Chicago, IL, USA) for fruitful conversations and Dr. Sean Hanlon (U. S. National Cancer Institute, Bethesda, MD, USA) for important suggestions and editing the manuscript. This work was supported by U.S. National Institutes of Health grants R01CA174388 and U54CA143868. A. B. C. is supported by an Achievement Rewards for College Scientists (ARCS) Foundation fellowship.	Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chang J, 2012, BRIT J CANCER, V106, P116, DOI 10.1038/bjc.2011.532; Chavez-Blanco A, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-22; Chen WC, 2013, INTEGR BIOL-UK, V5, P523, DOI 10.1039/c2ib20246h; Dasgupta AR, 2006, IEEE SPECTRUM, V43, P8; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; HEPPNER GH, 1984, CANCER RES, V44, P2259; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P2268, DOI 10.1073/pnas.71.6.2268; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Ronzoni S, 2005, CYTOM PART A, V66A, P52, DOI 10.1002/cyto.a.20151; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Wu PH, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015005; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615	22	20	20	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2667	2676		10.1096/fj.12-227108	http://dx.doi.org/10.1096/fj.12-227108			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23538711	Green Published			2022-12-25	WOS:000328841000016
J	Mastala, Y; Nyangulu, P; Banda, RV; Mhemedi, B; White, SA; Allain, TJ				Mastala, Yamikani; Nyangulu, Phempo; Banda, Rodrick V.; Mhemedi, Bongani; White, Sarah A.; Allain, Theresa J.			Vitamin D Deficiency in Medical Patients at a Central Hospital in Malawi: A Comparison with TB Patients from a Previous Study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; HYPOVITAMINOSIS D; HEART-FAILURE; DOUBLE-BLIND	Objectives: To determine the prevalence of vitamin D deficiency (VDD) in adult medical, non-tuberculous (non-TB) patients. To investigate associations with VDD. To compare the results with a similar study in TB patients at the same hospital. Design: Cross-sectional sample. Setting: Central hospital in Malawi. Participants: Adult non-TB patients (n = 157), inpatients and outpatients. Outcome Measures: The primary outcome was the prevalence of VDD. Potentially causal associations sought included nutritional status, in/outpatient status, HIV status, anti-retroviral therapy (ART) and, by comparison with a previous study, a diagnosis of tuberculosis (TB). Results: Hypovitaminosis D (<= 75 nmol/L) occurred in 47.8% (75/157) of patients, 16.6% (26/157) of whom had VDD (<= 50 nmol/L). None had severe VDD (<= 25 nmol/L). VDD was found in 22.8% (23/101) of in-patients and 5.4% (3/56) of outpatients. In univariable analysis in-patient status, ART use and low dietary vitamin D were significant predictors of VDD. VDD was less prevalent than in previously studied TB patients in the same hospital (68/161 = 42%). In multivariate analysis of the combined data set from both studies, having TB (OR 3.61, 95% CI 2.02-6.43) and being an in-patient (OR 2.70, 95% CI 1.46-5.01) were significant independent predictors of VDD. Conclusions: About half of adult medical patients without TB have suboptimal vitamin D status, which is more common in in-patients. VDD is much more common in TB patients than non-TB patients, even when other variables are controlled for, suggesting that vitamin D deficiency is associated with TB.	[Mastala, Yamikani; Nyangulu, Phempo; Banda, Rodrick V.; Mhemedi, Bongani; Allain, Theresa J.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [White, Sarah A.] Univ Malawi, Dept Community Hlth, Coll Med, Blantyre, Malawi	University of Malawi; University of Malawi	Allain, TJ (corresponding author), Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi.	theresa.allain@gmail.com		White, Sarah/0000-0001-5535-8075	College of Medicine	College of Medicine	Dr. Peter Davies made a personal donation to fund the vitamin D assay kits. The College of Medicine provided a small grant for purchase of consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2011, J CARDIOVASC PHARM T, V16, P354, DOI 10.1177/1074248410390214; Allavena C, 2012, J ANTIMICROB CHEMOTH, V67, P2222, DOI 10.1093/jac/dks176; Arabi A, 2010, NAT REV ENDOCRINOL, V6, P550, DOI 10.1038/nrendo.2010.146; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; CROWLE AJ, 1987, INFECT IMMUN, V55, P2945, DOI 10.1128/IAI.55.12.2945-2950.1987; DAVIES PDO, 1985, TUBERCLE, V66, P301, DOI 10.1016/0041-3879(85)90068-6; Elamin M, 2012, J CLIN ENDOCR METAB, V96, P1931; Friis H, 2008, J NUTR, V138, P2474, DOI 10.3945/jn.108.094979; Gotsman I, 2012, EUR J HEART FAIL, V14, P357, DOI 10.1093/eurjhf/hfr175; Ho-Pham LT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-306; Holick MF, 2010, ENDOCRIN METAB CLIN, V39, P381, DOI [10.1016/j.rdc.2012.03.013, 10.1016/j.ecl.2010.02.016]; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; Martineau AR, 2012, P NUTR SOC, V71, P84, DOI 10.1017/S0029665111003326; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Mehmedi B, 2010, INT J TUBERC LUNG D, V15, P408; Michos ED, 2012, NUTRITION, V28, P367, DOI 10.1016/j.nut.2011.10.015; Nansera D, 2011, INT J TUBERC LUNG D, V15, P1522, DOI 10.5588/ijtld.10.0701; Nursyam Elly Wijaya, 2006, Acta Med Indones, V38, P3; Sun Q, 2012, STROKE, V43, P1470, DOI 10.1161/STROKEAHA.111.636910; Van Den Bout-Van Den Beukel CJP, 2008, AIDS RES HUM RETROV, V24, P1375, DOI 10.1089/aid.2008.0058; Wejse C, 2007, AM J CLIN NUTR, V86, P1376, DOI 10.1093/ajcn/86.5.1376; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; YANG SL, 1993, ARCH BIOCHEM BIOPHYS, V303, P98, DOI 10.1006/abbi.1993.1260	24	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59017	10.1371/journal.pone.0059017	http://dx.doi.org/10.1371/journal.pone.0059017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555614	Green Submitted, Green Published, gold			2022-12-25	WOS:000317262200009
J	Nakagami, F; Koriyama, H; Nakagami, H; Osako, MK; Shimamura, M; Kyutoku, M; Miyake, T; Katsuya, T; Rakugi, H; Morishita, R				Nakagami, Futoshi; Koriyama, Hiroshi; Nakagami, Hironori; Osako, Mariana Kiomy; Shimamura, Munehisa; Kyutoku, Mariko; Miyake, Takashi; Katsuya, Tomohiro; Rakugi, Hiromi; Morishita, Ryuichi			Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice	PLOS ONE			English	Article							EXPERIMENTAL RENAL HYPERTENSION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ALZHEIMERS-DISEASE; ACTIVE IMMUNIZATION; BETA PEPTIDE; A-BETA; RENIN; PATHOGENESIS; RATS; IMMUNOGENICITY	Vaccines have been recently developed to treat various diseases such as cancer, rheumatoid arthritis and Alzheimer's disease in addition to infectious diseases. However, before use in the clinical setting, vaccines targeting self-antigens must be demonstrated to be effective and safe, evoking an adequate humoral immune response from B cells while avoiding T cell activation in response to self. Although the vaccine targeting angiotensin II (Ang II) is efficient in rodents and humans, little is known regarding the immunological activation and safety of the vaccine. In this study, we evaluated the efficiency and safety of an Ang II peptide vaccine in mice. Immunization with Ang II conjugated to keyhole limpet hemocyanin (KLH) successfully induced the production of anti-Ang II antibody, which blocked Ang II signaling in human aortic smooth muscle cells. However, Ang II itself did not activate T cells, as assessed by the proliferation and lymphokine production of T cells in immunized mice, whereas KLH activated T cells. In an Ang II-infused model, the non-immunized mice showed high blood pressure (BP), whereas the immunized mice (Ang II-KLH) showed a significant decrease in systolic BP, accompanied by significant reductions in cardiac hypertrophy and fibrosis. Importantly, anti-Ang II antibody titer was not elevated even after the administration of large amounts of Ang II, indicating that Ang II itself boosted antibody production, most likely due to less activation of T cells. In addition, no accumulation of inflammatory cells was observed in immunized mice, because endogenous Ang II would not activate T cells after immunization with Ang II-KLH. Taken together, these data indicate that vaccines targeting Ang II might be effective to decrease high BP and prevent cardiovascular complications without severe side effects.	[Nakagami, Futoshi; Koriyama, Hiroshi; Osako, Mariana Kiomy; Kyutoku, Mariko; Katsuya, Tomohiro; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Nakagami, Futoshi; Koriyama, Hiroshi; Osako, Mariana Kiomy; Rakugi, Hiromi] Osaka Univ, Dept Geriatr Med, Grad Sch Med, Suita, Osaka, Japan; [Nakagami, Hironori; Shimamura, Munehisa; Miyake, Takashi] Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Nakagami, H (corresponding author), Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Suita, Osaka, Japan.	nakagami@gts.med.osaka-u.ac.jp; morishita@cgt.med.osaka-u.ac.jp	Nakagami, Hironori/GLU-0570-2022; Osako, Mariana Kiomy/AGX-6892-2022; Osako, Mariana/G-2853-2013; Osako, Mariana Kiomy/H-3337-2019	Nakagami, Hironori/0000-0003-4494-3601; Osako, Mariana Kiomy/0000-0002-5021-8433; Rakugi, Hiromi/0000-0001-6508-4338	Japan Society for the Promotion of Science (JSPS); Japan Science and Technology Agency (JST)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was partially supported by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) and Adaptive and Seamless Technology Transfer Program (A-step) by from Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanyan MG, 2005, J IMMUNOL, V174, P1580, DOI 10.4049/jimmunol.174.3.1580; Ambuhl PM, 2007, J HYPERTENS, V25, P63, DOI 10.1097/HJH.0b013e32800ff5d6; Brown MT, 2004, ECOL MODEL, V178, P1, DOI 10.1016/j.ecolmodel.2003.12.001; Broytman O, 2004, J NEUROSCI RES, V75, P301, DOI 10.1002/jnr.10876; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; Delavallee L, 2010, SWISS MED WKLY, V140, P28, DOI 10.4414/smw.2010.13108; DEODHAR SD, 1964, J EXP MED, V119, P425, DOI 10.1084/jem.119.3.425; Dillman RO, 2011, CANCER BIOTHER RADIO, V26, P1, DOI 10.1089/cbr.2010.0902; Downham MR, 2003, BRIT J CLIN PHARMACO, V56, P505, DOI 10.1046/j.1365-2125.2003.01926.x; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; FRANK MH, 1963, CIRC RES, V12, P241, DOI 10.1161/01.RES.12.3.241; Gardiner SM, 2000, BRIT J PHARMACOL, V129, P1178, DOI 10.1038/sj.bjp.0703178; Gualtierotti R, 2010, AUTOIMMUN REV, V10, P3, DOI 10.1016/j.autrev.2010.09.007; Harding P, 2011, AM J PHYSIOL-HEART C, V300, pH1053, DOI 10.1152/ajpheart.00772.2010; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; HELMER OM, 1958, CIRCULATION, V17, P648, DOI 10.1161/01.CIR.17.4.648; KATZ JI, 1957, CIRC RES, V5, P137, DOI 10.1161/01.RES.5.2.137; MICHEL JB, 1990, CIRCULATION, V81, P1899, DOI 10.1161/01.CIR.81.6.1899; MICHEL JB, 1987, P NATL ACAD SCI USA, V84, P4346, DOI 10.1073/pnas.84.12.4346; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Plescia O J, 1969, Curr Top Microbiol Immunol, V50, P78; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Saito Y, 2006, CIRCULATION, V114, P1177, DOI 10.1161/CIRCULATIONAHA.105.602953; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; SKEGGS LT, 1975, CIRC RES, V37, P715, DOI 10.1161/01.RES.37.6.715; Thomas LJ, 2009, HUM VACCINES, V5, P79, DOI 10.4161/hv.5.2.6521; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; WAKERLIN GE, 1958, CIRCULATION, V17, P653, DOI 10.1161/01.CIR.17.4.653; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Yip HC, 1999, J IMMUNOL, V162, P3942	35	35	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60493	10.1371/journal.pone.0060493	http://dx.doi.org/10.1371/journal.pone.0060493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544146	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700105
J	Wei, T; Ou, B; Li, JB; Zhao, Y; Guo, DS; Zhu, YY; Chen, ZL; Gu, HY; Li, CY; Qin, GJ; Qu, LJ				Wei, Tong; Ou, Bin; Li, Jinbin; Zhao, Yang; Guo, Dongshu; Zhu, Youyong; Chen, Zhangliang; Gu, Hongya; Li, Chengyun; Qin, Genji; Qu, Li-Jia			Transcriptional Profiling of Rice Early Response to Magnaporthe oryzae Identified OsWRKYs as Important Regulators in Rice Blast Resistance	PLOS ONE			English	Article							DISEASE RESISTANCE; FUNCTIONAL-ANALYSIS; PROTEOMIC ANALYSIS; EXPRESSION; DEFENSE; ARABIDOPSIS; GENES; FLAGELLIN; INFECTION; REVEALS	Rice blast disease is a major threat to rice production worldwide, but the mechanisms underlying rice resistance to the causal agent Magnaporthe oryzae remain elusive. Therefore, we carried out a transcriptome study on rice early defense response to M. oryzae. We found that the transcriptional profiles of rice compatible and incompatible interactions with M oryzae were mostly similar, with genes regulated more prominently in the incompatible interactions. The functional analysis showed that the genes involved in signaling and secondary metabolism were extensively up-regulated. In particular, WRKY transcription factor genes were significantly enriched among the up-regulated genes. Overexpressing one of these WRKY genes, OsWRKY47, in transgenic rice plants conferred enhanced resistance against rice blast fungus. Our results revealed the sophisticated transcriptional reprogramming of signaling and metabolic pathways during rice early response to M. oryzae and demonstrated the critical roles of WRKY transcription factors in rice blast resistance.	[Wei, Tong; Ou, Bin; Zhao, Yang; Guo, Dongshu; Chen, Zhangliang; Gu, Hongya; Qin, Genji; Qu, Li-Jia] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Li, Jinbin] Yunnan Acad Agr Sci, Agr Environm & Resources Res Inst, Kunming, Peoples R China; [Zhao, Yang] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Zhu, Youyong; Li, Chengyun] Yunnan Agr Univ, Coll Agron, Kunming, Peoples R China; [Zhu, Youyong; Li, Chengyun] Yunnan Agr Univ, Key Lab Plant Pathol Yunnan Prov, Kunming, Peoples R China; [Chen, Zhangliang] China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Gu, Hongya; Qu, Li-Jia] Natl Plant Gene Res Ctr, Beijing, Peoples R China	Peking University; Yunnan Academy of Agricultural Sciences; China Agricultural University; Yunnan Agricultural University; Yunnan Agricultural University; China Agricultural University	Li, CY (corresponding author), Yunnan Agr Univ, Coll Agron, Kunming, Peoples R China.	chengyun@public.km.yn.cn; qingenji@pku.edu.cn; qulj@pku.edu.cn	Wei, Tong/F-5007-2010	Wei, Tong/0000-0002-2692-7192; Guo, Dongshu/0000-0002-1706-2318	National Transgenic Research Project [2011ZX08009-003-001-003]	National Transgenic Research Project	This work was supported by the National Transgenic Research Project (Grant No. 2011ZX08009-003-001-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhuiyan NH, 2009, J EXP BOT, V60, P509, DOI 10.1093/jxb/ern290; Caldo RA, 2004, PLANT CELL, V16, P2514, DOI 10.1105/tpc.104.023382; Chen XW, 2011, TRENDS PLANT SCI, V16, P451, DOI 10.1016/j.tplants.2011.04.003; Chen YH, 2006, J INTEGR PLANT BIOL, V48, P1084, DOI 10.1111/j.1744-7909.2006.00311.x; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Dardick C, 2007, PLANT PHYSIOL, V143, P579, DOI 10.1104/pp.106.087270; Delteil A, 2012, MOL PLANT PATHOL, V13, P72, DOI 10.1111/j.1364-3703.2011.00731.x; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Feng JX, 2011, EUR J PLANT PATHOL, V131, P221, DOI 10.1007/s10658-011-9801-7; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gowda M, 2007, PLANT PHYSIOL, V144, P524, DOI 10.1104/pp.107.095653; Hahne F, 2008, USE R, P193, DOI 10.1007/978-0-387-77240-0_13; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jantasuriyarat C, 2005, PLANT PHYSIOL, V138, P105, DOI 10.1104/pp.104.055624; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003337; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kim ST, 2004, PROTEOMICS, V4, P3569, DOI 10.1002/pmic.200400999; Kruger WM, 2002, PHYSIOL MOL PLANT P, V61, P41, DOI 10.1016/S0885-5765(02)90415-7; Li JinBin, 2005, Acta Phytophylacica Sinica, V32, P113; Liu JJ, 2008, PLANT CELL, V20, P1538, DOI 10.1105/tpc.108.059741; Liu JL, 2010, MOL PLANT PATHOL, V11, P419, DOI [10.1111/J.1364-3703.2009.00607.X, 10.1111/j.1364-3703.2009.00607.x]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAHER EA, 1994, P NATL ACAD SCI USA, V91, P7802, DOI 10.1073/pnas.91.16.7802; Morillo SA, 2006, CURR OPIN PLANT BIOL, V9, P460, DOI 10.1016/j.pbi.2006.07.009; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Parker D, 2009, PLANT J, V59, P723, DOI 10.1111/j.1365-313X.2009.03912.x; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ryu HS, 2009, PLANT BIOTECHNOL REP, V3, P167, DOI 10.1007/s11816-009-0087-6; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Seo YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002020; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sugano S, 2010, PLANT MOL BIOL, V74, P549, DOI 10.1007/s11103-010-9695-3; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Tao Z, 2009, PLANT PHYSIOL, V151, P936, DOI 10.1104/pp.109.145623; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Vergne E, 2007, NEW PHYTOL, V174, P159, DOI 10.1111/j.1469-8137.2007.01971.x; Wise RP, 2007, ANNU REV PHYTOPATHOL, V45, P329, DOI 10.1146/annurev.phyto.45.011107.143944; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Yang XY, 2007, PLANT CELL REP, V26, P219, DOI 10.1007/s00299-006-0229-z; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhao Y, 2012, NEW PHYTOL, V195, P450, DOI 10.1111/j.1469-8137.2012.04160.x; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	72	70	80	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59720	10.1371/journal.pone.0059720	http://dx.doi.org/10.1371/journal.pone.0059720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544090	Green Submitted, Green Published, gold			2022-12-25	WOS:000317480700050
J	Leggett, RM; Ramirez-Gonzalez, RH; Verweij, W; Kawashima, CG; Iqbal, Z; Jones, JDG; Caccamo, M; MacLean, D				Leggett, Richard M.; Ramirez-Gonzalez, Ricardo H.; Verweij, Walter; Kawashima, Cintia G.; Iqbal, Zamin; Jones, Jonathan D. G.; Caccamo, Mario; MacLean, Daniel			Identifying and Classifying Trait Linked Polymorphisms in Non-Reference Species by Walking Coloured de Bruijn Graphs	PLOS ONE			English	Article							NOVO; ALIGNMENT	Single Nucleotide Polymorphisms are invaluable markers for tracing the genetic basis of inheritable traits and the ability to create marker libraries quickly is vital for timely identification of target genes. Next-generation sequencing makes it possible to sample a genome rapidly, but polymorphism detection relies on having a reference genome to which reads can be aligned and variants detected. We present Bubbleparse, a method for detecting variants directly from next-generation reads without a reference sequence. Bubbleparse uses the de Bruijn graph implementation in the Cortex framework as a basis and allows the user to identify bubbles in these graphs that represent polymorphisms, quickly, easily and sensitively. We show that the Bubbleparse algorithm is sensitive and can detect many polymorphisms quickly and that it performs well when compared with polymorphism detection methods based on alignment to a reference in Arabidopsis thaliana. We show that the heuristic can be used to maximise the number of true polymorphisms returned, and with a proof-of-principle experiment show that Bubbleparse is very effective on data from unsequenced wild relatives of potato and enabled us to identify disease resistance linked genes quickly and easily.	[Leggett, Richard M.; Verweij, Walter; Kawashima, Cintia G.; Jones, Jonathan D. G.; MacLean, Daniel] Sainsbury Lab, Norwich, Norfolk, England; [Ramirez-Gonzalez, Ricardo H.; Caccamo, Mario] Genome Anal Ctr, Norwich, Norfolk, England; [Iqbal, Zamin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; The Genome Analysis Centre (TGAC); University of Oxford; Wellcome Centre for Human Genetics	MacLean, D (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	dan.maclean@tsl.ac.uk	Ramírez, Ricardo/H-4808-2019; Jones, Jonathan DG/J-5129-2012; MacLean, Dan/C-7046-2013	Ramírez, Ricardo/0000-0001-5745-7085; Jones, Jonathan DG/0000-0002-4953-261X; Iqbal, Zamin/0000-0001-8466-7547; Leggett, Richard/0000-0003-3044-4297; MacLean, Dan/0000-0003-1032-0887	Two Blades Foundation; Gatsby Charitable Foundation; BBSRC; BBSRC [BB/G02197X/1]; Biotechnology and Biological Sciences Research Council [BB/I023798/1, BB/H018697/1] Funding Source: researchfish; BBSRC [BBS/E/T/000PR5885, BB/H018697/1, BBS/E/T/000PR6193, BB/I023798/1] Funding Source: UKRI	Two Blades Foundation; Gatsby Charitable Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding sources: The Two Blades Foundation - http://2blades.org; The Gatsby Charitable Foundation - http://www.gatsby.org.uk; BBSRC - http://www.bbsrc.ac.uk and BBSRC grant BB/G02197X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Peterlongo P, 2010, LECT NOTES COMPUT SC, V6393, P147, DOI 10.1007/978-3-642-16321-0_14; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Rauscher GM, THEOR APPL GENET, V112, P674; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	12	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60058	10.1371/journal.pone.0060058	http://dx.doi.org/10.1371/journal.pone.0060058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536903	Green Published, gold, Green Submitted			2022-12-25	WOS:000317397200051
J	Bocedi, A; De Sanctis, G; Ciaccio, C; Tundo, GR; Di Masi, A; Fanali, G; Nicoletti, FP; Fasano, M; Smulevich, G; Ascenzi, P; Coletta, M				Bocedi, Alessio; De Sanctis, Giampiero; Ciaccio, Chiara; Tundo, Grazia R.; Di Masi, Alessandra; Fanali, Gabriella; Nicoletti, Francesco P.; Fasano, Mauro; Smulevich, Giulietta; Ascenzi, Paolo; Coletta, Massimo			Reciprocal Allosteric Modulation of Carbon Monoxide and Warfarin Binding to Ferrous Human Serum Heme-Albumin	PLOS ONE			English	Article							DRUG-BINDING; CRYSTAL-STRUCTURE; LIGAND-BINDING; FATTY-ACIDS; CRYSTALLOGRAPHIC ANALYSIS; ENZYMATIC-PROPERTIES; HUMAN HEMALBUMIN; ATOMIC-STRUCTURE; STRUCTURAL BASIS; NO DISSOCIATION	Human serum albumin (HSA), the most abundant protein in human plasma, could be considered as a prototypic monomeric allosteric protein, since the ligand-dependent conformational adaptability of HSA spreads beyond the immediate proximity of the binding site(s). As a matter of fact, HSA is a major transport protein in the bloodstream and the regulation of the functional allosteric interrelationships between the different binding sites represents a fundamental information for the knowledge of its transport function. Here, kinetics and thermodynamics of the allosteric modulation: (i) of carbon monoxide (CO) binding to ferrous human serum heme-albumin (HSA-heme-Fe(II)) by warfarin (WF), and (ii) of WF binding to HSA-heme-Fe(II) by CO are reported. All data were obtained at pH 7.0 and 25 degrees C. Kinetics of CO and WF binding to the FA1 and FA7 sites of HSA-heme-Fe(II), respectively, follows a multi-exponential behavior (with the same relative percentage for the two ligands). This can be accounted for by the existence of multiple conformations and/or heme-protein axial coordination forms of HSA-heme-Fe(II). The HSA-heme-Fe(II) populations have been characterized by resonance Raman spectroscopy, indicating the coexistence of different species characterized by four-, five-and six-coordination of the heme-Fe atom. As a whole, these results suggest that: (i) upon CO binding a conformational change of HSA-heme-Fe(II) takes place (likely reflecting the displacement of an endogenous ligand by CO), and (ii) CO and/or WF binding brings about a ligand-dependent variation of the HSA-heme-Fe(II) population distribution of the various coordinating species. The detailed thermodynamic and kinetic analysis here reported allows a quantitative description of the mutual allosteric effect of CO and WF binding to HSA-heme-Fe(II).	[Bocedi, Alessio; Ciaccio, Chiara; Tundo, Grazia R.; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [De Sanctis, Giampiero] Univ Camerino, Dept Mol Cellular & Anim Biol, I-62032 Camerino, MC, Italy; [Tundo, Grazia R.; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, Bari, Italy; [Di Masi, Alessandra; Ascenzi, Paolo] Univ Roma Tre, Dept Biol & Interdept Lab Electron Microscop, Rome, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Dept Struct & Funct Biol, Busto Arsizio, VA, Italy; [Nicoletti, Francesco P.; Smulevich, Giulietta] Univ Firenze, Dept Chem Ugo Schiff, Sesto Fiorentino, FI, Italy	University of Rome Tor Vergata; University of Camerino; Roma Tre University; University of Insubria; University of Florence	Coletta, M (corresponding author), Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy.	coletta@seneca.uniroma2.it	di Masi, Alessandra/K-2300-2018; Coletta, Massimiliano/GSN-5927-2022; Coletta, Massimo/N-9049-2015; Fasano, Mauro/A-7100-2008	Fasano, Mauro/0000-0003-0628-5871; TUNDO, Grazia Raffaella/0000-0002-3866-3171; Smulevich, Giulietta/0000-0003-3021-8919; COLETTA, Massimiliano/0000-0002-5489-9467				Adam SS, 2012, ANN INTERN IN PRESS; Ahmad E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038372; Ahmad E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026186; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Ascenzi P, 2006, MINI-REV MED CHEM, V6, P483, DOI 10.2174/138955706776361448; Ascenzi P, 2005, BIOCHEM MOL BIOL EDU, V33, P169, DOI 10.1002/bmb.2005.494033032470; Ascenzi P, 2005, BIOCHEM BIOPH RES CO, V334, P481, DOI 10.1016/j.bbrc.2005.06.127; Ascenzi P, 2008, BIOCHEM BIOPH RES CO, V369, P686, DOI 10.1016/j.bbrc.2008.02.077; Ascenzi P, 2007, BIOCHEM BIOPH RES CO, V353, P469, DOI 10.1016/j.bbrc.2006.12.041; Ascenzi P, 2010, BIOPHYS CHEM, V148, P16, DOI 10.1016/j.bpc.2010.03.001; Ascenzi P, 2009, IUBMB LIFE, V61, P1118, DOI 10.1002/iub.263; Ascenzi P, 2009, BIOCHEM BIOPH RES CO, V387, P83, DOI 10.1016/j.bbrc.2009.06.117; Baroni S, 2001, EUR J BIOCHEM, V268, P6214, DOI 10.1046/j.0014-2956.2001.02569.x; Bertucci C, 2002, CURR MED CHEM, V9, P1463, DOI 10.2174/0929867023369673; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bocedi A, 2005, FEBS J, V272, P6287, DOI 10.1111/j.1742-4658.2005.05015.x; Boffi A, 1999, BIOPHYS J, V77, P1143, DOI 10.1016/S0006-3495(99)76965-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabrera-Crespo J, 2000, BIOTECHNOL APPL BIOC, V31, P101, DOI 10.1042/BA19990095; Cao Y, 2012, J BIOL INORG CHEM, V17, P133, DOI 10.1007/s00775-011-0837-0; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CHEN RF, 1967, J BIOL CHEM, V242, P173; Chuang VTG, 2002, PHARMACEUT RES, V19, P1458, DOI 10.1023/A:1020496314081; Ciaccio C, 2008, IUBMB LIFE, V60, P112, DOI 10.1002/iub.6; Coletta M, 1996, EUR J BIOCHEM, V235, P49, DOI 10.1111/j.1432-1033.1996.00049.x; COLETTA M, 1985, J BIOL CHEM, V260, P4151; Curry S, 2002, VOX SANG, V83, P315, DOI 10.1111/j.1423-0410.2002.tb05326.x; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; DIANA FJ, 1989, J PHARM SCI-US, V78, P195, DOI 10.1002/jps.2600780304; Dockal M, 2000, PROTEIN SCI, V9, P1455, DOI 10.1110/ps.9.8.1455; Fanali G, 2005, FEBS J, V272, P4672, DOI 10.1111/j.1742-4658.2005.04883.x; Fanali G, 2007, FEBS J, V274, P4491, DOI 10.1111/j.1742-4658.2007.05978.x; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fanali G, 2009, FEBS J, V276, P2241, DOI 10.1111/j.1742-4658.2009.06952.x; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Fasano M, 2001, J BIOL INORG CHEM, V6, P650, DOI 10.1007/s007750100242; Fasano M, 2007, IUBMB LIFE, V59, P436, DOI 10.1080/15216540701474523; Fasano Mauro, 2008, V9, P121; Fitos I, 1999, CHIRALITY, V11, P115, DOI 10.1002/(SICI)1520-636X(1999)11:2<115::AID-CHIR6>3.0.CO;2-R; Fitos I, 2002, CHIRALITY, V14, P442, DOI 10.1002/chir.10113; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Gullotta F, 2012, IUBMB LIFE, V64, P378, DOI 10.1002/iub.1015; Gullotta F, 2012, BIOFACTORS, V38, P1, DOI 10.1002/biof.192; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; JANSSEN LHM, 1981, BIOCHIM BIOPHYS ACTA, V669, P244, DOI 10.1016/0005-2795(81)90247-6; Kamal JKA, 2002, J BIOL INORG CHEM, V7, P273, DOI 10.1007/s007750100294; Komatsu T, 2005, J AM CHEM SOC, V127, P15933, DOI 10.1021/ja054819u; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Kragh-Hansen U, 2006, J MOL BIOL, V363, P702, DOI 10.1016/j.jmb.2006.08.056; Minchiotti L, 2008, HUM MUTAT, V29, P1007, DOI 10.1002/humu.20754; Monzani E, 2001, BBA-PROTEIN STRUCT M, V1547, P302, DOI 10.1016/S0167-4838(01)00192-3; Nicoletti FP, 2008, J AM CHEM SOC, V130, P11677, DOI 10.1021/ja800966t; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2003, P NATL ACAD SCI USA, V100, P6440, DOI 10.1073/pnas.1137188100; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; RAY GB, 1994, J AM CHEM SOC, V116, P162, DOI 10.1021/ja00080a019; Sakurai Y, 2004, PHARM RES-DORDR, V21, P285, DOI 10.1023/B:PHAM.0000016241.84630.06; Simard JR, 2006, J MOL BIOL, V361, P336, DOI 10.1016/j.jmb.2006.06.028; SOGAMI M, 1968, BIOCHEMISTRY-US, V7, P2172, DOI 10.1021/bi00846a020; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Vogel KM, 2000, INORG CHIM ACTA, V297, P11, DOI 10.1016/S0020-1693(99)00253-4; Wardell M, 2002, BIOCHEM BIOPH RES CO, V291, P813, DOI 10.1006/bbrc.2002.6540; WILTING J, 1980, J BIOL CHEM, V255, P3032; Yamasaki K, 1999, BBA-PROTEIN STRUCT M, V1432, P313, DOI 10.1016/S0167-4838(99)00098-9; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016; Zunszain Patricia A, 2003, BMC Struct Biol, V3, P6, DOI 10.1186/1472-6807-3-6	70	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58842	10.1371/journal.pone.0058842	http://dx.doi.org/10.1371/journal.pone.0058842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555601	Green Submitted, Green Published, gold			2022-12-25	WOS:000316546400013
J	Kolpas, A; Busch, M; Li, H; Couzin, ID; Petzold, L; Moehlis, J				Kolpas, Allison; Busch, Michael; Li, Hong; Couzin, Iain D.; Petzold, Linda; Moehlis, Jeff			How the Spatial Position of Individuals Affects Their Influence on Swarms: A Numerical Comparison of Two Popular Swarm Dynamics Models	PLOS ONE			English	Article							COLLECTIVE BEHAVIOR; SELF-ORGANIZATION; FISH; INFORMATION; SCHOOLS	Schools of fish and flocks of birds are examples of self-organized animal groups that arise through social interactions among individuals. We numerically study two individual-based models, which recent empirical studies have suggested to explain self-organized group animal behavior: (i) a zone-based model where the group communication topology is determined by finite interacting zones of repulsion, attraction, and orientation among individuals; and (ii) a model where the communication topology is described by Delaunay triangulation, which is defined by each individual's Voronoi neighbors. The models include a tunable parameter that controls an individual's relative weighting of attraction and alignment. We perform computational experiments to investigate how effectively simulated groups transfer information in the form of velocity when an individual is perturbed. A cross-correlation function is used to measure the sensitivity of groups to sudden perturbations in the heading of individual members. The results show how relative weighting of attraction and alignment, location of the perturbed individual, population size, and the communication topology affect group structure and response to perturbation. We find that in the Delaunay-based model an individual who is perturbed is capable of triggering a cascade of responses, ultimately leading to the group changing direction. This phenomenon has been seen in self-organized animal groups in both experiments and nature.	[Kolpas, Allison] West Chester Univ Penn, Dept Math, W Chester, PA USA; [Busch, Michael; Petzold, Linda; Moehlis, Jeff] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA; [Li, Hong; Petzold, Linda] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Couzin, Iain D.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Princeton University	Kolpas, A (corresponding author), West Chester Univ Penn, Dept Math, W Chester, PA USA.	AKolpas@wcupa.edu	Kolpas, Allison/AAG-7071-2020; Couzin, Iain D./Q-6862-2018	Kolpas, Allison/0000-0003-0551-6957; Couzin, Iain D./0000-0001-8556-4558	Institute for Collaborative Biotechnologies from the U.S. Army Research Office [W911NF-09-0001]; National Science Foundation [PHY-0848755]; Office of Naval Research [N00014-09-1-1074]; Army Research Office [W911NG-11-1-0385]	Institute for Collaborative Biotechnologies from the U.S. Army Research Office; National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Army Research Office	This work was partially supported by the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office. The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. This work was also supported by National Science Foundation Grant PHY-0848755, Office of Naval Research Award N00014-09-1-1074, and Army Research Office Grant W911NG-11-1-0385 (to IDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AURENHAMMER F, 1991, COMPUT SURV, V23, P345, DOI 10.1145/116873.116880; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Camazine S., 2003, SELF ORG BIOL SYSTEM; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Couzin ID, 2007, NATURE, V445; Driver P. M., 1988, PROTEAN BEHAV BIOL U; Du Q, 1999, SIAM REV, V41, P637, DOI 10.1137/S0036144599352836; Gerlotto F, 2006, ICES J MAR SCI, V63, P1405, DOI 10.1016/j.icesjms.2006.04.023; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Kolpas A, 2008, THESIS U CALIFORNIA; Kolpas A, 2007, P NATL ACAD SCI USA, V104, P5931, DOI 10.1073/pnas.0608270104; KRAUSE J, 1993, OECOLOGIA, V93, P356, DOI 10.1007/BF00317878; Krause J, 2002, LIVING GROUPS; Li H, 2009, CONCURR COMP-PRACT E, V21, P725, DOI 10.1002/cpe.1330; MARTINEZ D R, 1970, Zeitschrift fuer Tierpsychologie, V27, P828; MAY RM, 1979, NATURE, V282, P778, DOI 10.1038/282778a0; NEILL SRS, 1974, J ZOOL, V172, P549, DOI 10.1111/j.1469-7998.1974.tb04385.x; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; PARTRIDGE BL, 1982, SCI AM, V246, P114, DOI 10.1038/scientificamerican0682-114; Pillot MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014487; PITCHER TJ, 1976, SCIENCE, V194, P963, DOI 10.1126/science.982056; Radakov D. V., 1973, SCH ECOLOGY FISH; Ristroph L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.194502; Sinclair A.R.E., 1979, SERENGETI DYNAMICS E; Tunstrom K, 2012, COLLECTIVE IN PRESS; UVAROV BP, 1928, GRASSHOPPERS LOCUSTS; WEIHS D, 1973, NATURE, V241, P290, DOI 10.1038/241290a0; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670; WITKIN SR, 1977, CONDOR, V79, P490, DOI 10.2307/1367730	36	22	22	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58525	10.1371/journal.pone.0058525	http://dx.doi.org/10.1371/journal.pone.0058525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555585	Green Published, Green Submitted, gold			2022-12-25	WOS:000316546400007
J	Shen, ZQ; Han, J; Wang, Y; Sahin, O; Zhang, QJ				Shen, Zhangqi; Han, Jing; Wang, Yang; Sahin, Orhan; Zhang, Qijing			The Contribution of ArsB to Arsenic Resistance in Campylobacter jejuni	PLOS ONE			English	Article							ESCHERICHIA-COLI; AS(III) METALLOCHAPERONE; SINORHIZOBIUM-MELILOTI; NUCLEOTIDE-SEQUENCE; REGULATORY PROTEIN; GENOME SEQUENCE; OPERON HOMOLOG; POULTRY LITTER; ANION PUMP; DETOXIFICATION	Arsenic, a toxic metalloid, exists in the natural environment and its organic form is approved for use as a feed additive for animal production. As a major foodborne pathogen of animal origin, Campylobacter is exposed to arsenic selection pressure in the food animal production environments. Previous studies showed that Campylobacter isolates from poultry were highly resistant to arsenic compounds and a 4-gene operon (containing arsP, arsR, arsC, and acr3) was associated with arsenic resistance in Campylobacter. However, this 4-gene operon is only present in some Campylobacter isolates and other arsenic resistance mechanisms in C. jejuni have not been characterized. In this study, we determined the role of several putative arsenic resistance genes including arsB, arsC2, and arsR3 in arsenic resistance in C. jejuni and found that arsB, but not the other two genes, contributes to the resistance to arsenite and arsenate. Inactivation of arsB in C. jejuni resulted in 8- and 4-fold reduction in the MICs of arsenite and arsenate, respectively, and complementation of the arsB mutant restored the MIC of arsenite. Additionally, overexpression of arsB in C. jejuni 11168 resulted in a 16-fold increase in the MIC of arsenite. PCR analysis of C. jejuni isolates from different animals hosts indicated that arsB and acr3 (the 4-gene operon) are widely distributed in various C. jejuni strains, suggesting that Campylobacter requires at least one of the two genes for adaptation to arsenic-containing environments. These results identify ArsB as an alternative mechanism for arsenic resistance in C. jejuni and provide new insights into the adaptive mechanisms of Campylobacter in animal food production environments.	[Shen, Zhangqi; Han, Jing; Wang, Yang; Sahin, Orhan; Zhang, Qijing] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; [Wang, Yang] China Agr Univ, Coll Vet Med, Dept Pharmacol & Toxicol, Beijing 100094, Peoples R China	Iowa State University; China Agricultural University	Zhang, QJ (corresponding author), Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.	zhang123@iastate.edu	Wang, Yang/ABD-5983-2021; Shen, Zhangqi/HCI-5736-2022; Zhang, Qijing/B-7530-2012	Wang, Yang/0000-0002-5928-9377; Shen, Zhangqi/0000-0003-4789-7540; Sahin, Orhan/0000-0003-0262-4581	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK063008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063008] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by grant number R01DK063008 from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajees AA, 2011, BIOMETALS, V24, P391, DOI 10.1007/s10534-010-9398-x; Basu A, 2001, MUTAT RES-REV MUTAT, V488, P171, DOI 10.1016/S1383-5742(01)00056-4; Butcher BG, 2000, APPL ENVIRON MICROB, V66, P1826, DOI 10.1128/AEM.66.5.1826-1833.2000; Butcher BG, 2002, MICROBIOL-SGM, V148, P3983, DOI 10.1099/00221287-148-12-3983; Cai J, 1998, MICROBIOL-SGM, V144, P2705, DOI 10.1099/00221287-144-10-2705; Chapman HD, 2002, POULTRY SCI, V81, P356, DOI 10.1093/ps/81.3.356; CHEN CM, 1986, J BIOL CHEM, V261, P5030; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; DIORIO C, 1995, J BACTERIOL, V177, P2050, DOI 10.1128/jb.177.8.2050-2056.1995; Flora SJS, 2011, FREE RADICAL BIO MED, V51, P257, DOI 10.1016/j.freeradbiomed.2011.04.008; FRANCISCO MJDS, 1989, MOL MICROBIOL, V3, P15, DOI 10.1111/j.1365-2958.1989.tb00098.x; Garbarino JR, 2003, ENVIRON SCI TECHNOL, V37, P1509, DOI 10.1021/es026219q; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Jackson BP, 2003, J ENVIRON QUAL, V32, P535, DOI 10.2134/jeq2003.0535; JI GY, 1992, J BACTERIOL, V174, P3684, DOI 10.1128/JB.174.11.3684-3694.1992; JI GY, 1992, P NATL ACAD SCI USA, V89, P9474, DOI 10.1073/pnas.89.20.9474; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin J, 2005, J BACTERIOL, V187, P7417, DOI 10.1128/JB.187.21.7417-7424.2005; Lin YF, 2006, P NATL ACAD SCI USA, V103, P15617, DOI 10.1073/pnas.0603974103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Maury L, 2003, J BACTERIOL, V185, P5363, DOI 10.1128/JB.185.18.5363-5371.2003; Mattew A, 2006, M2A9 CLSI; Muraoka WT, 2011, J BACTERIOL, V193, P1065, DOI 10.1128/JB.01252-10; Murphy JN, 2009, J BACTERIOL, V191, P6722, DOI 10.1128/JB.00801-09; Neyt C, 1997, J BACTERIOL, V179, P612, DOI 10.1128/jb.179.3.612-619.1997; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; ROSENSTEIN R, 1994, MOL GEN GENET, V242, P566, DOI 10.1007/BF00285280; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Saltikov CW, 2003, APPL ENVIRON MICROB, V69, P2800, DOI 10.1128/AEM.69.5.2800-2809.2003; Saltikov CW, 2002, APPL ENVIRON MICROB, V68, P280, DOI 10.1128/AEM.68.1.280-288.2002; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Suzuki K, 1998, APPL ENVIRON MICROB, V64, P411; TISA LS, 1990, J BIOL CHEM, V265, P190; Tuffin IM, 2005, MICROBIOL-SGM, V151, P3027, DOI 10.1099/mic.0.28131-0; Wang LP, 2009, APPL ENVIRON MICROB, V75, P5064, DOI 10.1128/AEM.00149-09; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; Wosten MMSM, 1998, J BACTERIOL, V180, P594; WU J, 1991, MOL MICROBIOL, V5, P1331, DOI 10.1111/j.1365-2958.1991.tb00779.x; WU JH, 1992, J BIOL CHEM, V267, P12570; Yang HC, 2005, J BACTERIOL, V187, P6991, DOI 10.1128/JB.187.20.6991-6997.2005; Yang JB, 2010, BIOCHEMISTRY-US, V49, P3658, DOI 10.1021/bi100026a; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Ye J, 2007, FEBS LETT, V581, P3996, DOI 10.1016/j.febslet.2007.07.039; Zhang YB, 2009, ANTON LEEUW INT J G, V96, P161, DOI 10.1007/s10482-009-9313-z	50	16	17	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58894	10.1371/journal.pone.0058894	http://dx.doi.org/10.1371/journal.pone.0058894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554953	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800045
J	Wang, SQ; He, JZ				Wang, Shanquan; He, Jianzhong			Phylogenetically Distinct Bacteria Involve Extensive Dechlorination of Aroclor 1260 in Sediment-Free Cultures	PLOS ONE			English	Article							MICROBIAL REDUCTIVE DECHLORINATION; POLYCHLORINATED BIPHENYL CONGENER; ANAEROBIC MICROORGANISMS; IN-SITU; DEHALOGENATION; IDENTIFICATION; POPULATION; SOILS; META; PCBS	Microbial reductive dechlorination of the persistent polychlorinated biphenyls (PCBs) is attracting much attention in cleanup of the contaminated environment. Nevertheless, most PCB dechlorinating cultures require presence of sediment or sediment substitutes to maintain their dechlorination activities which hinders subsequent bacterial enrichment and isolation processes. The information on enriching sediment-free PCB dechlorinating cultures is still limited. In this study, 18 microcosms established with soils and sediments were screened for their dechlorination activities on a PCB mixture Aroclor 1260. After one year of incubation, 10 out of 18 microcosms showed significant PCB dechlorination with distinct dechlorination patterns (e.g., Process H, N and T classified based on profiles of PCB congeners loss and new congeners formation). Through serial transfers in defined medium, six sediment-free PCB dechlorinating cultures (i.e., CW-4, CG-1, CG-3, CG-4, CG-5 and SG-1) were obtained without amending any sediment or sediment-substitutes. PCB dechlorination Process H was the most frequently observed dechlorination pattern, which was found in four sediment-free cultures (CW-4, CG-3, CG-4 and SG-1). Sediment-free culture CG-5 showed the most extensive PCB dechlorination among the six cultures, which was mediated by Process N, resulting in the accumulation of penta-(e.g., 236-24-CB) and tetra-chlorobiphenyls (tetra-CBs) (e.g., 24-24-CB, 24-25-CB, 24-26-CB and 25-26-CB) via dechlorinating 30.44% hepta-CBs and 59.12% hexa-CBs after three months of incubation. For culture CG-1, dechlorinators mainly attacked double flanked meta-chlorines and partially ortho-chlorines, which might represent a novel dechlorination pattern. Phylogenetic analysis showed distinct affiliation of PCB dechlorinators in the microcosms, including Dehalogenimonas and Dehalococcoides species. This study broadens our knowledge in microbial reductive dechlorination of PCBs, and provides essential information for culturing and stimulating PCB dechlorinators for in situ bioremediation applications.	[Wang, Shanquan; He, Jianzhong] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117548, Singapore	National University of Singapore	He, JZ (corresponding author), Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117548, Singapore.	jianzhong.he@nus.edu.sg	He, Jianzhong/J-2704-2018; WANG, Shanquan/Q-6455-2017	He, Jianzhong/0000-0003-1895-6628; WANG, Shanquan (Alan)/0000-0002-8491-9633; WANG, Shanquan/0000-0002-5880-5894	Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council [102 101 0025]	Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council(Agency for Science Technology & Research (A*STAR))	This study was supported by Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council under project number 102 101 0025 (http://www.a-star.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian L, 2009, APPL ENVIRON MICROB, V75, P4516, DOI 10.1128/AEM.00102-09; Agency for Toxic Substances and Disease Registry (ATSDR), 2000, TOX PROF POL BIPH UP; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bedard DL, 2006, APPL ENVIRON MICROB, V72, P2460, DOI 10.1128/AEM.72.4.2460-2470.2006; Bedard DL, 2003, DEHALOGENATION: MICROBIAL PROCESSES AND ENVIRONMENTAL APPLICATIONS, P443; Bedard DL, 1996, ENVIRON SCI TECHNOL, V30, P237, DOI 10.1021/es950262e; Bedard DL, 1998, APPL ENVIRON MICROB, V64, P1786; Bedard DL, 2008, ANNU REV MICROBIOL, V62, P253, DOI 10.1146/annurev.micro.62.081307.162733; Bedard DL, 2007, APPL ENVIRON MICROB, V73, P2513, DOI 10.1128/AEM.02909-06; Bedard Donna L., 1997, Environmental Science and Technology, V31, P3308, DOI 10.1021/es9703483; Berkaw M, 1996, APPL ENVIRON MICROB, V62, P2534, DOI 10.1128/AEM.62.7.2534-2539.1996; Beyer A, 2009, REV ENVIRON CONTAM T, V201, P137, DOI 10.1007/978-1-4419-0032-6_5; BOYLE AW, 1993, APPL ENVIRON MICROB, V59, P3027, DOI 10.1128/AEM.59.9.3027-3031.1993; BROWN J F JR, 1984, Northeastern Environmental Science, V3, P167; BROWN JF, 1990, ENVIRON TOXICOL CHEM, V9, P1215, DOI 10.1002/etc.5620091001; BROWN JF, 1987, SCIENCE, V236, P709, DOI 10.1126/science.236.4802.709; Chen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030862; Chow WL, 2010, ISME J, V4, P1020, DOI 10.1038/ismej.2010.27; Chu SG, 2004, ANAL CHEM, V76, P5486, DOI 10.1021/ac049526i; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLE JR, 1994, APPL ENVIRON MICROB, V60, P3536, DOI 10.1128/AEM.60.10.3536-3542.1994; Cutter L, 1998, APPL ENVIRON MICROB, V64, P2966; Cutter LA, 2001, ENVIRON MICROBIOL, V3, P699, DOI 10.1046/j.1462-2920.2001.00246.x; Davis JA, 2007, ENVIRON RES, V105, P67, DOI 10.1016/j.envres.2007.01.013; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Ding C, 2013, APPL ENVIRON MICROB, V79, P1110, DOI 10.1128/AEM.02919-12; Ding C, 2012, MICROB BIOTECHNOL, V5, P347, DOI 10.1111/j.1751-7915.2011.00313.x; Fagervold SK, 2007, APPL ENVIRON MICROB, V73, P3009, DOI 10.1128/AEM.02958-06; Fennell DE, 2004, ENVIRON SCI TECHNOL, V38, P2075, DOI 10.1021/es034989b; Field JA, 2008, ENVIRON POLLUT, V155, P1, DOI 10.1016/j.envpol.2007.10.016; Gomes HI, 2013, SCI TOTAL ENVIRON, V445, P237, DOI 10.1016/j.scitotenv.2012.11.098; Grimalt JO, 2004, CHEMOSPHERE, V54, P1549, DOI 10.1016/j.chemosphere.2003.09.047; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HartkampCommandeur LCM, 1996, CHEMOSPHERE, V32, P1275, DOI 10.1016/0045-6535(96)00039-2; He JZ, 2006, ENVIRON SCI TECHNOL, V40, P4429, DOI 10.1021/es052508d; He JZ, 2003, APPL ENVIRON MICROB, V69, P996, DOI 10.1128/AEM.69.2.996-1003.2003; Hong PY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009964; Loffler FE, 1997, APPL ENVIRON MICROB, V63, P2870, DOI 10.1128/AEM.63.7.2870-2875.1997; Loffler FE, 2006, CURR OPIN BIOTECH, V17, P274, DOI 10.1016/j.copbio.2006.05.001; May HD, 2008, APPL ENVIRON MICROB, V74, P2089, DOI 10.1128/AEM.01450-07; Moe WM, 2009, INT J SYST EVOL MICR, V59, P2692, DOI 10.1099/ijs.0.011502-0; Payne RB, 2011, ENVIRON SCI TECHNOL, V45, P8772, DOI 10.1021/es201553c; QUENSEN JF, 1988, SCIENCE, V242, P752, DOI 10.1126/science.242.4879.752; QUENSEN JF, 1990, APPL ENVIRON MICROB, V56, P2360, DOI 10.1128/AEM.56.8.2360-2369.1990; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Smullen LA, 1993, DEV CUSTOMIZED CONGE, P45; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VANDORT HM, 1991, APPL ENVIRON MICROB, V57, P1576, DOI 10.1128/AEM.57.5.1576-1578.1991; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang SQ, 2012, APPL MICROBIOL BIOT, V95, P1305, DOI 10.1007/s00253-012-4251-5; Weber R, 2000, ENVIRON SCI POLLUT R, V15, P363; Wiegel J, 2000, FEMS MICROBIOL ECOL, V32, P1, DOI 10.1111/j.1574-6941.2000.tb00693.x; Wu QZ, 2002, APPL ENVIRON MICROB, V68, P807, DOI 10.1128/AEM.68.2.807-812.2002; Wu QZ, 1997, APPL ENVIRON MICROB, V63, P4826, DOI 10.1128/AEM.63.12.4826-4832.1997; Wu QZ, 1998, APPL ENVIRON MICROB, V64, P1052; Wu QZ, 2000, APPL ENVIRON MICROB, V66, P49, DOI 10.1128/AEM.66.1.49-53.2000; Wu QZ, 1997, APPL ENVIRON MICROB, V63, P4818, DOI 10.1128/AEM.63.12.4818-4825.1997; Xing Y, 2005, CHEMOSPHERE, V60, P731, DOI 10.1016/j.chemosphere.2005.05.001; Yan J, 2009, ENVIRON MICROBIOL, V11, P833, DOI 10.1111/j.1462-2920.2008.01804.x; Yan J, 2009, APPL ENVIRON MICROB, V75, P7560, DOI 10.1128/AEM.01938-09; Ye L, 2011, ENVIRON SCI TECHNOL, V45, P7173, DOI 10.1021/es201045e; Yoshida N, 2009, APPL ENVIRON MICROB, V75, P2400, DOI 10.1128/AEM.02112-08; Zanaroli G, 2012, J HAZARD MATER, V209, P449, DOI 10.1016/j.jhazmat.2012.01.042	63	61	62	6	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59178	10.1371/journal.pone.0059178	http://dx.doi.org/10.1371/journal.pone.0059178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554991	Green Submitted, gold, Green Published			2022-12-25	WOS:000316409800066
J	Dann, SG; Golas, J; Miranda, M; Shi, C; Wu, J; Jin, G; Rosfjord, E; Upeslacis, E; Klippel, A				Dann, S. G.; Golas, J.; Miranda, M.; Shi, C.; Wu, J.; Jin, G.; Rosfjord, E.; Upeslacis, E.; Klippel, A.			p120 catenin is a key effector of a Ras-PKC epsilon oncogenic signaling axis	ONCOGENE			English	Article						protein kinase C; epithelial to mesenchymal transition; triple negative breast cancer; p120 catenin; drug discovery	PROTEIN-KINASE-C; BREAST-CANCER; CELL-GROWTH; E-CADHERIN; MESENCHYMAL TRANSITION; COMPLEX CONTROLS; GENE-EXPRESSION; PHOSPHORYLATION; P120-CATENIN; PROSTATE	Within the family of protein kinase C (PKC) molecules, the novel isoform PRKCE (PKC epsilon) acts as a bona fide oncogene in in vitro and in vivo models of tumorigenesis. Previous studies have reported expression of PKC epsilon in breast, prostate and lung tumors above that of normal adjacent tissue. Data from the cancer genome atlas suggest increased copy number of PRKCE in triple negative breast cancer (TNBC). We find that overexpression of PKC epsilon in a non-tumorigenic breast epithelial cell line is sufficient to overcome contact inhibition and results in the formation of cellular foci. Correspondingly, inhibition of PKC epsilon in a TNBC cell model results in growth defects in two-dimensional (2D) and three-dimensional (3D) culture conditions and orthotopic xenografts. Using stable isotope labeling of amino acids in a cell culture phosphoproteomic approach, we find that CTNND1/p120ctn phosphorylation at serine 268 (P-S268) occurs in a strictly PKC epsilon-dependent manner, and that loss of PKC epsilon signaling in TNBC cells leads to reversal of mesenchymal morphology and signaling. In a model of Ras activation, inhibition of PKC epsilon is sufficient to block mesenchymal cell morphology. Finally, treatment with a PKC epsilon ATP mimetic inhibitor, PF-5263555, recapitulates genetic loss of function experiments impairing p120ctn phosphorylation as well as compromising TNBC cell growth in vitro and in vivo. We demonstrate PKC epsilon as a tractable therapeutic target for TNBC, where p120ctn phosphorylation may serve as a readout for monitoring patient response.	[Dann, S. G.; Golas, J.; Miranda, M.; Shi, C.; Jin, G.; Rosfjord, E.; Upeslacis, E.; Klippel, A.] Pfizer Oncol Res Unit, Pearl River, NY 10965 USA; [Wu, J.] Pfizer Struct Biol & Biophys, Groton, CT USA	Pfizer; Pfizer	Dann, SG (corresponding author), Pfizer Oncol Res Unit, 401 N Middletown Rd, Pearl River, NY 10965 USA.	stephen.dann@pfizer.com		Rosfjord, Edward/0000-0002-3449-7444				Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; Benavides F, 2011, CELL CYCLE, V10, P268, DOI 10.4161/cc.10.2.14469; Bin Hafeez B, 2011, CANCER RES, V71, P2318, DOI 10.1158/0008-5472.CAN-10-4170; Brown MV, 2009, EXP CELL RES, V315, P39, DOI 10.1016/j.yexcr.2008.09.025; CACACE AM, 1993, ONCOGENE, V8, P2095; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng127; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Dohn MR, 2009, J CELL BIOL, V184, P437, DOI 10.1083/jcb.200807096; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Leask A, 2008, J CELL SCI, V121, P3459, DOI 10.1242/jcs.029215; Leenders F, 2004, EMBO J, V23, P3303, DOI 10.1038/sj.emboj.7600345; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Ozawa M, 2001, J CELL SCI, V114, P503; Paredes J, 2008, J CLIN PATHOL, V61, P856, DOI 10.1136/jcp.2007.052704; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prashad AS, 2009, BIOORG MED CHEM LETT, V19, P5799, DOI 10.1016/j.bmcl.2009.07.113; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shibata T, 2004, AM J PATHOL, V164, P2269, DOI 10.1016/S0002-9440(10)63783-2; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Sternberger M, 2002, ANTISENSE NUCLEIC A, V12, P131, DOI 10.1089/108729002760220734; Tuomi S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000135; WEINSTEIN IB, 1988, CANCER RES, V48, P4135; Wu J, 2007, J PROTEOME RES, V6, P4684, DOI 10.1021/pr070481m; Xia XB, 2006, EXP CELL RES, V312, P3336, DOI 10.1016/j.yexcr.2006.07.007; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	40	24	25	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2014	33	11					1385	1394		10.1038/onc.2013.91	http://dx.doi.org/10.1038/onc.2013.91			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD0SD	23542175				2022-12-25	WOS:000332943500006
J	Kim, HS; Caswell, CC; Foreman, R; Roop, RM; Crosson, S				Kim, Hye-Sook; Caswell, Clayton C.; Foreman, Robert; Roop, R. Martin, II; Crosson, Sean			The Brucella abortus General Stress Response System Regulates Chronic Mammalian Infection and Is Controlled by Phosphorylation and Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGMA-FACTOR MIMICRY; 2-COMPONENT SYSTEM; BACILLUS-SUBTILIS; STRUCTURAL BASIS; VIRULENCE; PHYR; MELITENSIS; MODEL; IDENTIFICATION; RECOGNITION	Brucella spp. are adept at establishing a chronic infection in mammals. We demonstrate that core components of the alpha-proteobacterial general stress response (GSR) system, PhyR and sigma(E1), are required for Brucella abortus stress survival in vitro and maintenance of chronic murine infection in vivo. Delta phyR and Delta rpoE1 null mutants exhibit decreased survival under acute oxidative and acid stress but are not defective in infection of primary murine macrophages or in initial colonization of BALB/c mouse spleens. However, Delta phyR and Delta rpoE1 mutants are attenuated in spleens beginning 1 month postinfection. Thus, the B. abortus GSR system is dispensable for colonization but is required to maintain chronic infection. A genome-scale analysis of the B. abortus GSR regulon identified stress response genes previously linked to virulence and genes that affect immunomodulatory components of the cell envelope. These data support a model in which the GSR system affects both stress survival and the interface between B. abortus and the host immune system. We further demonstrate that PhyR proteolysis is a unique feature of GSR control in B. abortus. Proteolysis of PhyR provides a mechanism to avoid spurious PhyR protein interactions that inappropriately activate GSR-dependent transcription. We conclude that the B. abortus GSR system regulates acute stress adaptation and long term survival within a mammalian host and that PhyR proteolysis is a novel regulatory feature in B. abortus that ensures proper control of GSR transcription.	[Kim, Hye-Sook; Crosson, Sean] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Kim, Hye-Sook; Foreman, Robert; Crosson, Sean] Argonne Natl Lab, Howard Taylor Ricketts Lab, Argonne, IL 60439 USA; [Caswell, Clayton C.; Roop, R. Martin, II] E Carolina Univ, Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA; [Foreman, Robert; Crosson, Sean] Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of North Carolina; East Carolina University; University of Chicago	Crosson, S (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St,GCIS W138, Chicago, IL 60637 USA.	scrosson@uchicago.edu	Crosson, Sean/AAE-2453-2022	Crosson, Sean/0000-0002-1727-322X	National Institutes of Health (NIH), NIAID, Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program (Region V "Great Lakes" RCE) [1U54AI057153]; NIH, NIAID [R01AI048499]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI048499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIAID, Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program (Region V "Great Lakes" RCE); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health (NIH), NIAID, Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program (Region V "Great Lakes" RCE; Grant 1U54AI057153) and NIH, NIAID, Grant R01AI048499.	Arenas GN, 2000, INFECT IMMUN, V68, P4255, DOI 10.1128/IAI.68.7.4255-4263.2000; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Bastiat B, 2010, J BACTERIOL, V192, P2255, DOI 10.1128/JB.01666-09; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Campagne S, 2012, P NATL ACAD SCI USA, V109, pE1405, DOI 10.1073/pnas.1117003109; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Delory M, 2006, J BACTERIOL, V188, P7707, DOI 10.1128/JB.00644-06; Endley S, 2001, J BACTERIOL, V183, P2454, DOI 10.1128/JB.183.8.2454-2462.2001; Ferooz J, 2011, MICROBIOL-SGM, V157, P1263, DOI 10.1099/mic.0.044875-0; Fiebig A, 2010, MOL MICROBIOL, V77, P236, DOI 10.1111/j.1365-2958.2010.07207.x; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Foreman R, 2012, J BACTERIOL, V194, P3038, DOI 10.1128/JB.00182-12; Francez-Charlot A, 2009, P NATL ACAD SCI USA, V106, P3467, DOI 10.1073/pnas.0810291106; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; GERHARDT P, 1958, BACTERIOL REV, V22, P81, DOI 10.1128/MMBR.22.2.81-98.1958; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Gourion B, 2008, J BACTERIOL, V190, P1027, DOI 10.1128/JB.01483-07; Gourion B, 2009, MOL MICROBIOL, V73, P291, DOI 10.1111/j.1365-2958.2009.06769.x; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Herrou J, 2012, P NATL ACAD SCI USA, V109, pE1415, DOI 10.1073/pnas.1116887109; Herrou J, 2010, MOL MICROBIOL, V78, P290, DOI 10.1111/j.1365-2958.2010.07323.x; Castano MJ, 2009, J CLIN MICROBIOL, V47, P2084, DOI 10.1128/JCM.02159-08; Kaczmarczyk A, 2011, J BACTERIOL, V193, P6629, DOI 10.1128/JB.06006-11; Kohler S, 2003, TRENDS MICROBIOL, V11, P215, DOI 10.1016/S0966-842X(03)00078-7; Lourenco RF, 2011, MOL MICROBIOL, V80, P1598, DOI 10.1111/j.1365-2958.2011.07668.x; Moreno E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P315, DOI 10.1007/0-387-30745-1_17; Naroeni A, 2001, INFECT IMMUN, V69, P486, DOI 10.1128/IAI.69.1.486-493.2001; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Robertson G. T., 2000, THESIS LOUISIANA STA; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Roop RM, 2004, MOL MICROBIOL, V52, P621, DOI 10.1111/j.1365-2958.2004.04017.x; Sangari FJ, 2007, INFECT IMMUN, V75, P774, DOI 10.1128/IAI.01244-06; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Solera J, 2010, INT J ANTIMICROB AG, V36, pS18, DOI 10.1016/j.ijantimicag.2010.06.015; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Steele KH, 2010, J BACTERIOL, V192, P4912, DOI 10.1128/JB.00231-10; Sun YH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00047; Terwagne M, 2013, CELL MICROBIOL, V15, P942, DOI 10.1111/cmi.12088; Ugalde JE, 2000, INFECT IMMUN, V68, P5716, DOI 10.1128/IAI.68.10.5716-5723.2000; Ugalde JE, 2003, INFECT IMMUN, V71, P6264, DOI 10.1128/IAI.71.11.6264-6269.2003; Vemulapalli TH, 2006, INFECT IMMUN, V74, P183, DOI 10.1128/IAI.74.1.183-191.2006; Zhang Y, 2007, J BACTERIOL, V189, P7669, DOI 10.1128/JB.00745-07	44	47	48	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13906	13916		10.1074/jbc.M113.459305	http://dx.doi.org/10.1074/jbc.M113.459305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23546883	Green Published, hybrid			2022-12-25	WOS:000318850300071
J	Van Itallie, CM; Aponte, A; Tietgens, AJ; Gucek, M; Fredriksson, K; Anderson, JM				Van Itallie, Christina M.; Aponte, Angel; Tietgens, Amber Jean; Gucek, Marjan; Fredriksson, Karin; Anderson, James Melvin			The N and C Termini of ZO-1 Are Surrounded by Distinct Proteins and Functional Protein Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION PROTEIN; CELL-ADHESION SITES; PDZ DOMAIN; E-CADHERIN; SEQUENCE SIMILARITY; BINDING PROTEIN; GENE-PRODUCT; ACTIN; POLARITY; MEMBRANE	The proteins and functional protein networks of the tight junction remain incompletely defined. Among the currently known proteins are barrier-forming proteins like occludin and the claudin family; scaffolding proteins like ZO-1; and some cytoskeletal, signaling, and cell polarity proteins. To define a more complete list of proteins and infer their functional implications, we identified the proteins that are within molecular dimensions of ZO-1 by fusing biotin ligase to either its N or C terminus, expressing these fusion proteins in Madin-Darby canine kidney epithelial cells, and purifying and identifying the resulting biotinylated proteins by mass spectrometry. Of a predicted proteome of similar to 9000, we identified more than 400 proteins tagged by biotin ligase fused to ZO-1, with both identical and distinct proteins near the N- and C-terminal ends. Those proximal to the N terminus were enriched in transmembrane tight junction proteins, and those proximal to the C terminus were enriched in cytoskeletal proteins. We also identified many unexpected but easily rationalized proteins and verified partial colocalization of three of these proteins with ZO-1 as examples. In addition, functional networks of interacting proteins were tagged, such as the basolateral but not apical polarity network. These results provide a rich inventory of proteins and potential novel insights into functions and protein networks that should catalyze further understanding of tight junction biology. Unexpectedly, the technique demonstrates high spatial resolution, which could be generally applied to defining other subcellular protein compartmentalization.	[Van Itallie, Christina M.; Tietgens, Amber Jean; Fredriksson, Karin; Anderson, James Melvin] NHLBI, Lab Tight Junct Struct & Funct, NIH, Bethesda, MD 20892 USA; [Aponte, Angel; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Van Itallie, CM (corresponding author), NHLBI, NIH, Bldg 50,Rm 45425,50 South Dr, Bethesda, MD 20892 USA.	Christina.vanitallie@nih.gov		Anderson, James/0000-0003-2765-7996	National Institutes of Health Division of Intramural Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005903, ZIAHL006176] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Division of Intramural Research.	Akashi M, 2011, BIOCHEM BIOPH RES CO, V413, P224, DOI 10.1016/j.bbrc.2011.08.073; Anastas JN, 2012, ONCOGENE, V31, P3696, DOI 10.1038/onc.2011.528; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BUTZ S, 1994, FEBS LETT, V355, P195, DOI 10.1016/0014-5793(94)01205-9; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Citi S, 2012, ANN NY ACAD SCI, V1257, P125, DOI 10.1111/j.1749-6632.2012.06506.x; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Cohen D, 2011, J CELL BIOL, V192, P525, DOI 10.1083/jcb.201007002; Cong WL, 2010, CURR BIOL, V20, P1408, DOI 10.1016/j.cub.2010.06.024; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dorfel MJ, 2009, ANN NY ACAD SCI, V1165, P69, DOI 10.1111/j.1749-6632.2009.04043.x; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Elbert M, 2006, MOL BIOL CELL, V17, P3345, DOI 10.1091/mbc.E06-03-0193; Etournay R, 2007, J CELL SCI, V120, P2838, DOI 10.1242/jcs.002568; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fletcher SJ, 2012, BIOL CELL, V104, P238, DOI 10.1111/boc.201100004; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gao L, 2002, GENE, V294, P99, DOI 10.1016/S0378-1119(02)00681-9; Giuliani C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000675; Gonzalez-Mariscal L, 2012, ANN NY ACAD SCI, V1257, P133, DOI 10.1111/j.1749-6632.2012.06537.x; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974; Huling JC, 2012, AM J PHYSIOL-RENAL, V302, pF401, DOI 10.1152/ajprenal.00457.2011; HULL BE, 1979, J CELL BIOL, V81, P67, DOI 10.1083/jcb.81.1.67; Ide N, 1999, ONCOGENE, V18, P7810, DOI 10.1038/sj.onc.1203153; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Ivanov AI, 2010, AM J PATHOL, V176, P134, DOI 10.2353/ajpath.2010.090220; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Katoh M, 2004, INT J ONCOL, V25, P535; Katsube T, 1998, J BIOL CHEM, V273, P29672, DOI 10.1074/jbc.273.45.29672; Kim Y, 2002, GENES CELLS, V7, P413, DOI 10.1046/j.1365-2443.2002.00524.x; Langton PF, 2009, CURR BIOL, V19, P1969, DOI 10.1016/j.cub.2009.10.027; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lee DBN, 2004, AM J PHYSIOL-RENAL, V287, pF481, DOI 10.1152/ajprenal.00175.2003; Lie PPY, 2009, FASEB J, V23, P2555, DOI 10.1096/fj.06-070573; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Luton F, 2004, MOL BIOL CELL, V15, P1134, DOI 10.1091/mbc.E03-10-0751; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Matsuda M, 2008, EXP CELL RES, V314, P939, DOI 10.1016/j.yexcr.2007.11.009; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Murase K, 2012, MED MOL MORPHOL, V45, P22, DOI 10.1007/s00795-010-0537-9; Muthuswamy SK, 2012, ANNU REV CELL DEV BI, V28, P599, DOI 10.1146/annurev-cellbio-092910-154244; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Nethe M, 2012, J CELL SCI, V125, P3430, DOI 10.1242/jcs.100925; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216; Ooshio T, 2004, J BIOL CHEM, V279, P31365, DOI 10.1074/jbc.M401957200; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Petit MM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-1; Rodgers LS, 2011, CYTOSKELETON, V68, P653, DOI 10.1002/cm.20547; Routhier EL, 2001, J BIOL CHEM, V276, P21670, DOI 10.1074/jbc.M101096200; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Sharma S, 2006, HUM MOL GENET, V15, P1972, DOI 10.1093/hmg/ddl120; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Stamatovic SM, 2012, MOL CELL BIOL, V32, P3414, DOI 10.1128/MCB.06678-11; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Utepbergenov DI, 2006, J BIOL CHEM, V281, P24671, DOI 10.1074/jbc.M512820200; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Walsh GS, 2011, DEVELOPMENT, V138, P3033, DOI 10.1242/dev.063842; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Yamazaki Y, 2008, BIOCHEMISTRY-US, V47, P5378, DOI 10.1021/bi8002567; Yap AS, 1998, J MEMBRANE BIOL, V163, P159, DOI 10.1007/s002329900380; Yates LL, 2013, DEV BIOL, V373, P267, DOI 10.1016/j.ydbio.2012.11.012; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	96	78	78	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13775	13788		10.1074/jbc.M113.466193	http://dx.doi.org/10.1074/jbc.M113.466193			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23553632	hybrid, Green Published			2022-12-25	WOS:000318850300059
J	Bottino, MC; Rosario, S; Grativol, C; Thiebaut, F; Rojas, CA; Farrineli, L; Hemerly, AS; Ferreira, PCG				Bottino, Mariana Carnavale; Rosario, Sabrina; Grativol, Clicia; Thiebaut, Flavia; Rojas, Cristian Antonio; Farrineli, Laurent; Hemerly, Adriana Silva; Gomes Ferreira, Paulo Cavalcanti			High-Throughput Sequencing of Small RNA Transcriptome Reveals Salt Stress Regulated MicroRNAs in Sugarcane	PLOS ONE			English	Article							GENE-EXPRESSION; COMPUTATIONAL IDENTIFICATION; RESPONSIVE MICRORNAS; ARABIDOPSIS; FAMILY; ROOTS; HOMEOSTASIS; ARGONAUTE1; TARGETS; MIRNAS	Salt stress is a primary cause of crop losses worldwide, and it has been the subject of intense investigation to unravel the complex mechanisms responsible for salinity tolerance. MicroRNA is implicated in many developmental processes and in responses to various abiotic stresses, playing pivotal roles in plant adaptation. Deep sequencing technology was chosen to determine the small RNA transcriptome of Saccharum sp cultivars grown on saline conditions. We constructed four small RNAs libraries prepared from plants grown on hydroponic culture submitted to 170 mM NaCl and harvested after 1 h, 6 hs and 24 hs. Each library was sequenced individually and together generated more than 50 million short reads. Ninety-eight conserved miRNAs and 33 miRNAs* were identified by bioinformatics. Several of the microRNA showed considerable differences of expression in the four libraries. To confirm the results of the bioinformatics-based analysis, we studied the expression of the 10 most abundant miRNAs and 1 miRNA* in Plants treated with 170 mM NaCl and in Plants with a severe treatment of 340 mM NaCl. The results showed that 11 selected miRNAs had higher expression in samples treated with severe salt treatment compared to the mild one. We also investigated the regulation of the same miRNAs in shoots of four cultivars grown on soil treated with 170 mM NaCl. Cultivars could be grouped according to miRNAs expression in response to salt stress. Furthermore, the majority of the predicted target genes had an inverse regulation with their correspondent microRNAs. The targets encode a wide range of proteins, including transcription factors, metabolic enzymes and genes involved in hormone signaling, probably assisting the plants to develop tolerance to salinity. Our work provides insights into the regulatory functions of miRNAs, thereby expanding our knowledge on potential salt-stressed regulated genes.	[Bottino, Mariana Carnavale; Rosario, Sabrina; Grativol, Clicia; Thiebaut, Flavia; Hemerly, Adriana Silva; Gomes Ferreira, Paulo Cavalcanti] Univ Fed Rio de Janeiro, Lab Biol Mol Plantas, Inst Bioquim Med, Rio De Janeiro, RJ, Brazil; [Rojas, Cristian Antonio] Univ Fed Integracao Latinoamer, Foz Do Iguacu, PR, Brazil; [Farrineli, Laurent] Fasteris SA, Plan Les Ouates, Switzerland	Universidade Federal do Rio de Janeiro; Universidade Federal da Integracao Latino-Americana	Ferreira, PCG (corresponding author), Univ Fed Rio de Janeiro, Lab Biol Mol Plantas, Inst Bioquim Med, Rio De Janeiro, RJ, Brazil.	paulof@bioqmed.ufrj.br	Ferreira, Paulo C G/I-2836-2015; Thiebaut, Flavia/AAU-5318-2021; Thiebaut, Flavia/B-3867-2018; Rojas, Cristian/X-1027-2018	Ferreira, Paulo C G/0000-0002-5510-999X; Thiebaut, Flavia/0000-0002-8833-1722; Rojas, Cristian/0000-0002-9085-6261; Grativol, Clicia/0000-0002-8873-701X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio (INCT); Financiadora de Estudos e Projetos (FINEP); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio (INCT); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors are grateful to Centro de Tecnologia Canavieira (CTC) for providing plant material from the drought experiment. Research is supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio (INCT), Financiadora de Estudos e Projetos (FINEP), Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Agarwal PK, 2012, MOL BIOTECHNOL; Azevedo R. A., 2011, Tropical Plant Biology, V4, P42, DOI 10.1007/s12042-011-9067-4; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beauclair L, 2010, PLANT J, V62, P454, DOI 10.1111/j.1365-313X.2010.04162.x; Choi D, 2004, PLANT CELL PHYSIOL, V45, P897, DOI 10.1093/pcp/pch098; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Debernardi JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002419; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; Esteves BS, 2008, OECOL BRAS, V4, P662, DOI DOI 10.4257/0EC0.2008.1204.06; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gao P, 2010, PLANTA, V231, P991, DOI 10.1007/s00425-010-1104-2; Gu RS, 2004, TREE PHYSIOL, V24, P265, DOI 10.1093/treephys/24.3.265; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P29; Irvine JE, 1999, THEOR APPL GENET, V98, P186, DOI 10.1007/s001220051057; Jeong DH, 2010, METHODS MOL BIOL, V592, P203, DOI 10.1007/978-1-60327-005-2_14; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Katiyar-Agarwal S, 2010, ANNU REV PHYTOPATHOL, V48, P225, DOI 10.1146/annurev-phyto-073009-114457; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kawashima CG, 2011, PLANT J, V66, P863, DOI 10.1111/j.1365-313X.2011.04547.x; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; L_auchli A., 2007, ADV MOL BREEDING DRO, P1, DOI DOI 10.1007/978-1-4020-5578-2_1; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Liang MX, 2006, PLANTA, V224, P1185, DOI 10.1007/s00425-006-0300-6; Liang MX, 2006, PLANT CELL ENVIRON, V29, P746, DOI 10.1111/j.1365-3040.2005.01435.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Lu C, 2010, METHODS MOL BIOL, V592, P107, DOI 10.1007/978-1-60327-005-2_8; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nogueira FTS, 2005, PLANT SCI, V169, P93, DOI 10.1016/j.plantsci.2005.03.008; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Pagariya MC, 2012, PLANT SCI, V184, P1, DOI 10.1016/j.plantsci.2011.12.002; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Schreiber L, 1999, J EXP BOT, V50, P1267, DOI 10.1093/jexbot/50.337.1267; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Suprasanna P, 2011, SUGAR TECH, V13, P322, DOI 10.1007/s12355-011-0103-3; Thiebaut F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-290; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Watt DA, 2003, J EXP BOT, V54, P1163, DOI 10.1093/jxb/erg128; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Yao DX, 2011, GENOMICS, V98, P47, DOI 10.1016/j.ygeno.2011.04.007; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang DF, 2008, PLANT SCI, V175, P809, DOI 10.1016/j.plantsci.2008.08.002; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang L, 2011, GENOMICS, V98, P460, DOI 10.1016/j.ygeno.2011.08.005; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	57	85	88	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59423	10.1371/journal.pone.0059423	http://dx.doi.org/10.1371/journal.pone.0059423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544066	Green Published, gold			2022-12-25	WOS:000317480700028
J	Chen, MH; Su, TP; Li, CT; Chang, WH; Chen, TJ; Bai, YM				Chen, Mu-Hong; Su, Tung-Ping; Li, Cheng-Ta; Chang, Wen-Han; Chen, Tzeng-Ji; Bai, Ya-Mei			Symptomatic Menopausal Transition Increases the Risk of New-Onset Depressive Disorder in Later Life: A Nationwide Prospective Cohort Study in Taiwan	PLOS ONE			English	Article							MIDLIFE WOMENS HEALTH; CHRONIC HEPATITIS-C; METABOLIC SYNDROME; CARDIOVASCULAR RISK; EARLY POSTMENOPAUSE; ASSOCIATION; HORMONES; MOOD; PREDICTORS; DISEASE	Introduction:The role of the menopausal transition and associated menopausal symptoms in the occurrence of depressive disorders has been discussed and debated for a long time. Most previous clinical studies had limited case samples, and did not control the attributable risk of medical comorbidities. Methods: Patients with a diagnosis of symptomatic menopausal transition and without a psychiatric history were enrolled in 2000 in Taiwan, and compared with age-matched controls (1:4). These subjects were followed to the end of 2010 to investigate the association between symptomatic menopausal transition and new-onset depressive disorder; the effect of medical comorbidities was also assessed. Results: A total of 5,837 women with symptomatic menopausal transition were identified, and compared with 23,348 age-matched controls in 2000. The follow-up showed that symptomatic menopausal transition was an independent risk factor for major depression (hazard ratio[HR]: 2.18, 95%CI: 1.79 similar to 2.65) and any depressive disorder (HR: 2.34, 95%CI: 2.08 similar to 2.63) after adjusting age at enrollment, monthly income, residence location, level of urbanization, and comorbid medical diseases. In addition, medical comorbidities, including cerebrovascular disease (HR: 1.77, 95% CI: 1.52 similar to 2.07), cardiovascular diseases (HR: 1.35, 95% CI: 1.15 similar to 1.57), congestive heart failure (HR: 1.35, 95% CI: 1.04 similar to 1.75), and liver diseases (HR: 1.19, 95% CI: 1.03 similar to 1.36) increased the risk of developing any depressive disorder. Conclusion:Our population cohort study, with the largest study sample and medical record diagnosis thus far, supports an association between symptomatic menopausal transition and depressive disorder in midlife women, and an increased risk of depressive disorder with medical comorbidities.	[Chen, Mu-Hong; Su, Tung-Ping; Li, Cheng-Ta; Chang, Wen-Han; Bai, Ya-Mei] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Su, Tung-Ping; Bai, Ya-Mei] Natl Yang Ming Univ, Coll Med, Dept Psychiat, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Li, Cheng-Ta] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Bai, YM (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	ymbi@mail2000.com.tw	Li, Cheng-Ta/AAI-5759-2021; Chen, TJ/AAH-8430-2021; Chen, MuHong/ACJ-6131-2022	Li, Cheng-Ta/0000-0002-0670-1153; Chen, MuHong/0000-0001-6516-1073	Taipei Veterans General Hospital [V101D-001-1]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	The study was supported by a grant from Taipei Veterans General Hospital (V101D-001-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri M, 2012, EUR J NEUROL, V19, P517, DOI 10.1111/j.1468-1331.2011.03583.x; Avis Nancy E., 1994, Annals of Epidemiology, V4, P214; Bosworth HB, 2001, PSYCHOSOM MED, V63, P603, DOI 10.1097/00006842-200107000-00013; Bromberger JT, 2011, PSYCHOL MED, V41, P1879, DOI 10.1017/S003329171100016X; Bromberger JT, 2009, PSYCHOL MED, V39, P55, DOI 10.1017/S0033291708003218; Bromberger JT, 2007, J AFFECT DISORDERS, V103, P267, DOI 10.1016/j.jad.2007.01.034; Bromberger JT, 2010, ARCH GEN PSYCHIAT, V67, P598, DOI 10.1001/archgenpsychiatry.2010.55; Bromberger JT, 2006, EVID-BASED MENT HEAL, V9, P110, DOI 10.1136/ebmh.9.4.110; Carta MG, 2012, J AFFECT DISORDERS, V141, P361, DOI 10.1016/j.jad.2012.03.020; Chae CU, 2011, OBSTET GYN CLIN N AM, V38, P477, DOI 10.1016/j.ogc.2011.05.005; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Codes L, 2007, GUT, V56, P390, DOI 10.1136/gut.2006.101931; Cohen LS, 2006, ARCH GEN PSYCHIAT, V63, P385, DOI 10.1001/archpsyc.63.4.385; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elwing JE, 2006, PSYCHOSOM MED, V68, P563, DOI 10.1097/01.psy.0000221276.17823.df; Freeman EW, 2006, ARCH GEN PSYCHIAT, V63, P375, DOI 10.1001/archpsyc.63.4.375; Freeman EW, 2004, ARCH GEN PSYCHIAT, V61, P62, DOI 10.1001/archpsyc.61.1.62; Frey Benicio N, 2008, Menopause Int, V14, P123, DOI 10.1258/mi.2008.008019; GOEMAERE S, 1990, J RHEUMATOL, V17, P1620; Graziottin Alessandra, 2009, Menopause Int, V15, P76, DOI 10.1258/mi.2009.009021; GREENDALE GA, 1993, J AM GERIATR SOC, V41, P426, DOI 10.1111/j.1532-5415.1993.tb06953.x; Greendale GA, 1999, LANCET, V353, P571, DOI 10.1016/S0140-6736(98)05352-5; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; Kaufert PA, 2008, MATURITAS, V61, P54, DOI 10.1016/j.maturitas.2008.09.009; Kok HS, 2006, J AM COLL CARDIOL, V47, P1976, DOI 10.1016/j.jacc.2005.12.066; Li CT, 2012, BRIT J PSYCHIAT, V200, P45, DOI 10.1192/bjp.bp.110.086983; Lin HL, 2013, CLIMACTERIC, V16, P381, DOI 10.3109/13697137.2012.707706; Lisabeth L, 2012, LANCET NEUROL, V11, P82, DOI 10.1016/S1474-4422(11)70269-1; Llaneza P, 2012, MATURITAS, V71, P120, DOI 10.1016/j.maturitas.2011.11.017; Marsh W BJ, 2011, N AM MEN SOC 22 ANN; Matthews KA, 2009, J AM COLL CARDIOL, V54, P2366, DOI 10.1016/j.jacc.2009.10.009; Mishra GD, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e402; Morrison MF, 2011, ARCH WOMEN MENT HLTH, V14, P375, DOI 10.1007/s00737-011-0231-5; Morrison MF, 2001, BIOL PSYCHIAT, V50, P705, DOI 10.1016/S0006-3223(01)01169-6; National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms, 2005, ANN INTERN MED 1, V142, P1003; Nelson HD, 2008, LANCET, V371, P760, DOI 10.1016/S0140-6736(08)60346-3; NIH State of the Science, 2005, NIH CONSENS STATE SC, V22, P1; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Ryan J, 2009, MENOPAUSE, V16, P509, DOI 10.1097/gme.0b013e31818d635f; Santoro N, 2005, J CLIN ENDOCR METAB, V90, P4836, DOI 10.1210/jc.2004-2063; Schmidt PJ, 2009, ANN NY ACAD SCI, V1179, P70, DOI 10.1111/j.1749-6632.2009.04982.x; Schmidt PJ, 2002, PSYCHONEUROENDOCRINO, V27, P907, DOI 10.1016/S0306-4530(02)00004-5; Siseles N, 2010, GYNECOL ENDOCRINOL, V26, P1, DOI 10.3109/09513590903080969; Vesco KK, 2007, CLIMACTERIC, V10, P448, DOI 10.1080/13697130701611267; Villa E, 2011, GASTROENTEROLOGY, V140, P818, DOI 10.1053/j.gastro.2010.12.027; Weinstein AA, 2011, PSYCHOSOMATICS, V52, P127, DOI 10.1016/j.psym.2010.12.019; Wise LA, 2002, J EPIDEMIOL COMMUN H, V56, P851, DOI 10.1136/jech.56.11.851; Woodard GA, 2011, MENOPAUSE, V18, P376, DOI 10.1097/gme.0b013e3181f6480e; Woods NF, 2008, MENOPAUSE, V15, P223, DOI 10.1097/gme.0b013e3181450fc2; Woods NF, 2007, J WOMENS HEALTH, V16, P667, DOI 10.1089/jwh.2006.0138; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064; Zuidersma M, 2012, PSYCHOL MED, V42, P683, DOI 10.1017/S0033291711001784	52	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59899	10.1371/journal.pone.0059899	http://dx.doi.org/10.1371/journal.pone.0059899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544108	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700068
J	Ferguson, AR; Irvine, KA; Gensel, JC; Nielson, JL; Lin, A; Ly, J; Segal, MR; Ratan, RR; Bresnahan, JC; Beattie, MS				Ferguson, Adam R.; Irvine, Karen-Amanda; Gensel, John C.; Nielson, Jessica L.; Lin, Amity; Ly, Johnathan; Segal, Mark R.; Ratan, Rajiv R.; Bresnahan, Jacqueline C.; Beattie, Michael S.			Derivation of Multivariate Syndromic Outcome Metrics for Consistent Testing across Multiple Models of Cervical Spinal Cord Injury in Rats	PLOS ONE			English	Article							NOGO-66 RECEPTOR ANTAGONIST; DELAYED TRANSPLANTATION; NEUROPROTECTIVE AGENT; LOCOMOTOR RECOVERY; CONTUSION; REASSESSMENT; METHYLPREDNISOLONE; MINOCYCLINE; AXONS; ERYTHROPOIETIN	Spinal cord injury (SCI) and other neurological disorders involve complex biological and functional change characterized preclinical models provide a powerful tool for understanding mechanisms of disease; however managing information produced by experimental models represents a significant challenge for translating findings across research projects and presents a substantial hurdle for translation of novel therapies to humans. In the present work we demonstrate a novel 'syndromic' information-processing approach for capitalizing on heterogeneous data from diverse preclinical models of SCI to discover translational outcomes for therapeutic testing. We first built a large, detailed repository of preclinical outcome data from 10 years of basic research on cervical SCI in rats, and then applied multivariate pattern detection techniques to extract features that are conserved across different injury models. We then applied this translational knowledge to derive a data-driven multivariate metric that provides a common 'ruler' for comparisons of outcomes across different types of injury (NYU/MASCIS weight drop injuries, Infinite Horizons (IH) injuries, and hemisection injuries). The findings revealed that each individual endpoint provides a different view of the SCI syndrome, and that considering any single outcome measure in isolation provides a misleading incomplete view of the SCI syndrome This limitation was overcome by taking a novel multivariate integrative approach for leveraging complex data from Preclinical models of neurological disease to identify therapies that target multiple outcomes. We suggest that applying this syndromic approach provides a roadmap for translating therapies for SCI and other complex neurological diseases.	[Ferguson, Adam R.; Nielson, Jessica L.; Lin, Amity; Ly, Johnathan; Bresnahan, Jacqueline C.; Beattie, Michael S.] Univ Calif San Francisco, Dept Neurol Surg, BASIC, San Francisco, CA 94143 USA; [Irvine, Karen-Amanda] Stanford Univ, Dept Comparat Med, Palo Alto, CA 94304 USA; [Gensel, John C.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Dept Physiol, Lexington, KY USA; [Segal, Mark R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Ctr Bioinformat & Mol Biostat, San Francisco, CA 94143 USA; [Ratan, Rajiv R.] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, Burke Cornell Med Res Inst, White Plains, NY USA	University of California System; University of California San Francisco; Stanford University; University of Kentucky; University of California System; University of California San Francisco; Cornell University	Ferguson, AR (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, BASIC, San Francisco, CA 94143 USA.	adam.ferguson@ucsf.edu; michael.beattie@ucsf.edu	Irvine, Karen-amanda/AFG-7716-2022; Irvine, Karen-amanda/AAF-1717-2022	Irvine, Karen-amanda/0000-0001-5259-1824; Irvine, Karen-amanda/0000-0001-5259-1824; , John/0000-0001-8980-108X; Nielson, Jessica/0000-0002-3677-3959; Ferguson, Adam/0000-0001-7102-1608	National Institutes of Health [NS067092, NS069537, NS038079, NS031193, AG032518, F32NS079030]; NYSCoRE [CO19772]; Wings for Life Foundation [WFLUS008/12]; Craig H. Neilsen Foundation [224308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS079030, R01NS067092, R01NS069537, R01NS038079, R01NS031193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032518, P01AG014930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSCoRE; Wings for Life Foundation; Craig H. Neilsen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants NS067092 (ARF), NS069537 (ARF), NS038079 (JCB and MSB), NS031193 (MSB and JCB), AG032518 (MSB and JCB), F32NS079030 (JLN); NYSCoRE CO19772 (MSB and JCB); Wings for Life Foundation grant WFLUS008/12 (ARF); and Craig H. Neilsen Foundation Grant 224308 (ARF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN CS, 1991, PHYSIOL BEHAV, V50, P263, DOI 10.1016/0031-9384(91)90065-V; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2010, EUR J NEUROSCI, V32, P290, DOI 10.1111/j.1460-9568.2010.07343.x; BEHRMANN DL, 1994, EXP NEUROL, V126, P61, DOI 10.1006/exnr.1994.1042; Biering-Sorensen F, 2011, SPINAL CORD, V49, P60, DOI 10.1038/sc.2010.90; Biering-Sorensen Fin, 2012, Top Spinal Cord Inj Rehabil, V18, P23; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CATTELL RB, 1969, EDUC PSYCHOL MEAS, V29, P781, DOI 10.1177/001316446902900405; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chretien JP, 2008, PLOS MED, V5, P367, DOI 10.1371/journal.pmed.0050072; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dominici N, 2012, NAT MED, V18, P1142, DOI 10.1038/nm.2845; Evans JA, 2011, SCIENCE, V331, P721, DOI 10.1126/science.1201765; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Ferguson AR, 2011, TRANSL STROKE RES, V2, P438, DOI 10.1007/s12975-011-0121-1; Ferguson AR, 2004, J NEUROTRAUM, V21, P1601, DOI 10.1089/neu.2004.21.1601; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Gensel JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033519; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grau JW, 2004, J NEUROTRAUM, V21, P1795, DOI 10.1089/neu.2004.21.1795; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; GUADAGNOLI E, 1991, MULTIVAR BEHAV RES, V26, P323, DOI 10.1207/s15327906mbr2602_7; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hastie T, 2009, ELEMENTS STAT LEARNI; Hook MA, 2004, J NEUROTRAUM, V21, P109, DOI 10.1089/089771504772695995; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; KORTH B, 1976, PSYCHOMETRIKA, V41, P531, DOI 10.1007/BF02296973; Lee JHT, 2012, JOVE-J VIS EXP, DOI 10.3791/3313; Li SX, 2003, J NEUROSCI, V23, P4219; Liu Y, 1999, J NEUROSCI, V19, P4370; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pinzon A, 2008, EXP NEUROL, V213, P129, DOI 10.1016/j.expneurol.2008.05.018; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2012, EXP NEUROL, V233, P615, DOI 10.1016/j.expneurol.2010.11.016; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Sharp K, 2010, EXP NEUROL; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Steward O, 2006, EXP NEUROL, V198, P483, DOI 10.1016/j.expneurol.2005.12.034; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Young W, 2002, PROG BRAIN RES, V137, P231	64	63	63	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59712	10.1371/journal.pone.0059712	http://dx.doi.org/10.1371/journal.pone.0059712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544088	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700048
J	Guloksuz, S; Wichers, M; Kenis, G; Russel, MGVM; Wauters, A; Verkerk, R; Arts, B; van Os, J				Guloksuz, Sinan; Wichers, Marieke; Kenis, Gunter; Russel, Maurice G. V. M.; Wauters, Annick; Verkerk, Robert; Arts, Baer; van os, Jim			Depressive Symptoms in Crohn's Disease: Relationship with Immune Activation and Tryptophan Availability	PLOS ONE			English	Article							QUALITY-OF-LIFE; INFLAMMATORY-BOWEL-DISEASE; ALPHA THERAPY; CYTOKINES; PATHOPHYSIOLOGY; ASSOCIATION; HYPOTHESIS; SYSTEM; IDO; QUESTIONNAIRE	Crohn's disease (CD) is associated with immune activation and depressive symptoms. This study determines the impact of anti-tumor necrosis factor (TNF)-alpha treatment in CD patients on depressive symptoms and the degree to which tryptophan (TRP) availability and immune markers mediate this effect. Fifteen patients with CD, eligible for anti-TNF-alpha treatment were recruited. Disease activity (Harvey-Bradshaw Index (HBI), Crohn's Disease Activity Index (CDAI)), fatigue (Multidimensional Fatigue Inventory (MFI)), quality of life (Inflammatory Bowel Disease Questionnaire (IBDQ)), symptoms of depression and anxiety (Symptom Checklist (SCL-90), Beck Depression Inventory (BDI), Hamilton Depression Rating Scale (HDRS)), immune activation (acute phase proteins (APP)), zinc and TRP availability were assessed before treatment and after 2, 4 and 8 weeks. Anti-TNF-alpha increased IBDQ scores and reduced all depression scores; however only SCL-90 depression scores remained decreased after correction for HBI. Positive APPs decreased, while negative APPs increased after treatment. After correction for HBI, both level and percentage of gamma fraction were associated with SCL-90 depression scores over time. After correction for HBI, patients with current/past depressive disorder displayed higher levels of positive APPs and lower levels of negative APPs and zinc. TRP availability remained invariant over time and there was no association between SCL-90 depression scores and TRP availability. Inflammatory reactions in CD are more evident in patients with comorbid depression, regardless of disease activity. Anti-TNF-alpha treatment in CD reduces depressive symptoms, in part independently of disease activity; there was no evidence that this effect was mediated by immune-induced changes in TRP availability.	[Guloksuz, Sinan; Wichers, Marieke; Kenis, Gunter; Arts, Baer; van os, Jim] Maastricht Univ Med Ctr, EURON, Dept Psychiat & Psychol, Maastricht, Netherlands; [Russel, Maurice G. V. M.] Med Spectrum Twente, Dept Gastroenterol & Hepatol, Enschede, Netherlands; [Wauters, Annick] ZNA Middelheim, Lab Clin Biol, Antwerp, Belgium; [Verkerk, Robert] Univ Antwerp, Med Biochem Lab, Antwerp, Belgium; [van os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Maastricht University; Maastricht University Medical Centre (MUMC); Medical Spectrum Twente; ZNA Middelheim Hospital; University of Antwerp; University of London; King's College London	Guloksuz, S (corresponding author), Maastricht Univ Med Ctr, EURON, Dept Psychiat & Psychol, Maastricht, Netherlands.	sguloksuz@yahoo.com	van Os, Jim/V-8884-2019; Guloksuz, Sinan/AAH-1076-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Wichers, Marieke/N-6667-2014; van Os, Jim/C-2113-2014	van Os, Jim/0000-0002-7245-1586; Guloksuz, Sinan/0000-0002-6626-1874; Wichers, Marieke/0000-0001-5024-9064; Verkerk, Robert/0000-0003-3042-3293	European Community [HEALTH-F2-2009-241909]	European Community(European Commission)	Sinan Guloksuz and Jim van Os are supported by the European Community's Seventh Framework Programme under Grant agreement no. HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banovic I, 2010, PSYCHOL HEALTH MED, V15, P394, DOI 10.1080/13548501003759155; Banovic I, 2009, J CROHNS COLITIS, V3, P25, DOI 10.1016/j.crohns.2008.10.003; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; BOSSCHER RJ, 1986, PSYCHOL REP, V58, P696, DOI 10.2466/pr0.1986.58.3.696; Camara RJA, 2011, INFLAMM BOWEL DIS, V17, P2358, DOI 10.1002/ibd.21623; Capuron L, 2003, BIOL PSYCHIAT, V54, P906, DOI 10.1016/S0006-3223(03)00173-2; Capuron L, 2002, MOL PSYCHIATR, V7, P468, DOI 10.1038/sj.mp.4000995; Christmas DM, 2011, NEUROPSYCH DIS TREAT, V7, P431, DOI 10.2147/NDT.S17573; COWEN PJ, 1989, J AFFECT DISORDERS, V16, P27, DOI 10.1016/0165-0327(89)90051-7; Cusin C, 2010, CURR CLIN PSYCHIAT, P7, DOI 10.1007/978-1-59745-387-5_2; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; HARVEY RF, 1980, LANCET, V1, P514; HELZER JE, 1984, GASTROENTEROLOGY, V86, P324; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Kenis G, 2011, INT J NEUROPSYCHOPH, V14, P247, DOI 10.1017/S1461145710000830; Kurina LM, 2001, J EPIDEMIOL COMMUN H, V55, P716, DOI 10.1136/jech.55.10.716; Kurz K, 2011, AUTOIMMUNITY, V44, P235, DOI 10.3109/08916934.2010.528476; Leonard BE, 2001, PROG NEURO-PSYCHOPH, V25, P767, DOI 10.1016/S0278-5846(01)00155-5; Leonard B, 2012, NEUROSCI BIOBEHAV R, V36, P764, DOI 10.1016/j.neubiorev.2011.12.005; Lichtenstein GR, 2002, INFLAMM BOWEL DIS, V8, P237, DOI 10.1097/00054725-200207000-00001; Licinio J, 1999, MOL PSYCHIATR, V4, P317, DOI 10.1038/sj.mp.4000586; Loftus EV, 2008, AM J GASTROENTEROL, V103, P3132, DOI 10.1111/j.1572-0241.2008.02175.x; Maes M, 1986, Acta Psychiatr Belg, V86, P257; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017; MAES M, 1994, PSYCHIAT RES, V54, P143, DOI 10.1016/0165-1781(94)90003-5; Maes M, 1999, J AFFECT DISORDERS, V56, P189, DOI 10.1016/S0165-0327(99)00011-7; MAES M, 1993, PSYCHIAT RES, V49, P151, DOI 10.1016/0165-1781(93)90102-M; Maes M, 1996, NEUROPSYCHOPHARMACOL, V15, P243, DOI 10.1016/0893-133X(95)00181-C; Maes M, 1997, EUR ARCH PSY CLIN N, V247, P154, DOI 10.1007/BF03033069; MAES M, 1995, J AFFECT DISORDERS, V34, P61, DOI 10.1016/0165-0327(94)00106-J; Mardini HE, 2004, DIGEST DIS SCI, V49, P492, DOI 10.1023/B:DDAS.0000020509.23162.cc; Miller A. H., 2012, ARCH GEN PSYCHIAT, P1, DOI DOI 10.1001/2013; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Minderhoud IM, 2007, WORLD J GASTROENTERO, V13, P2089, DOI 10.3748/wjg.v13.i14.2089; Mittermaier C, 2004, PSYCHOSOM MED, V66, P79, DOI 10.1097/01.PSY.0000106907.24881.F2; Myint AM, 2003, MED HYPOTHESES, V61, P519, DOI 10.1016/S0306-9877(03)00207-X; NORTH CS, 1991, ANN INTERN MED, V114, P381, DOI 10.7326/0003-4819-114-5-381; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Persoons P, 2005, ALIMENT PHARM THER, V22, P101, DOI 10.1111/j.1365-2036.2005.02535.x; Plevy SE, 1997, J IMMUNOL, V159, P6276; Porter RJ, 2005, J AFFECT DISORDERS, V86, P129, DOI 10.1016/j.jad.2004.11.006; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; ROBERTSON DAF, 1989, GUT, V30, P623, DOI 10.1136/gut.30.5.623; Russel MGVM, 1997, DIGESTION, V58, P282, DOI 10.1159/000201455; Savitz J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000643; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sluzewska A, 1996, PSYCHIAT RES, V64, P161, DOI 10.1016/S0165-1781(96)02783-7; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Soczynska JK, 2009, NEUROTOXICOLOGY, V30, P497, DOI 10.1016/j.neuro.2009.03.004; SONG C, 1994, J AFFECT DISORDERS, V30, P283, DOI 10.1016/0165-0327(94)90135-X; Strober W, 2010, CURR OPIN GASTROEN, V26, P310, DOI 10.1097/MOG.0b013e328339d099; Van Balkom BPJ, 2002, ALIMENT PHARM THER, V16, P1101, DOI 10.1046/j.1365-2036.2002.01268.x; van Donkelaar EL, 2011, MOL PSYCHIATR, V16, P695, DOI 10.1038/mp.2011.9; Van Gool AR, 2003, PHARM WORLD SCI, V25, P11, DOI 10.1023/A:1022449613907; VanHunsel F, 1996, PSYCHIAT RES, V65, P159, DOI 10.1016/S0165-1781(96)03010-7; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Wichers MC, 2004, J PSYCHIATR NEUROSCI, V29, P11; Yoshida EM, 1999, CAN J GASTROENTEROL, V13, P65, DOI 10.1155/1999/506915	60	34	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60435	10.1371/journal.pone.0060435	http://dx.doi.org/10.1371/journal.pone.0060435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544139	gold, Green Submitted, Green Published			2022-12-25	WOS:000317480700098
J	Schrock, A; Goke, F; Wagner, P; Bode, M; Franzen, A; Braun, M; Huss, S; Agaimy, A; Ihrler, S; Menon, R; Kirsten, R; Kristiansen, G; Bootz, F; Lengerke, C; Perner, S				Schroeck, Andreas; Goeke, Friederike; Wagner, Patrick; Bode, Maike; Franzen, Alina; Braun, Martin; Huss, Sebastian; Agaimy, Abbas; Ihrler, Stephan; Menon, Ropika; Kirsten, Robert; Kristiansen, Glen; Bootz, Friedrich; Lengerke, Claudia; Perner, Sven			Sex Determining Region Y-Box 2 (SOX2) Amplification Is an Independent Indicator of Disease Recurrence in Sinonasal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; GENE AMPLIFICATION; PROTEIN EXPRESSION; SELF-RENEWAL; LUNG; PLURIPOTENCY; FIBROBLASTS; ONCOGENE; OCT3/4; NASAL	Objectives: The transcription factor SOX2 (3q26.3-q27) is an embryonic stem cell factor contributing to the induction of pluripotency in terminally differentiated somatic cells. Recently, amplification of the SOX2 gene locus has been described in squamous cell carcinoma (SCC) of different organ sites. Aim of this study was to investigate amplification and expression status of SOX2 in sinonasal carcinomas and to correlate the results with clinico-pathological data. Materials and Methods: A total of 119 primary tumor samples from the sinonasal region were assessed by fluorescence in-situ hybridization and immunohistochemistry for SOX2 gene amplification and protein expression, respectively. Of these, 59 were SSCs, 18 sinonasal undifferentiated carcinomas (SNUC), 10 carcinomas associated with an inverted papilloma (INVC), 19 adenocarcinomas (AD) and 13 adenoid cystic carcinomas (ACC). Results: SOX2 amplifications were found in subsets of SCCs (37.5%), SNUCs (35.3%), INVCs (37.5%) and ADs (8.3%) but not in ACCs. SOX2 amplification resulted in increased protein expression. Patients with SOX2-amplified sinonasal carcinomas showed a significantly higher rate of tumor recurrences than SOX2 non-amplified tumors. Conclusion:This is the first study assessing SOX2 amplification and expression in a large cohort of sinonasal carcinomas. As opposed to AD and ACC, SOX2 amplifications were detected in more than 1/3 of all SCCs, SNUCs and INVCs. We therefore suggest that SNUCs are molecularly closely related to SCCs and INVCs and that these entities represent a subgroup of sinonasal carcinomas relying on SOX2 acquisition during oncogenesis. SOX2 amplification appears to identify sinonasal carcinomas that are more likely to relapse after primary therapy, suggesting that these patients might benefit from a more aggressive therapy regime.	[Schroeck, Andreas; Bootz, Friedrich] Univ Bonn, Dept Otorhinolaryngol Head & Neck Surg, Bonn, Germany; [Schroeck, Andreas; Goeke, Friederike; Bode, Maike; Franzen, Alina; Braun, Martin; Menon, Ropika; Kirsten, Robert; Perner, Sven] Univ Bonn, Dept Prostate Canc Res, Bonn, Germany; [Goeke, Friederike; Bode, Maike; Franzen, Alina; Braun, Martin; Menon, Ropika; Kirsten, Robert; Kristiansen, Glen; Perner, Sven] Univ Bonn, Inst Pathol, Bonn, Germany; [Wagner, Patrick] Winchester Med Ctr, Winchester, VA USA; [Huss, Sebastian] Univ Cologne, Inst Pathol, Cologne, Germany; [Agaimy, Abbas] Univ Erlangen Nurnberg, Inst Pathol, Erlangen, Germany; [Ihrler, Stephan] Univ Munich, Inst Pathol, Lab Dermatohistol & Oral Pathol, D-80539 Munich, Germany; [Lengerke, Claudia] Univ Tubingen, Med Ctr 2, Tubingen, Germany	University of Bonn; University of Bonn; University of Bonn; University of Cologne; University of Erlangen Nuremberg; University of Munich; Eberhard Karls University of Tubingen	Schrock, A (corresponding author), Univ Bonn, Dept Otorhinolaryngol Head & Neck Surg, Bonn, Germany.	andreas.schroeck@ukb.uni-bonn.de	Wagner, Patrick/AAZ-7790-2021; Lengerke, Claudia/AAV-8745-2021	Lengerke, Claudia/0000-0001-5442-2805	Rudolph-Becker-Foundation; Medical Faculty of the University of Bonn; DFG [PE 1179/4-1, LE 2483/4-1]	Rudolph-Becker-Foundation; Medical Faculty of the University of Bonn; DFG(German Research Foundation (DFG))	This study was supported by a grant of the Rudolph-Becker-Foundation (to SP), by a medical doctoral fellowship of the Medical Faculty of the University of Bonn (to MB) and a grant of the DFG (to SP (#PE 1179/4-1) and CL (#LE 2483/4-1)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; [Anonymous], 2010, CURR PROB CANCER, V34, P304, DOI 10.1016/j.currproblcancer.2010.07.001; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Du LT, 2011, ORAL ONCOL, V47, P709, DOI 10.1016/j.oraloncology.2011.05.017; Dulguerov P, 2001, CANCER-AM CANCER SOC, V92, P3012, DOI 10.1002/1097-0142(20011215)92:12<3012::AID-CNCR10131>3.0.CO;2-E; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Guntinas-Lichius O, 2007, EJSO-EUR J SURG ONC, V33, P222, DOI 10.1016/j.ejso.2006.10.033; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Khademi B, 2009, ORAL MAXILLOFAC SURG, V13, P191, DOI 10.1007/s10006-009-0170-8; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Maier S, 2011, HUM PATHOL, V42, P1078, DOI 10.1016/j.humpath.2010.11.010; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Sholl LM, 2010, APPL IMMUNOHISTO M M, V18, P55, DOI 10.1097/PAI.0b013e3181b16b88; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang Q, 2009, ANTICANCER RES, V29, P1233; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilbertz T, 2011, MODERN PATHOL, V24, P944, DOI 10.1038/modpathol.2011.49; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112	28	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59201	10.1371/journal.pone.0059201	http://dx.doi.org/10.1371/journal.pone.0059201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544055	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700017
J	Wierk, JK; Langbehn, A; Kamper, M; Richter, S; Burda, PC; Heussler, VT; Deschermeier, C				Wierk, Jannika Katharina; Langbehn, Annette; Kamper, Maria; Richter, Stefanie; Burda, Paul-Christian; Heussler, Volker Theo; Deschermeier, Christina			Plasmodium berghei MAPK1 Displays Differential and Dynamic Subcellular Localizations during Liver Stage Development	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; PROTEIN-KINASES; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CONTROLS CYTOKINESIS; NUCLEAR IMPORT; CELL-CYCLE; FALCIPARUM; ACTIVATION; ERK; KINETOCHORES	Mitogen-activated protein kinases (MAPKs) regulate key signaling events in eukaryotic cells. In the genomes of protozoan Plasmodium parasites, the causative agents of malaria, two genes encoding kinases with significant homology to other eukaryotic MAPKs have been identified (mapk1, mapk2). In this work, we show that both genes are transcribed during Plasmodium berghei liver stage development, and analyze expression and subcellular localization of the PbMAPK1 protein in liver stage parasites. Live cell imaging of transgenic parasites expressing GFP-tagged PbMAPK1 revealed a nuclear localization of PbMAPK1 in the early schizont stage mediated by nuclear localization signals in the C-terminal domain. In contrast, a distinct localization of PbMAPK1 in comma/ring-shaped structures in proximity to the parasite's nuclei and the invaginating parasite membrane was observed during the cytomere stage of parasite development as well as in immature blood stage schizonts. The PbMAPK1 localization was found to be independent of integrity of a motif putatively involved in ATP binding, integrity of the putative activation motif and the presence of a predicted coiled-coil domain in the C-terminal domain. Although PbMAPK1 knock out parasites showed normal liver stage development, the kinase may still fulfill a dual function in both schizogony and merogony of liver stage parasites regulated by its dynamic and stage-dependent subcellular localization.	[Wierk, Jannika Katharina; Langbehn, Annette; Kamper, Maria; Richter, Stefanie; Deschermeier, Christina] Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, D-20359 Hamburg, Germany; [Burda, Paul-Christian; Heussler, Volker Theo] Univ Bern, Inst Cell Biol, Bern, Switzerland	Bernhard Nocht Institut fur Tropenmedizin; University of Bern	Deschermeier, C (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	descherm@bni-hamburg.de	Heussler, Volker/H-9322-2019	Heussler, Volker/0000-0001-8028-9825; Burda, Paul-Christian/0000-0003-0461-4352	MALSIG (Signalling in life cycle stages of malaria parasites); EVIMalaR (European virtual institute of malaria research) EU consortia	MALSIG (Signalling in life cycle stages of malaria parasites); EVIMalaR (European virtual institute of malaria research) EU consortia	The work was supported by the MALSIG (Signalling in life cycle stages of malaria parasites) and the EVIMalaR (European virtual institute of malaria research) EU consortia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe MK, 1999, MOL CELL BIOL, V19, P1301; Arnot DE, 2011, INT J PARASITOL, V41, P71, DOI 10.1016/j.ijpara.2010.07.012; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Deschermeier C, 2012, CELL MICROBIOL, V14, P416, DOI 10.1111/j.1462-5822.2011.01729.x; Doerig CM, 1996, GENE, V177, P1, DOI 10.1016/0378-1119(96)00281-8; Dorin D, 1999, J BIOL CHEM, V274, P29912, DOI 10.1074/jbc.274.42.29912; Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x; Dorin-Semblat D, 2007, MOL MICROBIOL, V65, P1170, DOI 10.1111/j.1365-2958.2007.05859.x; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Figueiredo LM, 2005, NUCLEIC ACIDS RES, V33, P1111, DOI 10.1093/nar/gki260; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Frankel MB, 2009, DNA CELL BIOL, V28, P277, DOI 10.1089/dna.2009.0853; Gerald N, 2011, EUKARYOT CELL, V10, P474, DOI 10.1128/EC.00314-10; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gissot M, 2005, J MOL BIOL, V346, P29, DOI 10.1016/j.jmb.2004.11.045; Graeser R, 1997, MOL MICROBIOL, V23, P151, DOI 10.1046/j.1365-2958.1997.2071571.x; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002554; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Helm S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013653; Huang H, 2011, CELL CYCLE, V10, P3519, DOI 10.4161/cc.10.20.17791; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; KUN JFJ, 1995, MOL BIOCHEM PARASIT, V71, P249, DOI 10.1016/0166-6851(94)00047-Q; Lacey MR, 2007, J MOL EVOL, V64, P4, DOI 10.1007/s00239-005-0197-x; Lin DT, 1996, MOL BIOCHEM PARASIT, V78, P67, DOI 10.1016/S0166-6851(96)02608-4; Montagnac G, 2010, NAT CELL BIOL, V12, P308, DOI 10.1038/ncb0410-308; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Nivez MP, 2000, MOL BIOCHEM PARASIT, V111, P31, DOI 10.1016/S0166-6851(00)00294-2; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Rangarajan R, 2005, EMBO REP, V6, P464, DOI 10.1038/sj.embor.7400404; Rankin KE, 2010, CELL MICROBIOL, V12, P569, DOI 10.1111/j.1462-5822.2010.01454.x; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Rodriguez J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002324; Russo I, 2009, MOL MICROBIOL, V72, P229, DOI 10.1111/j.1365-2958.2009.06639.x; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Stanway RR, 2011, CELL MICROBIOL, V13, P1768, DOI 10.1111/j.1462-5822.2011.01657.x; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Tawk L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001286; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Tewari R, 2005, MOL MICROBIOL, V58, P1253, DOI 10.1111/j.1365-2958.2005.04793.x; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Tuteja R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/461979; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3	56	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59755	10.1371/journal.pone.0059755	http://dx.doi.org/10.1371/journal.pone.0059755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544094	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700054
J	Pang, WH; Wang, HF; Shi, L; Sun, YQ; Wang, XT; Wang, MM; Li, JF; Wang, HB; Shi, GG				Pang, Wenhui; Wang, Hefeng; Shi, Lei; Sun, Yueqi; Wang, Xiaoting; Wang, Mingming; Li, Jianfeng; Wang, Haibo; Shi, Guanggang			Immunomodulatory Effects of Escherichia coli ATCC 25922 on Allergic Airway Inflammation in a Mouse Model	PLOS ONE			English	Article							HYGIENE HYPOTHESIS; STEM-CELLS; EARLY-LIFE; RHINITIS; ASTHMA; IMMUNOLOGY; MECHANISMS; MICROBIOTA; SYMPTOMS; IMPACT	Background: Hygiene hypothesis demonstrates that the lack of microbial exposure would promote the development of allergic airway disease (AAD). Therefore, the gut microbiota, including Escherichia coli (E. coli), would probably offer a potential strategy for AAD. Objective: To investigate whether E. coli infection is able to suppress the induction of AAD and to elucidate the underlying mechanisms. Methods: Nonpathogenic E. coli ATCC 25922 was infected by gavage before AAD phase in three patterns: 10(8) or 10(6) CFU in neonates or 10(8) CFU in adults. Then mice were sensitized and challenged with ovalbumin (OVA) to induce allergic inflammation in both the upper and lower airways. Hallmarks of AAD, in terms of eosinophil infiltration and goblet cell metaplasia in subepithelial mucosa, Th2 skewing of the immune response, and levels of T regulate cells (Tregs), were examined by histological analysis, ELISA, and flow cytometry, respectively. Results: E. coli, especially neonatally infected with an optimal dose, attenuated allergic responses, including a decrease in nasal rubbing and sneezing, a reduction in eosinophil inflammation and goblet cell metaplasia in subepithelial mucosa, decreased serum levels of OVA-specific IgE, and reduced Th2 (IL-4) cytokines. In contrast, this effect came with an increase of Th1 (IFN-r and IL-2) cytokines, and an enhancement of IL-10-secreting Tregs in paratracheal lymph nodes (PTLN). Conclusion: E. coli suppresses allergic responses in mice, probably via a shift from Th1 to Th2 and/or induction of Tregs. Moreover, this infection is age-and dose-dependent, which may open up novel possibilities for new therapeutic interventions.	[Pang, Wenhui; Shi, Lei; Wang, Xiaoting; Wang, Mingming; Li, Jianfeng; Wang, Haibo; Shi, Guanggang] Shandong Univ, Prov Hosp, Dept Otorhinolaryngol Head & Neck Surg, Inst Eye & Otorhinolaryngol, Jinan 250100, Peoples R China; [Wang, Hefeng] Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China; [Sun, Yueqi] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolaryngol Hosp, Guangzhou 510275, Guangdong, Peoples R China	Shandong University; Shandong University; Sun Yat Sen University	Shi, GG (corresponding author), Shandong Univ, Prov Hosp, Dept Otorhinolaryngol Head & Neck Surg, Inst Eye & Otorhinolaryngol, Jinan 250100, Peoples R China.	shiguangangent@hotmail.com	Sun, Yueqi/N-4528-2018; Shi, Lei/AAR-5350-2020	Sun, Yueqi/0000-0002-2382-0429; 	Science and Technology Foundation of Shandong Province, China [2007HW104]; Shandong Provincial Natural Science Foundation, China [Y2006C73]; National Natural Science Foundation of China (NSFC) [30801279]	Science and Technology Foundation of Shandong Province, China; Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The authors thank each named author for their contributions to this work. This study was supported by grants from the Science and Technology Foundation of Shandong Province, China (2007HW104), the Shandong Provincial Natural Science Foundation, China (Y2006C73), and the National Natural Science Foundation of China (NSFC, 30801279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Boudeau J, 2003, ALIMENT PHARM THER, V18, P45, DOI 10.1046/j.1365-2036.2003.01638.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Cho KS, 2009, STEM CELLS, V27, P259, DOI 10.1634/stemcells.2008-0283; Compalati E, 2010, EXPERT REV CLIN IMMU, V6, P413, DOI [10.1586/ECI.10.15, 10.1586/eci.10.15]; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Hellings PW, 2001, CLIN EXP ALLERGY, V31, P782, DOI 10.1046/j.1365-2222.2001.01081.x; Henderson WR, 2005, J ALLERGY CLIN IMMUN, V116, P332, DOI 10.1016/j.jaci.2005.04.013; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jenerowicz D, 2012, ANN AGR ENV MED, V19, P475; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Leavy O, 2012, NAT REV IMMUNOL, V12, P319, DOI 10.1038/nri3213; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; LOBRY JR, 1992, J ANTIMICROB CHEMOTH, V29, P121, DOI 10.1093/jac/29.2.121; Lukacs NW, 2001, NAT REV IMMUNOL, V1, P108, DOI 10.1038/35100503; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Nauta AJ, 2008, EUR J PHARMACOL, V585, P354, DOI 10.1016/j.ejphar.2008.02.094; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Qiu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022004; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Robinson DS, 2009, CLIN EXP ALLERGY, V39, P1314, DOI 10.1111/j.1365-2222.2009.03301.x; Rose MA, 2011, BMC COMPLEM ALTERN M, V3, P11; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sauer A, 2009, J FOOD PROTECT, V72, P937, DOI 10.4315/0362-028X-72.5.937; Savilahti EM, CLIN EXP ALLERGY, V405- 411; Schaub B, 2006, J ALLERGY CLIN IMMUN, V117, P969, DOI 10.1016/j.jaci.2006.03.003; SHARMA V, 1992, J BACTERIOL, V174, P5057, DOI 10.1128/JB.174.15.5057-5062.1992; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Skapenko Alla, 2007, V136, P87; Smit JJ, 2003, CLIN EXP ALLERGY, V33, P1083, DOI 10.1046/j.1365-2222.2003.01727.x; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Thorburn AN, 2010, THORAX, V65, P1053, DOI 10.1136/thx.2009.131508; Uri J V, 1994, Acta Microbiol Immunol Hung, V41, P215; Wang DY, 2000, AM J RHINOL, V14, P325, DOI 10.2500/105065800781329483; Wold AE, 1998, ALLERGY, V53, P20, DOI 10.1111/j.1398-9995.1998.tb04953.x; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yokota E, 2008, INT IMMUNOPHARMACOL, V8, P1083, DOI 10.1016/j.intimp.2008.03.018; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219	47	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59174	10.1371/journal.pone.0059174	http://dx.doi.org/10.1371/journal.pone.0059174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536867	Green Published, gold, Green Submitted			2022-12-25	WOS:000317397200017
J	Stam, R; Jupe, J; Howden, AJM; Morris, JA; Boevink, PC; Hedley, PE; Huitema, E				Stam, Remco; Jupe, Julietta; Howden, Andrew J. M.; Morris, Jenny A.; Boevink, Petra C.; Hedley, Pete E.; Huitema, Edgar			Identification and Characterisation CRN Effectors in Phytophthora capsici Shows Modularity and Functional Diversity	PLOS ONE			English	Article							RXLR EFFECTORS; GENOME; SEQUENCE; PROTEINS; DELIVERY; REVEALS; NUCLEUS	Phytophthora species secrete a large array of effectors during infection of their host plants. The Crinkler (CRN) gene family encodes a ubiquitous but understudied class of effectors with possible but as of yet unknown roles in infection. To appreciate CRN effector function in Phytophthora, we devised a simple Crn gene identification and annotation pipeline to improve effector prediction rates. We predicted 84 full-length CRN coding genes and assessed CRN effector domain diversity in sequenced Oomycete genomes. These analyses revealed evidence of CRN domain innovation in Phytophthora and expansion in the Peronosporales. We performed gene expression analyses to validate and define two classes of CRN effectors, each possibly contributing to infection at different stages. CRN localisation studies revealed that P. capsici CRN effector domains target the nucleus and accumulate in specific sub-nuclear compartments. Phenotypic analyses showed that few CRN domains induce necrosis when expressed in planta and that one cell death inducing effector, enhances P. capsici virulence on Nicotiana benthamiana. These results suggest that the CRN protein family form an important class of intracellular effectors that target the host nucleus during infection. These results combined with domain expansion in hemibiotrophic and necrotrophic pathogens, suggests specific contributions to pathogen lifestyles. This work will bolster CRN identification efforts in other sequenced oomycete species and set the stage for future functional studies towards understanding CRN effector functions.	[Stam, Remco; Jupe, Julietta; Howden, Andrew J. M.; Huitema, Edgar] Univ Dundee, Div Plant Sci, Dundee, Scotland; [Stam, Remco; Jupe, Julietta; Howden, Andrew J. M.; Boevink, Petra C.; Hedley, Pete E.; Huitema, Edgar] James Hutton Inst, Dundee Effector Consortium, Dundee, Scotland; [Stam, Remco; Morris, Jenny A.; Boevink, Petra C.; Hedley, Pete E.] James Hutton Inst, Dundee, Scotland	University of Dundee; James Hutton Institute; James Hutton Institute	Stam, R (corresponding author), Univ Dundee, Div Plant Sci, Dundee, Scotland.	e.huitema@dundee.ac.uk	Huitema, Edgar/G-3760-2011; Boevink, Petra/AAO-6498-2021; Hedley, Peter/F-1149-2011; Stam, Remco/AAK-1881-2021	Huitema, Edgar/0000-0002-5766-0830; Boevink, Petra/0000-0002-7021-9097; Hedley, Peter/0000-0003-0866-324X; Stam, Remco/0000-0002-3444-6954	Royal Society of Edinburgh; Marie-Curie; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I00386X/1]; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); Biotechnology and Biological Sciences Research Council [BB/I00386X/1] Funding Source: researchfish; BBSRC [BB/I00386X/1] Funding Source: UKRI	Royal Society of Edinburgh; Marie-Curie(European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Huitema lab (RS, JJ, AH, EH) is supported by the Royal Society of Edinburgh (co-funded by Marie-Curie) and the Biotechnology and Biological Sciences Research Council (BBSRC, Grant BB/I00386X/1). PH, PB & JM are funded by The Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bierne H, 2012, CELL MICROBIOL, V14, P622, DOI 10.1111/j.1462-5822.2012.01758.x; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P9; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Deslandes L., 2012, TRENDS PLANT SCI; Deslandes L, 2011, PLANT SIGNAL BEHAV, V6, P42, DOI 10.4161/psb.6.1.13978; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Goodin MM, 2007, PLANT PHYSIOL, V145, P1100, DOI 10.1104/pp.107.106641; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hein I, 2009, MOL PLANT PATHOL, V10, P547, DOI [10.1111/J.1364-3703.2009.00547.X, 10.1111/j.1364-3703.2009.00547.x]; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kahsay RY, 2005, BIOINFORMATICS, V21, P1853, DOI 10.1093/bioinformatics/bti303; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Lamour KH, 2012, MOL PLANT MICROBE IN; Lamour KH, 2012, MOL PLANT PATHOL, V13, P329, DOI 10.1111/j.1364-3703.2011.00754.x; Latijnhouwers M, 2003, TRENDS MICROBIOL, V11, P462, DOI 10.1016/j.tim.2003.08.002; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Links MG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-503; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; Oliva R, 2010, CELL MICROBIOL, V12, P705, DOI 10.1111/j.1462-5822.2010.01471.x; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Savory EA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035796, 10.1371/journal.pone.0034701]; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Thines M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/j.pbi.2010.04.001; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Damme M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002875; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2006, FUNGAL GENET BIOL, V43, P20, DOI 10.1016/j.fgb.2005.10.003	45	110	117	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59517	10.1371/journal.pone.0059517	http://dx.doi.org/10.1371/journal.pone.0059517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536880	Green Submitted, Green Published, gold			2022-12-25	WOS:000317397200028
J	Chan, PH; Ghosh, B; Lai, HZ; Peng, HL; Mong, KKT; Chen, YC				Chan, Po-Han; Ghosh, Bhaswati; Lai, Hong-Zheng; Peng, Hwei-Ling; Mong, Kwok Kong Tony; Chen, Yu-Chie			Photoluminescent Gold Nanoclusters as Sensing Probes for Uropathogenic Escherichia coli	PLOS ONE			English	Article							NANODOTS; MANNOSE; ADHERENCE	Glycan-bound nanoprobes have been demonstrated as suitable sensing probes for bacteria containing glycan binding sites. In this study, we demonstrated a facile approach for generating glycan-bound gold nanoclusters (AuNCs). The generated AuNCs were used as sensing probes for corresponding target bacteria. Mannose-capped AuNCs (AuNCs@Mann) were generated and used as the model sensors for target bacteria. A one-step synthesis approach was employed to generate AuNCs@Mann. In this approach, an aqueous solution of tetrachloroauric acid and mannoside that functionized with a thiol group (Mann-SH) was stirred at room temperature for 48 h. The mannoside functions as reducing and capping agent. The size of the generated AuNCs@Mann is 1.95 +/- 0.27 nm, whereas the AuNCs with red photoluminescence have a maximum emission wavelength of similar to 630 nm (lambda(excitation) = 375 nm). The synthesis of the AuNCs@Mann was accelerated by microwave heating, which enabled the synthesis of the AuNCs@Mann to complete within 1 h. The generated AuNCs@Mann are capable of selectively binding to the urinary tract infection isolate Escherichia coli J96 containing the mannose binding protein FimH expressed on the type 1 pili. On the basis of the naked eye observation, the limit of detection of the sensing approach is as low as similar to 2 x 10(6) cells/mL.	[Chan, Po-Han; Ghosh, Bhaswati; Lai, Hong-Zheng; Mong, Kwok Kong Tony; Chen, Yu-Chie] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu, Taiwan; [Peng, Hwei-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Mong, KKT (corresponding author), Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu, Taiwan.	tmong@mail.nctu.edu.tw; yuchie@mail.nctu.edu.tw	Ghosh, Bhaswati/GLU-2181-2022; Mong, Kwok-Kong/V-2000-2019		National Science Council of Taiwan [NSC 100-2627-M-009-007]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan (NSC 100-2627-M-009-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett BJ, 1997, AM J MED SCI, V314, P245, DOI 10.1097/00000441-199710000-00007; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; CADDICK S, 1995, TETRAHEDRON, V51, P10403, DOI 10.1016/0040-4020(95)00662-R; Chen WY, 2010, NANOMEDICINE-UK, V5, P755, DOI 10.2217/NNM.10.43; Cushing BL, 2004, CHEM REV, V104, P3893, DOI 10.1021/cr030027b; Disney MD, 2004, J AM CHEM SOC, V126, P13343, DOI 10.1021/ja047936i; Grunstein D, 2011, J AM CHEM SOC, V133, P13957, DOI 10.1021/ja2036767; Huang CC, 2008, ANAL CHEM, V80, P1497, DOI 10.1021/ac701998f; Huang CC, 2009, ANAL CHEM, V81, P875, DOI 10.1021/ac8010654; Lidstrom P, 2001, TETRAHEDRON, V57, P9225, DOI 10.1016/S0040-4020(01)00906-1; Lin JH, 2010, ANALYST, V135, P104, DOI 10.1039/b916511h; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; OFEK I, 1978, INFECT IMMUN, V22, P247, DOI 10.1128/IAI.22.1.247-254.1978; Rodrigues DF, 2009, BIOFOULING, V25, P401, DOI 10.1080/08927010902833443; Shang L, 2011, NANO TODAY, V6, P401, DOI 10.1016/j.nantod.2011.06.004; Shiang YC, 2011, ANALYST, V136, P1177, DOI 10.1039/c0an00889c; Song YJ, 2011, ADV MATER, V23, P4215, DOI 10.1002/adma.201101853; Sun SH, 2006, ADV MATER, V18, P393, DOI 10.1002/adma.200501464; Tseng YT, 2011, BIOSENS BIOELECTRON, V27, P95, DOI 10.1016/j.bios.2011.06.021; Wen F, 2011, ANAL CHEM, V83, P1193, DOI 10.1021/ac1031447; Wolf Denise M., 2002, OMICS A Journal of Integrative Biology, V6, P91, DOI 10.1089/15362310252780852; Yang W, 2010, BIOMACROMOLECULES, V11, P1840, DOI 10.1021/bm100307d	22	32	32	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58064	10.1371/journal.pone.0058064	http://dx.doi.org/10.1371/journal.pone.0058064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554874	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800010
J	Ou, JX; Bharti, K; Nodari, A; Bertuzzi, S; Arnheiter, H				Ou, Jingxing; Bharti, Kapil; Nodari, Alessandro; Bertuzzi, Stefano; Arnheiter, Heinz			Vax1/2 Genes Counteract Mitf-Induced Respecification of the Retinal Pigment Epithelium	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MITF; EYE DEVELOPMENT; CELL-DIFFERENTIATION; ALAGILLE-SYNDROME; OPTIC VESICLE; NEURAL RETINA; HOMEOBOX GENE; BETA-CATENIN; EXPRESSION; TRANSDIFFERENTIATION	During vertebrate eye development, the transcription factor MITF acts to promote the development of the retinal pigment epithelium (RPE). In embryos with Mitf mutations, the future RPE hyperproliferates and is respecified as retinal tissue but only in a small portion of the dorsal RPE. Using a series of genetic crosses, we show that this spatial restriction of RPE respecification is brought about by persistent expression of the anti-retinogenic ventral homeodomain gene Vax2 in the dorso-proximal and both Vax1 and Vax2 in the ventral RPE. We further show that dorso-proximal RPE respecification in Vax2/Mitf double mutants and dorso-proximal and ventral RPE respecification in Vax1/2/Mitf triple mutants result from increased FGF/MAP kinase signaling. In none of the mutants, however, does the distal RPE show signs of hyperproliferation or respecification, likely due to local JAGGED1/NOTCH signaling. Expression studies and optic vesicle culture experiments also suggest a role for NOTCH signaling within the mutant dorsal RPE domains, where ectopic JAGGED1 expression may partially counteract the effects of FGF/ERK1/2 signaling on RPE respecification. The results indicate the presence of complex interplays between distinct transcription factors and signaling molecules during eye development and show how RPE phenotypes associated with mutations in one gene are modulated by expression changes in other genes.	[Ou, Jingxing; Bharti, Kapil; Nodari, Alessandro; Bertuzzi, Stefano; Arnheiter, Heinz] NINDS, Mammalian Dev Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Ou, JX (corresponding author), NINDS, Mammalian Dev Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	ouj@nei.nih.gov		Arnheiter, Heinz/0000-0003-2537-1134; Bertuzzi, Stefano/0000-0003-4562-3626	Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke; NATIONAL EYE INSTITUTE [ZIAEY000533, ZIAEY000531] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZZ, 1997, J NEUROSCI, V17, P1425; Barbieri AM, 2002, DEVELOPMENT, V129, P805; Barbieri AM, 1999, P NATL ACAD SCI USA, V96, P10729, DOI 10.1073/pnas.96.19.10729; Bertuzzi S, 1999, GENE DEV, V13, P3092, DOI 10.1101/gad.13.23.3092; Bharti K, 2008, DEVELOPMENT, V135, P1169, DOI 10.1242/dev.014142; Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; GUILLEMOT F, 1992, DEVELOPMENT, V114, P743; Hallonet M, 1998, DEVELOPMENT, V125, P2599; Hallsson JH, 2004, GENETICS, V167, P233, DOI 10.1534/genetics.167.1.233; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Horsford DJ, 2005, DEVELOPMENT, V132, P177, DOI 10.1242/dev.01571; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; McCright B, 2002, DEVELOPMENT, V129, P1075; Mochii M, 1998, DEV BIOL, V193, P47, DOI 10.1006/dbio.1997.8800; Mochii M, 1998, DEV BIOL, V196, P145, DOI 10.1006/dbio.1998.8864; Muller F, 2007, DEVELOPMENT, V134, P3483, DOI 10.1242/dev.02884; Mui SH, 2005, GENE DEV, V19, P1249, DOI 10.1101/gad.1276605; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; Ohsaki K, 1999, GENES CELLS, V4, P267, DOI 10.1046/j.1365-2443.1999.00257.x; Ou J, 2008, J PATHOL, V215, P421, DOI 10.1002/path.2371; Ou JX, 2010, INVEST OPHTH VIS SCI, V51, P1415, DOI 10.1167/iovs.09-4023; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; PITTACK C, 1991, DEVELOPMENT, V113, P577; Rowan S, 2004, DEVELOPMENT, V131, P5139, DOI 10.1242/dev.01300; Sakaguchi DS, 1997, DEV DYNAM, V209, P387, DOI 10.1002/(SICI)1097-0177(199708)209:4<387::AID-AJA6>3.0.CO;2-E; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Schouwey K, 2011, ONCOGENE, V30, P313, DOI 10.1038/onc.2010.428; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Tang K, 2010, DEVELOPMENT, V137, P725, DOI 10.1242/dev.040568; Tsukiji N, 2009, DEV BIOL, V326, P335, DOI 10.1016/j.ydbio.2008.11.029; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; Yuan ZR, 1998, HUM MOL GENET, V7, P1363, DOI 10.1093/hmg/7.9.1363; ZHAO SL, 1995, BRAIN RES, V677, P300, DOI 10.1016/0006-8993(95)00163-K	46	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59247	10.1371/journal.pone.0059247	http://dx.doi.org/10.1371/journal.pone.0059247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555005	Green Submitted, Green Published, gold			2022-12-25	WOS:000316409800075
J	Puta, C; Schulz, B; Schoeler, S; Magerl, W; Gabriel, B; Gabriel, HHW; Miltner, WHR; Weiss, T				Puta, Christian; Schulz, Birgit; Schoeler, Saskia; Magerl, Walter; Gabriel, Brunhild; Gabriel, Holger H. W.; Miltner, Wolfgang H. R.; Weiss, Thomas			Somatosensory Abnormalities for Painful and Innocuous Stimuli at the Back and at a Site Distinct from the Region of Pain in Chronic Back Pain Patients	PLOS ONE			English	Article							PARADOXICAL HEAT SENSATION; EVENT-RELATED POTENTIALS; THALAMIC NMDA RECEPTORS; NEUROGENIC HYPERALGESIA; ATTENTIONAL CONTROL; NATURAL-HISTORY; SENSITIZATION; PERCEPTION; MECHANISMS; INTENSITY	Chronic low back pain (CLBP) was shown to be associated with pathophysiological changes at several levels of the sensorimotor system. Changes in sensory thresholds have been reported but complete profiles of Quantitative Sensory Testing (QST) were only rarely obtained in CLBP patients. The aim of the present study was to investigate comprehensive QST profiles in CLBP at the painful site (back) and at a site distinct from their painful region (hand) and to compare these data with similar data in healthy controls. We found increased detection thresholds in CLBP patients compared to healthy controls for all innocuous stimuli at the back and extraterritorial to the painful region at the hand. Additionally, CLBP patients showed decreased pain thresholds at both sites. Importantly, there was no interaction between the investigated site and group, i.e. thresholds were changed both at the affected body site and for the site distinct from the painful region (hand). Our results demonstrate severe, widespread changes in somatosensory sensitivity in CLBP patients. These widespread changes point to alterations at higher levels of the neuraxis or/and to a vulnerability to nociceptive plasticity in CLBP patients.	[Puta, Christian; Schulz, Birgit; Gabriel, Holger H. W.] Univ Jena, Dept Sports Med & Hlth Promot, Jena, Germany; [Puta, Christian] Univ Jena, Ctr Interdisciplinary Prevent Dis Related Profess, Jena, Germany; [Schoeler, Saskia; Gabriel, Brunhild; Miltner, Wolfgang H. R.; Weiss, Thomas] Univ Jena, Dept Biol & Clin Psychol, Jena, Germany; [Magerl, Walter] Heidelberg Univ, Ctr Biomed & Med Technol Mannheim CBTM, Mannheim, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Ruprecht Karls University Heidelberg	Puta, C (corresponding author), Univ Jena, Dept Sports Med & Hlth Promot, Jena, Germany.	christian.puta@uni-jena.de	Puta, Christian/P-5562-2014	Puta, Christian/0000-0003-3936-4605	Federal Ministry of Education and Research BMBF [01EC1003B, 01EC1010]	Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF))	This study was funded by the Federal Ministry of Education and Research BMBF [01EC1003B, 01EC1010]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho CMS, 2009, EUR J PAIN, V13, P779, DOI 10.1016/j.ejpain.2008.10.002; APKARIAN AV, 1994, SOMATOSENS MOT RES, V11, P259, DOI 10.3109/08990229409051393; Balague F, 2007, LANCET, V369, P726, DOI 10.1016/S0140-6736(07)60340-7; Baumgartner U, 2002, PAIN, V96, P141, DOI 10.1016/S0304-3959(01)00438-9; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Blumenstiel K, 2011, CLIN J PAIN, V27, P682, DOI 10.1097/AJP.0b013e3182177654; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Dillmann J, 2000, NEUROSCI LETT, V284, P53, DOI 10.1016/S0304-3940(00)00957-5; EATON SA, 1990, NEUROSCI LETT, V110, P297, DOI 10.1016/0304-3940(90)90863-5; Eck J, 2011, PAIN, V152, P1104, DOI 10.1016/j.pain.2011.01.026; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Franz M, 2012, PAIN, V153, P1687, DOI 10.1016/j.pain.2012.04.029; Geber C, 2008, PAIN, V139, P73, DOI 10.1016/j.pain.2008.03.006; GREEN BG, 1991, SOMATOSENS MOT RES, V8, P301, DOI 10.3109/08990229109144754; Hansen C, 1996, BRAIN, V119, P1729, DOI 10.1093/brain/119.5.1729; Hautzinger M, 1994, BECK DEPRESSIONS INV; HOHMANN C, 2012, EVID-BASED COMPL ALT, V2012, DOI DOI 10.1155/2012/753583; Huge V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002742; Huge V, 2006, PAIN MED, V7, P501, DOI 10.1111/j.1526-4637.2006.00238.x; Jensen IB, 2009, PAIN, V142, P202, DOI 10.1016/j.pain.2008.12.015; Jung K, 2012, EUR J PAIN, V16, P509, DOI 10.1016/j.ejpain.2011.08.006; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Kolhekar R, 1997, PAIN, V71, P31, DOI 10.1016/S0304-3959(97)03334-4; Kosek E, 2002, EUR J PAIN, V6, P413, DOI 10.1016/S1090-3801(02)00041-1; Lang PM, 2006, PAIN, V124, P190, DOI 10.1016/j.pain.2006.04.011; Leffler AS, 2000, EUR J PAIN, V4, P57, DOI 10.1053/eujp.1999.0159; Legrain V, 2011, PAIN, V152, P453, DOI 10.1016/j.pain.2010.11.024; Lenz Frederick A, 2004, Suppl Clin Neurophysiol, V57, P50; Luomajoki H, 2011, BRIT J SPORT MED, V45, P437, DOI 10.1136/bjsm.2009.060731; Luoto S, 1999, SPINE, V24, P255, DOI 10.1097/00007632-199902010-00011; Magerl W, 2001, BRAIN, V124, P1754, DOI 10.1093/brain/124.9.1754; Magerl W, 2010, PAIN, V151, P598, DOI 10.1016/j.pain.2010.07.026; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; Moriwaki K, 1999, PAIN, V81, P1, DOI 10.1016/S0304-3959(98)00257-7; NATHAN PW, 1960, J NEUROL NEUROSUR PS, V23, P202, DOI 10.1136/jnnp.23.3.202; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; O'Neill S, 2007, EUR J PAIN, V11, P415, DOI 10.1016/j.ejpain.2006.05.009; Pertovaara A, 1998, EXP NEUROL, V149, P193, DOI 10.1006/exnr.1997.6688; Pfau DB, 2011, PAIN, V152, P1532, DOI 10.1016/j.pain.2011.02.037; Puta C, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-98; Richter M, 2010, PAIN, V148, P198, DOI 10.1016/j.pain.2009.08.009; ROLAND M, 1983, SPINE, V8, P145, DOI 10.1097/00007632-198303000-00005; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Romero YR, 2013, PAIN, V154, P135, DOI 10.1016/j.pain.2012.10.003; SIMONE DA, 1991, J NEUROPHYSIOL, V66, P228, DOI 10.1152/jn.1991.66.1.228; Strutton PH, 2005, J SPINAL DISORD TECH, V18, P420, DOI 10.1097/01.bsd.0000169063.84628.fe; Susser E, 1999, BRAIN, V122, P239, DOI 10.1093/brain/122.2.239; Tagliazucchi E, 2010, NEUROSCI LETT, V485, P26, DOI 10.1016/j.neulet.2010.08.053; Taimela S, 1999, SPINE, V24, P1322, DOI 10.1097/00007632-199907010-00009; Treede RD, 2008, EUR J PAIN, V12, P395, DOI 10.1016/j.ejpain.2007.11.008; Tsao H, 2010, J PAIN, V11, P1120, DOI 10.1016/j.jpain.2010.02.004; Tsao H, 2010, EUR J PAIN, V14, P832, DOI 10.1016/j.ejpain.2010.01.001; Wand BM, 2011, MANUAL THER, V16, P15, DOI 10.1016/j.math.2010.06.008; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Weiss T, 2003, NEUROSCI LETT, V340, P135, DOI 10.1016/S0304-3940(03)00103-4	61	45	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58885	10.1371/journal.pone.0058885	http://dx.doi.org/10.1371/journal.pone.0058885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554950	gold, Green Submitted, Green Published			2022-12-25	WOS:000316409800044
J	Vehling, S; Oechsle, K; Koch, U; Mehnert, A				Vehling, Sigrun; Oechsle, Karin; Koch, Uwe; Mehnert, Anja			Receiving Palliative Treatment Moderates the Effect of Age and Gender on Demoralization in Patients with Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; BREAST-CANCER; PSYCHOLOGICAL DISTRESS; PSYCHOSOMATIC RESEARCH; PSYCHOSOCIAL DISTRESS; DEPRESSIVE SYMPTOMS; DIAGNOSTIC-CRITERIA; SOCIAL SUPPORT; ERROR VARIANCE; CARE	Background: Existential distress is an important factor affecting psychological well-being in cancer patients. We studied occurrence and predictors of demoralization, a syndrome of existential distress, in particular the interaction of age, gender, and curative vs. palliative treatment phase. Methods: A cross-sectional sample of N = 750 patients with different tumor sites was recruited from in-and outpatient treatment facilities. Patients completed the following self-report questionnaires: Demoralization Scale, Patient Health Questionnaire-9, Illness-Specific Social Support Scale Short Version-8, and physical problems list of the NCCN Distress Thermometer. Moderated multiple regression analyses were conducted. Results: We found high demoralization in 15% and moderate demoralization in 8% of the sample. Curative vs. palliative treatment phase moderated the impact of age and gender on demoralization (three-way interaction: b = 1.30, P = 0.2): the effect of age on demoralization was negative for women receiving palliative treatment (b = -2.6, P = 0.2) and positive for men receiving palliative treatment (b = 2.5, P = 0.3). Effects of age and gender were not significant among patients receiving curative treatment. Female gender was associated with higher demoralization among younger patients receiving palliative treatment only. Analyses were controlled for significant effects of the number of physical problems (b = 6.10, P < 0.01) and social support (b = -3.17, P<0.01). Conclusions: Existential distress in terms of demoralization is a relevant problem within the spectrum of cancer-related distress. It is associated with a complex interaction of demographic and medical patient characteristics; existential challenges related to palliative treatment may exacerbate the impact of age-and gender-related vulnerability factors on demoralization. Psychosocial interventions should acknowledge this interaction in order to address the individual nature of existential distress in subgroups of cancer patients.	[Vehling, Sigrun; Koch, Uwe; Mehnert, Anja] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Oechsle, Karin] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol Pneumol, Hamburg, Germany; [Koch, Uwe] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Mehnert, Anja] Univ Med Ctr Leipzig, Div Psychosocial Oncol, Dept Med Psychol & Med Sociol, Leipzig, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University	Vehling, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	s.vehling@uke.de	tan, janie/AAH-9283-2021; Koch, Uwe/A-5825-2009; Mehnert-Theuerkauf, Anja/A-1177-2008; Vehling, Sigrun/AAD-2861-2021	Mehnert-Theuerkauf, Anja/0000-0002-6872-9805; Vehling, Sigrun/0000-0001-9314-4326	German Cancer Aid (Deutsche Krebshilfe) [107465]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	This study was supported by the German Cancer Aid (Deutsche Krebshilfe, Grant number 107465). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinis H, 1998, ORGAN RES METHODS, V1, P296, DOI 10.1177/109442819813002; Aiken L.S., 1991, MULTIPLE REGRESSION; ALEXANDER RA, 1994, PSYCHOL BULL, V115, P308, DOI 10.1037/0033-2909.115.2.308; Angelino AF, 2001, SUPPORT CARE CANCER, V9, P344, DOI 10.1007/s005200000195; Arden-Close E, 2008, PSYCHO-ONCOLOGY, V17, P1061, DOI 10.1002/pon.1363; Blank TO, 2008, CANCER-AM CANCER SOC, V112, P2569, DOI 10.1002/cncr.23444; Boscaglia N, 2007, PSYCHO-ONCOL, V16, P189, DOI 10.1002/pon.1044; Breitbart W, 2012, J CLIN ONCOL, V30, P1304, DOI 10.1200/JCO.2011.36.2517; Brothers BM, 2009, PSYCHO-ONCOLOGY, V18, P267, DOI 10.1002/pon.1394; Chochinov HM, 2009, J PAIN SYMPTOM MANAG, V38, P641, DOI 10.1016/j.jpainsymman.2009.04.021; Chochinov HM, 2006, CA-CANCER J CLIN, V56, P84, DOI 10.3322/canjclin.56.2.84; Clarke David M, 2005, World Psychiatry, V4, P96; Clarke DM, 2002, AUST NZ J PSYCHIAT, V36, P733, DOI 10.1046/j.1440-1614.2002.01086.x; Cockram CA, 2009, PSYCHOTHER PSYCHOSOM, V78, P342, DOI 10.1159/000235737; Connor MJ, 2011, NURS INQ, V18, P2, DOI 10.1111/j.1440-1800.2010.00501.x; Dawson JF, 2006, J APPL PSYCHOL, V91, P917, DOI 10.1037/0021-9010.91.4.917; DEFIGUEIREDO JM, 1993, COMPR PSYCHIAT, V34, P308, DOI 10.1016/0010-440X(93)90016-W; Fox J, 2008, APPL REGRESSION ANAL; Giese-Davis J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-441; Grassi L, 2005, PSYCHOTHER PSYCHOSOM, V74, P100, DOI 10.1159/000083168; Grassi L, 2004, PSYCHOSOMATICS, V45, P483, DOI 10.1176/appi.psy.45.6.483; Hagedoorn M, 2008, PSYCHOL BULL, V134, P1, DOI 10.1037/0033-2909.134.1.1; Jacobsen JC, 2006, INDIAN J PALLIAT CAR, V12, P8, DOI 10.4103/0973-1075.25913; Jacobsen Juliet C, 2007, Prim Care Companion J Clin Psychiatry, V9, P139; Jones JM, 2003, J PSYCHOSOM RES, V55, P411, DOI 10.1016/S0022-3999(03)00526-9; Kissane D, 2009, HDB PSYCHIAT PALLIAT, P324; Kissane DW, 2012, ARCH INTERN MED, V172, P1501, DOI 10.1001/archinternmed.2012.3633; Kissane DW, 2004, J PALLIATIVE CARE, V20, P269, DOI 10.1177/082585970402000402; Kissane DW, 2001, J PALLIAT CARE, V17, P12, DOI 10.1177/082585970101700103; Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x; Lee CY, 2012, SUPPORT CARE CANCER, V20, P2259, DOI 10.1007/s00520-011-1332-4; Lemay K, 2008, CLIN PSYCHOL REV, V28, P472, DOI 10.1016/j.cpr.2007.07.013; Lo C, 2010, AGEING SOC, V30, P325, DOI 10.1017/S0144686X09990201; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Mehnert A, 2010, EUR J CANCER CARE, V19, P736, DOI 10.1111/j.1365-2354.2009.01117.x; Mehnert A, 2006, PSYCHOTHER PSYCH MED, V56, P462, DOI 10.1055/s-2006-951828; Mehnert A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-70; Mehnert A, 2011, J PAIN SYMPTOM MANAG, V42, P768, DOI 10.1016/j.jpainsymman.2011.02.013; Miller S, 2011, SOC PSYCH PSYCH EPID, V46, P767, DOI 10.1007/s00127-010-0246-7; Monforte-Royo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037117; Mosher CE, 2005, J PSYCHOSOC ONCOL, V23, P101, DOI 10.1300/J077v23n02_07; Nelson CJ, 2009, ONCOLOGIST, V14, P891, DOI 10.1634/theoncologist.2009-0059; Nissim R, 2012, PALLIATIVE MED, V26, P713, DOI 10.1177/0269216311425096; Nolen-Hoeksema S, 2012, ANNU REV CLIN PSYCHO, V8, P161, DOI 10.1146/annurev-clinpsy-032511-143109; REVENSON TA, 1991, SOC SCI MED, V33, P807, DOI 10.1016/0277-9536(91)90385-P; Rodin Gary, 2008, J Am Acad Psychoanal Dyn Psychiatry, V36, P181, DOI 10.1521/jaap.2008.36.1.181; Rodin G, 2009, SOC SCI MED, V68, P562, DOI 10.1016/j.socscimed.2008.10.037; Rosenfeld B, 2004, PSYCHO-ONCOL, V13, P800, DOI 10.1002/pon.797; Ryan D, 2012, PALLIATIVE MED, V26, P162, DOI 10.1177/0269216311399663; Sachs E, 2012, AM J HOSP PALLIAT CA; Scheier MF, 2006, J CLIN ONCOL, V24, P2407, DOI 10.1200/JCO.2005.05.5244; Siegel K, 1999, J PSYCHOSOC ONCOL, V17, P1, DOI 10.1300/J077v17n01_01; Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1; Ullrich A., 2010, KLIN DIAGNOSTIK EVAL, V3, P359; Vehling S, 2011, SUPPORT CARE CANCER, V19, P513, DOI 10.1007/s00520-010-0845-6; Vehling S, 2012, PSYCHO-ONCOLOGY, V21, P54, DOI 10.1002/pon.1866; Whisman MA, 2005, J FAM PSYCHOL, V19, P111, DOI 10.1037/0893-3200.19.1.111	57	28	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59417	10.1371/journal.pone.0059417	http://dx.doi.org/10.1371/journal.pone.0059417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109ZC	23555030	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800088
J	Graham, SM; Raboud, J; McClelland, RS; Jaoko, W; Ndinya-Achola, J; Mandaliya, K; Overbaugh, J; Bayoumi, AM				Graham, Susan M.; Raboud, Janet; McClelland, R. Scott; Jaoko, Walter; Ndinya-Achola, Jeckoniah; Mandaliya, Kishor; Overbaugh, Julie; Bayoumi, Ahmed M.			Loss to Follow-Up as a Competing Risk in an Observational Study of HIV-1 Incidence	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CONTRACEPTIVE USE; INFECTION; ACQUISITION; WOMEN; MORTALITY; PROGRAMS; OUTCOMES; DISEASE; MOMBASA	Objective: Conventional survival estimates may be biased if loss to follow-up (LTF) is associated with the outcome of interest. Our goal was to assess whether the association between sexual risk behavior and HIV-1 acquisition changed after accounting for LTF with competing risks regression. Methods: HIV-1-seronegative women who enrolled in a Kenyan sex worker cohort from 1993-2007 were followed prospectively and tested for HIV at monthly clinic visits. Our primary predictor was self-reported sexual risk behavior in the past week, analyzed as a time-dependent covariate. Outcomes included HIV-1 acquisition and LTF. We analyzed the data using Cox proportional hazards regression and competing risks regression, in which LTF was treated as a competing event. Results: A total of 1,513 women contributed 4,150 person-years (py), during which 198 (13.1%) acquired HIV-1 infection (incidence, 4.5 per 100 py) and 969 (64.0%) were LTF (incidence, 23.4 per 100 py). After adjusting for potential confounders, women reporting unprotected sex with multiple partners were less likely to be lost to follow-up (adjusted sub-hazard ratio (aSHR) 0.50, 95% confidence interval (CI) 0.32-0.76, relative to no sexual activity). The risk of HIV-1 acquisition after reporting unprotected sex with multiple partners was similar with Cox regression (adjusted hazard ratio (aHR) 2.41, 95% CI 1.36-4.27) and competing risks regression (aSHR 2.47, 95% CI 1.33-4.58). Conclusions: Unprotected sex with multiple partners was associated with higher HIV-1 acquisition risk, but lower attrition. This differential attrition did not substantially bias Cox regression estimates when compared to competing risks regression results.	[Graham, Susan M.; McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Graham, Susan M.; McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA USA; [Graham, Susan M.; McClelland, R. Scott; Jaoko, Walter; Ndinya-Achola, Jeckoniah] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Raboud, Janet] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Raboud, Janet] Univ Hlth Network, Div Clin Decis Making & Hlth Care, Toronto, ON, Canada; [McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Mandaliya, Kishor] PathCare, Mombasa, Kenya; [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Bayoumi, Ahmed M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Bayoumi, Ahmed M.] St Michaels Hosp, Div Gen Internal Med, Toronto, ON M5B 1W8, Canada; [Bayoumi, Ahmed M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bayoumi, Ahmed M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Graham, SM (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	grahamsm@u.washington.edu	Jaoko, Walter/AAN-5048-2020; Graham, Susan/W-6133-2019	Graham, Susan/0000-0001-7847-8686; Jaoko, Walter/0000-0002-7134-6581	National Institutes of Health (NIH) [K23 AI-069990]; Ontario HIV Treatment Network Career Scientist Award; NIH [P01 HD64915, R01 AI38518, R01 AI71794, P30 AI027757]; NIH (National Institute of Allergy and Infectious Diseases (NIAID)); NIH (National Cancer Institute (NCI)); NIH (National Institute of Mental Health (NIMH)); NIH (National Institute on Drug Abuse (NIDA)); NIH (National Institute of Child Health and Human Development (NICHD)); NIH (National Heart, Lung, and Blood Institute (NHLBI)); NIH (National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD064915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038518, K23AI069990, R37AI038518, P30AI027757] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario HIV Treatment Network Career Scientist Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (National Institute of Allergy and Infectious Diseases (NIAID)); NIH (National Cancer Institute (NCI))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (National Institute of Mental Health (NIMH)); NIH (National Institute on Drug Abuse (NIDA))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (National Institute of Child Health and Human Development (NICHD))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH (National Heart, Lung, and Blood Institute (NHLBI))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH (National Institute on Aging (NIA))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SMG was supported by National Institutes of Health (NIH) grant K23 AI-069990, JR was supported by an Ontario HIV Treatment Network Career Scientist Award, and AMB holds a Chair in Applied Health Services Research from the Canadian Institutes of Health Research and the Ontario Ministry of Health and Long-Term Care. Ongoing support for the Mombasa Cohort includes NIH grants P01 HD64915, R01 AI38518, and R01 AI71794. Additional infrastructure support for the Mombasa Field Site was provided by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2007, AIDS, V21, P1771, DOI 10.1097/QAD.0b013e328270388a; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chi BH, 2010, AM J EPIDEMIOL, V171, P924, DOI 10.1093/aje/kwq008; Chohan V, 2009, SEX TRANSM INFECT, V85, P489, DOI 10.1136/sti.2009.036103; Cole SR, 2010, AIDS, V24, P2423, DOI 10.1097/QAD.0b013e32833dd0ec; Corbett AM, 2009, PERSPECT SEX REPRO H, V41, P218, DOI 10.1363/4121809; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P489, DOI 10.1046/j.1365-3156.2002.00889.x; Hoffmann O, 2004, SEX TRANSM INFECT, V80, P69, DOI 10.1136/sti.2004.011908; Kim HT, 2007, CLIN CANCER RES, V13, P559, DOI 10.1158/1078-0432.CCR-06-1210; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; Kristman VL, 2005, EUR J EPIDEMIOL, V20, P657, DOI 10.1007/s10654-005-7919-7; Lavreys L, 2004, J INFECT DIS, V189, P303, DOI 10.1086/380974; Lavreys L, 2004, AIDS, V18, P695, DOI 10.1097/00002030-200403050-00017; Lavreys L, 2000, CLIN INFECT DIS, V30, P486, DOI 10.1086/313718; Lavreys L, 2002, CLIN INFECT DIS, V35, P77, DOI 10.1086/340862; MARTIN HL, 1994, AIDS RES HUM RETROV, V10, pS235; McClelland RS, 2008, J INFECT DIS, V197, P1361, DOI 10.1086/587490; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; McClelland RS, 2011, SEX TRANSM DIS, V38, P429, DOI 10.1097/OLQ.0b013e31820369f6; McClelland RS, 2006, AIDS, V20, P269, DOI 10.1097/01.aids.0000196165.48518.7b; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Richter LM, 2009, EVAL PROGRAM PLANN, V32, P197, DOI 10.1016/j.evalprogplan.2008.12.002; Schoni-Affolter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027919; Tan DHS, 2011, JAIDS-J ACQ IMM DEF, V58, P38, DOI 10.1097/QAI.0b013e3182282cfc; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843	35	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59480	10.1371/journal.pone.0059480	http://dx.doi.org/10.1371/journal.pone.0059480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555041	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500090
J	Butler, MI; Stockwell, PA; Black, MA; Day, RC; Lamont, IL; Poulter, RTM				Butler, Margi I.; Stockwell, Peter A.; Black, Michael A.; Day, Robert C.; Lamont, Iain L.; Poulter, Russell T. M.			Pseudomonas syringae pv. actinidiae from Recent Outbreaks of Kiwifruit Bacterial Canker Belong to Different Clones That Originated in China	PLOS ONE			English	Article							MOBILE GENETIC ELEMENTS; CAUSAL AGENT; 1ST REPORT; GENOME; EVOLUTION; SEQUENCE; CHINENSIS; VIRULENCE; ALIGNMENT; TOOLS	A recently emerged plant disease, bacterial canker of kiwifruit (Actinidia deliciosa and A. chinensis), is caused by Pseudomonas syringae pv. actinidiae (PSA). The disease was first reported in China and Japan in the 1980s. A severe outbreak of PSA began in Italy in 2008 and has spread to other European countries. PSA was found in both New Zealand and Chile in 2010. To study the evolution of the pathogen and analyse the transmission of PSA between countries, genomes of strains from China and Japan (where the genus Actinidia is endemic), Italy, New Zealand and Chile were sequenced. The genomes of PSA strains are very similar. However, all strains from New Zealand share several single nucleotide polymorphisms (SNPs) that distinguish them from all other PSA strains. Similarly, all the PSA strains from the 2008 Italian outbreak form a distinct clonal group and those from Chile form a third group. In addition to the rare SNPs present in the core genomes, there is abundant genetic diversity in a genomic island that is part of the accessory genome. The island from several Chinese strains is almost identical to the island present in the New Zealand strains. The island from a different Chinese strain is identical to the island present in the strains from the recent Italian outbreak. The Chilean strains of PSA carry a third variant of this island. These genomic islands are integrative conjugative elements (ICEs). Sequencing of these ICEs provides evidence of three recent horizontal transmissions of ICE from other strains of Pseudomonas syringae to PSA. The analyses of the core genome SNPs and the ICEs, combined with disease history, all support the hypothesis of an independent Chinese origin for both the Italian and the New Zealand outbreaks and suggest the Chilean strains also originate from China.	[Butler, Margi I.; Stockwell, Peter A.; Black, Michael A.; Day, Robert C.; Lamont, Iain L.; Poulter, Russell T. M.] Univ Otago, Dept Biochem, Dunedin, New Zealand	University of Otago	Butler, MI (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	margi.butler@otago.ac.nz	Black, Michael/F-1484-2010	Butler, Margi/0000-0001-6863-3961; Black, Michael/0000-0003-1174-6054; Poulter, Russell/0000-0001-5848-646X; Lamont, Iain/0000-0002-7601-6354	(Ministry of Business, Innovation, and Employment) New Zealand Technology Transfer Voucher [PROP-27820-VCH-SEEKAKIWI]; New Zealand Genomics Ltd at Otago University; New Zealand Genomics Ltd at Massey University; New Zealand Genomics Ltd; Seeka Kiwi Fruit Industries	(Ministry of Business, Innovation, and Employment) New Zealand Technology Transfer Voucher; New Zealand Genomics Ltd at Otago University; New Zealand Genomics Ltd at Massey University; New Zealand Genomics Ltd; Seeka Kiwi Fruit Industries	The authors received funding from an Ministry for Primary Industries (now Ministry of Business, Innovation, and Employment.) New Zealand Technology Transfer Voucher awarded to Seeka Kiwifruit Industries (PROP-27820-VCH-SEEKAKIWI) (http://voucher.msi.govt.nz). New Zealand Genomics Ltd (http://www.nzgenomics.co.nz) at Otago University and Massey University subsidised the HiSeq and MiSeq genome sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by New Zealand Genomics Ltd and Seeka Kiwi Fruit Industries. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2011, BACTERIAL CANC KIWIF; [Anonymous], 2011, DETAILS PSEUDOMONAS; Australian Government Department of Agriculture Fisheries and Forestry, 2011, DET AS STRAIN BACT C; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balestra G.M., 2010, NEW DIS REPORTS, V22; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Blakney AJC, 2011, FEMS MICROBIOL ECOL, V77, P546, DOI 10.1111/j.1574-6941.2011.01136.x; Bull CT, 2011, PHYTOPATHOLOGY, V101, P847, DOI 10.1094/PHYTO-11-10-0318; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Chapman JR, 2012, PHYTOPATHOLOGY, V102, P1034, DOI 10.1094/PHYTO-03-12-0064-R; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Everett KR, 2011, AUSTRALAS PLANT DIS, V6, P67, DOI 10.1007/s13314-011-0023-9; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Ferrante P, 2010, PLANT PATHOL, V59, P954, DOI 10.1111/j.1365-3059.2010.02304.x; Ferrante P, 2009, J PHYTOPATHOL, V157, P768, DOI 10.1111/j.1439-0434.2009.01550.x; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hwang MSH, 2005, APPL ENVIRON MICROB, V71, P5182, DOI 10.1128/AEM.71.9.5182-5191.2005; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kim JF, 1998, MOL PLANT MICROBE IN, V11, P1247, DOI 10.1094/MPMI.1998.11.12.1247; Koh Y., 1994, KOREAN J PLANT PATHO, V10, P68; Korber B, 2000, HIV SIGNATURE SEQUEN; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; Martuza M., 2012, 2012 IEEE 2 PORT M B, P1; Mavrodi DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8; Mazzaglia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036518; O'Brien HE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-141; Pitman AR, 2005, CURR BIOL, V15, P2230, DOI 10.1016/j.cub.2005.10.074; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Roberts AP, TN NUMBER REGISTRY; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; SCORTICHINI M, 1994, PLANT PATHOL, V43, P1035, DOI 10.1111/j.1365-3059.1994.tb01654.x; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, IS FINDER DATABASE; Studholme DJ, 2011, MOL PLANT PATHOL, V12, P829, DOI [10.1111/J.1364-3703.2011.00713.X, 10.1111/j.1364-3703.2011.00713.x]; TAKIKAWA Y, 1989, Annals of the Phytopathological Society of Japan, V55, P437, DOI 10.3186/jjphytopath.55.437; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vanneste JL, 2011, PLANT DIS, V95, P1311, DOI 10.1094/PDIS-03-11-0195; Wang PW, 2007, MICROBIOL-SGM, V153, P2067, DOI 10.1099/mic.0.2006/001545-0; Wang Z., 1992, J SW AGR U; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382	46	97	110	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57464	10.1371/journal.pone.0057464	http://dx.doi.org/10.1371/journal.pone.0057464			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23555547	gold, Green Published, Green Submitted			2022-12-25	WOS:000315519000116
J	Tanaka, H; Akagi, K; Oneyama, C; Tanaka, M; Sasaki, Y; Kanou, T; Lee, YH; Yokogawa, D; Dobenecker, MW; Nakagawa, A; Okada, M; Ikegami, T				Tanaka, Hiroaki; Akagi, Ken-ichi; Oneyama, Chitose; Tanaka, Masakazu; Sasaki, Yuichi; Kanou, Takashi; Lee, Young-Ho; Yokogawa, Daisuke; Dobenecker, Marc-Werner; Nakagawa, Atsushi; Okada, Masato; Ikegami, Takahisa			Identification of a New Interaction Mode between the Src Homology 2 Domain of C-terminal Src Kinase (Csk) and Csk-binding Protein/Phosphoprotein Associated with Glycosphingolipid Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; AFFINITY PHOSPHOTYROSYL PEPTIDE; TRANSMEMBRANE ADAPTER PROTEIN; NMR CHEMICAL-SHIFTS; SH2 DOMAIN; CRYSTAL-STRUCTURES; FAMILY KINASES; SPECIFICITY; ACTIVATION; COMMUNICATION	Proteins with Src homology 2 (SH2) domains play major roles in tyrosine kinase signaling. Structures of many SH2 domains have been studied, and the regions involved in their interactions with ligands have been elucidated. However, these analyses have been performed using short peptides consisting of phosphotyrosine followed by a few amino acids, which are described as the canonical recognition sites. Here, we report the solution structure of the SH2 domain of C-terminal Src kinase (Csk) in complex with a longer phosphopeptide from the Csk-binding protein (Cbp). This structure, together with biochemical experiments, revealed the existence of a novel binding region in addition to the canonical phosphotyrosine 314-binding site of Cbp. Mutational analysis of this second region in cells showed that both canonical and novel binding sites are required for tumor suppression through the Cbp-Csk interaction. Furthermore, the data indicate an allosteric connection between Cbp binding and Csk activation that arises from residues in the beta B/beta C loop of the SH2 domain.	[Tanaka, Hiroaki; Tanaka, Masakazu; Sasaki, Yuichi; Lee, Young-Ho; Yokogawa, Daisuke; Nakagawa, Atsushi; Ikegami, Takahisa] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Akagi, Ken-ichi] Natl Inst Biomed Innovat, Osaka, Japan; [Oneyama, Chitose; Kanou, Takashi; Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Dobenecker, Marc-Werner] Rockefeller Univ, Lab Immune Cell Epigenet & Signaling, New York, NY 10065 USA	Osaka University; National Institute of Health Sciences - Japan; Osaka University; Rockefeller University	Ikegami, T (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamada Oka, Suita, Osaka 5650871, Japan.	tiik@protein.osaka-u.ac.jp	Ikegami, Takahisa/I-9626-2017; Nakagawa, Atsushi/M-5731-2019; Nakagawa, Atsushi/D-4329-2009; Yokogawa, Daisuke/AAC-6929-2022	Ikegami, Takahisa/0000-0002-1429-1844; Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861; Yokogawa, Daisuke/0000-0002-7574-0965; AKAGI, Ken-ichi/0000-0002-7051-4598	Grants-in-Aid for Scientific Research [25870407] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Bradshaw JM, 2000, J MOL BIOL, V299, P521; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEROME AE, 1990, J MAGN RESON, V88, P177, DOI 10.1016/0022-2364(90)90123-Q; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Goddard T. D., 1999, SPARKY 3; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Ia KK, 2010, GROWTH FACTORS, V28, P329, DOI 10.3109/08977194.2010.484424; Kanou T, 2011, MOL CANCER RES, V9, P103, DOI 10.1158/1541-7786.MCR-10-0340; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; Lin XF, 2006, J MOL BIOL, V357, P1263, DOI 10.1016/j.jmb.2006.01.046; Lin XF, 2005, BIOCHEMISTRY-US, V44, P1561, DOI 10.1021/bi048142j; Lin Z, 2006, ANGEW CHEM INT EDIT, V45, P1960, DOI 10.1002/anie.200503558; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Mikkola ET, 2010, J MOL BIOL, V399, P618, DOI 10.1016/j.jmb.2010.04.045; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; NARULA SS, 1995, STRUCTURE, V3, P1061, DOI 10.1016/S0969-2126(01)00242-8; Ogawa A, 2002, J BIOL CHEM, V277, P14351, DOI 10.1074/jbc.C200086200; Ogura K, 1999, J MOL BIOL, V289, P439, DOI 10.1006/jmbi.1999.2792; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfrepper KI, 2001, EUR J IMMUNOL, V31, P1825, DOI 10.1002/1521-4141(200106)31:6<1825::AID-IMMU1825>3.0.CO;2-V; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; SHAKA AJ, 1983, J MAGN RESON, V51, P169, DOI 10.1016/0022-2364(83)90117-8; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; Umitsu M, 2005, J BIOMOL NMR, V31, P365, DOI 10.1007/s10858-005-2450-4; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Wang H, 2002, BIOCHEMISTRY-US, V41, P5453, DOI 10.1021/bi011914g; WIDER G, 1991, Journal of Biomolecular NMR, V1, P93, DOI 10.1007/BF01874572; Wong L, 2005, J MOL BIOL, V351, P131, DOI 10.1016/j.jmb.2005.05.042; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	54	8	10	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15240	15254		10.1074/jbc.M112.439075	http://dx.doi.org/10.1074/jbc.M112.439075			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23548896	Green Published, hybrid			2022-12-25	WOS:000319452100051
J	Cao, ZY; Hulsizer, S; Cui, YJ; Pretto, DL; Kim, KH; Hagerman, PJ; Tassone, F; Pessah, IN				Cao, Zhengyu; Hulsizer, Susan; Cui, Yanjun; Pretto, Dalyir L.; Kim, Kyung Ho; Hagerman, Paul J.; Tassone, Flora; Pessah, Isaac N.			Enhanced Asynchronous Ca2+ Oscillations Associated with Impaired Glutamate Transport in Cortical Astrocytes Expressing Fmr1 Gene Premutation Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRAGILE-X-SYNDROME; CGG-REPEAT LENGTH; MOUSE MODEL; TREMOR/ATAXIA SYNDROME; MESSENGER-RNA; ACTIVATION; PLASTICITY; INVOLVEMENT; INDIVIDUALS; INCLUSIONS	Premutation CGG repeat expansions (55-200 CGG repeats; preCGG) within the fragile X mental retardation 1 (FMR1) gene can cause fragile X-associated tremor/ataxia syndrome. Defects in early neuronal migration and morphology, electrophysiological activity, and mitochondria trafficking have been described in a premutation mouse model, but whether preCGG mutations also affect astrocyte function remains unknown. PreCGG cortical astrocytes (similar to 170 CGG repeats) displayed 3-fold higher Fmr1 mRNA and 30% lower FMR1 protein (FMRP) when compared with WT. PreCGG astrocytes showed modest reductions in expression of glutamate (Glu) transporters GLT-1 and GLAST and attenuated Glu uptake (p<0.01). Consistent with astrocyte cultures in vitro, aged preCGG mice cerebral cortex also displayed reduced GLAST and GLT-1 expression. Approximately 65% of the WT and preCGG cortical astrocytes displayed spontaneous asynchronous Ca2+ oscillations. PreCGG astrocytes exhibited nearly 50% higher frequency of asynchronous Ca2+ oscillations (p < 0.01) than WT, a difference mimicked by chronic exposure of WT astrocytes to L-trans-pyrrolidine-2,4-dicarboxylic acid (L-trans-PDC) or by partial suppression of GLAST using siRNA interference. Acute challenge with Glu augmented the frequency of Ca2+ oscillations in both genotypes. Additionally, 10 mu M Glu elicited a sustained intracellular Ca2+ rise in a higher portion of preCGG astrocytes when compared with WT. Pharmacological studies showed that mGluR5, but not NMDA receptor, contributed to Glu hypersensitivity in preCGG astrocytes. These functional defects in preCGG astrocytes, especially in Glu signaling, may contribute to fragile X-associated tremor/ataxia syndrome neuropathology.	[Cao, Zhengyu; Hulsizer, Susan; Cui, Yanjun; Kim, Kyung Ho; Pessah, Isaac N.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Pretto, Dalyir L.; Hagerman, Paul J.; Tassone, Flora] Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Davis, CA 95616 USA; [Hagerman, Paul J.; Tassone, Flora; Pessah, Isaac N.] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Cao, ZY (corresponding author), Univ Calif Davis, 1 Shields Ave, Davis, CA 95616 USA.	zcao@ucdavis.edu	Pessah, Isaac N/K-7985-2017	Pessah, Isaac N/0000-0002-8149-588X	National Institutes of Health [RC1 AG036022, 1R01 HD064817, P01ES011269]; United States Environmental Protection Agency [R833292, R829388, HD02274]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274, R01HD064817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG036022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Environmental Protection Agency(United States Environmental Protection Agency); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RC1 AG036022 (to P. J. H. and I. N. P.), 1R01 HD064817 (to I. N. P.), and P01ES011269 (to I. N. P.). This work was also supported by the United States Environmental Protection Agency Grants R833292 and R829388 (to I. N. P.) and HD02274 (to F. T.).	Allen EG, 2004, HUM GENET, V114, P439, DOI 10.1007/s00439-004-1086-x; Amiri K, 2008, ARCH NEUROL-CHICAGO, V65, P19, DOI 10.1001/archneurol.2007.30; Arocena DG, 2005, HUM MOL GENET, V14, P3661, DOI 10.1093/hmg/ddi394; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Ben Achour S, 2010, NEURON GLIA BIOL, V6, P147, DOI 10.1017/S1740925X10000207; Berry-Kravis E, 2007, MOVEMENT DISORD, V22, P2018, DOI 10.1002/mds.21493; Bourgeois JA, 2009, J CLIN PSYCHIAT, V70, P852, DOI 10.4088/JCP.08m04476; Brouwer JR, 2008, PSYCHONEUROENDOCRINO, V33, P863, DOI 10.1016/j.psyneuen.2008.03.011; Brouwer JR, 2007, EXP CELL RES, V313, P244, DOI 10.1016/j.yexcr.2006.10.002; Brouwer JR, 2009, AM J MED GENET B, V150B, P782, DOI 10.1002/ajmg.b.30910; Brouwer JR, 2008, J NEUROCHEM, V107, P1671, DOI 10.1111/j.1471-4159.2008.05747.x; Cao ZY, 2012, TOXICOL SCI, V130, P362, DOI 10.1093/toxsci/kfs244; Cao ZY, 2012, HUM MOL GENET, V21, P2923, DOI 10.1093/hmg/dds118; Cao ZY, 2010, TOXICOL SCI, V114, P323, DOI 10.1093/toxsci/kfp312; Chen YC, 2010, HUM MOL GENET, V19, P196, DOI 10.1093/hmg/ddp479; Cunningham CL, 2011, HUM MOL GENET, V20, P64, DOI 10.1093/hmg/ddq432; Deng PY, 2011, J NEUROSCI, V31, P10971, DOI 10.1523/JNEUROSCI.2021-11.2011; Farzin F, 2006, J DEV BEHAV PEDIATR, V27, pS137, DOI 10.1097/00004703-200604002-00012; Goodlin-Jones BL, 2004, J DEV BEHAV PEDIATR, V25, P392, DOI 10.1097/00004703-200412000-00002; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; Greco CM, 2006, BRAIN, V129, P243, DOI 10.1093/brain/awh683; Hagerman PJ, 2008, J MED GENET, V45, P498, DOI 10.1136/jmg.2008.059055; Hagerman R, 2011, J NEURODEV DISORD, V3, P211, DOI 10.1007/s11689-011-9084-5; Hagerman RJ, 2006, J DEV BEHAV PEDIATR, V27, P63, DOI 10.1097/00004703-200602000-00012; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hessl D, 2005, AM J MED GENET B, V139B, P115, DOI 10.1002/ajmg.b.30241; Higashimori H., 2013, HUM MOL GEN IN PRESS; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Hunsaker MR, 2012, HIPPOCAMPUS, V22, P2260, DOI 10.1002/hipo.22043; Iliff AJ, 2013, HUM MOL GENET, V22, P1180, DOI 10.1093/hmg/dds525; Iwahashi C, 2009, J MOL DIAGN, V11, P281, DOI 10.2353/jmoldx.2009.080118; Jacobs S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-132; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; Jacquemont S, 2004, AM J MENT RETARD, V109, P154, DOI 10.1352/0895-8017(2004)109<154:AIIWTF>2.0.CO;2; Jacquemont S, 2007, LANCET NEUROL, V6, P45, DOI 10.1016/S1474-4422(06)70676-7; Kaplan ES, 2012, J NEUROCHEM, V123, P613, DOI 10.1111/j.1471-4159.2012.07936.x; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Padmashri R, 2008, NEUROSCIENCE, V151, P56, DOI 10.1016/j.neuroscience.2007.09.054; Potier B, 2010, AGING CELL, V9, P722, DOI 10.1111/j.1474-9726.2010.00593.x; Rodriguez-Revenga L, 2009, EUR J HUM GENET, V17, P1359, DOI 10.1038/ejhg.2009.51; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2007, AM J MED GENET B, V144B, P566, DOI 10.1002/ajmg.b.30482; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Tessier CR, 2011, NEUROBIOL DIS, V41, P147, DOI 10.1016/j.nbd.2010.09.002; Wenzel HJ, 2010, BRAIN RES, V1318, P155, DOI 10.1016/j.brainres.2009.12.077; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Yuskaitis CJ, 2010, BBA-MOL BASIS DIS, V1802, P1006, DOI 10.1016/j.bbadis.2010.06.015; Zur Nieden R, 2006, CEREB CORTEX, V16, P676, DOI 10.1093/cercor/bhj013	55	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13831	13841		10.1074/jbc.M112.441055	http://dx.doi.org/10.1074/jbc.M112.441055			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23553633	Green Published, hybrid			2022-12-25	WOS:000318850300064
J	Bao, SJ; Zhu, LB; Zhuang, Q; Wang, L; Xu, PX; Itoh, K; Holzman, IR; Lin, J				Bao, Sujin; Zhu, Libin; Zhuang, Qiang; Wang, Lucia; Xu, Pin-Xian; Itoh, Keiji; Holzman, Ian R.; Lin, Jing			Distribution Dynamics of Recombinant Lactobacillus in the Gastrointestinal Tract of Neonatal Rats	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; NECROTIZING ENTEROCOLITIS; MONITOR LACTOBACILLUS; PROBIOTICS; DELIVERY; INFANTS	One approach to deliver therapeutic agents, especially proteins, to the gastro-intestinal (GI) tract is to use commensal bacteria as a carrier. Germs Lactobacillus is an attractive candidate for use in this approach. However, a system for expressing exogenous proteins at a high level has been lacking in Lactobacillus. Moreover, it will be necessary to introduce the recombinant Lactobacillus into the GI tract, ideally by oral administration. Whether orally administered Lactobacillus can each and reside in the GI tract has not been explored in neonates. In this study, we have examined these issues in neonatal rats. To achieve a high level of protein expression in Lactobacillus, we tested the impact of three promoters and two backbones on protein expression levels using mRFP1, a red fluorescent protein, as a reporter. We found that a combination of an L-lactate dehydrogenase (IdhL) promoter of Lactobacillus sakei with a backbone from pLEM415 yielded the highest level of reporter expression. When this construct was used to transform Lactobacillus case!, Lactobacillus delbrueckii and Lactobacillus acidophilus, high levels of mRFP1 were detected in all these species and colonies of transformed Lactobacillus appeared pink under visible light. To test whether orally administered Lactobacillus can be retained in the GI tract of neonates, we fed the recombinant Lactobacillus casei to neonatal rats. We found that about 3% of the bacteria were retained in the GI tract of the rats at 24 h after oral feeding with more recombinant Lactobacillus in the stomach and small intestine than in the cecum and colon. No mortality was observed throughout this study with Lactobacillus. In contrast, all neonatal rats died within 24 hours after fed with transformed E. coli. Taken together, our results indicate that Lactobacillus has the potential to be used as a vehicle for the delivery of therapeutic agents to neonates.	[Bao, Sujin] St James Sch Med, Bonaire, Netherlands; [Bao, Sujin; Zhu, Libin; Lin, Jing] Wenzhou Med Coll, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Zhuang, Qiang] Wenzhou Med Coll, Affiliated Hosp 1, Wenzhou, Peoples R China; [Wang, Lucia; Xu, Pin-Xian; Itoh, Keiji; Holzman, Ian R.; Lin, Jing] Icahn Sch Med Mt Sinai, New York, NY USA	Wenzhou Medical University; Wenzhou Medical University; Icahn School of Medicine at Mount Sinai	Bao, SJ (corresponding author), St James Sch Med, Bonaire, Netherlands.	baosujin@yahoo.com; jing.lin@mssm.edu	Lin, Jing/I-5293-2019	Lin, Jing/0000-0002-4405-134X	NIH [R03-HD060753]; KMD Foundation [33431-7746]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD060753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KMD Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the NIH R03-HD060753 (to J.L.) and the KMD Foundation (2424 N Federal Hwy Ste 454 Boca Raton, Florida 33431-7746) (to S.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Deshpande G, 2010, PEDIATRICS, V125, P921, DOI 10.1542/peds.2009-1301; Duwat P, 1997, J BACTERIOL, V179, P4473, DOI 10.1128/jb.179.14.4473-4479.1997; Fanaroff AA, 2007, AM J OBSTET GYNECOL, V196; Fons M, 1997, PLASMID, V37, P199, DOI 10.1006/plas.1997.1290; Gory L, 2001, FEMS MICROBIOL LETT, V194, P127, DOI 10.1111/j.1574-6968.2001.tb09457.x; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Kelly D, 2011, J Pediatr Gastroenterol Nutr, V53 Suppl 2, pS32; Khani Soghra, 2012, Inflammation & Allergy Drug Targets, V11, P79; Kuwahara A, 2010, J BIOSCI BIOENG, V109, P189, DOI 10.1016/j.jbiosc.2009.08.002; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Lizier M, 2010, FEMS MICROBIOL LETT, V308, P8, DOI 10.1111/j.1574-6968.2010.01978.x; MARTEAU P, 1993, FEMS MICROBIOL REV, V12, P207, DOI [10.1016/0168-6445(93)90064-G, 10.1111/j.1574-6976.1993.tb00019.x]; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Steidler L, 2006, ANN NY ACAD SCI, V1072, P176, DOI 10.1196/annals.1326.031; THADEPALLI H, 1979, AM J SURG, V138, P845, DOI 10.1016/0002-9610(79)90309-X; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vanderhoof JA, 2000, J PEDIATR GASTR NUTR, V30, pS34, DOI 10.1097/00005176-200000002-00006; VANDERVOSSEN JMBM, 1987, APPL ENVIRON MICROB, V53, P2452, DOI 10.1128/AEM.53.10.2452-2457.1987; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Yu QH, 2007, FEMS MICROBIOL LETT, V275, P207, DOI 10.1111/j.1574-6968.2007.00877.x	24	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60007	10.1371/journal.pone.0060007	http://dx.doi.org/10.1371/journal.pone.0060007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544119	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700078
J	Ferreira, R; Artali, R; Benoit, A; Gargallo, R; Eritja, R; Ferguson, DM; Sham, YY; Mazzini, S				Ferreira, Ruben; Artali, Roberto; Benoit, Adam; Gargallo, Raimundo; Eritja, Ramon; Ferguson, David M.; Sham, Yuk Y.; Mazzini, Stefania			Structure and Stability of Human Telomeric G-Quadruplex with Preclinical 9-Amino Acridines	PLOS ONE			English	Article							PROXIMAL PROMOTER REGION; FORCE-FIELD; DNA; BINDING; TARGET; RECOGNITION; SELECTIVITY; DYNAMICS; GENE; NMR	G-quadruplexes are higher-order DNA structures formed from guanine-rich sequences, and have been identified as attractive anticancer drug targets. Elucidating the three-dimensional structure of G-quadruplex with 9-amino acridines and the specific interactions involved in binding selectivity are the key to understanding their mechanism of action. Fluorescence titration assays, competitive dialysis and NMR studies have been used to study the binding specificity of 9-amino acridines to DNA. Structural models of the complexes with the telomeric DNA G-quadruplex based on NMR measurements were developed and further examined by molecular dynamics simulations and free energy calculations. Selective binding of 9-amino acridines for G-quadruplex sequences were observed. These compounds bind between A and G-tetrads, involving significant pi-pi interactions and several strong hydrogen bonds. The specific interactions between different moieties of the 9-amino acridines to the DNA were examined and shown to play a significant role in governing the overall stabilities of DNA G-quadruplex complexes. Both 9-amino acridines, with similar binding affinities to the G-quadruplex, were shown to induce different level of structural stabilization through intercalation. This unique property of altering structural stability is likely a contributing factor for affecting telomerase function and, subsequently, the observed differences in the anticancer activities between the two 9-amino acridines.	[Ferreira, Ruben; Eritja, Ramon] CIBER BBN Networking Ctr Bioengn Biomat & Nanomed, IQAC CSIC, Inst Res Biomed, Barcelona, Spain; [Benoit, Adam; Ferguson, David M.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Gargallo, Raimundo] Univ Barcelona, Dept Analyt Chem, E-08028 Barcelona, Spain; [Sham, Yuk Y.] Univ Minnesota, Acad Hlth Ctr, Ctr Drug Design, Minneapolis, MN USA; [Mazzini, Stefania] Univ Milan, Dept Organ Chem, Dept Food Environm & Nutr Sci DEFENS, Milan, Italy	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Minnesota System; University of Minnesota Twin Cities; University of Barcelona; University of Minnesota System; University of Minnesota Twin Cities; University of Milan	Mazzini, S (corresponding author), Univ Milan, Dept Organ Chem, Dept Food Environm & Nutr Sci DEFENS, Milan, Italy.	stefania.mazzini@unimi.it	Sham, Yuk Y/A-6472-2011; Gargallo, Raimundo/A-6084-2017; Eritja, Ramon/B-5613-2008	Sham, Yuk Y/0000-0003-2601-8930; Gargallo, Raimundo/0000-0001-8716-8356; Eritja, Ramon/0000-0001-5383-9334; Scaglioni, Leonardo/0000-0002-9971-100X; Ferguson, David/0000-0001-6294-8057	Spanish Ministerio de Ciencia e Innovacion MICINN [CTQ2008-00177, CTQ2010-20541]; Generalitat de Catalunya [2009/SGR/208]; EU [MP0802]; University of Milano [PUR09]; MIUR [PRIN09]	Spanish Ministerio de Ciencia e Innovacion MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); EU(European Commission); University of Milano; MIUR(Ministry of Education, Universities and Research (MIUR))	This work was partially supported by grants from Spanish Ministerio de Ciencia e Innovacion MICINN (CTQ2008-00177, CTQ2010-20541), Generalitat de Catalunya, (2009/SGR/208), the EU COST action (MP0802), the University of Milano (PUR09) and by MIUR (Funds PRIN09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimondo P. B., 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P219, DOI 10.2174/1568011013354642; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Belmont P, 2007, ANTI-CANCER AGENT ME, V7, P139, DOI 10.2174/187152007780058669; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; BORTOLINI R, 1994, APPL MAGN RESON, V7, P71, DOI 10.1007/BF03162548; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Campbell NH, 2009, BIOCHEMISTRY-US, V48, P1675, DOI 10.1021/bi802233v; Cheng MK, 2008, J MED CHEM, V51, P963, DOI 10.1021/jm070587t; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Denny WA, 2002, CURR MED CHEM, V9, P1655; Dyson RM, 1997, ANAL CHIM ACTA, V353, P381, DOI 10.1016/S0003-2670(97)87800-2; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; Ferreira R, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/489060; Franceschin M, 2006, BIOORG MED CHEM LETT, V16, P1707, DOI 10.1016/j.bmcl.2005.12.001; Frisch M., 2016, GAUSSIAN 16 REVISION; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Goddard T. D., 2004, SPARKY, V3; Goodell JR, 2008, J MED CHEM, V51, P179, DOI 10.1021/jm701228e; Goodell JR, 2006, BIOORGAN MED CHEM, V14, P5467, DOI 10.1016/j.bmc.2006.04.044; GORENSTEIN DG, 1994, CHEM REV, V94, P1315, DOI 10.1021/cr00029a007; Granotier C, 2005, NUCLEIC ACIDS RES, V33, P4182, DOI 10.1093/nar/gki722; Gros J, 2007, NUCLEIC ACIDS RES, V35, P3064, DOI 10.1093/nar/gkm111; Guo K, 2007, J AM CHEM SOC, V129, P10220, DOI 10.1021/ja072185g; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; Hounsou C, 2007, CHEMMEDCHEM, V2, P655, DOI 10.1002/cmdc.200600286; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Mazzini S, 2004, ORG BIOMOL CHEM, V2, P505, DOI 10.1039/b312780j; Mazzini S, 1998, J CHEM SOC PERK T 2, P1983, DOI 10.1039/a802350f; Mazzini S, 2010, BIOORGAN MED CHEM, V18, P1497, DOI 10.1016/j.bmc.2010.01.012; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Naasani I, 1999, CANCER RES, V59, P4004; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Oppegard LM, 2009, EUR J PHARMACOL, V602, P223, DOI 10.1016/j.ejphar.2008.11.044; Palchaudhuri R, 2007, CURR OPIN BIOTECH, V18, P497, DOI 10.1016/j.copbio.2007.09.006; Phan AT, 2004, J AM CHEM SOC, V126, P8710, DOI 10.1021/ja048805k; Ragazzon P, 2007, METHODS, V43, P313, DOI 10.1016/j.ymeth.2007.08.003; Ragg E, 1998, J CHEM SOC P2, V2, P149; Rao L, 2011, J PHYS CHEM B, V115, P13701, DOI 10.1021/jp207265s; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sponer J, METHODS; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Sun D, 2008, MOL CANCER THER, V7, P880, DOI 10.1158/1535-7163.MCT-07-2119; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Topcu Z, 2001, J CLIN PHARM THER, V26, P405, DOI 10.1046/j.1365-2710.2001.00368.x; WANG Y, 1993, J MOL BIOL, V234, P1171, DOI 10.1006/jmbi.1993.1668; WANG Y, 1992, BIOCHEMISTRY-US, V31, P8112, DOI 10.1021/bi00150a002; White EW, 2007, BIOPHYS CHEM, V126, P140, DOI 10.1016/j.bpc.2006.06.006; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0	65	25	26	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e57701	10.1371/journal.pone.0057701	http://dx.doi.org/10.1371/journal.pone.0057701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554865	Green Published, gold			2022-12-25	WOS:000316409800009
J	Hansen, R; Berry, SH; Mukhopadhya, I; Thomson, JM; Saunders, KA; Nicholl, CE; Bisset, WM; Loganathan, S; Mahdi, G; Kastner-Cole, D; Barclay, AR; Bishop, J; Flynn, DM; McGrogan, P; Russell, RK; El-Omar, EM; Hold, GL				Hansen, Richard; Berry, Susan H.; Mukhopadhya, Indrani; Thomson, John M.; Saunders, Karin A.; Nicholl, Charlotte E.; Bisset, W. Michael; Loganathan, Sabarinathan; Mahdi, Gamal; Kastner-Cole, Dagmar; Barclay, Andy R.; Bishop, Jon; Flynn, Diana M.; McGrogan, Paraic; Russell, Richard K.; El-Omar, Emad M.; Hold, Georgina L.			The Microaerophilic Microbiota of De-Novo Paediatric Inflammatory Bowel Disease: The BISCUIT Study	PLOS ONE			English	Article							CAMPYLOBACTER-CONCISUS; CROHNS; DIVERSITY; CHILDREN; ASSOCIATION; IDENTIFICATION; BILE; PCR	Introduction: Children presenting for the first time with inflammatory bowel disease (IBD) offer a unique opportunity to study aetiological agents before the confounders of treatment. Microaerophilic bacteria can exploit the ecological niche of the intestinal epithelium; Helicobacter and Campylobacter are previously implicated in IBD pathogenesis. We set out to study these and other microaerophilic bacteria in de-novo paediatric IBD. Patients and Methods: 100 children undergoing colonoscopy were recruited including 44 treatment naive de-novo IBD patients and 42 with normal colons. Colonic biopsies were subjected to microaerophilic culture with Gram-negative isolates then identified by sequencing. Biopsies were also PCR screened for the specific microaerophilic bacterial groups: Helicobacteraceae, Campylobacteraceae and Sutterella wadsworthensis. Results: 129 Gram-negative microaerophilic bacterial isolates were identified from 10 genera. The most frequently cultured was S. wadsworthensis (32 distinct isolates). Unusual Campylobacter were isolated from 8 subjects (including 3 C. concisus, 1 C. curvus, 1 C. lari, 1 C. rectus, 3 C. showae). No Helicobacter were cultured. When comparing IBD vs. normal colon control by PCR the prevalence figures were not significantly different (Helicobacter 11% vs. 12%, p = 1.00; Campylobacter 75% vs. 76%, p = 1.00; S. wadsworthensis 82% vs. 71%, p = 0.312). Conclusions: This study offers a comprehensive overview of the microaerophilic microbiota of the paediatric colon including at IBD onset. Campylobacter appear to be surprisingly common, are not more strongly associated with IBD and can be isolated from around 8% of paediatric colonic biopsies. S. wadsworthensis appears to be a common commensal. Helicobacter species are relatively rare in the paediatric colon.	[Hansen, Richard; Berry, Susan H.; Mukhopadhya, Indrani; Thomson, John M.; Saunders, Karin A.; Nicholl, Charlotte E.; El-Omar, Emad M.; Hold, Georgina L.] Univ Aberdeen, Gastrointestinal Res Grp, Div Appl Med, Aberdeen, Scotland; [Hansen, Richard] Univ Aberdeen, Royal Aberdeen Childrens Hosp, Aberdeen, Scotland; [Bisset, W. Michael; Loganathan, Sabarinathan; Mahdi, Gamal] Royal Aberdeen Childrens Hosp, Dept Paediat Gastroenterol, Aberdeen, Scotland; [Kastner-Cole, Dagmar] Univ Dundee, Ninewells Hosp & Med Sch, Dept Paediat, Dundee DD1 9SY, Scotland; [Barclay, Andy R.; Bishop, Jon; Flynn, Diana M.; McGrogan, Paraic; Russell, Richard K.] Royal Hosp Sick Children, Dept Paediat Gastroenterol, Glasgow G3 8SJ, Lanark, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Dundee; University of Glasgow	Hold, GL (corresponding author), Univ Aberdeen, Gastrointestinal Res Grp, Div Appl Med, Foresterhill, Aberdeen, Scotland.	g.l.hold@abdn.ac.uk	Mukhopadhya, Indrani/K-1113-2019; Hold, Georgina Louise/AAG-9923-2020; El-Omar, Emad/AAT-7780-2021	Mukhopadhya, Indrani/0000-0003-2577-518X; Hold, Georgina Louise/0000-0001-7573-3397; Hansen, Richard/0000-0002-3944-6646; El-Omar, Emad/0000-0002-0011-3924	Chief Scientist Office in Scotland [CAF/08/01]; NHS Research Scotland career fellowship award; Yorkhill IBD fund; Chief Scientist Office [CAF/08/01] Funding Source: researchfish	Chief Scientist Office in Scotland; NHS Research Scotland career fellowship award; Yorkhill IBD fund; Chief Scientist Office	This work was funded by a Clinical Academic Training Fellowship from the Chief Scientist Office in Scotland (CAF/08/01) which also funded the salary of RH. The Royal Hospital for Sick Children, Glasgow IBD team is generously supported by the Catherine McEwan Foundation and the Yorkhill IBD fund. RKR is supported by an NHS Research Scotland career fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SJ, 2003, ALIMENT PHARM THER, V18, P481, DOI 10.1046/j.1365-2036.2003.01703.x; Benach JL, 2012, MBIO, V3, DOI 10.1128/mBio.00019-12; Benchimol EI, 2011, INFLAMM BOWEL DIS, V17, P423, DOI 10.1002/ibd.21349; Bohr URM, 2004, J CLIN MICROBIOL, V42, P2766, DOI 10.1128/JCM.42.6.2766-2768.2004; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; ELOMAR E, 1994, GUT, V35, P1385, DOI 10.1136/gut.35.10.1385; Escher JC, 2005, J PEDIATR GASTR NUTR, V41, P1; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; Grehan M, 2004, J CLIN MICROBIOL, V42, P874, DOI 10.1128/JCM.42.2.874-876.2004; Grehan M, 2002, APPL ENVIRON MICROB, V68, P5164, DOI 10.1128/AEM.68.10.5164-5166.2002; Hansen R, 2010, J GASTROENTEROL, V45, P266, DOI 10.1007/s00535-009-0191-y; Hansen R, 2012, AM J GASTROENTEROL, V107, P1913, DOI 10.1038/ajg.2012.335; Hansen R, 2011, FEMS IMMUNOL MED MIC, V61, P1, DOI 10.1111/j.1574-695X.2010.00744.x; Henderson P, 2012, INFLAMM BOWEL DIS, V18, P999, DOI 10.1002/ibd.21797; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Hope B, 2012, ARCH DIS CHILD, V97, P590, DOI 10.1136/archdischild-2011-300651; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaakoush NO, 2010, HELICOBACTER, V15, P549, DOI 10.1111/j.1523-5378.2010.00792.x; Keenan JI, 2010, COLORECTAL DIS, V12, P48, DOI 10.1111/j.1463-1318.2008.01672.x; Kronman MP, 2012, PEDIATRICS, V130, pE794, DOI 10.1542/peds.2011-3886; Kugathasan S, 2007, GUT, V56, P1696, DOI 10.1136/gut.2006.116467; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Laharie D, 2009, ALIMENT PHARM THER, V30, P283, DOI 10.1111/j.1365-2036.2009.04034.x; Lastovica AJ, 2000, J CLIN MICROBIOL, V38, P2798; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Linton D, 1996, RES MICROBIOL, V147, P707, DOI 10.1016/S0923-2508(97)85118-2; Mahendran V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025417; Man SM, 2008, HELICOBACTER, V13, P234, DOI 10.1111/j.1523-5378.2008.00607.x; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Martin-de-Carpi J, 2013, INFLAMM BOWEL DIS, V19, P73, DOI 10.1002/ibd.22980; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027076; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021490; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Shaw SY, 2010, AM J GASTROENTEROL, V105, P2687, DOI 10.1038/ajg.2010.398; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Thomson JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017184; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081; Wexler HM, 1996, INT J SYST BACTERIOL, V46, P252, DOI 10.1099/00207713-46-1-252; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Zhang L, 2006, J CLIN MICROBIOL, V44, P2276, DOI 10.1128/JCM.02017-05; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	50	53	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58825	10.1371/journal.pone.0058825	http://dx.doi.org/10.1371/journal.pone.0058825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554935	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000316252500048
J	Khusal, R; Dias, BD; Moodley, K; Penny, C; Reusch, U; Knackmuss, S; Little, M; Weiss, SFT				Khusal, Raksha; Dias, Bianca Da Costa; Moodley, Kiashanee; Penny, Clement; Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn; Weiss, Stefan F. T.			In Vitro Inhibition of Angiogenesis by Antibodies Directed against the 37kDa/67kDa Laminin Receptor	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPRESSION; CELLS; PROTEIN; LUNG; INVOLVEMENT; PROGRESSION; INVASION; COLON; GENE	The 37kDa/67kDa laminin receptor (LRP/LR) is a central receptor mediating interactions between tumour cells and the basement membrane and is thereby a key player in adhesion and invasion, essential processes in metastatic cancer. To affect continued tumour growth, tumours induce angiogenesis for the constant delivery of nutrients and oxygen. This study aims to determine the blocking effect of the anti-LRP/LR specific antibody, W3 on the angiogenic potential of HUVE (human umbilical vein endothelial) cells. Flow cytometric analysis revealed that 97% of HUVE cells display cell surface LRP/LR. An angiogenesis assay was conducted employing HUVE cells seeded on the basement membrane reconstituent Matrigel (TM) supplemented with the pro-angiogenic factor vascular endothelial growth factor (VEGF). Post 18h incubation at 37 degrees C tubular structures, namely tube lengths were assessed. Treatment of established tubular structures with 100 mg/ml anti-LRP/LR specific antibody completely blocked angiogenesis. Our findings suggest a central role of the 37kDa/67kDa LRP/LR in tube formation and recommends anti-LRP/LR specific antibodies as potential therapeutic tools for treatment of tumour angiogenesis.	[Khusal, Raksha; Dias, Bianca Da Costa; Moodley, Kiashanee; Weiss, Stefan F. T.] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa; [Penny, Clement] Univ Witwatersrand, Dept Internal Med, Johannesburg, South Africa; [Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn] Affimed Therapeut AG, Heidelberg, Germany	University of Witwatersrand; University of Witwatersrand	Weiss, SFT (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa.	stefan.weiss@wits.ac.za			National Research Foundation, the Republic of South Africa; Medical Research Council, the Republic of South Africa	National Research Foundation, the Republic of South Africa; Medical Research Council, the Republic of South Africa	This work was supported by the National Research Foundation, the Republic of South Africa and the Medical Research Council, the Republic of South Africa. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s), and therefore, the National Research Foundation does not accept any liability in this regard thereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlSaleh W, 1997, J PATHOL, V181, P287, DOI 10.1002/(SICI)1096-9896(199703)181:3<287::AID-PATH762>3.0.CO;2-W; Ardini E, 2002, CANCER RES, V62, P1321; Bargagna-Mohan P, 2006, INVEST OPHTH VIS SCI, V47, P4138, DOI 10.1167/iovs.05-1452; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Berno V, 2005, ENDOCR-RELAT CANCER, V12, P393, DOI 10.1677/erc.1.00870; Chen ZJ, 2009, J NEURO-ONCOL, V92, P121, DOI 10.1007/s11060-008-9742-y; CIOCE V, 1991, J NATL CANCER I, V83, P29, DOI 10.1093/jnci/83.1.29; de Manzoni G, 1998, ONCOLOGY-BASEL, V55, P456, DOI 10.1159/000011895; DELISSER HM, 1994, IMMUNOL TODAY, V15, P490, DOI 10.1016/0167-5699(94)90195-3; Dixelius J, 2004, J BIOL CHEM, V279, P23766, DOI 10.1074/jbc.M311675200; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fontanini G, 1997, CLIN CANCER RES, V3, P861; GASPARINI G, 1995, INT J CANCER, V60, P604, DOI 10.1002/ijc.2910600506; GRANT DS, 1992, J CELL PHYSIOL, V153, P614, DOI 10.1002/jcp.1041530324; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Hamid SA, 2003, MICROVASC RES, V66, P159, DOI 10.1016/S0026-2862(03)00054-2; Izuta H, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-45; KLAGSBRUN M, 1991, J CELL BIOCHEM, V47, P199, DOI 10.1002/jcb.240470302; Mbazima V, 2010, FRONT BIOSCI-LANDMRK, V15, P1150, DOI 10.2741/3667; Moehler TM, 2008, J CELL PHYSIOL, V215, P27, DOI 10.1002/jcp.21285; Moodley K, PLOS ONE IN PRESS; Nadji M, 1999, CANCER-AM CANCER SOC, V85, P432, DOI 10.1002/(SICI)1097-0142(19990115)85:2<432::AID-CNCR22>3.0.CO;2-J; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Omar A, 2011, EXPERT OPIN THER PAT, V21, P35, DOI 10.1517/13543776.2011.539203; Pelosi G, 1997, J PATHOL, V183, P62, DOI 10.1002/(SICI)1096-9896(199709)183:1<62::AID-PATH1095>3.0.CO;2-A; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; SCHNAPER HW, 1993, KIDNEY INT, V43, P20, DOI 10.1038/ki.1993.5; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Simon-Assmann P, 2011, INT J DEV BIOL, V55, P455, DOI 10.1387/ijdb.103223ps; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Tanaka M, 2000, CANCER LETT, V153, P161, DOI 10.1016/S0304-3835(00)00365-7; Veeravagu A, 2007, RECENT PAT ANTI-CANC, V2, P59, DOI 10.2174/157489207779561426; Waltregny D, 1997, JNCI-J NATL CANCER I, V89, P1224, DOI 10.1093/jnci/89.16.1224; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	39	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58888	10.1371/journal.pone.0058888	http://dx.doi.org/10.1371/journal.pone.0058888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554951	Green Published, gold			2022-12-25	WOS:000316252500053
J	Pelzer, ES; Allan, JA; Waterhouse, MA; Ross, T; Beagley, KW; Knox, CL				Pelzer, Elise S.; Allan, John A.; Waterhouse, Mary A.; Ross, Tara; Beagley, Kenneth W.; Knox, Christine L.			Microorganisms within Human Follicular Fluid: Effects on IVF	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; IMMUNODEFICIENCY-VIRUS TYPE-1; STIMULATING-HORMONE BINDING; MICROBIAL-FLORA; EMBRYO-TRANSFER; GARDNERELLA-VAGINALIS; BACTERIAL VAGINOSIS; ENDOMETRIUM; INFERTILITY; RECURRENCE	Our previous study reported microorganisms in human follicular fluid. The objective of this study was to test human follicular fluid for the presence of microorganisms and to correlate these findings with the in vitro fertilization (IVF) outcomes. In this study, 263 paired follicular fluids and vaginal swabs were collected from women undergoing IVF cycles, with various causes for infertility, and were cultured to detect microorganisms. The cause of infertility and the IVF outcomes for each woman were correlated with the microorganisms detected within follicular fluid collected at the time of transvaginal oocyte retrieval. Microorganisms isolated from follicular fluids were classified as: (1) 'colonizers' if microorganisms were detected within the follicular fluid, but not within the vaginal swab (at the time of oocyte retrieval); or (2) 'contaminants' if microorganisms detected in the vagina at the time of oocyte retrieval were also detected within the follicular fluid. The presence of Lactobacillus spp. in ovarian follicular fluids was associated with embryo maturation and transfer. This study revealed microorganisms in follicular fluid itself and that the presence of particular microorganisms has an adverse affect on IVF outcomes as seen by an overall decrease in embryo transfer rates and pregnancy rates in both fertile and infertile women, and live birth rates in women with idiopathic infertility. Follicular fluid microorganisms are a potential cause of adverse pregnancy outcomes in IVF in both infertile women and in fertile women with infertile male partners.	[Pelzer, Elise S.; Beagley, Kenneth W.; Knox, Christine L.] Queensland Univ Technol, Fac Sci & Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Pelzer, Elise S.; Waterhouse, Mary A.] Wesley Hosp, Womens Hlth Lab, Wesley Res Inst, Auchenflower, Qld, Australia; [Allan, John A.; Ross, Tara] Wesley Hosp, Wesley Hosp, Wesley Monash IVF, Auchenflower, Qld, Australia	Queensland University of Technology (QUT); Wesley Hospital; Wesley Hospital	Pelzer, ES (corresponding author), Queensland Univ Technol, Fac Sci & Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	epelzer@wesleyresearch.com.au	Beagley, Kenneth/J-1129-2012	Beagley, Kenneth/0000-0003-3112-6557; Knox, Christine/0000-0003-3997-6812; Pelzer, Elise/0000-0002-9825-7968	Wesley Research Institute	Wesley Research Institute	This work was supported by a Wesley Research Institute Grant. Laboratory work was performed in the John and Wendy Thorsen Women's Health Laboratory at the Wesley Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fozan H, 2003, OBSTET GYNECOL, V101, P164, DOI 10.1016/S0029-7844(02)02446-8; Bradshaw CS, 2006, J INFECT DIS, V194, P828, DOI 10.1086/506621; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Bricou A, 2008, EUR J OBSTET GYN R B, V138, P127, DOI 10.1016/j.ejogrb.2008.01.014; Busacca M, 2009, J MINIM INVAS GYN, V16, P142, DOI 10.1016/j.jmig.2008.12.013; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Cottell E, 1996, FERTIL STERIL, V66, P776, DOI 10.1016/S0015-0282(16)58635-X; Debattista Joseph, 2004, Infect Dis Obstet Gynecol, V12, P135, DOI 10.1080/10647440400020703; Eckert Linda O, 2003, Infect Dis Obstet Gynecol, V11, P11, DOI 10.1155/S1064744903000024; Egbase PE, 1996, HUM REPROD, V11, P1687; Egbase PE, 1999, LANCET, V354, P651, DOI 10.1016/S0140-6736(99)02415-0; Fanchin R, 1998, FERTIL STERIL, V70, P866, DOI 10.1016/S0015-0282(98)00277-5; Fukuda M, 2000, HUM REPROD, V15, P1921, DOI 10.1093/humrep/15.9.1921; GOULET M, 1995, J CLIN MICROBIOL, V33, P2823, DOI 10.1128/JCM.33.11.2823-2825.1995; GURGAN T, 1993, HUM REPROD, V8, P508; Hyman RW, 2012, J ASSIST REPROD GEN, V29, P105, DOI 10.1007/s10815-011-9694-6; Jakobsson Tell, 2008, Ann Clin Microbiol Antimicrob, V7, P14, DOI 10.1186/1476-0711-7-14; KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94; KLEBANOFF SJ, 1991, J EXP MED, V174, P289, DOI 10.1084/jem.174.1.289; Lan KC, 2010, FERTIL STERIL, V93, P2269, DOI 10.1016/j.fertnstert.2008.12.123; Last RJ., 1984, ANATOMY REGIONAL APP; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; McClure EM, 2009, SEMIN FETAL NEONAT M, V14, P182, DOI 10.1016/j.siny.2009.02.003; MOLLER BR, 1985, J REPROD FERTIL, V73, P237; Moore DE, 2000, FERTIL STERIL, V74, P1118, DOI 10.1016/S0015-0282(00)01624-1; Pelzer ES, 2011, HUM REPROD, V26, P1799, DOI 10.1093/humrep/der108; POTASHNIK G, 1987, BRIT MED J, V294, P219, DOI 10.1136/bmj.294.6566.219; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Romero R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/j.1365-3016.2001.00007.x; Sharpe K, 2006, FERTIL STERIL, V86, P11; SLUSS PM, 1983, BIOL REPROD, V29, P335, DOI 10.1095/biolreprod29.2.335; SLUSS PM, 1983, BIOL REPROD, V29, P1105, DOI 10.1095/biolreprod29.5.1105; SLUSS PM, 1994, EUR J ENDOCRINOL, V130, P259, DOI 10.1530/eje.0.1300259; SPENCE MR, 1982, SEX TRANSM DIS, V9, P37, DOI 10.1097/00007435-198201000-00007; Srinivasan S, 2008, INTERDISCIP PERSPECT, V2008; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Swidsinski A, 2011, FEMS IMMUNOL MED MIC, V61, P41, DOI 10.1111/j.1574-695X.2010.00743.x; Sznurkowski Jacek, 2005, Ginekol Pol, V76, P33; Toth A., 2011, Clinical and Experimental Medical Journal, V5, P143; Toth A, 2007, J GYNECOLOGY OBSTET, P7; Vercellini P, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.010; Viniker DA, 1999, HUM REPROD UPDATE, V5, P373, DOI 10.1093/humupd/5.4.373; WIEBOLD JL, 1987, J REPROD FERTIL, V79, P125, DOI 10.1530/jrf.0.0790125; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343	45	55	61	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59062	10.1371/journal.pone.0059062	http://dx.doi.org/10.1371/journal.pone.0059062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554970	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500064
J	Stipp, RN; Boisvert, H; Smith, DJ; Hofling, JF; Duncan, MJ; Mattos-Graner, RO				Stipp, Rafael N.; Boisvert, Heike; Smith, Daniel J.; Hoefling, Jose F.; Duncan, Margaret J.; Mattos-Graner, Renata O.			CovR and VicRK Regulate Cell Surface Biogenesis Genes Required for Biofilm Formation in Streptococcus mutans	PLOS ONE			English	Article							GLUCAN-BINDING-PROTEIN; GLUCOSYLTRANSFERASE GTFBC OPERON; SIGNAL-TRANSDUCTION PATHWAY; YYCF RESPONSE REGULATOR; GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; ORAL STREPTOCOCCI; MUREIN HYDROLASE; PNEUMONIAE R6; IN-VIVO	The two-component system VicRK and the orphan regulator CovR of Streptococcus mutans co-regulate a group of virulence genes associated with the synthesis of and interaction with extracellular polysaccharides of the biofilm matrix. Knockout mutants of vicK and covR display abnormal cell division and morphology phenotypes, although the gene function defects involved are as yet unknown. Using transcriptomic comparisons between parent strain UA159 with vicK (UAvic) or covR (UAcov) deletion mutants together with electrophoretic motility shift assays (EMSA), we identified genes directly regulated by both VicR and CovR with putative functions in cell wall/surface biogenesis, including gbpB, wapE, smaA, SMU.2146c, and lysM. Deletion mutants of genes regulated by VicR and CovR (wapE, lysM, smaA), or regulated only by VicR (SMU.2146c) or CovR (epsC) promoted significant alterations in biofilm initiation, including increased fragility, defects in microcolony formation, and atypical cell morphology and/or chaining. Significant reductions in mureinolytic activity and/or increases in DNA release during growth were observed in knockout mutants of smaA, wapE, lysM, SMU.2146c and epsC, implying roles in cell wall biogenesis. WapE and lysM mutations also affected cell hydrophobicity and sensitivity to osmotic or oxidative stress. Finally, vicR, covR and VicRK/CovR-targets (gbpB, wapE, smaA, SMU.2146c, lysM, epsC) are up-regulated in UA159 during biofilm initiation, in a sucrose-dependent manner. These data support a model in which VicRK and CovR coordinate cell division and surface biogenesis with the extracellular synthesis of polysaccharides, a process apparently required for formation of structurally stable biofilms in the presence of sucrose.	[Stipp, Rafael N.; Hoefling, Jose F.; Mattos-Graner, Renata O.] Univ Campinas UNICAMP, Dept Oral Diag, Piracicaba Dent Sch, Sao Paulo, Brazil; [Boisvert, Heike; Duncan, Margaret J.] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Smith, Daniel J.] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA	Universidade Estadual de Campinas; Harvard University; Forsyth Institute; Harvard University; Forsyth Institute	Mattos-Graner, RO (corresponding author), Univ Campinas UNICAMP, Dept Oral Diag, Piracicaba Dent Sch, Sao Paulo, Brazil.	rmgraner@fop.unicamp.br	Stipp, Rafael Nobrega/D-4518-2011; Mattos-Graner, Renata O/C-9410-2012	Stipp, Rafael Nobrega/0000-0001-5305-1299; Mattos-Graner, Renata O/0000-0001-8309-8135	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [proc. 07/56100-2, 09/54182-7, proc. 06/55933-8]; National Institutes of Health (NIH) Fogarty award [R03-TW-06324]; CAPES (PNPD);  [R01 DE15931];  [R37 DE06153]; FOGARTY INTERNATIONAL CENTER [R03TW006324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE006153] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health (NIH) Fogarty award; CAPES (PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ; ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, proc. 07/56100-2 and 09/54182-7) and the National Institutes of Health (NIH) Fogarty award R03-TW-06324. RNS was supported by FAPESP (proc. 06/55933-8) and CAPES (PNPD, 2010). MJD was supported by R01 DE15931 and R37 DE06153. DJS was supported by R37 DE06153. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2007, J BACTERIOL, V189, P6293, DOI 10.1128/JB.00546-07; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; Biswas I, 2008, J BACTERIOL, V190, P68, DOI 10.1128/JB.00990-07; Biswas I, 2007, J BACTERIOL, V189, P6521, DOI 10.1128/JB.00825-07; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P14993, DOI 10.1021/bi001627x; Catt DM, 2005, J BACTERIOL, V187, P7863, DOI 10.1128/JB.187.22.7863-7865.2005; Chong P, 2008, J BACTERIOL, V190, P4478, DOI 10.1128/JB.01961-07; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Churchward G, 2009, MICROBIOL-SGM, V155, P566, DOI 10.1099/mic.0.024620-0; Dmitriev A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020127; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; Frankel MB, 2010, MOL MICROBIOL, V78, P238, DOI 10.1111/j.1365-2958.2010.07334.x; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; GIBBONS RJ, 1983, INFECT IMMUN, V41, P1190, DOI 10.1128/IAI.41.3.1190-1196.1983; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Hung DCI, 2011, J BACTERIOL, V193, P3642, DOI 10.1128/JB.00155-11; Idone V, 2003, INFECT IMMUN, V71, P4351, DOI 10.1128/IAI.71.8.4351-4360.2003; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Layec S, 2008, RES MICROBIOL, V159, P507, DOI 10.1016/j.resmic.2008.06.008; Levesque CM, 2005, INFECT IMMUN, V73, P3773, DOI 10.1128/IAI.73.6.3773-3777.2005; Li YH, 2001, MICROBIOL-SGM, V147, P2841, DOI 10.1099/00221287-147-10-2841; MACRINA FL, 1982, GENE, V19, P345, DOI 10.1016/0378-1119(82)90025-7; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mattos-Graner RO, 2001, INFECT IMMUN, V69, P6931, DOI 10.1128/IAI.69.11.6931-6941.2001; Miller AA, 2001, MOL MICROBIOL, V40, P976, DOI 10.1046/j.1365-2958.2001.02441.x; Nakano K, 2006, J CLIN MICROBIOL, V44, P3313, DOI 10.1128/JCM.00377-06; Negrini TC, 2012, ORAL DIS, V18, P485, DOI 10.1111/j.1601-0825.2011.01896.x; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Ng WL, 2003, MOL MICROBIOL, V50, P1647, DOI 10.1046/j.1365-2958.2003.03806.x; Reck M, 2011, J BACTERIOL, V193, P5692, DOI 10.1128/JB.05424-11; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Sato Y, 2000, FEMS MICROBIOL LETT, V186, P187, DOI 10.1111/j.1574-6968.2000.tb09102.x; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Senadheera DB, 2012, J BACTERIOL, V194, P1307, DOI 10.1128/JB.06071-11; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Shah DSH, 2004, MICROBIOL-SGM, V150, P1947, DOI 10.1099/mic.0.26955-0; Shemesh M, 2006, CARBOHYD RES, V341, P2090, DOI 10.1016/j.carres.2006.05.010; Shemesh M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-51; Smith DJ, 2008, CURR TOP MICROBIOL, V319, P131; Smith EG, 2012, J DENT RES, V91, P133, DOI 10.1177/0022034511415415; Stephenson K., 2002, Current Drug Targets - Infectious Disorders, V2, P235, DOI 10.2174/1568005023342443; Stipp RN, 2008, ORAL MICROBIOL IMMUN, V23, P466, DOI 10.1111/j.1399-302X.2008.00451.x; Tremblay YDN, 2009, MICROBIOL-SGM, V155, P2856, DOI 10.1099/mic.0.028456-0; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; WEXLER DL, 1993, INFECT IMMUN, V61, P1259, DOI 10.1128/IAI.61.4.1259-1267.1993; Winkler ME, 2008, J BACTERIOL, V190, P2645, DOI 10.1128/JB.01682-07	57	66	68	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58271	10.1371/journal.pone.0058271	http://dx.doi.org/10.1371/journal.pone.0058271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554881	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500019
J	Yu, LJ; Volkert, MR				Yu, Lijian; Volkert, Michael R.			Differential Requirement for SUB1 in Chromosomal and Plasmid Double-Strand DNA Break Repair	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; TRANSCRIPTIONAL ACTIVATION; HOMOLOGOUS RECOMBINATION; HUMAN COACTIVATOR; HUMAN PC4; YEAST; COMPLEX; DAMAGE; GENE	Non homologous end joining (NHEJ) is an important process that repairs double strand DNA breaks (DSBs) in eukaryotic cells. Cells defective in NHEJ are unable to join chromosomal breaks. Two different NHEJ assays are typically used to determine the efficiency of NHEJ. One requires NHEJ of linearized plasmid DNA transformed into the test organism; the other requires NHEJ of a single chromosomal break induced either by HO endonuclease or the I-SceI restriction enzyme. These two assays are generally considered equivalent and rely on the same set of NHEJ genes. PC4 is an abundant DNA binding protein that has been suggested to stimulate NHEJ. Here we tested the role of PC4's yeast homolog SUB1 in repair of DNA double strand breaks using different assays. We found SUB1 is required for NHEJ repair of DSBs in plasmid DNA, but not in chromosomal DNA. Our results suggest that these two assays, while similar are not equivalent and that repair of plasmid DNA requires additional factor(s) that are not required for NHEJ repair of chromosomal double-strand DNA breaks. Possible roles for Sub1 proteins in NHEJ of plasmid DNA are discussed.	[Yu, Lijian; Volkert, Michael R.] Univ Massachusetts, Sch Med, Worcester, MA 01610 USA	University of Massachusetts System; University of Massachusetts Worcester	Volkert, MR (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01610 USA.	michael.volkert@umassmed.edu	yu, lijian/GSE-1701-2022	Volkert, Michael/0000-0002-0045-0912	National Institutes of Health (NIH) [CA100122]; University of Massachusetts Medical School; NATIONAL CANCER INSTITUTE [R01CA100122] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Medical School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are partially funded by National Institutes of Health (NIH) CA100122 and the University of Massachusetts Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Batta K, 2009, J MOL BIOL, V385, P788, DOI 10.1016/j.jmb.2008.11.008; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Calvo O, 2005, EMBO J, V24, P1009, DOI 10.1038/sj.emboj.7600575; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Daley JM, 2005, MOL CELL BIOL, V25, P896, DOI 10.1128/MCB.25.3.896-906.2005; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Haber JE, 2002, METHOD ENZYMOL, V350, P141, DOI 10.1016/S0076-6879(02)50961-7; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hegde V, 2000, NUCLEIC ACIDS RES, V28, P2779, DOI 10.1093/nar/28.14.2779; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Henry NL, 1996, J BIOL CHEM, V271, P21842, DOI 10.1074/jbc.271.36.21842; Hiom K, 2010, DNA REPAIR, V9, P1256, DOI 10.1016/j.dnarep.2010.09.018; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; KAISER K, 1995, EMBO J, V14, P3520, DOI 10.1002/j.1460-2075.1995.tb07358.x; Karathanasis E, 2002, GENETICS, V161, P1015; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Knaus R, 1996, EMBO J, V15, P1933, DOI 10.1002/j.1460-2075.1996.tb00544.x; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Koyama H, 2008, GENES CELLS, V13, P1113, DOI 10.1111/j.1365-2443.2008.01229.x; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lisby M, 2003, CELL CYCLE, V2, P479, DOI 10.4161/cc.2.5.483; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Monnat RJ, 1999, BIOCHEM BIOPH RES CO, V255, P88, DOI 10.1006/bbrc.1999.0152; Moscariello M, 2010, YEAST, V27, P837, DOI 10.1002/yea.1789; Ohnishi T, 2009, MUTAT RES-FUND MOL M, V669, P8, DOI 10.1016/j.mrfmmm.2009.06.010; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Schar P, 1997, GENE DEV, V11, P1912, DOI 10.1101/gad.11.15.1912; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Sugawara N, 2006, METHOD ENZYMOL, V408, P416, DOI 10.1016/S0076-6879(06)08026-8; Tachibana A, 2004, ADV BIOPHYS, V38, P21, DOI 10.1016/S0065-227X(04)80046-7; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van den Bosch M, 2002, BIOL CHEM, V383, P873; van Heemst D, 2004, DNA REPAIR, V3, P43, DOI 10.1016/j.dnarep.2003.09.004; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang JY, 2004, MOL CELL BIOL, V24, P6084, DOI 10.1128/MCB.24.13.6084-6093.2004; Werten S, 1998, EMBO J, V17, P5103, DOI 10.1093/emboj/17.17.5103; Westmoreland JW, 2010, DNA REPAIR, V9, P617, DOI 10.1016/j.dnarep.2010.02.008; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Windhofer F, 2008, MUTAT RES-FUND MOL M, V638, P56, DOI 10.1016/j.mrfmmm.2007.08.016; Wu WH, 1999, GENETICS, V153, P643; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	57	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58015	10.1371/journal.pone.0058015	http://dx.doi.org/10.1371/journal.pone.0058015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554872	Green Submitted, Green Published, gold			2022-12-25	WOS:000316252500012
J	Malloy, MT; McIntosh, DJ; Walters, TS; Flores, A; Goodwin, JS; Arinze, IJ				Malloy, Melanie Theodore; McIntosh, Deneshia J.; Walters, Treniqka S.; Flores, Andrea; Goodwin, J. Shawn; Arinze, Ifeanyi J.			Trafficking of the Transcription Factor Nrf2 to Promyelocytic Leukemia-Nuclear Bodies IMPLICATIONS FOR DEGRADATION OF NRF2 IN THE NUCLEUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; ANTIOXIDANT RESPONSE; OXIDATIVE STRESS; COVALENT MODIFICATION; SENSOR KEAP1; PROTEIN PML; RAR-ALPHA; SUMO; ACTIVATION; RNF4	Ubiquitylation of Nrf2 by the Keap1-Cullin3/RING box1 (Cul3-Rbx1) E3 ubiquitin ligase complex targets Nrf2 for proteasomal degradation in the cytoplasm and is an extensively studied mechanism for regulating the cellular level of Nrf2. Although mechanistic details are lacking, reports abound that Nrf2 can also be degraded in the nucleus. Here, we demonstrate that Nrf2 is a target for sumoylation by both SUMO-1 and SUMO-2. HepG2 cells treated with As2O3, which enhances attachment of SUMO-2/3 to target proteins, increased SUMO-2/3-modification (polysumoylation) of Nrf2. We show that Nrf2 traffics, in part, to promyelocytic leukemia-nuclear bodies (PML-NBs). Cell fractions harboring key components of PML-NBs did not contain biologically active Keap1 but contained modified Nrf2 as well as RING finger protein 4 (RNF4), a poly-SUMO-specific E3 ubiquitin ligase. Overexpression of wild-type RNF4, but not the catalytically inactive mutant, decreased the steady-state levels of Nrf2, measured in the PML-NB-enriched cell fraction. The proteasome inhibitor MG-132 interfered with this decrease, resulting in elevated levels of polysumoylated Nrf2 that was also ubiquitylated. Wild-type RNF4 accelerated the half-life (t(1/2)) of Nrf2, measured in PML-NB-enriched cell fractions. These results suggest that RNF4 mediates polyubiquitylation of polysumoylated Nrf2, leading to its subsequent degradation in PML-NBs. Overall, this work identifies Nrf2 as a target for sumoylation and provides a novel mechanism for its degradation in the nucleus, independent of Keap1.	Meharry Med Coll, Sch Med, Dept Neurosci & Pharmacol, Nashville, TN 37208 USA; [Goodwin, J. Shawn] Meharry Med Coll, Sch Med, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Arinze, Ifeanyi J.] Meharry Med Coll, Sch Med, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College; Meharry Medical College	Arinze, IJ (corresponding author), Meharry Med Coll, Sch Med, Dept Physiol, Nashville, TN 37208 USA.	iarinze@mmc.edu			National Institutes of Health [SC1CA143985, 5T32HL007737, 2S21MD000104, 5T32 GM07628, U01NS041071, U54CA91408, U54RR026140, S10RR0254970]; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences [ULITR000445]; National Institutes of Health RISE Grant [5R25GM059994]; Medical Scientist Training Program Grant [T32GM07347]; NATIONAL CANCER INSTITUTE [U54CA163069, SC1CA143985, U54CA091408] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025497, U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, R25GM059994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041071] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award from the National Center for Advancing Translational Sciences; National Institutes of Health RISE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants SC1CA143985. This work was also supported by Clinical and Translational Science Award ULITR000445 from the National Center for Advancing Translational Sciences.; Supported by National Institutes of Health RISE Grant 5R25GM059994 (to the School of Graduate Studies and Research, Meharry Medical College) and by Medical Scientist Training Program Grant T32GM07347 (to Vanderbilt University Medical School).; Supported by National Institutes of Health Grants 5T32HL007737 and 2S21MD000104.; Supported by National Institutes of Health Grant 5T32 GM07628.; Supported by National Institutes of Health RISE Grant 5R25GM059994.; We thank Dr. Angela Chen (National Sun Yat-Sen University, Kaohsiung, Taiwan) for providing us with expression plasmids for RFP-SUMO-1 and -2 and mutants thereof, Dr. Edward T. H. Yeh (University of Texas M. D. Anderson Cancer Center, Houston, TX) for providing us with expression plasmid for SENP1, and Dr. Ronald T. Hay (University of Dundee, Dundee, Scotland, UK) for providing us with expression plasmid for RNF4 and for mutant RNF4. We thank Dr. Michael L. Freeman and Dr. Sekhar Konjeti (Vanderbilt University) for guiding us on the purification of GST and GST-Nrf2. We thank Dr. Jianqi Yang and Azza Gasmelseed for their support and encouragement during the performance of this work. Confocal microscopy images were generated at the Meharry Medical College Morphology Core Laboratory, which is supported in part by National Institutes of Health Grants U01NS041071, U54CA91408, U54RR026140, and S10RR0254970.	Akileswaran L, 2001, J BIOL CHEM, V276, P17448, DOI 10.1074/jbc.M101171200; Aono J, 2003, BIOCHEM BIOPH RES CO, V305, P271, DOI 10.1016/S0006-291X(03)00728-9; Apopa PL, 2008, J BIOCHEM MOL TOXIC, V22, P63, DOI 10.1002/jbt.20212; Arinze IJ, 2005, J BIOL CHEM, V280, P9786, DOI 10.1074/jbc.M414006200; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bailey D, 2005, BIOCHEM J, V392, P271, DOI 10.1042/BJ20050873; Barchowsky A, 1999, FREE RADICAL BIO MED, V27, P1405, DOI 10.1016/S0891-5849(99)00186-0; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Chalkiadaki A, 2005, MOL CELL BIOL, V25, P5095, DOI 10.1128/MCB.25.12.5095-5105.2005; Chen A, 2006, J CELL BIOCHEM, V98, P895, DOI 10.1002/jcb.20703; Chowdhry S., 2012, ONCOGENE IN PRESS; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; de la Vega L, 2011, BBA-MOL CELL RES, V1813, P283, DOI 10.1016/j.bbamcr.2010.11.022; Duprez E, 1999, J CELL SCI, V112, P381; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Fabunmi RP, 2001, J CELL SCI, V114, P29; Flora SJS, 1999, CLIN EXP PHARMACOL P, V26, P865, DOI 10.1046/j.1440-1681.1999.03157.x; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Geoffroy MC, 2010, MOL BIOL CELL, V21, P4227, DOI 10.1091/mbc.E10-05-0449; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; He XQ, 2006, J BIOL CHEM, V281, P23620, DOI 10.1074/jbc.M604120200; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Kawai Y, 2011, J BIOL CHEM, V286, P7629, DOI 10.1074/jbc.M110.208173; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Kurki S, 2003, J CELL SCI, V116, P3917, DOI 10.1242/jcs.00714; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V., 2010, COLD SPRING HARBOR P, V2010; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lau A, 2013, ANTIOXID REDOX SIGN, V18, P91, DOI 10.1089/ars.2012.4754; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Martin SF, 2008, PROTEIN SCI, V17, P777, DOI 10.1110/ps.073369608; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Melchior Frauke, 2009, J Cell Biol, V187, P586, DOI 10.1083/jcb.1875pi; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Moller A, 2003, CANCER RES, V63, P4310; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Percherancier Y, 2009, J BIOL CHEM, V284, P16595, DOI 10.1074/jbc.M109.006387; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pi JB, 2002, ENVIRON HEALTH PERSP, V110, P331, DOI 10.1289/ehp.02110331; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Rinaldo C, 2008, BBA-MOL CELL RES, V1783, P2124, DOI 10.1016/j.bbamcr.2008.06.006; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sakurai T, 2006, CHEM RES TOXICOL, V19, P1196, DOI 10.1021/tx0601105; Sharma P, 2010, J CELL SCI, V123, P1227, DOI 10.1242/jcs.060160; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Spector David L, 2006, Cell, V127, P1071, DOI 10.1016/j.cell.2006.11.026; St-Germain JR, 2008, EPIGENETICS-US, V3, P342, DOI 10.4161/epi.3.6.7203; Stanek D, 2004, J CELL BIOL, V166, P1015, DOI 10.1083/jcb.200405160; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Sun Z, 2011, MOL CELL BIOL, V31, P1800, DOI 10.1128/MCB.05036-11; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Wu MM, 2001, ENVIRON HEALTH PERSP, V109, P1011, DOI 10.2307/3454955; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yoo NJ, 2012, HISTOPATHOLOGY, V60, P943, DOI 10.1111/j.1365-2559.2012.04178.x; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	96	54	58	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14569	14583		10.1074/jbc.M112.437392	http://dx.doi.org/10.1074/jbc.M112.437392			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543742	hybrid, Green Published			2022-12-25	WOS:000319253500058
J	Peskin, AV; Dickerhof, N; Poynton, RA; Paton, LN; Pace, PE; Hampton, MB; Winterbourn, CC				Peskin, Alexander V.; Dickerhof, Nina; Poynton, Rebecca A.; Paton, Louise N.; Pace, Paul E.; Hampton, Mark B.; Winterbourn, Christine C.			Hyperoxidation of Peroxiredoxins 2 and 3 RATE CONSTANTS FOR THE REACTIONS OF THE SULFENIC ACID OF THE PEROXIDATIC CYSTEINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SERUM-ALBUMIN; HYDROGEN-PEROXIDE; SULFINIC ACID; INACTIVATION; MECHANISM; KINETICS; PEROXYNITRITE; REACTIVITY; SULFIREDOXIN; OXIDATION	Typical 2-Cys peroxiredoxins (Prxs) react rapidly with H2O2 to form a sulfenic acid, which then condenses with the resolving cysteine of the adjacent Prx in the homodimer or reacts with another H2O2 to become hyperoxidized. Hyperoxidation inactivates the Prx and is implicated in cell signaling. Prxs vary in susceptibility to hyperoxidation. We determined rate constants for disulfide formation and hyperoxidation for human recombinant Prx2 and Prx3 by analyzing the relative proportions of hyperoxidized and dimeric products using mass spectrometry as a function of H2O2 concentration (in the absence of reductive cycling) and in competition with catalase at a fixed concentration of H2O2. This gave a second order rate constant for hyperoxidation of 12,000 M-1 s(-1) and a rate constant for disulfide formation of 2 s(-1) for Prx2. A similar hyperoxidation rate constant for Prx3 was measured, but its rate of disulfide formation was similar to 10-fold higher, making it is more resistant than Prx2 to hyperoxidation. There are two active sites within the homodimer, and at low H2O2 concentrations one site was hyperoxidized and the other present as a disulfide. Prx with two hyperoxidized sites formed progressively at higher H2O2 concentrations. Although the sulfenic acid forms of Prx2 and Prx3 are similar to 1000-fold less reactive with H2O2 than their active site thiols, they react several orders of magnitude faster than most reduced thiol proteins. This observation has important implications for understanding the mechanism of peroxide sensing in cells.	Univ Otago, Ctr Free Rad Res, Christchurch 8140, New Zealand; Univ Otago, Gravida Natl Ctr Growth & Dev, Christchurch 8140, New Zealand	University of Otago; University of Otago	Peskin, AV (corresponding author), Univ Otago Christchurch, Dept Pathol, Ctr Free Rad Res, POB 4345, Christchurch 8140, New Zealand.	alexander.peskin@otago.ac.nz	Pace, Paul E/A-3104-2012; Peskin, alexander/R-6457-2019; Hampton, Mark B/A-8490-2008	Pace, Paul E/0000-0003-1855-5760; Hampton, Mark B/0000-0002-7349-3729; peskin, alexander/0000-0001-9890-6043; Paton, Louise N/0000-0002-7055-5170; Dickerhof, Nina/0000-0003-2269-4595	Marsden Fund; Health Research Council of New Zealand	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Marsden Fund and the Health Research Council of New Zealand.	Ashby MT, 2006, J PHARM SCI-US, V95, P15, DOI 10.1002/jps.20521; Bae SH, 2011, HEPATOLOGY, V53, P945, DOI 10.1002/hep.24104; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; CHANCE B, 1949, J BIOL CHEM, V180, P947; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Hall A, 2010, J MOL BIOL, V402, P194, DOI 10.1016/j.jmb.2010.07.022; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jeong W, 2012, FREE RADICAL BIO MED, V53, P447, DOI 10.1016/j.freeradbiomed.2012.05.020; Kil IS, 2012, MOL CELL, V46, P584, DOI 10.1016/j.molcel.2012.05.030; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Nagy P, 2013, ANTIOXID REDOX SIGN, V18, P1623, DOI 10.1089/ars.2012.4973; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2010, BIOCHEM J, V432, P313, DOI 10.1042/BJ20101156; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Roussel X, 2009, J BIOL CHEM, V284, P33048, DOI 10.1074/jbc.M109.035352; Selles B, 2012, BIOCHEM J, V442, P369, DOI 10.1042/BJ20111378; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	30	110	114	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14170	14177		10.1074/jbc.M113.460881	http://dx.doi.org/10.1074/jbc.M113.460881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543738	hybrid, Green Published			2022-12-25	WOS:000319253500021
J	Zhang, WJ; Zhou, Q; Xu, W; Cai, YX; Yin, ZN; Gao, XM; Xiong, SD				Zhang, Weijuan; Zhou, Qian; Xu, Wei; Cai, Yanxing; Yin, Zhinan; Gao, Xiaoming; Xiong, Sidong			DNA-dependent Activator of Interferon-regulatory Factors (DAI) Promotes Lupus Nephritis by Activating the Calcium Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELLS; CYTOSOLIC DNA; I INTERFERON; IMMUNE-RESPONSES; DISEASE-ACTIVITY; INNATE IMMUNITY; MURINE LUPUS; ERYTHEMATOSUS; INDUCTION; MICE	DNA-dependent activator of interferon-regulatory factors (DAI) functions as a cytoplasmic DNA sensor that activates the innate immune system. We previously found that activated lymphocyte-derived self-apoptotic DNA (ALD-DNA) immunization led to pathological macrophage activation and M2b polarization, which could initiate and propagate murine lupus nephritis. However, the specificDNAsensor(s) as well as underlying molecular mechanisms involved in ALD-DNA-induced macrophage M2b polarization in systemic lupus erythematosus (SLE) disease remains unknown. In this study, we reported that DAI expression was significantly increased in SLE patients as well as in lupus mice. Gain-and loss-of-function studies revealed that DAI was involved in ALD-DNA-induced macrophage activation and M2b polarization. Moreover, ALD-DNA notably induced dimerization/oligomerization of DAI and consequently activation of nuclear factor kappa B (NF-kappa B) and interferon regulatory factor 3 (IRF3) signaling pathways via calcium signaling, resulting in macrophage activation and M2b polarization. More importantly, blockade of DAI in vivo or selective knockdown of DAI in macrophages could ameliorate SLE syndrome via blunting macrophage M2b polarization and inhibiting inflammatory response in lupus mice. Our results suggest that DAI could function as a DNA sensor and a regulator in ALD-DNA-induced macrophage M2b polarization and lupus nephritis, providing the possible molecular mechanisms involved in ALD-DNA-induced macrophage M2b polarization in SLE disease and making DAI as a potential therapeutic target for the treatment of SLE.	[Zhang, Weijuan; Zhou, Qian; Cai, Yanxing; Xiong, Sidong] Fudan Univ, Shanghai Med Coll, Inst Immunobiol, Shanghai 200032, Peoples R China; [Zhang, Weijuan; Zhou, Qian; Cai, Yanxing; Xiong, Sidong] Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200032, Peoples R China; [Xu, Wei; Gao, Xiaoming; Xiong, Sidong] Soochow Univ, Inst Biol Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China; [Xu, Wei; Gao, Xiaoming; Xiong, Sidong] Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China; [Yin, Zhinan] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Fudan University; Fudan University; Soochow University - China; Soochow University - China; Nankai University	Xiong, SD (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Immunobiol, 138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	sdxiongfd@126.com	Zhang, Weijuan/Q-1645-2019	Zhang, Weijuan/0000-0003-3494-3114	National Natural Science Foundation of China [30890141, 31100629, 31270863, 81273300]; Major State Basic Research Development Program of China [2013CB530501]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1075]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Shanghai STC [10JC1401400]; Postdoctoral Science Foundation of China [2012T50397]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Shanghai STC; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants of National Natural Science Foundation of China Grants 30890141, 31100629, 31270863, and 81273300, Major State Basic Research Development Program of China Grant 2013CB530501, Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, IRT1075), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Shanghai STC Grant 10JC1401400, and Postdoctoral Science Foundation of China Grant 2012T50397.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Amarzguioui M, 2006, NAT PROTOC, V1, P508, DOI 10.1038/nprot.2006.72; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bethunaickan R, 2011, J IMMUNOL, V186, P4994, DOI 10.4049/jimmunol.1003010; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Chen M, 2011, MOL IMMUNOL, V48, P1532, DOI 10.1016/j.molimm.2011.04.016; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Chung EY, 2006, CELL RES, V16, P154, DOI 10.1038/sj.cr.7310021; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Csiszar A, 2000, CLIN EXP IMMUNOL, V122, P464, DOI 10.1046/j.1365-2249.2000.01369.x; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Finke D, 2007, EUR J IMMUNOL, V37, P1702, DOI 10.1002/eji.200636719; Goubau D, 2010, NAT IMMUNOL, V11, P984, DOI 10.1038/ni1110-984; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagiwara E, 1996, ARTHRITIS RHEUM, V39, P379, DOI 10.1002/art.1780390305; Hill GS, 2001, KIDNEY INT, V59, P304, DOI 10.1046/j.1523-1755.2001.00492.x; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; HOUSSIAU FA, 1995, LUPUS, V4, P393, DOI 10.1177/096120339500400510; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; Jiang ZY, 2011, J IMMUNOL, V186, P1173, DOI 10.4049/jimmunol.1002342; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Lippmann J, 2008, CELL MICROBIOL, V10, P2579, DOI 10.1111/j.1462-5822.2008.01232.x; Liu HO, 2011, CANCER RES, V71, P7547, DOI 10.1158/0008-5472.CAN-11-2260; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Lladser A, 2011, MOL THER, V19, P594, DOI 10.1038/mt.2010.268; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Papatriantafyllou M, 2011, NAT REV IMMUNOL, V11, P569, DOI 10.1038/nri3057; Park YB, 1998, CLIN EXP RHEUMATOL, V16, P283; Qiao B, 2005, RHEUMATOLOGY, V44, P1108, DOI 10.1093/rheumatology/keh656; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; RIEBER M, 1989, BIOCHEM BIOPH RES CO, V159, P1441, DOI 10.1016/0006-291X(89)92271-7; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; Sean Eardley K, 2005, KIDNEY INT, V68, P437, DOI 10.1111/j.1523-1755.2005.00422.x; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tano JY, 2011, BIOCHEM BIOPH RES CO, V407, P432, DOI 10.1016/j.bbrc.2011.03.048; TERADA K, 1992, BIOCHEM BIOPH RES CO, V183, P797, DOI 10.1016/0006-291X(92)90553-W; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vinuesa CG, 2002, NATURE, V416, P595, DOI 10.1038/416595a; Wada T, 1996, KIDNEY INT, V49, P761, DOI 10.1038/ki.1996.105; Walport MJ, 2000, NAT GENET, V25, P135, DOI 10.1038/75963; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Wen ZK, 2007, RHEUMATOLOGY, V46, P1796, DOI 10.1093/rheumatology/kem275; Xu JJ, 2012, GASTROENTEROLOGY, V143, P199, DOI 10.1053/j.gastro.2012.03.053; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Yanai H, 2009, CURR OPIN IMMUNOL, V21, P17, DOI 10.1016/j.coi.2009.01.005; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Zhang WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022659; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	71	39	39	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13534	13550		10.1074/jbc.M113.457218	http://dx.doi.org/10.1074/jbc.M113.457218			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23553627	Green Published, hybrid			2022-12-25	WOS:000318850300037
J	Samanta, S; Pursell, B; Mercurio, AM				Samanta, Sanjoy; Pursell, Bryan; Mercurio, Arthur M.			IMP3 Protein Promotes Chemoresistance in Breast Cancer Cells by Regulating Breast Cancer Resistance Protein (ABCG2) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; GROWTH; PROLIFERATION; CHEMOTHERAPY; MITOXANTRONE	IMP3, a member of a family of insulin-like growth factor II (IGF-II) mRNA-binding proteins (IMPs), is expressed preferentially in triple-negative breast cancers, which are resistant to many chemotherapeutics. However, the mechanisms by which it impacts breast cancer have not been elucidated. We hypothesized a role for IMP3 in chemoresistance based on these observations. Depletion of IMP3 expression in triple-negative breast cancer cells increased their sensitivity to doxorubicin and mitoxantrone significantly but not to taxol. Given that doxorubicin and mitoxantrone are effluxed by breast cancer resistance protein (BCRP), we assessed whether IMP3 regulates BCRP. The data obtained demonstrate that IMP3 binds to BCRP mRNA and regulates BCRP expression. These findings are significant because they provide insight into the mechanism by which IMP3 contributes to aggressive cancers, and they highlight the potential for targeting this mRNA-binding protein for the clinical management of cancer.	[Samanta, Sanjoy; Pursell, Bryan; Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Mercurio, AM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB-408,364 Plantat St, Worcester, MA 01605 USA.	arthur.mercurio@umassmed.edu			National Institutes of Health [CA168464]; NATIONAL CANCER INSTITUTE [R01CA168464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA168464.	Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Griffiths Carrie L, 2012, J Pharm Pract, V25, P319, DOI 10.1177/0897190012442062; Hazlehurst LA, 1999, CANCER RES, V59, P1021; Ibrahim NK, 2000, ANN ONCOL, V11, P1597, DOI 10.1023/A:1008315312795; Ikeda K, 2011, DIAGN CYTOPATHOL, V39, P395, DOI 10.1002/dc.21398; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller-Pillasch F, 1999, MECH DEVELOP, V88, P95, DOI 10.1016/S0925-4773(99)00160-4; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Petit T, 2003, ANN SURG ONCOL, V10, P369, DOI 10.1245/ASO.2003.07.015; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; ROWINSKY EK, 1992, SEMIN ONCOL, V19, P646; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005	17	47	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12569	12573		10.1074/jbc.C112.442319	http://dx.doi.org/10.1074/jbc.C112.442319			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23539627	Green Published, hybrid			2022-12-25	WOS:000318555100015
J	Cashion, A; Stanfill, A; Thomas, F; Xu, LJ; Suttee, T; Eason, J; Ensell, M; Homayouni, R				Cashion, Ann; Stanfill, Ansley; Thomas, Fridtjof; Xu, Lijing; Suttee, Thomas; Eason, James; Ensell, Mang; Homayouni, Ramin			Expression Levels of Obesity-Related Genes Are Associated with Weight Change in Kidney Transplant Recipients	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; CARBOXYPEPTIDASE-E; APOLIPOPROTEIN-M; METABOLIC SYNDROME; LEPTIN; GAIN; DOPAMINE; SAMPLES	Background:The aim of this study was to investigate the association of gene expression profiles in subcutaneous adipose tissue with weight change in kidney transplant recipients and to gain insights into the underlying mechanisms of weight gain. Methodology/Principal Findings: A secondary data analysis was done on a subgroup (n=26) of existing clinical and gene expression data from a larger prospective longitudinal study examining factors contributing to weight gain in transplant recipients. Measurements taken included adipose tissue gene expression profiles at time of transplant, baseline and six-month weight, and demographic data. Using multivariate linear regression analysis controlled for race and gender, expression levels of 1553 genes were significantly (p<0.05) associated with weight change. Functional analysis using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes classifications identified metabolic pathways that were enriched in this dataset. Furthermore, GeneIndexer literature mining analysis identified a subset of genes that are highly associated with obesity in the literature and Ingenuity pathway analysis revealed several significant gene networks associated with metabolism and endocrine function. Polymorphisms in several of these genes have previously been linked to obesity. Conclusions/Significance: We have successfully identified a set of molecular pathways that taken together may provide insights into the mechanisms of weight gain in kidney transplant recipients. Future work will be done to determine how these pathways may contribute to weight gain.	[Cashion, Ann; Stanfill, Ansley; Ensell, Mang] Univ Tennessee, Ctr Hlth Sci, Dept Acute & Chron Care, Coll Nursing, Memphis, TN 38163 USA; [Cashion, Ann] NINR, NIH, Bethesda, MD 20892 USA; [Thomas, Fridtjof] Univ Tennessee, Ctr Hlth Sci, Dept Biostat & Epidemiol, Memphis, TN 38163 USA; [Xu, Lijing; Suttee, Thomas; Homayouni, Ramin] Univ Memphis, Dept Biol, Memphis, TN 38152 USA; [Eason, James] Methodist Univ Hosp Transplant Inst, Memphis, TN USA; [Eason, James] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Transplant Div, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Tennessee System; University of Tennessee Health Science Center	Cashion, A (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Acute & Chron Care, Coll Nursing, Memphis, TN 38163 USA.	ann.cashion@nih.gov	Homayouni, Ramin/U-2837-2019	Homayouni, Ramin/0000-0003-0186-5076; Stanfill, Ansley/0000-0001-7620-1130; Thomas, Fridtjof/0000-0003-1325-4870	NIH-NINR [USPHS R01 009270, USPHS 009270-0352]; NATIONAL INSTITUTE OF NURSING RESEARCH [ZIANR000030] Funding Source: NIH RePORTER	NIH-NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by NIH-NINR USPHS R01 009270 and NIH-NINR USPHS 009270-0352 (ARRA Summer Research Supplement Funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; Baum CL, 2001, JPEN-PARENTER ENTER, V25, P114, DOI 10.1177/0148607101025003114; Cashion AK, 2011, RES NURS HEALTH, V34, P408, DOI 10.1002/nur.20448; Cashion Ann K, 2007, Prog Transplant, V17, P40; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Cheung CYY, 2010, J CLIN ENDOCR METAB, V95, P1395, DOI 10.1210/jc.2009-1465; Clunk JM, 2001, AM J KIDNEY DIS, V38, P349, DOI 10.1053/ajkd.2001.26100; Cupples CK, 2012, PROG TRANSPLANT, V22, P62, DOI 10.7182/pit2012888; Dahlman I, 2007, INT J OBESITY, V31, P1629, DOI 10.1038/sj.ijo.0803657; Dolinkova M, 2008, MOL CELL ENDOCRINOL, V291, P63, DOI 10.1016/j.mce.2008.05.001; Dullaart RPF, 2009, CLIN CHIM ACTA, V406, P129, DOI 10.1016/j.cca.2009.06.010; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; Elster EA, 2008, CLIN TRANSPLANT, V22, P354, DOI 10.1111/j.1399-0012.2008.00792.x; Homayouni R, 2005, BIOINFORMATICS, V21, P104, DOI 10.1093/bioinformatics/bth464; Kalra SP, 2008, NUTRITION, V24, P820, DOI 10.1016/j.nut.2008.06.023; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Klimcakova E, 2011, J CLIN ENDOCR METAB, V96, pE73, DOI 10.1210/jc.2010-1575; Korsic Mirko, 2012, Front Biosci (Elite Ed), V4, P2734; Luo Guanghua, 2004, Lipids Health Dis, V3, P21, DOI 10.1186/1476-511X-3-21; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; Ooi EMM, 2010, ATHEROSCLEROSIS, V210, P326, DOI 10.1016/j.atherosclerosis.2009.11.024; Patel M G, 1998, J Ren Nutr, V8, P137, DOI 10.1016/S1051-2276(98)90005-X; Pratley RE, 2000, MOL GENET METAB, V70, P19, DOI 10.1006/mgme.2000.2995; Ramis JM, 2002, CELL MOL LIFE SCI, V59, P1960, DOI 10.1007/PL00012518; Rodriguez-Acebes S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-61; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STANLEY BG, 1986, PEPTIDES, V7, P1189; Storey John D, 2003, Methods Mol Biol, V224, P149; USRDS, 2011, ANN DAT REP ATL END; van den Ham ECH, 2003, TRANSPL INT, V16, P300, DOI 10.1111/j.1432-2277.2003.tb00304.x; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; Xu N, 2004, J NUTR BIOCHEM, V15, P579, DOI 10.1016/j.jnutbio.2004.03.001; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang HP, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-10	37	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59962	10.1371/journal.pone.0059962	http://dx.doi.org/10.1371/journal.pone.0059962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544116	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700075
J	Harmon-Threatt, AN; Ackerly, DD				Harmon-Threatt, Alexandra N.; Ackerly, David D.			Filtering across Spatial Scales: Phylogeny, Biogeography and Community Structure in Bumble Bees	PLOS ONE			English	Article							PROBOSCIS LENGTH; FUNCTIONAL TRAITS; HYMENOPTERA; DIVERSIFICATION; DISTRIBUTIONS; COEXISTENCE; COMPETITION; RESOURCES; PATTERNS; STRENGTH	Despite the expansion of phylogenetic community analysis to understand community assembly, few studies have used these methods on mobile organisms and it has been suggested the local scales that are typically considered may be too small to represent the community as perceived by organisms with high mobility. Mobility is believed to allow species to mediate competitive interactions quickly and thus highly mobile species may appear randomly assembled in local communities. At larger scales, however, biogeographical processes could cause communities to be either phylogenetically clustered or even. Using phylogenetic community analysis we examined patterns of relatedness and trait similarity in communities of bumble bees (Bombus) across spatial scales comparing: local communities to regional pools, regional communities to continental pools and the continental community to a global species pool. Species composition and data on tongue lengths, a key foraging trait, were used to test patterns of relatedness and trait similarity across scales. Although expected to exhibit limiting similarity, local communities were clustered both phenotypically and phylogenetically. Larger spatial scales were also found to have more phylogenetic clustering but less trait clustering. While patterns of relatedness in mobile species have previously been suggested to exhibit less structure in local communities and to be less clustered than immobile species, we suggest that mobility may actually allow communities to have more similar species that can simply limit direct competition through mobility.	[Harmon-Threatt, Alexandra N.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Ackerly, David D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Harmon-Threatt, Alexandra N.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Washington University (WUSTL)	Harmon-Threatt, AN (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	Aharmont@wustl.edu	Ackerly, David/A-1247-2009	Ackerly, David/0000-0002-1847-7398; Harmon-Threatt, Alexandra/0000-0002-3755-9321	NSF Graduate Research Fellowship Program; National Science Foundation's Graduate Research Fellowship Program (NSF-GRFP)	NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); National Science Foundation's Graduate Research Fellowship Program (NSF-GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD))	We Would like to thank the Kremen and Ackerly Labs, and the 2009 Integrative Biology 200B class at University of California Berkeley for comments that improved the manuscript, and acknowledge funding from the NSF Graduate Research Fellowship Program. We would also like to thank Sheila Colla, Amber Tripodi, Rosemary Malfi, Carol Kearns, Richard Hartfeld and Stephen Hendrix for contributing data on bumble bee communities.; This work was funded through a National Science Foundation's Graduate Research Fellowship Program (NSF-GRFP) to Alexandra N. Harmon-Threatt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2009, P NATL ACAD SCI USA, V106, P19699, DOI 10.1073/pnas.0901635106; Begon M, 1996, ECOLOGY INVIDIDUALS; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Cahill JF, 2008, PERSPECT PLANT ECOL, V10, P41, DOI 10.1016/j.ppees.2007.10.001; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2011, PHILOS T R SOC B, V366, P2545, DOI 10.1098/rstb.2011.0021; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cooper N, 2008, P ROY SOC B-BIOL SCI, V275, P2031, DOI 10.1098/rspb.2008.0420; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Emerson BC, 2005, CURR BIOL, V15, pR367, DOI 10.1016/j.cub.2005.05.016; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D., 2010, BUMBLEBEES; Graham CH, 2012, ECOLOGY, V93, pS99, DOI 10.1890/11-0493.1; Hagen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019997; HANSKI I, 1982, ANN ZOOL FENN, V19, P319; HARDER LD, 1983, OECOLOGIA, V57, P274, DOI 10.1007/BF00379591; HARDER LD, 1985, ECOLOGY, V66, P198, DOI 10.2307/1941320; HARDER LD, 1982, CAN J ZOOL, V60, P1073, DOI 10.1139/z82-148; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hoiss B, 2012, P ROY SOC B-BIOL SCI, V279, P4447, DOI 10.1098/rspb.2012.1581; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; INOUYE DW, 1977, J NEW YORK ENTOMOL S, V85, P253; JOHNSON RA, 1986, ECOLOGY, V67, P133, DOI 10.2307/1938511; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; MEDLER JOHN T., 1962, ANN ENTOMOL SOC AMER, V55, P212; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; MORSE DH, 1977, ANN ENTOMOL SOC AM, V70, P311, DOI 10.1093/aesa/70.3.311; MORSE DH, 1977, SCIENCE, V197, P678, DOI 10.1126/science.197.4304.678; Peat J, 2005, ECOL ENTOMOL, V30, P176, DOI 10.1111/j.0307-6946.2005.00676.x; PEKKARINEN A, 1984, ANN ENTOMOL FENN, V50, P97; Pellissier L, 2013, GLOBAL ECOL BIOGEOGR, V22, P577, DOI 10.1111/geb.12026; Potts SG, 2005, ECOL ENTOMOL, V30, P78, DOI 10.1111/j.0307-6946.2005.00662.x; Pyke GH, 2012, ENVIRON ENTOMOL, V41, P1332, DOI 10.1603/EN11284; RANTA E, 1980, OIKOS, V35, P298, DOI 10.2307/3544643; RANTA E, 1984, OIKOS, V43, P189, DOI 10.2307/3544768; RANTA E, 1982, OIKOS, V38, P202, DOI 10.2307/3544020; RANTA E, 1983, ANN ENTOMOL FENN, V49, P17; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Steffan-Dewenter I, 2008, ECOLOGY, V89, P1375, DOI 10.1890/06-1323.1; Stubbs WJ, 2004, J ECOL, V92, P557, DOI 10.1111/j.0022-0477.2004.00898.x; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Williams PH, 2008, APIDOLOGIE, V39, P46, DOI 10.1051/apido:2007052; Williams PH, 1996, P ROY SOC B-BIOL SCI, V263, P579, DOI 10.1098/rspb.1996.0087	52	29	29	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60446	10.1371/journal.pone.0060446	http://dx.doi.org/10.1371/journal.pone.0060446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544141	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700100
J	Pena-Chilet, M; Ibarrola-Villava, M; Martin-Gonzalez, M; Feito, M; Gomez-Fernandez, C; Planelles, D; Carretero, G; Lluch, A; Nagore, E; Ribas, G				Pena-Chilet, Maria; Ibarrola-Villava, Maider; Martin-Gonzalez, Manuel; Feito, Marta; Gomez-Fernandez, Cristina; Planelles, Dolores; Carretero, Gregorio; Lluch, Ana; Nagore, Eduardo; Ribas, Gloria			rs12512631 on the Group Specific Complement (Vitamin D-Binding Protein GC) Implicated in Melanoma Susceptibility	PLOS ONE			English	Article							D-RECEPTOR POLYMORPHISMS; CANCER; RISK; ASSOCIATION; GENES; DETERMINANTS; VDR	Background: Solar radiation should be avoided in melanoma patients. Nevertheless, this is the main means by which the body produces vitamin D. Evidence suggests a protective role against cancer for vitamin D. Since vitamin D performs its function by binding the receptor encoded by the vitamin D-receptor gene (VDR), most studies have focused on polymorphisms (SNPs) within this gene. However, the gene encoding the vitamin D-binding protein (GC) appears in recent studies as a major player in the role of a serum vitamin D level regulator and in Cutaneous Melanoma (CM) predisposition. Methods: We performed a case-control study of 12 polymorphisms on GC and 9 on VDR among 530 cases and 314 controls from Spanish population. Results: We found association between SNP rs12512631, located 3'downstream of GC, and risk of CM that seems to fit a dominant model (OR 1.63 950/0Cl 1.23-2.17 p-value 7x10(-4)). This association remained Bonferroni's correction and after adjustment for potential confounders (p-value 3x10(-3)) and even after increasing the sample size to 1729 individuals (p-value 0.0129). Moreover, we confirmed evidence of an association between CM susceptibility and the linkage disequilibrium block marked by tag-SNP rs222016 (p-value 0.032). This block covers the GC intron 1 region, with probable regulatory functions. Conclusion:To our knowledge, this is the first vitamin D pathway-related polymorphism study in melanoma risk conducted in the Spanish population. Furthermore, we show an association between polymorphisms in GC and melanoma risk, confirming recent studies in different populations.	[Pena-Chilet, Maria; Ibarrola-Villava, Maider; Lluch, Ana; Ribas, Gloria] Hlth Res Inst INCLIVA, Med Oncol & Haematol Unit, Valencia, Spain; [Martin-Gonzalez, Manuel] Hosp Ramon & Cajal, Dept Dermatol, E-28034 Madrid, Spain; [Feito, Marta; Gomez-Fernandez, Cristina] La Paz Univ Hosp, Dept Dermatol, Madrid, Spain; [Planelles, Dolores] Ctr Blood Transfus, Lab Histocompatibil Mol Biol, Valencia, Spain; [Carretero, Gregorio] Doctor Negrin Hosp, Dept Dermatol, Las Palmas Gran Canaria, Spain; [Nagore, Eduardo] Inst Valenciano Oncol, Dept Dermatol, Valencia, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Instituto Valenciano De Oncologia	Ribas, G (corresponding author), Hlth Res Inst INCLIVA, Med Oncol & Haematol Unit, Valencia, Spain.	gribasdespuig@gmail.com	PLANELLES, DOLORES/F-2689-2015; PLANELLES, DOLORES/AAS-5437-2020; Ribas-Despuig, Gloria/M-6190-2017; Nagore, Eduardo/Z-2126-2019; Peña-Chilet, Maria/A-8387-2015; Lluch, Ana/R-5493-2019; Ribas, Gloria/K-3379-2013	PLANELLES, DOLORES/0000-0001-6433-4825; PLANELLES, DOLORES/0000-0001-6433-4825; Nagore, Eduardo/0000-0003-3433-8707; Peña-Chilet, Maria/0000-0002-6445-9617; Lluch, Ana/0000-0003-2766-407X; Ribas, Gloria/0000-0001-6883-4130; Ibarrola-Villava, Maider/0000-0003-0946-8075; Bowcock, Anne/0000-0001-8691-9090	National Health System Ministry (Institute Carlos III) [Pl10_0405]; Generalitat Valenciana Conselleria d'Educacio VALi+d program [ACIF/2011/207]; Spanish Ministry of Science and Education [BES-2008-009234]; Spanish Ministry of Health [CP08_00069]	National Health System Ministry (Institute Carlos III); Generalitat Valenciana Conselleria d'Educacio VALi+d program; Spanish Ministry of Science and Education(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This study has been supported by a grant from the National Health System Ministry (Institute Carlos III) Pl10_0405. MPC is funded by the Generalitat Valenciana Conselleria d'Educacio VALi+d program (ACIF/2011/207). MIV is funded by the Spanish Ministry of Science and Education under a FPI grant (BES-2008-009234). GR is funded by the Spanish Ministry of Health (CP08_00069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, CANCER EPIDEM BIOMAR, V17, P1339, DOI 10.1158/1055-9965.EPI-08-0162; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Alimirah F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016024; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barroso E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-385; Bektas-Kayhan K, 2010, IN VIVO, V24, P755; Bishop JAN, 2005, DRUG TODAY, V41, P193, DOI 10.1358/dot.2005.41.3.892524; Chang CK, 2011, J GASTROINTEST CANC; Chishimba L, 2010, THORAX, V65, P456, DOI 10.1136/thx.2009.128793; Davies JR, 2011, CANCER CAUSE CONTROL, V22, P1471, DOI 10.1007/s10552-011-9827-3; Disanto G, 2011, J NEUROL, V258, P353, DOI 10.1007/s00415-010-5797-8; Field S, 2011, MOL ONCOL, V5, P197, DOI 10.1016/j.molonc.2011.01.007; Gapska P, 2009, CANCER EPIDEMIOL, V33, P103, DOI 10.1016/j.canep.2009.06.006; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hibler EA, 2012, CANCER EPIDEM BIOMAR, V21, P368, DOI 10.1158/1055-9965.EPI-11-0916; Holick MF, 2003, RECENT RESULTS CANC, V164, P3; Holick MF, 2003, MAYO CLIN PROC, V78, P1457, DOI 10.4065/78.12.1457; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Karami S, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/879362; Kidd LCR, 2005, PROSTATE, V64, P272, DOI 10.1002/pros.20204; Kostner K, 2009, ANTICANCER RES, V29, P3511; Kvaskoff M, 2011, TWIN RES HUM GENET, V14, P422, DOI 10.1375/twin.14.5.422; Laayouni H, 2010, HUM GENET, V127, P455, DOI 10.1007/s00439-010-0798-3; Lurie G, 2011, INT J CANCER, V128, P936, DOI 10.1002/ijc.25403; Mocellin S, 2008, CANCER-AM CANCER SOC, V113, P2398, DOI 10.1002/cncr.23867; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Orlow I, 2011, INT J CANC; Pani MA, 2002, J CLIN ENDOCR METAB, V87, P2564, DOI 10.1210/jc.87.6.2564; Poynter JN, 2010, CANCER EPIDEM BIOMAR, V19, P525, DOI 10.1158/1055-9965.EPI-09-0662; Randerson-Moor JA, 2009, EUR J CANCER, V45, P3271, DOI 10.1016/j.ejca.2009.06.011; Shen LH, 2010, J INT MED RES, V38, P1093, DOI 10.1177/147323001003800337; Smedby KE, 2011, AM J EPIDEMIOL, V173, P48, DOI 10.1093/aje/kwq340; Srinivasan M, 2011, J STEROID BIOCHEM, V123, P30, DOI 10.1016/j.jsbmb.2010.10.002; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0	36	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59607	10.1371/journal.pone.0059607	http://dx.doi.org/10.1371/journal.pone.0059607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544077	Green Submitted, Green Published, gold			2022-12-25	WOS:000317480700037
J	Yang, C; Liu, JF; Chai, BS; Fang, Q; Chai, N; Zhao, LY; Xue, YX; Luo, YX; Jian, M; Han, Y; Shi, HS; Lu, L; Wu, P; Wang, JS				Yang, Chang; Liu, Jian-Feng; Chai, Bai-Sheng; Fang, Qin; Chai, Ning; Zhao, Li-Yan; Xue, Yan-Xue; Luo, Yi-Xiao; Jian, Min; Han, Ying; Shi, Hai-Shui; Lu, Lin; Wu, Ping; Wang, Ji-Shi			Stress within a Restricted Time Window Selectively Affects the Persistence of Long-Term Memory	PLOS ONE			English	Article							INDUCED CORTISOL ELEVATIONS; MEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; SPATIAL MEMORY; FEAR MEMORIES; GLUCOCORTICOID-RECEPTORS; PSYCHOSOCIAL STRESS; DECLARATIVE MEMORY; PROTEIN-SYNTHESIS; LEARNING STRESS	The effects of stress on emotional memory are distinct and depend on the stages of memory. Memory undergoes consolidation and reconsolidation after acquisition and retrieval, respectively. Stress facilitates the consolidation but disrupts the reconsolidation of emotional memory. Previous research on the effects of stress on memory have focused on long-term memory (LTM) formation (tested 24 h later), but the effects of stress on the persistence of LTM (tested at least week later) are unclear. Recent findings indicated that the persistence of LTM requires late-phase protein synthesis in the 1 dorsal hippocampus. The present study investigated the effect of stress (i.e., cold water stress) during the late phase after the acquisition and retrieval of contextual fear memory in rats. We found that stress and corticosterone administration during the late phase (12 h) after acquisition, referred to as late consolidation, selectively enhanced the persistence of LTM, whereas stress during the late phase (12 h) after retrieval, referred to as late reconsolidation, selectively disrupted the restabilized persistence of LTM. Moreover, the effects of stress on the persistence of LTM were blocked by the corticosterone synthesis inhibitor metyrapone, which was administered before stress, suggesting that the glucocorticoid system is involved in the effects of stress on the persistence of LTM. We conclude that stress within a restricted time window after acquisition or retrieval selectively affects the persistence of LTM and depends on the glucocorticoid system.	[Yang, Chang; Chai, Bai-Sheng; Fang, Qin; Wang, Ji-Shi] Affiliated Hosp, Guiyang, Peoples R China; [Yang, Chang; Chai, Bai-Sheng; Fang, Qin; Wang, Ji-Shi] Guiyang Med Univ, Sch Pharm, Guiyang, Peoples R China; [Liu, Jian-Feng; Zhao, Li-Yan; Xue, Yan-Xue; Luo, Yi-Xiao; Jian, Min; Han, Ying; Lu, Lin; Wu, Ping] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Chai, Ning] Hebei Med Univ, Inst Mental Hlth, Shijiazhuang, Peoples R China; [Chai, Ning] Hebei Med Univ, Hebei Brain Ageing & Cognit Neurosci Lab, Shijiazhuang, Peoples R China; [Shi, Hai-Shui] Hebei Med Univ, Basic Med Coll, Dept Biochem & Mol Biol, Shijiazhuang, Peoples R China	Guizhou Medical University; Peking University; Hebei Medical University; Hebei Medical University; Hebei Medical University	Wu, P (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China.	wuping@bjmu.edu.cn; jswang_yg@yahoo.com	fang, qin/GQA-8223-2022	Liu, Jianfeng/0000-0002-3464-6462	Natural Science Foundation of China [81201032, 91132716, 31070958]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (no. 81201032, 91132716, and 31070958). No additional external funding received for this study. The authors declare that they do not have any conflicts of interest (financial or otherwise) related to the data presented in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie HC, 2006, PSYCHONEUROENDOCRINO, V31, P187, DOI 10.1016/j.psyneuen.2005.06.008; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Bekinschtein P, 2010, NEUROTOX RES, V18, P377, DOI 10.1007/s12640-010-9155-5; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; Cai WH, 2006, J NEUROSCI, V26, P9560, DOI 10.1523/JNEUROSCI.2397-06.2006; Costanzi M, 2011, LEARN MEMORY, V18, P508, DOI 10.1101/lm.2175811; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; de Quervain DJF, 2007, AM J PSYCHIAT, V164, P967, DOI 10.1176/appi.ajp.164.6.967; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Debiec J, 2010, NAT NEUROSCI, V13, P536, DOI 10.1038/nn.2520; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Elzinga BM, 2005, PSYCHIAT RES, V134, P211, DOI 10.1016/j.psychres.2004.11.007; Flavell CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1515; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; Miranda MI, 2008, LEARN MEMORY, V15, P468, DOI 10.1101/lm.964708; Izquierdo I, 1998, TRENDS NEUROSCI, V21, P423, DOI 10.1016/S0166-2236(98)01279-X; Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005; Joels M, 2011, TRENDS COGN SCI, V15, P280, DOI 10.1016/j.tics.2011.04.004; Katche C, 2012, NEUROBIOL LEARN MEM, V98, P220, DOI 10.1016/j.nlm.2012.08.001; Katche C, 2010, P NATL ACAD SCI USA, V107, P349, DOI 10.1073/pnas.0912931107; Kim JJ, 2005, J NEUROSCI, V25, P1532, DOI 10.1523/JNEUROSCI.4623-04.2005; Kindt M, 2013, BIOL PSYCHOL, V92, P43, DOI 10.1016/j.biopsycho.2011.09.016; KORNEYEV A, 1995, NEUROSCI LETT, V191, P19, DOI 10.1016/0304-3940(95)11546-3; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00168; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Lupien SJ, 2001, BEHAV BRAIN RES, V127, P137, DOI 10.1016/S0166-4328(01)00361-8; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Maren S, 2000, BEHAV BRAIN RES, V110, P97, DOI 10.1016/S0166-4328(99)00188-6; Maroun M, 2008, NEUROPSYCHOPHARMACOL, V33, P394, DOI 10.1038/sj.npp.1301401; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Medina JH, 2008, BEHAV BRAIN RES, V192, P61, DOI 10.1016/j.bbr.2008.02.006; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Oitzl MS, 1998, BRAIN RES, V797, P159, DOI 10.1016/S0006-8993(98)00387-4; Parfitt GM, 2012, BEHAV NEUROSCI, V126, P729, DOI 10.1037/a0029861; Payne JD, 2007, LEARN MEMORY, V14, P861, DOI 10.1101/lm.743507; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Roozendaal B, 1999, P NATL ACAD SCI USA, V96, P11642, DOI 10.1073/pnas.96.20.11642; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; Roozendaal B, 2003, P NATL ACAD SCI USA, V100, P1328, DOI 10.1073/pnas.0337480100; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Roozendaal B, 1996, PSYCHONEUROENDOCRINO, V21, P681, DOI 10.1016/S0306-4530(96)00028-5; Roozendaal B, 2007, PROG BRAIN RES, V167, P79, DOI 10.1016/S0079-6123(07)67006-X; Roozendaal B, 2009, J NEUROSCI, V29, P14299, DOI 10.1523/JNEUROSCI.3626-09.2009; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Rudy JW, 2004, NEUROSCI BIOBEHAV R, V28, P675, DOI 10.1016/j.neubiorev.2004.09.004; Sandi C, 1997, EUR J NEUROSCI, V9, P637, DOI 10.1111/j.1460-9568.1997.tb01412.x; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P44, DOI 10.1016/j.nlm.2008.02.002; Schwabe L, 2012, NEUROSCI BIOBEHAV R, V36, P1740, DOI 10.1016/j.neubiorev.2011.07.002; Si JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043973; Smeets T, 2007, BIOL PSYCHOL, V76, P116, DOI 10.1016/j.biopsycho.2007.07.001; Smeets T, 2008, PSYCHONEUROENDOCRINO, V33, P1378, DOI 10.1016/j.psyneuen.2008.07.009; Soeter M, 2011, LEARN MEMORY, V18, P357, DOI 10.1101/lm.2148511; Wang XY, 2008, J NEUROSCI, V28, P5602, DOI 10.1523/JNEUROSCI.0750-08.2008; Xue YX, 2012, SCIENCE, V336, P241, DOI 10.1126/science.1215070; Zhao LY, 2009, PSYCHOPHARMACOLOGY, V203, P599, DOI 10.1007/s00213-008-1406-2	68	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59075	10.1371/journal.pone.0059075	http://dx.doi.org/10.1371/journal.pone.0059075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544051	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700013
J	Zhang, W; Ma, YQ; Wang, Z; Ye, XX; Shui, JF				Zhang, Wei; Ma, Yongqing; Wang, Zhong; Ye, Xiaoxin; Shui, Junfeng			Some Soybean Cultivars Have Ability to Induce Germination of Sunflower Broomrape	PLOS ONE			English	Article							SEED-GERMINATION; PARASITIC WEEDS; OROBANCHE; STRIGA; STRIGOLACTONES; STIMULANTS; PLANTS; RESISTANCE; ALECTROL; GROWTH	Sunflower broomrape is a noxious parasitic weed which has caused severe damage to crop ecosystems. Trap crops can release a mixture of allelochemicals to induce the germination of sunflower broomrape. We studied the allelopathic effects of soybean on sunflower broomrape. Fourteen common soybean cultivars were grown in Pots. Samples were collected from soybean plants and rhizosphere soil at five growth stages (V1, V3, V5, R2, and R4). The allelopathic effects of soybean reached highest at the V3 stage. Methanolic extracts of soybean roots induced higher broomrape germination than methanolic extracts of stems or leaves. The germination rates induced by root extracts (10-fold dilution) were positively correlated with germination rates induced by stem (10-fold dilution) and leaf extracts (10-fold dilution). The broomrape germination rates induced by root extracts were also positively correlated with soybean nodule diameter and dry weight. The results indicated that soybeans could induce sunflower broomrape germination. We conclude that soybean has the potential to be used as a trap crop for sunflower broom rape.	[Zhang, Wei; Ma, Yongqing; Shui, Junfeng] Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi Provinc, Peoples R China; [Ma, Yongqing; Shui, Junfeng] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi Provinc, Peoples R China; [Wang, Zhong; Ye, Xiaoxin] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi Provinc, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Northwest A&F University - China	Ma, YQ (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi Provinc, Peoples R China.	mayongqing@ms.iswc.ac.cn	Ma, Yongqing/M-5616-2017	Ma, Yongqing/0000-0001-7525-9111	National "Twelfth Five-Year Plan" Science and Technology projects [2011BAD31B05]; National Natural Science Foundation [30870403]	National "Twelfth Five-Year Plan" Science and Technology projects; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work is supported by the National "Twelfth Five-Year Plan" Science and Technology projects (2011BAD31B05) and National Natural Science Foundation Project (30870403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BD, 2002, CROP PROT, V21, P533, DOI 10.1016/S0261-2194(01)00137-5; Akhtouch B, 2002, PLANT BREEDING, V121, P266, DOI 10.1046/j.1439-0523.2002.00701.x; Al-thahabi SA, 2006, THESIS OREGON STATE; Aly R, 2001, WEED TECHNOL, V15, P306, DOI 10.1614/0890-037X(2001)015[0306:BOCCIS]2.0.CO;2; An M, 2003, ECOL MODEL, V161, P53, DOI 10.1016/S0304-3800(02)00289-2; Botanga CJ, 2003, CROP SCI, V43, P483, DOI 10.2135/cropsci2003.0483; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fernandez-Aparicio M, 2009, ANN BOT-LONDON, V103, P423, DOI 10.1093/aob/mcn236; Foo E, 2011, PLANTA, V234, P1073, DOI 10.1007/s00425-011-1516-7; Joel D. M., 2007, Horticultural Reviews, V33, P267, DOI 10.1002/9780470168011.ch4; Ju Huiyan, 2002, Yingyong Shengtai Xuebao, V13, P723; JuradoExposito M, 1997, J AGR SCI, V129, P307, DOI 10.1017/S0021859697004723; Khanh TD, 2005, CROP PROT, V24, P421, DOI 10.1016/j.cropro.2004.09.020; Kohlen W, 2011, PLANT PHYSIOL, V155, P974, DOI 10.1104/pp.110.164640; Lins RD, 2006, WEED RES, V46, P313, DOI 10.1111/j.1365-3180.2006.00515.x; Ma YQ, 2013, CROP SCI, V53, P260, DOI 10.2135/cropsci2012.03.0197; Ma YQ, 2012, AGRON J, V104, P569, DOI 10.2134/agronj2011.0372; Ma YQ, 2012, SCI CHINA LIFE SCI, V55, P250, DOI 10.1007/s11427-012-4302-2; Ma YQ, 2005, ALLELOPATHY J, V15, P49; MESAGARCIA J, 1985, WEED RES, V25, P129, DOI 10.1111/j.1365-3180.1985.tb00627.x; Nadal S, 2008, CROP PROT, V27, P873, DOI 10.1016/j.cropro.2007.10.009; Odhiambo J. A., 2011, Archives of Phytopathology and Plant Protection, V44, P158, DOI 10.1080/03235400902952194; Olubunmi AA, 2012, AFR J PLANT SCI, V6, P57; PARKER C, 1994, BIOLOGY AND MANAGEMENT OF OROBANCHE, P17; Parker C, 1993, PARASITIC WEEDS WORL; RILEY D, 1969, SOIL SCI SOC AM PRO, V33, P905, DOI 10.2136/sssaj1969.03615995003300060031x; Rubiales D, 2006, EUPHYTICA, V147, P187, DOI 10.1007/s10681-006-7399-1; Rubiales D, 2005, PLANT DIS, V89, P528, DOI 10.1094/PD-89-0528A; Sato D, 2005, BIOSCI BIOTECH BIOCH, V69, P98, DOI 10.1271/bbb.69.98; Wang YY, 2009, ALLELOPATHY J, V24, P103; WHITNEY PJ, 1978, ANN APPL BIOL, V89, P475, DOI 10.1111/j.1744-7348.1978.tb05976.x; Xie X, 2008, PHYTOCHEMISTRY, V69, P427, DOI 10.1016/j.phytochem.2007.07.017; Xie X, 2007, J AGR FOOD CHEM, V55, P8067, DOI 10.1021/jf0715121; Yokota T, 1998, PHYTOCHEMISTRY, V49, P1967, DOI 10.1016/S0031-9422(98)00419-1; Yoneyama K., 2006, Natural products for pest management, 226th ACS National Meeting, Anaheim, California, USA, 28 March-1 April 2004, P88; Yoneyama K, 2001, P 7 INT PAR WEED S N, P123	37	12	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59715	10.1371/journal.pone.0059715	http://dx.doi.org/10.1371/journal.pone.0059715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544089	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700049
J	Janouskovec, J; Liu, SL; Martone, PT; Carre, W; Leblanc, C; Collen, J; Keeling, PJ				Janouskovec, Jan; Liu, Shao-Lun; Martone, Patrick T.; Carre, Wilfrid; Leblanc, Catherine; Collen, Jonas; Keeling, Patrick J.			Evolution of Red Algal Plastid Genomes: Ancient Architectures, Introns, Horizontal Gene Transfer, and Taxonomic Utility of Plastid Markers	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MITOCHONDRIAL COX1; RHODELLA-VIOLACEA; DNA; RHODOPHYTA; PHYCOERYTHRIN; BIODIVERSITY; ARTEMIS; ORIGIN; RBCL	Red algae have the most gene-rich plastid genomes known, but despite their evolutionary importance these genomes remain poorly sampled. Here we characterize three complete and one partial plastid genome from a diverse range of florideophytes. By unifying annotations across all available red algal plastid genomes we show they all share a highly compact and slowly-evolving architecture and uniquely rich gene complements. Both chromosome structure and gene content have changed very little during red algal diversification, and suggest that plastid-to nucleus gene transfers have been rare. Despite their ancient character, however, the red algal plastids also contain several unprecedented features, including a group II intron in a tRNA-Met gene that encodes the first example of red algal plastid intron maturase - a feature uniquely shared among florideophytes. We also identify a rare case of a horizontally-acquired proteobacterial operon, and propose this operon may have been recruited for plastid function and potentially replaced a nucleus-encoded plastid-targeted paralogue. Plastid genome phylogenies yield a fully resolved tree and suggest that plastid DNA is a useful tool for resolving red algal relationships. Lastly, we estimate the evolutionary rates among more than 200 plastid genes, and assess their usefulness for species and subspecies taxonomy by comparison to well-established barcoding markers such as cox1 and rbcL. Overall, these data demonstrates that red algal plastid genomes are easily obtainable using high-throughput sequencing of total genomic DNA, interesting from evolutionary perspectives, and promising in resolving red algal relationships at evolutionarily-deep and species/subspecies levels.	[Janouskovec, Jan; Martone, Patrick T.; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Liu, Shao-Lun] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Carre, Wilfrid; Leblanc, Catherine; Collen, Jonas] Univ Paris 06, Biol Stn, Roscoff, France; [Carre, Wilfrid] CNRS, Biol Stn, ABiMS, FR2424, Roscoff, France; [Leblanc, Catherine; Collen, Jonas] CNRS, Biol Stn, UMR Marine Plants & Biomol 7139, Roscoff, France	University of British Columbia; Tunghai University; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Janouskovec, J (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	janjan.cz@gmail.com	Janouškovec, Jan/ABA-2568-2021	Janouškovec, Jan/0000-0001-6547-749X; Keeling, Patrick/0000-0002-7644-0745	Canadian Institutes for Health Research [MOP-42517]; Taiwan NSC [NSC-101-2621-B-029-004]; Natural Science and Engineering Research Council; Genoscope	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Taiwan NSC(Ministry of Science and Technology, Taiwan); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genoscope	This work was supported by a grant from the Canadian Institutes for Health Research (MOP-42517) to PJK. PJK is a Fellow of the Canadian Institute for Advanced Research. SLL was supported by a Taiwan NSC grant (NSC-101-2621-B-029-004). PTM acknowledges funding provided by the Natural Science and Engineering Research Council. WC, CL and JC would like to thank Genoscope for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD C, 1992, P NATL ACAD SCI USA, V89, P9564, DOI 10.1073/pnas.89.20.9564; Binder S, 2007, PHYSIOL PLANTARUM, V129, P68, DOI 10.1111/j.1399-3054.2006.00800.x; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chan CX, 2011, CURR BIOL, V21, P328, DOI 10.1016/j.cub.2011.01.037; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Ciniglia C, 2004, MOL ECOL, V13, P1827, DOI 10.1111/j.1365-294X.2004.02180.x; Clarkston BE, 2010, BOTANY, V88, P119, DOI 10.1139/B09-101; Couceiro L, 2011, J PHYCOL, V47, P1258, DOI 10.1111/j.1529-8817.2011.01075.x; Cui XX, 2004, J MOL BIOL, V340, P211, DOI 10.1016/j.jmb.2004.05.004; Dai LX, 2003, NUCLEIC ACIDS RES, V31, P424, DOI 10.1093/nar/gkg049; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delwiche CF, 1996, MOL BIOL EVOL, V13, P873, DOI 10.1093/oxfordjournals.molbev.a025647; DESTOMBE C, 1991, CURR GENET, V19, P395, DOI 10.1007/BF00309601; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Freshwater DW, 2010, CRYPTOGAMIE ALGOL, V31, P435; Gabrielsen TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019132; Glockner G, 2000, J MOL EVOL, V51, P382; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hagopian JC, 2004, J MOL EVOL, V59, P464, DOI 10.1007/s00239-004-2638-3; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hughey JR, 2001, J PHYCOL, V37, P1091, DOI 10.1046/j.1529-8817.2001.01048.x; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knill T, 2009, PLANT MOL BIOL, V71, P227, DOI 10.1007/s11103-009-9519-5; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lindstrom SC, 2011, PHYCOLOGIA, V50, P661, DOI 10.2216/10-38.1; MANHART JR, 1990, NATURE, V345, P268, DOI 10.1038/345268a0; Martone PT, 2012, J PHYCOL, V48, P859, DOI 10.1111/j.1529-8817.2012.01190.x; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Monde RA, 2000, MOL GEN GENET, V263, P610, DOI 10.1007/s004380051208; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Ohta N, 1997, J MOL EVOL, V45, P688, DOI 10.1007/PL00006273; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; Presting GG, 2006, CAN J BOT, V84, P1434, DOI 10.1139/B06-117; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; Rice DW, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-31; Richaud C, 1997, P NATL ACAD SCI USA, V94, P11736, DOI 10.1073/pnas.94.21.11736; Robba L, 2006, AM J BOT, V93, P1101, DOI 10.3732/ajb.93.8.1101; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saunders GW, 2008, BOTANY, V86, P773, DOI 10.1139/B08-001; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Smith DR, 2012, MOL PHYLOGENET EVOL, V65, P339, DOI 10.1016/j.ympev.2012.06.017; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sutherland JE, 2011, J PHYCOL, V47, P1131, DOI 10.1111/j.1529-8817.2011.01052.x; Thomas JC, 1999, J BIOL CHEM, V274, P2472, DOI 10.1074/jbc.274.4.2472; Turmel M, 2006, MOL BIOL EVOL, V23, P1324, DOI 10.1093/molbev/msk018; Verbruggen H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-16; Yang EC, 2008, J APPL PHYCOL, V20, P161, DOI 10.1007/s10811-007-9201-8; Yang EC, 2006, MOL ECOL NOTES, V6, P533, DOI 10.1111/j.1471-8286.2005.01216.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Yoon HS, 2006, J PHYCOL, V42, P482, DOI 10.1111/j.1529-8817.2006.00210.x; Yusuf D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-432	56	91	92	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59001	10.1371/journal.pone.0059001	http://dx.doi.org/10.1371/journal.pone.0059001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536846	Green Submitted, Green Published, gold			2022-12-25	WOS:000317397200013
J	Tsai, HE; Wu, JC; Kung, ML; Liu, LF; Kuo, LH; Kuo, HM; Chen, SC; Chan, EC; Wu, CS; Tai, MH; Liu, GS				Tsai, Han-En; Wu, Jian-Ching; Kung, Mei-Lang; Liu, Li-Feng; Kuo, Lai-Hsin; Kuo, Hsiao-Mei; Chen, San-Cher; Chan, Elsa C.; Wu, Chieh-Shan; Tai, Ming-Hong; Liu, Guei-Sheung			Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROGNOSTIC-FACTOR; DOWN-REGULATION; CANCER CELLS; EXPRESSION; METASTASIS; ACTIVATION; CARCINOMA; PATHWAY; ANGIOGENESIS	Cutaneous malignant melanoma is the fastest increasing malignancy in humans. Hepatoma-derived growth factor (HDGF) is a novel growth factor identified from human hepatoma cell line. HDGF overexpression is correlated with poor prognosis in various types of cancer including melanoma. However, the underlying mechanism of HDGF overexpression in developing melanoma remains unclear. In this study, human melanoma cell lines (A375, A2058, MEL-RM and MM200) showed higher levels of HDGF gene expression, whereas human epidermal melanocytes (HEMn) expressed less. Exogenous application of HDGF stimulated colony formation and invasion of human melanoma cells. Moreover, HDGF overexpression stimulated the degree of invasion and colony formation of B16-F10 melanoma cells whereas HDGF knockdown exerted opposite effects in vitro. To evaluate the effects of HDGF on tumour growth and metastasis in vivo, syngeneic mouse melanoma and metastatic melanoma models were performed by manipulating the gene expression of HDGF in melanoma cells. It was found that mice injected with HDGF-overexpressing melanoma cells had greater tumour growth and higher metastatic capability. In contrast, mice implanted with HDGF-depleted melanoma cells exhibited reduced tumor burden and lung metastasis. Histological analysis of excised tumors revealed higher degree of cell proliferation and neovascularization in HDGF-overexpressing melanoma. The present study provides evidence that HDGF promotes tumor progression of melanoma and targeting HDGF may constitute a novel strategy for the treatment of melanoma.	[Tsai, Han-En; Kuo, Lai-Hsin; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Wu, Jian-Ching; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Kung, Mei-Lang] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 80424, Taiwan; [Kung, Mei-Lang] Natl Sun Yat Sen Univ, Ctr Nanosci & Nanotechnol, Kaohsiung 80424, Taiwan; [Liu, Li-Feng] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan; [Kuo, Hsiao-Mei] Chang Gung Univ, Coll Med, Dept Internal Med, Chang Gung Mem Hosp,Kaohsiung Med Ctr, Kaohsiung, Taiwan; [Chen, San-Cher; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Ctr Neurosci, Kaohsiung 80424, Taiwan; [Wu, Chieh-Shan] Kaohsiung Vet Gen Hosp, Div Dermatol, Kaohsiung, Taiwan; [Chan, Elsa C.; Liu, Guei-Sheung] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3010, Australia; [Liu, Guei-Sheung] Univ Melbourne, Dept Ophthalmol, Melbourne, Vic 3010, Australia	National Sun Yat Sen University; National Sun Yat Sen University; National Sun Yat Sen University; National Sun Yat Sen University; I Shou University; Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Centre for Eye Research Australia; University of Melbourne; University of Melbourne	Tai, MH (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan.	minghongtai@gmail.com; guei-sheung.liu@unimelb.edu.au	Liu, Guei-Sheung/Q-6472-2018	Liu, Guei-Sheung/0000-0003-3379-724X	National Science Council, Taiwan [NSC 100-2325-B-110-002-MY3, NSC-99-2321-B-110-005]; Kaohsiung Veterans General Hospital, Taiwan [VGHKS-99-036]; University of Melbourne	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital, Taiwan; University of Melbourne(University of Melbourne)	This work was supported by grants from the National Science Council, Taiwan (NSC 100-2325-B-110-002-MY3 and NSC-99-2321-B-110-005); Kaohsiung Veterans General Hospital, Taiwan (VGHKS-99-036); Early Career Researcher grant (from University of Melbourne for G. S. L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard K, 2003, CANCER RES, V63, P6716; Bonitsis N., 2006, Experimental Oncology, V28, P187; Chang KC, 2007, INT J CANCER, V121, P1059, DOI 10.1002/ijc.22803; Chen SC, 2012, J PATHOL, V228, P158, DOI 10.1002/path.3988; de Vries E, 2004, EUR J CANCER, V40, P2355, DOI 10.1016/j.ejca.2004.06.003; Everett AD, 2004, AM J PHYSIOL-LUNG C, V286, pL1194, DOI 10.1152/ajplung.00427.2003; Everett AD, 2001, J BIOL CHEM, V276, P37564, DOI 10.1074/jbc.M105109200; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Gavert N, 2008, TRENDS MOL MED, V14, P199, DOI 10.1016/j.molmed.2008.03.004; Grabacka M, 2006, CLIN CANCER RES, V12, P3028, DOI 10.1158/1078-0432.CCR-05-2556; Guo RR, 2008, BIOL PHARM BULL, V31, P696, DOI 10.1248/bpb.31.696; Hu TH, 2003, CANCER-AM CANCER SOC, V98, P1444, DOI 10.1002/cncr.11653; Kao YH, 2010, J HEPATOL, V52, P96, DOI 10.1016/j.jhep.2009.10.002; KLAGSBRUN M, 1986, P NATL ACAD SCI USA, V83, P2448, DOI 10.1073/pnas.83.8.2448; Kung ML, 2012, BIOCHEM BIOPH RES CO, V425, P169, DOI 10.1016/j.bbrc.2012.07.060; Lee KH, 2010, ONCOL RES, V19, P67, DOI 10.3727/096504010X12864748215043; Liu GS, 2006, MOL PHARMACOL, V69, P440, DOI 10.1124/mol.105.015404; Liu GS, 2012, FREE RADICAL BIO MED, V52, P1835, DOI 10.1016/j.freeradbiomed.2012.02.040; Mahabeleshwar GH, 2007, SEMIN ONCOL, V34, P555, DOI 10.1053/j.seminoncol.2007.09.009; Mikesh LM, 2010, MELANOMA RES, V20, P485, DOI 10.1097/CMR.0b013e32833fafb4; MOSEVITSKY MI, 1989, EUR J BIOCHEM, V185, P303, DOI 10.1111/j.1432-1033.1989.tb15116.x; NAKAMURA H, 1994, J BIOL CHEM, V269, P25143; NAKAMURA H, 1989, CLIN CHIM ACTA, V183, P273, DOI 10.1016/0009-8981(89)90361-6; Okuda Y, 2003, CANCER SCI, V94, P1034, DOI 10.1111/j.1349-7006.2003.tb01397.x; Rigel DS, 2000, CA-CANCER J CLIN, V50, P215, DOI 10.3322/canjclin.50.4.215; Tsai CN, 2002, P NATL ACAD SCI USA, V99, P10084, DOI 10.1073/pnas.152059399; Uyama H, 2006, CLIN CANCER RES, V12, P6043, DOI 10.1158/1078-0432.CCR-06-1064; Yamamoto S, 2006, CLIN CANCER RES, V12, P117, DOI 10.1158/1078-0432.CCR-05-1347; Yamamoto S, 2007, ANN SURG ONCOL, V14, P2141, DOI 10.1245/s10434-007-9369-9; Zhang J, 2006, CANCER RES, V66, P18, DOI 10.1158/0008-5472.CAN-04-3905; Zhang XD, 1999, CANCER RES, V59, P2747	31	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59345	10.1371/journal.pone.0059345	http://dx.doi.org/10.1371/journal.pone.0059345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536873	Green Submitted, Green Published, gold			2022-12-25	WOS:000317397200021
J	Dubois, V; Delort, L; Billard, H; Vasson, MP; Caldefie-Chezet, F				Dubois, Virginie; Delort, Laetitia; Billard, Hermine; Vasson, Marie-Paule; Caldefie-Chezet, Florence			Breast Cancer and Obesity: In Vitro Interferences between Adipokines and Proangiogenic Features and/or Antitumor Therapies?	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BODY-MASS INDEX; LEPTIN RECEPTOR; ADIPOSE-TISSUE; STIMULATES ANGIOGENESIS; MAMMARY TUMORIGENESIS; UP-REGULATION; ADIPONECTIN; PROLIFERATION; EXPRESSION	Obesity is now considered as a risk factor for breast cancer in postmenopausal women. Adipokine levels are modulated in obesity, and may play a role in carcinogenesis. Moreover, obesity increases risk of cancer mortality. Here, we hypothesized that this increase could be due to a modification in angiogenesis, capital event in the development of metastases, and/or in effectiveness of cancer treatments. To test these assumptions, following a same experimental design and simultaneously the effects of leptin and adiponectin on angiogenesis were investigated, and the impact of hyperleptinemia on anticancer drug effectiveness was measured in physiological and obesity situations. Focusing on angiogenesis, the proliferation of endothelial cells (HUVEC), which expressed leptin and adiponectin receptors, was stimulated by leptin and inhibited by adiponectin. Both adipokines globally reduced apoptosis and caspase activity. Leptin increased migration whereas adiponectin decreased migration, and leptin enhanced the area of the tubes formed by HUVEC cells while adiponectin inhibited their formation. MCF7 and MDA-MB-231 cells treated with leptin secreted more VEGF than untreated cells, whereas adiponectin treatment inhibited VEGF secretion. Finally, MCF7 cells pre-treated with leptin were more invasive than untreated cells. This effect was not reproduced in MDA-MB-231 cells. In the MCF7 breast cancer cell line, leptin could induce cell proliferation and reduced the efficacy of all breast cancer therapies (tamoxifen, 5-fluorouracil, taxol and vinblastin). These results suggest that, in obesity situation, leptin-in contrast to adiponectin - may promote tumor invasion and angiogenesis, leading to metastases 'apparition, and reduce treatment efficacy, which could explain the increased risk of cancer mortality in cases of overweight. The evidence suggests adipokines influence breast cancer issue and could play a significant role, especially in obese patients for which hyperleptinemia, hypoadiponectinemia and increased metastatic potential are described.	[Dubois, Virginie; Delort, Laetitia; Billard, Hermine; Caldefie-Chezet, Florence] Univ Clermont Ferrand 2, Univ Auvergne, UFR Pharm, Lab SVFp, Clermont Ferrand, France; [Delort, Laetitia; Billard, Hermine; Vasson, Marie-Paule; Caldefie-Chezet, Florence] CRNH Auvergne, ECREIN, INRA, UMR 1019, Clermont Ferrand, France; [Vasson, Marie-Paule] Ctr Jean Perrin, Unite Nutr, Clermont Ferrand, France; [Vasson, Marie-Paule; Caldefie-Chezet, Florence] CLARA, Reg Lyon Auvergne, Rhone Alpes, France	Universite Clermont Auvergne (UCA); INRAE; UNICANCER; Centre Jean Perrin	Caldefie-Chezet, F (corresponding author), Univ Clermont Ferrand 2, Univ Auvergne, UFR Pharm, Lab SVFp, Clermont Ferrand, France.	florence.caldefie-chezet@udamail.fr	FLORENCE, CALDEFIE-CHEZET FCC/U-3378-2018; delort, laetitia/C-3838-2014; vasson, marie-paule/ABA-2486-2021		Ligue Contre le Cancer; CLARA (Canceropole Lyon Auvergne Rhone-Alpes, France); French Ministry of Research and Technology	Ligue Contre le Cancer(Ligue nationale contre le cancer); CLARA (Canceropole Lyon Auvergne Rhone-Alpes, France); French Ministry of Research and Technology	This study received financial support from the 'Ligue Contre le Cancer' and from CLARA (Canceropole Lyon Auvergne Rhone-Alpes, France). Virginie Dubois is supported by a fellowship from the French Ministry of Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; BJORNTORP P, 1991, INT J OBESITY, V15, P67; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; BUSSE R, 1991, BASIC RES CARDIOL, V86, P7; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Chen CC, 2006, BREAST CANCER RES TR, V98, P121, DOI 10.1007/s10549-005-9139-y; Cleary MP, 1997, P SOC EXP BIOL MED, V216, P28, DOI 10.3181/00379727-216-44153B; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Fusco R, 2010, ENDOCR-RELAT CANCER, V17, P373, DOI 10.1677/ERC-09-0340; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Garofalo C, 2006, CLIN CANCER RES, V12, P1447, DOI 10.1158/1078-0432.CCR-05-1913; Goetze S, 2002, HYPERTENSION, V40, P748, DOI 10.1161/01.HYP.0000035522.63647.D3; Grossmann ME, 2010, CANCER METAST REV, V29, P641, DOI 10.1007/s10555-010-9252-1; Guerre-Millo M, 2004, DIABETES METAB, V30, P13, DOI 10.1016/S1262-3636(07)70084-8; Han CZ, 2005, ENDOCRINE, V26, P19, DOI 10.1385/ENDO:26:1:019; Hancke K, 2010, BREAST CANCER RES TR, V119, P367, DOI 10.1007/s10549-009-0577-9; Housa D, 2006, PHYSIOL RES, V55, P233, DOI 10.33549/physiolres.930848; Ishikawa M, 2004, CLIN CANCER RES, V10, P4325, DOI 10.1158/1078-0432.CCR-03-0749; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Jarde T, 2009, ENDOCR-RELAT CANCER, V16, P1197, DOI 10.1677/ERC-09-0043; Jiang HP, 2008, BIOCHEM BIOPH RES CO, V368, P1, DOI 10.1016/j.bbrc.2007.04.004; Kang JH, 2007, J KOREAN MED SCI, V22, P117, DOI 10.3346/jkms.2007.22.1.117; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Landskroner-Eiger S, 2009, CLIN CANCER RES, V15, P3265, DOI 10.1158/1078-0432.CCR-08-2649; Loi S, 2005, CANCER EPIDEM BIOMAR, V14, P1686, DOI 10.1158/1055-9965.EPI-05-0042; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Lukanova A, 2006, INT J CANCER, V118, P458, DOI 10.1002/ijc.21354; Marttunen MB, 2000, MATURITAS, V35, P175, DOI 10.1016/S0378-5122(00)00121-3; Masaki Takayuki, 2008, Transl Oncogenomics, V3, P45; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Melen-Mucha Gabriela, 2007, Endokrynol Pol, V58, P2; Nunez NP, 2004, CLIN CANCER RES, V10, P5375, DOI 10.1158/1078-0432.CCR-04-0261; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ozet A, 2001, JPN J CLIN ONCOL, V31, P424, DOI 10.1093/jjco/hye097; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Rasband W., 2006, IMAGEJ; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Stephenson GD, 2003, NUTR CANCER, V45, P1, DOI 10.1207/S15327914NC4501_1; Takahashi Y, 1997, J BIOL CHEM, V272, P12897, DOI 10.1074/jbc.272.20.12897; Umemoto Y, 1997, BLOOD, V90, P3438, DOI 10.1182/blood.V90.9.3438; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0	49	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58541	10.1371/journal.pone.0058541	http://dx.doi.org/10.1371/journal.pone.0058541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554900	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800019
J	Lochmann, T; Blanche, TJ; Butts, DA				Lochmann, Timm; Blanche, Timothy J.; Butts, Daniel A.			Construction of Direction Selectivity through Local Energy Computations in Primary Visual Cortex	PLOS ONE			English	Article							CELL RECEPTIVE-FIELDS; 2-DIMENSIONAL SPATIAL STRUCTURE; COMPLEX CELLS; GANGLION-CELLS; MOTION ENERGY; MACAQUE V1; AREA MT; NEURONS; RESPONSES; ORGANIZATION	Despite detailed knowledge about the anatomy and physiology of neurons in primary visual cortex (V1), the large numbers of inputs onto a given V1 neuron make it difficult to relate them to the neuron's functional properties. For example, models of direction selectivity (DS), such as the Energy Model, can successfully describe the computation of phase-invariant DS at a conceptual level, while leaving it unclear how such computations are implemented by cortical circuits. Here, we use statistical modeling to derive a description of DS computation for both simple and complex cells, based on physiologically plausible operations on their inputs. We present a new method that infers the selectivity of a neuron's inputs using extracellular recordings in macaque in the context of random bar stimuli and natural movies in cat. Our results suggest that DS is initially constructed in V1 simple cells through summation and thresholding of non-DS inputs with appropriate spatiotemporal relationships. However, this de novo construction of DS is rare, and a majority of DS simple cells, and all complex cells, appear to receive both excitatory and suppressive inputs that are already DS. For complex cells, these numerous DS inputs typically span a fraction of their overall receptive fields and have similar spatiotemporal tuning but different phase and spatial positions, suggesting an elaboration to the Energy Model that incorporates spatially localized computation. Furthermore, we demonstrate how these computations might be constructed from biologically realizable components, and describe a statistical model consistent with the feed-forward framework suggested by Hubel and Wiesel.	[Lochmann, Timm; Butts, Daniel A.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Lochmann, Timm; Butts, Daniel A.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA; [Blanche, Timothy J.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA; [Blanche, Timothy J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lochmann, T (corresponding author), Tech Univ Berlin, Neural Informat Proc Grp, Berlin, Germany.	lochman@ni.tu-berlin.de	Butts, Daniel A/B-8346-2008	Butts, Daniel A/0000-0002-0158-5317	National Science Foundation [IIS-0904430]; National Institutes of Health [5R21NS066260]; Direct For Computer & Info Scie & Enginr [0904430] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066260] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work supported by National Science Foundation IIS-0904430 (TL, DAB) and National Institutes of Health-5R21NS066260 (TJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Ahrens MB, 2008, NETWORK-COMP NEURAL, V19, P35, DOI 10.1080/09548980701813936; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Bialek W, 2005, FEATURES DIMENSIONS; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Butts DA, 2011, J NEUROSCI, V31, P11313, DOI 10.1523/JNEUROSCI.0434-11.2011; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P457, DOI 10.1113/jphysiol.1974.sp010618; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Fitzgerald JD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002249; Freeman J, 2012, ANN M SOC NEUR, P63102; Gerwinn S, 2008, NIPS, V20, P1; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Hastie T., 2009, UNSUPERVISED LEARNIN; Hastie T.J., 2017, STAT SCI; Heess N, 2010, J NEUROSCI, V30, P11300, DOI 10.1523/JNEUROSCI.1271-10.2010; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kayser C, 2003, J NEUROPHYSIOL, V90, P1910, DOI 10.1152/jn.00195.2003; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lau B, 2002, P NATL ACAD SCI USA, V99, P8974, DOI 10.1073/pnas.122173799; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Mante V, 2005, J NEUROPHYSIOL, V94, P788, DOI 10.1152/jn.01094.2004; Martinez LM, 2003, NEUROSCIENTIST, V9, P317, DOI 10.1177/1073858403252732; McFarland J, 2012, ANN M SOC NEUR, P63107; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Movshon JA, 1996, J NEUROSCI, V16, P7733; Nishimoto S, 2011, J NEUROSCI, V31, P14551, DOI 10.1523/JNEUROSCI.6801-10.2011; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Park I, 2011, NIPS, V24, P1; Park M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002219; Peterson MR, 2004, J NEUROSCI, V24, P3583, DOI 10.1523/JNEUROSCI.5398-03.2004; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pillow JW, 2006, J VISION, V6, P414, DOI 10.1167/6.4.9; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Priebe NJ, 2003, J NEUROSCI, V23, P5650; Rad KR, 2010, NETWORK-COMP NEURAL, V21, P142, DOI 10.3109/0954898X.2010.532288; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Rust NC, 2010, CURR OPIN NEUROBIOL, V20, P382, DOI 10.1016/j.conb.2010.04.013; Saleem AB, 2008, J VISION, V8, DOI 10.1167/8.13.2; Saul AB, 2005, J NEUROPHYSIOL, V94, P282, DOI 10.1152/jn.00868.2004; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; SZULBORSKI RG, 1990, VISION RES, V30, P249, DOI 10.1016/0042-6989(90)90040-R; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Touryan J, 2005, NEURON, V45, P781, DOI 10.1016/j.neuron.2005.01.029; Touryan J, 2002, J NEUROSCI, V22, P10811; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; Vintch B, 2012, NIPS, P25; Wielaard J, 2006, J NEUROPHYSIOL, V96, P2739, DOI 10.1152/jn.00346.2006	68	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58666	10.1371/journal.pone.0058666	http://dx.doi.org/10.1371/journal.pone.0058666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554913	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800021
J	Tang, QQ; Wu, W; Xu, X; Huang, L; Gao, Q; Chen, HJ; Sun, H; Xia, YK; Sha, JH; Wang, XR; Chen, DZ; Xu, Q				Tang, Qiuqin; Wu, Wei; Xu, Xia; Huang, Lu; Gao, Qiong; Chen, Huijuan; Sun, Hong; Xia, Yankai; Sha, Jiahao; Wang, Xinru; Chen, Daozhen; Xu, Qian			miR-141 Contributes to Fetal Growth Restriction by Regulating PLAG1 Expression	PLOS ONE			English	Article							PLACENTAL DEVELOPMENT; MATERNAL PLASMA; STEM-CELLS; MICRORNAS; INTRAUTERINE; MECHANISMS; DISEASE; MOUSE; IGF2; IDENTIFICATION	Background: Fetal growth restriction (FGR) is an important but poorly understood condition of pregnancy, which results in significant fetal, neonatal and long-term morbidity and mortality. Novel research has suggested that altered miRNA expression in the plasma and placenta is associated with adverse pregnancy. We hypothesized that aberrant expression of microRNA-141 (miR-141) in the placenta is associated with FGR. Additionally, expression levels of predicted target genes of miR-141 were also analyzed in placental tissues of FGR and normal controls. Methodology/Principal Findings: Using quantitative real time PCR, we analyzed the expression level of miR-141 and its target genes in placentas of FGR pregnancies (n = 21) and normal controls (n = 34). Western blot was used to detect the protein expression level of the target genes of miR-141. MiR-141 showed significant up regulation in FGR and significant down regulation of its targets, i.e. E2F transcription factor 3 (E2F3) protein, pleiomorphic adenoma gene 1 (PLAG1) mRNA and protein. Moreover, a positive correlation was found between PLAG1 and insulin-like growth factor 2 (IGF2) expression levels (Spearman r = 0.56, p<0.0001). MiR-141 yields an AUC of 0.83 with 88.5% sensitivity and 71.7% specificity for separating FGR from normal controls. This study indicates that miR-141 may be diagnostically important in FGR. Conclusions/Significance: Our results indicate that aberrant high expression level of miR-141 might play important roles in the pathogenesis of FGR by suppressing E2F3 and PLAG1. We propose that miR-141 may participate in a miR-141-PLAG1-IGF2 network relating to FGR development. These findings may provide new targets via miR-141 in diagnosis and therapy of FGR in the future.	[Tang, Qiuqin; Wu, Wei; Xu, Xia; Huang, Lu; Chen, Huijuan; Xu, Qian] Wuxi Hosp Maternal & Child Hlth Care, Dept Obstet, Wuxi, Peoples R China; [Tang, Qiuqin; Xu, Xia; Gao, Qiong] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China; [Wu, Wei; Xia, Yankai; Sha, Jiahao; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wu, Wei; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Sun, Hong] KULeuven, Dept Microbial & Mol Syst, Louvain, Belgium; [Chen, Daozhen] Wuxi Hosp Maternal & Child Hlth Care, Dept Lab, Wuxi, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; KU Leuven	Xu, Q (corresponding author), Wuxi Hosp Maternal & Child Hlth Care, Dept Obstet, Wuxi, Peoples R China.	xxpxq@hotmail.com	Tang, Qiuqin/X-4817-2019; Wang, Xin/AAN-8435-2021; Wu, Wei/C-4409-2012	Tang, Qiuqin/0000-0001-9110-9973; Wang, Xin/0000-0002-4457-7376; Wu, Wei/0000-0002-0267-1284	Key Project of Technology Development of Nanjing Medical University [2012NJMU002]	Key Project of Technology Development of Nanjing Medical University	This work was supported by grants Key Project of Technology Development of Nanjing Medical University (No. 2012NJMU002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Braem CV, 2002, J BIOL CHEM, V277, P19673, DOI 10.1074/jbc.M112112200; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chong JL, 2009, MOL CELL BIOL, V29, P414, DOI 10.1128/MCB.01161-08; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gisselsson D, 2001, AM J PATHOL, V159, P955, DOI 10.1016/S0002-9440(10)61771-3; Hensen K, 2004, DEV GROWTH DIFFER, V46, P459, DOI 10.1111/j.1440-169x.2004.00762.x; Hu MH, 2010, DIGEST DIS SCI, V55, P2365, DOI 10.1007/s10620-009-1008-9; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Koukoura O, 2011, INT J MOL MED, V28, P481, DOI 10.3892/ijmm.2011.754; Kusinski LC, 2011, PLACENTA, V32, P871, DOI 10.1016/j.placenta.2011.07.086; Lee DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012630; LIEBERMAN E, 1994, AM J PUBLIC HEALTH, V84, P1127, DOI 10.2105/AJPH.84.7.1127; Lin CC, 1998, OBSTET GYNECOL, V92, P1044, DOI 10.1016/S0029-7844(98)00328-7; Liu N, 2010, J MOL CELL BIOL, V2, P333, DOI 10.1093/jmcb/mjq029; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Nardozza LMM, 2012, ARCH GYNECOL OBSTET, V286, P1, DOI 10.1007/s00404-012-2330-6; Matsuyama A, 2011, VIRCHOWS ARCH, V458, P583, DOI 10.1007/s00428-011-1063-4; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Mullins E, 2012, AM J REPROD IMMUNOL, V68, P1, DOI 10.1111/j.1600-0897.2012.01132.x; Navarro A, 2010, YONSEI MED J, V51, P622, DOI 10.3349/ymj.2010.51.5.622; NEERHOF MG, 1995, CLIN PERINATOL, V22, P375; Ouseph MM, 2012, DEV CELL, V22, P849, DOI 10.1016/j.devcel.2012.01.013; Pan Q, 2008, SEMIN REPROD MED, V26, P479, DOI 10.1055/s-0028-1096128; Parisi T, 2007, MOL CELL BIOL, V27, P2283, DOI 10.1128/MCB.01854-06; Randhawa R, 2005, MOL GENET METAB, V86, P84, DOI 10.1016/j.ymgme.2005.07.028; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Smerieri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029562; Van Dyck F, 2004, J BIOL CHEM, V279, P36121, DOI 10.1074/jbc.M401753200; Vedmedovska N, 2011, EUR J OBSTET GYN R B, V155, P36, DOI 10.1016/j.ejogrb.2010.11.017; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zatkova A, 2004, GENE CHROMOSOME CANC, V39, P126, DOI 10.1002/gcc.10307	42	55	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58737	10.1371/journal.pone.0058737	http://dx.doi.org/10.1371/journal.pone.0058737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554918	Green Submitted, Green Published, gold			2022-12-25	WOS:000316409800024
J	Braybrook, SA; Peaucelle, A				Braybrook, Siobhan A.; Peaucelle, Alexis			Mechano-Chemical Aspects of Organ Formation in Arabidopsis thaliana: The Relationship between Auxin and Pectin	PLOS ONE			English	Article							CELL-WALL SYNTHESIS; METHYL-ESTERIFICATION; MECHANICAL-PROPERTIES; GROWTH; EXPANSIN; COLEOPTILE; PHYLLOTAXIS; INITIATION; STIFFNESS; CALCIUM	How instructive signals are translated into robust and predictable changes in growth is a central question in developmental biology. Recently, much interest has centered on the feedback between chemical instructions and mechanical changes for pattern formation in development. In plants, the patterned arrangement of aerial organs, or phyllotaxis, is instructed by the phytohormone auxin; however, it still remains to be seen how auxin is linked, at the apex, to the biochemical and mechanical changes of the cell wall required for organ outgrowth. Here, using Atomic Force Microscopy, we demonstrate that auxin reduces tissue rigidity prior to organ outgrowth in the shoot apex of Arabidopsis thaliana, and that the demethyl-esterification of pectin is necessary for this reduction. We further show that development of functional organs produced by pectin-mediated ectopic wall softening requires auxin signaling. Lastly, we demonstrate that coordinated localization of the auxin transport protein, PIN1, is disrupted in a naked-apex produced by increasing cell wall rigidity. Our data indicates that a feedback loop between the instructive chemical auxin and cell wall mechanics may play a crucial role in phyllotactic patterning.	[Braybrook, Siobhan A.] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Peaucelle, Alexis] Univ Paris Diderot, Lab Matiere & Syst Complexes, UFR Phys, Paris, France; [Peaucelle, Alexis] INRA Ctr Versailles Grignon, Inst Jean Pierre Bourgin, INRA AgroParisTech UMR1318, Versailles, France	University of Bern; UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Peaucelle, A (corresponding author), Univ Paris Diderot, Lab Matiere & Syst Complexes, UFR Phys, Paris, France.	Alexis.Peaucelle@versailles.inra.fr		Braybrook, Siobhan/0000-0002-4308-5580	Human Frontiers Science Program; Agence Nationale de la Recherche (ANR) [Blanc 2009 ANR-09-BLAN-0007-02, ANR-10-BLAN-1516 2010]; United States National Science Foundation [OISE-0853105]; Swiss National Science Foundation	Human Frontiers Science Program(Human Frontier Science Program); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); United States National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	AP was funded by the Human Frontiers Science Program, Agence Nationale de la Recherche (ANR) Blanc 2009 ANR-09-BLAN-0007-02 'GrowPec', ANR-10-BLAN-1516 2010 'Mechastem'. SB is funded by a United States National Science Foundation International Research Fellowship (Award No. OISE-0853105) and the Swiss National Science Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULBAKI AA, 1971, PLANT PHYSIOL, V47, P537, DOI 10.1104/pp.47.4.537; Bainbridge K, 2008, GENE DEV, V22, P810, DOI 10.1101/gad.462608; BAKER DB, 1965, PLANT PHYSIOL, V40, P345, DOI 10.1104/pp.40.2.345; BARKLEY GM, 1973, PLANT PHYSIOL, V52, P76, DOI 10.1104/pp.52.1.76; Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; BONNER JAMES, 1934, PROTOPLASMA, V21, P406, DOI 10.1007/BF01984529; Braybrook SA, 2012, PLANT SIGNAL BEHAV, V7, P1037, DOI 10.4161/psb.20768; Braybrook SA, 2010, PLANT CELL, V22, P1006, DOI 10.1105/tpc.110.073924; Burgert I., 2007, The expanding cell, P191; Cassereau L, 2012, NAT MATER, V11, P490, DOI 10.1038/nmat3345; Cho A, 2004, SCIENCE, V303, P782, DOI 10.1126/science.303.5659.782; CLELAND R, 1958, PHYSIOL PLANTARUM, V11, P599, DOI 10.1111/j.1399-3054.1958.tb08255.x; CLELAND R, 1956, PLANT PHYSIOL, V31, P350, DOI 10.1104/pp.31.5.350; CLELAND R, 1960, PLANT PHYSIOL, V35, P581, DOI 10.1104/pp.35.5.581; CLELAND R, 1971, ANN REV PLANT PHYSIO, V22, P197, DOI 10.1146/annurev.pp.22.060171.001213; CLELAND R, 1973, P NATL ACAD SCI USA, V70, P3092, DOI 10.1073/pnas.70.11.3092; CLELAND R, 1963, PLANT PHYSIOL, V38, P12, DOI 10.1104/pp.38.1.12; Cosgrove DJ, 1998, PLANT PHYSIOL, V118, P333, DOI 10.1104/pp.118.2.333; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Feraru E, 2011, CURR BIOL, V21, P338, DOI 10.1016/j.cub.2011.01.036; Fernandes AN, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021916; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hayot CM, 2012, J EXP BOT, V63, P2525, DOI 10.1093/jxb/err428; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Heyn ANJ, 1931, MECH ZELLSTRECKUNG; Hofte H, 2012, FRONT PLANT SCI, V3; HOSON T, 1993, J PLANT RES, V106, P369, DOI 10.1007/BF02345982; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kaku T, 2002, PLANT CELL PHYSIOL, V43, P21, DOI 10.1093/pcp/pcf004; Kierzkowski D, 2012, SCIENCE, V335, P1096, DOI 10.1126/science.1213100; Krupinski P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001560; LINERS F, 1994, PLANTA, V192, P545, DOI 10.1007/BF00203593; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Milani P, 2011, PLANT J, V67, P1116, DOI 10.1111/j.1365-313X.2011.04649.x; Mirabet V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002389; Nakayama N, 2012, CURR BIOL, V22, P1468, DOI 10.1016/j.cub.2012.06.050; OKADA K, 1994, PLANT MOL BIOL, V26, P1357, DOI 10.1007/BF00016480; ORDIN L, 1957, PLANT PHYSIOL, V32, P216, DOI 10.1104/pp.32.3.216; Peaucelle A, 2008, CURR BIOL, V18, P1943, DOI 10.1016/j.cub.2008.10.065; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Peters WS, 2001, PLANT PHYSIOL, V125, P2173, DOI 10.1104/pp.125.4.2173; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Proseus TE, 1999, PLANT PHYSIOL, V119, P775, DOI 10.1104/pp.119.2.775; Radotic K, 2012, BIOPHYS J, V103, P386, DOI 10.1016/j.bpj.2012.06.046; RAY PM, 1965, PLANT PHYSIOL, V40, P353, DOI 10.1104/pp.40.2.353; RAYLE D, 1970, PLANT PHYSIOL, V46, P250, DOI 10.1104/pp.46.2.250; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Reinhardt D, 1998, PLANT CELL, V10, P1427, DOI 10.1105/tpc.10.9.1427; Reinitz J, 2012, NATURE, V482, P464, DOI 10.1038/482464a; Smith RS, 2009, PLANT CELL ENVIRON, V32, P1258, DOI 10.1111/j.1365-3040.2009.01997.x; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Soding H, 1931, JB WISS BOT, V74, P127; Suslov D, 2006, J EXP BOT, V57, P2183, DOI 10.1093/jxb/erj177; TAGAWA T, 1957, PLANT PHYSIOL, V32, P207, DOI 10.1104/pp.32.3.207; TREITEL O, 1946, J COLL SCI IMP U TOK, V1, P327, DOI 10.1016/0095-8522(46)90022-0; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; UHRSTROM I, 1969, PHYSIOL PLANTARUM, V22, P271, DOI 10.1111/j.1399-3054.1969.tb07376.x; Urdy S, 2012, BIOL REV, V87, P786, DOI 10.1111/j.1469-185X.2012.00221.x; Uyttewaal M, 2012, CELL, V149, P439, DOI 10.1016/j.cell.2012.02.048; Van Sandt VST, 2007, ANN BOT-LONDON, V100, P1467, DOI 10.1093/aob/mcm248; Verbelen JP, 2007, EXPANDING CELL; Zhao QX, 2008, PLANT PHYSIOL, V147, P1874, DOI 10.1104/pp.108.116962	68	154	155	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57813	10.1371/journal.pone.0057813	http://dx.doi.org/10.1371/journal.pone.0057813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554870	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500010
J	Kavanagh, DPJ; Yemm, AI; Zhao, Y; Frampton, J; Kalia, N				Kavanagh, Dean P. J.; Yemm, Adrian I.; Zhao, Yan; Frampton, Jon; Kalia, Neena			Mechanisms of Adhesion and Subsequent Actions of a Haematopoietic Stem Cell Line, HPC-7, in the Injured Murine Intestinal Microcirculation In Vivo	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; BONE-MARROW; TNF-ALPHA; PROGENITOR CELLS; E-SELECTIN; RECRUITMENT; EXPRESSION; BLOOD; SDF-1; INFLAMMATION	Objectives: Although haematopoietic stem cells (HSCs) migrate to injured gut, therapeutic success clinically remains poor. This has been partially attributed to limited local HSC recruitment following systemic injection. Identifying site specific adhesive mechanisms underpinning HSC-endothelial interactions may provide important information on how to enhance their recruitment and thus potentially improve therapeutic efficacy. This study determined (i) the integrins and inflammatory cyto/chemokines governing HSC adhesion to injured gut and muscle (ii) whether pre-treating HSCs with these cyto/chemokines enhanced their adhesion and (iii) whether the degree of HSC adhesion influenced their ability to modulate leukocyte recruitment. Methods: Adhesion of HPC-7, a murine HSC line, to ischaemia-reperfused (IR) injured mouse gut or cremaster muscle was monitored intravitally. Critical adhesion molecules were identified by pre-treating HPC-7 with blocking antibodies to CD18 and CD49d. To identify cyto/chemokines capable of recruiting HPC-7, adhesion was monitored following tissue exposure to TNF-alpha, IL-1 beta or CXCL12. The effects of pre-treating HPC-7 with these cyto/chemokines on surface integrin expression/clustering, adhesion to ICAM-1/VCAM-1 and recruitment in vivo was also investigated. Endogenous leukocyte adhesion following HPC-7 injection was again determined intravitally. Results: IR injury increased HPC-7 adhesion in vivo, with intestinal adhesion dependent upon CD18 and muscle adhesion predominantly relying on CD49d. Only CXCL12 pre-treatment enhanced HPC-7 adhesion within injured gut, likely by increasing CD18 binding to ICAM-1 and/or CD18 surface clustering on HPC-7. Leukocyte adhesion was reduced at 4 hours post-reperfusion, but only when local HPC-7 adhesion was enhanced using CXCL12. Conclusion: This data provides evidence that site-specific molecular mechanisms govern HPC-7 adhesion to injured tissue. Importantly, we show that HPC-7 adhesion is a modulatable event in IR injury and further demonstrate that adhesion instigated by injury alone is not sufficient for mediating anti-inflammatory effects. Enhancing local HSC presence may therefore be essential to realising their clinical potential.	[Kavanagh, Dean P. J.; Yemm, Adrian I.; Zhao, Yan; Kalia, Neena] Univ Birmingham, Coll Med & Dent Sci, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Frampton, Jon] Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, Sch Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Kalia, N (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Ctr Cardiovasc Sci, Birmingham, W Midlands, England.	n.kalia@bham.ac.uk		Yemm, Adrian/0000-0001-9508-5710; KALIA, NEENA/0000-0003-2960-7829	British Heart Foundation [PG/08/043/25067]; Royal Society [12043]; Bardhan Research and Education Trust [09-0675]; British Heart Foundation [PG/11/114/29282] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Royal Society(Royal Society of London); Bardhan Research and Education Trust; British Heart Foundation(British Heart Foundation)	This study was funded by the British Heart Foundation (DK, NK): PG/08/043/25067; The Royal Society (YZ, NK): 12043; Bardhan Research and Education Trust (AY, NK): 09-0675. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Allakhverdi Z, 2012, ALLERGY, V67, P4, DOI 10.1111/j.1398-9995.2011.02703.x; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Chen BP, 1997, IMMUNOL REV, V157, P41, DOI 10.1111/j.1600-065X.1997.tb00972.x; Connor EM, 1999, J LEUKOCYTE BIOL, V65, P349, DOI 10.1002/jlb.65.3.349; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Esposito E, 2007, J LEUKOCYTE BIOL, V81, P1032, DOI 10.1189/jlb.0706480; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Fukatsu K, 2004, JPEN-PARENTER ENTER, V28, P224, DOI 10.1177/0148607104028004224; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Granick JL, 2012, BONE MARROW RES, DOI 10.1155/2012/165107; Guan YF, 2009, AM J PHYSIOL-GASTR L, V297, pG187, DOI 10.1152/ajpgi.90595.2008; Henninger DD, 1997, J IMMUNOL, V158, P1825; Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Katayama Y, 2004, BLOOD, V104, P2020, DOI 10.1182/blood-2003-12-4157; Kavanagh DPJ, 2010, GUT, V59, P79, DOI 10.1136/gut.2008.168054; Kavanagh DP, 2012, CELL TRANSPLANT; Khalil PN, 2007, GASTROENTEROLOGY, V132, P944, DOI 10.1053/j.gastro.2006.12.029; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kyriakides C, 2000, J TRAUMA, V48, P32, DOI 10.1097/00005373-200001000-00006; Lundberg AH, 2000, ANN SURG, V231, P213, DOI 10.1097/00000658-200002000-00010; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mejia-Vilet JM, 2007, AM J PHYSIOL-RENAL, V293, pF78, DOI 10.1152/ajprenal.00077.2007; Mifflin RC, 2011, AM J PHYSIOL-GASTR L, V300, pG684, DOI 10.1152/ajpgi.00474.2010; Montecucco F, 2008, CELL SIGNAL, V20, P557, DOI 10.1016/j.cellsig.2007.11.008; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Oktar BK, 2002, AM J PHYSIOL-GASTR L, V282, pG647, DOI 10.1152/ajpgi.2002.282.4.G647; Orelio C, 2009, HAEMATOL-HEMATOL J, V94, P462, DOI 10.3324/haematol.13728; Otto WR, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-20; Oyama Y, 2005, GASTROENTEROLOGY, V128, P552, DOI 10.1053/j.gastro.2004.11.051; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; PETTIPHER ER, 1986, P NATL ACAD SCI USA, V83, P8749, DOI 10.1073/pnas.83.22.8749; Pinto do O P, 1998, EMBO J, V17, P5744, DOI 10.1093/emboj/17.19.5744; Playford RJ, 2005, J PATHOL, V205, P417, DOI 10.1002/path.1722; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; Ross EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002338; Santiago B, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1900; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Souza DG, 2004, J IMMUNOL, V172, P2542, DOI 10.4049/jimmunol.172.4.2542; Sumpio BE, 2003, HAIMOVICIS VASCULAR, P137; TURNER ML, 1995, STEM CELLS, V13, P311, DOI 10.1002/stem.5530130312; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Wyble CW, 1997, J SURG RES, V73, P107, DOI 10.1006/jsre.1997.5207; Yoshida T, 2007, NEUROSCIENCE, V145, P923, DOI 10.1016/j.neuroscience.2006.12.067; Yu T, 2010, AM J PHYSIOL-CELL PH, V299, pC399, DOI 10.1152/ajpcell.00039.2009	47	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59150	10.1371/journal.pone.0059150	http://dx.doi.org/10.1371/journal.pone.0059150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554986	gold, Green Submitted, Green Published			2022-12-25	WOS:000316252500070
J	Meng, J; Zhu, QH; Zhang, LL; Li, CY; Li, L; She, ZC; Huang, BY; Zhang, GF				Meng, Jie; Zhu, Qihui; Zhang, Linlin; Li, Chunyan; Li, Li; She, Zhicai; Huang, Baoyu; Zhang, Guofan			Genome and Transcriptome Analyses Provide Insight into the Euryhaline Adaptation Mechanism of Crassostrea gigas	PLOS ONE			English	Article							MARKER GENES; OYSTER; SALINITY; EXPRESSION; STRESS; TAURINE; TEMPERATURE; POPULATION; LARVAE; GROWTH	Background: The Pacific oyster, Crassostrea gigas, has developed special mechanisms to regulate its osmotic balance to adapt to fluctuations of salinities in coastal zones. To understand the oyster's euryhaline adaptation, we analyzed salt stress effectors metabolism pathways under different salinities (salt 5, 10, 15, 20, 25, 30 and 40 for 7 days) using transcriptome data, physiology experiment and quantitative real-time PCR. Results: Transcriptome data uncovered 189, 480, 207 and 80 marker genes for monitoring physiology status of oysters and the environment conditions. Three known salt stress effectors (involving ion channels, aquaporins and free amino acids) were examined. The analysis of ion channels and aquaporins indicated that 7 days long-term salt stress inhibited voltage-gated Na+/K+ channel and aquaporin but increased calcium-activated K+ channel and Ca2+ channel. As the most important category of osmotic stress effector, we analyzed the oyster FAAs metabolism pathways (including taurine, glycine, alanine, beta-alanine, proline and arginine) and explained FAAs functional mechanism for oyster low salinity adaptation. FAAs metabolism key enzyme genes displayed expression differentiation in low salinity adapted individuals comparing with control which further indicated that FAAs played important roles for oyster salinity adaptation. A global metabolic pathway analysis (iPath) of oyster expanded genes displayed a co-expansion of FAAs metabolism in C. gigas compared with seven other species, suggesting oyster's powerful ability regarding FAAs metabolism, allowing it to adapt to fluctuating salinities, which may be one important mechanism underlying euryhaline adaption in oyster. Additionally, using transcriptome data analysis, we uncovered salt stress transduction networks in C. gigas. Conclusions: Our results represented oyster salt stress effectors functional mechanisms under salt stress conditions and explained the expansion of FAAs metabolism pathways as the most important effectors for oyster euryhaline adaptation. This study was the first to explain oyster euryhaline adaptation at a genome-wide scale in C. gigas.	[Meng, Jie; Zhu, Qihui; Zhang, Linlin; Li, Chunyan; Li, Li; She, Zhicai; Huang, Baoyu; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Meng, Jie; Zhu, Qihui; Li, Chunyan; She, Zhicai; Huang, Baoyu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	lili@qdio.ac.cn; gfzhang@qdio.ac.cn	Zhang, Linlin/I-4970-2014; LI, LI/GVS-5344-2022; Li, Li/AEM-3636-2022; li, li/HII-4157-2022; li, li/GPX-3938-2022	Zhang, Linlin/0000-0003-0247-7710; 	National Basic Research Program of China (973 Program) [2010CB126402]; National Natural Science Foundation of China [40730845]; National High Technology Research and Development Program (863 program) [2012AA10A405]; Mollusk Research and Development Center, CARS, Taishan Scholars Climbing Program of Shandong; Oversea Taishan Scholar Program of Shandon	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); Mollusk Research and Development Center, CARS, Taishan Scholars Climbing Program of Shandong; Oversea Taishan Scholar Program of Shandon	This research was supported by National Basic Research Program of China (973 Program, No. 2010CB126402), the National Natural Science Foundation of China (No. 40730845), National High Technology Research and Development Program (863 program, No. 2012AA10A405), Mollusk Research and Development Center, CARS, Taishan Scholars Climbing Program of Shandong and Oversea Taishan Scholar Program of Shandon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DKA, 1999, AFR J ECOL, V37, P424, DOI 10.1046/j.1365-2028.1999.00197.x; Bartol IK, 1999, J EXP MAR BIOL ECOL, V237, P157, DOI 10.1016/S0022-0981(98)00175-0; Berger VJ, 1997, HYDROBIOLOGIA, V355, P115, DOI 10.1023/A:1003023322263; Birdsey GM, 2005, P ROY SOC B-BIOL SCI, V272, P833, DOI 10.1098/rspb.2004.3011; BISHOP SH, 1994, J EXP ZOOL, V268, P151, DOI 10.1002/jez.1402680213; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; BROWN JR, 1988, MAR ECOL PROG SER, V45, P225, DOI 10.3354/meps045225; Chow ML, 2001, PHYSIOL GENOMICS, V5, P99, DOI 10.1152/physiolgenomics.2001.5.2.99; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Duchateau PN, 2001, J LIPID RES, V42, P620; Farcy E, 2009, CELL STRESS CHAPERON, V14, P371, DOI 10.1007/s12192-008-0091-8; Gilchrist DG, 1998, ANNU REV PHYTOPATHOL, V36, P393, DOI 10.1146/annurev.phyto.36.1.393; GUNTER G, 1964, ECOLOGY, V45, P181, DOI 10.2307/1937124; Han Q, 2006, BIOCHEM J, V397, P473, DOI 10.1042/BJ20060469; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hedgecock D, 2005, J SHELLFISH RES, V24, P429, DOI 10.2983/0730-8000(2005)24[429:TCFSTP]2.0.CO;2; Heilmayer O, 2008, ESTUAR COAST SHELF S, V79, P179, DOI 10.1016/j.ecss.2008.03.022; Hirschi KD, 1999, PLANT CELL, V11, P2113, DOI 10.1105/tpc.11.11.2113; Hofmann GE, 2007, MAR ECOL PROG SER, V332, P249, DOI 10.3354/meps332249; Hosoi M, 2003, FISHERIES SCI, V69, P395, DOI 10.1046/j.1444-2906.2003.00634.x; Hosoi M, 2007, FISHERIES SCI, V73, P385, DOI 10.1111/j.1444-2906.2007.01346.x; HOYAUX J, 1976, COMP BIOCHEM PHYS A, V53, P361, DOI 10.1016/S0300-9629(76)80157-0; Huang X, 2002, GENETICS, V160, P561; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; JACOBSEN JG, 1968, PHYSIOL REV, V48, P424, DOI 10.1152/physrev.1968.48.2.424; Laing I, 2002, AQUACULTURE, V205, P171, DOI 10.1016/S0044-8486(01)00663-9; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lambert IH, 2004, NEUROCHEM RES, V29, P27, DOI 10.1023/B:NERE.0000010433.08577.96; Lang RP, 2009, MAR BIOTECHNOL, V11, P650, DOI 10.1007/s10126-009-9181-6; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li WJ, 2000, BBA-GENE STRUCT EXPR, V1493, P225, DOI 10.1016/S0167-4781(00)00152-4; Liang MX, 2006, PLANT CELL ENVIRON, V29, P746, DOI 10.1111/j.1365-3040.2005.01435.x; Luna-Acosta A, 2011, FISH SHELLFISH IMMUN, V31, P795, DOI 10.1016/j.fsi.2011.07.016; Luna-Acosta A, 2011, COMP BIOCHEM PHYS B, V159, P220, DOI 10.1016/j.cbpb.2011.04.009; MACINNES JR, 1979, ARCH ENVIRON CON TOX, V8, P553, DOI 10.1007/BF01055036; MANAHAN DT, 1989, MAR ECOL PROG SER, V53, P247, DOI 10.3354/meps053247; Marom S, 1998, J MEMBRANE BIOL, V161, P105, DOI 10.1007/s002329900318; MCCARTY NA, 1992, PHYSIOL REV, V72, P1037, DOI 10.1152/physrev.1992.72.4.1037; Meng XL, 2011, AQUACULTURE, V316, P88, DOI 10.1016/j.aquaculture.2011.03.003; Pauley G B, 1988, FISH WILDLIFE SERVIC, V82, P28; Payn RA, 2009, WATER RESOUR RES, V45; PIERCE SK, 1981, J EXP ZOOL, V215, P247, DOI 10.1002/jez.1402150304; Santoni V, 2003, BIOCHEM J, V373, P289, DOI 10.1042/BJ20030159; SATO K, 1992, J AGR FOOD CHEM, V40, P806, DOI 10.1021/jf00017a019; SHUMWAY SE, 1977, MAR BIOL, V41, P153, DOI 10.1007/BF00394023; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sussarellu R, 2010, MAR GENOM, V3, P133, DOI 10.1016/j.margen.2010.08.005; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Takimoto K, 1997, CIRC RES, V81, P533, DOI 10.1161/01.RES.81.4.533; Tirard CT, 1997, COMP BIOCHEM PHYS A, V116, P43, DOI 10.1016/S0300-9629(96)00115-6; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Wei JZ, 2000, PLANT SCI, V159, P135, DOI 10.1016/S0168-9452(00)00344-7; WELBORN JR, 1995, J EXP BIOL, V198, P1791; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao ZG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045675, 10.1371/journal.pone.0046244]; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	63	109	121	11	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58563	10.1371/journal.pone.0058563	http://dx.doi.org/10.1371/journal.pone.0058563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554902	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500030
J	Wang, Z; Li, AY; Guo, QH; Zhang, JP; An, Q; Guo, YJ; Chu, L; Weiss, JW; Ji, ES				Wang, Zhuo; Li, Ai-Ying; Guo, Qiu-Hong; Zhang, Jian-Ping; An, Qi; Guo, Ya-jing; Chu, Li; Weiss, J. Woodrow; Ji, En-Sheng			Effects of Cyclic Intermittent Hypoxia on ET-1 Responsiveness and Endothelial Dysfunction of Pulmonary Arteries in Rats	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; NITRIC-OXIDE; INDUCED HYPERTENSION; RENAL VASOCONSTRICTION; CARDIOVASCULAR-DISEASE; BLOOD-VESSELS; RECEPTORS; RELEASE; CELLS; PATHOPHYSIOLOGY	Obstructive sleep apnoea (OSA) is a risk factor for cardiovascular disorders and in some cases is complication of pulmonary hypertension. We simulated OSA by exposing rats to cyclic intermittent hypoxia (CIH) to investigate its effect on pulmonary vascular endothelial dysfunction. Sprague-Dawley Rats were exposed to CIH (FiO(2) 9% for 1 min, repeated every 2 min for 8 h/day, 7 days/wk for 3 wk), and the pulmonary arteries of normoxia and CIH treated rats were analyzed for expression of endothelin-1 (ET-1) and ET receptors by histological, immunohistochemical, RT-PCR and Western Blot analyses, as well as for contractility in response to ET-1. In the pulmonary arteries, ET-1 expression was increased, and ET-1 more potently elicited constriction of the pulmonary artery in CIH rats than in normoxic rats. Exposure to CIH induced marked endothelial cell damage associated with a functional decrease of endothelium-dependent vasodilatation in the pulmonary artery. Compared with normoxic rats, ETA receptor expression was increased in smooth muscle cells of the CIH rats, while the expression of ETB receptors was decreased in endothelial cells. These results demonstrated endothelium-dependent vasodilation was impaired and the vasoconstrictor responsiveness increased by CIH. The increased responsiveness to ET-1 induced by intermittent hypoxia in pulmonary arteries of rats was due to increased expression of ETA receptors predominantly, meanwhile, decreased expression of ETB receptors in the endothelium may also participate in it.	[Wang, Zhuo; An, Qi; Guo, Ya-jing; Ji, En-Sheng] Dept Physiol, Shijiazhuang, Hebei, Peoples R China; [Li, Ai-Ying] Dept Biochem, Shijiazhuang, Hebei, Peoples R China; [Guo, Qiu-Hong; Zhang, Jian-Ping; Chu, Li] Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China; [Weiss, J. Woodrow] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Weiss, JW (corresponding author), Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA.	jweiss@bidmc.harvard.edu; jejesphy50@gmail.com			National Natural Science Foundation of China [30971195, 81170069]; Hebei Province Natural Science Foundation [C2011206031, C2009001053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Province Natural Science Foundation(Natural Science Foundation of Hebei Province)	This work was supported by grants from the National Natural Science Foundation of China (numbers 30971195 and 81170069) and the Hebei Province Natural Science Foundation (numbers C2011206031 and C2009001053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahdadi KJ, 2005, HYPERTENSION, V45, P705, DOI 10.1161/01.HYP.0000153794.52852.04; Allahdadi KJ, 2008, AM J PHYSIOL-HEART C, V294, pH920, DOI 10.1152/ajpheart.01264.2007; Bananian Sevag, 2002, Heart Dis, V4, P296, DOI 10.1097/00132580-200209000-00006; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; BOULANGER C, 1990, J CLIN INVEST, V85, P587, DOI 10.1172/JCI114477; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Cacoub P, 1997, CARDIOVASC RES, V33, P196, DOI 10.1016/S0008-6363(96)00189-7; Chakkarwar VA, 2011, VASC PHARMACOL, V55, P163, DOI 10.1016/j.vph.2011.08.215; Chataigneau T, 1999, BRIT J PHARMACOL, V126, P219, DOI 10.1038/sj.bjp.0702300; Davenport AP, 2002, PHARMACOL REV, V54, P219, DOI 10.1124/pr.54.2.219; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797; DORLEANSJUSTE P, 1994, BRIT J PHARMACOL, V113, P1257, DOI 10.1111/j.1476-5381.1994.tb17133.x; Dupuis J, 1998, AM HEART J, V135, P614, DOI 10.1016/S0002-8703(98)70276-5; Flowers MA, 1995, AM J PHYSIOL-HEART C, V269, pH1988, DOI 10.1152/ajpheart.1995.269.6.H1988; FUKURODA T, 1994, BIOCHEM BIOPH RES CO, V199, P1461, DOI 10.1006/bbrc.1994.1395; Gellai M, 1997, PHARMACOLOGY, V55, P299, DOI 10.1159/000139542; Higashi T, 1997, AM J PHYSIOL-LUNG C, V272, pL287, DOI 10.1152/ajplung.1997.272.2.L287; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; HIRATA Y, 1995, CIRCULATION, V91, P1229, DOI 10.1161/01.CIR.91.4.1229; Kanagy NL, 2001, HYPERTENSION, V37, P511, DOI 10.1161/01.HYP.37.2.511; Karkoulias K, 2010, CURR MED CHEM, V17, P1059; Kato M, 2000, CIRCULATION, V102, P2607; Kraiczi H, 2000, J APPL PHYSIOL, V89, P493, DOI 10.1152/jappl.2000.89.2.493; Liu YZ, 2009, J APPL PHYSIOL, V106, P259, DOI 10.1152/japplphysiol.90626.2008; LUSCHER TF, 1991, CIRCULATION, V83, P701, DOI 10.1161/01.CIR.83.2.701; MACLEAN MR, 1994, J CARDIOVASC PHARM, V23, P838, DOI 10.1097/00005344-199405000-00022; MADEDDU P, 1991, CLIN INVEST MED, V14, P600; Marshall JL, 1999, BRIT J PHARMACOL, V128, P809, DOI 10.1038/sj.bjp.0702846; Minchenko A, 2000, MOL CELL BIOCHEM, V208, P53, DOI 10.1023/A:1007042729486; Miyauchi T, 1999, ANNU REV PHYSIOL, V61, P391, DOI 10.1146/annurev.physiol.61.1.391; NAMIKI A, 1992, LIFE SCI, V50, P677, DOI 10.1016/0024-3205(92)90470-A; Phillips BG, 1999, J HYPERTENS, V17, P61, DOI 10.1097/00004872-199917010-00010; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Sajkov D, 2009, PROG CARDIOVASC DIS, V51, P363, DOI 10.1016/j.pcad.2008.06.001; Schiffrin EL, 1999, HYPERTENSION, V34, P876, DOI 10.1161/01.HYP.34.4.876; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Soma S, 1999, AM J RESP CELL MOL, V20, P620, DOI 10.1165/ajrcmb.20.4.3356; Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4; USHIOFUKAI M, 1992, BIOCHEM BIOPH RES CO, V184, P518, DOI 10.1016/0006-291X(92)91225-F; Weiss JW, 2007, EXP PHYSIOL, V92, P21, DOI 10.1113/expphysiol.2006.035733; Wolk R, 2003, CIRCULATION, V108, P9, DOI 10.1161/01.CIR.0000072346.56728.E4; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zhou YB, 2003, AM J PHYSIOL-HEART C, V285, pH2797, DOI 10.1152/ajpheart.00466.2003	43	7	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58078	10.1371/journal.pone.0058078	http://dx.doi.org/10.1371/journal.pone.0058078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23555567	Green Published, Green Submitted, gold			2022-12-25	WOS:000315637900078
J	Rajbhandari, P; Schalper, KA; Solodin, NM; Ellison-Zelski, SJ; Lu, KP; Rimm, DL; Alarid, ET				Rajbhandari, P.; Schalper, K. A.; Solodin, N. M.; Ellison-Zelski, S. J.; Lu, K. Ping; Rimm, D. L.; Alarid, E. T.			Pin1 modulates ER alpha levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation	ONCOGENE			English	Article						breast cancer; E3 ligase; proteasome; survival	ESTROGEN-RECEPTOR-ALPHA; PROLYL ISOMERASE PIN1; GENE-EXPRESSION; POSTTRANSLATIONAL MODIFICATIONS; TRANSCRIPTIONAL ACTIVATION; SUBCELLULAR-LOCALIZATION; DIFFERENTIAL REGULATION; E6-ASSOCIATED PROTEIN; TAMOXIFEN RESISTANCE; DOWN-REGULATION	Estrogen receptor-alpha (ER alpha) is an important biomarker used to classify and direct therapy decisions in breast cancer (BC). Both ER alpha protein and its transcript, ESR1, are used to predict response to tamoxifen therapy, yet certain tumors have discordant levels of ER alpha protein and ESR1, which is currently unexplained. Cellular ER alpha protein levels can be controlled post-translationally by the ubiquitin-proteasome pathway through a mechanism that depends on phosphorylation at residue S118. Phospho-S118 (pS118-ER alpha) is a substrate for the peptidyl prolyl isomerase, Pin1, which mediates cis-trans isomerization of the pS118-P119 bond to enhance ER alpha transcriptional function. Here, we demonstrate that Pin1 can increase ER alpha protein without affecting ESR1 transcript levels by inhibiting proteasome-dependent receptor degradation. Pin1 disrupts ER alpha ubiquitination by interfering with receptor interactions with the E3 ligase, E6AP, which also is shown to bind pS118-ER alpha. Quantitative in situ assessments of ER alpha protein, ESR1, and Pin1 in human tumors from a retrospective cohort show that Pin1 levels correlate with ER alpha protein but not to ESR1 levels. These data show that ER alpha protein is post-translationally regulated by Pin1 in a proportion of breast carcinomas. As Pin1 impacts both ER alpha protein levels and transactivation function, these data implicate Pin1 as a potential surrogate marker for predicting outcome of ER alpha-positive BC.	[Rajbhandari, P.; Solodin, N. M.; Ellison-Zelski, S. J.; Alarid, E. T.] Univ Wisconsin, UW Carbone Comprehens Canc Ctr, Dept Oncol, Madison, WI 53705 USA; [Schalper, K. A.; Rimm, D. L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Lu, K. Ping] Harvard Univ, Sch Med, Dept Med, Canc Biol Program,Beth Isreal Deaconess Med Ctr, Boston, MA USA	University of Wisconsin System; University of Wisconsin Madison; Yale University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rajbhandari, P (corresponding author), Univ Wisconsin, UW Carbone Comprehens Canc Ctr, Dept Oncol, Wisconsin Inst Med Res 6151, Madison, WI 53705 USA.	alarid@oncology.wisc.edu		Rajbhandari, Prashant/0000-0002-8146-3861; Rimm, David/0000-0001-5820-4397	NIH [CA159578, T32 CA009135]; Genoptix/Novartis; NATIONAL CANCER INSTITUTE [R01CA159578, T32CA009135] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genoptix/Novartis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank McArdle Laboratories for Cancer Research for support of this project. We also thank the UW Carbone Comprehensive Cancer Center (UWCCC) for use of its shared services to complete this research. We thank Drs Pierre Chambon, Vladimir Spiegelman, Robert Kalejta and Greg Finn for providing us appropriate expression plasmids and reagents. We also thank Dr Wei Xu for insightful comments. This work was supported by NIH grants CA159578 (to E.T.A.) and T32 CA009135 (to P.R.) and a sponsored research award from Genoptix/Novartis (to D.R.).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Alarid ET, 2006, MOL ENDOCRINOL, V20, P1972, DOI 10.1210/me.2005-0481; Atsriku C, 2009, MOL CELL PROTEOMICS, V8, P467, DOI 10.1074/mcp.M800282-MCP200; Bhatt S, 2012, MOL CELL BIOL, V32, P1928, DOI 10.1128/MCB.06561-11; Bordeaux JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036559; BORRAS M, 1994, J STEROID BIOCHEM, V48, P325, DOI 10.1016/0960-0760(94)90072-8; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chen HZ, 2012, ONCOGENE, V31, P2876, DOI 10.1038/onc.2011.463; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Duong V, 2007, CANCER RES, V67, P5513, DOI 10.1158/0008-5472.CAN-07-0967; Duplessis TT, 2011, ENDOCRINOLOGY, V152, P2517, DOI 10.1210/en.2010-1281; Eakin CM, 2007, P NATL ACAD SCI USA, V104, P5794, DOI 10.1073/pnas.0610887104; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; Faus H, 2006, BIOMED PHARMACOTHER, V60, P520, DOI 10.1016/j.biopha.2006.07.082; Fowler AM, 2006, MOL ENDOCRINOL, V20, P291, DOI 10.1210/me.2005-0288; Fowler AM, 2004, FASEB J, V18, P81, DOI 10.1096/fj.03-0038com; Frech MS, 2005, CANCER RES, V65, P681; Fujimoto Y, 2010, J BIOL CHEM, V285, P3126, DOI 10.1074/jbc.M109.055095; Gao XH, 2005, ENDOCRINOLOGY, V146, P1707, DOI 10.1210/en.2004-1198; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Harrell JC, 2007, CANCER RES, V67, P10582, DOI 10.1158/0008-5472.CAN-07-1655; Harrell JC, 2006, CANCER RES, V66, P9308, DOI 10.1158/0008-5472.CAN-06-1769; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Kato K, 1997, ONCOGENE, V15, P3037, DOI 10.1038/sj.onc.1201497; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; Khanal P, 2012, ONCOGENE, V31, P3845, DOI 10.1038/onc.2011.548; Kim C, 2011, J CLIN ONCOL, V29, P4160, DOI 10.1200/JCO.2010.32.9615; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Lu Q, 2003, J BIOL CHEM, V278, P4639, DOI 10.1074/jbc.M210949200; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Marsaud V, 2003, MOL ENDOCRINOL, V17, P2013, DOI 10.1210/me.2002-0269; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakajima A, 2007, BIOCHEM BIOPH RES CO, V357, P245, DOI 10.1016/j.bbrc.2007.03.134; Namgoong GM, 2010, J BIOL CHEM, V285, P23829, DOI 10.1074/jbc.M109.092874; Picard N, 2008, MOL ENDOCRINOL, V22, P317, DOI 10.1210/me.2007-0281; Pulikkan JA, 2010, LEUKEMIA, V24, P914, DOI 10.1038/leu.2010.37; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Ramamoorthy S, 2008, NUCL RECEPT SIGNAL, V6, pe006; Ramamoorthy S, 2012, BREAST CANCER RES TR, V132, P97, DOI 10.1007/s10549-011-1567-2; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Sun J, 2012, MOL ENDOCRINOL, V26, P1567, DOI 10.1210/me.2012-1140; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Wang YL, 2009, J BIOCHEM, V145, P331, DOI 10.1093/jb/mvn177; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Welsh AW, 2011, J CLIN ONCOL, V29, P2978, DOI 10.1200/JCO.2010.32.9706; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Wulf G, 2003, BREAST CANCER RES, V5, P76, DOI 10.1186/bcr572; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yang QY, 2009, J BIOL CHEM, V284, P23980, DOI 10.1074/jbc.M109.022814; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	72	56	58	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2014	33	11					1438	1447		10.1038/onc.2013.78	http://dx.doi.org/10.1038/onc.2013.78			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD0SD	23542176	Green Accepted			2022-12-25	WOS:000332943500011
J	Haeussler, DJ; Pimentel, DR; Hou, X; Burgoyne, JR; Cohen, RA; Bachschmid, MM				Haeussler, Dagmar J.; Pimentel, David R.; Hou, Xiuyun; Burgoyne, Joseph R.; Cohen, Richard A.; Bachschmid, Markus M.			Endomembrane H-Ras Controls Vascular Endothelial Growth Factor-induced Nitric-oxide Synthase-mediated Endothelial Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ANGIOGENESIS; PLASMA-MEMBRANE; GOLGI-APPARATUS; PROTEIN-KINASE; NO SYNTHESIS; ACTIVATION; PATHWAYS; PHOSPHORYLATION; LOCALIZATION; INTEGRATION	We demonstrate for the first time that endomembrane-delimited H-Ras mediates VEGF-induced activation of endothelial nitric-oxide synthase (eNOS) and migratory response of human endothelial cells. Using thiol labeling strategies and immunofluorescent cell staining, we found that only 31% of total H-Ras is S-palmitoylated, tethering the small GTPase to the plasma membrane but leaving the function of the large majority of endomembrane-localized H-Ras unexplained. Knockdown of H-Ras blocked VEGF-induced PI3K-dependent Akt (Ser-473) and eNOS (Ser-1177) phosphorylation and nitric oxide-dependent cell migration, demonstrating the essential role of H-Ras. Activation of endogenous H-Ras led to recruitment and phosphorylation of eNOS at endomembranes. The loss of migratory response in cells lacking endogenous H-Ras was fully restored by modest overexpression of an endomembrane-delimited H-Ras palmitoylation mutant. These studies define a newly recognized role for endomembrane-localized H-Ras in mediating nitric oxide-dependent proangiogenic signaling.	[Haeussler, Dagmar J.; Hou, Xiuyun; Cohen, Richard A.; Bachschmid, Markus M.] Boston Univ, Sch Med, Vasc Biol Sect, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Pimentel, David R.] Boston Univ, Sch Med, Myocardial Biol Unit, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Burgoyne, Joseph R.] Kings Coll London, London SE1 7EH, England	Boston University; Boston University; University of London; King's College London	Bachschmid, MM (corresponding author), Boston Univ, Sch Med, Vasc Biol Sect, Whitaker Cardiovasc Inst, Boston, MA 02118 USA.	bach@bu.edu		Bachschmid, Markus Michael/0000-0002-0748-5528; Burgoyne, Joseph/0000-0001-7325-7382; Pimentel, David/0000-0002-0537-7195; /0000-0002-1070-6408	National Institutes of Health [PO1 HL 068758, R37 HL104017]; NHLBI [HHSN268201000031C]; Wellcome Trust [085483/Z/08/Z]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758, R37HL104017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL 068758, R37 HL104017, and NHLBI contract number HHSN268201000031C. This work was also supported by a Sir Henry Wellcome postdoctoral fellowship from the Wellcome Trust (Sponsor Reference 085483/Z/08/Z; to J. R. B.).	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ahearn IM, 2011, MOL CELL, V41, P173, DOI 10.1016/j.molcel.2011.01.001; Bajaj A, 2010, CANCER RES, V70, P3803, DOI 10.1158/0008-5472.CAN-09-2648; Balla A, 2011, J BIOL CHEM, V286, P5319, DOI 10.1074/jbc.M110.176933; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Cheng CM, 2011, MOL CELL BIOL, V31, P983, DOI 10.1128/MCB.00137-10; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; D'Angelo G, 1999, MOL ENDOCRINOL, V13, P692, DOI 10.1210/me.13.5.692; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Doanes AM, 1999, BIOCHEM BIOPH RES CO, V255, P545, DOI 10.1006/bbrc.1999.0227; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Evangelista AM, 2012, ANTIOXID REDOX SIGN, V17, P1099, DOI 10.1089/ars.2011.4022; Fulton D, 2004, J BIOL CHEM, V279, P30349, DOI 10.1074/jbc.M402155200; Gelinas DS, 2002, BRIT J PHARMACOL, V137, P1021, DOI 10.1038/sj.bjp.0704956; Gonzalez E, 2002, J BIOL CHEM, V277, P39554, DOI 10.1074/jbc.M207299200; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Haeussler DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023160; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Henis YI, 2009, MOL MEMBR BIOL, V26, P80, DOI 10.1080/09687680802649582; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Jin T, 2012, CELL RES, V22, P661, DOI 10.1038/cr.2011.161; Jobin CM, 2003, BIOCHEMISTRY-US, V42, P11716, DOI 10.1021/bi035066w; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; Kawasaki K, 2008, J CELL BIOL, V181, P131, DOI 10.1083/jcb.200709127; Kim CK, 2010, MOL PHARMACOL, V78, P142, DOI 10.1124/mol.110.063586; Koika V, 2010, VASC PHARMACOL, V53, P215, DOI 10.1016/j.vph.2010.08.004; Kumar VB, 1999, ANAL BIOCHEM, V269, P17, DOI 10.1006/abio.1999.4013; Meadows KN, 2004, ONCOGENE, V23, P192, DOI 10.1038/sj.onc.1206921; Miura S, 2003, ARTERIOSCL THROM VAS, V23, P802, DOI 10.1161/01.ATV.0000066134.79956.58; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rotblat B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011991; Serban D, 2008, CIRC RES, V102, P1350, DOI 10.1161/CIRCRESAHA.107.169664; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WILLINGHAM MC, 1980, CELL, V19, P1005, DOI 10.1016/0092-8674(80)90091-4; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Zachary I, 2003, BIOCHEM SOC T, V31, P1171	47	9	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15380	15389		10.1074/jbc.M112.427765	http://dx.doi.org/10.1074/jbc.M112.427765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23548900	hybrid, Green Published			2022-12-25	WOS:000319452100062
J	Boutigny, S; Saini, A; Baidoo, EEK; Yeung, N; Keasling, JD; Butland, G				Boutigny, Sylvain; Saini, Avneesh; Baidoo, Edward E. K.; Yeung, Natasha; Keasling, Jay D.; Butland, Gareth			Physical and Functional Interactions of a Monothiol Glutaredoxin and an Iron Sulfur Cluster Carrier Protein with the Sulfur-donating Radical S-Adenosyl-L-methionine Enzyme MiaB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; TRANSFER-RNA; AZOTOBACTER-VINELANDII; 4FE-4S CLUSTERS; SAM ENZYMES; COMPLEXES; FORMS; NFUA; METHYLTHIOLATION; IDENTIFICATION	The biosynthesis of iron sulfur (FeS) clusters, their trafficking from initial assembly on scaffold proteins via carrier proteins to final incorporation into FeS apoproteins, is a highly coordinated process enabled by multiprotein systems encoded in iscRSUAh-scBAfdx and sufABCDSE operons in Escherichia coli. Although these systems are believed to encode all factors required for initial cluster assembly and transfer to FeS carrier proteins, accessory factors such as monothiol glutaredoxin, GrxD, and the FeS carrier protein NfuA are located outside of these defined systems. These factors have been suggested to function both as shuttle proteins acting to transfer clusters between scaffold and carrier proteins and in the final stages of FeS protein assembly by transferring clusters to client FeS apoproteins. Here we implicate both of these factors in client protein interactions. We demonstrate specific interactions between GrxD, NfuA, and the methylthiolase MiaB, a radical S-adenosyl-L-methionine-dependent enzyme involved in the maturation of a subset of tRNAs. We show that GrxD and NfuA physically interact with MiaB with affinities compatible with an in vivo function. We furthermore demonstrate that NfuA is able to transfer its cluster in vitro to MiaB, whereas GrxD is unable to do so. The relevance of these interactions was demonstrated by linking the activity of MiaB with GrxD and NfuA in vivo. We observe a severe defect in in vivo MiaB activity in cells lacking both GrxD and NfuA, suggesting that these proteins could play complementary roles in maturation and repair of MiaB.	[Boutigny, Sylvain; Saini, Avneesh; Yeung, Natasha; Butland, Gareth] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Baidoo, Edward E. K.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Baidoo, Edward E. K.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI	Butland, G (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	gpbutland@lbl.gov	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088	National Institutes of Health from the NIGMS [GM088196]; Office of Science, of the United States Department of Energy through an E. O. Lawrence Fellowship [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088196] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, of the United States Department of Energy through an E. O. Lawrence Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM088196 from the NIGMS. This work was also supported by the Director, Office of Science, of the United States Department of Energy under Contract DE-AC02-05CH11231 through an E. O. Lawrence Fellowship (to N. Y.).	Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Atta M, 2012, BBA-PROTEINS PROTEOM, V1824, P1223, DOI 10.1016/j.bbapap.2011.11.007; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Esberg B, 1999, J BACTERIOL, V181, P7256, DOI 10.1128/JB.181.23.7256-7265.1999; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Gao-Sheridan HS, 1998, J BIOL CHEM, V273, P5514, DOI 10.1074/jbc.273.10.5514; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Lanz ND, 2012, BBA-PROTEINS PROTEOM, V1824, P1196, DOI 10.1016/j.bbapap.2012.07.009; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Pierrel F, 2003, J BIOL CHEM, V278, P29515, DOI 10.1074/jbc.M301518200; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Pierrel F, 2002, J BIOL CHEM, V277, P13367, DOI 10.1074/jbc.C100609200; Pinske C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031755; Pinske C, 2012, J BACTERIOL, V194, P346, DOI 10.1128/JB.06024-11; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Santos JM, 2002, MOL MICROBIOL, V45, P1729, DOI 10.1046/j.1365-2958.2002.03131.x; Shakamuri P, 2012, J AM CHEM SOC, V134, P15213, DOI 10.1021/ja306061x; Shepard EM, 2011, CURR OPIN CHEM BIOL, V15, P319, DOI 10.1016/j.cbpa.2011.02.012; Ugulava NB, 2003, BIOCHEMISTRY-US, V42, P2708, DOI 10.1021/bi0261084; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Waller JC, 2012, J BACTERIOL, V194, P362, DOI 10.1128/JB.06226-11; Waller JC, 2010, P NATL ACAD SCI USA, V107, P10412, DOI 10.1073/pnas.0911586107; Yeung N, 2011, BIOCHEMISTRY-US, V50, P8957, DOI 10.1021/bi2008883	36	25	25	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14200	14211		10.1074/jbc.M113.460360	http://dx.doi.org/10.1074/jbc.M113.460360			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543739	Green Published, hybrid			2022-12-25	WOS:000319253500024
J	Hall, JA; Yan, DL				Hall, Jason A.; Yan, Dalai			The Molecular Basis of K+ Exclusion by the Escherichia coli Ammonium Channel AmtB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PROTEIN; TRANSPORTER AMT-1; CRYSTAL-STRUCTURE; MECHANISM; SUBSTRATE; BACTERIA; FAMILY; NITROGEN; DEPROTONATION; AMT/MEP/RH	Members of the Amt family of channels mediate the transport of ammonium. The form of ammonium, NH3 or NH4+, carried by these proteins remains controversial, and the mechanism by which they select against K+ ions is unclear. We describe here a set of Escherichia coli AmtB proteins carrying mutations at the conserved twin-histidine site within the conduction pore that have altered substrate specificity and now transport K+. Subsequent work established that AmtB-mediated K+ uptake occurred against a concentration gradient and was membrane potential-dependent. These findings indicate that the twin-histidine element serves as a filter to prevent K+ conduction and strongly support the notion that Amt proteins transport cations (NH4+ or, in mutant proteins, K+) rather than NH3 gas molecules through their conduction pores.	[Hall, Jason A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Yan, Dalai] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	University of California System; University of California San Diego; Indiana University System; Indiana University Bloomington	Hall, JA (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jahall@ucsd.edu			National Institutes of Health [GM38361]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038361, R01GM038361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM38361 (to Sydney Kustu).	Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BENDER RA, 1977, J BACTERIOL, V132, P100, DOI 10.1128/JB.132.1.100-105.1977; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200; Boogerd FC, 2011, FEBS LETT, V585, P23, DOI 10.1016/j.febslet.2010.11.055; Booth IR, 1999, NOVART FDN SYMP, V221, P19; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Bostick DL, 2007, PLOS COMPUT BIOL, V3, P231, DOI 10.1371/journal.pcbi.0030022; BOUSSIBA S, 1984, J BACTERIOL, V160, P204, DOI 10.1128/JB.160.1.204-210.1984; Capone D. G., 2000, MICROBIAL ECOLOGY OC, P455; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; Gruswitz F, 2007, P NATL ACAD SCI USA, V104, P42, DOI 10.1073/pnas.0609796104; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; Guether M, 2009, PLANT PHYSIOL, V150, P73, DOI 10.1104/pp.109.136390; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Hall JA, 2011, P NATL ACAD SCI USA, V108, P13270, DOI 10.1073/pnas.1108451108; Inwood WB, 2009, GENETICS, V183, P1327, DOI 10.1534/genetics.109.103747; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; Javelle A, 2007, J STRUCT BIOL, V159, P243, DOI 10.1016/S1047-8477(07)00165-7; Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kim M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.46; KLEINER D, 1981, BIOCHIM BIOPHYS ACTA, V641, P138, DOI 10.1016/0005-2736(81)90577-0; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Lin YC, 2009, J PHYS CHEM B, V113, P4922, DOI 10.1021/jp810651m; Loque D, 2009, J BIOL CHEM, V284, P24988, DOI 10.1074/jbc.M109.020842; Ludewig U, 2006, TRANSFUS CLIN BIOL, V13, P111, DOI 10.1016/j.tracli.2006.02.012; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; MILLERO FJ, 2006, CHEM OCEANOGR, P55; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neuhauser B, 2009, FEBS LETT, V583, P2833, DOI 10.1016/j.febslet.2009.07.039; Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; RHOADS DB, 1976, J GEN PHYSIOL, V67, P325, DOI 10.1085/jgp.67.3.325; Sogaard R, 2009, PFLUG ARCH EUR J PHY, V458, P733, DOI 10.1007/s00424-009-0665-z; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; Ullmann RT, 2012, J PHYS CHEM B, V116, P9690, DOI 10.1021/jp305440f; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; Walter B, 2008, J BACTERIOL, V190, P2611, DOI 10.1128/JB.01896-07; Wang SH, 2012, J AM CHEM SOC, V134, P10419, DOI 10.1021/ja300129x; Yang HY, 2007, BIOPHYS J, V92, P877, DOI 10.1529/biophysj.106.090191; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	53	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14080	14086		10.1074/jbc.M113.457952	http://dx.doi.org/10.1074/jbc.M113.457952			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23546877	Green Published, hybrid			2022-12-25	WOS:000319253500013
J	Cheng, C; Li, WG; Zhang, Z; Yoshimura, S; Hao, QY; Zhang, C; Wang, Z				Cheng, Cong; Li, Weiguang; Zhang, Zheng; Yoshimura, Shohei; Hao, Qinyu; Zhang, Chi; Wang, Zhao			MicroRNA-144 Is Regulated by Activator Protein-1 (AP-1) and Decreases Expression of Alzheimer Disease-related A Disintegrin and Metalloprotease 10 (ADAM10)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALPHA-SECRETASE ADAM10; C-JUN; BETA; NEURONS; BRAIN; FOS; TRANSCRIPTION; BINDING; GENES	Amyloid beta-peptide (A beta) accumulating in the brain of Alzheimer disease (AD) patients is believed to be the main pathophysiologcal cause of the disease. Proteolytic processing of the amyloid precursor protein by alpha-secretase ADAM10 (a disintegrin and metalloprotease 10) protects the brain from the production of the A beta. Meanwhile, dysregulation or aberrant expression of microRNAs (miRNAs) has been widely documented in AD patients. In this study, we demonstrated that overexpression of miR-144, which was previously reported to be increased in elderly primate brains and AD patients, significantly decreased activity of the luciferase reporter containing the ADAM10 3'-untranslated region (3'-UTR) and suppressed the ADAM10 protein level, whereas the miR-144 inhibitor led to an increase of the luciferase activity. The negative regulation caused by miR-144 was strictly dependent on the binding of the miRNA to its recognition element in the ADAM10 3'-UTR. Moreover, we also showed that activator protein-1 regulates the transcription of miR-144 and the up-regulation of miR-144 at least partially induces the suppression of the ADAM10 protein in the presence of A beta. In addition, we found that miR-451, a miRNA processed from a single gene locus with miR-144, is also involved in the regulation of ADAM10 expression. Taken together, our data therefore demonstrate miR-144/451 is a negative regulator of the ADAM10 protein and suggest a mechanistic role for miR-144/451 in AD pathogenesis.	[Cheng, Cong; Li, Weiguang; Zhang, Zheng; Hao, Qinyu; Zhang, Chi; Wang, Zhao] Tsinghua Univ, Sch Med, Minist Educ, Prot Sci Key Lab, Beijing 100084, Peoples R China; [Yoshimura, Shohei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pharmacol, Okayama 7008558, Japan	Tsinghua University; Okayama University	Wang, Z (corresponding author), Tsinghua Univ, Sch Med, Minist Educ, Prot Sci Key Lab, Beijing 100084, Peoples R China.	zwang@tsinghua.edu.cn	Yoshimura, Shohei/HCI-7392-2022; zhang, zheng/HCH-9684-2022	Yoshimura, Shohei/0000-0001-8549-8941; Zhang, Chi/0000-0002-9188-6307	"J&J-Tsinghua Co-managed Fund"; Chinese National Basic Research Program (973 Project) [2007CB507406]	"J&J-Tsinghua Co-managed Fund"; Chinese National Basic Research Program (973 Project)(National Basic Research Program of China)	This work was supported by a grant from the "J&J-Tsinghua Co-managed Fund" and the Chinese National Basic Research Program (973 Project, No. 2007CB507406).	ANDERSON AJ, 1995, J NEUROCHEM, V65, P1487; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein HG, 2003, J NEUROCYTOL, V32, P153, DOI 10.1023/B:NEUR.0000005600.61844.a6; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Bozyczko-Coyne D, 2002, CNS NEUROL DISORD-DR, V1, P31, DOI 10.2174/1568007023339472; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; Doberstein K, 2011, CARCINOGENESIS, V32, P1713, DOI 10.1093/carcin/bgr195; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Fellgiebel A, 2009, J GERIATR PSYCH NEUR, V22, P3, DOI 10.1177/0891988708327810; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Gatta LB, 2002, NEUROREPORT, V13, P2031, DOI 10.1097/00001756-200211150-00008; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kawaji H, 2011, NUCLEIC ACIDS RES, V39, pD856, DOI 10.1093/nar/gkq1112; Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lammich S, 2010, J BIOL CHEM, V285, P15753, DOI 10.1074/jbc.M110.110742; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lee SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022312; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu W, 2012, NEUROBIOL AGING, V33, P522, DOI 10.1016/j.neurobiolaging.2010.04.034; Long JM, 2011, BIOCHEM BIOPH RES CO, V404, P889, DOI 10.1016/j.bbrc.2010.12.053; Marcus DL, 1998, NEUROBIOL AGING, V19, P393, DOI 10.1016/S0197-4580(98)00077-3; Mehler MF, 2006, J PHYSIOL-LONDON, V575, P333, DOI 10.1113/jphysiol.2006.113191; Misawa A, 2010, ONCOL RES, V19, P23, DOI 10.3727/096504010X12828372551759; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Patel N, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-10; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thakur A, 2007, J NEUROSCI RES, V85, P1668, DOI 10.1002/jnr.21298; Vilardo E, 2010, J BIOL CHEM, V285, P18344, DOI 10.1074/jbc.M110.112664; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Vukic V, 2009, NEUROBIOL DIS, V34, P95, DOI 10.1016/j.nbd.2008.12.007; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Xu J, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-01-j0001.2001; Yankner BA, 2000, NATURE, V404, P125, DOI 10.1038/35004673; Yin KJ, 2002, J NEUROSCI, V22, P9764; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007; Zhu Q, 2012, ONCOL REP, V27, P1660, DOI 10.3892/or.2012.1682; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	70	72	77	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13748	13761		10.1074/jbc.M112.381392	http://dx.doi.org/10.1074/jbc.M112.381392			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23546882	Green Published, hybrid			2022-12-25	WOS:000318850300057
J	Liu, JB; Wang, J; Luo, F; Wang, ZM; Wang, Y				Liu, Jingbo; Wang, Jun; Luo, Fen; Wang, Zhiming; Wang, Yin			Reconstruction of the Abdominal Vagus Nerve Using Sural Nerve Grafts in Canine Models	PLOS ONE			English	Article							GASTRIC-CANCER SURGERY; RADICAL PROSTATECTOMY; PRESERVING GASTRECTOMY; SUBTOTAL GASTRECTOMY; ERECTILE DYSFUNCTION	Background: Recently, vagus nerve preservation or reconstruction of vagus has received increasing attention. The present study aimed to investigate the feasibility of reconstructing the severed vagal trunk using an autologous sural nerve graft. Methods: Ten adult Beagle dogs were randomly assigned to two groups of five, the nerve grafting group (TG) and the vagal resection group (VG). The gastric secretion and emptying functions in both groups were assessed using Hollander insulin and acetaminophen tests before surgery and three months after surgery. All dogs underwent laparotomy under general anesthesia. In TG group, latency and conduction velocity of the action potential in a vagal trunk were measured, and then nerves of 4 cm long were cut from the abdominal anterior and posterior vagal trunks. Two segments of autologous sural nerve were collected for performing end-to-end anastomoses with the cut ends of vagal trunk (8-0 nylon suture, 3 sutures for each anastomosis). Dogs in VG group only underwent partial resections of the anterior and posterior vagal trunks. Laparotomy was performed in dogs of TG group, and latency and conduction velocity of the action potential in their vagal trunks were measured. The grafted nerve segment was removed, and stained with anti-neurofilament protein and toluidine blue. Results: Latency of the action potential in the vagal trunk was longer after surgery than before surgery in TG group, while the conduction velocity was lower after surgery. The gastric secretion and emptying functions were weaker after surgery in dogs of both groups, but in TG group they were significantly better than in VG group. Anti-neurofilament protein staining and toluidine blue staining showed there were nerve fibers crossing the anastomosis of the vagus and sural nerves in dogs of TG group. Conclusion: Reconstruction of the vagus nerve using the sural nerve is technically feasible.	[Liu, Jingbo] Fudan Univ, Huashan Hosp, Dept Hand Surg, Shanghai 200433, Peoples R China; [Liu, Jingbo] Minist Hlth, Key Lab Hand Reconstruct, Shanghai, Peoples R China; [Liu, Jingbo] Key Lab Peripheral Nerve & Microsurg, Shanghai, Peoples R China; [Wang, Jun; Luo, Fen; Wang, Zhiming] Fudan Univ, Dept Gen Surg, Huashan Hosp, Shanghai 200433, Peoples R China; [Wang, Yin] Fudan Univ, Huashan Hosp, Dept Neuropathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, ZM (corresponding author), Fudan Univ, Dept Gen Surg, Huashan Hosp, Shanghai 200433, Peoples R China.	Luofen1025@126.com; Wzhm824@126.com						Ando H, 2008, ANN SURG, V247, P976, DOI 10.1097/SLA.0b013e31816ffb1c; Ando S, 2008, ANZ J SURG, V78, P172, DOI 10.1111/j.1445-2197.2007.04396.x; Briganti A, 2007, WORLD J UROL, V25, P143, DOI 10.1007/s00345-007-0148-9; Burnett AL, 2003, J UROLOGY, V170, pS31, DOI 10.1097/01.ju.0000075604.60090.60; Davis JW, 2009, EUR UROL, V55, P1135, DOI 10.1016/j.eururo.2008.08.051; Flores-Perez C, 2011, BIOMED CHROMATOGR, V25, P760, DOI 10.1002/bmc.1511; Fukagawa T, 2009, J GASTROINTEST SURG, V13, P886, DOI 10.1007/s11605-009-0832-8; Hagiwara A, 2002, AM J SURG, V183, P692, DOI 10.1016/S0002-9610(02)00854-1; Hanson GR, 2008, CAN J UROL, V15, P3990; Kodama M, 1997, SURG TODAY, V27, P741, DOI 10.1007/BF02384988; Nomura E, 2003, HEPATO-GASTROENTEROL, V50, P2246; Porpiglia F, 2005, BJU INT, V95, P1267, DOI 10.1111/j.1464-410X.2005.05501.x; Sim HG, 2006, UROLOGY, V68, P1290, DOI 10.1016/j.urology.2006.08.1064; Tomita R, 2010, HEPATO-GASTROENTEROL, V57, P984; Wolford Larry M, 2011, Atlas Oral Maxillofac Surg Clin North Am, V19, P91, DOI 10.1016/j.cxom.2010.11.008	15	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e58903	10.1371/journal.pone.0058903	http://dx.doi.org/10.1371/journal.pone.0058903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555604	gold, Green Published, Green Submitted			2022-12-25	WOS:000317263900007
J	Quinn, EM; Cormican, P; Kenny, EM; Hill, M; Anney, R; Gill, M; Corvin, AP; Morris, DW				Quinn, Emma M.; Cormican, Paul; Kenny, Elaine M.; Hill, Matthew; Anney, Richard; Gill, Michael; Corvin, Aiden P.; Morris, Derek W.			Development of Strategies for SNP Detection in RNA-Seq Data: Application to Lymphoblastoid Cell Lines and Evaluation Using 1000 Genomes Data	PLOS ONE			English	Article							3,000 SHARED CONTROLS; WIDE ASSOCIATION; GENE-EXPRESSION; HUMAN TRANSCRIPTOME; COMMON DISEASES; WHOLE GENOME; IDENTIFICATION; POPULATION; DISCOVERY; GENOTYPES	Next-generation RNA sequencing (RNA-seq) maps and analyzes transcriptomes and generates data on sequence variation in expressed genes. There are few reported studies on analysis strategies to maximize the yield of quality RNA-seq SNP data. We evaluated the performance of different SNP-calling methods following alignment to both genome and transcriptome by applying them to RNA-seq data from a HapMap lymphoblastoid cell line sample and comparing results with sequence variation data from 1000 Genomes. We determined that the best method to achieve high specificity and sensitivity, and greatest number of SNP calls, is to remove duplicate sequence reads after alignment to the genome and to call SNPs using SAMtools. The accuracy of SNP calls is dependent on sequence coverage available. In terms of specificity, 89% of RNA-seq SNPs calls were true variants where coverage is >10X. In terms of sensitivity, at >10X coverage 92% of all expected SNPs in expressed exons could be detected. Overall, the results indicate that RNA-seq SNP data are a very useful by-product of sequence-based transcriptome analysis. If RNA-seq is applied to disease tissue samples and assuming that genes carrying mutations relevant to disease biology are being expressed, a very high proportion of these mutations can be detected.	[Morris, Derek W.] Trinity Coll Dublin, TrinSeq, Dublin, Ireland; Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin, Ireland; Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Morris, DW (corresponding author), Trinity Coll Dublin, TrinSeq, Dublin, Ireland.	derek.morris@tcd.ie	Morris, Derek/AAW-8343-2021; Kenny, Elaine/D-1644-2014	Morris, Derek/0000-0002-3413-570X; Anney, Richard/0000-0002-6083-407X; Walters, James/0000-0002-6980-4053; Gill, Michael/0000-0003-0206-5337; Corvin, Aiden/0000-0001-6717-4089; Kenny, Elaine/0000-0003-4676-3436	Science Foundation Ireland (SFI) [SFI/07/RFP/GEN/F327/EC07]; Wellcome Trust	Science Foundation Ireland (SFI)(Science Foundation Ireland); Wellcome Trust(Wellcome TrustEuropean Commission)	Next generation sequencing was performed in TrinSeq (Trinity Genome Sequencing Laboratory; http://www.medicine.tcd.ie/sequencing), a core facility funded by Science Foundation Ireland (SFI) under Grant No. [SFI/07/RFP/GEN/F327/EC07] to Dr. Morris. Ms. Quinn's PhD studentship is funded by the Wellcome Trust and SFI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Bullaughey K, 2009, HUM MOL GENET, V18, P4296, DOI 10.1093/hmg/ddp382; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gresham D, 2008, NAT REV GENET, V9, P291, DOI 10.1038/nrg2335; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Herbeck JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006915; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Huang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027288; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Koehler R, 2011, BIOINFORMATICS, V27, P272, DOI 10.1093/bioinformatics/btq640; Ku CS, 2010, J HUM GENET, V55, P403, DOI 10.1038/jhg.2010.55; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Ratan A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-130; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tejero ME, 2008, HEREDITY, V101, P60, DOI 10.1038/hdy.2008.28; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Vidal RO, 2012, GENET MOL BIOL, V35, P331, DOI 10.1590/S1415-47572012000200014; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wulff BE, 2011, NAT REV GENET, V12, P81, DOI 10.1038/nrg2915; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545	44	92	96	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58815	10.1371/journal.pone.0058815	http://dx.doi.org/10.1371/journal.pone.0058815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555596	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000317418500016
J	Seth, AK; De la Garza, M; Fang, RC; Hong, SJ; Galiano, RD				Seth, Akhil K.; De la Garza, Mauricio; Fang, Robert C.; Hong, Seok J.; Galiano, Robert D.			Excisional Wound Healing Is Delayed in a Murine Model of Chronic Kidney Disease	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; QUALITY-OF-LIFE; UNITED-STATES; UREMIA; PREVALENCE; MOUSE; RATS	Background: Approximately 15% of the United States population suffers from chronic kidney disease (CKD), often demonstrating an associated impairment in wound healing. This study outlines the development of a surgical murine model of CKD in order to investigate the mechanisms underlying this impairment. Methods: CKD was induced in mice by partial cauterization of one kidney cortex and contralateral nephrectomy, modifying a previously published technique. After a minimum of 6-weeks, splinted, dorsal excisional wounds were created to permit assessment of wound healing parameters. Wounds were harvested on postoperative days (POD) 0, 3, 7, and 14 for histological, immunofluorescent, and quantitative PCR (qPCR). Results: CKD mice exhibited deranged blood chemistry and hematology profiles, including profound uremia and anemia. Significant decreases in re-epithelialization and granulation tissue deposition rates were found in uremic mice wounds relative to controls. On immunofluorescent analysis, uremic mice demonstrated significant reductions in cellular proliferation (BrdU) and angiogenesis (CD31), with a concurrent increase in inflammation (CD45) as compared to controls. CKD mice also displayed differential expression of wound healing-related genes (VEGF, IL-1 beta, eNOS, iNOS) on qPCR. Conclusions: These findings represent the first reported investigation of cutaneous healing in a CKD animal model. Ongoing studies of this significantly delayed wound healing phenotype include the establishment of renal failure model in diabetic strains to study the combined effects of CKD and diabetes.	[Seth, Akhil K.; De la Garza, Mauricio; Fang, Robert C.; Hong, Seok J.; Galiano, Robert D.] Northwestern Univ, Lab Wound Repair & Regenerat Med, Div Plast & Reconstruct Surg, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Galiano, RD (corresponding author), Northwestern Univ, Lab Wound Repair & Regenerat Med, Div Plast & Reconstruct Surg, Feinberg Sch Med, Chicago, IL 60611 USA.	rgaliano@northwestern.edu			Division of Plastic Surgery at Northwestern University Feinberg School of Medicine	Division of Plastic Surgery at Northwestern University Feinberg School of Medicine	This work was supported by internal funds within the Division of Plastic Surgery at Northwestern University Feinberg School of Medicine. None of the authors have any financial disclosures or commercial associations that may pose a conflict of interest with any information presented in this manuscript. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	AHN ST, 1990, ANN PLAS SURG, V24, P17, DOI 10.1097/00000637-199001000-00004; Alssema M, 2012, DIABETES CARE, V35, P741, DOI 10.2337/dc11-1417; Cheung AHS, 2001, INFECT DIS CLIN N AM, V15, P775, DOI 10.1016/S0891-5520(05)70172-0; COLIN JF, 1979, BRIT J SURG, V66, P793, DOI 10.1002/bjs.1800661113; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; GAGNON RF, 1983, UROL RES, V11, P11, DOI 10.1007/BF00272702; GAGNON RF, 1988, UROL RES, V16, P119, DOI 10.1007/BF00261969; GAGNON RF, 1990, NEPHRON, V54, P70, DOI 10.1159/000185812; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; GILCHREST BA, 1980, LANCET, V2, P1271; Gottrup F, 2000, WOUND REPAIR REGEN, V8, P83, DOI 10.1046/j.1524-475x.2000.00083.x; Gurjala AN, 2011, WOUND REPAIR REGEN, V19, P400, DOI 10.1111/j.1524-475X.2011.00690.x; Kennedy DJ, 2008, AM J PHYSIOL-RENAL, V294, pF450, DOI 10.1152/ajprenal.00472.2007; Krasner D, 1998, Ostomy Wound Manage, V44, P38; KURSH ED, 1977, J SURG RES, V23, P37, DOI 10.1016/0022-4804(77)90188-3; LUNDIN AP, 1995, KIDNEY INT, V47, P1775, DOI 10.1038/ki.1995.245; Martens CR, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/267257; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b; Mylonas AI, 2000, BRIT J ORAL MAX SURG, V38, P35, DOI 10.1054/bjom.1999.0029; NAYMAN J, 1966, ANN SURG, V164, P227, DOI 10.1097/00000658-196608000-00007; Obrador GT, 2002, SEMIN NEPHROL, V22, P441, DOI 10.1053/snep.2002.2002.35962; Owen WF, 2003, J AM SOC NEPHROL, V14, pS76, DOI 10.1097/01.ASN.0000070145.00225.EC; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; PHILLIPS T, 1994, J AM ACAD DERMATOL, V31, P49, DOI 10.1016/S0190-9622(94)70134-2; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; SHINDO K, 1982, JPN J SURG, V12, P46, DOI 10.1007/BF02469015; Shurraw S, 2011, ARCH INTERN MED, V171, P1920, DOI 10.1001/archinternmed.2011.537; STPETER WL, 2007, J MANAGE CARE PHARM, V13, pS2; Valabhji J, 2012, J RENAL CARE, V38, P99, DOI 10.1111/j.1755-6686.2012.00284.x; Wang SP, 1996, SURGERY, V120, P328, DOI 10.1016/S0039-6060(96)80306-0; Weiner DE, 2007, J MANAGE CARE PHARM, V13, pS1; Werdin Frank, 2009, Eplasty, V9, pe19; YUE DK, 1987, DIABETES, V36, P295, DOI 10.2337/diabetes.36.3.295; Zotta E, 2008, J NEPHROL, V21, P947	37	32	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59979	10.1371/journal.pone.0059979	http://dx.doi.org/10.1371/journal.pone.0059979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536900	Green Submitted, gold, Green Published			2022-12-25	WOS:000317397200048
J	Yokoyama, Y; Kakudate, N; Sumida, F; Matsumoto, Y; Gilbert, GH; Gordan, VV				Yokoyama, Yoko; Kakudate, Naoki; Sumida, Futoshi; Matsumoto, Yuki; Gilbert, Gregg H.; Gordan, Valeria V.			Dentists' Dietary Perception and Practice Patterns in a Dental Practice-Based Research Network	PLOS ONE			English	Article							RESTORATIVE TREATMENT THRESHOLDS; PRIMARY CARIES; ORAL-HEALTH; NUTRITION; ATTITUDES; GUIDELINES; CANCER	Background: Dental caries are largely preventable, and epidemiological evidence for a relationship between diet and oral health is abundant. To date, however, dentists' perceptions about the role of diet and dentists' practice patterns regarding diet counseling have not been clarified. Objective: The purposes of this study were to: (1) examine discordance between dentists' perception of the importance of diet in caries treatment planning and their actual provision of diet counseling to patients, and (2) identify dentists' characteristics associated with their provision of diet counseling. Design: The study used a cross-sectional study design consisting of a questionnaire survey in Japan. Participants: The study queried dentists working in outpatient dental practices who were affiliated with the Dental Practice-Based Research Network Japan (JDPBRN), which aims to allow dentists to investigate research questions and share experiences and expertise (n = 282). Measurement: Dentists were asked about their perceptions on the importance of diet and their practice patterns regarding diet counseling, as well as patient, practice, and dentist background data. Results: The majority of participants (n = 116, 63%) recognized that diet is "more important" to oral health. However, among participants who think diet is "more important" (n = 116), only 48% (n = 56) provide diet counseling to more than 20% of their patients. Multiple logistic regression analysis suggested that several variables were associated with providing diet counseling; dentist gender, practice busyness, percentage of patients interested in caries prevention, caries risk assessment, and percentage of patients who receive blood pressure screening. Conclusions: Some discordance exists between dentists' perception of the importance of diet in caries treatment planning and their actual practice pattern regarding diet counseling to patients. Reducing this discordance may require additional dentist education, including nutritional and systemic disease concepts; patient education to increase perception of the importance of caries prevention; or removing barriers to practices' implementation of counseling.	[Yokoyama, Yoko] Japan Soc Promot Sci, Tokyo, Japan; [Yokoyama, Yoko] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol, Suita, Osaka, Japan; [Kakudate, Naoki] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA; [Kakudate, Naoki] Kyoto Univ, Grad Sch Med & Publ Hlth, Kyoto, Japan; [Sumida, Futoshi] Nagayama Family Dent Clin, Sapporo, Hokkaido, Japan; [Matsumoto, Yuki] Wing Town Dent Clin, Okazaki, Aichi, Japan; [Gilbert, Gregg H.] Univ Alabama Birmingham, Sch Dent, Dept Clin & Community Sci, Birmingham, AL 35294 USA; [Gordan, Valeria V.] Univ Florida, Coll Dent, Dept Restorat Dent Sci, Gainesville, FL USA	Japan Society for the Promotion of Science; National Cerebral & Cardiovascular Center - Japan; Stanford University; Kyoto University; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida	Yokoyama, Y (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	info@dentalpbrn.jp		Yokoyama, Yoko/0000-0002-4249-004X	National Institutes of Health [U01-DE-16746, U01-DE-16747, U19-DE-22516]; Japan Society for the Promotion of Science (JSPS), Japan [23- 10883]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U19DE022516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE016747, U01DE016746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Certain components of this investigation were supported by National Institutes of Health grants U01-DE-16746, U01-DE-16747, and U19-DE-22516; a Grant-in-Aid for JSPS Fellows Grant number 23- 10883 from the Japan Society for the Promotion of Science (JSPS), Japan. Opinions and assertions contained herein are those of the authors and are not to be construed as necessarily representing the views of the respective organizations or the National Institutes of Health or the JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; Bader JD, 1997, COMMUNITY DENT ORAL, V25, P97, DOI 10.1111/j.1600-0528.1997.tb00905.x; Centers for Disease Control and Prevention, 2012, PREV DENT CAR COMM P; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Dyer TA, 2006, BRIT DENT J, V200, P679, DOI 10.1038/sj.bdj.4813731; Gilbert GH, 2006, MED CARE, V44, P414, DOI 10.1097/01.mlr.0000207491.28719.93; Gilbert GH, 2008, J AM DENT ASSOC, V139, P74, DOI 10.14219/jada.archive.2008.0024; Gordan VV, 2010, J AM DENT ASSOC, V141, P171, DOI 10.14219/jada.archive.2010.0136; Gordan Valeria V., 2009, General Dentistry, V57, P654; Greenberg BL, 2012, J PUBLIC HEALTH DENT, V72, P28, DOI 10.1111/j.1752-7325.2011.00280.x; Greenberg BL, 2010, J AM DENT ASSOC, V141, P52, DOI 10.14219/jada.archive.2010.0021; Harris R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006540.pub2; Kakudate N, 2012, J DENT RES, V91, P1202, DOI 10.1177/0022034512464778; Kelly SAM, 2008, BRIT DENT J, V205, DOI 10.1038/sj.bdj.2008.655; Kelly SA, 2008, BR DENT J, V205, P196; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Makhija Sonia K., 2009, General Dentistry, V57, P270; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Ministry of Health Labour and Welfare, 2010, SURV PHYS DENT PHARM; Nunn ME, 2009, J DENT RES, V88, P361, DOI 10.1177/0022034509334043; Palacios C, 2009, ORAL DIS, V15, P369, DOI 10.1111/j.1601-0825.2009.01571.x; Riley JL, 2012, J AM DENT ASSOC, V143, P1002, DOI 10.14219/jada.archive.2012.0329; Riley JL, 2011, J AM DENT ASSOC, V142, P429, DOI 10.14219/jada.archive.2011.0199; Scully C, 2007, J AM DENT ASSOC, V138, p7S, DOI 10.14219/jada.archive.2007.0359; Tinanoff Norman, 2002, Pediatr Dent, V24, P543; Touger-Decker R, 2001, J AM DIET ASSOC, V101, P63, DOI 10.1016/S0002-8223(01)00017-7; Touger-Decker R, 2007, J AM DIET ASSOC, V107, P1418, DOI 10.1016/j.jada.2007.06.003; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2012, OR HLTH; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	31	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59615	10.1371/journal.pone.0059615	http://dx.doi.org/10.1371/journal.pone.0059615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536883	gold, Green Published			2022-12-25	WOS:000317397200031
J	Zeng, LY; Zhang, PL; Shi, LL; Yamamoto, V; Lu, WG; Wang, K				Zeng, Liyun; Zhang, Peilin; Shi, Lingling; Yamamoto, Vicky; Lu, Wange; Wang, Kai			Functional Impacts of NRXN1 Knockdown on Neurodevelopment in Stem Cell Models	PLOS ONE			English	Article							COPY-NUMBER VARIATION; AUTISM SPECTRUM DISORDER; PROTEIN INTERACTION NETWORK; SYNAPTIC-TRANSMISSION; MENTAL-RETARDATION; HUMAN BRAIN; RNA-SEQ; PLURIPOTENT; SCHIZOPHRENIA; GENE	Exonic deletions in NRXN1 have been associated with several neurodevelopmental disorders, including autism, schizophrenia and developmental delay. However, the molecular mechanism by which NRXN1 deletions impact neurodevelopment remains unclear. Here we used human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) as models to investigate the functional impacts of NRXN1 knockdown. We first generated hiPSCs from skin fibroblasts and differentiated them into neural stem cells (NSCs). We reduced NRXN1 expression in NSCs via a controlled shRNAmir-based knockdown system during differentiation, and monitored the transcriptome alteration by RNA-Seq and quantitative PCR at several time points. Interestingly, half reduction of NRXN1 expression resulted in changes of expression levels for the cell adhesion pathway (20 genes, P = 2.8x10(-6)) and neuron differentiation pathway (13 genes, P = 2.1x10(-4)), implicating that single-gene perturbation can impact biological networks important for neurodevelopment. Furthermore, astrocyte marker GFAP was significantly reduced in a time dependent manner that correlated with NRXN1 reduction. This observation was reproduced in both hiPSCs and hESCs. In summary, based on in vitro models, NRXN1 deletions impact several biological processes during neurodevelopment, including synaptic adhesion and neuron differentiation. Our study highlights the utility of stem cell models in understanding the functional roles of copy number variations (CNVs) in conferring susceptibility to neurodevelopmental diseases.	[Zeng, Liyun; Shi, Lingling; Wang, Kai] Univ So Calif, Keck Sch Med, Zilhka Neurogenet Inst, Los Angeles, CA 90033 USA; [Zhang, Peilin; Yamamoto, Vicky; Lu, Wange] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Yamamoto, Vicky; Lu, Wange] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lu, WG (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	wangelu@usc.edu; kaiwang@usc.edu		Zeng, Liyun/0000-0001-5959-8295	Zilkha Neurogenetic Institute; NIH [P30MH089877]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH089877] Funding Source: NIH RePORTER	Zilkha Neurogenetic Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study is supported by start-up funds from the Zilkha Neurogenetic Institute to K. W. and NIH grant P30MH089877 (PI: Levitt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Barker Alison J, 2008, Commun Integr Biol, V1, P207; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; BRENNAND KJ, 2011, NATURE; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Fatemi SH, 2008, SYNAPSE, V62, P501, DOI 10.1002/syn.20519; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fernandez T, 2008, AM J HUM GENET, V82, P1385, DOI 10.1016/j.ajhg.2008.04.021; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Harrison V, 2011, AM J MED GENET A, V155A, P2826, DOI 10.1002/ajmg.a.34255; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Konopka G, 2012, MOL PSYCHIATR, V17, P202, DOI 10.1038/mp.2011.60; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Middeldorp J, 2009, FASEB J, V23, P2710, DOI 10.1096/fj.08-127696; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Missler M, 1998, J NEUROSCI, V18, P3630; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Ross P Joel, 2010, F1000 Biol Rep, V2, P84, DOI 10.3410/B2-84; Rothermundt M, 2004, MOL PSYCHIATR, V9, P897, DOI 10.1038/sj.mp.4001548; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruiz S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015526; Saporta MA, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt78; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Vaccarino FM, 2011, J CHILD PSYCHOL PSYC, V52, P504, DOI 10.1111/j.1469-7610.2010.02348.x; Vesce S, 1999, CELL MOL LIFE SCI, V56, P991, DOI 10.1007/s000180050488; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Zhu H, 2011, NAT REV GENET, V12, P266, DOI 10.1038/nrg2951	80	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59685	10.1371/journal.pone.0059685	http://dx.doi.org/10.1371/journal.pone.0059685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536886	Green Submitted, Green Published, gold			2022-12-25	WOS:000317397200034
J	Webster, NL; Zufferey, C; Pane, JA; Coulson, BS				Webster, Nicole L.; Zufferey, Christel; Pane, Jessica A.; Coulson, Barbara S.			Alteration of the Thymic T Cell Repertoire by Rotavirus Infection Is Associated with Delayed Type 1 Diabetes Development in Non-Obese Diabetic Mice	PLOS ONE			English	Article							SMALL-INTESTINAL MUCOSA; PANCREATIC LYMPH-NODES; INTRAEPITHELIAL LYMPHOCYTES; COXSACKIEVIRUS-B4 INFECTION; B7 FAMILY; ONSET; EXPRESSION; MOUSE; AUTOIMMUNITY; PATHOGENESIS	Rotaviruses are implicated as a viral trigger for the acceleration of type 1 diabetes in children. Infection of adult non-obese diabetic (NOD) mice with rotavirus strain RRV accelerates diabetes development, whereas RRV infection in infant NOD mice delays diabetes onset. In this study of infant mice, RRV titers and lymphocyte populations in the intestine, mesenteric lymph nodes (MLN) and thymus of NOD mice were compared with those in diabetes-resistant BALB/c and C57BL/6 mice. Enhanced intestinal RRV infection occurred in NOD mice compared with the other mouse strains. This was associated with increases in the frequency of CD8 alpha beta TCR alpha beta intraepithelial lymphocytes, and their PD-L1 expression. Virus spread to the MLN and T cell numbers there also were greatest in NOD mice. Thymic RRV infection is shown here in all mouse strains, often in combination with alterations in T cell ontogeny. Infection lowered thymocyte numbers in infant NOD and C57BL/6 mice, whereas thymocyte production was unaltered overall in infant BALB/c mice. In the NOD mouse thymus, effector CD4(+) T cell numbers were reduced by infection, whereas regulatory T cell numbers were maintained. It is proposed that maintenance of thymic regulatory T cell numbers may contribute to the increased suppression of inflammatory T cells in response to a strong stimulus observed in pancreatic lymph nodes of adult mice infected as infants. These findings show that rotavirus replication is enhanced in diabetes-prone mice, and provide evidence that thymic T cell alterations may contribute to the delayed diabetes onset following RRV infection.	[Webster, Nicole L.; Zufferey, Christel; Pane, Jessica A.; Coulson, Barbara S.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	University of Melbourne	Coulson, BS (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	barbarac@unimelb.edu.au	Neil, Jessica/GLS-0700-2022	Coulson, Barbara/0000-0002-2110-8147; , Jessica/0000-0003-2824-3701	Juvenile Diabetes Research Foundation [27-2011-281]; National Health and Medical Research Council of Australia [509008, 350253, 628319]; University of Melbourne [600667]; Swiss National Science Foundation [PBBEP3 128392]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the Juvenile Diabetes Research Foundation Award 27-2011-281 (B.S.C.), together with Project Grant 509008 and Senior Research Fellowships 350253 and 628319 (B.S.C.) from the National Health and Medical Research Council of Australia. N.W. was supported by Early Career Researcher Grant 600667 from The University of Melbourne and C.Z. received a Fellowship for Prospective Researchers from the Swiss National Science Foundation (#PBBEP3 128392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; BEAGLEY KW, 1995, J IMMUNOL, V154, P5611; Bharhani MS, 2007, INT IMMUNOL, V19, P567, DOI 10.1093/intimm/dxm022; Binda E, 2009, J IMMUNOL METHODS, V344, P26, DOI 10.1016/j.jim.2009.02.006; Blutt SE, 2006, J VIROL, V80, P6702, DOI 10.1128/JVI.00329-06; Brilot F, 2008, J MED VIROL, V80, P659, DOI 10.1002/jmv.21016; Buesa J, 1999, VIROLOGY, V257, P424, DOI 10.1006/viro.1999.9646; BURNS JW, 1995, VIROLOGY, V207, P143, DOI 10.1006/viro.1995.1060; CHATTERJEE NK, 1992, J MED VIROL, V38, P124, DOI 10.1002/jmv.1890380210; COULSON BS, 1985, J VIROL, V54, P14, DOI 10.1128/JVI.54.1.14-20.1985; COULSON BS, 1991, J VIROL, V65, P5968, DOI 10.1128/JVI.65.11.5968-5974.1991; Crawford SE, 2006, J VIROL, V80, P4820, DOI 10.1128/JVI.80.10.4820-4832.2006; CUFF CF, 1993, EUR J IMMUNOL, V23, P1333, DOI 10.1002/eji.1830230622; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Dong HD, 1999, NAT MED, V5, P1365; Feuerer M, 2007, P NATL ACAD SCI USA, V104, P18181, DOI 10.1073/pnas.0708899104; Filippi CM, 2009, J CLIN INVEST, V119, P1515, DOI 10.1172/JCI38503; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; Fujiura Y, 1996, J IMMUNOL, V156, P2710; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Graham KL, 2008, J VIROL, V82, P6139, DOI 10.1128/JVI.00597-08; Graham KL, 2007, J VIROL, V81, P6446, DOI 10.1128/JVI.00205-07; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; HANAFUSA T, 1994, DIABETES RES CLIN PR, V24, pS307, DOI 10.1016/0168-8227(94)90267-4; Hewish MJ, 2000, J VIROL, V74, P228, DOI 10.1128/JVI.74.1.228-236.2000; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Honeyman MC, 2000, DIABETES, V49, P1319, DOI 10.2337/diabetes.49.8.1319; Jaidane H, 2012, CLIN EXP IMMUNOL, V168, P39, DOI 10.1111/j.1365-2249.2011.04558.x; Jaidane H, 2012, J VIROL, V86, P11151, DOI 10.1128/JVI.00726-12; Jaimes MC, 2005, J VIROL, V79, P4568, DOI 10.1128/JVI.79.8.4568-4579.2005; Jeker LT, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007807; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; Kwon H, 2005, J AUTOIMMUN, V24, P11, DOI 10.1016/j.jaut.2004.10.002; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Londrigan SL, 2000, J GEN VIROL, V81, P2203, DOI 10.1099/0022-1317-81-9-2203; Lozanoska-Ochser B, 2009, CLIN EXP IMMUNOL, V157, P119, DOI 10.1111/j.1365-2249.2009.03940.x; Lundqvist C, 1996, J IMMUNOL, V157, P1926; Maclaren N, 1999, J AUTOIMMUN, V12, P279, DOI 10.1006/jaut.1999.0281; McNeal MM, 2002, J VIROL, V76, P560, DOI 10.1128/JVI.76.2.560-568.2002; Muller S, 2000, J IMMUNOL, V164, P1986, DOI 10.4049/jimmunol.164.4.1986; OFFIT PA, 1991, J VIROL, V65, P1318, DOI 10.1128/JVI.65.3.1318-1324.1991; ONODERA T, 1991, THYMUS, V18, P95; PARSONS KR, 1993, VET IMMUNOL IMMUNOP, V39, P355, DOI 10.1016/0165-2427(93)90067-E; Rowe JH, 2008, J IMMUNOL, V180, P7553, DOI 10.4049/jimmunol.180.11.7553; Solomon M, 2004, ADV IMMUNOL, V84, P239, DOI 10.1016/S0065-2776(04)84007-0; Talay O, 2009, P NATL ACAD SCI USA, V106, P2741, DOI 10.1073/pnas.0813367106; TerSteege JCA, 1997, DEV IMMUNOL, V5, P121, DOI 10.1155/1997/34891; Tritt M, 2008, DIABETES, V57, P113, DOI 10.2337/db06-1700; Wetzel JD, 2006, J VIROL, V80, P3078, DOI 10.1128/JVI.80.6.3078-3082.2006; Wu AJ, 2002, P NATL ACAD SCI USA, V99, P12287, DOI 10.1073/pnas.172382999; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415	54	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59182	10.1371/journal.pone.0059182	http://dx.doi.org/10.1371/journal.pone.0059182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554993	gold, Green Published			2022-12-25	WOS:000316409800068
J	Cai, YJ; Wang, WS; Yang, Y; Sun, LH; Teitelbaum, DH; Yang, H				Cai, Yu-Jiao; Wang, Wen-Sheng; Yang, Yang; Sun, Li-Hua; Teitelbaum, Daniel H.; Yang, Hua			Up-Regulation of Intestinal Epithelial Cell Derived IL-7 Expression by Keratinocyte Growth Factor through STAT1/IRF-1, IRF-2 Pathway	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; II TRANSACTIVATOR CIITA; JAK-STAT PATHWAYS; GENE-EXPRESSION; ADMINISTRATION ALTERS; DEVELOPMENT SUGGESTS; IFN-GAMMA; T-CELLS; IN-VIVO; INTERLEUKIN-7	Background: Epithelial cells(EC)-derived interleukin-7 (IL-7) plays a crucial role in control of development and homeostasis of neighboring intraepithelial lymphocytes (IEL), and keratinocyte growth factor (KGF) exerts protective effects on intestinal epithelial cells and up-regulates EC-derived IL-7 expression through KGFR pathway. This study was to further investigate the molecular mechanism involved in the regulation of IL-7 expression by KGF in the intestine. Methods: Intestinal epithelial cells (LoVo cells) and adult C57BL/6J mice were treated with KGF. Epithelial cell proliferation was studied by flow cytometry for BrdU-incorporation and by immunohistochemistry for PCNA staining. Western blot was used to detect the changes of expression of P-Tyr-STAT1, STAT1, and IL-7 by inhibiting STAT1. Alterations of nuclear extracts and total proteins of IRF-1, IRF-2 and IL-7 following IRF-1 and IRF-2 RNA interference with KGF treatment were also measured with western blot. Moreover, IL-7 mRNA expressions were also detected by Real-time PCR and IL-7 protein level in culture supernatants was measured by enzyme linked immunosorbent assay(ELISA). Results: KGF administration significantly increased LoVo cell proliferation and also increased intestinal wet weight, villus height, crypt depth and crypt cell proliferation in mice. KGF treatment led to increased levels of P-Tyr-STAT1, RAPA and AG490 both blocked P-Tyr-STAT1 and IL-7 expression in LoVo cells. IRF-1 and IRF-2 expression in vivo and in vitro were also up-regulated by KGF, and IL-7 expression was decreased after IRF-1 and IRF-2 expression was silenced by interfering RNA, respectively. Conclusion: KGF could up-regulate IL-7 expression through the STAT1/IRF-1, IRF-2 signaling pathway, which is a new insight in potential effects of KGF on the intestinal mucosal immune system.	[Cai, Yu-Jiao; Wang, Wen-Sheng; Yang, Yang; Sun, Li-Hua; Yang, Hua] Third Mil Med Univ, Dept Gen Surg, Xinqiao Hosp, Chongqing, Peoples R China; [Teitelbaum, Daniel H.; Yang, Hua] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA	Army Medical University; University of Michigan System; University of Michigan	Yang, H (corresponding author), Third Mil Med Univ, Dept Gen Surg, Xinqiao Hosp, Chongqing, Peoples R China.	huayang@tmmu.edu.cn			National Natural Science Foundation of China [30973113, 81020108023, 81000830]; Chongqing Science and Technology Commission International Key Collaboration Project [CSTC 201110008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Commission International Key Collaboration Project	This study was supported by the National Natural Science Foundation of China (No. 30973113 to H.Y.; No. 81020108023 to H.Y.; No. 81000830 to Y.J.C.), and the Chongqing Science and Technology Commission International Key Collaboration Project (CSTC 201110008 to H.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragane Y, 1997, J IMMUNOL, V158, P5393; BILENKER M, 1995, DIGEST DIS SCI, V40, P1744, DOI 10.1007/BF02212696; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; BRAZZELL RK, 1991, INVEST OPHTH VIS SCI, V32, P336; Cai YJ, 2012, INT J CLIN EXP PATHO, V5, P569; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Erickson M, 2002, BLOOD, V100, P3269, DOI 10.1182/blood-2002-04-1036; Farrell CL, 1998, CANCER RES, V58, P933; FINCH PW, 1995, DEV DYNAM, V203, P223, DOI 10.1002/aja.1002030210; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Geiselhart LA, 2001, J IMMUNOL, V166, P3019, DOI 10.4049/jimmunol.166.5.3019; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HOUSLEY RM, 1994, J CLIN INVEST, V94, P1764, DOI 10.1172/JCI117524; Leaman DW, 1996, MOL CELL BIOL, V16, P369; Liang QW, 1998, INVEST OPHTH VIS SCI, V39, P1329; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Min DL, 2002, BLOOD, V99, P4592, DOI 10.1182/blood.V99.12.4592; Monteleone G, 1998, GUT, V43, P620, DOI 10.1136/gut.43.5.620; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; Munro H.N., 1969, MAMMALIAN PROTEIN ME, P465; Nepomuceno RR, 2003, CANCER RES, V63, P4472; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Verschuren MCM, 1996, J IMMUNOL, V156, P3806; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152; Wu SL, 2005, CANCER-AM CANCER SOC, V103, P1054, DOI 10.1002/cncr.20869; Yang H, 2005, CYTOKINE, V31, P419, DOI 10.1016/j.cyto.2005.06.014; Yang H, 2004, J IMMUNOL, V172, P4151, DOI 10.4049/jimmunol.172.7.4151; Zhao M, 2007, MOL IMMUNOL, V44, P2923, DOI 10.1016/j.molimm.2007.01.009; ZLOTNIK A, 1995, CURR OPIN IMMUNOL, V7, P206, DOI 10.1016/0952-7915(95)80005-0	37	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58647	10.1371/journal.pone.0058647	http://dx.doi.org/10.1371/journal.pone.0058647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554911	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500037
J	Dufour, J; Pommier, A; Alves, G; De Boussac, H; Lours-Calet, C; Volle, DH; Lobaccaro, JMA; Baron, S				Dufour, Julie; Pommier, Aurelien; Alves, Georges; De Boussac, Hugues; Lours-Calet, Corinne; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere			Lack of Liver X Receptors Leads to Cell Proliferation in a Model of Mouse Dorsal Prostate Epithelial Cell	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; CANCER-CELLS; HUMAN HEALTH; LXR-ALPHA; MICE; CHOLESTEROL; EXPRESSION; ANDROGEN; GROWTH; PROGRESSION	Recent studies underline the implication of Liver X Receptors (LXRs) in several prostate diseases such as benign prostatic hyperplasia (BPH) and prostate cancer. In order to understand the molecular mechanisms involved, we derived epithelial cells from dorsal prostate (MPECs) of wild type (WT) or Lxr alpha beta-/- mice. In the WT MPECs, our results show that LXR activation reduces proliferation and correlates with the modification of the AKT-survival pathway. Moreover, LXRs regulate lipid homeostasis with the regulation of Abca1, Abcg1 and Idol, and, in a lesser extent, Srebp1, Fas and Acc. Conversely cells derived from Lxr alpha beta-/- mice show a higher basal phosphorylation and consequently activation of the survival/proliferation transduction pathways AKT and MAPK. Altogether, our data point out that the cell model we developed allows deciphering the molecular mechanisms inducing the cell cycle arrest. Besides, we show that activated LXRs regulate AKT and MAPK transduction pathways and demonstrate that LXRs could be good pharmacological targets in prostate disease such as cancer.	[Dufour, Julie; Pommier, Aurelien; Alves, Georges; De Boussac, Hugues; Lours-Calet, Corinne; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere] Univ Clermont Ferrand, Clermont Univ, Clermont Ferrand, France; [Dufour, Julie; Pommier, Aurelien; Alves, Georges; De Boussac, Hugues; Lours-Calet, Corinne; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere] CNRS, UMR GReD 6293, Aubiere, France; [Dufour, Julie; Pommier, Aurelien; Alves, Georges; De Boussac, Hugues; Lours-Calet, Corinne; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere] INSERM, UMR GReD 1103, Aubiere, France; [Dufour, Julie; Pommier, Aurelien; Alves, Georges; De Boussac, Hugues; Lours-Calet, Corinne; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere] Ctr Rech Nutr Humaine Auvergne, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Baron, S (corresponding author), Univ Clermont Ferrand, Clermont Univ, Clermont Ferrand, France.	Silvere.BARON@univ-bpclermont.fr	LOBACCARO, Jean-Marc/L-6151-2015; Lobaccaro, Jean-Marc/Q-3926-2019; Volle, David H/P-6155-2014	Lobaccaro, Jean-Marc/0000-0001-9890-2392; Volle, David H/0000-0003-0843-0550	Association de Recherche sur les Tumeurs Prostatiques; Ligue contre le Cancer (Allier committee); Fondation pour la Recherche Medicale (FRM); Fondation BNP-Paribas; Association pour la Recherche contre le Cancer (ARC); Canceropole Lyon Rhone-alpes Auvergne (CLARA); MNERT; ARC; Region Auvergne program; Region Auvergne "Nouveau Chercheur" program	Association de Recherche sur les Tumeurs Prostatiques; Ligue contre le Cancer (Allier committee); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation BNP-Paribas; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Canceropole Lyon Rhone-alpes Auvergne (CLARA); MNERT; ARC(Australian Research Council); Region Auvergne program(Region Auvergne-Rhone-Alpes); Region Auvergne "Nouveau Chercheur" program(Region Auvergne-Rhone-Alpes)	This study was supported by research grants from Association de Recherche sur les Tumeurs Prostatiques, Ligue contre le Cancer (Allier committee), Fondation pour la Recherche Medicale (FRM), Fondation BNP-Paribas, Association pour la Recherche contre le Cancer (ARC) and Canceropole Lyon Rhone-alpes Auvergne (CLARA). A. Pommier and J. Dufour were funded by MNERT and ARC grants. G. Alves was funded by Region Auvergne program. H. De Boussac was funded by Region Auvergne "Nouveau Chercheur" program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Berquin IM, 2005, J BIOL CHEM, V280, P36442, DOI 10.1074/jbc.M504945200; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chuu CP, 2006, CANCER RES, V66, P6482, DOI 10.1158/0008-5472.CAN-06-0632; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dufour J, 2012, CURR OPIN PHARMACOL, V12, P724, DOI 10.1016/j.coph.2012.06.012; Esquenet M, 1996, PROSTATE, V28, P182, DOI 10.1002/(SICI)1097-0045(199603)28:3<182::AID-PROS5>3.0.CO;2-H; Faulds MH, 2010, CURR OPIN PHARMACOL, V10, P692, DOI 10.1016/j.coph.2010.07.003; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P558, DOI 10.1073/pnas.0811295106; MANIN M, 1992, ENDOCRINOLOGY, V131, P2378, DOI 10.1210/en.131.5.2378; Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pizer ES, 2001, PROSTATE, V47, P102, DOI 10.1002/pros.1052; Pommier AJC, 2010, ONCOGENE, V29, P2712, DOI 10.1038/onc.2010.30; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rossi S, 2003, MOL CANCER RES, V1, P707; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Viennois E, 2012, ENDOCRINOLOGY, V153, P3211, DOI 10.1210/en.2011-1996; Viennois E, 2012, MOL CELL ENDOCRINOL, V351, P129, DOI 10.1016/j.mce.2011.08.036; Viennois E, 2011, EXPERT OPIN THER TAR, V15, P219, DOI 10.1517/14728222.2011.547853	23	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58876	10.1371/journal.pone.0058876	http://dx.doi.org/10.1371/journal.pone.0058876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554947	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500052
J	Esposito, A; Campana, L; Palmisano, A; De Cobelli, F; Canu, T; Santarella, F; Colantoni, C; Monno, A; Vezzoli, M; Pezzetti, G; Manfredi, AA; Rovere-Querini, P; Del Maschio, A				Esposito, Antonio; Campana, Lara; Palmisano, Anna; De Cobelli, Francesco; Canu, Tamara; Santarella, Francesco; Colantoni, Caterina; Monno, Antonella; Vezzoli, Michela; Pezzetti, Giulio; Manfredi, Angelo A.; Rovere-Querini, Patrizia; Del Maschio, Alessandro			Magnetic Resonance Imaging at 7T Reveals Common Events in Age-Related Sarcopenia and in the Homeostatic Response to Muscle Sterile Injury	PLOS ONE			English	Article							SKELETAL-MUSCLE; FIBER TRACKING; HUMAN CALF; DIFFUSION; DAMAGE; MICE; REGENERATION; RELAXATION; T2	Skeletal muscle remodeling in response to various noxae physiologically includes structural changes and inflammatory events. The possibility to study those phenomena in-vivo has been hampered by the lack of validated imaging tools. In our study, we have relied on multiparametric magnetic resonance imaging for quantitative monitoring of muscle changes in mice experiencing age-related sarcopenia or active regeneration after sterile acute injury of tibialis anterior muscle induced by cardiotoxin (CTX) injection. The extent of myofibrils' necrosis, leukocyte infiltration, and regeneration have been evaluated and compared with parameters from magnetic resonance imaging: T2-mapping (T2 relaxation time; T2-rt), diffusion-tensor imaging (fractional anisotropy, F. A.) and diffusion weighted imaging (apparent diffusion coefficient, ADC). Inflammatory leukocytes within the perimysium and heterogeneous size of fibers characterized aged muscles. They displayed significantly increased T2-rt (P<0.05) and F. A. (P<0.05) compared with young muscles. After acute damage T2-rt increased in otherwise healthy young muscles with a peak at day 3, followed by a progressive decrease to basal values. F. A. dropped 24 hours after injury and afterward increased above the basal level in the regenerated muscle (from day 7 to day 15) returning to the basal value at the end of the follow up period. The ADC displayed opposite kinetics. T2-rt positively correlated with the number of infiltrating leucocytes retrieved by immunomagnetic bead sorting from the tissue (r = 0.92) and with the damage/infiltration score (r = 0.88) while F. A. correlated with the extent of tissue regeneration evaluated at various time points after injury (r = 0.88). Our results indicate that multiparametric MRI is a sensitive and informative tool for monitoring inflammatory and structural muscle changes in living experimental animals; particularly, it allows identifying the increase of T2-rt and F. A. as common events reflecting inflammatory infiltration and muscle regeneration in the transient response of the tissue to acute injury and in the persistent adaptation to aging.	[Esposito, Antonio; Palmisano, Anna; De Cobelli, Francesco; Canu, Tamara; Colantoni, Caterina; Pezzetti, Giulio; Del Maschio, Alessandro] Ist Sci San Raffaele, Dept Radiol, I-20132 Milan, Italy; [Esposito, Antonio; Palmisano, Anna; De Cobelli, Francesco; Canu, Tamara; Colantoni, Caterina; Pezzetti, Giulio; Del Maschio, Alessandro] Ist Sci San Raffaele, Preclin MR & US Facil, Expt Imaging Ctr, I-20132 Milan, Italy; [Esposito, Antonio; Palmisano, Anna; De Cobelli, Francesco; Santarella, Francesco; Colantoni, Caterina; Vezzoli, Michela; Manfredi, Angelo A.; Del Maschio, Alessandro] Univ Vita Salute San Raffaele, Milan, Italy; [Campana, Lara; Santarella, Francesco; Monno, Antonella; Vezzoli, Michela; Rovere-Querini, Patrizia] Ist Sci San Raffaele, Div Regenerat Med Stem Cell & Gene Therapy, Innate Immun & Tissue Remodeling Unit, I-20132 Milan, Italy; [Manfredi, Angelo A.] Ist Sci San Raffaele, Div Regenerat Med Stem Cell & Gene Therapy, Autoimmun & Vasc Inflammat Unit, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Esposito, A (corresponding author), Ist Sci San Raffaele, Dept Radiol, I-20132 Milan, Italy.	esposito.antonio@hsr.it	Tamara, Canu/ABG-8524-2020; Esposito, Antonio/AAZ-7967-2020; Colantoni, Caterina/AAC-1624-2019; DE COBELLI, Francesco/AAC-6488-2022; Manfredi, Angelo A./C-7018-2014; Rovere-Querini, Patrizia/J-2340-2012; Vezzoli, Michela/AAN-7355-2020; Palmisano, Anna/AAN-3242-2020; Campana, Lara/AAI-9372-2020; Esposito, Antonio/K-5088-2018	Tamara, Canu/0000-0002-4589-9377; Esposito, Antonio/0000-0002-1170-6266; DE COBELLI, Francesco/0000-0003-4014-3711; Manfredi, Angelo A./0000-0001-8370-6970; Palmisano, Anna/0000-0002-1564-2060; Campana, Lara/0000-0003-1805-4755; Esposito, Antonio/0000-0002-1170-6266; Santarella, Francesco/0000-0002-4941-0014; Colantoni, Caterina/0000-0002-2622-1691	Italian Ministry of Health (Fondo per gli Investimenti della Ricerca di Base-IDEAS); Italian Ministry of Health (Ricerca Finalizzata); Association Francaise contre les Myopathies [15440]; Ministero dell'Istruzione, dell'Universita' e della Ricerca	Italian Ministry of Health (Fondo per gli Investimenti della Ricerca di Base-IDEAS); Italian Ministry of Health (Ricerca Finalizzata)(Ministry of Health, Italy); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Ministero dell'Istruzione, dell'Universita' e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministry of Health (Fondo per gli Investimenti della Ricerca di Base-IDEAS to PRQ and Ricerca Finalizzata to AAM and PRQ), by the Association Francaise contre les Myopathies (Grant 15440 to PRQ), and by the Ministero dell'Istruzione, dell'Universita' e della Ricerca (to AAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027283; Beenakker KGM, 2010, AGEING RES REV, V9, P431, DOI 10.1016/j.arr.2010.05.005; Bosurgi L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00062; BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535; Collins-Hooper H, 2012, STEM CELLS, V30, P1182, DOI 10.1002/stem.1088; Curiel RV, 2009, ANN NY ACAD SCI, V1154, P101, DOI 10.1111/j.1749-6632.2009.04386.x; Damon BM, 2002, MAGN RESON MED, V48, P97, DOI 10.1002/mrm.10198; Fearon KCH, 2011, NEW ENGL J MED, V365, P565, DOI 10.1056/NEJMcibr1106880; Fleckenstein JL, 1996, SKELETAL MUSCLE EVAL; Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011; Heemskerk AM, 2005, MAGNET RESON MED, V53, P1333, DOI 10.1002/mrm.20476; Heemskerk AM, 2007, RADIOLOGY, V243, P413, DOI 10.1148/radiol.2432060491; Heemskerk AM, 2009, MAGN RESON MED, V61, P467, DOI 10.1002/mrm.21819; Holt LJ, 2012, FASEB J, V26, P3658, DOI 10.1096/fj.11-199349; Jia Y, 2012, FASEB J, V26, P2847, DOI 10.1096/fj.11-196618; Julienne CM, 2012, J CACHEXIA SARCOPENI, V3, P265, DOI 10.1007/s13539-012-0071-9; Loerakker S, 2011, MAGN RESON MED, V66, P528, DOI 10.1002/mrm.22801; Malafarina V, 2012, MATURITAS, V71, P109, DOI 10.1016/j.maturitas.2011.11.012; Mammen AL, 2011, NAT REV NEUROL, V7, P343, DOI 10.1038/nrneurol.2011.63; Marqueste T, 2008, J APPL PHYSIOL, V105, P299, DOI 10.1152/japplphysiol.00738.2007; Mathur S, 2011, MUSCLE NERVE, V43, P878, DOI 10.1002/mus.21986; Matthews GDK, 2011, ANN NY ACAD SCI, V1237, P95, DOI 10.1111/j.1749-6632.2011.06236.x; McKay BR, 2012, FASEB J, V26, P2509, DOI 10.1096/fj.11-198663; Paylor B, 2011, CURR TOP DEV BIOL, V96, P139, DOI 10.1016/B978-0-12-385940-2.00006-1; Saab G, 1999, MAGNET RESON MED, V42, P150, DOI 10.1002/(SICI)1522-2594(199907)42:1<150::AID-MRM20>3.0.CO;2-5; Saupe N, 2008, INVEST RADIOL, V43, P612, DOI 10.1097/RLI.0b013e31817e909f; Schwenzer NF, 2009, NMR BIOMED, V22, P1047, DOI 10.1002/nbm.1409; Vezzoli M, 2011, ANTIOXID REDOX SIGN, V15, P2161, DOI 10.1089/ars.2010.3341; Wishnia A, 2001, NEUROMUSCULAR DISORD, V11, P50, DOI 10.1016/S0960-8966(00)00164-4	29	37	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59308	10.1371/journal.pone.0059308	http://dx.doi.org/10.1371/journal.pone.0059308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555016	gold, Green Published, Green Submitted			2022-12-25	WOS:000316252500079
J	Dolk, T; Liepelt, R; Prinz, W; Fiehler, K				Dolk, Thomas; Liepelt, Roman; Prinz, Wolfgang; Fiehler, Katja			Visual Experience Determines the Use of External Reference Frames in Joint Action Control	PLOS ONE			English	Article							S-R COMPATIBILITY; ACTION CO-REPRESENTATION; OTHERS ACTIONS; HAND CORRESPONDENCE; ACTION-BLIND; WOODEN HAND; PERCEPTION; GAZE; PARIETAL; SYSTEM	Vision plays a crucial role in human interaction by facilitating the coordination of one's own actions with those of others in space and time. While previous findings have demonstrated that vision determines the default use of reference frames, little is known about the role of visual experience in coding action-space during joint action. Here, we tested if and how visual experience influences the use of reference frames in joint action control. Dyads of congenitally-blind, blindfolded-sighted, and seeing individuals took part in an auditory version of the social Simon task, which required each participant to respond to one of two sounds presented to the left or right of both participants. To disentangle the contribution of external-agent-based and response-based-reference frames during joint action, participants performed the task with their respective response (right) hands uncrossed or crossed over one another. Although the location of the auditory stimulus was completely task-irrelevant, participants responded overall faster when the stimulus location spatially corresponded to the required response side than when they were spatially non-corresponding: a phenomenon known as the social Simon effect (SSE). In sighted participants, the SSE occurred irrespective of whether hands were crossed or uncrossed, suggesting the use of external, response-based reference frames. Congenitally-blind participants also showed an SSE, but only with uncrossed hands. We argue that congenitally-blind people use both agent-based and response-based reference frames resulting in conflicting spatial information when hands are crossed and, thus, canceling out the SSE. These results imply that joint action control functions on the basis of external reference frames independent of the presence or (transient/permanent) absence of vision. However, the type of external reference frames used for organizing motor control in joint action seems to be determined by visual experience.	[Dolk, Thomas; Prinz, Wolfgang] Max Planck Inst Human Cognit & Brain Sci, Dept Psychol, Leipzig, Germany; [Liepelt, Roman] Univ Munster, Inst Psychol, D-48149 Munster, Germany; [Fiehler, Katja] Univ Giessen, Dept Psychol, D-35390 Giessen, Germany	Max Planck Society; University of Munster; Justus Liebig University Giessen	Dolk, T (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Psychol, Leipzig, Germany.	dolk@cbs.mpg.de; katja.fiehler@psychol.uni-giessen.de		Liepelt, Roman/0000-0002-4656-6267				Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boucher Jean-David, 2012, Front Neurorobot, V6, P3, DOI 10.3389/fnbot.2012.00003; Dittrich K, 2012, ATTEN PERCEPT PSYCHO, V74, P911, DOI 10.3758/s13414-012-0304-1; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; Dolk T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00084; Fiehler K, 2009, NEUROPSYCHOLOGIA, V47, P897, DOI 10.1016/j.neuropsychologia.2008.12.023; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Grynszpan O, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00094; Guagnano D, 2010, COGNITION, V114, P348, DOI 10.1016/j.cognition.2009.10.008; Harrar V, 2010, EXP BRAIN RES, V203, P615, DOI 10.1007/s00221-010-2252-0; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 1996, Q J EXP PSYCHOL-A, V49, P546, DOI 10.1080/027249896392496; Hommel B, 1997, ADV PSYCHOL, V118, P281; Hommel B, 2010, EFFORTLESS ATTENTION, P121, DOI DOI 10.7551/MITPRESS/9780262013840.003.0006; Hommel B, 2011, ACTA PSYCHOL, V136, P189, DOI 10.1016/j.actpsy.2010.04.011; Innocenti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036390; Keith GP, 2010, J NEUROPHYSIOL, V103, P117, DOI 10.1152/jn.91191.2008; Knoblich G, 2006, CURR DIR PSYCHOL SCI, V15, P99, DOI 10.1111/j.0963-7214.2006.00415.x; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; LANDAU B, 1981, SCIENCE, V213, P1275, DOI 10.1126/science.7268438; Lehrl S, 1984, MEHRFACH WORTSCHATZ; Liepelt R, 2008, J EXP PSYCHOL HUMAN, V34, P578, DOI 10.1037/0096-1523.34.3.578; Liepelt R, 2012, NEUROPSYCHOLOGIA, V50, P3775, DOI 10.1016/j.neuropsychologia.2012.10.027; Liepelt R, 2013, PSYCHOL RES-PSYCH FO, V77, P240, DOI 10.1007/s00426-012-0425-0; Liepelt R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00086; Liepelt R, 2011, PSYCHOL RES-PSYCH FO, V75, P366, DOI 10.1007/s00426-010-0314-3; Liepelt R, 2008, NEUROIMAGE, V43, P784, DOI 10.1016/j.neuroimage.2008.08.007; Memelink J, 2013, PSYCHOL RES-PSYCH FO, V77, P249, DOI 10.1007/s00426-012-0435-y; Muller BCN, 2011, NEUROPSYCHOLOGIA, V49, P1373, DOI 10.1016/j.neuropsychologia.2011.01.022; Occelli V, 2013, PSYCHOL BULL, V139, P189, DOI 10.1037/a0028416; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Ramsey R, 2012, PSYCHOL RES-PSYCH FO, V76, P494, DOI 10.1007/s00426-011-0393-9; Reuschel J, 2012, J NEUROSCI, V32, P2422, DOI 10.1523/JNEUROSCI.2714-11.2012; Roder B, 2007, P NATL ACAD SCI USA, V104, P4753, DOI 10.1073/pnas.0607158104; Roswarski TE, 2003, PSYCHOL RES-PSYCH FO, V67, P43, DOI 10.1007/s00426-002-0107-4; Ruys KI, 2010, J EXP SOC PSYCHOL, V46, P1130, DOI 10.1016/j.jesp.2010.05.016; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Schilbach L, 2011, SOC COGN AFFECT NEUR, V6, P393, DOI 10.1093/scan/nsq067; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Sebanz N, 2005, COGN NEUROPSYCHOL, V22, P433, DOI 10.1080/02643290442000121; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; SIMON JR, 1970, J EXP PSYCHOL, V86, P97, DOI 10.1037/h0029783; Smith MA, 2005, J NEUROPHYSIOL, V93, P1742, DOI 10.1152/jn.00306.2004; Stenzel A, 2012, J EXP PSYCHOL HUMAN, V38, P1073, DOI 10.1037/a0029493; Tsai CC, 2008, J COGNITIVE NEUROSCI, V20, P2015, DOI 10.1162/jocn.2008.20144; Tsai CC, 2007, PSYCHOL SCI, V18, P1058, DOI 10.1111/j.1467-9280.2007.02025.x; Vlainic E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00208; WALLACE RJ, 1971, J EXP PSYCHOL, V88, P354, DOI 10.1037/h0030892; Wascher E, 2001, J EXP PSYCHOL HUMAN, V27, P731, DOI 10.1037//0096-1523.27.3.731; Welsh TN, 2009, HUM MOVEMENT SCI, V28, P726, DOI 10.1016/j.humov.2009.07.006	58	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59008	10.1371/journal.pone.0059008	http://dx.doi.org/10.1371/journal.pone.0059008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WI	23536848	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100110
J	Su, H; Xu, T; Ganapathy, S; Shadfan, M; Long, M; Huang, THM; Thompson, I; Yuan, ZM				Su, H.; Xu, T.; Ganapathy, S.; Shadfan, M.; Long, M.; Huang, T. H-M; Thompson, I.; Yuan, Z-M			Elevated snoRNA biogenesis is essential in breast cancer	ONCOGENE			English	Article						breast cancer; fibrillarin; nucleolar stress; p53; snoRNA	RIBOSOMAL-PROTEIN L23; RNA-POLYMERASE-I; P53 ISOFORMS; TRANSLATION; GENES; INHIBITION; EXPRESSION; NUCLEOLUS; INDUCTION; APOPTOSIS	Hyperactive ribosomal biogenesis is widely observed in cancer, which has been partly attributed to the increased rDNA transcription by Pol I in cancer. However, whether small nucleolar RNAs (snoRNAs), a class of non-coding RNAs crucial in ribosomal RNA (rRNA) maturation and functionality, are involved in cancer remains elusive. We report that snoRNAs and fibrillarin (FBL, an enzymatic small nucleolar ribonucleoprotein, snoRNP) are frequently overexpressed in both murine and human breast cancer as well as in prostate cancers, and significantly, that this overexpression is essential for tumorigenicity in vitro and in vivo. We demonstrate that when the elevated snoRNA pathway is suppressed, the tumor suppressor p53 can act as a sentinel of snoRNP perturbation, the activation of which mediates the growth inhibitory effect. On the other hand, high level of FBL interferes with the activation of p53 by stress. We further show that p53 activation by FBL knockdown is not only regulated by the ribosomal protein-MDM2-mediated protein stabilization pathway, but also by enhanced PTB-dependent, cap-independent translation. Together, our data uncover an essential role of deregulated snoRNA biogenesis in tumors and a new mechanism of nucleolar modulation of p53.	[Su, H.; Xu, T.; Ganapathy, S.; Shadfan, M.; Long, M.; Yuan, Z-M] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, San Antonio, TX 78229 USA; [Ganapathy, S.; Long, M.; Yuan, Z-M] Harvard Univ, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Huang, T. H-M] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Thompson, I.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Harvard University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Yuan, ZM (corresponding author), Harvard Univ, Dept Genet & Complex Dis, Boston, MA 02115 USA.	zyuan@hsph.harvard.edu			 [NIH/NCI. 2 R01 CA85679-10];  [R01 CA125144]; NATIONAL CANCER INSTITUTE [R01CA125144, R01CA085679] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by NIH/NCI. 2 R01 CA85679-10; R01 CA125144 for Zhi-Min Yuan.	Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DERENZINI M, 1991, INT REV EXP PATHOL, V32, P149; Derenzini M, 2009, HISTOPATHOLOGY, V54, P753, DOI 10.1111/j.1365-2559.2008.03168.x; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Grover R, 2008, CELL CYCLE, V7, P2189, DOI 10.4161/cc.7.14.6271; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Krastev DB, 2011, NAT CELL BIOL, V13, P809, DOI 10.1038/ncb2264; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Mahata B, 2012, ONCOGENE, V31, P3060, DOI 10.1038/onc.2011.482; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Vogt PK, 2001, TRENDS MOL MED, V7, P482, DOI 10.1016/S1471-4914(01)02161-X; Wang WZ, 2008, FEBS LETT, V582, P2689, DOI 10.1016/j.febslet.2008.06.048; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Williams GT, 2012, NAT REV CANCER, V12, P84, DOI 10.1038/nrc3195; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	32	118	125	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2014	33	11					1348	1358		10.1038/onc.2013.89	http://dx.doi.org/10.1038/onc.2013.89			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD0SD	23542174				2022-12-25	WOS:000332943500002
J	Wilson, N; Nghiem, N; Mhurchu, CN; Eyles, H; Baker, MG; Blakely, T				Wilson, Nick; Nhung Nghiem; Mhurchu, Cliona Ni; Eyles, Helen; Baker, Michael G.; Blakely, Tony			Foods and Dietary Patterns That Are Healthy, Low-Cost, and Environmentally Sustainable: A Case Study of Optimization Modeling for New Zealand	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; COLORECTAL-CANCER; RISK-FACTORS; METAANALYSIS; SECURITY; COHORT; CONSUMPTION; PREVENTION	Objective: Global health challenges include non-communicable disease burdens, ensuring food security in the context of rising food prices, and environmental constraints around food production, e.g., greenhouse gas [GHG] emissions. We therefore aimed to consider optimized solutions to the mix of food items in daily diets for a developed country population: New Zealand (NZ). Methods: We conducted scenario development and linear programming to model 16 diets (some with uncertainty). Data inputs included nutrients in foods, food prices, food wastage and food-specific GHG emissions. Findings: This study identified daily dietary patterns that met key nutrient requirements for as little as a median of NZ$ 3.17 per day (US$ 2.41/d) (95% simulation interval [SI]=NZ$ 2.86 to 3.50/d). Diets that included "more familiar meals" for New Zealanders, increased the cost. The optimized diets also had low GHG emission profiles compared with the estimate for the 'typical NZ diet e.g., 1.62 kg CO(2)e/d for one scenario (95%SI=1.39 to 1.85 kg CO(2)e) compared with 10.1 kg CO(2)e/d, respectively. All of the optimized low-cost and low-GHG dietary patterns had likely health advantages over the current NZ dietary pattern, i.e., lower cardiovascular disease and cancer risk. Conclusions: We identified optimal foods and dietary patterns that would lower the risk of non-communicable diseases at low cost and with low greenhouse gas emission profiles. These results could help guide central and local government decisions around which foods to focus policies on. That is which foods are most suitable for: food taxes (additions and exemptions); healthy food vouchers and subsidies; and for increased use by public institutions involved in food preparation.	[Wilson, Nick; Nhung Nghiem; Baker, Michael G.; Blakely, Tony] Univ Otago, Dept Publ Hlth, Wellington, Wellington Sout, New Zealand; [Mhurchu, Cliona Ni; Eyles, Helen] Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand	University of Otago; University of Auckland	Wilson, N (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, Wellington Sout, New Zealand.	nick.wilson@otago.ac.nz		Ni Mhurchu, Cliona/0000-0002-1144-9167; Nghiem, Nhung/0000-0003-0078-4549; Blakely, Tony/0000-0002-6995-4369	Health Research Council of New Zealand [10/248]; Heart Foundation of New Zealand [1380, 1463]	Health Research Council of New Zealand(Health Research Council of New Zealand); Heart Foundation of New Zealand	This project was part of the BODE3 Program which receives funding support from the Health Research Council of New Zealand (Project number 10/248). CNM holds the Heart Foundation of New Zealand Senior Fellowship (Grant 1380). HE holds a Heart Foundation of New Zealand Research Fellowship (Grant 1463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune D, 2012, BREAST CANCER RES TR, V134, P479, DOI 10.1007/s10549-012-2118-1; Aune D, 2011, BMJ-BRIT MED J, V343, pd6617; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Berners-Lee M, 2012, ENERG POLICY, V43, P184, DOI 10.1016/j.enpol.2011.12.054; Briend A, 2003, J PEDIATR GASTR NUTR, V36, P12, DOI 10.1097/00005176-200301000-00006; Carter KN, 2011, SOC SCI MED, V72, P1463, DOI 10.1016/j.socscimed.2011.03.009; Carter KN, 2010, AUST NZ J PUBL HEAL, V34, P602, DOI 10.1111/j.1753-6405.2010.00615.x; Carter P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4229; Cumberlege J., 2010, FAIR SOC HEARLY LIVE; Drewnowski A, 2011, J AM COLL NUTR, V30, p422S, DOI 10.1080/07315724.2011.10719986; Elliot P, 2007, SODIUM INTAKES WORLD; Faber J, 2012, BEHAV CLIMATE CHANGE; Garnett T., 2008, COOKING STORM FOOD G; Hawkes C, 2009, NUTR REV, V67, P333, DOI 10.1111/j.1753-4887.2009.00206.x; Human Nutrition University of Otago, FOOD COST SURV; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Loef M, 2012, J NUTR HEALTH AGING, V16, P626, DOI 10.1007/s12603-012-0097-x; Macdiarmid JI, 2012, AM J CLIN NUTR, V96, P632, DOI 10.3945/ajcn.112.038729; Macdiarmid JI, 2012, P NUTR SOC; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Maillot M, 2010, PUBLIC HEALTH NUTR, V13, P1178, DOI 10.1017/S1368980009993028; Masset G, 2009, J NUTR, V139, P1541, DOI 10.3945/jn.109.104398; McLean RM, 2011, NEW ZEAL MED J, V124, P68; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Metzgar M, 2011, NUTR RES, V31, P444, DOI 10.1016/j.nutres.2011.05.008; MHURCHU CN, 2007, NZ MED J, V120, pU2388; Ministry for the Environment (MfE), 2010, NZ GREENH GAS INV 19; Morris JN, 2000, J EPIDEMIOL COMMUN H, V54, P885, DOI 10.1136/jech.54.12.885; Morton SMB., 2012, GROWING NZ LONGITUDI; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; NHMRC and MOH, 2006, NUTR REF VAL AUSTR N; NHS England, 2010, CARB EM NHS ENGL CAR; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Otto MCD, 2012, AM J CLIN NUTR, V96, P397, DOI 10.3945/ajcn.112.037770; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Parnell WR, 2001, NEW ZEAL MED J, V114, P141; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Rush E, 2007, ASIA PAC J CLIN NUTR, V16, P448; Saunders C., 2006, Research Report - Agribusiness & Economics Research Unit, Lincoln University; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Sherzai A, 2012, NUTR REV, V70, P423, DOI 10.1111/j.1753-4887.2012.00490.x; Smedman A, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.5170; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Statistics New Zealand, 2011, FOOD PRIC IND 2011; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Thow AM, 2011, PUBLIC HEALTH NUTR, V14, P176, DOI 10.1017/S1368980010002053; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; University of Otago and Ministry of Health, 2011, FOC NUTR KEY FIND 20; Vieux F, 2012, ECOL ECON, V75, P91, DOI 10.1016/j.ecolecon.2012.01.003; Wilson N, 2012, B WORLD HEALTH ORGAN, V90, P88, DOI 10.2471/BLT.11.091470; Wilson Nick, 2007, N Z Med J, V120, pU2665; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; WRAP (The Waste and Resources Action Programme), 2009, HOUS FOOD DRINK WAST; Yusof AS, 2012, ASIAN PAC J CANCER P, V13, P4713, DOI 10.7314/APJCP.2012.13.9.4713	56	93	93	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59648	10.1371/journal.pone.0059648	http://dx.doi.org/10.1371/journal.pone.0059648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544082	gold, Green Published			2022-12-25	WOS:000317480700042
J	Fujii, W; Kano, K; Sugiura, K; Naito, K				Fujii, Wataru; Kano, Kiyoshi; Sugiura, Koji; Naito, Kunihiko			Repeatable Construction Method for Engineered Zinc Finger Nuclease Based on Overlap Extension PCR and TA-Cloning	PLOS ONE			English	Article							KNOCKOUT RATS; GENE; GENERATION; DESIGN; SYSTEM	Zinc finger nuclease (ZFN) is a useful tool for endogenous site-directed genome modification. The development of an easier, less expensive and repeatedly usable construction method for various sequences of ZFNs should contribute to the further widespread use of this technology. Here, we establish a novel construction method for ZFNs. Zinc finger (ZF) fragments were synthesized by PCR using short primers coding DNA recognition helices of the ZF domain. DNA-binding domains composed of 4 to 6 ZFs were synthesized by overlap extension PCR of these PCR products, and the DNA-binding domains were joined with a nuclease vector by TA cloning. The short primers coding unique DNA recognition helices can be used repeatedly for other ZFN constructions. By using this novel OLTA (OverLap extension PCR and TA-cloning) method, arbitrary ZFN vectors were synthesized within 3 days, from the designing to the sequencing of the vector. Four different ZFN sets synthesized by OLTA showed nuclease activities at endogenous target loci. Genetically modified mice were successfully generated using ZFN vectors constructed by OLTA. This method, which enables the construction of intended ZFNs repeatedly and inexpensively in a short period of time, should contribute to the advancement of ZFN technology.	[Fujii, Wataru; Sugiura, Koji; Naito, Kunihiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Resource Sci, Tokyo, Japan; [Kano, Kiyoshi] Yamaguchi Univ, Dev Biol Lab, Joint Fac Vet Med, Yamaguchi, Japan; [Kano, Kiyoshi] Yamaguchi Univ, United Grad Sch Vet Sci, BSCTR, Yamaguchi, Japan	University of Tokyo; Yamaguchi University; Yamaguchi University	Fujii, W (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Resource Sci, Tokyo, Japan.	wtrfj.watarufujii@gmail.com; aknaito@mail.ecc.u-tokyo.ac.jp	Sugiura, Koji/AAE-2966-2019	Sugiura, Koji/0000-0001-8945-3353; Fujii, Wataru/0000-0002-6438-7350	Japan Society for the Promotion of Science [11J02886, 22380147, 24658232]; Grants-in-Aid for Scientific Research [11J02886] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for JSPS Fellows (11J02886 to WF), Grant-in-Aid for Scientific Research (no. 22380147 to KN) and Grant-in-Aid for Challenging Exploratory Research (no. 24658232 to KN) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI 10.1038/nbt.1935; Bhakta MS, 2013, GENOME RES IN PRESS; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231; Cradick TJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-152; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Fu F, 2009, NUCLEIC ACIDS RES, V37, pD279, DOI 10.1093/nar/gkn606; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gonzalez B, 2010, NAT PROTOC, V5, P791, DOI 10.1038/nprot.2010.34; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041796; Mackay JP, 2010, ENG ZINC FINGER PROT; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Naito K, 1999, J MAMM OVA RES, V16, P154; Osborn MJ, 2011, HUM GENE THER, V22, P1155, DOI 10.1089/hum.2011.072; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez-Pinera P, 2012, CURR OPIN CHEM BIOL, V16, P268, DOI 10.1016/j.cbpa.2012.06.007; Perez-Pinera P, 2012, NUCLEIC ACIDS RES, V40, P3741, DOI 10.1093/nar/gkr1214; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Salles FJ, 1999, METH MOL B, V118, P441; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Shimizu Y, 2011, BIOCHEMISTRY-US, V50, P5033, DOI 10.1021/bi200393g; Wolfe SA, 1999, J MOL BIOL, V285, P1917, DOI 10.1006/jmbi.1998.2421; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153	39	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59801	10.1371/journal.pone.0059801	http://dx.doi.org/10.1371/journal.pone.0059801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536890	Green Submitted, Green Published, gold			2022-12-25	WOS:000317397200038
J	Daniels, DR; Turner, MS				Daniels, D. Robert; Turner, Matthew S.			Islands of Conformational Stability for Filopodia	PLOS ONE			English	Article							ACROSOMAL PROCESS; POLYMER	Filopodia are long, thin protrusions formed when bundles of fibers grow outwardly from a cell surface while remaining closed in a membrane tube. We study the subtle issue of the mechanical stability of such filopodia and how this depends on the deformation of the membrane that arises when the fiber bundle adopts a helical configuration. We calculate the ground state conformation of such filopodia, taking into account the steric interaction between the membrane and the enclosed semiflexible fiber bundle. For typical filopodia we find that a minimum number of fibers is required for filopodium stability. Our calculation elucidates how experimentally observed filopodia can obviate the classical Euler buckling condition and remain stable up to several tens of mm. We briefly discuss how experimental observation of the results obtained in this work for the helical-like deformations of enclosing membrane tubes in filopodia could possibly be observed in the acrosomal reactions of the sea cucumber Thyone, and the horseshoe crab Limulus. Any realistic future theories for filopodium stability are likely to rely on an accurate treatment of such steric effects, as analysed in this work.	[Daniels, D. Robert] Swansea Univ, Multidisciplinary Nanotechnol Ctr, Coll Engn, Swansea, W Glam, Wales; [Turner, Matthew S.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Turner, Matthew S.] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England	Swansea University; University of Warwick; University of Warwick	Daniels, DR (corresponding author), Swansea Univ, Multidisciplinary Nanotechnol Ctr, Coll Engn, Swansea, W Glam, Wales.	d.r.daniels@swansea.ac.uk	Turner, Matthew/D-1121-2011	Turner, Matthew/0000-0002-3441-678X	EPSRC [EP/I005439/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I005439/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Alberts B, 2002, MOL BIOL CELL; Boal D, 2001, MECH CELL; Bray D., 1992, CELL MOVEMENTS; BRIEHL RW, 1995, J MOL BIOL, V245, P710, DOI 10.1006/jmbi.1994.0057; Daniels DR, 2010, BIOPHYS J, V98, P1139, DOI 10.1016/j.bpj.2009.11.053; Daniels DR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238101; Daniels DR, 2004, J CHEM PHYS, V121, P7401, DOI 10.1063/1.1794551; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; DEROSIER D, 1980, J MOL BIOL, V137, P375, DOI 10.1016/0022-2836(80)90163-1; Fournier JB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.018103; Fygenson DK, 1997, PHYS REV LETT, V79, P4497, DOI 10.1103/PhysRevLett.79.4497; Hannezo E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.018101; Hu YF, 2008, BIOPHYS J, V94, P1428, DOI 10.1529/biophysj.107.117473; Marenduzzo D, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/28/283102; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Morrison G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011924; Nelson D, 1989, STAT MECH MEMBRANES; Pronk S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258102; Safran S. A., 1994, STAT THERMODYNAMICS; Santangelo CD, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.061501; TILNEY LG, 1982, J CELL BIOL, V93, P820, DOI 10.1083/jcb.93.3.820; Wood W, 2002, INT J BIOCHEM CELL B, V34, P726, DOI 10.1016/S1357-2725(01)00172-8	24	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59010	10.1371/journal.pone.0059010	http://dx.doi.org/10.1371/journal.pone.0059010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555612	Green Published, gold, Green Submitted			2022-12-25	WOS:000316546400018
J	Houssaini, A; Assoumou, L; Miller, V; Calvez, V; Marcelin, AG; Flandre, P				Houssaini, Allal; Assoumou, Lambert; Miller, Veronica; Calvez, Vincent; Marcelin, Anne-Genevieve; Flandre, Philippe			Scoring Methods for Building Genotypic Scores: An Application to Didanosine Resistance in a Large Derivation Set	PLOS ONE			English	Article							DRUG-SUSCEPTIBILITY PHENOTYPE; VIROLOGICAL RESPONSE; HIV-1 RESISTANCE; PROTEASE; VALIDATION; PREDICTION; MORTALITY; RITONAVIR; PATTERNS; THERAPY	Background: Several attempts have been made to determine HIV-1 resistance from genotype resistance testing. We compare scoring methods for building weighted genotyping scores and commonly used systems to determine whether the virus of a HIV-infected patient is resistant. Methods and Principal Findings: Three statistical methods (linear discriminant analysis, support vector machine and logistic regression) are used to determine the weight of mutations involved in HIV resistance. We compared these weighted scores with known interpretation systems (ANRS, REGA and Stanford HIV-db) to classify patients as resistant or not. Our methodology is illustrated on the Forum for Collaborative HIV Research didanosine database (N = 1453). The database was divided into four samples according to the country of enrolment (France, USA/Canada, Italy and Spain/UK/Switzerland). The total sample and the four country-based samples allow external validation (one sample is used to estimate a score and the other samples are used to validate it). We used the observed precision to compare the performance of newly derived scores with other interpretation systems. Our results show that newly derived scores performed better than or similar to existing interpretation systems, even with external validation sets. No difference was found between the three methods investigated. Our analysis identified four new mutations associated with didanosine resistance: D123S, Q207K, H208Y and K223Q. Conclusions: We explored the potential of three statistical methods to construct weighted scores for didanosine resistance. Our proposed scores performed at least as well as already existing interpretation systems and previously unrecognized didanosine-resistance associated mutations were identified. This approach could be used for building scores of genotypic resistance to other antiretroviral drugs.	[Houssaini, Allal; Assoumou, Lambert; Calvez, Vincent; Marcelin, Anne-Genevieve; Flandre, Philippe] INSERM, U943, Paris, France; [Houssaini, Allal; Assoumou, Lambert; Calvez, Vincent; Marcelin, Anne-Genevieve; Flandre, Philippe] Univ Paris 06, UMR S 943, Paris, France; [Miller, Veronica] George Washington Univ, Washington, DC USA; [Marcelin, Anne-Genevieve] Grp Hosp Pitie Salpetriere, Virol Lab, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; George Washington University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Houssaini, A (corresponding author), INSERM, U943, Paris, France.	ahoussaini@ccde.chups.jussieu.fr	Flandre, Philippe/N-6314-2017; Marcelin, Anne-Genevieve/D-8272-2014	Flandre, Philippe/0000-0002-2612-3522; Marcelin, Anne-Genevieve/0000-0003-4808-8999	SIDACTION [FJC-1/AO20-2/09]; European Community [223131]; French Agence National de Recherches sur le Sida et les hepatites virales (ANRS); Association de Recherche en Virologie en Dermatologie (ARVD)	SIDACTION; European Community(European Commission); French Agence National de Recherches sur le Sida et les hepatites virales (ANRS); Association de Recherche en Virologie en Dermatologie (ARVD)	AH is grateful for the financial support of SIDACTION in the form of a PhD fellowship (Grant FJC-1/AO20-2/09). This work was supported by the European Community Seventh Framework Program (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" (Grant agreement no. 223131), the French Agence National de Recherches sur le Sida et les hepatites virales (ANRS) and the Association de Recherche en Virologie en Dermatologie (ARVD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2002, WILEY SERIES PROBABI, DOI 10.1002/0471249688; Altmann A, 2007, ANTIVIR THER, V12, P169; Assoumou L, 2008, J INFECT DIS, V198, P470, DOI 10.1086/590156; Assoumou L, 2010, J ANTIMICROB CHEMOTH, V65, P752, DOI 10.1093/jac/dkq034; Assoumou L, 2010, AIDS, V24, P365, DOI 10.1097/QAD.0b013e32833338ba; Beerenwinkel N, 2002, P NATL ACAD SCI USA, V99, P8271, DOI 10.1073/pnas.112177799; Cozzi-Lepri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025665; De Luca A, 2011, ANTIVIR THER, V16, P489, DOI 10.3851/IMP1799; Descamps D, 2009, J ANTIMICROB CHEMOTH, V63, P585, DOI 10.1093/jac/dkn544; DiRienzo AG, 2003, STAT MED, V22, P2785, DOI 10.1002/sim.1516; Draghici S, 2003, BIOINFORMATICS, V19, P98, DOI 10.1093/bioinformatics/19.1.98; Frentz D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011505; Grant RM, 1996, CURR OPIN INFECT DIS, V9, P7, DOI 10.1097/00001432-199602000-00003; Houssaaini A, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/478467; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kandathil AJ, 2009, AIDS RES HUM RETROV, V25, P315, DOI 10.1089/aid.2008.0177; Kijak G H, 2003, HIV Med, V4, P72, DOI 10.1046/j.1468-1293.2003.00131.x; King MS, 2007, ANTIMICROB AGENTS CH, V51, P3067, DOI 10.1128/AAC.00388-07; Larder B, 2007, ANTIVIR THER, V12, P15; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Marcelin AG, 2005, ANTIMICROB AGENTS CH, V49, P1739, DOI 10.1128/AAC.49.5.1739-1744.2005; Marcelin AG, 2008, ANTIMICROB AGENTS CH, V52, P3237, DOI 10.1128/AAC.00133-08; Masquelier B, 2008, J ANTIMICROB CHEMOTH, V61, P1362, DOI 10.1093/jac/dkn127; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Prosperi MCF, 2009, ANTIVIR THER, V14, P433; Ravela J, 2003, JAIDS-J ACQ IMM DEF, V33, P8, DOI 10.1097/00126334-200305010-00002; Rhee SY, 2006, P NATL ACAD SCI USA, V103, P17355, DOI 10.1073/pnas.0607274103; Sevin AD, 2000, J INFECT DIS, V182, P59, DOI 10.1086/315673; Shafer RW, 2002, CLIN MICROBIOL REV, V15, P247, DOI 10.1128/CMR.15.2.247-277.2002; Sinisi SE, 2007, STAT APPL GENET MOL, V6; Vapnik V., 1998, STAT LEARNING THEORY; Vella S, 1995, J ACQ IMMUN DEF SYND, V10, pS20; Vora S, 2006, AIDS, V20, P35, DOI 10.1097/01.aids.0000196179.11293.fc; Wang K, 2004, ANTIVIR THER, V9, P343; Zazzi M, 2011, HIV MED, V12, P211, DOI 10.1111/j.1468-1293.2010.00871.x	36	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59014	10.1371/journal.pone.0059014	http://dx.doi.org/10.1371/journal.pone.0059014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555613	Green Published, gold, Green Submitted			2022-12-25	WOS:000316546400019
J	Chamaille-Jammes, S; Mtare, G; Makuwe, E; Fritz, H				Chamaille-Jammes, Simon; Mtare, Godfrey; Makuwe, Edwin; Fritz, Herve			African Elephants Adjust Speed in Response to Surface-Water Constraint on Foraging during the Dry-Season	PLOS ONE			English	Article							ANIMAL MOVEMENT; DENSITY; SAVANNA; HETEROGENEITY	Most organisms need to acquire various resources to survive and reproduce. Individuals should adjust their behavior to make optimal use of the landscape and limit the costs of trade-offs emerging from the use of these resources. Here we study how African elephants Loxodonta africana travel to foraging places between regular visits to waterholes. Elephant herds were tracked using GPS collars during two consecutive dry seasons in Hwange National Park, Zimbabwe. We segmented each individual movement track at each visit to water to define foraging trips, and then used trip-level statistics to build an understanding of movement strategies. Travel speed within these individually-consistent movement bouts was also analyzed to understand if speed was better linked to distance to water or progression in the trip over time. We found that elephants went further from water when drinking less often, which could result from a trade-off between drinking and foraging in less depleted, far from water, places. Speed increased towards the beginning and the end of the trips, and was also greater than observed during the wet season, suggesting that elephants were trying to save time. Numerous short trips traveled at greater speed, particularly when commuting to a different waterhole, was tentatively explained by the inability to drink at specific waterholes due to intra-specific interference. Unexpectedly elephants did not always minimize travel time by drinking at the closest waterhole, but the extra distance traveled remained never more than a few kilometers. Our results show how individuals may adjust movement behavior to deal with resource trade-offs at the landscape scale. We also highlight how behavioral context, here progression in the trip, may be more important than spatial context, here distance to water, in explaining animal movement patterns.	[Chamaille-Jammes, Simon] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Mtare, Godfrey; Makuwe, Edwin] Hwange Natl Pk, Zimbabwe Parks & Wildlife Management Author, Sci Serv, Hwange, Zimbabwe; [Fritz, Herve] CNRS, Lab Biometrie & Biol Evolut, UMR 5558, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Chamaille-Jammes, S (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France.	simon.chamaille@cefe.cnrs.fr	Fritz, Herve/D-1729-2014; Chamaillé-Jammes, Simon/B-3833-2009	Fritz, Herve/0000-0002-7106-3661; Chamaillé-Jammes, Simon/0000-0003-0505-6620	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-08-BLAN-0022, ANR-11-CEPL-003]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was partially funded by the "Centre National de la Recherche Scientifique'' and grants ANR-08-BLAN-0022 and ANR-11-CEPL-003 from the "Agence Nationale de la Recherche''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2012, LME4 LINEAR MIXED EF; BOVET P, 1991, ANIM BEHAV, V42, P57, DOI 10.1016/S0003-3472(05)80605-0; Cain JW, 2012, J ZOOL, V286, P58, DOI 10.1111/j.1469-7998.2011.00848.x; Chamaille-Jammes S, 2006, INT J REMOTE SENS, V27, P5185, DOI 10.1080/01431160600702392; Chamaille-Jammes S, 2007, J TROP ECOL, V23, P725, DOI 10.1017/S0266467407004531; Chamaille-Jammes S, 2008, J ANIM ECOL, V77, P135, DOI 10.1111/j.1365-2656.2007.01307.x; Chamaille-Jammes S, 2007, AUSTRAL ECOL, V32, P740, DOI 10.1111/j.1442-9993.2007.01761.x; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; Chamaille-Jammes S, 2009, ECOGRAPHY, V32, P871, DOI 10.1111/j.1600-0587.2009.05785.x; Cornelis D, 2011, J MAMMAL, V92, P1287, DOI 10.1644/10-MAMM-A-397.1; de Knegt HJ, 2011, J ANIM ECOL, V80, P270, DOI 10.1111/j.1365-2656.2010.01764.x; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; McClintock BT, 2012, ECOL MONOGR, V82, P335, DOI 10.1890/11-0326.1; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; O'Connor TG, 2007, BIOL CONSERV, V136, P329, DOI 10.1016/j.biocon.2006.12.014; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; R Core Team, 2012, R LANG ENV STAT COMP; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Western D., 1975, E AFR WILDL J, V13, P265, DOI DOI 10.1111/J.1365-2028.1975.TB00139.X; Young KD, 2010, J ANIM ECOL, V79, P662, DOI 10.1111/j.1365-2656.2010.01667.x	23	39	40	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59164	10.1371/journal.pone.0059164	http://dx.doi.org/10.1371/journal.pone.0059164			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554989	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800064
J	Ostrowski, SR; Berg, RMG; Windelov, NA; Meyer, MAS; Plovsing, RR; Moller, K; Johansson, PI				Ostrowski, Sisse R.; Berg, Ronan M. G.; Windelov, Nis A.; Meyer, Martin A. S.; Plovsing, Ronni R.; Moller, Kirsten; Johansson, Par I.			Discrepant Fibrinolytic Response in Plasma and Whole Blood during Experimental Endotoxemia in Healthy Volunteers	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; TISSUE-PLASMINOGEN ACTIVATOR; ABDOMINAL AORTIC-ANEURYSM; CRITICALLY-ILL PATIENTS; MULTIPLE ORGAN FAILURE; PROTEIN-C; ENDOTHELIAL GLYCOCALYX; ACUTE COAGULOPATHY; ROTATION THROMBELASTOGRAPHY; PLATELET-FUNCTION	Background: Sepsis induces early activation of coagulation and fibrinolysis followed by late fibrinolytic shutdown and progressive endothelial damage. The aim of the present study was to investigate and compare the functional hemostatic response in whole blood and plasma during experimental human endotoxemia by the platelet function analyzer, Multiplate and by standard and modified thrombelastography (TEG). Methods: Prospective physiologic study of nine healthy male volunteers undergoing endotoxemia by means of a 4-hour infusion of E. coli lipopolysaccharide (LPS, 0.5 ng/kg/hour), with blood sampled at baseline and at 4 h and 6 h. Physiological and standard biochemical data and coagulation tests, TEG (whole blood: TEG, heparinase-TEG, Functional Fibrinogen; plasma: TEG +/- tissue-type plasminogen activator (tPA)) and Multiplate (TRAPtest, ADPtest, ASPItest, COLtest) were recorded. Mixed models with Tukey post hoc tests and correlations were applied. Results: Endotoxemia induced acute SIRS with increased HR, temperature, WBC, CRP and procalcitonin and decreased blood pressure. It also induced a hemostatic response with platelet consumption and reduced APTT while INR increased (all p<0.05). Platelet aggregation decreased (all tests, p<0.05), whereas TEG whole blood clot firmness increased (G, p = 0.05). Furthermore, during endotoxemia (4 h), whole blood fibrinolysis increased (clot lysis time (CLT), p<0.001) and Functional Fibrinogen clot strength decreased (p = 0.049). After endotoxemia (6 h), whole blood fibrinolysis was reduced (CLT, p<0.05). In contrast to findings in whole blood, the plasma fibrin clot became progressively more resistant towards tPA-induced fibrinolysis at both 4 h and 6 h (p<0.001). Conclusions: Endotoxemia induced a hemostatic response with reduced primary but enhanced secondary hemostasis, enhanced early fibrinolysis and fibrinogen consumption followed by downregulation of fibrinolysis, with a discrepant fibrinolytic response in plasma and whole blood. The finding that blood cells are critically involved in the vasculo-fibrinolytic response to acute inflammation is important given that disturbances in the vascular system contribute significantly to morbidity and mortality in critically ill patients.	[Ostrowski, Sisse R.; Meyer, Martin A. S.; Johansson, Par I.] Rigshosp, Transfus Med Sect, Capital Reg Blood Bank, DK-2100 Copenhagen, Denmark; [Berg, Ronan M. G.; Moller, Kirsten] Rigshosp, Dept Infect Dis, Sect M7641, Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark; [Windelov, Nis A.] Rigshosp, Ctr Head & Orthoped, Dept Anesthesia, DK-2100 Copenhagen, Denmark; [Plovsing, Ronni R.] Rigshosp, Dept Anesthesia, Sect 4131, Intens Care Unit, DK-2100 Copenhagen, Denmark; [Moller, Kirsten] Rigshosp, Dept Neuroanesthesiol, Neurointens Care Unit, DK-2100 Copenhagen, Denmark; [Johansson, Par I.] Univ Texas Houston, Sch Med, Dept Surg, Ctr Translat Injury Res CeTIR, Houston, TX USA	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Texas System; University of Texas Health Science Center Houston	Ostrowski, SR (corresponding author), Rigshosp, Transfus Med Sect, Capital Reg Blood Bank, DK-2100 Copenhagen, Denmark.	sisse.ostrowski@gmail.com	Plovsing, Ronni Thermann Reitz/A-7233-2014; Johansson, Pär I/P-9283-2015; Johansson, Pär/GQB-1032-2022; Ostrowski, Sisse R/E-7423-2011; Meyer, Martin A. S./J-2951-2013; Moller, Kirsten/A-4751-2009	Johansson, Pär I/0000-0001-9778-5964; Johansson, Pär/0000-0001-9778-5964; Ostrowski, Sisse R/0000-0001-5288-3851; Meyer, Martin A. S./0000-0002-6312-2457; Moller, Kirsten/0000-0003-3058-1072; Berg, Ronan/0000-0002-5757-9506	Foundation of Merchant Jakob Ehrenreich and Grete Ehrenreich; Foundation of 1870; Toyota Foundation; Christian Larsen and Judge Ella Larsen's grant; Classen Trust Jubilee Foundation; P. Carl Petersen Foundation; University Hospital Rigshospitalet; Faculty of Health Sciences, University of Copenhagen; Danish Council for Independent Research - Medical Sciences; Commission of the European Communities [223576 - MYOAGE]; Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research [09-067009, 09-075724]	Foundation of Merchant Jakob Ehrenreich and Grete Ehrenreich; Foundation of 1870; Toyota Foundation; Christian Larsen and Judge Ella Larsen's grant; Classen Trust Jubilee Foundation; P. Carl Petersen Foundation; University Hospital Rigshospitalet; Faculty of Health Sciences, University of Copenhagen; Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Commission of the European Communities(European Commission); Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The study was supported by The Foundation of Merchant Jakob Ehrenreich and Grete Ehrenreich, The Foundation of 1870, The Toyota Foundation, Christian Larsen and Judge Ella Larsen's grant, The Classen Trust Jubilee Foundation, The P. Carl Petersen Foundation, University Hospital Rigshospitalet, and the Faculty of Health Sciences, University of Copenhagen. The study was further supported by the Danish Council for Independent Research - Medical Sciences, the Commission of the European Communities (grant agreement number 223576 - MYOAGE). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation. CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant number 09-067009 and 09-075724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam DJ, 2004, ANN VASC SURG, V18, P572, DOI 10.1007/s10016-004-0087-5; Adamzik M, 2011, SHOCK, V35, P339, DOI 10.1097/SHK.0b013e318204bff6; Adamzik M, 2010, CRIT CARE, V14, DOI 10.1186/cc9284; Adrie C, 2005, J AM COLL CARDIOL, V46, P21, DOI 10.1016/j.jacc.2005.03.046; Agarwal S, 2008, LIVER TRANSPLANT, V14, P855, DOI 10.1002/lt.21437; Alt E, 2004, CLIN HEMORHEOL MICRO, V30, P107; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Becker BF, 2010, CARDIOVASC RES, V87, P300, DOI 10.1093/cvr/cvq137; Berg RMG, 2012, AM J PHYSIOL-REG I, V303, pR1127, DOI 10.1152/ajpregu.00242.2012; BRADBURY AW, 1995, J VASC SURG, V21, P484, DOI 10.1016/S0741-5214(95)70291-1; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brown LM, 2011, J TRAUMA, V71, pS337, DOI 10.1097/TA.0b013e318227f67c; Carroll RC, 2009, TRANSL RES, V154, P34, DOI 10.1016/j.trsl.2009.04.001; Chakroun T, 2006, THROMB HAEMOSTASIS, V95, P822, DOI 10.1160/TH05-07-0500; Cicala C, 1997, LIFE SCI, V60, pL31; Collins PW, 2006, BRIT J HAEMATOL, V135, P220, DOI 10.1111/j.1365-2141.2006.06281.x; Cotton BA, 2009, J TRAUMA, V66, P41, DOI 10.1097/TA.0b013e31819313bb; COWAN DH, 1976, JAMA-J AM MED ASSOC, V235, P1230, DOI 10.1001/jama.235.12.1230; CRYER PE, 1980, NEW ENGL J MED, V303, P436; Daudel F, 2009, CRIT CARE, V13, DOI 10.1186/cc7765; Dejouvencel T, 2010, BLOOD, V115, P2048, DOI 10.1182/blood-2009-06-228817; Dirkmann D, 2012, ANESTH ANALG, V114, P1182, DOI 10.1213/ANE.0b013e31823b6683; Dong HP, 2010, KAOHSIUNG J MED SCI, V26, P584, DOI 10.1016/S1607-551X(10)70090-5; Dunser Martin W, 2009, J Intensive Care Med, V24, P293, DOI 10.1177/0885066609340519; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Eralp O, 2011, J VET INTERN MED, V25, P524, DOI 10.1111/j.1939-1676.2011.0698.x; Esmon CT, 2004, CRIT CARE MED, V32, pS219, DOI 10.1097/01.CCM.0000127036.27343.48; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Frith D, 2012, CURR OPIN CRIT CARE, V18, P631, DOI 10.1097/MCC.0b013e3283599ab9; Gando S, 2007, THROMB RES, V120, P87, DOI 10.1016/j.thromres.2006.07.009; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Goerlinger K, 2007, TRANSFUS MED HEMOTH, V34, P396, DOI 10.1159/000109642; Gonano C, 2006, CRIT CARE, V10, DOI 10.1186/cc5098; Grant HW, 1997, PEDIATR SURG INT, V12, P289, DOI 10.1007/s003830050133; HAWKEY CM, 1975, BRIT J HAEMATOL, V29, P377, DOI 10.1111/j.1365-2141.1975.tb01835.x; Johansson PI, 2012, J THROMB HAEMOST, V10, P207, DOI 10.1111/j.1538-7836.2011.04589.x; Johansson PI, 2010, MED HYPOTHESES, V75, P564, DOI 10.1016/j.mehy.2010.07.031; Johansson PI, 2008, BRIT J HAEMATOL, V143, P559, DOI 10.1111/j.1365-2141.2008.07379.x; Johansson PI, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-45; Johansson PI, 2008, TRANSFUSION, V48, P2377, DOI 10.1111/j.1537-2995.2008.01846.x; Johansson PI, 2010, BLOOD COAGUL FIBRIN, V21, P168, DOI 10.1097/MBC.0b013e3283367882; Jonnalagadda D, 2012, BLOOD, V120, P5209, DOI 10.1182/blood-2012-07-445080; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Khurana S, 1997, J LAB CLIN MED, V130, P401, DOI 10.1016/S0022-2143(97)90040-8; Kim YH, 1999, SCIENCE, V284, P647, DOI 10.1126/science.284.5414.647; Kristova Viera, 1993, Acta Physiologica Hungarica, V81, P363; Lacroix R, 2012, HAEMATOL-HEMATOL J, V97, P1864, DOI 10.3324/haematol.2012.066167; Leemann H, 2010, J TRAUMA, V69, P1403, DOI 10.1097/TA.0b013e3181faaa25; Leslie M, 2010, SCIENCE, V328, P562, DOI 10.1126/science.328.5978.562; Levi M, 2008, SEMIN THROMB HEMOST, V34, P417, DOI 10.1055/s-0028-1092871; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Levrat A, 2008, BRIT J ANAESTH, V100, P792, DOI 10.1093/bja/aen083; Li ZY, 2011, THROMB RES, V127, P184, DOI 10.1016/j.thromres.2010.10.010; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; MAKHMUDOV RM, 1985, COR VASA, V27, P456; Mesters RM, 2000, CRIT CARE MED, V28, P2209, DOI 10.1097/00003246-200007000-00005; Morel O, 2009, HAEMATOL-HEMATOL J, V94, P313, DOI 10.3324/haematol.2009.003657; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Munnix ICA, 2009, THROMB HAEMOSTASIS, V102, P1149, DOI 10.1160/TH09-05-0289; Nelson A, 2008, SHOCK, V30, P623, DOI 10.1097/SHK.0b013e3181777da3; Nielsen VG, 2005, ACTA ANAESTH SCAND, V49, P222, DOI 10.1111/j.1399-6576.2005.00602.x; Nydam TL, 2011, J TRAUMA, V70, P401, DOI 10.1097/TA.0b013e31820b5c85; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Ostrowski SR, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-64; Ostrowski SR, 2011, MED HYPOTHESES, V77, P798, DOI 10.1016/j.mehy.2011.07.040; Ostrowski SR, 2012, J CRIT CARE; Raivio P, 2007, J THORAC CARDIOV SUR, V133, P44, DOI 10.1016/j.jtcvs.2006.10.003; Raza I, 2012, J THROMB HAEMOST, P10; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Salim A, 2009, J TRAUMA, V66, P1349, DOI 10.1097/TA.0b013e318191b8af; Schochl H, 2012, RESUSCITATION, P10; Schochl H, 2009, J TRAUMA, V67, P125, DOI 10.1097/TA.0b013e31818b2483; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Sefrin P, 1987, Prog Clin Biol Res, V236A, P477; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Senzolo M, 2007, BLOOD COAGUL FIBRIN, V18, P227, DOI 10.1097/MBC.0b013e328010bd3d; Sharma P, 2010, AM J CLIN PATHOL, V134, P97, DOI 10.1309/AJCPPZ4J6CAFYDVM; Sivula M, 2009, BLOOD COAGUL FIBRIN, V20, P419, DOI 10.1097/MBC.0b013e32832a76e1; Spiel AO, 2006, J THROMB HAEMOST, V4, P411, DOI 10.1111/j.1538-7836.2006.01715.x; Spiel AO, 2012, CLIN SCI LOND; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Taudorf S, 2007, CLIN VACCINE IMMUNOL, V14, P250, DOI 10.1128/CVI.00380-06; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015; Tsai HJ, 2012, BLOOD COAGUL FIBRIN, V23, P118, DOI 10.1097/MBC.0b013e32834ee170; Ueno H, 2002, CRIT CARE MED, V30, P2242, DOI 10.1097/00003246-200210000-00011; vanderPoll T, 1997, J EXP MED, V185, P1143, DOI 10.1084/jem.185.6.1143; Velik-Salchner C, 2009, BLOOD COAGUL FIBRIN, V20, P41, DOI 10.1097/MBC.0b013e32831be9ad; VENDSALU A, 1960, ACTA PHYSIOL SCAND, V49, P1; von Kanel R, 2000, EUR J HAEMATOL, V65, P357, DOI 10.1034/j.1600-0609.2000.065006357.x; Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x; Wohner N, 2011, ARTERIOSCL THROM VAS, V31, P2306, DOI 10.1161/ATVBAHA.111.229088; Woth G, 2011, J THROMB THROMBOLYS, V31, P6, DOI 10.1007/s11239-010-0486-0; Xing K, 2012, CRIT CARE, V16, DOI 10.1186/cc11145; Yaguchi A, 2004, J THROMB HAEMOST, V2, P2096, DOI 10.1111/j.1538-7836.2004.01009.x; Zambruni A, 2004, SCAND J GASTROENTERO, V39, P830, DOI 10.1080/00365520410004433	100	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59368	10.1371/journal.pone.0059368	http://dx.doi.org/10.1371/journal.pone.0059368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555024	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800085
J	Xing, XK; Ma, XT; Hart, MM; Wang, AR; Guo, SX				Xing, Xiaoke; Ma, Xueting; Hart, Miranda M.; Wang, Airong; Guo, Shunxing			Genetic Diversity and Evolution of Chinese Traditional Medicinal Fungus Polyporus umbellatus (Polyporales, Basidiomycota)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; POLYMORPHISM; SCLEROTIUM; REVEALS; RDNA; DNA	Background: Polyporus umbellatus is an important medicinal fungus distributed throughout most area of China. Its wide distribution may have resulted in substantial intraspecific genetic diversity for the fungus, potentially creating variation in its medical value. To date, we know little about the intraspecific genetic diversity of P. umbellatus. Methodology/Principal Findings: The objective of this research was to assess genetic differences of P. umbellatus from geographically diverse regions of China based on nrDNA ITS and 28S rRNA (LSU, large subunit) sequences. Significant sequence variations in the ITS and LSU sequences were detected. All sclerotial samples were clustered into four clades based on phylogenetic analysis of ITS, LSU and a combined data set of both regions. Heterogeneity of ITS and LSU sequences was detected in 5 and 7 samples respectively. All clone sequences clustered into the same clade except for one LSU clone sequences (from Henan province) which clustered into two clades (Clade I and Clade II). Significant genetic divergence in P. umbellatus was observed and the genetic diversification was greater among sclerotial samples from Shaanxi, Henan and Gansu provinces than among other provinces. Polymorphism of ITS and LSU sequences indicated that in China, P. umbellatus may spread from a center (Shaanxi, Henan and Gansu province) to other regions. Conclusions/Significance: We found sclerotial samples of P. umbellatus contained levels of intraspecific genetic diversity. These findings suggested that P. umbellatus populations in Shaanxi, Henan and Gansu are important resources of genetic diversity and should be conserved accordingly.	[Xing, Xiaoke; Ma, Xueting; Wang, Airong; Guo, Shunxing] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Xing, Xiaoke; Ma, Xueting; Wang, Airong; Guo, Shunxing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Hart, Miranda M.] Univ British Columbia Okanagan, Kelowna, BC, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of British Columbia; University of British Columbia Okanagan	Guo, SX (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	guosx2000@yahoo.com.cn	Hart, Miranda m/D-1562-2011		National Natural Sciences Foundation of China [30830117, 30901013]; International Science and Technology Cooperation Projects of China [2011DFA31260]; Specialized Research Fund for the Doctoral Program of Higher Education [20091106110003]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Projects of China; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was financially supported by the National Natural Sciences Foundation of China (No. 30830117 and No. 30901013), the International Science and Technology Cooperation Projects of China (No. 2011DFA31260) and Specialized Research Fund for the Doctoral Program of Higher Education (20091106110003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PHARM PEOPL REP CHIN, V1; Binder M, 2002, MOL PHYLOGENET EVOL, V22, P76, DOI 10.1006/mpev.2001.1043; Dai YC, 1996, ANN BOT FENN, V33, P153; Dai YC, 2012, MYCOSCIENCE, V53, P49, DOI 10.1007/s10267-011-0134-3; Dai YC, 2009, INT J MED MUSHROOMS, V11, P287, DOI 10.1615/IntJMedMushr.v11.i3.80; Dai YuCheng, 2010, Mycosystema, V29, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Hibbett David S., 1992, Transactions of the Mycological Society of Japan, V33, P533; Hughes KW, 1999, MYCOLOGIA, V91, P978, DOI 10.2307/3761628; Imazeki R, 1989, COLORED ILLUSTRATION, VII; Ko KS, 2002, MYCOTAXON, V82, P315; Kruger D., 2004, Feddes Repertorium, V115, P530, DOI 10.1002/fedr.200311052; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J.Y., 1988, COLORED KOREAN MUSHR; Li, 2008, MODERN CHINESE MED, V10, P43; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu K, 2009, ACTA EDULIS FUNGI, V16, P11; Liu Zhijun, 2001, Journal of Herbal Pharmacotherapy, V1, P25, DOI 10.1080/J157v01n03_03; Miettinen O, 2012, CLADISTICS, V28, P251, DOI 10.1111/j.1096-0031.2011.00380.x; MIYAZAKI T, 1973, CHEM PHARM BULL, V21, P2545; NUNEZ M, 1995, SYNOPSIS FUNGORUM, V10; Okabe I, 2003, MYCOL RES, V107, P164, DOI 10.1017/S0953756203007160; Pannecoucque J, 2009, MYCOLOGIA, V101, P26, DOI 10.3852/08-084; Shen Q, 2002, MYCOLOGIA, V94, P472, DOI 10.2307/3761781; Sotome K, 2008, MYCOLOGIA, V100, P603, DOI 10.3852/07-191R; Sun Y, 2008, BIOORG MED CHEM LETT, V18, P3417, DOI 10.1016/j.bmcl.2008.04.008; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Vasaitis R, 2009, MYCOL RES, V113, P326, DOI 10.1016/j.mycres.2008.11.009; VILGALYS R, 1990, Journal of Bacteriology, V172, P4238; Wang QM, 2008, APPL ENVIRON MICROB, V74, P2604, DOI 10.1128/AEM.02223-07; White T. J., 1990, RCR PROTOCOLS GUIDE; Xu JT, 1997, MED MYCOLOGY CHINA; Yang Li-juan, 2004, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V20, P234; Yao L, 2006, GUIDELINES GOOD AGR; Yuan D, 2004, BIOL PHARM BULL, V27, P867, DOI 10.1248/bpb.27.867; Zeng Xing, 2011, Chinese Journal of Immunology, V27, P414; Zhao YY, 2009, J ETHNOPHARMACOL, V126, P184, DOI 10.1016/j.jep.2009.07.033	40	6	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58807	10.1371/journal.pone.0058807	http://dx.doi.org/10.1371/journal.pone.0058807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554929	Green Submitted, gold, Green Published			2022-12-25	WOS:000316409800031
J	Neo, ML; Erftemeijer, PLA; van Beek, JKL; van Maren, DS; Teo, SLM; Todd, PA				Neo, Mei Lin; Erftemeijer, Paul L. A.; van Beek, Jan K. L.; van Maren, Dirk S.; Teo, Serena L-M.; Todd, Peter A.			Recruitment constraints in Singapore's fluted giant clam (Tridacna squamosa) population-A dispersal model approach	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MARINE INVERTEBRATE; GENETIC-STRUCTURE; BENTHIC INVERTEBRATES; STOCK ENHANCEMENT; LARVAL TRANSPORT; CONNECTIVITY; RESTOCKING; CROCEA; SETTLEMENT	Recruitment constraints on Singapore's dwindling fluted giant clam, Tridacna squamosa, population were studied by modelling fertilisation, larval transport, and settlement using real-time hydrodynamic forcing combined with knowledge of spawning characteristics, larval development, behaviour, and settlement cues. Larval transport was simulated using a finite-volume advection-diffusion model coupled to a three-dimensional hydrodynamic model. Three recruitment constraint hypotheses were tested: 1) there is limited connectivity between Singapore's reefs and other reefs in the region, 2) there is limited exchange within Singapore's Southern Islands, and 3) there exist low-density constraints to fertilisation efficacy (component Allee effects). Results showed that connectivity among giant clam populations was primarily determined by residual hydrodynamic flows and spawning time, with greatest chances of successful settlement occurring when spawning and subsequent larval dispersal coincided with the period of lowest residual flow. Simulations suggested poor larval transport from reefs located along the Peninsular Malaysia to Singapore, probably due to strong surface currents between the Andaman Sea and South China Sea combined with a major land barrier disrupting larval movement among reefs. The model, however, predicted offshore coral reefs to the southeast of Singapore (Bintan and Batam) may represent a significant source of larvae. Larval exchange within Singapore's Southern Islands varied substantially depending on the locations of source and sink reefs as well as spawning time; but all simulations resulted in low settler densities (2.1-68.6 settled individuals per 10,000 m(2)). Poor fertilisation rates predicted by the model indicate that the low density and scattered distribution of the remaining T. squamosa in Singapore are likely to significantly inhibit any natural recovery of local stocks.	[Neo, Mei Lin; Todd, Peter A.] Natl Univ Singapore, Dept Biol Sci, Expt Marine Ecol Lab, Singapore 117548, Singapore; [Neo, Mei Lin; Teo, Serena L-M.] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore; [Erftemeijer, Paul L. A.] Sinclair Knight Merz, Perth, WA, Australia; [Erftemeijer, Paul L. A.] Univ Western Australia, UWA Oceans Inst, Crawley, Australia; [van Beek, Jan K. L.; van Maren, Dirk S.] Deltares, Delft, Netherlands	National University of Singapore; National University of Singapore; University of Western Australia; Deltares	Todd, PA (corresponding author), Natl Univ Singapore, Dept Biol Sci, Expt Marine Ecol Lab, Singapore 117548, Singapore.	dbspat@nus.edu.sg	van Maren, Dirk Sebastiaan/AAG-8759-2019; Todd, Peter A/H-8410-2012; Erftemeijer, Paul/U-7485-2018	van Beek, Jan/0000-0002-4019-7202; Neo, Mei Lin/0000-0002-0141-8164; Erftemeijer, Paul/0000-0002-2904-7422	Building with Nature Singapore Supportive Modelling project [1201442.002]; National Parks Board's Coastal & Marine Environment [R-154-000-504-490]; Singapore-Delft Water Alliance's Marine & Coastal Research Programme (Theme 2) [R-264-001-001-272]	Building with Nature Singapore Supportive Modelling project; National Parks Board's Coastal & Marine Environment; Singapore-Delft Water Alliance's Marine & Coastal Research Programme (Theme 2)	The research presented in this work was carried out as part of the Building with Nature Singapore Supportive Modelling project (1201442.002). This study was also supported by the National Parks Board's Coastal & Marine Environment grant number R-154-000-504-490 and Singapore-Delft Water Alliance's Marine & Coastal Research Programme (Theme 2) grant number R-264-001-001-272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams T. J. H., 1988, ACIAR MONOGRAPH, P78; Alcala A.C., 1986, Silliman Journal, V33, P45; Alcazar S.N., 1986, Silliman Journal, V33, P65; Arnold WS, 2008, REV FISH SCI, V16, P65, DOI 10.1080/10641260701678140; BABCOCK RC, 1994, BIOL BULL-US, V186, P17, DOI 10.2307/1542033; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Bell JD, 2005, ADV MAR BIOL, V49, P1, DOI 10.1016/S0065-2881(05)49001.X; Bell JD, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P437; Bell JD, 2006, FISH RES, V80, P1, DOI 10.1016/j.fishres.2006.03.008; BENZIE JAH, 1992, CORAL REEFS, V11, P135, DOI 10.1007/BF00255467; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Bolle LJ, 2009, MAR ECOL PROG SER, V390, P195, DOI 10.3354/meps08177; Botsford LW, 2003, ECOL APPL, V13, pS25; BRALEY R D, 1987, Micronesica, V20, P215; BRALEY RD, 1984, CORAL REEFS, V3, P221, DOI 10.1007/BF00288258; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; CHIA FS, 1984, CAN J ZOOL, V62, P1205, DOI 10.1139/z84-176; Chou LM, 2004, HYDROBIOLOGIA, V515, P91, DOI 10.1023/B:HYDR.0000027321.23230.2f; Copland J. W., 1988, AUSTR CTR INT AGR RE, V9; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; DeBoer TS, 2008, CONSERV BIOL, V22, P1255, DOI 10.1111/j.1523-1739.2008.00983.x; DENNY MW, 1989, AM NAT, V117, P838; Deredec Anne, 2007, Ecoscience, V14, P440, DOI 10.2980/1195-6860(2007)14[440:IOTAEF]2.0.CO;2; DiNitto D, 2010, GO FLOW FIELD MODELL, P137; Ellis S., 1998, CTR TROPICAL SUBTROP, V130; Erftemeijer PLA, 2008, MAR ECOL PROG SER, V358, P115, DOI 10.3354/meps07304; Erftemeijer PLA, 2009, MAR ECOL PROG SER, V390, P167, DOI 10.3354/meps08173; FITT WK, 1984, AQUACULTURE, V39, P181, DOI 10.1016/0044-8486(84)90265-5; FITT WK, 1981, BIOL BULL, V161, P213, DOI 10.2307/1540800; Gascoigne J, 2004, MAR ECOL PROG SER, V269, P49, DOI 10.3354/meps269049; Gerritsen H, 2009, P 8 INT C HYDR CHIL; Goh N.K.C., 1992, 3 ASEAN SCI TECHN WE, P55; Gomez ED, 2006, FISH RES, V80, P46, DOI 10.1016/j.fishres.2006.03.017; Green A, 1999, CORAL REEFS, V18, P205, DOI 10.1007/s003380050183; Guest JR, 2008, AQUAT CONSERV, V18, P570, DOI 10.1002/aqc.888; Guest JR, 2005, CORAL REEFS, V24, P112, DOI 10.1007/s00338-004-0433-7; GWYTHER J, 1981, AQUACULTURE, V24, P197, DOI 10.1016/0044-8486(81)90057-0; Hadfield MG, 2004, BIOL BULL-US, V207, P28, DOI 10.2307/1543626; Han L, 2008, J EXP MAR BIOL ECOL, V359, P77, DOI 10.1016/j.jembe.2008.02.021; Heslinga G.A., 1990, GIANT CLAM FARMING; HESLINGA GA, 1987, BIOSCIENCE, V37, P332, DOI 10.2307/1310689; Hobday AJ, 2001, REV FISH BIOL FISHER, V10, P493; Huang DW, 2007, J EXP MAR BIOL ECOL, V342, P269, DOI 10.1016/j.jembe.2006.10.051; Huang DW, 2009, RAFFLES B ZOOL, P69; JAMESON SC, 1976, PAC SCI, V30, P219; Knights AM, 2006, MAR ECOL PROG SER, V326, P167, DOI 10.3354/meps326167; Kochzius M, 2008, MOL ECOL, V17, P3775, DOI 10.1111/j.1365-294X.2008.03803.x; LABARBERA M, 1974, MAR BIOL, V25, P233, DOI 10.1007/BF00394969; Latama Gunarto, 1995, Phuket Marine Biological Center Special Publication, V15, P79; Launder B.E., 1972, MATH MODELS TURBULEN; Leendertse J. J., 1987, 3 DIMENSIONAL ALTERN; Lesser GR, 2004, COAST ENG, V51, P883, DOI 10.1016/j.coastaleng.2004.07.014; Liao PC, 2007, CONSERV GENET, V8, P89, DOI 10.1007/s10592-006-9151-8; Lipcius RN, 2008, REV FISH SCI, V16, P101, DOI 10.1080/10641260701812574; Luijendijk AP, 2001, THESIS DELFT U TECHN; Manuel JL, 1997, J PLANKTON RES, V19, P1929, DOI 10.1093/plankt/19.12.1929; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Miller K, 2003, CORAL REEFS, V22, P99, DOI 10.1007/s00338-003-0290-9; Morgan LE, 2001, LOW WAKE FI, V17, P667; MUNRO PE, 1983, COMP BIOCHEM PHYS C, V74, P219, DOI 10.1016/0742-8413(83)90177-9; Munro PE, 1993, ICLARM C P, V39; Nash W.J., 1988, ACIAR Monograph Series, P89; Neo M.L., 2011, Nature in Singapore, V4, P157; Neo ML, 2012, RAFFLES B ZOOL, P67; Neo ML, 2012, AQUAT BIOL, V14, P265, DOI 10.3354/ab00400; Neo ML, 2011, J ETHOL, V29, P85, DOI 10.1007/s10164-010-0226-0; Neo ML, 2011, J EXP MAR BIOL ECOL, V397, P21, DOI 10.1016/j.jembe.2010.11.008; Neo ML, 2009, HYDROBIOLOGIA, V625, P83, DOI 10.1007/s10750-008-9698-0; NUNNEY L, 1993, TRENDS ECOL EVOL, V8, P234, DOI 10.1016/0169-5347(93)90197-W; Nuryanto A, 2007, HAYATI J BIOSCI, V14, P162, DOI DOI 10.4308/HJB.14.4.162; Ooi SK, 2009, P 23 IAHR C VANC 9 1; Palumbi SR, 2003, ECOL APPL, V13, pS146; PEARSON RG, 1991, AUST J MAR FRESH RES, V42, P241; Postma L., 1994, DELWAQ USERS MANUAL; Purchon R. D., 1954, Bulletin of the Raffles Museum Singapore, V25, P47; Ravago-Gotanco RG, 2007, MAR ECOL PROG SER, V336, P161, DOI 10.3354/meps336161; Riddle AM, 1996, J MARINE SYST, V8, P133, DOI 10.1016/0924-7963(96)00003-6; Roegner GC, 2000, J PLANKTON RES, V22, P1779, DOI 10.1093/plankt/22.9.1779; Roelvink JA, 1994, HYDROINFORMATICS, P451; SCHELTEMA RS, 1988, BIOL BULL, V174, P145, DOI 10.2307/1541781; Shanks AL, 2003, ECOL APPL, V13, pS159; STELLING GS, 1994, INT J NUMER METH FL, V18, P915, DOI 10.1002/fld.1650181003; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Tan Aileen Shau-Hwai, 2001, Phuket Marine Biological Center Special Publication, V25, P349; Tan ASH, 1998, PHUKET MAR BIOL CTR, V18, P107; Thia-Eng C, 2000, MAR POLLUT BULL, V41, P160, DOI 10.1016/S0025-326X(00)00108-9; Todd Peter A., 2008, Tentacle, V16, P24; van Maren DS, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007615; van Maren DS, 2011, 1201442002ZKS; WADA S. K., 1954, JAPANESE JOUR ZOOL, V11, P273; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Young Craig M., 1995, P249; Zhang Z, 2007, ATMOS ENVIRON, V41, P5236, DOI 10.1016/j.atmosenv.2006.05.086	94	22	23	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58819	10.1371/journal.pone.0058819	http://dx.doi.org/10.1371/journal.pone.0058819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23555597	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200116
J	Zhang, Q; Zhang, SF; Wang, CX; Gao, X; Zhou, Y; Zhou, H; Wang, AX; Wu, JW; Bian, LH; Wu, SL; Zhao, XQ				Zhang, Qian; Zhang, Shufeng; Wang, Chunxue; Gao, Xiang; Zhou, Yong; Zhou, Heng; Wang, Anxin; Wu, Jianwei; Bian, Liheng; Wu, Shouling; Zhao, Xingquan			Ideal Cardiovascular Health Metrics on the Prevalence of Asymptomatic Intracranial Artery Stenosis: A Cross-Sectional Study	PLOS ONE			English	Article							TRANSCRANIAL DOPPLER; RISK-FACTORS; CEREBRAL ATHEROSCLEROSIS; OCCLUSIVE LESIONS; CHINESE PATIENTS; STROKE RISK; BODY-WEIGHT; MORTALITY; DISEASE; GENDER	Background and Purpose: Intracranial Artery Stenosis (ICAS) is one of the most common causes of ischemic stroke in Asia. Previous studies have shown the number of ideal cardiovascular health (CVH) metrics was associated with lower risk of stroke. This study aimed to investigate the relationship between ideal CVH metrics and prevalence of ICAS. Methods: A random sample of 5,412 participants (selected from Kailuan Study as a reference population) aged 40 years or older (40.10% women), free of stroke, transient ischemic attack, and coronary disease, were enrolled in the Asymptomatic Polyvascular Abnormalities Community study from 2010 to 2011. We collected information on the seven CVH metrics (including smoking, body mass index, dietary intake, physical activity, blood pressure, total cholesterol and fasting blood glucose); and assessed ICAS by transcranial Doppler. The relationship between the ideal CVH metrics and prevalence of ICAS was analyzed using the multivariate logistic regression. Results: After adjusting for age, sex, and other potential confounders, the adjusted odds ratios(95% confidence interval) for ICAS were 0.76(0.58-0.99), 0.55(0.43-0.72), 0.49(0.37-0.65), 0.43(0.31-0.61), and 0.36(0.22-0.62), respectively, for those having 2, 3, 4, 5, and 6-7 ideal CVH metrics compared with those having 0-1 ideal metric(p-trend<0.0001). Similar inverse associations were observed in different age and gender groups (all p-trends<0.05). Conclusion: We found a clear gradient relationship between the number of ideal CVH metrics and lower prevalence of ICAS in a Chinese population, which supports the importance of ideal health behaviors and factors in the prevention of ICAS.	[Zhang, Qian; Zhang, Shufeng; Wang, Chunxue; Zhou, Yong; Zhou, Heng; Wang, Anxin; Wu, Jianwei; Bian, Liheng; Zhao, Xingquan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Qian] Chinese Peoples Armed Police Forces, Gen Hosp, Dept Cell Transplantat, Beijing, Peoples R China; [Zhang, Shufeng] Chinese Peoples Armed Police Forces, Gen Hosp, Dept Neurol, Beijing, Peoples R China; [Gao, Xiang] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Gao, Xiang] Harvard Univ, Sch Med, Boston, MA USA; [Gao, Xiang] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wu, Shouling] Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China	Capital Medical University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Wu, SL (corresponding author), Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; zxq@vip.163.com	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; , Xiang/0000-0003-2617-6509	Ministry of Science and Technology; Ministry of Health of the People's Republic of China [2008BAI52B03]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China	This study is performed as a collaborative study supported by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China. The Grant number is 2008BAI52B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenillas JF, 2011, STROKE, V42, pS20, DOI 10.1161/STROKEAHA.110.597278; Babikian VL, 2000, J NEUROIMAGING, V10, P101, DOI 10.1111/jon2000102101; Bae HJ, 2007, CEREBROVASC DIS, V24, P355, DOI 10.1159/000106982; Bambs C, 2011, FUTUR CARDIOL, V7, P447, DOI [10.2217/fca.11.38, 10.2217/FCA.11.38]; Boddu DB, 2011, J NEUROIMAGING, V21, pe34, DOI 10.1111/j.1552-6569.2009.00412.x; de Kleijn MJJ, 2002, AM J EPIDEMIOL, V155, P339, DOI 10.1093/aje/155.4.339; Dong C, 2012, CIRCULATION; Duggirala R, 1996, STROKE, V27, P833, DOI 10.1161/01.STR.27.5.833; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Feldmann E, 2007, NEUROLOGY, V68, P2099, DOI 10.1212/01.wnl.0000261488.05906.c1; FLORA GC, 1968, CIRCULATION, V38, P859, DOI 10.1161/01.CIR.38.5.859; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Gao S, 2002, J NEUROIMAGING, V12, P213, DOI 10.1177/10528402012003001; Gomez CR, 2001, ARCH NEUROL-CHICAGO, V58, P1687, DOI 10.1001/archneur.58.10.1687; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Huang HW, 2007, CEREBROVASC DIS, V24, P111, DOI 10.1159/000103125; Huang YN, 1997, NEUROLOGY, V48, P524, DOI 10.1212/WNL.48.2.524; INGALL TJ, 1991, ARCH NEUROL-CHICAGO, V48, P687, DOI 10.1001/archneur.1991.00530190033011; ITOH T, 1993, STROKE, V24, P1192, DOI 10.1161/01.STR.24.8.1192; Kim YS, 2011, GENDER MED, V8, P14, DOI 10.1016/j.genm.2011.01.001; Kublickiene K, 2008, PHARMACOL REP, V60, P49; Li H, 2003, J CLIN NEUROSCI, V10, P30, DOI 10.1016/S0967-5868(02)00264-3; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lopez-Cancio E, 2012, ATHEROSCLEROSIS, V221, P221, DOI 10.1016/j.atherosclerosis.2011.12.020; Miller AA, 2007, STROKE, V38, P2142, DOI 10.1161/STROKEAHA.106.477406; Park Kwang-Yeol, 2006, J Clin Neurol, V2, P29, DOI 10.3988/jcn.2006.2.1.29; Qureshi AI, 2009, ANN NEUROL, V66, P730, DOI 10.1002/ana.21768; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Segura T, 2001, NEUROLOGY, V56, P497, DOI 10.1212/WNL.56.4.497; Siddiq F, 2012, NEUROEPIDEMIOLOGY, V38, P148, DOI 10.1159/000335498; Suwanwela Nijasri C., 2006, Journal of the Medical Association of Thailand, V89, P2021; Uehara T, 2005, EUR J NEUROL, V12, P218, DOI 10.1111/j.1468-1331.2004.00959.x; Uehara T, 1998, CEREBROVASC DIS, V8, P267, DOI 10.1159/000015864; Wong KS, 2007, NEUROLOGY, V68, P2035, DOI 10.1212/01.wnl.0000264427.09191.89; Wong KS, 2007, NEUROLOGY, V68, P2031, DOI 10.1212/01.wnl.0000264426.63544.ee; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Wong KS, 1998, NEUROLOGY, V50, P812, DOI 10.1212/WNL.50.3.812; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Wu S, 2012, CIRC CARDIOVASC QUAL; Yoo JH, 1998, STROKE, V29, P2478, DOI 10.1161/01.STR.29.12.2478; Yuan JM, 1998, INT J EPIDEMIOL, V27, P824, DOI 10.1093/ije/27.5.824; Zhang YQ, 2012, NEUROL RES, V34, P359, DOI 10.1179/1743132812Y.0000000024; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	45	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58923	10.1371/journal.pone.0058923	http://dx.doi.org/10.1371/journal.pone.0058923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554958	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500057
J	Schumm, P; Schumm, W; Scoglio, C				Schumm, Phillip; Schumm, Walter; Scoglio, Caterina			Impact of Preventive Responses to Epidemics in Rural Regions	PLOS ONE			English	Article							INFLUENZA VACCINE; VIRUS; TRANSMISSION; ROBUSTNESS; RESPECT; SPREAD	Various epidemics have arisen in rural locations through human-animal interaction, such as the H1N1 outbreak of 2009. Through collaboration with local government officials, we have surveyed a rural county and its communities and collected a dataset characterizing the rural population. From the respondents' answers, we build a social (face-to-face) contact network. With this network, we explore the potential spread of epidemics through a Susceptible-Latent-Infected-Recovered (SLIR) disease model. We simulate an exact model of a stochastic SLIR Poisson process with disease parameters representing a typical influenza-like illness. We test vaccine distribution strategies under limited resources. We examine global and location-based distribution strategies, as a way to reach critical individuals in the rural setting. We demonstrate that locations can be identified through contact metrics for use in vaccination strategies to control contagious diseases.	[Schumm, Phillip; Scoglio, Caterina] Kansas State Univ, Dept Elect & Comp Engn, K State EpiCtr, Manhattan, KS 66506 USA; [Schumm, Walter] Kansas State Univ, Dept Family Studies & Human Sci, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Scoglio, C (corresponding author), Kansas State Univ, Dept Elect & Comp Engn, K State EpiCtr, Manhattan, KS 66506 USA.	caterina@ksu.edu	Schumm, Walter/AAF-4347-2020; Schumm, Walter/H-5051-2019	Schumm, Walter/0000-0003-3097-3551; Scoglio, Caterina/0000-0003-4486-9229	Center for Engagement and Community Development at Kansas State University [DMS-1201427]; National Science Foundation; Kansas State University Open Access Publishing Fund; Direct For Mathematical & Physical Scien [1201427] Funding Source: National Science Foundation	Center for Engagement and Community Development at Kansas State University; National Science Foundation(National Science Foundation (NSF)); Kansas State University Open Access Publishing Fund; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work has been supported by the Center for Engagement and Community Development at Kansas State University, and by the National Science Foundation under Award DMS-1201427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Steven Kubler and other officials of the City of Chanute for helpful discussion and information. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund.	[Anonymous], 1978, MAIL TELEPHONE SURVE; Araz OM, 2012, HEALTH CARE MANAG SC, V15, P175, DOI 10.1007/s10729-012-9199-6; Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Campbell H, 2010, SURVEYS STUDY EPIDEM; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; CDC, 2012, CDC SEAS INFL FLU WH; CDC, 2012, CDC SEAS INFL FLU Q; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Cornforth DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001062; Dillman DA, 1999, MAIL INTERNET SURVEY; Fielding JE, 2011, EMERG INFECT DIS, V17, P1181, DOI 10.3201/eid1707.101959; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Gallos LK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045104; Ghani A, 2010, PLOS CURR, V1; Glasser J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012777; Kooij RE, 2009, LECT NOTES COMPUT SC, V5550, P562, DOI 10.1007/978-3-642-01399-7_44; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Schneider CM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061911; Scoglio C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011569; Smyth JD, 2010, AM BEHAV SCI, V53, P1423, DOI 10.1177/0002764210361695; Smyth JoleneD., 2008, INTERNET MAIL MIXED; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Youssef M, 2011, J COMPUT SCI-NETH, V2, P286, DOI 10.1016/j.jocs.2011.03.001	32	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59028	10.1371/journal.pone.0059028	http://dx.doi.org/10.1371/journal.pone.0059028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536851	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100113
J	Zgheib, A; Lamy, S; Annabi, B				Zgheib, Alain; Lamy, Sylvie; Annabi, Borhane			Epigallocatechin Gallate Targeting of Membrane Type 1 Matrix Metalloproteinase-mediated Src and Janus Kinase/Signal Transducers and Activators of Transcription 3 Signaling Inhibits Transcription of Colony-stimulating Factors 2 and 3 in Mesenchymal Stromal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW; GREEN TEA; GLUCOSE-6-PHOSPHATE TRANSPORTER; ENDOTHELIAL-CELLS; MT1-MMP; EXPRESSION; INVASION; GROWTH; PHOSPHORYLATION; PROLIFERATION	Epigallocatechin gallate (EGCG), a major form of tea catechins, possesses immunomodulatory and antiangiogenic effects, both of which contribute to its chemopreventive properties. In this study, we evaluated the impact of EGCG treatment on the expression of colony-stimulating factors (CSF) secreted from human bone marrow-derived mesenchymal stromal cells (MSCs), all of which also contribute to the immunomodulatory and angiogenic properties of these cells. MSCs were activated with concanavalin A (ConA), a Toll-like receptor (TLR)-2 and TLR-6 agonist as well as a membrane type 1 matrix metalloproteinase (MT1-MMP) inducer, which increased granulocyte macrophage-CSF (GM-CSF, CSF-2), granulocyte CSF (G-CSF, CSF-3), and MT1-MMP gene expression. EGCG antagonized the ConA-induced CSF-2 and CSF-3 gene expression, and this process required an MT1-MMP-mediated sequential activation of the Src and JAK/STAT pathways. Gene silencing of MT1-MMP expression further demonstrated its requirement in the phosphorylation of Src and STAT3, whereas overexpression of a nonphosphorylatable MT1-MMP mutant (Y573F) abrogated CSF-2 and CSF-3 transcriptional increases. Given that MSCs are recruited within vascularizing tumors and are believed to contribute to tumor angiogenesis, possibly through secretion of CSF-2 and CSF-3, our study suggests that diet-derived polyphenols such as EGCG may exert chemopreventive action through pharmacological targeting of the MT1-MMP intracellular signaling.	[Zgheib, Alain; Lamy, Sylvie; Annabi, Borhane] Univ Quebec, Lab Oncol Mol, Ctr Rech BIOMED, Dept Chim, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	Annabi, B (corresponding author), Univ Quebec, Lab Oncol Mol, CP 8888,Succ Ctr Ville, Montreal, PQ H3C 3P8, Canada.	annabi.borhane@uqam.ca			Chaire de Recherche en Prevention et Traitement du Cancer; Natural Sciences and Engineering Research Council of Canada (NSERC)	Chaire de Recherche en Prevention et Traitement du Cancer; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the "Chaire de Recherche en Prevention et Traitement du Cancer" and by the Natural Sciences and Engineering Research Council of Canada (NSERC).	Abarrategi A, 2011, CLIN TRANSL ONCOL, V13, P611, DOI 10.1007/s12094-011-0706-x; Akla N, 2012, EXP CELL RES, V318, P2498, DOI 10.1016/j.yexcr.2012.08.003; Annabi B, 2004, J BIOL CHEM, V279, P21888, DOI 10.1074/jbc.M313694200; Annabi B, 2003, EXP HEMATOL, V31, P640, DOI 10.1016/S0301-472X(03)00090-0; Annabi B, 2002, BBA-MOL CELL RES, V1542, P209, DOI 10.1016/S0167-4889(01)00187-2; Annabi B, 2004, J CELL BIOCHEM, V91, P1146, DOI 10.1002/jcb.10763; Annabi B, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-8; Arroyo AG, 2007, CURR PHARM DESIGN, V13, P1787, DOI 10.2174/138161207780831284; Bautz F, 2001, BLOOD, V97, P3433, DOI 10.1182/blood.V97.11.3433; Bauvois B, 2004, ONCOGENE, V23, P317, DOI 10.1038/sj.onc.1207124; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Birnbaum T, 2007, J NEURO-ONCOL, V83, P241, DOI 10.1007/s11060-007-9332-4; BOCCHIETTO E, 1993, J CELL PHYSIOL, V155, P89, DOI 10.1002/jcp.1041550112; BUSSOLINO F, 1991, J CLIN INVEST, V87, P986, DOI 10.1172/JCI115107; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; Byun EB, 2012, BIOCHEM BIOPH RES CO, V426, P480, DOI 10.1016/j.bbrc.2012.08.096; Byun EH, 2011, FEBS LETT, V585, P814, DOI 10.1016/j.febslet.2011.02.010; Currie JC, 2007, J BIOL CHEM, V282, P8142, DOI 10.1074/jbc.M610894200; Eisenach PA, 2012, J BIOL CHEM, V287, P11533, DOI 10.1074/jbc.M111.306340; Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711; Ferriz-Martinez RA., 2010, NEW APPROACHES TREAT, P71; Gonzalo P, 2010, BIOFACTORS, V36, P248, DOI 10.1002/biof.99; Goutagny N, 2012, TARGET ONCOL, V7, P29, DOI 10.1007/s11523-012-0213-1; Grote K., 2011, SCI WORLD J, V11, P71; Huang WH, 2013, ONCOGENE, V32, P4343, DOI 10.1038/onc.2012.458; Ingvarsen S, 2013, J BIOL CHEM, V288, P10195, DOI 10.1074/jbc.M112.447169; KANELLOPOULOS JM, 1985, EUR J IMMUNOL, V15, P479, DOI 10.1002/eji.1830150512; Kong Y, 2011, INT IMMUNOPHARMACOL, V11, P1407, DOI 10.1016/j.intimp.2011.04.025; Lin RZ, 2012, ANGIOGENESIS, V15, P443, DOI 10.1007/s10456-012-9272-2; Lord-Dufour S, 2009, STEM CELLS, V27, P489, DOI 10.1634/stemcells.2008-0855; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Meriane M, 2006, STEM CELLS, V24, P2557, DOI 10.1634/stemcells.2006-0209; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Nyalendo C, 2008, CARCINOGENESIS, V29, P1655, DOI 10.1093/carcin/bgn159; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Pratt J, 2012, GLYCOBIOLOGY, V22, P1245, DOI 10.1093/glycob/cws093; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Ribatti D, 2012, LEUKEMIA RES, V36, P537, DOI 10.1016/j.leukres.2012.02.003; Sassoli Chiara, 2012, Cells, V1, P832, DOI 10.3390/cells1040832; Savinov AY, 2013, EXP THER MED, V5, P438, DOI 10.3892/etm.2012.821; Sina A., 2009, CANC LETT, V279, P171; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Sun XT, 2012, WORLD J GASTROENTERO, V18, P4925, DOI 10.3748/wjg.v18.i35.4925; Umegaki K, 2001, J NUTR SCI VITAMINOL, V47, P402, DOI 10.3177/jnsv.47.402; Yang CS, 1998, CANCER EPIDEM BIOMAR, V7, P351; Yoshioka T, 2006, CARDIOVASC RES, V70, P61, DOI 10.1016/j.cardiores.2005.12.013	47	36	37	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13378	13386		10.1074/jbc.M113.456533	http://dx.doi.org/10.1074/jbc.M113.456533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23548906	Green Published, hybrid			2022-12-25	WOS:000318850300023
J	Moreno, JC; Pizarro, L; Fuentes, P; Handford, M; Cifuentes, V; Stange, C				Moreno, Juan Camilo; Pizarro, Lorena; Fuentes, Paulina; Handford, Michael; Cifuentes, Victor; Stange, Claudia			Levels of Lycopene beta-Cyclase 1 Modulate Carotenoid Gene Expression and Accumulation in Daucus carota	PLOS ONE			English	Article							PHYTOENE SYNTHASE; EPSILON-CYCLASE; FUNCTIONAL-CHARACTERIZATION; BIOSYNTHETIC-PATHWAY; ARABIDOPSIS-THALIANA; STRUCTURAL GENES; TOMATO REVEALS; CLONING; DESATURASE; ENZYME	Plant carotenoids are synthesized and accumulated in plastids through a highly regulated pathway. Lycopene beta-cyclase (LCYB) is a key enzyme involved directly in the synthesis of alpha-carotene and beta-carotene through the cyclization of lycopene. Carotenoids are produced in both carrot (Daucus carota) leaves and reserve roots, and high amounts of alpha-carotene and beta-carotene accumulate in the latter. In some plant models, the presence of different isoforms of carotenogenic genes is associated with an organ-specific function. D. carota harbors two Lcyb genes, of which DcLcyb1 is expressed in leaves and storage roots during carrot development, correlating with an increase in carotenoid levels. In this work, we show that DcLCYB1 is localized in the plastid and that it is a functional enzyme, as demonstrated by heterologous complementation in Escherichia coli and over expression and post transcriptional gene silencing in carrot. Transgenic plants with higher or reduced levels of DcLcyb1 had incremented or reduced levels of chlorophyll, total carotenoids and beta-carotene in leaves and in the storage roots, respectively. In addition, changes in the expression of DcLcyb1 are accompanied by a modulation in the expression of key endogenous carotenogenic genes. Our results indicate that DcLcyb1 does not possess an organ specific function and modulate carotenoid gene expression and accumulation in carrot leaves and storage roots.	[Moreno, Juan Camilo; Pizarro, Lorena; Fuentes, Paulina; Handford, Michael; Stange, Claudia] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Moreno, Juan Camilo; Fuentes, Paulina] Max Planck Inst Mol Pflanzenphysiol, Potsdam, Germany; [Cifuentes, Victor] Univ Chile, Fac Ciencias, Dept Ecol, Santiago, Chile	Universidad de Chile; Max Planck Society; Universidad de Chile	Stange, C (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile.	cstange@uchile.cl	Handford, Michael/C-6127-2012; Stange, Claudia/H-7411-2013	Stange, Claudia/0000-0002-2265-0472; Pizarro, Lorena/0000-0001-5954-5839; Handford, Michael/0000-0003-0969-3192; Moreno Beltran, Juan Camilo/0000-0001-9722-5262	Chilean grant [FONDEF D10I1022]	Chilean grant	This work was funded by the Chilean grant FONDEF D10I1022. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrazem O, 2010, J EXP BOT, V61, P105, DOI 10.1093/jxb/erp283; Alquezar B, 2009, J EXP BOT, V60, P1783, DOI 10.1093/jxb/erp048; Ampomah-Dwamena C, 2009, J EXP BOT, V60, P3765, DOI 10.1093/jxb/erp218; Bai L, 2009, PLANT J, V59, P588, DOI 10.1111/j.1365-313X.2009.03899.x; Bang H, 2007, MOL BREEDING, V20, P63, DOI 10.1007/s11032-006-9076-4; Baranska M, 2006, PLANTA, V224, P1028, DOI 10.1007/s00425-006-0289-x; BEYER P, 1991, J BIOL CHEM, V266, P17072; Blas AL, 2010, PLANT PHYSIOL, V152, P2013, DOI 10.1104/pp.109.152298; Bollag W, 1996, FASEB J, V10, P938, DOI 10.1096/fasebj.10.9.8801175; Botella-Pavia P, 2004, PLANT J, V40, P188, DOI 10.1111/j.1365-313X.2004.02198.x; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Bouvier F, 1996, J BIOL CHEM, V271, P28861, DOI 10.1074/jbc.271.46.28861; Bramley PM, 2002, J EXP BOT, V53, P2107, DOI 10.1093/jxb/erf059; Briton G, 2008, CAROTENOIDS HDB; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; Britton G., 2008, CAROTENOIDS HDB; Chaudhary N, 2010, MOL GENET GENOMICS, V283, P13, DOI 10.1007/s00438-009-0495-x; Chen WP, 2002, PLANT CELL REP, V20, P929, DOI 10.1007/s00299-001-0419-7; Clotault J, 2008, J EXP BOT, V59, P3563, DOI 10.1093/jxb/ern210; Conti A, 2004, PLANT CELL PHYSIOL, V45, P445, DOI 10.1093/pcp/pch052; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.2307/3870254; Cunningham FX, 2002, PURE APPL CHEM, V74, P1409, DOI 10.1351/pac200274081409; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Devitt LC, 2010, J EXP BOT, V61, P33, DOI 10.1093/jxb/erp284; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Dong HL, 2007, CELL RES, V17, P458, DOI 10.1038/cr.2007.37; Fang J, 2008, PLANT J, V54, P177, DOI 10.1111/j.1365-313X.2008.03411.x; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Fuentes P, 2012, PLANT MOL BIOL, V79, P47, DOI 10.1007/s11103-012-9893-2; Giorio G, 2007, TRANSGENIC RES, V16, P15, DOI 10.1007/s11248-006-9025-3; Hable WE, 1998, MOL GEN GENET, V257, P167; Handford M, 2012, MOL PLANT, V5, P1263, DOI 10.1093/mp/sss074; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hornero-Mendez D, 2002, FEBS LETT, V515, P133, DOI 10.1016/S0014-5793(02)02453-5; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; HUGUENEY P, 1995, PLANT J, V8, P417, DOI 10.1046/j.1365-313X.1995.08030417.x; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Joyard J, 2009, MOL PLANT, V2, P1154, DOI 10.1093/mp/ssp088; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Kato M, 2004, PLANT PHYSIOL, V134, P824, DOI 10.1104/pp.103.031104; Krubasik P, 2000, BIOCHEM SOC T, V28, P806, DOI 10.1042/BST0280806; Lange BM, 2003, PLANT MOL BIOL, V51, P925, DOI 10.1023/A:1023005504702; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; Matthews PD, 2003, J EXP BOT, V54, P2215, DOI 10.1093/jxb/erg235; Mendes-Pinto MM, 2009, ARCH BIOCHEM BIOPHYS, V483, P236, DOI 10.1016/j.abb.2009.01.008; Nelson JL, 2003, J NUTR, V133, P3117, DOI 10.1093/jn/133.10.3117; Niklitschek M, 2008, BIOL RES, V41, P93, DOI 10.4067/S0716-97602008000100011; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Pecker I, 1996, PLANT MOL BIOL, V30, P807, DOI 10.1007/BF00019013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pogson B, 1996, PLANT PHYSIOL, V111, P109; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Romer S, 2005, PLANTA, V221, P305, DOI 10.1007/s00425-005-1533-5; Romer S, 2000, NAT BIOTECHNOL, V18, P666, DOI 10.1038/76523; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Ronen G, 1999, PLANT J, V17, P341, DOI 10.1046/j.1365-313X.1999.00381.x; Rosati C, 2000, PLANT J, V24, P413, DOI 10.1046/j.1365-313x.2000.00880.x; Salinas P, 2006, PLANT CELL PHYSIOL, V47, P1295, DOI 10.1093/pcp/pcj100; Sandmann G, 2006, METAB ENG, V8, P291, DOI 10.1016/j.ymben.2006.01.005; Simkin AJ, 2003, Z NATURFORSCH C, V58, P371; Singh M, 2003, PLANT CELL, V15, P874, DOI 10.1105/tpc.010249; Skelton RL, 2006, CELL RES, V16, P731, DOI 10.1038/sj.cr.7310081; Stange C, 2012, ADVANCES IN PHOTOSYNTHESIS - FUNDAMENTAL ASPECTS, P77; Stange C, 2008, BIOL RES, V41, P289, DOI [10.4067/S0716-97602008000300006, /S0716-97602008000300006]; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Van Norman JM, 2007, PLANT J, V49, P619, DOI 10.1111/j.1365-313X.2006.02982.x; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Woitsch S, 2003, PLANT PHYSIOL, V132, P1508, DOI 10.1104/pp.102.019364; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453	72	60	68	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e58144	10.1371/journal.pone.0058144	http://dx.doi.org/10.1371/journal.pone.0058144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555569	Green Published, Green Submitted, gold			2022-12-25	WOS:000317263900003
J	Furuta, M; Kozaki, K; Tanimoto, K; Tanaka, S; Arii, S; Shimamura, T; Niida, A; Miyano, S; Inazawa, J				Furuta, Mayuko; Kozaki, Ken-ichi; Tanimoto, Kousuke; Tanaka, Shinji; Arii, Shigeki; Shimamura, Teppei; Niida, Atsushi; Miyano, Satoru; Inazawa, Johji			The Tumor-Suppressive miR-497-195 Cluster Targets Multiple Cell-Cycle Regulators in Hepatocellular Carcinoma	PLOS ONE			English	Article							ONCOGENE ADDICTION; MICRORNA GENES; CANCER; TRANSITION; EXPRESSION; SIGNATURES	MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression and commonly deregulated carcinogenesis. To explore functionally crucial tumor-suppressive (TS)-miRNAs in hepatocellular carcinoma (HCC), we performed integrative function- and expression-based screenings of TS-miRNAs in six HCC cell lines. The screenings identified seven miRNAs, which showed growth-suppressive activities through the overexpression of each miRNA and were endogenously downregulated in HCC cell lines. Further expression analyses using a large panel of HCC cell lines and primary tumors demonstrated four miRNAs, miR-101, -195, -378 and -497, as candidate TS-miRNAs frequently silenced in HCCs. Among them, two clustered miRNAs miR-195 and miR-497 showed significant growth-suppressive activity with induction of G1 arrest. Comprehensive exploration of their targets using Argonute2-immunoprecipitation-deep-sequencing (Ago2-IP-seq) and genome-wide expression profiling after their overexpression followed by pathway analysis, revealed a significant enrichment of cell cycle regulators. Among the candidates, we successfully identified CCNE1, CDC25A, CCND3, CDK4, and BTRC as direct targets for miR-497 and rniR-195. Moreover, target genes frequently upregulated in HCC in a tumor-specific manner, such as CDK6, CCNE1, CDC25A and CDK4, showed an inverse correlation in the expression of miR-195 and miR-497, and their targets. These results suggest the molecular pathway regulating cell cycle progression to be integrally altered by downregulation of miR-195 and miR-497 expression, leading to the aberrant cell proliferation in hepatocarcinogenesis.	[Furuta, Mayuko; Kozaki, Ken-ichi; Inazawa, Johji] Tokyo Med & Dent Univ, Dept Mol Cytogenet, Med Res Inst, Tokyo, Japan; [Furuta, Mayuko; Kozaki, Ken-ichi; Inazawa, Johji] Tokyo Med & Dent Univ, Grad Sch Med, Sch Biomed Sci, Tokyo, Japan; [Furuta, Mayuko; Inazawa, Johji] Tokyo Med & Dent Univ, Grad Sch Med, Global Ctr Excellence GCOE Program Int Res Ctr Mo, Tokyo, Japan; [Kozaki, Ken-ichi] Tokyo Med & Dent Univ, Grad Sch Med, Dept Therapeut Genom, Tokyo, Japan; [Kozaki, Ken-ichi; Inazawa, Johji] Tokyo Med & Dent Univ, Grad Sch Med, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Tanimoto, Kousuke] Tokyo Med & Dent Univ, Grad Sch Med, Genome Lab, Tokyo, Japan; [Tanaka, Shinji; Arii, Shigeki] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan; [Furuta, Mayuko] Univ Tokyo, Japan Soc Promot Sci, Inst Med Sci, Tokyo, Japan; [Shimamura, Teppei; Niida, Atsushi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Society for the Promotion of Science; University of Tokyo; University of Tokyo	Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Dept Mol Cytogenet, Med Res Inst, Tokyo, Japan.	johinaz.cgen@mri.tmd.ac.jp	Kozaki, Ken-ichi/M-6281-2014	Kozaki, Ken-ichi/0000-0003-3286-819X; Miyano, Satoru/0000-0002-1753-6616; Shimamura, Teppei/0000-0003-2994-872X	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare, Japan; New Energy and Industrial Technology Development Organization (NEDO)	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	Grant-in-Aid for Scientific Research (A), (B), (C), and JSPS Fellows, and Scientific Research on Priority Areas and Innovative Areas, and a Global Center of Excellence (GCOE) Program for International Research Center for Molecular Science in Tooth and Bone Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a Health and Labour Sciences Research Grant by the Ministry of Health, Labour and Welfare, Japan; a grant from the New Energy and Industrial Technology Development Organization (NEDO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Flavin RJ, 2009, MODERN PATHOL, V22, P197, DOI 10.1038/modpathol.2008.135; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kamb A, 2003, MOL BIOL CELL, V14, P2201, DOI 10.1091/mbc.E02-11-0732; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Matsumura S, 2012, CLIN CANCER RES, V18, P3541, DOI 10.1158/1078-0432.CCR-11-1007; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Soon PSH, 2009, CLIN CANCER RES, V15, P7684, DOI 10.1158/1078-0432.CCR-09-1587; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Suzuki H, 2011, CANCER RES, V71, P5646, DOI 10.1158/0008-5472.CAN-11-1076; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007	33	125	131	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60155	10.1371/journal.pone.0060155	http://dx.doi.org/10.1371/journal.pone.0060155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544130	gold, Green Submitted, Green Published			2022-12-25	WOS:000317480700089
J	Jakobsen, H; Bojer, MS; Marinus, MG; Xu, T; Struve, C; Krogfelt, KA; Lobner-Olesen, A				Jakobsen, Henrik; Bojer, Martin S.; Marinus, Martin G.; Xu, Tao; Struve, Carsten; Krogfelt, Karen A.; Lobner-Olesen, Anders			The Alkaloid Compound Harmane Increases the Lifespan of Caenorhabditis elegans during Bacterial Infection, by Modulating the Nematode's Innate Immune Response	PLOS ONE			English	Article							ESCHERICHIA-COLI; WORM; MAP	The nematode Caenorhabditis elegans has in recent years been proven to be a powerful in vivo model for testing antimicrobial compounds. We report here that the alkaloid compound Harmane (2-methyl-beta-carboline) increases the lifespan of nematodes infected with a human pathogen, the Shiga toxin-producing Escherichia coli O157:H7 strain EDL933 and several other bacterial pathogens. This was shown to be unrelated to the weak antibiotic effect of Harmane. Using GFP-expressing E coli EDL933, we showed that Harmane does not lower the colonization burden in the nematodes. We also found that the expression of the putative immune effector gene F35E12.5 was up-regulated in response to Harmane treatment. This indicates that Harmane stimulates the innate immune response of the nematode; thereby increasing its lifespan during bacterial infection. Expression of F35E12.5 is predominantly regulated through the p38 MAPK pathway; however, intriguingly the lifespan extension resulting from Harmane was higher in p38 MAPK-deficient nematodes. This indicates that Harmane has a complex effect on the innate immune system of C. elegans. Harmane could therefore be a useful tool in the further research into C. elegans immunity. Since the innate immunity of C. elegans has a high degree of evolutionary conservation, drugs such as Harmane could also be possible alternatives to classic antibiotics. The C. elegans model could prove to be useful for selection and development of such drugs.	[Jakobsen, Henrik; Bojer, Martin S.] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark; [Jakobsen, Henrik; Bojer, Martin S.; Struve, Carsten; Krogfelt, Karen A.] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Marinus, Martin G.; Xu, Tao] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Lobner-Olesen, Anders] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Roskilde University; Statens Serum Institut; University of Massachusetts System; University of Massachusetts Worcester; University of Copenhagen	Lobner-Olesen, A (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	lobner@bio.ku.dk	Løbner-Olesen, Anders/K-4344-2014; Krogfelt, Karen Angeliki A/O-8145-2016; Krogfelt, Karen Angeliki/P-2430-2018	Løbner-Olesen, Anders/0000-0002-0344-6417; Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Bojer, Martin Saxtorph/0000-0002-8488-9593	Basic and Clinical Microbiology (BCM) program (Roskilde University); Danish Council for Strategic Research; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Basic and Clinical Microbiology (BCM) program (Roskilde University); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HJ and MSB were both partially supported by the Basic and Clinical Microbiology (BCM) program (Roskilde University). KAK and ALO are members of the Danish Centre for Antibiotic Research and Development (DanCARD) supported by the Danish Council for Strategic Research. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kim F. Rewitz and Julie L. Hentze from University of Copenhagen for use of equipment and for assistance with the qRT-PCR experiments. We also thank Hong Cao and the University of Massachusetts Medical School Small Molecule Screening Core Facility for their help in the two-hybrid screen. The C. elegans strains used in this study Were obtained from the Caenorhabditis Genetics Center (CGC), which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Bojer MS, 2012, MICROBES INFECT, V14, P1034, DOI 10.1016/j.micinf.2012.06.002; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; BRENNER S, 1974, GENETICS, V77, P71; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Marsh EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016839; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; Portal-Celhay C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-49; Pukkila-Worley R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002733; Reza V. R. M., 2007, Journal of Pharmacology and Toxicology, V2, P677; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Stiernagle Theresa, 2006, WormBook, P1; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183	25	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60519	10.1371/journal.pone.0060519	http://dx.doi.org/10.1371/journal.pone.0060519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544153	Green Submitted, Green Published, gold			2022-12-25	WOS:000317480700112
J	Tian, JC; Wang, XP; Long, LP; Romeis, J; Naranjo, SE; Hellmich, RL; Wang, P; Earle, ED; Shelton, AM				Tian, Jun-Ce; Wang, Xiang-Ping; Long, Li-Ping; Romeis, Joerg; Naranjo, Steven E.; Hellmich, Richard L.; Wang, Ping; Earle, Elizabeth D.; Shelton, Anthony M.			Bt Crops Producing Cry1Ac, Cry2Ab and Cry1F Do Not Harm the Green Lacewing, Chrysoperla rufilabris	PLOS ONE			English	Article							TRANSGENIC INSECTICIDAL CROPS; BACILLUS-THURINGIENSIS; NATURAL ENEMIES; METAANALYSIS RESPONSE; BIOLOGICAL-CONTROL; DIAMONDBACK MOTH; TRICHOPLUSIA-NI; CABBAGE-LOOPER; RESISTANCE; PLANTS	The biological control function provided by natural enemies is regarded as a protection goal that should not be harmed by. he application of any new pest management tool. Plants producing Cry proteins from the bacterium, Bacillus thuringiensis (Bt), have become a major tactic for controlling pest Lepidoptera on cotton and maize and risk assessment studies are needed to ensure they do not harm important natural enemies. However, using Cry protein susceptible hosts as prey often compromises such studies. To avoid this problem we utilized pest Lepidoptera, cabbage looper (Trichoplusia ni) and fall armyworm (Spodoptera frugiperda), that were resistant to Cry1Ac produced in Bt broccoli (T. ni), Cry1Ac/Cry2Ab produced in Bt cotton (T ni), and Cry1F produced in Bt maize (S. frugiperda). Larvae of these species were fed Bt plants or non-Bt plants and then exposed to predaceous larvae of the green lacewing Chrysoperla rufilabris. Fitness parameters (larval survival, development time, fecundity and egg hatch) of C. rufilabris were assessed over two generations. There were no differences in any of the fitness parameters regardless if C. rufilabris consumed prey (71 ni or S. frugiperda) that had consumed Bt or non-plants. Additional studies confirmed that the prey contained bioactive Cry proteins when they were consumed by the predator. These studies confirm that Cry1Ac, Cry2Ab and Cry1F do not pose a hazard to the important predator C. rufilabris. This study also demonstrates the power of using resistant hosts when assessing the risk of genetically modified plants on non-target organisms.	[Tian, Jun-Ce; Wang, Xiang-Ping; Long, Li-Ping; Wang, Ping; Shelton, Anthony M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Tian, Jun-Ce] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect & Microbiol, Hangzhou, Zhejiang, Peoples R China; [Wang, Xiang-Ping] Yangtze Univ, Coll Agr, Jinzhou, Hubei, Peoples R China; [Long, Li-Ping] Guangxi Acad Agr Sci, Rice Res Inst, Nanning, Guangxi, Peoples R China; [Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Naranjo, Steven E.] USDA ARS, Arid Land Agr Res Ctr, Maricopa, AZ USA; [Hellmich, Richard L.] Iowa State Univ, USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Hellmich, Richard L.] Iowa State Univ, Dept Entomol, Ames, IA USA; [Earle, Elizabeth D.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA	Cornell University; Zhejiang Academy of Agricultural Sciences; Yangtze University; Guangxi Academy of Agricultural Sciences; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; United States Department of Agriculture (USDA); Iowa State University; United States Department of Agriculture (USDA); Iowa State University; Cornell University	Shelton, AM (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	ams5@cornell.edu	JunCe, Tian/F-6931-2013; Tian, Jun-Ce/M-6947-2019; Romeis, Joerg/J-5360-2013	JunCe, Tian/0000-0001-7870-7127; Tian, Jun-Ce/0000-0001-7870-7127; Romeis, Joerg/0000-0003-3652-8360	USDA National Institute of Food and Agriculture [2010-33522-21772]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This project was supported by the Biotechnology Risk Assessment Program Competitive Grant No. 2010-33522-21772 from the USDA National Institute of Food and Agriculture. (http://www.csrees.usda.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Chen M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002284; Ferry N, 2006, TRANSGENIC RES, V15, P501, DOI 10.1007/s11248-006-0021-4; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1991, ENTOMOL EXP APPL, V58, P1, DOI 10.1007/BF00163307; Iracheta MM, 2000, J INVERTEBR PATHOL, V76, P70, DOI 10.1006/jipa.2000.4946; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Kain WC, 2004, J ECON ENTOMOL, V97, P2073, DOI 10.1603/0022-0493-97.6.2073; Lawo NC, 2010, J INSECT PHYSIOL, V56, P1702, DOI 10.1016/j.jinsphys.2010.06.012; Li HR, 2004, BIOCHEM BIOPH RES CO, V323, P52, DOI 10.1016/j.bbrc.2004.08.054; Li YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022185, 10.1371/journal.pone.0026302]; Lovei GL, 2009, ENVIRON ENTOMOL, V38, P293, DOI 10.1603/022.038.0201; McEwen PK, 2001, LACEWINGS CROP ENV; METZ TD, 1995, MOL BREEDING, V1, P309, DOI 10.1007/BF01248408; Naranjo SE, 2009, CAB REV PERSPECTIVES, P11; Nienstedt KM, 2012, SCI TOTAL ENVIRON, V415, P31, DOI 10.1016/j.scitotenv.2011.05.057; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J., 2008, INTEGRATION INSECT R; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2013, CHEMOSPHERE, V90, P901, DOI 10.1016/j.chemosphere.2012.09.035; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Sanvido O, 2012, ENVIRON SCI POLICY, V15, P82, DOI 10.1016/j.envsci.2011.08.006; SAS Institute, 2001, P US MAN VERS 6; Schuler TH, 2004, J INSECT PHYSIOL, V50, P435, DOI 10.1016/j.jinsphys.2004.03.001; Schwartz PH, 1985, AGR HDB USDA, V589, P329; SHELTON AM, 1991, J ENTOMOL SCI, V26, P17, DOI 10.18474/0749-8004-26.1.17; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Shelton AM, 2012, ENVIRON ENTOMOL, V41, P1047, DOI 10.1603/EN11238a; Shelton AM, 2009, ENVIRON ENTOMOL, V38, P1533, DOI 10.1603/022.038.0603; Shelton AM, 2009, TRANSGENIC RES, V18, P317, DOI 10.1007/s11248-009-9260-5; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Sutherland D.W.S., 1984, U S Department of Agriculture Technical Bulletin, P1; Tian JC, 2012, TRANSGENIC RES, V21, P1303, DOI 10.1007/s11248-012-9604-4; Torres JB, 2006, ENTOMOL EXP APPL, V120, P11, DOI 10.1111/j.1570-7458.2006.00422.x; van Lenteren JC, 2012, BIOCONTROL, V57, P1, DOI 10.1007/s10526-011-9395-1	36	42	43	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60125	10.1371/journal.pone.0060125	http://dx.doi.org/10.1371/journal.pone.0060125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544126	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700085
J	Sahu, G; Bera, AK				Sahu, Giriraj; Bera, Amal Kanti			Contribution of Intracellular Calcium and pH in Ischemic Uncoupling of Cardiac Gap Junction Channels Formed of Connexins 43, 40, and 45: A Critical Function of C-Terminal Domain	PLOS ONE			English	Article							VOLTAGE-DEPENDENCE; GATING PROPERTIES; CALMODULIN; EXPRESSION; CELL; HEMICHANNELS; CONDUCTANCE; INHIBITION; NEURONS; BINDING	Ischemia is known to inhibit gap junction (GJ) mediated intercellular communication. However the detail mechanisms of this inhibition are largely unknown. In the present study, we determined the vulnerability of different cardiac GJ channels formed of connexins (Cxs) 43, 40, and 45 to simulated ischemia, by creating oxygen glucose deprived (OGD) condition. 5 minutes of OGD decreased the junctional conductance (Gj) of Cx43, Cx40 and Cx45 by 53 +/- 3%, 64 +/- 1% and 85 +/- 2% respectively. Reduction of G(j) was prevented completely by restricting the change of both intracellular calcium ([Ca2+](i)) and pH (pH(i)) with potassium phosphate buffer. Clamping of either [Ca2+](i) or pH(i), through BAPTA (2 mM) or HEPES (80 mM) respectively, offered partial resistance to ischemic uncoupling. Anti-calmodulin antibody attenuated the uncoupling of Cx43 and Cx45 significantly but not of Cx40. Furthermore, OGD could reduce only 26 +/- 2% of G(j) in C-terminus (CT) truncated Cx43 (Cx43-Delta 257). Tethering CT of Cx43 to the CT-truncated Cx40 (Cx40-Delta 249), and Cx45 (Cx45-Delta 272) helped to resist OGD mediated uncoupling. Moreover, CT domain played a significant role in determining the junction current density and plaque diameter. Our results suggest; OGD mediated uncoupling of G(j) channels is primarily due to elevated [Ca2+](i) and acidic pH(i), though the latter contributes more. Among Cx43, Cx40 and Cx45, Cx43 is the most resistant to OGD while Cx45 is the most sensitive one. CT of Cx43 has major necessary elements for OGD induced uncoupling and it can complement CT of Cx40 and Cx45.	[Sahu, Giriraj; Bera, Amal Kanti] Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Bera, AK (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India.	amal@iitm.ac.in	Sahu, Giriraj/GXF-2849-2022	Sahu, Giriraj/0000-0001-6566-9563; Bera, Amal Kanti/0000-0003-0362-5578	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anumonwo JMB, 2001, CIRC RES, V88, P666, DOI 10.1161/hh0701.088833; Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; Burr GS, 2005, BIOCHEM BIOPH RES CO, V335, P1191, DOI 10.1016/j.bbrc.2005.08.007; Cascio WE, 2005, J ELECTROCARDIOL, V38, P55, DOI 10.1016/j.jelectrocard.2005.06.019; Chandrasekhar A, 2012, CELL BIOCHEM FUNCT, V30, P89, DOI 10.1002/cbf.2794; Choi BH, 2007, J NEUROSURG-SPINE, V7, P54, DOI 10.3171/SPI-07/07/054; Choi BH, 2007, NEUROSCI LETT, V412, P118, DOI 10.1016/j.neulet.2006.11.015; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Dhein S, 2006, ADV CARDIOL, V42, P198, DOI 10.1159/000092570; Diarra A, 1999, NEUROSCIENCE, V93, P1003, DOI 10.1016/S0306-4522(99)00230-4; Francis R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026379; GarciaDorado D, 1997, CIRCULATION, V96, P3579; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; He DS, 1999, P NATL ACAD SCI USA, V96, P6495, DOI 10.1073/pnas.96.11.6495; KLEBER AG, 1987, CIRC RES, V61, P271, DOI 10.1161/01.RES.61.2.271; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lurtz MM, 2007, AM J PHYSIOL-CELL PH, V293, pC1806, DOI 10.1152/ajpcell.00630.2006; Maass K, 2007, CIRC RES, V101, P1283, DOI 10.1161/CIRCRESAHA.107.162818; Maass K, 2009, CARDIOVASC RES, V84, P361, DOI 10.1093/cvr/cvp250; Mao AJ, 2000, J BIOL CHEM, V275, P34407, DOI 10.1074/jbc.M003917200; Martinez AD, 2002, CIRC RES, V90, P1100, DOI 10.1161/01.RES.0000019580.64013.31; Miura T, 2010, AM J PHYSIOL-HEART C, V298, pH1115, DOI 10.1152/ajpheart.00879.2009; Moreno AP, 2004, CARDIOVASC RES, V62, P276, DOI 10.1016/j.cardiores.2004.03.003; Nicholson BJ, 2003, J CELL SCI, V116, P4479, DOI 10.1242/jcs.00821; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Peracchia C, 1996, PFLUG ARCH EUR J PHY, V431, P379, DOI 10.1007/BF02207275; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Rackauskas M, 2007, BIOPHYS J, V92, P1952, DOI 10.1529/biophysj.106.099358; Revilla A, 1999, BIOPHYS J, V77, P1374, DOI 10.1016/S0006-3495(99)76986-9; RUBIN JB, 1992, P NATL ACAD SCI USA, V89, P3820, DOI 10.1073/pnas.89.9.3820; Schulz R, 2007, HEART FAIL REV, V12, P261, DOI 10.1007/s10741-007-9032-3; SCHWIENING CJ, 1994, J PHYSIOL-LONDON, V475, P59, DOI 10.1113/jphysiol.1994.sp020049; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Sotkis A, 2001, CELL COMMUN ADHES, V8, P277, DOI 10.3109/15419060109080737; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Swain SM, 2012, STEM CELL RES, V9, P59, DOI 10.1016/j.scr.2012.04.005; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Valiunas V, 2000, CIRC RES, V86, pE42, DOI 10.1161/01.RES.86.2.e42; von Maltzahn J, 2009, EUR J CELL BIOL, V88, P481, DOI 10.1016/j.ejcb.2009.04.004; Vozzi C, 1999, J MOL CELL CARDIOL, V31, P991, DOI 10.1006/jmcc.1999.0937; WELSH MJ, 1982, SCIENCE, V216, P642, DOI 10.1126/science.6280283; WHITE RL, 1990, J GEN PHYSIOL, V95, P1061, DOI 10.1085/jgp.95.6.1061; Xu Q, 2012, AM J PHYSIOL-CELL PH, V302, pC1548, DOI 10.1152/ajpcell.00319.2011; ZHANG L, 1993, J NEUROPHYSIOL, V69, P118, DOI 10.1152/jn.1993.69.1.118	47	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60506	10.1371/journal.pone.0060506	http://dx.doi.org/10.1371/journal.pone.0060506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536911	Green Submitted, gold, Green Published			2022-12-25	WOS:000317397200059
J	De la Fuente, IM; Cortes, JM; Pelta, DA; Veguillas, J				De la Fuente, Ildefonso M.; Cortes, Jesus M.; Pelta, David A.; Veguillas, Juan			Attractor Metabolic Networks	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; BIOCHEMICAL OSCILLATIONS; NEURAL-NETWORKS; KINETIC-MODEL; SLIME-MOLD; ORGANIZATION; DYNAMICS; BEHAVIOR; FAMILIARITY; ORGANELLES	Background: The experimental observations and numerical studies with dissipative metabolic networks have shown that cellular enzymatic activity self-organizes spontaneously leading to the emergence of a Systemic Metabolic Structure in the cell, characterized by a set of different enzymatic reactions always locked into active states (metabolic core) while the rest of the catalytic processes are only intermittently active. This global metabolic structure was verified for Escherichia coli, Helicobacter pylori and Saccharomyces cerevisiae, and it seems to be a common key feature to all cellular organisms. In concordance with these observations, the cell can be considered a complex metabolic network which mainly integrates a large ensemble of self-organized multienzymatic complexes interconnected by substrate fluxes and regulatory signals, where multiple autonomous oscillatory and quasi-stationary catalytic patterns simultaneously emerge. The network adjusts the internal metabolic activities to the external change by means of flux plasticity and structural plasticity. Methodology/Principal Findings: In order to research the systemic mechanisms involved in the regulation of the cellular enzymatic activity we have studied different catalytic activities of a dissipative metabolic network under different external stimuli. The emergent biochemical data have been analysed using statistical mechanic tools, studying some macroscopic properties such as the global information and the energy of the system. We have also obtained an equivalent Hopfield network using a Boltzmann machine. Our main result shows that the dissipative metabolic network can behave as an attractor metabolic network. Conclusions/Significance: We have found that the systemic enzymatic activities are governed by attractors with capacity to store functional metabolic patterns which can be correctly recovered from specific input stimuli. The network attractors regulate the catalytic patterns, modify the efficiency in the connection between the multienzymatic complexes, and stably retain these modifications. Here for the first time, we have introduced the general concept of attractor metabolic network, in which this dynamic behavior is observed.	[De la Fuente, Ildefonso M.; Cortes, Jesus M.; Veguillas, Juan] BioCruces Hlth Res Inst, Quantitat Biomed Unit, Baracaldo, Basque Country, Spain; [De la Fuente, Ildefonso M.] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [De la Fuente, Ildefonso M.] Univ Basque Country, EHU UPV, Dept Math, Leioa, Basque Country, Spain; [Cortes, Jesus M.] Ikerbasque Basque Fdn Sci, Bilbao, Basque Country, Spain; [Pelta, David A.] Univ Granada, Dept Comp Sci & Artificial Intelligence, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Basque Country; Basque Foundation for Science; University of Granada	De la Fuente, IM (corresponding author), BioCruces Hlth Res Inst, Quantitat Biomed Unit, Baracaldo, Basque Country, Spain.	mtpmadei@ehu.es	Pelta, David/B-6978-2008; Cortes, Jesus/D-9949-2012; Pelta, David A./ABG-9763-2020	Cortes, Jesus/0000-0002-9059-8194; Pelta Mochcovsky, David Alejandro/0000-0002-7653-1452; De la Fuente, Ildefonso/0000-0001-6548-7583	Junta de Andalucia Proyecto de Excelencia [P09FQM-4682]; UPV/EHU [US11/13]; Spanish Ministry of Economy and Competitiveness [TIN2011-27696-C02-01]; Ikerbasque, The Basque Foundation for Science	Junta de Andalucia Proyecto de Excelencia(Junta de Andalucia); UPV/EHU; Spanish Ministry of Economy and Competitiveness(Spanish Government); Ikerbasque, The Basque Foundation for Science	Funding provided by Junta de Andalucia Proyecto de Excelencia P09FQM-4682 and the University-Society grant US11/13 of the UPV/EHU. DAP acknowledges support from project TIN2011-27696-C02-01, Spanish Ministry of Economy and Competitiveness. JMC is supported by Ikerbasque, The Basque Foundation for Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKLEY DH, 1985, COGNITIVE SCI, V9, P147; Albrecht E, 1998, P NATL ACAD SCI USA, V95, P5039, DOI 10.1073/pnas.95.9.5039; Allegrini P, 1998, PHYS REV E, V57, P4558, DOI 10.1103/PhysRevE.57.4558; Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Amit Daniel J., 1992, MODELING BRAIN FUNCT; AMIT DJ, 1987, ANN PHYS-NEW YORK, V173, P30, DOI 10.1016/0003-4916(87)90092-3; [Anonymous], 1999, NUMERICAL OPTIMIZATI; Aon MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003624; Ashlock D, 2006, EVOLUTIONARY COMPUTA; Audit B, 2004, J BIOL PHYS, V30, P33, DOI 10.1023/B:JOBP.0000016438.86794.8e; Bier M, 1996, BIOPHYS CHEM, V62, P15, DOI 10.1016/S0301-4622(96)02195-3; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Bogacz R, 2003, HIPPOCAMPUS, V13, P494, DOI 10.1002/hipo.10093; Bonner JT, 2010, P NATL ACAD SCI USA, V107, P5267, DOI 10.1073/pnas.1000861107; Boyd S., 2004, CONVEX OPTIMIZATION; Bremer H, 1996, ESCHERICHIA COLI SAL; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Cech TR, 2000, SCIENCE, V289, P878, DOI 10.1126/science.289.5481.878; Cormen T., 2009, INTRO ALGORITHMS; Cortes JM, 2010, NEURAL COMPUT, V22, P448, DOI 10.1162/neco.2009.12-08-921; Das M, 2003, J NEUROPHYSIOL, V89, P833, DOI 10.1152/jn.00757.2002; De la Fuente IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030162; De la Fuente IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027224; De la Fuente IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009484; De la Fuente IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007510; De La Fuente IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003100; De la Fuente IM, 2006, ANN BIOMED ENG, V34, P295, DOI 10.1007/s10439-005-9026-z; De La Fuente IM, 1999, B MATH BIOL, V61, P573, DOI 10.1006/bulm.1999.0103; De la Fuente IM, 1999, BIOSYSTEMS, V50, P83, DOI 10.1016/S0303-2647(98)00094-X; De la Fuente IM, 1998, FRACTALS, V6, P95, DOI 10.1142/S0218348X98000110; de la Fuente IM, 1998, ACTA BIOTHEOR, V46, P37, DOI 10.1023/A:1000899820111; De La Fuente IM, 1998, B MATH BIOL, V60, P689; De la Fuentea IM, 1999, J BIOL SYST, V7, P113, DOI 10.1142/S0218339099000103; DelaFuente IM, 1996, BIOSYSTEMS, V39, P87, DOI 10.1016/0303-2647(95)01603-1; delaFuente IM, 1996, BIOPHYS J, V71, P2375, DOI 10.1016/S0006-3495(96)79431-6; DELAFUENTE IM, 1995, BIOSYSTEMS, V35, P1, DOI 10.1016/0303-2647(94)01473-K; Dussutour A, 2010, P NATL ACAD SCI USA, V107, P4607, DOI 10.1073/pnas.0912198107; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Glick BS, 2007, NAT CELL BIOL, V9, P130, DOI 10.1038/ncb0207-130; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; Goldbeter A., 1990, RYTHMES CHAOS SYSTEM; Goldbeter A, 2007, ADV CHEM PHYS, V135, P253; Gonze D, 2004, INT J QUANTUM CHEM, V98, P228, DOI 10.1002/qua.10875; Gough J, 2009, EUROPEAN SPACE AGENC, V3, P43; Greve A, 2010, HIPPOCAMPUS, V20, P235, DOI 10.1002/hipo.20606; Greve A, 2009, BIOL CYBERN, V100, P11, DOI 10.1007/s00422-008-0275-4; Hertz JA, 2018, INTRO THEORY NEURAL; Hinton G.E., 2007, SCHOLARPEDIA, V2, P1668, DOI 10.4249/scholarpedia.1668; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jennings HS, 1905, BEHAV LOWER ORGANISM; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kappen HJ, 1998, NEURAL COMPUT, V10, P1137, DOI 10.1162/089976698300017386; Karp PD, 2001, SCIENCE, V293, P2040, DOI 10.1126/science.1064621; Kass L, 1996, J PHOTOCH PHOTOBIO B, V35, P105, DOI 10.1016/1011-1344(96)07301-0; Kazachenko VN, 2007, BIOCHEM MOSC SUPPL S, V1, P169, DOI 10.1134/S1990747807020109; Kessler D, 1982, CELL BIOL PHYS DIDYM; KOHONEN T, 1972, IEEE T COMPUT, VC 21, P353, DOI 10.1109/TC.1972.5008975; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Latty T, 2011, P ROY SOC B-BIOL SCI, V278, P539, DOI 10.1098/rspb.2010.1624; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Marro J., 1999, NONEQUILIBRIUM PHASE, DOI 10.1017/CBO9780511524288; de la Fuente IM, 2010, INT J MOL SCI, V11, P3540, DOI 10.3390/ijms11093540; Marwan W, 2010, SCIENCE, V327, P419, DOI 10.1126/science.1185570; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Miyaji T., 2008, INT J PURE APPL MATH, V47, P353; Mogilevskaya E, 2006, J BIOL PHYS, V32, P245, DOI 10.1007/s10867-006-9015-y; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Nakagaki T, 2004, P ROY SOC B-BIOL SCI, V271, P2305, DOI 10.1098/rspb.2004.2856; Nakagaki T, 2004, BIOPHYS CHEM, V107, P1, DOI 10.1016/S0301-4622(03)00189-3; Nakagaki T, 2001, RES MICROBIOL, V152, P767, DOI 10.1016/S0923-2508(01)01259-1; Nakagaki T, 2001, BIOPHYS CHEM, V92, P47, DOI 10.1016/S0301-4622(01)00179-X; Nakagaki T, 2008, SOFT MATTER, V4, P57, DOI 10.1039/b706317m; Nelson L. D., 2004, LEHNINGER PRINCIPLES; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Pang CNI, 2008, PROTEOMICS, V8, P425, DOI 10.1002/pmic.200700801; Peretto P., 1992, INTRO MODELING NEURA; Pershin YV, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021926; Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501; Roudi Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051915; Russell PJ, 2002, IGENETICS, P16; Saigusa T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018101; Sear RP, 2005, J PHYS-CONDENS MAT, V17, pS3587, DOI 10.1088/0953-8984/17/45/052; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Shirakawa T, 2007, BIOPHYS CHEM, V128, P253, DOI 10.1016/j.bpc.2007.04.010; Sidiropoulou K, 2009, NAT NEUROSCI, V12, P190, DOI 10.1038/nn.2245; Stein LD, 2004, NATURE, V431, P915, DOI 10.1038/431915a; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; Thomas MC, 2006, ELEMENTS INFORM THEO; Tsuda S, 2007, BIOSYSTEMS, V87, P215, DOI 10.1016/j.biosystems.2006.09.016; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; UEDA T, 1986, EXP CELL RES, V162, P486, DOI 10.1016/0014-4827(86)90352-6; Van Bogelen RA, 1996, ESCHERICHIA COLI SAL; Viswanathan GM, 1997, BIOPHYS J, V72, P866, DOI 10.1016/S0006-3495(97)78721-6; Weiner JH, 2008, BBA-BIOMEMBRANES, V1778, P1698, DOI 10.1016/j.bbamem.2007.07.020; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Yang CR, 2005, J BIOL CHEM, V280, P11224, DOI 10.1074/jbc.M411471200; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	104	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58284	10.1371/journal.pone.0058284	http://dx.doi.org/10.1371/journal.pone.0058284			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554883	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800011
J	Lee, KM; Ahn, KH				Lee, Kyoung-Min; Ahn, Kyung-Ha			The Frontal Eye Fields Limit the Capacity of Visual Short-Term Memory in Rhesus Monkeys	PLOS ONE			English	Article							WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; INTRAPARIETAL SULCUS; NEURAL ACTIVITY; INACTIVATION; ATTENTION; RESOURCES; STORAGE; TARGET; SHIFTS	The frontal eye fields (FEF) in rhesus monkeys have been implicated in visual short-term memory (VSTM) as well as control of visual attention. Here we examined the importance of the area in the VSTM capacity and the relationship between VSTM and attention, using the chemical inactivation technique and multi-target saccade tasks with or without the need of target-location memory. During FEF inactivation, serial saccades to targets defined by color contrast were unaffected, but saccades relying on short-term memory were impaired when the target count was at the capacity limit of VSTM. The memory impairment was specific to the FEF-coded retinotopic locations, and subject to competition among targets distributed across visual fields. These results together suggest that the FEF plays a crucial role during the entry of information into VSTM, by enabling attention deployment on targets to be remembered. In this view, the memory capacity results from the limited availability of attentional resources provided by FEF: The FEF can concurrently maintain only a limited number of activations to register the targets into memory. When lesions render part of the area unavailable for activation, the number would decrease, further reducing the capacity of VSTM.	[Lee, Kyoung-Min; Ahn, Kyung-Ha] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital	Lee, KM (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.	kminlee@snu.ac.kr			National Research Foundation of Republic of Korea [800-20100003, 800-20110005]	National Research Foundation of Republic of Korea(National Research Foundation of Korea)	Supported by a grant from the National Research Foundation of Republic of Korea (Grants No. 800-20100003 and 800-20110005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; Alvarez GA, 2012, J VISION, V12, DOI 10.1167/12.5.9; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bays PM, 2007, NEUROREPORT, V18, P1207, DOI 10.1097/WNR.0b013e328244e6c3; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buschman TJ, 2011, P NATL ACAD SCI USA, V108, P11252, DOI 10.1073/pnas.1104666108; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N, 2009, SCIENCE, V323, DOI 10.1126/science.1166478; Dias EC, 1995, J NEUROPHYSIOL, V74, P2744, DOI 10.1152/jn.1995.74.6.2744; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; Elmore LC, 2011, CURR BIOL, V21, P975, DOI 10.1016/j.cub.2011.04.031; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Harrison A, 2010, CEREB CORTEX, V20, P2478, DOI 10.1093/cercor/bhp314; Heyselaar E, 2011, J VISION, V11, DOI 10.1167/11.3.11; Inoue M, 2004, CEREB CORTEX, V14, P106, DOI 10.1093/cercor/bhg109; Keller EL, 2008, J NEUROPHYSIOL, V100, P2726, DOI 10.1152/jn.90673.2008; Lara AH, 2012, J VISION, V12, DOI 10.1167/12.3.13; Lee KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039886; Lu ZL, 2005, P NATL ACAD SCI USA, V102, P1797, DOI 10.1073/pnas.0408402102; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Monosov IE, 2009, J NEUROPHYSIOL, V102, P3656, DOI 10.1152/jn.00750.2009; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Offen S, 2010, J VISION, V10, DOI 10.1167/10.11.28; Pisella L, 2004, NEUROSCI BIOBEHAV R, V28, P181, DOI 10.1016/j.neubiorev.2004.03.003; Rouder JN, 2008, P NATL ACAD SCI USA, V105, P5975, DOI 10.1073/pnas.0711295105; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Sommer MA, 1997, EXP BRAIN RES, V116, P229, DOI 10.1007/PL00005752; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Umemoto A, 2010, COGNITION, V117, P69, DOI 10.1016/j.cognition.2010.07.001; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P8780, DOI 10.1073/pnas.1117465109; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Wardak C, 2010, CEREB CORTEX, V20, P2464, DOI 10.1093/cercor/bhp315; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Wright AA, 2007, J EXP ANAL BEHAV, V88, P405, DOI 10.1901/jeab.2007.88-405; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	45	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59606	10.1371/journal.pone.0059606	http://dx.doi.org/10.1371/journal.pone.0059606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555049	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800105
J	Li, YX; Wang, XY; Zheng, HY; Wang, CY; Minvielle, S; Magrangeas, F; Avet-Loiseau, H; Shah, PK; Zhang, Y; Munshi, NC; Li, C				Li, Yingxiang; Wang, Xujun; Zheng, Haiyang; Wang, Chengyang; Minvielle, Stephane; Magrangeas, Florence; Avet-Loiseau, Herve; Shah, Parantu K.; Zhang, Yong; Munshi, Nikhil C.; Li, Cheng			Classify Hyperdiploidy Status of Multiple Myeloma Patients Using Gene Expression Profiles	PLOS ONE			English	Article							PROBE LEVEL; ABNORMALITIES; PATHOGENESIS; PREDICTION; ANEUPLOIDY; PROGNOSIS	Multiple myeloma (MM) is a cancer of antibody-making plasma cells. It frequently harbors alterations in DNA and chromosome copy numbers, and can be divided into two major subtypes, hyperdiploid (HMM) and non-hyperdiploid multiple myeloma (NHMM). The two subtypes have different survival prognosis, possibly due to different but converging paths to oncogenesis. Existing methods for identifying the two subtypes are fluorescence in situ hybridization (FISH) and copy number microarrays, with increased cost and sample requirements. We hypothesize that chromosome alterations have their imprint in gene expression through dosage effect. Using five MM expression datasets that have HMM status measured by FISH and copy number microarrays, we have developed and validated a K-nearest-neighbor method to classify MM into HMM and NHMM based on gene expression profiles. Classification accuracy for test datasets ranges from 0.83 to 0.88. This classification will enable researchers to study differences and commonalities of the two MM subtypes in disease biology and prognosis using expression datasets without need for additional subtype measurements. Our study also supports the advantages of using cancer specific characteristics in feature design and pooling multiple rounds of classification results to improve accuracy. We provide R source code and processed datasets at www.ChengLiLab.org/software.	[Li, Yingxiang; Wang, Xujun; Zheng, Haiyang; Wang, Chengyang; Zhang, Yong; Li, Cheng] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Minvielle, Stephane; Magrangeas, Florence; Avet-Loiseau, Herve] Univ Nantes, Unite Mixte Genom Canc, Ctr Hosp Univ Nantes, Inserm UMR892,CNRS 6299, Nantes, France; [Shah, Parantu K.; Li, Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Shah, Parantu K.; Li, Cheng] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Munshi, Nikhil C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Munshi, Nikhil C.] Harvard Univ, Sch Med, Boston, MA USA; [Munshi, Nikhil C.] Boston VA Healthcare Syst, Boston, MA USA	Tongji University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Li, C (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China.	lch3000@gmail.com	Munshi, Nikhil/ABE-2338-2021; Zhang, Yong/B-4838-2011; Magrangeas, Florence/L-3080-2015; Minvielle, Stéphane/K-8251-2015; Avet-Loiseau, Herve/P-8872-2014	Zhang, Yong/0000-0001-6316-2734; Avet-Loiseau, Herve/0000-0002-3050-0140; Minvielle, Stephane/0000-0003-1389-312X; wang, xujun/0000-0002-7152-611X; Magrangeas, Florencce/0000-0002-5031-3748	National Basic Research Program of China (973 Program) [2010CB944904]; National Institutes of Health (NIH) [R01 GM077122]; NIH [RO1-124929, PO1-155258, P50-100007, PO1-78378]; Dept. of Veterans Affairs Merit Review Awards; Claudia Adams Barr Program in Innovative Basic Cancer Research; Multiple Myeloma Career Development Award; French National Research Agency [R08079NS]; NATIONAL CANCER INSTITUTE [P50CA100707, P01CA155258, P01CA078378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077122] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs Merit Review Awards(US Department of Veterans Affairs); Claudia Adams Barr Program in Innovative Basic Cancer Research; Multiple Myeloma Career Development Award; French National Research Agency(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Research Program of China (973 Program; No. 2010CB944904) (YL, XW, HZ, CW, YZ) and National Institutes of Health (NIH) R01 GM077122 (CL). This work was also supported in part by NIH grants RO1-124929, PO1-155258, P50-100007 and PO1-78378 to NCM and CL and from the Dept. of Veterans Affairs Merit Review Awards to NCM. PKS was supported by Claudia Adams Barr Program in Innovative Basic Cancer Research and the Multiple Myeloma Career Development Award. SM and FM were supported by French National Research Agency, Grant R08079NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli L, 2007, BRIT J HAEMATOL, V136, P565, DOI 10.1111/j.1365-2141.2006.06467.x; Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Avet-Loiseau H, 2009, J CLIN ONCOL, V27, P4585, DOI 10.1200/JCO.2008.20.6136; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Chng WJ, 2006, GENE CHROMOSOME CANC, V45, P1111, DOI 10.1002/gcc.20375; Debes-Marun CS, 2003, LEUKEMIA, V17, P427, DOI 10.1038/sj.leu.2402797; Fassas ABT, 2002, BRIT J HAEMATOL, V118, P1041, DOI 10.1046/j.1365-2141.2002.03757.x; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hertzberg L, 2007, GENE CHROMOSOME CANC, V46, P75, DOI 10.1002/gcc.20391; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Mohamed AN, 2007, AM J HEMATOL, V82, P1080, DOI 10.1002/ajh.20998; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ripley BD, 2008, PATTERN RECOGNITION; Smadja NV, 1998, LEUKEMIA, V12, P960, DOI 10.1038/sj.leu.2401041; Venebles WN, 1994, MODERN APPL STAT S P; Zhou YM, 2012, BLOOD, V119, pE148, DOI 10.1182/blood-2011-10-388702	22	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58809	10.1371/journal.pone.0058809	http://dx.doi.org/10.1371/journal.pone.0058809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554930	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800032
J	Kuprys, PV; Davis, SM; Hauer, TM; Meltser, M; Tzfati, Y; Kirk, KE				Kuprys, Paulius V.; Davis, Shaun M.; Hauer, Tyler M.; Meltser, Max; Tzfati, Yehuda; Kirk, Karen E.			Identification of Telomerase RNAs from Filamentous Fungi Reveals Conservation with Vertebrates and Yeasts	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERASE; TEMPLATE BOUNDARY DEFINITION; SECONDARY STRUCTURE; ASPERGILLUS-NIDULANS; REVERSE-TRANSCRIPTASE; BUDDING YEAST; TRIPLE-HELIX; SEQUENCE; BINDING; TETRAHYMENA	Telomeres are the nucleoprotein complexes at eukaryotic chromosomal ends. Telomeric DNA is synthesized by the ribonucleoprotein telomerase, which comprises a telomerase reverse transcriptase (TERT) and a telomerase RNA (TER). TER contains a template for telomeric DNA synthesis. Filamentous fungi possess extremely short and tightly regulated telomeres. Although TERT is well conserved between most organisms, TER is highly divergent and thus difficult to identify. In order to identify the TER sequence, we used the unusually long telomeric repeat sequence of Aspergillus oryzae together with reverse-transcription-PCR and identified a transcribed sequence that contains the potential template within a region predicted to be single stranded. We report the discovery of TERs from twelve other related filamentous fungi using comparative genomic analysis. These TERs exhibited strong conservation with the vertebrate template sequence, and two of these potentially use the identical template as humans. We demonstrate the existence of important processing elements required for the maturation of yeast TERs such as an Sm site, a 5' splice site and a branch point, within the newly identified TER sequences. RNA folding programs applied to the TER sequences show the presence of secondary structures necessary for telomerase activity, such as a yeast-like template boundary, pseudoknot, and a vertebrate-like three-way junction. These telomerase RNAs identified from filamentous fungi display conserved structural elements from both yeast and vertebrate TERs. These findings not only provide insights into the structure and evolution of a complex RNA but also provide molecular tools to further study telomere dynamics in filamentous fungi.	[Kuprys, Paulius V.; Davis, Shaun M.; Hauer, Tyler M.; Meltser, Max; Kirk, Karen E.] Lake Forest Coll, Dept Biol, Lake Forest, IL 60045 USA; [Tzfati, Yehuda] Hebrew Univ Jerusalem, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Tzfati, Y (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	tzfati@cc.huji.ac.il; kirk@lakeforest.edu		Tzfati, Yehuda/0000-0001-7720-435X	National Science Foundation [MCB 0950957]; United States-Israel Binational Science Foundation [2009204]	National Science Foundation(National Science Foundation (NSF)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by a National Science Foundation grant MCB 0950957 (www.nsf.gov) to Karen E. Kirk and a United States-Israel Binational Science Foundation grant 2009204 (http://www.bsf.org.il) to Yehuda Tzfati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; AUTEXIER C, 1994, GENE DEV, V8, P563, DOI 10.1101/gad.8.5.563; Berman AJ, 2011, NAT STRUCT MOL BIOL, V18, P1371, DOI 10.1038/nsmb.2174; Bhattacharyya A, 1997, NUCLEIC ACIDS RES, V25, P1426, DOI 10.1093/nar/25.7.1426; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blackburn EH, 2011, COLD SPRING HARBOR P, V3; Bley CJ, 2011, P NATL ACAD SCI USA, V108, P20333, DOI 10.1073/pnas.1100270108; Box JA, 2008, NATURE, V456, P910, DOI 10.1038/nature07584; Brevet V, 2003, EMBO J, V22, P1697, DOI 10.1093/emboj/cdg155; Brown Y, 2007, NUCLEIC ACIDS RES, V35, P6280, DOI 10.1093/nar/gkm713; Chang PK, 2010, INT J FOOD MICROBIOL, V138, P189, DOI 10.1016/j.ijfoodmicro.2010.01.033; Chang PK, 2005, FUNGAL GENET BIOL, V42, P914, DOI 10.1016/j.fgb.2005.07.004; Chapon C, 1997, RNA, V3, P1337; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Chen JL, 2002, NUCLEIC ACIDS RES, V30, P592, DOI 10.1093/nar/30.2.592; Cifuentes-Rojas C, 2011, P NATL ACAD SCI USA, V108, P73, DOI 10.1073/pnas.1013021107; Dandjinou AT, 2004, CURR BIOL, V14, P1148, DOI 10.1016/j.cub.2004.05.054; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Futagami T, 2011, EUKARYOT CELL, V10, P1586, DOI 10.1128/EC.05224-11; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gavory G, 2002, NUCLEIC ACIDS RES, V30, P4470, DOI 10.1093/nar/gkf575; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Gunisova S, 2009, RNA, V15, P546, DOI 10.1261/rna.1194009; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; JONES MH, 1990, EMBO J, V9, P2555, DOI 10.1002/j.1460-2075.1990.tb07436.x; Kabaha MA, 2008, MOL CELL BIOL, V28, P1875, DOI 10.1128/MCB.01683-07; Kachouri-Lafond R, 2009, FEBS LETT, V583, P3605, DOI 10.1016/j.febslet.2009.10.034; Koering CE, 2000, NUCLEIC ACIDS RES, V28, P2519, DOI 10.1093/nar/28.13.2519; Kusumoto KI, 2003, APPL MICROBIOL BIOT, V61, P247, DOI 10.1007/s00253-002-1193-3; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Lin J, 2004, P NATL ACAD SCI USA, V101, P14713, DOI 10.1073/pnas.0405879101; LINGNER J, 1994, GENE DEV, V8, P1984, DOI 10.1101/gad.8.16.1984; Liu F, 2012, RNA, V18, P973, DOI 10.1261/rna.030924.111; LIU ZP, 1991, GENE DEV, V5, P49, DOI 10.1101/gad.5.1.49; Lue NF, 2010, TRENDS BIOCHEM SCI, V35, P8, DOI 10.1016/j.tibs.2009.08.006; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Mason DX, 2003, MOL CELL BIOL, V23, P5606, DOI 10.1128/MCB.23.16.5606-5613.2003; McCormickGraham M, 1996, MOL CELL BIOL, V16, P1871; MCCORMICKGRAHAM M, 1995, NUCLEIC ACIDS RES, V23, P1091, DOI 10.1093/nar/23.7.1091; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; Mitchell M, 2010, NAT STRUCT MOL BIOL, V17, P513, DOI 10.1038/nsmb.1777; Moon IK, 2007, FRONT BIOSCI, V12, P4595, DOI 10.2741/2412; Moriarty TJ, 2004, MOL CELL BIOL, V24, P3720, DOI 10.1128/MCB.24.9.3720-3733.2004; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Payne GA, 2006, MED MYCOL, V44, pS9, DOI 10.1080/13693780600835716; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Qi XD, 2013, NUCLEIC ACIDS RES, V41, P450, DOI 10.1093/nar/gks980; Qi XD, 2012, EMBO J, V31, P150, DOI 10.1038/emboj.2011.363; Qiao F, 2008, NAT STRUCT MOL BIOL, V15, P634, DOI 10.1038/nsmb.1420; ROMERO DP, 1991, CELL, V67, P343, DOI 10.1016/0092-8674(91)90186-3; Sato A, 2011, DNA RES, V18, P165, DOI 10.1093/dnares/dsr009; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Shefer K, 2007, MOL CELL BIOL, V27, P2130, DOI 10.1128/MCB.01826-06; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Takahashi T, 2006, BIOSCI BIOTECH BIOCH, V70, P135, DOI 10.1271/bbb.70.135; Tang W, 2012, NATURE, V484, P260, DOI 10.1038/nature10924; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tzfati Y, 2000, SCIENCE, V288, P863, DOI 10.1126/science.288.5467.863; Tzfati Y, 2003, GENE DEV, V17, P1779, DOI 10.1101/gad.1099403; Tzfati Y, 2012, TELOMERASES CHEM BIO; Ulyanov NB, 2007, NUCLEIC ACIDS RES, V35, P6150, DOI 10.1093/nar/gkm660; Underwood DH, 2004, MOL CELL BIOL, V24, P912, DOI 10.1128/MCB.24.2.912-923.2004; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Wang ZR, 2009, MOL CELL BIOL, V29, P5389, DOI 10.1128/MCB.00528-09; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354; Wortman JR, 2009, FUNGAL GENET BIOL, V46, pS2, DOI 10.1016/j.fgb.2008.12.003; Ye AJ, 2002, INT J SYST EVOL MICR, V52, P2297, DOI 10.1099/00207713-52-6-2297; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	79	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58661	10.1371/journal.pone.0058661	http://dx.doi.org/10.1371/journal.pone.0058661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23555591	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400045
J	Leinonen, JV; Emanuelov, AK; Platt, Y; Helman, Y; Feinberg, Y; Lotan, C; Beeri, R				Leinonen, Jussi V.; Emanuelov, Avishag K.; Platt, Yardanna; Helman, Yaron; Feinberg, Yael; Lotan, Chaim; Beeri, Ronen			Left Atrial Appendages from Adult Hearts Contain a Reservoir of Diverse Cardiac Progenitor Cells	PLOS ONE			English	Article							STEM-CELLS; BONE-MARROW; PRESSURE-OVERLOAD; THERAPY; CARDIOMYOCYTES; REGENERATION; MULTIPOTENT; EXPRESSION; DISEASE; ORIGIN	Aims: There is strong evidence supporting the claim that endogenous cardiac progenitor cells (CPCs) are key players in cardiac regeneration, but the anatomic source and phenotype of the master cardiac progenitors remains uncertain. Our aim was to investigate the different cardiac stem cell populations in the left atrial appendage (LAA) and their fates. Methods and Results: We investigated the CPC content and profile of adult murine LAAs using immunohistochemistry and flow cytometry. We demonstrate that the LAA contains a large number of CPCs relative to other areas of the heart, representing over 20% of the total cell number. We grew two distinct CPC populations from the LAA by varying the degree of proteolysis. These differed by their histological location, surface marker profiles and growth dynamics. Specifically, CD45(pos) cells grew with milder proteolysis, while CD45(neg) cells grew mainly with more intense proteolysis. Both cell types could be induced to differentiate into cells with cardiomyocyte markers and organelles, albeit by different protocols. Many CD45(pos) cells expressed CD45 initially and rapidly lost its expression while differentiating. Conclusions: Our results demonstrate that the left atrial appendage plays a role as a reservoir of multiple types of progenitor cells in murine adult hearts. Two different types of CPCs were isolated, differing in their epicardial-myocardial localization. Considering studies demonstrating layer-specific origins of different cardiac progenitor cells, our findings may shed light on possible pathways to study and utilize the diversity of endogenous progenitor cells in the adult heart.	[Leinonen, Jussi V.; Emanuelov, Avishag K.; Platt, Yardanna; Helman, Yaron; Feinberg, Yael; Lotan, Chaim; Beeri, Ronen] Hadassah Hebrew Univ Med Ctr, Inst Heart, Cardiovasc Res Ctr, Jerusalem, Israel	Hebrew University of Jerusalem	Beeri, R (corresponding author), Hadassah Hebrew Univ Med Ctr, Inst Heart, Cardiovasc Res Ctr, Jerusalem, Israel.	rbeeri@hadassah.org.il	Beeri, Ronen/A-4035-2009	Beeri, Ronen/0000-0002-8014-0702	US-Israel Binational Science Foundation [2005250]; NIH/NHLBI [R01HL072265]; Finnish Foundation for Cardiovascular Research, Helsinki, Finland; Foundation of Jorma and Martha Sihvola, Lahti, Finland; USAID's American Schools and Hospitals Abroad (ASHA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072265] Funding Source: NIH RePORTER	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Finnish Foundation for Cardiovascular Research, Helsinki, Finland; Foundation of Jorma and Martha Sihvola, Lahti, Finland; USAID's American Schools and Hospitals Abroad (ASHA)(United States Agency for International Development (USAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant 2005250, from the US-Israel Binational Science Foundation (www.BSF.org.il) and grant R01HL072265 from NIH/NHLBI (to Dr Beeri- sub contract)(www.nhlbi.nih.gov). Dr Leinonen was supported by a grant from Finnish Foundation for Cardiovascular Research, Helsinki, Finland (www.sydantutkimussaatio.fi)and Foundation of Jorma and Martha Sihvola, Lahti, Finland (no website). Program for upgrading the Flow Cytometry laboratory in the Core Research Facility of the Hebrew University of Jerusalem was supported by a grant from USAID's American Schools and Hospitals Abroad (ASHA)(www.usaid.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Angert D, 2011, CIRC RES, V108, P1226, DOI 10.1161/CIRCRESAHA.110.239046; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Douglas YL, 2006, AM J CARDIOL, V97, P662, DOI 10.1016/j.amjcard.2005.11.019; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Gambini E, 2011, CARDIOVASC RES, V89, P362, DOI 10.1093/cvr/cvq292; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Itzhaki-Alfia A, 2009, CIRCULATION, V120, P2559, DOI 10.1161/CIRCULATIONAHA.109.849588; Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Moorman A, 2003, HEART, V89, P806, DOI 10.1136/heart.89.7.806; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Pouly J, 2008, J THORAC CARDIOV SUR, V135, P673, DOI 10.1016/j.jtcvs.2007.10.024; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; Rosenblatt-Velin N, 2012, FASEB J, V26, P229, DOI 10.1096/fj.11-189605; Sandstedt J, 2010, BASIC RES CARDIOL, V105, P545, DOI 10.1007/s00395-010-0088-1; Shivtiel S, 2008, J EXP MED, V205, P2381, DOI 10.1084/jem.20080072; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Sturzu AC, 2011, CIRC RES, V108, P353, DOI 10.1161/CIRCRESAHA.110.227066; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; VLIEGEN HW, 1991, EUR HEART J, V12, P488, DOI 10.1093/oxfordjournals.eurheartj.a059928; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	34	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59228	10.1371/journal.pone.0059228	http://dx.doi.org/10.1371/journal.pone.0059228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555001	Green Submitted, Green Published, gold			2022-12-25	WOS:000316252500074
J	Natividad, KDT; Junankar, SR; Redzwan, NM; Nair, R; Wirasinha, RC; King, C; Brink, R; Swarbrick, A; Batten, M				Natividad, Karlo D. T.; Junankar, Simon R.; Redzwan, Norhanani Mohd; Nair, Radhika; Wirasinha, Rushika C.; King, Cecile; Brink, Robert; Swarbrick, Alexander; Batten, Marcel			Interleukin-27 Signaling Promotes Immunity against Endogenously Arising Murine Tumors	PLOS ONE			English	Article							REGULATORY T-CELLS; CUTTING EDGE; COMPLETE REGRESSION; ADAPTIVE IMMUNITY; TH1 RESPONSES; IL-27; ANTITUMOR; BIOLOGY; BET; CARCINOGENESIS	Interleukin-27 (IL-27) is a pleiotropic cytokine but its immunosuppressive effects predominate during many in vivo immunological challenges. Despite this, evidence from tumor cell line transfer models suggested that IL-27 could promote immune responses in the tumor context. However, the role of IL-27 in immunity against tumors that develop in situ and in tumor immunosurveillance remain undefined. In this study, we demonstrate that tumor development and growth are accelerated in IL-27 receptor alpha (Il27ra)-deficient mice. Enhanced tumor growth in both carcinogen-induced fibrosarcoma and oncogene-driven mammary carcinoma was associated with decreased interferon-gamma production by CD4 and CD8 T cells and increased numbers of regulatory T-cells (T-reg). This is the first study to show that IL-27 promotes protective immune responses against endogenous tumors, which is critical as the basis for future development of an IL-27 based therapeutic agent.	[Natividad, Karlo D. T.; Redzwan, Norhanani Mohd; Wirasinha, Rushika C.; King, Cecile; Brink, Robert; Batten, Marcel] Garvan Inst Med Res, Immunol Dis Div, Sydney, NSW, Australia; [Junankar, Simon R.; Nair, Radhika; Swarbrick, Alexander] Garvan Inst Med Res, Canc Div, Sydney, NSW, Australia; [King, Cecile; Brink, Robert; Swarbrick, Alexander; Batten, Marcel] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia	Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney	Batten, M (corresponding author), Garvan Inst Med Res, Immunol Dis Div, Sydney, NSW, Australia.	m.batten@garvan.org.au	Junankar, Simon/B-7677-2019; Swarbrick, Alexander/E-6107-2010; Brink, Robert/B-7910-2010; Junankar, Simon/O-2009-2019; King, Cecile/Q-9794-2019	Swarbrick, Alexander/0000-0002-3051-5676; Brink, Robert/0000-0002-9586-3655; Junankar, Simon/0000-0002-3965-8278; King, Cecile/0000-0003-2193-2563; Mohd Redzwan, Norhanani/0000-0002-5710-4009; Nair, Radhika/0000-0002-6585-3384; Batten, Marcel/0000-0002-3726-3790; Wirasinha, Rushika/0000-0002-2839-2697	National Health and Medical Research Council, Australia [APP1031277]; Cancer Institute New South Wales [08ECF110]; National Breast Cancer Foundation Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales; National Breast Cancer Foundation Australia	M.B. is the recipient of a Career Development Fellowship (APP1031277) from the National Health and Medical Research Council (http://www.nhmrc.gov.au/), Australia. This work was also supported by an Early Career Fellowship (M. B.; 08ECF110) from the Cancer Institute New South Wales (http://www.cancerinstitute.org.au/). A. S. is the recipient of an Early Career Fellowship from the National Breast Cancer Foundation Australia (http://www.nbcf.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2004, J IMMUNOL, V172, P4672, DOI 10.4049/jimmunol.172.8.4672; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; Elkord E, 2010, EXPERT OPIN BIOL TH, V10, P1573, DOI 10.1517/14712598.2010.529126; Emtage PCR, 1999, HUM GENE THER, V10, P697, DOI 10.1089/10430349950018463; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Honda K, 2005, INFLAMM BOWEL DIS, V11, P1044, DOI 10.1097/01.MIB.0000191611.05466.1f; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Mayer KD, 2008, J IMMUNOL, V180, P693, DOI 10.4049/jimmunol.180.2.693; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Putzer BM, 1998, HUM GENE THER, V9, P707, DOI 10.1089/hum.1998.9.5-707; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Ruffell B, 2010, CYTOKINE GROWTH F R, V21, P3, DOI 10.1016/j.cytogfr.2009.11.002; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; Salcedo R, 2009, J IMMUNOL, V182, P4328, DOI 10.4049/jimmunol.0800471; Schreiber TH, 2009, BRIT J CANCER, V101, P381, DOI 10.1038/sj.bjc.6605198; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Shinozaki Y, 2009, INT J CANCER, V124, P1372, DOI 10.1002/ijc.24107; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tao YP, 2012, J CANC RES CLIN ONCO; Teng MWL, 2010, CANCER RES, V70, P7800, DOI 10.1158/0008-5472.CAN-10-1681; Teng MWL, 2010, CANCER RES, V70, P2665, DOI 10.1158/0008-5472.CAN-09-1574; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Welm AL, 2005, P NATL ACAD SCI USA, V102, P4324, DOI 10.1073/pnas.0500470102; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshimoto T, 2008, J IMMUNOL, V180, P6527, DOI 10.4049/jimmunol.180.10.6527; Zahn S, 2005, EUR J IMMUNOL, V35, P1106, DOI 10.1002/eji.200425926; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482	50	18	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57469	10.1371/journal.pone.0057469	http://dx.doi.org/10.1371/journal.pone.0057469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554861	Green Submitted, gold, Green Published			2022-12-25	WOS:000316252500003
J	Tofteland, S; Naseer, U; Lislevand, JH; Sundsfjord, A; Samuelsen, O				Tofteland, Stale; Naseer, Umaer; Lislevand, Jan Helge; Sundsfjord, Arnfinn; Samuelsen, Orjan			A Long-Term Low-Frequency Hospital Outbreak of KPC-Producing Klebsiella pneumoniae Involving Intergenus Plasmid Diffusion and a Persisting Environmental Reservoir	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; HYDROLYZING BETA-LACTAMASE; SEQUENCE TYPE 258; ESCHERICHIA-COLI; MOLECULAR EPIDEMIOLOGY; RESISTANT-KLEBSIELLA; RISK-FACTORS; CARBAPENEM RESISTANCE; ENTEROBACTER-CLOACAE; STRAIN	Background: To study the molecular characteristics of a long-term, low frequency outbreak of bla(KPC-2) in a low prevalence setting involving the hospital environment. Methodology/Principal Findings: KPC-producing bacteria were screened by selective chromogenic agar and Real-Time PCR. The presence of antibiotic resistance genes was ascribed by PCRs and subsequent sequencing, and the KPC-producing isolates were phylogenetically typed using PFGE and multi-locus sequence typing. Bla(KPC-2)-plasmids were identified and analysed by S1-nuclease-PFGE hybridization and PCR based replicon typing. A similar to 97 kb IncFII plasmid was seen to carry bla(KPC-2) in all of the clinical isolates, in one of the isolates recovered from screened patients (1/136), and in the Klebsiella pneumoniae and Enterobacter asburiae isolates recovered from the environment (sinks) in one intensive care unit. The K. pneumoniae strain ST258 was identified in 6 out of 7 patients. An intergenus spread to E. asburiae and an interspecies spread to two different K. pneumoniae clones (ST27 and ST461) of the bla(KPC-2) plasmid was discovered. K. pneumoniae ST258 and genetically related E. asburiae strains were found in isolates of both human and environmental origins. Conclusions/Significance: We document a clonal transmission of the K. pneumoniae ST258 strain, and an intergenus plasmid diffusion of the IncFII plasmid carrying bla(KPC-2) in this outbreak. A major reservoir in the patient population could not be unveiled. However, the identification of a persisting environmental reservoir of strains with molecular determinants linked to human isolates, suggests a possible role of the environment in the maintenance of this long-term outbreak.	[Tofteland, Stale; Lislevand, Jan Helge] Sorlandet Hosp HF, Dept Clin Microbiol, Kristiansand, Norway; [Naseer, Umaer; Sundsfjord, Arnfinn; Samuelsen, Orjan] Univ Hosp North Norway, Dept Microbiol & Infect Control, Reference Ctr Detect Antimicrobial Resistance, Tromso, Norway; [Naseer, Umaer; Sundsfjord, Arnfinn] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Res Grp Host Microbe Interact, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Tofteland, S (corresponding author), Sorlandet Hosp HF, Dept Clin Microbiol, Kristiansand, Norway.	staale.tofteland@sshf.no	Sundsfjord, Arnfinn/F-9668-2018; Samuelsen, Ørjan/K-9068-2019	Sundsfjord, Arnfinn/0000-0002-3728-2270; Samuelsen, Ørjan/0000-0002-5525-2614	SArlandet Hospital HF; Northern Norway Regional Health Authority Medical Research Programme	SArlandet Hospital HF; Northern Norway Regional Health Authority Medical Research Programme	The study was supported by a fellowship from SArlandet Hospital HF and a research grant from the Northern Norway Regional Health Authority Medical Research Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LN, 2011, ANTIMICROB AGENTS CH, V55, P3579, DOI 10.1128/AAC.01783-10; Bagattini M, 2006, J ANTIMICROB CHEMOTH, V57, P979, DOI 10.1093/jac/dkl077; Baraniak A, 2011, ANTIMICROB AGENTS CH, V55, P5493, DOI 10.1128/AAC.05118-11; Bennett JW, 2009, ANTIMICROB AGENTS CH, V53, P292, DOI 10.1128/AAC.00931-08; BINGEN EH, 1993, J CLIN MICROBIOL, V31, P179, DOI 10.1128/JCM.31.2.179-184.1993; Cai JC, 2008, ANTIMICROB AGENTS CH, V52, P2014, DOI 10.1128/AAC.01539-07; Calfee D, 2008, INFECT CONT HOSP EP, V29, P966, DOI 10.1086/590661; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2011, INT J MED MICROBIOL, V301, P654, DOI 10.1016/j.ijmm.2011.09.003; Carattoli A, 2010, J ANTIMICROB CHEMOTH, V65, P2070, DOI 10.1093/jac/dkq269; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Curiao T, 2010, J ANTIMICROB CHEMOTH, V65, P1608, DOI 10.1093/jac/dkq174; Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P5370, DOI 10.1128/AAC.05202-11; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; D'Agata EMC, 1999, J CLIN MICROBIOL, V37, P3065; de Jong EHJ, 2012, 22 EUR C CLIN MICR I; Dominguez MC, 2011, 51 INT C ANT AG CHEM; Falagas ME, 2007, J ANTIMICROB CHEMOTH, V60, P1124, DOI 10.1093/jac/dkm356; Folkehelseinstituttet, 2009, FOR KONTR SPREDN MUL; Hindiyeh M, 2008, J CLIN MICROBIOL, V46, P2879, DOI 10.1128/JCM.00661-08; Hobson RP, 1996, J HOSP INFECT, V33, P249, DOI 10.1016/S0195-6701(96)90011-0; Hota S, 2009, INFECT CONT HOSP EP, V30, P25, DOI 10.1086/592700; Hussein K, 2009, INFECT CONT HOSP EP, V30, P666, DOI 10.1086/598244; Kac G, 2004, INFECT CONT HOSP EP, V25, P852, DOI 10.1086/502308; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Leavitt A, 2010, J ANTIMICROB CHEMOTH, V65, P243, DOI 10.1093/jac/dkp417; Lowe C, 2012, EMERG INFECT DIS, V18, P1242, DOI 10.3201/eid1808.111268; Lucet JC, 1996, CLIN INFECT DIS, V22, P430, DOI 10.1093/clinids/22.3.430; Mataseje LF, 2011, J ANTIMICROB CHEMOTH, V66, P1273, DOI 10.1093/jac/dkr092; Mathers AJ, 2011, MBIO, V2, DOI 10.1128/mBio.00204-11; Navon-Venezia S, 2006, ANTIMICROB AGENTS CH, V50, P3098, DOI 10.1128/AAC.00438-06; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pena C, 1998, ANTIMICROB AGENTS CH, V42, P53, DOI 10.1128/AAC.42.1.53; Petrella S, 2008, ANTIMICROB AGENTS CH, V52, P3725, DOI 10.1128/AAC.00163-08; Rasheed JK, 2008, J CLIN MICROBIOL, V46, P2066, DOI 10.1128/JCM.02038-07; Samuelsen O, 2009, J ANTIMICROB CHEMOTH, V63, P654, DOI 10.1093/jac/dkp018; Sandegren L, 2012, J ANTIMICROB CHEMOTH, V67, P74, DOI 10.1093/jac/dkr405; Sidjabat HE, 2009, CLIN INFECT DIS, V49, P1736, DOI 10.1086/648077; Skippen I, 2006, J HOSP INFECT, V64, P115, DOI 10.1016/j.jhin.2006.05.010; Souli M, 2010, CLIN INFECT DIS, V50, P364, DOI 10.1086/649865; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; The European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2012, EUCAST CLIN BREAKP T; Velasco C, 2009, J HOSP INFECT, V73, P157, DOI 10.1016/j.jhin.2009.06.013; Wendt C, 2010, EUR J CLIN MICROBIOL, V29, P563, DOI 10.1007/s10096-010-0896-0; Wiener J, 1999, JAMA-J AM MED ASSOC, V281, P517, DOI 10.1001/jama.281.6.517; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zarkotou O, 2010, J CLIN MICROBIOL, V48, P2271, DOI 10.1128/JCM.02301-09	49	78	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59015	10.1371/journal.pone.0059015	http://dx.doi.org/10.1371/journal.pone.0059015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536849	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100111
J	Lyssenko, NN; Nickel, M; Tang, CR; Phillips, MC				Lyssenko, Nicholas N.; Nickel, Margaret; Tang, Chongren; Phillips, Michael C.			Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability	FASEB JOURNAL			English	Article						macrophage reverse cholesterol transport; HDL quality; reconstituted HDL; discoidal HDL	REVERSE CHOLESTEROL TRANSPORT; APOA-I; PLASMA-MEMBRANE; CROSS-LINKING; CARDIOVASCULAR-DISEASE; TANGIER DISEASE; MESSENGER-RNA; HDL PARTICLES; ABCA1 GENE; EFFLUX	Nascent high-density lipoprotein (HDL) particles arise in different sizes. We have sought to uncover factors that control this size heterogeneity. Gel filtration, native PAGE, and protein cross-linking were used to analyze the size heterogeneity of nascent HDL produced by BHK-ABCA1, RAW 264.7, J774, and HepG2 cells under different levels of two factors considered as a ratio, the availability of apolipoprotein AI (apoAI) -accessible cell lipid, and concentration of extracellular lipid-free apoAI. Increases in the available cell lipid:apoAI ratio due to either elevated ATP-binding cassette transporter A1 (ABCA1) expression and activity or raised cell density (i.e., increasing numerator) shifted the production of nascent HDL from smaller particles with fewer apoAI molecules per particle and fewer molecules of choline-phospholipid and cholesterol per apoAI molecule to larger particles that contained more apoAI and more lipid per molecule of apoAI. A further shift to larger particles was observed in BHK-ABCA1 cells when the available cell lipid:apoAI ratio was raised still higher by decreasing the apoAI concentration (i.e., the denominator). These changes in nascent HDL biogenesis were reminiscent of the transition that occurs in the size composition of reconstituted HDL in response to an increasing initial lipid:apoAI molar ratio. Thus, the ratio of available cell lipid:apoAI is a fundamental cause of nascent HDL size heterogeneity, and rHDL formation is a good model of nascent HDL biogenesis.Lyssenko, N. N., Nickel, M., Tang, C., Phillips, M. C. Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability.	[Lyssenko, Nicholas N.; Nickel, Margaret; Phillips, Michael C.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Gastroenterol Hepatol & Nutr,Lipid Res Grp, Philadelphia, PA 19104 USA; [Tang, Chongren] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle	Phillips, MC (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr Ste 1102,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	phillipsmi@email.chop.edu		Phillips, Michael/0000-0002-7147-8007	U.S. National Institutes of Health (NIH) [HL22633]; American Heart Association postdoctoral fellowship [10POST3630047]; NIH National Research Service Award individual postdoctoral fellowship [HL107065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633, F32HL107065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NIH National Research Service Award individual postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank David Nguyen for radiolabeling apoAI and assistance with gas-liquid chromatography, Ginny Kellner-Weibel for assistance with gas-liquid chromatography, Debra K. Shivers and the Tissue Culture Core facility for assistance with cell culture, and Sissel Lund-Katz, Eric Alexander, and Palaniappan Sevugan Chetty for insightful discussions. This research was supported by U.S. National Institutes of Health (NIH) grant HL22633. N.N.L. was supported by an American Heart Association postdoctoral fellowship (10POST3630047) and an NIH National Research Service Award individual postdoctoral fellowship (HL107065).	Alexander ET, 2011, ARTERIOSCL THROM VAS, V31, P320, DOI 10.1161/ATVBAHA.110.216226; ASSMANN G, 1977, J CLIN INVEST, V60, P242, DOI 10.1172/JCI108761; Asztalos BF, 2007, J LIPID RES, V48, P592, DOI 10.1194/jlr.M600403-JLR200; Asztalos BF, 2001, ATHEROSCLEROSIS, V156, P217, DOI 10.1016/S0021-9150(00)00643-2; BELLINI F, 1984, BIOCHIM BIOPHYS ACTA, V777, P209, DOI 10.1016/0005-2736(84)90422-X; Besler C, 2012, EMBO MOL MED, V4, P251, DOI 10.1002/emmm.201200224; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Chisholm JW, 2002, J LIPID RES, V43, P36; Costet P, 2003, MOL CELL BIOL, V23, P7756, DOI 10.1128/MCB.23.21.7756-7766.2003; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Denis M, 2008, J BIOL CHEM, V283, P16178, DOI 10.1074/jbc.M709597200; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; EISENBERG S, 1984, J LIPID RES, V25, P1017; Faulkner LE, 2008, J LIPID RES, V49, P1322, DOI 10.1194/jlr.M800048-JLR200; FORTE TM, 1993, J LIPID RES, V34, P317; Gillotte KL, 1998, J LIPID RES, V39, P1918; GLOMSET JA, 1970, AM J CLIN NUTR, V23, P1129; Graversen JH, 2008, LIPIDS, V43, P467, DOI 10.1007/s11745-008-3169-2; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Haghpassand M, 2001, J CLIN INVEST, V108, P1315, DOI 10.1172/JCI200112810; Hayashi M, 2005, J LIPID RES, V46, P1703, DOI 10.1194/jlr.M500092-JLR200; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Kiss RS, 2003, J BIOL CHEM, V278, P10119, DOI 10.1074/jbc.M300137200; KLANSEK JJ, 1995, J LIPID RES, V36, P2261; Krimbou L, 2005, J LIPID RES, V46, P1668, DOI 10.1194/jlr.M500038-JLR200; Le Goff W, 2006, ARTERIOSCL THROM VAS, V26, P527, DOI 10.1161/01.ATV.0000201042.00725.84; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lin GR, 2000, ATHEROSCLEROSIS, V149, P359, DOI 10.1016/S0021-9150(99)00503-1; Liu LJ, 2003, J BIOL CHEM, V278, P42976, DOI 10.1074/jbc.M308420200; Lund-Katz S, 2010, SUBCELL BIOCHEM, V51, P183, DOI 10.1007/978-90-481-8622-8_7; Lyssenko NN, 2012, BBA-MOL CELL BIOL L, V1821, P456, DOI 10.1016/j.bbalip.2011.07.020; Lyssenko NN, 2011, ARTERIOSCL THROM VAS, V31, P2700, DOI 10.1161/ATVBAHA.111.234906; Massey JB, 2008, BBA-MOL CELL BIOL L, V1781, P245, DOI 10.1016/j.bbalip.2008.03.003; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MILLER GJ, 1980, ANNU REV MED, V31, P97, DOI 10.1146/annurev.me.31.020180.000525; MILLER JCE, 1983, P NATL ACAD SCI-BIOL, V80, P1511, DOI 10.1073/pnas.80.6.1511; Negi S, 2010, J CLIN LIPIDOL, V4, P365, DOI 10.1016/j.jacl.2010.08.008; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; RITTER MC, 1977, J BIOL CHEM, V252, P1208; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; SCANU AM, 1982, CRC CR REV BIOCH MOL, V13, P109, DOI 10.3109/10409238209108711; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Sontag TJ, 2012, J LIPID RES, V53, P951, DOI 10.1194/jlr.M021154; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; SWANEY JB, 1986, METHOD ENZYMOL, V128, P613; SWANEY JB, 1980, J BIOL CHEM, V255, P877; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; TALL AR, 1978, BIOCHIM BIOPHYS ACTA, V513, P185, DOI 10.1016/0005-2736(78)90172-4; Tian SM, 2002, BBA-PROTEINS PROTEOM, V1599, P56, DOI 10.1016/S1570-9639(02)00377-1; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Vaughan AM, 2009, J LIPID RES, V50, P285, DOI 10.1194/jlr.M800366-JLR200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2010, J BIOL CHEM, V285, P31965, DOI 10.1074/jbc.M110.126292; Verghese PB, 2008, ARCH BIOCHEM BIOPHYS, V478, P161, DOI 10.1016/j.abb.2008.07.025; Zheng P, 2001, BBA-MOL CELL BIOL L, V1534, P121, DOI 10.1016/S1388-1981(01)00183-4; ZORICH NL, 1987, BIOCHIM BIOPHYS ACTA, V919, P181, DOI 10.1016/0005-2760(87)90206-2	67	25	25	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2880	2892		10.1096/fj.12-216564	http://dx.doi.org/10.1096/fj.12-216564			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23543682	Green Published			2022-12-25	WOS:000328841000036
J	Chikazawa, M; Otaki, N; Shibata, T; Miyashita, H; Kawai, Y; Maruyama, S; Toyokuni, S; Kitaura, Y; Matsuda, T; Uchida, K				Chikazawa, Miho; Otaki, Natsuki; Shibata, Takahiro; Miyashita, Hiroaki; Kawai, Yoshichika; Maruyama, Shoichi; Toyokuni, Shinya; Kitaura, Yasuyuki; Matsuda, Tsukasa; Uchida, Koji			Multispecificity of Immunoglobulin M Antibodies Raised against Advanced Glycation End Products INVOLVEMENT OF ELECTRONEGATIVE POTENTIAL OF ANTIGENS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PATTERN-RECOGNITION RECEPTORS; OXIDATION-SPECIFIC EPITOPES; LOW-DENSITY-LIPOPROTEIN; CELL-SURFACE PROTEIN; DIABETIC COMPLICATIONS; HUMAN LENS; NATURAL AUTOANTIBODIES; MONOCLONAL-ANTIBODIES; GENE-EXPRESSION	Advanced glycation end products (AGEs) are a heterogeneous and complex group of compounds that are formed when reducing sugars, such as dehydroascorbic acid, react in a nonenzymatic way with amino acids in proteins and other macromolecules. AGEs are prevalent in the diabetic vasculature and contribute to the development of atherosclerosis. The presence and accumulation of AGEs in many different cell types affect the extracellular and intracellular structure and function. In the present study, we studied the immune response to the dehydroascorbic acid-derived AGEs and provide multiple lines of evidence suggesting that the AGEs could be an endogenous source of innate epitopes recognized by natural IgM antibodies. Prominent IgM titers to the AGEs were detected in the sera of normal mice and were significantly accelerated by the immunization with the AGEs. Patients with systemic lupus erythematosus (SLE), a potentially fatal systemic autoimmune disease characterized by the increased production of autoantibodies, showed significantly higher serum levels of the IgM titer against the AGEs than healthy individuals. A progressive increase in the IgM response against the AGEs was also observed in the SLE-prone mice. Strikingly, a subset of monoclonal antibodies, showing a specificity toward the AGEs, prepared from normal mice immunized with the AGEs and from the SLE mice cross-reacted with the double-stranded DNA. Moreover, they also cross-reacted with several other modified proteins, including the acetylated proteins, suggesting that the multiple specificity of the antibodies might be ascribed, at least in part, to the increased electronegative potential of the proteins. These findings suggest that the protein modification by the endogenous carbonyl compounds, generating electronegative proteins, could be a source of multispecific natural antibodies.	[Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan; [Kitaura, Yasuyuki] Nagoya Univ, Grad Sch Bioagr Sci, Lab Nutr Biochem, Nagoya, Aichi 4648601, Japan; [Matsuda, Tsukasa] Nagoya Univ, Grad Sch Bioagr Sci, Lab Mol Bioregulat, Nagoya, Aichi 4648601, Japan; [Maruyama, Shoichi] Nagoya Univ, Grad Sch Med Sci, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Toyokuni, Shinya] Nagoya Univ, Grad Sch Med Sci, Dept Pathol & Biol Responses, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Nagoya University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Toyokuni, Shinya/C-1358-2010; Toyokuni, Shinya/ABE-7714-2021; Shibata, Takahiro/I-6872-2014	Toyokuni, Shinya/0000-0002-5757-1109; Toyokuni, Shinya/0000-0002-5757-1109; Uchida, Koji/0000-0003-3894-5299; Shibata, Takahiro/0000-0003-3194-607X	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the project "Signaling Functions of Reactive Oxygen Species (ROS Signal)," Grants-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area), Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antone SM, 1997, J IMMUNOL, V159, P5422; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Baynes JW., 1989, PROG CLIN BIOL RES, V304, P1; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Chan TM, 2002, J AM SOC NEPHROL, V13, P1219, DOI 10.1097/01.ASN.0000014223.71109.13; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Diaw L, 1997, J IMMUNOL, V158, P968; DUNN JA, 1990, BIOCHEMISTRY-US, V29, P10964, DOI 10.1021/bi00501a014; Engelbertsen D, 2012, J INTERN MED, V271, P82, DOI 10.1111/j.1365-2796.2011.02411.x; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Gronwall C, 2012, CLIN IMMUNOL, V142, P390, DOI 10.1016/j.clim.2012.01.002; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Hartvigsen K, 2009, J LIPID RES, V50, pS388, DOI 10.1194/jlr.R800100-JLR200; Hayakawa K, 2000, CURR OPIN IMMUNOL, V12, P346, DOI 10.1016/S0952-7915(00)00098-4; HOLMBERG D, 1987, EUR J IMMUNOL, V17, P399, DOI 10.1002/eji.1830170315; JACOB L, 1987, P NATL ACAD SCI USA, V84, P2956, DOI 10.1073/pnas.84.9.2956; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kowal C, 1999, EUR J IMMUNOL, V29, P1901, DOI 10.1002/(SICI)1521-4141(199906)29:06<1901::AID-IMMU1901>3.0.CO;2-L; LIMPANASITHIKUL W, 1995, J IMMUNOL, V155, P967; Lindemose S, 2011, NUCLEIC ACIDS RES, V39, P6269, DOI 10.1093/nar/gkr204; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; Nemet I, 2011, J BIOL CHEM, V286, P37128, DOI 10.1074/jbc.M111.245100; PENNELL CA, 1988, J IMMUNOL, V141, P2788; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Shibata T, 2011, J BIOL CHEM, V286, P19943, DOI 10.1074/jbc.M110.187047; Shibayama P, 1999, DIABETES, V48, P1842, DOI 10.2337/diabetes.48.9.1842; Shoenfeld Y, 2005, ARTHRITIS RHEUM, V52, P2599, DOI 10.1002/art.21252; Spatz L, 1997, METHODS, V11, P70, DOI 10.1006/meth.1996.0389; Tessier F, 1999, J BIOL CHEM, V274, P20796, DOI 10.1074/jbc.274.30.20796; THOMPSON KM, 1992, IMMUNOLOGY, V76, P146; Vlassara H, 2001, DIABETES-METAB RES, V17, P436, DOI 10.1002/dmrr.233; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Witte T, 2008, CLIN REV ALLERG IMMU, V34, P345, DOI 10.1007/s12016-007-8046-x; WITZTUM JL, 1984, P NATL ACAD SCI-BIOL, V81, P3204, DOI 10.1073/pnas.81.10.3204; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	42	26	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13204	13214		10.1074/jbc.M113.452177	http://dx.doi.org/10.1074/jbc.M113.452177			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23543734	Green Published, hybrid			2022-12-25	WOS:000318850300007
J	Chan, CS; Jungreis, I; Kellis, M				Chan, Clara S.; Jungreis, Irwin; Kellis, Manolis			Heterologous Stop Codon Readthrough of Metazoan Readthrough Candidates in Yeast	PLOS ONE			English	Article							LUCIFERASE ASSAY SYSTEM; TRANSLATION TERMINATION; DOWNSTREAM; EFFICIENCY; PSI+	Recent analysis of genomic signatures in mammals, flies, and worms indicates that functional translational stop codon readthrough is considerably more abundant in metazoa than previously recognized, but this analysis provides only limited clues about the function or mechanism of readthrough. If an mRNA known to be read through in one species is also read through in another, perhaps these questions can be studied in a simpler setting. With this end in mind, we have investigated whether some of the readthrough genes in human, fly, and worm also exhibit readthrough when expressed in S. cerevisiae. We found that readthrough was highest in a gene with a post stop hexamer known to trigger readthrough, while other metazoan readthrough genes exhibit borderline readthrough in S. cerevisiae.	[Chan, Clara S.] MIT, Dept Biol, Cambridge, MA USA; [Jungreis, Irwin; Kellis, Manolis] MIT, CSAIL, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kellis, M (corresponding author), MIT, CSAIL, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630	NIH [5U54HG004555-03]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004555] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NIH 5U54HG004555-03, which is described here: http://projectreporter.nih.gov/project_info_description.cfm?aid = 7685458. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; Cimino PA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002423; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Keeling KM, 2004, RNA, V10, P691, DOI 10.1261/rna.5147804; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; McNabb DS, 2005, EUKARYOT CELL, V4, P1539, DOI 10.1128/EC.4.9.1539-1549.2005; Namy O, 2001, EMBO REP, V2, P787, DOI 10.1093/embo-reports/kve176; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; Namy O, 2012, COMMUNICATION; Salas-Marco J, 2005, J MOL BIOL, V348, P801, DOI 10.1016/j.jmb.2005.03.025; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; SKUZESKI JM, 1991, J MOL BIOL, V218, P365, DOI 10.1016/0022-2836(91)90718-L; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991	18	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59450	10.1371/journal.pone.0059450	http://dx.doi.org/10.1371/journal.pone.0059450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544069	Green Submitted, Green Published, gold			2022-12-25	WOS:000317480700030
J	Eraud, C; Riviere, M; Lormee, H; Fox, JW; Ducamp, JJ; Boutin, JM				Eraud, Cyril; Riviere, Marcel; Lormee, Herve; Fox, James W.; Ducamp, Jean-Jacques; Boutin, Jean-Marie			Migration Routes and Staging Areas of Trans-Saharan Turtle Doves Appraised from Light-Level Geolocators	PLOS ONE			English	Article							STREPTOPELIA-TURTUR; POPULATION-DYNAMICS; SONGBIRD MIGRATION; BREEDING ECOLOGY; LESSER KESTRELS; SURVIVAL RATES; TRACKING; CICONIA; LONG; MOVEMENTS	The identification of migration routes, wintering grounds and stopover sites are crucial issues for the understanding of the Palearctic-African bird migration system as well as for the development of relevant conservation strategies for trans-Saharan migrants. Using miniaturized light-level geolocators we report a comprehensive and detailed year round track of a granivorous trans-Saharan migrant, the European Turtle Dove (Streptopelia turtur). From five recovered loggers, our data provide new insights on migratory journeys and winter destinations of Turtle Doves originating from a breeding population in Western France. Data confirm that Turtle Doves wintered in West Africa. The main wintering area encompassed Western Mali the Inner Delta Niger and the Malian/Mauritanian border. Some individuals also extended their wintering ranges over North Guinea, North-West of Burkina Faso and the Ivory-Coast Our results reveal that all individuals did not spend the winter period at a single location; some of them experienced a clear eastward shift of several hundred kilometres. We also found evidence for a loop migration pattern, with a post-breeding migration flyway lying west of the spring route. Finally, we found that on their way back to breeding grounds Turtle Doves needed to refuel after crossing the Sahara desert. Contrary to previous suggestions, our data reveal that birds used stopover sites for several weeks presumably in Morocco and North Algeria. This later finding is a crucial issue for future conservation strategies because environmental conditions on these staging areas might play a pivotal role in population dynamics of this declining species.	[Eraud, Cyril; Lormee, Herve; Boutin, Jean-Marie] Off Natl Chasse & Faune Sauvage, Villiers En Bois, France; [Riviere, Marcel] Maisonneuve, St Pierre Doleron, France; [Fox, James W.] Migrate Technol Ltd, Cambridge, England; [Ducamp, Jean-Jacques] CNRS, UPR 1934, Ctr Etud Biol Chize, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS)	Eraud, C (corresponding author), Off Natl Chasse & Faune Sauvage, Villiers En Bois, France.	cyril.eraud@oncfs.gouv.fr			Office National de la Chasse et de la Faune Sauvage	Office National de la Chasse et de la Faune Sauvage	This work was funded by the Office National de la Chasse et de la Faune Sauvage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer NJ., 2002, MIGRATION ATLAS MOVE, P420; Akesson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041195; Alerstam T, 2007, PLOS BIOL, V5, P1656, DOI 10.1371/journal.pbio.0050197; Bachler E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009566; BAIRLEIN F, 1985, OECOLOGIA, V66, P141, DOI 10.1007/BF00378566; Bairlein F, 2012, BIOL LETT; Bairlein Franz, 2009, Ringing & Migration, V24, P162; Barbraud C, 1999, IBIS, V141, P469, DOI 10.1111/j.1474-919X.1999.tb04416.x; BIEBACH H, 1986, OECOLOGIA, V69, P370, DOI 10.1007/BF00377059; BirdLife International, 2012, SPEC FACTSH STREPT T; Browne SJ, 2005, BIRD STUDY, V52, P1, DOI 10.1080/00063650509461368; Browne SJ, 2004, IBIS, V146, P125, DOI 10.1111/j.1474-919X.2004.00235.x; Catry I, 2011, IBIS, V153, P154, DOI 10.1111/j.1474-919X.2010.01073.x; Cramp S, 1985, BIRDS W PALEARCTIC, V4; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; EI Mastour A, 1988, B MENS O N C, V127, P43; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Eraud C, 2009, IBIS, V151, P186, DOI 10.1111/j.1474-919X.2008.00876.x; Eraud C, 2011, CONDOR, V113, P150, DOI 10.1525/cond.2011.090141; EVANS TR, 1994, WILSON BULL, V106, P154; FOX J. W., 2009, BAS GEOLOCATOR UNPUB; Hill C., 2001, ELECT TAGGING TRACKI, P315, DOI DOI 10.1007/978-94-017-1402-0_17; Hill Roger D., 1994, P227; Jarry G., 1991, HIVERNAGE TOURTERELL; Jarry G, 1994, STATUT BIOL TOURTERE; KANYAMIBWA S, 1990, IBIS, V132, P27, DOI 10.1111/j.1474-919X.1990.tb01013.x; Kirby JS, 2008, BIRD CONSERV INT, V18, pS49, DOI 10.1017/S0959270908000439; Klaassen RHG, 2011, BIOL LETTERS, V7, P833, DOI 10.1098/rsbl.2011.0343; Lisovski S, 2012, METHODS ECOL EVOL, V3, P1055, DOI 10.1111/j.2041-210X.2012.00248.x; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Mainguy J, 2002, CONDOR, V104, P156, DOI 10.1650/0010-5422(2002)104[0156:ABCARE]2.0.CO;2; MOLLER AP, 1989, J ANIM ECOL, V58, P1051, DOI 10.2307/5141; MOREL G, 1973, Terre et la Vie, V27, P523; MOREL G J, 1988, Alauda, V56, P85; Morel M.Y., 1987, Malimbus, V9, P23; MOREL M-Y, 1986, Alauda, V54, P121; MOREL M-Y, 1985, Alauda, V53, P100; Newton I, 2007, IBIS, V149, P453, DOI 10.1111/j.1474-919X.2007.00704.x; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Norris DR, 2006, BIOL LETTERS, V2, P148, DOI 10.1098/rsbl.2005.0397; Norris DR, 2005, OIKOS, V109, P178, DOI 10.1111/j.0030-1299.2005.13671.x; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Payevsky V.A, 2006, ENTOMOL REV, V86, P82, DOI [10.1134/S001387380610006X, DOI 10.1134/S001387380610006X]; PEACH W, 1991, IBIS, V133, P300, DOI 10.1111/j.1474-919X.1991.tb04573.x; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Risely K, 2010, 599 BTO; RODGERS AR, 2007, HRT HOME RANGE TOOLS; Rodriguez A, 2009, DIVERS DISTRIB, V15, P1010, DOI 10.1111/j.1472-4642.2009.00600.x; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Schaub M, 2005, J ANIM ECOL, V74, P656, DOI 10.1111/j.1365-2656.2005.00961.x; Schmaljohann H, 2007, P R SOC B, V274, P735, DOI 10.1098/rspb.2006.0011; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Strandberg R, 2010, BIOL LETTERS, V6, P297, DOI 10.1098/rsbl.2009.0785; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; SZEP T, 1995, IBIS, V137, P162, DOI 10.1111/j.1474-919X.1995.tb03235.x; Thevenot M, 2003, BRIT ORNITHOLOGIST U, V20; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wilson R.P., 1992, P131; Woodrey Mark S., 2005, U S Forest Service General Technical Report PSW, V191, P653; Zwarts L., 2009, LIVING EDGE WETLANDS	62	25	26	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59396	10.1371/journal.pone.0059396	http://dx.doi.org/10.1371/journal.pone.0059396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544064	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700026
J	Hughes, AD; Park, C; Davies, J; Francis, D; Thom, SAM; Mayet, J; Parker, KH				Hughes, Alun D.; Park, Chloe; Davies, Justin; Francis, Darrel; Thom, Simon A. McG; Mayet, Jamil; Parker, Kim H.			Limitations of Augmentation Index in the Assessment of Wave Reflection in Normotensive Healthy Individuals	PLOS ONE			English	Article							BLOOD-PRESSURE; ARTERIAL STIFFNESS; INTENSITY ANALYSIS; INPUT IMPEDANCE; AGE; VELOCITY; PULSE; MEN; METAANALYSIS; WOMEN	Objectives: Augmentation index (AIx) is widely used as a measure of wave reflection. We compared the relationship between AIx and age, height and sex with 'gold standard' measures of wave reflection derived from measurements of pressure and flow to establish how well AIx measures wave reflection. Materials and Methods:Measurements of carotid pressure and flow velocity were made in the carotid artery of 65 healthy normotensive individuals (age 21-78 yr; 43 male) and pulse wave analysis, wave intensity analysis and wave separation was performed; waveforms were classified into type A, B or C. AIx, the time of the first shoulder (T-s), wave reflection index (WRI) and the ratio of backward to forward pressure (P-b/P-f) were calculated. Results: AIx did not correlate with log WRI or P-b/P-f. When AIx was restricted to positive values AIx and log WRI were positively correlated (r = 0.33; p = 0.04). In contrast log WRI and P-b/P-f were closely correlated (r = 0.66; p<0.001). There was no correlation between the T-s and the timing of P-b or the reflected wave identified by wave intensity analysis. Wave intensity analysis showed that the morphology of type C waveforms (negative AIx) was principally due to a forward travelling (re-reflected) decompression wave in mid-systole. AIx correlated positively with age, inversely with height and was higher in women. In contrast log WRI and P-b/P-f showed negative associations with age, were unrelated to height and did not differ significantly by gender. Conclusions: AIx has serious limitations as a measure of wave reflection. Negative AIx values derived from Type C waves should not be used as estimates of wave reflection magnitude.	[Hughes, Alun D.; Park, Chloe; Davies, Justin; Francis, Darrel; Thom, Simon A. McG; Mayet, Jamil] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England; [Hughes, Alun D.; Park, Chloe; Davies, Justin; Francis, Darrel; Thom, Simon A. McG; Mayet, Jamil] Imperial Coll Healthcare NHS Trust, London, England; [Parker, Kim H.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Imperial College London; Imperial College London; Imperial College London	Hughes, AD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England.	a.hughes@imperial.ac.uk	Hughes, Alun David/N-3781-2013	Hughes, Alun David/0000-0001-5432-5271; Park, Chloe/0000-0001-8302-7484; Thom, Simon/0000-0002-3020-1351	British Heart Foundation; Wellcome Trust; Biomedical Research Centre Award; BHF Research Centre Excellence Award; British Heart Foundation [FS/10/38/28268, PG/08/103/26133] Funding Source: researchfish; National Institute for Health Research [CL-2006-21-003(1)] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Biomedical Research Centre Award; BHF Research Centre Excellence Award; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported in part by grants from the British Heart Foundation and the Wellcome Trust. A Hughes, J Mayet and S Thom received support from a Biomedical Research Centre Award to Imperial NHS Healthcare Trust and a BHF Research Centre Excellence Award to Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksi AJ, 2009, J AM COLL CARDIOL, V54, P2087, DOI 10.1016/j.jacc.2009.06.049; Davies JE, 2006, AM J PHYSIOL-HEART C, V290, pH878, DOI 10.1152/ajpheart.00751.2005; Davies JE, 2010, AM J PHYSIOL-HEART C, V298, pH580, DOI 10.1152/ajpheart.00875.2009; Hughes AD, 2009, MED BIOL ENG COMPUT, V47, P207, DOI 10.1007/s11517-009-0444-1; Keenan Nora L., 2011, Morbidity and Mortality Weekly Report, V60, P94; KELLY R, 1989, CIRCULATION, V80, P1652, DOI 10.1161/01.CIR.80.6.1652; Khir AW, 2001, J BIOMECH, V34, P1145, DOI 10.1016/S0021-9290(01)00076-8; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; London GM, 1996, KIDNEY INT, V50, P600, DOI 10.1038/ki.1996.355; Manisty C, 2010, J AM COLL CARDIOL, V56, P24, DOI 10.1016/j.jacc.2010.03.030; Manisty CH, 2009, HYPERTENSION, V54, P724, DOI 10.1161/HYPERTENSIONAHA.108.125740; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Mitchell GF, 2010, CIRCULATION, V122, P1379, DOI 10.1161/CIRCULATIONAHA.109.914507; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; MURGO JP, 1980, CIRCULATION, V62, P105, DOI 10.1161/01.CIR.62.1.105; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; O'Brien, 1996, Blood Press Monit, V1, P55; PARKER KH, 1990, J BIOMECH ENG-T ASME, V112, P322, DOI 10.1115/1.2891191; Parker KH, 2009, MED BIOL ENG COMPUT, V47, P175, DOI 10.1007/s11517-009-0439-y; Segers P, 2007, PHYSIOL MEAS, V28, P1045, DOI 10.1088/0967-3334/28/9/006; Segers P, 2007, HYPERTENSION, V49, P1248, DOI 10.1161/HYPERTENSIONAHA.106.085480; TAKAZAWA K, 1995, HYPERTENSION, V26, P520, DOI 10.1161/01.HYP.26.3.520; Trachet B, 2010, ANN BIOMED ENG, V38, P876, DOI 10.1007/s10439-010-9945-1; van Trijp MJCA, 2004, EUR J CLIN INVEST, V34, P825, DOI 10.1111/j.1365-2362.2004.01433.x; Verbeke F, 2011, HYPERTENSION, V58, P833, DOI 10.1161/HYPERTENSIONAHA.111.176594; Wang KL, 2010, HYPERTENSION, V55, P799, DOI 10.1161/HYPERTENSIONAHA.109.139964; WESTERHOF N, 1972, CARDIOVASC RES, V6, P648, DOI 10.1093/cvr/6.6.648; Zambanini A, 2005, AM J PHYSIOL-HEART C, V289, pH270, DOI 10.1152/ajpheart.00636.2003; Zambanini A, 2002, COMPUT CARDIOL, V29, P717, DOI 10.1109/CIC.2002.1166873	31	79	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59371	10.1371/journal.pone.0059371	http://dx.doi.org/10.1371/journal.pone.0059371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544061	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700023
J	Prabhakara, S; Khedkar, S; Shambat, SM; Srinivasan, R; Basu, A; Norrby-Teglund, A; Seshasayee, ASN; Arakere, G				Prabhakara, Sushma; Khedkar, Supriya; Shambat, Srikanth Mairpady; Srinivasan, Rajalakshmi; Basu, Atanu; Norrby-Teglund, Anna; Seshasayee, Aswin Sai Narain; Arakere, Gayathri			Genome Sequencing Unveils a Novel Sea Enterotoxin-Carrying PVL Phage in Staphylococcus aureus ST772 from India	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; GENE-EXPRESSION DATA; STRAINS; IDENTIFICATION; PATHOGENESIS; RESISTANCE; DIVERSITY; EMERGENCE; EVOLUTION; LINEAGES	Staphylococcus aureus is a major human pathogen, first recognized as a leading cause of hospital-acquired infections. Community-associated S. aureus (CA-SA) pose a greater threat due to increase in severity of infection and disease among children and healthy adults. CA-SA strains in India are genetically diverse, among which is the sequence type (ST) 772, which has now spread to Australia, Europe and Japan. Towards understanding the genetic characteristics of ST772, we obtained draft genome sequences of five relevant clinical isolates and studied the properties of their PVL-carrying prophages, whose presence is a defining hallmark of CA-SA. We show that this is a novel prophage, which carries the structural genes of the hlb-carrying prophage and includes the sea enterotoxin. This architecture probably emerged early within the ST772 lineage, at least in India. The sea gene, unique to ST772 PVL, despite having promoter sequence characteristics typical of low expression, appears to be highly expressed during early phase of growth in laboratory conditions. We speculate that this might be a consequence of its novel sequence context. The crippled nature of the hlb-converting prophage in ST772. suggests that widespread mobility of the sea enterotoxin might be a selective force behind its 'transfer' to the PVL prophage. Wild type ST772 strains induced strong proliferative responses as well as high cytotoxic activity against neutrophils, likely mediated by superantigen SEA and the PVL toxin respectively. Both proliferation and cytotoxicity were markedly reduced in a cured ST772 strain indicating the impact of the phage on virulence. The presence of SEA alongside he genes for the immune system-modulating PVL toxin may contribute to the success and virulence of ST772.	[Prabhakara, Sushma; Arakere, Gayathri] Indian Inst Sci, Soc Innovat & Dev, Bengaluru, India; [Khedkar, Supriya; Srinivasan, Rajalakshmi; Seshasayee, Aswin Sai Narain] GKVK, TIER, Natl Ctr Biol Sci, Bengaluru, India; [Basu, Atanu] Natl Inst Virol, Pune, Maharashtra, India; [Shambat, Srikanth Mairpady; Norrby-Teglund, Anna] Karolinska Inst, Karolinska Univ Hosp, Ctr Infect Med F59, Stockholm, Sweden	Indian Institute of Science (IISC) - Bangalore; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Karolinska Institutet; Karolinska University Hospital	Seshasayee, ASN (corresponding author), GKVK, TIER, Natl Ctr Biol Sci, Bengaluru, India.	aswin@ncbs.res.in; gayathri.arakere@gmail.com		Srinivasan, Rajalakshmi/0000-0003-4020-2339; Mairpady Shambat, Srikanth/0000-0002-0527-3978; , Supriya/0000-0001-6606-2202	Council for Scientific & Industrial Research (CSIR), India [09/860(0122)/2011-EMR-I]; NCBS core budget; Department of Science and Technology, Government of India [SR/S2/RJN-49/2010]; Department of Biotechnology [BT/IN/New Indigo/16/GA/2010]; Swedish International Development Agency	Council for Scientific & Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); NCBS core budget; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology; Swedish International Development Agency	SP is a junior research fellow under BT/IN/New Indigo/16/GA/2010. SK is supported by fellowship [09/860(0122)/2011-EMR-I] from the Council for Scientific & Industrial Research (CSIR), India. ASNS is funded by the NCBS core budget and the Ramanujan Fellowship (SR/S2/RJN-49/2010) from the Department of Science and Technology, Government of India. GA is funded by Department of Biotechnology (BT/IN/New Indigo/16/GA/2010) and Swedish International Development Agency funding to ANT and GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz S, 2008, JPN J INFECT DIS, V61, P393; Boakes E, 2011, J CLIN MICROBIOL, V49, P684, DOI 10.1128/JCM.01917-10; Boakes E, 2012, J CLIN MICROBIOL, V50, P1773, DOI 10.1128/JCM.06421-11; Brennan GI, 2012, J CLIN MICROBIOL, V50, P841, DOI 10.1128/JCM.06354-11; Cao R, 2012, APPL ENVIRON MICROB, V78, P4942, DOI 10.1128/AEM.00803-12; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; D'Souza N, 2010, J CLIN MICROBIOL, V48, P1806, DOI 10.1128/JCM.01867-09; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; Dauwalder O, 2006, J LEUKOCYTE BIOL, V80, P753, DOI 10.1189/jlb.0306232; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; Fortier LC, 2007, APPL ENVIRON MICROB, V73, P7358, DOI 10.1128/AEM.00582-07; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Graves SF, 2012, J LEUKOCYTE BIOL, V92, P361, DOI 10.1189/jlb.1111575; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XX, 2008, J CLIN MICROBIOL, V46, P3246, DOI 10.1128/JCM.00136-08; Ma XX, 2006, J CLIN MICROBIOL, V44, P4515, DOI 10.1128/JCM.00985-06; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; Nadig S, 2012, CLIN OPHTHALMOL, V6, P165, DOI 10.2147/OPTH.S23878; Narita S, 2001, GENE, V268, P195, DOI 10.1016/S0378-1119(01)00390-0; Neela Vasanthakumari, 2009, Int J Infect Dis, V13, pe131, DOI 10.1016/j.ijid.2008.07.009; Nguyen HM, 2010, J IMMUNOL METHODS, V356, P1, DOI 10.1016/j.jim.2010.03.005; Otter JA, 2010, CLIN MICROBIOL INFEC, V16, P68, DOI 10.1111/j.1469-0691.2009.02925.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perret M, 2012, CELL MICROBIOL, V14, P1019, DOI 10.1111/j.1462-5822.2012.01772.x; Prabhakara S, 2012, J BACTERIOL, V194, P3727, DOI 10.1128/JB.00480-12; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Raphae IL, 2004, NUCLEIC ACIDS RES, V32, P45; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sambrook J., 2001, MOL CLONING LAB MANU; Schelin J, 2011, VIRULENCE, V2, P580, DOI 10.4161/viru.2.6.18122; Shambat S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-64; Tattevin P, 2012, CLIN INFECT DIS, V55, P781, DOI 10.1093/cid/cis527; Tong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037212; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wirtz C, 2009, MICROBIOL-SGM, V155, P3491, DOI 10.1099/mic.0.032466-0; Yamaguchi T, 2012, JPN J INFECT DIS, V65, P175; Yeung KY, 2001, BIOINFORMATICS, V17, P763, DOI 10.1093/bioinformatics/17.9.763; Yoong P, 2012, INFECT IMMUN, V80, P2894, DOI 10.1128/IAI.06360-11; Zanger P, 2012, CLIN INFECT DIS, V54, P483, DOI 10.1093/cid/cir822; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang M, 2011, FEMS MICROBIOL LETT, V323, P20, DOI 10.1111/j.1574-6968.2011.02355.x	46	23	24	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60013	10.1371/journal.pone.0060013	http://dx.doi.org/10.1371/journal.pone.0060013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544121	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000317480700080
J	Romon, M; Perez-Guzman, MD; Jimenez-Rabadan, P; Esteso, MC; Garcia-Alvarez, O; Maroto-Morales, A; Anel-Lopez, L; Soler, AJ; Fernandez-Santos, MR; Garde, JJ				Romon, Manuel; Dolores Perez-Guzman, M.; Jimenez-Rabadan, Pilar; Esteso, Milagros C.; Garcia-Alvarez, Olga; Maroto-Morales, Alejandro; Anel-Lopez, Luis; Soler, Ana J.; Rocio Fernandez-Santos, M.; Julian Garde, J.			Sperm Cell Population Dynamics in Ram Semen during the Cryopreservation Process	PLOS ONE			English	Article							ACROSOMAL INTEGRITY; MORPHOMETRIC SUBPOPULATIONS; HEAD MORPHOMETRY; MEMBRANE-CHANGES; FROZEN STORAGE; VIABILITY; BOAR; SPERMATOZOA; EJACULATE; IDENTIFICATION	Background:Sperm cryopreservation has become an indispensable tool in biology. Initially, studies were aimed towards the development of efficient freezing protocols in different species that would allow for an efficient storage of semen samples for long periods of time, ensuring its viability. Nowadays, it is widely known that an important individual component exists in the cryoresistance of semen, and efforts are aimed at identifying those sperm characteristics that may allow us to predict this cryoresistance. This knowledge would lead, ultimately, to the design of optimized freezing protocols for the sperm characteristics of each male. Methodology/Principal Findings: We have evaluated the changes that occur in the sperm head dimensions throughout the cryopreservation process. We have found three different patterns of response, each of one related to a different sperm quality at thawing. We have been able to characterize males based on these patterns. For each male, its pattern remained constant among different ejaculates. This latter would imply that males always respond in the same way to freezing, giving even more importance to this sperm feature. Conclusions/Significance:Changes in the sperm head during cryopreservation process have resulted useful to identify the ability of semen of males for freezing. We suggest that analyses of these response patterns would represent an important tool to characterize the cryoresistance of males when implemented within breeding programs. We also propose follow-up experiments to examine the outcomes of the use of different freezing protocols depending on the pattern of response of males.	[Romon, Manuel; Dolores Perez-Guzman, M.; Jimenez-Rabadan, Pilar] Junta Comunidades Castilla La Mancha, CERSYRA, Valdepenas, Spain; [Esteso, Milagros C.] INIA, Dpto Reprod Anim, Madrid, Spain; [Garcia-Alvarez, Olga; Maroto-Morales, Alejandro; Anel-Lopez, Luis; Soler, Ana J.; Rocio Fernandez-Santos, M.; Julian Garde, J.] SaBio CSIC UCLM JCCM, Albacete, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha	Romon, M (corresponding author), Junta Comunidades Castilla La Mancha, CERSYRA, Valdepenas, Spain.	mramon@jccm.es	Soler, Ana Josefa/AAB-1024-2020; Fernandez, Manuel Ramon/B-5755-2014; López-Brea, José Julián Garde/AAE-5894-2019; ANEL-LÓPEZ, LUIS/AAP-2438-2020; Soler, Ana Josefa/M-8209-2013; Garde, Julian J/O-5607-2015; Esteso, Milagros C/K-7895-2014; Fernández-Santos, Maria Rocío/H-1522-2018; Anel-Lopez, Luis/K-6546-2017; garcia-alvarez, olga/L-4424-2014; garcia-alvarez, olga/AAM-5128-2020	Soler, Ana Josefa/0000-0002-6429-5157; Fernandez, Manuel Ramon/0000-0003-4179-9894; López-Brea, José Julián Garde/0000-0002-3667-6518; ANEL-LÓPEZ, LUIS/0000-0001-7179-5742; Soler, Ana Josefa/0000-0002-6429-5157; Garde, Julian J/0000-0002-3667-6518; Esteso, Milagros C/0000-0002-8963-5736; Fernández-Santos, Maria Rocío/0000-0002-3359-1623; Anel-Lopez, Luis/0000-0001-7179-5742; garcia-alvarez, olga/0000-0003-4310-0557; garcia-alvarez, olga/0000-0003-4310-0557	Education and Science Council of Castilla-La Mancha [PCC08-0105-8042]; DOC-INIA program	Education and Science Council of Castilla-La Mancha; DOC-INIA program	This work was supported by the Education and Science Council of Castilla-La Mancha (PCC08-0105-8042). Manuel Ramon was supported by the DOC-INIA program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2008, THERIOGENOLOGY, V70, P1498, DOI 10.1016/j.theriogenology.2008.06.097; ARMITAGE WJ, 1986, CRYOBIOLOGY, V23, P116, DOI 10.1016/0011-2240(86)90002-7; Arruda RP, 2002, THERIOGENOLOGY, V58, P253; Benson JD, 2012, THERIOGENOLOGY, V78, P1682, DOI 10.1016/j.theriogenology.2012.06.007; Curry MR, 2000, CRYOBIOLOGY, V41, P167, DOI 10.1006/cryo.2000.2277; Esteso MC, 2003, REPROD DOMEST ANIM, V41, P241; FISER PS, 1989, CRYOBIOLOGY, V26, P64, DOI 10.1016/0011-2240(89)90033-3; Garcia-Alvarez O, 2009, THERIOGENOLOGY, V72, P160, DOI 10.1016/j.theriogenology.2009.02.002; Gravance CG, 2009, ANIM REPROD SCI, V114, P81, DOI 10.1016/j.anireprosci.2008.09.014; Gravance CG, 1998, J ANDROL, V19, P704; HAMMERSTEDT RH, 1990, J ANDROL, V11, P73; Hernandez M, 2006, INT J ANDROL, V29, P583, DOI 10.1111/j.1365-2605.2006.00699.x; Hidalgo M, 2007, ANIM REPROD SCI, V100, P61, DOI 10.1016/j.anireprosci.2006.07.003; Holt WV, 2000, THERIOGENOLOGY, V53, P47, DOI 10.1016/S0093-691X(99)00239-3; Januskauskas A, 2003, THERIOGENOLOGY, V60, P743, DOI 10.1016/S0093-691X(03)00050-5; Maroto-Morales A, 2010, THERIOGENOLOGY, V73, P437, DOI 10.1016/j.theriogenology.2009.10.003; Martin G, 2004, BIOL REPROD, V71, P28, DOI 10.1095/biolreprod.103.024281; Martinez-Pastor F, 2005, BIOL REPROD, V72, P316, DOI 10.1095/biolreprod.104.032730; Martinez-Pastor F, 2010, REPROD DOMEST ANIM, V45, P67, DOI 10.1111/j.1439-0531.2010.01622.x; MAZUR P, 1989, CRYOBIOLOGY, V26, P1, DOI 10.1016/0011-2240(89)90030-8; Nunez-Martinez I, 2007, ZYGOTE, V15, P257, DOI 10.1017/S0967199407004248; Pena AI, 2003, THERIOGENOLOGY, V59, P1725, DOI 10.1016/S0093-691X(02)01233-5; Pena AI, 2001, J REP FER S, P371; Pena FJ, 2005, J ANDROL, V26, P716, DOI 10.2164/jandrol.05030; Pena FJ, 2004, ZYGOTE, V12, P117, DOI 10.1017/S096719940400262X; Petrunkina AM, 2004, REPRODUCTION, V128, P829, DOI 10.1530/rep.1.00296; QUINN PJ, 1989, J BIOENERG BIOMEMBR, V21, P3, DOI 10.1007/BF00762209; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramon M, 2012, THERIOGENOLOGY, V77, P1661, DOI 10.1016/j.theriogenology.2011.12.011; Rijsselaere T, 2004, THERIOGENOLOGY, V62, P1292, DOI 10.1016/j.theriogenology.2004.01.005; Roldan ERS, 1998, P ROY SOC B-BIOL SCI, V265, P243, DOI 10.1098/rspb.1998.0288; SALAMON S, 1995, ANIM REPROD SCI, V38, P1, DOI 10.1016/0378-4320(94)01328-J; SALAMON S, 1995, ANIM REPROD SCI, V37, P185, DOI 10.1016/0378-4320(94)01327-I; Sancho S, 2007, REPRODUCTION, V134, P111, DOI 10.1530/REP-07-0118; SCHNEIDER U, 1984, THERIOGENOLOGY, V21, P68, DOI 10.1016/0093-691X(84)90307-8; Soler AJ, 2003, J ANDROL, V24, P746; Stolovicki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020530; Thomas CA, 1997, BIOL REPROD, V56, P991, DOI 10.1095/biolreprod56.4.991; Thurston LM, 2002, BIOL REPROD, V66, P545, DOI 10.1095/biolreprod66.3.545; Thurston LM, 2002, CRYOLETTERS, V23, P255; Thurston LM, 2001, J ANDROL, V22, P382	41	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59189	10.1371/journal.pone.0059189	http://dx.doi.org/10.1371/journal.pone.0059189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544054	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700016
J	Galbiati, S; Damin, F; Pinzani, P; Mancini, I; Vinci, S; Chiari, M; Orlando, C; Cremonesi, L; Ferrari, M				Galbiati, Silvia; Damin, Francesco; Pinzani, Pamela; Mancini, Irene; Vinci, Serena; Chiari, Marcella; Orlando, Claudio; Cremonesi, Laura; Ferrari, Maurizio			A New Microarray Substrate for Ultra-Sensitive Genotyping of KRAS and BRAF Gene Variants in Colorectal Cancer	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; DNA MICROARRAYS; MUTATIONS; INTERFERENCE; SILICON; SLIDES; TRIAL; CHIP	Molecular diagnostics of human cancers may increase accuracy in prognosis, facilitate the selection of the optimal therapeutic regimen, improve patient outcome, reduce costs of treatment and favour development of personalized approaches to patient care. Moreover sensitivity and specificity are fundamental characteristics of any diagnostic method. We developed a highly sensitive microarray for the detection of common KRAS and BRAF oncogenic mutations. In colorectal cancer, KRAS and BRAF mutations have been shown to identify a cluster of patients that does not respond to anti-EGFR therapies; the identification of these mutations is therefore clinically extremely important. To verify the technical characteristics of the microarray system for the correct identification of the KRAS mutational status at the two hotspot codons 12 and 13 and of the BRAF(V600E) mutation in colorectal tumor, we selected 75 samples previously characterized by conventional and CO-amplification at Lower Denaturation temperature-PCR (COLD-PCR) followed by High Resolution Melting analysis and direct sequencing. Among these samples, 60 were collected during surgery and immediately steeped in RNAlater while the 15 remainders were formalin-fixed and paraffin-embedded (FFPE) tissues. The detection limit of the proposed method was different for the 7 KRAS mutations tested and for the V600E BRAF mutation. In particular, the microarray system has been able to detect a minimum of about 0.01% of mutated alleles in a background of wild-type DNA. A blind validation displayed complete concordance of results. The excellent agreement of the results showed that the new microarray substrate is highly specific in assigning the correct genotype without any enrichment strategy.	[Galbiati, Silvia; Cremonesi, Laura; Ferrari, Maurizio] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, Genom Unit Diag Human Pathol, I-20132 Milan, Italy; [Damin, Francesco; Chiari, Marcella] CNR, Ist Chim Riconoscimento Mol, I-20133 Milan, Italy; [Pinzani, Pamela; Mancini, Irene; Vinci, Serena; Orlando, Claudio] Univ Florence, Dept Clin Physiopathol, Clin Biochem Unit, Florence, Italy; [Ferrari, Maurizio] Univ Vita Salute San Raffaele, Milan, Italy; [Ferrari, Maurizio] Diagnost & Ric San Raffaele SpA, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); University of Florence; Vita-Salute San Raffaele University	Galbiati, S (corresponding author), Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, Genom Unit Diag Human Pathol, I-20132 Milan, Italy.	galbiati.silvia@hsr.it	Pinzani, P./K-7022-2018; Galbiati, Silvia/AAC-1218-2019; Damin, Francesco/AAL-8998-2021; Mancini, Irene/K-2126-2018	Pinzani, P./0000-0003-4017-3574; Galbiati, Silvia/0000-0003-1642-8506; Damin, Francesco/0000-0003-1780-7823; Mancini, Irene/0000-0002-7814-6435; Chiari, Marcella/0000-0002-4670-1430				Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Cretich M, 2008, SENSOR ACTUAT B-CHEM, V132, P258, DOI 10.1016/j.snb.2008.01.033; Cretich M, 2010, ANAL BIOCHEM, V397, P84, DOI 10.1016/j.ab.2009.09.050; Cretich M, 2009, ANAL CHEM, V81, P5197, DOI 10.1021/ac900658c; Eng C, 2010, ONCOLOGIST, V15, P73, DOI 10.1634/theoncologist.2009-0167; Ferrari F, 2006, HUM MUTAT, V27, P201, DOI 10.1002/humu.20294; Fouque B, 2005, BIOSENS BIOELECTRON, V20, P2335, DOI 10.1016/j.bios.2004.08.009; Galbiati S, 2008, ELECTROPHORESIS, V29, P4714, DOI 10.1002/elps.200800242; Ho-Pun-Cheung A, 2006, LAB INVEST, V86, P304, DOI 10.1038/labinvest.3700387; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Mancini I, 2010, J MOL DIAGN, V12, P705, DOI 10.2353/jmoldx.2010.100018; Marquette CA, 2007, TALANTA, V71, P1312, DOI 10.1016/j.talanta.2006.06.039; Moiseev L, 2006, P NATL ACAD SCI USA, V103, P2623, DOI 10.1073/pnas.0511214103; Moutereau S, 2004, HUM MUTAT, V23, P621, DOI 10.1002/humu.20045; Oliviero G, 2008, ANAL CHIM ACTA, V630, P161, DOI 10.1016/j.aca.2008.09.069; Pajic M, 2011, HUM GENET, V130, P93, DOI 10.1007/s00439-011-0990-0; Pinzani P, 2011, CLIN CHIM ACTA, V412, P901, DOI 10.1016/j.cca.2011.01.014; Pirri G, 2004, ANAL CHEM, V76, P1352, DOI 10.1021/ac0352629; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Smalley KSM, 2010, CURR OPIN INVEST DR, V11, P699; Stenirri S, 2004, CLIN CHEM, V50, P1336, DOI 10.1373/clinchem.2004.033241; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Volle JN, 2003, BIOSENS BIOELECTRON, V19, P457, DOI 10.1016/S0956-5663(03)00201-X	27	13	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59939	10.1371/journal.pone.0059939	http://dx.doi.org/10.1371/journal.pone.0059939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536897	Green Published, gold, Green Submitted			2022-12-25	WOS:000317397200045
J	Chapman, BB; Hegg, A; Ljungberg, P				Chapman, Ben B.; Hegg, Alexander; Ljungberg, Peter			Sex and the Syndrome: Individual and Population Consistency in Behaviour in Rock Pool Prawn Palaemon elegans	PLOS ONE			English	Article							STICKLEBACKS GASTEROSTEUS-ACULEATUS; COD GADUS-MORHUA; ANIMAL PERSONALITIES; POECILIA-RETICULATA; SOCIAL-CONTEXT; BOLDNESS; ADSPERSUS; SQUILLA; DIFFERENTIATION; CONSEQUENCES	Animal personality has been widely documented across a range of species. The concept of personality is composed of individual behavioural consistency across time and between situations, and also behavioural trait correlations known as behavioural syndromes. Whilst many studies have now investigated the stability of individual personality traits, few have analysed the stability over time of entire behavioural syndromes. Here we present data from a behavioural study of rock pool prawns. We show that prawns are temporally consistent in a range of behaviours, including activity, exploration and boldness, and also that a behavioural syndrome is evident in this population. We find correlations between many behavioural traits (activity, boldness, shoaling and exploration). In addition, behavioural syndrome structure was consistent over time. Finally, few studies have explicitly studied the role of sex differences in personality traits, behavioural consistency and syndrome structure. We report behavioural differences between male and female prawns but no differences in patterns of consistency. Our study adds to the growing literature on animal personality, and provides evidence showing that syndromes themselves can exhibit temporal consistency.	[Chapman, Ben B.; Hegg, Alexander; Ljungberg, Peter] Lund Univ, Dept Biol, Aquat Ecol Unit, Lund, Skane, Sweden	Lund University	Chapman, BB (corresponding author), Lund Univ, Dept Biol, Aquat Ecol Unit, Lund, Skane, Sweden.	ben.chapman@biol.lu.se		Ljungberg, Peter/0000-0003-1168-4375	EU; Anna and Edwin Berger Foundation	EU(European Commission); Anna and Edwin Berger Foundation	BBC was funded by an EU FP7 Marie Curie fellowship. Financial support was provided from Anna and Edwin Berger Foundation to PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens B, 2012, ECOLOGY LETT; [Anonymous], 2010, R LANG ENV STAT COMP; Bell A, 2012, BEHAV ECOLOGY; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; BERGLUND A, 1981, OECOLOGIA, V49, P300, DOI 10.1007/BF00347589; BERGLUND A, 1980, HOLARCTIC ECOL, V3, P111; BERGLUND A, 1981, OIKOS, V36, P158, DOI 10.2307/3544440; BERGLUND A, 1983, MAR BIOL, V77, P49, DOI 10.1007/BF00393209; Briffa M, 2008, P R SOC B, V275, P1305, DOI 10.1098/rspb.2008.0025; Brodersen J, 2012, BIOL LETTERS, V8, P21, DOI 10.1098/rsbl.2011.0634; Buss A. H., 1988, PERSONALITY EVOLUTIO; Chapman BB, 2008, ANIM BEHAV, V76, P923, DOI 10.1016/j.anbehav.2008.03.022; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Chapman BB, 2011, ANIM BEHAV, V82, P391, DOI 10.1016/j.anbehav.2011.05.019; Chapman BB, 2009, BEHAV ECOL SOCIOBIOL, V63, P1757, DOI 10.1007/s00265-009-0796-4; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Evans SR, 2007, ANIM BEHAV, V74, P1691, DOI 10.1016/j.anbehav.2007.03.017; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Ioannou CC, 2009, BIOL LETTERS, V5, P191, DOI 10.1098/rsbl.2008.0758; Johnson JC, 2007, ANIM BEHAV, V74, P1131, DOI 10.1016/j.anbehav.2007.02.006; Krause J, 2002, LIVING GROUPS; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Ljungberg P, 2012, MARINE BIOL; Ljungberg P, 2012, MAR ECOL PROG SER, V466, P215, DOI 10.3354/meps09932; Minderman J, 2009, BEHAV ECOL, V20, P830, DOI 10.1093/beheco/arp067; Moen FE, 2009, DJURLIV HAVET NORDEU; Mowles SL, 2012, BEHAV ECOL SOCIOBIOL, V66, P1087, DOI 10.1007/s00265-012-1359-7; Persson A, 2012, MAR ECOL PROG SER, V456, P245, DOI 10.3354/meps09705; Persson M, 2008, MAR ECOL PROG SER, V371, P203, DOI 10.3354/meps07674; Piyapong C, 2010, BEHAV ECOL, V21, P3, DOI 10.1093/beheco/arp142; Pruitt JN, 2012, AM NAT, V179, P217, DOI 10.1086/663680; Pruitt JN, 2009, ANIM BEHAV, V78, P175, DOI 10.1016/j.anbehav.2009.04.016; RIECHERT SE, 1993, ANIM BEHAV, V46, P669, DOI 10.1006/anbe.1993.1243; Ruuskanen S, 2010, HORM BEHAV, V57, P119, DOI 10.1016/j.yhbeh.2009.09.017; Schuett W, 2011, DEV PSYCHOBIOL, V53, P631, DOI 10.1002/dev.20538; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	46	22	22	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59437	10.1371/journal.pone.0059437	http://dx.doi.org/10.1371/journal.pone.0059437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555034	Green Submitted, Green Published, gold			2022-12-25	WOS:000316409800091
J	Carlson, KJ; Jashashvili, T; Houghton, K; Westaway, MC; Patel, BA				Carlson, Kristian J.; Jashashvili, Tea; Houghton, Kimberley; Westaway, Michael C.; Patel, Biren A.			Joint Loads in Marsupial Ankles Reflect Habitual Bipedalism versus Quadrupedalism	PLOS ONE			English	Article							SUBCHONDRAL BONE; TERRESTRIAL LOCOMOTION; APPARENT DENSITY; FORELIMB KINEMATICS; ARBOREAL LOCOMOTION; COMPLIANT WALKING; MAYULESTES-FEROX; ENERGETIC COST; HAND POSTURES; PAPIO-ANUBIS	Joint surfaces of limb bones are loaded in compression by reaction forces generated from body weight and musculotendon complexes bridging them. In general, joints of eutherian mammals have regions of high radiodensity subchondral bone that are better at resisting compressive forces than low radiodensity subchondral bone. Identifying similar form-function relationships between subchondral radiodensity distribution and joint load distribution within the marsupial postcranium, in addition to providing a richer understanding of marsupial functional morphology, can serve as a phylogenetic control in evaluating analogous relationships within eutherian mammals. Where commonalities are established across phylogenetic borders, unifying principles in mammalian physiology, morphology, and behavior can be identified. Here, we assess subchondral radiodensity patterns in distal tibiae of several marsupial taxa characterized by different habitual activities (e. g., locomotion). Computed tomography scanning, maximum intensity projection maps, and pixel counting were used to quantify radiodensity in 41 distal tibiae of bipedal (5 species), arboreal quadrupedal (4 species), and terrestrial quadrupedal (5 species) marsupials. Bipeds (Macropus and Wallabia) exhibit more expansive areas of high radiodensity in the distal tibia than arboreal (Dendrolagus, Phascolarctos, and Trichosurus) or terrestrial quadrupeds (Sarcophilus, Thylacinus, Lasiorhinus, and Vombatus), which may reflect the former carrying body weight only through the hind limbs. Arboreal quadrupeds exhibit smallest areas of high radiodensity, though they differ non-significantly from terrestrial quadrupeds. This could indicate slightly more compliant gaits by arboreal quadrupeds compared to terrestrial quadrupeds. The observed radiodensity patterns in marsupial tibiae, though their statistical differences disappear when controlling for phylogeny, corroborate previously documented patterns in primates and xenarthrans, potentially reflecting inferred limb use during habitual activities such as locomotion. Despite the complex nature of factors contributing to joint loads, broad observance of these patterns across joints and across a variety of taxa suggests that subchondral radiodensity can be used as a unifying form-function principle within Mammalia.	[Carlson, Kristian J.; Jashashvili, Tea; Houghton, Kimberley] Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Jashashvili, Tea] Georgian Natl Museum, Dept Geol & Paleontol, Tbilisi, Georgia; [Westaway, Michael C.] Queensland Museum, Cultures & Hist Program, Brisbane, Qld 4101, Australia; [Patel, Biren A.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	University of Witwatersrand; Indiana University System; Indiana University Bloomington; Queensland Museum; University of Southern California	Carlson, KJ (corresponding author), Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa.	kristian.carlson@wits.ac.za	Patel, Biren/B-8373-2016		African Origins Platform of the Department of Science and Technology (South Africa); National Research Foundation of South Africa; University of the Witwatersrand	African Origins Platform of the Department of Science and Technology (South Africa); National Research Foundation of South Africa(National Research Foundation - South Africa); University of the Witwatersrand	Funding for the project was provided by the African Origins Platform of the Department of Science and Technology (South Africa), the National Research Foundation of South Africa, and the University of the Witwatersrand. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1975, J ZOOL, V177, P265, DOI 10.1111/j.1469-7998.1975.tb05983.x; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Bassarova M, 2009, J MAMM EVOL, V16, P1, DOI 10.1007/s10914-008-9093-7; BAUDINETTE RV, 1994, AUST J ZOOL, V42, P103, DOI 10.1071/ZO9940103; BAUDINETTE RV, 1992, AM J PHYSIOL, V262, pR771, DOI 10.1152/ajpregu.1992.262.5.R771; Beck RMD, 2008, J MAMMAL, V89, P175, DOI 10.1644/06-MAMM-A-437.1; Bennett MB, 2000, PHYSIOL BIOCHEM ZOOL, V73, P726, DOI 10.1086/318110; BIEWENER AA, 1995, J EXP BIOL, V198, P1829; Biewener AA., 2003, ANIMAL LOCOMOTION; Byron CD, 2004, J ZOOL, V263, P101, DOI 10.1017/S0952836904004935; Carlson KJ, 2005, J ZOOL, V266, P261, DOI 10.1017/S0952836905006874; Carlson KJ, 2006, J ANAT, V208, P659, DOI 10.1111/j.1469-7580.2006.00555.x; Carlson KJ, 2010, AM J PHYS ANTHROPOL, V142, P273, DOI 10.1002/ajpa.21224; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; CURREY J, 1984, AM ZOOL, V24, P5; Daley MA, 2010, BIOL LETTERS, V6, P418, DOI 10.1098/rsbl.2010.0175; DAWSON TJ, 1973, NATURE, V246, P313, DOI 10.1038/246313a0; Eckstein F, 1999, ANAT EMBRYOL, V199, P85, DOI 10.1007/s004290050212; FARLEY CT, 1993, J EXP BIOL, V185, P71; GARLAND T, 1988, J ZOOL, V215, P505, DOI 10.1111/j.1469-7998.1988.tb02856.x; Herzog W, 2003, LANGENBECK ARCH SURG, V388, P305, DOI 10.1007/s00423-003-0402-6; Hunt KD, 1996, PRIMATES, V37, P363, DOI 10.1007/BF02381373; Jones C, 2010, FIELD GUIDE AUSTR MA; Kram R, 1998, COMP BIOCHEM PHYS B, V120, P41, DOI 10.1016/S0305-0491(98)00022-4; Lammers AR, 2004, J EXP BIOL, V207, P4325, DOI 10.1242/jeb.01231; Larney E, 2004, AM J PHYS ANTHROPOL, V125, P42, DOI 10.1002/ajpa.10366; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; McGowan CR, 2008, COMP BIOCHEM PHYS A, V150, P151, DOI 10.1016/j.cbpa.2006.06.018; McGowan CP, 2005, J EXP BIOL, V208, P41, DOI 10.1242/jeb.01305; Meredith RW, 2009, MOL PHYLOGENET EVOL, V51, P554, DOI 10.1016/j.ympev.2009.02.009; MULLERGERBL M, 1992, J BONE MINER RES, V7, pS411; Nowak MG, 2010, AM J PHYS ANTHROPOL, V142, P180, DOI 10.1002/ajpa.21210; Patel BA, 2008, BIOL LETTERS, V4, P486, DOI 10.1098/rsbl.2008.0297; Patel BA, 2007, J HUM EVOL, V52, P130, DOI 10.1016/j.jhevol.2006.08.007; Patel BA, 2012, J EXP BIOL, V215, P115, DOI 10.1242/jeb.063107; Patel BA, 2010, INT J PRIMATOL, V31, P191, DOI 10.1007/s10764-010-9394-6; Patel BA, 2010, ANAT REC, V293, P710, DOI 10.1002/ar.21128; Patel BA, 2010, AM J PHYS ANTHROPOL, V141, P222, DOI 10.1002/ajpa.21138; Patel BA, 2009, AM J PHYS ANTHROPOL, V140, P92, DOI 10.1002/ajpa.21039; Polk JD, 2008, ANAT REC, V291, P293, DOI 10.1002/ar.20653; PRIDMORE PA, 1992, J MORPHOL, V211, P137, DOI 10.1002/jmor.1052110203; RADIN EL, 1970, J BONE JOINT SURG AM, VA 52, P444, DOI 10.2106/00004623-197052030-00004; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sasaki K, 2010, J BIOMECH, V43, P2780, DOI 10.1016/j.jbiomech.2010.06.011; Schmitt D, 1999, J ZOOL, V248, P149, DOI 10.1017/S0952836999006020; Schmitt D, 2004, J HUM EVOL, V46, P239, DOI 10.1016/j.jhevol.2003.11.008; Schmitt D, 2002, AM J PHYS ANTHROPOL, V118, P231, DOI 10.1002/ajpa.10048; Shapiro LJ, 2012, J EXP BIOL, V215, P480, DOI 10.1242/jeb.062588; Stevens NJ, 2006, J EXP ZOOL PART A, V305A, P953, DOI 10.1002/jez.a.336; Su A, 2011, THESIS STONY BROOK U; Szalay Frederick S., 2001, Geodiversitas, V23, P139; Szalay FS, 2006, EVOLUTIONARY HIST MA; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; WINDSOR DE, 1971, J ZOOL, V163, P165, DOI 10.1111/j.1469-7998.1971.tb04530.x	57	9	9	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58811	10.1371/journal.pone.0058811	http://dx.doi.org/10.1371/journal.pone.0058811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554931	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500045
J	Arnold, R; Pussell, BA; Pianta, TJ; Grinius, V; Lin, CSY; Kiernan, MC; Howells, J; Jardine, MJ; Krishnan, AV				Arnold, Ria; Pussell, Bruce A.; Pianta, Timothy J.; Grinius, Virginija; Lin, Cindy S-Y.; Kiernan, Matthew C.; Howells, James; Jardine, Meg J.; Krishnan, Arun V.			Effects of Hemodiafiltration and High Flux Hemodialysis on Nerve Excitability in End-Stage Kidney Disease	PLOS ONE			English	Article							ONLINE HEMODIAFILTRATION; BETA-2-MICROGLOBULIN LEVELS; AXONAL EXCITABILITY; PARATHYROID-HORMONE; MYELINATED AXONS; NEUROPATHY; MECHANISMS; PARAMETERS; CONDUCTION; MORTALITY	Objectives: Peripheral neuropathy is the most common neurological complication in end-stage kidney disease. While high flux hemodialysis (HFHD) and hemodiafiltration (HDF) have become the preferred options for extracorporeal dialysis therapy, the effects of these treatments on nerve excitability have not yet been examined. Methods: An observational proof-of-concept study of nerve excitability and neuropathy was undertaken in an incident dialysis population (n = 17) receiving either HFHD or HDF. Nerve excitability techniques were utilised to assess nerve ion channel function and membrane potential, in conjunction with clinical assessment and standard nerve conduction studies. A mathematical model of axonal excitability was used to investigate the underlying basis of the observed changes. Nerve excitability was recorded from the median nerve, before, during and after a single dialysis session and correlated with corresponding biochemical markers. Differences in nerve excitability were compared to normal controls with longitudinal follow-up over an 18 month period. Results: Nerve excitability was performed in patient cohorts treated with either HFHD (n = 9) or online HDF (n = 8), with similar neuropathy status. Nerve excitability measures in HDF-treated patients were significantly closer to normal values compared to HFHD patients obtained over the course of a dialysis session (p < 0.05). Longitudinal studies revealed stability of nerve excitability findings, and thus maintenance of improved nerve function in the HDF group. Conclusions: This study has provided evidence that nerve excitability in HDF-treated patients is significantly closer to normal values prior to dialysis, across a single dialysis session and at longitudinal follow-up. These findings offer promise for the management of neuropathy in ESKD and should be confirmed in randomised trials.	[Arnold, Ria; Lin, Cindy S-Y.; Krishnan, Arun V.] Univ New S Wales, Translat Neurosci Facil, Sydney, NSW, Australia; [Pussell, Bruce A.; Pianta, Timothy J.; Grinius, Virginija] Prince Wales Hosp, Dept Nephrol, Sydney, NSW, Australia; [Pussell, Bruce A.; Pianta, Timothy J.; Kiernan, Matthew C.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Kiernan, Matthew C.] Neurosci Res Australia, Sydney, NSW, Australia; [Howells, James] Univ Sydney, Sydney, NSW 2006, Australia; [Howells, James] Royal Prince Alfred Hosp, Inst Clin Neurosci, Sydney, NSW, Australia; [Jardine, Meg J.] Concord Repatriat Gen Hosp, Dept Nephrol, Sydney, NSW, Australia; [Jardine, Meg J.] George Inst Global Hlth, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Neuroscience Research Australia; University of Sydney; University of Sydney; Concord Repatriation General Hospital; George Institute for Global Health; University of Sydney	Krishnan, AV (corresponding author), Univ New S Wales, Translat Neurosci Facil, Sydney, NSW, Australia.	arun.krishnan@unsw.edu.au	Kiernan, Matthew C/E-4460-2011; Jardine, Meg/AFR-1699-2022; Jardine, Meg/AAS-1864-2020	Jardine, Meg/0000-0002-0160-2375; Jardine, Meg/0000-0002-0160-2375; Kiernan, Matthew/0000-0001-9054-026X; Pianta, Timothy/0000-0002-9196-4889; Arnold, Ria/0000-0002-7469-6587; Lin, Cindy Shin-Yi/0000-0003-2379-7369; Krishnan, Arun/0000-0001-8883-8825	University of New South Wales; National Health and Medical Research Council of Australia [568680, 630425]; Jacquot Research Establishment Award	University of New South Wales; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Jacquot Research Establishment Award	RA and TP were each supported by an Australian Postgraduate Award from the University of New South Wales. AK was supported by a Career Development Award from the National Health and Medical Research Council of Australia (grant 568680). MJ was supported by a Jacquot Research Establishment Award. Grant support was provided by the National Health and Medical Research Council of Australia (grant 630425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABB AL, 1981, AM J KIDNEY DIS, V1, P46, DOI 10.1016/S0272-6386(81)80011-X; BARRETT EF, 1982, J PHYSIOL-LONDON, V323, P117, DOI 10.1113/jphysiol.1982.sp014064; Bostock H, 2004, NEPHROL DIAL TRANSPL, V19, P1054, DOI 10.1093/ndt/gfh093; BOSTOCK H, 1991, J PHYSIOL-LONDON, V441, P537, DOI 10.1113/jphysiol.1991.sp018766; BURKE D, 1993, MUSCLE NERVE, V16, P1025, DOI 10.1002/mus.880161005; Canaud B, 2006, KIDNEY INT, V69, P2087, DOI 10.1038/sj.ki.5000447; Carracedo J, 2006, J AM SOC NEPHROL, V17, P2315, DOI 10.1681/ASN.2006020105; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Cornblath DR, 1999, NEUROLOGY, V53, P1660, DOI 10.1212/WNL.53.8.1660; Eknoyan G, 1997, KIDNEY INT, V52, P1395; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Filiopoulos V, 2008, AM J NEPHROL, V28, P949, DOI 10.1159/000142724; GOLDSTEIN DA, 1978, J CLIN INVEST, V62, P88, DOI 10.1172/JCI109118; Guth HJ, 2003, INT J ARTIF ORGANS, V26, P181, DOI 10.1177/039139880302600301; Hojs-Fabjan T, 2006, WIEN KLIN WOCHENSCHR, V118, P29, DOI 10.1007/s00508-006-0547-8; Howells J, 2012, J PHYSIOL-LONDON, V590, P1625, DOI 10.1113/jphysiol.2011.225573; Jankelowitz SK, 2007, J PHYSIOL-LONDON, V581, P927, DOI 10.1113/jphysiol.2006.123661; Kiernan MC, 2005, ANN NEUROL, V57, P339, DOI 10.1002/ana.20395; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Kiernan MC, 2002, BRAIN, V125, P1366, DOI 10.1093/brain/awf123; Kiernan MC, 2000, BRAIN, V123, P2542, DOI 10.1093/brain/123.12.2542; Krishnan AV, 2008, J PERIPHER NERV SYST, V13, P7, DOI 10.1111/j.1529-8027.2008.00155.x; Krishnan AV, 2007, MUSCLE NERVE, V35, P273, DOI 10.1002/mus.20713; Krishnan AV, 2006, BRAIN, V129, P1585, DOI 10.1093/brain/awl099; Krishnan AV, 2009, NAT REV NEUROL, V5, P542, DOI 10.1038/nrneurol.2009.138; Krishnan AV, 2006, J NEUROL NEUROSUR PS, V77, P548, DOI 10.1136/jnnp.2005.079988; Krishnan AV, 2005, BRAIN, V128, P2164, DOI 10.1093/brain/awh558; Laaksonen S, 2002, MUSCLE NERVE, V25, P884, DOI 10.1002/mus.10159; Ledebo I, 2008, CLIN KIDNEY J, V1, P403, DOI 10.1093/ndtplus/sfn148; Lehning EJ, 1996, J NEUROCHEM, V66, P493; Lin CSY, 2008, BRAIN, V131, P2510, DOI 10.1093/brain/awn152; Lin CSY, 2011, ARCH NEUROL-CHICAGO, V68, P862, DOI 10.1001/archneurol.2011.137; Lin CL, 2001, BLOOD PURIFICAT, V19, P301, DOI 10.1159/000046958; MALBERTI F, 1991, BLOOD PURIFICAT, V9, P285, DOI 10.1159/000170026; Park SB, 2009, J CLIN ONCOL, V27, P1243, DOI 10.1200/JCO.2008.19.3425; Schiffl H, 2007, EUR J MED RES, V12, P26; SLATOPOLSKY E, 1980, AM J PHYSIOL, V239, pF1, DOI 10.1152/ajprenal.1980.239.1.F1; Stys PK, 2005, J NEUROL SCI, V233, P3, DOI 10.1016/j.jns.2005.03.031; Tilki HE, 2009, J ELECTROMYOGR KINES, V19, P500, DOI 10.1016/j.jelekin.2007.10.011; Van den Neucker K, 1998, Electromyogr Clin Neurophysiol, V38, P467; Vogel W, 1995, AXON; Ward RA, 2000, J AM SOC NEPHROL, V11, P2344, DOI 10.1681/ASN.V11122344	42	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59055	10.1371/journal.pone.0059055	http://dx.doi.org/10.1371/journal.pone.0059055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536855	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100116
J	Menz, MHM; Phillips, RD; Dixon, KW; Peakall, R; Didham, RK				Menz, Myles H. M.; Phillips, Ryan D.; Dixon, Kingsley W.; Peakall, Rod; Didham, Raphael K.			Mate-Searching Behaviour of Common and Rare Wasps and the Implications for Pollen Movement of the Sexually Deceptive Orchids They Pollinate	PLOS ONE			English	Article							REPRODUCTIVE-BEHAVIOR; CALADENIA ORCHIDACEAE; GENETIC-ANALYSIS; EVOLUTION; INFLORESCENCES; SPECIALIZATION; HYMENOPTERA; AUSTRALIA; SYSTEM; RARITY	Pollinator behaviour directly affects patterns of pollen movement and outcrossing rates in plants. In orchids pollinated by sexual deception of insects, patterns of pollen movement are primarily determined by the mate-searching behaviour of the deceived males. Here, using a capture-mark-recapture study (CMR) and dietary analysis, we compare mate-searching behaviour in relation to local abundance of two pollinator species and explore the implications for pollen movement in sexually deceptive Drakaea (Orchidaceae). Drakaea are pollinated solely by the sexual deception of male thynnine wasps. The rare Drakaea elastica and widespread D. livida occur sympatrically and are pollinated by the rare but locally common Zaspilothynnus gilesi, and the widespread and abundant Z. nigripes, respectively. Local abundance was significantly different with Z. nigripes twice as abundant as Z. gilesi. For the 653 marked wasps, there was no significant difference in median movement distance between Z. gilesi and Z. nigripes. However, the maximum movement distance was twice as high for Z. gilesi (556 m) compared with Z. nigripes (267 m). This is up to three times greater than previously reported for thynnines in CMR studies. Recapture rates were six times higher in Z. gilesi (57%) compared to Z. nigripes (9%). Pollen loads and wasp longevity were similar, suggesting that this difference in recapture rate arises due to differences in the number of males moving at a scale >500 m rather than through diet or mortality. Differences in the frequency of longer movements may arise due to variation in the spatial distribution of the wingless females. We predict that pollen movement will largely be restricted to within populations of Drakaea (<500 m), with few movements between populations (>500 m).	[Menz, Myles H. M.; Phillips, Ryan D.; Dixon, Kingsley W.] Bot Gardens & Pk Author, Kings Pk & Bot Garden, Perth, WA, Australia; [Menz, Myles H. M.; Phillips, Ryan D.; Dixon, Kingsley W.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [Menz, Myles H. M.; Phillips, Ryan D.; Peakall, Rod] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Didham, Raphael K.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Didham, Raphael K.] CSIRO Ecosyst Sci, Ctr Environm & Life Sci, Perth, WA, Australia	University of Western Australia; Australian National University; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Menz, MHM (corresponding author), Bot Gardens & Pk Author, Kings Pk & Bot Garden, Perth, WA, Australia.	myles.menz@bgpa.wa.gov.au	Phillips, Ryan/HDM-9720-2022; Didham, Raphael K/B-5953-2011; Menz, Myles H. M./AAP-6756-2020; Dixon, Kingsley W/A-8133-2016; Menz, Myles/A-2238-2017; Peakall, Rod/C-9623-2009; Menz, Myles/HHZ-9580-2022	Menz, Myles H. M./0000-0002-3347-5411; Dixon, Kingsley W/0000-0001-5989-2929; Menz, Myles/0000-0002-3347-5411; Peakall, Rod/0000-0001-9407-8404; Menz, Myles/0000-0002-3347-5411	Holsworth Wildlife Research Endowment; Main Roads Western Australia; Australian Research Council (ARC) [LP098338]	Holsworth Wildlife Research Endowment; Main Roads Western Australia; Australian Research Council (ARC)(Australian Research Council)	This study was funded by the Holsworth Wildlife Research Endowment, Main Roads Western Australia and an Australian Research Council (ARC) Linkage Grant (LP098338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 2000, J NAT HIST, V34, P629, DOI 10.1080/002229300299480; Alcock J, 2005, J NAT HIST, V39, P2809, DOI 10.1080/00222930500114384; ALCOCK J, 1981, J KANSAS ENTOMOL SOC, V54, P681; ALCOCK J, 1978, ZOOL J LINN SOC-LOND, V64, P293, DOI 10.1111/j.1096-3642.1978.tb01075.x; Bowman A., 2010, R PACKAGE SM NONPARA; BROWN AP, 1998, W AUSTR THREATENED F; BURRELL R. W., 1935, JOUR NEW YORK ENT SOC, V43, P19; Department of Environment and Conservation, 2008, GLOSS LEAF HAMM ORCH; Dixon KW, 2009, SCIENCE, V325, P571, DOI 10.1126/science.1176295; Ellis AG, 2010, AM NAT, V176, pE143, DOI 10.1086/656487; Gaskett AC, 2011, BIOL REV, V86, P33, DOI 10.1111/j.1469-185X.2010.00134.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Given BB, 1953, T R ENTOMOL SOC LOND, V105, P1; Goh MZ, 2010, ANIM BEHAV, V80, P391, DOI 10.1016/j.anbehav.2010.05.021; *GOV W AUSTR, 2000, BUSH FOR, V1; Griffiths KE, 2011, MOL PHYLOGENET EVOL, V59, P195, DOI 10.1016/j.ympev.2011.02.004; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; Hagen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019997; Hopper SD, 2007, AUST SYST BOT, V20, P252, DOI 10.1071/SB06033; JANVIER HIPPOLYTE, 1933, ANN SCI NAT ZOOL, V16, P209; Langlois TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045973; Menz MHM, 2011, TRENDS PLANT SCI, V16, P4, DOI 10.1016/j.tplants.2010.09.006; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; PAULUS HF, 1990, ISRAEL J BOT, V39, P43; Peakall R, 1996, EVOLUTION, V50, P2207, DOI 10.1111/j.1558-5646.1996.tb03611.x; PEAKALL R, 1990, FUNCT ECOL, V4, P159, DOI 10.2307/2389335; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2004, BEHAV ECOL SOCIOBIOL, V56, P579, DOI 10.1007/s00265-004-0816-3; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Phillips RD, 2013, J ECOL, V101, P826, DOI 10.1111/1365-2745.12068; Phillips RD, 2011, J ECOL, V99, P858, DOI 10.1111/j.1365-2745.2011.01797.x; Phillips RD, 2011, J BIOGEOGR, V38, P487, DOI 10.1111/j.1365-2699.2010.02413.x; Phillips RD, 2009, AUST J BOT, V57, P287, DOI 10.1071/BT08154; PYKE GH, 1981, ANIM BEHAV, V29, P889, DOI 10.1016/S0003-3472(81)80025-5; PYKE GH, 1978, THEOR POPUL BIOL, V13, P72, DOI 10.1016/0040-5809(78)90036-9; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schiestl FP, 2003, SCIENCE, V302, P437, DOI 10.1126/science.1087835; Schiestl FP, 1999, NATURE, V399, P421, DOI 10.1038/20829; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; SMITH T J R, 1970, Journal of the Australian Entomological Society, V9, P196; SMITH T J R, 1971, Journal of the Australian Entomological Society, V10, P265; SMITH T J R, 1970, Journal of the Australian Entomological Society, V9, P183; Stoutamire W., 1975, American Orchid Society Bulletin, V44, P226; STOUTAMIRE WP, 1983, AUST J BOT, V31, P383, DOI 10.1071/BT9830383; Townsend PA, 2005, ECOLOGY, V86, P466, DOI 10.1890/03-0607; Vereecken NJ, 2012, P ROY SOC B-BIOL SCI, V279, P4786, DOI 10.1098/rspb.2012.1804; Wand M, 2011, KERNSMOOTH FUNCTIONS; Whitehead MR, 2013, BEHAV ECOL, V24, P162, DOI 10.1093/beheco/ars149; Whitehead MR, 2012, AGR FOREST ENTOMOL, V14, P171, DOI 10.1111/j.1461-9563.2011.00556.x; Wikelski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010738; WOOLLER RD, 1983, AUST WILDLIFE RES, V10, P443	51	19	20	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59111	10.1371/journal.pone.0059111	http://dx.doi.org/10.1371/journal.pone.0059111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536860	Green Published, gold			2022-12-25	WOS:000316251100120
J	Wu, YT; Janetopoulos, C				Wu, Yuantai; Janetopoulos, Chris			Systematic Analysis of gamma-Aminobutyric Acid (GABA) Metabolism and Function in the Social Amoeba Dictyostelium discoideum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE-BRAIN; 2 ISOFORMS; EXPRESSION; GENE; TRANSPORTER; DIFFERENTIATION; RECEPTOR; PROTEIN; GENOME; IDENTIFICATION	While GABA has been suggested to regulate spore encapsulation in the social amoeba Dictyostelium discoideum, the metabolic profile and other potential functions of GABA during development remain unclear. In this study, we investigated the homeostasis of GABA metabolism by disrupting genes related to GABA metabolism and signaling. Extracellular levels of GABA are tightly regulated during early development, and GABA is generated by the glutamate decarboxylase, GadB, during growth and in early development. However, overexpression of the prespore-specific homologue, GadA, in the presence of GadB reduces production of extracellular GABA. Perturbation of extracellular GABA levels delays the process of aggregation. Cytosolic GABA is degraded by the GABA transaminase, GabT, in the mitochondria. Disruption of a putative vesicular GABA transporter (vGAT) homologue DdvGAT reduces secreted GABA. We identified the GABAB receptor-like family member GrlB as the major GABA receptor during early development, and either disruption or overexpression of GrlB delays aggregation. This delay is likely the result of an abolished pre-starvation response and late expression of several "early" developmental genes. Distinct genes are employed for GABA generation during sporulation. During sporulation, GadA alone is required for generating GABA and DdvGAT is likely responsible for GABA secretion. GrlE but not GrlB is the GABA receptor during late development.	[Wu, Yuantai; Janetopoulos, Chris] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Janetopoulos, Chris] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Janetopoulos, C (corresponding author), Vanderbilt Univ, Dept Biol Sci, 465 21st Ave South, Nashville, TN 37235 USA.	c.janetopoulos@vanderbilt.edu			National Institutes of Health [GM080370]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080370 (to C. J.).	Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399; Anjard C, 2006, DEVELOPMENT, V133, P2253, DOI 10.1242/dev.02399; Anjard C, 2009, DEVELOPMENT, V136, P803, DOI 10.1242/dev.032607; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Charette SJ, 2004, BIOTECHNIQUES, V36, P574, DOI 10.2144/04364BM01; CLARKE M, 1987, DIFFERENTIATION, V34, P79, DOI 10.1111/j.1432-0436.1987.tb00053.x; DeBiase D, 1996, PROTEIN EXPRES PURIF, V8, P430; Ehrenman K, 2004, J BIOL CHEM, V279, P837, DOI 10.1074/jbc.M310539200; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; Gomer RH, 2011, DEV GROWTH DIFFER, V53, P482, DOI 10.1111/j.1440-169X.2010.01248.x; HADWIGER JA, 1991, P NATL ACAD SCI USA, V88, P8213, DOI 10.1073/pnas.88.18.8213; Heidel AJ, 2011, GENOME RES, V21, P1882, DOI 10.1101/gr.121137.111; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Iranfar N, 2001, MOL BIOL CELL, V12, P2590, DOI 10.1091/mbc.12.9.2590; JAKOBY WB, 1959, J BIOL CHEM, V234, P2145; Journet A, 2012, PROTEOMICS, V12, P241, DOI 10.1002/pmic.201100313; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Kleppner S. R., 2002, ENCY HUMAN BRAIN, P353; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; LIU QR, 1993, J BIOL CHEM, V268, P2106; LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145; LOPEZCORCUERA B, 1992, J BIOL CHEM, V267, P17491; Maeda Y, 2011, DEV GROWTH DIFFER, V53, P463, DOI 10.1111/j.1440-169X.2011.01264.x; Maruo T, 2004, EUKARYOT CELL, V3, P1241, DOI 10.1128/EC.3.5.1241-1248.2004; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MELDRUM BS, 1989, BRIT J CLIN PHARMACO, V27, pS3, DOI 10.1111/j.1365-2125.1989.tb03454.x; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Prabhu Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-44; Prabhu Y, 2007, DEV BIOL, V312, P29, DOI 10.1016/j.ydbio.2007.08.055; Prabhu Y, 2006, EUR J CELL BIOL, V85, P937, DOI 10.1016/j.ejcb.2006.04.003; Reddy PH, 1999, TRENDS NEUROSCI, V22, P248, DOI 10.1016/S0166-2236(99)01415-0; ROBERTS E, 1950, J BIOL CHEM, V187, P55; ROBERTS E, 1953, J BIOL CHEM, V203, P195; Shelp BJ, 2012, TRENDS PLANT SCI, V17, P57, DOI 10.1016/j.tplants.2011.12.006; Sillo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-291; Siu CH, 2011, DEV GROWTH DIFFER, V53, P518, DOI 10.1111/j.1440-169X.2011.01267.x; SNAARJAGALSKA BE, 1991, EUR J BIOCHEM, V195, P715, DOI 10.1111/j.1432-1033.1991.tb15758.x; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; STEWARD FC, 1949, SCIENCE, V110, P439; Sucgang R, 1997, DEV BIOL, V192, P181, DOI 10.1006/dbio.1997.8720; Taniura H, 2006, J BIOL CHEM, V281, P12336, DOI 10.1074/jbc.M512723200	46	9	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15280	15290		10.1074/jbc.M112.427047	http://dx.doi.org/10.1074/jbc.M112.427047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23548898	Green Published, hybrid			2022-12-25	WOS:000319452100054
J	Nambi, S; Gupta, K; Bhattacharyya, M; Ramakrishnan, P; Ravikumar, V; Siddiqui, N; Thomas, AT; Visweswariah, SS				Nambi, Subhalaxmi; Gupta, Kallol; Bhattacharyya, Moitrayee; Ramakrishnan, Parvathy; Ravikumar, Vaishnavi; Siddiqui, Nida; Thomas, Ann Terene; Visweswariah, Sandhya S.			Cyclic AMP-dependent Protein Lysine Acylation in Mycobacteria Regulates Fatty Acid and Propionate Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA SYNTHETASE; SUBSTRATE-SPECIFICITY; NUCLEOTIDE CYCLASES; STRUCTURAL INSIGHTS; METHYLCITRATE CYCLE; IN-VIVO; TUBERCULOSIS; ENZYME; BIOSYNTHESIS; REQUIRES	Acetylation of lysine residues is a posttranslational modification that is used by both eukaryotes and prokaryotes to regulate a variety of biological processes. Here we identify multiple substrates for the cAMP-dependent protein lysine acetyltransferase from Mycobacterium tuberculosis (KATmt). We demonstrate that a catalytically important lysine residue in a number of FadD (fatty acyl CoA synthetase) enzymes is acetylated by KATmt in a cAMP-dependent manner and that acetylation inhibits the activity of FadD enzymes. A sirtuin-like enzyme can deacetylate multiple FadDs, thus completing the regulatory cycle. Using a strain deleted for the KATmt ortholog in Mycobacterium bovis Bacillus Calmette-Guerin (BCG), we show for the first time that acetylation is dependent on intracellular cAMP levels. KATmt can utilize propionyl CoA as a substrate and, therefore, plays a critical role in alleviating propionyl CoA toxicity in mycobacteria by inactivating acyl CoA synthetase (ACS). The precision by which mycobacteria can regulate the metabolism of fatty acids in a cAMP-dependent manner appears to be unparalleled in other biological organisms and is ideally suited to adapt to the complex environment that pathogenic mycobacteria experience in the host.	[Nambi, Subhalaxmi; Ramakrishnan, Parvathy; Ravikumar, Vaishnavi; Siddiqui, Nida; Thomas, Ann Terene; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Gupta, Kallol; Bhattacharyya, Moitrayee] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet	Visweswariah, Sandhya/Q-7500-2019	Visweswariah, Sandhya/0000-0003-2786-7344; Nambi, Subhalaxmi/0000-0001-7104-659X; Siddiqui, Nida/0000-0002-5416-8533; Gupta, Kallol/0000-0002-3557-3242	Department of Biotechnology, Council for Scientific and Industrial Research; Department of Science and Technology, Government of India; Research Associate Fellowship from the Indian Institute of Science	Department of Biotechnology, Council for Scientific and Industrial Research; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Research Associate Fellowship from the Indian Institute of Science	This work was supported by the Department of Biotechnology, Council for Scientific and Industrial Research, by the Department of Science and Technology, Government of India, and by a Research Associate Fellowship from the Indian Institute of Science (to S. N.).	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Andersson CS, 2012, STRUCTURE, V20, P1062, DOI 10.1016/j.str.2012.03.012; Bai G, 2011, CELL MICROBIOL, V13, P349, DOI 10.1111/j.1462-5822.2010.01562.x; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Casabon I, 2013, MOL MICROBIOL, V87, P269, DOI 10.1111/mmi.12095; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crosby HA, 2012, J BIOL CHEM, V287, P41392, DOI 10.1074/jbc.M112.417360; Dam T, 2006, J INFECT DIS, V193, P1135, DOI 10.1086/501469; Dass BKM, 2008, J BACTERIOL, V190, P3824, DOI 10.1128/JB.00138-08; Dormeyer W, 2005, METHODS, V36, P376, DOI 10.1016/j.ymeth.2005.03.006; Duckworth BP, 2012, CURR TOP MED CHEM, V12, P766; Dunphy KY, 2010, J INFECT DIS, V201, P1232, DOI 10.1086/651452; Ferreras JA, 2008, CHEM BIOL, V15, P51, DOI 10.1016/j.chembiol.2007.11.010; Ficner R, 2009, CURR TOP MED CHEM, V9, P235, DOI 10.2174/156802609788085304; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hotter GS, 2005, J BACTERIOL, V187, P2267, DOI 10.1128/JB.187.7.2267-2277.2005; Jatana N, 2011, J MOL MODEL, V17, P301, DOI 10.1007/s00894-010-0727-3; Khare G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008387; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HJ, 2012, NAT STRUCT MOL BIOL, V19, P811, DOI 10.1038/nsmb.2318; Li R, 2011, ACTA BIOCH BIOPH SIN, V43, P891, DOI 10.1093/abbs/gmr076; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; Liu L, 1999, MOL CELL BIOL, V19, P1202; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Nambi S, 2012, J BIOL CHEM, V287, P18115, DOI 10.1074/jbc.M111.328112; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shenoy AR, 2004, COMP FUNCT GENOM, V5, P17, DOI 10.1002/cfg.349; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Simeone R, 2010, FEBS J, V277, P2715, DOI [10.1111/j.1742-4658.2010.07688.x, 10.1111/j.1742-464X.2010.07688.x]; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Thao S, 2011, MBIO, V2, DOI 10.1128/mBio.00216-11; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t	59	77	78	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14114	14124		10.1074/jbc.M113.463992	http://dx.doi.org/10.1074/jbc.M113.463992			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23553634	Green Published, hybrid			2022-12-25	WOS:000319253500016
J	Ringel, P; Krausze, J; van den Heuvel, J; Curth, U; Pierik, AJ; Herzog, S; Mendel, RR; Kruse, T				Ringel, Phillip; Krausze, Joern; van den Heuvel, Joop; Curth, Ute; Pierik, Antonio J.; Herzog, Stephanie; Mendel, Ralf R.; Kruse, Tobias			Biochemical Characterization of Molybdenum Cofactor-free Nitrate Reductase from Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; IN-VITRO FORMATION; ASPERGILLUS-NIDULANS; ESCHERICHIA-COLI; PICHIA-PASTORIS; GENOME SEQUENCE; PROTEIN; PURIFICATION; INVOLVEMENT; MUTANT	Nitrate reductase (NR) is a complex molybdenum cofactor (Moco)-dependent homodimeric metalloenzyme that is vitally important for autotrophic organism as it catalyzes the first and rate-limiting step of nitrate assimilation. Beside Moco, eukaryotic NR also binds FAD and heme as additional redox active cofactors, and these are involved in electron transfer from NAD(P)H to the enzyme molybdenum center where reduction of nitrate to nitrite takes place. We report the first biochemical characterization of a Moco-free eukaryotic NR from the fungus Neurospora crassa, documenting that Moco is necessary and sufficient to induce dimer formation. The molybdenum center of NR reconstituted in vitro from apo-NR and Moco showed an EPR spectrum identical to holo-NR. Analysis of mutants unable to bind heme or FAD revealed that insertion of Moco into NR occurs independent from the insertion of any other NR redox cofactor. Furthermore, we showed that at least in vitro the active site formation of NR is an autonomous process.	[Ringel, Phillip; Herzog, Stephanie; Mendel, Ralf R.; Kruse, Tobias] Braunschweig Univ Technol, Dept Plant Biol, D-38106 Braunschweig, Germany; [Krausze, Joern; van den Heuvel, Joop] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, D-38124 Braunschweig, Germany; [Curth, Ute] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Pierik, Antonio J.] Univ Marburg, Inst Cytobiol & Cytopathol, Core Facil Prot Spect, D-35032 Marburg, Germany	Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Philipps University Marburg	Mendel, RR (corresponding author), Braunschweig Univ Technol, Dept Plant Biol, Humboldt St 1, D-38106 Braunschweig, Germany.	r.mendel@tu-bs.de	Pierik, Antonio J/G-1108-2010	Pierik, Antonio J/0000-0002-1509-6370	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	[Anonymous], PYMOL MOL GRAPH SYST; Barbier GG, 2004, PROTEIN EXPRES PURIF, V37, P61, DOI 10.1016/j.pep.2004.05.021; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell WH, 1999, ANNU REV PLANT PHYS, V50, P277, DOI 10.1146/annurev.arplant.50.1.277; CAMPBELL WH, 1990, TRENDS BIOCHEM SCI, V15, P315, DOI 10.1016/0968-0004(90)90021-3; Campbell WH, 2001, CELL MOL LIFE SCI, V58, P194, DOI 10.1007/PL00000847; DEVRIES SE, 1986, PLANT SCI, V44, P105, DOI 10.1016/0168-9452(86)90078-6; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; EVANS HJ, 1952, ARCH BIOCHEM BIOPHYS, V39, P234, DOI 10.1016/0003-9861(52)90281-6; Fischer K, 2005, PLANT CELL, V17, P1167, DOI 10.1105/tpc.104.029694; Fischer K, 2006, J BIOL CHEM, V281, P30186, DOI 10.1074/jbc.M603919200; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; GARRETT RH, 1969, J BIOL CHEM, V244, P2870; GARRETT RH, 1967, P NATL ACAD SCI USA, V58, P1603, DOI 10.1073/pnas.58.4.1603; Gonzalez C, 1995, MOL GEN GENET, V249, P456; GUTTERIDGE S, 1983, BIOCHEM J, V213, P137, DOI 10.1042/bj2130137; HORNER RD, 1983, BIOCHIM BIOPHYS ACTA, V744, P7, DOI 10.1016/0167-4838(83)90333-3; Ilbert M, 2003, J BIOL CHEM, V278, P28787, DOI 10.1074/jbc.M302730200; KAY CJ, 1990, BIOCHEM J, V272, P545, DOI 10.1042/bj2720545; KAY CJ, 1989, BIOCHEMISTRY-US, V28, P5750, DOI 10.1021/bi00440a008; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KETCHUM PA, 1970, P NATL ACAD SCI USA, V66, P1016, DOI 10.1073/pnas.66.3.1016; KETCHUM PA, 1973, J BACTERIOL, V116, P600, DOI 10.1128/JB.116.2.600-609.1973; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lanciano P, 2007, J BIOL CHEM, V282, P17468, DOI 10.1074/jbc.M700994200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laue M. T., 1991, ANAL ULTRACENTRIFUGA, P90; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lillo C, 2004, J EXP BOT, V55, P1275, DOI 10.1093/jxb/erh132; Macheroux P, 1999, METH MOL B, V131, P1; Magalon A, 2011, COORDIN CHEM REV, V255, P1159, DOI 10.1016/j.ccr.2010.12.031; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; MCDONALD DW, 1974, EUR J BIOCHEM, V46, P169, DOI 10.1111/j.1432-1033.1974.tb03609.x; Mendel RR, 2012, BBA-MOL CELL RES, V1823, P1568, DOI 10.1016/j.bbamcr.2012.02.007; Mertens JA, 2000, PLANT PHYSIOL, V123, P743, DOI 10.1104/pp.123.2.743; MINAGAWA N, 1982, J BIOCHEM, V91, P761, DOI 10.1093/oxfordjournals.jbchem.a133763; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; NASON A, 1970, P NATL ACAD SCI USA, V65, P137, DOI 10.1073/pnas.65.1.137; NUSSAUME L, 1995, PLANT CELL, V7, P611, DOI 10.1105/tpc.7.5.611; OKAMOTO PM, 1991, MOL GEN GENET, V227, P213, DOI 10.1007/BF00259673; Orme-Johnson W. H., 1980, MOLYBDENUM MOLYBDENU, P327; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; PAN SS, 1978, BIOCHIM BIOPHYS ACTA, V523, P297, DOI 10.1016/0005-2744(78)90033-5; Poll A.M., 1991, PLANT SCI LIMERICK, V76, P201; REDINBAUGH MG, 1985, J BIOL CHEM, V260, P3380; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; Zhao H., 2013, ANAL BIOCH IN PRESS	54	17	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14657	14671		10.1074/jbc.M113.457960	http://dx.doi.org/10.1074/jbc.M113.457960			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23539622	hybrid, Green Published			2022-12-25	WOS:000319253500065
J	Yang, L; Sha, HB; Davisson, RL; Qi, L				Yang, Liu; Sha, Haibo; Davisson, Robin L.; Qi, Ling			Phenformin Activates the Unfolded Protein Response in an AMP-activated Protein Kinase (AMPK)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; GENE-EXPRESSION; CELL FATE; INHIBITION; APOPTOSIS; PHOSPHORYLATION; PATHWAY; IRE1; PERK	Activation of the unfolded protein response (UPR) is associated with the disruption of endoplasmic reticulum (ER) homeostasis and has been implicated in the pathogenesis of many human metabolic diseases, including obesity and type 2 diabetes. However, the nature of the signals activating UPR under these conditions remains largely unknown. Using a method that we recently optimized to directly measure UPR sensor activation, we screened the effect of various metabolic drugs on UPR activation and show that the anti-diabetic drug phenformin activates UPR sensors IRE1 alpha and pancreatic endoplasmic reticulum kinase (PERK) in both an ER-dependent and ER-independent manner. Mechanistically, AMP-activated protein kinase (AMPK) activation is required but not sufficient to initiate phenformin-mediated IRE1 alpha and PERK activation, suggesting the involvement of additional factor(s). Interestingly, activation of the IRE1 alpha (but not PERK) pathway is partially responsible for the cytotoxic effect of phenformin. Together, our data show the existence of a non-canonical UPR whose activation requires the cytosolic kinase AMPK, adding another layer of complexity to UPR activation upon metabolic stress.	[Yang, Liu; Qi, Ling] Cornell Univ, Coll Vet Med, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Sha, Haibo; Qi, Ling] Cornell Univ, Coll Vet Med, Div Nutr Sci, Ithaca, NY 14853 USA; [Davisson, Robin L.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Qi, L (corresponding author), Cornell Univ, Coll Vet Med, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA.	lq35@cornell.edu		Qi, Ling/0000-0001-8229-0184	National Institutes of Health [R01 DK082582, R21 AA020351]; American Diabetes Association [7-08-JF-46, 1-12-CD-04]; American Heart Association [12PRE9400033]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207, R01HL063887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA020351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK082582 and R21 AA020351 (to L. Q.). This work was also supported by American Diabetes Association Grants 7-08-JF-46 and 1-12-CD-04 (to L. Q.).; Supported in part by American Heart Association Founders Affiliate Predoctoral Fellowship 12PRE9400033.	Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Appleyard MVCL, 2012, BRIT J CANCER, V106, P1117, DOI 10.1038/bjc.2012.56; ASSAN R, 1975, DIABETES, V24, P791, DOI 10.2337/diabetes.24.9.791; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Caraci F, 2003, LIFE SCI, V74, P643, DOI 10.1016/j.lfs.2003.07.015; CHANCE B, 1963, J BIOL CHEM, V238, P418; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; DAVIDOFF F, 1968, J CLIN INVEST, V47, P2331, DOI 10.1172/JCI105918; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Dong YZ, 2010, DIABETES, V59, P1386, DOI 10.2337/db09-1637; Gomez E, 2008, BIOCHEM J, V410, P485, DOI 10.1042/BJ20071367; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; He Y, 2010, GENE EXPRESSION, V15, P13, DOI 10.3727/105221610X12819686555051; He Y, 2012, J SYST ENG ELECTRON, V23, P1, DOI 10.1109/JSEE.2012.00001; Heishi M, 2008, J TOXICOL SCI, V33, P339, DOI 10.2131/jts.33.339; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee EK, 2012, NEPHRON EXP NEPHROL, V121, pE38, DOI 10.1159/000342802; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu J, 2012, ENDOCRINOLOGY, V153, P5275, DOI 10.1210/en.2012-1418; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; Meares GP, 2011, MOL CELL BIOL, V31, P4286, DOI 10.1128/MCB.05668-11; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qi L, 2011, METHOD ENZYMOL, V490, P137, DOI 10.1016/B978-0-12-385114-7.00008-8; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Quentin T, 2012, DIS MODEL MECH, V5, P259, DOI 10.1242/dmm.008110; Sha HB, 2011, TRENDS ENDOCRIN MET, V22, P374, DOI 10.1016/j.tem.2011.05.002; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; SOLS A, 1954, J BIOL CHEM, V210, P581; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Xue Z, 2011, J BIOL CHEM, V286, P30859, DOI 10.1074/jbc.M111.273714; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621; Young CN, 2012, J CLIN INVEST, V122, P3960, DOI 10.1172/JCI64583; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	54	19	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13631	13638		10.1074/jbc.M113.462762	http://dx.doi.org/10.1074/jbc.M113.462762			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23548904	Green Published, hybrid			2022-12-25	WOS:000318850300045
J	Zimmerman, MW; Homanics, GE; Lazo, JS				Zimmerman, Mark W.; Homanics, Gregg E.; Lazo, John S.			Targeted Deletion of the Metastasis-Associated Phosphatase Ptp4a3 (PRL-3) Suppresses Murine Colon Cancer	PLOS ONE			English	Article							TYROSINE PHOSPHATASE; MUTANT MICE; MOUSE MODEL; EXPRESSION; CARCINOGENESIS; INVASION; PROTEIN; 1,2-DIMETHYLHYDRAZINE; TUMORS; BETA	Ptp4a3 (commonly known as PRL-3) is an enigmatic member of the Ptp4a family of prenylated protein tyrosine phosphatases that are highly expressed in many human cancers. Despite strong correlations with tumor metastasis and poor patient prognosis, there is very limited understanding of this gene family's role in malignancy. Therefore, we created a gene-targeted murine knockout model for Ptp4a3, the most widely studied Ptp4a family member. Mice deficient for Ptp4a3 were grossly normal. Fewer homozygous-null males were observed at weaning, however, and they maintained a decreased body mass. Although Ptp4a3 is normally associated with late-stage cancer and metastasis, we observed increased Ptp4a3 expression in the colon of wildtype mice immediately following treatment with the carcinogen azoxymethane. To investigate the role of Ptp4a3 in malignancy, we used the most commonly studied murine colitis-associated colon cancer model. Wildtype mice treated with azoxymethane and dextran sodium sulfate developed approximately 7-10 tumors per mouse in the distal colon. The resulting tumor tissue had 4-fold more Ptp4a3 mRNA relative to normal colon epithelium and increased PTP4A3 protein. Ptp4a3-null mice developed 50% fewer colon tumors than wildtype mice after exposure to azoxymethane and dextran sodium sulfate. Tumors from the Ptp4a3-null mice had elevated levels of both IGF1R beta and c-MYC compared to tumors replete with Ptp4a3, suggesting an enhanced cell signaling pathway engagement in the absence of the phosphatase. These results provide the first definitive evidence implicating Ptp4a3 in colon tumorigenesis and highlight the potential value of the phosphatase as a therapeutic target for early stage malignant disease.	[Zimmerman, Mark W.; Homanics, Gregg E.; Lazo, John S.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Homanics, Gregg E.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Lazo, John S.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia	Lazo, JS (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	lazo@virginia.edu		Homanics, Gregg/0000-0003-3641-8153	National Institutes of Health [AA10422, F31AA019597A]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010422, R37AA010422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This was funded by National Institutes of Health grant AA10422 and fellowship F31AA019597A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; De Robertis M., 2011, J CARCINOG, V10; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Dong Y, 2012, AKT J BIOL IN PRESS; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Goo K, 2006, CANCER RES, V66, P9625, DOI 10.1158/0008-5472.CAN-06-0726; Guda K, 2003, MOL CARCINOGEN, V37, P51, DOI 10.1002/mc.10120; Guzinska-Ustymowicz K, 2011, ANTI-CANCER AGENT ME, V11, P99, DOI 10.2174/187152011794941145; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Kanneganti M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/342637; Kohno H, 2005, CANCER SCI, V96, P69, DOI 10.1111/j.1349-7006.2005.00020.x; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; McParland V, 2011, BIOCHEMISTRY-US, V50, P7579, DOI 10.1021/bi201095z; Mollevi DG, 2008, BRIT J CANCER, V99, P1718, DOI 10.1038/sj.bjc.6604747; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Ooki A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-122; OTOOLE SM, 1993, CANCER RES, V53, P3895; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Reich R, 2011, INT J MOL SCI, V12, P1133, DOI 10.3390/ijms12021133; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Zhao WB, 2008, INT J MOL MED, V22, P187, DOI 10.3892/ijmm_00000007; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	30	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58300	10.1371/journal.pone.0058300	http://dx.doi.org/10.1371/journal.pone.0058300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555575	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000317262200004
J	Bevacqua, S; Cerasti, E; Falcone, R; Cervelloni, M; Brunamonti, E; Ferraina, S; Genovesio, A				Bevacqua, Sara; Cerasti, Erika; Falcone, Rossella; Cervelloni, Milena; Brunamonti, Emiliano; Ferraina, Stefano; Genovesio, Aldo			Macaque Monkeys Can Learn Token Values from Human Models through Vicarious Reward	PLOS ONE			English	Article							CEBUS-APELLA; CAPUCHIN MONKEYS; RHESUS-MONKEYS; IMITATION; PRIMATES; CUES	Monkeys can learn the symbolic meaning of tokens, and exchange them to get a reward. Monkeys can also learn the symbolic value of a token by observing conspecifics but it is not clear if they can learn passively by observing other actors e.g., humans. To answer this question, we tested two monkeys in a token exchange paradigm in three experiments. Monkeys learned token values through observation of human models exchanging them. We used, after a phase of object familiarization, different sets of tokens. One token of each set was rewarded with a bit of apple. Other tokens had zero value neutral tokens). Each token was presented only in one set. During the observation phase, monkeys watched the human model exchange tokens and watched them consume rewards (vicarious rewards). In the test phase, the monkeys were asked to exchange one of the tokens for food reward. Sets of three tokens were used in the first experiment and sets of two tokens were used in the second and third experiments. The valuable token was presented with different probabilities in the observation phase during the first and second experiments in which the monkeys exchanged the valuable token more frequently than any of the neutral tokens. The third experiments examined the effect of unequal probabilities. Our results support the view that monkeys can learn from non-conspecific actors through vicarious reward, even a symbolic task like the token-exchange task.	[Bevacqua, Sara; Cerasti, Erika; Falcone, Rossella; Cervelloni, Milena; Brunamonti, Emiliano; Ferraina, Stefano; Genovesio, Aldo] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy	Sapienza University Rome	Genovesio, A (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy.	aldo.genovesio@uniroma1.it	ferraina, stefano/M-5230-2018	ferraina, stefano/0000-0001-6100-2438; FALCONE, ROSSELLA/0000-0001-5068-2984; Genovesio, Aldo/0000-0003-2521-143X; Brunamonti, Emiliano/0000-0002-5119-6950	'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie [P288/09]	'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie	This work was supported by the 'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie (Protocol number: P288/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addessi E, 2007, P ROY SOC B-BIOL SCI, V274, P2579, DOI 10.1098/rspb.2007.0726; [Anonymous], 1956, LEARNING INSTINCT AN; Bandura A., 1971, SOCIAL LEARNING THEO; Bourjade M, 2012, ANIM COGN, V15, P783, DOI 10.1007/s10071-012-0502-1; Brosnan SF, 2005, PRIMATES, V46, P173, DOI 10.1007/s10329-005-0125-0; Brosnan SF, 2004, FOLIA PRIMATOL, V75, P317, DOI 10.1159/000080209; Brosnan SF, 2004, J COMP PSYCHOL, V118, P133, DOI 10.1037/0735-7036.118.2.133; Davis KM, 2011, J COMP PSYCHOL, V125, P404, DOI 10.1037/a0024784; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; Evans TA, 2010, J COMP PSYCHOL, V124, P369, DOI 10.1037/a0019855; Falcone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040283; Falcone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032209; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kohts N, 1935, SCI MEMOIRS MUSCUM D; Kumashiro M, 2003, INT J PSYCHOPHYSIOL, V50, P81, DOI 10.1016/S0167-8760(03)00126-0; Leadbeater E, 2009, BIOL LETTERS, V5, P310, DOI 10.1098/rsbl.2008.0692; Meunier M, 2007, NEUROBIOL LEARN MEM, V88, P243, DOI 10.1016/j.nlm.2007.04.015; Miklosi A, 1999, BIOL REV, V74, P347, DOI 10.1017/S000632319900537X; Monfardini E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00127; Paukner A, 2005, BIOL LETTERS, V1, P219, DOI 10.1098/rsbl.2004.0291; Pele M, 2010, ANIM COGN, V13, P745, DOI 10.1007/s10071-010-0325-x; Schuster S, 2006, CURR BIOL, V16, P378, DOI 10.1016/j.cub.2005.12.037; Spence KW, 1937, PSYCHOL BULL, V34, P806, DOI 10.1037/h0061498; Westergaard GC, 2004, ANIM COGN, V7, P19, DOI 10.1007/s10071-003-0181-z; Westergaard Gregory Charles, 1998, Animal Cognition, V1, P101, DOI 10.1007/s100710050014; Wolfe JB., 1936, COMP PSYCHOL MONOGR, V12, P72; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004; ZENTALL TR, 1972, SCIENCE, V178, P1220, DOI 10.1126/science.178.4066.1220	32	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59961	10.1371/journal.pone.0059961	http://dx.doi.org/10.1371/journal.pone.0059961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544115	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700074
J	Greenway, KT; LeGresley, EB; Pinto, BM				Greenway, Kyle T.; LeGresley, Eric B.; Pinto, B. Mario			The Influence of 150-Cavity Binders on the Dynamics of Influenza A Neuraminidases as Revealed by Molecular Dynamics Simulations and Combined Clustering	PLOS ONE			English	Article							BINDING; N1; OSELTAMIVIR; INHIBITORS; DESIGN	Neuraminidase inhibitors are the main pharmaceutical agents employed for treatments of influenza infections. The neuraminidase structures typically exhibit a 150-cavity, an exposed pocket that is adjacent to the catalytic site. This site offers promising additional contact points for improving potency of existing pharmaceuticals, as well as generating entirely new candidate inhibitors. Several inhibitors based on known compounds and designed to interact with 150 cavity residues have been reported. However, the dynamics of any of these inhibitors remains unstudied and their viability remains unknown. This work reports the outcome of long-term, all-atom molecular dynamics simulations of four such inhibitors, along with three standard inhibitors for comparison. Each is studied in complex with four representative neuraminidase structures, which are also simulated in the absence of ligands for comparison, resulting in a total simulation time of 9.6 mu s. Our results demonstrate that standard inhibitors characteristically reduce the mobility of these dynamic proteins, while the 150-binders do not, instead giving rise to many unique conformations. We further describe an improved RMSD-based clustering technique that isolates these conformations - the structures of which are provided to facilitate future molecular docking studies - and reveals their interdependence. We find that this approach confers many advantages over previously described techniques, and the implications for rational drug design are discussed.	[Greenway, Kyle T.; LeGresley, Eric B.; Pinto, B. Mario] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Pinto, BM (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	bpinto@sfu.ca		Greenway, Kyle/0000-0002-7829-493X; LeGresley, Eric/0000-0002-5286-5693	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	KTG received a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). BMP received funding from the same organization. All calculations were performed with the resources of Compute Canada (https://computecanada.ca/index.php/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RE, 2007, J AM CHEM SOC, V129, P7764, DOI 10.1021/ja0723535; Amaro RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1390; [Anonymous], PYMOL MOL GRAPH SYST; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Du J, 2012, DRUG DISCOV TODAY, V17, P1111, DOI 10.1016/j.drudis.2012.06.002; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Frisch M.J., 2016, GAUSSIAN; Garcia-Sosa AT, 2008, J CHEM INF MODEL, V48, P2074, DOI 10.1021/ci800242z; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jefferson T, 2011, COCHRANE DB SYST REV, V2011; Kar P, 2012, J PHYS CHEM B, V116, P6137, DOI 10.1021/jp3022612; Lawrenz M, 2010, PROTEINS, V78, P2523, DOI 10.1002/prot.22761; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; Li Y, 2009, J MOL GRAPH MODEL, V28, P203, DOI 10.1016/j.jmgm.2009.07.001; Mohan S, 2010, J MED CHEM, V53, P7377, DOI 10.1021/jm100822f; Park JW, 2010, EUR J MED CHEM, V45, P536, DOI 10.1016/j.ejmech.2009.10.040; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Rudrawar S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1114; Rungrotmongkol T, 2009, ANTIVIR RES, V82, P51, DOI 10.1016/j.antiviral.2009.01.008; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Udommaneethanakit T, 2009, J CHEM INF MODEL, V49, P2323, DOI 10.1021/ci900277r; Vavricka CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002249; Venkatramani L, 2006, J MOL BIOL, V356, P651, DOI 10.1016/j.jmb.2005.11.061; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wen WH, 2010, BIOORGAN MED CHEM, V18, P4074, DOI 10.1016/j.bmc.2010.04.010; Ye DJ, 2012, EUR J MED CHEM, V54, P764, DOI 10.1016/j.ejmech.2012.06.033	37	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59873	10.1371/journal.pone.0059873	http://dx.doi.org/10.1371/journal.pone.0059873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544106	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700066
J	Jaakkonen, T; Kari, A; Forsman, JT				Jaakkonen, Tuomo; Kari, Annemari; Forsman, Jukka T.			Flycatchers Copy Conspecifics in Nest-Site Selection but Neither Personal Experience nor Frequency of Tutors Have an Effect	PLOS ONE			English	Article							BREEDING HABITAT SELECTION; PUBLIC INFORMATION; INVESTMENT DECISIONS; COLLARED FLYCATCHER; ADAPTIVE USE; FITNESS; CHIMPANZEES; COMPETITOR; PREFERENCE; EVOLUTION	Using the behavior of others in guiding one's own behavior is a common strategy in animals. The prevailing theory predicts that young age and the inexperience of an individual are expected to increase the probability of adopting the behaviors of others. Also, the most common behavior in the population should be copied. Here, we tested the above predictions by examining social information use in the selection of nest-site features with a field experiment using a wild cavity nesting bird, the collared flycatcher (Ficedula albicollis). We used an experimental design in which geometric symbols depict nest-site features. By manipulating the apparent symbol choices of early settled individuals and monitoring the choices of later arriving birds, we can study social information use without bias from learned or innate Preferences. Flycatchers were found to use social information in the selection of nest site features, with about 60% of the population preferring the manipulated conspecific choices. However, age and experience as explanatory factors suggested by the social information use theory did not explain the choices. The present result, in concert with earlier similar experiments, implies that flycatchers may in some situations rely more on iriterspecific information in the selection of nest-site characteristics.	[Jaakkonen, Tuomo; Kari, Annemari; Forsman, Jukka T.] Univ Oulu, Dept Biol, Oulu, Finland	University of Oulu	Jaakkonen, T (corresponding author), Univ Oulu, Dept Biol, Oulu, Finland.	tuomo.jaakkonen@oulu.fi; jukka.forsman@oulu.fi			Academy of Finland [122665, 125720]; Ella and Georg Ehrnrooth Foundation	Academy of Finland(Academy of Finland); Ella and Georg Ehrnrooth Foundation	This work was funded by the Academy of Finland (project numbers 122665 and 125720) and Ella and Georg Ehrnrooth Foundation (May 2011, May 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatalo RV, 1996, NATURE, V382, P708, DOI 10.1038/382708a0; ALATALO RV, 1982, BIRD BEHAV, V4, P42, DOI 10.3727/015613882791560576; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Coolen I, 2003, P ROY SOC B-BIOL SCI, V270, P2413, DOI 10.1098/rspb.2003.2525; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doligez B, 2004, J ANIM ECOL, V73, P75, DOI 10.1111/j.1365-2656.2004.00782.x; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Doligez B, 1999, J ANIM ECOL, V68, P1193, DOI 10.1046/j.1365-2656.1999.00362.x; Dubois F, 2012, P ROY SOC B-BIOL SCI, V279, P1977, DOI 10.1098/rspb.2011.2342; Forsman JT, 2002, P ROY SOC B-BIOL SCI, V269, P1619, DOI 10.1098/rspb.2002.2065; Forsman JT, 2008, BEHAV ECOL, V19, P539, DOI 10.1093/beheco/arn005; Forsman JT, 2012, BIOL LETTERS, V8, P341, DOI 10.1098/rsbl.2011.0970; Forsman JT, 2011, ANIM BEHAV, V81, P879, DOI 10.1016/j.anbehav.2011.01.029; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; Kendal RL, 2005, ADV STUD BEHAV, V35, P333, DOI 10.1016/S0065-3454(05)35008-X; Laland KN, 1998, BEHAV ECOL, V9, P493, DOI 10.1093/beheco/9.5.493; Laland KN, 2004, LEARN BEHAV, V32, P4; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; Martin TE, 1996, NATURE, V380, P338, DOI 10.1038/380338a0; Morand-Ferron J, 2011, P ROY SOC B-BIOL SCI, V278, P1223, DOI 10.1098/rspb.2010.1769; Nordell SE, 1998, ECOL LETT, V1, P74; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Seppanen JT, 2007, CURR BIOL, V17, P1248, DOI 10.1016/j.cub.2007.06.034; Seppanen JT, 2011, P ROY SOC B-BIOL SCI, V278, P1736, DOI 10.1098/rspb.2010.1610; Svensson L., 1992, IDENTIFICATION GUIDE; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Venables W., 2013, MODERN APPL STAT S, V53, P86; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023; Zuberbuhler K, 2000, P ROY SOC B-BIOL SCI, V267, P713, DOI 10.1098/rspb.2000.1061	33	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60395	10.1371/journal.pone.0060395	http://dx.doi.org/10.1371/journal.pone.0060395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544136	gold, Green Published			2022-12-25	WOS:000317480700095
J	Sheard, JM; Ash, S; Mellick, GD; Silburn, PA; Kerr, GK				Sheard, Jamie M.; Ash, Susan; Mellick, George D.; Silburn, Peter A.; Kerr, Graham K.			Markers of Disease Severity Are Associated with Malnutrition in Parkinson's Disease	PLOS ONE			English	Article							BODY-COMPOSITION; OLDER-ADULTS; NUTRITIONAL-STATUS; WEIGHT-LOSS; HOME; RISK; CARE; INTERVENTION; PROGRESSION; PREVALENCE	Objective: In Parkinson's disease (PD), commonly reported risk factors for malnutrition in other populations commonly occur. Few studies have explored which of these factors are of particular importance in malnutrition in PD. The aim was to identify the determinants of nutritional status in people with Parkinson's disease (PWP). Methods: Community-dwelling PWP (>18 years) were recruited (n=125; 73M/52F; Mdn 70 years). Self-report assessments included Beck's Depression Inventory (BDI), Spielberger Trait Anxiety Inventory (STAI), Scales for Outcomes in Parkinson's disease - Autonomic (SCOPA-AUT), Modified Constipation Assessment Scale (MCAS) and Freezing of Gait Questionnaire (FOG-Q). Information about age, PD duration, medications, co-morbid conditions and living situation was obtained. Addenbrooke's Cognitive Examination (ACE-R), Unified Parkinson's Disease Rating Scale (UPDRS) II and UPDRS III were performed. Nutritional status was assessed using the Subjective Global Assessment (SGA) as part of the scored Patient-Generated Subjective Global Assessment (PG-SGA). Results: Nineteen (15%) were malnourished (SGA-B). Median PG-SGA score was 3. More of the malnourished were elderly (84% vs. 71%) and had more severe disease (H&Y: 21% vs. 5%). UPDRS II and UPDRS III scores and levodopa equivalent daily dose (LEDD)/body weight(mg/kg) were significantly higher in the malnourished (Mdn 18 vs. 15; 20 vs. 15; 10.1 vs. 7.6 respectively). Regression analyses revealed older age at diagnosis, higher LEDD/body weight (mg/kg), greater UPDRS III score, lower STAI score and higher BDI score as significant predictors of malnutrition (SGA-B). Living alone and higher BDI and UPDRS III scores were significant predictors of a higher log-adjusted PG-SGA score. Conclusions: In this sample of PWP, the rate of malnutrition was higher than that previously reported in the general community. Nutrition screening should occur regularly in those with more severe disease and depression. Community support should be provided to PWP living alone. Dopaminergic medication should be reviewed with body weight changes.	[Sheard, Jamie M.; Ash, Susan; Kerr, Graham K.] Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia; [Sheard, Jamie M.; Kerr, Graham K.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Movement Neurosci Program, Brisbane, Qld 4001, Australia; [Mellick, George D.] Griffith Univ, Australia Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Silburn, Peter A.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Griffith University; University of Queensland	Sheard, JM (corresponding author), Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia.	jamie.sheard@qut.edu.au	Ash, Susan/I-9664-2012; Mellick, George D./A-7650-2010	Ash, Susan/0000-0003-2078-7560; Mellick, George D./0000-0002-7211-4651; Sheard, Jamie/0000-0002-1730-4831; Kerr, Graham/0000-0002-1008-256X	Parkinson's Queensland, Inc.	Parkinson's Queensland, Inc.	Parkinson's Queensland, Inc. (http://parkinsons-qld.org.au/) provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders did advertise the study in their newsletter and on their website for the purpose of recruiting participants.	Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Alves G, 2005, NEUROLOGY, V65, P1436, DOI 10.1212/01.wnl.0000183359.50822.f2; [Anonymous], 2009, NUTR DIET, V66, pS1; Arabia G, 2002, NEUROL SCI, V23, pS53, DOI 10.1007/s100720200066; Bachmann CG, 2009, EUR J NEUROL, V16, P895, DOI 10.1111/j.1468-1331.2009.02617.x; Bauer J, 2002, EUR J CLIN NUTR, V56, P779, DOI 10.1038/sj.ejcn.1601412; BEYER PL, 1995, J AM DIET ASSOC, V95, P979, DOI 10.1016/S0002-8223(95)00269-3; Buchanan RJ, 2002, PARKINSONISM RELAT D, V8, P369, DOI 10.1016/S1353-8020(02)00004-4; Campbell KL, 2008, AM J KIDNEY DIS, V51, P748, DOI 10.1053/j.ajkd.2007.12.015; Campbell KL, 2007, J RENAL NUTR, V17, P189, DOI 10.1053/j.jrn.2006.12.005; Christensson L, 2002, EUR J CLIN NUTR, V56, P810, DOI 10.1038/sj.ejcn.1601394; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Dissanayaka NNW, 2011, J AFFECT DISORDERS, V132, P82, DOI 10.1016/j.jad.2011.01.021; EDWARDS LL, 1991, MOVEMENT DISORD, V6, P151, DOI 10.1002/mds.870060211; Elia M, 2005, NUTRITION, V21, P1100, DOI 10.1016/j.nut.2005.03.005; Encarnacion EV, 2008, EUR NEUROL, V60, P57, DOI 10.1159/000131893; Endevelt R, 2011, J NUTR HEALTH AGING, V15, P624, DOI 10.1007/s12603-011-0074-9; Evatt ML, 2009, MOVEMENT DISORD, V24, P635, DOI 10.1002/mds.22260; Guest JF, 2011, CLIN NUTR, V30, P422, DOI 10.1016/j.clnu.2011.02.002; Johansson Y, 2009, J CLIN NURS, V18, P1354, DOI 10.1111/j.1365-2702.2008.02552.x; Laky B, 2008, AM J CLIN NUTR, V87, P1678, DOI 10.1093/ajcn/87.6.1678; Landi F, 2012, J NUTR HEALTH AGING, V16, P79, DOI 10.1007/s12603-011-0064-y; Leggo M, 2008, NUTR DIET, V65, P162, DOI 10.1111/j.1747-0080.2008.00239.x; Loewdalt B, 2006, GERONTOLOGY, V52, P160, DOI 10.1159/000091825; Mamhidir AG, 2006, J NUTR HEALTH AGING, V10, P255; Miller M., 2000, Australian Journal of Nutrition and Dietetics, V57, P152; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; Ottery F, 2000, CLIN GUIDE ONCOLOGY, P11; Pai MK, 2011, BIOMED RES-INDIA, V22, P120; Parker BA, 2004, MECH AGEING DEV, V125, P859, DOI 10.1016/j.mad.2004.05.006; Poewe W, 2007, J NEUROL, V254, P49, DOI 10.1007/s00415-007-5008-4; Post B, 2007, MOVEMENT DISORD, V22, P1839, DOI 10.1002/mds.21537; Rolland Y, 2008, J NUTR HEALTH AGING, V12, P433, DOI 10.1007/BF02982704; Saka B, 2010, CLIN NUTR, V29, P745, DOI 10.1016/j.clnu.2010.04.006; SCOTT DM, 2009, DRUG TOP, V153, P40; Sharma JC, 2010, PARKINSONISM RELAT D, V16, P490, DOI 10.1016/j.parkreldis.2010.06.003; Sharma JC, 2006, PARKINSONISM RELAT D, V12, P499, DOI 10.1016/j.parkreldis.2006.07.002; Shatenstein B, 2001, J GERONTOL A-BIOL, V56, pM483, DOI 10.1093/gerona/56.8.M483; Sheard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053290; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Thomas P, 2003, J Nutr Health Aging, V7, P166; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Uc EY, 2006, MOVEMENT DISORD, V21, P930, DOI 10.1002/mds.20837; van der Marck MA, 2012, PARKINSONISM RELAT D, V18, P263, DOI 10.1016/j.parkreldis.2011.10.016; Verbaan D, 2007, NEUROLOGY, V69, P333, DOI 10.1212/01.wnl.0000266593.50534.e8; Visvanathan R, 2003, J AM GERIATR SOC, V51, P1007, DOI 10.1046/j.1365-2389.2003.51317.x; Wang G, 2010, PARKINSONISM RELAT D, V16, P119, DOI 10.1016/j.parkreldis.2009.08.009	47	39	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e57986	10.1371/journal.pone.0057986	http://dx.doi.org/10.1371/journal.pone.0057986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544041	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700004
J	Velo, P; Leiras, R; Canedo, A				Velo, Patricia; Leiras, Roberto; Canedo, Antonio			Electrophysiological Study of Supraspinal Input and Spinal Output of Cat's Subnucleus Reticularis Dorsalis (SRD) Neurons	PLOS ONE			English	Article							PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; ADJACENT CUNEATE NUCLEUS; DESCENDING PROJECTIONS; EFFERENT PROJECTIONS; BRAIN-STEM; RETICULOSPINAL NEURONS; NOCICEPTIVE NEURONS; CONDUCTION-VELOCITY; RAT; HORN	This work addressed the study of subnucleus reticularis dorsalis (SRD) neurons in relation to their supraspinal input and the spinal terminating sites of their descending axons. SRD extracellular unitary recordings from anesthetized cats aimed to specifically test, 1) the rostrocaudal segmental level reached by axons of spinally projecting (SPr) neurons collateralizing or not to or through the ipsilateral nucleus reticularis gigantocellularis (NRGc), 2) whether SPr fibers bifurcate to the thalamus, and 3) the effects exerted on SRD cells by electrically stimulating the locus coeruleus, the periaqueductal grey, the nucleus raphe magnus, and the mesencephalic locomotor region. From a total of 191 SPr fibers tested to cervical 2 (Ce2), thoracic 5 (Th5) and lumbar5 (Lu5) stimulation, 81 ended between Ce2 and Th5 with 39 of them branching to or through the NRGc; 21/49 terminating between Th5 and Lu5 collateralized to or through the same nucleus, as did 34/61 reaching Lu5. The mean antidromic conduction velocity of SPr fibers slowed in the more proximal segments and increased with terminating distance along the cord. None of the 110 axons tested sent collaterals to the thalamus; instead thalamic stimulation induced long-latency polysynaptic responses in most cells but also short-latency, presumed monosynaptic, in 7.9% of the tested neurons (18/227). Antidromic and orthodromic spikes were elicited from the locus coeruleus and nucleus raphe magnus, but exclusively orthodromic responses were observed following stimulation of the periaqueductal gray or mesencephalic locomotor region. The results suggest that information from pain-and-motor-related supraspinal structures converge on SRD cells that through SPr axons having conduction velocities tuned to their length may affect rostral and caudal spinal cord neurons at fixed delays, both directly and in parallel through different descending systems. The SRD will thus play a dual functional role by simultaneously regulating dorsal horn ascending noxious information and pain-related motor responses.	[Velo, Patricia; Leiras, Roberto; Canedo, Antonio] Fac Med, Dept Physiol, Santiago De Compostela, Spain		Canedo, A (corresponding author), Fac Med, Dept Physiol, Santiago De Compostela, Spain.	antonio.canedo@usc.es		Canedo, Antonio/0000-0002-1728-3954; Leiras, Roberto/0000-0001-7232-2904	Spanish Ministerio de Ciencia y Tecnologia [BFU2009-12803]; Xunta de Galicia [09CSA010208PR]	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	Work supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (BFU2009-12803) and the Xunta de Galicia (09CSA010208PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA A, 1993, NEUROSCIENCE, V55, P1093, DOI 10.1016/0306-4522(93)90323-8; Almeida A, 2000, EUR J PAIN, V4, P373, DOI 10.1053/eujp.2000.0193; Almeida A, 1997, EUR J NEUROSCI, V9, P686, DOI 10.1111/j.1460-9568.1997.tb01417.x; ALMEIDA A, 1995, NEUROREPORT, V6, P1245, DOI 10.1097/00001756-199506090-00004; ALSTERMARK B, 1987, NEUROSCI LETT, V74, P286, DOI 10.1016/0304-3940(87)90311-9; BASBAUM AI, 1979, J COMP NEUROL, V187, P513, DOI 10.1002/cne.901870304; BASBAUM AI, 1978, J COMP NEUROL, V178, P209, DOI 10.1002/cne.901780203; BEMENT SL, 1969, EXP NEUROL, V24, P147, DOI 10.1016/0014-4886(69)90012-0; BERNARD JF, 1990, NEUROSCI LETT, V116, P257, DOI 10.1016/0304-3940(90)90083-L; BOBILLIER P, 1976, BRAIN RES, V113, P449, DOI 10.1016/0006-8993(76)90050-0; BOWSHER D, 1968, J NEUROPHYSIOL, V31, P288, DOI 10.1152/jn.1968.31.2.288; BRINDLEY GS, 1980, J NEUROL NEUROSUR PS, V43, P1083, DOI 10.1136/jnnp.43.12.1083; BURTON H, 1968, Brain Research, V11, P357, DOI 10.1016/0006-8993(68)90031-0; CAMERON AA, 1995, J COMP NEUROL, V351, P585, DOI 10.1002/cne.903510408; Canedo A, 1997, PROG NEUROBIOL, V51, P287, DOI 10.1016/S0301-0082(96)00058-5; CANEDO A, 1993, J PHYSIOL-LONDON, V463, P475, DOI 10.1113/jphysiol.1993.sp019606; Canedo A, 2000, EUR J NEUROSCI, V12, P2515, DOI 10.1046/j.1460-9568.2000.00107.x; CASEY K L, 1971, International Journal of Neuroscience, V2, P29, DOI 10.3109/00207457109146990; CASEY KL, 1989, BRAIN RES, V501, P150, DOI 10.1016/0006-8993(89)91036-6; CASEY KL, 1969, EXP NEUROL, V25, P35, DOI 10.1016/0014-4886(69)90070-3; CHAN SHH, 1979, EXP NEUROL, V66, P356, DOI 10.1016/0014-4886(79)90086-4; Chomiak T, 2008, J NEUROPHYSIOL, V100, P327, DOI 10.1152/jn.90392.2008; Chomiak T, 2007, J PHYSIOL-LONDON, V579, P403, DOI 10.1113/jphysiol.2006.124057; CLOUGH JFM, 1968, J PHYSIOL-LONDON, V198, P167, DOI 10.1113/jphysiol.1968.sp008599; DARIANSM.I, 1965, J NEUROPHYSIOL, V28, P682, DOI 10.1152/jn.1965.28.4.682; Davies PW, 1968, MED PHYSL, V2, P1073; DREW T, 1986, J NEUROPHYSIOL, V55, P375, DOI 10.1152/jn.1986.55.2.375; ECCLES JC, 1975, J NEUROPHYSIOL, V38, P513, DOI 10.1152/jn.1975.38.3.513; FIELDS HL, 1978, ANNU REV PHYSIOL, V40, P217, DOI 10.1146/annurev.ph.40.030178.001245; Fujino Y, 1996, BRAIN RES, V715, P225, DOI 10.1016/0006-8993(96)00019-4; FUNG SJ, 1987, ARCH ITAL BIOL, V125, P171; GARCIARILL E, 1987, BRAIN RES, V411, P13, DOI 10.1016/0006-8993(87)90676-7; GRILL WM, 1995, IEEE ENG MED BIOL, V14, P375, DOI 10.1109/51.395310; Hermann DM, 1997, J CHEM NEUROANAT, V13, P1, DOI 10.1016/S0891-0618(97)00019-7; Hill AV, 1936, PROC R SOC SER B-BIO, V119, P305, DOI 10.1098/rspb.1936.0012; HOCKFIELD S, 1978, BRAIN RES, V139, P333, DOI 10.1016/0006-8993(78)90933-2; HOLSTEGE G, 1982, PROG BRAIN RES, V57, P145, DOI 10.1016/S0079-6123(08)64128-X; HUNT CC, 1954, J GEN PHYSIOL, V38, P117, DOI 10.1085/jgp.38.1.117; JANKOWSKA E, 1972, J PHYSIOL-LONDON, V222, P597, DOI 10.1113/jphysiol.1972.sp009817; Jordan LM, 1998, ANN NY ACAD SCI, V860, P83, DOI 10.1111/j.1749-6632.1998.tb09040.x; Kuncel AM, 2004, CLIN NEUROPHYSIOL, V115, P2431, DOI 10.1016/j.clinph.2004.05.031; Kuwabara N, 2000, BRAIN RES, V878, P79, DOI 10.1016/S0006-8993(00)02695-0; Le Bars D, 2002, BRAIN RES REV, V40, P29, DOI 10.1016/S0165-0173(02)00186-8; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Leiras R, 2010, J NEUROSCI, V30, P15383, DOI 10.1523/JNEUROSCI.2193-10.2010; Leite-Almeida H, 2006, NEUROSCIENCE, V140, P577, DOI 10.1016/j.neuroscience.2006.02.022; LIPSKI J, 1981, J NEUROSCI METH, V4, P1, DOI 10.1016/0165-0270(81)90015-7; MANCIA M, 1974, BRAIN RES, V69, P297, DOI 10.1016/0006-8993(74)90008-0; MARTIN GF, 1988, NEUROSCIENCE, V25, P87, DOI 10.1016/0306-4522(88)90008-5; MATSUYAMA K, 1988, BRAIN RES, V460, P124, DOI 10.1016/0006-8993(88)91212-7; McIntyre CC, 1999, BIOPHYS J, V76, P878, DOI 10.1016/S0006-3495(99)77251-6; McIntyre CC, 2000, ANN BIOMED ENG, V28, P219, DOI 10.1114/1.262; Monconduit L, 2002, EUR J NEUROSCI, V16, P937, DOI 10.1046/j.1460-9568.2002.02148.x; Morgan MM, 1996, PAIN, V66, P307, DOI 10.1016/0304-3959(96)03061-8; Morgan MM, 1999, NEUROSCIENCE, V88, P489, DOI 10.1016/S0306-4522(98)00238-3; Nauta WJH, 1958, RETICULAR FORMATION, P3; PEARL GS, 1980, BRAIN RES BULL, V5, P203, DOI 10.1016/0361-9230(80)90194-X; Perlmutter SI, 1998, J NEUROPHYSIOL, V80, P2475, DOI 10.1152/jn.1998.80.5.2475; PETERSON BW, 1975, EXP BRAIN RES, V23, P333; Peterson BW, 1980, RETICULAR FORMATION, P171; Peterson BW, 1984, BRAIN STEM CONTROL S, P141; Raboisson P, 1996, J COMP NEUROL, V367, P503, DOI 10.1002/(SICI)1096-9861(19960415)367:4<503::AID-CNE3>3.0.CO;2-8; RAPOPORT S, 1977, J PHYSIOL-LONDON, V272, P367, DOI 10.1113/jphysiol.1977.sp012049; RINDOS AJ, 1984, EXP NEUROL, V86, P208, DOI 10.1016/0014-4886(84)90182-1; ROWE MJ, 1968, J PHYSIOL-LONDON, V196, P19, DOI 10.1113/jphysiol.1968.sp008491; SANDKUHLER J, 1984, BRAIN RES, V305, P67, DOI 10.1016/0006-8993(84)91120-X; Scheibel ME, 1958, RETICULAR FORMATION, P31; SHIGENAGA Y, 1983, BRAIN RES, V277, P201, DOI 10.1016/0006-8993(83)90928-9; SHIZGAL P, 1991, BEHAV BRAIN RES, V42, P151, DOI 10.1016/S0166-4328(05)80006-3; SIEGEL JM, 1979, BRAIN RES REV, V1, P69, DOI 10.1016/0165-0173(79)90017-1; Soto C, 2011, J PHYSIOL-LONDON, V589, P4383, DOI 10.1113/jphysiol.2011.212464; Soto-Sanchez C, 2008, PAIN, V140, P190, DOI 10.1016/j.pain.2008.08.007; STEEVES JD, 1984, BRAIN RES, V307, P263, DOI 10.1016/0006-8993(84)90480-3; TAKAHASHI K, 1967, J NEUROPHYSIOL, V30, P22, DOI 10.1152/jn.1967.30.1.22; TAVARES I, 1994, EXP BRAIN RES, V99, P455; TSUKAHARA N, 1967, EXP BRAIN RES, V4, P18; TSUMOTO T, 1972, BRAIN RES, V44, P666, DOI 10.1016/0006-8993(72)90332-0; UDO M, 1970, J NEUROPHYSIOL, V33, P227, DOI 10.1152/jn.1970.33.2.227; VALVERDE F, 1961, J COMP NEUROL, V116, P71, DOI 10.1002/cne.901160105; Velo P, 2010, 2010 NEUR M PLANN; VERTES RP, 1986, NEUROSCIENCE, V19, P873, DOI 10.1016/0306-4522(86)90305-2; VILLANUEVA L, 1989, J NEUROPHYSIOL, V61, P391, DOI 10.1152/jn.1989.61.2.391; VILLANUEVA L, 1988, J NEUROPHYSIOL, V60, P980, DOI 10.1152/jn.1988.60.3.980; Villanueva L, 1998, J COMP NEUROL, V390, P133; Villanueva L, 1996, PAIN, V67, P231, DOI 10.1016/0304-3959(96)03121-1; VILLANUEVA L, 1995, J COMP NEUROL, V352, P11, DOI 10.1002/cne.903520103; Villanueva Luis, 1995, Biological Research, V28, P113; WALTZER R, 1984, BRAIN RES, V293, P153, DOI 10.1016/0006-8993(84)91462-8; WATT DGD, 1976, J NEUROPHYSIOL, V39, P1375, DOI 10.1152/jn.1976.39.6.1375; WAXMAN SG, 1977, PROG NEUROBIOL, V8, P297, DOI 10.1016/0301-0082(77)90009-0; Winer JA, 2002, HEARING RES, V168, P181, DOI 10.1016/S0378-5955(02)00489-6; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	92	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60686	10.1371/journal.pone.0060686	http://dx.doi.org/10.1371/journal.pone.0060686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544161	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700120
J	Choi, Y; Hur, CG; Park, T				Choi, Youngshim; Hur, Cheol-Goo; Park, Taesun			Induction of Olfaction and Cancer-Related Genes in Mice Fed a High-Fat Diet as Assessed through the Mode-of-Action by Network Identification Analysis	PLOS ONE			English	Article							COLORECTAL-CANCER; BREAST-CANCER; GROWTH-FACTOR; EXPRESSION ANALYSIS; ODORANT RECEPTORS; PROTEIN-KINASE; OBESE SUBJECTS; CELL-CYCLE; INSULIN; RISK	The pathophysiological mechanisms underlying the development of obesity and metabolic diseases are not well understood. To gain more insight into the genetic mediators associated with the onset and progression of diet-induced obesity and metabolic diseases, we studied the molecular changes in response to a high-fat diet (HFD) by using a mode-of-action by network identification (MNI) analysis. Oligo DNA microarray analysis was performed on visceral and subcutaneous adipose tissues and muscles of male C57BL/6N mice fed a normal diet or HFD for 2, 4, 8, and 12 weeks. Each of these data was queried against the MNI algorithm, and the lists of top 5 highly ranked genes and gene ontology (GO)-annotated pathways that were significantly overrepresented among the 100 highest ranked genes at each time point in the 3 different tissues of mice fed the HFD were considered in the present study. The 40 highest ranked genes identified by MNI analysis at each time point in the different tissues of mice with diet-induced obesity were subjected to clustering based on their temporal patterns. On the basis of the above-mentioned results, we investigated the sequential induction of distinct olfactory receptors and the stimulation of cancer-related genes during the development of obesity in both adipose tissues and muscles. The top 5 genes recognized using the MNI analysis at each time point and gene cluster identified based on their temporal patterns in the peripheral tissues of mice provided novel and often surprising insights into the potential genetic mediators for obesity progression.	[Choi, Youngshim; Park, Taesun] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Seoul 120749, South Korea; [Hur, Cheol-Goo] Korea Res Inst Biosci & Biotechnol, Plant Syst Engn Res Ctr, Taejon, South Korea	Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Park, T (corresponding author), Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Seoul 120749, South Korea.	tspark@yonsei.ac.kr		Park, Taesun/0000-0002-9752-9407	National Research Foundation of Korea (NRF); Korean government (MEST) [2012-0000643]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2012-0000643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2011, CANCER LETT, V300, P1, DOI 10.1016/j.canlet.2010.09.008; Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Barbuio R, 2007, J ENDOCRINOL, V194, P539, DOI 10.1677/JOE-07-0234; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Chen LY, 2002, J IMMUNOL, V169, P3934, DOI 10.4049/jimmunol.169.7.3934; Chen PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000092; Chen QZ, 2009, J LEUKOCYTE BIOL, V85, P539, DOI 10.1189/jlb.0308219; Clouthier DE, 1997, J CLIN INVEST, V100, P2697, DOI 10.1172/JCI119815; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fraser MM, 2005, CANCER RES, V65, P6228, DOI 10.1158/0008-5472.CAN-05-0650; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; Gloyn AL, 2002, DIABETOLOGIA, V45, P580, DOI 10.1007/s00125-002-0779-8; Guo FJ, 2010, WORLD J GASTROENTERO, V16, P1465, DOI 10.3748/wjg.v16.i12.1465; Hsu KL, 2006, NAT CHEM BIOL, V2, P153, DOI 10.1038/nchembio767; Hu C, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-3; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; Jaeschke A, 2005, P NATL ACAD SCI USA, V102, P6931, DOI 10.1073/pnas.0502143102; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Kelley JR, 2003, ANTICANCER RES, V23, P2007; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kim JY, 2007, ARCH BIOCHEM BIOPHYS, V464, P100, DOI 10.1016/j.abb.2007.04.018; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Lyon RC, 2009, CHEM-BIOL INTERACT, V178, P283, DOI 10.1016/j.cbi.2008.10.025; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Mejia A, 2009, EXPERT REV MOL DIAGN, V9, P777, DOI [10.1586/erm.09.67, 10.1586/ERM.09.67]; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Munoz-Alonso MJ, 2000, J BIOL CHEM, V275, P32406, DOI 10.1074/jbc.M000841200; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Naderi A, 2010, INT J CANCER, V126, P1596, DOI 10.1002/ijc.24866; Oesterreich S, 2003, J CELL BIOCHEM, V90, P653, DOI 10.1002/jcb.10685; Ostrakhovitch EA, 2010, BREAST CANCER RES TR, V119, P773, DOI 10.1007/s10549-009-0372-7; Palouzier-Paulignan B, 2012, CHEM SENSES; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Rho JH, 2008, J PROTEOME RES, V7, P2959, DOI 10.1021/pr8000892; Richardson BE, 2004, OBES SURG, V14, P967, DOI 10.1381/0960892041719617; Richardson BE, 2012, OBES SURG, V22, P283, DOI 10.1007/s11695-011-0487-x; RUGGERI BA, 1989, CANCER RES, V49, P4130; Saydah SH, 2003, CANCER EPIDEM BIOMAR, V12, P412; Seeman T, 2010, PEDIATR NEPHROL, V25, P2375, DOI 10.1007/s00467-010-1591-1; Simchen U, 2006, EUR J CLIN NUTR, V60, P698, DOI 10.1038/sj.ejcn.1602371; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Sorensen CS, 2010, CELL CYCLE, V9, P450, DOI 10.4161/cc.9.3.10513; Soukas A, 2000, GENE DEV, V14, P963; Storey John D, 2003, Methods Mol Biol, V224, P149; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; Wang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006979; Xing HM, 2006, NAT PROTOC, V1, P2551, DOI 10.1038/nprot.2006.300; Xu JY, 2011, J GASTROEN HEPATOL, V26, P700, DOI 10.1111/j.1440-1746.2010.06563.x; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101	58	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e56610	10.1371/journal.pone.0056610	http://dx.doi.org/10.1371/journal.pone.0056610			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555558	Green Submitted, Green Published, gold			2022-12-25	WOS:000317418500003
J	Balana, B; Bahima, L; Bodhinathan, K; Taura, JJ; Taylor, NM; Nettleton, MY; Ciruela, F; Slesinger, PA				Balana, Bartosz; Bahima, Laia; Bodhinathan, Karthik; Taura, Jaume J.; Taylor, Natalie M.; Nettleton, Margaret Y.; Ciruela, Francisco; Slesinger, Paul A.			Ras-Association Domain of Sorting Nexin 27 Is Critical for Regulating Expression of GIRK Potassium Channels	PLOS ONE			English	Article							BETA-GAMMA-SUBUNITS; PROTEIN; TRAFFICKING; ROLES; ACTIVATION; ENDOSOMES; RECEPTORS; INTERACT; RALGDS; SNX27	G protein-gated inwardly rectifying potassium (GIRK) channels play an important role in regulating neuronal excitability. Sorting nexin 27b (SNX27b), which reduces surface expression of GIRK channels through a PDZ domain interaction, contains a putative Ras-association (RA) domain with unknown function. Deleting the RA domain in SNX27b (SNX27b-Delta RA) prevents the down-regulation of GIRK2c/GIRK3 channels. Similarly, a point mutation (K305A) in the RA domain disrupts regulation of GIRK2c/GIRK3 channels and reduces H-Ras binding in vitro. Finally, the dominant-negative H-Ras (S17N) occludes the SNX27b-dependent decrease in surface expression of GIRK2c/GIRK3 channels. Thus, the presence of a functional RA domain and the interaction with Ras-like G proteins comprise a novel mechanism for modulating SNX27b control of GIRK channel surface expression and cellular excitability.	[Balana, Bartosz; Bahima, Laia; Bodhinathan, Karthik; Taura, Jaume J.; Taylor, Natalie M.; Nettleton, Margaret Y.; Slesinger, Paul A.] Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; [Slesinger, Paul A.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY USA; [Bahima, Laia; Ciruela, Francisco] Univ Barcelona, Unitat Farmacol, Dept Patol & Terapeut Expt, Barcelona, Spain	Salk Institute; Icahn School of Medicine at Mount Sinai; University of Barcelona	Ciruela, F (corresponding author), Univ Barcelona, Unitat Farmacol, Dept Patol & Terapeut Expt, Barcelona, Spain.	fciruela@ub.edu; paul.slesinger@mssm.edu	Ciruela, F./A-5096-2013; Bodhinathan, Karthik/B-9693-2009	Ciruela, F./0000-0003-0832-3739; Bodhinathan, Karthik/0000-0003-2938-9008	National Institute on Drug Abuse [DA019022]; National Institute on Alcohol Abuse and Alcoholism [AA018734]; Instituto de Salud Carlos III [PY-1278/08-2]; San Diego Foundation [C-2011-00207]; American Heart Association [12POST9830002]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019022] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); San Diego Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by funds from National Institute on Drug Abuse (DA019022; PAS) and National Institute on Alcohol Abuse and Alcoholism (AA018734; PAS), Instituto de Salud Carlos III (PY-1278/08-2; LB), the Blasker-Rose-Miah fund of The San Diego Foundation (C-2011-00207; BB) and the American Heart Association Postdoctoral Fellowship (12POST9830002; KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balana B, 2011, P NATL ACAD SCI US; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Cai L, 2011, MOL CELL BIOL, V31, P1734, DOI 10.1128/MCB.01044-10; Ciruela F, 2008, CURR OPIN BIOTECH, V19, P338, DOI 10.1016/j.copbio.2008.06.003; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Joubert L, 2004, J CELL SCI, V117, P5367, DOI 10.1242/jcs.01379; Kajii Y, 2003, MOL PSYCHIATR, V8, P434, DOI 10.1038/sj.mp.4001258; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; MacNeil AJ, 2007, BIOCHEM BIOPH RES CO, V359, P848, DOI 10.1016/j.bbrc.2007.05.162; Mizutani R, 2011, GENE EXPR PATTERNS, V11, P33, DOI 10.1016/j.gep.2010.08.007; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nassirpour R, 2007, CHANNELS, V1, P331, DOI 10.4161/chan.5191; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rincon E, 2007, MOL CELL PROTEOMICS, V6, P1073, DOI 10.1074/mcp.M700047-MCP200; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757	31	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59800	10.1371/journal.pone.0059800	http://dx.doi.org/10.1371/journal.pone.0059800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536889	Green Published, gold, Green Submitted			2022-12-25	WOS:000317397200037
J	Yamamoto, T; Yoshimatsu, H; Yamamoto, N; Narushima, M; Iida, T; Koshima, I				Yamamoto, Takumi; Yoshimatsu, Hidehiko; Yamamoto, Nana; Narushima, Mitsunaga; Iida, Takuya; Koshima, Isao			Side-to-End Lymphaticovenular Anastomosis through Temporary Lymphatic Expansion	PLOS ONE			English	Article							LOWER-EXTREMITY LYMPHEDEMA; INDOCYANINE GREEN LYMPHOGRAPHY; INTRAVASCULAR STENTING METHOD; STAGE	Objective: The number of bypasses is the most important factor in lymphaticovenular anastomosis (LVA) for lymphedema treatment. Side-to-end (S-E) LVA, which can bypass bidirectional lymph flows via one anastomosis, is considered to be the most efficient bypass, but creation of lateral window to a small lymphatic vessel is technically demanding. To overcome the difficulty, we introduced S-E anastomosis through temporary lymphatic expansion (SEATTLE) procedure in S-E LVA. Methods: This was a retrospective observational study set in a teaching hospital. Forty eight lower extremity lymphedema (LEL) patients underwent LVA. S-E LVAs were performed with (SEATTLE group) or without (non-SEATTLE group) temporary lymphatic expansion. S-E LVAs were evaluated to compare anastomosis result in SEATTLE and non-SEATTLE groups. Results: S-E LVAs resulted in 44 anastomoses in SEATTLE group (n = 25) and 37 anastomoses in non-SEATTLE group (n = 23). LEL index reduction in SEATTLE group was significantly greater than that in non-SEATTLE group (16.5 +/- 14.5 vs. 10.9 +/- 11.8, P = 0.041). Success rate of S-E LVA in SEATTLE group was significantly higher than that in non-SEATTLE group (95.5% vs 81.1%, P = 0.040). Thirty seven of 44 (84.1%) lymph vessels in SEATTLE group were successfully dilated by temporary lymphatic expansion maneuver. All of 9 failed S-E LVAs used a lymphatic vessel with diameter of 0.35 mm or smaller. Conclusions: The SEATTLE procedure facilitates S-E LVA by a simple and easy maneuver. When the diameter of the lymphatic vessel is 0.35 mm or smaller even after the temporary lymphatic expansion maneuver, S-E LVA is not recommended due to relatively high failure rate.	[Yamamoto, Takumi; Yoshimatsu, Hidehiko; Yamamoto, Nana; Narushima, Mitsunaga; Iida, Takuya; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan	University of Tokyo	Yamamoto, T (corresponding author), Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan.	tyamamoto-tky@umin.ac.jp	Yamamoto, Takumi/Y-7658-2019; Yoshimatsu, Hidehiko/AAA-8955-2020		Takeda Science Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF))	The grant was provided by Takeda Science Foundation (http://www.takeda-sci.or.jp). The funders had no role in study design, data collection and analysis, decision to publish, orb preparation of the manuscript.	[Anonymous], 2009, LYMPHOLOGY, V42, P51; Armer JM, 2005, CANCER INVEST, V23, P76, DOI 10.1081/CNV-200048707; Chang DW, 2010, PLAST RECONSTR SURG, V126, P752, DOI 10.1097/PRS.0b013e3181e5f6a9; Devoogdt N, 2010, EUR J OBSTET GYN R B, V149, P3, DOI 10.1016/j.ejogrb.2009.11.016; Koshima I, 2004, ANN PLAS SURG, V53, P261, DOI 10.1097/01.sap.0000120319.89926.07; Koshima I, 2003, J RECONSTR MICROSURG, V19, P209; Koshima I, 2000, J RECONSTR MICROSURG, V16, P437, DOI 10.1055/s-2006-947150; McNeely ML, 2011, CANCER-AM CANCER SOC, V117, P1136, DOI 10.1002/cncr.25513; Nagase Takashi, 2005, Int J Clin Oncol, V10, P304, DOI 10.1007/s10147-005-0518-5; Narushima M, 2010, PLAST RECONSTR SURG, V125, P935, DOI 10.1097/PRS.0b013e3181cb64da; Szuba A, 2000, AM J MED, V109, P296, DOI 10.1016/S0002-9343(00)00503-9; Warren AG, 2007, ANN PLAS SURG, V59, P464, DOI 10.1097/01.sap.0000257149.42922.7e; YAMADA Y, 1969, Nagoya Journal of Medical Science, V32, P1; Yamamoto T, 2012, MICROSURGERY; Yamamoto T, 2012, ANN PLAST SURG; Yamamoto T, ANN PLAST S IN PRESS; Yamamoto T, 2011, ANN PLAS SURG, V67, P637, DOI 10.1097/SAP.0b013e318208fd75; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P1541, DOI 10.1016/j.bjps.2011.05.025; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P812, DOI 10.1016/j.bjps.2010.10.011	23	47	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59523	10.1371/journal.pone.0059523	http://dx.doi.org/10.1371/journal.pone.0059523			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536881	gold, Green Published, Green Submitted			2022-12-25	WOS:000317397200029
J	Koido, S; Homma, S; Okamoto, M; Namiki, Y; Takakura, K; Takahara, A; Odahara, S; Tsukinaga, S; Yukawa, T; Mitobe, J; Matsudaira, H; Nagatsuma, K; Uchiyama, K; Kajihara, M; Arihiro, S; Imazu, H; Arakawa, H; Kan, S; Komita, H; Ito, M; Ohkusa, T; Gong, JL; Tajiri, H				Koido, Shigeo; Homma, Sadamu; Okamoto, Masato; Namiki, Yoshihisa; Takakura, Kazuki; Takahara, Akitaka; Odahara, Shunichi; Tsukinaga, Shintaro; Yukawa, Toyokazu; Mitobe, Jimi; Matsudaira, Hiroshi; Nagatsuma, Keisuke; Uchiyama, Kan; Kajihara, Mikio; Arihiro, Seiji; Imazu, Hiroo; Arakawa, Hiroshi; Kan, Shin; Komita, Hideo; Ito, Masaki; Ohkusa, Toshifumi; Gong, Jianlin; Tajiri, Hisao			Combined TLR2/4-Activated Dendritic/Tumor Cell Fusions Induce Augmented Cytotoxic T Lymphocytes	PLOS ONE			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1; STREPTOCOCCAL PREPARATION; COLORECTAL-CANCER; TUMOR-CELLS; PSK; ACTIVATION; THERAPY; CD4(+); OK-432; MICE	Induction of antitumor immunity by dendritic cell (DC)-tumor fusion cells (DC/tumor) can be modulated by their activation status. In this study, to address optimal status of DC/tumor to induce efficient antigen-specific cytotoxic T lymphocytes (CTLs), we have created various types of DC/tumor: 1) un-activated DC/tumor; 2) penicillin-killed Streptococcus pyogenes (OK-432; TLR4 agonist)-activated DC/tumor; 3) protein-bound polysaccharides isolated from Coriolus versicolor (PSK; TLR2 agonist)-activated DC/tumor; and 4) Combined OK-432- and PSK-activated DC/tumor. Moreover, we assessed the effects of TGF-beta 1 derived from DC/tumor on the induction of MUC1-specific CTLs. Combined TLR2- and TLR4-activated DC/tumor overcame immune-suppressive effect of TGF-beta 1 in comparison to those single activated or un-activated DC/tumor as demonstrated by: 1) up-regulation of MHC class II and CD86 expression on DC/tumor; 2) increased fusion efficiency; 3) increased production of fusions derived IL-12p70; 4) activation of CD4(+) and CD8(+) T cells that produce high levels of IFN-gamma; 5) augmented induction of CTL activity specific for MUC1; and 6) superior efficacy in inhibiting CD4(+)CD25(+)Foxp3(+) T cell generation. However, DC/tumor-derived TGF-beta 1 reduced the efficacy of DC/tumor vaccine in vitro. Incorporating combined TLRs-activation and TGF-beta 1-blockade of DC/tumor may enhance the effectiveness of DC/tumor-based cancer vaccines and have the potential applicability to the field of adoptive immunotherapy.	[Koido, Shigeo; Takakura, Kazuki; Takahara, Akitaka; Odahara, Shunichi; Tsukinaga, Shintaro; Yukawa, Toyokazu; Mitobe, Jimi; Matsudaira, Hiroshi; Nagatsuma, Keisuke; Uchiyama, Kan; Kajihara, Mikio; Arihiro, Seiji; Arakawa, Hiroshi; Komita, Hideo; Ohkusa, Toshifumi; Tajiri, Hisao] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Koido, Shigeo; Namiki, Yoshihisa] Jikei Univ, Sch Med, Inst Clin Med & Res, Tokyo, Japan; [Koido, Shigeo; Homma, Sadamu; Kan, Shin; Komita, Hideo; Ito, Masaki] Jikei Univ, Sch Med, Dept Oncol, Inst DNA Med, Tokyo, Japan; [Okamoto, Masato] Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res, Tokyo, Japan; [Imazu, Hiroo; Arakawa, Hiroshi] Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan; [Gong, Jianlin] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Jikei University; Jikei University; Jikei University; Keio University; Jikei University; Boston University	Koido, S (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan.	shigeo_koido@jikei.ac.jp	大草, 敏史/HGD-2376-2022	Gong, Jianlin/0000-0003-0910-014X	Ministry of Education, Cultures, Sports, Science and Technology of Japan; Foundation for Promotion of Cancer Research; Mitsui Life Social Welfare Foundation; Japan Medical Association; Grants-in-Aid for Scientific Research [25463119] Funding Source: KAKEN	Ministry of Education, Cultures, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Promotion of Cancer Research; Mitsui Life Social Welfare Foundation; Japan Medical Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Cultures, Sports, Science and Technology of Japan, the Foundation for Promotion of Cancer Research, Mitsui Life Social Welfare Foundation, Grant in-Aid of the Japan Medical Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani V, 2007, CANCER RES, V67, P10519, DOI 10.1158/0008-5472.CAN-07-0079; Ghorpade DS, 2011, J BIOL CHEM, V286, P31347, DOI 10.1074/jbc.M111.232413; Gong JL, 1997, NAT MED, V3, P558, DOI 10.1038/nm0597-558; Harada M, 1997, INT J CANCER, V70, P362, DOI 10.1002/(SICI)1097-0215(19970127)70:3<362::AID-IJC19>3.0.CO;2-H; Huang A, 2003, CLIN EXP IMMUNOL, V134, P270, DOI 10.1046/j.1365-2249.2003.02295.x; INGE TH, 1992, CANCER RES, V52, P1386; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Koido S, 2007, J IMMUNOL, V179, P4874, DOI 10.4049/jimmunol.179.7.4874; Koido S, 2013, ANTICANCER RES, V33, P347; Koido S, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/516768; Koido S, 2010, CLIN IMMUNOL, V135, P384, DOI 10.1016/j.clim.2010.02.003; Liu LZ, 2002, NAT MED, V8, P185, DOI 10.1038/nm0202-185; Lu HL, 2011, CLIN CANCER RES, V17, P6742, DOI 10.1158/1078-0432.CCR-11-1142; Lu HL, 2011, CLIN CANCER RES, V17, P67, DOI 10.1158/1078-0432.CCR-10-1763; Mou HB, 2011, TRANSPL P, V43, P2049, DOI 10.1016/j.transproceed.2011.02.054; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Shibata M, 2002, CANCER INVEST, V20, P166, DOI 10.1081/CNV-120001142; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tamagawa K, 2012, LANGENBECK ARCH SURG, V397, P475, DOI 10.1007/s00423-011-0896-2; TANAKA N, 1994, CANCER, V74, P3097, DOI 10.1002/1097-0142(19941215)74:12<3097::AID-CNCR2820741206>3.0.CO;2-P; Zheng RX, 2008, CANCER RES, V68, P4045, DOI 10.1158/0008-5472.CAN-07-6669	22	22	25	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59280	10.1371/journal.pone.0059280	http://dx.doi.org/10.1371/journal.pone.0059280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555011	Green Submitted, Green Published, gold			2022-12-25	WOS:000316409800079
J	Maazi, H; Singh, AK; Speak, AO; Lombardi, V; Lam, J; Khoo, B; Inn, KS; Sharpe, AH; Jung, JU; Akbari, O				Maazi, Hadi; Singh, Abinav K.; Speak, Anneliese O.; Lombardi, Vincent; Lam, Jonathan; Khoo, Bryant; Inn, Kyung Soo; Sharpe, Arlene H.; Jung, Jae U.; Akbari, Omid			Lack of PD-L1 Expression by iNKT Cells Improves the Course of Influenza A Infection	PLOS ONE			English	Article							INVARIANT NKT CELLS; CD8(+) T-CELLS; NATURAL-KILLER; REGULATORY T; IMMUNE-RESPONSES; INTERFERON-GAMMA; GENE-EXPRESSION; VIRUS-INFECTION; IFN-ALPHA/BETA; B7 FAMILY	There is evidence indicating that invariant Natural Killer T (iNKT) cells play an important role in defense against influenza A virus (IAV). However, the effect of inhibitory receptor, programmed death-1 (PD-1), and its ligands, programmed death ligand (PD-L) 1 and 2 on iNKT cells in protection against IAV remains to be elucidated. Here we investigated the effects of these co-stimulatory molecules on iNKT cells in the response to influenza. We discovered that compare to the wild type, PD-L1 deficient mice show reduced sensitivity to IAV infection as evident by reduced weight loss, decreased pulmonary inflammation and cellular infiltration. In contrast, PD-L2 deficient mice showed augmented weight loss, pulmonary inflammation and cellular infiltration compare to the wild type mice after influenza infection. Adoptive transfer of iNKT cells from wild type, PD-L1 or PD-L2 deficient mice into iNKT cell deficient mice recapitulated these findings. Interestingly, in our transfer system PD-L1(-/-)-derived iNKT cells produced high levels of interferon-gamma whereas PD-L2(-/-)-derived iNKT cells produced high amounts of interleukin-4 and 13 suggesting a role for these cytokines in sensitivity to influenza. We identified that PD-L1 negatively regulates the frequency of iNKT cell subsets in the lungs of IAV infected mice. Altogether, these results demonstrate that lack of PD-L1 expression by iNKT cells reduces the sensitivity to IAV and that the presence of PD-L2 is important for dampening the deleterious inflammatory responses after IAV infection. Our findings potentially have clinical implications for developing new therapies for influenza.	[Maazi, Hadi; Singh, Abinav K.; Speak, Anneliese O.; Lombardi, Vincent; Lam, Jonathan; Khoo, Bryant; Inn, Kyung Soo; Jung, Jae U.; Akbari, Omid] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Southern California; Harvard University; Harvard Medical School	Akbari, O (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	akbari@usc.edu	Inn, Kyung-Soo/AAJ-4118-2020	Maazi, Hadi/0000-0002-8979-3769; Speak, Anneliese/0000-0003-4890-4685	National Institutes of Health [R01 AI066020]; Senior Research Training Fellowship from the American Lung Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Senior Research Training Fellowship from the American Lung Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health R01 AI066020 grant (to O.A.) and a Senior Research Training Fellowship from the American Lung Association (to V.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2010, MUCOSAL IMMUNOL, V3, P81, DOI 10.1038/mi.2009.112; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; BARKER WH, 1982, ARCH INTERN MED, V142, P85, DOI 10.1001/archinte.142.1.85; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bocek P, 2004, J EXP MED, V199, P1619, DOI 10.1084/jem.20032014; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; CLEMENTS ML, 1986, J CLIN MICROBIOL, V23, P66, DOI 10.1128/JCM.23.1.66-72.1986; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Diana J, 2011, J EXP MED, V208, P729, DOI 10.1084/jem.20101692; Dong HD, 1999, NAT MED, V5, P1365; Droebner K, 2008, VACCINE, V26, P6965, DOI 10.1016/j.vaccine.2008.09.051; Dulgerian LR, 2011, IMMUNOLOGY, V133, P29, DOI 10.1111/j.1365-2567.2011.03406.x; Durante-Mangoni E, 2004, J IMMUNOL, V173, P2159, DOI 10.4049/jimmunol.173.3.2159; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Erickson JJ, 2012, J CLIN INVEST, V122, P2967, DOI 10.1172/JCI62860; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; Hatta Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001139; Ho LP, 2008, EUR J IMMUNOL, V38, P1913, DOI 10.1002/eji.200738017; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kerzerho J, 2012, J ALLERGY CLIN IMMUN; Kishimoto K, 2002, J CLIN INVEST, V109, P1471, DOI 10.1172/JCI14947; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Liang SC, 2006, EUR J IMMUNOL, V36, P58, DOI 10.1002/eji.200535458; Liu TY, 2008, EUR J IMMUNOL, V38, P1012, DOI 10.1002/eji.200737838; Lombardi V, 2010, J IMMUNOL, V184, P2107, DOI 10.4049/jimmunol.0901208; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Matsumoto K, 2004, J IMMUNOL, V172, P2530, DOI 10.4049/jimmunol.172.4.2530; Moran TM, 1996, J VIROL, V70, P5230, DOI 10.1128/JVI.70.8.5230-5235.1996; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; MURPHY BR, 1973, J INFECT DIS, V128, P488, DOI 10.1093/infdis/128.4.488; Paget C, 2011, J IMMUNOL, V186, P5590, DOI 10.4049/jimmunol.1002348; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Ronni T, 1997, J IMMUNOL, V158, P2363; Sareneva T, 1998, J IMMUNOL, V160, P6032; Singh AK, 2011, ALLERGY, V66, P155, DOI 10.1111/j.1398-9995.2010.02458.x; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; Terabe M, 2007, TRENDS IMMUNOL, V28, P491, DOI 10.1016/j.it.2007.05.008; Tessmer MS, 2009, EXPERT OPIN THER TAR, V13, P153, DOI [10.1517/14712590802653601 , 10.1517/14712590802653601]; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Van Dommelen SLH, 2004, IMMUNOL CELL BIOL, V82, P332, DOI 10.1111/j.0818-9641.2004.01261.x; Wood KJ, 2006, TRENDS IMMUNOL, V27, P183, DOI 10.1016/j.it.2006.02.008; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103	62	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59599	10.1371/journal.pone.0059599	http://dx.doi.org/10.1371/journal.pone.0059599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555047	Green Submitted, Green Published, gold			2022-12-25	WOS:000316409800103
J	Singh, P; Saxena, R; Srinivas, G; Pande, G; Chattopadhyay, A				Singh, Pushpendra; Saxena, Roopali; Srinivas, Gunda; Pande, Gopal; Chattopadhyay, Amitabha			Cholesterol Biosynthesis and Homeostasis in Regulation of the Cell Cycle	PLOS ONE			English	Article							SEROTONIN(1A) RECEPTOR; MEMBRANE CHOLESTEROL; SIGNALING PATHWAY; DNA-SYNTHESIS; INHIBITION; MEVALONATE; GROWTH; ORGANIZATION; REQUIREMENT; PROGRESSION	The cell cycle is a ubiquitous, multi-step process that is essential for growth and proliferation of cells. The role of membrane lipids in cell cycle regulation is not explored well, although a large number of cytoplasmic and nuclear regulators have been identified. We focus in this work on the role of membrane cholesterol in cell cycle regulation. In particular, we have explored the stringency of the requirement of cholesterol in the regulation of cell cycle progression. For this purpose, we utilized distal and proximal inhibitors of cholesterol biosynthesis, and monitored their effect on cell cycle progression. We show that cholesterol content increases in S phase and inhibition of cholesterol biosynthesis results in cell cycle arrest in G1 phase under certain conditions. Interestingly, G1 arrest mediated by cholesterol biosynthesis inhibitors could be reversed upon metabolic replenishment of cholesterol. Importantly, our results show that the requirement of cholesterol for G1 to S transition is absolute, and even immediate biosynthetic precursors of cholesterol, differing with cholesterol merely in a double bond, could not replace cholesterol for reversing the cell cycle arrest. These results are useful in the context of diseases, such as cancer and Alzheimer's disease, that are associated with impaired cholesterol biosynthesis and homeostasis.	[Singh, Pushpendra; Saxena, Roopali; Srinivas, Gunda; Pande, Gopal; Chattopadhyay, Amitabha] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Pande, G (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	gpande@ccmb.res.in; amit@ccmb.res.in		Gunda, Srinivas/0000-0003-2053-2330; Pande, Gopal/0000-0002-0730-1389	Council of Scientific and Industrial Research; Department of Science and Technology, Government of India; Jawaharlal Nehru Centre for Advanced Scientific Research	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India))	This work was supported by the Council of Scientific and Industrial Research and Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; P.S. thanks Jawaharlal Nehru Centre for Advanced Scientific Research for the award of a Research Fellowship. R. S. thanks the Council of Scientific and Industrial Research for the award of a Research Fellowship. A. C. is an Adjunct Professor at the Special Centre for Molecular Medicine of Jawaharlal Nehru University (New Delhi, India) and Indian Institute of Science Education and Research (Mohali, India), and Honorary Professor of the Jawaharlal Nehru Centre for Advanced Scientific Research (Bangalore, India). A. C. gratefully acknowledges J.C. Bose Fellowship (Department of Science and Technology, Govt. of India). We thank Md. Jafurulla for help in organizing the manuscript and members of A.C.'s laboratory for critically reading the manuscript.	Amundson DM, 1999, J BIOCHEM BIOPH METH, V38, P43, DOI 10.1016/S0165-022X(98)00036-0; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; Brown AJ, 2007, CLIN EXP PHARMACOL P, V34, P135, DOI 10.1111/j.1440-1681.2007.04565.x; BROWN MS, 1974, J BIOL CHEM, V249, P7306; CHAKRABARTI R, 1991, J BIOL CHEM, V266, P12216; Chauhan NB, 2003, J LIPID RES, V44, P2019, DOI 10.1194/jlr.R300010-JLR200; CHEN HW, 1975, P NATL ACAD SCI USA, V72, P1950, DOI 10.1073/pnas.72.5.1950; CHEN HW, 1974, NATURE, V251, P419, DOI 10.1038/251419a0; Chevy F, 2002, J LIPID RES, V43, P1192, DOI 10.1194/jlr.M200082-JLR200; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; DEAN PN, 1974, J CELL BIOL, V60, P523, DOI 10.1083/jcb.60.2.523; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; DVORNIK D, 1963, J AM CHEM SOC, V85, P3309, DOI 10.1021/ja00903a066; Fernandez C, 2005, J LIPID RES, V46, P920, DOI 10.1194/jlr.M400407-JLR200; Fernandez C, 2004, EXP CELL RES, V300, P109, DOI 10.1016/j.yexcr.2004.06.029; FOX MH, 1980, CYTOMETRY, V1, P71, DOI 10.1002/cyto.990010114; Ganguly S, 2010, BIOPHYS J, V99, P1397, DOI 10.1016/j.bpj.2010.06.031; Gimpl G, 2002, PROG BRAIN RES, V139, P43; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hawk MA, 1996, CANCER LETT, V109, P217, DOI 10.1016/S0304-3835(96)04465-5; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Kennady PK, 2004, CYTOM PART A, V62A, P97, DOI 10.1002/cyto.a.20091; KEYOMARSI K, 1991, CANCER RES, V51, P3602; KRITCHEVSKY SB, 1992, ANNU REV NUTR, V12, P391, DOI 10.1146/annurev.nu.12.070192.002135; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; LANGAN TJ, 1987, J NEUROCHEM, V49, P513, DOI 10.1111/j.1471-4159.1987.tb02894.x; Martin M, 2010, BBA-MOL CELL BIOL L, V1801, P934, DOI 10.1016/j.bbalip.2010.03.011; Martinez-Botas J, 2001, BBA-MOL CELL BIOL L, V1532, P185, DOI 10.1016/S1388-1981(01)00125-1; MCCLARE CWF, 1971, ANAL BIOCHEM, V39, P527, DOI 10.1016/0003-2697(71)90443-X; Menge T, 2005, NAT REV NEUROSCI, V6, P325, DOI 10.1038/nrn1652; NARISAWA T, 1994, CARCINOGENESIS, V15, P2045, DOI 10.1093/carcin/15.9.2045; Nguyen MM, 2003, MOL CELL BIOL, V23, P8970, DOI 10.1128/MCB.23.24.8970-8981.2003; Paila YD, 2008, BBA-BIOMEMBRANES, V1778, P1508, DOI 10.1016/j.bbamem.2008.03.002; Paila YD, 2010, SUBCELL BIOCHEM, V51, P439, DOI 10.1007/978-90-481-8622-8_16; Pande G, 1996, CYTOMETRY, V24, P55, DOI 10.1002/(SICI)1097-0320(19960501)24:1<55::AID-CYTO7>3.0.CO;2-H; Papakostas GI, 2004, EUR NEUROPSYCHOPHARM, V14, P135, DOI 10.1016/S0924-977X(03)00099-3; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Porter FD, 2008, EUR J HUM GENET, V16, P535, DOI 10.1038/ejhg.2008.10; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; QUESNEYHUNEEUS V, 1983, J BIOL CHEM, V258, P378; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Sanchez-Wandelmer J, 2010, NEUROSCIENCE, V167, P143, DOI 10.1016/j.neuroscience.2010.01.051; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Shrivastava S, 2010, BIOCHEMISTRY-US, V49, P5426, DOI 10.1021/bi100276b; Singh P, 2007, BIOCHEM BIOPH RES CO, V358, P495, DOI 10.1016/j.bbrc.2007.04.135; Singh P, 2009, BBA-BIOMEMBRANES, V1788, P2169, DOI 10.1016/j.bbamem.2009.07.004; SIPERSTEIN MD, 1984, J LIPID RES, V25, P1462; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Suarez Y, 2005, BBA-MOL CELL BIOL L, V1734, P203, DOI 10.1016/j.bbalip.2005.02.003; SUMI S, 1992, GASTROENTEROLOGY, V103, P982, DOI 10.1016/0016-5085(92)90032-T; Thibault A, 1996, CLIN CANCER RES, V2, P483; Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005	57	70	72	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58833	10.1371/journal.pone.0058833	http://dx.doi.org/10.1371/journal.pone.0058833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554937	gold, Green Published			2022-12-25	WOS:000316409800035
J	Zellin, M; Conci, M; von Muhlenen, A; Muller, HJ				Zellin, Martina; Conci, Markus; von Muehlenen, Adrian; Mueller, Hermann J.			Here Today, Gone Tomorrow - Adaptation to Change in Memory-Guided Visual Search	PLOS ONE			English	Article							SPATIAL CONTEXT; IMPLICIT; EXPLICIT	Visual search for a target object can be facilitated by the repeated presentation of an invariant configuration of nontargets ('contextual cueing'). Here, we tested adaptation of learned contextual associations after a sudden, but permanent, relocation of the target. After an initial learning phase targets were relocated within their invariant contexts and repeatedly presented at new locations, before they returned to the initial locations. Contextual cueing for relocated targets was neither observed after numerous presentations nor after insertion of an overnight break. Further experiments investigated whether learning of additional, previously unseen context-target configurations is comparable to adaptation of existing contextual associations to change. In contrast to the lack of adaptation to changed target locations, contextual cueing developed for additional invariant configurations under identical training conditions. Moreover, across all experiments, presenting relocated targets or additional contexts did not interfere with contextual cueing of initially learned invariant configurations. Overall, the adaptation of contextual memory to changed target locations was severely constrained and unsuccessful in comparison to learning of an additional set of contexts, which suggests that contextual cueing facilitates search for only one repeated target location.	[Zellin, Martina; Conci, Markus; Mueller, Hermann J.] Univ Munich, Dept Psychol, Munich, Germany; [von Muehlenen, Adrian] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England	University of Munich; University of Warwick	Zellin, M (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	martina.zellin@psy.lmu.de		von Muhlenen, Adrian/0000-0001-8338-8554	Deutsche Forschungsgemeinschaft (DFG) [CO 1002/1-1, FOR 480]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de) project grants (CO 1002/1-1; FOR 480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00012; Albouy G, 2006, BRAIN RES, V1090, P163, DOI 10.1016/j.brainres.2006.03.076; Anderson M. C., 1996, MEMORY, P237, DOI DOI 10.1016/B978-012102570-0/50010-0; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Beesley T, 2010, Q J EXP PSYCHOL, V63, P108, DOI 10.1080/17470210902831767; Brady TF, 2007, J EXP PSYCHOL HUMAN, V33, P798, DOI 10.1037/0096-1523.33.4.798; Brady TF, 2011, J VISION, V11, DOI 10.1167/11.5.4; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chun MM, 2000, TRENDS COGN SCI, V4, P170, DOI 10.1016/S1364-6613(00)01476-5; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Chun MM, 2003, J EXP PSYCHOL LEARN, V29, P224, DOI 10.1037/0278-7393.29.2.224; Conci M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00409; Conci M, 2012, VIS COGN, V20, P746, DOI 10.1080/13506285.2012.694376; Conci M, 2011, PSYCHOL RES-PSYCH FO, V75, P279, DOI 10.1007/s00426-010-0306-3; Conci M, 2009, ATTEN PERCEPT PSYCHO, V71, P1514, DOI 10.3758/APP.71.7.1514; Gebhart AL, 2009, COGNITIVE SCI, V33, P1087, DOI 10.1111/j.1551-6709.2009.01041.x; Geyer T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00272; Ghilardi MF, 2009, J NEUROPHYSIOL, V101, P2218, DOI 10.1152/jn.01138.2007; Jiang YH, 2005, PSYCHON B REV, V12, P524, DOI 10.3758/BF03193799; Junge JA, 2007, VIS COGN, V15, P1, DOI 10.1080/13506280600859706; Kunar MA, 2011, ATTEN PERCEPT PSYCHO, V73, P2077, DOI 10.3758/s13414-011-0164-0; Lleras A, 2004, SPATIAL VISION, V17, P465, DOI 10.1163/1568568041920113; Luhmann CC, 2011, VIS COGN, V19, P846, DOI 10.1080/13506285.2011.586653; Makovski T, 2010, Q J EXP PSYCHOL, V63, P216, DOI 10.1080/17470210903281590; Manginelli AA, 2009, PSYCHOL RES-PSYCH FO, V73, P212, DOI 10.1007/s00426-008-0211-1; Mednick SC, 2009, VISION RES, V49, P2557, DOI 10.1016/j.visres.2009.04.011; Ogawa H, 2006, PSYCHON B REV, V13, P543, DOI 10.3758/BF03193883; Olson IR, 2001, BRAIN, V124, P1417, DOI 10.1093/brain/124.7.1417; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Sanchez DJ, 2012, J EXP PSYCHOL HUMAN, V38, P439, DOI 10.1037/a0026347; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; Shanks DR, 2010, ANNU REV PSYCHOL, V61, P273, DOI 10.1146/annurev.psych.093008.100519; Smyth AC, 2008, MEM COGNITION, V36, P403, DOI 10.3758/MC.36.2.403; Stephan MA, 2009, EXP BRAIN RES, V196, P253, DOI 10.1007/s00221-009-1845-y; Tseng P, 2011, PERCEPTION, V40, P822, DOI 10.1068/p6833; Tunney RJ, 2003, EXP PSYCHOL, V50, P124, DOI 10.1026//1618-3169.50.2.124; van Asselen M, 2009, ATTEN PERCEPT PSYCHO, V71, P76, DOI 10.3758/APP.71.1.76; van den Bos E, 2010, PSYCHOL RES-PSYCH FO, V74, P138, DOI 10.1007/s00426-009-0227-1; Westerberg CE, 2011, NEUROPSYCHOLOGIA, V49, P3439, DOI 10.1016/j.neuropsychologia.2011.08.019; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Zellin M, 2011, ATTEN PERCEPT PSYCHO, V73, P2065, DOI 10.3758/s13414-011-0175-x	42	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59466	10.1371/journal.pone.0059466	http://dx.doi.org/10.1371/journal.pone.0059466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109ZC	23555038	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000316409800095
J	Trigas, P; Panitsa, M; Tsiftsis, S				Trigas, Panayiotis; Panitsa, Maria; Tsiftsis, Spyros			Elevational Gradient of Vascular Plant Species Richness and Endemism in Crete - The Effect of Post-Isolation Mountain Uplift on a Continental Island System	PLOS ONE			English	Article							SMALL MAMMAL DIVERSITY; ALTITUDINAL GRADIENT; RAPOPORTS RULE; GEOMETRIC CONSTRAINTS; DISTRIBUTION PATTERNS; LATE MIOCENE; HUMAN IMPACT; SCALE; AREA; GREECE	Understanding diversity patterns along environmental gradients and their underlying mechanisms is a major topic in current biodiversity research. In this study, we investigate for the first time elevational patterns of vascular plant species richness and endemism on a long-isolated continental island (Crete) that has experienced extensive post-isolation mountain uplift. We used all available data on distribution and elevational ranges of the Cretan plants to interpolate their presence between minimum and maximum elevations in 100-m elevational intervals, along the entire elevational gradient of Crete (0-2400 m). We evaluate the influence of elevation, area, mid-domain effect, elevational Rapoport effect and the post-isolation mountain uplift on plant species richness and endemism elevational patterns. Furthermore, we test the influence of the island condition and the post-isolation mountain uplift to the elevational range sizes of the Cretan plants, using the Peloponnese as a continental control area. Total species richness monotonically decreases with increasing elevation, while endemic species richness has a unimodal response to elevation showing a peak at mid-elevation intervals. Area alone explains a significant amount of variation in species richness along the elevational gradient. Mid-domain effect is not the underlying mechanism of the elevational gradient of plant species richness in Crete, and Rapoport's rule only partly explains the observed patterns. Our results are largely congruent with the post-isolation uplift of the Cretan mountains and their colonization mainly by the available lowland vascular plant species, as high-elevation specialists are almost lacking from the Cretan flora. The increase in the proportion of Cretan endemics with increasing elevation can only be regarded as a result of diversification processes towards Cretan mountains (especially mid-elevation areas), supported by elevation-driven ecological isolation. Cretan plants have experienced elevational range expansion compared to the continental control area, as a result of ecological release triggered by increased species impoverishment with increasing elevation.	[Trigas, Panayiotis] Agr Univ Athens, Dept Agr Biotechnol, Athens, Greece; [Panitsa, Maria] Univ Ioannina, Dept Environm & Nat Resources Management, Agrinion, Greece; [Tsiftsis, Spyros] Aristotle Univ Thessaloniki, Sch Biol, Dept Bot, GR-54006 Thessaloniki, Greece	Agricultural University of Athens; University of Ioannina; Aristotle University of Thessaloniki	Trigas, P (corresponding author), Agr Univ Athens, Dept Agr Biotechnol, Athens, Greece.	trigas@aua.gr	Tsiftsis, Spyros/Y-7700-2019; Panitsa, Maria/S-4814-2019	Tsiftsis, Spyros/0000-0002-3389-9089; Panitsa, Maria/0000-0003-2388-3400				Acharya BK, 2011, ACTA OECOL, V37, P329, DOI 10.1016/j.actao.2011.03.005; Acharya KP, 2011, J BIOGEOGR, V38, P1821, DOI 10.1111/j.1365-2699.2011.02511.x; [Anonymous], 2004, ISLAND ECOLOGY; Atherden MA, 1999, HOLOCENE, V9, P183, DOI 10.1191/095968399673523574; Bachman S, 2004, ECOGRAPHY, V27, P299, DOI 10.1111/j.0906-7590.2004.03759.x; Baniya CB, 2012, FOLIA GEOBOT, V47, P135, DOI 10.1007/s12224-011-9113-x; Berry P. E., 1995, FLORA VENEZUELAN GUA, V1, P161; Bhattarai KR, 2006, DIVERS DISTRIB, V12, P373, DOI 10.1111/j.1366-9516.2006.00244.x; Bhattarai KR, 2003, GLOBAL ECOL BIOGEOGR, V12, P327, DOI 10.1046/j.1466-822X.2003.00044.x; Bittkau C, 2005, MOL ECOL, V14, P4065, DOI 10.1111/j.1365-294X.2005.02725.x; Bohling N., 2003, GRAMINEAE POACEAE FL; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Cardelus CL, 2006, J ECOL, V94, P144, DOI 10.1111/j.1365-2745.2005.01052.x; Cellinese N, 2009, J BIOGEOGR, V36, P1253, DOI 10.1111/j.1365-2699.2008.02077.x; Chatzaki M, 2005, J BIOGEOGR, V32, P813, DOI 10.1111/j.1365-2699.2004.01189.x; Chilton L, 2008, FLORA CRETE S2; CHILTON L, 1997, FLORA CRETE S; Colwell R.K., 2006, RANGEMODEL MONTE CAR; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; Colwell RK, 2008, ECOGRAPHY, V31, P4, DOI 10.1111/j.2008.0906-7590.05347.x; Colwell RK, 2010, PHILOS T R SOC B, V365, P3695, DOI 10.1098/rstb.2010.0293; D'Agata C.D.C., 2009, BOCCONEA, V23, P301; Denslow JS, 2003, ANN MO BOT GARD, V90, P119, DOI 10.2307/3298531; Dermitzakis M.D., 1991, Accademia Nazionale dei Lincei Atti Convegni Lincei (Rome), V85, P263; Dermitzakis MD, 1981, ANN GEOL PAYS HELL, V30, P245; DIAMOND JM, 1973, SCIENCE, V179, P759, DOI 10.1126/science.179.4075.759; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Efstratiou N., 2005, DID FARMING REACH EU, P143; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Fassoulas C, 2005, B GEOLOGICAL SOC GRE, V37, P201; Fauquette S, 1998, PALAEOGEOGR PALAEOCL, V144, P183, DOI 10.1016/S0031-0182(98)00083-2; Fu CZ, 2006, ECOGRAPHY, V29, P919, DOI 10.1111/j.2006.0906-7590.04802.x; Ganas A, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005599; Gaston KJ, 1998, TRENDS ECOL EVOL, V13, P70, DOI 10.1016/S0169-5347(97)01236-6; Georgiakakis P, 2010, HYSTRIX, V21, P43; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; GREUTER W, 1971, Boissiera, V19, P329; Greuter W., 1972, Taxonomy phytogeography and evolution., P161; Greuter W., 1979, PLANTS ISLANDS, P87; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Grytnes JA, 2006, J BIOGEOGR, V33, P1838, DOI 10.1111/j.1365-2699.2006.01554.x; Hastie TJ., 1990, GEN ADDITIVE MODELS; Heaney LR, 2001, GLOBAL ECOL BIOGEOGR, V10, P15, DOI 10.1046/j.1466-822x.2001.00227.x; Hulme P. E., 2008, Plant invasions: human perception, ecological impacts and management, P39; Jacquemyn H, 2005, J BIOGEOGR, V32, P1751, DOI 10.1111/j.1365-2699.2005.01307.x; Jimenez-Moreno G, 2010, REV PALAEOBOT PALYNO, V162, P403, DOI 10.1016/j.revpalbo.2009.08.001; Kallimanis AS, 2011, ACTA OECOL, V37, P65, DOI 10.1016/j.actao.2010.11.008; Kallimanis AS, 2008, GLOBAL ECOL BIOGEOGR, V17, P532, DOI 10.1111/j.1466-8238.2008.00393.x; Keeley S. C., 2011, The biology of island floras, P57; Kerr JT, 1999, GLOBAL ECOL BIOGEOGR, V8, P47, DOI 10.1046/j.1365-2699.1999.00315.x; Kessler M, 2002, J BIOGEOGR, V29, P1159, DOI 10.1046/j.1365-2699.2002.00773.x; Kessler M, 2000, PLANT ECOL, V149, P181, DOI 10.1023/A:1026500710274; Kessler M, 2011, GLOBAL ECOL BIOGEOGR, V20, P868, DOI 10.1111/j.1466-8238.2011.00653.x; Kluge J, 2006, DIVERS DISTRIB, V12, P535, DOI 10.1111/j.1366-9516.2006.00231.x; Lasram FB, 2009, MAR ECOL PROG SER, V376, P253, DOI 10.3354/meps07786; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lymberakis P, 2003, CRUSTACEANA MONOGR, V2, P217; Lymberakis P, 2003, THESIS U ATHENS, P233; LYRINTZIS G, 1995, LAND DEGRAD REHABIL, V6, P79, DOI 10.1002/ldr.3400060203; MAC ARTHUR ROBERT H., 1967; Major J., 1988, ANAL BIOGEOGRAPHY, P117, DOI DOI 10.1007/978-94-009-0435-4; MAYR E, 1976, P NATL ACAD SCI USA, V73, P1765, DOI 10.1073/pnas.73.5.1765; MCCAIN C. M., 2010, ENCY LIFE SCI, DOI [DOI 10.1002/9780470015902.A0022548, 10.1002/9780470015902.a0022548]; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; Medail F, 1999, CONSERV BIOL, V13, P1510, DOI 10.1046/j.1523-1739.1999.98467.x; Meulenkamp J. E., 1985, GEOLOGICAL EVOLUTION, P307; MEULENKAMP JE, 1988, TECTONOPHYSICS, V146, P203, DOI 10.1016/0040-1951(88)90091-1; MEULENKAMP JE, 1994, TECTONOPHYSICS, V234, P53, DOI 10.1016/0040-1951(94)90204-6; MEULENKAMP JE, 1971, OPERA BOT, V30, P5; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Odland A, 1999, ECOGRAPHY, V22, P548, DOI 10.1111/j.1600-0587.1999.tb01285.x; Panitsa M, 2010, ACTA OECOL, V36, P431, DOI 10.1016/j.actao.2010.04.004; Papanastasis V. P. S., 2002, J MEDITERR ECOL, V3, P53; Parmakelis A, 2005, EVOLUTION, V59, P991; Poulakakis N, 2005, MOL ECOL, V14, P2433, DOI 10.1111/j.1365-294X.2005.02588.x; Press J. R., 1993, FLORA CRETAN AREA AN; Prodon R, 2002, ECOLOGY, V83, P1294, DOI 10.2307/3071944; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rosenweig ML, 1997, SPECIES DIVERSITY SP; Rowe R, 2009, ECOGRAPHY, V32, P411, DOI 10.1111/j.1600-0587.2008.05538.x; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Sauer J, 2011, THESIS U HAMBURG GER; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; *STATSOFT INC, 2004, STATISTICA DAT AN SO; Steinbauer MJ, 2013, ACTA OECOL, V47, P52, DOI 10.1016/j.actao.2012.11.004; Steinbauer MJ, 2012, ECOGRAPHY, V35, P23, DOI 10.1111/j.1600-0587.2011.07064.x; Steinbauer MJ, 2010, ERDKUNDE, V64, P57, DOI 10.3112/erdkunde.2010.01.05; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; STRID A, 1986, P ROY SOC EDINB B, V89, P59, DOI 10.1017/S0269727000008903; Strid A, 1997, FLORA HELLENICA, V1; Trichas A, 1996, THESIS U CRETE; Trigas P, 2012, FOLIA GEOBOT, V47, P421, DOI 10.1007/s12224-012-9130-4; Vardinoyannis K, 1994, THESIS U ATHENS GREE; Velona A, 2010, MOL PHYLOGENET EVOL, V56, P1051, DOI 10.1016/j.ympev.2010.04.037; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Wang GH, 2003, PLANT ECOL, V165, P169, DOI 10.1023/A:1022236115186; Wang ZH, 2007, DIVERS DISTRIB, V13, P845, DOI 10.1111/j.1472-4642.2007.00335.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Willerslev E, 2002, ECOGRAPHY, V25, P109, DOI 10.1034/j.1600-0587.2002.250113.x; Willinghofer S, 2012, PLANT ECOL, V213, P407, DOI 10.1007/s11258-011-9986-z; Zachariasse WJ, 2008, GEOL SOC AM BULL, V120, P976, DOI 10.1130/B26175.1; Zhang DC, 2009, BIODIVERS CONSERV, V18, P699, DOI 10.1007/s10531-008-9534-x; Zidianakis G, 2007, GEODIVERSITAS, V29, P351; [No title captured]	108	78	84	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59425	10.1371/journal.pone.0059425	http://dx.doi.org/10.1371/journal.pone.0059425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555031	gold, Green Submitted, Green Published			2022-12-25	WOS:000316252500089
J	Lu, XY; Fan, JH; Yan, Y; Wang, XD				Lu, Xuyang; Fan, Jihui; Yan, Yan; Wang, Xiaodan			Responses of Soil CO2 Fluxes to Short-Term Experimental Warming in Alpine Steppe Ecosystem, Northern Tibet	PLOS ONE			English	Article							CARBON-DIOXIDE; TEMPERATURE-DEPENDENCE; BOREAL FOREST; RESPIRATION; EFFLUX; PLANTATION; COMMUNITY; PATTERNS; BALANCE; ENGLAND	Soil carbon dioxide (CO2) emission is one of the largest fluxes in the global carbon cycle. Therefore small changes in the size of this flux can have a large effect on atmospheric CO2 concentrations and potentially constitute a powerful positive feedback to the climate system. Soil CO2 fluxes in the alpine steppe ecosystem of Northern Tibet and their responses to short-term experimental warming were investigated during the growing season in 2011. The results showed that the total soil CO2 emission fluxes during the entire growing season were 55.82 and 104.31 g C m(-2) for the control and warming plots, respectively. Thus, the soil CO2 emission fluxes increased 86.86% with the air temperature increasing 3.74 degrees C. Moreover, the temperature sensitivity coefficient (Q(10)) of the control and warming plots were 2.10 and 1.41, respectively. The soil temperature and soil moisture could partially explain the temporal variations of soil CO2 fluxes. The relationship between the temporal variation of soil CO2 fluxes and the soil temperature can be described by exponential equation. These results suggest that warming significantly promoted soil CO2 emission in the alpine steppe ecosystem of Northern Tibet and indicate that this alpine ecosystem is very vulnerable to climate change. In addition, soil temperature and soil moisture are the key factors that controls soil organic matter decomposition and soil CO2 emission, but temperature sensitivity significantly decreases due to the rise in temperature.	[Lu, Xuyang; Fan, Jihui; Yan, Yan; Wang, Xiaodan] Chinese Acad Sci, Inst Mt Hazards & Environm, Key Lab Mt Surface Proc & Ecol Regulat, Chengdu, Sichuan, Peoples R China; [Lu, Xuyang; Fan, Jihui] Chinese Acad Sci, Inst Mt Hazards & Environm, Wetland Ecosyst Observat & Expt Stn, Xainza, Tibet, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS	Lu, XY (corresponding author), Chinese Acad Sci, Inst Mt Hazards & Environm, Key Lab Mt Surface Proc & Ecol Regulat, Chengdu, Sichuan, Peoples R China.	xylu@imde.ac.cn; wxd@imde.ac.cn		Lu, Xuyang/0000-0001-6653-6009	National Natural Science Foundation of China [41001177, 41201053]; One Hundred Young Persons Project of Institute of Mountain Hazards and Environment [SDSQB-2010-02]; 135 Strategic Program of the Institute of Mountain Hazards and Environment [sds-135-1203-03]; Action-plan of the Chinese Academy of Sciences (CAS) for West Development [KZCX2-XB3-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Hundred Young Persons Project of Institute of Mountain Hazards and Environment; 135 Strategic Program of the Institute of Mountain Hazards and Environment; Action-plan of the Chinese Academy of Sciences (CAS) for West Development	This work was supported by the National Natural Science Foundation of China (Grant No. 41001177 and 41201053), the One Hundred Young Persons Project of Institute of Mountain Hazards and Environment (Grant No. SDSQB-2010-02), the 135 Strategic Program of the Institute of Mountain Hazards and Environment (Grant No. sds-135-1203-03), and the Action-plan of the Chinese Academy of Sciences (CAS) for West Development (Grant No. KZCX2-XB3-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril A, 2005, FOREST ECOL MANAG, V206, P399, DOI 10.1016/j.foreco.2004.11.014; Alm J, 1999, ECOLOGY, V80, P161, DOI 10.1890/0012-9658(1999)080[0161:CBOABB]2.0.CO;2; Almagro M, 2009, SOIL BIOL BIOCHEM, V41, P594, DOI 10.1016/j.soilbio.2008.12.021; Aronson EL, 2009, AGR FOREST METEOROL, V149, P1791, DOI 10.1016/j.agrformet.2009.06.007; Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Bekku YS, 2003, APPL SOIL ECOL, V22, P205, DOI 10.1016/S0929-1393(02)00158-0; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Bronson DR, 2008, GLOBAL CHANGE BIOL, V14, P856, DOI 10.1111/j.1365-2486.2007.01508.x; Contosta AR, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00133.1; Cross A, 2010, GEODERMA, V157, P126, DOI 10.1016/j.geoderma.2010.04.003; Djukic I, 2010, SOIL BIOL BIOCHEM, V42, P155, DOI 10.1016/j.soilbio.2009.10.006; Falk M, 2005, AGR FOREST METEOROL, V135, P269, DOI 10.1016/j.agrformet.2005.12.005; Gao QZ, 2010, QUATERN INT, V226, P143, DOI 10.1016/j.quaint.2009.10.035; Gao QZ, 2009, RESTOR ECOL, V17, P320, DOI 10.1111/j.1526-100X.2009.00527.x; Geng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034968; Hirota M, 2006, ECOSYSTEMS, V9, P673, DOI 10.1007/s10021-006-0029-x; Hollister RD, 2006, ARCT ANTARCT ALP RES, V38, P206, DOI 10.1657/1523-0430(2006)38[206:STATRT]2.0.CO;2; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; King AJ, 2008, SOIL BIOL BIOCHEM, V40, P2605, DOI 10.1016/j.soilbio.2008.06.026; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Lu XY, 2012, ARCT ANTARCT ALP RES, V44, P188, DOI 10.1657/1938-4246-44.2.188; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Moyano FE, 2012, BIOGEOSCIENCES, V9, P1173, DOI 10.5194/bg-9-1173-2012; Oberbauer SF, 2007, ECOL MONOGR, V77, P221, DOI 10.1890/06-0649; ORCHARD VA, 1983, SOIL BIOL BIOCHEM, V15, P447, DOI 10.1016/0038-0717(83)90010-X; Pihlatie M, 2007, TELLUS B, V59, P458, DOI 10.1111/j.1600-0889.2007.00278.x; Pregitzer K, 2006, OECOLOGIA, V148, P503, DOI 10.1007/s00442-006-0381-8; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Savage KE, 2001, GLOBAL BIOGEOCHEM CY, V15, P337, DOI 10.1029/1999GB001248; Schaefer DA, 2009, SOIL BIOL BIOCHEM, V41, P1000, DOI 10.1016/j.soilbio.2008.11.015; Schindlbacher A, 2008, PLANT SOIL, V303, P323, DOI 10.1007/s11104-007-9511-2; Schindlbacher A, 2012, GLOBAL CHANGE BIOL, V18, P2270, DOI 10.1111/j.1365-2486.2012.02696.x; Shi PL, 2006, AGR FOREST METEOROL, V137, P220, DOI 10.1016/j.agrformet.2006.02.008; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sullivan B, 2008, FOREST ECOL MANAG, V255, P4047, DOI 10.1016/j.foreco.2008.03.051; Taneva L, 2006, GLOBAL CHANGE BIOL, V12, P983, DOI 10.1111/j.1365-2486.2006.01147.x; Van Oijen M, 1999, GLOB CHANGE BIOL, V5, P411, DOI 10.1046/j.1365-2486.1999.00233.x; Vincent G, 2006, SOIL BIOL BIOCHEM, V38, P2527, DOI 10.1016/j.soilbio.2006.03.009; Wen XF, 2006, AGR FOREST METEOROL, V137, P166, DOI 10.1016/j.agrformet.2006.02.005; Wu G, 2007, COLLOID SURFACE B, V60, P250, DOI 10.1016/j.colsurfb.2007.06.022; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Xu ZF, 2010, PLANT SOIL, V336, P183, DOI 10.1007/s11104-010-0461-8; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013	47	41	44	12	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59054	10.1371/journal.pone.0059054	http://dx.doi.org/10.1371/journal.pone.0059054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536854	Green Submitted, Green Published, gold			2022-12-25	WOS:000316251100115
J	Linschooten, JO; Verhofstad, N; Gutzkow, K; Olsen, AK; Yauk, C; Oligschlager, Y; Brunborg, G; van Schooten, FJ; Godschalk, RWL				Linschooten, Joost O.; Verhofstad, Nicole; Gutzkow, Kristine; Olsen, Ann-Karin; Yauk, Carole; Oligschlager, Yvonne; Brunborg, Gunnar; van Schooten, Frederik J.; Godschalk, Roger W. L.			Paternal lifestyle as a potential source of germline mutations transmitted to offspring	FASEB JOURNAL			English	Article						MoBa; cigarette smoking; genomic instability	PARTICULATE AIR-POLLUTION; CIGARETTE-SMOKING; HERITABLE MUTATIONS; NORWEGIAN MOTHER; CHILDHOOD-CANCER; LINE MUTATIONS; TOBACCO-SMOKE; DNA-DAMAGE; RISK; COHORT	Paternal exposure to high levels of radioactivity causes heritable germline minisatellite mutations. However, the effect of more general paternal exposures, such as cigarette smoking, on germline mutations remains unexplored. We analyzed two of the most commonly used minisatellite loci (CEB1 and B6.7) to identify germline mutations in blood samples of complete mother-father-child triads from the Norwegian Mother and Child Cohort Study (MoBa). The presence of mutations was subsequently related to general lifestyle factors, including paternal smoking before the partner became pregnant. Paternally derived mutations at the B6.7 locus (mutation frequency 0.07) were not affected by lifestyle. In contrast, high gross yearly income as a general measure of a healthy lifestyle coincided with low-mutation frequencies at the CEB1 locus (P=0.047). Income was inversely related to smoking behavior, and paternally derived CEB1 mutations were dose dependently increased when the father smoked in the 6 mo before pregnancy, 0.21 vs. 0.05 in smoking and nonsmoking fathers, respectively (P=0.061). These results suggest that paternal lifestyle can affect the chance of heritable mutations in unstable repetitive DNA sequences. To our knowledge, this is the first study reporting an effect of lifestyle on germline minisatellite mutation frequencies in a human population with moderate paternal exposures.Linschooten, J. O., Verhofstad, N., Gutzkow, K., Olsen, A.-K., Yauk, C., Oligschlager, Y., Brunborg, G., van Schooten, F. J., Godschalk, R. W. L. Paternal lifestyle as a potential source of germline mutations transmitted to offspring.	[Linschooten, Joost O.; Verhofstad, Nicole; Oligschlager, Yvonne; van Schooten, Frederik J.; Godschalk, Roger W. L.] Maastricht Univ, Sch Nutr Metab & Toxicol, Dept Toxicol, Maastricht, Netherlands; [Gutzkow, Kristine; Olsen, Ann-Karin; Brunborg, Gunnar] Norwegian Inst Publ Hlth, Dept Chem & Radiat, Div Environm Med, Oslo, Norway; [Yauk, Carole] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Maastricht University; Norwegian Institute of Public Health (NIPH); Carleton University	Godschalk, RWL (corresponding author), Sch Nutr Toxicol & Metab NUTRIM, Dept Toxicol, Univ Singel 50,POB 616, NL-6200 MD Maastricht, Netherlands.	r.godschalk@maastrichtuniversity.nl		Yauk, Carole/0000-0002-6725-3454; Olsen, Ann-Karin/0000-0003-3982-5213; Yauk, Carole/0000-0003-4919-876X	European Union (EU) [FOOD-CT-2005-016320]; Norwegian Ministry of Health; Ministry of Education and Research; U.S. National Institutes of Health (NIH)/National Instiute of Environmental Health Sciences [N01-ES-75558]; NIH/National Institute of Neurological Disorders and Stroke [UO1 NS 047537-01, UO1 NS 047537-06A1]; Norwegian Research Council/FUGE [151918/S10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	European Union (EU)(CGIAREuropean Commission); Norwegian Ministry of Health; Ministry of Education and Research; U.S. National Institutes of Health (NIH)/National Instiute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Newborns and Genotoxic Exposure Risks (NewGeneris) study was funded by the European Union (EU contract FOOD-CT-2005-016320). The study population originated from the Norwegian Mother and Child Cohort Study (MoBa), which is supported by the Norwegian Ministry of Health and the Ministry of Education and Research, the U.S. National Institutes of Health (NIH)/National Instiute of Environmental Health Sciences (contract N01-ES-75558), NIH/National Institute of Neurological Disorders and Stroke (grants UO1 NS 047537-01 and UO1 NS 047537-06A1), and the Norwegian Research Council/FUGE (grant 151918/S10). The authors are grateful to all the participating families in Norway, who take part in this ongoing cohort study. The authors thank Dr. Elin Alsaker (Norwegian Institute of Public Health) for assisting in data analysis.	Anderson Diana, 2005, Toxicol Appl Pharmacol, V207, P506, DOI 10.1016/j.taap.2005.01.022; Boffetta P, 2000, ENVIRON HEALTH PERSP, V108, P73, DOI 10.2307/3454298; Bois P, 1999, CELL MOL LIFE SCI, V55, P1636, DOI 10.1007/s000180050402; Davies BG, 2007, BRIT J CANCER, V96, P1265, DOI 10.1038/sj.bjc.6603706; DeMarini DM, 2012, ENVIRON MOL MUTAGEN, V53, P166, DOI 10.1002/em.21685; Dubrova YE, 2003, SWISS MED WKLY, V133, P474; Dubrova YE, 1997, MUTAT RES-FUND MOL M, V381, P267; Dubrova YE, 1996, NATURE, V380, P683, DOI 10.1038/380683a0; Dubrova YE, 2002, AM J HUM GENET, V71, P801, DOI 10.1086/342729; Dubrova YE, 2006, MUTAT RES-FUND MOL M, V602, P74, DOI 10.1016/j.mrfmmm.2006.08.001; Elshal MF, 2009, CLIN BIOCHEM, V42, P589, DOI 10.1016/j.clinbiochem.2008.11.012; Friedler G, 1996, PHARMACOL BIOCHEM BE, V55, P691, DOI 10.1016/S0091-3057(96)00286-9; Hurles M, 2012, NAT GENET, V44, P1174, DOI 10.1038/ng.2448; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Laubenthal J, 2012, FASEB J, V26, P3946, DOI 10.1096/fj.11-201194; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Marchetti F, 2011, P NATL ACAD SCI USA, V108, P12811, DOI 10.1073/pnas.1106896108; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Olsen AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011349; Potts RJ, 1999, MUTAT RES-FUND MOL M, V423, P103, DOI 10.1016/S0027-5107(98)00242-5; Rehkopf DH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-383; Robbins WA, 2005, CYTOGENET GENOME RES, V111, P371, DOI 10.1159/000086914; Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Sepaniak S, 2006, TOXICOLOGY, V223, P54, DOI 10.1016/j.tox.2006.03.001; Shi QH, 2001, MOL REPROD DEV, V59, P417, DOI 10.1002/mrd.1048; Singer TM, 2010, ENVIRON MOL MUTAGEN, V51, P919, DOI 10.1002/em.20613; Sipinen V, 2010, MUTAGENESIS, V25, P417, DOI 10.1093/mutage/geq024; Somers CM, 2004, SCIENCE, V304, P1008, DOI 10.1126/science.1095815; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Tamaki K, 1999, HUM MOL GENET, V8, P879, DOI 10.1093/hmg/8.5.879; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; Vergnaud G, 2000, GENOME RES, V10, P899, DOI 10.1101/gr.10.7.899; Verhofstad N, 2008, MUTAGENESIS, V23, P241, DOI 10.1093/mutage/gen022; Verhofstad N, 2011, TOXICOL SCI, V119, P218, DOI 10.1093/toxsci/kfq325; Yauk C, 1998, MUTAT RES-REV MUTAT, V411, P1, DOI 10.1016/S1383-5742(98)00003-9; Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105; Yauk CL, 2007, CANCER RES, V67, P5103, DOI 10.1158/0008-5472.CAN-07-0279; Yauk CL, 2004, MUTAT RES-REV MUTAT, V566, P169, DOI 10.1016/j.mrrev.2003.08.001; Yauk CL, 1996, P NATL ACAD SCI USA, V93, P12137, DOI 10.1073/pnas.93.22.12137; Yauk CL, 2012, MUTAT RES, V752, P6; ZHANG J, 1992, INT J EPIDEMIOL, V21, P273, DOI 10.1093/ije/21.2.273	44	40	40	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2873	2879		10.1096/fj.13-227694	http://dx.doi.org/10.1096/fj.13-227694			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23538710	Green Published			2022-12-25	WOS:000328841000035
J	Temel, DB; Dutta, K; Alphonse, S; Nourikyan, J; Grangeasse, C; Ghose, R				Temel, Deniz B.; Dutta, Kaushik; Alphonse, Sebastien; Nourikyan, Julien; Grangeasse, Christophe; Ghose, Ranajeet			Regulatory Interactions between a Bacterial Tyrosine Kinase and Its Cognate Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-PROTEIN PHOSPHATASE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; CAPSULAR POLYSACCHARIDES; STREPTOCOCCUS-PNEUMONIAE; SUBSTRATE RECOGNITION; PHOSPHORYLATION; WZC; AUTOPHOSPHORYLATION; EXOPOLYSACCHARIDE	The cyclic process of autophosphorylation of the C-terminal tyrosine cluster (YC) of a bacterial tyrosine kinase and its subsequent dephosphorylation following interactions with a counter-acting tyrosine phosphatase regulates diverse physiological processes, including the biosynthesis and export of polysaccharides responsible for the formation of biofilms or virulence-determining capsules. We provide here the first detailed insight into this hitherto uncharacterized regulatory interaction at residue-specific resolution using Escherichia coli Wzc, a canonical bacterial tyrosine kinase, and its opposing tyrosine phosphatase, Wzb. The phosphatase Wzb utilizes a surface distal to the catalytic elements of the kinase, Wzc, to dock onto its catalytic domain (Wzc(CD)). Wzc(CD) binds in a largely YC-independent fashion near the Wzb catalytic site, inducing allosteric changes therein. YC dephosphorylation is proximity-mediated and reliant on the elevated concentration of phosphorylated YC near the Wzb active site resulting from Wzc(CD) docking. Wzb principally recognizes the phosphate of its phosphotyrosine substrate and further stabilizes the tyrosine moiety through ring stacking interactions with a conserved active site tyrosine.	[Temel, Deniz B.; Alphonse, Sebastien; Ghose, Ranajeet] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Temel, Deniz B.; Ghose, Ranajeet] CUNY, Grad Ctr, New York, NY 10016 USA; [Dutta, Kaushik] New York Struct Biol Ctr, New York, NY 10027 USA; [Nourikyan, Julien; Grangeasse, Christophe] Univ Lyon 1, BMSSI UMR 5086, CNRS, Inst Biol & Chim Prot, F-69367 Lyon, France	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Dutta, K (corresponding author), New York Struct Biol Ctr, 89 Convent Ave, New York, NY 10027 USA.	dutta@nysbc.org; rghose@sci.ccny.cuny.edu		Alphonse, Sebastien/0000-0002-2054-2005; Nourikyan, Julien/0000-0001-9943-1326; Grangeasse, Christophe/0000-0002-5484-4589	National Institutes of Health [GM084278, AI101792, 2G12RR03060, 8G12MD007603, CO6RR015495, P41GM066354]; CNRS, Universite de Lyon; Agence National de la Recherche [ANR-08-BLAN-0143, ANR-10-BLAN-1303-01]; New York State Office for Science, Technology, and Academic Research (NYSTAR); Keck Foundation; New York City Economic Development Corporation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015495, G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084278, P41GM066354] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS, Universite de Lyon(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche(French National Research Agency (ANR)); New York State Office for Science, Technology, and Academic Research (NYSTAR); Keck Foundation(W.M. Keck Foundation); New York City Economic Development Corporation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants GM084278 and AI101792. This work was also supported by CNRS, Universite de Lyon, and the Agence National de la Recherche (ANR-08-BLAN-0143 and ANR-10-BLAN-1303-01). The NMR facilities at City College of New York are partially supported by National Institutes of Health Grants 2G12RR03060 and 8G12MD007603. Facilities at the New York Structural Biology Center are supported by National Institutes of Health Grants CO6RR015495 and P41GM066354; the New York State Office for Science, Technology, and Academic Research (NYSTAR); the Keck Foundation; and the New York City Economic Development Corporation.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Bechet E, 2009, AMINO ACIDS, V37, P499, DOI 10.1007/s00726-009-0237-8; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BOGGS PT, 1989, ACM T MATH SOFTWARE, V15, P348, DOI 10.1145/76909.76913; Byrne JP, 2011, J BACTERIOL, V193, P2341, DOI 10.1128/JB.00074-11; Chen HB, 2008, P NATL ACAD SCI USA, V105, P19660, DOI 10.1073/pnas.0807752105; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Cowan-Jacob SW, 2006, CELL MOL LIFE SCI, V63, P2608, DOI 10.1007/s00018-006-6202-8; Cozzone AJ, 2004, ARCH MICROBIOL, V181, P171, DOI 10.1007/s00203-003-0640-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doublet P, 2002, J BIOL CHEM, V277, P37339, DOI 10.1074/jbc.M204465200; Duclos B, 1996, J MOL BIOL, V259, P891, DOI 10.1006/jmbi.1996.0366; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Grangeasse C, 1997, GENE, V204, P259, DOI 10.1016/S0378-1119(97)00554-4; Grangeasse C, 1998, J MOL BIOL, V278, P339, DOI 10.1006/jmbi.1998.1650; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Grangeasse C, 2012, PHILOS T R SOC B, V367, P2640, DOI 10.1098/rstb.2011.0424; Grangeasse C, 2010, BBA-PROTEINS PROTEOM, V1804, P628, DOI 10.1016/j.bbapap.2009.08.018; Hagelueken G, 2009, J MOL BIOL, V392, P678, DOI 10.1016/j.jmb.2009.07.026; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jadeau F, 2008, BIOINFORMATICS, V24, P2427, DOI 10.1093/bioinformatics/btn462; Jadeau F, 2012, NUCLEIC ACIDS RES, V40, pD321, DOI 10.1093/nar/gkr915; Jers C, 2008, EXPERT REV PROTEOMIC, V5, P619, DOI 10.1586/14789450.5.4.619; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kolot M, 2008, VIROLOGY, V375, P383, DOI 10.1016/j.virol.2008.02.011; Lacour S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003053; Latham MP, 2009, J AM CHEM SOC, V131, P5052, DOI 10.1021/ja900695m; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Lemak A, 2011, J BIOMOL NMR, V49, P27, DOI 10.1007/s10858-010-9458-0; Lescop E, 2006, J BIOL CHEM, V281, P19570, DOI 10.1074/jbc.M601263200; Madhurantakam C, 2005, J BACTERIOL, V187, P2175, DOI 10.1128/JB.187.6.2175-2181.2005; MANAI M, 1982, BIOCHEM BIOPH RES CO, V107, P981, DOI 10.1016/0006-291X(82)90619-2; Mao Y, 2006, LETT APPL MICROBIOL, V42, P642, DOI 10.1111/j.1472-765X.2006.01875.x; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Muratore KE, 2007, ACS CHEM BIOL, V2, P454, DOI 10.1021/cb7001285; Nadler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037984; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Obadia B, 2007, J MOL BIOL, V367, P42, DOI 10.1016/j.jmb.2006.12.048; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Paiment A, 2002, J BACTERIOL, V184, P6437, DOI 10.1128/JB.184.23.6437-6447.2002; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Petranovic D, 2007, MOL MICROBIOL, V63, P1797, DOI 10.1111/j.1365-2958.2007.05625.x; Pettiford SM, 2003, LEUKEMIA, V17, P366, DOI 10.1038/sj.leu.2402767; Preneta R, 2002, COMP BIOCHEM PHYS B, V131, P103, DOI 10.1016/S1096-4959(01)00490-0; Rainey MA, 2005, J AM CHEM SOC, V127, P10494, DOI 10.1021/ja052915p; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Stehle T, 2012, J BIOL CHEM, V287, P34569, DOI 10.1074/jbc.M112.399261; Tabernero L, 2008, FEBS J, V275, P867, DOI 10.1111/j.1742-4658.2008.06251.x; Temel DB, 2014, BIOMOL NMR ASSIGN, V8, P37, DOI 10.1007/s12104-012-9448-0; Tsygankov AY, 2003, FRONT BIOSCI-LANDMRK, V8, pS595, DOI 10.2741/1106; Vega C, 2011, J MOL BIOL, V413, P24, DOI 10.1016/j.jmb.2011.08.015; Vincent C, 1999, J BACTERIOL, V181, P3472, DOI 10.1128/JB.181.11.3472-3477.1999; Vincent C, 2000, J MOL BIOL, V304, P311, DOI 10.1006/jmbi.2000.4217; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	67	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15212	15228		10.1074/jbc.M113.457804	http://dx.doi.org/10.1074/jbc.M113.457804			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23543749	hybrid, Green Published			2022-12-25	WOS:000319452100049
J	Cestari, I; Stuart, K				Cestari, Igor; Stuart, Kenneth			Inhibition of Isoleucyl-tRNA Synthetase as a Potential Treatment for Human African Trypanosomiasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANCE; CELL-CYCLE; BRUCEI; TARGETS; SITE; SELECTION; DISEASES; MODEL	Trypanosoma brucei sp. causes human African trypanosomiasis (HAT; African sleeping sickness). The parasites initially proliferate in the hemolymphatic system and then invade the central nervous system, which is lethal if not treated. New drugs are needed for HAT because the approved drugs are few, toxic, and difficult to administer, and drug resistance is spreading. We showed by RNAi knockdown that T. brucei isoleucyl-tRNA synthetase is essential for the parasites in vitro and in vivo in a mouse model of infection. By structure prediction and experimental analysis, we also identified small molecules that inhibit recombinant isoleucyl-tRNA synthetase and that are lethal to the parasites in vitro and highly selective compared with mammalian cells. One of these molecules acts as a competitive inhibitor of the enzyme and cures mice of the infection. Because members of this class of molecules are known to cross the blood-brain barrier in humans and to be tolerated, they may be attractive as leading candidates for drug development for HAT.	[Cestari, Igor; Stuart, Kenneth] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Stuart, Kenneth] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Stuart, K (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	ken.stuart@seattlebiomed.org			National Institutes of Health [R01 AI078962, 5T32AI007509-12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078962, T32AI007509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI078962 (to K. S) and National Institutes of Health Fellowship 5T32AI007509-12 administered by the University of Washington (to I. C.).	Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Alsford S, 2012, NUCLEIC ACIDS RES, V40, P10150, DOI 10.1093/nar/gks813; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Badjatia N, 2013, MOL CELL BIOL, V33, P1965, DOI 10.1128/MCB.00156-13; Barrett MP, 2011, FUTURE MICROBIOL, V6, P1037, DOI [10.2217/FMB.11.88, 10.2217/fmb.11.88]; Barrett MP, 2010, CURR OPIN INFECT DIS, V23, P603, DOI 10.1097/QCO.0b013e32833f9fd0; Bishop AC, 2002, P NATL ACAD SCI USA, V99, P585, DOI 10.1073/pnas.012611299; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Cestari I, 2013, J BIOMOL SCREEN, V18, P490, DOI 10.1177/1087057112465980; Chitanga S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001454; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Fevre EM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000333; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Frevert U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043913; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Inoue M, 2005, J BIOL CHEM, V280, P14085, DOI 10.1074/jbc.M412336200; Jacobs RT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001151; Koh CY, 2012, STRUCTURE, V20, P1681, DOI 10.1016/j.str.2012.07.011; LANDRY ML, 1982, JAMA-J AM MED ASSOC, V247, P332, DOI 10.1001/jama.247.3.332; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; MORSE GD, 1993, CLIN PHARMACOKINET, V24, P101, DOI 10.2165/00003088-199324020-00002; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Nishihara K, 2000, APPL ENVIRON MICROB, V66, P884, DOI 10.1128/AEM.66.3.884-889.2000; Nomanbhoy TK, 2001, BIOORG MED CHEM LETT, V11, P1485, DOI 10.1016/S0960-894X(01)00127-5; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Rettig J, 2012, NUCLEIC ACIDS RES, V40, P1299, DOI 10.1093/nar/gkr794; Rottenberg ME, 2005, J INFECT DIS, V192, P1658, DOI 10.1086/496896; Schimmel P, 1998, FASEB J, V12, P1599, DOI 10.1096/fasebj.12.15.1599; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	37	14	14	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14256	14263		10.1074/jbc.M112.447441	http://dx.doi.org/10.1074/jbc.M112.447441			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548908	Green Published, hybrid			2022-12-25	WOS:000319253500030
J	Guengerich, FP				Guengerich, F. Peter			Thematic Minireview Series: Metals in Biology 2013	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								One-half of the available protein structures contain metals, explaining their roles as essential trace elements. Metals are also critical in many aspects of nucleic acid biochemistry. This prologue briefly introduces the fifth of the Thematic Series on Metals in Biology, which began in the Journal of Biological Chemistry in 2009. The five minireviews in this 2013 series deal with the molybdenum prosthetic group (a pterin known as Moco); the biosynthesis of the "M-cluster" molybdenum prosthetic group of nitrogenase; the biosynthesis of the nickel-based metallocenter of the enzyme urease; several of the processing, transport, and medical aspects of cobalamins; and the growing roles of heme sensor proteins.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			NIEHS NIH HHS [P30 ES000267] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Guengerich FP, 2012, J BIOL CHEM, V287, P13508, DOI 10.1074/jbc.R112.355933; Guengerich FP, 2010, J BIOL CHEM, V285, P26727, DOI 10.1074/jbc.R110.150870; Guengerich FP, 2009, J BIOL CHEM, V284, P18557, DOI 10.1074/jbc.M109.003863; Guengerich FP, 2009, J BIOL CHEM, V284, P709, DOI 10.1074/jbc.R800060200; Rosen BP, 2011, BIOESSAYS, V33, P350, DOI 10.1002/bies.201100012; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258	7	8	8	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13164	13164		10.1074/jbc.R113.467712	http://dx.doi.org/10.1074/jbc.R113.467712			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539620	Green Published, hybrid			2022-12-25	WOS:000318850300001
J	Kera, Y; Katoh, Y; Ohta, M; Matsumoto, M; Takano-Yamamoto, T; Igarashi, K				Kera, Yohei; Katoh, Yasutake; Ohta, Mineto; Matsumoto, Mitsuyo; Takano-Yamamoto, Teruko; Igarashi, Kazuhiko			Methionine Adenosyltransferase II-dependent Histone H3K9 Methylation at the COX-2 Gene Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; MAT2A GENE; MAMMALIAN-CELLS; CARCINOMA CELLS; DNA; TRANSCRIPTION; EXPRESSION; CHROMATIN; PROTEINS; GROWTH	Methionine adenosyltransferase (MAT) synthesizes S-adenosylmethionine (AdoMet), which is utilized as a methyl donor in transmethylation reactions involving histones. MATII alpha, a MAT isozyme, serves as a transcriptional corepressor in the oxidative stress response and forms the AdoMet-integrating transcription regulation module, affecting histone methyltransferase activities. However, the identities of genes regulated by MATII alpha or its associated methyltransferases are unclear. We show that MATII alpha represses the expression of cyclooxygenase 2 (COX-2), encoded by Ptgs2, by specifically interacting with histone H3K9 methyltransferase SETDB1, thereby promoting the trimethylation of H3K9 at the COX-2 locus. We discuss both gene-specific and epigenome-wide functions of MATII alpha.	[Kera, Yohei; Katoh, Yasutake; Ohta, Mineto; Matsumoto, Mitsuyo; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; [Kera, Yohei; Katoh, Yasutake; Ohta, Mineto; Matsumoto, Mitsuyo; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi 9808575, Japan; [Kera, Yohei; Takano-Yamamoto, Teruko] Tohoku Univ, Grad Sch Dent, Dept Orthoped & Dentofacial Orthoped, Sendai, Miyagi 9808575, Japan; [Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST)	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.	igarashi@med.tohoku.ac.jp	Matsumoto, Mitsuyo/AAC-3065-2019	Igarashi, Kazuhiko/0000-0002-2470-2475	Ministry of Education, Science, Sports, and Culture of Japan; global COE (Center of Excellence) program for Network Medicine, Tohoku University; Biomedical Research Core of Tohoku University School of Medicine; Grants-in-Aid for Scientific Research [23249085] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); global COE (Center of Excellence) program for Network Medicine, Tohoku University; Biomedical Research Core of Tohoku University School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan, and the global COE (Center of Excellence) program for Network Medicine, Tohoku University. This work was also supported in part by the Biomedical Research Core of Tohoku University School of Medicine.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Cai JX, 1998, CANCER RES, V58, P1444; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; Dohi Y, 2008, NAT STRUCT MOL BIOL, V15, P1246, DOI 10.1038/nsmb.1516; Fowler Brian, 2005, Semin Vasc Med, V5, P77; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Halim AB, 1999, J BIOL CHEM, V274, P29720, DOI 10.1074/jbc.274.42.29720; Halim AB, 2001, J BIOL CHEM, V276, P9784, DOI 10.1074/jbc.M002347200; Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Jani TS, 2009, CELL RES, V19, P358, DOI 10.1038/cr.2008.314; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kotb M, 1997, TRENDS GENET, V13, P51, DOI 10.1016/S0168-9525(97)01013-5; LeGros HL, 2000, J BIOL CHEM, V275, P2359, DOI 10.1074/jbc.275.4.2359; Li B., 2007, CELL, V4, P653; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Markham GD, 2009, CELL MOL LIFE SCI, V66, P636, DOI 10.1007/s00018-008-8516-1; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Popovich DG, 2002, ARCH BIOCHEM BIOPHYS, V406, P1, DOI 10.1016/S0003-9861(02)00398-3; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Rodriguez JL, 2007, INT J BIOCHEM CELL B, V39, P842, DOI 10.1016/j.biocel.2007.01.009; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Sherratt PJ, 2003, BIOCHEM PHARMACOL, V66, P51, DOI 10.1016/S0006-2952(03)00206-5; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Yang HP, 2011, BIOCHEM J, V436, P507, DOI 10.1042/BJ20101754; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang T, 2013, ACTA HISTOCHEM, V115, P48, DOI 10.1016/j.acthis.2012.03.006; Zhu YN, 2012, MOL CELL, V46, P408, DOI 10.1016/j.molcel.2012.05.011	38	50	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13592	13601		10.1074/jbc.M112.429738	http://dx.doi.org/10.1074/jbc.M112.429738			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539621	Green Published, hybrid			2022-12-25	WOS:000318850300041
J	Liu, YJ; Fan, HB; Jin, Y; Ren, CG; Jia, XE; Wang, L; Chen, Y; Dong, M; Zhu, KY; Dong, ZW; Ye, BX; Zhong, Z; Deng, M; Liu, TX; Ren, RB				Liu, Yi-Jie; Fan, Hong-Bo; Jin, Yi; Ren, Chun-Guang; Jia, Xiao-E; Wang, Lei; Chen, Yi; Dong, Mei; Zhu, Kang-Yong; Dong, Zhi-Wei; Ye, Bai-Xin; Zhong, Zhong; Deng, Min; Liu, Ting Xi; Ren, Ruibao			Cannabinoid Receptor 2 Suppresses Leukocyte Inflammatory Migration by Modulating the JNK/c-Jun/Alox5 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL GENETICS; CB2 RECEPTOR; C-JUN; ANTITUMOR-ACTIVITY; SMALL MOLECULES; IN-VITRO; ZEBRAFISH; EXPRESSION; MODEL; CANNABIDIOL	Inflammatory migration of immune cells is involved in many human diseases. Identification of molecular pathways and modulators controlling inflammatory migration could lead to therapeutic strategies for treating human inflammation-associated diseases. The role of cannabinoid receptor type 2 (Cnr2) in regulating immune function had been widely investigated, but the mechanism is not fully understood. Through a chemical genetic screen using a zebrafish model for leukocyte migration, we found that both anagonist of the Cnr2 and inhibitor of the 5-lipoxygenase (Alox5, encoded by alox5) inhibit leukocyte migration in response to acute injury. These agents have a similar effect on migration of human myeloid cells. Consistent with these results, we found that inactivation of Cnr2 by zinc finger nuclease-mediated mutagenesis enhances leukocyte migration, while inactivation of Alox5 blocks leukocyte migration. Further investigation indicates that there is a signaling link between Cnr2 and Alox5 and that alox5 is a target of c-Jun. Cnr2 activation down-regulates alox5 expression by suppressing the JNK/c-Jun activation. These studies demonstrate that Cnr2, JNK, and Alox5 constitute a pathway regulating leukocyte migration. The cooperative effect between the Cnr2 agonist and Alox5 inhibitor also provides a potential therapeutic strategy for treating human inflammation-associated diseases.	[Liu, Yi-Jie; Jin, Yi; Chen, Yi; Ye, Bai-Xin; Liu, Ting Xi; Ren, Ruibao] Shanghai Jiao Tong Univ, Sch Med, RuiJin Hosp, Shanghai Inst Hematol,State Key Lab Med Genom, Shanghai 200025, Peoples R China; [Fan, Hong-Bo; Ren, Chun-Guang; Jia, Xiao-E; Wang, Lei; Dong, Mei; Zhu, Kang-Yong; Dong, Zhi-Wei; Deng, Min; Liu, Ting Xi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Fan, Hong-Bo; Ren, Chun-Guang; Jia, Xiao-E; Wang, Lei; Dong, Mei; Zhu, Kang-Yong; Dong, Zhi-Wei; Deng, Min; Liu, Ting Xi] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Zhong, Zhong] GlaxoSmithKline Res & Dev China, Shanghai 201203, Peoples R China; [Ren, Ruibao] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Ren, Ruibao] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; GlaxoSmithKline; Brandeis University; Brandeis University	Zhong, Z (corresponding author), GlaxoSmithKline Res & Dev China, Shanghai 201203, Peoples R China.	zhong.z.zhong@gsk.com; mdeng@sibs.ac.cn; ren@brandeis.edu	ren, Chunguang/L-9609-2019		National Basic Research Program of China [2007CB947003, 2011CB964803]; National Natural Science Foundation of China [30830047, 31000636]; Chinese Academy of Science [XDA 01010106]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program of China (2007CB947003 and 2011CB964803), the National Natural Science Foundation of China (30830047, 31000636), and the Strategic Priority Research Program of the Chinese Academy of Science (XDA 01010106).	Adhikary S, 2012, BLOOD, V120, P3741, DOI 10.1182/blood-2012-06-435362; Basu S, 2011, IMMUNOL RES, V51, P26, DOI 10.1007/s12026-011-8210-5; Borner C, 2009, J BIOL CHEM, V284, P35450, DOI 10.1074/jbc.M109.006338; Castillo A, 2010, NEUROBIOL DIS, V37, P434, DOI 10.1016/j.nbd.2009.10.023; Clifton JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012386; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Correa F, 2010, GLIA, V58, P135, DOI 10.1002/glia.20907; Correa F, 2009, BIOCHEM PHARMACOL, V77, P86, DOI 10.1016/j.bcp.2008.09.014; Csoka B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006409; Fraczek LA, 2011, MOL IMMUNOL, V49, P201, DOI 10.1016/j.molimm.2011.08.013; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/j.molimm.2006.01.005; Griffin G, 1997, EUR J PHARMACOL, V339, P53, DOI 10.1016/S0014-2999(97)01336-8; Grose R, 2003, CURR BIOL, V13, pR678, DOI 10.1016/S0960-9822(03)00607-9; Gustafsson K, 2006, MOL PHARMACOL, V70, P1612, DOI 10.1124/mol.106.025981; Hosoda H, 2011, LIFE SCI, V89, P115, DOI 10.1016/j.lfs.2011.05.007; Klegeris A, 2003, J LEUKOCYTE BIOL, V73, P369, DOI 10.1189/jlb.1002482; Klegeris A, 2003, BRIT J PHARMACOL, V139, P775, DOI 10.1038/sj.bjp.0705304; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Krens SFG, 2006, GENE EXPR PATTERNS, V6, P1019, DOI 10.1016/j.modgep.2006.04.008; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Lam CS, 2006, NEUROSCIENCE, V138, P83, DOI 10.1016/j.neuroscience.2005.10.069; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Loynes CA, 2010, J LEUKOCYTE BIOL, V87, P203, DOI 10.1189/jlb.0409255; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Massi P, 2008, J NEUROCHEM, V104, P1091, DOI 10.1111/j.1471-4159.2007.05073.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; Monteiro APT, 2011, J IMMUNOL, V186, P6562, DOI 10.4049/jimmunol.1002400; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; NEWTON CA, 1994, INFECT IMMUN, V62, P4015, DOI 10.1128/IAI.62.9.4015-4020.1994; Ni X, 2004, MULT SCLER J, V10, P158, DOI 10.1191/1352458504ms1009oa; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Olea-Herrero N, 2009, BRIT J CANCER, V101, P940, DOI 10.1038/sj.bjc.6605248; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Raborn ES, 2008, J NEUROIMMUNE PHARM, V3, P117, DOI 10.1007/s11481-007-9077-z; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Ridges S, 2012, BLOOD, V119, P5621, DOI 10.1182/blood-2011-12-398818; Romero-Sandoval EA, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-25; Sacerdote P, 2005, J NEUROIMMUNOL, V159, P97, DOI 10.1016/j.jneuroim.2004.10.003; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Seo J, 2010, J CELL BIOCHEM, V110, P1022, DOI 10.1002/jcb.22616; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Szekanecz Z, 2006, CURR DRUG TARGETS, V7, P91, DOI 10.2174/138945006775270231; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tschop J, 2009, J IMMUNOL, V183, P499, DOI 10.4049/jimmunol.0900203; Venkatesh N, 2004, P NATL ACAD SCI USA, V101, P8969, DOI 10.1073/pnas.0402803101; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Wu XR, 2006, ARTERIOSCL THROM VAS, V26, P2414, DOI 10.1161/01.ATV.0000238361.07225.fc; Yeh JRJ, 2009, NAT CHEM BIOL, V5, P236, DOI 10.1038/nchembio.147; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447; Zhang Y, 2008, J IMMUNOL, V181, P2155, DOI 10.4049/jimmunol.181.3.2155	62	45	45	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13551	13562		10.1074/jbc.M113.453811	http://dx.doi.org/10.1074/jbc.M113.453811			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539630	hybrid, Green Published			2022-12-25	WOS:000318850300038
J	Cusimano, MD; Cho, N; Amin, K; Shirazi, M; McFaull, SR; Do, MT; Wong, MC; Russell, K				Cusimano, Michael D.; Cho, Newton; Amin, Khizer; Shirazi, Mariam; McFaull, Steven R.; Do, Minh T.; Wong, Matthew C.; Russell, Kelly			Mechanisms of Team-Sport-Related Brain Injuries in Children 5 to 19 Years Old: Opportunities for Prevention	PLOS ONE			English	Article							HEAD-INJURIES; ICE HOCKEY; BODY-CHECKING; SOCCER; EPIDEMIOLOGY; CONCUSSIONS; AGREEMENT; RISK	Background: There is a gap in knowledge about the mechanisms of sports-related brain injuries. The objective of this study was to determine the mechanisms of brain injuries among children and youth participating in team sports. Methods: We conducted a retrospective case series of brain injuries suffered by children participating in team sports. The Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP) database was searched for brain injury cases among 5-19 year-olds playing ice hockey, soccer, American football (football), basketball, baseball, or rugby between 1990 and 2009. Mechanisms of injury were classified as "struck by player,'' "struck by object,'' "struck by sport implement,'' "struck surface,'' and "other.'' A descriptive analysis was performed. Results: There were 12,799 brain injuries related to six team sports (16.2% of all brain injuries registered in CHIRPP). Males represented 81% of injuries and the mean age was 13.2 years. Ice hockey accounted for the greatest number of brain injuries (44.3%), followed by soccer (19.0%) and football (12.9%). In ice hockey, rugby, and basketball, striking another player was the most common injury mechanism. Football, basketball, and soccer also demonstrated high proportions of injuries due to contact with an object (e.g., post) among younger players. In baseball, a common mechanism in the 5-9 year-old group was being hit with a bat as a result of standing too close to the batter (26.1% males, 28.3% females). Interpretation: Many sports-related brain injury mechanisms are preventable. The results suggest that further efforts aimed at universal rule changes, safer playing environments, and the education of coaches, players, and parents should be targeted in maximizing prevention of sport-related brain injury using a multifaceted approach.	[Cusimano, Michael D.; Cho, Newton; Amin, Khizer; Shirazi, Mariam; Wong, Matthew C.; Russell, Kelly] Univ Toronto, St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [McFaull, Steven R.; Do, Minh T.] Publ Hlth Agcy Canada, Hlth Surveillance & Epidemiol Div, Ottawa, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Public Health Agency of Canada	Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada.	cusimanom@smh.ca	Cusimano, Michael/X-4059-2019; Cusimano, Michael/GWR-1025-2022	Cusimano, Michael/0000-0002-9989-0650; Russell, Kelly/0000-0002-9159-9201	Canadian Institute of Health Research Strategic Team Grant in Applied Injury Research [TIR-103946]	Canadian Institute of Health Research Strategic Team Grant in Applied Injury Research(Canadian Institutes of Health Research (CIHR))	This research was supported by Canadian Institute of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.cihr-irsc.gc.ca/e/193.html	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; Canadian Fitness & Lifestyle Research Institute, 2011, GETT KIDS ACT 2010 P; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cusimano Michael D, 2011, Open Med, V5, pe57; Cusimano MD, 2010, NEUROSURGERY, V67, P1404, DOI 10.1227/NEU.0b013e3181f209f1; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Hassan A, 2009, CAN J CARDIOL, V25, P207, DOI 10.1016/S0828-282X(09)70062-5; Juhn MS, 2002, CLIN J SPORT MED, V12, P46, DOI 10.1097/00042752-200201000-00014; Kang J., 2012, INT J INJ CONTROL SA, P1; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Macarthur C, 1997, AM J EPIDEMIOL, V145, P834; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Pickett W, 2000, Inj Prev, V6, P9, DOI 10.1136/ip.6.1.9; Statistics Canada, 2010, AGE SEX; Turk EE, 2008, BRIT J SPORT MED, V42, P604, DOI 10.1136/bjsm.2007.038505; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	25	38	38	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58868	10.1371/journal.pone.0058868	http://dx.doi.org/10.1371/journal.pone.0058868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555602	Green Published, gold			2022-12-25	WOS:000317262200007
J	Shimada, M; Abe, S; Takahashi, T; Shiozaki, K; Okuda, M; Mizukami, H; Klinman, DM; Ozawa, K; Okuda, K				Shimada, Masaru; Abe, Shinya; Takahashi, Toru; Shiozaki, Kazumasa; Okuda, Mitsue; Mizukami, Hiroaki; Klinman, Dennis M.; Ozawa, Keiya; Okuda, Kenji			Prophylaxis and Treatment of Alzheimer's Disease by Delivery of an Adeno-Associated Virus Encoding a Monoclonal Antibody Targeting the Amyloid Beta Protein	PLOS ONE			English	Article							PHASE-I TRIAL; TRANSGENIC MICE; MOUSE MODEL; A-BETA(42) IMMUNIZATION; IMMUNE-RESPONSE; MEMORY DEFICITS; SKELETAL-MUSCLE; BRAIN DELIVERY; GENE DELIVERY; VIRAL VECTOR	We previously reported on a monoclonal antibody (mAb) that targeted amyloid beta (A beta) protein. Repeated injection of that mAb reduced the accumulation of A beta protein in the brain of human A beta transgenic mice (Tg2576). In the present study, cDNA encoding the heavy and light chains of this mAb were subcloned into an adeno-associated virus type 1 (AAV) vector with a 2A/furin adapter. A single intramuscular injection of 3.0x10(10) viral genome of these AAV vectors into C57BL/6 mice generated serum anti-A beta Ab levels up to 0.3 mg/ml. Anti-A beta Ab levels in excess of 0.1 mg/ml were maintained for up to 64 weeks. The effect of AAV administration on A beta levels in vivo was examined. A significant decrease in A beta levels in the brain of Tg2576 mice treated at 5 months (prophylactic) or 10 months (therapeutic) of age was observed. These results support the use of AAV vector encoding anti-A beta Ab for the prevention and treatment of Alzheimer's disease.	[Shimada, Masaru; Abe, Shinya; Takahashi, Toru; Okuda, Kenji] Yokohama City Univ, Dept Mol Biodef Res, Yokohama, Kanagawa 232, Japan; [Shiozaki, Kazumasa] Yokohama City Univ, Dept Psychiat, Yokohama, Kanagawa 232, Japan; [Okuda, Mitsue] Okuda Dent Clin, Yokohama, Kanagawa, Japan; [Mizukami, Hiroaki; Ozawa, Keiya] Jichi Med Sch, Ctr Mol Med, Div Genet Therapeut, Mibu, Tochigi, Japan; [Klinman, Dennis M.] NCI, Expt Immunol Lab, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA	Yokohama City University; Yokohama City University; Jichi Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Okuda, K (corresponding author), Yokohama City Univ, Dept Mol Biodef Res, Yokohama, Kanagawa 232, Japan.	kokuda@chojuken.net	Mizukami, Hiroaki/D-7674-2013	Mizukami, Hiroaki/0000-0001-8954-874X; Shimada, Masaru/0000-0002-5271-4238	Ministry of Education, Science, Sports, Culture of Japan; Ministry of Health and Welfare of Japan; NATIONAL CANCER INSTITUTE [ZIABC010852] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports, Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant-in-aid for the Ministry of Education, Science, Sports, Culture of Japan, and the Ministry of Health and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 1999, GLIA, V25, P324, DOI 10.1002/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Black RS, 2010, ALZ DIS ASSOC DIS, V24, P198, DOI 10.1097/WAD.0b013e3181c53b00; Brantly ML, 2006, HUM GENE THER, V17, P1177, DOI 10.1089/hum.2006.17.1177; Carty NC, 2008, MOL THER, V16, P1580, DOI 10.1038/mt.2008.148; Chackerian B, 2006, VACCINE, V24, P6321, DOI 10.1016/j.vaccine.2006.05.059; Check E, 2002, NATURE, V415, P462, DOI 10.1038/415462a; Chu J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-1; Dafnis I, 2010, J NEUROCHEM, V115, P873, DOI 10.1111/j.1471-4159.2010.06756.x; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Farlow MR, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt39; Feng X, 2004, FRONT BIOSCI-LANDMRK, V9, P1540, DOI 10.2741/1323; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499; Fleisher AS, 2012, NEUROBIOL AGING; Fukuchi K, 2006, NEUROBIOL DIS, V23, P502, DOI 10.1016/j.nbd.2006.04.012; Hara H, 2004, J ALZHEIMERS DIS, V6, P483; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jiang HY, 2006, MOL THER, V14, P452, DOI 10.1016/j.ymthe.2006.05.004; Karlnoski RA, 2008, J NEUROIMMUNE PHARM, V3, P187, DOI 10.1007/s11481-008-9114-6; Kou JH, 2011, J ALZHEIMERS DIS, V27, P23, DOI 10.3233/JAD-2011-110230; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Liu YX, 2009, MOL THER, V17, P1381, DOI 10.1038/mt.2009.115; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; McCarron MO, 2004, LANCET NEUROL, V3, P484, DOI 10.1016/S1474-4422(04)00825-7; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nikolic WV, 2007, P NATL ACAD SCI USA, V104, P2507, DOI 10.1073/pnas.0609377104; Okada T, 2005, HUM GENE THER, V16, P1212, DOI 10.1089/hum.2005.16.1212; Okura Y, 2006, P NATL ACAD SCI USA, V103, P9619, DOI 10.1073/pnas.0600966103; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Ryan DA, 2010, MOL THER, V18, P1471, DOI 10.1038/mt.2010.111; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schroeter S, 2008, J NEUROSCI, V28, P6787, DOI 10.1523/JNEUROSCI.2377-07.2008; Shoji M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030302; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sudol KL, 2009, MOL THER, V17, P2031, DOI 10.1038/mt.2009.174; Takuma H, 2008, NEUROREPORT, V19, P615, DOI 10.1097/WNR.0b013e3282fb78c4; Tamura Y, 2005, NEUROBIOL DIS, V20, P541, DOI 10.1016/j.nbd.2005.04.007; Wilcock DM, 2006, J NEUROSCI, V26, P5340, DOI 10.1523/JNEUROSCI.0695-06.2006; Xin KQ, 2001, HUM GENE THER, V12, P1047, DOI 10.1089/104303401750214276; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	51	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e57606	10.1371/journal.pone.0057606	http://dx.doi.org/10.1371/journal.pone.0057606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555563	Green Submitted, gold, Green Published			2022-12-25	WOS:000317262200002
J	Granada, AE; Bordyugov, G; Kramer, A; Herzel, H				Granada, Adrian E.; Bordyugov, Grigory; Kramer, Achim; Herzel, Hanspeter			Human Chronotypes from a Theoretical Perspective	PLOS ONE			English	Article							PHASE-RESPONSE CURVE; CIRCADIAN PACEMAKER; ENTRAINMENT; PERIOD; DYNAMICS; CLOCK; MODEL; STIMULI; SYSTEM; RHYTHM	The endogenous circadian timing system has evolved to synchronize an organism to Periodically recurring environmental conditions. Those external time cues are called Zeitgebers: When entrained by a Zeitgeber, the intrinsic oscillator adopts a fixed Phase relation psi to the Zeitgeber Here, we systematically study how the phase of entrainment depends on clock and Zitgeber properties. We combine numerical simulations of amplitude-phase models with predictions from analytically tractable models. In this way we derive relations between the Phase of entrainment psi to the mismatch between the endogenous and Zeitgeber period, the Zeitgeber strength,and the range of entrainment. A core result is "180 degrees rule" asserting that the phase psi varies over a range of about 180 degrees within the entrainment range. The 180 degrees rule implies that clocks with a narrow entrainment range ("strong oscillators") exhibit quite flexible entrainment phases. We argue that this high sensitivity of the entrainment phase contributes to the wide range of human chronotypes.	[Granada, Adrian E.; Bordyugov, Grigory; Herzel, Hanspeter] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany; [Kramer, Achim] Charite, Lab Chronobiol, D-13353 Berlin, Germany	Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Herzel, H (corresponding author), Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany.	h.herzel@biologie.hu-berlin.de	Granada, Adrian/AAR-3743-2020	Granada, Adrian/0000-0003-0537-9091; Kramer, Achim/0000-0001-9671-6078	BMBF (BCCN) [01GQ1001C]; DFG [SFB 618, SPP 1395, GRK 1742]	BMBF (BCCN)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	The authors thank the BMBF (BCCN, grant 01GQ1001C) and the DFG (SFB 618, SPP 1395, GRK 1742) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; ASCHOFF J, 1978, NATURWISSENSCHAFTEN, V65, P80, DOI 10.1007/BF00440545; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Beersma DGM, 2009, J BIOL RHYTHM, V24, P153, DOI 10.1177/0748730408330196; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Comas M, 2006, J BIOL RHYTHM, V21, P362, DOI 10.1177/0748730406292446; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; DAAN S, 1975, OECOLOGIA, V18, P269, DOI 10.1007/BF00345851; Duffing G., 1918, ZAMM Z ANGEW MATH ME; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Duffy JF, 2005, J BIOL RHYTHM, V20, P326, DOI 10.1177/0748730405277983; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Geier F, 2005, J BIOL RHYTHM, V20, P83, DOI 10.1177/0748730404269309; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Granada A, 2009, METHOD ENZYMOL, V454, P1, DOI 10.1016/S0076-6879(08)03801-9; Granada AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007057; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; GUEVARA MR, 1981, SCIENCE, V214, P1350, DOI 10.1126/science.7313693; Harada T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.088301; HOFFMANN K, 1969, Z VERGL PHYSIOL, V62, P93, DOI 10.1007/BF00298045; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Kramer G., 1952, Ibis, V94, P265, DOI 10.1111/j.1474-919X.1952.tb01817.x; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Pittendrigh C., 1981, BIOL RHYTHMS, P95, DOI DOI 10.1007/978-1-4615-6552-9_7; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Relogio A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002309; Remi J, 2010, J BIOL RHYTHM, V25, P318, DOI 10.1177/0748730410379081; Roenneberg T, 2003, J BIOL RHYTHM, V18, P183, DOI 10.1177/0748730403018003001; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T., 2012, INTERNAL TIME; Sporl F, 2011, J INVEST DERMATOL, V131, P338, DOI 10.1038/jid.2010.315; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Westermark PO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000580; WEVER R, 1964, KYBERNETIK, V2, P127, DOI 10.1007/BF00306797; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	43	65	65	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59464	10.1371/journal.pone.0059464	http://dx.doi.org/10.1371/journal.pone.0059464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544070	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700031
J	Kano, F; Tomonaga, M				Kano, Fumihiro; Tomonaga, Masaki			Head-Mounted Eye Tracking of a Chimpanzee under Naturalistic Conditions	PLOS ONE			English	Article							EXPERIMENTER-GIVEN CUES; OBJECT-CHOICE TASKS; PAN-TROGLODYTES; PONGO-PYGMAEUS; MOVEMENTS; HUMANS; MONKEYS; FACES; STRATEGIES	This study offers a new method for examining the bodily, manual, and eye movements of a chimpanzee at the micro-level. A female chimpanzee wore a lightweight head-mounted eye tracker (60 Hz) on her head while engaging in daily interactions with the human experimenter. The eye tracker recorded her eye movements accurately while the chimpanzee freely moved her head, hands, and body. Three video cameras recorded the bodily and manual movements of the chimpanzee from multiple angles. We examined how the chimpanzee viewed the experimenter in this interactive setting and how the eye movements were related to the ongoing interactive contexts and actions. We prepared two experimentally defined contexts in each session: a face-to-face greeting phase upon the appearance of the experimenter in the experimental room, and a subsequent face-to-face task phase that included manual gestures and fruit rewards. Overall, the general viewing pattern of the chimpanzee, measured in terms of duration of individual fixations, length of individual saccades, and total viewing duration of the experimenter's face/body, was very similar to that observed in previous eye-tracking studies that used non-interactive situations, despite the differences in the experimental settings. However, the chimpanzee viewed the experimenter and the scene objects differently depending on the ongoing context and actions. The chimpanzee viewed the experimenter's face and body during the greeting phase, but viewed the experimenter's face and hands as well as the fruit reward during the task phase. These differences can be explained by the differential bodily/manual actions produced by the chimpanzee and the experimenter during each experimental phase (i.e., greeting gestures, task cueing). Additionally, the chimpanzee's viewing pattern varied depending on the identity of the experimenter (i.e., the chimpanzee's prior experience with the experimenter). These methods and results offer new possibilities for examining the natural gaze behavior of chimpanzees.	[Kano, Fumihiro; Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Kano, Fumihiro] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Kyoto University; Japan Society for the Promotion of Science	Kano, F (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	fkanou@pri.kyoto-u.ac.jp		Kano, Fumihiro/0000-0003-4534-6630	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [16002001, 19300091, 20002001, 212299]; JSPS/MEXT global COE programs [D07, A06]; Grants-in-Aid for Scientific Research [23220006] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS/MEXT global COE programs; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was financially supported by the Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Japan Grants-in-Aid for Scientific Research (nos. 16002001, 19300091, 20002001, 212299) and the JSPS/MEXT global COE programs (D07 and A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JR, 1995, ANIM BEHAV, V49, P201, DOI 10.1016/0003-3472(95)80168-5; Anderson JR, 1996, BEHAV PROCESS, V37, P47; Berg DJ, 2009, J VISION, V9, DOI 10.1167/9.5.19; Castelhano MS, 2009, J VISION, V9, DOI 10.1167/9.3.6; Deaner RO, 2003, CURR BIOL, V13, P1609, DOI 10.1016/j.cub.2003.08.025; DeAngelus M, 2009, VIS COGN, V17, P790, DOI 10.1080/13506280902793843; Franchak JM, 2011, CHILD DEV, V82, P1738, DOI 10.1111/j.1467-8624.2011.01670.x; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; Hashiya K, 1997, JPN PSYCHOL RES, V39, P182, DOI 10.1111/1468-5884.00052; Hattori Y, 2010, BIOL LETTERS, V6, P610, DOI 10.1098/rsbl.2010.0120; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Itakura S, 1998, J COMP PSYCHOL, V112, P119, DOI 10.1037/0735-7036.112.2.119; Izumi A, 2004, ANIM COGN, V7, P179, DOI 10.1007/s10071-004-0212-4; Kano F, 2011, VISION RES, V51, P2348, DOI 10.1016/j.visres.2011.09.006; Kano F, 2011, ANIM COGN, V14, P879, DOI 10.1007/s10071-011-0422-5; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; KEATING CF, 1993, J COMP PSYCHOL, V107, P131, DOI 10.1037/0735-7036.107.2.131; Kojima S, 2003, PRIMATES, V44, P225, DOI 10.1007/s10329-002-0014-8; LAND M, 1995, NATURE, V377, P339, DOI 10.1038/377339a0; Land M, 1999, PERCEPTION, V28, P1311, DOI 10.1068/p2935; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; Myowa-Yamakoshi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1695; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; Parr LA, 1998, J COGNITIVE NEUROSCI, V10, P615, DOI 10.1162/089892998563013; Peignot P, 1999, J COMP PSYCHOL, V113, P253, DOI 10.1037/0735-7036.113.3.253; Pelz JB, 2001, VISION RES, V41, P3587, DOI 10.1016/S0042-6989(01)00245-0; Poss SR, 2006, AM J PRIMATOL, V68, P978, DOI 10.1002/ajp.20304; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Ruiz April, 2009, Animal Cognition, V12, P427, DOI 10.1007/s10071-008-0202-z; Shepherd SV, 2010, CURR BIOL, V20, P649, DOI 10.1016/j.cub.2010.02.032; Shepherd SV, 2006, METHODS, V38, P185, DOI 10.1016/j.ymeth.2005.12.003; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Somppi S, 2012, ANIM COGN, V15, P163, DOI 10.1007/s10071-011-0442-1; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Tomonaga M, 2010, MIND CHIMPANZEE ECOL; Tomonaga M, 2007, PRIMATES, V48, P1, DOI 10.1007/s10329-006-0011-4; Turano KA, 2003, VISION RES, V43, P333, DOI 10.1016/S0042-6989(02)00498-4; Williams FJ, 2011, J NEUROSCI METH, V194, P259, DOI 10.1016/j.jneumeth.2010.10.022	44	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59785	10.1371/journal.pone.0059785	http://dx.doi.org/10.1371/journal.pone.0059785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544099	Green Submitted, Green Published, gold			2022-12-25	WOS:000317480700059
J	Lamers, RP; Cavallari, JF; Burrows, LL				Lamers, Ryan P.; Cavallari, Joseph F.; Burrows, Lori L.			The Efflux Inhibitor Phenylalanine-Arginine Beta-Naphthylamide (PA beta N) Permeabilizes the Outer Membrane of Gram-Negative Bacteria	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEIN; MEXA-MEXB-OPRM; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; LACTAMASE INDUCTION; BILE-SALTS; PUMPS; SYSTEM	Active efflux of antimicrobial agents is a primary mechanism by which bacterial pathogens can become multidrug resistant. The combined use of efflux pump inhibitors (EPIs) with pump substrates is under exploration to overcome efflux-mediated multidrug resistance. Phenylalanine-arginine beta-naphthylamide (PA beta N) is a well-studied EPI that is routinely combined with. fluoroquinolone antibiotics, but few studies have assessed its utility in combination with beta-lactam antibiotics. The initial goal of this study was to assess the efficacy of beta-lactams in combination with PA beta N against the opportunistic pathogen pseudomoneas aeruginosa. PA beta N reduced the minimal inhibitory concentrations (MICs) of several beta-lactam antibiotics against P. aeruginosa; however, the susceptibility changes were not due entirely to efflux inhibition. Upon PA beta N treatment, intracellular levels of the chromosomally-encoded AmpC beta-lactamase that inactivates beta-lactam antibiotics were significantly reduced and AmpC levels in supernatants correspondingly increased, potentially due to perrneabilization of the outer membrane. PP PA beta N treatment caused a significant increase in uptake of 8-anilino-1-naphthylenesulfonic acid, a fluorescent hydrophobic probe, and sensitized P aeruginosa to bulky antibiotics (e.g. vancomycin) that are normally incapable of crossing the outer membrane, as well as to detergent-like bile salts. Supplementation of growth media with magnesium to stabilize the outer membrane increased MICs in the presence of PA beta N and restored resistance to vancomycin. Thus, PAN permeabilizes bacterial membranes in a concentration-dependent manner at levels below those typically used in combination studies, and this additional mode of action should be considered when using PA beta N as a control for efflux studies.	[Lamers, Ryan P.; Cavallari, Joseph F.; Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Burrows, LL (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	burrowl@mcmaster.ca			Canada-UK Partnership on Antibiotic Resistance [114045]; Michael G. DeGroote Fellowship in Basic Biomedical Science	Canada-UK Partnership on Antibiotic Resistance; Michael G. DeGroote Fellowship in Basic Biomedical Science	This study was funded by a Canada-UK Partnership on Antibiotic Resistance-114045 award to LLB. RPL is the recipient of the Michael G. DeGroote Fellowship in Basic Biomedical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askoura M, 2011, LIBYAN J MED, V6, DOI [10.3402/Ijm.v6i0.5870, DOI 10.3402/IJM.V6I0.5870]; Balemans W, 2012, ANTIMICROB AGENTS CH, V56, P4131, DOI 10.1128/AAC.00273-12; Beadle BM, 2001, PROTEIN SCI, V10, P1254, DOI 10.1110/ps.52001; Drusano GL, 2012, ANTIMICROB AGENTS CH, V56, P231, DOI 10.1128/AAC.05252-11; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Kus JV, 2011, J BACTERIOL, V193, P4509, DOI 10.1128/JB.00200-11; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Li XZ, 2000, J ANTIMICROB CHEMOTH, V45, P433, DOI 10.1093/jac/45.4.433; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Lomovskaya O, 2006, BIOCHEM PHARMACOL, V71, P910, DOI 10.1016/j.bcp.2005.12.008; Lomovskaya O, 2001, J MOL MICROB BIOTECH, V3, P225; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; Mark BL, 2011, FUTURE MICROBIOL, V6, P1415, DOI [10.2217/FMB.11.128, 10.2217/fmb.11.128]; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018547; Moya B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000353; Mulet X, 2011, ANTIMICROB AGENTS CH, V55, P4560, DOI 10.1128/AAC.00519-11; Nicola G, 2010, BIOCHEMISTRY-US, V49, P8094, DOI 10.1021/bi100879m; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 1998, DRUG RESIST UPDATE, V1, P93, DOI 10.1016/S1368-7646(98)80023-X; Pages JM, 2005, TRENDS MOL MED, V11, P382, DOI 10.1016/j.molmed.2005.06.006; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Renau TE, 1999, J MED CHEM, V42, P4928, DOI 10.1021/jm9904598; Schweizer HP, 2012, EXPERT OPIN DRUG DIS, V7, P633, DOI 10.1517/17460441.2012.688949; Srikumar R, 1999, J ANTIMICROB CHEMOTH, V44, P537, DOI 10.1093/jac/44.4.537; Stickland HG, 2010, J PROTEOME RES, V9, P2957, DOI 10.1021/pr9011415; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Suzuki H, 2003, ANAL SCI, V19, P1239, DOI 10.2116/analsci.19.1239; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357; Zechini B., 2009, DRUG DISCOVERY, V4, P37; Zhang LJ, 2000, ANTIMICROB AGENTS CH, V44, P3317, DOI 10.1128/AAC.44.12.3317-3321.2000	39	166	168	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60666	10.1371/journal.pone.0060666	http://dx.doi.org/10.1371/journal.pone.0060666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544160	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700119
J	Nauta, AC; Grova, M; Montoro, DT; Zimmermann, A; Tsai, M; Gurtner, GC; Galli, SJ; Longaker, MT				Nauta, Allison C.; Grova, Monica; Montoro, Daniel T.; Zimmermann, Andrew; Tsai, Mindy; Gurtner, Geoffrey C.; Galli, Stephen J.; Longaker, Michael T.			Evidence That Mast Cells Are Not Required for Healing of Splinted Cutaneous Excisional Wounds in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; FIBROBLAST PROLIFERATION; GENE-EXPRESSION; PROMOTION; NUMBERS; LOCUS; MODEL	Wound healing is a complex biological process involving the interaction of many cell types to replace lost or damaged tissue. Although the biology of wound healing has been extensively investigated, few studies have focused on the role of mast cells. In this study, we investigated the possible role of mast cells in wound healing by analyzing aspects of cutaneous excisional wound healing in three types of genetically mast cell-deficient mice. We found that C57BL/6-Kit(W-sh/W-sh), WBB6F(1)-Kit(W/W-v), and Cpa3-Cre; Mcl-1(fl/fl) mice re-epithelialized splinted excisional skin wounds at rates very similar to those in the corresponding wild type or control mice. Furthermore, at the time of closure, scars were similar in the genetically mast cell-deficient mice and the corresponding wild type or control mice in both quantity of collagen deposition and maturity of collagen fibers, as evaluated by Masson's Trichrome and Picro-Sirius red staining. These data indicate that mast cells do not play a significant non-redundant role in these features of the healing of splinted full thickness excisional cutaneous wounds in mice.	[Nauta, Allison C.; Grova, Monica; Montoro, Daniel T.; Zimmermann, Andrew; Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Div Plast & Reconstruct Surg, Dept Surg,Sch Med, Stanford, CA 94305 USA; [Nauta, Allison C.] Oregon Hlth & Sci Univ, Dept Surg, Div Plast & Reconstruct Surg, Portland, OR 97201 USA; [Grova, Monica] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University; Oregon Health & Science University; University of California System; University of California San Francisco; Stanford University; Stanford University	Galli, SJ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	sgalli@stanford.edu; longaker@stanford.edu		Tsai, Mindy/0000-0002-8421-4721; Montoro, Daniel/0000-0002-6222-2149	Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation; United States Public Health Service [AI23990, AI070813, CA72074]; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, R37AI023990] Funding Source: NIH RePORTER	Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge the Hagey Laboratory for Pediatric Regenerative Medicine and the Oak Foundation, as well as United States Public Health Service grants (to S.J.G.) AI23990, AI070813 and CA72074 for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; Bradding P, 1996, CLIN EXP ALLERGY, V26, P13, DOI 10.1111/j.1365-2222.1996.tb00051.x; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; CHERVENI.PA, 1969, J CELL PHYSIOL, V73, P25, DOI 10.1002/jcp.1040730104; Collington SJ, 2011, TRENDS IMMUNOL, V32, P478, DOI 10.1016/j.it.2011.08.002; Coneely J, 2010, J SURG RES, V164, pE73, DOI 10.1016/j.jss.2010.04.035; Egozi EI, 2003, WOUND REPAIR REGEN, V11, P46, DOI 10.1046/j.1524-475X.2003.11108.x; Foley TT, 2011, PLAST RECONSTR SURG, V127, P1478, DOI 10.1097/PRS.0b013e318208d0bb; Gailit J, 2001, J INVEST DERMATOL, V117, P1113, DOI 10.1046/j.1523-1747.2001.15211.x; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; GALLI SJ, 1987, BLOOD, V69, P1661; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; GORDON JR, 1994, J EXP MED, V180, P2027, DOI 10.1084/jem.180.6.2027; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Iba Y, 2004, INT IMMUNOPHARMACOL, V4, P1873, DOI 10.1016/j.intimp.2004.08.009; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kendall JC, 1997, J ALLERGY CLIN IMMUN, V99, P113; KISCHER CW, 1972, TEX REP BIOL MED, V30, P327; KITAMURA Y, 1978, BLOOD, V52, P447; Kohyama T, 2010, MOL CELL BIOCHEM, V337, P77, DOI 10.1007/s11010-009-0287-y; Kulka M, 2009, J LEUKOCYTE BIOL, V86, P1217, DOI 10.1189/jlb.0908517; Lilla JN, 2011, BLOOD, V118, P6930, DOI 10.1182/blood-2011-03-343962; LYON MF, 1982, GENET RES, V39, P315, DOI 10.1017/S001667230002098X; Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001; NAKANO T, 1989, BLOOD, V74, P1552; Ng MFY, 2010, INT WOUND J, V7, P55, DOI 10.1111/j.1742-481X.2009.00651.x; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Noli C, 2001, VET DERMATOL, V12, P303, DOI 10.1046/j.0959-4493.2001.00272.x; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; RUSSELL JD, 1977, J CELL PHYSIOL, V93, P389, DOI 10.1002/jcp.1040930310; Shih B, 2010, WOUND REPAIR REGEN, V18, P139, DOI 10.1111/j.1524-475X.2009.00553.x; Shiota N, 2010, INT ARCH ALLERGY IMM, V151, P80, DOI 10.1159/000232573; Szpaderska AM, 2003, J INVEST DERMATOL, V120, P1130, DOI 10.1046/j.1523-1747.2003.12253.x; TONO T, 1992, BLOOD, V80, P1448; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; Weller K, 2006, FASEB J, V20, P2366, DOI 10.1096/fj.06-5837fje; Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009; Wilgus TA, 2012, J INVEST DERMATOL, V132, P493, DOI 10.1038/jid.2011.343; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Wong VW, 2011, FASEB J, V25, P4498, DOI 10.1096/fj.10-178087; Wulff BC, 2012, J INVEST DERMATOL, V132, P458, DOI 10.1038/jid.2011.324; Younan G, 2010, J IMMUNOL, V185, P7681, DOI 10.4049/jimmunol.1002803; Younan GJ, 2011, PLAST RECONSTR SURG, V128, p649E, DOI 10.1097/PRS.0b013e318230c55d; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391	48	34	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59167	10.1371/journal.pone.0059167	http://dx.doi.org/10.1371/journal.pone.0059167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544053	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700015
J	Sebek, P; Altman, J; Platek, M; Cizek, L				Sebek, Pavel; Altman, Jan; Platek, Michal; Cizek, Lukas			Is Active Management the Key to the Conservation of Saproxylic Biodiversity? Pollarding Promotes the Formation of Tree Hollows	PLOS ONE			English	Article							TRADITIONAL LAND-USE; OSMODERMA-EREMITA; COLEOPTERA; FOREST; PREFERENCES; WOODLANDS; ABUNDANCE; DYNAMICS; BEETLES	Trees with hollows are key features sustaining biodiversity in wooded landscapes. They host rich assemblages of often highly specialised organisms. Hollow trees, however, have become rare and localised in Europe. Many of the associated biota is thus declining or endangered. The challenge of its conservation, therefore, is to safeguard the presence of hollow trees in sufficient numbers. Populations of numerous species associated with tree hollows and dead wood are often found in habitats that were formed by formerly common traditional silvicultural practices such as coppicing, pollarding or pasture. Although it has been occasionally mentioned that such practices increase the formation of hollows and the availability of often sun-exposed dead wood, their effect has never been quantified. Our study examined the hollow incidence in pollard and non-pollard (unmanaged) willows and the effect of pollarding on incremental growth rate by tree ring analysis. The probability of hollow occurrence was substantially higher in pollard than in non-pollard trees. Young pollards, especially, form hollows much more often than non-pollards; for instance, in trees of 50 cm DBH, the probability of hollow ocurrence was similar to 0.75 in pollards, but only similar to 0.3 in non-pollards. No difference in growth rate was found. Pollarding thus leads to the rapid formation of tree hollows, a habitat usually associated with old trees. It is therefore potentially a very important tool in the restoration of saproxylic habitats and conservation of hollow-dependent fauna. If applied along e.g. roads and watercourses, pollarding could also be used to increase landscape connectivity for saproxylic organisms. In reserves where pollarding was formerly practiced, its restoration would be necessary to prevent loss of saproxylic biodiversity. Our results point to the importance of active management measures for maintaining availability, and spatial and temporal continuity of deadwood microhabitats.	[Sebek, Pavel; Platek, Michal; Cizek, Lukas] Acad Sci Czech Republ, Inst Entomol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Sebek, Pavel; Altman, Jan; Platek, Michal; Cizek, Lukas] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Altman, Jan] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Sebek, P (corresponding author), Acad Sci Czech Republ, Inst Entomol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	pav.sebek@gmail.com	Sebek, Pavel/O-4522-2017; Cizek, Lukas/G-7905-2014; Altman, Jan/B-4305-2015; Cizek, Lukas/K-7111-2015; Sebek, Pavel/AAC-9599-2021	Cizek, Lukas/0000-0002-6447-2002; Cizek, Lukas/0000-0002-6447-2002; Sebek, Pavel/0000-0003-3341-4771	Czech Science Foundation [P504/12/1952]; Technology Agency of the Czech Republic [TA02021501]; Grant Agency of University of South Bohemia [145/2010/P]; project Biodiversity of Forest Ecosystems [CZ.1.07/2.3.00/20.0064]; European Social Fund; state budget of the Czech Republic	Czech Science Foundation(Grant Agency of the Czech Republic); Technology Agency of the Czech Republic; Grant Agency of University of South Bohemia; project Biodiversity of Forest Ecosystems; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	The study and its authors were supported by the Czech Science Foundation (P504/12/1952; http://www.gacr.cz), the Technology Agency of the Czech Republic (TA02021501; http://www.tacr.cz), Grant Agency of University of South Bohemia (145/2010/P; http://www.jcu.cz/research/gaju), and the project Biodiversity of Forest Ecosystems (CZ.1.07/2.3.00/20.0064; http://biodiverzita.pri.jcu.cz) co-financed by the European Social Fund and the state budget of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2012, EUR J ENTOMOL, V109, P553, DOI 10.14411/eje.2012.069; Alexander KNA, 1998, ECOLOGICAL HISTORY OF EUROPEAN FORESTS, P73; Alexander KNA, 2008, LANDSC ARCHACOL ECOL, V7, P12; Alexander KNA, 2012, SAPROXYLIC BEETLES E, P7; ALLEN A W, 1990, Northern Journal of Applied Forestry, V7, P179; Altman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055770; Ball IR, 1999, FOREST ECOL MANAG, V123, P179, DOI 10.1016/S0378-1127(99)00026-2; Biodiversity and Pollards, 2012, BIOD POLL; Butler J, 2010, LANDSC ARCHACOL ECOL, V8, P54, DOI [10.1007/978-94-007-6159-9_25, DOI 10.1007/978-94-007-6159-9_25]; Castro Alberto, 2012, Munibe (Ciencias Naturales - Natur Zientziak), V60, P77; Chiari S, 2013, INSECT CONSERV DIVER, V6, P309, DOI 10.1111/j.1752-4598.2012.00215.x; Dryad, 2013, INT DIG RESP; Dubois GF, 2009, LANDSCAPE URBAN PLAN, V91, P152, DOI 10.1016/j.landurbplan.2008.12.009; Fan ZF, 2004, FOREST ECOL MANAG, V193, P399, DOI 10.1016/j.foreco.2004.02.008; Fan ZF, 2003, FOREST ECOL MANAG, V179, P231, DOI 10.1016/S0378-1127(02)00522-4; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gouix N, 2011, THESIS U P M CURIE P; Gouix N, 2012, BIODIVERS CONSERV, V21, P421, DOI 10.1007/s10531-011-0190-1; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Hauck D, 2006, INVENTARIZACE STORMU; Hedin J, 2008, BIODIVERS CONSERV, V17, P675, DOI 10.1007/s10531-007-9299-7; Hedl R, 2010, DIVERS DISTRIB, V16, P267, DOI 10.1111/j.1472-4642.2010.00637.x; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jansson N, 2009, BIODIVERS CONSERV, V18, P3891, DOI 10.1007/s10531-009-9687-2; Jonsson MT, 2011, APPL VEG SCI, V14, P120, DOI 10.1111/j.1654-109X.2010.01096.x; Koch AJ, 2008, FOREST ECOL MANAG, V255, P674, DOI 10.1016/j.foreco.2007.09.042; Kohler F, 2000, TOTHOLZKAFER NATURWA; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Leppik E, 2011, LICHENOLOGIST, V43, P257, DOI 10.1017/S002428291100003X; Lequet A, 2012, ROSALIE ALPES ROSALI; Lush M, 2005, ENGLISH NATURE RES R; Mansion D, 2010, TRONGES ARBRE PAYSAN; Moe B, 1997, PLANT ECOL, V129, P157, DOI 10.1023/A:1009720132726; Niklasson M, 2010, J ECOL, V98, P1319, DOI 10.1111/j.1365-2745.2010.01710.x; Oleksa A, 2007, POL J ECOL, V55, P315; PACKHAM JR, 1992, FUNCTIONAL ECOLOGY W; Parviainen J, 2000, FORESTRY, V73, P107, DOI 10.1093/forestry/73.2.107; Plieninger T, 2006, ENVIRON SCI POLICY, V9, P317, DOI 10.1016/j.envsci.2006.03.001; R Core Team, 2022, R LANG ENV STAT COMP; Rackham O, 2003, ANCIENT WOODLAND ITS; Ranius T., 2005, Animal Biodiversity and Conservation, V28, P1; Ranius T., 2002, Animal Biodiversity and Conservation, V25, P53; Ranius T, 2002, BIODIVERS CONSERV, V11, P931, DOI 10.1023/A:1015364020043; Ranius T, 2009, FOREST ECOL MANAG, V257, P303, DOI 10.1016/j.foreco.2008.09.007; Read H. J., 1996, INC P M HOST CORP LO; Robles H, 2011, FOREST ECOL MANAG, V261, P1428, DOI 10.1016/j.foreco.2011.01.029; Rozas V, 2004, FOREST ECOL MANAG, V195, P205, DOI 10.1016/j.foreco.2004.02.058; Schweingruber F. H., 1996, Tree rings and environment: dendroecology.; SCIEM, 2012, PERS AN SYST TREER R; Sebek P., 2012, SAPROXYLIC BEETLES E, P67; Speight M.C.D., 1989, Council of Europe Nature and Environment Series, P1; Spitzer L, 2008, BIOL CONSERV, V141, P827, DOI 10.1016/j.biocon.2008.01.005; Stokland JN, 2012, ECOL BIODIVERS CONS, P248; Thomas P, 2000, TREES THEIR NATURAL, P230; Thomas PA, 2007, ECOLOGY OF WOODLANDS AND FORESTS: DESCRIPTION, DYNAMICS AND DIVERSITY, P1, DOI 10.1017/CBO9780511805578; Todarello P, 2007, P LINN SOC N S W, V128, P1; Vandekerkhove K, 2011, SILVA FENN, V45, P909, DOI 10.14214/sf.78; Vera F. W. M., 2000, Grazing ecology and forest history, DOI 10.1079/9780851994420.0000; Vignon V, 2003, P 2 PAN EUR C SAPR B, P36; Vignon V, 2006, PIQUE PRUNE HIST SAU; Vodka S, 2009, J INSECT CONSERV, V13, P553, DOI 10.1007/s10841-008-9202-1; Vuidot A, 2011, BIOL CONSERV, V144, P441, DOI 10.1016/j.biocon.2010.09.030; Whitehead P.F., 2003, P 2 PAN EUR C SAPR B, P1; Zmihorski M, 2009, FOLIA ZOOL, V58, P207	64	73	76	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60456	10.1371/journal.pone.0060456	http://dx.doi.org/10.1371/journal.pone.0060456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544142	Green Submitted, gold, Green Published			2022-12-25	WOS:000317480700101
J	Yao, XH; Nguyen, HK; Nyomba, BLG				Yao, Xing-Hai; Nguyen, Hoa K.; Nyomba, B. L. Gregoire			Prenatal Ethanol Exposure Causes Glucose Intolerance with Increased Hepatic Gluconeogenesis and Histone Deacetylases in Adult Rat Offspring: Reversal by Tauroursodeoxycholic Acid	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; INSULIN-RESISTANCE; ALCOHOL EXPOSURE; MOUSE MODEL; EXPRESSION; DIFFERENTIATION; ACETYLATION; DEGRADATION; SUPPRESSION	Prenatal ethanol exposure results in increased glucose production in adult rat offspring and this may involve modulation of protein acetylation by cellular stress. We used adult male offspring of dams given ethanol during gestation days 1-7 (early), 8-14 (mid) and 15-21 (late) compared with those from control dams. A group of ethanol offspring was treated with tauroursodeoxycholic acid (TUDCA) for 3 weeks. We determined gluconeogenesis, phosphoenolpyruvate carboxykinase PEPCK) glucose-6-phosphatase, hepatic free radicals, histone deacetylases (HDAC), acetylated foxo1, acetylated PEPCK, and C/EBP homologous protein as a marker of endoplasmic reticulum stress. prenatal ethanol during either of the 3 weeks of pregnancy increased gluconeogenesis, gluconeogenic genes, oxidative and endoplasmic reticulum stresses, sirtuin-2 and HDAC3, 4, 5, and 7 in adult offspring. Conversely, prenatal ethanol reduced acetylation of foxo1 and PEPCK. Treatment of adult ethanol offspring with TUDCA reversed all these abnormalities. Thus, prenatal exposure of rats to ethanol results in long lasting oxidative and endoplasmic reticulum stresses explaining increased expression of gluconeogenic genes and HDAC proteins which, by deacetylating foxo1 and PEPCK, contribute to increased gluconeogenesis. These anomalies occurred regardless of the time of ethanol exposure during pregnancy, including early embryogenesis. As these anomalies were reversed by treatment of the adult offspring with TUDCA, this compound has therapeutic potentials in the treatment of glucose intolerance associated with prenatal ethanol exposure.	[Yao, Xing-Hai; Nyomba, B. L. Gregoire] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Nguyen, Hoa K.] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Nyomba, BLG (corresponding author), Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada.	bnyomba@cc.umanitoba.ca		Nyomba, B. L. Gregoire/0000-0001-9472-607X	Canadian Diabetes Association	Canadian Diabetes Association	This work was supported by the Canadian Diabetes Association (www.Diabetes.Ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo M, 2011, ALCOHOL CLIN EXP RES, V35, P1550, DOI 10.1111/j.1530-0277.2011.01492.x; Barr M, 2000, ENVIRON HEALTH PERSP, V108, P569, DOI 10.2307/3454548; Batta Kiran, 2007, Subcell Biochem, V41, P193; Berger E, 2011, BIOCHEM BIOPH RES CO, V409, P610, DOI 10.1016/j.bbrc.2011.05.043; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Brocardo PS, 2011, BRAIN RES REV, V67, P209, DOI 10.1016/j.brainresrev.2011.02.001; CASTELLS S, 1981, DEV PHARMACOL THERAP, V3, P232, DOI 10.1159/000457447; Chen L, 2005, J APPL PHYSIOL, V99, P528, DOI 10.1152/japplphysiol.01098.2004; Chen L, 2004, J APPL PHYSIOL, V96, P167, DOI 10.1152/japplphysiol.00751.2003; Chen L, 2003, ENDOCRINOLOGY, V144, P500, DOI 10.1210/en.2002-220623; Cohen-Kerem R, 2003, NEUROTOXICOL TERATOL, V25, P1, DOI 10.1016/S0892-0362(02)00324-0; Dembele K, 2006, AM J PHYSIOL-REG I, V291, pR796, DOI 10.1152/ajpregu.00633.2005; Downes CP, 2004, BIOCHEM SOC T, V32, P338, DOI 10.1042/BST0320338; Elton CW, 2002, J ENDOCRINOL, V173, P63, DOI 10.1677/joe.0.1730063; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fofana B, 2010, PROTEOMICS, V10, P417, DOI 10.1002/pmic.200800969; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Grucza RA, 2010, ARCH GEN PSYCHIAT, V67, P1301, DOI 10.1001/archgenpsychiatry.2010.155; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kahali S, 2012, FASEB J, V26, P2437, DOI 10.1096/fj.11-193706; Kaminen-Ahola N, 2010, BIRTH DEFECTS RES A, V88, P818, DOI 10.1002/bdra.20729; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Ke ZJ, 2011, ALCOHOL CLIN EXP RES, V35, P1574, DOI 10.1111/j.1530-0277.2011.01503.x; Nguyen KH, 2012, ALCOHOL, V46, P89, DOI 10.1016/j.alcohol.2011.04.001; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miller SDW, 2007, HEPATOLOGY, V46, P496, DOI 10.1002/hep.21689; Miura K, 2008, HEPATOLOGY, V48, P1420, DOI 10.1002/hep.22486; Nammi S, 2007, AM J PHYSIOL-REG I, V292, pR1101, DOI 10.1152/ajpregu.00255.2006; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oiso H, 2011, BIOCHEM BIOPH RES CO, V404, P166, DOI 10.1016/j.bbrc.2010.11.086; Pennington JS, 2002, ALCOHOL CLIN EXP RES, V26, P848, DOI 10.1097/00000374-200206000-00015; Rabbani B, 2012, GENE, V503, P215, DOI 10.1016/j.gene.2012.04.080; Rodrigues CMP, 2003, BIOCHEMISTRY-US, V42, P3070, DOI 10.1021/bi026979d; Sokol TJ, 2005, J PEDIATR GASTR NUTR, V41, P235, DOI 10.1097/01.MPG.0000170600.80640.88; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Vangipuram SD, 2012, ALCOHOL CLIN EXP RES, V36, P788, DOI 10.1111/j.1530-0277.2011.01682.x; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Yao XH, 2006, J APPL PHYSIOL, V100, P642, DOI 10.1152/japplphysiol.01115.2005; Yao XH, 2008, AM J PHYSIOL-REG I, V294, pR1797, DOI 10.1152/ajpregu.00804.2007; Yao XH, 2007, AM J PHYSIOL-REG I, V292, pR1926, DOI 10.1152/ajpregu.00822.2006; Young TK, 2002, ARCH PEDIAT ADOL MED, V156, P651, DOI 10.1001/archpedi.156.7.651; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	48	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59680	10.1371/journal.pone.0059680	http://dx.doi.org/10.1371/journal.pone.0059680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544086	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700046
J	Steinweg, JM; Jagadamma, S; Frerichs, J; Mayes, MA				Steinweg, J. Megan; Jagadamma, Sindhu; Frerichs, Joshua; Mayes, Melanie A.			Activation Energy of Extracellular Enzymes in Soils from Different Biomes	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; THERMODYNAMIC PARAMETERS; PSYCHROPHILIC ENZYMES; THEORETICAL-MODEL; PHENOL OXIDASE; KINETICS; PEROXIDASE; DECOMPOSITION; LACCASE; CARBON	Enzyme dynamics are being incorporated into soil carbon cycling models and accurate representation of enzyme kinetics is an important step in predicting belowground nutrient dynamics. A scarce number of studies have measured activation energy (E-a) in soils and fewer studies have measured E-a in arctic and tropical soils, or in subsurface soils. We determined the E-a for four typical lignocellulose degrading enzymes in the A and B horizons of seven soils covering six different soil orders. We also elucidated which soil properties predicted any measurable differences in E-a. beta-glucosidase, cellobiohydrolase, phenol oxidase and peroxidase activities were measured at five temperatures, 4, 21, 30, 40, and 60 degrees C. E-a was calculated using the Arrhenius equation. b-glucosidase and cellobiohydrolase E-a values for both A and B horizons in this study were similar to previously reported values, however we could not make a direct comparison for B horizon soils because of the lack of data. There was no consistent relationship between hydrolase enzyme E-a and the environmental variables we measured. Phenol oxidase was the only enzyme that had a consistent positive relationship between E-a and pH in both horizons. The E-a in the arctic and subarctic zones for peroxidase was lower than the hydrolases and phenol oxidase values, indicating peroxidase may be a rate limited enzyme in environments under warming conditions. By including these six soil types we have increased the number of soil oxidative enzyme E-a values reported in the literature by 50%. This study is a step towards better quantifying enzyme kinetics in different climate zones.	[Steinweg, J. Megan] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Steinweg, J. Megan; Jagadamma, Sindhu; Mayes, Melanie A.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Jagadamma, Sindhu; Mayes, Melanie A.] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN USA; [Frerichs, Joshua] Univ Tennessee, Knoxville, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Steinweg, JM (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	steinwegjm@ornl.gov	Jagadamma, Sindhu/F-7168-2012	Jagadamma, Sindhu/0000-0003-4831-3308	Laboratory Directed Research and Development (LDRD) Program of the Oak Ridge National Laboratory (ORNL) [DE-AC05-00OR22725]; U.S. Government [DE-AC05-00OR22725]	Laboratory Directed Research and Development (LDRD) Program of the Oak Ridge National Laboratory (ORNL); U.S. Government	This research was funded by the Laboratory Directed Research and Development (LDRD) Program of the Oak Ridge National Laboratory (ORNL), managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725. Collection and processing of soil samples from Brazil was supported by CNPq. The submitted manuscript has been authored by a contractor of the U.S. Government under contract DE-AC05-00OR22725. Accordingly, the U.S. Government retains a nonexclusive, royalty-free license to publish or reproduce the published form of this contribution, or allow others to do so, for U. S. Government purposes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas N, 2001, BIORESOURCE TECHNOL, V80, P29, DOI 10.1016/S0960-8524(01)00063-3; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; BROWNPETERSON NJ, 1993, J BACTERIOL, V175, P4197, DOI 10.1128/JB.175.13.4197-4202.1993; BURNS RG, 1986, SPECIAL PUBLICATION, V1, P429; Caldwell BA, 2005, PEDOBIOLOGIA, V49, P637, DOI 10.1016/j.pedobi.2005.06.003; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Dane JD, 2004, HYDROMETER METHOD 4, P278; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; DENG SP, 1994, SOIL BIOL BIOCHEM, V26, P1347, DOI 10.1016/0038-0717(94)90216-X; Di Nardo C, 2004, SOIL BIOL BIOCHEM, V36, P1539, DOI 10.1016/j.soilbio.2004.07.013; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Feller G, 2003, CELL MOL LIFE SCI, V60, P648, DOI 10.1007/s00018-003-2155-3; German DP, 2012, GLOBAL CHANGE BIOL, V18, P1468, DOI 10.1111/j.1365-2486.2011.02615.x; Ghori MI, 2011, BRAZ J MICROBIOL, V42, P22, DOI 10.1590/S1517-83822011000100003; GIANFREDA L, 1992, SOIL BIOL BIOCHEM, V24, P51, DOI 10.1016/0038-0717(92)90241-O; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Goncalves EM, 2007, J FOOD ENG, V81, P693, DOI 10.1016/j.jfoodeng.2007.01.011; HEWSON WD, 1975, CAN J CHEM, V53, P1928, DOI 10.1139/v75-268; Hochachka P. W., 1984, BIOCH ADAPTATION; Huston AL, 2000, ENVIRON MICROBIOL, V2, P383, DOI 10.1046/j.1462-2920.2000.00118.x; Koch O, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002983; KUZNETSOV AM, 1987, FEBS LETT, V215, P219, DOI 10.1016/0014-5793(87)80149-7; Lawrence CR, 2009, SOIL BIOL BIOCHEM, V41, P1923, DOI 10.1016/j.soilbio.2009.06.016; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Marx MC, 2005, SOIL BIOL BIOCHEM, V37, P35, DOI 10.1016/j.soilbio.2004.05.024; MCCLAUGHERTY CA, 1990, SOIL BIOL BIOCHEM, V22, P29, DOI 10.1016/0038-0717(90)90056-6; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Nannipieri P., 1996, HUMIC SUBSTANCES TER, P293, DOI DOI 10.1016/B978-044481516-3/50008-6; Niemetz R, 2003, PHYTOCHEMISTRY, V62, P301, DOI 10.1016/S0031-9422(02)00557-5; Parham JA, 2000, SOIL BIOL BIOCHEM, V32, P1183, DOI 10.1016/S0038-0717(00)00034-1; Quiquampoix H, 2000, BOOK SOIL P, P171; SARKAR JM, 1989, SOIL BIOL BIOCHEM, V21, P223, DOI 10.1016/0038-0717(89)90098-9; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Shi W, 2011, SOIL BIOL, V22, P43, DOI 10.1007/978-3-642-14225-3_3; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; SKOPP J, 1990, SOIL SCI SOC AM J, V54, P1619, DOI 10.2136/sssaj1990.03615995005400060018x; Steinweg JM, 2008, SOIL BIOL BIOCHEM, V40, P2722, DOI 10.1016/j.soilbio.2008.07.002; Stone MM, 2012, GLOBAL CHANGE BIOL, V18, P1173, DOI 10.1111/j.1365-2486.2011.02545.x; Stricker AR, 2008, APPL MICROBIOL BIOT, V78, P211, DOI 10.1007/s00253-007-1322-0; Stursova M, 2011, PLANT SOIL, V338, P99, DOI 10.1007/s11104-010-0296-3; Toscano G, 2003, ENZYME MICROB TECH, V33, P47, DOI 10.1016/S0141-0229(03)00080-2; Trasar-Cepeda C, 2007, SOIL BIOL BIOCHEM, V39, P311, DOI 10.1016/j.soilbio.2006.08.002; Wallenstein M, 2011, SOIL BIOL, V22, P245, DOI 10.1007/978-3-642-14225-3_13; Wallenstein MD, 2008, SOIL BIOL BIOCHEM, V40, P2098, DOI 10.1016/j.soilbio.2008.01.024; Wang G, 2012, ECOLOGICAL IN PRESS; Wang GS, 2012, FEMS MICROBIOL ECOL, V81, P610, DOI 10.1111/j.1574-6941.2012.01389.x; Wang GS, 2012, SOIL BIOL BIOCHEM, V48, P28, DOI 10.1016/j.soilbio.2012.01.011; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	49	37	38	4	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59943	10.1371/journal.pone.0059943	http://dx.doi.org/10.1371/journal.pone.0059943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536898	gold, Green Published			2022-12-25	WOS:000317397200046
J	Tiller, D; Russ, M; Greiser, KH; Nuding, S; Ebelt, H; Kluttig, A; Kors, JA; Thiery, J; Bruegel, M; Haerting, J; Werdan, K				Tiller, Daniel; Russ, Martin; Greiser, Karin Halina; Nuding, Sebastian; Ebelt, Henning; Kluttig, Alexander; Kors, Jan A.; Thiery, Joachim; Bruegel, Mathias; Haerting, Johannes; Werdan, Karl			Prevalence of Symptomatic Heart Failure with Reduced and with Normal Ejection Fraction in an Elderly General Population-The CARLA Study	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; EUROPEAN-SOCIETY; RISK-FACTORS; DIASTOLIC DYSFUNCTION; NATRIURETIC PEPTIDE; DISEASE; TRENDS; ECHOCARDIOGRAPHY; RECOMMENDATIONS; EPIDEMIOLOGY	Background/Objectives: Chronic heart failure (CHF) is one of the most important public health concerns in the industrialized world having increasing incidence and prevalence. Although there are several studies describing the prevalence of heart failure with reduced ejection fraction (HFREF) and heart failure with normal ejection fraction (HFNEF) in selected populations, there are few data regarding the prevalence and the determinants of symptomatic heart failure in the general population. Methods: Cross-sectional data of a population-based German sample (1,779 subjects aged 45-83 years) were analyzed to determine the prevalence and determinants of chronic SHF and HFNEF defined according to the European Society of Cardiology using symptoms, echocardiography and serum NT-proBNP. Prevalence was age-standardized to the German population as of December 31st, 2005. Results: The overall age-standardized prevalence of symptomatic CHF was 7.7% (95%CI 6.0-9.8) for men and 9.0% (95% CI 7.0-11.5) for women. The prevalence of CHF strongly increased with age from 3.0% among 45-54-year-old subjects to 22.0% among 75-83-year-old subjects. Symptomatic HFREF could be shown in 48% (n = 78), symptomatic HFNEF in 52% (n = 85) of subjects with CHF. The age-standardized prevalence of HFREF was 3.8 % (95%CI 2.4-5.8) for women and 4.6 % (95%CI 3.6-6.3) for men. The age-standardized prevalence of HFNEF for women and men was 5.1 % (95%CI 3.8-7.0) and 3.0 % (95%CI 2.1-4.5), respectively. Persons with CHF were more likely to have hypertension (PR = 3.4; 95%CI 1.6-7.3) or to have had a previous myocardial infarction (PR = 2.5, 95%CI 1.8-3.5). Conclusion: The prevalence of symptomatic CHF appears high in this population compared with other studies. While more women were affected by HFNEF than men, more male subjects suffered from HFREF. The high prevalence of symptomatic CHF seems likely to be mainly due to the high prevalence of cardiovascular risk factors in this population.	[Tiller, Daniel; Greiser, Karin Halina; Kluttig, Alexander; Haerting, Johannes] Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, D-06108 Halle, Saale, Germany; [Russ, Martin; Nuding, Sebastian; Ebelt, Henning; Werdan, Karl] Univ Halle Wittenberg, Univ Clin Halle Saale, Dept Med 3, D-06108 Halle, Germany; [Greiser, Karin Halina] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Kors, Jan A.] Erasmus Univ, Dept Med Informat, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Thiery, Joachim; Bruegel, Mathias] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04109 Leipzig, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Helmholtz Association; German Cancer Research Center (DKFZ); Erasmus University Rotterdam; Erasmus MC; Leipzig University	Tiller, D (corresponding author), Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, D-06108 Halle, Saale, Germany.	daniel.tiller@medizin.uni-halle.de	Russ, Martin/V-8221-2019		Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the Collaborative Research Center 598 at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg; Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg; Federal Employment Office; Ministry of Education and Cultural Affairs of Saxony-Anhalt	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the Collaborative Research Center 598 at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg(German Research Foundation (DFG)); Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg; Federal Employment Office; Ministry of Education and Cultural Affairs of Saxony-Anhalt	This study was funded by a grant from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the Collaborative Research Center 598 "Heart failure in the elderly-cellular mechanisms and therapy" at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg; by a grant of the Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg; by the Federal Employment Office; and by the Ministry of Education and Cultural Affairs of Saxony-Anhalt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, BRIT MED J, V313, P1448; Aurigemma GP, 2001, J AM COLL CARDIOL, V37, P1042, DOI 10.1016/S0735-1097(01)01110-X; Azevedo A, 2007, EUR J HEART FAIL, V9, P391, DOI 10.1016/j.ejheart.2006.10.017; de Sa DDC, 2010, HEART, V96, P528, DOI 10.1136/hrt.2009.177980; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Fay MP, 1997, STAT MED, V16, P791; Gaasch WH, 2004, ANNU REV MED, V55, P373, DOI 10.1146/annurev.med.55.091902.104417; Goetze JP, 2006, EUR HEART J, V27, P3004, DOI 10.1093/eurheartj/ehl406; Gorelik O, 2009, CLIN RES CARDIOL, V98, P224, DOI 10.1007/s00392-009-0746-1; Greiser Karin H, 2005, BMC Cardiovasc Disord, V5, P33, DOI 10.1186/1471-2261-5-33; Greiser KH, 2009, EUR J EPIDEMIOL, V24, P123, DOI 10.1007/s10654-009-9317-z; Hoes A. W., 1998, European Heart Journal, V19, pL2; Hsich EM, 2009, J AM COLL CARDIOL, V54, P491, DOI 10.1016/j.jacc.2009.02.066; Kalsch H, 2010, CLIN RES CARDIOL, V99, P175, DOI 10.1007/s00392-009-0104-3; Kannel W B, 2000, Heart Fail Rev, V5, P167; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Le Jemtel TH, 2007, J AM COLL CARDIOL, V49, P171, DOI 10.1016/j.jacc.2006.08.046; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Luchner A, 2000, J HYPERTENS, V18, P1121, DOI 10.1097/00004872-200018080-00018; Luers C, 2010, CLIN RES CARDIOL, V99, P217, DOI 10.1007/s00392-009-0108-z; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; MATTIASSON I, 1990, BRIT MED J, V301, P461, DOI 10.1136/bmj.301.6750.461; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McKelvie RS, 2010, J CARD FAIL, V16, P128, DOI 10.1016/j.cardfail.2009.09.007; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Moebus S, 2008, DTSCH ARZTEBL INT, V105, P207, DOI 10.3238/artzebl.2008.0207; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Muller-Nordhorn J, 2004, J EPIDEMIOL COMMUN H, V58, P481, DOI 10.1136/jech.2003.013367; Naimi AI, 2009, CIRCULATION, V119, pE305; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Prineas R., 1982, MINNESOTA CODE MANUA; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Task FM, 2012, EUR HEART J; Tehrani Faramarz, 2010, Clin Cardiol, V33, pE1, DOI 10.1002/clc.20615; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Vasan RS, 1996, ARCH INTERN MED, V156, P1789, DOI 10.1001/archinte.156.16.1789; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Volzke H, 2006, DTSCH ARZTEBL, V103	47	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59225	10.1371/journal.pone.0059225	http://dx.doi.org/10.1371/journal.pone.0059225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555000	Green Published, gold			2022-12-25	WOS:000316409800073
J	Yang, HQ; Liu, L; Shin, HD; Li, JH; Du, GC; Chen, J				Yang, Haiquan; Liu, Long; Shin, Hyun-dong; Li, Jianghua; Du, Guocheng; Chen, Jian			Structure-Guided Systems-Level Engineering of Oxidation-Prone Methionine Residues in Catalytic Domain of an Alkaline alpha-Amylase from Alkalimonas amylolytica for Significant Improvement of Both Oxidative Stability and Catalytic Efficiency	PLOS ONE			English	Article							PROTEIN THERMAL-STABILITY; HYDROGEN-BONDS; SALT BRIDGE; BACILLUS; PURIFICATION; REPLACEMENT; RESISTANCE; STRAIN	High oxidative stability and catalytic efficiency are required for the alkaline alpha-amylases to keep the enzymatic performance under the harsh conditions in detergent industries. In this work, we attempted to significantly improve both the oxidative stability and catalytic efficiency of an alkaline alpha-amylase from Alkalimonas amylolytica by engineering the five oxidation-prone methionine residues around the catalytic domain via a systematic approach. Specifically, based on the tertiary structure analysis, five methionines (Met 145, Met 214, Met 229, Met 247 and Met 317) were individually substituted with oxidation-resistant threonine, isoleucine and alaline, respectively. Among the created 15 mutants, 7 mutants M145A, M145I, M214A, M229A, M229T, M247T and M317I showed significantly enhanced oxidative stability or catalytic efficiency. In previous work, we found that the replacement of M247 with leucine could significantly improve the oxidative stability. Thus, these 8 positive mutants (M145A, M145I, M214A, M229A, M229T, M247T, M247L and M317I) were used to conduct the second round of combinational mutations. Among the constructed 85 mutants (25 two-point mutants, 36 three-point mutants, 16 four-point mutants and 8 five-point mutants), the mutant M145I-214A-229T-247T-317I showed a 5.4-fold increase in oxidative stability and a 3.0-fold increase in catalytic efficiency. Interestingly, the specific activity, alkaline stability and thermal stability of this mutant were also increased. The increase of salt bridge and hydrogen bonds around the catalytic domain contributed to the significantly improved catalytic efficiency and stability, as revealed by the three-dimensional structure model of wild-type alkaline alpha-amylase and its mutant M145I-214A-229T-247T-317I. With the significantly improved oxidative stability and catalytic efficiency, the mutant M145I-214A-229T-247T-317I has a great potential as a detergent additive, and this structure-guided systems engineering strategy may be useful for the protein engineering of the other microbial enzymes to fulfill industrial requirements.	[Yang, Haiquan; Liu, Long; Li, Jianghua; Du, Guocheng] Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China; [Yang, Haiquan; Liu, Long; Li, Jianghua; Du, Guocheng] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Shin, Hyun-dong] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Chen, Jian] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; University System of Georgia; Georgia Institute of Technology; Jiangnan University	Liu, L (corresponding author), Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China.	longliu@jiangnan.edu.cn; jchen@jiangnan.edu.cn	li, jianghua/GXG-4735-2022		Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 Project [111-2-06]; National High Technology Research and Development Program of China (863 Program) [2012AA022202]; 973 Program [2012CB720806]	Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 Project(Ministry of Education, China - 111 Project); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China)	This work was financially supported by Priority Academic Program Development of Jiangsu Higher Education Institutions, the 111 Project (111-2-06), National High Technology Research and Development Program of China (863 Program, 2012AA022202), and 973 Program (2012CB720806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Ali M, 2006, BIOCHEM J, V394, P51, DOI 10.1042/BJ20050726; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Binter A, 2009, FEBS J, V276, P5263, DOI 10.1111/j.1742-4658.2009.07222.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo Rodriguez V, 2006, ELECTRON J BIOTECHN, V9, P0717; BROSNAN MP, 1992, EUR J BIOCHEM, V203, P225, DOI 10.1111/j.1432-1033.1992.tb19850.x; FUWA H, 1954, J BIOCHEM-TOKYO, V41, P583, DOI 10.1093/oxfordjournals.jbchem.a126476; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gumpena R, 2012, PROTEIN SCI, V21, P727, DOI 10.1002/pro.2060; GUO H, 1994, J PHYS CHEM-US, V98, P7104, DOI 10.1021/j100080a002; Hagihara H, 2001, APPL ENVIRON MICROB, V67, P1744, DOI 10.1128/AEM.67.4.1744-1750.2001; Hagihara H, 2001, EUR J BIOCHEM, V268, P3974, DOI 10.1046/j.1432-1327.2001.02308.x; Khemakhem B, 2009, BIOTECHNOL BIOENG, V102, P380, DOI 10.1002/bit.22083; KIM TU, 1995, APPL ENVIRON MICROB, V61, P3105, DOI 10.1128/AEM.61.8.3105-3112.1995; Kurosawa K, 2006, APPL ENVIRON MICROB, V72, P71, DOI 10.1128/AEM.72.1.71-77.2006; Lin LL, 2003, CURR MICROBIOL, V46, P211, DOI 10.1007/s00284-002-3846-y; Liu YH, 2008, APPL MICROBIOL BIOT, V80, P795, DOI 10.1007/s00253-008-1580-5; Murakami S, 2008, ENZYME MICROB TECH, V43, P321, DOI 10.1016/j.enzmictec.2008.05.006; Russell GL, 2002, J SURFACTANTS DETERG, V5, P5, DOI 10.1007/s11743-002-0198-9; Tan TC, 2008, J MOL BIOL, V378, P852, DOI 10.1016/j.jmb.2008.02.041; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wang Nan, 2006, Biotechnology Journal, V1, P1258, DOI 10.1002/biot.200600098; Yang HQ, 2012, BIOTECHNOL PROGR, V28, P1271, DOI 10.1002/btpr.1611; Yang HQ, 2012, APPL ENVIRON MICROB, V78, P7519, DOI 10.1128/AEM.01307-12	25	10	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e57403	10.1371/journal.pone.0057403	http://dx.doi.org/10.1371/journal.pone.0057403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554859	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800007
J	Bhathena, J; Martoni, C; Kulamarva, A; Tomaro-Duchesneau, C; Malhotra, M; Paul, A; Urbanska, AM; Prakash, S				Bhathena, Jasmine; Martoni, Christopher; Kulamarva, Arun; Tomaro-Duchesneau, Catherine; Malhotra, Meenakshi; Paul, Arghya; Urbanska, Aleksandra Malgorzata; Prakash, Satya			Oral Probiotic Microcapsule Formulation Ameliorates Non-Alcoholic Fatty Liver Disease in Bio F1B Golden Syrian Hamsters	PLOS ONE			English	Article							FERULIC ACID; INSULIN-RESISTANCE; GUT-MICROBIOTA; ESTERASE; CELLS; INFLAMMATION; ABSORPTION; MECHANISMS; INTESTINE; RELEASE	The beneficial effect of a microencapsulated feruloyl esterase producing Lactobacillus fermentum ATCC 11976 formulation for use in non-alcoholic fatty liver disease (NAFLD) was investigated. For which Bio F1B Golden Syrian hamsters were fed a methionine deficient/choline devoid diet to induce non-alcoholic fatty liver disease. Results, for the first time, show significant clinical benefits in experimental animals. Examination of lipids show that concentrations of hepatic free cholesterol, esterified cholesterol, triglycerides and phospholipids were significantly lowered in treated animals. In addition, serum total cholesterol, triglycerides, uric acid and insulin resistance were found to decrease in treated animals. Liver histology evaluations showed reduced fat deposits. Western blot analysis shows significant differences in expression levels of key liver enzymes in treated animals. In conclusion, these findings suggest the excellent potential of using an oral probiotic formulation to ameliorate NAFLD.	[Prakash, Satya] McGill Univ, Dept Biomed Engn, Fac Med, Biomed Technol & Cell Therapy Res Lab, Montreal, PQ, Canada; McGill Univ, Fac Med, Artificial Cells & Organs Res Ctr, Montreal, PQ, Canada	McGill University; McGill University	Prakash, S (corresponding author), McGill Univ, Dept Biomed Engn, Fac Med, Biomed Technol & Cell Therapy Res Lab, Montreal, PQ, Canada.	satya.prakash@mcgill.ca	Tomaro-Duchesneau, Catherine/H-2839-2019; Paul, Arghya/AAT-4155-2020	Tomaro-Duchesneau, Catherine/0000-0001-5811-3268; Paul, Arghya/0000-0003-4788-0378; /0000-0002-4902-2353	Natural Science and Engineering Research Council (NSERC): Idea to Innovation (I2I) by Micropharma, Montreal, Canada [205811]; Canadian Institutes of Health Research (CIHR); Canada Graduate Scholarship from NSERC; Alexander Graham Bell Canada Graduate Scholarship from NSERC; FRSQ Doctoral Award; Post Graduate Scholarship from NSERC	Natural Science and Engineering Research Council (NSERC): Idea to Innovation (I2I) by Micropharma, Montreal, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Graduate Scholarship from NSERC; Alexander Graham Bell Canada Graduate Scholarship from NSERC; FRSQ Doctoral Award; Post Graduate Scholarship from NSERC	The authors would like to acknowledge support by grants from the Natural Science and Engineering Research Council (NSERC): Idea to Innovation (I2I) Grant supported by Micropharma, Montreal, Canada (Grant # 205811) (to SP), a Doctoral Research Award from the Canadian Institutes of Health Research (CIHR) (to JB), a Canada Graduate Scholarship from NSERC (to CM), an Alexander Graham Bell Canada Graduate Scholarship from NSERC (to AK, CTD and AP), a FRSQ Doctoral Award (to MM) and a Post Graduate Scholarship from NSERC (to AMU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mukdsi MCA, 2012, LETT APPL MICROBIOL, V54, P18, DOI 10.1111/j.1472-765X.2011.03166.x; Adam A, 2002, J NUTR, V132, P1962, DOI 10.1093/jn/132.7.1962; Andreasen MF, 2001, FREE RADICAL BIO MED, V31, P304, DOI 10.1016/S0891-5849(01)00585-8; Anstee Quentin M, 2011, BMJ, V343, pd3897, DOI 10.1136/bmj.d3897; Balasubashini MS, 2004, PHYTOTHER RES, V18, P310, DOI 10.1002/ptr.1440; Bhathena J, 2008, BIOTECHNOL APPL BIOC, V50, P1, DOI 10.1042/BA20070007; Bhathena J, 2007, APPL MICROBIOL BIOT, V75, P1023, DOI 10.1007/s00253-007-0908-x; Bhathena J, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.S6-006; Bhathena J, 2011, DIABETES METAB SYNDR, V4, P195, DOI 10.2147/DMSO.S18435; Bookman ID, 2006, LIVER INT, V26, P566, DOI 10.1111/j.1478-3231.2006.01256.x; Buchanan CJ, 1996, J SCI FOOD AGR, V71, P459, DOI 10.1002/(SICI)1097-0010(199608)71:4&lt;459::AID-JSFA602&gt;3.0.CO;2-H; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS39; de Roos B, 2005, FASEB J, V19, P1746, DOI 10.1096/fj.05-3953fje; Delaney B, 2003, J NUTR, V133, P468, DOI 10.1093/jn/133.2.468; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Fraser A, 2007, HEPATOLOGY, V46, P158, DOI 10.1002/hep.21667; Gill HS, 2004, POSTGRAD MED J, V80, P516, DOI 10.1136/pgmj.2003.008664; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Iacono A, 2011, J NUTR BIOCHEM, V22, P699, DOI 10.1016/j.jnutbio.2010.10.002; Jones ML, 2013, EXPERT OPIN BIOL THE; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Kern SM, 2003, J AGR FOOD CHEM, V51, P6050, DOI 10.1021/jf0302299; Lee RG, 2000, J LIPID RES, V41, P1991; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Liang KH, 2003, KIDNEY INT, V64, P192, DOI 10.1046/j.1523-1755.2003.00041.x; Lirussi F, 2007, COCHRANE DB SYST REV, V1; Loguercio C, 2005, J CLIN GASTROENTEROL, V39, P540, DOI 10.1097/01.mcg.0000165671.25272.0f; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Musso G, 2010, CURR OPIN LIPIDOL, V21, P76, DOI 10.1097/MOL.0b013e3283347ebb; Ng DS, 2004, REV ENDOCR METAB DIS, V5, P311, DOI 10.1023/B:REMD.0000045102.70521.af; Ohnishi M, 2004, BIOFACTORS, V21, P315, DOI 10.1002/biof.552210161; Prakash S, 1996, NAT MED, V2, P883, DOI 10.1038/nm0896-883; Prakash S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/981214; Reid AA, 2005, J MICROENCAPSUL, V22, P603, DOI 10.1080/02652040500162840; Saha S, 2012, EXPERT OPIN BIOL TH, V12, P1207, DOI 10.1517/14712598.2012.693474; Sato M, 2008, BRIT J NUTR, V99, P1013, DOI 10.1017/S0007114507839006; Tomaro-Duchesneau C., 2012, International Journal of Probiotics and Prebiotics, V7, P23; Tomaro-Duchesneau C, 2013, J PHARMACEUTICS, V2013, DOI 10.1155/2013/103527; Tomaro-Duchesneau C, 2012, PHARMACEUTICALS, V5, P236, DOI 10.3390/ph5020236; Wende G, 1997, J SCI FOOD AGR, V73, P296, DOI 10.1002/(SICI)1097-0010(199703)73:3&lt;296::AID-JSFA737&gt;3.0.CO;2-0; Yamasaki Tomoyuki, 2008, Nihon Rinsho, V66, P766; Yan E, 2007, NUTR REV, V65, P376, DOI [10.1301/nr.2007.aug.376-384, 10.1111/j.1753-4887.2007.tb00315.x]; Zhao Z, 2003, J AGR FOOD CHEM, V51, P5534, DOI 10.1021/jf034455u; Zvenigorodskaia L A, 2010, Eksp Klin Gastroenterol, P25	45	29	32	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58394	10.1371/journal.pone.0058394	http://dx.doi.org/10.1371/journal.pone.0058394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554890	gold, Green Published, Green Submitted			2022-12-25	WOS:000316252500023
J	Dijkstra, JA; Buckman, KL; Ward, D; Evans, DW; Dionne, M; Chen, CY				Dijkstra, Jennifer A.; Buckman, Kate L.; Ward, Darren; Evans, David W.; Dionne, Michele; Chen, Celia Y.			Experimental and Natural Warming Elevates Mercury Concentrations in Estuarine Fish	PLOS ONE			English	Article							MICROBIAL SULFATE REDUCTION; FUNDULUS-HETEROCLITUS L; SALT-MARSH; METHYLMERCURY PRODUCTION; REDUCING BACTERIA; MARINE ECOSYSTEMS; CLIMATE-CHANGE; GUT CONTENTS; FOOD WEBS; TEMPERATURE	Marine food webs are the most important link between the global contaminant, methylmercury (MeHg), and human exposure through consumption of seafood. Warming temperatures may increase human exposure to MeHg, a potent neurotoxin, by increasing MeHg production as well as bioaccumulation and trophic transfer through marine food webs. Studies of the effects of temperature on MeHg bioaccumulation are rare and no study has specifically related temperature to MeHg fate by linking laboratory experiments with natural field manipulations in coastal ecosystems. We performed laboratory and field experiments on MeHg accumulation under varying temperature regimes using the killifish, Fundulus heteroclitus. Temperature treatments were established in salt pools on a coastal salt marsh using a natural temperature gradient where killifish fed on natural food sources. Temperatures were manipulated across a wider range in laboratory experiments with killifish exposed to MeHg enriched food. In both laboratory microcosms and field mesocosms, MeHg concentrations in killifish significantly increased at elevated temperatures. Moreover, in field experiments, other ancillary variables (salinity, MeHg in sediment, etc.) did not relate to MeHg bioaccumulation. Modeling of laboratory experimental results suggested increases in metabolic rate as a driving factor. The elevated temperatures we tested are consistent with predicted trends in climate warming, and indicate that in the absence of confounding factors, warmer sea surface temperatures could result in greater in bioaccumulation of MeHg in fish, and consequently, increased human exposure.	[Dijkstra, Jennifer A.; Dionne, Michele] Wells Natl Estuarine Res Reserve, Wells, ME 04090 USA; [Buckman, Kate L.; Chen, Celia Y.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Ward, Darren] Humboldt State Univ, Fisheries Biol Dept, Arcata, CA 95521 USA; [Evans, David W.] NOAA, Ctr Coastal Fisheries & Habitat Res, Beaufort, NC USA	Dartmouth College; California State University System; California State Polytechnic University, Humboldt; National Oceanic Atmospheric Admin (NOAA) - USA	Dijkstra, JA (corresponding author), Wells Natl Estuarine Res Reserve, Wells, ME 04090 USA.	jdijkstra@ccom.unh.edu			NIEHS (NIH) [P42 ES007373]; Maine Sea Grant [DV-08-017]; George and Eleanor Ford Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER	NIEHS (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Maine Sea Grant; George and Eleanor Ford Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this research was provided by NIEHS (NIH #P42 ES007373) and Maine Sea Grant (#DV-08-017). Funding for J. A. Dijkstra was provided by the George and Eleanor Ford Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able KW, 2012, ESTUAR COAST, V35, P743, DOI 10.1007/s12237-011-9471-x; Al-Raei AM, 2009, OCEAN DYNAM, V59, P351, DOI 10.1007/s10236-009-0186-5; ALLEN EA, 1994, ESTUARIES, V17, P462, DOI 10.2307/1352676; [Anonymous], 2007, PHYS SCI BAS CONTR W; Balcom PH, 2008, MAR CHEM, V109, P1, DOI 10.1016/j.marchem.2007.09.005; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Bloom NS, 1997, FRESEN J ANAL CHEM, V358, P371, DOI 10.1007/s002160050432; Breitburg DL, 1999, LIMNOL OCEANOGR, V44, P837, DOI 10.4319/lo.1999.44.3_part_2.0837; Carrie J, 2010, ENVIRON SCI TECHNOL, V44, P316, DOI 10.1021/es902582y; Chen C, 2008, ECOHEALTH, V5, P399, DOI 10.1007/s10393-008-0201-1; Chen CY, 2009, ENVIRON SCI TECHNOL, V43, P1804, DOI 10.1021/es8017122; Chen CY, 2005, ENVIRON SCI TECHNOL, V39, P115, DOI 10.1021/es0403007; Cherkasov AS, 2007, J THERM BIOL, V32, P162, DOI 10.1016/j.jtherbio.2007.01.005; Chetelat J, 2009, GLOBAL CHANGE BIOL, V15, P706, DOI 10.1111/j.1365-2486.2008.01729.x; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; COMPEAU GC, 1987, APPL ENVIRON MICROB, V53, P261, DOI 10.1128/AEM.53.2.261-265.1987; Compeau GC, 1994, APPL ENVIRON MICROB, V48, P1203; Dijkstra JA, 2011, GLOBAL CHANGE BIOL, V17, P2360, DOI 10.1111/j.1365-2486.2010.02371.x; Driscoll CT, 2012, ENVIRON RES, V119, P118, DOI 10.1016/j.envres.2012.05.002; Dutton J, 2011, ENVIRON TOXICOL CHEM, V30, P2107, DOI 10.1002/etc.600; Eagles-Smith CA, 2009, ENVIRON SCI TECHNOL, V43, P8658, DOI 10.1021/es901400c; FERNANDEZDELGADO C, 1989, ESTUAR COAST SHELF S, V29, P573, DOI 10.1016/0272-7714(89)90011-5; Fitzgerald WF, 2007, CHEM REV, V107, P641, DOI 10.1021/cr050353m; Fogarty M, 2008, MITIG ADAPT STRAT GL, V13, P453, DOI 10.1007/s11027-007-9131-4; FRITZ ES, 1975, CAN J ZOOL, V53, P361, DOI 10.1139/z75-047; Frohne T, 2012, BIOGEOSCIENCES, V9, P493, DOI 10.5194/bg-9-493-2012; GILMOUR CC, 1992, ENVIRON SCI TECHNOL, V26, P2281, DOI 10.1021/es00035a029; Hall BD, 2008, ENVIRON POLLUT, V154, P124, DOI 10.1016/j.envpol.2007.12.017; Hammerschmidt CR, 2006, GEOCHIM COSMOCHIM AC, V70, P918, DOI 10.1016/j.gca.2005.10.020; Hammerschmidt CR, 2004, ENVIRON SCI TECHNOL, V38, P1487, DOI 10.1021/es034528q; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Hollweg TA, 2010, LIMNOL OCEANOGR, V55, P2703, DOI 10.4319/lo.2010.55.6.2703; Jackson B, 2009, ENVIRON SCI TECHNOL, V43, P2463, DOI 10.1021/es802656p; Karimi R, 2007, P NATL ACAD SCI USA, V104, P7477, DOI 10.1073/pnas.0611261104; Kneib RT, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P267; Leung KMY, 2000, J MAR BIOL ASSOC UK, V80, P647, DOI 10.1017/S0025315400002472; MacKenzie RA, 2008, MAR ECOL PROG SER, V368, P217, DOI 10.3354/meps07560; Madon SP, 2001, ECOL MODEL, V136, P149, DOI 10.1016/S0304-3800(00)00416-6; Martinez-Cortizas A, 1999, SCIENCE, V284, P939, DOI 10.1126/science.284.5416.939; Marvin-DiPasquale MC, 2003, ENVIRON GEOL, V43, P260, DOI 10.1007/s00254-002-0623-y; Mason RP, 2012, ENVIRON RES, V119, P101, DOI 10.1016/j.envres.2012.03.013; Mason RP, 1998, MAR CHEM, V61, P37, DOI 10.1016/S0304-4203(98)00006-1; McMahon KW, 2005, ESTUARIES, V28, P966, DOI 10.1007/BF02696024; MEREDITH WH, 1979, ESTUAR COAST MAR SCI, V8, P99, DOI 10.1016/0302-3524(79)90066-5; Modassir, 2000, ASIAN FISH SCI, V13, P335; Nixon SX, 2004, ESTUARIES, V27, P397, DOI 10.1007/BF02803532; Nordlie FG, 2003, REV FISH BIOL FISHER, V13, P281, DOI 10.1023/B:RFBF.0000033050.51699.84; Pallud C, 2006, GEOCHIM COSMOCHIM AC, V70, P1148, DOI 10.1016/j.gca.2005.11.002; Pickhardt PC, 2002, P NATL ACAD SCI USA, V99, P4419, DOI 10.1073/pnas.072531099; Roman HA, 2011, ENVIRON HEALTH PERSP, V119, P607, DOI 10.1289/ehp.1003012; Sanz-Lazaro C, 2011, ECOL APPL, V21, P2664, DOI 10.1890/10-2219.1; Scheuhammer AM, 1998, ENVIRON TOXICOL CHEM, V17, P191, DOI 10.1002/etc.5620170208; Shanley JB, 2005, ECOTOXICOLOGY, V14, P125, DOI 10.1007/s10646-004-6264-z; Sheffield PE, 2011, ENVIRON HEALTH PERSP, V119, P291, DOI 10.1289/ehp.1002233; Skyllberg U, 2007, AMBIO, V36, P437, DOI 10.1579/0044-7447(2007)36[437:NMPAAB]2.0.CO;2; Sokolova IM, 2008, CLIM RES, V37, P181, DOI 10.3354/cr00764; Sunderland EM, 2007, ENVIRON HEALTH PERSP, V115, P235, DOI 10.1289/ehp.9377; Sunderland EM, 2012, ENVIRON RES, V119, P27, DOI 10.1016/j.envres.2012.03.011; Sunderland EM, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003425; Taylor DL, 2012, MAR POLLUT BULL, V64, P807, DOI 10.1016/j.marpolbul.2012.01.013; Taylor VF, 2011, ANAL METHODS-UK, V3, P1143, DOI 10.1039/c0ay00528b; Taylor VF, 2008, ANAL BIOANAL CHEM, V392, P1283, DOI 10.1007/s00216-008-2403-3; Trombulak SC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020574; Trudel M, 2001, ECOL APPL, V11, P517, DOI 10.1890/1051-0761(2001)011[0517:PMCIFU]2.0.CO;2; Tsui MTK, 2006, ENVIRON SCI TECHNOL, V40, P4025, DOI 10.1021/es052377g; Tsui MTK, 2004, AQUAT TOXICOL, V70, P245, DOI 10.1016/j.aquatox.2004.09.006; Ullrich SM, 2001, CRIT REV ENV SCI TEC, V31, P241, DOI 10.1080/20016491089226; US Environmental Protection Agency, 1998, MERC SOL SOL THERM D; Wainright SC, 2000, MAR ECOL PROG SER, V200, P77, DOI 10.3354/meps200077; Wang R, 2011, ENVIRON TOXICOL CHEM, V30, P2142, DOI 10.1002/etc.604; Ward DM, 2010, ANN NY ACAD SCI, V1195, P62, DOI 10.1111/j.1749-6632.2010.05456.x; Ward DM, 2010, T AM FISH SOC, V139, P1, DOI 10.1577/T09-032.1; Ward DM, 2010, ENVIRON SCI TECHNOL, V44, P3245, DOI 10.1021/es902639a; Weinstein MP, 2000, T AM FISH SOC, V129, P797, DOI 10.1577/1548-8659(2000)129<0797:TROTSM>2.3.CO;2	74	66	68	3	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58401	10.1371/journal.pone.0058401	http://dx.doi.org/10.1371/journal.pone.0058401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554891	Green Submitted, Green Published, gold			2022-12-25	WOS:000316252500024
J	Plaut, RD; Mocca, CP; Prabhakara, R; Merkel, TJ; Stibitz, S				Plaut, Roger D.; Mocca, Christopher P.; Prabhakara, Ranjani; Merkel, Tod J.; Stibitz, Scott			Stably Luminescent Staphylococcus aureus Clinical Strains for Use in Bioluminescent Imaging	PLOS ONE			English	Article							METHICILLIN-RESISTANT; MOUSE MODEL; IN-VIVO; VIRULENCE; SEQUENCE; GENOME; GENE; REPLACEMENT; EVOLUTION; INFECTION	In vivo bioluminescent imaging permits the visualization of bacteria in live animals, allowing researchers to monitor, both temporally and spatially, the progression of infection in each animal. We sought to engineer stably luminescent clinical strains of Staphylococcus aureus, with the goal of using such strains in mouse models. The gram-positive shuttle vector pMAD was used as the backbone for an integration plasmid. A chloramphenicol resistance gene, a modified lux operon from Photorhabdus luminescens, and approximately 650 bp of homology to the chromosome of the USA300 S. aureus strain NRS384 were added, generating plasmid pRP1195. Electroporation into strain RN4220 followed by temperature shift led to integration of pRP1195 into the chromosome. The integrated plasmid was transferred to clinical strains by phage transduction. Luminescent strains displayed no in vitro growth defects. Moreover, luminescence was stable in vitro after three rounds of subculture over 48 hours of growth in the absence of antibiotics. Mice were infected with a luminescent strain of NRS384 in skin and intravenous models. In a mouse skin model, luminescent bacteria were present in lesions that formed and cleared over the course of several days, and in an intravenous model, bacteria inoculated in the mouse tail vein were observed spreading to multiple tissues. No statistically significant difference in virulence was observed between NRS384 and the luminescent strain in either infection model. These preliminary data suggest that this luminescent USA300 strain is suitable for use in mouse models. Similar strains were engineered using other sequenced clinical strains. Because these strains are stably luminescent, they should prove useful in animal models of infection.	[Plaut, Roger D.; Mocca, Christopher P.; Prabhakara, Ranjani; Merkel, Tod J.; Stibitz, Scott] US FDA, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Plaut, RD (corresponding author), US FDA, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	Roger.Plaut@fda.hhs.gov	Plaut, Roger D./B-2340-2013	Plaut, Roger D./0000-0002-0883-972X	Food and Drug Administration Medical Countermeasures Initiative; National Institute of Allergy and Infectious Diseases/National Institutes of Health [HHSN272200700055C]	Food and Drug Administration Medical Countermeasures Initiative; National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Stanley Kim was supported by the Food and Drug Administration Medical Countermeasures Initiative. Strain NRS384 was obtained through the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA; www.narsa.net) Program, supported under National Institute of Allergy and Infectious Diseases/National Institutes of Health Contract No. HHSN272200700055C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae Taeok, 2008, V416, P103, DOI 10.1007/978-1-59745-321-9_7; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Christie GE, 2010, VIROLOGY, V407, P381, DOI 10.1016/j.virol.2010.08.036; Cybulski RJ, 2009, INFECT IMMUN, V77, P274, DOI 10.1128/IAI.00515-08; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; GRAY GS, 1983, MOL BIOL EVOL, V1, P57; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Loving CL, 2009, INFECT IMMUN, V77, P255, DOI 10.1128/IAI.00633-08; McNamara Peter J., 2008, P89; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Steinhuber A, 2008, INT J MED MICROBIOL, V298, P599, DOI 10.1016/j.ijmm.2007.09.008	22	57	59	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59232	10.1371/journal.pone.0059232	http://dx.doi.org/10.1371/journal.pone.0059232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555002	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500075
J	Shu, CL; Jing-Yang-Lai; Su, LC; Chuu, CP; Fukui, Y				Shu, Chung-Li; Jing-Yang-Lai; Su, Liang-Cheng; Chuu, Chih-Pin; Fukui, Yasuhisa			SWAP-70: A New Type of Oncogene	PLOS ONE			English	Article								SWAP-70 is a protein that has been suggested to be involved in regulation of actin rearrangement. Having discovered that an artificially-derived mutant of SWAP-70 can transform mouse embryo fibroblasts, we searched for naturally-occurring mutations in the SWAP-70 gene, finding listings for several on the Web at www.sanger.ac.uk/genetics/CGP/cosmic/, including three mutations found in ovarian cancers. (The number of such mutations has now reached 13 out of 228 tumors). We created expression vectors for the mutant SWAP-70 proteins and introduced these into NIH3T3 cells. The cells expressing the mutant SWAP-70 constructs exhibited faster growth than the parental or wild-type SWAP-70-expressing cells. In most instances, cells that are able to grow in soft agar will form tumors in nude mice. While SWAP-70-transformed cells grew in soft agar, they failed to form tumors in nude mice. This result implies that transformation by the SWAP-70 mutants is unique. The cells bearing the mutant SWAP-70 genes were sensitive to nutrient starvation, supporting the idea that they are transformed cells. However, they failed to pile up and demonstrated contact inhibition, unlike most normal transformed cells. Upon expression of human SWAP-70 genes, MEK1 was activated. This activation appeared to contribute to the saturation density of the cells. As SWAP-70 has been shown to be the last protein to receive signals from cytokines, it is likely that there is a putative feedback signaling pathway, and that disorder of this signaling pathway can transform cells. Accordingly, this may explain why SWAP-70-transformed cells have different characteristics than most transformed cells.	[Shu, Chung-Li; Jing-Yang-Lai; Su, Liang-Cheng; Chuu, Chih-Pin; Fukui, Yasuhisa] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan Town, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Fukui, Y (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan Town, Miaoli County, Taiwan.	990412@nhri.org.tw	Chuu, Chih-Pin/B-1086-2010; Chuu, Chih-Pin/N-6697-2019; Fukui, Yasuhisa/E-8806-2010		National Health Research Institute [01A1-CSPP04-014]; National Science Council Taiwan [101-2300-B-400-015]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This paper is supported by a grant from National Health Research Institute 01A1-CSPP04-014 and from National Science Council Taiwan 101-2300-B-400-015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Fukui Y, 2007, BIOCHEM BIOPH RES CO, V356, P512, DOI 10.1016/j.bbrc.2007.03.011; Fukui Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014180; Ihara S, 2006, J CELL SCI, V119, P500, DOI 10.1242/jcs.02767; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Wakamatsu I, 2006, MOL CELL BIOCHEM, V293, P137, DOI 10.1007/s11010-006-9236-1	8	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59245	10.1371/journal.pone.0059245	http://dx.doi.org/10.1371/journal.pone.0059245			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555004	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500076
J	Chen, YL; Hu, NT				Chen, Yih-Lin; Hu, Nien-Tai			Function-Related Positioning of the Type II Secretion ATPase of Xanthomonas campestris pv. campestris	PLOS ONE			English	Article							PROTEIN SECRETION; OUTER-MEMBRANE; CHOLERA-TOXIN; PILUS; COMPLEX; SYSTEM; BIOGENESIS; GENE; EPSL; ARCHITECTURE	Gram-negative bacteria use the type II secretion (T2S) system to secrete exoproteins for attacking animal or plant cells or to obtain nutrients from the environment. The system is unique in helping folded proteins traverse the outer membrane. The secretion machine comprises multiple proteins spanning the cell envelope and a cytoplasmic ATPase. Activity of the ATPase, when copurified with the cytoplasmic domain of an interactive ATPase partner, is stimulated by an acidic phospholipid, suggesting the membrane-associated ATPase is actively engaged in secretion. How the stimulated ATPase activity is terminated when secretion is complete is unclear. We fused the T2S ATPase of Xanthomonas campestris pv. campestris, the causal agent of black rot in the crucifers, with fluorescent protein and found that the ATPase in secretion-proficient cells was mainly diffused in cytoplasm. Focal spots at the cell periphery were detectable only in a few cells. The discrete foci were augmented in abundance and intensity when the secretion channel was depleted and the exoprotein overproduced. The foci abundance was inversely related to secretion efficiency of the secretion channel. Restored function of the secretion channel paralleled reduced ATPase foci abundance. The ATPase foci colocalized with the secretion channel. The ATPase may be transiently associated with the T2S machine by alternating between a cytoplasmic and a machine-associated state in a secretion-dependent manner. This provides a logical means for terminating the ATPase activity when secretion is completed. Function-related dynamic assembly may be the essence of the T2S machine.	[Chen, Yih-Lin; Hu, Nien-Tai] Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan	National Chung Hsing University	Hu, NT (corresponding author), Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan.	nthu@nchu.edu.tw			National Science Council of the Republic of China [NSC97-2321-B-005-011, NSC98-2321-B-005-002, NSC99-2321-B-005-001, NSC100-2321-B-005-001, NSC101-2321-B-005-001]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was funded by grants from the National Science Council of the Republic of China: NSC97-2321-B-005-011, NSC98-2321-B-005-002, NSC99-2321-B-005-001, NSC100-2321-B-005-001 and NSC101-2321-B-005-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2011, MBIO, V2, DOI 10.1128/mBio.00218-11; Arts J, 2007, J BACTERIOL, V189, P2069, DOI 10.1128/JB.01236-06; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bulyha I, 2009, MOL MICROBIOL, V74, P691, DOI 10.1111/j.1365-2958.2009.06891.x; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Campos M, 2010, P NATL ACAD SCI USA, V107, P13081, DOI 10.1073/pnas.1001703107; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Chen LY, 1996, J BIOL CHEM, V271, P2703, DOI 10.1074/jbc.271.5.2703; Chiang P, 2005, J BACTERIOL, V187, P829, DOI 10.1128/JB.187.3.829-839.2005; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Durand E, 2005, J BIOL CHEM, V280, P31378, DOI 10.1074/jbc.M505812200; Francetic O, 2007, J BACTERIOL, V189, P1783, DOI 10.1128/JB.01230-06; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; HU NT, 1992, J BACTERIOL, V174, P2679, DOI 10.1128/jb.174.8.2679-2687.1992; Hu NT, 1998, MICROBIOL-SGM, V144, P1479, DOI 10.1099/00221287-144-6-1479; HU NT, 1992, J GEN MICROBIOL, V138, P1647, DOI 10.1099/00221287-138-8-1647; Hwang JW, 2003, J BACTERIOL, V185, P6695, DOI 10.1128/JB.185.22.6695-6701.2003; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; KAMOUN S, 1992, MOL MICROBIOL, V6, P809, DOI 10.1111/j.1365-2958.1992.tb01531.x; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Lee HM, 2001, J BACTERIOL, V183, P528, DOI 10.1128/JB.183.2.528-535.2001; Lybarger SR, 2009, J BACTERIOL, V191, P3149, DOI 10.1128/JB.01701-08; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Shiue SJ, 2006, EMBO J, V25, P1426, DOI 10.1038/sj.emboj.7601036; Spagnuolo J, 2010, MOL MICROBIOL, V76, P133, DOI 10.1111/j.1365-2958.2010.07085.x; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408	42	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59123	10.1371/journal.pone.0059123	http://dx.doi.org/10.1371/journal.pone.0059123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536861	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100121
J	Bartholomeeusen, K; Fujinaga, K; Xiang, YH; Peterlin, BM				Bartholomeeusen, Koen; Fujinaga, Koh; Xiang, Yanhui; Peterlin, B. Matija			Histone Deacetylase Inhibitors (HDACis) That Release the Positive Transcription Elongation Factor b (P-TEFb) from Its Inhibitory Complex Also Activate HIV Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BET BROMODOMAIN INHIBITION; REACTIVATES LATENT HIV-1; CYCLIN T1; 7SK SNRNA; EXPRESSION; TYPE-1; TAT; REPLICATION; ESTABLISHMENT; EQUILIBRIUM	Numerous studies have looked at the effects of histone deacetylase inhibitors (HDACis) on HIV reactivation in established transformed cell lines and primary CD4(+) T cells. However, their findings remain confusing, and differences between effects of class I- and class II-specific HDACis persist. Because no clear picture emerged, we decided to determine how HDACis reactivate HIV in transformed cell lines and primary cells. We found that neither histone H3 nor tubulin acetylation correlated with HIV reactivation in Jurkat and HeLa cells. Rather, HDACis that could reactivate HIV in chromatin or on episomal plasmids also released free positive transcription elongation factor b (P-TEFb) from its inhibitory 7SK snRNP. In resting primary CD4(+) T cells, where levels of P-TEFb are vanishingly low, the most potent HDACi, suberoylanilide hydroxyamic acid (SAHA), had minimal effects. In contrast, when these cells were treated with a PKC agonist, bryostatin 1, which increased levels of P-TEFb, then SAHA once again reactivated HIV. We conclude that HDACis, which can reactivate HIV, work via the release of free P-TEFb from the 7SK snRNP.	[Bartholomeeusen, Koen; Fujinaga, Koh; Xiang, Yanhui; Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA; [Bartholomeeusen, Koen; Fujinaga, Koh; Xiang, Yanhui; Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Microbiol, San Francisco, CA 94143 USA; [Bartholomeeusen, Koen; Fujinaga, Koh; Xiang, Yanhui; Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Immunol, San Francisco, CA 94143 USA; [Xiang, Yanhui] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Peterlin, BM (corresponding author), Rm U432,CSF,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu	bartholomeeusen, koen/J-1843-2015	bartholomeeusen, koen/0000-0001-9576-2400	Collaboratory of AIDS Researchers for Eradication (CARE) Center Grant [U19 AI96113]; University of California San Francisco Center for AIDS Research grant; American Foundation for AIDS Research Grant [108241-51-RGRL]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI049104, U19AI096113] Funding Source: NIH RePORTER	Collaboratory of AIDS Researchers for Eradication (CARE) Center Grant; University of California San Francisco Center for AIDS Research grant; American Foundation for AIDS Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Collaboratory of AIDS Researchers for Eradication (CARE) Center Grant U19 AI96113.; Supported by a University of California San Francisco Center for AIDS Research grant.; Supported by American Foundation for AIDS Research Grant 108241-51-RGRL.	Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Barboric M, 2010, NAT STRUCT MOL BIOL, V17, P928, DOI 10.1038/nsmb0810-928; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Budhiraja S, 2013, J VIROL, V87, P1211, DOI 10.1128/JVI.02413-12; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chiang KR, 2012, VIRUSES-BASEL, V4, P1390, DOI 10.3390/v4091390; Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11; Cho SY, 2009, EMBO J, V28, P1407, DOI 10.1038/emboj.2009.99; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Contreras X, 2006, FUTURE VIROL, V1, P733, DOI 10.2217/17460794.1.6.733; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; FELBER BK, 1988, SCIENCE, V239, P184, DOI 10.1126/science.3422113; Friedman J, 2011, J VIROL, V85, P9078, DOI 10.1128/JVI.00836-11; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Gallastegui E, 2012, J VIROL, V86, P3795, DOI 10.1128/JVI.05972-11; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; He NH, 2011, J NEUROIMMUNE PHARM, V6, P260, DOI 10.1007/s11481-011-9267-6; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Heltweg B, 2004, J MED CHEM, V47, P5235, DOI 10.1021/jm0497592; Hoque M, 2011, J MOL BIOL, V410, P917, DOI 10.1016/j.jmb.2011.03.060; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Lassen KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030176; LEONARD J, 1989, J VIROL, V63, P4919, DOI 10.1128/JVI.63.11.4919-4924.1989; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Marshall RM, 2006, FRONT BIOSCI-LANDMRK, V11, P2598, DOI 10.2741/1994; Mbonye U, 2011, CURR HIV RES, V9, P554, DOI 10.2174/157016211798998736; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Sahu GK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-400; Schroder S, 2012, J BIOL CHEM, V287, P1090, DOI 10.1074/jbc.M111.282855; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shishido T, 2012, J VIROL, V86, P9055, DOI 10.1128/JVI.00793-12; Siliciano RF, 2012, DRUG DISCOV TODAY; Sung TL, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-66; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tyagi M, 2010, J VIROL, V84, P6425, DOI 10.1128/JVI.01519-09; Wender PA, 2011, P NATL ACAD SCI USA, V108, P6721, DOI 10.1073/pnas.1015270108; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Ying H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048832; Ying H, 2010, INT J MOL MED, V26, P265, DOI 10.3892/ijmm_00000461; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008; Zumer K, 2012, MOL CELL BIOL, V32, P1354, DOI 10.1128/MCB.06359-11	61	60	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14400	14407		10.1074/jbc.M113.464834	http://dx.doi.org/10.1074/jbc.M113.464834			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23539624	Green Published, hybrid			2022-12-25	WOS:000319253500043
J	van der Post, S; Subramani, DB; Backstram, M; Johansson, MEV; Vester-Christensen, MB; Mandel, U; Bennett, EP; Clausen, H; Dahlen, G; Sroka, A; Potempa, J; Hansson, GC				van der Post, Sjoerd; Subramani, Durai B.; Backstrom, Malin; Johansson, Malin E. V.; Vester-Christensen, Malene B.; Mandel, Ulla; Bennett, Eric P.; Clausen, Henrik; Dahlen, Gunnar; Sroka, Aneta; Potempa, Jan; Hansson, Gunnar C.			Site-specific O-Glycosylation on the MUC2 Mucin Protein Inhibits Cleavage by the Porphyromonas gingivalis Secreted Cysteine Protease (RgpB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL TUMORAL CALCINOSIS; VIRULENCE FACTORS; C-TERMINUS; 3 MEMBERS; COLON; GINGIPAINS; INTESTINE; LAYERS; GEL; MUTATIONS	The colonic epithelial surface is protected by an inner mucus layer that the commensal microflora cannot penetrate. We previously demonstrated that Entamoeba histolytica secretes a protease capable of dissolving this layer that is required for parasite penetration. Here, we asked whether there are bacteria that can secrete similar proteases. We screened bacterial culture supernatants for such activity using recombinant fragments of the MUC2 mucin, the major structural component, and the only gel-forming mucin in the colonic mucus. MUC2 has two central heavily O-glycosylated mucin domains that are protease-resistant and has cysteine-rich N and C termini responsible for polymerization. Culture supernatants of Porphyromonas gingivalis, a bacterium that secretes proteases responsible for periodontitis, cleaved the MUC2 C-terminal region, whereas the N-terminal region was unaffected. The active enzyme was isolated and identified as Arg-gingipain B (RgpB). Two cleavage sites were localized to IR down arrow TT and NR down arrow QA. IR down arrow TT cleavage will disrupt the MUC2 polymers. Because this site has two potential O-glycosylation sites, we tested whether recombinant GalNAc-transferases (GalNAc-Ts) could glycosylate a synthetic peptide covering the IRTT sequence. Only GalNAc-T3 was able to glycosylate the second Thr in IRTT, rendering the sequence resistant to cleavage by RgpB. Furthermore, when GalNAc-T3 was expressed in CHO cells expressing the MUC2 C terminus, the second threonine was glycosylated, and the protein became resistant to RgpB cleavage. These findings suggest that bacteria can produce proteases capable of dissolving the inner protective mucus layer by specific cleavages in the MUC2 mucin and that this cleavage can be modulated by site-specific O-glycosylation.	[van der Post, Sjoerd; Subramani, Durai B.; Backstrom, Malin; Johansson, Malin E. V.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, S-40530 Gothenburg, Sweden; [Dahlen, Gunnar] Univ Gothenburg, Dept Oral Microbiol, S-40530 Gothenburg, Sweden; [Vester-Christensen, Malene B.; Mandel, Ulla; Bennett, Eric P.; Clausen, Henrik] Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med & Odontol, DK-2200 Copenhagen, Denmark; [Sroka, Aneta] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Oral Hlth & Syst Dis Grp, Louisville, KY 40202 USA	University of Gothenburg; University of Gothenburg; University of Copenhagen; Jagiellonian University; University of Louisville	Hansson, GC (corresponding author), Univ Gothenburg, Dept Med Biochem, S-40530 Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se	Johansson, Malin E. V./HCH-7451-2022; Hansson, Gunnar C/A-1236-2009; Potempa, Jan/AAA-6850-2021; Subramani, Durai/N-1448-2013; Hansson, Gunnar C./AAF-7324-2019; clausen, henrik/AAD-8016-2021; Bennett, Eric/AAG-6120-2020	Hansson, Gunnar C/0000-0002-1900-1869; Subramani, Durai/0000-0002-2256-3096; Hansson, Gunnar C./0000-0002-1900-1869; Bennett, Eric/0000-0002-4976-0647; Sroka, Aneta/0000-0002-3386-5364; Johansson, Malin E. V./0000-0002-4237-6677; Potempa, Jan/0000-0002-3600-7461; Clausen, Henrik/0000-0002-0915-5055; Mandel, Ulla/0000-0001-7012-9836; van der Post, Sjoerd/0000-0002-7965-5311	National Institutes of Health [DE 09761]; Swedish Research Council [746121027]; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation [2011.0025]; IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUAALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; Mucosal Immunology Studies Team (MIST) consortium [U01AI095473]; Swedish Foundation for Strategic Research; Mucus-Bacteria-Colitis Center of the Innate Immunity Program; Foundation for Polish Science TEAM Project [DPS/424-329/10]; National Science Center [2012/04/A/NZ1/00051]; European Union [POIG.02.01.00-12-064/08]; centre of excellence grant from the University of Copenhagen; Danish National Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUAALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; Mucosal Immunology Studies Team (MIST) consortium; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Mucus-Bacteria-Colitis Center of the Innate Immunity Program; Foundation for Polish Science TEAM Project; National Science Center(National Science Centre, Poland); European Union(European Commission); centre of excellence grant from the University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 09761. This work was also supported by Swedish Research Council Grant 746121027; a grant from the Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation Grant 2011.0025; grants from the IngaBritt and Arne Lundberg Foundation, Sahlgren's University Hospital (LUAALF), Wilhelm and Martina Lundgren's Foundation, Torsten och Ragnar Soderbergs Stiftelser, the Sahlgrenska Academy; Mucosal Immunology Studies Team (MIST) consortium Grant U01AI095473; the Swedish Foundation for Strategic Research, the Mucus-Bacteria-Colitis Center of the Innate Immunity Program; Foundation for Polish Science TEAM Project DPS/424-329/10; National Science Center Grant 2012/04/A/NZ1/00051; European Union Grant POIG.02.01.00-12-064/08; and a centre of excellence grant from the University of Copenhagen and the Danish National Research Foundation.	Abe N, 1998, J BIOCHEM, V123, P305; Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Ambort D, 2011, BIOCHEM J, V436, P61, DOI 10.1042/BJ20102066; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Asker N, 1998, J BIOL CHEM, V273, P18857, DOI 10.1074/jbc.273.30.18857; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baudet M, 2010, MOL CELL PROTEOMICS, V9, P415, DOI 10.1074/mcp.M900359-MCP200; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; CARLSTEDT I, 1993, J BIOL CHEM, V268, P18771; Curtis MA, 1999, J PERIODONTAL RES, V34, P464, DOI 10.1111/j.1600-0765.1999.tb02282.x; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Huang ZH, 1999, ANAL BIOCHEM, V268, P305, DOI 10.1006/abio.1998.3085; Ichikawa S, 2010, AM J MED GENET A, V152A, P896, DOI 10.1002/ajmg.a.33337; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kato K, 2001, GLYCOBIOLOGY, V11, P821, DOI 10.1093/glycob/11.10.821; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103; Lidell ME, 2003, BIOCHEM J, V372, P335, DOI 10.1042/BJ20030003; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; Lu AP, 2009, J PROTEOME RES, V8, P2418, DOI 10.1021/pr8010364; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; PIKE R, 1994, J BIOL CHEM, V269, P406; Potempa J, 1998, J BIOL CHEM, V273, P21648, DOI 10.1074/jbc.273.34.21648; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Subramani DB, 2010, BENEF MICROBES, V1, P343, DOI 10.3920/BM2010.0039; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; WHITEHEAD RH, 1987, IN VITRO CELL DEV B, V23, P436; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yoshino T, 2007, FEMS MICROBIOL LETT, V270, P75, DOI 10.1111/j.1574-6968.2007.00651.x	41	61	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14636	14646		10.1074/jbc.M113.459479	http://dx.doi.org/10.1074/jbc.M113.459479			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23546879	hybrid, Green Published			2022-12-25	WOS:000319253500063
J	Gabrielli, F; Salvi, R; Garulli, C; Kalogris, C; Arima, S; Tardella, L; Monaci, P; Pupa, SM; Tagliabue, E; Montani, M; Quaglino, E; Stramucci, L; Curcio, C; Marchini, C; Amici, A				Gabrielli, Federico; Salvi, Roberto; Garulli, Chiara; Kalogris, Cristina; Arima, Serena; Tardella, Luca; Monaci, Paolo; Pupa, Serenella M.; Tagliabue, Elda; Montani, Maura; Quaglino, Elena; Stramucci, Lorenzo; Curcio, Claudia; Marchini, Cristina; Amici, Augusto			Identification of Relevant Conformational Epitopes on the HER2 Oncoprotein by Using Large Fragment Phage Display (LFPD)	PLOS ONE			English	Article							DNA VACCINATION; BREAST-CANCER; PROTECTIVE IMMUNITY; MAMMARY CARCINOMAS; WILD-TYPE; T-CELL; ANTIBODY; ELECTROPORATION; REGION; TUMORS	We developed a new phage-display based approach, the Large Fragment Phage Display (LFPD), that can be used for mapping conformational epitopes on target molecules of immunological interest. LFPD uses a simplified and more effective phage-display approach in which only a limited set of larger fragments (about 100 aa in length) are expressed on the phage surface. Using the human HER2 oncoprotein as a target, we identified novel B-cell conformational epitopes. The same homologous epitopes were also detected in rat HER2 and all corresponded to the epitopes predicted by computational analysis (PEPITO software), showing that LFPD gives reproducible and accurate results. Interestingly, these newly identified HER2 epitopes seem to be crucial for an effective immune response against HER2-overexpressing breast cancers and might help discriminating between metastatic breast cancer and early breast cancer patients. Overall, the results obtained in this study demonstrated the utility of LFPD and its potential application to the detection of conformational epitopes on many other molecules of interest, as well as, the development of new and potentially more effective B-cell conformational epitopes based vaccines.	[Gabrielli, Federico; Garulli, Chiara; Kalogris, Cristina; Monaci, Paolo; Montani, Maura; Marchini, Cristina; Amici, Augusto] Univ Camerino, Dept Biosci & Biotechnol, I-62032 Camerino, MC, Italy; [Salvi, Roberto] Univ Lille 2, Fac Med, Lille, France; [Arima, Serena] Univ Roma La Sapienza, Dept Methods & Models Econ Terr & Finance, Rome, Italy; [Tardella, Luca] Univ Roma La Sapienza, Dept Stat Sci, Rome, Italy; [Pupa, Serenella M.; Tagliabue, Elda] Fdn IRCCS, Ist Nazl Tumori, AmadeoLab, Mol Targeting Unit,Dept Expt Oncol & Mol Med, Milan, Italy; [Quaglino, Elena] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Stramucci, Lorenzo; Curcio, Claudia] Univ G DAnnunzio, Aging Res Ctr, Chieti, Italy	University of Camerino; Universite de Lille - ISITE; Universite de Lille; Sapienza University Rome; Sapienza University Rome; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Turin; G d'Annunzio University of Chieti-Pescara	Marchini, C (corresponding author), Univ Camerino, Dept Biosci & Biotechnol, I-62032 Camerino, MC, Italy.	cristina.marchini@unicam.it; augusto.amici@unicam.it	Curcio, Claudia/AAB-3638-2019; Stramucci, Lorenzo/I-2561-2018; Pupa, Serenella/K-6388-2016; Tagliabue, Elda/B-9377-2017	Stramucci, Lorenzo/0000-0001-9839-2441; Pupa, Serenella/0000-0002-4592-6830; Tagliabue, Elda/0000-0001-9877-2903; Amici, Augusto/0000-0002-4634-1500; Marchini, Cristina/0000-0001-7692-8428; TARDELLA, Luca/0000-0002-5703-3909; Garulli, Chiara/0000-0002-5292-2336; Quaglino, Elena/0000-0002-8151-9124; CURCIO, Claudia/0000-0001-5306-4399	Italian Association for Cancer Research (AIRC) [IG11889]; Italian Ministry for the Universities and Research	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for the Universities and Research	The experimental data herein were obtained through grants from the Italian Association for Cancer Research (AIRC, IG11889) and the Italian Ministry for the Universities and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici A, 2000, GENE THER, V7, P703, DOI 10.1038/sj.gt.3301151; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Curcio C, 2003, J CLIN INVEST, V111, P1161, DOI 10.1172/JCI200317426; DISIS ML, 1994, CANCER RES, V54, P16; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Jacob JB, 2010, CANCER RES, V70, P119, DOI 10.1158/0008-5472.CAN-09-2554; Jiang BH, 2005, J BIOL CHEM, V280, P4656, DOI 10.1074/jbc.M411047200; LIN TM, 1981, J CLIN MICROBIOL, V13, P646, DOI 10.1128/JCM.13.4.646-651.1981; Nagata Y, 1997, J IMMUNOL, V159, P1336; Orlandi R, 1997, BIOL CHEM, V378, P1387, DOI 10.1515/bchm.1997.378.11.1387; Peoples GE, 2005, J CLIN ONCOL, V23, P7536, DOI 10.1200/JCO.2005.03.047; Quaglino E, 2004, CANCER RES, V64, P2858, DOI 10.1158/0008-5472.CAN-03-2962; Quaglino E, 2010, CANCER RES, V70, P2604, DOI 10.1158/0008-5472.CAN-09-2548; Rolla S, 2008, HUM GENE THER, V19, P229, DOI 10.1089/hum.2006.196; Rolla S, 2006, J IMMUNOL, V177, P7626, DOI 10.4049/jimmunol.177.11.7626; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spadaro M, 2005, CLIN CANCER RES, V11, P1941, DOI 10.1158/1078-0432.CCR-04-1873; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Yip YL, 2001, J IMMUNOL, V166, P5271, DOI 10.4049/jimmunol.166.8.5271	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58358	10.1371/journal.pone.0058358	http://dx.doi.org/10.1371/journal.pone.0058358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555577	Green Published, gold, Green Submitted			2022-12-25	WOS:000317262200005
J	Braem, MGM; Voorhuis, M; Van der Schouw, YT; Peeters, PHM; Schouten, LJ; Eijkemans, MJC; Broekmans, FJ; Onland-Moretl, NC				Braem, Marieke G. M.; Voorhuis, Marlies; Van der Schouw, Yvonne T.; Peeters, Petra H. M.; Schouten, Leo J.; Eijkemans, Marinus J. C.; Broekmans, Frank J.; Onland-Moret, N. Charlotte			Interactions between Genetic Variants in AMH and AMHR2 May Modify Age at Natural Menopause	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; RISK-FACTORS; CANCER; LOCI; ASSOCIATION; DESIGN; COHORT; WOMEN	The onset of menopause has important implications on women's fertility and health. We previously identified genetic variants in genes involved in initial follicle recruitment as potential modifiers of age at natural menopause. The objective of this study was to extend our previous study, by searching for pairwise interactions between tagging single nucleotide polymorphisms (tSNPs) in the 5 genes previously selected (AMH, AMHR2, BMP15, FOXL2, GDF9). We performed a cross-sectional study among 3445 women with a natural menopause participating in the Prospect-EPIC study, a population-based prospective cohort study, initiated between 1993 and 1997. Based on the model-based multifactor dimensionality reduction (MB-MDR) test with a permutation-based maxT correction for multiple testing, we found a statistically significant interaction between rs10407022 in AMH and rs11170547 in AMHR2 (p = 0.019) associated with age at natural menopause. Rs10407022 did not have a statistically significant main effect. However, rs10407022 is an eQTL SNP that has been shown to influence mRNA expression levels in lymphoblastoid cell lines. This study provides additional insights into the genetic background of age at natural menopause and suggests a role of the AMH signaling pathway in the onset of natural menopause. However, these results remain suggestive and replication by independent studies is necessary	[Braem, Marieke G. M.; Voorhuis, Marlies; Van der Schouw, Yvonne T.; Peeters, Petra H. M.; Onland-Moret, N. Charlotte] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Voorhuis, Marlies; Broekmans, Frank J.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Schouten, Leo J.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands; [Eijkemans, Marinus J. C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Biostat & Res Support, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Maastricht University; Utrecht University; Utrecht University Medical Center	Braem, MGM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	M.G.M.Braem@umcutrecht.nl	Onland-Moret, N. Charlotte/G-9185-2011; Schouten, Leo J/AAB-2275-2019; van der Schouw, Yvonne T./F-8327-2014; Schouten, Leo J/G-3713-2012	Onland-Moret, N. Charlotte/0000-0002-2360-913X; Schouten, Leo J/0000-0003-3361-7560; van der Schouw, Yvonne T./0000-0002-4605-435X; 	Dutch Cancer Society [UU2008-4267]; Dutch Organisation for Scientific Research (NOW) [92003575]	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Organisation for Scientific Research (NOW)	MGMB and NCO-M are financially supported by the Dutch Cancer Society (UU2008-4267). MV is financially supported by a grant from the Dutch Organisation for Scientific Research (NOW, project 92003575). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, World Health Organ Tech Rep Ser, V866, P1; Boker LK, 2001, EUR J EPIDEMIOL, V17, P1047, DOI 10.1023/A:1020009325797; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; de Bruin JP, 2001, HUM REPROD, V16, P2014, DOI 10.1093/humrep/16.9.2014; Dossus L, 2010, INT J CANCER, V127, P442, DOI 10.1002/ijc.25050; Freeman EW, 2012, J CLIN ENDOCR METAB, V97, P1673, DOI 10.1210/jc.2011-3032; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; John JMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029594; Kevenaar ME, 2007, HUM REPROD, V22, P2382, DOI 10.1093/humrep/dem176; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Monninkhof EM, 1999, BREAST CANCER RES TR, V55, P285, DOI 10.1023/A:1006277207963; Moore JH, 2010, ADV GENET, V72, P101, DOI [10.1016/B978-0-12-380862-2.00005-9, 10.1016/S0065-2660(10)72005-8]; Ossewaarde ME, 2005, EPIDEMIOLOGY, V16, P556, DOI 10.1097/01.ede.0000165392.35273.d4; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Salehi F, 2008, J TOXICOL ENV HEAL B, V11, P301, DOI 10.1080/10937400701876095; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Stolk L, 2009, NAT GENET, V41, P645, DOI 10.1038/ng.387; Treloar SA, 1998, LANCET, V352, P1084, DOI 10.1016/S0140-6736(05)79753-1; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Visser JA, 2012, NAT REV ENDOCRINOL, V8, P331, DOI 10.1038/nrendo.2011.224; Voorhuis M, 2011, J CLIN ENDOCR METAB, V96, pE473, DOI 10.1210/jc.2010-1799; Williams RBH, 2007, GENOME RES, V17, P1707, DOI 10.1101/gr.6981507	24	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59819	10.1371/journal.pone.0059819	http://dx.doi.org/10.1371/journal.pone.0059819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544102	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700062
J	Nakamura, S; Takizawa, H; Shimazawa, M; Hashimoto, Y; Sugitani, S; Tsuruma, K; Hara, H				Nakamura, Shinsuke; Takizawa, Haruka; Shimazawa, Masamitsu; Hashimoto, Yuhei; Sugitani, Sou; Tsuruma, Kazuhiro; Hara, Hideaki			Mild Endoplasmic Reticulum Stress Promotes Retinal Neovascularization via Induction of BiP/GRP78	PLOS ONE			English	Article							ANCHORED T-CADHERIN; ANTI-VEGF THERAPY; MOLECULAR CHAPERONE; ENDOTHELIAL-CELLS; PROTEIN GRP78; GROWTH-FACTOR; ACTIVATION; RECEPTOR; SURFACE; MECHANISMS	Endoplasmic reticulum (ER) stress occurs as a result of accumulation of unfolded or misfolded proteins in the ER and is involved in the mechanisms of various diseases, such as cancer and neurodegeneration. The goal of the present study was to clarify the relationship between ER stress and pathological neovascularization in the retina. Proliferation and migration of human retinal microvascular endothelial cells (HRMEC) were assessed in the presence of ER stress inducers, such as tunicamycin and thapsigargin. The expression of ER chaperone immunoglobulin heavy-chain binding protein (BiP), known as Grp78, was evaluated by real time RT-PCR, immunostaining, and Western blotting. Tunicamycin or thapsigargin was injected into the intravitreal body of oxygen-induced retinopathy (OIR) model mice at postnatal day 14 (P14) and retinal neovascularization was quantified at P17. The expression and localization of BiP in the retina was also evaluated in the OIR model. Exposure to tunicamycin and thapsigargin increased the proliferation and migration of HRMEC. Tunicamycin enhanced the expression of BiP in HRMEC at both the mRNA level and at the protein level on the cell surface, and increased the formation of a BiP/T-cadherin immunocomplex. In OIR model mice, retinal neovascularization was accelerated by treatments with ER stress inducers. BiP was particularly observed in the pathological vasculature and retinal microvascular endothelial cells, and the increase of BiP expression was correlated with retinal neovascularization. In conclusion, ER stress may contribute to the formation of abnormal vasculature in the retina via BiP complexation with T-cadherin, which then promotes endothelial cell proliferation and migration.	[Nakamura, Shinsuke; Takizawa, Haruka; Shimazawa, Masamitsu; Hashimoto, Yuhei; Sugitani, Sou; Tsuruma, Kazuhiro; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan	Gifu Pharmaceutical University	Hara, H (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp			Gifu pharmaceutical University	Gifu pharmaceutical University	Funding was provided by Gifu pharmaceutical University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2011, FREE RADICAL RES, V45, P1083, DOI 10.3109/10715762.2011.595408; Banerjee A, 2011, J BIOL CHEM, V286, P29127, DOI 10.1074/jbc.M110.169771; BARINAGA M, 1995, SCIENCE, V267, P452, DOI 10.1126/science.7824943; Bhattacharjee G, 2005, ARTERIOSCL THROM VAS, V25, P1737, DOI 10.1161/01.ATV.0000173419.31242.56; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chikaraishi Y, 2007, EXP EYE RES, V84, P529, DOI 10.1016/j.exer.2006.11.007; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; Arevalo JF, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/584238; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Horster R, 2011, GRAEF ARCH CLIN EXP, V249, P645, DOI 10.1007/s00417-010-1588-2; Inokuchi Y, 2009, INVEST OPHTH VIS SCI, V50, P334, DOI 10.1167/iovs.08-2123; Ivanov D, 2004, EXP CELL RES, V293, P207, DOI 10.1016/j.yexcr.2003.09.030; Jardeleza MSR, 2009, SEMIN OPHTHALMOL, V24, P87, DOI 10.1080/08820530902800330; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Joshi MB, 2007, FASEB J, V21, P3083, DOI 10.1096/fj.06-7723com; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Kuo TH, 1998, ONCOGENE, V17, P1903, DOI 10.1038/sj.onc.1202110; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li B, 2008, MOL VIS, V14, P1122; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Muether PS, 2011, GRAEF ARCH CLIN EXP, V249, P633, DOI 10.1007/s00417-010-1520-9; Nakamura S, 2011, CURR NEUROVASC RES, V8, P25, DOI 10.2174/156720211794520224; Nakamura S, 2011, ARTERIOSCL THROM VAS, V31, P1041, DOI 10.1161/ATVBAHA.111.223594; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Philippova M, 2005, FASEB J, V19, P588, DOI 10.1096/fj.04-2430fje; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Raiter A, 2010, J VASC RES, V47, P399, DOI 10.1159/000281580; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Romano MR, 2009, EUR J OPHTHALMOL, V19, P618, DOI 10.1177/112067210901900416; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Sogawa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011945; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Tripathi RC, 1998, OPHTHALMOLOGY, V105, P232, DOI 10.1016/S0161-6420(98)92782-8; Tsuruma K, 2010, J NEUROCHEM, V113, P1545, DOI 10.1111/j.1471-4159.2010.06724.x; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Xu D, 2009, AM J PHYSIOL-LUNG C, V297, pL44, DOI 10.1152/ajplung.90626.2008	45	35	40	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60517	10.1371/journal.pone.0060517	http://dx.doi.org/10.1371/journal.pone.0060517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544152	Green Submitted, gold, Green Published			2022-12-25	WOS:000317480700111
J	Roth, MS; Fan, TY; Deheyn, DD				Roth, Melissa S.; Fan, Tung-Yung; Deheyn, Dimitri D.			Life History Changes in Coral Fluorescence and the Effects of Light Intensity on Larval Physiology and Settlement in Seriatopora hystrix	PLOS ONE			English	Article							REEF-BUILDING CORALS; GFP-LIKE PROTEINS; POCILLOPORA-DAMICORNIS; SCLERACTINIAN CORALS; CENSUS TECHNIQUES; GENE-EXPRESSION; SOUTHERN TAIWAN; PLANULA LARVAE; UV-RADIATION; RED-SEA	Fluorescence is common in both coral adult and larval stages, and is produced by fluorescent proteins that absorb higher energy light and emit lower energy light. This study investigated the changes of coral fluorescence in different life histo stages and the effects of parental light environment on larval fluorescence, larval endosymbiotic dinoflagellate abundance, larval size and settlement in the brooding coral Seriatopora hystrix. Data showed that coral fluorescence changed during development from green in larvae to cyan in adult colonies. In larvae, two green fluorescent proteins (GFPs) co-occur where the peak emission of one GFP overlaps with the peak excitation of the second GFP allowing the potential for energy transfer. Coral larvae showed great variation in GFP fluorescence, dinoflagellate abundance, and size. There was no obvious relationship between green fluorescence intensity and dirioflagellate abundance, green fluorescence intensity and larval size, or dinoflagellate abundance and larval size. Larvae of parents from high and low light treatments showed similar green fluorescence intensity, yet small but significant differences in size, dinoflagellate abundance, and settlement. The large variation in larval physiology combined with subtle effects of parental environment on larval characteristics seem to indicate that even though adult corals produce larvae with a wide range of physiological capacities, these larvae can still show small preferences for settling in similar habitats as their parents. These data highlight the importance of environmental conditions at the onset of life history and parent colony effects on coral larvae.	[Roth, Melissa S.; Deheyn, Dimitri D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Fan, Tung-Yung] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Fan, Tung-Yung] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolut, Pingtung, Taiwan	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Museum of Marine Biology & Aquarium; National Dong Hwa University	Roth, MS (corresponding author), Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA USA.	Melissa.S.Roth@gmail.com		Roth, Melissa/0000-0001-7389-5982	National Science Foundation East Asia and Pacific Summer Institutes; National Science Council in Taiwan; Air Force Office of Scientific Research Biomimetics, Biomaterials, and Biointerfacial Sciences program [FA9550-07-1-0027]	National Science Foundation East Asia and Pacific Summer Institutes; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Air Force Office of Scientific Research Biomimetics, Biomaterials, and Biointerfacial Sciences program(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research was supported by a National Science Foundation East Asia and Pacific Summer Institutes (MSR); the National Science Council in Taiwan (MSR); the Air Force Office of Scientific Research Biomimetics, Biomaterials, and Biointerfacial Sciences program (grant # FA9550-07-1-0027; DDD). Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the Air Force Office of Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Apprill AM, 2007, CORAL REEFS, V26, P387, DOI 10.1007/s00338-007-0209-y; Baird AH, 2006, CORAL REEFS, V25, P73, DOI 10.1007/s00338-005-0072-7; Baker A, 1995, ULTRAVIOLET RAD CORA, P149; Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; Bomati EK, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-77; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; CATALASTUCKI R, 1959, NATURE, V183, P949, DOI 10.1038/183949a0; D'Angelo C, 2008, MAR ECOL PROG SER, V364, P97, DOI 10.3354/meps07588; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Dove SG, 1995, BIOL BULL, V189, P288, DOI 10.2307/1542146; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Dove SG, 2008, PLANT CELL ENVIRON, V31, P1523, DOI 10.1111/j.1365-3040.2008.01852.x; Fan TY, 2006, MAR ECOL PROG SER, V321, P133, DOI 10.3354/meps321133; Fan TY, 2002, ZOOL STUD, V41, P288; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Gaither MR, 2010, J EXP MAR BIOL ECOL, V386, P45, DOI 10.1016/j.jembe.2010.02.003; Gilmore AM, 2003, PHOTOCHEM PHOTOBIOL, V77, P515, DOI 10.1562/0031-8655(2003)077<0515:STROTE>2.0.CO;2; Gruber DF, 2008, BIOL BULL-US, V215, P143, DOI 10.2307/25470695; Harii S, 2002, MAR BIOL, V141, P39, DOI 10.1007/s00227-002-0812-y; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hirose M, 2000, BIOL BULL, V199, P68, DOI 10.2307/1542708; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; Kawaguti S., 1969, Micronesica, V5, P313; Kawaguti S, 1944, CONTR PALAO TROP BIO, V2, P616; Kenkel CD, 2011, P ROY SOC B-BIOL SCI, V278, P2691, DOI 10.1098/rspb.2010.2344; Kuffner IB, 2001, MAR ECOL PROG SER, V217, P251, DOI 10.3354/meps217251; Leutenegger A, 2007, FEBS J, V274, P2496, DOI 10.1111/j.1742-4658.2007.05785.x; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Matz MV, 2006, PHOTOCHEM PHOTOBIOL, V82, P345, DOI 10.1562/2005-08-18-RA-653; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P402, DOI 10.4319/lo.2003.48.1_part_2.0402; Meng PJ, 2008, ENVIRON POLLUT, V156, P67, DOI 10.1016/j.envpol.2007.12.039; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Mundy CN, 1998, J EXP MAR BIOL ECOL, V223, P235, DOI 10.1016/S0022-0981(97)00167-6; Padilla-Gamino JL, 2013, CORAL REEFS, V32, P137, DOI 10.1007/s00338-012-0957-1; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Palmer CV, 2009, BIOL BULL-US, V216, P68, DOI 10.1086/BBLv216n1p68; Permata WD, 2000, MAR ECOL PROG SER, V200, P191, DOI 10.3354/meps200191; Piniak GA, 2005, CORAL REEFS, V24, P496, DOI 10.1007/s00338-005-0495-1; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P133, DOI 10.3354/meps001133; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Roth MS, 2009, MAR ECOL PROG SER, V376, P133, DOI 10.3354/meps07787; Roth M. S., 2007, BIOL CORALS DEV FUND, P95; Roth MS, 2010, J EXP BIOL, V213, P3644, DOI 10.1242/jeb.040881; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Sherman CDH, 2008, HEREDITY, V100, P296, DOI 10.1038/sj.hdy.6801076; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; TAKABAYASHI M, 1995, MAR BIOL, V123, P705, DOI 10.1007/BF00349113; TITLYANOV EA, 1991, SYMBIOSIS, V10, P249; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vermeij MJA, 2002, PHOTOSYNTHETICA, V40, P423, DOI 10.1023/A:1022635327172; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron JEN, 1976, MONOGRAPH SER AUST I, V1, P59; Wellington GM, 2003, MAR BIOL, V143, P1185, DOI 10.1007/s00227-003-1150-4; Wilkinson C, 2008, STATUS CORAL REEFS W; Zar JH, 1999, BIOSTATISTICAL ANAL	61	29	29	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59476	10.1371/journal.pone.0059476	http://dx.doi.org/10.1371/journal.pone.0059476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544072	gold, Green Submitted, Green Published			2022-12-25	WOS:000317480700032
J	Dunn, MR; Stevens, DW; Forman, JS; Connell, A				Dunn, Matthew R.; Stevens, Darren W.; Forman, Jeffrey S.; Connell, Amelia			Trophic Interactions and Distribution of Some Squaliforme Sharks, Including New Diet Descriptions for Deania calcea and Squalus acanthias	PLOS ONE			English	Article							DEMERSAL FISH COMMUNITY; DEEP-SEA SHARKS; SPINY DOGFISH; NEW-ZEALAND; CHATHAM RISE; CONTINENTAL-SLOPE; FEEDING ECOLOGY; PREDATION MORTALITY; ETMOPTERUS-BAXTERI; SOUTH-ISLAND	Squaliforme sharks are a common but relatively vulnerable bycatch in many deep water fisheries. Eleven species of squaliforme shark are commonly caught at depths of 200-1200 m on Chatham Rise, New Zealand, and their diversity suggests they might occupy different niches. The diets of 133 Deania calcea and 295 Squalus acanthias were determined from examination of stomach contents. The diet of D. calcea was characterised by mesopelagic fishes, and S. acanthias by benthic to pelagic fishes, but was more adaptive and included likely scavenging. Multivariate analyses found the most important predictors of diet variability in S. acanthias were year, bottom temperature, longitude, and fish weight. The diet of the nine other commonly caught squaliforme sharks was reviewed, and the spatial and depth distribution of all species on Chatham Rise described from research bottom trawl survey catches. The eleven species had a variety of different diets, and depth and location preferences, consistent with niche separation to reduce interspecific competition. Four trophic groups were identified, characterised by: mesopelagic fishes and invertebrates (Centroselachus crepidater, D. calcea, and Etmopterus lucifer); mesopelagic and benthopelagic fishes and invertebrates (Centroscymnus owstoni, Etmopterus baxteri); demersal and benthic fishes (Centrophorus squamosus, Dalatias licha, Proscymnodon plunketi); and a generalist diet of fishes and invertebrates (S. acanthias). The trophic levels of the species in each of the four groups were estimated as 4.18-4.24, 4.20-4.23, 4.24-4.48, and 3.84 respectively. The diet of Oxynotus bruniensis and Squalus griffini are unknown. The different niches occupied by different species are likely to influence their vulnerability to bottom trawl fisheries. Some species may benefit from fisheries through an increased availability of scavenged prey.	[Dunn, Matthew R.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Stevens, Darren W.; Forman, Jeffrey S.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand	Victoria University Wellington; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Dunn, MR (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	matthew.dunn@vuw.ac.nz			New Zealand Ministry for Primary Industries [ZBD2004-02]; New Zealand Foundation for Research, Science and Technology [C01X0501]; NIWA [FIPR1201]	New Zealand Ministry for Primary Industries; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); NIWA	This work was funded by the New Zealand Ministry for Primary Industries project ZBD2004-02, the New Zealand Foundation for Research, Science and Technology project C01X0501 (Coasts & Oceans OBI, IO2), and NIWA project FIPR1201. The New Zealand Ministry for Primary Industries had a role in determining the availability of the samples and scope of the study, and allowing the research to be published, but had no role in the design and completion of the data collection and analysis, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MK, 2002, ENVIRON BIOL FISH, V63, P193; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Avsar D, 2001, ESTUAR COAST SHELF S, V52, P269, DOI 10.1006/ecss.2000.0749; BABA O, 1987, B JPN SOC SCI FISH, V53, P417; Baird SJ, 2012, 88 NZ AQ ENV BIOD MI; Belleggia M, 2012, HYDROBIOLOGIA, V684, P57, DOI 10.1007/s10750-011-0967-y; BLABER SJM, 1987, MAR BIOL, V95, P345, DOI 10.1007/BF00409564; Blackwell RG, 2010, 57 NZ AQ ENV BIOD MI; Bowman RE, 2000, 155 NOAA NMFSNE; Bulman CM, 2002, MAR FRESHWATER RES, V53, P59, DOI 10.1071/MF01057; Bundy A, 2011, J FISH BIOL, V78, P514, DOI 10.1111/j.1095-8649.2010.02868.x; Capape C, 2008, VIE MILIEU, V58, P57; CARRASSON M, 1992, MAR ECOL PROG SER, V82, P21, DOI 10.3354/meps082021; Clark MR, 2000, FISH RES, V45, P217, DOI 10.1016/S0165-7836(99)00121-6; CLARK MR, 1989, J FISH BIOL, V35, P465, DOI 10.1111/j.1095-8649.1989.tb02999.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Compagno LJV., 1984, FAO FISH SYNOP, P20; Connell AM, 2010, NEW ZEAL J MAR FRESH, V44, P289, DOI 10.1080/00288330.2010.515232; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; Demirhan SA, 2007, FISH RES, V85, P210, DOI 10.1016/j.fishres.2007.02.009; Doonan IJ, 2011, 201120 NZ FISH ASS M; Dunn MR, 2009, NEW ZEAL J MAR FRESH, V43, P1103, DOI 10.1080/00288330.2009.9626533; Dunn MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013647; Dunn MR, 2010, DEEP-SEA RES PT I, V57, P923, DOI 10.1016/j.dsr.2010.02.006; Dunn MR, 2010, MAR ECOL PROG SER, V407, P209, DOI 10.3354/meps08580; EBERT DA, 1992, S AFR J MARINE SCI, V12, P601; Ellis JR, 1996, J MAR BIOL ASSOC UK, V76, P89, DOI 10.1017/S0025315400029039; Forman JS, 2012, J FISH BIOL, V80, P1546, DOI 10.1111/j.1095-8649.2012.03255.x; Francis MP, 1998, MAR FRESHWATER RES, V49, P579, DOI 10.1071/MF97076; FUJITA T, 1995, MAR BIOL, V123, P219; GARRICK J. A. F., 1959, TRANS ROY SOC NEW ZEALAND, V87, P271; Garrison LP, 2000, MAR ECOL PROG SER, V202, P231, DOI 10.3354/meps202231; Graham KJ, 2001, MAR FRESHWATER RES, V52, P549, DOI 10.1071/MF99174; Hallett CS, 2011, ICES J MAR SCI, V68, P157, DOI 10.1093/icesjms/fsq143; HANCHET S, 1991, J FISH BIOL, V39, P313, DOI 10.1111/j.1095-8649.1991.tb04365.x; Jones MRL, 2008, NEW ZEAL J MAR FRESH, V42, P333, DOI 10.1080/00288330809509961; Karachle PK, 2010, RAPPORT COMMISSION I, V39, P553; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Laptikhovsky VV, 2001, J MAR BIOL ASSOC UK, V81, P1015, DOI 10.1017/S0025315401004994; Last PR, 2009, SHARKS RAYS AUSTR; LIVINGSTON ME, 1990, NEW ZEAL J MAR FRESH, V24, P503, DOI 10.1080/00288330.1990.9516442; Macpherson E., 1979, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V25-26, P49; MACPHERSON E, 1987, S AFR J MARINE SCI, V5, P585, DOI 10.2989/025776187784522432; MAUCHLINE J, 1983, MAR BIOL, V75, P269, DOI 10.1007/BF00406012; McClatchie S, 2003, DEEP-SEA RES PT I, V50, P1263, DOI 10.1016/S0967-0637(03)00128-6; McMillan PJ, 2011, 68 NZ AQ ENV BIOD MI; Ministry for Primary Industries, 2012, REP FISH ASS PLEN MA; Ministry for Primary Industries, 2008, NAT PLAN ACT SHARKS; Moustahfid H, 2009, ICES J MAR SCI, V66, P445, DOI 10.1093/icesjms/fsn217; Murphy RJ, 2001, NEW ZEAL J MAR FRESH, V35, P343, DOI 10.1080/00288330.2001.9517005; O'Driscoll RL, 2011, 201147 NZ FISH ASS M; Pasquaud S, 2010, ESTUAR COAST SHELF S, V86, P237, DOI 10.1016/j.ecss.2009.11.019; Pethybridge H, 2011, J EXP MAR BIOL ECOL, V409, P290, DOI 10.1016/j.jembe.2011.09.009; Pinkas L, 1971, FISH B CALIF DEP FIS; Preciado I, 2009, J FISH BIOL, V75, P1331, DOI 10.1111/j.1095-8649.2009.02367.x; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Ryer CH, 2004, ICES J MAR SCI, V61, P1157, DOI 10.1016/j.icesjms.2004.06.004; Stergiou KI, 2001, REV FISH BIOL FISHER, V11, P217, DOI 10.1023/A:1020556722822; Stevens DW, 2011, MAR BIOL, V158, P59, DOI 10.1007/s00227-010-1542-1; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; TANASICHUK RW, 1991, CAN J FISH AQUAT SCI, V48, P2118, DOI 10.1139/f91-251; Tirasin EM, 1999, MAR ECOL PROG SER, V182, P243; Tyrrell MC, 2008, ICES J MAR SCI, V65, P1689, DOI 10.1093/icesjms/fsn185; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wetherbee BM, 2000, FISH B-NOAA, V98, P189; White WT, 2012, J FISH BIOL, V80, P897, DOI 10.1111/j.1095-8649.2012.03268.x; YANO K, 1984, B JPN SOC SCI FISH, V50, P249	67	15	15	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59938	10.1371/journal.pone.0059938	http://dx.doi.org/10.1371/journal.pone.0059938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536896	Green Submitted, Green Published, gold			2022-12-25	WOS:000317397200044
J	Hamilton, EJ; Martin, N; Makepeace, A; Sillars, BA; Davis, WA; Davis, TME				Hamilton, Emma J.; Martin, Natalie; Makepeace, Ashley; Sillars, Brett A.; Davis, Wendy A.; Davis, Timothy M. E.			Incidence and Predictors of Hospitalization for Bacterial Infection in Community-Based Patients with Type 2 Diabetes: The Fremantle Diabetes Study0	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ACQUIRED PNEUMONIA; GLYCEMIC CONTROL; POSTMENOPAUSAL WOMEN; COMMON INFECTIONS; WESTERN-AUSTRALIA; PRIMARY-CARE; RISK; POPULATION; BACTEREMIA	Background: The few studies that have examined the relationship between diabetes and bacterial infections have utilized administrative databases and/or have had limited/incomplete data including recognized infection risk factors. The aim of this study was to determine the incidence and associates of bacterial infection severe enough to require hospitalization in well-characterized community-based patients with type 2 diabetes. Methods and Findings: We studied a cohort of 1,294 patients (mean +/- SD age 64.1 +/- 11.3 years) from the longitudinal observational Fremantle Diabetes Study Phase I (FDS1) and 5,156 age-, gender-and zip-code-matched non-diabetic controls. The main outcome measure was incident hospitalization for bacterial infection as principal diagnosis between 1993 and 2010. We also examined differences in statin use in 52 FDS1 pairs hospitalized with pneumonia (cases) or a contemporaneous non-infection-related cause (controls). During 12.0 +/- 5.4 years of follow-up, 251 (19.4%) patients were hospitalized on 368 occasions for infection (23.7/1,000 patient-years). This was more than double the rate in matched controls (incident rate ratio (IRR) (95% CI), 2.13 (1.88-2.42), P < 0.001). IRRs for pneumonia, cellulitis, and septicemia/bacteremia were 1.86 (1.55-2.21), 2.45 (1.92-3.12), and 2.08 (1.41-3.04), respectively (P < 0.001). Among the diabetic patients, older age, male sex, prior recent infection-related hospitalization, obesity, albuminuria, retinopathy and Aboriginal ethnicity were baseline variables independently associated with risk of first hospitalization with any infection (P <= 0.005). After adjustment for these variables, baseline statin treatment was not significant (hazard ratio (95% CI), 0.70 (0.39-1.25), P = 0.22). Statin use at hospitalization for pneumonia among the case-control pairs was similar (23.1% vs. 13.5%, P = 0.27). Conclusions: The risk of severe infection is increased among type 2 diabetic patients and is not reduced by statin therapy. There are a number of other easily-accessible sociodemographic and clinical variables that could be used to optimize infection-related education, prevention and management in type 2 diabetes.	[Hamilton, Emma J.; Makepeace, Ashley] Fremantle Hosp, Dept Endocrinol & Diabet, Fremantle, WA, Australia; [Martin, Natalie] Fremantle Hosp, Dept Geriatr Med, Fremantle, WA, Australia; [Makepeace, Ashley; Sillars, Brett A.; Davis, Wendy A.; Davis, Timothy M. E.] Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, Fremantle, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Davis, TME (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, Fremantle, WA, Australia.	tim.davis@uwa.edu.au	Davis, Timothy ME/M-5144-2014	Davis, Wendy/0000-0002-5709-8235; Hamilton, Emma/0000-0003-1617-6353; Davis, Timothy/0000-0003-0749-7411	Raine Foundation, University of Western Australia; National Health and Medical Research Council of Australia	Raine Foundation, University of Western Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The Fremantle Diabetes Study Phase I was supported by the Raine Foundation, University of Western Australia. TMED is supported by a National Health and Medical Research Council of Australia Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; Barcia AM, 2005, CLIN INFECT DIS, V41, pS498, DOI 10.1086/432005; Boyko EJ, 2002, DIABETES CARE, V25, P1778, DOI 10.2337/diacare.25.10.1778; Chua D, 2007, ANN PHARMACOTHER, V41, P647, DOI 10.1345/aph.1H550; Davis TM, 2013, INT J EPIDEMIOL; Davis TME, 2000, DIABETIC MED, V17, P667, DOI 10.1046/j.1464-5491.2000.00359.x; Davis TME, 2005, J DIABETES COMPLICAT, V19, P259, DOI 10.1016/j.jdiacomp.2005.03.003; Davis TME, 2004, DIABETOLOGIA, V47, P395, DOI 10.1007/s00125-004-1344-4; Davis WA, 2004, DIABETES CARE, V27, P752, DOI 10.2337/diacare.27.3.752; Falagas ME, 2008, J ANTIMICROB CHEMOTH, V61, P774, DOI 10.1093/jac/dkn019; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Game F, 2010, NAT REV ENDOCRINOL, V6, P43, DOI 10.1038/nrendo.2009.243; Gorter KJ, 2010, FAM PRACT, V27, P379, DOI 10.1093/fampra/cmq026; Guvener M, 2002, ENDOCR J, V49, P531, DOI 10.1507/endocrj.49.531; Hirji I, 2012, J DIABETES COMPLICAT; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Hounsom L, 2011, POSTGRAD MED J, V87, P757, DOI 10.1136/pgmj.2010.116616; Jackson SL, 2005, DIABETES CARE, V28, P1730, DOI 10.2337/diacare.28.7.1730; Jacups SP, 2011, VACCINE, V29, P5386, DOI 10.1016/j.vaccine.2011.05.082; Jamsen E, 2012, J BONE JOINT SURG AM, V94, pe1011; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Karunajeewa H, 2005, DIABETOLOGIA, V48, P1288, DOI 10.1007/s00125-005-1794-3; Kish TD, 2010, AM J GERIATR PHARMAC, V8, P485, DOI 10.1016/S1543-5946(10)80002-9; Kornum JB, 2008, DIABETES CARE, V31, P1541, DOI 10.2337/dc08-0138; Laupland KB, 2011, INFECTION, V39, P405, DOI 10.1007/s15010-011-0149-x; Laupland KB, 2004, CRIT CARE MED, V32, P992, DOI 10.1097/01.CCM.0000119424.31648.1E; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Lepper PM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3397; Magliano DJ, 2012, EUR J ENDOCRINOL, V167, P589, DOI 10.1530/EJE-12-0053; Mancuso P, 2012, PULM PHARM THER; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mongardon N, 2012, CRIT CARE, V16, DOI 10.1186/cc11471; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Myint PK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001030; PATEL MS, 1991, MED J AUSTRALIA, V155, P218, DOI 10.5694/j.1326-5377.1991.tb142224.x; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Stapleton A, 2002, AM J MED, V113, p80S; Thomsen RW, 2011, J INFECTION, V63, P8, DOI 10.1016/j.jinf.2011.05.013; Thomsen RW, 2004, DIABETES CARE, V27, P1143, DOI 10.2337/diacare.27.5.1143; Thomsen RW, 2012, OPEN INFECT DIS J S1, V6, P27, DOI DOI 10.2174/1874279301206010027; THORNTON GF, 1971, MED CLIN N AM, V55, P931, DOI 10.1016/S0025-7125(16)32487-7; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; van den Hoek HL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7281; WALTERS DP, 1992, DIABETIC MED, V9, P354, DOI 10.1111/j.1464-5491.1992.tb01796.x; WHEAT LJ, 1980, DIABETES CARE, V3, P187, DOI 10.2337/diacare.3.1.187; Williams P, 1997, INT J EPIDEMIOL, V26, P797, DOI 10.1093/ije/26.4.797	51	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60502	10.1371/journal.pone.0060502	http://dx.doi.org/10.1371/journal.pone.0060502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536910	Green Published, gold, Green Submitted			2022-12-25	WOS:000317397200058
J	Sabater, L; Hoftberger, R; Boronat, A; Saiz, A; Dalmau, J; Graus, F				Sabater, Lidia; Hoeftberger, Romana; Boronat, Anna; Saiz, Albert; Dalmau, Josep; Graus, Francesc			Antibody Repertoire in Paraneoplastic Cerebellar Degeneration and Small Cell Lung Cancer	PLOS ONE			English	Article							EATON-MYASTHENIC-SYNDROME; CALCIUM-CHANNEL ANTIBODIES; LIMBIC ENCEPHALITIS; DISORDERS; ANTIGENS; SUBUNITS; TUMOR	The goal of this study is to determine whether patients with paraneoplastic cerebellar degeneration (PCD) and small-cell lung cancer (SCLC) have a specific repertoire of antibodies, if SOX1 antibodies (SOX1-ab) can predict the presence of SCLC, and if antibodies to cell surface antigens occur in this syndrome. Antibody analysis was done using immunohistochemistry on rat brain, immunoblot with recombinant antigens, screening of cDNA expression libraries, and immunolabeling of live neurons in 39 patients with PCD and SCLC. VGCC-ab were measured by RIA, and SOX1-ab, Hu-ab, and ZIC4-ab by immunoblot. Lambert-Eaton myastenic syndrome (LEMS) was present in 10 of 23 patients with electrophysiological studies. At least one antibody was detected in 72% of patients. The individual frequencies were: 49% SOX1-ab, 44% VGCC-ab, 31% Hu-ab, and 13% ZIC4-ab. SOX1-ab occurred in 76% of patients with VGCC-ab and 27% of those without VGCC-ab (p = 0.0036). SOX1-ab were not found in 39 patients with sporadic late-onset cerebellar ataxia, 23 with cerebellar ataxia and glutamic acid decarboxylase antibodies, and 73 with PCD and cancer types other than SCLC (31 without onconeural antibodies, 25 with Yo-ab, 17 with Tr-ab). Five patients (13%) had antibodies against unknown neuronal cell surface antigens but none of them improved with immunotherapy. One serum immunoreacted against the axon initial segment of neurons and another serum against ELKS1, a protein highly expressed in the cerebellum that interacts with the beta4-subunit of the VGCC. In conclusion, 72% of patients with PCD and SCLC had one or more antibodies that indicate the presence of this tumor. In these patients, VGCC-ab and SOX1-ab occur tightly associated. SOX1-ab are predictors of SCLC in ataxia patients with a specificity of 100% and sensitivity of 49%. Unlike limbic encephalitis with SCLC, antibodies to cell surface antigens other than VGCC-ab, are infrequent and do not predict response to treatment.	[Sabater, Lidia; Hoeftberger, Romana; Boronat, Anna; Saiz, Albert; Graus, Francesc] Univ Barcelona, Hosp Clin, Serv Neurol, Barcelona, Spain; [Sabater, Lidia; Hoeftberger, Romana; Boronat, Anna; Saiz, Albert; Graus, Francesc] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Dalmau, Josep] Hosp Clin Barcelona, Inst Catalana Recerca & Estudis Avancats ICREA, IDIBAPS, Barcelona, Spain; [Dalmau, Josep] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Pennsylvania	Sabater, L (corresponding author), Univ Barcelona, Hosp Clin, Serv Neurol, Barcelona, Spain.	lisabate@clinic.ub.es	Graus, Francesc/K-9904-2018; Sabater, Lidia/U-7570-2019; Saiz, Albert/K-8236-2014; Sabater, Lidia/C-7627-2018	Saiz, Albert/0000-0002-5793-8791; Dalmau, Josep/0000-0001-5856-2813; Graus, Francesc/0000-0002-8924-8322; Sabater, Lidia/0000-0001-8556-6166	Fondo de Investigaciones Sanitarias. Madrid. Spain [FIS PS09/0193]; Fonds zur Forderung der wissenschaftlichen Forschung, Austria [J3230]; NIH [RO1NS077851]; NCI [RO1CA089054]; Fondo de Investigaciones Sanitarias (FIS) [11/01780]; Fundacio la Marato de TV3; Euroimmun; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA089054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077851] Funding Source: NIH RePORTER	Fondo de Investigaciones Sanitarias. Madrid. Spain(Instituto de Salud Carlos III); Fonds zur Forderung der wissenschaftlichen Forschung, Austria(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Fundacio la Marato de TV3; Euroimmun; ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study has been supported in part by Fondo de Investigaciones Sanitarias. Madrid. Spain (#FIS PS09/0193 FG), the Fonds zur Forderung der wissenschaftlichen Forschung, Austria, Project J3230 (RH), and NIH RO1NS077851, NCI RO1CA089054, Fondo de Investigaciones Sanitarias (FIS, 11/01780), and Fundacio la Marato de TV3 (JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Dalmau has a research grant from Euroimmun, and receives royalties from patents for the use of Ma2 and NMDAR as autoantibody tests. He has no financial competing interests such as ownership of stocks or shares, paid employment or consultancy, board membership, travel grants and honoraria for speaking or participation at meetings, products in development or marketed products, or gifts of any kind etc. The relation of Dr. Dalmau with the company Euroimmun does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. None of the other contributors have any conflicts of interest.	Ances BM, 2005, BRAIN, V128, P1764, DOI 10.1093/brain/awh526; Billings SE, 2012, NEUROREPORT, V23, P49, DOI 10.1097/WNR.0b013e32834e7deb; Boronat A, 2011, NEUROLOGY, V76, P795, DOI 10.1212/WNL.0b013e31820e7b8d; Chen RS, 2007, CELL BIOCHEM BIOPHYS, V47, P178, DOI 10.1007/s12013-007-0002-0; Dalmau J, 2008, LANCET NEUROL, V7, P327, DOI 10.1016/S1474-4422(08)70060-7; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Graus F, 2001, BRAIN, V124, P1138, DOI 10.1093/brain/124.6.1138; Graus F, 2002, NEUROLOGY, V59, P764, DOI 10.1212/WNL.59.5.764; Gure AO, 2000, P NATL ACAD SCI USA, V97, P4198, DOI 10.1073/pnas.97.8.4198; Lorenzoni PJ, 2008, J NEUROL SCI, V270, P194, DOI 10.1016/j.jns.2008.02.004; Maddison P, 1998, J NEUROL NEUROSUR PS, V65, P213, DOI 10.1136/jnnp.65.2.213; Mason WP, 1997, BRAIN, V120, P1279, DOI 10.1093/brain/120.8.1279; Pellkofer HL, 2009, MUSCLE NERVE, V40, P305, DOI 10.1002/mus.21315; Pellkofer HL, 2008, J NEUROIMMUNOL, V204, P136, DOI 10.1016/j.jneuroim.2008.08.002; Sabater L, 2008, J NEUROIMMUNOL, V196, P188, DOI 10.1016/j.jneuroim.2008.03.013; Sabater L, 2008, NEUROLOGY, V70, P924, DOI 10.1212/01.wnl.0000281663.81079.24; Shams'ili S, 2009, NEUROSCI LETT, V467, P169, DOI 10.1016/j.neulet.2009.10.031; Titulaer MJ, 2009, J CLIN ONCOL, V27, P4260, DOI 10.1200/JCO.2008.20.6169; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Voltz R, 1999, MUSCLE NERVE, V22, P119, DOI 10.1002/(SICI)1097-4598(199901)22:1<119::AID-MUS19>3.0.CO;2-5	20	49	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60438	10.1371/journal.pone.0060438	http://dx.doi.org/10.1371/journal.pone.0060438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536908	Green Published, gold, Green Submitted			2022-12-25	WOS:000317397200056
J	Li, J; Zhao, L; He, X; Zeng, YJ; Dai, SS				Li, Jun; Zhao, Li; He, Xie; Zeng, Yi-Jun; Dai, Shuang-Shuang			Sinomenine Protects against Lipopolysaccharide-Induced Acute Lung Injury in Mice via Adenosine A(2A) Receptor Signaling	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ISCHEMIA-REPERFUSION INJURY; NF-KAPPA-B; ALKALOID SINOMENINE; CYTOKINE EXPRESSION; MAST-CELLS; IN-VIVO; ACTIVATION; INFLAMMATION; NEUTROPHILS	Sinomenine (SIN) is a bioactive alkaloid extracted from the Chinese medicinal plant Sinomenium acutum, which is widely used in the clinical treatment of rheumatoid arthritis (RA). However, its role in acute lung injury (ALI) is unclear. In this study, we investigate the role of SIN in lipopolysaccharide (LPS)-induced ALI in mice. After ALI, lung water content and histological signs of pulmonary injury were attenuated, whereas the PaO2/FIO2 (P/F) ratios were elevated significantly in the mice pretreated with SIN. Additionally, SIN markedly inhibited inflammatory cytokine TNF-alpha and IL-1 beta expression levels as well as neutrophil infiltration in the lung tissues of the mice. Microarray analysis and real-time PCR showed that SIN treatment upregulated adenosine A(2A) receptor (A(2A)R) expression, and the protective effect of SIN was abolished in A(2A)R knockout mice. Further investigation in isolated mouse neutrophils confirmed the upregulation of A(2A)R by SIN and showed that A(2A)R-cAMP-PKA signaling was involved in the anti-inflammatory effect of SIN. Taken together, these findings demonstrate an A(2A)R-associated anti-inflammatory effect and the protective role of SIN in ALI, which suggests a potential novel approach to treat ALI.	[Li, Jun] Third Mil Med Univ, Southwest Hosp, Dept Cardiothorac Surg, Chongqing, Peoples R China; [Zhao, Li; He, Xie; Zeng, Yi-Jun; Dai, Shuang-Shuang] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Dai, SS (corresponding author), Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China.	tmmubiodss@yahoo.com.cn			National Natural Science Foundation of China [81172817]; Natural Science Foundation of Chongqing, China [CSTC2009BB5317]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing, China(Natural Science Foundation of Chongqing)	This work is supported by National Natural Science Foundation of China (81172817), Natural Science Foundation of Chongqing, China (CSTC2009BB5317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Allen-Gipson DS, 2006, AM J PHYSIOL-LUNG C, V290, pL849, DOI 10.1152/ajplung.00373.2005; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Bonneau O, 2006, AM J PHYSIOL-LUNG C, V290, pL1036, DOI 10.1152/ajplung.00422.2005; Bshesh K, 2002, J LEUKOCYTE BIOL, V72, P1027; Candinas D, 1996, TRANSPLANTATION, V62, P1855, DOI 10.1097/00007890-199612270-00030; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Cheng Y, 2009, INT IMMUNOPHARMACOL, V9, P894, DOI 10.1016/j.intimp.2009.03.014; Dai SS, 2010, J NEUROCHEM, V113, P1536, DOI 10.1111/j.1471-4159.2010.06716.x; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Ellman PI, 2008, J SURG RES, V149, P3, DOI 10.1016/j.jss.2007.08.008; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Folkesson HG, 2012, AM J PHYSIOL-LUNG C, V303, pL259, DOI 10.1152/ajplung.00395.2011; Gazoni LM, 2008, J THORAC CARDIOV SUR, V135, P156, DOI 10.1016/j.jtcvs.2007.08.041; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Heyn J, 2012, SHOCK, V37, P156, DOI 10.1097/SHK.0b013e31823f16bc; HOJO H, 1985, J IMMUNOPHARMACOL, V7, P33, DOI 10.3109/08923978509026467; Huang J, 2007, J ETHNOPHARMACOL, V114, P180, DOI 10.1016/j.jep.2007.07.036; Kim HM, 2000, J ETHNOPHARMACOL, V70, P135, DOI 10.1016/S0378-8741(99)00160-9; Kok T. W., 2005, Angiogenesis, V8, P3, DOI 10.1007/s10456-005-2892-z; KONDO Y, 1994, BIOCHEM PHARMACOL, V48, P1050, DOI 10.1016/0006-2952(94)90378-6; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Lin MC, 1997, J CLIN INVEST, V99, P737, DOI 10.1172/JCI119219; LIU L, 1994, ARZNEIMITTEL-FORSCH, V44-2, P1223; LIU L, 1994, INT J IMMUNOPHARMACO, V16, P685, DOI 10.1016/0192-0561(94)90142-2; Liu LA, 1996, INT J IMMUNOPHARMACO, V18, P529, DOI 10.1016/S0192-0561(96)00025-2; Lukashev D, 2004, J IMMUNOL, V173, P21, DOI 10.4049/jimmunol.173.1.21; Malcolm KC, 2003, AM J PHYSIOL-LUNG C, V284, pL663, DOI 10.1152/ajplung.00094.2002; Mark W, 2003, TRANSPLANTATION, V75, P940, DOI 10.1097/01.TP.0000056610.22062.03; Martin TR, 2002, J CLIN INVEST, V110, P1603, DOI 10.1172/JCI200217302; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; Nadeem A, 2007, AM J PHYSIOL-LUNG C, V292, pL1335, DOI 10.1152/ajplung.00416.2006; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Reece TB, 2005, J THORAC CARDIOV SUR, V129, P1137, DOI 10.1016/j.jtcvs.2004.11.042; Reutershan J, 2007, J IMMUNOL, V179, P1254, DOI 10.4049/jimmunol.179.2.1254; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sharma AK, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-58; Spicuzza L, 2006, EUR J PHARMACOL, V533, P77, DOI 10.1016/j.ejphar.2005.12.056; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Vieregge B, 1999, PLANTA MED, V65, P80, DOI 10.1055/s-2006-960446; Wang QX, 2011, INT IMMUNOPHARMACOL, V11, P373, DOI 10.1016/j.intimp.2010.11.018; Wang Y, 2005, J ETHNOPHARMACOL, V98, P37, DOI 10.1016/j.jep.2004.12.022; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wu RQ, 2006, CRIT CARE MED, V34, P1273, DOI 10.1097/01.CCM.0000208437.93725.18; YAMASAKI H, 1976, ACTA MED OKAYAMA, V30, P1; Zhao Y, 2007, INT IMMUNOPHARMACOL, V7, P637, DOI 10.1016/j.intimp.2007.01.007; Zhong H, 2003, J IMMUNOL, V171, P338, DOI 10.4049/jimmunol.171.1.338	50	26	34	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59257	10.1371/journal.pone.0059257	http://dx.doi.org/10.1371/journal.pone.0059257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555007	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800076
J	Li, X; Zhang, TC; Qiao, Q; Ren, ZM; Zhao, JY; Yonezawa, T; Hasegawa, M; Crabbe, MJC; Li, JQ; Zhong, Y				Li, Xi; Zhang, Ti-Cao; Qiao, Qin; Ren, Zhumei; Zhao, Jiayuan; Yonezawa, Takahiro; Hasegawa, Masami; Crabbe, M. James C.; Li, Jianqiang; Zhong, Yang			Complete Chloroplast Genome Sequence of Holoparasite Cistanche deserticola (Orobanchaceae) Reveals Gene Loss and Horizontal Gene Transfer from Its Host Haloxylon ammodendron (Chenopodiaceae)	PLOS ONE			English	Article							PLASTID GENOME; TRANSFER-RNA; SECONDARY STRUCTURE; FLOWERING PLANTS; DNA; EVOLUTION; DISINTEGRATION; RECOMBINATION; POLYMORPHISM; TRANSCRIPTS	Background: The central function of chloroplasts is to carry out photosynthesis, and its gene content and structure are highly conserved across land plants. Parasitic plants, which have reduced photosynthetic ability, suffer gene losses from the chloroplast (cp) genome accompanied by the relaxation of selective constraints. Compared with the rapid rise in the number of cp genome sequences of photosynthetic organisms, there are limited data sets from parasitic plants. Principal Findings/Significance: Here we report the complete sequence of the cp genome of Cistanche deserticola, a holoparasitic desert species belonging to the family Orobanchaceae. The cp genome of C. deserticola is greatly reduced both in size (102,657 bp) and in gene content, indicating that all genes required for photosynthesis suffer from gene loss and pseudogenization, except for psbM. The striking difference from other holoparasitic plants is that it retains almost a full set of tRNA genes, and it has lower dN/dS for most genes than another close holoparasitic plant, E. virginiana, suggesting that Cistanche deserticola has undergone fewer losses, either due to a reduced level of holoparasitism, or to a recent switch to this life history. We also found that the rpoC2 gene was present in two copies within C. deserticola. Its own copy has much shortened and turned out to be a pseudogene. Another copy, which was not located in its cp genome, was a homolog of the host plant, Haloxylon ammodendron (Chenopodiaceae), suggesting that it was acquired from its host via a horizontal gene transfer.	[Li, Xi; Zhang, Ti-Cao; Qiao, Qin; Zhao, Jiayuan; Yonezawa, Takahiro; Hasegawa, Masami; Zhong, Yang] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China; [Ren, Zhumei] Shanxi Univ, Coll Life Sci & Technol, Taiyuan, Peoples R China; [Crabbe, M. James C.] Univ Bedfordshire, Inst Biomed Environm Sci & Technol, Fac Creat Arts Technol & Sci, Luton, Beds, England; [Li, Jianqiang] Chinese Acad Sci, Wuhan Bot Garden, Wuhan, Peoples R China; [Zhong, Yang] Tibet Univ, Inst Biodivers Sci & Geobiol, Lhasa, Peoples R China	Fudan University; Shanxi University; University of Bedfordshire; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Tibet University	Li, JQ (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Wuhan, Peoples R China.	jianqiangl@hotmail.com; yangzhong@fudan.edu.cn	Zhang, Ticao/AHB-1915-2022	Zhang, Ticao/0000-0002-8578-6131; Qiao, Qin/0000-0003-2085-6853; Yonezawa, Takahiro/0000-0002-0012-1887	National Science Foundation of China [30925004, 91131901, 31070197]; China Postdoctoral Science Foundation [20100480550, 2011M500538]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is supported by the National Science Foundation of China [30925004, 91131901 to Zhong Y; 31070197 to Li JQ]; and China Postdoctoral Science Foundation [20100480550, 2011M500538 to Zhang TC and Qiao Q]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Asakura Y, 2006, PLANT PHYSIOL, V142, P1656, DOI 10.1104/pp.106.088096; Barkman TJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-248; Bennett JR, 2006, AM J BOT, V93, P1039, DOI 10.3732/ajb.93.7.1039; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cai ZQ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-77; Carlsson J, 2007, THEOR APPL GENET, V115, P627, DOI 10.1007/s00122-007-0593-2; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Davis CC, 2004, SCIENCE, V305, P676, DOI 10.1126/science.1100671; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; GRAY MW, 1993, CURR OPIN GENET DEV, V3, P884, DOI 10.1016/0959-437X(93)90009-E; Grivet D, 2001, MOL ECOL NOTES, V1, P345, DOI 10.1046/j.1471-8278.2001.00107.x; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Haddrill PR, 2008, BIOL LETTERS, V4, P758, DOI 10.1098/rsbl.2008.0376; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heinze B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-4; HESS WR, 1994, MOL GEN GENET, V242, P305, DOI 10.1007/BF00280420; Jansen R. K., 2012, GENOMICS CHLOROPLAST, P103, DOI [10.1007/978-94-007-2920-9, DOI 10.1007/978-94-007-2920-9_5]; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kim DH, 2006, CURR GENET, V49, P59, DOI 10.1007/s00294-005-0032-3; Koulintchenko M, 2003, EMBO J, V22, P1245, DOI 10.1093/emboj/cdg128; Krause K, 2008, CURR GENET, V54, P111, DOI 10.1007/s00294-008-0208-8; Krause K, 2012, ORGANELLE GENETICS: EVOLUTION OF ORGANELLE GENOMES AND GENE EXPRESSION, P79, DOI 10.1007/978-3-642-22380-8_4; Krause K, 2011, PLANTA, V234, P647, DOI 10.1007/s00425-011-1494-9; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin LW, 2002, J ETHNOPHARMACOL, V83, P177, DOI 10.1016/S0378-8741(02)00147-2; Logacheva MD, 2011, GENOME BIOL EVOL, V3, P1296, DOI 10.1093/gbe/evr102; Martin M, 2010, PLANT PHYSIOL BIOCH, V48, P636, DOI 10.1016/j.plaphy.2010.04.009; McNeal JR, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-57; Mower JP, 2004, NATURE, V432, P165, DOI 10.1038/432165b; Nickrent DL, 2003, PARASITIC PLANT CONN; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Olmstead RG, 2001, AM J BOT, V88, P348, DOI 10.2307/2657024; Olson LE, 2002, MOL BIOL EVOL, V19, P93, DOI 10.1093/oxfordjournals.molbev.a003987; Oxelman B, 2005, TAXON, V54, P411, DOI 10.2307/25065369; Park JM, 2007, MOL PHYLOGENET EVOL, V43, P974, DOI 10.1016/j.ympev.2006.10.011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quinones V, 1996, PLANT MOL BIOL, V31, P937, DOI 10.1007/BF00019483; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; SHIMADA H, 1991, NUCLEIC ACIDS RES, V19, P983, DOI 10.1093/nar/19.5.983; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tobe K, 2000, AUST J BOT, V48, P455, DOI 10.1071/BT99013; Vogel J, 1997, J MOL BIOL, V270, P179, DOI 10.1006/jmbi.1997.1115; Wakasugi T, 1998, PLANT MOL BIOL REP, V16, P231, DOI 10.1023/A:1007564209282; Wang Xiang-yan, 2009, Zhongguo Yaolixue Tongbao, V25, P787; Westwood JH, 2010, TRENDS PLANT SCI, V15, P227, DOI 10.1016/j.tplants.2010.01.004; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; Wolfe AD, 1998, MOL BIOL EVOL, V15, P1243, DOI 10.1093/oxfordjournals.molbev.a025853; Wolfe AD, 2005, FOLIA GEOBOT, V40, P115, DOI 10.1007/BF02803229; Wolfe AD, 2004, SYST BOT, V29, P1011, DOI 10.1600/0363644042451008; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; WOLFE KH, 1992, J MOL EVOL, V35, P304, DOI 10.1007/BF00161168; Woloszynska M, 2004, PLANT MOL BIOL, V56, P811, DOI 10.1007/s11103-004-5183-y; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zhang Z.-Y., 1990, FLORA REIPUBLICAE PO, V69, P69; Zoschke R, 2010, P NATL ACAD SCI USA, V107, P3245, DOI 10.1073/pnas.0909400107	68	73	73	7	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58747	10.1371/journal.pone.0058747	http://dx.doi.org/10.1371/journal.pone.0058747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554920	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800026
J	Sarrafpour, B; Swain, M; Li, Q; Zoellner, H				Sarrafpour, Babak; Swain, Michael; Li, Qing; Zoellner, Hans			Tooth Eruption Results from Bone Remodelling Driven by Bite Forces Sensed by Soft Tissue Dental Follicles: A Finite Element Analysis	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT CELLS; GENE-EXPRESSION; STRESS-ANALYSIS; CRANIOFACIAL GROWTH; STRAIN DISTRIBUTION; ENDOTHELIAL-CELLS; MANDIBULAR BONE; MUSCLE-ACTIVITY; PART I; RAT	Intermittent tongue, lip and cheek forces influence precise tooth position, so we here examine the possibility that tissue remodelling driven by functional bite-force-induced jaw-strain accounts for tooth eruption. Notably, although a separate true 'eruptive force' is widely assumed, there is little direct evidence for such a force. We constructed a three dimensional finite element model from axial computerized tomography of an 8 year old child mandible containing 12 erupted and 8 unerupted teeth. Tissues modelled included: cortical bone, cancellous bone, soft tissue dental follicle, periodontal ligament, enamel, dentine, pulp and articular cartilage. Strain and hydrostatic stress during incisive and unilateral molar bite force were modelled, with force applied via medial and lateral pterygoid, temporalis, masseter and digastric muscles. Strain was maximal in the soft tissue follicle as opposed to surrounding bone, consistent with follicle as an effective mechanosensor. Initial numerical analysis of dental follicle soft tissue overlying crowns and beneath the roots of unerupted teeth was of volume and hydrostatic stress. To numerically evaluate biological significance of differing hydrostatic stress levels normalized for variable finite element volume, 'biological response units' in Nmm were defined and calculated by multiplication of hydrostatic stress and volume for each finite element. Graphical representations revealed similar overall responses for individual teeth regardless if incisive or right molar bite force was studied. There was general compression in the soft tissues over crowns of most unerupted teeth, and general tension in the soft tissues beneath roots. Not conforming to this pattern were the unerupted second molars, which do not erupt at this developmental stage. Data support a new hypothesis for tooth eruption, in which the follicular soft tissues detect bite-force-induced bone-strain, and direct bone remodelling at the inner surface of the surrounding bony crypt, with the effect of enabling tooth eruption into the mouth.	[Sarrafpour, Babak; Zoellner, Hans] Univ Sydney, Westmead Hosp, Dept Oral Pathol & Oral Med, Cellular & Mol Pathol Res Unit,Fac Dent, Westmead, NSW 2145, Australia; [Swain, Michael] Univ Sydney, Fac Dent, Biomat Sci Unit, Westmead, NSW 2145, Australia; [Li, Qing] Univ Sydney, Fac Engn, Sch Aerosp Mech & Mech Engn, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney; University of Sydney	Sarrafpour, B (corresponding author), Univ Sydney, Westmead Hosp, Dept Oral Pathol & Oral Med, Cellular & Mol Pathol Res Unit,Fac Dent, Westmead, NSW 2145, Australia.	babak.sarrafpour@sydney.edu.au	Swain, Michael V/J-7266-2017; Li, Qing/B-3422-2009; Zoellner, Hans/GWQ-7168-2022	Li, Qing/0000-0002-7930-2145; Swain, Michael/0000-0002-8801-8656; Zoellner, Hans/0000-0003-4804-2464	Australian Dental Research Fund	Australian Dental Research Fund	No direct funding was obtained for this work, which was supported solely from internal departmental funds. However, the authors acknowledge the support of the Australian Dental Research Fund for separate related work. The internal university funding resources used to fund the current work were available without any role of the University administration in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBS JH, 1984, EXP NEUROL, V85, P469, DOI 10.1016/0014-4886(84)90024-4; Ainamo J, 1976, ERUPTION OCCLUSION T, P97; Al-Sukhun J, 2007, J BIOMED MATER RES A, V80A, P247, DOI 10.1002/jbm.a.30881; AVERY JK, 2001, ORAL DEV HISTOLOGY; BEERTSEN W, 1974, ARCH ORAL BIOL, V19, P1087, DOI 10.1016/0003-9969(74)90235-0; BERKOVIT.BK, 1969, ARCH ORAL BIOL, V14, P771, DOI 10.1016/0003-9969(69)90168-X; Berkovitz B K, 1990, Dent Update, V17, P206; Carrion JB, 2009, INT J PERIODONT REST, V29, P333; Bolitho C, 2007, J VASC RES, V44, P313, DOI 10.1159/000101777; Bourauel C, 2000, J Orofac Orthop, V61, P266, DOI 10.1007/s000560050012; BURNMURDOCH RA, 1981, ARCH ORAL BIOL, V26, P939, DOI 10.1016/0003-9969(81)90155-2; CAHILL DR, 1980, J ORAL PATHOL MED, V9, P189, DOI 10.1111/j.1600-0714.1980.tb00377.x; Carpenter RD, 2008, BIOMECH MODEL MECHAN, V7, P227, DOI 10.1007/s10237-007-0087-9; Carpenter RD, 2010, BIOMECH MODEL MECHAN, V9, P317, DOI 10.1007/s10237-009-0178-x; Chen DC, 2000, J DENT, V28, P583, DOI 10.1016/S0300-5712(00)00041-5; COMPAGNON D, 1991, J PROSTHET DENT, V66, P29, DOI 10.1016/0022-3913(91)90347-Y; Daegling DJ, 2009, AM J PHYS ANTHROPOL, V138, P306, DOI 10.1002/ajpa.20929; DECHOW PC, 1993, AM J PHYS ANTHROPOL, V90, P291, DOI 10.1002/ajpa.1330900304; Emmanuel C, 2002, CYTOKINE, V18, P237, DOI 10.1006/cyto.2002.1042; Field C, 2008, ARCH ORAL BIOL, V53, P1129, DOI 10.1016/j.archoralbio.2008.06.013; Field C, 2012, J DENT, V40, P48, DOI 10.1016/j.jdent.2011.10.003; Field C, 2010, J BIOMECH, V43, P1771, DOI 10.1016/j.jbiomech.2010.02.016; Field C, 2009, AM J ORTHOD DENTOFAC, V135, P174, DOI 10.1016/j.ajodo.2007.03.032; Fragiskos FD, 2007, ORAL SURG; Frost H. M., 1964, PLAST RECONSTR SURG, V33, P196; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; GAENGLER P, 1983, J PERIODONTAL RES, V18, P86, DOI 10.1111/j.1600-0765.1983.tb00339.x; Garat JA, 2005, J PERIODONTAL RES, V40, P441, DOI 10.1111/j.1600-0765.2005.00809.x; GARNER LD, 1973, J DENT RES, V52, P698, DOI 10.1177/00220345730520041001; Geng JP, 2001, J PROSTHET DENT, V85, P585, DOI 10.1067/mpr.2001.115251; Groning F, 2012, ANAT REC, V295, P853, DOI 10.1002/ar.22455; Groning F, 2011, AM J PHYS ANTHROPOL, V144, P593, DOI 10.1002/ajpa.21447; Hammond AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029121; HART RT, 1992, J BIOMECH, V25, P261, DOI 10.1016/0021-9290(92)90025-V; HELLSING E, 1987, AM J ORTHOD DENTOFAC, V91, P286, DOI 10.1016/0889-5406(87)90168-5; HYLANDER WL, 1979, J MORPHOL, V159, P253, DOI 10.1002/jmor.1051590208; HYLANDER WL, 1984, AM J PHYS ANTHROPOL, V64, P1, DOI 10.1002/ajpa.1330640102; Ichim I, 2007, DENT MATER, V23, P1553, DOI 10.1016/j.dental.2007.02.003; Ichim I, 2007, ARCH ORAL BIOL, V52, P465, DOI 10.1016/j.archoralbio.2006.10.020; Kamegai T, 2005, EUR J ORTHODONT, V27, P53, DOI 10.1093/ejo/cjh090; Kang YG, 2010, J DENT RES, V89, P1444, DOI 10.1177/0022034510378521; KATONA TR, 1987, ARCH ORAL BIOL, V32, P367, DOI 10.1016/0003-9969(87)90093-8; Katona TR, 2001, AM J ORTHOD DENTOFAC, V120, P263, DOI 10.1067/mod.2001.116086; KILIARIDIS S, 1995, ACTA ODONTOL SCAND, V53, P196, DOI 10.3109/00016359509005972; Kishen A, 2007, DENT MATER, V23, P1296, DOI 10.1016/j.dental.2006.11.018; KORIOTH TWP, 1994, J DENT RES, V73, P56, DOI 10.1177/00220345940730010801; KORIOTH TWP, 1992, AM J PHYS ANTHROPOL, V88, P69, DOI 10.1002/ajpa.1330880107; Koussoulakou DS, 2009, INT J BIOL SCI, V5, P226; Lee SS, 2010, INT J LEGAL MED, V124, P659, DOI 10.1007/s00414-010-0513-x; Li W, 2004, BIOMATERIALS, V25, P4987, DOI 10.1016/j.biomaterials.2004.01.010; Lin D, 2010, J BIOMECH, V43, P287, DOI 10.1016/j.jbiomech.2009.08.024; Lin D, 2009, J MECH BEHAV BIOMED, V2, P410, DOI 10.1016/j.jmbbm.2008.11.007; Liu D, 2005, EUR J ORAL SCI, V113, P404, DOI 10.1111/j.1600-0722.2005.00245.x; Liu DW, 2006, EUR J ORAL SCI, V114, P42, DOI 10.1111/j.1600-0722.2006.00283.x; Lucero JC, 1999, J ACOUST SOC AM, V106, P2834, DOI 10.1121/1.428108; MARKS SC, 1984, ARCH ORAL BIOL, V29, P311, DOI 10.1016/0003-9969(84)90105-5; McCollum M, 2001, J ANAT, V199, P153, DOI 10.1046/j.1469-7580.2001.19910153.x; Mellal A, 2004, CLIN ORAL IMPLAN RES, V15, P239, DOI 10.1111/j.1600-0501.2004.01000.x; Miles TS, 2007, ARCH ORAL BIOL, V52, P347, DOI 10.1016/j.archoralbio.2006.12.017; Nelson S.J., 2010, WHEELERS DENT ANATOM, V9th; Nilforoushan D, 2009, ANGLE ORTHOD, V79, P502, DOI 10.2319/050808-252.1; Ohshima H, 2005, ARCH ORAL BIOL, V50, P153, DOI 10.1016/j.archoralbio.2004.09.008; OLUWASANMI JO, 1976, PLAST RECONSTR SURG, V57, P342, DOI 10.1097/00006534-197603000-00011; PERERA KAS, 1981, J ANAT, V133, P281; POSEN AL, 1972, ANGLE ORTHOD, V42, P285; PROFFIT WR, 1978, ANGLE ORTHOD, V48, P175; Reitan K, 1960, AM J ORTHOD DENTOFAC, V46, P881, DOI [10.1016/0002-9416(60)90091-9, DOI 10.1016/0002-9416(60)90091-9]; Roberts W E, 1999, J Indiana Dent Assoc, V78, P24; Romanes GJ., 1983, CUNNINGHAMS MANUAL P, V14th; Saifuddin M, 2003, J ORAL REHABIL, V30, P578, DOI 10.1046/j.1365-2842.2003.00991.x; Sarrafpour B, 2012, ARCH ORAL BIOL, V57, P1070, DOI 10.1016/j.archoralbio.2012.05.001; Shapira Y, 2011, AM J ORTHOD DENTOFAC, V139, P563, DOI 10.1016/j.ajodo.2009.02.033; SIMARDSAVOIE S, 1976, AM J ORTHOD DENTOFAC, V70, P304, DOI 10.1016/0002-9416(76)90336-5; Sloten JV, 1998, P I MECH ENG H, V212, P489, DOI 10.1243/0954411981534240; STEEDLE JR, 1985, AM J ORTHOD DENTOFAC, V87, P56, DOI 10.1016/0002-9416(85)90174-5; Tanaka E, 2001, INT J ORAL MAX SURG, V30, P421, DOI 10.1054/ijom.2001.0132; TENCATE AR, 1976, AM J ORTHOD DENTOFAC, V69, P155; Topouzelis N, 2010, DENT TRAUMATOL, V26, P335, DOI 10.1111/j.1600-9657.2010.00915.x; Tseng ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019171; vanEijden TMGJ, 1997, ANAT REC, V248, P464; VANHASSE.HJ, 1972, ARCH ORAL BIOL, V17, P183, DOI 10.1016/0003-9969(72)90146-X; Vollmer D, 2000, J CRANIO MAXILL SURG, V28, P91, DOI 10.1054/jcms.2000.0125; Waters K, 1987, SIGGRAPH COMPUTER GR, V21, P17; WILLIAMS KR, 1984, BIOMATERIALS, V5, P347, DOI 10.1016/0142-9612(84)90033-4; Wise GE, 2008, J DENT RES, V87, P414, DOI 10.1177/154405910808700509; Wise GE, 2004, EUR J ORAL SCI, V112, P439, DOI 10.1111/j.1600-0722.2004.00156.x; Wise GE, 2002, CRIT REV ORAL BIOL M, V13, P323, DOI 10.1177/154411130201300403; Wise GE, 2003, J DENT RES, V82, P298, DOI 10.1177/154405910308200411; Wolff J, 1892, GESETZ TRANSFORMATIO; Wu JP, 2011, DNA CELL BIOL, V30, P865, DOI 10.1089/dna.2010.1139; Yao SM, 2007, ARCH ORAL BIOL, V52, P228, DOI 10.1016/j.archoralbio.2006.10.008; Yao SM, 2004, ARCH ORAL BIOL, V49, P451, DOI 10.1016/j.archoralbio.2004.01.009; Zoellner H, 1999, MICROVASC RES, V57, P162, DOI 10.1006/mvre.1998.2126; ZOELLNER H, 1993, LYMPHOKINE CYTOK RES, V12, P93	94	46	56	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58803	10.1371/journal.pone.0058803	http://dx.doi.org/10.1371/journal.pone.0058803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554928	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800030
J	Yang, ZZ; Grote, DM; Ziesmer, SC; Xiu, B; Yates, NR; Secreto, FJ; Hodge, LS; Witzig, TE; Novak, AJ; Ansell, SM				Yang, Zhi-Zhang; Grote, Deanna M.; Ziesmer, Steven C.; Xiu, Bing; Yates, Nicole R.; Secreto, Frank J.; Hodge, Lucy S.; Witzig, Thomas E.; Novak, Anne J.; Ansell, Stephen M.			Soluble and Membrane-Bound TGF-beta-Mediated Regulation of Intratumoral T Cell Differentiation and Function in B-Cell Non-Hodgkin Lymphoma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; DEPENDENT MECHANISM; IMMUNE-RESPONSES; FOXP3 EXPRESSION; BINDING-PROTEIN; IN-VIVO; TGF-BETA-1; RECEPTOR; SURFACE	While the effect of TGF-beta on malignant B cells in non-Hodgkin lymphoma (NHL) has been previously evaluated, studies to specifically define the role of TGF-beta in tumor immunity in B-cell NHL are limited. We found that soluble TGF-beta, secreted by both lymphoma cells and intratumoral T cells, is present in the serum of patients with B-cell NHL. Soluble TGF-beta promoted regulatory T (T-reg) cells by enhancing expression of Foxp3 in CD4(+) T cells and suppressed effector helper T (T-H) cells by inhibiting expression of IFN-gamma and IL-17. Blockade of the IL-2 signaling pathway diminished the effect of soluble TGF-b on T cell differentiation. Furthermore, we found that membrane-bound TGF-beta is expressed specifically on the surface of malignant B cells in B-cell NHL. TGF-beta was able to bind to the surface of lymphoma B cells through an interaction with heparan sulfate (HS) but not through the TGF-beta receptor. We showed that pretreatment of lymphoma B cells with TGF-beta significantly inhibits the proliferation and cytokine production of intratumoral T cells. Taken together, these results suggest that tumor-associated soluble and membrane-bound TGF-beta are involved in the regulation of intratumoral T cell differentiation and function in B-cell NHL.	[Yang, Zhi-Zhang; Grote, Deanna M.; Ziesmer, Steven C.; Yates, Nicole R.; Secreto, Frank J.; Hodge, Lucy S.; Witzig, Thomas E.; Novak, Anne J.; Ansell, Stephen M.] Mayo Clin, Coll Med, Div Hematol, Rochester, MN 55905 USA; [Xiu, Bing] Tongji Univ, Tongji Hosp, Dept Hematol, Shanghai 200092, Peoples R China	Mayo Clinic; Tongji University	Yang, ZZ (corresponding author), Mayo Clin, Coll Med, Div Hematol, Rochester, MN 55905 USA.	yang.zhizhang@mayo.edu; ansell.stephen@mayo.edu			National Institutes of Health [CA92104, CA97274]; Lymphoma Research Foundation; Leukemia & Lymphoma Society; Predolin Foundation; NATIONAL CANCER INSTITUTE [P50CA097274, R01CA092104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Predolin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA92104 and CA97274 from the National Institutes of Health, the Lymphoma Research Foundation, the Leukemia & Lymphoma Society and the Predolin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Ahn YO, 2009, J IMMUNOL, V182, P6114, DOI 10.4049/jimmunol.0803725; Baker K, 2008, INT J CANCER, V122, P1695, DOI 10.1002/ijc.23312; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bollard CM, 2002, BLOOD, V99, P3179, DOI 10.1182/blood.V99.9.3179; Bright JJ, 1997, J IMMUNOL, V159, P175; BUTZOW R, 1993, J CELL BIOL, V122, P721, DOI 10.1083/jcb.122.3.721; CHANG H, 1995, LEUKEMIA LYMPHOMA, V19, P165, DOI 10.3109/10428199509059672; Chen G, 2007, BLOOD, V109, P5301, DOI 10.1182/blood-2006-06-032128; Chung JS, 2011, BLOOD, V117, P3382, DOI 10.1182/blood-2010-08-302034; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Das L, 2008, J IMMUNOL, V180, P1490, DOI 10.4049/jimmunol.180.3.1490; DELMISTRO A, 1994, LEUKEMIA, V8, P1214; FISCHER P, 1988, BLOOD, V72, P234; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Foster AE, 2008, J IMMUNOTHER, V31, P500, DOI 10.1097/CJI.0b013e318177092b; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Han SH, 1998, J PHARMACOL EXP THER, V287, P1105; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hodge LS, 2011, BLOOD, V117, pE190, DOI 10.1182/blood-2010-12-326868; Inman GJ, 2000, J GEN VIROL, V81, P1567, DOI 10.1099/0022-1317-81-6-1567; Isufi I, 2007, J INTERF CYTOK RES, V27, P543, DOI 10.1089/jir.2007.0009; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226; MCCAFFREY TA, 1994, J CELL PHYSIOL, V159, P51, DOI 10.1002/jcp.1041590108; McKarns SC, 2000, IMMUNOPHARMACOLOGY, V48, P101, DOI 10.1016/S0162-3109(00)00183-1; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Oida T, 2003, J IMMUNOL, V170, P2516, DOI 10.4049/jimmunol.170.5.2516; Ostroukhova M, 2004, J CLIN INVEST, V114, P28, DOI 10.1172/JC1200420509; Piek E, 1997, J CELL PHYSIOL, V173, P447, DOI 10.1002/(SICI)1097-4652(199712)173:3<447::AID-JCP17>3.0.CO;2-8; Santos DD, 2007, EXP HEMATOL, V35, P1366, DOI 10.1016/j.exphem.2007.05.022; SING GK, 1990, CELL GROWTH DIFFER, V1, P549; TWEEDDALE ME, 1987, BLOOD, V69, P1307; Vega JL, 2010, OCUL IMMUNOL INFLAMM, V18, P459, DOI 10.3109/09273948.2010.509532; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xie YF, 2009, CANCER RES, V69, P7756, DOI 10.1158/0008-5472.CAN-09-0496; Yamada Y, 2010, INVEST OPHTH VIS SCI, V51, P2548, DOI 10.1167/iovs.09-4233; Yang ZZ, 2007, BLOOD, V110, P2537, DOI 10.1182/blood-2007-03-082578; Yang ZZ, 2006, CANCER RES, V66, P10145, DOI 10.1158/0008-5472.CAN-06-1822; Yang ZZ, 2011, BLOOD, V118, P2809, DOI 10.1182/blood-2011-03-340885; Yang ZZ, 2009, CANCER RES, V69, P5522, DOI 10.1158/0008-5472.CAN-09-0266; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	48	36	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59456	10.1371/journal.pone.0059456	http://dx.doi.org/10.1371/journal.pone.0059456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555036	Green Submitted, gold, Green Published			2022-12-25	WOS:000316409800093
J	Heel, T; Vogel, GF; Lammirato, A; Schneider, R; Auer, B				Heel, Thomas; Vogel, Georg F.; Lammirato, Andrea; Schneider, Rainer; Auer, Bernhard			FlgM as a Secretion Moiety for the Development of an Inducible Type III Secretion System	PLOS ONE			English	Article							FLAGELLAR GENE-EXPRESSION; ANTI-SIGMA FACTOR; ESCHERICHIA-COLI; TRANSCRIPTIONAL CONTROL; SALMONELLA-TYPHIMURIUM; REGULATORY SYSTEM; TRANSPOSON TN7; MESSENGER-RNA; ACTIVATOR; COMPLEX	Regulation and assembly of the flagellar type III secretion system is one of the most investigated and best understood regulational cascades in molecular biology. Depending on the host organism, flagellar morphogenesis requires the interplay of more than 50 genes. Direct secretion of heterologous proteins to the supernatant is appealing due to protection against cellular proteases and simplified downstream processing. As Escherichia coli currently remains the predominant host organism used for recombinant prokaryotic protein expression, the generation of a strain that exhibits inducible flagellar secretion would be highly desirable for biotechnological applications. Here, we report the first engineered Escherichia coli mutant strain featuring flagellar morphogenesis upon addition of an external inducer. Using FlgM as a sensor for direct secretion in combination with this novel strain may represent a potent tool for significant improvements in future engineering of an inducible type III secretion for heterologous proteins.	[Heel, Thomas; Schneider, Rainer; Auer, Bernhard] Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria; [Heel, Thomas; Schneider, Rainer; Auer, Bernhard] Austrian Ctr Ind Biotechnol, Graz, Austria; [Heel, Thomas; Schneider, Rainer; Auer, Bernhard] Univ Innsbruck, Ctr Mol Biosci CMBI, A-6020 Innsbruck, Austria; [Vogel, Georg F.] Med Univ Innsbruck, Div Histol & Embryol, A-6020 Innsbruck, Austria; [Lammirato, Andrea] Med Univ Innsbruck, Div Cell Biol, A-6020 Innsbruck, Austria	University of Innsbruck; Austrian Centre of Industrial Biotechnology; University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Heel, T (corresponding author), Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria.	Thomash@caltech.edu		Vogel, Georg-Friedrich/0000-0002-2515-4490	Austrian Ministry of Economics and Labor, the federal state of Vienna; Austrian Ministry of Economics and Labor, the federal state of Tyrol; Sandoz GmbH; Boehringer Ingelheim Austria GmbH; Austrian government	Austrian Ministry of Economics and Labor, the federal state of Vienna; Austrian Ministry of Economics and Labor, the federal state of Tyrol; Sandoz GmbH; Boehringer Ingelheim Austria GmbH(Boehringer Ingelheim); Austrian government	The present work was performed within the Austrian Center of Industrial Biotechnology (ACIB), a competence center funded by the Austrian Ministry of Economics and Labor, the federal states of Vienna and Tyrol and by its industrial partners Sandoz GmbH and Boehringer Ingelheim Austria GmbH. The funders had no role in the study design data collection and analysis, decision to publish, or preparation of the manuscript.; The Austrian Center for Industrial Biotechnology is a research center, which is financed partly by the Austrian government and by industry partners. Thomas Heel was an employee of this research center. The research program is decided in a scientific steering committee in which universities (as representatives of the government) and the companies are represented. The outcome of the research can be used by the industrial partners, however, they can also decide to give the results free for publication, which they did in this case. So the authors can declare that, "This does not alter their adherence to all the PLOS ONE policies on sharing data and materials."	Aizawa SI, 1996, MOL MICROBIOL, V19, P1, DOI 10.1046/j.1365-2958.1996.344874.x; Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Aldridge PD, 2006, GENE DEV, V20, P2315, DOI 10.1101/gad.380406; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Barembruch C, 2007, MOL MICROBIOL, V65, P76, DOI 10.1111/j.1365-2958.2007.05770.x; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Claret L, 2002, J MOL BIOL, V321, P185, DOI 10.1016/S0022-2836(02)00600-9; GAY NJ, 1986, BIOCHEM J, V234, P111, DOI 10.1042/bj2340111; Georgiou G, 2005, CURR OPIN BIOTECH, V16, P538, DOI 10.1016/j.copbio.2005.07.008; GILLEN KL, 1991, J BACTERIOL, V173, P6453, DOI 10.1128/jb.173.20.6453-6459.1991; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; GRINGAUZ E, 1988, J BACTERIOL, V170, P2832, DOI 10.1128/jb.170.6.2832-2840.1988; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Ide N, 1999, GENES GENET SYST, V74, P113, DOI 10.1266/ggs.74.113; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Karlinsey JE, 2000, MOL MICROBIOL, V37, P1220, DOI 10.1046/j.1365-2958.2000.02081.x; Karlinsey JE, 2000, CELL, V102, P487, DOI 10.1016/S0092-8674(00)00053-2; KUTSUKAKE K, 1994, MOL GEN GENET, V243, P605, DOI 10.1007/BF00279569; KUTSUKAKE K, 1994, J BACTERIOL, V176, P3598, DOI 10.1128/JB.176.12.3598-3605.1994; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; Lloyd SA, 2001, TRENDS MICROBIOL, V9, P367, DOI 10.1016/S0966-842X(01)02100-X; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Macnab RM, 1999, J BACTERIOL, V181, P7149, DOI 10.1128/JB.181.23.7149-7153.1999; Majander K, 2005, NAT BIOTECHNOL, V23, P475, DOI 10.1038/nbt1077; Mergulhao FJM, 2005, BIOTECHNOL ADV, V23, P177, DOI 10.1016/j.biotechadv.2004.11.003; Minamino T, 2004, J MOL MICROB BIOTECH, V7, P5, DOI 10.1159/000077865; OHNISHI K, 1992, MOL MICROBIOL, V6, P3149, DOI 10.1111/j.1365-2958.1992.tb01771.x; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Siegele DA, 2010, FEMS MICROBIOL LETT, V309, P94, DOI 10.1111/j.1574-6968.2010.02021.x; Singer HM, 2012, MBIO, V3, DOI 10.1128/mBio.00115-12; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Tsolis RM, 1999, INFECT IMMUN, V67, P4879, DOI 10.1128/IAI.67.9.4879-4885.1999; Wozniak CE, 2008, J MOL BIOL, V379, P936, DOI 10.1016/j.jmb.2008.04.043; Wozniak CE, 2009, J BACTERIOL, V191, P1498, DOI 10.1128/JB.01177-08; Yamamoto S, 2006, J BACTERIOL, V188, P6703, DOI 10.1128/JB.00799-06; Yanagihara S, 1999, GENES GENET SYST, V74, P105, DOI 10.1266/ggs.74.105; Young GM, 1999, J BACTERIOL, V181, P2823, DOI 10.1128/JB.181.9.2823-2833.1999	40	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59034	10.1371/journal.pone.0059034	http://dx.doi.org/10.1371/journal.pone.0059034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554966	Green Submitted, Green Published, gold			2022-12-25	WOS:000316252500061
J	Jin, M; Jusiak, B; Bai, ZL; Mardon, G				Jin, Meng; Jusiak, Barbara; Bai, Zengliang; Mardon, Graeme			Eyes Absent Tyrosine Phosphatase Activity Is Not Required for Drosophila Development or Survival	PLOS ONE			English	Article							BRANCHIOOTORENAL SYNDROME; GENETIC-CONTROL; CELL-SURVIVAL; HUMAN HOMOLOG; PROTEIN; EYA; MUTATIONS; ACTIVATION; REVEALS; EXPRESSION	Eyes absent (Eya) is an evolutionarily conserved transcriptional coactivator and protein phosphatase that regulates multiple developmental processes throughout the metazoans. Drosophila eya is necessary for survival as well as for the formation of the adult eye. Eya contains a tyrosine phosphatase domain, and mutations altering presumptive active-site residues lead to strongly reduced activities in ectopic eye induction, in vivo genetic rescue using the Gal4-UAS system, and in vitro phosphatase assays. However, these mutations have not been analyzed during normal development with the correct levels, timing, and patterns of endogenous eya expression. To investigate whether the tyrosine phosphatase activity of Eya plays a role in Drosophila survival or normal eye formation, we generated three eya genomic rescue (eyaGR) constructs that alter key active-site residues and tested them in vivo. In striking contrast to previous studies, all eyaGR constructs fully restore eye formation as well as viability in an eya null mutant background. We conclude that the tyrosine phosphatase activity of Eya is not required for normal eye development or survival in Drosophila. Our study suggests the need for a re-evaluation of the mechanism of Eya action and underscores the importance of studying genes in their native context.	[Jin, Meng; Bai, Zengliang] Shandong Univ, Lab Dev Immunol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Jusiak, Barbara; Mardon, Graeme] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jin, Meng; Mardon, Graeme] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Program Cell & Mol Biol, Houston, TX 77030 USA	Shandong University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bai, ZL (corresponding author), Shandong Univ, Lab Dev Immunol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	zengliangbai@sdu.edu.cn; gmardon@bcm.edu	Jin, Meng/AAI-7085-2020	Jin, Meng/0000-0002-1525-0876; /0000-0001-6439-0456	Retina Research Foundation; National Eye Institute [R01 EY011232]; Chinese Scholarship Council; NEI/NIH [EY-002520]; China Scholarship Council (CSC); NATIONAL EYE INSTITUTE [R01EY011232, P30EY002520] Funding Source: NIH RePORTER	Retina Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Chinese Scholarship Council(China Scholarship Council); NEI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); China Scholarship Council (CSC)(China Scholarship Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the Retina Research Foundation, National Eye Institute grant R01 EY011232 (GM), the Chinese Scholarship Council (MJ), and the NEI/NIH Core Grant for Vision Research EY-002520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Nele Haelterman for ERG technical assistance, Ilaria Rebay for providing the ro-lacZ<SUP>tau</SUP> fly stock and Georg Halder for comments on the manuscript. MJ thanks the China Scholarship Council (CSC) for financial support.	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Anderson AM, 2012, DEVELOPMENT, V139, P991, DOI 10.1242/dev.077255; Azuma N, 2000, HUM MOL GENET, V9, P363, DOI 10.1093/hmg/9.3.363; Bonini NM, 1998, DEV BIOL, V196, P42, DOI 10.1006/dbio.1997.8845; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Boyle M, 1997, DEVELOPMENT, V124, P971; Bui QT, 2000, GENETICS, V155, P709; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HEISENBERG M, 1971, J EXP BIOL, V55, P85; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Jusiak B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050776; Koushika SP, 1996, CURR BIOL, V6, P1634, DOI 10.1016/S0960-9822(02)70787-2; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Liu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042725; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Pappu KS, 2004, INT J DEV BIOL, V48, P913, DOI 10.1387/ijdb.041875kp; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pepple KL, 2007, GENETICS, V175, P125, DOI 10.1534/genetics.106.065680; Petersen N.S., 1990, Advances in Genetics, V28, P275; Rayapureddi JP, 2006, FEBS LETT, V580, P3853, DOI 10.1016/j.febslet.2006.06.009; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Robin TP, 2012, MOL CANCER RES, V10, P1098, DOI 10.1158/1541-7786.MCR-12-0086; Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003; Tadjuidje E., 2012, CELL MOL LIFE SCI; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Xiong WJ, 2009, DEV CELL, V16, P271, DOI 10.1016/j.devcel.2008.12.005; Xu PX, 1997, P NATL ACAD SCI USA, V94, P11974, DOI 10.1073/pnas.94.22.11974; Zhang L, 2005, CANCER RES, V65, P925; Zimmerman JE, 1997, GENOME RES, V7, P128, DOI 10.1101/gr.7.2.128	43	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58818	10.1371/journal.pone.0058818	http://dx.doi.org/10.1371/journal.pone.0058818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554934	Green Submitted, Green Published, gold			2022-12-25	WOS:000316252500047
J	Yang, BK; Ma, CC; Chen, ZS; Yi, WN; McNutt, MA; Wang, Y; Korteweg, C; Gu, J				Yang, Baokai; Ma, Changchun; Chen, Zhengshan; Yi, Weining; McNutt, Michael A.; Wang, Yun; Korteweg, Christine; Gu, Jiang			Correlation of Immunoglobulin G Expression and Histological Subtype and Stage in Breast Cancer	PLOS ONE			English	Article							CHAIN CONSTANT-REGION; KAPPA-LIGHT-CHAIN; DUCTAL CARCINOMA; CELL-LINES; JAPANESE WOMEN; RISK-FACTORS; PLASMA IGA; IN-SITU; TUMORS; PREVENTION	Introduction: Recently, growing evidence indicates that immunoglobulins (Igs) are not only produced by mature B lymphocytes or plasma cells, but also by various normal cells types at immune privileged sites and neoplasm, including breast cancer. However, the association of breast cancer derived IgG with genesis and development of the disease has not yet been established. Methods: In this study we examined the expression of IgG in 186 breast cancers, 20 benign breast lesions and 30 normal breast tissues. Both immunohistochemistry with antibodies to Ig kappa (immunoglobulin G kappa light chain) and Ig gamma (immunoglobulin G heavy chain) and in situ hybridization with an antisense probe to IgG1 heavy chain constant region gene were performed. Various clinicopathological features were also analyzed. Results: We found that IgG is specifically expressed in human breast cancer cells. Both infiltrating ductal carcinoma and infiltrating lobular carcinoma had significantly greater numbers of Ig kappa and Ig gamma positive cancer cells as compared with medullary carcinoma, carcinoma in situ, and benign lesions (all p<0.05). In addition, IgG expression was correlated with breast cancer histological subtypes (p<0.01) and AJCC stages (p<0.05), with more abundance of IgG expression in more malignant histological subtypes or in more advanced stage of the disease. Conclusions: IgG expression in breast cancer cells is correlated with malignancy and AJCC stages of the cancers. This suggests that breast cancer derived IgG may be associated with genesis, development and prognosis of the cancer.	[Yang, Baokai; Chen, Zhengshan; McNutt, Michael A.; Wang, Yun; Gu, Jiang] Peking Beijing Univ, Dept Pathol, Sch Basic Med Sci, Hlth Sci Ctr, Beijing, Peoples R China; [Ma, Changchun; Chen, Zhengshan; Korteweg, Christine; Gu, Jiang] Shantou Univ, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Dept Pathol & Pathophysiol, Coll Med, Shantou, Peoples R China; [Ma, Changchun] Shantou Univ, Dept Radiat Oncol, Canc Hosp, Coll Med, Shantou, Peoples R China; [Yi, Weining] Peking Beijing Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing, Peoples R China; [Wang, Yun] NIMH, Mol Pathophysiol Lab, NIH, Bethesda, MD 20892 USA	Peking University; Shantou University; Shantou University; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Gu, J (corresponding author), Peking Beijing Univ, Dept Pathol, Sch Basic Med Sci, Hlth Sci Ctr, Beijing, Peoples R China.	jguemailbox@gmail.com	Chen, Zhengshan/J-7499-2014; Ma, Changchun/AAI-4282-2020	Gu, Jiang/0000-0002-0706-8329	Li Fu Educational Foundation; 111 project of the Ministry of Education, China [B07001]; National Natural Science Foundation of China [81030033, 30971150]; Science and Technology Funding of Shantou [186]	Li Fu Educational Foundation; 111 project of the Ministry of Education, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Funding of Shantou	This work was supported by the Li Fu Educational Foundation, 111 project of the Ministry of Education, China (No. B07001), the National Natural Science Foundation of China (Nos. 81030033 and 30971150 to J.G.) and the Science and Technology Funding of Shantou (No. 186 to C. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, WHO CLASSIFICATION T; Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Chen ZS, 2010, CANCER-AM CANCER SOC, V116, P1953, DOI 10.1002/cncr.24892; Chen ZS, 2009, AM J PATHOL, V174, P1139, DOI 10.2353/ajpath.2009.080879; Chu JS, 1998, CANCER LETT, V131, P145, DOI 10.1016/S0304-3835(98)00118-9; Cowan WK, 2000, J CLIN PATHOL, V53, P140, DOI 10.1136/jcp.53.2.140; Edhemovic I, 2001, EUR J SURG ONCOL, V27, P545, DOI 10.1053/ejso.2001.1134; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gu J., 1997, ANAL MORPHOLOGY THEO; Heimann R, 2000, CANCER RES, V60, P298; Hoff ER, 2002, AM J CLIN PATHOL, V117, P916, DOI 10.1309/4NTU-N6K4-F8JF-EWRX; Kimoto Y, 1998, GENE CHROMOSOME CANC, V22, P83, DOI 10.1002/(SICI)1098-2264(1998)22:1<83::AID-GCC12>3.0.CO;2-O; Lee G., 2012, AM J IMMUNOL, V8, P101, DOI [10.3844/ajisp.2012.101.116, DOI 10.3844/AJISP.2012.101.116]; Lee G, 2009, CANCER BIOMARK, V5, P177, DOI 10.3233/CBM-2009-0102; Lee G, 2009, CANCER BIOL THER, V8, P161, DOI 10.4161/cbt.8.2.7117; Lee G, 2008, CANCER BIOL THER, V7, P2007, DOI 10.4161/cbt.7.12.6984; Li M, 2004, INT J BIOCHEM CELL B, V36, P2250, DOI 10.1016/j.biocel.2004.03.017; Liu HD, 2007, CELL SIGNAL, V19, P419, DOI 10.1016/j.cellsig.2006.07.012; Lonning PE, 2007, ANN ONCOL, V18, P3, DOI 10.1093/annonc/mdm260; Ma C, 2013, CURRENT MOL IN PRESS, V13; Molland JG, 2004, BREAST, V13, P389, DOI 10.1016/j.breast.2004.03.004; Pedersen L, 1995, EUR J CANCER, V31A, P2289, DOI 10.1016/0959-8049(95)00408-4; PETTINGALE KW, 1977, BRIT J CANCER, V36, P550, DOI 10.1038/bjc.1977.230; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pierce E, 1998, J CLIN PATHOL-MOL PA, V51, P90, DOI 10.1136/mp.51.2.90; Qiu XY, 2003, CANCER RES, V63, P6488; Rivenbark AG, 2012, EXP MOL PATHOL, V93, P391, DOI 10.1016/j.yexmp.2012.10.018; ROYDS JA, 1993, J NATL CANCER I, V85, P727, DOI 10.1093/jnci/85.9.727; Schmidt M, 2012, CLIN CANCER RES, V18, P2695, DOI 10.1158/1078-0432.CCR-11-2210; Shiao YH, 2000, CANCER EPIDEM BIOMAR, V9, P631; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SILVERSTEIN MJ, 1995, LANCET, V345, P1154; Singletary SE, 2006, CA-CANCER J CLIN, V56, P37, DOI 10.3322/canjclin.56.1.37; Tirona MT, 2010, CANCER INVEST, V28, P743, DOI 10.3109/07357907.2010.494321; WANG DY, 1977, EUR J CANCER, V13, P1405, DOI 10.1016/0014-2964(77)90153-0; WANG DY, 1979, CANCER, V44, P492, DOI 10.1002/1097-0142(197908)44:2<492::AID-CNCR2820440219>3.0.CO;2-V; WANG DY, 1977, CANCER, V39, P2190, DOI 10.1002/1097-0142(197705)39:5<2190::AID-CNCR2820390536>3.0.CO;2-C; WELLINGS SR, 1973, J NATL CANCER I, V50, P1111, DOI 10.1093/jnci/50.5.1111; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Zhang LY, 2012, HUM PATHOL, V43, P423, DOI 10.1016/j.humpath.2011.05.020; Zhang SA, 2010, CELL MOL LIFE SCI, V67, P985, DOI 10.1007/s00018-009-0231-z; Zhou JH, 2004, CELL MOL IMMUNOL, V1, P247	43	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58706	10.1371/journal.pone.0058706	http://dx.doi.org/10.1371/journal.pone.0058706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554916	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500040
J	Chu, HT; Hsiao, WWL; Tsao, TTH; Hsu, DF; Chen, CC; Lee, SA; Kao, CY				Chu, Hsueh-Ting; Hsiao, William W. L.; Tsao, Theresa T. H.; Hsu, D. Frank; Chen, Chaur-Chin; Lee, Sheng-An; Kao, Cheng-Yan			SeqEntropy: Genome-Wide Assessment of Repeats for Short Read Sequencing	PLOS ONE			English	Article							ASSEMBLIES; MAP; DNA	Background: Recent studies on genome assembly from short-read sequencing data reported the limitation of this technology to reconstruct the entire genome even at very high depth coverage. We investigated the limitation from the perspective of information theory to evaluate the effect of repeats on short-read genome assembly using idealized (error-free) reads at different lengths. Methodology/Principal Findings: We define a metric H-(k) to be the entropy of sequencing reads at a read length k and use the relative loss of entropy Delta H-(k) to measure the impact of repeats for the reconstruction of whole-genome from sequences of length k. In our experiments, we found that entropy loss correlates well with de-novo assembly coverage of a genome, and a score of Delta H-(k)>1% indicates a severe loss in genome reconstruction fidelity. The minimal read lengths to achieve Delta H-(k)<1% are different for various organisms and are independent of the genome size. For example, in order to meet the threshold of Delta H-(k)<1%, a read length of 60 bp is needed for the sequencing of human genome (3.2 10(9) bp) and 320 bp for the sequencing of fruit fly (1.8 x 10(8) bp). We also calculated the Delta H-(k) scores for 2725 prokaryotic chromosomes and plasmids at several read lengths. Our results indicate that the levels of repeats in different genomes are diverse and the entropy of sequencing reads provides a measurement for the repeat structures. Conclusions/Significance:The proposed entropy-based measurement, which can be calculated in seconds to minutes in most cases, provides a rapid quantitative evaluation on the limitation of idealized short-read genome sequencing. Moreover, the calculation can be parallelized to scale up to large euakryotic genomes. This approach may be useful to tune the sequencing parameters to achieve better genome assemblies when a closely related genome is already available.	[Chu, Hsueh-Ting] Asia Univ, Dept Biomed informat, Taichung, Taiwan; [Chu, Hsueh-Ting] Asia Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan; [Hsiao, William W. L.] British Columbia Publ Hlth Microbiol & Reference, Vancouver, BC, Canada; [Hsiao, William W. L.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; [Hsiao, William W. L.] Univ British Columbia, Lab Med, Vancouver, BC V5Z 1M9, Canada; [Tsao, Theresa T. H.; Kao, Cheng-Yan] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Hsu, D. Frank] Fordham Univ, Dept Comp & Informat Sci, New York, NY 10023 USA; [Chen, Chaur-Chin] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Lee, Sheng-An] Kainan Univ, Dept Informat Management, Tao Yuan, Taiwan	Asia University Taiwan; Asia University Taiwan; University of British Columbia; University of British Columbia; National Taiwan University; Fordham University; National Tsing Hua University; Nan Kai University Technology	Lee, SA (corresponding author), Kainan Univ, Dept Informat Management, Tao Yuan, Taiwan.	shengan@gmail.com; cykao@csie.ntu.edu.tw						Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bischof DF, 2006, GENOMICS, V88, P633, DOI 10.1016/j.ygeno.2006.06.018; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brown Jr J, 2006, GENOMES; Cerveau N, 2011, GENOME BIOL EVOL, V3, P1175, DOI 10.1093/gbe/evr096; Cho NH, 2007, P NATL ACAD SCI USA, V104, P7981, DOI 10.1073/pnas.0611553104; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Nakayama K, 2008, DNA RES, V15, P185, DOI 10.1093/dnares/dsn011; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Schneider T. D., 1995, INFORM THEORY PRIMER; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sundquist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000484; Tammi MT, 2002, BIOINFORMATICS, V18, P379, DOI 10.1093/bioinformatics/18.3.379; Wetzel J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-95; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	21	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59484	10.1371/journal.pone.0059484	http://dx.doi.org/10.1371/journal.pone.0059484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544073	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700033
J	Ruan, WJ; Unsain, N; Desbarats, J; Fon, EA; Barker, PA				Ruan, Wenjing; Unsain, Nicolas; Desbarats, Julie; Fon, Edward A.; Barker, Philip A.			Wengen, the Sole Tumour Necrosis Factor Receptor in Drosophila, Collaborates with Moesin to Control Photoreceptor Axon Targeting during Development	PLOS ONE			English	Article							VISUAL-SYSTEM; PRONEURAL GENES; TNF SUPERFAMILY; NEURITE GROWTH; NOGO RECEPTOR; PROTEIN; EIGER; CELL; FLAMINGO; PATHWAY	Photoreceptor neurons (R cells) in the Drosophila eye define a map of visual space by connecting to targets in distinct layers of the optic lobe, with R1-6 cells connecting to the lamina (the first optic ganglion) and R7 and R8 cells connecting to the medulla (the second optic ganglion). Here, we show that Wengen (Wgn) directly binds Moesin (Moe) through a cytosolic membrane proximal domain and this interaction is important for mediating two distinct aspects of axonal targeting. First, we show that loss of wgn or moe function disrupts cell autonomous R8 axon targeting. Second, we report that wgn or moe mutants show defects in R2-R5 targeting that result from disruption of non-cell autonomous effects, which are secondary to the cell autonomous R8 phenotype. Thus, these studies reveal that the Wgn-Moe signaling cascade plays a key role in photoreceptor target field innervations through cell autonomous and non cell autonomous mechanisms.	[Ruan, Wenjing; Unsain, Nicolas; Desbarats, Julie; Fon, Edward A.; Barker, Philip A.] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada	McGill University	Fon, EA (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada.	ted.fon@mcgill.ca; phil.barker@mcgill.ca	Unsain, Nicolas/AGZ-4095-2022	Desbarats, Julie/0000-0002-2495-7152	Canadian Institutes of Health Research [204868, 224928]; National Sciences and Engineering Research Council of Canada [231901]; Parkinson Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Parkinson Society	This work was supported by independent grants to E.A.F (204868) and P.A.B. (224928) from the Canadian Institutes of Health Research and the National Sciences and Engineering Research Council of Canada to P.A.B.(231901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Lindsay Osso for help With quantification, Drs. Yong Rao (McGill University), Pejmun Haghighi (McGill University), Xiaohang Yang (National University of Singapore) and Hugo Bellen (Baylor College of Medicine) who generously provided materials used in this study. W.J.R. is recipient of a Parkinson Society Canada fellowship and E.A.F is an FRSQ Chercheur Boursier Senior Clinical Fellow. P.A.B is an FRSQ Chercheur National and is a James McGill Scholar.	Babcock DT, 2011, CURR BIOL, V21, P1525, DOI 10.1016/j.cub.2011.08.020; Babcock Daniel T, 2009, Commun Integr Biol, V2, P517; Ben-Zvi A, 2007, J NEUROSCI, V27, P13000, DOI 10.1523/JNEUROSCI.3373-07.2007; Chien CT, 1996, P NATL ACAD SCI USA, V93, P13239, DOI 10.1073/pnas.93.23.13239; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Hakeda-Suzuki S, 2011, NAT NEUROSCI, V14, P314, DOI 10.1038/nn.2756; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; Kanda H, 2002, J BIOL CHEM, V277, P28372, DOI 10.1074/jbc.C200324200; Karagiosis SA, 2004, DEVELOPMENT, V131, P725, DOI 10.1242/dev.00976; Kauppila S, 2003, ONCOGENE, V22, P4860, DOI 10.1038/sj.onc.1206715; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; Meinertzhagen Ian A., 1993, P1363; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Ruan WJ, 2008, MOL BIOL CELL, V19, P3192, DOI 10.1091/mbc.E08-02-0161; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Wang H, 2006, SHOCK, V25, P25, DOI 10.1097/00024382-200606001-00075; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; White NM, 2000, DEVELOPMENT, V127, P1681; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; Yu L, 2010, J NEUROSCI, V30, P12151, DOI 10.1523/JNEUROSCI.1494-10.2010; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	43	5	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60091	10.1371/journal.pone.0060091	http://dx.doi.org/10.1371/journal.pone.0060091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544124	Green Submitted, gold, Green Published			2022-12-25	WOS:000317480700083
J	Stollar, V; Mensah, V; Adams, S; Li, ML				Stollar, Victor; Mensah, Virginia; Adams, Sandra; Li, Mei-Ling			Evolution of Sindbis Virus with a Low-Methionine-Resistant Phenotype Is Dependent Both on a Pre-Existing Mutation and on the Methionine Concentration in the Medium	PLOS ONE			English	Article							RNA-POLYMERASE; MUTANT; METHYLTRANSFERASE; REPLICATION; EXPRESSION; FIDELITY; ENCODES; CLONES; CELLS; NSP1	SVIm21 is a mutant of Sindbis virus which was isolated by serial passage of virus in mosquito cells maintained in low-methionine medium; it therefore has a low-methionine-resistant (LMR) Phenotype. This Phenotype requires mutations at nts 319 and 321; these mutations result in Arg to Leu and Ser to Cys changes at positions 87 and 88 respectively in the viral methyl transferase, nsP1. To better understand the genesis of SVIm21, we carried out serial passages of viruses having only one of these amino acid changes, but in mosquito cells maintained in normal methionine-medium. Whether the Passage was begun with SV319 or with SV321, the dominant virus population which emerged always acquired the second SVIm21 amino acid change. However, when the Passage was begun with virus having neither the nt 319 or the nt321 mutation, even after many Passages neither of these mutations. was seen in the passaged virus population. Virus with the LMR phenotype emerged earlier when the virus encoded a wild type RDRP. (Passage 4) rather than the mutant RDRP encoded by SVpzf (passage 7). When the methionine concentration in the medium of mosquito cells was increased to 250 mu M, more than 20 passages were required until the LMR phenotype predominated. Competition experiments were carried out to compare the relative fitness of SVIm21, SVwt, SV319 and SV321 to each other. Our results indicated that SVIm21 was dominant to SVwt, as well as to both SV319 and SV321. However, SV319 and SV321 were able to co-exist with SVwt implying that in these mixed infection the presence of SVwt inhibited the emergence of SVIm21. Finally, our experiments highlight how a virus population by mutation and selection can adapt to the intracellular concentration of a simple metabolite, S-adenosylmethionine.	[Stollar, Victor; Mensah, Virginia; Li, Mei-Ling] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Stollar, Victor] Canc Inst New Jersey, New Brunswick, NJ USA; [Adams, Sandra] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Montclair State University	Li, ML (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	lime@umdnj.edu			NIH/NIAID Public Health Service [AI-49273, AI-070728]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049273, R01AI070728] Funding Source: NIH RePORTER	NIH/NIAID Public Health Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH/NIAID Public Health Service grants AI-49273 and AI-070728. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHOLA T, 1995, P NATL ACAD SCI USA, V92, P507, DOI 10.1073/pnas.92.2.507; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; BOFILL M, 1995, J BIOL CHEM, V270, P29690, DOI 10.1074/jbc.270.50.29682; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; Delgado T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002866; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; Domingo E, 2007, FIELDS VIROLOGY, P389; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; DURBIN RK, 1985, VIROLOGY, V144, P529, DOI 10.1016/0042-6822(85)90294-6; Heyduk E, 2003, ANAL BIOCHEM, V316, P1, DOI 10.1016/S0003-2697(03)00004-6; Lemm JA, 1998, J VIROL, V72, P6546, DOI 10.1128/JVI.72.8.6546-6553.1998; Lin YH, 2000, VIROLOGY, V272, P61, DOI 10.1006/viro.2000.0329; MI S, 1990, VIROLOGY, V178, P429, DOI 10.1016/0042-6822(90)90340-W; MI S, 1989, VIROLOGY, V170, P385, DOI 10.1016/0042-6822(89)90429-7; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987; SARVER N, 1977, VIROLOGY, V80, P390, DOI 10.1016/S0042-6822(77)80014-7; SCHEIDEL LM, 1989, VIROLOGY, V173, P408, DOI 10.1016/0042-6822(89)90553-9; Sitole LJ, 2013, MOL BIOSYST, V9, P18, DOI 10.1039/c2mb25318f	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60504	10.1371/journal.pone.0060504	http://dx.doi.org/10.1371/journal.pone.0060504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544150	Green Submitted, Green Published, gold			2022-12-25	WOS:000317480700109
J	Liu, ZQ; Chen, DC; Sheng, L; Liu, AY				Liu, Zhenqiu; Chen, Dechang; Sheng, Li; Liu, Amy Y.			Class Prediction and Feature Selection with Linear Optimization for Metagenomic Count Data	PLOS ONE			English	Article							TAXONOMIC CLASSIFICATION; DNA-SEQUENCES	The amount of metagenomic data is growing rapidly while the computational methods for metagenome analysis are still in their infancy. It is important to develop novel statistical learning tools for the prediction of associations between bacterial communities and disease phenotypes and for the detection of differentially abundant features. In this study, we presented a novel statistical learning method for simultaneous association prediction and feature selection with metagenomic samples from two or multiple treatment populations on the basis of count data. We developed a linear programming based support vector machine with L-1 and joint L-1,L-infinity penalties for binary and multiclass classifications with metagenomic count data (metalinprog). We evaluated the performance of our method on several real and simulation datasets. The proposed method can simultaneously identify features and predict classes with the metagenomic count data.	[Liu, Zhenqiu] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Chen, Dechang] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Sheng, Li] Drexel Univ, Dept Math, Philadelphia, PA 19104 USA; [Liu, Amy Y.] Brown Univ, Dept Appl Math, Providence, RI 02912 USA	University System of Maryland; University of Maryland Baltimore; Uniformed Services University of the Health Sciences - USA; Drexel University; Brown University	Liu, ZQ (corresponding author), Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA.	zliu@umm.edu			National Science Foundation (NSF) [ADT-1220747, CCF-0729080]; National Cancer Institute [1R03CA133899]; NATIONAL CANCER INSTITUTE [R03CA133899] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by National Science Foundation (NSF) grant ADT-1220747, the 1R03CA133899 grant from National Cancer Institute, and the NSF CCF-0729080 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jeiroudi G, 2009, J OPTIMIZ THEORY APP, V141, P231, DOI 10.1007/s10957-008-9500-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026624; Antonov AV, 2004, BIOINFORMATICS, V20, P3284, DOI 10.1093/bioinformatics/bth376; Antonov AV, 2004, BIOINFORMATICS, V20, P644, DOI 10.1093/bioinformatics/btg462; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bergamaschi L, 2004, COMPUT OPTIM APPL, V28, P149, DOI 10.1023/B:COAP.0000026882.34332.1b; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dagliyan O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014579; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; Glass Elizabeth M, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5368; Huson D, 2007, GENOME RES, V17; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Knights D., 2010, FEMS MICROBIOL REV, DOI [10.1111/j.1574-6976, DOI 10.1111/J.1574-6976]; Liu ZQ, 2011, BIOINFORMATICS, V27, P3242, DOI 10.1093/bioinformatics/btr547; Liu ZQ, 2010, IEEE ACM T COMPUT BI, V7, P100, DOI 10.1109/TCBB.2008.17; Lozupone C, 2010, ISME J, V5, DOI DOI 10.1128/AEM.01541-09; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Mohammed MH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S4; NAGARSENKER PB, 1984, BIOMETRIKA, V71, P405; Parks DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-328; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quattoni A, 2009, P 26 ANN INT C MACH; Rosen G, 2010, BIOINFORMATICS, V27; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt M, 2008, P C COMP VIS PATT RE; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Tropp J, 2006, SIGNAL PROCESS, V86; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Tzahor S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-229; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Zheng Hao, 2010, Journal of Bioinformatics and Computational Biology, V8, P995, DOI 10.1142/S0219720010005051	40	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e53253	10.1371/journal.pone.0053253	http://dx.doi.org/10.1371/journal.pone.0053253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555553	Green Published, Green Submitted, gold			2022-12-25	WOS:000317418500001
J	Li, HX; Fan, HX; Wang, Z; Zheng, JH; Cao, WW				Li, Haixia; Fan, Haixia; Wang, Zhu; Zheng, Jinhua; Cao, Wenwu			Potentiation of Scutellarin on Human Tongue Carcinoma Xenograft by Low-Intensity Ultrasound	PLOS ONE			English	Article							LOW-LEVEL ULTRASOUND; IN-VITRO; SONODYNAMIC THERAPY; CANCER-CHEMOTHERAPY; FOCUSED ULTRASOUND; CELLS; DELIVERY; PERMEABILIZATION; SONOSENSITIZER; DRUGS	Scutellarin 7-O-beta-D-glucuronide (scutellarin) has shown great potential as a chemotherapeutic agent for cancer treatment, but only at high dosage. Here we investigate the possibility of using low intensity ultrasound to reduce the scutellarin dosage. Ultrasound intensities of 1.0 W/cm(2) and 0.05 W/cm(2) were used for in vivo and in vitro experiments, respectively, and a very low dosage of scutellarin (15 nM) was used. Tumor-bearing Balb/c mice and SAS human-tongue squamous carcinoma cell suspensions were used for the in vivo and in vitro experiments, respectively. Each kind of subjects was divided into control, ultrasound-alone, scutellarin-alone, and combined ultrasound-scutellarin treatment groups. Only the combined treatment showed strong anticancer effects. In the in vivo case, the combined treatment significantly delayed tumor growth, initiated cellular chromatin changes (including a decrease in the number of cytoplasmic organelles and fragmentation of condensed nuclear chromatin), inhibited tumor angiogenesis and lymphangiogenesis, stopped cancer-cell proliferation, decreased MMP-2 and MMP-9 expression levels and caused cancer-cell apoptosis. In the in vitro case, the combined treatment produced cancer cell-shape irregularity in a manner seriously fractured microvilli, inhibited cancer-cell migratory and invasion activities, and induced cancer-cell apoptosis. Because the combined treatment did not increase intracellular ROS production, scutellarin is not a sonosensitizer so that the anticancer effect is not through sonodynamic therapy. Low-intensity ultrasound is merely increasing the permeability of scutellarin into cancer cells. Based on our results, one may perform localized chemotherapy using much reduced dosage of the drug with the help of low intensity ultrasound, which will greatly minimize side effects.	[Li, Haixia; Wang, Zhu; Zheng, Jinhua; Cao, Wenwu] Harbin Inst Technol, Lab Sono & Phototheranost Technol, Harbin 150006, Heilongjiang, Peoples R China; [Li, Haixia; Fan, Haixia; Zheng, Jinhua] Harbin Med Univ, Dept Anat, Coll Basic Med Sci, Harbin, Heilongjiang, Peoples R China; [Cao, Wenwu] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA	Harbin Institute of Technology; Harbin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cao, WW (corresponding author), Harbin Inst Technol, Lab Sono & Phototheranost Technol, Harbin 150006, Heilongjiang, Peoples R China.	dzk@psu.edu	金华, 郑/GWM-7529-2022; Cao, Wenwu/F-6091-2012	Cao, Wenwu/0000-0002-2447-1486	scientific and technical key task of Heilongjiang Provence, China [GC10C306]	scientific and technical key task of Heilongjiang Provence, China	This research was supported by the scientific and technical key task of Heilongjiang Provence, China with the fund number of GC10C306. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Vicente JC, 2007, J ORAL PATHOL MED, V36, P415, DOI 10.1111/j.1600-0714.2007.00546.x; DeVita VT, 2012, NEW ENGL J MED, V366, P2207, DOI 10.1056/NEJMra1204479; Feril LB, 2008, J MED ULTRASON, V35, P161, DOI 10.1007/s10396-008-0195-x; Gao ZXZ, 2010, BIOCHEM BIOPH RES CO, V400, P151, DOI 10.1016/j.bbrc.2010.08.034; Goh D, 2005, J AGR FOOD CHEM, V53, P8197, DOI 10.1021/jf051506+; Griffin XL, 2012, COCHRANE DB SYST REV, V2; Hancock H, 2009, CLIN EXP METASTAS, V26, P729, DOI 10.1007/s10585-009-9272-9; Harrison GH, 1996, ULTRASOUND MED BIOL, V22, P355, DOI 10.1016/0301-5629(95)02053-5; Huang D, 2004, CANCER SCI, V95, P845, DOI 10.1111/j.1349-7006.2004.tb02192.x; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koch MO, 2007, J UROLOGY, V178, P2366, DOI 10.1016/j.juro.2007.08.014; Li HX, 2010, ONCOL REP, V24, P1153, DOI 10.3892/or_00000967; Li YS, 2008, CANCER LETT, V266, P156, DOI 10.1016/j.canlet.2008.02.041; Mazeron R, 2009, ORAL ONCOL, V45, P402, DOI 10.1016/j.oraloncology.2009.01.010; McDannold N, 2012, CANCER RES, V72, P3652, DOI 10.1158/0008-5472.CAN-12-0128; Miller DL, 2006, ULTRASOUND MED BIOL, V32, P1097, DOI 10.1016/j.ultrasmedbio.2006.03.013; Newman CMH, 2007, GENE THER, V14, P465, DOI 10.1038/sj.gt.3302925; Nomikou N, 2010, CANCER LETT, V288, P94, DOI 10.1016/j.canlet.2009.06.028; Oosterhof GON, 1997, EUR UROL, V32, P91, DOI 10.1159/000480887; Rosenthal I, 2004, ULTRASON SONOCHEM, V11, P349, DOI 10.1016/j.ultsonch.2004.03.004; Schroeder A, 2009, CHEM PHYS LIPIDS, V162, P1, DOI 10.1016/j.chemphyslip.2009.08.003; Scully C, 2009, ORAL ONCOL, V45, P301, DOI 10.1016/j.oraloncology.2009.01.004; Shah JP, 2009, ORAL ONCOL, V45, P394, DOI 10.1016/j.oraloncology.2008.05.017; Shibaguchi H, 2011, ANTICANCER RES, V31, P2425; Shohet RV, 2000, CIRCULATION, V101, P2554, DOI 10.1161/01.CIR.101.22.2554; Song W, 2011, ANTICANCER RES, V31, P39; Specenier PM, 2009, ORAL ONCOL, V45, P409, DOI 10.1016/j.oraloncology.2008.05.014; Suh SJ, 2007, PHYTOTHER RES, V21, P135, DOI 10.1002/ptr.2010; Sundaram J, 2003, BIOPHYS J, V84, P3087, DOI 10.1016/S0006-3495(03)70034-4; Teicher BA, 2002, TUMOR MODEL CANC RES, P407; Wang RS, 2010, BIOMED PHARMACOTHER, V64, P309, DOI 10.1016/j.biopha.2009.09.011; Weidner N, 1991, NEW ENGL J MED, V32, P1, DOI DOI 10.1056/NEJM19910103; Yu T, 2001, ULTRASONICS, V39, P307, DOI 10.1016/S0041-624X(01)00051-8; Yu TH, 2006, TECHNOL CANCER RES T, V5, P51, DOI 10.1177/153303460600500107; Yu TH, 2004, ULTRASON SONOCHEM, V11, P95, DOI 10.1016/S1350-4177(03)00157-3; Zolochevska Olga, 2012, Front Biosci (Schol Ed), V4, P988; Zolochevska O, 2011, HUM GENE THER, V22, P1537, DOI 10.1089/hum.2011.076	37	36	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59473	10.1371/journal.pone.0059473	http://dx.doi.org/10.1371/journal.pone.0059473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536878	Green Published, gold			2022-12-25	WOS:000317397200026
J	Babur, BK; Ghanavi, P; Levett, P; Lott, WB; Klein, T; Cooper-White, JJ; Crawford, R; Doran, MR				Babur, Betul Kul; Ghanavi, Parisa; Levett, Peter; Lott, William B.; Klein, Travis; Cooper-White, Justin J.; Crawford, Ross; Doran, Michael R.			The Interplay between Chondrocyte Redifferentiation Pellet Size and Oxygen Concentration	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; MESENCHYMAL STEM-CELLS; MICROCARRIERS ENHANCES REDIFFERENTIATION; FORMATION IN-VITRO; HYALURONIC-ACID; CARTILAGE DEFECTS; STROMAL CELLS; KNEE; IMPLANTATION; CULTURES	Chondrocytes dedifferentiate during ex vivo expansion on 2-dimensional surfaces. Aggregation of the expanded cells into 3-dimensional pellets, in the presence of induction factors, facilitates their redifferentiation and restoration of the chondrogenic phenotype. Typically 1x10(5)-5x10(5) chondrocytes are aggregated, resulting in "macro" pellets having diameters ranging from 1-2 mm. These macropellets are commonly used to study redifferentiation, and recently macropellets of autologous chondrocytes have been implanted directly into articular cartilage defects to facilitate their repair. However, diffusion of metabolites over the 1-2 mm pellet length-scales is inefficient, resulting in radial tissue heterogeneity. Herein we demonstrate that the aggregation of 2x10(5) human chondrocytes into micropellets of 166 cells each, rather than into larger single macropellets, enhances chondrogenic redifferentiation. In this study, we describe the development of a cost effective fabrication strategy to manufacture a microwell surface for the large-scale production of micropellets. The thousands of micropellets were manufactured using the microwell platform, which is an array of 360x360 mu m microwells cast into polydimethylsiloxane (PDMS), that has been surface modified with an electrostatic multilayer of hyaluronic acid and chitosan to enhance micropellet formation. Such surface modification was essential to prevent chondrocyte spreading on the PDMS. Sulfated glycosaminoglycan (sGAG) production and collagen II gene expression in chondrocyte micropellets increased significantly relative to macropellet controls, and redifferentiation was enhanced in both macro and micropellets with the provision of a hypoxic atmosphere (2% O-2). Once micropellet formation had been optimized, we demonstrated that micropellets could be assembled into larger cartilage tissues. Our results indicate that micropellet amalgamation efficiency is inversely related to the time cultured as discreet microtissues. In summary, we describe a micropellet production platform that represents an efficient tool for studying chondrocyte redifferentiation and demonstrate that the micropellets could be assembled into larger tissues, potentially useful in cartilage defect repair.	[Babur, Betul Kul; Ghanavi, Parisa; Lott, William B.; Doran, Michael R.] Queensland Univ Technol, Fac Hlth, Inst Hlth & Biomed Innovat, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia; [Babur, Betul Kul; Ghanavi, Parisa; Lott, William B.; Doran, Michael R.] Translat Res Inst, Brisbane, Qld, Australia; [Levett, Peter; Klein, Travis; Crawford, Ross] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Cooper-White, Justin J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Tissue Engn & Microfluid Lab, Brisbane, Qld, Australia; [Doran, Michael R.] Mater Med Res Inst, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Queensland; Mater Research	Doran, MR (corresponding author), Queensland Univ Technol, Fac Hlth, Inst Hlth & Biomed Innovat, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia.	michael.doran@qut.edu.au	Klein, Travis/J-1117-2012; Lott, William/J-1062-2012	Klein, Travis/0000-0002-6669-7766; Lott, William/0000-0001-7118-7560; Crawford, Ross/0000-0001-6079-1316; Cooper-White, Justin/0000-0002-1920-8229; Doran, Michael/0000-0001-5876-4757	Australian National Health and Medical Research Council (NHMRC), Perpetual Philanthropies	Australian National Health and Medical Research Council (NHMRC), Perpetual Philanthropies	This study was funded by the Australian National Health and Medical Research Council (NHMRC), Perpetual Philanthropies, and a generous donation from Mr. James Carruthers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderer U, 2002, J BONE MINER RES, V17, P1420, DOI 10.1359/jbmr.2002.17.8.1420; Banu N, 2007, J BIOMED MATER RES A, V80A, P257, DOI 10.1002/jbm.a.30931; Bhattacharya S, 2005, J MICROELECTROMECH S, V14, P590, DOI 10.1109/JMEMS.2005.844746; Boeuf S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt31; Bongaerts JHH, 2009, BIOMACROMOLECULES, V10, P1287, DOI 10.1021/bm801079a; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Cameron HU, 1997, CAN J SURG, V40, P114; Cao Z, 2012, BIOTECHNOL LETT, V34, P1151, DOI 10.1007/s10529-012-0884-9; Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021; Cherubino P, 2003, J Orthop Surg (Hong Kong), V11, P10; Cook MM, 2012, TISSUE ENG PART C-ME, V18, P319, DOI [10.1089/ten.tec.2011.0159, 10.1089/ten.TEC.2011.0159]; Coyle CH, 2009, J ORTHOP RES, V27, P793, DOI 10.1002/jor.20816; Croucher LJ, 2000, BBA-MOL BASIS DIS, V1502, P297, DOI 10.1016/S0925-4439(00)00055-7; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; Doran MR, 2010, TISSUE ENG PART C-ME, V16, P407, DOI [10.1089/ten.tec.2009.0367, 10.1089/ten.TEC.2009.0367]; Doran MR, 2010, BIOMATERIALS, V31, P5137, DOI 10.1016/j.biomaterials.2010.03.015; Erisken C, 2011, TISSUE ENG PT A, V17, P1239, DOI [10.1089/ten.tea.2009.0693, 10.1089/ten.TEA.2009.0693]; Fu YQ, 2009, J VAC SCI TECHNOL B, V27, P1520, DOI 10.1116/1.3065991; Gillogly SD, 1998, J ORTHOP SPORT PHYS, V28, P241, DOI 10.2519/jospt.1998.28.4.241; Giovannini S, 2010, EUR CELLS MATER, V20, P245; Goldberg AJ, 2005, J BONE JOINT SURG BR, V87B, P128, DOI 10.1302/0301-620X.87B1.14154; Grayson WL, 2010, OSTEOARTHR CARTILAGE, V18, P714, DOI 10.1016/j.joca.2010.01.008; Haasper C, 2009, KNEE SURG SPORT TR A, V17, P1384, DOI 10.1007/s00167-009-0791-3; Harris JD, 2011, OSTEOARTHR CARTILAGE, V19, P779, DOI 10.1016/j.joca.2011.02.010; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; HOLTZER H, 1960, P NATL ACAD SCI USA, V46, P1533, DOI 10.1073/pnas.46.12.1533; Hsieh-Bonassera ND, 2009, TISSUE ENG PT A, V15, P3513, DOI [10.1089/ten.tea.2008.0628, 10.1089/ten.TEA.2008.0628]; Imabayashi H, 2003, EXP CELL RES, V288, P35, DOI 10.1016/S0014-4827(03)00130-7; Kabiri M, 2012, BIOCHEM BIOPH RES CO, V419, P142, DOI 10.1016/j.bbrc.2012.01.017; Klein TJ, 2009, TISSUE ENG PART B-RE, V15, P143, DOI 10.1089/ten.TEB.2008.0563; Kon E, 2009, AM J SPORT MED, V37, P33, DOI 10.1177/0363546508323256; Liebman J., 2001, CURRENT PROTOCOLS PH; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Lutzner J, 2009, NAT REV RHEUMATOL, V5, P309, DOI 10.1038/nrrheum.2009.88; Malda J, 2003, BIOMATERIALS, V24, P5153, DOI 10.1016/S0142-9612(03)00428-9; Malda J, 2003, TISSUE ENG, V9, P939, DOI 10.1089/107632703322495583; Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560; Perrot S, 1996, DRUGS, V52, P21, DOI 10.2165/00003495-199600523-00005; Shahin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023119; Siebold R, 2011, KNEE SURG SPORT TR A, V19, P2036, DOI 10.1007/s00167-011-1505-1; Tallheden T, 2004, OSTEOARTHR CARTILAGE, V12, P525, DOI 10.1016/j.joca.2004.03.004; Tan GK, 2010, BIOMATERIALS, V31, P6104, DOI 10.1016/j.biomaterials.2010.04.018; Tare RS, 2005, BIOCHEM BIOPH RES CO, V333, P609, DOI 10.1016/j.bbrc.2005.05.117; Teixeira LSM, 2012, EUR CELLS MATER, V23, P387, DOI 10.22203/eCM.v023a30; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Van Assche D, 2010, KNEE SURG SPORT TR A, V18, P486, DOI 10.1007/s00167-009-0955-1; Vavken P, 2010, OSTEOARTHR CARTILAGE, V18, P857, DOI 10.1016/j.joca.2010.03.005; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Yen CN, 2008, BIOTECHNOL PROGR, V24, P452, DOI 10.1021/bp0702828	50	59	61	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58865	10.1371/journal.pone.0058865	http://dx.doi.org/10.1371/journal.pone.0058865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554943	gold, Green Published, Green Submitted			2022-12-25	WOS:000316409800039
J	Jensen, HA; Styskal, LE; Tasseff, R; Bunaciu, RP; Congleton, J; Varner, JD; Yen, A				Jensen, Holly A.; Styskal, Lauren E.; Tasseff, Ryan; Bunaciu, Rodica P.; Congleton, Johanna; Varner, Jeffrey D.; Yen, Andrew			The Src-Family Kinase Inhibitor PP2 Rescues Inducible Differentiation Events in Emergent Retinoic Acid-Resistant Myeloblastic Leukemia Cells	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; LIGAND-BINDING DOMAIN; HL-60 CELLS; PHOSPHORYLATION SITES; MYELOID-LEUKEMIA; RECEPTOR-ALPHA; PROTEIN-KINASE; RAF-1 KINASE; C-RAF; ACTIVATION	Retinoic acid is an embryonic morphogen and dietary factor that demonstrates chemotherapeutic efficacy in inducing maturation in leukemia cells. Using HL60 model human myeloid leukemia cells, where all-trans retinoic acid (RA) induces granulocytic differentiation, we developed two emergent RA-resistant HL60 cell lines which are characterized by loss of RA-inducible G1/G0 arrest, CD11b expression, inducible oxidative metabolism and p47(phox) expression. However, RA-treated RA-resistant HL60 continue to exhibit sustained MEK/ERK activation, and one of the two sequentially emergent resistant lines retains RA-inducible CD38 expression. Other signaling events that define the wild-type (WT) response are compromised, including c-Raf phosphorylation and increased expression of c-Cbl, Vav1, and the Src-family kinases (SFKs) Lyn and Fgr. As shown previously in WT HL60 cells, we found that the SFK inhibitor PP2 significantly increases G1/G0 cell cycle arrest, CD38 and CD11b expression, c-Raf phosphorylation and expression of the aforementioned regulators in RA-resistant HL60. The resistant cells were potentially incapable of developing inducible oxidative metabolism. These results motivate the concept that RA resistance can occur in steps, wherein growth arrest and other differentiation events may be recovered in both emergent lines. Investigating the mechanistic anomalies in resistant cell lines is of therapeutic significance and helps to mechanistically understand the response to retinoic acid's biological effects in WT HL60 cells.	[Jensen, Holly A.; Tasseff, Ryan; Varner, Jeffrey D.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY USA; [Styskal, Lauren E.] Cornell Univ, Dept Biol Engn, Ithaca, NY USA; [Bunaciu, Rodica P.; Congleton, Johanna; Yen, Andrew] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA	Cornell University; Cornell University; Cornell University	Yen, A (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA.	ay13@cornell.edu		Bunaciu, Rodica/0000-0002-3101-0928	National Institutes of Health (NIH) [CA033505, CA152870]; NYSTEM New York State Department of Health; National Science Foundation CAREER (NSF) [CBET-0846876]; NATIONAL CANCER INSTITUTE [R01CA033505, R01CA152870] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [0846876] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM New York State Department of Health; National Science Foundation CAREER (NSF)(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by grants from the National Institutes of Health (NIH) (R01 # CA033505 and CA152870) and a NYSTEM New York State Department of Health grant to Andrew Yen. The authors acknowledge the gracious financial support of the National Science Foundation CAREER (NSF # CBET-0846876) to Jeffrey Varner for support of H.A.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Bertagnolo V, 2004, CELL SIGNAL, V16, P423, DOI 10.1016/j.cellsig.2003.09.013; Bertagnolo V, 2005, EXP CELL RES, V306, P56, DOI 10.1016/j.yexcr.2004.12.001; BIRNIE GD, 1988, BRIT J CANCER, V58, P41; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Brugnoli F, 2010, EXP CELL RES, V316, P38, DOI 10.1016/j.yexcr.2009.09.004; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; COLLINS SJ, 1979, J EXP MED, V149, P969, DOI 10.1084/jem.149.4.969; COLLINS SJ, 1987, BLOOD, V70, P1233; Congleton J, 2012, LEUKEMIA, V26, P1180, DOI 10.1038/leu.2011.390; DE LUCA LM, 1991, FASEB J, V5, P2924; Dhillon AS, 2007, CELL CYCLE, V6, P3, DOI 10.4161/cc.6.1.3593; Dore BT, 1996, LEUKEMIA RES, V20, P761, DOI 10.1016/0145-2126(96)00043-4; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; FONTANA JA, 1981, P NATL ACAD SCI-BIOL, V78, P3863, DOI 10.1073/pnas.78.6.3863; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hoyos B, 2005, J BIOL CHEM, V280, P6872, DOI 10.1074/jbc.M412695200; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; KATAGIRI K, 1991, J IMMUNOL, V146, P701; Kobayashi T, 2001, REDOX REP, V6, P27, DOI 10.1179/135100001101536003; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kropf PL, 2010, LEUKEMIA, V24, P663, DOI 10.1038/leu.2009.267; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lamkin TJ, 2006, J CELL BIOCHEM, V97, P1328, DOI 10.1002/jcb.20745; Lee M, 2004, J BIOL CHEM, V279, P48692, DOI 10.1074/jbc.M403132200; Lee M, 2006, BIOCHEM BIOPH RES CO, V350, P450, DOI 10.1016/j.bbrc.2006.09.067; Li ZP, 2006, BIOCHEM BIOPH RES CO, V341, P363, DOI 10.1016/j.bbrc.2005.12.193; MAZZONE A, 1995, HAEMATOLOGICA, V80, P161; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mehta K, 1997, BLOOD, V89, P3607, DOI 10.1182/blood.V89.10.3607.3607_3607_3614; Miranda MB, 2007, MOL CANCER THER, V6, P3081, DOI 10.1158/1535-7163.MCT-07-0514; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Opavsky MA, 2002, J CLIN INVEST, V109, P1561, DOI 10.1172/JCI200213971; Pandolfi PP, 2007, ACUTE PROMYELOCYTIC; PRATT MAC, 1990, MOL CELL BIOL, V10, P6445, DOI 10.1128/MCB.10.12.6445; ROBERTSON KA, 1992, BLOOD, V80, P1885; Roginskaya V, 1999, LEUKEMIA, V13, P855, DOI 10.1038/sj.leu.2401429; Shao WL, 1997, BLOOD, V89, P4282, DOI 10.1182/blood.V89.12.4282; Shen MQ, 2008, CANCER RES, V68, P8761, DOI 10.1158/0008-5472.CAN-08-1058; Shen MQ, 2009, J BIOL CHEM, V284, P25664, DOI 10.1074/jbc.M109.014241; Smith J, 2009, EXP CELL RES, V315, P2241, DOI 10.1016/j.yexcr.2009.03.004; Spreafico A, 2008, FASEB J, V22, P1560, DOI 10.1096/fj.07-9873com; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Tran NH, 2003, J BIOL CHEM, V278, P11221, DOI 10.1074/jbc.M210318200; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Yamaguchi K, 2005, CANCER CHEMOTH PHARM, V56, P585, DOI 10.1007/s00280-005-1030-3; Yen A, 2006, EUR J CELL BIOL, V85, P117, DOI 10.1016/j.ejcb.2005.09.020; YEN A, 1987, CANCER RES, V47, P129; Yen A, 1998, CANCER RES, V58, P3163; Zumaquero E, 2010, EXP CELL RES, V316, P2692, DOI 10.1016/j.yexcr.2010.05.032	54	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58621	10.1371/journal.pone.0058621	http://dx.doi.org/10.1371/journal.pone.0058621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554907	gold, Green Submitted, Green Published			2022-12-25	WOS:000316409800020
J	Mayo, C; de los Santos, LF; Kruse, J; Blackwell, CR; McLemore, LB; Pafundi, D; Stoker, J; Herman, M				Mayo, Charles; de los Santos, Luis Fong; Kruse, Jon; Blackwell, Charles R.; McLemore, Luke B.; Pafundi, Deanna; Stoker, Joshua; Herman, Michael			Report on Use of a Methodology for Commissioning and Quality Assurance of a VMAT System	PLOS ONE			English	Article							PASSING RATES; RAPIDARC; QA; DOSIMETRY; DELIVERY	Introduction: Results of use of methodology for VMAT commissioning and quality assurance, utilizing both control point tests and dosimetric measurements are presented. Methods and Materials: A generalizable, phantom measurement approach is used to characterize the accuracy of the measurement system. Correction for angular response of the measurement system and inclusion of couch structures are used to characterize the full range gantry angles desirable for clinical plans. A dose based daily QA measurement approach is defined. Results: Agreement in the static vs. VMAT picket fence control point test was better than 0.5 mm. Control point tests varying gantry rotation speed, leaf speed and dose rate, demonstrated agreement with predicted values better than 1%. Angular dependence of the MatriXX array, varied over a range of 0.94-1.06, with respect to the calibration condition. Phantom measurements demonstrated central axis dose accuracy for un-modulated four field box plans was >= 2.5% vs. 1% with and without angular correction respectively with better results for VMAT (0.4%) vs. IMRT (1.6%) plans. Daily QA results demonstrated average agreement all three chambers within 0.4% over 9 month period with no false positives at a 3% threshold. Discussion: The methodology described is simple in design and characterizes both the inherit limitations of the measurement system as well at the dose based measurements that may be directly related to patient plan QA.	[Mayo, Charles; de los Santos, Luis Fong; Kruse, Jon; Blackwell, Charles R.; McLemore, Luke B.; Pafundi, Deanna; Stoker, Joshua; Herman, Michael] Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA	Mayo Clinic	Mayo, C (corresponding author), Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA.	mayo.charles@mayo.edu		Stoker, Joshua/0000-0002-0486-1495				Bedford JL, 2009, INT J RADIAT ONCOL, V73, P537, DOI 10.1016/j.ijrobp.2008.08.055; Chandraraj V, 2011, J APPL CLIN MED PHYS, V12, P338, DOI 10.1120/jacmp.v12i2.3367; Clivio A, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-129; Dobler B, 2011, RADIOTHER ONCOL, V99, P86, DOI 10.1016/j.radonc.2011.01.024; Ezzell GA, 2009, MED PHYS, V36, P5359, DOI 10.1118/1.3238104; Gloi AM, 2011, J APPL CLIN MED PHYS, V12, P39, DOI 10.1120/jacmp.v12i2.3251; Iftimia I, 2010, J APPL CLIN MED PHYS, V11, P130, DOI 10.1120/jacmp.v11i4.3164; Klein EE, 2009, MED PHYS, V36, P4197, DOI 10.1118/1.3190392; Kruse JJ, 2010, MED PHYS, V37, P2516, DOI 10.1118/1.3425781; Ling CC, 2008, INT J RADIAT ONCOL, V72, P575, DOI 10.1016/j.ijrobp.2008.05.060; Masi L, 2011, MED PHYS, V38, P612, DOI 10.1118/1.3533900; Nelms BE, 2011, MED PHYS, V38, P1037, DOI 10.1118/1.3544657; Palta JR, 2003, INTENSITY MODULATED, V29, P593; Van Esch A, 2011, MED PHYS, V38, P5146, DOI 10.1118/1.3622672; Zhen HM, 2011, MED PHYS, V38, P5477, DOI 10.1118/1.3633904	15	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58877	10.1371/journal.pone.0058877	http://dx.doi.org/10.1371/journal.pone.0058877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554948	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800042
J	Nayak, RC; Keshava, S; Esmon, CT; Pendurthi, UR; Rao, LVM				Nayak, Ramesh C.; Keshava, Shiva; Esmon, Charles T.; Pendurthi, Usha R.; Rao, L. Vijaya Mohan			Rab GTPases Regulate Endothelial Cell Protein C Receptor-Mediated Endocytosis and Trafficking of Factor VIIa	PLOS ONE			English	Article							RECYCLING ENDOSOME; PATHWAY; BINDING; FUSION; COMPARTMENT; INHIBITION; DISEASE; GTP	Recent studies have established that factor VIIa (FVIIa) binds to the endothelial cell protein C receptor (EPCR). FVIIa binding to EPCR may promote the endocytosis of this receptor/ligand complex. Rab GTPases are known to play a crucial role in the endocytic and exocytic pathways of receptors or receptor/ligand complexes. The present study was undertaken to investigate the role of Rab GTPases in the intracellular trafficking of EPCR and FVIIa. CHO-EPCR cells and human umbilical vein endothelial cells (HUVEC) were transduced with recombinant adenoviral vectors to express wild-type, constitutively active, or dominant negative mutant of various Rab GTPases. Cells were exposed to FVIIa conjugated with AF488 fluorescent probe (AF488-FVIIa), and intracellular trafficking of FVIIa, EPCR, and Rab proteins was evaluated by immunofluorescence confocal microscopy. In cells expressing wild-type or constitutively active Rab4A, internalized AF488-FVIIa accumulated in early/sorting endosomes and its entry into the recycling endosomal compartment (REC) was inhibited. Expression of constitutively active Rab5A induced large endosomal structures beneath the plasma membrane where EPCR and FVIIa accumulated. Dominant negative Rab5A inhibited the endocytosis of EPCR-FVIIa. Expression of constitutively active Rab11 resulted in retention of accumulated AF488-FVIIa in the REC, whereas expression of a dominant negative form of Rab11 led to accumulation of internalized FVIIa in the cytoplasm and prevented entry of internalized FVIIa into the REC. Expression of dominant negative Rab11 also inhibited the transport of FVIIa across the endothelium. Overall our data show that Rab GTPases regulate the internalization and intracellular trafficking of EPCR-FVIIa.	[Nayak, Ramesh C.; Keshava, Shiva; Pendurthi, Usha R.; Rao, L. Vijaya Mohan] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Esmon, Charles T.] Howard Hughes Med Inst, Oklahoma Med Res Fdn, Coagulat Biol Lab, Oklahoma City, OK USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Howard Hughes Medical Institute; Oklahoma Medical Research Foundation	Rao, LVM (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA.	Vijay.Rao@uthct.edu		Nayak, Ramesh/0000-0002-3206-8152	National Institutes of Health [HL58869, HL107483]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107483, R01HL058869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL58869 and HL107483 to LVMR from the National Institutes of Health. CTE is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Clark CA, 2012, J THROMB HAEMOST, V10, P2383, DOI 10.1111/j.1538-7836.2012.04917.x; Duvernay MT, 2005, CELL SIGNAL, V17, P1457, DOI 10.1016/j.cellsig.2005.05.020; Esseltine JL, 2011, MOL PHARMACOL, V79, P175, DOI 10.1124/mol.110.068379; Etzion S, 2010, J MOL CELL CARDIOL, V49, P931, DOI 10.1016/j.yjmcc.2010.08.011; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Ghosh S, 2007, J BIOL CHEM, V282, P11849, DOI 10.1074/jbc.M609283200; Ginsberg SD, 2010, J ALZHEIMERS DIS, V22, P631, DOI 10.3233/JAD-2010-101080; Gopalakrishnan R, 2010, J THROMB HAEMOST, V8, P301, DOI 10.1111/j.1538-7836.2009.03696.x; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Hou QS, 2008, CANCER RES, V68, P4623, DOI 10.1158/0008-5472.CAN-07-5870; Hsu VW, 2010, CURR OPIN CELL BIOL, V22, P528, DOI 10.1016/j.ceb.2010.05.008; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Laszik Z, 1997, CIRCULATION, V96, P3633; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; LI GP, 1993, J BIOL CHEM, V268, P24475; Lopez-Sagaseta J, 2007, J THROMB HAEMOST, V5, P1817, DOI 10.1111/j.1538-7836.2007.02648.x; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; MERESSE S, 1995, J CELL SCI, V108, P3349; Nayak RC, 2009, BLOOD, V114, P1974, DOI 10.1182/blood-2009-03-208900; Odley A, 2004, P NATL ACAD SCI USA, V101, P7082, DOI 10.1073/pnas.0308335101; Osanai K, 2008, AM J PATHOL, V173, P1265, DOI 10.2353/ajpath.2008.080056; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Regan LM, 1996, J BIOL CHEM, V271, P17499, DOI 10.1074/jbc.271.29.17499; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Roberts RL, 1999, J CELL SCI, V112, P3667; Rosenfeld JL, 2002, RECEPTOR CHANNEL, V8, P87, DOI 10.1080/10606820212398; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Sen P, 2011, BLOOD, V118, P2635, DOI 10.1182/blood-2011-05-354571; Sen P, 2011, BLOOD, V117, P3199, DOI 10.1182/blood-2010-09-310706; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang XY, 2000, J BIOL CHEM, V275, P29138, DOI 10.1074/jbc.M004410200; Wu GY, 2001, CIRC RES, V89, P1130, DOI 10.1161/hh2401.100427; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	42	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59304	10.1371/journal.pone.0059304	http://dx.doi.org/10.1371/journal.pone.0059304			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555015	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800083
J	Messner, B; Kern, J; Wiedemann, D; Schwaiger, S; Turkcan, A; Ploner, C; Trockenbacher, A; Aumayr, K; Bonaros, N; Laufer, G; Stuppner, H; Untergasser, G; Bernhard, D				Messner, Barbara; Kern, Johann; Wiedemann, Dominik; Schwaiger, Stefan; Tuerkcan, Adrian; Ploner, Christian; Trockenbacher, Alexander; Aumayr, Klaus; Bonaros, Nikolaos; Laufer, Guenther; Stuppner, Hermann; Untergasser, Gerold; Bernhard, David			5-Methoxyleoligin, a Lignan from Edelweiss, Stimulates CYP26B1-Dependent Angiogenesis In Vitro and Induces Arteriogenesis in Infarcted Rat Hearts In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR; LEONTOPODIUM-ALPINUM; INTIMAL HYPERPLASIA; MAJOR LIGNAN; MECHANISMS; LEOLIGIN; CADMIUM	Background: Insufficient angiogenesis and arteriogenesis in cardiac tissue after myocardial infarction (MI) is a significant factor hampering the functional recovery of the heart. To overcome this problem we screened for compounds capable of stimulating angiogenesis, and herein investigate the most active molecule, 5-Methoxyleoligin (5ML), in detail. Methods and Results: 5ML potently stimulated endothelial tube formation, angiogenic sprouting, and angiogenesis in a chicken chorioallantoic membrane assay. Further, microarray- and knock down-based analyses revealed that 5ML induces angiogenesis by upregulation of CYP26B1. In an in vivo rat MI model 5ML potently increased the number of arterioles in the peri-infarction and infarction area, reduced myocardial muscle loss, and led to a significant increase in LV function (plus 21% 28 days after MI). Conclusion: The present study shows that 5ML induces CYP26B1-dependent angiogenesis in vitro, and arteriogenesis in vivo. Whether or not CYP26B1 is relevant for in vivo arteriogenesis is not clear at the moment. Importantly, 5ML-induced arteriogenesis in vivo makes the compound even more interesting for a post MI therapy. 5ML may constitute the first low molecular weight compound leading to an improvement of myocardial function after MI.	[Messner, Barbara; Wiedemann, Dominik; Tuerkcan, Adrian; Laufer, Guenther; Bernhard, David] Med Univ Vienna, Dept Surg, Cardiac Surg Res Lab, Vienna, Austria; [Kern, Johann; Untergasser, Gerold] Med Univ Innsbruck, Div Internal Med 5, A-6020 Innsbruck, Austria; [Wiedemann, Dominik; Bonaros, Nikolaos; Bernhard, David] Med Univ Innsbruck, Cardiac Surg Res Lab, Dept Cardiac Surg, A-6020 Innsbruck, Austria; [Schwaiger, Stefan; Stuppner, Hermann] Univ Innsbruck, Inst Pharm Pharmacognosy, A-6020 Innsbruck, Austria; [Ploner, Christian] Med Univ Innsbruck, Dept Plast & Reconstruct Surg, A-6020 Innsbruck, Austria; [Trockenbacher, Alexander] Med Univ Innsbruck, Bioctr, Div Mol Pathophysiol, A-6020 Innsbruck, Austria; [Aumayr, Klaus] Med Univ Vienna, Dept Pathol, Vienna, Austria	Medical University of Vienna; Medical University of Innsbruck; Medical University of Innsbruck; University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Vienna	Bernhard, D (corresponding author), Med Univ Vienna, Dept Surg, Cardiac Surg Res Lab, Vienna, Austria.	David.Bernhard@i-med.ac.at	Messner, Barbara/GLS-8150-2022; Bonaros, Nikolaos/N-7236-2017; Wiedemann, Dominik/AAH-2649-2020; Schwaiger, Stefan/W-8296-2019	Messner, Barbara/0000-0001-8331-6497; Bonaros, Nikolaos/0000-0002-7656-5812; Wiedemann, Dominik/0000-0002-2055-8293; Schwaiger, Stefan/0000-0002-3731-7349; Bernhard, David/0000-0002-2383-6607; Ploner, Christian/0000-0002-0313-2960; Turkcan, Adrian/0000-0002-9750-1690	TWF ("Tiroler Zukunftsstiftung"); Austrain Science Fund (FWF) [DNTI S10703]; Austrian National Bank [14745, 14590]	TWF ("Tiroler Zukunftsstiftung"); Austrain Science Fund (FWF); Austrian National Bank	This project was supported by the TWF ("Tiroler Zukunftsstiftung"), the Austrain Science Fund (FWF; DNTI S10703, the Austrian National Bank Project 14745 to D. B. and also by the Austrian National Bank Project 14590 to B. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhard D, 2006, ARTERIOSCL THROM VAS, V26, P833, DOI 10.1161/01.ATV.0000205616.70614.e5; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Cai WJ, 2008, ACTA BIOCH BIOPH SIN, V40, P681, DOI 10.1111/j.1745-7270.2008.00436.x; Chen P, 2005, AM J PATHOL, V166, P615, DOI 10.1016/S0002-9440(10)62282-1; Coats AJS, 2011, INT J CARDIOL, V153, P239, DOI 10.1016/j.ijcard.2011.10.119; Dobner MJ, 2004, PLANTA MED, V70, P502, DOI 10.1055/s-2004-827148; Duwensee K, 2011, ATHEROSCLEROSIS, V219, P109, DOI 10.1016/j.atherosclerosis.2011.07.023; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Henderson B, 2008, ATHEROSCLEROSIS, V201, P298, DOI 10.1016/j.atherosclerosis.2008.02.022; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Korff T, 1999, J CELL SCI, V112, P3249; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Messner B, 2009, ARTERIOSCL THROM VAS, V29, P1392, DOI 10.1161/ATVBAHA.109.190082; Michaelis UR, 2003, FASEB J, V17, P770, DOI 10.1096/fj.02-0640fje; Nikol S, 2008, MOL THER, V16, P972, DOI 10.1038/mt.2008.33; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; Pieske B, 2004, EUR HEART J SUPPL, V6, pD66, DOI 10.1016/j.ehjsup.2004.05.019; Reisinger U, 2009, CARDIOVASC RES, V82, P542, DOI 10.1093/cvr/cvp059; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SASAYAMA S, 1992, CIRCULATION, V85, P1197, DOI 10.1161/01.CIR.85.3.1197; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Schwaiger S, 2004, PLANTA MED, V70, P978, DOI 10.1055/s-2004-832625; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Yu W, 2011, CANCER CHEMOTH PHARM, V68, P619, DOI 10.1007/s00280-010-1521-8; Zeller I, 2010, ARTERIOSCL THROM VAS, V30, P1733, DOI 10.1161/ATVBAHA.110.211011	29	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58342	10.1371/journal.pone.0058342	http://dx.doi.org/10.1371/journal.pone.0058342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554885	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500021
J	Moore, HM; Bai, BY; Matilainen, O; Colis, L; Peltonen, K; Laiho, M				Moore, Henna M.; Bai, Baoyan; Matilainen, Olli; Colis, Laureen; Peltonen, Karita; Laiho, Marikki			Proteasome Activity Influences UV-Mediated Subnuclear Localization Changes of NPM	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; RIBOSOMAL-PROTEINS; UBIQUITIN; NUCLEOLUS; P53; BIOGENESIS; DAMAGE; RECOGNITION; DEGRADATION; COMPONENTS	UV damage activates cellular stress signaling pathways, causes DNA helix distortions and inhibits transcription by RNA polymerases I and II. In particular, the nucleolus, which is the site of RNA polymerase I transcription and ribosome biogenesis, disintegrates following UV damage. The disintegration is characterized by reorganization of the subnucleolar structures and change of localization of many nucleolar proteins. Here we have queried the basis of localization change of nucleophosmin (NPM), a nucleolar granular component protein, which is increasingly detected in the nucleoplasm following UV radiation. Using photobleaching experiments of NPM-fluorescent fusion protein in live human cells we show that NPM mobility increases after UV damage. However, we show that the increase in NPM nucleoplasmic abundance after UV is independent of UV-activated cellular stress and DNA damage signaling pathways. Unexpectedly, we find that proteasome activity affects NPM redistribution. NPM nucleolar expression was maintained when the UV-treated cells were exposed to proteasome inhibitors or when the expression of proteasome subunits was inhibited using RNAi. However, there was no evidence of increased NPM turnover in the UV damaged cells, or that ubiquitin or ubiquitin recycling affected NPM localization. These findings suggest that proteasome activity couples to nucleolar protein localizations in UV damage stress.	[Moore, Henna M.; Matilainen, Olli; Peltonen, Karita; Laiho, Marikki] Univ Helsinki, Mol Canc Biol Program, Helsinki, Finland; [Bai, Baoyan; Colis, Laureen; Laiho, Marikki] Johns Hopkins Univ Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Bai, Baoyan; Colis, Laureen; Laiho, Marikki] Johns Hopkins Univ Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA	University of Helsinki; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Laiho, M (corresponding author), Univ Helsinki, Mol Canc Biol Program, Helsinki, Finland.	mlaiho1@jhmi.edu		Peltonen, Karita Dolores/0000-0002-3063-451X; Matilainen, Olli/0000-0001-9939-4828	Academy of Finland [251307]; Finnish Cancer Organisations; K. Albin Johanssons stiftelse; Magnus Ehrnrooth Foundation; Maud Kuistila Memorial Foundation; Ida Montin Foundation	Academy of Finland(Academy of Finland); Finnish Cancer Organisations; K. Albin Johanssons stiftelse; Magnus Ehrnrooth Foundation; Maud Kuistila Memorial Foundation; Ida Montin Foundation	This work was funded by Academy of Finland (grant no. 251307), Finnish Cancer Organisations, K. Albin Johanssons stiftelse, Magnus Ehrnrooth Foundation, The Maud Kuistila Memorial Foundation, and The Ida Montin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Arabi A, 2003, J CELL SCI, V116, P1707, DOI 10.1242/jcs.00370; Bancaud Aurelien, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.top90; Beryink S, 2007, DNA REPAIR, V6, P1231, DOI 10.1016/j.dnarep.2007.01.012; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Boyd MT, 2011, J CELL BIOL, V194, P689, DOI 10.1083/jcb.201105143; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cioce M, 2006, J CELL BIOL, V175, P401, DOI 10.1083/jcb.200604099; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Cornish T, 2008, ARCH PATHOL LAB MED, V132, P856; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Endo A, 2009, J BIOL CHEM, V284, P27918, DOI 10.1074/jbc.M109.037218; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Latonen L, 2011, ONCOGENE, V30, P790, DOI 10.1038/onc.2010.469; Leary DJ, 2001, FEBS LETT, V509, P145, DOI 10.1016/S0014-5793(01)03143-X; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Lo D, 2012, J BIOL CHEM, V287, P10013, DOI 10.1074/jbc.M111.335141; Louvet E, 2005, EXP CELL RES, V304, P457, DOI 10.1016/j.yexcr.2004.11.018; Mattsson K, 2001, P NATL ACAD SCI USA, V98, P1012, DOI 10.1073/pnas.031566998; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Moore HM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009241; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; REDMAN KL, 1989, NATURE, V338, P438, DOI 10.1038/338438a0; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; Scharf A, 2007, HISTOCHEM CELL BIOL, V127, P591, DOI 10.1007/s00418-006-0266-2; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Shcherbik Natalia, 2010, Genes Cancer, V1, P681; Stark LA, 2009, EMBO REP, V10, P35, DOI 10.1038/embor.2008.230; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; WARNER JR, 1977, J MOL BIOL, V115, P315, DOI 10.1016/0022-2836(77)90157-7; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	59	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59096	10.1371/journal.pone.0059096	http://dx.doi.org/10.1371/journal.pone.0059096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554979	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500068
J	Burnett, BJ; Altman, RB; Ferrao, R; Alejo, JL; Kaur, N; Kanji, J; Blanchard, SC				Burnett, Benjamin J.; Altman, Roger B.; Ferrao, Ryan; Alejo, Jose L.; Kaur, Navdep; Kanji, Joshua; Blanchard, Scott C.			Elongation Factor Ts Directly Facilitates the Formation and Disassembly of the Escherichia coli Elongation Factor Tu center dot GTP center dot Aminoacyl-tRNA Ternary Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EF-TU; GUANINE-NUCLEOTIDES; CONFORMATIONAL-CHANGE; PROTEIN-BIOSYNTHESIS; BACTERIAL RIBOSOME; KINETIC MECHANISM; CRYSTAL-STRUCTURE; P-LOOP; BINDING; TRANSLATION	Aminoacyl-tRNA enters the translating ribosome in a ternary complex with elongation factor Tu (EF-Tu) and GTP. Here, we describe bulk steady state and pre-steady state fluorescence methods that enabled us to quantitatively explore the kinetic features of Escherichia coli ternary complex formation and decay. The data obtained suggest that both processes are controlled by a nucleotide-dependent, rate-determining conformational change in EF-Tu. Unexpectedly, we found that this conformational change is accelerated by elongation factor Ts (EF-Ts), the guanosine nucleotide exchange factor for EF-Tu. Notably, EF-Ts attenuates the affinity of EF-Tu for GTP and destabilizes ternary complex in the presence of non-hydrolyzable GTP analogs. These results suggest that EF-Ts serves an unanticipated role in the cell of actively regulating the abundance and stability of ternary complex in a manner that contributes to rapid and faithful protein synthesis.	[Burnett, Benjamin J.; Altman, Roger B.; Alejo, Jose L.; Kaur, Navdep; Kanji, Joshua; Blanchard, Scott C.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Ferrao, Ryan; Blanchard, Scott C.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University; Cornell University	Blanchard, SC (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA.	scb2005@med.cornell.edu	Blanchard, Scott C./A-5804-2009	Blanchard, Scott C./0000-0003-2717-9365; Alejo, Jose/0000-0002-1952-4109	National Institutes of Health [GM079238, MH099491]; National Science Foundation Faculty Early Career Development Award [MCB-0747230]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Faculty Early Career Development Award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079238 and MH099491. This work was also supported by National Science Foundation Faculty Early Career Development Award MCB-0747230.	Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; ABRAHAMSON JK, 1985, BIOCHEMISTRY-US, V24, P692, DOI 10.1021/bi00324a023; Altman RB, 2012, NAT METHODS, V9, P68, DOI [10.1038/nmeth.1774, 10.1038/NMETH.1774]; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bremer H., 1987, ESCHERICHIA COLI SAL, V2, P1527, DOI [10.1046/j.1365-2486.2000.06017.x, DOI 10.1046/J.1365-2486.2000.06017.X]; BUBUNENKO MG, 1992, BIOCHIMIE, V74, P419, DOI 10.1016/0300-9084(92)90081-O; Cai YC, 2000, J BIOL CHEM, V275, P20308, DOI 10.1074/jbc.M001899200; Chapman SJ, 2012, J BIOL CHEM, V287, P1229, DOI 10.1074/jbc.M111.294850; Dahl LD, 2006, J BIOL CHEM, V281, P21139, DOI 10.1074/jbc.M602068200; Dale T., BIOCHEMISTRY, V43, P6159; DELARIA K, 1991, ARCH BIOCHEM BIOPHYS, V286, P207, DOI 10.1016/0003-9861(91)90029-I; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Endo M, 2003, J BIOL CHEM, V278, P843, DOI 10.1074/jbc.M209714200; Fersht A., 1985, ENZYME STRUCTURE MEC; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Gonzalez RL, 2007, RNA, V13, P2091, DOI 10.1261/rna.499407; Goodrich J., 2007, BINDING KINETICS MOL; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Gromadski KB, 2007, J BIOL CHEM, V282, P35629, DOI 10.1074/jbc.M707245200; HAZLETT TL, 1989, BIOCHEMISTRY-US, V28, P4109, DOI 10.1021/bi00435a073; HOPFIELD JJ, 1976, P NATL ACAD SCI USA, V73, P1164, DOI 10.1073/pnas.73.4.1164; JANIAK F, 1990, BIOCHEMISTRY-US, V29, P4268, DOI 10.1021/bi00470a002; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Kristensen O, 1996, FEBS LETT, V399, P59, DOI 10.1016/S0014-5793(96)01281-1; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Levitus M, 2011, Q REV BIOPHYS, V44, P123, DOI 10.1017/S0033583510000247; LOUIE A, 1985, BIOCHEMISTRY-US, V24, P6433, DOI 10.1021/bi00344a019; MILLER DL, 1970, BIOCHEM BIOPH RES CO, V38, P1016, DOI 10.1016/0006-291X(70)90341-4; MIYAJIMA A, 1978, J BIOCHEM, V83, P453, DOI 10.1093/oxfordjournals.jbchem.a131932; Munro JB, 2010, NAT STRUCT MOL BIOL, V17, P1470, DOI 10.1038/nsmb.1925; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nissen P, 1996, BIOCHIMIE, V78, P921, DOI 10.1016/S0300-9084(97)86714-4; OTT G, 1989, EUR J BIOCHEM, V184, P345, DOI 10.1111/j.1432-1033.1989.tb15025.x; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Parmeggiani A, 2006, FEBS LETT, V580, P4576, DOI 10.1016/j.febslet.2006.07.039; Parmeggiani A, 2006, BIOCHEMISTRY-US, V45, P6846, DOI 10.1021/bi0525122; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; PINGOUD A, 1977, EUR J BIOCHEM, V78, P403, DOI 10.1111/j.1432-1033.1977.tb11752.x; PLUMBRIDGE JA, 1980, NUCLEIC ACIDS RES, V8, P827; PODKOWINSKI J, 1989, ACTA BIOCHIM POL, V36, P235; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; Rodnina MV, 1999, FEMS MICROBIOL REV, V23, P317, DOI 10.1016/S0168-6445(99)00010-8; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; RODNINA MV, 1995, EMBO J, V14, P2613, DOI 10.1002/j.1460-2075.1995.tb07259.x; Rodnina MV, 1995, BIOCHEM CELL BIOL, V73, P1221, DOI 10.1139/o95-132; ROMERO G, 1985, J BIOL CHEM, V260, P6167; Sanderson LE, 2007, J MOL BIOL, V368, P119, DOI 10.1016/j.jmb.2007.01.075; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schmitt E, 2012, NAT STRUCT MOL BIOL, V19, P450, DOI 10.1038/nsmb.2259; SCHWARTZBACH CJ, 1991, J BIOL CHEM, V266, P16324; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stumber M, 2002, J MOL BIOL, V323, P899, DOI 10.1016/S0022-2836(02)01010-0; Takeshita D, 2012, NAT STRUCT MOL BIOL, V19, P229, DOI 10.1038/nsmb.2204; THOMPSON RC, 1982, J BIOL CHEM, V257, P6677; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogeley L, 2001, J BIOL CHEM, V276, P17149, DOI 10.1074/jbc.M100017200; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; WATSON BS, 1995, BIOCHEMISTRY-US, V34, P7904, DOI 10.1021/bi00024a015; Weaver R. F., 2007, MOL BIOL; WEISSBACH H, 1972, ARCH BIOCHEM BIOPHYS, V149, P110, DOI 10.1016/0003-9861(72)90304-9; WEISSBACH H, 1970, ARCH BIOCHEM BIOPHYS, V137, P262, DOI 10.1016/0003-9861(70)90433-9; Wieden HJ, 2010, BIOPHYS J, V99, P3735, DOI 10.1016/j.bpj.2010.10.013; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Young TS, 2011, P NATL ACAD SCI USA, V108, P13053, DOI 10.1073/pnas.1110435108	73	26	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13917	13928		10.1074/jbc.M113.460014	http://dx.doi.org/10.1074/jbc.M113.460014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539628	Green Published, hybrid			2022-12-25	WOS:000318850300072
J	Bell, AV				Bell, Adrian Viliami			Evolutionary Thinking in Microeconomic Models: Prestige Bias and Market Bubbles	PLOS ONE			English	Article							CULTURAL-DIVERSITY; BEHAVIOR; TRANSMISSION	Evolutionary models broadly support a number of social learning strategies likely important in economic behavior. Using a simple model of price dynamics, I show how prestige bias, or copying of famed (and likely successful) individual, influences price equilibria and investor disposition in a way that exacerbates or creates market bubbles. I discuss how integrating the social learning and demographic forces important in cultural evolution with economic models provides a fruitful line of inquiry into real-world behavior.	Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Bell, AV (corresponding author), Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA.	adrian.bell@anthro.utah.edu						Alesina A, 2005, J ECON LIT, V43, P762, DOI 10.1257/002205105774431243; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Asch SE, 1956, PSYCHOL MONOGR, V70, P70; Blanchard OJ, 1982, BUBBLES RATIONAL EXP, P295; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R., 2005, ORIGIN EVOLUTION CUL; Boyd R, 1993, RATIONALITY IMITATIO, P131; Boyd R, 2009, J THEOR BIOL, V257, P331, DOI 10.1016/j.jtbi.2008.12.007; Calvo GA, 2000, CONTAGION GLOBALIZAT; Chudek M, 2012, EVOL HUM BEHAV, V33, P46, DOI 10.1016/j.evolhumbehav.2011.05.005; Collins P.W., 1965, MAN CULTURE ANIMALS, V78; Dass N, 2008, REV FINANC STUD, V21, P51, DOI 10.1093/rfs/hhm033; DeMarzo PM, 2008, REV FINANC STUD, V21, P19, DOI 10.1093/rfs/hhm032; Edwards S, 2000, WORLD ECON, V23, P873, DOI 10.1111/1467-9701.00307; Efferson C, 2008, EVOL HUM BEHAV, V29, P56, DOI 10.1016/j.evolhumbehav.2007.08.003; Fearon JD, 2003, J ECON GROWTH, V8, P195, DOI 10.1023/A:1024419522867; Ferraro PJ, 2007, ECON INQ, V45, P217, DOI 10.1111/j.1465-7295.2006.00013.x; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Foley William A., 1986, PAPUAN LANGUAGES NEW; Grin F, 2006, EC CONSIDERATIONS LA; HANNAN MT, 1981, AM SOCIOL REV, V46, P19, DOI 10.2307/2095024; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Hong L, 2004, P NATL ACAD SCI USA, V101, P16385, DOI 10.1073/pnas.0403723101; Horner V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010625; Jones EL, 2000, CASE SHARED WORLD LA; LIEBERMAN PH, 1969, SCIENCE, V164, P1185, DOI 10.1126/science.164.3884.1185; LUX T, 1995, ECON J, V105, P881, DOI 10.2307/2235156; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; Mitchell WC, 1923, BUSINESS CYDES; Nisbett R., 1996, NEW DIRECTIONS SOCIA; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Ottaviano GIP, 2006, J ECON GEOGR, V6, P9, DOI 10.1093/jeg/lbi002; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; Salamon S, 1984, ETHNIC ORIGIN EXPLAN, V1; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069	38	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59805	10.1371/journal.pone.0059805	http://dx.doi.org/10.1371/journal.pone.0059805			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544100	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700060
J	Martin, S; Harper, CB; May, LM; Coulson, EJ; Meunier, FA; Osborne, SL				Martin, Sally; Harper, Callista B.; May, Linda M.; Coulson, Elizabeth J.; Meunier, Frederic A.; Osborne, Shona L.			Inhibition of PIKfyve by YM-201636 Dysregulates Autophagy and Leads to Apoptosis-Independent Neuronal Cell Death	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; CAUSES NEURODEGENERATION; ENDOCYTOSED RECEPTORS; NERVOUS-SYSTEM; PROTEIN; MATURATION; PI(3,5)P-2; TRANSPORT; VAC14; MICE	The lipid phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P-2), synthesised by PIKfyve, regulates a number of intracellular membrane trafficking pathways. Genetic alteration of the PIKfyve complex, leading to even a mild reduction in PtdIns(3,5)P-2 results in marked neurodegeneration via an uncharacterised mechanism. In the present study we have shown that selectively inhibiting PIKfyve activity, using YM-201636, significantly reduces the survival of primary mouse hippocampal neurons in culture. YM-201636 treatment promoted vacuolation of endolysosomal membranes followed by apoptosis-independent cell death. Many vacuoles contained intravacuolar membranes and inclusions reminiscent of autolysosomes. Accordingly, YM-201636 treatment increased the level of the autophagosomal marker protein LC3-II, an effect that was potentiated by inhibition of lysosomal proteases, suggesting that alterations in autophagy could be a contributing factor to neuronal cell death.	[Martin, Sally; Harper, Callista B.; May, Linda M.; Coulson, Elizabeth J.; Meunier, Frederic A.; Osborne, Shona L.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland	Meunier, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	f.meunier@uq.edu.au; s.osborne@uq.edu.au	Osborne, Shona/C-8290-2009; Martin, Sally/A-7150-2010; Coulson, Elizabeth J./C-8766-2009; Meunier, Frederic A/C-8161-2009	Martin, Sally/0000-0001-9294-5404; Coulson, Elizabeth J./0000-0003-3783-6197; Meunier, Frederic A/0000-0001-6400-1107; Osborne, Shona/0000-0002-7012-9278	National Health and Medical Research Council Australia [631418]	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council Australia (S.L.O grant number 631418). F.A.M. and E.J.C. are Research Fellows of the National Health and Medical Research Council Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2010, J ORG CHEM, V75, P3541, DOI 10.1021/jo100393c; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Ferguson CJ, 2012, HUM MOL GENET, V21, P3525, DOI 10.1093/hmg/dds179; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Ikonomov OC, 2003, MOL BIOL CELL, V14, P4581, DOI 10.1091/mbc.E03-04-0222; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Kajta M, 2006, BRAIN RES, V1116, P64, DOI 10.1016/j.brainres.2006.07.105; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nicot AS, 2006, MOL BIOL CELL, V17, P3062, DOI 10.1091/mbc.e05-12-1120; Osborne SL, 2008, J BIOL CHEM, V283, P2804, DOI 10.1074/jbc.M704856200; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sandvig K, 2002, ANNU REV CELL DEV BI, V18, P1, DOI 10.1146/annurev.cellbio.18.011502.142107; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2012, AM J PHYSIOL-CELL PH, V303, pC436, DOI 10.1152/ajpcell.00105.2012; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tooze SA, 2008, CURR OPIN NEUROBIOL, V18, P504, DOI 10.1016/j.conb.2008.09.015; Tsuruta F, 2009, J CELL BIOL, V187, P279, DOI 10.1083/jcb.200903028; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wen PJ, 2011, PROG LIPID RES, V50, P52, DOI 10.1016/j.plipres.2010.08.001; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104; Zhang YL, 2012, EMBO J, V31, P3442, DOI 10.1038/emboj.2012.200	43	60	62	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60152	10.1371/journal.pone.0060152	http://dx.doi.org/10.1371/journal.pone.0060152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544129	Green Published, gold			2022-12-25	WOS:000317480700088
J	van Raan, AFJ				van Raan, Anthony F. J.			Universities Scale Like Cities	PLOS ONE			English	Article							BIBLIOMETRIC STATISTICAL PROPERTIES; CUMULATIVE ADVANTAGE; SCIENCE; RULES	Recent studies of urban scaling show that important socioeconomic city characteristics such as wealth and innovation capacity exhibit a nonlinear, particularly a power law scaling with population size. These nonlinear effects are common to all cities, with similar power law exponents. These findings mean that the larger the city, the more disproportionally they are places of wealth and innovation. Local properties of cities cause a deviation from the expected behavior as predicted by the power law scaling. In this paper we demonstrate that universities show a similar behavior as cities in the distribution of the 'gross university income' in terms of total number of citations over 'size in terms of total number of publications. Moreover, the power law exponents for university scaling are comparable to those for urban scaling. We find that deviations from the expected behavior can indeed be explained by specific local properties of universities, particularly the field specific composition of a university, and its quality in terms of field normalized citation impact. By studying both the set of the 500 largest universities worldwide and a specific subset of these 500 universities -the top-100 European universities- we are also able to distinguish between properties of universities with as well as without selection of one specific local property, the quality of a university in terms of its average field-normalized citation impact. It also reveals an interesting observation concerning the working of a crucial property in networked systems, preferential attachment.	Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	van Raan, AFJ (corresponding author), Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands.	vanraan@cwts.leidenuniv.nl		van Raan, Anthony/0000-0001-8980-5937	Leiden University	Leiden University	This work is part of the institute's research theme Science Systems funded by Leiden University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Bonitz M, 2005, SCIENTOMETRICS, V64, P375, DOI 10.1007/s11192-005-0256-5; Jamtveit B, 2009, P NATL ACAD SCI USA, V106, P13160, DOI 10.1073/pnas.0903190106; Katz JS, 2005, MEAS-INTERDISCIP RES, V3, P24, DOI 10.1207/s15366359mea0301_3; Katz JS, 1999, RES POLICY, V28, P501, DOI 10.1016/S0048-7333(99)00010-4; Katz JS., 2000, SCI PUBL POLICY, V27, P23, DOI [DOI 10.3152/147154300781782156, 10.3152/147154300781782156]; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MERTON RK, 1988, ISIS, V79, P606, DOI 10.1086/354848; Perc M, 2012, J R SOC INTERFACE, V9, P3323, DOI 10.1098/rsif.2012.0491; Perc M, 2010, J INFORMETR, V4, P475, DOI 10.1016/j.joi.2010.04.003; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; van Raan AFJ, 2006, J AM SOC INF SCI TEC, V57, P408, DOI 10.1002/asi.20284; van Raan AFJ, 2008, J AM SOC INF SCI TEC, V59, P565, DOI 10.1002/asi.20765; van Raan AFJ, 2008, J AM SOC INF SCI TEC, V59, P461, DOI 10.1002/asi.20761; van Raan AFJ, 2006, J AM SOC INF SCI TEC, V57, P1919, DOI 10.1002/asi.20389; van Raan AFJ, 2011, SCIENTOMETRICS, V88, P495, DOI 10.1007/s11192-011-0382-1; van Raan T, 2011, NATURE, V469, P34, DOI 10.1038/469034a; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P2419, DOI 10.1002/asi.22708	22	29	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59384	10.1371/journal.pone.0059384	http://dx.doi.org/10.1371/journal.pone.0059384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544062	gold, Green Submitted, Green Published			2022-12-25	WOS:000317480700024
J	Masszi, G; Horvath, EM; Tarszabo, R; Benko, R; Novak, A; Buday, A; Tokes, AM; Nadasy, GL; Hamar, P; Benyo, Z; Varbiro, S				Masszi, Gabriella; Horvath, Eszter Maria; Tarszabo, Robert; Benko, Rita; Novak, Agnes; Buday, Anna; Tokes, Anna-Maria; Nadasy, Gyorgy L.; Hamar, Peter; Benyo, Zoltan; Varbiro, Szabolcs			Reduced Estradiol-Induced Vasodilation and Poly-(ADP-Ribose) Polymerase (PARP) Activity in the Aortas of Rats with Experimental Polycystic Ovary Syndrome (PCOS)	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; POLY(ADP-RIBOSE) POLYMERASE; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; HEART-FAILURE; CELL-DEATH; ACTIVATION; WOMEN; ESTROGEN; INHIBITION	Polycystic ovary syndrome (PCOS) is a complex endocrine disorder characterized by hyperandrogenism and insulin resistance, both of which have been connected to atherosclerosis. Indeed, an increased risk of clinical manifestations of arterial vascular diseases has been described in PCOS. On the other hand endothelial dysfunction can be detected early on, before atherosclerosis develops. Thus we assumed that vascular dysfunction is also related directly to the hormonal imbalance rather than to its metabolic consequences. To detect early functional changes, we applied a novel rodent model of PCOS: rats were either sham operated or hyperandrogenism was achieved by implanting subcutaneous pellets of dihydrotestosterone (DHT). After ten weeks, myograph measurements were performed on isolated aortic rings. Previously we described an increased contractility to norepinephrine (NE). Here we found a reduced immediate relaxation to estradiol treatment in pre-contracted aortic rings from hyperandrogenic rats. Although the administration of vitamin D-3 along with DHT reduced responsiveness to NE, it did not restore relaxation to estradiol. Poly-(ADP-ribose) polymerase (PARP) activity was assessed by poly-ADP-ribose immunostaining. Increased PAR staining in ovaries and circulating leukocytes from DHT rats showed enhanced DNA damage, which was reduced by concomitant vitamin D-3 treatment. Surprisingly, PAR staining was reduced in both the endothelium and vascular smooth muscle cells of the aorta rings from hyperandrogenic rats. Thus in the early phase of PCOS, vascular tone is already shifted towards vasoconstriction, characterized by reduced vasorelaxation and vascular dysfunction is concomitant with altered PARP activity. Based on our findings, PARP inhibitors might have a future perspective in restoring metabolic disorders in PCOS.	[Masszi, Gabriella; Novak, Agnes] Bajcsy Zsilinszky Hosp, Cardiol Unit, Budapest, Hungary; [Horvath, Eszter Maria; Benko, Rita; Benyo, Zoltan] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1085 Budapest, Hungary; [Nadasy, Gyorgy L.; Varbiro, Szabolcs] Semmelweis Univ, Dept Obstet Gynecol 32, H-1085 Budapest, Hungary; [Tarszabo, Robert; Buday, Anna; Hamar, Peter] Semmelweis Univ, Dept Pathophysiol, H-1085 Budapest, Hungary; [Tokes, Anna-Maria] Semmelweis Univ, Dept Pathol, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University	Masszi, G (corresponding author), Bajcsy Zsilinszky Hosp, Cardiol Unit, Budapest, Hungary.	gmasszi@bni.hu; varbiroszabolcs@gmail.com	Horvath, Eszter/I-9128-2017; Benko, Rita/I-9646-2017; Tokes, Anna-Maria/S-5713-2017	Horvath, Eszter/0000-0002-0517-1269; Benko, Rita/0000-0001-7740-9128; Tokes, Anna-Maria/0000-0002-9581-7536; Varbiro, Szabolcs/0000-0002-7109-6906; Benyo, Zoltan/0000-0001-6015-0359	European Foundation; Hungarian NIH [ALAP1-01298/2009, K81972, NF69278]; Scientific Healthcare Council (ETT) [427/2009]; Hungarian National Developmental Agency (NFU) [TAMOP 4.2.1/B-09/1/KMR-2010-001]; Hungarian Society of Hypertension; National Grants of the Hungarian Government Fund; Hungarian Academy of Sciences	European Foundation(European Science Foundation (ESF)); Hungarian NIH; Scientific Healthcare Council (ETT); Hungarian National Developmental Agency (NFU); Hungarian Society of Hypertension; National Grants of the Hungarian Government Fund; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This study was supported by a Servier Grant from the European Foundation for the Study of Diabetes as well as by grants from the Hungarian NIH (ALAP1-01298/2009), Scientific Healthcare Council (ETT) (427/2009) and the Hungarian National Developmental Agency (NFU) (TAMOP 4.2.1/B-09/1/KMR-2010-001). This study was sponsored by a research grant of the Hungarian Society of Hypertension, and National Grants of the Hungarian Government Fund, Hungarian NIH (K81972, NF69278). Eszter M. Horvath was supported by the Janos Bolyai Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Clinical Endocrinologists, 2005, POS STAT MET CARD CO, V11; Andersen HL, 1999, BRIT J PHARMACOL, V126, P159, DOI 10.1038/sj.bjp.0702289; Ardabili HR, 2012, NUTR RES, V32, P195, DOI 10.1016/j.nutres.2012.02.001; Buday A, 2010, AM J PHYSIOL-HEART C, V299, pH386, DOI 10.1152/ajpheart.01042.2009; Christian RC, 2003, J CLIN ENDOCR METAB, V88, P2562, DOI 10.1210/jc.2003-030334; Cignarella A, 2001, MED RES REV, V21, P171, DOI 10.1002/1098-1128(200103)21:2<171::AID-MED1005>3.0.CO;2-4; de Groot PCM, 2011, HUM REPROD UPDATE, V17, P495, DOI 10.1093/humupd/dmr001; Erdelyi K, 2005, CELL MOL LIFE SCI, V62, P751, DOI 10.1007/s00018-004-4506-0; Firouzabadi Raziah dehghani, 2012, Complement Ther Clin Pract, V18, P85, DOI 10.1016/j.ctcp.2012.01.005; Horvath EM, 2009, DIABETOLOGIA, V52, P952, DOI 10.1007/s00125-009-1304-0; Horvath EM, 2011, METHODS MOL BIOL, V780, P267, DOI 10.1007/978-1-61779-270-0_16; Jog NR, 2009, J IMMUNOL, V182, P7297, DOI 10.4049/jimmunol.0803565; Kravariti M, 2005, J CLIN ENDOCR METAB, V90, P5088, DOI 10.1210/jc.2005-0151; Lakhani K, 2000, CLIN SCI, V98, P661, DOI 10.1042/cs0980661; Li M, 2008, AM J PHYSIOL-HEART C, V294, pH2444, DOI 10.1152/ajpheart.01121.2007; Mabley JG, 2005, J PHARMACOL EXP THER, V315, P812, DOI 10.1124/jpet.105.090480; Mabley JG, 2007, INT J MOL MED, V19, P947; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Miller VM, 2010, WOMENS HEALTH, V6, P737, DOI [10.2217/whe.10.53, 10.2217/WHE.10.53]; Molnar A, 2006, MOL MED, V12, P143, DOI 10.2119/2006-00043.Molnar; Morrow DA, 2009, J THROMB THROMBOLYS, V27, P359, DOI 10.1007/s11239-008-0230-1; New G, 2000, CORONARY ARTERY DIS, V11, P253, DOI 10.1097/00019501-200005000-00008; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Perez Torres I, 2007, LIFE SCI, V80, P2170, DOI 10.1016/j.lfs.2007.04.006; Perusquia M, 2010, AM J PHYSIOL-HEART C, V298, pH1301, DOI 10.1152/ajpheart.00753.2009; Przybylski R, 2010, NUTR METAB CARDIOVAS, V20, P641, DOI 10.1016/j.numecd.2009.07.009; Puurunen J, 2011, J CLIN ENDOCR METAB, V96, P1827, DOI 10.1210/jc.2011-0039; Soriano FG, 2001, CIRC RES, V89, P684, DOI 10.1161/hh2001.097797; Szabo C, 2006, TRENDS PHARMACOL SCI, V27, P626, DOI 10.1016/j.tips.2006.10.003; Toth-Zsamboki E, 2006, MOL MED, V12, P221, DOI 10.2119/2006-00055.Toth-Zsamboki; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Virag Laszlo, 2005, Current Vascular Pharmacology, V3, P209, DOI 10.2174/1570161054368625; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Xu ZR, 2010, EUR J PHARMACOL, V643, P254, DOI 10.1016/j.ejphar.2010.06.039; Yao L, 2008, INT J CARDIOL, V123, P366, DOI 10.1016/j.ijcard.2007.06.069; Yuan M, 2009, EXP NEUROL, V217, P210, DOI 10.1016/j.expneurol.2009.02.012	40	14	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e55589	10.1371/journal.pone.0055589	http://dx.doi.org/10.1371/journal.pone.0055589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555555	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000317418500002
J	Geng, LY; Chaudhuri, A; Talmon, G; Wisecarver, JL; Wang, J				Geng, Liying; Chaudhuri, Anathbandhu; Talmon, Geoffrey; Wisecarver, James L.; Wang, Jing			TGF-Beta Suppresses VEGFA-Mediated Angiogenesis in Colon Cancer Metastasis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; COLORECTAL-CANCER; EXPRESSION; RECEPTOR; RESISTANCE; AUTOCRINE; CELLS; MALIGNANCY; MUTATION; PATHWAY	The FET cell line, derived from an early stage colon carcinoma, is non-tumorigenic in athymic nude mice. Engineered FET cells that express TGF-alpha (FET alpha) display constitutively active EGFR/ErbB signaling. These cells readily formed xenograft tumors in athymic nude mice. Importantly, FET alpha cells retained their response to TGF-beta-mediated growth inhibition, and, like the parental FET cells, expression of a dominant negative TGF-beta type II receptor (DNRII) in FET alpha cells (FET alpha/DNRII) abrogated responsiveness to TGF-beta-induced growth inhibition and apoptosis under stress conditions in vitro and increased metastatic potential in an orthotopic model in vivo, which indicates metastasis suppressor activity of TGF-beta signaling in this model. Cancer angiogenesis is widely regarded as a key attribute for tumor formation and progression. Here we show that TGF-beta signaling inhibits expression of vascular endothelial growth factor A (VEGFA) and that loss of autocrine TGF-beta in FET alpha/DNRII cells resulted in increased expression of VEGFA. Regulation of VEGFA expression by TGF-beta is not at the transcriptional level but at the post-transcriptional level. Our results indicate that TGF-beta decreases VEGFA protein stability through ubiquitination and degradation in a PKA-and Smad3-dependent and Smad2-independent pathway. Immunohistochemical (IHC) analyses of orthotopic tumors showed significantly reduced TGF-beta signaling, increased CD31 and VEGFA staining in tumors of FET alpha/DNRII cells as compared to those of vector control cells. These results indicate that inhibition of TGF-beta signaling increases VEGFA expression and angiogenesis, which could potentially contribute to enhanced metastasis of those cells in vivo. IHC studies performed on human colon adenocarcinoma specimens showed that TGF-beta signaling is inversely correlated with VEGFA expression, indicating that TGF-beta-mediated suppression of VEGFA expression exists in colon cancer patients.	[Geng, Liying; Chaudhuri, Anathbandhu; Wang, Jing] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Talmon, Geoffrey; Wisecarver, James L.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Wang, J (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	jjwang@unmc.edu	Chaudhuri, Anathbandhu/F-2501-2017	Chaudhuri, Anathbandhu/0000-0003-4833-3077	National Institutes of Health [P20RR018759, R01CA140988-01]; NATIONAL CANCER INSTITUTE [R01CA140988] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health grants P20RR018759 and R01CA140988-01 (http://projectreporter.nih.gov/project_info_description.cfm?aid=8215881&icde=14708223&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC) to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiri G, 1998, ONCOGENE, V17, P227, DOI 10.1038/sj.onc.1202019; Bendardaf R, 2008, ANTICANCER RES, V28, P3865; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bertolini F, 2011, BRIT J CANCER, V104, P1079, DOI 10.1038/bjc.2011.43; Bornes S, 2007, CIRC RES, V100, P305, DOI 10.1161/01.RES.0000258873.08041.c9; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; Fatyol K, 2001, J BIOL CHEM, V276, P28421, DOI 10.1074/jbc.M102847200; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fleming N, 2012, CANC RES; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hajra KM, 2004, APOPTOSIS, V9, P691, DOI 10.1023/B:APPT.0000045786.98031.1d; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Klinger M, 2010, ANN SURG ONCOL, V17, P2059, DOI 10.1245/s10434-010-0972-9; Losi L, 2007, ONCOL REP, V17, P1095; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Papageorgis P, 2011, CANCER RES, V71, P998, DOI 10.1158/0008-5472.CAN-09-3269; Qian D, 2004, MOL REPROD DEV, V68, P198, DOI 10.1002/mrd.20061; Rajput A, 2007, CANCER RES, V67, P665, DOI 10.1158/0008-5472.CAN-06-2773; Riedel K, 2007, ARCH MED RES, V38, P45, DOI 10.1016/j.arcmed.2006.04.010; Simms NAK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-221; SUN LZ, 1994, J BIOL CHEM, V269, P26449; Tejpar S, 2012, ONCOLOGIST, V17, P1039, DOI 10.1634/theoncologist.2012-0068; Valdes F, 2002, MOL CANCER RES, V1, P68; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; Wang J, 2004, J BIOL CHEM, V279, P40237, DOI 10.1074/jbc.M401665200; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; WU SP, 1993, CELL GROWTH DIFFER, V4, P115; WU SP, 1992, J CELL BIOL, V116, P187, DOI 10.1083/jcb.116.1.187; Ye SC, 1999, CANCER RES, V59, P4725; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang BX, 2010, GASTROENTEROLOGY, V138, P969, DOI 10.1053/j.gastro.2009.11.004; Zhu B, 2010, PROSTATE, V70, P17, DOI 10.1002/pros.21033	36	50	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59918	10.1371/journal.pone.0059918	http://dx.doi.org/10.1371/journal.pone.0059918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536895	Green Published, Green Submitted, gold			2022-12-25	WOS:000317397200043
J	Juan-Mateu, J; Gonzalez-Quereda, L; Rodriguez, MJ; Verdura, E; Lazaro, K; Jou, C; Nascimento, A; Jimenez-Mallebrera, C; Colomer, J; Monges, S; Lubieniecki, F; Foncuberta, ME; Pascual-Pascual, SI; Molano, J; Baiget, M; Gallano, P				Juan-Mateu, Jonas; Gonzalez-Quereda, Lidia; Jose Rodriguez, Maria; Verdura, Edgard; Lazaro, Kira; Jou, Cristina; Nascimento, Andres; Jimenez-Mallebrera, Cecilia; Colomer, Jaume; Monges, Soledad; Lubieniecki, Fabiana; Eugenia Foncuberta, Maria; Ignacio Pascual-Pascual, Samuel; Molano, Jesus; Baiget, Montserrat; Gallano, Pia			Interplay between DMD Point Mutations and Splicing Signals in Dystrophinopathy Phenotypes	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; NONSENSE MUTATION; MESSENGER-RNA; VARIABLE PHENOTYPES; SOMATIC MOSAICISM; SEQUENCE MOTIFS; MOLECULAR-BASIS; GENE; EXON; PROTEIN	DMD nonsense and frameshift mutations lead to severe Duchenne muscular dystrophy while in-frame mutations lead to milder Becker muscular dystrophy. Exceptions are found in 10% of cases and the production of alternatively spliced transcripts is considered a key modifier of disease severity. Several exonic mutations have been shown to induce exon-skipping, while splice site mutations result in exon-skipping or activation of cryptic splice sites. However, factors determining the splicing pathway are still unclear. Point mutations provide valuable information regarding the regulation of pre-mRNA splicing and elements defining exon identity in the DMD gene. Here we provide a comprehensive analysis of 98 point mutations related to clinical phenotype and their effect on muscle mRNA and dystrophin expression. Aberrant splicing was found in 27 mutations due to alteration of splice sites or splicing regulatory elements. Bioinformatics analysis was performed to test the ability of the available algorithms to predict consequences on mRNA and to investigate the major factors that determine the splicing pathway in mutations affecting splicing signals. Our findings suggest that the splicing pathway is highly dependent on the interplay between splice site strength and density of regulatory elements.	[Juan-Mateu, Jonas; Gonzalez-Quereda, Lidia; Jose Rodriguez, Maria; Verdura, Edgard; Lazaro, Kira; Baiget, Montserrat; Gallano, Pia] Hosp Santa Creu & Sant Pau, Serv Genet, Barcelona, Spain; [Juan-Mateu, Jonas; Gonzalez-Quereda, Lidia; Jose Rodriguez, Maria; Verdura, Edgard; Lazaro, Kira; Baiget, Montserrat; Gallano, Pia] CIBERER U705, Barcelona, Spain; [Juan-Mateu, Jonas] Univ Barcelona, Barcelona, Spain; [Jou, Cristina] Hosp St Joan de Deu, Serv Anat Patol, Barcelona, Spain; [Nascimento, Andres; Jimenez-Mallebrera, Cecilia; Colomer, Jaume] Hosp St Joan de Deu, Serv Neurol, Unitat Patol Neuromuscular, Barcelona, Spain; [Monges, Soledad] Hosp Nacl Pediat Garrahan, Serv Neuropediat, Buenos Aires, DF, Argentina; [Lubieniecki, Fabiana] Hosp Nacl Pediat Garrahan, Serv Patol, Buenos Aires, DF, Argentina; [Eugenia Foncuberta, Maria] Hosp Nacl Pediat Garrahan, Serv Genet, Buenos Aires, DF, Argentina; [Ignacio Pascual-Pascual, Samuel] Hosp Univ Materno Infantil La Paz, Serv Neurol Pediat, Madrid, Spain; [Molano, Jesus] Hosp Univ Materno Infantil La Paz, Unidad Genet Mol, Madrid, Spain; [Molano, Jesus] Hosp Univ Materno Infantil La Paz, CIBERER U753, Madrid, Spain	Hospital of Santa Creu i Sant Pau; University of Barcelona; University of Barcelona; University of Barcelona; Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Gallano, P (corresponding author), Hosp Santa Creu & Sant Pau, Serv Genet, Barcelona, Spain.	pgallano@santpau.cat	Gonzalez, Lidia/E-7669-2013; Jiménez-Mallebrera, Cecilia/F-5030-2016	Gonzalez, Lidia/0000-0003-0715-6414; Jiménez-Mallebrera, Cecilia/0000-0001-8203-7103; FONCUBERTA, MARIA EUGENIA/0000-0003-1054-7715; Molano Mateos, Jesus/0000-0002-9289-1239; Pascual Pascual, Samuel Ignacio/0000-0002-5428-8121; Verdura, Edgard/0000-0003-3856-2060; Juan-Mateu, Jonas/0000-0001-9749-6441	Fondo de Investigacion Sanitaria [PI08/0347]; CIBER de Enfermedades Raras initiatives of Instituto de Salud Carlos III [U-705)]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); CIBER de Enfermedades Raras initiatives of Instituto de Salud Carlos III	This study was supported by grants from Fondo de Investigacion Sanitaria (PI08/0347) and CIBER de Enfermedades Raras (U-705) initiatives of Instituto de Salud Carlos III (www.isciii.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2007, RNA, V13, P1609, DOI 10.1261/rna.653607; Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Baralle M, 2006, FEBS LETT, V580, P4449, DOI 10.1016/j.febslet.2006.07.018; BEGGS AH, 1991, AM J HUM GENET, V49, P54; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Disset A, 2006, HUM MOL GENET, V15, P999, DOI 10.1093/hmg/ddl015; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Fajkusova L, 2001, NEUROMUSCULAR DISORD, V11, P133, DOI 10.1016/S0960-8966(00)00169-3; Flanigan KM, 2011, HUM MUTAT, V32, P299, DOI 10.1002/humu.21426; Flanigan KM, 2003, AM J HUM GENET, V72, P931, DOI 10.1086/374176; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Ginjaar IB, 2000, EUR J HUM GENET, V8, P793, DOI 10.1038/sj.ejhg.5200535; Gurvich OL, 2009, HUM MUTAT, V30, P633, DOI 10.1002/humu.20913; Habara Y, 2009, J MED GENET, V46, P542, DOI 10.1136/jmg.2008.061259; Helderman-van den Enden ATJM, 2003, NEUROMUSCULAR DISORD, V13, P317, DOI 10.1016/S0960-8966(02)00285-7; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Juan-Mateu J, 2011, CLIN GENETICS; Juan-Mateu J, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-82; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Kesari A, 2009, AM J MED GENET A, V149A, P1499, DOI 10.1002/ajmg.a.32891; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Melis MA, 1998, HUM MUTAT, pS137; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Nishiyama A, 2008, ANN HUM GENET, V72, P717, DOI 10.1111/j.1469-1809.2008.00468.x; Pagani F, 2003, HUM MOL GENET, V12, P1111, DOI 10.1093/hmg/ddg131; Popplewell LJ, 2010, NEUROMUSCULAR DISORD, V20, P102, DOI 10.1016/j.nmd.2009.10.013; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Roca X, 2003, NUCLEIC ACIDS RES, V31, P6321, DOI 10.1093/nar/gkg830; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Shiga N, 1997, J CLIN INVEST, V100, P2204, DOI 10.1172/JCI119757; Sironi M, 2004, NUCLEIC ACIDS RES, V32, P1783, DOI 10.1093/nar/gkh341; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Takeshima Y, 2010, J HUM GENET, V55, P379, DOI 10.1038/jhg.2010.49; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tran VK, 2006, J MED GENET, V43, P924, DOI 10.1136/jmg.2006.042317; Tuffery-Giraud S, 2005, EUR J HUM GENET, V13, P1254, DOI 10.1038/sj.ejhg.5201478; Tuffery-Giraud S, 1999, HUM MUTAT, V14, P359, DOI 10.1002/(SICI)1098-1004(199911)14:5<359::AID-HUMU1>3.3.CO;2-B; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; WINNARD AV, 1995, AM J HUM GENET, V56, P158; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103; Zhang CL, 2008, P NATL ACAD SCI USA, V105, P5797, DOI 10.1073/pnas.0801692105; Zhang XHF, 2005, GENOME RES, V15, P768, DOI 10.1101/gr.3217705; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	56	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59916	10.1371/journal.pone.0059916	http://dx.doi.org/10.1371/journal.pone.0059916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536893	Green Submitted, Green Published, gold			2022-12-25	WOS:000317397200041
J	Wang, LL; Pasha, Z; Wang, SY; Li, N; Feng, YL; Lu, G; Millard, RW; Ashraf, M				Wang, Linlin; Pasha, Zeeshan; Wang, Shuyun; Li, Ning; Feng, Yuliang; Lu, Gang; Millard, Ronald W.; Ashraf, Muhammad			Protein Kinase G1 alpha Overexpression Increases Stem Cell Survival and Cardiac Function after Myocardial Infarction	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; CYCLIC-GMP; BONE-MARROW; ISCHEMIC CARDIOMYOPATHY; GROWTH-FACTOR; PHOSPHODIESTERASE-5 INHIBITION; NITRIC-OXIDE; CGMP; EXPRESSION; TRANSPLANTATION	Background: We hypothesized that overexpression of cGMP-dependent protein kinase type 1 alpha (PKG1 alpha) could mimic the effect of tadalafil on the survival of bone marrow derived mesenchymal stem cells (MSCs) contributing to regeneration of the ischemic heart. Methods and Results: MSCs from male rats were transduced with adenoviral vector encoding for PKG1 alpha ((MSCs)-M-PKG1 alpha). Controls included native MSCs ((MSCs)-M-Nat) and MSCs transduced with an empty vector ((MSCs)-M-Null). PKG1 alpha activity was increased approximately 20, 5 and 16 fold respectively in (MSCs)-M-PKG1 alpha. (MSCs)-M-PKG1 alpha showed improved survival under oxygen and glucose deprivation (OGD) which was evidenced by lower LDH release, caspase-3/7 activity and number of positive TUNEL cells. Anti-apoptotic proteins pAkt, pGSK3 beta, and Bcl-2 were significantly increased in (MSCs)-M-PKG1 alpha compared to (MSCs)-M-Nat and (MSCs)-M-Null. Higher release of multiple prosurvival and angiogenic factors such as HGF, bFGF, SDF-1 and Ang-1 was observed in (MSCs)-M-PKG1 alpha before and after OGD. In a female rat model of acute myocardial infarction, (MSCs)-M-PKG1 alpha group showed higher survival compared with (MSCs)-M-Null group at 3 and 7 days after transplantation as determined by TUNEL staining and sry-gene quantitation by real-time PCR. Increased anti-apoptotic proteins and paracrine factors in vitro were also identified. Immunostaining for cardiac troponin I combined with GFP showed increased myogenic differentiation of (MSCs)-M-PKG1 alpha. At 4 weeks after transplantation, compared to DMEM group and (MSCs)-M-Null group, (MSCs)-M-PKG1 alpha group showed increased blood vessel density in infarct and peri-infarct areas (62.5 +/- 7.7; 68.8 +/- 7.3 per microscopic view, p < 0.05) and attenuated infarct size (27.2 +/- 2.5%, p < 0.01). Heart function indices including ejection fraction (52.1 +/- 2.2%, p < 0.01) and fractional shortening (24.8%+/- 1.3%, p < 0.01) were improved significantly in (MSCs)-M-PKG1 alpha group. Conclusion: Overexpression of PKG1 alpha transgene could be a powerful approach to improve MSCs survival and their angiomyogenic potential in the infarcted heart.	[Wang, Linlin; Pasha, Zeeshan; Wang, Shuyun; Li, Ning; Feng, Yuliang; Lu, Gang; Millard, Ronald W.; Ashraf, Muhammad] Univ Cincinnati, Coll Med, Dept Pathol, Cincinnati, OH USA; [Wang, Linlin; Pasha, Zeeshan; Wang, Shuyun; Li, Ning; Feng, Yuliang; Lu, Gang; Millard, Ronald W.; Ashraf, Muhammad] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Ashraf, M (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol, Cincinnati, OH USA.	ashrafm@ucmail.uc.edu	Ashraf, Muhammad/ABB-3463-2021		National Institutes of Health [HL095375, HL087246]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095375, R01HL087246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health grants HL095375, HL087246. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, PROTEIN EXPRES PURIF, V79, P271, DOI 10.1016/j.pep.2011.05.001; Boerth NJ, 1997, J VASC RES, V34, P245, DOI 10.1159/000159231; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Das A, 2008, J BIOL CHEM, V283, P29572, DOI 10.1074/jbc.M801547200; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453; DRAIJER R, 1995, CIRC RES, V77, P897, DOI 10.1161/01.RES.77.5.897; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Feil R, 2002, CIRC RES, V90, P1080, DOI 10.1161/01.RES.0000019586.95768.40; Frantz S, 2013, EUR HEART J, V34, P1233, DOI 10.1093/eurheartj/ehr445; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Haider HK, 2010, AM J PHYSIOL-HEART C, V299, pH1395, DOI 10.1152/ajpheart.00437.2010; Hoke NN, 2012, STEM CELLS, V30, P326, DOI 10.1002/stem.789; House SL, 2003, CIRCULATION, V108, P3140, DOI 10.1161/01.CIR.0000105723.91637.1C; Jang YH, 2012, CARDIOVASC THER, V30, P264, DOI 10.1111/j.1755-5922.2011.00301.x; Jiang YB, 2010, BASIC RES CARDIOL, V105, P431, DOI 10.1007/s00395-009-0079-2; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li LH, 2012, AM J PHYSIOL-HEART C, V302, pH2112, DOI 10.1152/ajpheart.00339.2011; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; Lu G, 2010, CARDIOVASC RES, V88, P277, DOI 10.1093/cvr/cvq293; Makkar RR, 2005, J CARDIOVASC PHARM T, V10, P225, DOI 10.1177/107424840501000403; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Noort WA, 2010, PANMINERVA MED, V52, P27; Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Pasha Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023667; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Soff GA, 1997, J CLIN INVEST, V100, P2580, DOI 10.1172/JCI119801; Trachtenberg B, 2011, AM HEART J, V161, P487, DOI 10.1016/j.ahj.2010.11.024; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; van der Velden JLJ, 2008, J BIOL CHEM, V283, P358, DOI 10.1074/jbc.M707812200; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Wollert KC, 2002, HYPERTENSION, V39, P87, DOI 10.1161/hy1201.097292; Yang YJ, 2009, ARTERIOSCL THROM VAS, V29, P2076, DOI 10.1161/ATVBAHA.109.189662; Yang ZJ, 2006, GENE THER, V13, P1564, DOI 10.1038/sj.gt.3302820; Yang ZJ, 2009, MOL BIOL REP, V36, P1323, DOI 10.1007/s11033-008-9315-3; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C	46	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60087	10.1371/journal.pone.0060087	http://dx.doi.org/10.1371/journal.pone.0060087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536905	Green Submitted, gold, Green Published			2022-12-25	WOS:000317397200053
J	Choudhary, R; Baturin, D; Fosmire, S; Freed, B; Porter, CC				Choudhary, Rashmi; Baturin, Dmitry; Fosmire, Susan; Freed, Brian; Porter, Christopher C.			Knockdown of HPRT for Selection of Genetically Modified Human Hematopoietic Progenitor Cells	PLOS ONE			English	Article							RESISTANT BONE-MARROW; IN-VIVO SELECTION; GENE-THERAPY; LENTIVIRAL VECTOR; MEDIATED TRANSFER; RETROVIRUS; MDR1; IMMUNODEFICIENCY; TRANSPLANTATION; CHEMOTHERAPY	The inability to obtain sufficient numbers of transduced cells remains a limitation in gene therapy. One strategy to address this limitation is in vivo pharmacologic selection of transduced cells. We have previously shown that knockdown of HPRT using lentiviral delivered shRNA facilitates efficient selection of transduced murine hematopoietic progenitor cells (HPC) using 6-thioguanine (6TG). Herein, we now extend these studies to human HPC. We tested multiple shRNA constructs in human derived cell lines and identified the optimal shRNA sequence for knockdown of HPRT and 6TG resistance. We then tested this vector in human umbilical cord blood derived HPC in vitro and in NOD/SCID recipients. Knockdown of HPRT effectively provided resistance to 6TG in vitro. 6TG treatment of mice resulted in increased percentages of transduced human CD45(+) cells in the peripheral blood and in the spleen in particular, in both myeloid and lymphoid compartments. 6TG treatment of secondary recipients resulted in higher percentages of transduced human cells in the bone marrow, confirming selection from the progeny of long-term repopulating HPCs. However, the extent of selection of cells in the bone marrow at the doses of 6TG tested and the toxicity of higher doses, suggest that this strategy may be limited to selection of more committed progenitor cells. Together, these data suggest that human HPC can be programmed to be resistant to purine analogs, but that HPRT knockdown/6TG-based selection may not be robust enough for in vivo selection.	[Choudhary, Rashmi; Baturin, Dmitry; Fosmire, Susan; Porter, Christopher C.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Freed, Brian] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Freed, Brian] Univ Colorado, Sch Med, Dept Immunol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Porter, CC (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA.	chris.porter@ucdenver.edu	Porter, Christopher/AAE-8918-2020	Porter, Christopher/0000-0001-8774-0180	United States National Heart Lung and Blood Institute [HL094921]; NATIONAL CANCER INSTITUTE [T32CA082086, P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094921] Funding Source: NIH RePORTER	United States National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a research grant to CCP from the United States National Heart Lung and Blood Institute (HL094921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abonour R, 2000, NAT MED, V6, P652, DOI 10.1038/76225; Adair JE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003425; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Beard BC, 2010, J CLIN INVEST, V120, P2345, DOI 10.1172/JCI40767; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; COREY CA, 1990, BLOOD, V75, P337; Cowan KH, 1999, CLIN CANCER RES, V5, P1619; Davis BM, 2000, BLOOD, V95, P3078; Erlichman C, 2001, CANC CHEMOTHERAPY BI, P67; Giordano FA, 2011, HUM GENE THER, V22, P697, DOI 10.1089/hum.2010.088; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacke K, 2012, EXP HEMATOL, V40, P3, DOI 10.1016/j.exphem.2011.09.009; Hesdorffer C, 1998, J CLIN ONCOL, V16, P165, DOI 10.1200/JCO.1998.16.1.165; Hildinger M, 1998, HUM GENE THER, V9, P33, DOI 10.1089/hum.1998.9.1-33; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Masunaga Y, 2007, ANN PHARMACOTHER, V41, P21, DOI 10.1345/aph.1H219; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Maze R, 1996, P NATL ACAD SCI USA, V93, P206, DOI 10.1073/pnas.93.1.206; Metais JY, 2008, MOL THER, V16, P439, DOI 10.1038/sj.mt.6300372; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Pedersen-Bjergaard J, 2002, BLOOD, V99, P1909, DOI 10.1182/blood.V99.6.1909; Porter CC, 2008, BLOOD, V112, P4466, DOI 10.1182/blood-2008-03-146571; Pui CH, 2000, BRIT J HAEMATOL, V109, P13, DOI 10.1046/j.1365-2141.2000.01843.x; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; SORRENTINO BP, 1992, SCIENCE, V257, P99, DOI 10.1126/science.1352414; Warlick CA, 2002, J PHARMACOL EXP THER, V300, P50, DOI 10.1124/jpet.300.1.50; WILLIAMS DA, 1987, J EXP MED, V166, P210, DOI 10.1084/jem.166.1.210; Zielske SP, 2003, J CLIN INVEST, V112, P1561, DOI 10.1172/JCI200317922	32	6	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59594	10.1371/journal.pone.0059594	http://dx.doi.org/10.1371/journal.pone.0059594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555045	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800101
J	Durif, CMF; Browman, HI; Phillips, JB; Skiftesvik, AB; Vollestad, LA; Stockhausen, HH				Durif, Caroline M. F.; Browman, Howard I.; Phillips, John B.; Skiftesvik, Anne Berit; Vollestad, L. Asbjorn; Stockhausen, Hans H.			Magnetic Compass Orientation in the European Eel	PLOS ONE			English	Article							RED-SPOTTED NEWT; ANGUILLA-ANGUILLA; SILVER EELS; ENVIRONMENTAL-FACTORS; AMERICAN EELS; SPAWNING MIGRATION; JAPONICA; ROSTRATA; RESPONSES	European eel migrate from freshwater or coastal habitats throughout Europe to their spawning grounds in the Sargasso Sea. However, their route (similar to 6000 km) and orientation mechanisms are unknown. Several attempts have been made to prove the existence of magnetoreception in Anguilla sp., but none of these studies have demonstrated magnetic compass orientation in earth-strength magnetic field intensities. We tested eels in four altered magnetic field conditions where magnetic North was set at geographic North, South, East, or West. Eels oriented in a manner that was related to the tank in which they were housed before the test. At lower temperature (under 12 degrees C), their orientation relative to magnetic North corresponded to the direction of their displacement from the holding tank. At higher temperatures (12-17 degrees C), eels showed bimodal orientation along an axis perpendicular to the axis of their displacement. These temperature-related shifts in orientation may be linked to the changes in behavior that occur between the warm season (during which eels are foraging) and the colder fall and winter (during which eels undertake their migrations). These observations support the conclusion that 1. eels have a magnetic compass, and 2. they use this sense to orient in a direction that they have registered moments before they are displaced. The adaptive advantage of having a magnetic compass and learning the direction in which they have been displaced becomes clear when set in the context of the eel's seaward migration. For example, if their migration is halted or blocked, as it is the case when environmental conditions become unfavorable or when they encounter a barrier, eels would be able to resume their movements along their old bearing when conditions become favorable again or when they pass by the barrier.	[Durif, Caroline M. F.; Browman, Howard I.; Skiftesvik, Anne Berit] Austevoll Res Stn, Inst Marine Res, Storebo, Norway; [Phillips, John B.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Vollestad, L. Asbjorn] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Stockhausen, Hans H.] Inst Marine Res, N-5024 Bergen, Norway	Institute of Marine Research - Norway; Virginia Polytechnic Institute & State University; University of Oslo; Institute of Marine Research - Norway	Durif, CMF (corresponding author), Austevoll Res Stn, Inst Marine Res, Storebo, Norway.	caroline.durif@imr.no	Browman, Howard/B-4441-2009; Browman, Howard/CAA-2802-2022; Vøllestad, Leif Asbjørn/H-7305-2019; Durif, Caroline/A-6406-2011; Skiftesvik, Anne Berit/M-1266-2013	Browman, Howard/0000-0002-6282-7316; Browman, Howard/0000-0002-6282-7316; Vøllestad, Leif Asbjørn/0000-0002-9389-7982; Skiftesvik, Anne Berit/0000-0002-7754-5661	Research Council of Norway [NFR] [159222]; University of Oslo; Norwegian Institute of Marine Research; Norwegian Institute of Marine Research: Sensory biology and behaviour project; Fine scale interactions in the plankton	Research Council of Norway [NFR](Research Council of Norway); University of Oslo; Norwegian Institute of Marine Research; Norwegian Institute of Marine Research: Sensory biology and behaviour project; Fine scale interactions in the plankton	This study was funded by the Research Council of Norway [NFR grant number 159222], The University of Oslo and the Norwegian Institute of Marine Research. CMFD, HIB, ABS, and HS were supported by the Norwegian Institute of Marine Research: Sensory biology and behaviour project and Fine scale interactions in the plankton in support of trophodynamic models project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Als TD, 2011, MOL ECOL, V20, P1333, DOI 10.1111/j.1365-294X.2011.05011.x; Baras E, 1998, HYDROBIOLOGIA, V372, P187, DOI 10.1023/A:1017072213791; Batschelet, 1981, CIRCULAR STAT BIOL; Branover G. G., 1971, J ICHTHYOL+, V11, P608; Daverat F, 2006, MAR ECOL PROG SER, V308, P231, DOI 10.3354/meps308231; Deutschlander ME, 1999, NATURE, V400, P324, DOI 10.1038/22450; Deutschlander ME, 2000, COPEIA, P413; Diego-Rasilla FJ, 2007, ETHOLOGY, V113, P474, DOI 10.1111/j.1439-0310.2007.01334.x; Durif C, 2005, J FISH BIOL, V66, P1025, DOI 10.1111/j.0022-1112.2005.00662.x; Durif C, 2002, AM FISH S S, V33, P343; Durif CMF, 2008, FISHERIES MANAG ECOL, V15, P127, DOI 10.1111/j.1365-2400.2008.00593.x; Durif CMF, 2008, AQUAT LIVING RESOUR, V21, P163, DOI 10.1051/alr:2008031; FERGUSON DE, 1966, BEHAVIOUR, V26, P105, DOI 10.1163/156853966X00047; Freake MJ, 2002, COPEIA, P466; Hart V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051100; Hellinger J, 2012, J COMP PHYSIOL A, V198, P593, DOI 10.1007/s00359-012-0732-3; Hellinger J, 2009, J COMP PHYSIOL A, V195, P873, DOI 10.1007/s00359-009-0466-z; Jellyman DJ, 1996, NEW ZEAL J MAR FRESH, V30, P171; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; KARLSSON L, 1985, HELGOLANDER MEERESUN, V39, P71, DOI 10.1007/BF01997522; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; MARDIA KV, 1976, BIOMETRIKA, V63, P403, DOI 10.2307/2335637; MERRITT R, 1983, REV SCI INSTRUM, V54, P879, DOI 10.1063/1.1137480; Nishi T, 2005, J FISH BIOL, V67, P1213, DOI 10.1111/j.1095-8649.2005.00817.x; Nishi T, 2005, FISHERIES SCI, V71, P101, DOI 10.1111/j.1444-2906.2005.00936.x; Nishi T, 2004, J EXP BIOL, V207, P2965, DOI 10.1242/jeb.01131; PHILLIPS JB, 1986, J COMP PHYSIOL A, V158, P103, DOI 10.1007/BF00614524; Phillips JB, 2006, ANIMAL SPATIAL COGNI; Phillips JB, 2010, J EXP BIOL, V213, P3247, DOI 10.1242/jeb.020792; QUINN TP, 1982, J COMP PHYSIOL, V147, P547, DOI 10.1007/BF00612020; QUINN TP, 1980, J COMP PHYSIOL, V137, P243, DOI 10.1007/BF00657119; ROMMEL SA, 1973, J FISH RES BOARD CAN, V30, P657, DOI 10.1139/f73-114; Schmidt J, 1923, PHILOS T R SOC LON B, V211, P179, DOI 10.1098/rstb.1923.0004; Shcherbakov D, 2005, CURR BIOL, V15, pR161, DOI 10.1016/j.cub.2005.02.039; SOUZA JJ, 1988, COMP BIOCHEM PHYS A, V90, P57, DOI 10.1016/0300-9629(88)91005-5; Tabeke A, 2012, SCI REPORTS, V2, P1; Tesch F.-W., 1992, Ecology of Freshwater Fish, V1, P52, DOI 10.1111/j.1600-0633.1992.tb00007.x; Tesch F-W., 2003, EEL; TESCH FW, 1974, HELGOLAND WISS MEER, V26, P382, DOI 10.1007/BF01627623; TESCH FW, 1991, MEERESFORSCHUNG, V33, P183; VOLLESTAD LA, 1986, CAN J FISH AQUAT SCI, V43, P1909, DOI 10.1139/f86-236; WALKER MM, 1984, J COMP PHYSIOL, V155, P673, DOI 10.1007/BF00610853; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; WALKER MM, 1986, NATURWISSENSCHAFTEN, V73, P12, DOI 10.1007/BF01168800; Watene EM, 2002, AM FISH S S, V33, P295; Westerberg H, 2007, ICES J MAR SCI, V64, P1457, DOI 10.1093/icesjms/fsm079; Westin L, 1977, Contributions Asko Lab., VNo. 17, P1; White EM, 1997, J FISH BIOL, V50, P1104, DOI 10.1006/jfbi.1996.0383; ZIMMERMAN MA, 1975, HELGOLAND WISS MEER, V27, P175, DOI 10.1007/BF01611805	50	47	48	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59212	10.1371/journal.pone.0059212	http://dx.doi.org/10.1371/journal.pone.0059212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554997	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000316409800070
J	McKinley, ET; Ayers, GD; Smith, RA; Saleh, SA; Zhao, P; Washington, MK; Coffey, RJ; Manning, HC				McKinley, Eliot T.; Ayers, Gregory D.; Smith, R. Adam; Saleh, Samir A.; Zhao, Ping; Washington, Mary Kay; Coffey, Robert J.; Manning, H. Charles			Limits of [F-18]-FLT PET as a Biomarker of Proliferation in Oncology	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; COLORECTAL-CANCER; IN-VIVO; CELLULAR PROLIFERATION; IMAGING PROLIFERATION; BREAST-CANCER; F-18-FLT PET; KINETIC-ANALYSIS; THORACIC TUMORS; BRAIN-TUMORS	Background: Non-invasive imaging biomarkers of cellular proliferation hold great promise for quantifying response to personalized medicine in oncology. An emerging approach to assess tumor proliferation utilizes the positron emission tomography (PET) tracer 3'-deoxy-3'[F-18]-fluorothymidine, [F-18]-FLT. Though several studies have associated serial changes in [F-18]-FLT-PET with elements of therapeutic response, the degree to which [F-18]-FLT-PET quantitatively reflects proliferative index has been continuously debated for more that a decade. The goal of this study was to elucidate quantitative relationships between [F-18]-FLT-PET and cellular metrics of proliferation in treatment naive human cell line xenografts commonly employed in cancer research. Methods and Findings: [F-18]-FLT-PET was conducted in human cancer xenograft-bearing mice. Quantitative relationships between PET, thymidine kinase 1 (TK1) protein levels and immunostaining for proliferation markers (Ki67, TK1, PCNA) were evaluated using imaging-matched tumor specimens. Overall, we determined that [F-18]-FLT-PET reflects TK1 protein levels, yet the cell cycle specificity of TK1 expression and the extent to which tumors utilize thymidine salvage for DNA synthesis decouple [F-18]-FLT-PET data from standard estimates of proliferative index. Conclusions: Our findings illustrate that [F-18]-FLT-PET reflects tumor proliferation as a function of thymidine salvage pathway utilization. Unlike more general proliferation markers, such as Ki67, [F-18]-FLT PET reflects proliferative indices to variable and potentially unreliable extents. [F-18]-FLT-PET cannot discriminate moderately proliferative, thymidine salvage-driven tumors from those of high proliferative index that rely primarily upon de novo thymidine synthesis. Accordingly, the magnitude of [F-18]-FLT uptake should not be considered a surrogate of proliferative index. These data rationalize the diversity of [F-18]-FLT-PET correlative results previously reported and suggest future best-practices when [F-18]-FLT-PET is employed in oncology.	[McKinley, Eliot T.; Smith, R. Adam; Saleh, Samir A.; Zhao, Ping; Manning, H. Charles] Vanderbilt Univ, Med Ctr, VUIIS, Nashville, TN 37235 USA; [McKinley, Eliot T.; Manning, H. Charles] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Ayers, Gregory D.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Washington, Mary Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Washington, Mary Kay; Coffey, Robert J.] Vanderbilt Univ, Dept Med, Sch Med, Nashville, TN USA; [Washington, Mary Kay; Coffey, Robert J.; Manning, H. Charles] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Program Chem & Phys Biol, Nashville, TN USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Manning, HC (corresponding author), Vanderbilt Univ, Med Ctr, VUIIS, Nashville, TN 37235 USA.	henry.c.manning@vanderbilt.edu			National Cancer Institute [R01 CA140628, RC1 CA145138, K25 CA127349, P50 CA128323, P50 CA95103, U24 CA126588]; Kleberg Foundation [5P30 DK058404, S10 RR17858];  [R25 CA136440]; NATIONAL CANCER INSTITUTE [R01CA140628, RC1CA145138, P50CA128323, R25CA136440, U24CA126588, P50CA095103, K25CA127349] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kleberg Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by grants from the National Cancer Institute: R01 CA140628, RC1 CA145138, K25 CA127349, P50 CA128323, P50 CA95103, U24 CA126588, The Kleberg Foundation, 5P30 DK058404, and S10 RR17858. E. T. McKinley was supported by a training grant in imaging science R25 CA136440. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Barthel H, 2003, CANCER RES, V63, P3791; Brockenbrough JS, J NUCL MED, V52, P1181; Buck AK, 2002, CANCER RES, V62, P3331; Buck AK, 2006, CANCER RES, V66, P11055, DOI 10.1158/0008-5472.CAN-06-1955; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen W, 2005, J NUCL MED, V46, P945; Choi SJ, 2005, EUR J NUCL MED MOL I, V32, P653, DOI 10.1007/s00259-004-1742-3; Cobben DCP, 2003, CANCER RES, V63, P8558; Dittmann H, 2003, EUR J NUCL MED MOL I, V30, P1407, DOI 10.1007/s00259-003-1257-3; DY DY, 1992, CANCER RES, V52, P917; Efron B., 1994, INTRO BOOTSTRAP; Francis DL, 2003, GUT, V52, P1602, DOI 10.1136/gut.52.11.1602; Grierson JR, 2004, NUCL MED BIOL, V31, P829, DOI 10.1016/j.nucmedbio.2004.06.004; Grierson JR, 2000, NUCL MED BIOL, V27, P143, DOI 10.1016/S0969-8051(99)00104-3; Kenny LM, 2005, CANCER RES, V65, P10104, DOI 10.1158/0008-5472.CAN-04-4297; Kim SJ, 2008, J NUCL MED, V49, P2057, DOI 10.2967/jnumed.108.053215; Krieger-Hinck N, 2006, ANTICANCER RES, V26, P3467; Li W, J CHROMATOGR B, V879, P2963; Mankoff DA, 2007, CLIN CANCER RES, V13, P3460, DOI 10.1158/1078-0432.CCR-07-0074; Manning HC, 2008, CLIN CANCER RES, V14, P7413, DOI 10.1158/1078-0432.CCR-08-0239; McKinley ET, ANN NUCL MED; Moroz MA, CLIN CANC RES, V17, P1099; Muzi M, 2005, J NUCL MED, V46, P371; Muzi M, 2006, J NUCL MED, V47, P1612; Muzic RF, 2001, J NUCL MED, V42, P636; OLIVE M, 1993, IN VITRO CELL DEV-AN, V29A, P239; Reinhardt MJ, 1997, J NUCL MED, V38, P280; Schwartz JL, 2003, J NUCL MED, V44, P2027; Shah C, 2009, CLIN CANCER RES, V15, P4712, DOI 10.1158/1078-0432.CCR-08-2635; Shields AF, 1998, J NUCL MED, V39, P1757; Shields AF, 1996, J NUCL MED, V37, P290; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Smyczek-Gargya B, 2004, EUR J NUCL MED MOL I, V31, P720, DOI 10.1007/s00259-004-1462-8; van Westreenen HL, 2005, J NUCL MED, V46, P400; Wagner M, 2003, CANCER RES, V63, P2681; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang H, 2009, J NUCL MED, V50, P1857, DOI 10.2967/jnumed.109.064238; Yamamoto Y, 2007, EUR J NUCL MED MOL I, V34, P1610, DOI 10.1007/s00259-007-0449-7; Yamamoto Y, 2009, NUCL MED COMMUN, V30, P841, DOI 10.1097/MNM.0b013e328330294d; Yap CS, 2006, CHEST, V129, P393, DOI 10.1378/chest.129.2.393; Zhang CC, CLIN CANC RES	42	74	75	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58938	10.1371/journal.pone.0058938	http://dx.doi.org/10.1371/journal.pone.0058938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554961	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800049
J	Mu, J; Pang, Q; Guo, YH; Chen, JG; Zeng, W; Huang, YJ; Zhang, J; Feng, B				Mu, Jiao; Pang, Qi; Guo, Yan-Hong; Chen, Ji-Gang; Zeng, Wei; Huang, Yong-Jun; Zhang, Jun; Feng, Bing			Functional Implications of MicroRNA-215 in TGF-beta 1-Induced Phenotypic Transition of Mesangial Cells by Targeting CTNNBIP1	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; INDUCED COLLAGEN EXPRESSION; DIABETIC-NEPHROPATHY; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; CRYPTOSPORIDIUM-PARVUM; RENAL-DISEASE; CATENIN; KIDNEY; ACTIVATION	Mesangial cell (MC) phenotypic transition is crucial for the progression of diabetic nephropathy. A major stimulus mediating high glucose-induced MC phenotypic transition is TGF-beta 1. Our current study focuses on microRNA-215 (miR-215) and investigates its role in TGF-beta 1-mediated MC phenotypic transition. Using real-time quantitative PCR (qRT-PCR) and northern blotting, we determined that the miR-192/215 family is dramatically upregulated under diabetic conditions both in vitro and in vivo. Gain-and loss-of-function approaches demonstrated that miR-215 inhibition significantly inhibited TGF-beta 1-induced mouse mesangial cell (MMC) phenotypic transition, whereas miR-215 upregulation promoted MMC phenotypic transition. Interestingly, these changes were not detected in cells that were treated with TGF-beta 1 and miR-192 mimics or inhibitors. These results suggest that miR-215 participates in TGF-beta 1-induced MMC phenotypic transition. Luciferase reporter assays were used to identify whether catenin-beta interacting protein 1 (CTNNBIP1) is a direct target of miR-215, which was predicted by bioinformatic analysis. Mechanistic studies revealed that CTNNBIP1 suppresses Wnt/beta-catenin signaling and that miR-215 promotes beta-catenin activation and upregulates alpha-SMA and fibronectin expression in TGF-beta 1-treated MMCs by targeting CTNNBIP1. In addition, in vivo miR-215 silencing with a specific antagomir significantly increased CTNNBIP1 protein expression, resulting in reduced beta-catenin activity and decreased alpha-SMA and fibronectin expression in db/db mouse kidney glomeruli. Taken together, our findings indicate that miR-215 plays an essential role in MC phenotypic transition by regulating the CTNNBIP1/beta-catenin pathway, which is related to the pathogenesis of diabetic nephropathy.	[Feng, Bing] Third Mil Med Univ, Inst Nephrol Chongqing, Xinqiao Hosp, Chongqing, Peoples R China; Third Mil Med Univ, Dept Nephrol, Xinqiao Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University	Feng, B (corresponding author), Third Mil Med Univ, Inst Nephrol Chongqing, Xinqiao Hosp, Chongqing, Peoples R China.	fxb1359462@163.com			National Natural Science Foundation of China [31100927, 30900690]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from two National Natural Science Foundation of China: No.31100927 and No.30900690. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2012, J BIOL CHEM, V287, P20430, DOI 10.1074/jbc.M111.275610; Amrouche L, 2011, M S-MED SCI, V27, P398, DOI 10.1051/medsci/2011274016; Balakumar P, 2009, J CARDIOVASC PHARM, V54, P129, DOI 10.1097/FJC.0b013e3181ad2190; Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Burns WC, 2006, J AM SOC NEPHROL, V17, P2484, DOI 10.1681/ASN.2006050525; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chen XM, 2005, J IMMUNOL, V175, P7447, DOI 10.4049/jimmunol.175.11.7447; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Du R, 2010, BIOCHEM BIOPH RES CO, V391, P135, DOI 10.1016/j.bbrc.2009.11.019; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; FLOEGE J, 1992, CLIN INVESTIGATOR, V70, P857; Fogo AB, 1999, EXP NEPHROL, V7, P147; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; Herrera GA, 2006, ULTRASTRUCT PATHOL, V30, P471, DOI 10.1080/01913120600932594; Hoffman BB, 1998, KIDNEY INT, V54, P1107, DOI 10.1046/j.1523-1755.1998.00119.x; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; JOHNSON RJ, 1992, J AM SOC NEPHROL, V2, pS190; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2011, KIDNEY INT, V80, P358, DOI 10.1038/ki.2011.43; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kaucsar T, 2010, ADV DRUG DELIVER REV, V62, P1390, DOI 10.1016/j.addr.2010.10.003; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Kim TH, 2011, TOHOKU J EXP MED, V223, P45, DOI 10.1620/tjem.223.45; Kim YS, 2003, KIDNEY INT, V64, P1702, DOI 10.1046/j.1523-1755.2003.00286.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li JYZ, 2010, NEPHROLOGY, V15, P599, DOI 10.1111/j.1440-1797.2010.01363.x; Li WT, 2011, DIGEST LIVER DIS, V43, P559, DOI 10.1016/j.dld.2011.02.016; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu Z, 2012, ARCH DERMATOL RES, V304, P195, DOI 10.1007/s00403-011-1178-0; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Lussier CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012378; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mishra R, 2008, J BIOL CHEM, V283, P10461, DOI 10.1074/jbc.M800902200; Mishra R, 2008, ARTERIOSCL THROM VAS, V28, P541, DOI 10.1161/ATVBAHA.107.157339; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; Park CW, 2007, J AM SOC NEPHROL, V18, P1227, DOI 10.1681/ASN.2006070778; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Simonson MS, 2007, KIDNEY INT, V71, P846, DOI 10.1038/sj.ki.5002180; Song B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-96; Stow JL, 2004, AM J PHYSIOL-CELL PH, V286, pC745, DOI 10.1152/ajpcell.00563.2003; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tago K, 2000, GENE DEV, V14, P1741; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Wu DC, 2009, J AM SOC NEPHROL, V20, P554, DOI 10.1681/ASN.2008040445; Wu Z, 2011, ONCOGENE, V30, P3979, DOI 10.1038/onc.2011.129; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	64	65	70	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58622	10.1371/journal.pone.0058622	http://dx.doi.org/10.1371/journal.pone.0058622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554908	gold, Green Published, Green Submitted			2022-12-25	WOS:000316252500034
J	Wada, K; Smith, DR				Wada, Koji; Smith, Derek R.			Influenza Vaccination Uptake among the Working Age Population of Japan: Results from a National Cross-Sectional Survey	PLOS ONE			English	Article							INEQUALITIES	Background: Influenza vaccination rates among Japanese people of working age (20-69 years) is currently suboptimal, and the reasons for this have not been clearly elucidated. This study examined factors associated with vaccination intention among the working age population in Japan during September 2011, one-month prior to influenza vaccination becoming available. Methodology/Principal Findings: A web-based survey of intention to be vaccinated against influenza in the coming season was undertaken among 3,129 Japanese aged 20 to 69 years. Multinomial logistic regression analysis was used to explore the associations between vaccination intent and other variables. Influenza vaccination intent was associated with having been vaccinated in the previous year (Odds Ratio (OR): 3.81; 95% Confidence Interval (CI): 3.75-3.86), the number of children per household (one compared with zero; OR: 1.37; 95% CI: 1.11-1.65), and household income ($50,000 to <$100,000 compared with $0 to <$ 50,000; OR: 1.30; 95% CI: 1.07-1.54). Smoking was inversely associated with influenza vaccine uptake (current smokers compared with non-smokers; OR: 0.79; 95% CI: 0.61-0.98). A history of either the survey respondent or a household member having being medically diagnosed with influenza in the previous year was not statistically associated with future influenza vaccination intent. Conclusions/Significance: Overall, this suggests that intention to be vaccinated among working age Japanese is associated with a past history of influenza vaccination, having children, and the household's income. As such, consideration of these factors should now form the cornerstone of strategies to encourage increased uptake of vaccination against influenza in future years.	[Wada, Koji] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan; [Smith, Derek R.] Univ Newcastle, Fac Hlth, Sch Hlth Sci, Ourimbah, Australia	Kitasato University; University of Newcastle	Wada, K (corresponding author), Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan.	kwada-sgy@umin.ac.jp	Smith, Derek/F-4844-2010	Smith, Derek/0000-0002-8202-2523	Ministry of Education, Culture, Sports, Science and Technology, Japan [23790705]; Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare, Japan	This work was supported by a Grant-in-Aid for Young Scientists (B) (23790705) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and partly funded by a Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Committee on Immunization Practices, 2012, Ann Intern Med, V156, P211, DOI 10.7326/0003-4819-156-3-201202070-00388; Armstrong K, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(00)00263-4; Bagdure D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015173; Ciblak MA, 2013, VACCINE, V31, P518, DOI 10.1016/j.vaccine.2012.11.022; Eastwood K, 2010, MED J AUSTRALIA, V192, P33, DOI 10.5694/j.1326-5377.2010.tb03399.x; Hirota Y, 2008, VACCINE, V26, P6451, DOI 10.1016/j.vaccine.2008.06.042; Hirotsu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031519; Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056; Hothersall EJ, 2012, PRIM CARE RESP J, V21, P302, DOI 10.4104/pcrj.2012.00056; Janks M, 2012, INFLUENZA RES TREAT, V2012, DOI DOI 10.1155/2012/182565; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Kontos EZ, 2012, AM J PUBLIC HEALTH, V102, P1911, DOI 10.2105/AJPH.2011.300435; Mangtani P, 2005, PREV MED, V41, P545, DOI 10.1016/j.ypmed.2005.02.001; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Nicholson KG, 1999, EPIDEMIOL INFECT, V123, P103, DOI 10.1017/S095026889900271X; Nobuhara H, 2007, J HLTH WELFARE STAT, V54, P44; O'Riordan S, 2010, CAN MED ASSOC J, V182, P39, DOI 10.1503/cmaj.091724; Plans-Rubio Pedro, 2007, Int J Chron Obstruct Pulmon Dis, V2, P41, DOI 10.2147/copd.2007.2.1.41; Rachiotis G, 2010, EUROSURVEILLANCE, V15, P8; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Smith DR, 2009, PUBLIC HEALTH, V123, P196, DOI 10.1016/j.puhe.2008.12.003; SteelFisher Gillian K, 2010, N Engl J Med, V362, pe65, DOI 10.1056/NEJMp1005102; SUBAR AF, 1990, AM J PUBLIC HEALTH, V80, P1323, DOI 10.2105/AJPH.80.11.1323; Wada K, 2011, PANDEMIC H1N1 2009 J; Wada K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1065; Yi SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018893	27	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59272	10.1371/journal.pone.0059272	http://dx.doi.org/10.1371/journal.pone.0059272			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WV	23555010	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500078
J	Wong, CH; Wu, Z; Yu, Q				Wong, C. H.; Wu, Z.; Yu, Q.			CTSL2 is a pro-apoptotic target of E2F1 and a modulator of histone deacetylase inhibitor and DNA damage-induced apoptosis	ONCOGENE			English	Article						E2F1; apoptosis; CTSL2	CELL-DEATH; CANCER; INDUCTION; P53; EXPRESSION; LYSOSOMES; PATHWAYS; THERAPY; GENES; LIFE	Aberrant regulation of the pRB/E2F1 pathway has been invariably linked to inappropriate proliferation and/apoptosis in human cancers. Therefore, understanding the intricacies of the signaling pathway and identification of novel E2F1 targets involved in apoptosis could pave way for new therapeutic manipulation. Here, we identified CTSL2 (cathepsin L2/cathepsin V) as a novel E2F1 target that participates in E2F1-dependent apoptosis. We showed that E2F1 directly binds to CTSL2 promoter and that CTSL2 is regulated by both exogenous and endogenous E2F1. RNAi-mediated depletion of CTSL2 effectively abrogated ectopic E2F1-induced apoptosis, coupled with reduced lysosomal membrane permeabilization (LMP) and mitochondrial membrane depolarization. CTSL2 knockdown also inhibited apoptosis mediated by the endogenous E2F1 activated by DNA damage. Furthermore, we showed that CTSL2 depletion in cancer cells resulted in inhibition of histone deacetylase inhibitor (HDACi)-induced apoptosis, and conversely ectopic overexpression of CTSL2-sensitized cancer cells to HDACi. This study uncovered a novel E2F1 target implicated in LMP and apoptosis activation, as well as in the modulation of HDACi and chemotherapeutic drugs response.	[Wong, C. H.; Yu, Q.] Agcy Sci Technol & Res, Genome Inst Singapore, Canc Biol & Pharmacol, Singapore 138672, Singapore; [Wu, Z.] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100094, Peoples R China; [Yu, Q.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Yu, Q.] DUKE NUS Grad Med Sch Singapore, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); China Agricultural University; National University of Singapore; National University of Singapore	Yu, Q (corresponding author), Agcy Sci Technol & Res, Genome Inst Singapore, Canc Biol & Pharmacol, 60 Biopolis St,02-01, Singapore 138672, Singapore.	yuq@gis.a-star.edu.sg		Yu, Qiang/0000-0003-2132-8278	Agency for Science, Technology and Research for Singapore	Agency for Science, Technology and Research for Singapore	We thank Dr Kristian Helin for the ER-E2F1 plasmids, Dr Joseph Nevins for the adenoviral E2F1, Dr Andrew Turnell for adenoviral E1A and Dr Claudio Brancolini for IMR90-E1A cells. We are grateful to Li Juntao for providing assistance in data analysis. This work was supported by the Agency for Science, Technology and Research for Singapore.	Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Dyniacht BD, 2008, CANCER CELL, V13, P1, DOI 10.1016/j.ccr.2007.12.017; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Ivanova S, 2008, METHOD ENZYMOL, V442, P183, DOI 10.1016/S0076-6879(08)01409-2; Jaattela M, 2004, CELL DEATH DIFFER, V11, P135, DOI 10.1038/sj.cdd.4401333; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Lin WC, 2001, GENE DEV, V15, P1833; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Putzer BM, 2007, J CELL MOL MED, V11, P239, DOI 10.1111/j.1582-4934.2007.00030.x; Putzer BM, 2000, GENE THER, V7, P1317, DOI 10.1038/sj.gt.3301235; Santamaria I, 1998, CANCER RES, V58, P1624; Sevenich L, 2010, BIOCHIMIE, V92, P1674, DOI 10.1016/j.biochi.2010.03.014; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Tan J, 2006, J BIOL CHEM, V281, P10508, DOI 10.1074/jbc.M512719200; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Wu ZL, 2009, INT J BIOCHEM CELL B, V41, P2389, DOI 10.1016/j.biocel.2009.06.004; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046749; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102	32	7	7	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2014	33	10					1249	1257		10.1038/onc.2013.72	http://dx.doi.org/10.1038/onc.2013.72			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AC6KI	23542171				2022-12-25	WOS:000332631100005
J	Liu, HJ; Chen, JW; Huang, RYC; Weisz, D; Gross, ML; Pakrasi, HB				Liu, Haijun; Chen, Jiawei; Huang, Richard Y. -C.; Weisz, Daniel; Gross, Michael L.; Pakrasi, Himadri B.			Mass Spectrometry-based Footprinting Reveals Structural Dynamics of Loop E of the Chlorophyll-binding Protein CP43 during Photosystem II Assembly in the Cyanobacterium Synechocystis 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE-STABILIZING PROTEIN; CRYSTAL-STRUCTURE; 12-KDA PROTEIN; PSB27; COMPLEX; CLUSTER; IDENTIFICATION; COMPONENTS; VULCANUS; RESIDUES	The PSII repair cycle is required for sustainable photosynthesis in oxygenic photosynthetic organisms. In cyanobacteria and higher plants, proteolysis of the precursor D1 protein (pD1) to expose a C-terminal carboxylate group is an essential step leading to coordination of the Mn4CaO5 cluster, the site of water oxidation. Psb27 appears to associate with both pD1- and D1-containing PSII assembly intermediates by closely interacting with CP43. Here, we report that reduced binding affinity between CP43 and Psb27 is triggered by the removal of the C-terminal extension of the pD1 protein. A mass spectrometry-based footprinting strategy was adopted to probe solvent-exposed aspartic and glutamic acid residues on the CP43 protein. By comparing the extent of footprinting between HT3 Delta ctpA Delta 27PSII and HT3 Delta ctpAPSII, two genetically modified PSII assembly complexes, we found that Psb27 binds to CP43 on the side of Loop E distal to the pseudo-symmetrical D1-D2 axis. By comparing a second pair of PSII assembly complexes, we discovered that Loop E of CP43 undergoes a significant conformational rearrangement due to the removal of the pD1 C-terminal extension, altering the Psb27-CP43 binding interface. The significance of this conformational rearrangement is discussed in the context of recruitment of the PSII lumenal extrinsic proteins and Mn4CaO5 cluster assembly. In addition to CP43's previously known function as one of the core PSII antenna proteins, this work demonstrates that Loop E of CP43 plays an important role in the functional assembly of the Water Oxidizing Center (WOC) during PSII biogenesis.	[Liu, Haijun; Weisz, Daniel; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Chen, Jiawei; Huang, Richard Y. -C.; Weisz, Daniel; Gross, Michael L.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137,1 Brookings Dr, St Louis, MO 63130 USA.	Pakrasi@wustl.edu		Liu, Haijun/0000-0003-0537-0302; Huang, Richard/0000-0002-7172-110X	National Institutes of Health [P41 GM103422];  [NSF-MCB0745611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0745611] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant P41 GM103422 (to M. L. G.) and by NSF-MCB0745611 (to H. B. P.).	Bentley FK, 2008, BIOCHEMISTRY-US, V47, P11637, DOI 10.1021/bi800804h; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; Cormann KU, 2009, BIOCHEMISTRY-US, V48, P8768, DOI 10.1021/bi9012726; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eaton-Rye J. J., 2005, PHOTOSYSTEM, P95; Fagerlund RD, 2011, J PHOTOCH PHOTOBIO B, V104, P191, DOI 10.1016/j.jphotobiol.2011.01.022; Frankel LK, 2012, BIOCHEMISTRY-US, V51, P6371, DOI 10.1021/bi300650n; HOARE DG, 1967, J BIOL CHEM, V242, P2447; Hutchison RS, 1998, BIOCHEMISTRY-US, V37, P5643, DOI 10.1021/bi9724467; Hwang HJ, 2008, BIOCHEMISTRY-US, V47, P9747, DOI 10.1021/bi800568p; Kashino Y, 2002, PLANT CELL PHYSIOL, V43, P1366, DOI 10.1093/pcp/pcf168; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kashino Y, 2001, ELECTROPHORESIS, V22, P1004, DOI 10.1002/1522-2683()22:6<1004::AID-ELPS1004>3.0.CO;2-Y; Komenda J, 2012, PLANT PHYSIOL, V158, P476, DOI 10.1104/pp.111.184184; Liu HJ, 2011, P NATL ACAD SCI USA, V108, P18536, DOI 10.1073/pnas.1111597108; Liu HJ, 2011, J BIOL CHEM, V286, P24865, DOI 10.1074/jbc.M111.246231; Lydakis-Simantiris N, 1999, BIOCHEMISTRY-US, V38, P15528, DOI 10.1021/bi991599m; Mabbitt PD, 2009, BIOCHEMISTRY-US, V48, P8771, DOI 10.1021/bi901309c; Mendoza VL, 2009, MASS SPECTROM REV, V28, P785, DOI 10.1002/mas.20203; Michoux F, 2012, PHOTOSYNTH RES, V110, P169, DOI 10.1007/s11120-011-9712-7; Nakamura T, 2004, PROTEOMICS, V4, P2558, DOI 10.1002/pmic.200300812; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Nowaczyk MM, 2012, BBA-BIOENERGETICS, V1817, P1339, DOI 10.1016/j.bbabio.2012.02.017; Popelkova H, 2003, BIOCHEMISTRY-US, V42, P6193, DOI 10.1021/bi0207115; Popelkova L, 2011, J PHOTOCH PHOTOBIO B, V104, P179, DOI 10.1016/j.jphotobiol.2011.01.015; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; SHEN JR, 1992, FEBS LETT, V301, P145, DOI 10.1016/0014-5793(92)81235-E; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; SWAISGOOD H, 1973, J BIOCHEM, V74, P77, DOI 10.1093/oxfordjournals.jbchem.a130233; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wei LL, 2010, J BIOL CHEM, V285, P21391, DOI 10.1074/jbc.M110.105064; Wen JZ, 2009, P NATL ACAD SCI USA, V106, P6134, DOI 10.1073/pnas.0901691106; Zhang H, 2012, INT J MASS SPECTROM, V312, P78, DOI 10.1016/j.ijms.2011.07.015; Zhang H, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.005678, 10.1074/mcp.M111.009936, 10.1186/1476-4598-10-108]	36	33	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14212	14220		10.1074/jbc.M113.467613	http://dx.doi.org/10.1074/jbc.M113.467613			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23546881	hybrid, Green Published			2022-12-25	WOS:000319253500025
J	Yue, J; Pan, YD; Sun, LF; Zhang, K; Liu, J; Lu, L; Chen, JF				Yue, Jiao; Pan, YouDong; Sun, LiFang; Zhang, Kun; Liu, Jie; Lu, Ling; Chen, JianFeng			The Unique Disulfide Bond-stabilized W1 beta 4-beta 1 Loop in the alpha(4)beta-Propeller Domain Regulates Integrin alpha(4)beta(7) Affinity and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DIVALENT-CATIONS; BINDING-SITES; FIRM ADHESION; OUTSIDE-IN; ACTIVATION; DISTINCT; SUBUNIT; LIGAND; LFA-1	Integrin alpha(4)beta(7) mediates rolling and firm adhesion of lymphocytes pre- and post-activation, which is distinct from most integrins only mediating firm cell adhesion upon activation. This two-phase cell adhesion suggests a unique molecular basis for the dynamic interaction of alpha(4)beta(7) with its ligand, mucosal addressin cell adhesion molecule 1 (MAdCAM-1). Here we report that a disulfide bond-stabilized W1 beta 4-beta 1 loop in alpha(4) beta-propeller domain plays critical roles in regulating integrin alpha(4)beta(7) affinity and signaling. Either breaking the disulfide bond or deleting the disulfide bond-occluded segment in the W1 beta 4-beta 1 loop inhibited rolling cell adhesion supported by the low-affinity interaction between MAdCAM-1 and inactive alpha(4)beta(7) but negligibly affected firm cell adhesion supported by the high-affinity interaction between MAdCAM-1 and Mn2+-activated alpha(4)beta(7). Additionally, disrupting the disulfide bond or deleting the disulfide bond-occluded segment not only blocked the conformational change and activation of alpha(4)beta(7) triggered by talin or phorbol-12-myristate-13-acetate via inside-out signaling but also disrupted integrin-mediated outside-in signaling and impaired phosphorylation of focal adhesion kinase and paxillin. Thus, these findings reveal a particular molecular basis for alpha(4)beta(7)-mediated rolling cell adhesion and a novel regulatory element of integrin affinity and signaling.	[Yue, Jiao; Pan, YouDong; Sun, LiFang; Zhang, Kun; Liu, Jie; Lu, Ling; Chen, JianFeng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, JF (corresponding author), Inst Biochem & Cell Biol, 320 YueYang Rd, Shanghai 200031, Peoples R China.	jfchen@sibcb.ac.cn			National Basic Research Program of China [2010CB529703]; National Natural Science Foundation of China [31190061, 31271487, 30970604]; Science and Technology Commission of Shanghai Municipality [11JC1414200]; Shanghai Pujiang Program [08PJ14106]; China Postdoctoral Science Foundation [2011M500079, 2012T50445]; Postdoctoral Research Program from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012KIP503]; Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) scholarship program	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Pujiang Program(Shanghai Pujiang Program); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Research Program from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) scholarship program	This work was supported by National Basic Research Program of China Grant 2010CB529703; by National Natural Science Foundation of China Grants 31190061, 31271487, and 30970604; by Science and Technology Commission of Shanghai Municipality Grant 11JC1414200; by Shanghai Pujiang Program Grant 08PJ14106; by China Postdoctoral Science Foundation Grants 2011M500079 and 2012T50445; and by Postdoctoral Research Program from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grant 2012KIP503. We acknowledge the support of the Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) scholarship program.	ANDREW DP, 1994, J IMMUNOL, V153, P3847; Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Barton SJ, 2004, BIOCHEM J, V380, P401, DOI 10.1042/BJ20031973; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen JS, 2006, AM J RESP CRIT CARE, V174, P103; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; de Chateau M, 2001, BIOCHEMISTRY-US, V40, P13972, DOI 10.1021/bi011582f; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; HAMANN A, 1994, J IMMUNOL, V152, P3282; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Lanzarotto F, 2006, DRUGS, V66, P1179, DOI 10.2165/00003495-200666090-00002; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; LAZAROVITS AI, 1984, J IMMUNOL, V133, P1857; Leitinger B, 2000, BBA-MOL CELL RES, V1498, P91, DOI 10.1016/S0167-4889(00)00086-0; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Narayan M, 2012, FEBS J, V279, P2272, DOI 10.1111/j.1742-4658.2012.08636.x; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; Pan YP, 2010, P NATL ACAD SCI USA, V107, P21388, DOI 10.1073/pnas.1015487107; SCHWEIGHOFFER T, 1993, J IMMUNOL, V151, P717; Sigal A, 2000, J IMMUNOL, V165, P442, DOI 10.4049/jimmunol.165.1.442; Sun H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208900; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tidswell M, 1997, J IMMUNOL, V159, P1497; TOZEREN A, 1994, J CELL SCI, V107, P3153; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077	47	5	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14228	14237		10.1074/jbc.M113.462630	http://dx.doi.org/10.1074/jbc.M113.462630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23553626	hybrid, Green Published			2022-12-25	WOS:000319253500027
J	Liu, HY; Quampah, A; Chen, JH; Li, JR; Huang, ZR; He, QL; Zhu, SJ; Shi, CH				Liu, Haiying; Quampah, Alfred; Chen, Jinhong; Li, Jinrong; Huang, Zhuangrong; He, Qiuling; Zhu, Shuijin; Shi, Chunhai			QTL Mapping Based on Different Genetic Systems for Essential Amino Acid Contents in Cottonseeds in Different Environments	PLOS ONE			English	Article							UPLAND COTTON; TRAITS; IDENTIFICATION; POPULATION; GOSSYPIUM; ENDOSPERM; QUALITY; RICE; L.	Cottonseeds are rich in various essential amino acids. However, the inheritance of them at molecular level are still not defined across various genetic systems. In the present study, using a newly developed mapping model that can analyze the embryo and maternal main effects as well as QTL x environment interaction effects on quantitative quality trait loci (QTLs) in cottonseeds, a study on QTL located in the tetraploid embryo and tetraploid maternal plant genomes for essential amino acid contents in cottonseeds under different environments was carried out, using the immortal F-2 (IF2) populations from a set of 188 recombinant inbred lines derived from an intraspecific hybrid cross of two upland cotton germplasms HS46 and MARKCBUCAG8US-1-88 as experimental materials. The results showed a total of 35 QTLs associated with these quality traits in cottonseeds. Nineteen QTLs were subsequently mapped on chromosome 5, 6 and 8 in sub-A genome and chromosome 15, 18, 22 and 23 in sub-D genome. Eighteen QTLs were also found having QTL x environment (QE) interaction effects. The genetic main effects from QTLs located on chromosomes in the embryo and maternal plant genomes and their QE effects in different environments were all important for these essential amino acids in cottonseeds. The results suggested that the influence of environmental factors on the expression of some QTLs located in different genetic systems should be considered when improving for these amino acids. This study can serve as the foundation for the improvement of these essential amino acids in cottonseeds.	[Liu, Haiying; Quampah, Alfred; Chen, Jinhong; Li, Jinrong; Huang, Zhuangrong; He, Qiuling; Zhu, Shuijin; Shi, Chunhai] Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhu, SJ (corresponding author), Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	shjzhu@zju.edu.cn; chhshi@zju.edu.cn	Huang, Zhuangrong/AAV-2846-2020	Huang, Zhuangrong/0000-0002-9145-5582	National Basic Research Program (973 program) [2010CB126006]; National High Technology Research and Development Program of China [2011AA10A102]	National Basic Research Program (973 program)(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The project is support by the National Basic Research Program (973 program. No: 2010CB126006) and the National High Technology Research and Development Program of China (2011AA10A102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AMINO ACIDS ANIMAL N; Ashokkumar K., 2011, INT RES J PLANT SCI, V2; Cai YF, 2010, AGRON SUSTAIN DEV, V30, P181, DOI 10.1051/agro/2008024; Cherry J. P., 1978, 1978 Proceedings Beltwide Cotton Production Research Conferences. Jan. 9-11, 1978, Dallas, Texas (Brown, J.M. (Editor))., P47; Doerge RW, 1996, GENETICS, V142, P285; Falconer D. S, 1996, INTRO QUANTITATIVE G; Gutierrez OA, 2006, NAT COTT COUNC BELTW, P826; Huang ZR, 2011, SPECTROSC SPECT ANAL, V31, P2692, DOI 10.3964/j.issn.1000-0593(2011)10-2692-05; JI D, 1988, Acta Agronomica Sinica, V14, P1; Ji DF, 1985, ACTA AGR U ZHENJIANG, V11, P257; Jiang C, 2000, THEOR APPL GENET, V100, P409, DOI 10.1007/s001220050054; KHATTAB AH, 1977, J AGR SCI, V88, P55, DOI 10.1017/S0021859600033761; Kohel RJ, 1978, 187 USDA ARSS; McCouch S. R., 1997, NEWLETT, V14, P11; MEREDITH WR, 1978, CROP SCI, V18, P577, DOI 10.2135/cropsci1978.0011183X001800040013x; OBrien RD, 2005, BAILEYS IND OIL FAT; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Shappley Z. W., 1998, Journal of Cotton Science, V2, P153; Shi CH, 2009, CROP PASTURE SCI, V60, P295, DOI 10.1071/CP08234; Song XL, 2007, SEED SCI RES, V17, P243, DOI 10.1017/S0960258507834957; Sun QA, 2010, MOL BIOL REP, V37, P3319, DOI 10.1007/s11033-009-9918-3; Sun S. K., 1987, Scientia Agricultura Sinica, V20, P12; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Wu J, 2000, NAT COTT COUNC BELTW; Wu JX, 2009, EUPHYTICA, V165, P231, DOI 10.1007/s10681-008-9748-8; Wu JX, 2004, EUPHYTICA, V140, P171, DOI 10.1007/s10681-004-2897-5; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Ye ZH, 2003, EUPHYTICA, V129, P183, DOI 10.1023/A:1021974901501; Zheng X, 2008, THEOR APPL GENET, V116, P335, DOI 10.1007/s00122-007-0671-5	29	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e57531	10.1371/journal.pone.0057531	http://dx.doi.org/10.1371/journal.pone.0057531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555562	Green Submitted, Green Published, gold			2022-12-25	WOS:000317263900002
J	Beer, LA; Wang, H; Tang, HY; Cao, ZJ; Chang-Wong, T; Tanyi, JL; Zhang, RG; Liu, Q; Speicher, DW				Beer, Lynn A.; Wang, Huan; Tang, Hsin-Yao; Cao, Zhijun; Chang-Wong, Tony; Tanyi, Janos L.; Zhang, Rugang; Liu, Qin; Speicher, David W.			Identification of Multiple Novel Protein Biomarkers Shed by Human Serous Ovarian Tumors into the Blood of Immunocompromised Mice and Verified in Patient Sera	PLOS ONE			English	Article							CANCER-CELLS; PROTEOMIC ANALYSIS; PLASMA; MARKERS; COMPLEX; CARCINOMAS; STRATEGY	The most cancer-specific biomarkers in blood are likely to be proteins shed directly by the tumor rather than less specific inflammatory or other host responses. The use of xenograft mouse models together with in-depth proteorne analysis for identification of human proteins in the mouse blood is an under-utilized strategy that can clearly identify proteins shed by the tumor. In the current study, 268 human proteins shed into mouse blood from human OVCAR-3 serous tumors were identified based upon human vs. mouse species differences using a four-dimensional plasma proteome fractionation strategy. A multi-step prioritization and verification strategy was subsequently developed to efficiently select some of the most promising biomarkers from this large number of candidates. A key step was parallel analysis of human proteins detected in the tumor supernatant, because substantially greater sequence coverage for many of the human proteins initially detected in the xenograft mouse plasma confirmed assignments as tumor derived human proteins. Verification of candidate biomarkers in patient sera was facilitated by in-depth, label-free quantitative comparisons of serum pools from patients with ovarian cancer and benign ovarian tumors. The only proteins that advanced to multiple reaction monitoring (MRM) assay development were those that exhibited increases in ovarian cancer patients compared with benign tumor controls. MRM assays were facilely developed for all 11 novel biomarker candidates selected by this process and analysis of larger pools of patient sera suggested that all 11 proteins are promising candidate biomarkers that should be further evaluated on individual patient blood samples.	[Beer, Lynn A.; Wang, Huan; Tang, Hsin-Yao; Cao, Zhijun; Chang-Wong, Tony; Liu, Qin; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA USA; [Beer, Lynn A.; Wang, Huan; Tang, Hsin-Yao; Cao, Zhijun; Chang-Wong, Tony; Liu, Qin; Speicher, David W.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Tanyi, Janos L.] Univ Penn, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA; [Zhang, Rugang] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA	The Wistar Institute; The Wistar Institute; University of Pennsylvania; The Wistar Institute	Speicher, DW (corresponding author), Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA USA.	speicher@wistar.org	Cao, Zhijun/T-2981-2019; cao, zhijun/F-4776-2012	Cao, Zhijun/0000-0001-5429-484X; Tang, Hsin-Yao/0000-0003-1838-018X	National Institutes of Health (NIH) [CA131582, CA010813]; Reproductive Scientist Development Program, NIH [5K12HD00849]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA010815, R01CA163377, R01CA131582] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reproductive Scientist Development Program, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grant CA131582 to DWS and an institutional grant to The Wistar Institute, National Cancer Institute (NCI) Cancer Core Grant CA010813), and by the Reproductive Scientist Development Program, NIH grant 5K12HD00849 to JLT (www.nih.gov). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011137; Andersen JD, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-21; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Beer LA, 2011, J PROTEOME RES, V10, P1126, DOI 10.1021/pr1008866; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Clarke-Pearson DL, 2009, NEW ENGL J MED, V361, P170, DOI 10.1056/NEJMcp0901926; Cramer DW, 2011, CANCER PREV RES, V4, P365, DOI 10.1158/1940-6207.CAPR-10-0195; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Faca VM, 2009, CANCER RES, V69, P728, DOI 10.1158/0008-5472.CAN-08-3087; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; Hellstrom I, 2003, CANCER RES, V63, P3695; Heubner M, 2011, GYNECOL ONCOL, V120, P233, DOI 10.1016/j.ygyno.2010.10.014; Hoffman SA, 2007, J CHROMATOGR B, V849, P43, DOI 10.1016/j.jchromb.2006.10.069; JACOBS I, 1989, HUM REPROD, V4, P1; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kuhn E, 2004, PROTEOMICS, V4, P1175, DOI 10.1002/pmic.200300670; Kuk C, 2009, MOL CELL PROTEOMICS, V8, P661, DOI 10.1074/mcp.M800313-MCP200; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Nowee ME, 2007, J PATHOL, V213, P46, DOI 10.1002/path.2217; Pitteri SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007916; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Sasaroli D, 2009, BIOMARK MED, V3, P275, DOI 10.2217/BMM.09.21; Su AI, 2001, CANCER RES, V61, P7388; Tang HY, 2012, J PROTEOME RES, V11, P678, DOI 10.1021/pr200603h; Tang HY, 2005, EXPERT REV PROTEOMIC, V2, P295, DOI 10.1586/14789450.2.3.295; Tang HY, 2005, PROTEOMICS, V5, P3329, DOI 10.1002/pmic.200401275; Tchagang AB, 2008, MOL CANCER THER, V7, P27, DOI 10.1158/1535-7163.MCT-07-0565; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Wang H, 2011, J PROTEOME RES, V10, P4993, DOI 10.1021/pr200464c; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; WOOLAS RP, 1993, JNCI-J NATL CANCER I, V85, P1748, DOI 10.1093/jnci/85.21.1748; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yue Wen, 2004, Ai Zheng, V23, P141; Zhang Y, 2012, PROTEOMICS, V12, P1883, DOI 10.1002/pmic.201100654; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193; Zuo X, 2001, ELECTROPHORESIS, V22, P1603, DOI 10.1002/1522-2683(200105)22:9<1603::AID-ELPS1603>3.0.CO;2-I	40	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60129	10.1371/journal.pone.0060129	http://dx.doi.org/10.1371/journal.pone.0060129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544127	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700086
J	Kalani, A; Mohan, A; Godbole, MM; Bhatia, E; Gupta, A; Sharma, RK; Tiwari, S				Kalani, Anuradha; Mohan, Aradhana; Godbole, Madan M.; Bhatia, Eesh; Gupta, Amit; Sharma, Raj Kumar; Tiwari, Swasti			Wilm's Tumor-1 Protein Levels in Urinary Exosomes from Diabetic Patients with or without Proteinuria	PLOS ONE			English	Article							PODOCYTE; DISEASE; BIOMARKERS; PROTEOMICS; EXCRETION; HEALTH; SERUM	Background: Podocyte injury is an early feature of diabetic nephropathy (DN). Recently, urinary exosomal Wilm's tumor-1 protein (WT1), shed by renal epithelial cells, has been proposed as a novel biomarker for podocyte injury. However, its usefulness as biomarker for early diabetic nephropathy has not been verified yet. We investigated urinary exosomal WT1 in type-1 diabetic patients to confirm its role as a non-invasive biomarker for predicting early renal function decline. Methods:The expression of WT1 protein in urinary exosomes from spot urine samples of type-1 diabetes mellitus patients (n=48) and healthy controls (n=25) were analyzed. Patients were divided based on their urinary albumin excretion, ACR (mg/g creatinine) into non- proteinuria group (ACR<30 mg/g, n=30) and proteinuria group (ACR>30 mg/g, n=18). Regression analysis was used to assess the association between urinary exosomal levels of WT1 with parameters for renal function. Receiver Operating Characteristic (ROC) curve analysis was used to determine the diagnostic performance of exosomal WT-1. Results: WT1 protein was detected in 33 out of 48 diabetic patients and in only 1 healthy control. The levels of urinary exosomal WT1 protein is significantly higher (p = 0.001) in patients with proteinuria than in those without proteinuria. In addition, all the patients with proteinuria but only half of the patients without proteinuria were positive for exosomal WT1. We found that the level of exosomal WT1 were associated with a significant increase in urine protein-to-creatinine ratio, albumin-to-creatinine ratio, and serum creatinine as well as a decline in eGFR. Furthermore, patients exhibiting WT1-positive urinary exosomes had decreased renal function compared to WT1-negative patients. ROC analysis shows that WT-1 effectively predict GFR<60 ml. min-1/1.73 m(2). Conclusion: The predominant presence of WT1 protein in urinary exosomes of diabetic patients and increase in its expression level with decline in renal function suggest that it could be useful as early non-invasive marker for diabetic nephropathy.	[Kalani, Anuradha; Mohan, Aradhana; Godbole, Madan M.; Tiwari, Swasti] Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, Lucknow, Uttar Pradesh, India; [Godbole, Madan M.; Bhatia, Eesh] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow, Uttar Pradesh, India; [Gupta, Amit; Sharma, Raj Kumar] Sanjay Gandhi Postgrad Inst Med Sci, Dept Nephrol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Tiwari, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, Lucknow, Uttar Pradesh, India.	tiwaris@sgpgi.ac.in	Kalani, Anuradha/GYE-2711-2022		SGPGI- Intramural research grant; Department of Science and Technology, Government of India [SR/FR/LS-143/2010]; University Grant Commission, India [F 2-89/98]; Department of Biotechnology, India	SGPGI- Intramural research grant; Department of Science and Technology, Government of India(Department of Science & Technology (India)); University Grant Commission, India(University Grants Commission, India); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by SGPGI- Intramural research grant and the Department of Science and Technology, Government of India (SR/FR/LS-143/2010) grant to ST. AM was supported by a Junior Research Fellowship from University Grant Commission, India (F 2-89/98; SA I). AK was supported by a Research Associate Fellowship from Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramham K, 2009, QJM-INT J MED, V102, P523, DOI 10.1093/qjmed/hcp071; Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399; Fernandez-Llama P, 2010, KIDNEY INT, V77, P736, DOI 10.1038/ki.2009.550; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Hara M, 2005, J AM SOC NEPHROL, V16, P408, DOI 10.1681/ASN.2004070564; Hu J, 2009, CLIN EXP HYPERTENS, V31, P49, DOI 10.1080/10641960802409788; Kubo K, 1999, EUR J CLIN INVEST, V29, P824; Lee H, 2012, PEDIATR NEPHROL, V27, P317, DOI 10.1007/s00467-011-2035-2; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lezaic V, 2010, J MED BIOCHEM, V29, P288, DOI 10.2478/v10011-010-0046-3; Marshall SM, 2004, POSTGRAD MED J, V80, P624, DOI 10.1136/pgmj.2004.021287; Michaud JLR, 2007, CLIN SCI, V112, P325, DOI 10.1042/CS20060143; Perkins BA, 2010, KIDNEY INT, V77, P57, DOI 10.1038/ki.2009.399; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Su J, 2010, DIABETES RES CLIN PR, V87, P167, DOI 10.1016/j.diabres.2009.10.022; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Vogelmann SU, 2003, AM J PHYSIOL-RENAL, V285, pF40, DOI 10.1152/ajprenal.00404.2002; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Woredekal Yalemzewd, 2008, Pediatr Endocrinol Rev, V5 Suppl 4, P999; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Yadav I, 2011, Indian J Nephrol, V21, P219, DOI 10.4103/0971-4065.85479; Zheng M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020431; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273; Zhou H, 2008, KIDNEY INT, V74, P613, DOI 10.1038/ki.2008.206	25	97	110	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60177	10.1371/journal.pone.0060177	http://dx.doi.org/10.1371/journal.pone.0060177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544132	Green Submitted, Green Published, gold			2022-12-25	WOS:000317480700091
J	Verhoeven, TJ; Nolte, JW; Maal, TJJ; Berge, SJ; Becking, AG				Verhoeven, Tim J.; Nolte, Jitske W.; Maal, Thomas J. J.; Berge, Stefaan J.; Becking, Alfred G.			Unilateral Condylar Hyperplasia: A 3-Dimensional Quantification of Asymmetry	PLOS ONE			English	Article							FACIAL ASYMMETRY	Purpose: Objective quantifications of facial asymmetry in patients with Unilateral Condylar Hyperplasia (UCH) have not yet been described in literature. The aim of this study was to objectively quantify soft-tissue asymmetry in patients with UCH and to compare the findings with a control group using a new method. Material and Methods:Thirty 3D photographs of patients diagnosed with UCH were compared with 30 3D photographs of healthy controls. As UCH presents particularly in the mandible, a new method was used to isolate the lower part of the face to evaluate asymmetry of this part separately. The new method was validated by two observers using 3D photographs of five patients and five controls. Results: A significant difference (0.79 mm) between patients and controls whole face asymmetry was found. lntra- and inter-observer differences of 0.011 mm (-0.034-0.011) and 0.017 mm (-0.007-0.042) respectively were found. These differences are irrelevant in clinical practice. Conclusion: After objective quantification, a significant difference was identified in soft-tissue asymmetry between patients with UCH and controls. The method used to isolate mandibular asymmetry was found to be valid and a suitable tool to evaluate facial asymmetry.	[Verhoeven, Tim J.; Maal, Thomas J. J.; Berge, Stefaan J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [Nolte, Jitske W.] Vrije Univ Amsterdam, Med Ctr, Dept Oral & Maxillofacial Surg Oral Pathol, Amsterdam, Netherlands; [Nolte, Jitske W.] Acad Ctr Dent Amsterdam, Amsterdam, Netherlands; [Becking, Alfred G.] Emma Children Hosp Amsterdam, Acad Med Ctr, Dept Oral & Maxillofacial Surg, Amsterdam, Netherlands	Radboud University Nijmegen; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Verhoeven, TJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands.	t.verhoeven@mka.umcn.nl	Bergé, S.J./H-8011-2014; Becking, Alfred G/G-9420-2016; Verhoeven, Tim/P-6916-2018; Maal, Thomas JJ/L-4497-2015; Berge, Stefaan/AAP-3708-2020	Becking, Alfred G/0000-0002-6371-4671; Maal, Thomas JJ/0000-0002-1702-4733; 				BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bochnen C, 2007, P 5 INT C 3 D DIG IM; Chia MS., 2008, ORTHO UPDATE, V1, P44, DOI DOI 10.12968/ortu.2008.1.2.44; De Groeve P, 2001, LECT NOTES COMPUTER, V2208, P991; EGYEDI P, 1969, Australian Dental Journal, V14, P12; FERRARIO VF, 1994, J ORAL MAXIL SURG, V52, P1126, DOI 10.1016/0278-2391(94)90528-2; GRAY RJM, 1990, INT J ORAL MAX SURG, V19, P65, DOI 10.1016/S0901-5027(05)80196-1; Hajeer Mohammad Y, 2002, Int J Adult Orthodon Orthognath Surg, V17, P318; Hwang HS, 2007, AM J ORTHOD DENTOFAC, V132, DOI 10.1016/j.ajodo.2007.01.017; IANNETTI G, 1989, ORAL SURG ORAL MED O, V68, P673, DOI 10.1016/0030-4220(89)90154-0; Jones RHB, 2012, J ORAL MAXIL SURG, V70, P1413, DOI 10.1016/j.joms.2011.03.047; Kaban LB, 2009, J CRANIOFAC SURG, V20, P622, DOI 10.1097/SCS.0b013e318195249c; Kau CH, 2007, INT J MED ROBOT COMP, V3, P97, DOI 10.1002/rcs.141; Maal TJJ, 2008, INT J ORAL MAX SURG, V37, P641, DOI 10.1016/j.ijom.2008.04.012; Maal TJJ, 2011, INT J ORAL MAX SURG, V40, P1252, DOI 10.1016/j.ijom.2011.02.033; Maal TJJ, 2010, J ORAL MAXIL SURG, V68, P2391, DOI 10.1016/j.joms.2009.10.017; Meyer-Marcotty P, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2008.11.023; Nitzan DW, 2008, J ORAL MAXIL SURG, V66, P312, DOI 10.1016/j.joms.2007.08.046; OBWEGESER HL, 1986, J MAXILLOFAC SURG, V14, P183, DOI 10.1016/S0301-0503(86)80290-9; Plooij JM, 2009, INT J ORAL MAX SURG, V38, P267, DOI 10.1016/j.ijom.2008.12.009; Primozic J, 2011, EUROPEAN J ORTHODONT, V350, P7; Primozic J, 2009, EUR J ORTHODONT, V31, P352, DOI 10.1093/ejo/cjp041; Saridin CP, 2011, INT J ORAL MAX SURG, V40, P11, DOI 10.1016/j.ijom.2010.09.015; Swennen GRJ, 2005, 3 DIMENSIONAL CEPHAL, P320; Verhoeven TJ, 2013, INT J ORAL MAX SURG, V42, P19, DOI 10.1016/j.ijom.2012.05.036; Villanueva-Alcojol L, 2011, J ORAL MAXIL SURG, V69, P447, DOI 10.1016/j.joms.2010.04.025	26	15	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59391	10.1371/journal.pone.0059391	http://dx.doi.org/10.1371/journal.pone.0059391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544063	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700025
J	Kurpios, NA; Girgis-Gabardo, A; Hallett, RM; Rogers, S; Gludish, DW; Kockeritz, L; Woodgett, J; Cardiff, R; Hassell, JA				Kurpios, Natasza A.; Girgis-Gabardo, Adele; Hallett, Robin M.; Rogers, Stephen; Gludish, David W.; Kockeritz, Lisa; Woodgett, James; Cardiff, Robert; Hassell, John A.			Single Unpurified Breast Tumor-Initiating Cells from Multiple Mouse Models Efficiently Elicit Tumors in Immune-Competent Hosts	PLOS ONE			English	Article							CANCER STEM-CELLS; ACUTE MYELOID-LEUKEMIA; MAMMARY-TUMORS; METASTATIC-DISEASE; NEU PROTOONCOGENE; CLONAL EVOLUTION; PROGENITOR CELLS; TRANSGENIC MICE; IN-VITRO; IDENTIFICATION	The tumor-initiating cell (TIC) frequency of bulk tumor cell populations is one of the criteria used to distinguish malignancies that follow the cancer stem cell model from those that do not. However, tumor-initiating cell frequencies may be influenced by experimental conditions and the extent to which tumors have progressed, parameters that are not always addressed in studies of these cells. We employed limiting dilution cell transplantation of minimally manipulated tumor cells from mammary tumors of several transgenic mouse models to determine their tumor-initiating cell frequency. We determined whether the tumors that formed following tumor cell transplantation phenocopied the primary tumors from which they were isolated and whether they could be serially transplanted. Finally we investigated whether propagating primary tumor cells in different tissue culture conditions affected their resident tumor-initiating cell frequency. We found that tumor-initiating cells comprised between 15% and 50% of the bulk tumor cell population in multiple independent mammary tumors from three different transgenic mouse models of breast cancer. Culture of primary mammary tumor cells in chemically-defined, serum-free medium as non-adherent tumorspheres preserved TIC frequency to levels similar to that of the primary tumors from which they were established. By contrast, propagating the primary tumor cells in serum-containing medium as adherent populations resulted in a several thousand-fold reduction in their tumor-initiating cell fraction. Our findings suggest that experimental conditions, including the sensitivity of the transplantation assay, can dramatically affect estimates of tumor initiating cell frequency. Moreover, conditional on cell culture conditions, the tumor-initiating cell fraction of bulk mouse mammary tumor cell preparations can either be maintained at high or low frequency in vitro thus permitting comparative studies of tumorigenic and non-tumorigenic cancer cells.	[Kurpios, Natasza A.; Girgis-Gabardo, Adele; Hallett, Robin M.; Rogers, Stephen; Gludish, David W.; Hassell, John A.] McMaster Univ, Dept Biochem & Biomed Sci, Ctr Funct Genom, Hamilton, ON, Canada; [Kockeritz, Lisa; Woodgett, James] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Cardiff, Robert] Univ Calif Davis, Dept Pathol, Davis, CA 95616 USA	McMaster University; University of Toronto; University of California System; University of California Davis	Hassell, JA (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Ctr Funct Genom, Hamilton, ON, Canada.	hassell@mcmaster.ca	Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797; Gludish, David/0000-0002-3537-4585	Canadian Breast Cancer Research Alliance; Ontario Institute for Cancer Research; Canadian Breast Cancer Foundation (Ontario); Canadian Stem Cell Network	Canadian Breast Cancer Research Alliance; Ontario Institute for Cancer Research; Canadian Breast Cancer Foundation (Ontario); Canadian Stem Cell Network	The authors' research was supported by grants from the Canadian Breast Cancer Research Alliance, the Ontario Institute for Cancer Research, the Canadian Breast Cancer Foundation (Ontario) and the Canadian Stem Cell Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cardiff RD, 2001, VET PATHOL, V38, P357, DOI 10.1354/vp.38-4-357; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; DEOME KB, 1959, CANCER RES, V19, P515; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hallett RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033976; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kondratyev M, 2012, ONCOGENE, V31, P93, DOI 10.1038/onc.2011.212; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Kurpios NA, 2009, DEV BIOL, V325, P106, DOI 10.1016/j.ydbio.2008.09.033; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Maglione JE, 2004, MOL CANCER THER, V3, P941; Maglione JE, 2001, CANCER RES, V61, P8298; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; PULLAN S, 1996, EPITHELIAL CELL CULT; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shepherd TG, 2001, CURR BIOL, V11, P1739, DOI 10.1016/S0960-9822(01)00536-X; Siegel PM, 1996, P NATL ACAD SCI USA, V93, P8878, DOI 10.1073/pnas.93.17.8878; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711; Smalley MJ, 1999, J HISTOCHEM CYTOCHEM, V47, P1513, DOI 10.1177/002215549904701203; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Vaillant F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2851; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Youn BS, 2006, BIOTECHNOL PROGR, V22, P801, DOI 10.1021/bp050430z; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107	57	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58151	10.1371/journal.pone.0058151	http://dx.doi.org/10.1371/journal.pone.0058151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555570	Green Published, gold, Green Submitted			2022-12-25	WOS:000317418500006
J	Jaramillo, VDA; Vargas, WA; Sukno, SA; Thon, MR				Armijos Jaramillo, Vinicio Danilo; Alberto Vargas, Walter; Ana Sukno, Serenella; Thon, Michael R.			Horizontal Transfer of a Subtilisin Gene from Plants into an Ancestor of the Plant Pathogenic Fungal Genus Colletotrichum	PLOS ONE			English	Article							MONOCOT-DICOT DIVERGENCE; SERINE PROTEASES; CELL-DEATH; PROTEIN; SUBTILASES; GENOME; FAMILY; PURIFICATION; PHYLOGENIES; EVOLUTION	The genus Colletotrichum contains a large number of phytopathogenic fungi that produce enormous economic losses around the world. The effect of horizontal gene transfer (HGT) has not been studied yet in these organisms. Inter-Kingdom HGT into fungal genomes has been reported in the past but knowledge about the HGT between plants and fungi is particularly limited. We describe a gene in the genome of several species of the genus Colletotrichum with a strong resemblance to subtilisins typically found in plant genomes. Subtilisins are an important group of serine proteases, widely distributed in all of the kingdoms of life. Our hypothesis is that the gene was acquired by Colletotrichum spp. through (HGT) from plants to a Colletotrichum ancestor. We provide evidence to support this hypothesis in the form of phylogenetic analyses as well as a characterization of the similarity of the subtilisin at the primary, secondary and tertiary structural levels. The remarkable level of structural conservation of Colletotrichum plant-like subtilisin (CPLS) with plant subtilisins and the differences with the rest of Colletotrichum subtilisins suggests the possibility of molecular mimicry. Our phylogenetic analysis indicates that the HGT event would have occurred approximately 150-155 million years ago, after the divergence of the Colletotrichum lineage from other fungi. Gene expression analysis shows that the gene is modulated during the infection of maize by C. graminicola suggesting that it has a role in plant disease. Furthermore, the upregulation of the CPLS coincides with the downregulation of several plant genes encoding subtilisins. Based on the known roles of subtilisins in plant pathogenic fungi and the gene expression pattern that we observed, we postulate that the CPLSs have an important role in plant infection.	[Armijos Jaramillo, Vinicio Danilo; Alberto Vargas, Walter; Ana Sukno, Serenella; Thon, Michael R.] Univ Salamanca, Ctr Hispano Luso Invest Agr, Dept Genet & Microbiol, Villamayor, Spain	University of Salamanca	Thon, MR (corresponding author), Univ Salamanca, Ctr Hispano Luso Invest Agr, Dept Genet & Microbiol, Villamayor, Spain.	mthon@usal.es	Armijos-Jaramillo, Vinicio Danilo/Q-4988-2019; Thon, Michael/M-9463-2014; Sukno, Serenella A/K-1449-2014; Sukno, Serenella/T-5919-2019	Armijos-Jaramillo, Vinicio Danilo/0000-0003-2965-2515; Thon, Michael/0000-0002-7225-7003; Sukno, Serenella A/0000-0003-3248-6490; Sukno, Serenella/0000-0003-3248-6490	Ministerio de Ciencia e Innovacion (MICINN) of Spain [AGL2011-29446, AGL2012-34139]; Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion of Ecuador; Juan de la Cierva Program [JCI-2009-05364]	Ministerio de Ciencia e Innovacion (MICINN) of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion of Ecuador; Juan de la Cierva Program	This research was supported by funds from the Ministerio de Ciencia e Innovacion (MICINN) of Spain (grants AGL2011-29446 and AGL2012-34139). VDAJ was supported by a graduate fellowship from the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion of Ecuador. W.A.V was supported by a fellowship from the Juan de la Cierva Program (JCI-2009-05364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, P NATL ACAD SCI USA, V103, P2851, DOI 10.1073/pnas.0507892103; Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Broad Institute of Harvard and MIT, COLL SEQ PROJ; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; BRYAN P, 1995, BIOCHEMISTRY-US, V34, P10310, DOI 10.1021/bi00032a026; Bryant MK, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-168; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cedzich A, 2009, J BIOL CHEM, V284, P14068, DOI 10.1074/jbc.M900370200; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chichkova NV, 2010, EMBO J, V29, P1149, DOI 10.1038/emboj.2010.1; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Coffeen WC, 2004, PLANT CELL, V16, P857, DOI 10.1105/tpc.017947; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Donatti AC, 2008, CURR MICROBIOL, V56, P256, DOI 10.1007/s00284-007-9071-y; Drummond AJ, 2011, GENEIOUS V5 5; Dunasevsky YE, 2007, BIOCHEMISTRY-MOSCOW+, V72, P345, DOI 10.1134/S0006297907030145; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Gogarten JP, 2003, CURR BIOL, V13, pR53, DOI 10.1016/S0960-9822(02)01426-4; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton JMU, 2003, BIOCHEM J, V370, P57, DOI 10.1042/BJ20021125; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Heuer Holger, 2007, Environmental Biosafety Research, V6, P3, DOI 10.1051/ebr:2007034; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; IKEMURA H, 1988, J BIOL CHEM, V263, P12959; Jorda L, 1999, J BIOL CHEM, V274, P2360, DOI 10.1074/jbc.274.4.2360; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim SE, 2012, J MICROBIOL BIOTECHN, V22, P563, DOI 10.4014/jmb.1110.10066; Kleemann J, 2008, MICROBIOL-SGM, V154, P1204, DOI 10.1099/mic.0.2007/014944-0; Latunde-Dada AO, 2001, MOL PLANT PATHOL, V2, P187, DOI 10.1046/j.1464-6722.2001.00069.x; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; Meichtry J, 1999, PLANT MOL BIOL, V39, P749, DOI 10.1023/A:1006193414434; Mi H, 2009, NUCLEIC ACIDS RES, V38, pD204, DOI DOI 10.1093/NAR/GKP1019; Muszewska A, 2011, MOL BIOL EVOL, V28, P3395, DOI 10.1093/molbev/msr176; Nakagawa M, 2010, J BIOL CHEM, V285, P29797, DOI 10.1074/jbc.M109.083162; Nembaware V, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-10; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; OHTA Y, 1990, MOL MICROBIOL, V4, P295, DOI 10.1111/j.1365-2958.1990.tb00596.x; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P17223, DOI 10.1073/pnas.0907587106; Pearce G, 2010, P NATL ACAD SCI USA, V107, P14921, DOI 10.1073/pnas.1007568107; Perfect SE, 2001, MOL PLANT PATHOL, V2, P101, DOI 10.1046/j.1364-3703.2001.00055.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Reddy PV, 1996, PLANT PHYSIOL, V111, P1209, DOI 10.1104/pp.111.4.1209; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Richards TA, 2009, PLANT CELL, V21, P1897, DOI 10.1105/tpc.109.065805; Rolland T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006515; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rose R, 2010, PLANT SIGNAL BEHAV, V5, P180, DOI 10.4161/psb.5.2.11069; Rosewich UL, 2000, ANNU REV PHYTOPATHOL, V38, P325, DOI 10.1146/annurev.phyto.38.1.325; Saeki K, 2000, BIOCHEM BIOPH RES CO, V279, P313, DOI 10.1006/bbrc.2000.3931; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schrodinger L., 2020, PYMOL; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SIEZEN RJ, 1991, PROTEIN ENG, V4, P719, DOI 10.1093/protein/4.7.719; Slot JC, 2010, P NATL ACAD SCI USA, V107, P10136, DOI 10.1073/pnas.0914418107; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Sreedhar L, 1999, GENE, V235, P121, DOI 10.1016/S0378-1119(99)00201-2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takano Yoshitaka, 2004, Journal of General Plant Pathology, V70, P390, DOI 10.1007/s10327-004-0147-2; Takeda N, 2009, PLANT J, V58, P766, DOI 10.1111/j.1365-313X.2009.03824.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Techtmann SM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00132; Tiburcio RA, 2010, J MOL EVOL, V70, P85, DOI 10.1007/s00239-009-9311-9; Tornero P, 1996, P NATL ACAD SCI USA, V93, P6332, DOI 10.1073/pnas.93.13.6332; Tornero P, 1997, J BIOL CHEM, V272, P14412, DOI 10.1074/jbc.272.22.14412; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; Vargas WA, 2012, PLANT PHYSIOL, V158, P1342, DOI 10.1104/pp.111.190397; Withers-Martinez C, 2012, INT J PARASITOL, V42, P597, DOI 10.1016/j.ijpara.2012.04.005; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Yang JK, 2005, BIOTECHNOL LETT, V27, P1123, DOI 10.1007/s10529-005-8461-0	89	23	23	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59078	10.1371/journal.pone.0059078	http://dx.doi.org/10.1371/journal.pone.0059078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554975	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800056
J	Gouba, N; Raoult, D; Drancourt, M				Gouba, Nina; Raoult, Didier; Drancourt, Michel			Plant and Fungal Diversity in Gut Microbiota as Revealed by Molecular and Culture Investigations	PLOS ONE			English	Article							DNA EXTRACTION METHODS; IDENTIFICATION; PCR; WATER; ASPERGILLUS; PATHOGENS; BACTERIAL; STARTER; ECOLOGY; CHEESE	Background: Few studies describing eukaryotic communities in the human gut microbiota have been published. The objective of this study was to investigate comprehensively the repertoire of plant and fungal species in the gut microbiota of an obese patient. Methodology/Principal Findings: A stool specimen was collected from a 27-year-old Caucasian woman with a body mass index of 48.9 who was living in Marseille, France. Plant and fungal species were identified using a PCR-based method incorporating 25 primer pairs specific for each eukaryotic phylum and universal eukaryotic primers targeting 18S rRNA, internal transcribed spacer (ITS) and a chloroplast gene. The PCR products amplified using these primers were cloned and sequenced. Three different culture media were used to isolate fungi, and these cultured fungi were further identified by ITS sequencing. A total of 37 eukaryotic species were identified, including a Diatoms (Blastocystis sp.) species, 18 plant species from the Streptophyta phylum and 18 fungal species from the Ascomycota, Basidiomycota and Chytridiocomycota phyla. Cultures yielded 16 fungal species, while PCR-sequencing identified 7 fungal species. Of these 7 species of fungi, 5 were also identified by culture. Twenty-one eukaryotic species were discovered for the first time in human gut microbiota, including 8 fungi (Aspergillus flavipes, Beauveria bassiana, Isaria farinosa, Penicillium brevicompactum, Penicillium dipodomyicola, Penicillium camemberti, Climacocystis sp. and Malassezia restricta). Many fungal species apparently originated from food, as did 11 plant species. However, four plant species (Atractylodes japonica, Fibraurea tinctoria, Angelica anomala, Mitella nuda) are used as medicinal plants. Conclusions/Significance: Investigating the eukaryotic components of gut microbiota may help us to understand their role in human health.	[Gouba, Nina; Raoult, Didier; Drancourt, Michel] Aix Marseille Univ, URMITE, UMR63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Drancourt, M (corresponding author), Aix Marseille Univ, URMITE, UMR63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France.	michel.drancourt@univmed.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Abdullahi I, 2005, APPL MICROBIOL BIOT, V68, P368, DOI 10.1007/s00253-005-1952-z; Asefa DT, 2009, INT J FOOD MICROBIOL, V128, P435, DOI 10.1016/j.ijfoodmicro.2008.09.024; Atkins Simon D., 2004, Journal of Applied Genetics, V45, P3; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Bragulat MR, 2008, LETT APPL MICROBIOL, V47, P286, DOI 10.1111/j.1472-765X.2008.02422.x; Callahan HA, 2002, J EUKARYOT MICROBIOL, V49, P119, DOI 10.1111/j.1550-7408.2002.tb00354.x; Santos HLC, 2010, PARASITOL RES, V106, P883, DOI 10.1007/s00436-010-1728-y; Chabchoub N, 2009, AM J TROP MED HYG, V80, P24, DOI 10.4269/ajtmh.2009.80.24; Chai LYA, 2010, CRIT REV MICROBIOL, V36, P282, DOI 10.3109/1040841X.2010.489506; Chen Y, 2011, DIAGN MICR INFEC DIS, V70, P492, DOI 10.1016/j.diagmicrobio.2010.04.005; Desquesnes M, 2001, INT J PARASITOL, V31, P610, DOI 10.1016/S0020-7519(01)00161-8; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Dopheide A, 2008, APPL ENVIRON MICROB, V74, P1740, DOI 10.1128/AEM.01438-07; Fredricks DN, 2005, J CLIN MICROBIOL, V43, P5122, DOI 10.1128/JCM.43.10.5122-5128.2005; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Giraud F, 2010, INT J FOOD MICROBIOL, V137, P204, DOI 10.1016/j.ijfoodmicro.2009.11.014; Goerges S, 2008, APPL ENVIRON MICROB, V74, P2210, DOI 10.1128/AEM.01663-07; Griffiths LJ, 2006, J MED MICROBIOL, V55, P1187, DOI 10.1099/jmm.0.46510-0; Hayes DC, 2003, J VET DIAGN INVEST, V15, P390, DOI 10.1177/104063870301500417; Hong MH, 2010, ARCH PHARM RES, V33, P843, DOI 10.1007/s12272-010-0606-6; Inoue Y, 2005, J IMMUNOL, V175, P5439, DOI 10.4049/jimmunol.175.8.5439; Kabli Saleh A, 2007, MET ENV ARID LAND AG, V18, P87; Khatib R, 2001, MYCOSES, V44, P151, DOI 10.1046/j.1439-0507.2001.00639.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klich MA, 2009, TOXICOL IND HEALTH, V25, P657, DOI 10.1177/0748233709348271; Kolisko M, 2010, ENVIRON MICROBIOL, V12, P2700, DOI 10.1111/j.1462-2920.2010.02239.x; Kuiper MW, 2006, APPL ENVIRON MICROB, V72, P5750, DOI 10.1128/AEM.00085-06; Kullberg BJ, 2002, EUR J MED RES, V7, P183; Lee YW, 2011, ANN DERMATOL, V23, P156, DOI 10.5021/ad.2011.23.2.156; LEEMING JP, 1987, J CLIN MICROBIOL, V25, P2017, DOI 10.1128/JCM.25.10.2017-2019.1987; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Li Q, 2012, DESALIN WATER TREAT, V43, P43, DOI 10.1080/19443994.2012.672197; Lin SJ, 2006, APPL ENVIRON MICROB, V72, P5626, DOI 10.1128/AEM.00586-06; Mirhendi H, 2005, J MICROBIOL METH, V61, P281, DOI 10.1016/j.mimet.2004.11.016; Muellner AN, 2001, INT J SYST EVOL MICR, V51, P783; Nam YD, 2008, J MICROBIOL, V46, P491, DOI 10.1007/s12275-008-0199-7; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Pandey PK, 2012, J BIOSCIENCES, V37, P221, DOI 10.1007/s12038-012-9197-3; Parfrey LW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00153; Pelandakis M, 2002, APPL ENVIRON MICROB, V68, P2061, DOI 10.1128/AEM.68.4.2061-2065.2002; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Pounder JI, 2007, J CLIN MICROBIOL, V45, P568, DOI 10.1128/JCM.01684-06; Provan J, 2004, EUR J PHYCOL, V39, P43, DOI 10.1080/09670260310001636668; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Rodriguez A, 2012, INT J FOOD MICROBIOL, V155, P10, DOI 10.1016/j.ijfoodmicro.2012.01.007; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Senapin S, 2011, AQUACULT INT, V19, P693, DOI 10.1007/s10499-010-9384-x; Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195; Sonjak S, 2011, FOOD MICROBIOL, V28, P373, DOI 10.1016/j.fm.2010.09.007; Stensvold CR, 2011, TRENDS PARASITOL, V27, P53, DOI 10.1016/j.pt.2010.11.005; Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Tilg H, 2009, GASTROENTEROLOGY, V136, P1476, DOI 10.1053/j.gastro.2009.03.030; Tsai Franklin, 2009, Curr Gastroenterol Rep, V11, P307, DOI 10.1007/s11894-009-0045-z; Valdez JG, 2009, PLANT PATHOL, V58, P352, DOI 10.1111/j.1365-3059.2008.01960.x; Westwood Greg S, 2005, Clin Mol Allergy, V3, P1, DOI 10.1186/1476-7961-3-1; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wright SG, 2012, INFECT DIS CLIN N AM, V26, P323, DOI 10.1016/j.idc.2012.03.009; Yim SM, 2010, ANN DERMATOL, V22, P41, DOI 10.5021/ad.2010.22.1.41	64	59	64	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59474	10.1371/journal.pone.0059474	http://dx.doi.org/10.1371/journal.pone.0059474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555039	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800096
J	Pan, Q; Ju, ZH; Huang, JM; Zhang, Y; Qi, C; Gao, Q; Zhou, L; Li, QL; Wang, LL; Zhong, JF; Liu, M; Wang, CF				Pan, Qing; Ju, Zhihua; Huang, Jinming; Zhang, Yan; Qi, Chao; Gao, Qin; Zhou, Lei; Li, Qiuling; Wang, Lingling; Zhong, Jifeng; Liu, Mei; Wang, Changfa			PLCz Functional Haplotypes Modulating Promoter Transcriptional Activity Are Associated with Semen Quality Traits in Chinese Holstein Bulls	PLOS ONE			English	Article							PHOSPHOLIPASE-C-ZETA; SINGLE-NUCLEOTIDE POLYMORPHISMS; OSCILLATION-INDUCING ACTIVITY; CANDIDATE GENE MARKERS; GROWTH-HORMONE GENE; CA2+ OSCILLATIONS; SPERM QUALITY; INOSITOL 1,4,5-TRISPHOSPHATE; EGG ACTIVATION; BINDING LECTIN	The sperm-specific phospholipase C zeta (PLCz) is a candidate sperm-borne oocyte-activating factor that triggers a characteristic series of physiological stimuli via cytoplasmic Ca2+ oscillations during fertilization. The molecular mechanisms involved in the regulation of PLCz gene expression remain largely unknown. To explore the genetic variations in the 5'-flanking region of the PLCz gene and their common haplotypes in Chinese Holstein bulls, as well as to determine whether these variations affect bovine semen quality traits and transcriptional activity, DNA samples were collected from Chinese Holstein bulls and sequenced for the identification of genetic variants in the 59-flanking region of PLCz. Two genetic variants were identified, and their haplotypic profiles were constructed. The two novel genetic variations (g. 2456 G>A and g. +65 T>C) were genotyped in 424 normal Chinese Holstein bulls. Bioinformatics analysis revealed that both loci are in transcription factor binding sites of the core promoter region. The association studies revealed that the two genetic variations and their haplotype combinations significantly affected semen quality traits. Using serially truncated constructs of the bovine PLCz promoters and the luciferase reporter, we found that a 726 bp (-641 nt to +112 nt) fragment constitutes the core promoter region. Furthermore, four haplotypes, H1H1 (GTGT), H2H2 (GCGC), H3H3 (ATAT), and H4H4 (ACAC), were significantly associated with semen quality traits and successfully transfected into MLTC-1 cell lines. The luciferase reporter assay showed that the different haplotypes exhibited distinct promoter activities. Maximal promoter activity was demonstrated by the H2H2 haplotypes, as compared with the other haplotypes. To the best of our knowledge, this study is the first report on genetic variants and their respective haplotypes in the 5'-flanking region of PLCz gene that can influence the semen quality of Chinese Holstein bulls as well as contribute to the transcriptional activity of the PLCz promoter.	[Pan, Qing; Ju, Zhihua; Huang, Jinming; Zhang, Yan; Qi, Chao; Gao, Qin; Zhou, Lei; Li, Qiuling; Wang, Lingling; Zhong, Jifeng; Wang, Changfa] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan, Peoples R China; [Pan, Qing; Liu, Mei] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Shandong Academy of Agricultural Sciences; Nanjing Normal University	Liu, M (corresponding author), Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	meiliunj@163.com; wcf1967@yahoo.com.cn			National Science and Technology Pillar Program during the 12th Five-Year Plan of China [2011BAD19B04]; Modern Agro-industry Technology Research System [CARS-37]; State Major Project of Transgenic [2011ZX08007-004]; Well-bred Program of Shandong Province [2012LZ10-06]; Key Scientific and Technological Project of Shandong Province [2009GG20002033]	National Science and Technology Pillar Program during the 12th Five-Year Plan of China; Modern Agro-industry Technology Research System; State Major Project of Transgenic; Well-bred Program of Shandong Province; Key Scientific and Technological Project of Shandong Province	This work was partially supported by grants the National Science and Technology Pillar Program during the 12th Five-Year Plan of China (Grant no. 2011BAD19B04), the Modern Agro-industry Technology Research System (Grant no. CARS-37), State Major Project of Transgenic (2011ZX08007-004), the Well-bred Program of Shandong Province (Grant no. 2012LZ10-06), and the Key Scientific and Technological Project of Shandong Province (Grant no. 2009GG20002033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford-Guaus SJ, 2011, BIOL REPROD, V85, P78, DOI 10.1095/biolreprod.110.089466; Brind S, 2000, DEV BIOL, V223, P251, DOI 10.1006/dbio.2000.9728; Capparelli R, 2008, IMMUNOGENETICS, V60, P157, DOI 10.1007/s00251-008-0284-4; Coward K, 2005, REPRODUCTION, V130, P157, DOI 10.1530/rep.1.00707; Cox LJ, 2002, REPRODUCTION, V124, P611, DOI 10.1530/rep.0.1240611; Daghigh-Kia H., 2007, THESIS U BONN BONN, P135; Dai LS, 2009, ANIM REPROD SCI, V114, P14, DOI 10.1016/j.anireprosci.2008.08.021; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Fujimoto S, 2004, DEV BIOL, V274, P370, DOI 10.1016/j.ydbio.2004.07.025; Gorbai A, 2009, AFR J MICROBIOL RES, V3, P809; Gorbani A, 2009, AFR J BIOTECHNOL, V8, P4811; Gredler B, 2007, REPROD DOMEST ANIM, V42, P326, DOI 10.1111/j.1439-0531.2006.00778.x; Heytens E, 2009, HUM REPROD, V24, P2417, DOI 10.1093/humrep/dep207; Huang SY, 2002, ANIM REPROD SCI, V70, P99, DOI 10.1016/S0378-4320(01)00202-0; Ito M, 2008, BIOL REPROD, V78, P1081, DOI 10.1095/biolreprod.108.067801; Jellerette T, 2000, DEV BIOL, V223, P238, DOI 10.1006/dbio.2000.9675; Jones KT, 2000, DEV BIOL, V225, P1, DOI 10.1006/dbio.2000.9826; JOSHI CP, 1987, NUCLEIC ACIDS RES, V15, P6643, DOI 10.1093/nar/15.16.6643; Ju ZH, 2012, DNA CELL BIOL, V31, P1038, DOI 10.1089/dna.2011.1555; Kaewmala K, 2012, REPROD DOMEST ANIM, V47, P213, DOI 10.1111/j.1439-0531.2011.01831.x; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kealey CG, 2006, J ANIM SCI, V84, P283, DOI 10.2527/2006.842283x; Knott JG, 2005, BIOL REPROD, V72, P992, DOI 10.1095/biolreprod.104.036244; Kouchi Z, 2004, J BIOL CHEM, V279, P10408, DOI 10.1074/jbc.M313801200; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Lin CL, 2006, ANIM REPROD SCI, V92, P349, DOI 10.1016/j.anireprosci.2005.05.023; Liu XY, 2012, AFR J MICROBIOL RES, V6, P594, DOI 10.5897/AJMR11.1429; Liu XY, 2011, ANIM REPROD SCI, V129, P14, DOI 10.1016/j.anireprosci.2011.10.003; Long AD, 1999, GENOME RES, V9, P720; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Mathevon M, 1998, J DAIRY SCI, V81, P3321, DOI 10.3168/jds.S0022-0302(98)75898-9; MIYAZAKI S, 1993, DEV BIOL, V158, P62, DOI 10.1006/dbio.1993.1168; Ohl DA, 2008, UROL CLIN N AM, V35, P211, DOI 10.1016/j.ucl.2008.01.014; Parmentier I, 1999, DOMEST ANIM ENDOCRIN, V17, P139, DOI 10.1016/S0739-7240(99)00031-4; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; TAMULI MK, 1994, ANIM REPROD SCI, V35, P247, DOI 10.1016/0378-4320(94)90040-X; Wang PQ, 2011, GENET MOL RES, V10, P731, DOI 10.4238/vol10-2gmr1091; Wang Xuting, 2005, Toxicol Appl Pharmacol, V207, P84, DOI 10.1016/j.taap.2004.09.024; Wimmers K, 2005, ANIM GENET, V36, P152, DOI 10.1111/j.1365-2052.2005.01267.x; Wu H, 2001, BIOL REPROD, V64, P1338, DOI 10.1095/biolreprod64.5.1338; Yang WC, 2011, MOL BIOL REP, V38, P3411, DOI 10.1007/s11033-010-0450-2; Yoneda A, 2006, REPRODUCTION, V132, P393, DOI 10.1530/rep.1.01018; Yoon SY, 2008, J CLIN INVEST, V118, P3671, DOI 10.1172/JCI36942; Yoon SY, 2007, REPRODUCTION, V134, P695, DOI 10.1530/REP-07-0259; Young C, 2009, FERTIL STERIL, V91, P2230, DOI 10.1016/j.fertnstert.2008.05.021	49	20	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58795	10.1371/journal.pone.0058795	http://dx.doi.org/10.1371/journal.pone.0058795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554927	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800029
J	Yang, DH; Kang, JH; Park, YB; Park, YJ; Oh, HS; Kim, SB				Yang, Dong Hoon; Kang, Ji Hoon; Park, Young Bae; Park, Young Jae; Oh, Hwan Sup; Kim, Seoung Bum			Association Rule Mining and Network Analysis in Oriental Medicine	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; KNOWLEDGE DISCOVERY	Extracting useful and meaningful patterns from large volumes of text data is of growing importance. In the present study we analyze vast amounts of prescription data, generated from the book of oriental medicine to identify the relationships between the symptoms and the associated medicines used to treat these symptoms. The oriental medicine book used in this study (called Bangyakhappyeon) contains a large number of prescriptions to treat about 54 categorized symptoms and lists the corresponding herbal materials. We used an association rule algorithm combined with network analysis and found useful and informative relationships between the symptoms and medicines.	[Yang, Dong Hoon; Park, Young Bae; Park, Young Jae] Kyung Hee Univ, Dept Biofunct Med & Diagnost, Seoul, South Korea; [Kang, Ji Hoon; Kim, Seoung Bum] Korea Univ, Sch Ind Management Engn, Seoul, South Korea; [Oh, Hwan Sup] Kyung Hee Univ, Dept Human Informat Oriental Med, Interdisciplinary Programs, Yongin, Gyeonggi Do, South Korea; [Oh, Hwan Sup] Kyung Hee Univ, Dept Mech Engn, Yongin, Gyeonggi Do, South Korea	Kyung Hee University; Korea University; Kyung Hee University; Kyung Hee University	Kim, SB (corresponding author), Korea Univ, Sch Ind Management Engn, Seoul, South Korea.	sbkim1@korea.ac.kr			Brain Korea 21	Brain Korea 21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was support in part by Brain Korea 21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Agrawal R., 1994, P 20 INT C VER LARG, P487; Cao CG, 2004, ARTIF INTELL MED, V32, P3, DOI 10.1016/j.artmed.2004.01.015; Fayyad U, 1996, AI MAG, V17, P37; Feng Y, 2006, ARTIF INTELL MED, V38, P219, DOI 10.1016/j.artmed.2006.07.005; Fu X, 2012, CHINESE J INTEGRATIV, P1; Hong CD, 2001, J ALTERN COMPLEM MED, V7, pS33; Hunyadi Daniel, 2011, European Computing Conference. Proceedings of the European Computing Conference (ECC '11), P376; Jang ES, 2007, KOREAN J OREINTAL ME, V13, P143; Jiang Y, 2003, WORLD SCI TECHNOL MO, V5, P33; 홍대기, 2011, [Journal of Korean Medicine, 대한한의학회지], V32, P56; Li C, 2004, LECT NOTES COMPUT SC, V3289, P246; Li S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S6; Memon N, 2010, DAT AMINING SOCIAL N; Riondato M, 2012, MACHINE LEARNING KNO, P5; Shang E., 2010, WORLD SCI TECHNOLOGY, V12, P377; Tan P., 2006, INTRO DATA MINING; Witten IH, 2011, MOR KAUF D, P1; [姚美村 Yao Meicun], 2002, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V25, P48; Zhou XZ, 2010, J BIOMED INFORM, V43, P650, DOI 10.1016/j.jbi.2010.01.002; Zhou XZ, 2005, LECT NOTES COMPUT SC, V3735, P396	21	33	33	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59241	10.1371/journal.pone.0059241	http://dx.doi.org/10.1371/journal.pone.0059241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555003	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800074
J	Duran, C; Chien, LT; Hartzell, HC				Duran, Charity; Chien, Li-Ting; Hartzell, H. Criss			Drosophila Bestrophin-1 Currents Are Regulated by Phosphorylation via a CaMKII Dependent Mechanism	PLOS ONE			English	Article							PROTEIN-KINASE-II; CL-CHANNELS; CHLORIDE CHANNELS; ANION CHANNELS; CELL-VOLUME; CALCIUM; INHIBITOR	Cell swelling induced by hypo-osmotic stress results in activation of volume-regulated anion channels (VRAC) that drive a compensatory regulatory volume decrease. We have previously shown that the Best1 gene in Drosophila encodes a VRAC that is also activated by increases in intracellular Ca2+. The role of Best1 as a VRAC has recently been independently confirmed by the Clapham lab in an unbiased RNAi screen. Although dBest1 is clearly a volume-regulated channel, its mechanisms of regulation remain unknown. Here we investigate Drosophila Best1 (dBest1) regulation using the Drosophila S2 cell model system. Because dBest1 activates slowly after establishing whole-cell recording, we tested the hypothesis that the channel is activated by phosphorylation. Two experiments indicate that phosphorylation is required for dBest1 activation: nonspecific protein kinase inhibitors or intracellular perfusion with the non-hydrolyzable ATP analog AMP-PNP dramatically reduce the amplitude of dBest1 currents. Furthermore, intracellular perfusion with ATP-gamma-S augments channel activation. The kinase responsible for dBest1 activation is likely Ca2+/calmodulin dependent kinase II (CaMKII), because specific inhibitors of this kinase dramatically inhibit dBest1 current activation. Neither specific PKA inhibitors nor inactive control inhibitors have effects on dBest1currents. Our results demonstrate that dBest1 currents are regulated by phosphorylation via a CaMKII dependent mechanism.	[Hartzell, H. Criss] Emory Univ Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; Emory Univ Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA USA	Emory University; Emory University	Hartzell, HC (corresponding author), Emory Univ Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	criss.hartzell@emory.edu			National Institutes of Health (NIH) [EYO14852, GM60448]; National Eye Institute (NEI) [5T32EY007092-25]; NATIONAL EYE INSTITUTE [R01EY014852, T32EY007092, P30EY006360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH) EYO14852, GM60448, and National Eye Institute (NEI) training grant 5T32EY007092-25. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Chien LT, 2007, J GEN PHYSIOL, V130, P513, DOI 10.1085/jgp.200709795; Chien LT, 2006, J GEN PHYSIOL, V128, P247, DOI 10.1085/jgp.200609581; Chien LT, 2008, J GEN PHYSIOL, V132, P537, DOI 10.1085/jgp.200810065; de Tassigny AD, 2003, FUND CLIN PHARMACOL, V17, P539, DOI 10.1046/j.1472-8206.2003.00197.x; Eggermont J, 2001, CELL BIOCHEM BIOPHYS, V35, P263, DOI 10.1385/CBB:35:3:263; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; HOFFMANN EK, 1989, PHYSIOL REV, V69, P315, DOI 10.1152/physrev.1989.69.2.315; HOLEVINSKY KO, 1994, J MEMBRANE BIOL, V140, P13; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Marmorstein LY, 2002, J BIOL CHEM, V277, P30591, DOI 10.1074/jbc.M204269200; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; NISHIMOTO I, 1991, NEURON, V6, P547, DOI 10.1016/0896-6273(91)90057-7; Schlenker T, 1996, AM J PHYSIOL-GASTR L, V271, pG304, DOI 10.1152/ajpgi.1996.271.2.G304; Stotz S, 2012, BIOPHYS J, DOI [10.1016/j.bpj.2011.11.2999 ed. 550a, DOI 10.1016/J.BPJ.2011.11.2999ED.550A]; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; Xiao QH, 2009, J PHYSIOL-LONDON, V587, P4379, DOI 10.1113/jphysiol.2009.176800; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200	22	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58875	10.1371/journal.pone.0058875	http://dx.doi.org/10.1371/journal.pone.0058875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554946	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500051
J	Jezbera, J; Jezberova, J; Kasalicky, V; Simek, K; Hahn, MW				Jezbera, Jan; Jezberova, Jitka; Kasalicky, Vojtech; Simek, Karel; Hahn, Martin W.			Patterns of Limnohabitans Microdiversity across a Large Set of Freshwater Habitats as Revealed by Reverse Line Blot Hybridization	PLOS ONE			English	Article							COMMUNITY COMPOSITION; BACTERIA; LAKE; ASYMBIOTICUS; BIOGEOGRAPHY; TEMPERATE; RESERVOIR; UBIQUITY; RIVERS; RATES	Among abundant freshwater Betaproteobacteria, only few groups are considered to be of central ecological importance. One of them is the well-studied genus Limnohabitans and mainly its R-BT subcluster, investigated previously mainly by fluorescence in situ hybridization methods. We designed, based on sequences from a large Limnohabitans culture collection, 18 RLBH (Reverse Line Blot Hybridization) probes specific for different groups within the genus Limnohabitans by targeting diagnostic sequences on their 16 S-23 S rRNA ITS regions. The developed probes covered in sum 92% of the available isolates. This set of probes was applied to environmental DNA originating from 161 different European standing freshwater habitats to reveal the microdiversity (intra-genus) patterns of the Limnohabitans genus along a pH gradient. Investigated habitats differed in various physicochemical parameters, and represented a very broad range of standing freshwater habitats. The Limnohabitans microdiversity, assessed as number of RLBH-defined groups detected, increased significantly along the gradient of rising pH of habitats. 14 out of 18 probes returned detection signals that allowed predictions on the distribution of distinct Limnohabitans groups. Most probe-defined Limnohabitans groups showed preferences for alkaline habitats, one for acidic, and some seemed to lack preferences. Complete niche-separation was indicated for some of the probe-targeted groups. Moreover, bimodal distributions observed for some groups of Limnohabitans, suggested further niche separation between genotypes within the same probe-defined group. Statistical analyses suggested that different environmental parameters such as pH, conductivity, oxygen and altitude influenced the distribution of distinct groups. The results of our study do not support the hypothesis that the wide ecological distribution of Limnohabitans bacteria in standing freshwater habitats results from generalist adaptations of these bacteria. Instead, our observations suggest that the genus Limnohabitans, as well as its R-BT subgroup, represent ecologically heterogeneous taxa, which underwent pronounced ecological diversification.	[Jezbera, Jan; Jezberova, Jitka; Kasalicky, Vojtech; Simek, Karel] ASCR, Ctr Biol, Vvi, Inst Hydrobiol, Ceske Budejovice, Czech Republic; [Hahn, Martin W.] Univ Innsbruck, Res Inst Limnol, Mondsee, Austria	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Innsbruck	Jezbera, J (corresponding author), ASCR, Ctr Biol, Vvi, Inst Hydrobiol, Ceske Budejovice, Czech Republic.	jezbera@hbu.cas.cz	Simek, Karel/F-8930-2014; Šimek, Karel/AAB-1956-2021; Hahn, Martin W./B-9998-2008; Kasalicky, Vojtech/F-8578-2014; Jezberova, Jitka/G-1024-2014; Jezbera, Jan/B-5657-2015; Kasalicky, Vojtech/AAC-2903-2021	Šimek, Karel/0000-0002-7058-9063; Hahn, Martin W./0000-0003-0501-2556; Kasalicky, Vojtech/0000-0002-9132-8321; Jezberova, Jitka/0000-0001-5000-9319; Kasalicky, Vojtech/0000-0002-9132-8321	Czech Grant Agency [P504/10/0566, EEF/10/E011]	Czech Grant Agency(Grant Agency of the Czech Republic)	This study was financially supported by the Czech Grant Agency projects P504/10/0566 and EEF/10/E011 awarded to Jan Jezbera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buck U, 2009, ENVIRON MICROBIOL, V11, P1854, DOI 10.1111/j.1462-2920.2009.01910.x; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Crump BC, 2003, APPL ENVIRON MICROB, V69, P2253, DOI 10.1128/AEM.69.4.2253-2268.2003; Crump BC, 2005, LIMNOL OCEANOGR, V50, P1718, DOI 10.4319/lo.2005.50.6.1718; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P2946, DOI 10.1099/ijs.0.022384-0; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P1358, DOI 10.1099/ijs.0.013292-0; Hahn MW, 2005, APPL ENVIRON MICROB, V71, P766, DOI 10.1128/AEM.71.2.766-773.2005; Hahn MW, 2004, J MICROBIOL METH, V57, P379, DOI 10.1016/j.mimet.2004.02.004; HANSKI I, 1997, METAPOPULATION BIOL; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jezbera J, 2005, FEMS MICROBIOL ECOL, V52, P351, DOI 10.1016/j.femsec.2004.12.001; Jezbera J, 2012, FEMS MICROBIOL ECOL, V81, P467, DOI 10.1111/j.1574-6941.2012.01372.x; Jezbera J, 2011, ENVIRON MICROBIOL, V13, P922, DOI 10.1111/j.1462-2920.2010.02396.x; Jezberova J, 2010, ENVIRON MICROBIOL, V12, P658, DOI 10.1111/j.1462-2920.2009.02106.x; Kasalicky V, 2013, PLOS ONE IN PRESS; Kasalicky V, 2010, INT J SYST EVOL MICR, V60, P2710, DOI 10.1099/ijs.0.018952-0; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Liao PC, 2007, MICROB ECOL, V54, P497, DOI 10.1007/s00248-007-9217-2; Lindstrom ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025883; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; O'Malley MA, 2008, STUD HIST PHI PART C, V39, P314, DOI 10.1016/j.shpsc.2008.06.005; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; Simek K, 2010, APPL ENVIRON MICROB, V76, P3762, DOI 10.1128/AEM.00774-10; Simek K, 2010, APPL ENVIRON MICROB, V76, P631, DOI 10.1128/AEM.02203-09; TERBRAAK CJF, 1998, CANOCO WINDOWS VERSI; Whitfield J, 2005, SCIENCE, V310, P960, DOI 10.1126/science.310.5750.960; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141; Zwart G, 2003, APPL ENVIRON MICROB, V69, P5875, DOI 10.1128/AEM.69.10.5875-5883.2003	32	31	33	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58527	10.1371/journal.pone.0058527	http://dx.doi.org/10.1371/journal.pone.0058527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554898	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500028
J	Turturro, MV; Christenson, MC; Larson, JC; Young, DA; Brey, EM; Papavasiliou, G				Turturro, Michael V.; Christenson, Megan C.; Larson, Jeffery C.; Young, Daniel A.; Brey, Eric M.; Papavasiliou, Georgia			MMP-Sensitive PEG Diacrylate Hydrogels with Spatial Variations in Matrix Properties Stimulate Directional Vascular Sprout Formation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIRECTED CELL-MIGRATION; COVALENTLY IMMOBILIZED GRADIENTS; VEGF; MUSCLE; SCAFFOLDS; ANGIOGENESIS; ORGANIZATION; DEGRADATION; FIBRONECTIN	The spatial presentation of immobilized extracellular matrix (ECM) cues and matrix mechanical properties play an important role in directed and guided cell behavior and neovascularization. The goal of this work was to explore whether gradients of elastic modulus, immobilized matrix metalloproteinase (MMP)-sensitivity, and YRGDS cell adhesion ligands are capable of directing 3D vascular sprout formation in tissue engineered scaffolds. PEGDA hydrogels were engineered with mechanical and biofunctional gradients using perfusion-based frontal photopolymerization (PBFP). Bulk photopolymerized hydrogels with uniform mechanical properties, degradation, and immobilized biofunctionality served as controls. Gradient hydrogels exhibited an 80.4% decrease in elastic modulus and a 56.2% decrease in immobilized YRGDS. PBFP hydrogels also demonstrated gradients in hydrogel degradation with degradation times ranging from 10-12 hours in the more crosslinked regions to 4-6 hours in less crosslinked regions. An in vitro model of neovascularization, composed of co-culture aggregates of endothelial and smooth muscle cells, was used to evaluate the effect of these gradients on vascular sprout formation. Aggregate invasion in gradient hydrogels occurred bi-directionally with sprout alignment observed in the direction parallel to the gradient while control hydrogels with homogeneous properties resulted in uniform invasion. In PBFP gradient hydrogels, aggregate sprout length was found to be twice as long in the direction parallel to the gradient as compared to the perpendicular direction after three weeks in culture. This directionality was found to be more prominent in gradient regions of increased stiffness, crosslinked MMP-sensitive peptide presentation, and immobilized YRGDS concentration.	[Turturro, Michael V.; Christenson, Megan C.; Larson, Jeffery C.; Young, Daniel A.; Brey, Eric M.; Papavasiliou, Georgia] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Brey, Eric M.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL USA	Illinois Institute of Technology; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Papavasiliou, G (corresponding author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.	papavasiliou@iit.edu	Young, Daniel/F-9652-2017; Papavailiou, Georgia/D-2645-2014	Young, Daniel/0000-0003-1214-9577; Papavailiou, Georgia/0000-0002-6730-7360	Searle Funds at the Chicago Community Trust; National Institutes of Health [R21HL094916]; Veterans Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094916] Funding Source: NIH RePORTER	Searle Funds at the Chicago Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank the CBC-UIC Research Resources Center Proteomics and Informatics Services Facility, which was established by a grant from The Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium, for their help with performing mass spectroscopy on our synthesized peptides. The authors would also like to acknowledge the laboratory of Professor David Venerus in the department of Chemical and Biological Engineering at the Illinois Institute of Technology for providing access for mechanical testing of our samples. Finally the authors thank Dr. Howard Greisler (Edward Hines Jr. VA Hospital, Hines, Illinois) for his stimulating discussions and input during the early phases of this work.; This work was supported by National Institutes of Health (Grant No. R21HL094916) and the Veterans Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200; Borselli C, 2007, J BIOMED MATER RES A, V80A, P297, DOI 10.1002/jbm.a.30896; Borselli C, 2010, J BIOMED MATER RES A, V92A, P94, DOI 10.1002/jbm.a.32332; Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046; Brey EA, 2004, ANN BIOMED ENG, V32, P1100, DOI 10.1114/B:ABME.0000036646.17362.c4; Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca; Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n; Cai KY, 2009, COLLOID SURFACE B, V72, P230, DOI 10.1016/j.colsurfb.2009.04.008; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; DeKosky BJ, 2010, TISSUE ENG PART C-ME, V16, P1533, DOI 10.1089/ten.tec.2009.0761; DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020; DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021; Francis-Sedlak ME, 2010, MICROVASC RES, V80, P3, DOI 10.1016/j.mvr.2009.12.005; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050; Guarnieri D, 2008, MACROMOL SYMP, V266, P36, DOI 10.1002/masy.200850607; Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Kraehenbuehl TP, 2009, BIOMATERIALS, V30, P4318, DOI 10.1016/j.biomaterials.2009.04.057; Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381; Liu LY, 2007, LANGMUIR, V23, P11168, DOI 10.1021/la701435x; Mac Gabhann F, 2007, J APPL PHYSIOL, V102, P722, DOI 10.1152/japplphysiol.00800.2006; Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5; Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104; Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574; Odedra D, 2011, ACTA BIOMATER, V7, P3027, DOI 10.1016/j.actbio.2011.05.002; Papavasiliou G, 2010, J INVEST MED, V58, P838, DOI 10.231/JIM.0b013e3181f18e38; Patterson J, 2011, BIOMATERIALS, V32, P1301, DOI 10.1016/j.biomaterials.2010.10.016; Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061; Porter AM, 2011, BIOMACROMOLECULES, V12, P242, DOI 10.1021/bm101220b; Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091; Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304; Smith JT, 2006, EXP CELL RES, V312, P2424, DOI 10.1016/j.yexcr.2006.04.005; Smith JT, 2009, COMB CHEM HIGH T SCR, V12, P598, DOI 10.2174/138620709788681871; Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Turturro MV, 2012, J BIOMAT SCI-POLYM E, V23, P917, DOI 10.1163/092050611X566450; Wallace CS, 2007, AM J PHYSIOL-HEART C, V293, pH1978, DOI 10.1152/ajpheart.00618.2007; Wang Z, 2012, J MATER SCI-MATER M, V14, P14; West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k; Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571; Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje	46	55	60	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58897	10.1371/journal.pone.0058897	http://dx.doi.org/10.1371/journal.pone.0058897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554954	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500055
J	Mao, B; Hu, F; Cheng, J; Wang, P; Xu, M; Yuan, F; Meng, S; Wang, Y; Yuan, Z; Bi, W				Mao, B.; Hu, F.; Cheng, J.; Wang, P.; Xu, M.; Yuan, F.; Meng, S.; Wang, Y.; Yuan, Z.; Bi, W.			SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma	ONCOGENE			English	Article						SIRT1; YAP; acetylation; transcription; hepatocellular carcinoma	TRANSCRIPTION FACTORS; GROWTH-CONTROL; DNA-DAMAGE; ACETYLATION; DEACETYLASE; ACTIVATION; YAP; PATHWAY; INACTIVATION; MODULATION	The MST/YAP (mammalian Ste20-like kinase/Yes-associated protein 2) pathway plays an important role in hepatocellular carcinoma (HCC). Although post-translational modification-especially MST/Lats (large tumor suppressor)-mediated phosphorylation and PP1 (protein phosphatase-1)-mediated dephosphorylation-has been found to regulate the activity of YAP2, very little is known about its acetylation. In our experiments, we observed that the expression of SIRT1 is significantly upregulated in the tumor samples of the hepatocarcinoma patients, and SIRT1 mRNA level positively correlates with connective tissue growth factor (CTGF) mRNA level. We then found that SIRT1 deacetylates YAP2 protein in HCC cells and SIRT1-mediated deacetylation increases the YAP2/TEAD4 association, leading to YAP2/TEAD4 transcriptional activation and upregulated cell growth in HCC cells. Moreover, knockdown of SIRT1 blocks the cisplatin (CDDP)-induced nuclear translocation of YAP2 and enhances the chemosensitivity of HCC cells to CDDP treatment. Together, our findings reveal a new regulatory mechanism of YAP2 by the SIRT1-mediated deacetylation that may be involved in HCC tumorigenesis and drug resistance.	[Mao, B.; Cheng, J.; Wang, P.; Yuan, Z.] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Hu, F.] Tianjin Hosp, Dept Orthoped, Tianjin, Peoples R China; [Xu, M.; Yuan, F.; Wang, Y.; Bi, W.] Chinese Peoples Liberat Army Gen Hosp, Clin Div Surg, Dept Orthoped, Beijing 100853, Peoples R China; [Meng, S.] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China; [Meng, S.; Yuan, Z.] Chinese Hippo Consortium, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese People's Liberation Army General Hospital; Dalian Medical University	Yuan, Z (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.	zqyuan@ibp.ac.cn; biwenzhi@sina.com	Yuan, Zengqiang/G-5245-2017		National Science Foundation of China [81172553, 81201564, 81125010, 81030025]; Ministry of Science and Technology of China [973-2009CB918704, 973-2012CB910701]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank Dr Depei Liu for the gift of all the SIRT1 plasmids; Dr Lei Zhang for the 3*SD binding site artificial-luciferase reporter plasmid; Dr Zhixiong Xiao for the p73 antibody; Ursula Adams for manuscript editing; and Xudong Zhao and Su Liu of IBP core facility center for technical support. This work was supported by the National Science Foundation of China (81172553, 81201564, 81125010 and 81030025), and the Ministry of Science and Technology of China (973-2009CB918704 and 973-2012CB910701).	Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Dai JM, 2007, J CELL PHYSIOL, V210, P161, DOI 10.1002/jcp.20831; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hata S, J BIOL CHEM, V287, P22089; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Mao BB, 2011, INT J BIOCHEM CELL B, V43, P1573, DOI 10.1016/j.biocel.2011.07.006; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Molloy D, 2006, VIROLOGY, V355, P115, DOI 10.1016/j.virol.2006.05.004; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Urtasun R, 2011, HEPATOLOGY, V54, P2149, DOI 10.1002/hep.24587; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024288; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	32	112	121	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2014	33	11					1468	1474		10.1038/onc.2013.88	http://dx.doi.org/10.1038/onc.2013.88			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD0SD	23542177				2022-12-25	WOS:000332943500014
J	Bonnet, M; Kurz, M; Mesa, S; Briand, C; Hennecke, H; Grutter, MG				Bonnet, Mariette; Kurz, Mareike; Mesa, Socorro; Briand, Christophe; Hennecke, Hauke; Gruetter, Markus G.			The Structure of Bradyrhizobium japonicum Transcription Factor FixK(2) Unveils Sites of DNA Binding and Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATABOLITE ACTIVATOR PROTEIN; LISTERIA-MONOCYTOGENES; ALLOSTERIC CONTROL; KEY REGULATOR; COMPLEX; OXYGEN; FNR; CASCADE; LEGUME; MODEL	FixK(2) is a regulatory protein that activates a large number of genes for the anoxic and microoxic, endosymbiotic, and nitrogen-fixing life styles of the alpha-proteobacterium Bradyrhizobium japonicum. FixK(2) belongs to the cAMP receptor protein (CRP) superfamily. Although most CRP family members are coregulated by effector molecules, the activity of FixK(2) is negatively controlled by oxidation of its single cysteine (Cys-183) located next to the DNA-binding domain and possibly also by proteolysis. Here, we report the three-dimensional x-ray structure of FixK(2), a representative of the FixK subgroup of the CRP superfamily. Crystallization succeeded only when (i) an oxidation- and protease-insensitive protein variant (FixK(2)(C183S)-His(6)) was used in which Cys-183 was replaced with serine and the C terminus was fused with a hexahistidine tag and (ii) this protein was allowed to form a complex with a 30-mer double-stranded target DNA. The structure of the FixK(2)-DNA complex was solved at a resolution of 1.77 angstrom, at which the protein formed a homodimer. The precise protein-DNA contacts were identified, which led to an affirmation of the canonical target sequence, the so-called FixK(2) box. The C terminus is surface-exposed, which might explain its sensitivity to specific cleavage and degradation. The oxidation-sensitive Cys-183 is also surface-exposed and in close proximity to DNA. Therefore, we propose a mechanism whereby the oxo acids generated after oxidation of the cysteine thiol cause an electrostatic repulsion, thus preventing specific DNA binding.	[Bonnet, Mariette; Mesa, Socorro; Hennecke, Hauke] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Kurz, Mareike; Briand, Christophe; Gruetter, Markus G.] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Grutter, MG (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	gruetter@bioc.uzh.ch	Mesa, Socorro/G-7775-2015	Mesa, Socorro/0000-0001-7285-3940; , Mariette/0000-0001-5825-1708	Swiss National Science Foundation; ETH Zurich; University of Zurich; National Center of Competence in Research (NCCR) for Structural Biology; Ministerio de Economia y Competitividad of Spain	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); University of Zurich; National Center of Competence in Research (NCCR) for Structural Biology(Swiss National Science Foundation (SNSF)); Ministerio de Economia y Competitividad of Spain(Spanish Government)	This work was supported in part by grants from the Swiss National Science Foundation (to H. H., S. M., and M. G. G.) and by funds from ETH Zurich and University of Zurich. Work in the laboratory of M. G. G. was supported through the framework of the National Center of Competence in Research (NCCR) for Structural Biology.; Supported by the Ministerio de Economia y Competitividad of Spain. Present address: Dept. of Soil Microbiology and Symbiotic Systems, Estacion Experimental del Zaidin, CSIC, E-18008 Granada, Spain.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; Bonnet M, 2013, FEBS LETT, V587, P88, DOI 10.1016/j.febslet.2012.11.014; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chang C, 2009, MOL PLANT, V2, P370, DOI 10.1093/mp/ssn090; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Dufour YS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001027; Eiting M, 2005, MOL MICROBIOL, V56, P433, DOI 10.1111/j.1365-2958.2005.04561.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fic E, 2009, J MOL MICROB BIOTECH, V17, P1, DOI 10.1159/000178014; Giardina G, 2011, BIOCHEM SOC T, V39, P294, DOI 10.1042/BST0390294; Herler M, 2001, J BACTERIOL, V183, P5562, DOI 10.1128/JB.183.19.5562-5570.2001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Levy C, 2008, MOL MICROBIOL, V70, P151, DOI 10.1111/j.1365-2958.2008.06399.x; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Masloboeva N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043421; Mesa S, 2005, J BACTERIOL, V187, P3329, DOI 10.1128/JB.187.10.3329-3338.2005; Mesa S, 2008, J BACTERIOL, V190, P6568, DOI 10.1128/JB.00748-08; Mesa S, 2009, P NATL ACAD SCI USA, V106, P21860, DOI 10.1073/pnas.0908097106; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nellen-Anthamatten D, 1998, J BACTERIOL, V180, P5251, DOI 10.1128/JB.180.19.5251-5255.1998; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Pauly N, 2006, J EXP BOT, V57, P1769, DOI 10.1093/jxb/erj184; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Zhao MX, 2010, P NATL ACAD SCI USA, V107, P12487, DOI 10.1073/pnas.1001556107	34	17	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14238	14246		10.1074/jbc.M113.465484	http://dx.doi.org/10.1074/jbc.M113.465484			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23546876	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000319253500028
J	Ahmad, A; Crupi, R; Campolo, M; Genovese, T; Esposito, E; Cuzzocrea, S				Ahmad, Akbar; Crupi, Rosalia; Campolo, Michela; Genovese, Tiziana; Esposito, Emanuela; Cuzzocrea, Salvatore			Absence of TLR4 Reduces Neurovascular Unit and Secondary Inflammatory Process after Traumatic Brain Injury in Mice	PLOS ONE			English	Article							NITRIC-OXIDE-SYNTHASE; TOLL-LIKE RECEPTORS; SPINAL-CORD-INJURY; NF-KAPPA-B; EXPRESSION; NEUROPROTECTION; ACTIVATION; SYSTEM; INHIBITION; RELEASE	Background: Traumatic brain injury (TBI) initiates a neuroinflammatory cascade that contributes to neuronal damage and behavioral impairment. Toll-like receptors (TLRs) are signaling receptors in the innate immune system, although emerging evidence indicates their role in brain injury. We have therefore investigated the role played by TLR4 signaling pathway in the development of mechanisms of secondary inflammatory process in traumatic brain injury (TBI) differ in mice that lack a functional TLR4 signaling pathway. Methods/Principal Findings: Controlled cortical impact injury was performed on TLR4 knockout (KO) mice (C57BL/10ScNJ) and wild-type (WT) mice (C57BL/10ScNJ). TBI outcome was evaluated by determination of infarct volume and assessment of neurological scores. Brains were collected at 24 h after TBI. When compared to WT mice, TLR4 KO mice had lower infarct volumes and better outcomes in neurological and behavioral tests (evaluated by EBST and rotarod test). Mice that lacked TLR4 had minor expression of TBI-induced GFAP, Chymase, Tryptase, IL-1 beta, iNOS, PARP and Nitrotyrosine mediators implicated in brain damage. The translocation of expression of p-JNK, I kappa B-alpha and NF-kappa B pathway were also lower in brains from TLR4 KO mice. When compared to WT mice, resulted in significant augmentation of all the above described parameters. In addition, apoptosis levels in TLR4 KO mice had minor expression of Bax while on the contrary with Bcl-2. Conclusions/Significance: Our results clearly demonstrated that absence of TLR4 reduces the development of neuroinflammation, tissues injury events associated with brain trauma and may play a neuroprotective role in TBI in mice.	[Ahmad, Akbar; Crupi, Rosalia; Campolo, Michela; Genovese, Tiziana; Esposito, Emanuela; Cuzzocrea, Salvatore] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy; [Cuzzocrea, Salvatore] Univ Manchester, Manchester, Lancs, England	University of Messina; University of Manchester	Cuzzocrea, S (corresponding author), Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy.	salvator@unime.it	AHMAD, AKBAR/D-6621-2013; Crupi, Rosalia/U-4364-2019; Campolo, Michela/K-6432-2016	AHMAD, AKBAR/0000-0003-4341-0352; Crupi, Rosalia/0000-0002-7629-3132; Campolo, Michela/0000-0002-5124-3876; Cuzzocrea, Salvatore/0000-0001-6131-3690; Esposito, Emanuela/0000-0002-2663-6387; GENOVESE, Tiziana/0000-0002-3335-7327; Ahmad, Akbar/0000-0003-1841-9670	Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, Messina, Italy	Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, Messina, Italy	Funding provided by the Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, Messina, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Bar-Peled O, 1999, J NEUROSCI RES, V55, P542, DOI 10.1002/(SICI)1097-4547(19990301)55:5<542::AID-JNR2>3.0.CO;2-7; Barcia C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002977; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Cao GD, 2002, J NEUROSCI, V22, P5423; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Chvatal A, 2007, J NEUROSCI RES, V85, P260, DOI 10.1002/jnr.21113; Cuzzocrea S, 2001, SHOCK, V16, P51, DOI 10.1097/00024382-200116010-00010; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Glezer I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000310; GORDON JR, 1991, J EXP MED, V174, P103, DOI 10.1084/jem.174.1.103; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Heneka MT, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-22; Hwang D, 2001, FASEB J, V15, P2556, DOI 10.1096/fj.01-0432com; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Jou I, 2006, AM J PATHOL, V168, P1619, DOI 10.2353/ajpath.2006.050924; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; KOWNATZKI E, 1982, MOL IMMUNOL, V19, P1297, DOI 10.1016/0161-5890(82)90296-6; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee JY, 2005, BIOCHEM PHARMACOL, V70, P1231, DOI 10.1016/j.bcp.2005.07.020; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mishra BB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-53; O'Neill LAJ, 2003, BIOCHEM SOC T, V31, P643, DOI 10.1042/BST0310643; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Owens T, 2005, BRAIN RES REV, V48, P178, DOI 10.1016/j.brainresrev.2004.12.007; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Schabitz WR, 1999, STROKE, V30, P427, DOI 10.1161/01.STR.30.2.427; Schomacher M, 2008, BRAIN RES, V1240, P213, DOI 10.1016/j.brainres.2008.09.019; SHEA TB, 1994, BIOTECHNIQUES, V16, P1126; Sirin BH, 2002, ACTA CARDIOL, V57, P279, DOI 10.2143/AC.57.4.2005427; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Trendelenburg G, 2008, J CEREBR BLOOD F MET, V28, P867, DOI 10.1038/sj.jcbfm.9600609; Vanzani MC, 2005, MEDICINA-BUENOS AIRE, V65, P213; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	57	88	96	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e57208	10.1371/journal.pone.0057208	http://dx.doi.org/10.1371/journal.pone.0057208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555560	gold, Green Published, Green Submitted			2022-12-25	WOS:000317262200001
J	Lobo, J; Bettencourt, LMA; Strumsky, D; West, GB				Lobo, Jose; Bettencourt, Luis M. A.; Strumsky, Deborah; West, Geoffrey B.			Urban Scaling and the Production Function for Cities	PLOS ONE			English	Article							AGGLOMERATION ECONOMIES; CITY; DETERMINANTS; LOCALIZATION; RETURNS; GROWTH	The factors that account for the differences in the economic productivity of urban areas have remained difficult to measure and identify unambiguously. Here we show that a microscopic derivation of urban scaling relations for economic quantities vs. population, obtained from the consideration of social and infrastructural properties common to all cities, implies an effective model of economic output in the form of a Cobb-Douglas type production function. As a result we derive a new expression for the Total Factor Productivity (TFP) of urban areas, which is the standard measure of economic productivity per unit of aggregate production factors (labor and capital). Using these results we empirically demonstrate that there is a systematic dependence of urban productivity on city population size, resulting from the mismatch between the size dependence of wages and labor, so that in contemporary US cities productivity increases by about 11% with each doubling of their population. Moreover, deviations from the average scale dependence of economic output, capturing the effect of local factors, including history and other local contingencies, also manifest surprising regularities. Although, productivity is maximized by the combination of high wages and low labor input, high productivity cities show invariably high wages and high levels of employment relative to their size expectation. Conversely, low productivity cities show both low wages and employment. These results shed new light on the microscopic processes that underlie urban economic productivity, explain the emergence of effective aggregate urban economic output models in terms of labor and capital inputs and may inform the development of economic theory related to growth.	[Lobo, Jose] Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA; [Bettencourt, Luis M. A.; West, Geoffrey B.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Strumsky, Deborah] Univ N Carolina, Dept Geog & Earth Sci, Charlotte, NC 28223 USA	Arizona State University; Arizona State University-Tempe; The Santa Fe Institute; University of North Carolina; University of North Carolina Charlotte	Lobo, J (corresponding author), Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA.	jose.lobo@asu.edu	Bettencourt, Luis/R-9861-2019; Strumsky, Deborah/F-5795-2013		Rockefeller Foundation; James S. McDonnell Foundation [220020195]; National Science Foundation [103522]; John Templeton Foundation [15705]	Rockefeller Foundation; James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation	This research was partially supported by the Rockefeller Foundation, the James S. McDonnell Foundation (grant no. 220020195), the National Science Foundation (grant no. 103522), the John Templeton Foundation (grant no. 15705) and by a gift from the Bryan J. and June B. Zwan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel JR, 2012, J REGIONAL SCI, V52, P562, DOI 10.1111/j.1467-9787.2011.00742.x; Barenblatt IG, 2003, SCALING; BATTY M, 1976, ENVIRON PLANN A, V8, P189, DOI 10.1068/a080189; Beaudry C, 2009, RES POLICY, V38, P318, DOI 10.1016/j.respol.2008.11.010; Bettencourt L. M. A., 2013, 1301004 SANT FE I; Bettencourt LMA, 2012, 1209014 SANT FE I; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Blumenthal P, 2009, URBAN STUD, V46, P605, DOI 10.1177/0042098008100997; CARLINO GA, 1979, J REGIONAL SCI, V19, P363, DOI 10.1111/j.1467-9787.1979.tb00601.x; Combes PP, 2011, J ECON GEOGR, V11, P253, DOI 10.1093/jeg/lbq038; Drennan M, 2002, URBAN STUD, V39, P1129, DOI 10.1080/00420980220135527; Duranton G., 2004, HDB CITYAL URBAN EC, V4, P2063, DOI [DOI 10.1016/S1574-0080(04)80005-1, 10.1016/S1574-0080(04)80005-1]; Florida R, 2008, J ECON GEOGR, V8, P615, DOI 10.1093/jeg/lbn023; GLAESER EL, 1995, J MONETARY ECON, V36, P117, DOI 10.1016/0304-3932(95)01206-2; GLAESER EL, 1992, J POLIT ECON, V100, P1126, DOI 10.1086/261856; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Henderson JV, 1988, URBAN DEV THEORY FAC; Jones CI, 2010, AM ECON J-MACROECON, V2, P224, DOI 10.1257/mac.2.1.224; Knudsen B, 2008, ANN ASSOC AM GEOGR, V98, P461, DOI 10.1080/00045600701851150; Lobo J, 1999, GROWTH CHANGE, V30, P106, DOI 10.1111/0017-4815.00106; Lobo J, 2002, URBAN STUD, V39, P529, DOI 10.1080/00420980220112810; MOOMAW RL, 1988, URBAN STUD, V25, P150, DOI 10.1080/00420988820080201; MOOMAW RL, 1981, Q J ECON, V96, P675, DOI 10.2307/1880747; Ortman SG, 2013, 1301001 SANT FE I; OSullivan Arthur., 2011, URBAN EC, V8th; Puga D, 2010, J REGIONAL SCI, V50, P203, DOI 10.1111/j.1467-9787.2009.00657.x; RAUCH JE, 1993, J URBAN ECON, V34, P380, DOI 10.1006/juec.1993.1042; Rosenthal SS, 2001, J URBAN ECON, V50, P191, DOI 10.1006/juec.2001.2230; SEGAL D, 1976, REV ECON STAT, V58, P339, DOI 10.2307/1924956; SHAIKH A, 1974, REV ECON STAT, V56, P115, DOI 10.2307/1927538; SHEFER D, 1973, J REGIONAL SCI, V13, P55, DOI 10.1111/j.1467-9787.1973.tb00377.x; SOLOW RM, 1957, REV ECON STAT, V39, P312, DOI 10.2307/1926047; SVEIKAUSKAS L, 1975, Q J ECON, V89, P393, DOI 10.2307/1885259; USLANER EM, 1976, AM J POLIT SCI, V20, P125, DOI 10.2307/2110513	36	92	94	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58407	10.1371/journal.pone.0058407	http://dx.doi.org/10.1371/journal.pone.0058407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544042	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700005
J	Zheng, MM; Zhang, ZF; Bemis, K; Belch, AR; Pilarski, LM; Shively, JE; Kirshner, J				Zheng, Mary M.; Zhang, Zhifang; Bemis, Kyle; Belch, Andrew R.; Pilarski, Linda M.; Shively, John E.; Kirshner, Julia			The Systemic Cytokine Environment Is Permanently Altered in Multiple Myeloma	PLOS ONE			English	Article							CHRONIC INFLAMMATION; T-CELLS; IL-7; PROFILES; CANCER; PROLIFERATION; MECHANISMS; SURVIVAL; INCREASE; RECEPTOR	Multiple myeloma (MM) is an incurable bone marrow malignancy of the B cell lineage. Utilizing multiplex Luminex technology we measured levels of 25 cytokines in the plasma of normal donors (n=177), those with monoclonal gammopathy of undetermined significance (n=8), and MM patients (n=55) with either active disease, on treatment, or in remission. The cytokine levels were compared between normal donors and MM patients as well as between various phases of MM, and discriminant analysis was used to create a predictive classification model based on the differentially expressed cytokines. Evaluating age- and gender dependence of cytokine expression, we determined that with age there is a shift toward a pro-inflammatory environment. Moreover, we observed a strong gender bias in cytokine expression. However, the profile of differentially expressed cytokines was heavily skewed toward an anti-inflammatory, pro-tumorigenic response in patients with MM. Significantly, our predictive model placed all patients in remission in the same category as those with active disease. Thus, our study demonstrates that the homeostasis of systemic cytokines is not restored when MM patients enter remission, suggesting that once an individual has cancer, the microenvironent is permanently altered and the system is primed for a relapse.	[Zheng, Mary M.; Kirshner, Julia] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Zhang, Zhifang; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Div Immunol, Duarte, CA 91010 USA; [Bemis, Kyle] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Belch, Andrew R.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Belch, Andrew R.; Pilarski, Linda M.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Pilarski, Linda M.] Univ Alberta, Dept Med Oncol, Edmonton, AB, Canada	Purdue University System; Purdue University; Purdue University West Lafayette Campus; City of Hope; Beckman Research Institute of City of Hope; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Alberta; University of Alberta; University of Alberta	Kirshner, J (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	jkirshne@purdue.edu			Canadian Institutes of Health Research; Alberta Cancer Board Research Initiatives Program; Indiana Clinical and Translational Sciences Institute; Project Development Teams (PDT) pilot grants from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [TR000006]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Board Research Initiatives Program; Indiana Clinical and Translational Sciences Institute; Project Development Teams (PDT) pilot grants from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award	This work was funded by grants from the Canadian Institutes of Health Research and the Alberta Cancer Board Research Initiatives Program. The mass spectrometry analysis was funded by the Indiana Clinical and Translational Sciences Institute funded, in part by the Project Development Teams (PDT) pilot grants (Grant # TR000006) from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataille R, 1997, HEMATOL ONCOL CLIN N, V11, P349, DOI 10.1016/S0889-8588(05)70435-4; Bikker A, 2012, RHEUMATOLOGY, V51, P996, DOI 10.1093/rheumatology/ker448; Bonafe M, 2012, BIOESSAYS, V34, P40, DOI 10.1002/bies.201100104; Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Chipeta J, 1998, CELL IMMUNOL, V183, P149, DOI 10.1006/cimm.1998.1244; Corfe SA, 2012, SEMIN IMMUNOL, V24, P198, DOI 10.1016/j.smim.2012.02.001; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Forsey RJ, 2003, MECH AGEING DEV, V124, P487, DOI 10.1016/S0047-6374(03)00025-3; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Frassanito MA, 2001, CLIN EXP IMMUNOL, V125, P190, DOI 10.1046/j.1365-2249.2001.01582.x; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Fulop T, 2011, DISCOV MED, V11, P537, DOI 10.1016/j.coi.2004.01.009; Gangemi S, 2005, MEDIAT INFLAMM, P245, DOI 10.1155/MI.2005.245; Gonda TA, 2009, CELL CYCLE, V8, P2005, DOI 10.4161/cc.8.13.8985; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Kikuchi K, 2008, J IMMUNOL, V181, P383, DOI 10.4049/jimmunol.181.1.383; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kirshner J, 2008, BLOOD, V112, P2935, DOI 10.1182/blood-2008-02-142430; KLEIN B, 1992, HEMATOL ONCOL CLIN N, V6, P273, DOI 10.1016/S0889-8588(18)30344-7; Kowalska M, 2011, MED ONCOL, V28, P194, DOI 10.1007/s12032-009-9403-9; Kroning H, 1997, ACTA HAEMATOL-BASEL, V98, P116; Krueger C, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-88; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Li ZG, 2008, CANCER RES, V68, P8687, DOI 10.1158/0008-5472.CAN-08-0449; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; LU ZY, 1995, STEM CELLS, V13, P28; Malkin CJ, 2004, J CLIN ENDOCR METAB, V89, P3313, DOI 10.1210/jc.2003-031069; Matsui W, 2012, BIOL BLOOD MARROW TR, V18, pS27, DOI 10.1016/j.bbmt.2011.10.036; Morley JE, 2004, J GERONTOL A-BIOL, V59, P924; Nevala WK, 2009, CLIN CANCER RES, V15, P1931, DOI 10.1158/1078-0432.CCR-08-1980; Nitsche A, 2003, STEM CELLS, V21, P236, DOI 10.1634/stemcells.21-2-236; Nucci M, 2009, CLIN INFECT DIS, V49, P1211, DOI 10.1086/605664; Ouyang XS, 2011, CELL IMMUNOL, V266, P208, DOI 10.1016/j.cellimm.2010.10.007; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; RIANCHO JA, 1994, GERONTOLOGY, V40, P8; Salazar-Onfray F, 1999, MED ONCOL, V16, P86, DOI 10.1007/BF02785841; Sartono E, 1997, J INFECT DIS, V175, P1276, DOI 10.1086/593701; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tinhofer I, 2000, BLOOD, V95, P610, DOI 10.1182/blood.V95.2.610; Yu WG, 1996, INT IMMUNOL, V8, P855, DOI 10.1093/intimm/8.6.855; Zhang Xiu-Lian, 2012, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V20, P930	45	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58504	10.1371/journal.pone.0058504	http://dx.doi.org/10.1371/journal.pone.0058504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544044	Green Submitted, gold, Green Published			2022-12-25	WOS:000317480700007
J	Chen, TS; Chen, M; Chen, JQ				Chen, Tongsheng; Chen, Min; Chen, Jingqin			Ionizing Radiation Potentiates Dihydroartemisinin-Induced Apoptosis of A549 Cells via a Caspase-8-Dependent Pathway	PLOS ONE			English	Article							BAX TRANSLOCATION; DNA-DAMAGE; IN-VITRO; ARTEMISININ; BINDING	This report is designed to explore the molecular mechanism by which dihydroartemisinin (DHA) and ionizing radiation (IR) induce apoptosis in human lung adenocarcinoma A549 cells. DHA treatment induced a concentration-and time-dependent reactive oxygen species (ROS)-mediated cell death with typical apoptotic characteristics such as breakdown of mitochondrial membrane potential (Delta psi(m)), caspases activation, DNA fragmentation and phosphatidylserine (PS) externalization. Inhibition of caspase-8 or -9 significantly blocked DHA-induced decrease of cell viability and activation of caspase-3, suggesting the dominant roles of caspase-8 and -9 in DHA-induced apoptosis. Silencing of proapoptotic protein Bax but not Bak significantly inhibited DHA-induced apoptosis in which Bax but not Bak was activated. In contrast to DHA treatment, low-dose (2 or 4 Gy) IR induced a long-playing generation of ROS. Interestingly, IR treatment for 24 h induced G2/M cell cycle arrest that disappeared at 36 h after treatment. More importantly, IR synergistically potentiated DHA-induced generation of ROS, activation of caspase-8 and -3, irreparable G(2)/M arrest and apoptosis, but did not enhance DHA-induced loss of Delta psi(m) and activation of caspase-9. Taken together, our results strongly demonstrate the remarkable synergistic efficacy of combination treatment with DHA and low-dose IR for A549 cells in which IR potentiates DHA-induced apoptosis largely by enhancing the caspase-8-mediated extrinsic pathway.	[Chen, Tongsheng] S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; S China Normal Univ, SATCM Grade Lab Chinese Med & Photon Technol 3, Coll Biophoton, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Chen, TS (corresponding author), S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.	chentsh@scnu.edu.cn			National Natural Science Foundation of China [31071218, 61178078]; Department of Education and Finance of Guangdong Province [cxzd115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education and Finance of Guangdong Province	This research was supported by the National Natural Science Foundation of China; Contract grant number: 31071218 and 61178078, and by the Key Project of the Department of Education and Finance of Guangdong Province; Contract grant number: cxzd115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Denissova NG, 2012, CARCINOGENESIS, V33, P149, DOI 10.1093/carcin/bgr236; Dey S, 2003, CLIN CANCER RES, V9, P1557; Disbrow GL, 2005, CANCER RES, V65, P10854, DOI 10.1158/0008-5472.CAN-05-1216; Field JK, 2008, BRIT J CANCER, V99, P557, DOI 10.1038/sj.bjc.6604509; Gillissen B, 2007, J CELL BIOL, V179, P701, DOI 10.1083/jcb.200703040; Handrick R, 2010, MOL CANCER THER, V9, P2497, DOI 10.1158/1535-7163.MCT-10-0051; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Huang G, 2010, ANTICANCER RES, V30, P937; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Kim SJ, 2006, J CANCER RES CLIN, V132, P129, DOI 10.1007/s00432-005-0052-x; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Lu JJ, 2010, BIOCHEM PHARMACOL, V80, P22, DOI 10.1016/j.bcp.2010.02.016; Lu YY, 2010, FEBS LETT, V584, P4019, DOI 10.1016/j.febslet.2010.08.014; Lu YY, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3481141; Mercer AE, 2007, J BIOL CHEM, V282, P9372, DOI 10.1074/jbc.M610375200; Popowich DA, 2010, AM J PHYSIOL-HEART C, V298, pH2192, DOI 10.1152/ajpheart.00535.2009; Pore MM, 2013, CANCER LETT, V332, P359, DOI 10.1016/j.canlet.2010.09.012; Thompson JS, 2010, APOPTOSIS, V15, P705, DOI 10.1007/s10495-010-0487-7; Tribble DL, 1999, ARTERIOSCL THROM VAS, V19, P1387, DOI 10.1161/01.ATV.19.6.1387; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Xiao FL, 2012, APOPTOSIS, V17, P600, DOI 10.1007/s10495-012-0706-5; Zhang LL, 2010, J CELL PHYSIOL, V224, P218, DOI 10.1002/jcp.22123; Zhang YJ, 2009, MOL BIOL CELL, V20, P3077, DOI 10.1091/mbc.E08-11-1109; Zhou CJ, 2012, J CELL PHYSIOL, V227, P3778, DOI 10.1002/jcp.24086; Zhou HJ, 2010, CANCER CHEMOTH PHARM, V66, P21, DOI 10.1007/s00280-009-1129-z	26	25	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59827	10.1371/journal.pone.0059827	http://dx.doi.org/10.1371/journal.pone.0059827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536891	gold, Green Published, Green Submitted			2022-12-25	WOS:000317397200039
J	Sousa, SR; Vetter, I; Ragnarsson, L; Lewis, RJ				Sousa, Silmara R.; Vetter, Irina; Ragnarsson, Lotten; Lewis, Richard J.			Expression and Pharmacology of Endogenous Ca-v Channels in SH-SY5Y Human Neuroblastoma Cells	PLOS ONE			English	Article							NEURONAL CALCIUM-CHANNEL; RECOMBINANT N-TYPE; GATED ION CHANNELS; OMEGA-CONOTOXINS; FUNCTIONAL EXPRESSION; HIPPOCAMPAL-NEURONS; MIBEFRADIL BLOCK; CA(V)2.2; RAT; SUBUNIT	SH-SY5Y human neuroblastoma cells provide a useful in vitro model to study the mechanisms underlying neurotransmission and nociception. These cells are derived from human sympathetic neuronal tissue and thus, express a number of the Ca-v channel subtypes essential for regulation of important physiological functions, such as heart contraction and nociception, including the clinically validated pain target Ca(v)2.2. We have detected mRNA transcripts for a range of endogenous expressed subtypes Ca(v)1.3, Ca(v)2.2 (including two Ca(v)1.3, and three Ca(v)2.2 splice variant isoforms) and Ca(v)3.1 in SH-SY5Y cells; as well as Ca-v auxiliary subunits alpha(2)delta(1-3), beta(1), beta(3), beta(4), gamma(1), gamma(4-5), and gamma(7). Both high-and low-voltage activated Ca-v channels generated calcium signals in SH-SY5Y cells. Pharmacological characterisation using omega-conotoxins CVID and MVIIA revealed significantly (similar to 10-fold) higher affinity at human versus rat Ca(v)2.2, while GVIA, which interacts with Ca(v)2.2 through a distinct pharmacophore had similar affinity for both species. CVID, GVIA and MVIIA affinity was higher for SH-SY5Y membranes vs whole cells in the binding assays and functional assays, suggesting auxiliary subunits expressed endogenously in native systems can strongly influence Ca(v)2.2 channels pharmacology. These results may have implications for strategies used to identify therapeutic leads at Ca(v)2.2 channels.	[Sousa, Silmara R.; Vetter, Irina; Ragnarsson, Lotten; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	r.lewis@imb.uq.edu.au	Lewis, Richard/T-8763-2019; Lewis, Richard J/E-8674-2013; Vetter, Irina/A-6035-2010; Ragnarsson, Lotten/A-8632-2012	Lewis, Richard/0000-0003-3470-923X; Lewis, Richard J/0000-0003-3470-923X; Vetter, Irina/0000-0002-3594-9588; Ragnarsson, Lotten/0000-0002-7137-1656; Rodrigues de Sousa, Silmara/0000-0002-2130-4439	NHMRC; UQIRTA; ARC	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); UQIRTA; ARC(Australian Research Council)	This work was supported by an NHMRC Program Grant (RJL), an UQIRTA scholarship to SRS and NHMRC fellowships to RJL and IV. The FLIPR was supported by an ARC Linkage Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD SN, 1988, BRAIN RES, V453, P247; Alicino I, 2012, PAIN, V153, P245, DOI 10.1016/j.pain.2011.10.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Arnoult C, 1998, MOL PHARMACOL, V53, P1104; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Benjamin ER, 2006, BIOCHEM PHARMACOL, V72, P770, DOI 10.1016/j.bcp.2006.06.003; Berecki G, 2010, MOL PHARMACOL, V77, P139, DOI 10.1124/mol.109.058834; BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540; BRUST PF, 1993, NEUROPHARMACOLOGY, V32, P1089, DOI 10.1016/0028-3908(93)90004-M; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2003, PHARMACOL REV, V55, P575, DOI 10.1124/pr.55.4.7; Catterall WA, 2011, COLD SPRING HARBOR P, V3; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Chiou WF, 2006, NEUROCHEM INT, V49, P256, DOI 10.1016/j.neuint.2006.01.022; Cizkova D, 2002, EXP BRAIN RES, V147, P456, DOI 10.1007/s00221-002-1217-3; Dai G, 2008, ASSAY DRUG DEV TECHN, V6, P195, DOI 10.1089/adt.2008.136; DOLD KM, 1990, ANAL BIOCHEM, V184, P67, DOI 10.1016/0003-2697(90)90013-Y; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Feng ZP, 2001, J BIOL CHEM, V276, P15728, DOI 10.1074/jbc.M100406200; Ferron L, 2008, J NEUROSCI, V28, P10604, DOI 10.1523/JNEUROSCI.2709-08.2008; Finley MFA, 2010, ASSAY DRUG DEV TECHN, V8, P685, DOI 10.1089/adt.2010.0311; Furukawa T, 1999, J PHARMACOL EXP THER, V291, P464; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Jimenez C, 2000, NEUROPHARMACOLOGY, V39, P1, DOI 10.1016/S0028-3908(99)00153-7; Kaneko S, 2002, J NEUROSCI, V22, P82, DOI 10.1523/JNEUROSCI.22-01-00082.2002; Kang MG, 2001, J BIOL CHEM, V276, P32917, DOI 10.1074/jbc.M100787200; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; LAMBERT DG, 1990, MOL BRAIN RES, V8, P263, DOI 10.1016/0169-328X(90)90026-A; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; Lipscombe D, 2007, CHANNELS, V1, P225, DOI 10.4161/chan.4809; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; MAUBECIN VA, 1995, J NEUROCHEM, V64, P2544; Maximov A, 2002, J NEUROSCI, V22, P6939; Moss FJ, 2002, EMBO J, V21, P1514, DOI 10.1093/emboj/21.7.1514; Motin L, 2007, EUR J NEUROSCI, V25, P435, DOI 10.1111/j.1460-9568.2006.05299.x; Mould J, 2004, J BIOL CHEM, V279, P34705, DOI 10.1074/jbc.M310848200; Nielsen KJ, 2000, J MOL RECOGNIT, V13, P55, DOI 10.1002/(SICI)1099-1352(200003/04)13:2<55::AID-JMR488>3.0.CO;2-O; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; REEVE HL, 1994, EUR J NEUROSCI, V6, P943, DOI 10.1111/j.1460-9568.1994.tb00588.x; REUVENY E, 1993, BRAIN RES, V603, P64, DOI 10.1016/0006-8993(93)91300-H; Sandoval A, 2007, CELL MOL NEUROBIOL, V27, P901, DOI 10.1007/s10571-007-9210-9; Schroeder CI, 2006, MAR DRUGS, V4, P193, DOI 10.3390/md403193; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; Sonnier H, 2000, CELL MOL LIFE SCI, V57, P514, DOI 10.1007/PL00000712; Szabo Z, 2006, EUR J NEUROSCI, V24, P709, DOI 10.1111/j.1460-9568.2006.04947.x; Todorovic SM, 1998, J NEUROPHYSIOL, V79, P240, DOI 10.1152/jn.1998.79.1.240; TROMBLEY PQ, 1991, J NEUROSCI, V11, P435; VAUGHAN PFT, 1995, GEN PHARMACOL-VASC S, V26, P1191, DOI 10.1016/0306-3623(94)00312-B; Vetter I, 2012, BIOCHEM PHARMACOL, V83, P1562, DOI 10.1016/j.bcp.2012.02.022; Viana F, 1997, CELL CALCIUM, V22, P299, DOI 10.1016/S0143-4160(97)90068-3; WAGNER JA, 1988, J NEUROSCI, V8, P3354; Wallace MS, 2010, CLIN J PAIN, V26, P635, DOI 10.1097/AJP.0b013e3181e017df; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Xie XM, 2007, ASSAY DRUG DEV TECHN, V5, P191, DOI 10.1089/adt.2006.054; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zamponi GW, 2004, NEURON, V41, P3, DOI 10.1016/S0896-6273(03)00846-8	63	48	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59293	10.1371/journal.pone.0059293	http://dx.doi.org/10.1371/journal.pone.0059293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536870	gold, Green Published, Green Submitted			2022-12-25	WOS:000317397200018
J	You, WC; Wang, CX; Pan, YX; Zhang, X; Zhou, XM; Zhang, XS; Shi, JX; Zhou, ML				You, Wan-Chun; Wang, Chun-xi; Pan, Yun-xi; Zhang, Xin; Zhou, Xiao-ming; Zhang, Xiang-sheng; Shi, Ji-xin; Zhou, Meng-liang			Activation of Nuclear Factor-kappa B in the Brain after Experimental Subarachnoid Hemorrhage and Its Potential Role in Delayed Brain Injury	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CELL-DEATH; RAT-BRAIN; PYRROLIDINE DITHIOCARBAMATE; DNA FRAGMENTATION; GLOBAL-ISCHEMIA; INHIBITION; APOPTOSIS; NEURONS; INFLAMMATION	It has been reported that inflammation is involved in brain injury after subarachnoid hemorrhage (SAH). Nuclear factor-kappa B (NF-kappa B) is a key transcriptional regulator of inflammatory genes. Here, we used pyrrolidine dithiocarbamate(PDTC), an inhibitor of NF-kappa B, through intracisternal injection to study the role of NF-kappa B in delayed brain injury after SAH. A total of 55 rabbits were randomly divided into five groups: the control group; the SAH groups including Day-3, 5, and 7 SAH groups (the rabbits in these groups were sacrificed at 3, 5, 7 days after SAH, respectively); and the PDTC group (n = 11 for each group). Electrophoretic mobility shift assay (EMSA) was performed to detect NF-kappa B DNA-binding activity. The mRNA levels of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, and intercellular adhesion molecule (ICAM)-1 were evaluated by RT-PCR analysis. Deoxyribonucleic acid fragmentation was detected by TUNEL and p65 immunoactivity was assessed by immunohistochemistry. Our results showed the activation of NF-kappa B after SAH, especially at day 3 and 5. The activated p65 was detected in neurons. NF-kappa B DNA-binding activity was suppressed by intracisternal administration of PDTC. Increased levels of the TNF-alpha, IL-1 beta, and ICAM-1 mRNA were found in the brain at day 5 after SAH, and which were suppressed in the PDTC group. The number of TUNEL-positive cells also decreased significantly in the PDTC group compared with that in the Day-5 SAH group. These results demonstrated that the activated NF-kappa B in neurons after SAH plays an important role in regulating the expressions of inflammatory genes in the brain, and ultimately contributes to delayed brain injury.	[You, Wan-Chun; Wang, Chun-xi; Pan, Yun-xi; Zhang, Xin; Zhou, Xiao-ming; Zhang, Xiang-sheng; Shi, Ji-xin; Zhou, Meng-liang] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Zhou, ML (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China.	mengliangzhou@yahoo.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of China (NSFC) [81000503, 81070921, 81271297]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (NSFC): No. 81000503(MZ), No. 81070921, and No. 81271297 (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2001, STROKE, V32, P212, DOI 10.1161/01.STR.32.1.212; Aoki T, 2012, NEUROSURGERY, V70, P1534, DOI 10.1227/NEU.0b013e318246a390; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bian X, 2002, J BIOL CHEM, V277, P42144, DOI 10.1074/jbc.M203891200; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Bremner P, 2002, J PHARM PHARMACOL, V54, P453, DOI 10.1211/0022357021778637; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Calfee-Mason KG, 2004, TOXICOL APPL PHARM, V199, P1, DOI 10.1016/j.taap.2004.03.006; Carcamo JM, 2002, BIOCHEMISTRY-US, V41, P12995, DOI 10.1021/bi0263210; Chabicovsky M, 2010, BASIC CLIN PHARMACOL, V107, P758, DOI 10.1111/j.1742-7843.2010.00573.x; Cheng AC, 2006, J AGR FOOD CHEM, V54, P4215, DOI 10.1021/jf060269n; Clemens JA, 1997, STROKE, V28, P1073, DOI 10.1161/01.STR.28.5.1073; Clemens JA, 1998, STROKE, V29, P677, DOI 10.1161/01.STR.29.3.677; Crack PJ, 2006, STROKE, V37, P1533, DOI 10.1161/01.STR.0000221708.17159.64; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Gabriel C, 1999, MOL BRAIN RES, V65, P61, DOI 10.1016/S0169-328X(98)00330-1; GUERRINI L, 1995, P NATL ACAD SCI USA, V92, P9077, DOI 10.1073/pnas.92.20.9077; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hill WD, 2001, BRAIN RES BULL, V55, P375, DOI 10.1016/S0361-9230(01)00503-2; Isomura I, 2006, MICROBIOL IMMUNOL, V50, P559, DOI 10.1111/j.1348-0421.2006.tb03827.x; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Malaguarnera L, 2003, APOPTOSIS, V8, P539, DOI 10.1023/A:1025550726803; Manna SK, 2000, J IMMUNOL, V165, P5962, DOI 10.4049/jimmunol.165.10.5962; MATHIESEN T, 1993, J NEUROSURG, V78, P562, DOI 10.3171/jns.1993.78.4.0562; Matz P, 1996, STROKE, V27, P504, DOI 10.1161/01.STR.27.3.504; Matz PG, 1996, J NEUROSURG, V85, P138, DOI 10.3171/jns.1996.85.1.0138; Matz PG, 2000, STROKE, V31, P2450, DOI 10.1161/01.STR.31.10.2450; Matz PG, 2000, BRAIN RES, V858, P312, DOI 10.1016/S0006-8993(99)02454-3; Meyer S, 1997, FEBS LETT, V413, P354, DOI 10.1016/S0014-5793(97)00930-7; Nurmi A, 2004, J NEUROCHEM, V91, P755, DOI 10.1111/j.1471-4159.2004.02756.x; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; PHILLIPS LH, 1980, NEUROLOGY, V30, P1034, DOI 10.1212/WNL.30.10.1034; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Prunell GF, 2005, NEUROSURGERY, V56, P1082, DOI 10.1227/01.NEU.0000157966.76590.39; Qin ZH, 1999, J NEUROSCI, V19, P4023; REISINGER EC, 1990, LANCET, V335, P679, DOI 10.1016/0140-6736(90)90802-C; Roman-Blas JA, 2006, OSTEOARTHR CARTILAGE, V14, P839, DOI 10.1016/j.joca.2006.04.008; SALMINEN A, 1995, BIOCHEM BIOPH RES CO, V212, P939, DOI 10.1006/bbrc.1995.2060; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Seegers H, 2000, NEUROSCI LETT, V288, P241, DOI 10.1016/S0304-3940(00)01245-3; Sehba FA, 2006, NEUROL RES, V28, P381, DOI 10.1179/016164106X114991; Stephenson D, 2000, J CEREBR BLOOD F MET, V20, P592, DOI 10.1097/00004647-200003000-00017; VERHAEGEN S, 1995, BIOCHEM PHARMACOL, V50, P1021, DOI 10.1016/0006-2952(95)00233-P; Wen Y, 2004, BRAIN RES, V1008, P147, DOI 10.1016/j.brainres.2004.02.019; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004; Zhou ML, 2007, J CEREBR BLOOD F MET, V27, P1583, DOI 10.1038/sj.jcbfm.9600456; Zhou ML, 2007, J NEUROSCI METH, V159, P318, DOI 10.1016/j.jneumeth.2006.07.026; ZIEGLERHEITBROCK HWL, 1993, J IMMUNOL, V151, P6986	54	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60290	10.1371/journal.pone.0060290	http://dx.doi.org/10.1371/journal.pone.0060290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536907	gold, Green Submitted, Green Published			2022-12-25	WOS:000317397200055
J	Zhang, T; Zhao, XQ; Huang, LY; Liu, XY; Zong, Y; Zhu, LH; Yang, DC; Fu, BY				Zhang, Ting; Zhao, Xiuqin; Huang, Liyu; Liu, Xiaoyue; Zong, Ying; Zhu, Linghua; Yang, Daichang; Fu, Binying			Tissue-Specific Transcriptomic Profiling of Sorghum propinquum using a Rice Genome Array	PLOS ONE			English	Article							RHIZOME-SPECIFIC GENES; OLIGONUCLEOTIDE MICROARRAYS; DIFFERENTIAL EXPRESSION; SUCROSE TRANSPORTER; REGULATORY ELEMENTS; CDNA MICROARRAY; DOMAIN PROTEIN; CIS-ELEMENT; ARABIDOPSIS; IDENTIFICATION	Sorghum (Sorghum bicolor) is one of the world's most important cereal crops. S. propinquum is a perennial wild relative of S. bicolor with well-developed rhizomes. Functional genomics analysis of S. propinquum, especially with respect to molecular mechanisms related to rhizome growth and development, can contribute to the development of more sustainable grain, forage, and bioenergy cropping systems. In this study, we used a whole rice genome oligonucleotide microarray to obtain tissue-specific gene expression profiles of S. propinquum with special emphasis on rhizome development. A total of 548 tissue-enriched genes were detected, including 31 and 114 unique genes that were expressed predominantly in the rhizome tips (RT) and internodes (RI), respectively. Further GO analysis indicated that the functions of these tissue-enriched genes corresponded to their characteristic biological processes. A few distinct cis-elements, including ABA-responsive RY repeat CATGCA, sugar-repressive TTATCC, and GA-responsive TAACAA, were found to be prevalent in RT-enriched genes, implying an important role in rhizome growth and development. Comprehensive comparative analysis of these rhizome-enriched genes and rhizome-specific genes previously identified in Oryza longistaminata and S. propinquum indicated that phytohormones, including ABA, GA, and SA, are key regulators of gene expression during rhizome development. Co-localization of rhizome-enriched genes with rhizome-related QTLs in rice and sorghum generated functional candidates for future cloning of genes associated with rhizome growth and development.	[Zhang, Ting; Zhao, Xiuqin; Huang, Liyu; Liu, Xiaoyue; Zong, Ying; Zhu, Linghua; Fu, Binying] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Zhang, Ting; Yang, Daichang] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Wuhan University	Yang, DC (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	dyang@whu.edu.cn; fubinying@caas.cn	zhang, ting/ABG-5784-2020	zhang, ting/0000-0001-9231-1604	National Natural Science Foundation of China [30760094, U0836605]; MOA [2008ZX001 003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOA	This work was supported by the National Natural Science Foundation of China (Grant No. 30760094 and U0836605) and the Key Project from MOA (Grant No. 2008ZX001 003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Bagnaresi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-176; Buchanan CD, 2005, PLANT MOL BIOL, V58, P699, DOI 10.1007/s11103-005-7876-2; CHITTENDEN LM, 1994, THEOR APPL GENET, V87, P925, DOI 10.1007/BF00225786; Clayton W.D., 2006, GRASSBASE ONLINE WOR; Davey MW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-436; Degenhardt J, 1996, PLANT CELL, V8, P31, DOI 10.1105/tpc.8.1.31; Doggett H., 1988, ECON BOT, V2nd ed.; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ezcurra I, 1999, PLANT MOL BIOL, V40, P699, DOI 10.1023/A:1006206124512; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; FUJIWARA T, 1994, PLANT MOL BIOL, V24, P261, DOI 10.1007/BF00020166; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Fusada N, 2005, PLANT MOL BIOL, V59, P631, DOI 10.1007/s11103-005-0579-x; GASSER SM, 1989, INT REV CYTOL, V119, P57; GHESQUIERE A, 1991, RICE GENETICS II, P729; GHESQUIERE A, 1992, RGN, V9, P28; Guo Y, 2005, J VIROL, V79, P14392, DOI 10.1128/JVI.79.22.14392-14403.2005; Horvath DP, 2003, PLANT J, V34, P125, DOI 10.1046/j.1365-313X.2003.01706.x; Hu FY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-18; Hu FY, 2003, P NATL ACAD SCI USA, V100, P4050, DOI 10.1073/pnas.0630531100; HUANG N, 1990, PLANT MOL BIOL, V14, P655, DOI 10.1007/BF00016499; Jackson D. P, 1991, IN SITU HYBRIDIZATIO, P163; Jang CS, 2009, HEREDITY, V102, P266, DOI 10.1038/hdy.2008.119; Jang CS, 2006, PLANT PHYSIOL, V142, P1148, DOI 10.1104/pp.106.082891; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Kang XJ, 2007, PLANT J, V52, P937, DOI 10.1111/j.1365-313X.2007.03295.x; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kassahn KS, 2007, MOL ECOL, V16, P1749, DOI 10.1111/j.1365-294X.2006.03178.x; Kellogg EA, 1998, P NATL ACAD SCI USA, V95, P2005, DOI 10.1073/pnas.95.5.2005; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kim DW, 2006, PLANT CELL, V18, P2958, DOI 10.1105/tpc.106.045229; Koch M, 2006, PLANT J, V47, P629, DOI 10.1111/j.1365-313X.2006.02813.x; Koyama T, 2010, PLANT CELL, V22, P3574, DOI 10.1105/tpc.110.075598; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Lu CA, 2002, PLANT CELL, V14, P1963, DOI 10.1105/tpc.001735; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Maekawa M., 1998, J BREEDING GENET, V30, P69; Martin V, 2009, FEBS LETT, V583, P3425, DOI 10.1016/j.febslet.2009.09.055; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Murcha MW, 2005, J BIOL CHEM, V280, P16476, DOI 10.1074/jbc.M413299200; Nakashima K, 2006, PLANT MOL BIOL, V60, P51, DOI 10.1007/s11103-005-2418-5; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Nishiuchi T, 2004, J BIOL CHEM, V279, P55355, DOI 10.1074/jbc.M409674200; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Ouyang J, 2010, PLANT SCI, V179, P374, DOI 10.1016/j.plantsci.2010.06.013; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Park ES, 2011, P NATL ACAD SCI USA, V108, P17456, DOI 10.1073/pnas.1114210108; Park SJ, 2006, PLANTA, V223, P932, DOI 10.1007/s00425-005-0148-1; PATERSON AH, 1995, P NATL ACAD SCI USA, V92, P6127, DOI 10.1073/pnas.92.13.6127; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Planchais S, 2002, PLANT MOL BIOL, V50, P111, DOI 10.1023/A:1016018711532; Pratt LH, 2005, PLANT PHYSIOL, V139, P869, DOI 10.1104/pp.105.066134; Renn SCP, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-42; Rosenow D.T., 2000, SORGHUM ORIGIN HIST; Salzman RA, 2005, PLANT PHYSIOL, V138, P352, DOI 10.1104/pp.104.058206; SANDAL NN, 1987, NUCLEIC ACIDS RES, V15, P1507, DOI 10.1093/nar/15.4.1507; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Scofield GN, 2007, J EXP BOT, V58, P3155, DOI 10.1093/jxb/erm153; Scofield GN, 2007, J EXP BOT, V58, P483, DOI 10.1093/jxb/erl217; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Sun QW, 2008, P NATL ACAD SCI USA, V105, P13679, DOI 10.1073/pnas.0805901105; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vainonen JP, 2008, FEBS J, V275, P1767, DOI 10.1111/j.1742-4658.2008.06335.x; Volodarsky D, 2009, PLANT PHYSIOL, V150, P1796, DOI 10.1104/pp.109.138289; Walker SJ, 2006, J NEUROSCI METH, V152, P179, DOI 10.1016/j.jneumeth.2005.09.007; Wang KH, 2010, J EXP BOT, V61, P551, DOI 10.1093/jxb/erp334; Welchen E, 2005, PLANT PHYSIOL, V139, P88, DOI 10.1104/pp.105.065920; Yamaji N, 2009, PLANT CELL, V21, P2878, DOI 10.1105/tpc.109.069831; Yang SS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-85; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang T, 2012, J PLANT BIOL, V55, P33, DOI 10.1007/s12374-011-9187-2; Zhao XQ, 2012, J PLANT BIOL, V55, P73, DOI 10.1007/s12374-011-9192-5; Zhu-Salzman K, 2004, PLANT PHYSIOL, V134, P420, DOI 10.1104/pp.103.028324	86	5	5	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60202	10.1371/journal.pone.0060202	http://dx.doi.org/10.1371/journal.pone.0060202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536906	Green Published, gold, Green Submitted			2022-12-25	WOS:000317397200054
J	Rowzee, AM; Perez-Riveros, PJ; Zheng, CY; Krygowski, S; Baum, BJ; Cawley, NX				Rowzee, Anne M.; Perez-Riveros, Paola J.; Zheng, Changyu; Krygowski, Sarah; Baum, Bruce J.; Cawley, Niamh X.			Expression and Secretion of Human Proinsulin-B10 from Mouse Salivary Glands: Implications for the Treatment of Type I Diabetes Mellitus	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; INSULIN-RECEPTOR ISOFORM; CARBOXYPEPTIDASE-E; CELL LINE; MUTANT PROINSULIN; EPITHELIAL-CELLS; SKELETAL-MUSCLE; MICE; THERAPY; HYPERPROINSULINEMIA	Adenovirus (Ad) mediated expression of therapeutic proteins from salivary glands can result in the delivery of biologically active proteins into the circulation where they impart their physiological function. In recent years, Ad vector delivery to salivary glands (SGs) has emerged as a viable option for gene therapy. Here, we engineered a variant of human proinsulin (hProinsulin-B10) into an Ad vector and demonstrated its ability to transduce cell lines, and express a bioactive protein that induces the phosphorylation of AKT, a key insulin signaling molecule. We also examined its expression in mice following delivery of the vector to the parotid gland (PTG), the submandibular gland (SMG) or to the liver via the tail vein and assessed transgenic protein expression and vector containment for each delivery method. In all cases, hProinsulin-B10 was expressed and secreted into the circulation. Lower levels of circulating hProinsulin-B10 were obtained from the PTG while higher levels were obtained from the tail vein and the SMG; however, vector particle containment was best when delivered to the SMG. Expression of hProinsulin-B10 in the SMG of chemically induced diabetic mice prevented excessive hyperglycemia observed in untreated mice. These results demonstrate that hProinsulin-B10 can be expressed and secreted into the circulation from SGs and can function physiologically in vivo. The ability to remediate a diabetic phenotype in a model of type 1 diabetes mellitus is the first step in an effort that may lead to a possible therapy for diabetes.	[Rowzee, Anne M.; Perez-Riveros, Paola J.; Zheng, Changyu; Krygowski, Sarah; Baum, Bruce J.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Cawley, Niamh X.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Cawley, NX (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	cawleyn@mail.nih.gov			Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Dental and Craniofacial Research, National Institutes of Health (Bethesda, MD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056] Funding Source: NIH RePORTER	Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Dental and Craniofacial Research, National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Dental and Craniofacial Research, National Institutes of Health (Bethesda, MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaansen J, 2011, HUM GENE THER, V22, P84, DOI 10.1089/hum.2010.097; Adriaansen J, 2008, HUM GENE THER, V19, P1021, DOI 10.1089/hum.2008.079; Baum B, 2012, P NATL ACAD IN PRESS; Baum BJ, 2010, ORAL ONCOL, V46, P4, DOI 10.1016/j.oraloncology.2009.09.004; BAVENHOLM P, 1995, CIRCULATION, V92, P1422, DOI 10.1161/01.CIR.92.6.1422; BROWN AM, 1989, J ORAL PATHOL MED, V18, P206, DOI 10.1111/j.1600-0714.1989.tb00764.x; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Burkhardt BR, 2005, FEBS LETT, V579, P5759, DOI 10.1016/j.febslet.2005.09.060; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Cawley NX, 2003, ENDOCRINOLOGY, V144, P292, DOI 10.1210/en.2002-220588; CHAN SJ, 1987, P NATL ACAD SCI USA, V84, P2194, DOI 10.1073/pnas.84.8.2194; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Cotrim Ana P, 2006, Dent Clin North Am, V50, P157, DOI 10.1016/j.cden.2005.11.002; Cotrim AP, 2006, DENT CLIN N AM, V50, pvii; GABBAY KH, 1976, NEW ENGL J MED, V294, P911, DOI 10.1056/NEJM197604222941701; GROSS DJ, 1989, P NATL ACAD SCI USA, V86, P4107, DOI 10.1073/pnas.86.11.4107; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; He X, 1998, GENE THER, V5, P537, DOI 10.1038/sj.gt.3300622; Hermann LS, 1999, DIABETES OBES METAB, V1, P227, DOI 10.1046/j.1463-1326.1999.00034.x; Hsu PYJ, 2005, J GENE MED, V7, P1311, DOI 10.1002/jgm.779; Isenman L, 1999, AM J PHYSIOL-ENDOC M, V276, pE223, DOI 10.1152/ajpendo.1999.276.2.E223; Kumar M, 2007, GENE THER, V14, P162, DOI 10.1038/sj.gt.3302836; LAZARUS N R, 1970, Journal of Clinical Investigation, V49, P487, DOI 10.1172/JCI106258; Malaguarnera R, 2012, ENDOCRINOLOGY, V153, P2152, DOI 10.1210/en.2011-1843; Marcovina S, 2007, CLIN CHEM, V53, P711, DOI 10.1373/clinchem.2006.082214; Martinenghi S, 2002, GENE THER, V9, P1429, DOI 10.1038/sj.gt.3301804; MASTRANGELI A, 1994, AM J PHYSIOL, V266, pG1146, DOI 10.1152/ajpgi.1994.266.6.G1146; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Oh TK, 2006, DIABETES RES CLIN PR, V71, P233, DOI 10.1016/j.diabres.2005.08.005; Perez P, 2010, INT J BIOCHEM CELL B, V42, P773, DOI 10.1016/j.biocel.2010.02.012; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Ren B, 2007, DIABETOLOGIA, V50, P1910, DOI 10.1007/s00125-007-0722-0; Roder ME, 1996, J CLIN ENDOCR METAB, V81, P1634, DOI 10.1210/jc.81.4.1634; Rowzee AM, 2009, ENDOCRINOLOGY, V150, P3611, DOI 10.1210/en.2008-1473; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; Shaw JAM, 2002, J ENDOCRINOL, V172, P653, DOI 10.1677/joe.0.1720653; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; Steiner DF, 1996, DIABETES METAB, V22, P94; STOLL RW, 1971, ENDOCRINOLOGY, V88, P714, DOI 10.1210/endo-88-3-714; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Voutetakis A, 2004, P NATL ACAD SCI USA, V101, P3053, DOI 10.1073/pnas.0400136101; Voutetakis A, 2010, ENDOCRINOLOGY, V151, P4566, DOI 10.1210/en.2010-0193; Yudkin JS, 2002, DIABETOLOGIA, V45, P327, DOI 10.1007/s00125-001-0756-7; Zheng CY, 2008, MOL THER, V16, P1089, DOI 10.1038/mt.2008.56; Zheng CY, 2010, J GENE MED, V12, P3, DOI 10.1002/jgm.1416; Zheng CY, 2005, MOL THER, V12, P528, DOI 10.1016/j.ymthe.2005.03.008	48	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59222	10.1371/journal.pone.0059222	http://dx.doi.org/10.1371/journal.pone.0059222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554999	Green Submitted, Green Published, gold			2022-12-25	WOS:000316409800072
J	Samanta, T; Roymahapatra, G; Porto, WF; Seth, S; Ghorai, S; Saha, S; Sengupta, J; Franco, OL; Dinda, J; Mandal, SM				Samanta, Tapastaru; Roymahapatra, Gourisankar; Porto, William F.; Seth, Saikat; Ghorai, Sudipta; Saha, Suman; Sengupta, Jayangshu; Franco, Octavio L.; Dinda, Joydev; Mandal, Santi M.			N, N '-Olefin Functionalized Bis-Imidazolium Gold(I) Salt Is an Efficient Candidate to Control Keratitis-Associated Eye Infection	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; HETEROCYCLIC CARBENES; COMPLEXES; RESISTANCE	Keratitis treatment has become more complicated due to the emergence of bacterial or fungal pathogens with enhanced antibiotic resistance. The pharmaceutical applications of N-heterocyclic carbene complexes have received remarkable attention due to their antimicrobial properties. In this paper, the new precursor, 3,3'-(p-phenylenedimethylene) bis{1-(2-methyl-allyl) imidazolium} bromide (1a) and its analogous PF6 salt (1b) were synthesized. Furthermore, silver(I) and gold(I) - N-heterocyclic carbene (NHC) complexes [Ag2LBr2/Au2LBr2; 2a/3a], [(Ag2L2)(PF6)(2)/(Au2L2)(PF6) 2; 2b/3b] were developed from their corresponding ligands. All compounds were screened for their antimicrobial activities against multiple keratitis-associated human eye pathogens, including bacteria and fungi. Complexes 2a and 3a showed highest activity, and the effectiveness of 3a was also studied, focusing eradication of pathogen biofilm. Furthermore, the structures of 1a, 2a and 3b were determined using single crystal X-ray analysis, 2b and 3a were optimized theoretically. The mechanism of action of 3a was evaluated by scanning electron microscopy and docking experiments, suggesting that its target is the cell membrane. In summary, 3a may be helpful in developing antimicrobial therapies in patients suffering from keratitis-associated eye infections caused by multidrug-resistant pathogens.	[Samanta, Tapastaru; Roymahapatra, Gourisankar; Dinda, Joydev] Haldia Inst Technol, Sch Appl Sci, Haldia, W Bengal, India; [Mandal, Santi M.] Indian Inst Technol, Ctr Res Facil, Kharagpur 721302, W Bengal, India; [Porto, William F.; Franco, Octavio L.] Posgrad Ciencias Genom & Biotecnol UCB, Ctr Anal Prot & Bioquim, Brasilia, DF, Brazil; [Seth, Saikat; Ghorai, Sudipta] Egra Sarada Sashibhusan Mahavidyalaya, Mugberia Gangadhar Coll, Midnapore, W Bengal, India; [Saha, Suman; Sengupta, Jayangshu] Priyamvada Birla Aravind Eye Hosp, Kolkata, W Bengal, India	Haldia Institute of Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Mandal, SM (corresponding author), Indian Inst Technol, Ctr Res Facil, Kharagpur 721302, W Bengal, India.	mandalsm@gmail.com	Mandal, Santi M./AAF-7156-2020; Dinda, Joydev/AHA-1483-2022; Seth, Saikat Kumar/H-4122-2013; Roymahapatra, Gourisankar/AAC-7585-2020; Dinda, Joydev/M-7432-2017; SAHA, SUMAN/GLS-7922-2022; Franco, Octavio L/T-3020-2017	Seth, Saikat Kumar/0000-0003-4904-6926; Roymahapatra, Gourisankar/0000-0002-8018-5206; Dinda, Joydev/0000-0002-8780-6300; Porto, William/0000-0002-4739-8250; Mandal, Santi M/0000-0002-0119-7138; Franco, Octavio/0000-0001-9546-0525				[Anonymous], 2004, GAUSSIAN 03 REVISION; Arulmozhiraja S, 2002, J PHYS CHEM A, V106, P1765, DOI 10.1021/jp013558h; Barnes NA, 2011, DALTON T, V40, P1743, DOI 10.1039/c0dt01014f; BERNERSPRICE SJ, 1986, CANCER RES, V46, P5486; Bikadi Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025815; CLSI, 2007, M100S17 CLSI; Croes S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-229; Hahn EF, 2007, J ORGANOMET CHEM, V692, P4630, DOI 10.1016/j.jorganchem.2007.04.025; Herrmann WA, 2002, ANGEW CHEM INT EDIT, V41, P1290, DOI 10.1002/1521-3773(20020415)41:8<1290::AID-ANIE1290>3.0.CO;2-Y; Hindi KM, 2009, CHEM REV, V109, P3859, DOI 10.1021/cr800500u; Huang W, 2007, J ORGANOMET CHEM, V692, P3804, DOI 10.1016/j.jorganchem.2007.05.019; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Knapp AR, 2010, INORG CHIM ACTA, V364, P125, DOI 10.1016/j.ica.2010.08.008; Lillo V, 2007, CHEM COMMUN, P3380, DOI 10.1039/b705197b; Lu PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034643; Mandal SM, 2012, J CELL BIOCHEM, V113, P184, DOI 10.1002/jcb.23343; Mellon M., 2001, HOGGING IT ESTIMATES; Mitchell BM, 2007, INVEST OPHTH VIS SCI, V48, P774, DOI 10.1167/iovs.06-0793; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; Ozdemir I, 2004, APPL ORGANOMET CHEM, V18, P318, DOI 10.1002/aoc.668; Parthasarathi R, 2003, J PHYS CHEM A, V107, P10346, DOI 10.1021/jp035620b; Platania CBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044316; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Roymahapatra G, 2012, CURR MED CHEM, V19, P4184, DOI 10.2174/092986712802430090; Saha Suman, 2009, Oman J Ophthalmol, V2, P114, DOI 10.4103/0974-620X.57310; Sahu K, 2009, J PHOTOCH PHOTOBIO B, V96, P9, DOI 10.1016/j.jphotobiol.2009.03.008; Schuster O, 2009, CHEM REV, V109, P3445, DOI 10.1021/cr8005087; Sengupta J, 2012, J INFECT CHEMOTHER, V18, P698, DOI 10.1007/s10156-012-0398-3; Sheldrick GM, 1997, SHELX76 PROGRAMME RE; Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011; Willcox MDP, 2011, CLIN EXP OPTOM, V94, P161, DOI 10.1111/j.1444-0938.2010.00536.x	31	49	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58346	10.1371/journal.pone.0058346	http://dx.doi.org/10.1371/journal.pone.0058346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554886	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800013
J	Wang, HF; Xiao, B; Wang, MY; Shao, MA				Wang, Huifang; Xiao, Bo; Wang, Mingyu; Shao, Ming'an			Modeling the Soil Water Retention Curves of Soil-Gravel Mixtures with Regression Method on the Loess Plateau of China	PLOS ONE			English	Article							PEDOTRANSFER FUNCTIONS; HYDRAULIC-PROPERTIES; COARSE FRAGMENTS; ROCK FRAGMENTS; STONY SOILS; CONDUCTIVITY; CENTRIFUGE; VALIDITY	Soil water retention parameters are critical to quantify flow and solute transport in vadose zone, while the presence of rock fragments remarkably increases their variability. Therefore a novel method for determining water retention parameters of soil-gravel mixtures is required. The procedure to generate such a model is based firstly on the determination of the quantitative relationship between the content of rock fragments and the effective saturation of soil-gravel mixtures, and then on the integration of this relationship with former analytical equations of water retention curves (WRCs). In order to find such relationships, laboratory experiments were conducted to determine WRCs of soil-gravel mixtures obtained with a clay loam soil mixed with shale clasts or pebbles in three size groups with various gravel contents. Data showed that the effective saturation of the soil-gravel mixtures with the same kind of gravels within one size group had a linear relation with gravel contents, and had a power relation with the bulk density of samples at any pressure head. Revised formulas for water retention properties of the soil-gravel mixtures are proposed to establish the water retention curved surface models of the power-linear functions and power functions. The analysis of the parameters obtained by regression and validation of the empirical models showed that they were acceptable by using either the measured data of separate gravel size group or those of all the three gravel size groups having a large size range. Furthermore, the regression parameters of the curved surfaces for the soil-gravel mixtures with a large range of gravel content could be determined from the water retention data of the soil-gravel mixtures with two representative gravel contents or bulk densities. Such revised water retention models are potentially applicable in regional or large scale field investigations of significantly heterogeneous media, where various gravel sizes and different gravel contents are present.	[Wang, Huifang; Xiao, Bo] Beijing Acad Agr & Forestry Sci, Beijing Res & Dev Ctr Grass & Environm, Beijing, Peoples R China; [Wang, Huifang; Wang, Mingyu] Chinese Acad Sci, Grad Univ, Ctr Water Syst Secur, Beijing, Peoples R China; [Wang, Huifang; Xiao, Bo; Shao, Ming'an] Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China	Beijing Academy of Agriculture & Forestry; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Xiao, B (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Res & Dev Ctr Grass & Environm, Beijing, Peoples R China.	xiaoboxb@gmail.com	Xiao, Bo/F-9722-2013	Xiao, Bo/0000-0002-9544-4207	Natural Science Foundation of China [50479063, 41001156]; Program of Hundreds of Talents of Chinese Academy of Sciences [99T3005WA2]; Key National Science & Technology Water Project [2009ZX07212-003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Hundreds of Talents of Chinese Academy of Sciences; Key National Science & Technology Water Project	This study was funded by Natural Science Foundation of China (No. 50479063 and 41001156), by the Program of Hundreds of Talents of Chinese Academy of Sciences (99T3005WA2), and by The Key National Science & Technology Water Project (No. 2009ZX07212-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bittelli M, 2009, SOIL SCI SOC AM J, V73, P1453, DOI 10.2136/sssaj2008.0082; Bouma J, 1989, ADV SOIL SCI, V9, P225; BOUWER H, 1984, GROUND WATER, V22, P696, DOI 10.1111/j.1745-6584.1984.tb01438.x; Brooks R., 1964, HYDROLOGY PAPERS COL, V3, P3; Brouwer J, 2000, SOIL SCI SOC AM J, V64, P1603, DOI 10.2136/sssaj2000.6451603x; Cornelis WM, 2001, SOIL SCI SOC AM J, V65, P638, DOI 10.2136/sssaj2001.653638x; Cousin I, 2003, CATENA, V53, P97, DOI 10.1016/S0341-8162(03)00037-7; Cuniglio R, 2009, GEODERMA, V148, P375, DOI 10.1016/j.geoderma.2008.11.005; Dann R, 2009, VADOSE ZONE J, V8, P651, DOI 10.2136/vzj2008.0174; Das B.M., 2010, GEOTECHNICAL ENG HDB; Fies JC, 2002, EUR J SOIL SCI, V53, P95, DOI 10.1046/j.1365-2389.2002.00431.x; GARDNER WH, 1986, AGRONOMY, V9, P493, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C21; HANSON CT, 1979, SOIL SCI SOC AM J, V43, P819, DOI 10.2136/sssaj1979.03615995004300040044x; Indrawan IGB, 2006, ENG GEOL, V82, P154, DOI 10.1016/j.enggeo.2005.10.003; Ippisch O, 2006, ADV WATER RESOUR, V29, P1780, DOI 10.1016/j.advwatres.2005.12.011; Khaleel R, 1997, WATER RESOUR RES, V33, P1875, DOI 10.1029/97WR01068; Khanzode RM, 2002, CAN GEOTECH J, V39, P1209, DOI 10.1139/T02-060; Klute A., 1986, METHODS SOIL ANAL 1; Li YS, 1981, SOILS, V4, P143, DOI [10. 13758/j. cnki. tr. 1981. 04. 007, DOI 10.13758/J.CNKI.TR.1981.04.007]; Ma DH, 2008, EUR J SOIL SCI, V59, P950, DOI 10.1111/j.1365-2389.2008.01055.x; Mace A, 1998, GROUND WATER, V36, P465, DOI 10.1111/j.1745-6584.1998.tb02818.x; Margesin R, 2005, DETERMINATION CHEM P, P47; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Minasny B, 1999, GEODERMA, V93, P225, DOI 10.1016/S0016-7061(99)00061-0; NIELSEN DR, 1986, WATER RESOUR RES, V22, P89, DOI DOI 10.1029/WR022I09SP0089S; Omuto CT, 2009, GEODERMA, V149, P235, DOI 10.1016/j.geoderma.2008.12.001; Pachepsky Y, 2001, SOIL SCI SOC AM J, V65, P460, DOI 10.2136/sssaj2001.652460x; Patil NG, 2012, J IRRIG DRAIN ENG, V138, P177, DOI 10.1061/(ASCE)IR.1943-4774.0000375; Phillips JD, 2005, EARTH SURF PROC LAND, V30, P429, DOI 10.1002/esp.1152; POESEN J, 1994, CATENA, V23, P1, DOI 10.1016/0341-8162(94)90050-7; Puhlmann H, 2012, J PLANT NUTR SOIL SC, V175, P221, DOI 10.1002/jpln.201100139; RAVINA I, 1984, SOIL SCI SOC AM J, V48, P736, DOI 10.2136/sssaj1984.03615995004800040008x; Reatto A, 2008, SOIL SCI SOC AM J, V72, P1547, DOI 10.2136/sssaj2007.0355N; Sauer TJ, 2002, SOIL SCI SOC AM J, V66, P1947, DOI 10.2136/sssaj2002.1947; Scheinost AC, 1997, GEODERMA, V78, P129, DOI 10.1016/S0016-7061(97)00046-3; Smagin AV, 2012, EURASIAN SOIL SCI+, V45, P416, DOI 10.1134/S1064229312040126; van Genuchten MT, 1987, DOCUMENTED COMPUTE 2; van Genuchten MT, 1987, DOCUMENTED COMPUTE 1; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Vereecken H, 2007, VADOSE ZONE J, V6, P1, DOI 10.2136/vzj2006.0055; Vogel T, 2000, ADV WATER RESOUR, V24, P133, DOI 10.1016/S0309-1708(00)00037-3	41	11	11	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59475	10.1371/journal.pone.0059475	http://dx.doi.org/10.1371/journal.pone.0059475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555040	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800097
J	Walsh, MP; Duncan, B; Larabee, S; Krauss, A; Davis, JPE; Cui, YZ; Kim, SY; Guimond, M; Bachovchin, W; Fry, TJ				Walsh, Meghaan P.; Duncan, Brynn; Larabee, Shannon; Krauss, Aviva; Davis, Jessica P. E.; Cui, Yongzhi; Kim, Su Young; Guimond, Martin; Bachovchin, William; Fry, Terry J.			Val-BoroPro Accelerates T Cell Priming via Modulation of Dendritic Cell Trafficking Resulting in Complete Regression of Established Murine Tumors	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; DIPEPTIDYL PEPTIDASE-IV; PHASE-II TRIAL; ANTITUMOR IMMUNITY; ADAPTIVE IMMUNITY; SMALL-MOLECULE; CANCER; IMMUNOSURVEILLANCE; CHEMOTHERAPY; TALABOSTAT	Although tumors naturally prime adaptive immune responses, tolerance may limit the capacity to control progression and can compromise effectiveness of immune-based therapies for cancer. Post-proline cleaving enzymes (PPCE) modulate protein function through N-terminal dipeptide cleavage and inhibition of these enzymes has been shown to have antitumor activity. We investigated the mechanism by which Val-boroPro, a boronic dipeptide that inhibits post-proline cleaving enzymes, mediates tumor regression and tested whether this agent could serve as a novel immune adjuvant to dendritic cell vaccines in two different murine syngeneic murine tumors. In mice challenged with MB49, which expresses the HY antigen complex, T cell responses primed by the tumor with and without Val-boroPro were measured using interferon gamma ELISPOT. Antibody depletion and gene-deficient mice were used to establish the immune cell subsets required for tumor regression. We demonstrate that Val-boroPro mediates tumor eradication by accelerating the expansion of tumor-specific T cells. Interestingly, T cells primed by tumor during Val-boroPro treatment demonstrate increased capacity to reject tumors following adoptive transfer without further treatment of the recipient. Val-boroPro -mediated tumor regression requires dendritic cells and is associated with enhanced trafficking of dendritic cells to tumor draining lymph nodes. Finally, dendritic cell vaccination combined with Val-boroPro treatment results in complete regression of established tumors. Our findings demonstrate that Val-boroPro has antitumor activity and a novel mechanism of action that involves more robust DC trafficking with earlier priming of T cells. Finally, we show that Val-boroPro has potent adjuvant properties resulting in an effective therapeutic vaccine.	[Walsh, Meghaan P.; Duncan, Brynn; Larabee, Shannon; Krauss, Aviva; Davis, Jessica P. E.; Cui, Yongzhi; Kim, Su Young; Fry, Terry J.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Guimond, Martin] Univ Montreal, Maisonneuve Rosemont Hosp, Montreal, PQ, Canada; [Bachovchin, William] Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Biochem, Boston, MA 02111 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universite de Montreal; Tufts University	Fry, TJ (corresponding author), NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	fryt@mail.nih.gov	william.bachovchin@tufts.edu/AAA-3538-2022	Larabee, Shannon/0000-0003-4308-3099; Duncan, Brynn/0000-0003-2739-9712	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011295] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2004, CANCER RES, V64, P5471, DOI 10.1158/0008-5472.CAN-04-0447; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Cristillo AD, 2008, BIOCHEM BIOPH RES CO, V370, P22, DOI 10.1016/j.bbrc.2008.02.145; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eager RM, 2009, CLIN ONCOL-UK, V21, P464, DOI 10.1016/j.clon.2009.04.007; Eager RM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-263; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fry TJ, 2009, CANCER IMMUNOL IMMUN, V58, P1257, DOI 10.1007/s00262-008-0638-7; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gerner MY, 2008, J IMMUNOL, V181, P155, DOI 10.4049/jimmunol.181.1.155; Gerner MY, 2009, J IMMUNOL, V182, P2726, DOI 10.4049/jimmunol.0803479; Ghiringhelli F, 2007, CURR OPIN IMMUNOL, V19, P224, DOI 10.1016/j.coi.2007.02.003; Gorrell MD, 2005, CLIN SCI, V108, P277, DOI 10.1042/CS20040302; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Jones B, 2003, BLOOD, V102, P1641, DOI 10.1182/blood-2003-01-0208; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kusmartsev S, 2009, NAT REV UROL, V6, P540, DOI 10.1038/nrurol.2009.177; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Meadors JL, 2011, PEDIATR BLOOD CANCER, V57, P921, DOI 10.1002/pbc.23048; Meany H, 2010, JNCI-J NATL CANCER I, V102, P909, DOI 10.1093/jnci/djq174; Melchionda F, 2005, J CLIN INVEST, V115, P1177, DOI 10.1172/JCI200523134; Melchionda F, 2004, J IMMUNOTHER, V27, P329, DOI 10.1097/00002371-200409000-00001; Mele DA, 2011, EUR J IMMUNOL, V41, P1583, DOI 10.1002/eji.201041157; Murillo O, 2009, EUR J IMMUNOL, V39, P2424, DOI 10.1002/eji.200838958; Nakano H, 1997, EUR J IMMUNOL, V27, P215, DOI 10.1002/eji.1830270132; Narra K, 2007, CANCER BIOL THER, V6, P1691, DOI 10.4161/cbt.6.11.4874; Nemunaitis J, 2006, CANCER INVEST, V24, P553, DOI 10.1080/07357900600894732; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Pennisi A, 2009, BRIT J HAEMATOL, V145, P775, DOI 10.1111/j.1365-2141.2009.07696.x; Peters A, 2010, AM J MED, V123, pS28, DOI 10.1016/j.amjmed.2009.12.007; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2008, NEW ENGL J MED, V359, P1072, DOI 10.1056/NEJMc081511; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Sharp R, 2002, NAT MED, V8, P1276, DOI 10.1038/nm787; Van Damme J, 1999, Chem Immunol, V72, P42, DOI 10.1159/000058725; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Weigel BJ, 2003, CLIN CANCER RES, V9, P3105; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	52	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58860	10.1371/journal.pone.0058860	http://dx.doi.org/10.1371/journal.pone.0058860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554941	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500050
J	Pfaffen, S; Abdulqadir, R; Le Brun, NE; Murphy, MEP				Pfaffen, Stephanie; Abdulqadir, Raz; Le Brun, Nick E.; Murphy, Michael E. P.			Mechanism of Ferrous Iron Binding and Oxidation by Ferritin from a Pennate Diatom	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI BACTERIOFERRITIN; PYROCOCCUS-FURIOSUS; CRYSTAL-STRUCTURE; HIGH-RESOLUTION; HUMAN H; HYDROLYSIS; STORAGE; ECFTNA; CHEMISTRY; SITES	A novel ferritin was recently found in Pseudo-nitzschia multiseries (PmFTN), a marine pennate diatom that plays a major role in global primary production and carbon sequestration into the deep ocean. Crystals of recombinant PmFTN were soaked in iron and zinc solutions, and the structures were solved to 1.65-2.2-angstrom resolution. Three distinct iron binding sites were identified as determined from anomalous dispersion data from aerobically grown ferrous soaked crystals. Sites A and B comprise the conserved ferroxidase active site, and site C forms a pathway leading toward the central cavity where iron storage occurs. In contrast, crystal structures derived from anaerobically grown and ferrous soaked crystals revealed only one ferrous iron in the active site occupying site A. In the presence of dioxygen, zinc is observed bound to all three sites. Iron oxidation experiments using stopped-flow absorbance spectroscopy revealed an extremely rapid phase corresponding to Fe(II) oxidation at the ferroxidase site, which is saturated after adding 48 ferrous iron to apo-PmFTN (two ferrous iron per subunit), and a much slower phase due to iron core formation. These results suggest an ordered stepwise binding of ferrous iron and dioxygen to the ferroxidase site in preparation for catalysis and a partial mobilization of iron from the site following oxidation.	[Pfaffen, Stephanie; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Abdulqadir, Raz; Le Brun, Nick E.] Univ E Anglia, Ctr Mol & Struct Biochem, Sch Chem, Norwich NR4 7TJ, Norfolk, England	University of British Columbia; University of East Anglia	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	Michael.Murphy@ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Abdulqadir, Raz/0000-0003-4014-8213; Le Brun, Nick/0000-0001-9780-4061	Natural Sciences and Engineering Research Council of Canada discovery grant; Canadian Foundation for Innovation; Biotechnology and Biological Sciences Research Council [BB/I021884/1]; United States Department of Energy Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; BBSRC [BB/I021884/1] Funding Source: UKRI	Natural Sciences and Engineering Research Council of Canada discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada discovery grant and the Canadian Foundation for Innovation (to M. E. P. M.) and Biotechnology and Biological Sciences Research Council Grant BB/I021884/1 (to N. E. L. B.).; Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the United States Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393), and the National Center for Research Resources (Grant P41RR001209).	BAUMINGER ER, 1991, BIOCHIM BIOPHYS ACTA, V1118, P48, DOI 10.1016/0167-4838(91)90440-B; Bertini I, 2012, J AM CHEM SOC, V134, P6169, DOI 10.1021/ja210084n; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Crow A, 2009, J AM CHEM SOC, V131, P6808, DOI 10.1021/ja8093444; d'Estaintot BL, 2004, J MOL BIOL, V340, P277, DOI 10.1016/j.jmb.2004.04.036; Ebrahimi KH, 2012, NAT CHEM BIOL, V8, P941, DOI [10.1038/NCHEMBIO.1071, 10.1038/nchembio.1071]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Hwang J, 2000, SCIENCE, V287, P122, DOI 10.1126/science.287.5450.122; Johnson E, 2005, STRUCTURE, V13, P637, DOI 10.1016/j.str.2005.01.019; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Lu Y, 1996, INORG CHEM, V35, P1692, DOI 10.1021/ic9513189; Marchetti A, 2009, NATURE, V457, P467, DOI 10.1038/nature07539; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; SCHWARTZ JH, 2010, PRESERVATION, V62, P2; Stillman TJ, 2001, J MOL BIOL, V307, P587, DOI 10.1006/jmbi.2001.4475; Tatur J, 2005, FEBS LETT, V579, P4729, DOI 10.1016/j.febslet.2005.07.045; Tatur J, 2007, J BIOL INORG CHEM, V12, P615, DOI 10.1007/s00775-007-0212-3; Theil E. C., 2001, HDB METALLOPROTEINS, V2, P771; Treffry A, 1998, J BIOL INORG CHEM, V3, P682, DOI 10.1007/s007750050282; TREFFRY A, 1992, FEBS LETT, V302, P108, DOI 10.1016/0014-5793(92)80417-F; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; Treffry A, 1997, BIOCHEMISTRY-US, V36, P432, DOI 10.1021/bi961830l; Turano P, 2010, P NATL ACAD SCI USA, V107, P545, DOI 10.1073/pnas.0908082106; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Willies SC, 2009, J BIOL INORG CHEM, V14, P201, DOI 10.1007/s00775-008-0438-8; Wong SG, 2009, J BIOL CHEM, V284, P18873, DOI 10.1074/jbc.M901747200; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Yang XK, 2000, BIOCHEM J, V349, P783, DOI 10.1042/bj3490783; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f; Yasmin S, 2011, J BIOL CHEM, V286, P3473, DOI 10.1074/jbc.M110.175034	33	45	46	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14917	14925		10.1074/jbc.M113.454496	http://dx.doi.org/10.1074/jbc.M113.454496			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23548912	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000319452100022
J	Narayanan, M; Gabrieli, DJ; Leung, SA; Elguindy, MM; Glaser, CA; Saju, N; Sinha, SC; Nakamaru-Ogiso, E				Narayanan, Madhavan; Gabrieli, David J.; Leung, Steven A.; Elguindy, Mahmoud M.; Glaser, Carl A.; Saju, Nitha; Sinha, Subhash C.; Nakamaru-Ogiso, Eiko			Semiquinone and Cluster N6 Signals in His-tagged Proton-translocating NADH:Ubiquinone Oxidoreductase (Complex I) from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; IRON-SULFUR CLUSTERS; MITOCHONDRIAL RESPIRATORY-CHAIN; CONSERVED CHARGED RESIDUES; UBIQUINONE OXIDOREDUCTASE; ELECTRON-TRANSFER; PHOTOAFFINITY ANALOG; EPR CHARACTERIZATION; CRYSTAL-STRUCTURE; SUBUNIT	NADH:ubiquinone oxidoreductase (complex I) pumps protons across the membrane using downhill redox energy. The Escherichia coli complex I consists of 13 different subunits named NuoA-N coded by the nuo operon. Due to the low abundance of the protein and some difficulty with the genetic manipulation of its large similar to 15-kb operon, purification of E. coli complex I has been technically challenging. Here, we generated a new strain in which a polyhistidine sequence was inserted upstream of nuoE in the operon. This allowed us to prepare large amounts of highly pure and active complex I by efficient affinity purification. The purified complex I contained 0.94 +/- 0.1 mol of FMN, 29.0 +/- 0.37 mol of iron, and 1.99 +/- 0.07 mol of ubiquinone/1 mol of complex I. The extinction coefficient of isolated complex I was 495 mM(-1)cm(-1) at 274 nm and 50.3 mM(-1)cm(-1) at 410 nm. NADH: ferricyanide activity was 219 +/- 9.7 mu mol/min/mg by using HEPES-Bis-Tris propane, pH 7.5. Detailed EPR analyses revealed two additional iron-sulfur cluster signals, N6a and N6b, in addition to previously assigned signals. Furthermore, we found small but significant semiquinone signal(s), which have been reported only for bovine complex I. The line width was similar to 12 G, indicating its neutral semiquinone form. More than 90% of the semiquinone signal originated from the single entity with P-1/2 (half-saturation power level) = 1.85 milliwatts. The semiquinone signal(s) decreased by 60% when with asimicin, a potent complex I inhibitor. The functional role of semiquinone and the EPR assignment of clusters N6a/N6b are discussed.	[Narayanan, Madhavan; Gabrieli, David J.; Leung, Steven A.; Elguindy, Mahmoud M.; Glaser, Carl A.; Saju, Nitha; Nakamaru-Ogiso, Eiko] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA; [Sinha, Subhash C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Pennsylvania; Scripps Research Institute	Nakamaru-Ogiso, E (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, 422 Curie Blvd, Philadelphia, PA 19104 USA.	eikoo@mail.med.upenn.edu		Elguindy, Mahmoud/0000-0001-9151-1751	National Institutes of Health Grant [RO1GM097409]; American Heart Association Grant [11SDG5560001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097409] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Grant(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM097409 (to E. N.-O.). This work was also supported by American Heart Association Grant 11SDG5560001 (to E. N.-O.).	Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bowyer J. R., 1985, COENZYME Q, P409; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Braun M, 1998, BIOCHEMISTRY-US, V37, P1861, DOI 10.1021/bi971176p; Bridges HR, 2012, BIOCHEMISTRY-US, V51, P149, DOI 10.1021/bi201644x; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; CARTER P, 1971, ANAL BIOCHEM, V40, P450, DOI 10.1016/0003-2697(71)90405-2; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; CRANE F. L., 1971, Methods in Enzymology, V18C, P137, DOI 10.1016/S0076-6879(71)18022-6; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Esterhazy D, 2008, BIOCHEMISTRY-US, V47, P3964, DOI 10.1021/bi702243b; Han HN, 2004, CHEM-EUR J, V10, P2149, DOI 10.1002/chem.200305557; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; Murai M, 2007, BIOCHEMISTRY-US, V46, P6409, DOI 10.1021/bi7003697; Mustafa G, 2008, J BIOL CHEM, V283, P28169, DOI 10.1074/jbc.M804938200; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Nakamaru-Ogiso E, 2002, J BIOL CHEM, V277, P1680, DOI 10.1074/jbc.M108796200; Nakamaru-Ogiso E., 2012, STRUCTURAL PERSPECTI, P61; Nakamaru-Ogiso E, 2008, J BIOL CHEM, V283, P25979, DOI 10.1074/jbc.M804015200; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1901, DOI 10.1016/j.bbabio.2010.05.012; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1891, DOI 10.1016/j.bbabio.2010.06.010; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2005, FEBS LETT, V579, P500, DOI 10.1016/j.febslet.2004.11.107; OHNISHI T, 1975, BIOCHIM BIOPHYS ACTA, V387, P475, DOI 10.1016/0005-2728(75)90087-0; Ohnishi T, 1998, BBA-BIOENERGETICS, V1365, P301, DOI 10.1016/S0005-2728(98)00082-6; Ohnishi T, 2008, BBA-BIOENERGETICS, V1777, P703, DOI 10.1016/j.bbabio.2008.04.032; Pohl T, 2007, BIOCHEMISTRY-US, V46, P10694, DOI 10.1021/bi701057t; Pohl T, 2007, BIOCHEMISTRY-US, V46, P6588, DOI 10.1021/bi700371c; Rapisarda VA, 2002, ARCH BIOCHEM BIOPHYS, V405, P87, DOI 10.1016/S0003-9861(02)00277-1; RUPP H, 1978, BIOCHIM BIOPHYS ACTA, V537, P255, DOI 10.1016/0005-2795(78)90509-3; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shinzawa-Itoh K, 2010, BIOCHEMISTRY-US, V49, P487, DOI 10.1021/bi9016318; Shiraishi Y, 2012, BIOCHEMISTRY-US, V51, P1953, DOI 10.1021/bi300047h; Sinha PK, 2012, J BIOL CHEM, V287, P17363, DOI 10.1074/jbc.M111.329649; SLED VD, 1994, BIOCHEMISTRY-US, V33, P10069, DOI 10.1021/bi00199a034; Tocilescu MA, 2010, BBA-BIOENERGETICS, V1797, P1883, DOI 10.1016/j.bbabio.2010.05.009; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Treberg JR, 2011, J BIOL CHEM, V286, P17579, DOI 10.1074/jbc.M111.227751; Uhlmann M, 2005, BIOCHEMISTRY-US, V44, P1653, DOI 10.1021/bi048136n; Velazquez I, 2005, FEBS LETT, V579, P3164, DOI 10.1016/j.febslet.2005.05.005; Verkhovsky M, 2012, BBA-BIOENERGETICS, V1817, P1550, DOI 10.1016/j.bbabio.2012.04.013; VINOGRADOV AD, 1995, FEBS LETT, V370, P83, DOI 10.1016/0014-5793(95)00803-H; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; YAGI T, 1988, J BIOL CHEM, V263, P16150; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104; Yano T, 1999, J BIOL CHEM, V274, P28598, DOI 10.1074/jbc.274.40.28598; Yano T, 2005, BIOCHEMISTRY-US, V44, P1744, DOI 10.1021/bi048132i; Yip CY, 2011, J BIOL CHEM, V286, P5023, DOI 10.1074/jbc.M110.194993; Zickermann V, 2000, BBA-BIOENERGETICS, V1459, P61, DOI 10.1016/S0005-2728(00)00113-4	67	11	11	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14310	14319		10.1074/jbc.M113.467803	http://dx.doi.org/10.1074/jbc.M113.467803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543743	hybrid, Green Published			2022-12-25	WOS:000319253500035
J	Debarnot, U; Piolino, P; Baron, JC; Guillot, A				Debarnot, Ursula; Piolino, Pascale; Baron, Jean-Claude; Guillot, Aymeric			Mental Rotation: Effects of Gender, Training and Sleep Consolidation	PLOS ONE			English	Article							MOTOR MEMORY CONSOLIDATION; SEX-DIFFERENCES; SPATIAL ABILITIES; DAYTIME NAPS; REM-SLEEP; PERFORMANCE; SKILL; IMAGERY; IMPROVEMENT; ACTIVATION	A wide range of experimental studies have provided evidence that a night of sleep contributes to memory consolidation. Mental rotation (MR) skill is characterized by fundamental aspect of both cognitive and motor abilities which can be improved within practice sessions, but little is known about the effect of consolidation after MR practice. In the present study, we investigated the effect of MR training and the following corresponding day- and sleep-related time consolidations in taking into account the well-established gender difference in MR. Forty participants (20 women) practiced a computerized version of the Vandenberg and Kuse MR task. Performance was evaluated before MR training, as well as prior to, and after a night of sleep or a similar daytime interval. Data showed that while men outperformed women during the pre-training test, brief MR practice was sufficient for women to achieve equivalent performance. Only participants subjected to a night of sleep were found to enhance MR performance during the retest, independently of gender. These results provide first evidence that a night of sleep facilitates MR performance compared with spending a similar daytime interval regardless gender of the participants. Since MR is known to involve motor processes, the present data might contribute to schedule relevant mental practice interventions for fruitful applications in rehabilitation and motor learning processes.	[Debarnot, Ursula; Piolino, Pascale; Baron, Jean-Claude] Univ Paris 05, Ctr Psychiat & Neurosci, INSERM, UMR S894, Paris, France; [Debarnot, Ursula; Piolino, Pascale] Inst Psychol, Lab Memoire & Cognit, Boulogne Billancourt, France; [Debarnot, Ursula; Guillot, Aymeric] Univ Lyon 1, Ctr Rech & Innovat Sport, EA 647, F-69622 Villeurbanne, France; [Debarnot, Ursula] Inst Psychol, Lab Neuropsychol & Vieillissement, Boulogne, France; [Piolino, Pascale; Guillot, Aymeric] Inst Univ France, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France	Debarnot, U (corresponding author), Univ Paris 05, Ctr Psychiat & Neurosci, INSERM, UMR S894, Paris, France.	Ursula.debarnot@gmail.com	Piolino, pascale/F-8075-2014	Piolino, pascale/0000-0002-7787-924X; baron, jean-claude/0000-0002-5264-2588				Agniel A, 1987, PROTOCOLE EVALUATION; Amorim MA, 2006, J EXP PSYCHOL GEN, V135, P327, DOI 10.1037/0096-3445.135.3.327; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Brown RM, 2007, J NEUROSCI, V27, P10468, DOI 10.1523/JNEUROSCI.2799-07.2007; Buhry L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/203462; Butler T, 2006, NEUROIMAGE, V32, P445, DOI 10.1016/j.neuroimage.2006.03.030; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Clements-Stephens AM, 2009, NEUROSCI LETT, V449, P155, DOI 10.1016/j.neulet.2008.10.094; Colom R, 2007, COGN NEUROPSYCHOL, V24, P867, DOI 10.1080/02643290701781557; CORBALLIS MC, 1982, J EXP PSYCHOL HUMAN, V8, P215, DOI 10.1037/0096-1523.8.2.215; Curtze C, 2010, EXP BRAIN RES, V201, P527, DOI 10.1007/s00221-009-2067-z; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; Debarnot U, ARCH ITALIE IN PRESS; Debarnot U, 2011, COGN AFFECT BEHAV NE, V11, P541, DOI 10.3758/s13415-011-0052-z; Debarnot U, 2010, BRAIN COGNITION, V74, P52, DOI 10.1016/j.bandc.2010.06.004; Debarnot U, 2009, SLEEP, V32, P1559, DOI 10.1093/sleep/32.12.1559; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Eisenegger C, 2007, EUR J NEUROSCI, V25, P1240, DOI 10.1111/j.1460-9568.2007.05354.x; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Fiorio M, 2007, NEUROPSYCHOLOGIA, V45, P2346, DOI 10.1016/j.neuropsychologia.2007.02.005; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gaab N, 2004, NEUROREPORT, V15, P731, DOI 10.1097/00001756-200403220-00032; Genzel L, 2012, PSYCHONEUROENDOCRINO, V37, P987, DOI 10.1016/j.psyneuen.2011.11.006; Guillot A, 2007, ADV HEALTH SCI EDUC, V12, P491, DOI 10.1007/s10459-006-9021-7; Harris IM, 2002, NEUROPSYCHOLOGY, V16, P524, DOI 10.1037//0894-4105.16.4.524; Heil M, 2008, Q J EXP PSYCHOL, V61, P683, DOI 10.1080/17470210701822967; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Hoppe C, 2012, BRAIN COGNITION, V78, P14, DOI 10.1016/j.bandc.2011.10.008; Hoyek N, 2009, TEACH LEARN MED, V21, P201, DOI 10.1080/10401330903014178; Jausovec N, 2012, INTELLIGENCE, V40, P151, DOI 10.1016/j.intell.2012.01.005; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Jordan K, 2010, J INDIVID DIFFER, V31, P83, DOI 10.1027/1614-0001/a000015; KARNI A, 1995, LANCET, V345, P395, DOI 10.1016/S0140-6736(95)90386-0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Kass SJ, 1998, HUM PERFORM, V11, P337, DOI 10.1207/s15327043hup1104_3; Koscik T, 2009, BRAIN COGNITION, V69, P451, DOI 10.1016/j.bandc.2008.09.004; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Kuriyama K, 2008, J NEUROSCI, V28, P10145, DOI 10.1523/JNEUROSCI.2039-08.2008; Linn MC, 1986, PSYCHOL GENDER ADV M, P67; Lizarraga MLSD, 2003, SEX ROLES, V49, P277; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2004, Bull Mem Acad R Med Belg, V159, P167; Marusan M., 2006, P 3 CENTR EUR MULT V, P77; Neubauer AC, 2010, INTELLIGENCE, V38, P529, DOI 10.1016/j.intell.2010.06.001; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parsons TD, 2004, NEUROPSYCHOLOGIA, V42, P555, DOI 10.1016/j.neuropsychologia.2003.08.014; PETERS M, 1995, BRAIN COGNITION, V28, P39, DOI 10.1006/brcg.1995.1032; Peters M, 2008, BRAIN COGNITION, V66, P260, DOI 10.1016/j.bandc.2007.09.003; Peters M, 2007, ARCH SEX BEHAV, V36, P251, DOI 10.1007/s10508-006-9166-8; Peters Michael, 2005, Brain Cogn, V57, P176, DOI 10.1016/j.bandc.2004.08.052; Podzebenko K, 2005, J COGNITIVE NEUROSCI, V17, P24, DOI 10.1162/0898929052879996; Prime DJ, 2010, J COGNITIVE NEUROSCI, V22, P2437, DOI 10.1162/jocn.2009.21337; Robertson EM, 2012, CURR BIOL, V22, pR66, DOI 10.1016/j.cub.2011.11.051; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Rose F.D., 1998, VIRTUAL ENV CLIN PSY; Semrud-Clikeman M, 2012, INT J NEUROSCI; Semrud-Clikeman M, 2012, INT J NEUROSCI, V122, P590, DOI 10.3109/00207454.2012.693999; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shepard RN., 1982, J HIST BEHAV SCI, V19, P301, DOI 10.2307/1422825; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Stransky D, 2010, J EXP PSYCHOL-APPL, V16, P349, DOI 10.1037/a0021702; Tomasino B, 2004, J COGNITIVE NEUROSCI, V16, P878, DOI 10.1162/089892904970753; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Walker MP, 2010, NAT REV NEUROSCI, V11, DOI 10.1038/nrn2762-c1; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wang B, 2009, J ZHEJIANG UNIV-SC B, V10, P536, DOI 10.1631/jzus.B0820384; Warrington EK., 1991, VISUAL OBJECT SPACE; Wexler M, 1998, COGNITION, V68, P77, DOI 10.1016/S0010-0277(98)00032-8; Willingham DB, 1999, PSYCHOL SCI, V10, P531, DOI 10.1111/1467-9280.00201; Yu QB, 2009, NEUROREPORT, V20, P43, DOI 10.1097/WNR.0b013e32831c50f4; Zacks J, 1999, NEUROPSYCHOLOGIA, V37, P1029, DOI 10.1016/S0028-3932(99)00012-3; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013	82	19	19	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60296	10.1371/journal.pone.0060296	http://dx.doi.org/10.1371/journal.pone.0060296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544134	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700093
J	Lei, RL; Chen, HS; Huang, BY; Chen, YC; Chen, PKT; Lee, HY; Chang, CW; Wu, CL				Lei, Ruoh-Lih; Chen, Huey-Shys; Huang, Bao-Yuan; Chen, Yueh-Chih; Chen, Philip Kuo-Ting; Lee, Huei-Ying; Chang, Chi-Wen; Wu, Chih-Lung			Population-Based Study of Birth Prevalence and Factors Associated with Cleft Lip and/or Palate in Taiwan 2002-2009	PLOS ONE			English	Article							PSYCHOSOCIAL ADJUSTMENT; CHILDREN	Background: Facial cleft deformities, including cleft lip with or without cleft palate (CL/P) and cleft palate (CP), are common congenital birth anomalies, especially in Asia. This study aimed to analyze the prevalence of CL/P and CP and to identify associated factors in Taiwan. Methods: This population-based epidemiological study retrospectively analyzed birth data obtained from the Department of Health in Taiwan for years 2002-2009. Frequency distribution, percentages and related predictors were investigated, and findings were presented by types of cleft deformities. Logistic regression analysis was performed to identify factors associated with cleft deformities. Results: Overall prevalence of cleft deformities among 1,705,192 births was 0.1% for CL/P and 0.04% for CP over the 8-year study period. Higher prevalence of CL/P or CP was observed with multiple pregnancies, being male for CL/P, being female for CP, gestational age <= 37 weeks and lower birth weight (<1.5 kg). Both CL/P and CP were significantly associated with gestational age < 37 weeks and birth weight < 1.5 kg (all P < 0.0001). CL/P was significantly associated with multiple parities (P = 0.0004-0.002). Male newborns and female newborns were significantly associated with CL/P and CP, respectively (both P < 0.0001). Conclusions: Overall prevalence for congenital cleft deformities in study subjects was 0.1%, in keeping with high rates in Asia. Results suggest the need for awareness and early identification of those at high risk for cleft deformities, including newborns with gestational age < 37 weeks, weighing < 1.5 kg at birth and women with multiple parities, as a potential strategy to counter long-term adverse effects on speech and language in this population.	[Lei, Ruoh-Lih; Chen, Yueh-Chih; Lee, Huei-Ying] HungKuang Univ, Coll Med & Nursing, Dept Nursing, Taichung, Taiwan; [Chen, Huey-Shys] Univ Toledo, Coll Nursing, Nursing Practice Program, Dept Hlth Promot Outcomes Syst & Policy, Toledo, OH 43606 USA; [Huang, Bao-Yuan] Cent Taiwan Univ Sci & Technol, Dept Childhood Educ & Enterprise Management, Taichung, Taiwan; [Chen, Philip Kuo-Ting] Chang Gung Univ, Chang Gung Mem Hosp, Craniofacial Ctr, Tao Yuan, Taiwan; [Lee, Huei-Ying] Kaohsiung Med Univ, Coll Nursing, Dept Nursing, Kaohsiung, Taiwan; [Chang, Chi-Wen] Chang Gung Univ, Coll Med, Dept Nursing, Tao Yuan, Taiwan; [Wu, Chih-Lung] Chung Shan Med Univ, Sch Med, Chung Shan Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan	Hungkuang University; University System of Ohio; University of Toledo; Central Taiwan University Science & Technology; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lei, RL (corresponding author), HungKuang Univ, Coll Med & Nursing, Dept Nursing, Taichung, Taiwan.	lilylei@sunrise.hk.edu.tw	Lei, Ruoh Lih/AAJ-4179-2020		HungKuang - Mednur Research [HK-MNRC-99-8]	HungKuang - Mednur Research	This study was supported by grants HungKuang - Mednur Research (HK-MNRC-99-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Omari F, 2004, CLEFT PALATE-CRAN J, V41, P609, DOI 10.1597/03-034.1; Aqrabawi H E, 2008, East Mediterr Health J, V14, P356; Basseri B, 2011, PLAST RECONSTR SURG, V127, P1255, DOI 10.1097/PRS.0b013e3182043af6; DAS SK, 1995, SOUTHERN MED J, V88, P437, DOI 10.1097/00007611-199504000-00011; Department of Health Executive Yuan, LIST REL INF IT; Gregg TA, 2008, CLEFT PALATE-CRAN J, V45, P141, DOI 10.1597/06-045.1; Hunt O, 2005, EUR J ORTHODONT, V27, P274, DOI 10.1093/ejo/cji004; Hutchinson K, 2011, CLEFT PALATE-CRAN J, V48, P497, DOI 10.1597/09-046; Jagomagi Triin, 2010, Stomatologija, V12, P105; Kim S, 2002, J KOREAN MED SCI, V17, P49, DOI 10.3346/jkms.2002.17.1.49; Liou JD, 2011, INT J GYNECOL OBSTET, V113, P211, DOI 10.1016/j.ijgo.2010.12.016; Mastroiacovo P, 2011, CLEFT PALATE-CRAN J, V48, P66, DOI 10.1597/09-217; Merritt Linda, 2005, Adv Neonatal Care, V5, P64, DOI 10.1016/j.adnc.2004.12.006; Messer LC, 2010, ANN EPIDEMIOL, V20, P32, DOI 10.1016/j.annepidem.2009.09.006; Mossey P A, 2011, Adv Dent Res, V23, P247, DOI 10.1177/0022034511402083; Patil SB, 2011, PLAST RECONSTR SURG, V127, P327, DOI 10.1097/PRS.0b013e3181f95b9c; Pope AW, 2005, CLEFT PALATE-CRAN J, V42, P556, DOI 10.1597/04-066R.1; Pope AW, 2005, CLEFT PALATE-CRAN J, V42, P349, DOI 10.1597/04-043R.1; Rozendaal AM, 2011, ARCH DIS CHILD-FETAL, V96, pF212, DOI 10.1136/adc.2010.193599; TYAN ML, 1982, P SOC EXP BIOL MED, V171, P41, DOI 10.3181/00379727-171-41474; Wang W, 2009, PAEDIATR PERINAT EP, V23, P310, DOI 10.1111/j.1365-3016.2009.01025.x; Wang ZR, 2000, TRACING PROGRAM REGI; WHO, 2008, WHO REP	23	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58690	10.1371/journal.pone.0058690	http://dx.doi.org/10.1371/journal.pone.0058690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555592	Green Submitted, gold, Green Published			2022-12-25	WOS:000317418500014
J	Sotnikov, I; Veremeyko, T; Starossom, SC; Barteneva, N; Weiner, HL; Ponomarev, ED				Sotnikov, Ilya; Veremeyko, Tatyana; Starossom, Sarah C.; Barteneva, Natalia; Weiner, Howard L.; Ponomarev, Eugene D.			Platelets Recognize Brain-Specific Glycolipid Structures, Respond to Neurovascular Damage and Promote Neuroinflammation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MICROVASCULAR ENDOTHELIAL-CELLS; SIALIC-ACID; MULTIPLE-SCLEROSIS; ALZHEIMER-DISEASE; PERTUSSIS TOXIN; ISCHEMIC-STROKE; SPINAL-CORD; GANGLIOSIDES; BLOOD	Platelets respond to vascular damage and contribute to inflammation, but their role in the neurodegenerative diseases is unknown. We found that the systemic administration of brain lipid rafts induced a massive platelet activation and degranulation resulting in a life-threatening anaphylactic-like response in mice. Platelets were engaged by the sialated glycosphingolipids (gangliosides) integrated in the rigid structures of astroglial and neuronal lipid rafts. The brain-abundant gangliosides GT1b and GQ1b were specifically recognized by the platelets and this recognition involved multiple receptors with P-selectin (CD62P) playing the central role. During the neuroinflammation, platelets accumulated in the central nervous system parenchyma, acquired an activated phenotype and secreted proinflammatory factors, thereby triggering immune response cascades. This study determines a new role of platelets which directly recognize a neuronal damage and communicate with the cells of the immune system in the pathogenesis of neurodegenerative diseases.	[Sotnikov, Ilya; Veremeyko, Tatyana; Starossom, Sarah C.; Weiner, Howard L.; Ponomarev, Eugene D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Sotnikov, Ilya] Emory Univ, Sch Med, Div Neonatal Perinatal Med, Atlanta, GA USA; [Barteneva, Natalia] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA USA; [Ponomarev, Eugene D.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Emory University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Chinese University of Hong Kong	Weiner, HL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu; eponomarev@cuhk.edu.hk	Barteneva, Natalie/V-3826-2019; Barteneva, Natasha/B-9094-2017; Ponomarev, Eugene D./K-1546-2013	Barteneva, Natalie/0000-0002-8109-1754; Ponomarev, Eugene D./0000-0002-0871-8522; Sotnikov, ILya/0000-0001-9968-2803; Starossom, Sarah/0000-0001-7935-9910	 [R01 NS071039-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071039] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported in part by R01 NS071039-01A1 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y; Armstrong RC, 1998, METHODS, V16, P282, DOI 10.1006/meth.1998.0685; BAKRY N, 1991, J PHARMACOL EXP THER, V258, P830; Banerjee S, 2007, ANNU REV NEUROSCI, V30, P235, DOI 10.1146/annurev.neuro.30.051606.094345; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; CANANZI AR, 1987, ACTA NEUROL SCAND, V76, P79, DOI 10.1111/j.1600-0404.1987.tb03550.x; CHEN M, 1995, BIOCHEM BIOPH RES CO, V213, P96, DOI 10.1006/bbrc.1995.2103; CHRONOS NAF, 1993, CIRCULATION, V88, P2035, DOI 10.1161/01.CIR.88.5.2035; Ciabattoni G, 2007, NEUROBIOL AGING, V28, P336, DOI 10.1016/j.neurobiolaging.2005.12.011; CSERR HF, 1984, AM J PHYSIOL, V246, pR277, DOI 10.1152/ajpregu.1984.246.3.R277; DeBruin LS, 2007, NEUROCHEM RES, V32, P213, DOI 10.1007/s11064-006-9137-4; DIBIASE A, 1990, NEUROCHEM RES, V15, P519, DOI 10.1007/BF00966210; Erpenbeck L, 2010, BLOOD, V115, P3427, DOI 10.1182/blood-2009-10-247296; Feng D, 1998, INT ARCH ALLERGY IMM, V116, P188, DOI 10.1159/000023944; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Franks ZG, 2010, ANN NY ACAD SCI, V1207, P11, DOI 10.1111/j.1749-6632.2010.05733.x; Freire E, 2004, J CELL SCI, V117, P4067, DOI 10.1242/jcs.01276; Gaglia MA, 2010, AM HEART J, V160, P595, DOI 10.1016/j.ahj.2010.06.007; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Ge SJ, 2006, J NEUROIMMUNOL, V177, P209, DOI 10.1016/j.jneuroim.2006.05.012; GORE PJ, 1986, BIOCHIM BIOPHYS ACTA, V876, P36, DOI 10.1016/0005-2760(86)90315-2; Gresele P, 1998, J CLIN INVEST, V101, P667, DOI 10.1172/JCI575; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Horstman LL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-10; Jabbar AA, 2006, PEDIATR BLOOD CANCER, V46, P292, DOI 10.1002/pbc.20326; Jain S, 2010, ARTERIOSCL THROM VAS, V30, P2362, DOI 10.1161/ATVBAHA.110.207514; Jirouskova M, 2007, J THROMB HAEMOST, V5, P661, DOI 10.1111/j.1538-7836.2007.02407.x; Jung JE, 2010, MOL NEUROBIOL, V41, P172, DOI 10.1007/s12035-010-8102-z; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; KIJIMASUDA I, 1988, CANCER RES, V48, P3728; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; KIM SU, 1986, J NEUROSCI RES, V15, P303, DOI 10.1002/jnr.490150303; Kowalska MA, 2010, THROMB RES, V125, P292, DOI 10.1016/j.thromres.2009.11.023; Langer HF, 2012, CIRC RES, V110, P1202, DOI 10.1161/CIRCRESAHA.111.256370; LEDEEN RW, 1978, J SUPRAMOL STR CELL, V8, P1, DOI 10.1002/jss.400080102; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Lian TS, 1997, PHARMACEUT RES, V14, P1309, DOI 10.1023/A:1012195932724; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Lu CM, 2008, J NEUROSCI RES, V86, P2624, DOI 10.1002/jnr.21716; Mandic R, 2002, THROMB RES, V106, P137, DOI 10.1016/S0049-3848(02)00087-7; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; MAZUROV AV, 1988, BIOCHIM BIOPHYS ACTA, V968, P167, DOI 10.1016/0167-4889(88)90004-3; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; McNicol Archibald, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P99, DOI 10.2174/187152908784533739; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; MUNOZ JJ, 1987, INFECT IMMUN, V55, P1004, DOI 10.1128/IAI.55.4.1004-1008.1987; Nutikka A, 2003, GLYCOCONJUGATE J, V20, P33, DOI 10.1023/B:GLYC.0000016740.69726.fb; Ohba M, 2004, ORAL MICROBIOL IMMUN, V19, P26, DOI 10.1046/j.0902-0055.2002.00107.x; Persaud-Sawin DA, 2009, J LIPID RES, V50, P759, DOI 10.1194/jlr.D800037-JLR200; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Prinetti A, 2009, BBA-BIOMEMBRANES, V1788, P184, DOI 10.1016/j.bbamem.2008.09.001; Proia RL, 2004, NAT GENET, V36, P1147, DOI 10.1038/ng1104-1147; Qi F, 2008, TRANSPLANTATION, V86, P1267, DOI 10.1097/TP.0b013e318188d433; Racke MK, 2005, TRENDS IMMUNOL, V26, P289, DOI 10.1016/j.it.2005.03.012; Rapoport E, 2003, BIOORG MED CHEM LETT, V13, P675, DOI 10.1016/S0960-894X(02)00998-8; Saito M, 2000, ARCH BIOCHEM BIOPHYS, V376, P371, DOI 10.1006/abbi.2000.1729; Sato C, 2002, J BIOL CHEM, V277, P45299, DOI 10.1074/jbc.M206046200; Seidel G, 2011, INT J MED MICROBIOL, V301, P204, DOI 10.1016/j.ijmm.2010.08.018; Semple JW, 2010, CELL MOL LIFE SCI, V67, P499, DOI 10.1007/s00018-009-0205-1; Sevush S, 1998, ARCH NEUROL-CHICAGO, V55, P530, DOI 10.1001/archneur.55.4.530; Sheremata WA, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-27; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; STENBERG PE, 1991, J CELL PHYSIOL, V147, P7, DOI 10.1002/jcp.1041470103; Stoll G, 2008, BLOOD, V112, P3555, DOI 10.1182/blood-2008-04-144758; SUZUMURA A, 1984, BRAIN RES, V324, P379, DOI 10.1016/0006-8993(84)90054-4; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Tonra JR, 2001, J COMP NEUROL, V430, P131; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; VOMEL T, 1985, ARCH GERONTOL GERIAT, V4, P125, DOI 10.1016/0167-4943(85)90026-3; Walkowiak B, 2000, THROMB RES, V99, P495, DOI 10.1016/S0049-3848(00)00282-6; Wen FQ, 1999, ARTERIOSCL THROM VAS, V19, P519, DOI 10.1161/01.ATV.19.3.519; Weyrich AS, 2003, J THROMB HAEMOST, V1, P1897, DOI 10.1046/j.1538-7836.2003.00304.x; Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113; WRIGHT HP, 1965, LANCET, V2, P1109; Yanagisawa K, 2007, BBA-BIOMEMBRANES, V1768, P1943, DOI 10.1016/j.bbamem.2007.01.018; Yoshida A, 2002, BRIT J PHARMACOL, V137, P146, DOI 10.1038/sj.bjp.0704852; Zibitsker DE, 1961, J SCI ARTICLES BYELO, P143; Zucker-Franklin D, 2000, AM J PATHOL, V157, P69, DOI 10.1016/S0002-9440(10)64518-X	86	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58979	10.1371/journal.pone.0058979	http://dx.doi.org/10.1371/journal.pone.0058979			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555611	Green Submitted, Green Published, gold			2022-12-25	WOS:000317418500019
J	Kelly, S; Maini, PK				Kelly, Steven; Maini, Philip K.			DendroBLAST: Approximate Phylogenetic Trees in the Absence of Multiple Sequence Alignments	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; BAYESIAN-INFERENCE; PROTEIN SEQUENCES; DATABASE; GAPS; ALGORITHMS; SUPERTREES; ACCURACY; FAMILIES	The rapidly growing availability of genome information has created considerable demand for both fast and accurate phylogenetic inference algorithms. We present a novel method called DendroBLAST for reconstructing phylogenetic dendrograms/trees from protein sequences using BLAST. This method differs from other methods by incorporating a simple model of sequence evolution to test the effect of introducing sequence changes on the reliability of the bipartitions in the inferred tree. Using realistic simulated sequence data we demonstrate that this method produces phylogenetic trees that are more accurate than other commonly-used distance based methods though not as accurate as maximum likelihood methods from good quality multiple sequence alignments. In addition to tests on simulated data, we use DendroBLAST to generate input trees for a supertree reconstruction of the phylogeny of the Archaea. This independent analysis produces an approximate phylogeny of the Archaea that has both high precision and recall when compared to previously published analysis of the same dataset using conventional methods. Taken together these results demonstrate that approximate phylogenetic trees can be produced in the absence of multiple sequence alignments, and we propose that these trees will provide a platform for improving and informing downstream bioinformatic analysis. A web implementation of the DendroBLAST method is freely available for use at http://www.dendroblast.com/.	[Kelly, Steven] Univ Oxford, Dept Plant Sci, Oxford, England; [Kelly, Steven; Maini, Philip K.] Univ Oxford, Math Inst, Ctr Math Biol, Oxford, England; [Kelly, Steven; Maini, Philip K.] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Oxford; University of Oxford; University of Oxford	Kelly, S (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	steven.kelly@plants.ox.ac.uk	Kelly, Steven/F-7237-2011	Kelly, Steven/0000-0001-8583-5362	Biotechnology and Biological Sciences Research Council [BB/D020190/1]; BBSRC [BB/D020190/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council through BB/D020190/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cantarel BL, 2006, MOL BIOL EVOL, V23, P2090, DOI 10.1093/molbev/msl080; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Dessimoz C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r37; Dwivedi B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-211; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, NUCLEIC ACIDS RES, V38, P2145, DOI 10.1093/nar/gkp1196; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Golubchik T, 2007, MOL BIOL EVOL, V24, P2433, DOI 10.1093/molbev/msm176; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagopian R, 2010, NUCLEIC ACIDS RES, V38, pW29, DOI 10.1093/nar/gkq298; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Holland B, 2007, SYST BIOL, V56, P57, DOI 10.1080/10635150601167013; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jordan G, 2012, MOL BIOL EVOL, V29, P1125, DOI 10.1093/molbev/msr272; Jothi R, 2006, BIOINFORMATICS, V22, P779, DOI 10.1093/bioinformatics/btl009; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Kelil A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-286; Kelly S, 2010, PHILOS T R SOC LON B; Kriventseva EV, 2003, NUCLEIC ACIDS RES, V31, P388, DOI 10.1093/nar/gkg035; Lake JA, 2008, SYST BIOL, V57, P835, DOI 10.1080/10635150802555933; Liu K, 2009, SCIENCE, V324, P1561, DOI 10.1126/science.1171243; Liu XM, 2011, J THEOR BIOL, V284, P106, DOI 10.1016/j.jtbi.2011.06.020; Loewenstein Y, 2008, BIOINFORMATICS, V24, pI41, DOI 10.1093/bioinformatics/btn174; Novak A, 2008, BIOINFORMATICS, V24, P2403, DOI 10.1093/bioinformatics/btn457; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Piaggio-Talice R., 2004, COMPU BIOL, P173; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Reinert G, 2009, J COMPUT BIOL, V16, P1615, DOI 10.1089/cmb.2009.0198; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Walter R., 1976, PRINCIPLES MATH ANAL; Yona G, 2000, NUCLEIC ACIDS RES, V28, P49, DOI 10.1093/nar/28.1.49	41	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58537	10.1371/journal.pone.0058537	http://dx.doi.org/10.1371/journal.pone.0058537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554899	Green Submitted, Green Published, gold			2022-12-25	WOS:000316409800018
J	Qin, YF; Chen, MJ; Wu, W; Xu, B; Tang, R; Chen, XJ; Du, GZ; Lu, CC; Meeker, JD; Zhou, ZM; Xia, YK; Wang, XR				Qin, Yufeng; Chen, Minjian; Wu, Wei; Xu, Bin; Tang, Rong; Chen, Xiaojiao; Du, Guizhen; Lu, Chuncheng; Meeker, John D.; Zhou, Zuomin; Xia, Yankai; Wang, Xinru			Interactions between Urinary 4-tert-Octylphenol Levels and Metabolism Enzyme Gene Variants on Idiopathic Male Infertility	PLOS ONE			English	Article							BISPHENOL-A; DRINKING-WATER; IN-VITRO; POLYMORPHISMS; EXPOSURE; 4-N-OCTYLPHENOL; SUSCEPTIBILITY; CHLOROPHENOL; ASSOCIATION; OCTYLPHENOL	Octylphenol (OP) and Trichlorophenol (TCP) act as endocrine disruptors and have effects on male reproductive function. We studied the interactions between 4-tert-Octylphenol (4-t-OP), 4-n-Octylphenol (4-n-OP), 2,3,4-Trichlorophenol (2,3,4-TCP), 2,4,5-Trichlorophenol (2,4,5-TCP) urinary exposure levels and polymorphisms in selected xenobiotic metabolism enzyme genes among 589 idiopathic male infertile patients and 396 controls in a Han-Chinese population. Ultra high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was used to measure alkylphenols and chlorophenols in urine. Polymorphisms were genotyped using the SNPstream platform and the Taqman method. Among four phenols that were detected, we found that only exposure to 4-t-OP increased the risk of male infertility (P-trend = 1.70 x 10(-7)). The strongest interaction was between 4-t-OP and rs4918758 in CYP2C9 (P-inter = 6.05 x 10(-7)). It presented a significant monotonic increase in risk estimates for male infertility with increasing 4-t-OP exposure levels among men with TC/CC genotype (low level compared with non-exposed, odds ratio (OR) = 2.26, 95% confidence intervals (CI) = 1.06, 4.83; high level compared with non-exposed, OR = 9.22, 95% CI = 2.78, 30.59), but no associations observed among men with TT genotype. We also found interactions between 4-t-OP and rs4986894 in CYP2C19, and between rs1048943 in CYP1A1, on male infertile risk (P-inter = 8.09 x 10(-7), P-inter = 3.73 x 10(-4), respectively). We observed notable interactions between 4-t-OP exposure and metabolism enzyme gene polymorphisms on idiopathic infertility in Han-Chinese men.	[Qin, Yufeng; Chen, Minjian; Wu, Wei; Xu, Bin; Tang, Rong; Chen, Xiaojiao; Du, Guizhen; Lu, Chuncheng; Zhou, Zuomin; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Qin, Yufeng; Chen, Minjian; Wu, Wei; Xu, Bin; Tang, Rong; Chen, Xiaojiao; Du, Guizhen; Lu, Chuncheng; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Meeker, John D.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA	Nanjing Medical University; Nanjing Medical University; University of Michigan System; University of Michigan	Xia, YK (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	yankaixia@njmu.edu.cn; xrwang@njmu.edu.cn	Wang, Xin/AAN-8435-2021; Wu, Wei/C-4409-2012	Wang, Xin/0000-0002-4457-7376; Wu, Wei/0000-0002-0267-1284; Meeker, John/0000-0001-8357-5085; qin, yufeng/0000-0002-3947-7610	National Basic Research Program of China (973 Program) [2012CBA01306, 2009CB941703]; National Natural Science Foundation of China [81072328]; Key Project of National Natural Science Foundation [30930079]; Key Project of MOE [211063]; Program for Postgraduates Research Innovation in University of Jiangsu Province [CXZZ12-0600]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Project of MOE; Program for Postgraduates Research Innovation in University of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported in part by National Basic Research Program of China (973 Program, 2012CBA01306, 2009CB941703); National Natural Science Foundation of China (81072328); The Key Project of National Natural Science Foundation (30930079); The Key Project of MOE (211063). The Program for Postgraduates Research Innovation in University of Jiangsu Province (CXZZ12-0600). Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul Y, 2008, REPROD TOXICOL, V25, P67, DOI 10.1016/j.reprotox.2007.10.007; Barry KH, 2011, ENVIRON HEALTH PERSP, V119, P1726, DOI 10.1289/ehp.1103454; Blake CA, 2004, REPROD TOXICOL, V18, P43, DOI 10.1016/j.reprotox.2003.09.003; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Boockfor FR, 1997, BIOL REPROD, V57, P267, DOI 10.1095/biolreprod57.2.267; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; David A, 2009, MAR POLLUT BULL, V58, P953, DOI 10.1016/j.marpolbul.2009.04.021; Denomme GA, 2005, TRANSFUSION, V45, P660, DOI 10.1111/j.1537-2995.2005.04365.x; Feng QZ, 2009, J HAZARD MATER, V167, P282, DOI 10.1016/j.jhazmat.2008.12.115; Fuortes L, 1997, AM J IND MED, V31, P445, DOI 10.1002/(SICI)1097-0274(199704)31:4&lt;445::AID-AJIM11&gt;3.0.CO;2-#; Gregory M, 2009, J TOXICOL ENV HEAL A, V72, P1553, DOI 10.1080/15287390903232434; Guengerich FP, 2001, MUTAT RES-REV MUTAT, V488, P195, DOI 10.1016/S1383-5742(01)00059-X; Hart SN, 2008, PHARMACOGENET GENOM, V18, P11, DOI 10.1097/FPC.0b013e3282f2f121; Hawker DW, 2011, WATER RES, V45, P768, DOI 10.1016/j.watres.2010.08.053; Hirvonen A, 1999, ENVIRON HEALTH PERSP, V107, P37, DOI 10.2307/3434470; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Isidori M, 2006, CHEMOSPHERE, V64, P135, DOI 10.1016/j.chemosphere.2005.10.047; Ji GX, 2012, FREE RADICAL BIO MED, V52, P775, DOI 10.1016/j.freeradbiomed.2011.11.032; Ji GX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013145; Kim SK, 2007, ENVIRON TOXICOL, V22, P449, DOI 10.1002/tox.20280; Kisselev P, 2005, CANCER RES, V65, P2972, DOI 10.1158/0008-5472.CAN-04-3543; Lampi P, 2000, EUR J EPIDEMIOL, V16, P245, DOI 10.1023/A:1007622317866; Lee CR, 2002, PHARMACOGENETICS, V12, P251, DOI 10.1097/00008571-200204000-00010; Ma YB, 2011, TOXICOLOGY, V282, P146, DOI 10.1016/j.tox.2011.01.024; Miners J, 2002, PHARMACOGENETICS, V12, P91, DOI 10.1097/00008571-200203000-00002; Mirabelli MC, 2000, AM J IND MED, V37, P532, DOI 10.1002/(SICI)1097-0274(200005)37:5&lt;532::AID-AJIM9&gt;3.0.CO;2-A; Niwa T, 2002, BIOL PHARM BULL, V25, P235, DOI 10.1248/bpb.25.235; Nomura S, 2008, LIFE SCI, V83, P223, DOI 10.1016/j.lfs.2008.06.009; Pedersen SN, 1999, SCI TOTAL ENVIRON, V233, P89, DOI 10.1016/S0048-9697(99)00182-5; Routledge EJ, 1997, J BIOL CHEM, V272, P3280, DOI 10.1074/jbc.272.6.3280; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sumpter JP, 1998, TOXICOL LETT, V103, P337, DOI 10.1016/S0378-4274(98)00328-2; Takahashi H, 2001, CLIN PHARMACOKINET, V40, P587, DOI 10.2165/00003088-200140080-00003; Turesky RJ, 2004, CURR DRUG METAB, V5, P169, DOI 10.2174/1389200043489036; WHITE E, 1994, JNCI-J NATL CANCER I, V86, P505, DOI 10.1093/jnci/86.7.505; Xia YK, 2008, FERTIL STERIL, V89, P1743, DOI 10.1016/j.fertnstert.2007.05.049; Ying GG, 2006, ENVIRON INT, V32, P417, DOI 10.1016/j.envint.2005.07.004	40	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59398	10.1371/journal.pone.0059398	http://dx.doi.org/10.1371/journal.pone.0059398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555028	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800086
J	Verreault, M; Weppler, SA; Stegeman, A; Warburton, C; Strutt, D; Masin, D; Bally, MB				Verreault, Maite; Weppler, Sherry A.; Stegeman, Amelia; Warburton, Corinna; Strutt, Dita; Masin, Dana; Bally, Marcel B.			Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-B/AKT; PHASE-II TRIAL; INTEGRIN-LINKED KINASE; HIGH-GRADE GLIOMAS; FACTOR RECEPTOR; MAMMALIAN TARGET; C-ALPHA; PHOSPHATIDYLINOSITOL 3-KINASE; MOTIF PHOSPHORYLATION	The PI3K/AKT/mTOR pathway is commonly over activated in glioblastoma (GBM), and Rictor was shown to be an important regulator downstream of this pathway. EGFR overexpression is also frequently found in GBM tumors, and both EGFR and Rictor are associated with increased proliferation, invasion, metastasis and poor prognosis. This research evaluated in vitro and in vivo whether the combined silencing of EGFR and Rictor would result in therapeutic benefits. The therapeutic potential of targeting these proteins in combination with conventional agents with proven activity in GBM patients was also assessed. In vitro validation studies were carried out using siRNA-based gene silencing methods in a panel of three commercially available human GBM cell lines, including two PTEN mutant lines (U251MG and U118MG) and one PTEN-wild type line (LN229). The impact of EGFR and/or Rictor silencing on cell migration and sensitivity to chemotherapeutic drugs in vitro was determined. In vivo validation of these studies was focused on EGFR and/or Rictor silencing achieved using doxycycline-inducible shRNA-expressing U251MG cells implanted orthotopically in Rag2M mice brains. Target silencing, tumor size and tumor cell proliferation were assessed by quantification of immunohistofluorescence-stained markers. siRNA-mediated silencing of EGFR and Rictor reduced U251MG cell migration and increased sensitivity of the cells to irinotecan, temozolomide and vincristine. In LN229, co-silencing of EGFR and Rictor resulted in reduced cell migration, and increased sensitivity to vincristine and temozolomide. In U118MG, silencing of Rictor alone was sufficient to increase this line's sensitivity to vincristine and temozolomide. In vivo, while the silencing of EGFR or Rictor alone had no significant effect on U251MG tumor growth, silencing of EGFR and Rictor together resulted in a complete eradication of tumors. These data suggest that the combined silencing of EGFR and Rictor should be an effective means of treating GBM.	[Verreault, Maite] Hop La Pitie Salpetriere, Brain & Bone Marrow Inst Res Ctr, Paris, France; [Weppler, Sherry A.; Stegeman, Amelia; Warburton, Corinna; Strutt, Dita; Masin, Dana; Bally, Marcel B.] British Columbia Canc Agcy, Expt Therapeut, Vancouver, BC V5Z 4E6, Canada; [Bally, Marcel B.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Bally, Marcel B.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Bally, Marcel B.] Ctr Drug Res & Dev, Vancouver, BC, Canada	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Verreault, M (corresponding author), Hop La Pitie Salpetriere, Brain & Bone Marrow Inst Res Ctr, Paris, France.	maiteverreault@gmail.com; mbally@bccrc.ca	Verreault, Maite/AAZ-3637-2020	Verreault, Maite/0000-0001-6708-7698; Bally, Marcel/0000-0002-1994-4787	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The research described in this original paper was supported by grant funding from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia MS, 2010, CANCER LETT, V298, P139, DOI 10.1016/j.canlet.2010.08.014; Albert Ladislau, 2009, Cancer Genomics & Proteomics, V6, P255; Allen C, 2006, CANCER RES, V66, P11840, DOI 10.1158/0008-5472.CAN-06-1200; Arao T, 2006, INT J CANCER, V118, P483, DOI 10.1002/ijc.21340; Arwert E, 2007, CANCER RES, V67, P7335, DOI 10.1158/0008-5472.CAN-07-0077; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Boado Ruben J, 2005, NeuroRx, V2, P139, DOI 10.1602/neurorx.2.1.139; Brandes AA, 2004, J CLIN ONCOL, V22, P4779, DOI 10.1200/JCO.2004.06.181; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chakravarti A, 2002, CANCER RES, V62, P200; Chang SM, 2005, INVEST NEW DRUG, V23, P357, DOI 10.1007/s10637-005-1444-0; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Cho KK, 1999, INT J DEV NEUROSCI, V17, P447, DOI 10.1016/S0736-5748(99)00054-4; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Das G, 2011, MOL CARCINOGEN, V50, P412, DOI 10.1002/mc.20723; de Groot JF, 2008, J NEURO-ONCOL, V90, P89, DOI 10.1007/s11060-008-9637-y; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Edwards LA, 2005, ONCOGENE, V24, P3596, DOI 10.1038/sj.onc.1208427; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; Ermoian RP, 2002, CLIN CANCER RES, V8, P1100; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fan QW, 2011, CURR TOP MICROBIOL, V347, P279, DOI 10.1007/82_2010_67; Fan QW, 2003, CANCER RES, V63, P8930; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Franceschi E, 2007, BRIT J CANCER, V96, P1047, DOI 10.1038/sj.bjc.6603669; Galanis E, 2005, J CLIN ONCOL, V23, P5294, DOI 10.1200/JCO.2005.23.622; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Grill J, 2001, CLIN CANCER RES, V7, P641; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gulati N, 2009, INT J ONCOL, V35, P731, DOI 10.3892/ijo_00000386; Guo H, 2009, J NEUROCHEM, V109, P203, DOI 10.1111/j.1471-4159.2009.05946.x; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Huang PH, 2009, SCI SIGNAL, V2; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Kang CS, 2006, CANCER GENE THER, V13, P530, DOI 10.1038/sj.cgt.7700932; Kappelle AC, 2001, NEUROLOGY, V56, P118, DOI 10.1212/WNL.56.1.118; Karpel-Massler G, 2009, MOL CANCER RES, V7, P1000, DOI 10.1158/1541-7786.MCR-08-0479; Koul D, 2008, CANCER BIOL THER, V7, P1321, DOI 10.4161/cbt.7.9.6954; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Kreisl TN, 2009, J NEURO-ONCOL, V92, P99, DOI 10.1007/s11060-008-9741-z; Kruger JS, 2003, MOL CANCER RES, V1, P801; Lassman Andrew B, 2004, Curr Neurol Neurosci Rep, V4, P228, DOI 10.1007/s11910-004-0043-3; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Li XY, 2011, J NEURO-ONCOL, V103, P453, DOI 10.1007/s11060-010-0424-1; Liu JM, 2008, ADV THER, V25, P389, DOI 10.1007/s12325-008-0050-x; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Marcoux N, 2003, ONCOGENE, V22, P6100, DOI 10.1038/sj.onc.1206712; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Moscatello DK, 1998, J BIOL CHEM, V273, P200, DOI 10.1074/jbc.273.1.200; Nakamura JL, 2007, EXPERT OPIN THER TAR, V11, P463, DOI 10.1517/14728222.11.4.463; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Raizer JJ, 2010, NEURO-ONCOLOGY, V12, P95, DOI 10.1093/neuonc/nop015; Rao RD, 2005, NEOPLASIA, V7, P921, DOI 10.1593/neo.05361; Reardon DA, 2010, J NEURO-ONCOL, V96, P219, DOI 10.1007/s11060-009-9950-0; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sanchez-Martin M, 2008, CURR STEM CELL RES T, V3, P197, DOI 10.2174/157488808785740370; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sathornsumetee S, 2006, EXPERT REV ANTICANC, V6, P1087, DOI 10.1586/14737140.6.7.1087; Saydam O, 2005, MOL THER, V12, P803, DOI 10.1016/j.ymthe.2005.07.534; Shinomiya N, 2004, CANCER RES, V64, P7962, DOI 10.1158/0008-5472.CAN-04-1043; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Tian XX, 1998, NEUROPATH APPL NEURO, V24, P389; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Turner CD, 2002, NEURO-ONCOLOGY, V4, P102, DOI 10.1093/neuonc/4.2.109; Verreault M, 2011, ANTICANCER RES, V31, P2161; Verreault M, 2009, OLIGONUCLEOTIDES, V19, P129, DOI 10.1089/oli.2008.0157; Vollmann A, 2006, INT J ONCOL, V28, P1531; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Westhoff MA, 2009, ONCOGENE, V28, P3586, DOI 10.1038/onc.2009.215; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wong MLH, 2007, J CLIN NEUROSCI, V14, P301, DOI 10.1016/j.jocn.2006.11.005; Yung WKA, 2010, NEURO-ONCOLOGY, V12, P1061, DOI 10.1093/neuonc/noq072; Zhang Y, 2004, CLIN CANCER RES, V10, P3667, DOI 10.1158/1078-0432.CCR-03-0740	94	20	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59597	10.1371/journal.pone.0059597	http://dx.doi.org/10.1371/journal.pone.0059597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555046	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800102
J	Delfino, KR; Rodriguez-Zas, SL				Delfino, Kristin R.; Rodriguez-Zas, Sandra L.			Transcription Factor-MicroRNA-Target Gene Networks Associated with Ovarian Cancer Survival and Recurrence	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; C-MYC; ALTERED EXPRESSION; DNA METHYLATION; CELL-SURVIVAL; GROWTH; BETA; OVEREXPRESSION; PROGRESSION; RESISTANCE	The identification of reliable transcriptome biomarkers requires the simultaneous consideration of regulatory and target elements including microRNAs (miRNAs), transcription factors (TFs), and target genes. A novel approach that integrates multivariate survival analysis, feature selection, and regulatory network visualization was used to identify reliable biomarkers of ovarian cancer survival and recurrence. Expression profiles of 799 miRNAs, 17,814 TFs and target genes and cohort clinical records on 272 patients diagnosed with ovarian cancer were simultaneously considered and results were validated on an independent group of 146 patients. Three miRNAs (hsa-miR-16, hsa-miR-22*, and ebv-miR-BHRF1-2*) were associated with both ovarian cancer survival and recurrence and 27 miRNAs were associated with either one hazard. Two miRNAs (hsa-miR-521 and hsa-miR-497) were cohort-dependent, while 28 were cohort-independent. This study confirmed 19 miRNAs previously associated with ovarian cancer and identified two miRNAs that have previously been associated with other cancer types. In total, the expression of 838 and 734 target genes and 12 and eight TFs were associated (FDR-adjusted Pvalue <0.05) with ovarian cancer survival and recurrence, respectively. Functional analysis highlighted the association between cellular and nucleotide metabolic processes and ovarian cancer. The more direct connections and higher centrality of the miRNAs, TFs and target genes in the survival network studied suggest that network-based approaches to prognosticate or predict ovarian cancer survival may be more effective than those for ovarian cancer recurrence. This study demonstrated the feasibility to infer reliable miRNA-TF-target gene networks associated with survival and recurrence of ovarian cancer based on the simultaneous analysis of co-expression profiles and consideration of the clinical characteristics of the patients.	[Delfino, Kristin R.; Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Stat, Urbana, IL 61801 USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	rodrgzzs@illinois.edu		Rodriguez-Zas, Sandra/0000-0003-1122-4758	NCI [1R03CA143975]; NIH/NIDA [R21DA027548]; NCI/NHGRI TCGA DAC (NIH/NHGRI) [1988]; NATIONAL CANCER INSTITUTE [R03CA143975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027548] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NCI/NHGRI TCGA DAC (NIH/NHGRI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The support of NCI (Grant Number: 1R03CA143975) to SRZ and KRD, NIH/NIDA (Grant Number: R21DA027548) to SRZ, and NCI/NHGRI TCGA DAC (NIH/NHGRI Project Number: 1988) to SRZ are greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Azawi D, 2008, ONCOGENE, V27, P3021, DOI 10.1038/sj.onc.1210964; Azuma T, 2000, J HUM GENET, V45, P192, DOI 10.1007/s100380050210; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Boren T, 2009, GYNECOL ONCOL, V113, P249, DOI 10.1016/j.ygyno.2009.01.014; Chen CH, 2005, INT J GYNECOL CANCER, V15, P878, DOI 10.1111/j.1525-1438.2005.00150.x; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen X, CANC RES, V72, P2294; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; Dahiya N, 2010, ENDOCR-RELAT CANCER, V17, pF77, DOI 10.1677/ERC-09-0203; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Delfino KR, 2011, CANCER GENOM PROTEOM, V8, P173; Delfino KR, 2010, NEUROPEPTIDES, V44, P31, DOI 10.1016/j.npep.2009.11.002; Do TV, 2008, MOL CANCER RES, V6, P695, DOI 10.1158/1541-7786.MCR-07-0294; Docquier F, 2005, CANCER RES, V65, P5112, DOI 10.1158/0008-5472.CAN-03-3498; Dodson H, 2011, WOMEN VARIANTS CLOCK; Drakaki A, 2009, CURR GENOMICS, V10, P35, DOI 10.2174/138920209787581299; Eitan R, 2009, GYNECOL ONCOL, V114, P253, DOI 10.1016/j.ygyno.2009.04.024; Filippova GN, 2002, CANCER RES, V62, P48; Fox J., 2002, R S PLUS COMPANION A; Gao ZJ, 2011, CLIN CANCER RES, V17, P1065, DOI 10.1158/1078-0432.CCR-10-1644; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Heckman CA, 2006, ONCOGENE, V25, P888, DOI 10.1038/sj.onc.1209127; Hiranuma C, 2004, INT J MOL MED, V13, P413; Hoffman AE, 2010, CANCER RES, V70, P1459, DOI 10.1158/0008-5472.CAN-09-3798; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Inan S, 2006, HISTOL HISTOPATHOL, V21, P1055, DOI 10.14670/HH-21.1055; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Johnson SAS, 2003, MOL CELL BIOL, V23, P3043, DOI 10.1128/MCB.23.9.3043-3051.2003; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kobayashi D, 2002, ANTICANCER RES, V22, P3963; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Le Bechec A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-67; Li AJ, 2003, AM J OBSTET GYNECOL, V189, P22, DOI 10.1067/mob.2003.328; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; Lurie G, 2009, CANCER CAUSE CONTROL, V20, P47, DOI 10.1007/s10552-008-9216-8; Mahner S, 2008, BRIT J CANCER, V99, P1269, DOI 10.1038/sj.bjc.6604650; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Mayr D, 2008, PATHOL RES PRACT, V204, P823, DOI 10.1016/j.prp.2008.07.009; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Miles Gregory D, 2012, BMC Res Notes, V5, P164, DOI 10.1186/1756-0500-5-164; Muller HM, 2004, ANN NY ACAD SCI, V1022, P44, DOI 10.1196/annals.1318.008; Nakagawa M, 2007, ONCOL REP, V18, P769; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Ohuchida K, 2012, ANN SURG ONCOL, V19, P2394, DOI 10.1245/s10434-012-2252-3; Schaubel DE, 2007, BIOMETRICAL J, V49, P719, DOI 10.1002/bimj.200610349; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shih IM, 2009, FUTURE ONCOL, V5, P1641, DOI [10.2217/fon.09.126, 10.2217/FON.09.126]; Smith BJ, 2007, BEEHIVE SUITE TOOLS; Sunde JS, 2006, CANCER RES, V66, P8404, DOI 10.1158/0008-5472.CAN-06-0683; Suzuki F, 2008, CANCER SCI, V99, P2365, DOI 10.1111/j.1349-7006.2008.00988.x; Tanaka Y, 2004, J BIOL CHEM, V279, P8567, DOI 10.1074/jbc.M309131200; Unoki M, 2003, ONCOGENE, V22, P2172, DOI 10.1038/sj.onc.1206222; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; von Gruenigen VE, 2010, J PAIN SYMPTOM MANAG, V39, P839, DOI 10.1016/j.jpainsymman.2009.09.022; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; Wisman GBA, 2003, INT J ONCOL, V23, P1451; Wu M, 2012, BRIEF BIOINFORM, V13, P150, DOI 10.1093/bib/bbr029; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Young N, 2006, J NATL CANCER I, V98, P1060, DOI 10.1093/jnci/djj299; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhou X, 2012, ONCOL REP, V27, P447, DOI 10.3892/or.2011.1482; ZOREFSHANI E, 1994, J CANCER RES CLIN, V120, P717, DOI 10.1007/BF01194269	72	59	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58608	10.1371/journal.pone.0058608	http://dx.doi.org/10.1371/journal.pone.0058608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554906	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500033
J	Shao, LJ; Zhou, ZS; Cai, Y; Castro, P; Dakhov, O; Shi, P; Bai, YX; Ji, HX; Shen, WH; Wang, JH				Shao, Longjiang; Zhou, Zhansong; Cai, Yi; Castro, Patricia; Dakhov, Olga; Shi, Ping; Bai, Yaoxia; Ji, Huixiang; Shen, Wenhao; Wang, Jianghua			Celastrol Suppresses Tumor Cell Growth through Targeting an AR-ERG-NF-kappa B Pathway in TMPRSS2/ERG Fusion Gene Expressing Prostate Cancer	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVITY; SIGNALING PATHWAYS; IKK-EPSILON; P65 SUBUNIT; NUDE-MICE; GOD VINE; PHOSPHORYLATION; PROGRESSION; ACTIVATION; KINASE	The TMPRSS2/ERG (T/E) fusion gene is present in the majority of all prostate cancers (PCa). We have shown previously that NF-kappa B signaling is highly activated in these T/E fusion expressing cells via phosphorylation of NF-kB p65 Ser536 (p536). We therefore hypothesize that targeting NF-kB signaling may be an efficacious approach for the subgroup of PCas that carry T/E fusions. Celastrol is a well known NF-kB inhibitor, and thus may inhibit T/E fusion expressing PCa cell growth. We therefore evaluated Celastrol's effects in vitro and in vivo in VCaP cells, which express the T/E fusion gene. VCaP cells were treated with different concentrations of Celastrol and growth inhibition and target expression were evaluated. To test its ability to inhibit growth in vivo, 0.5 mg/kg Celastrol was used to treat mice bearing subcutaneous VCaP xenograft tumors. Our results show Celastrol can significantly inhibit the growth of T/E fusion expressing PCa cells both in vitro and in vivo through targeting three critical signaling pathways: AR, ERG and NF-kB in these cells. When mice received 0.5 mg/kg Celastrol for 4 times/week, significant growth inhibition was seen with no obvious toxicity or significant weight loss. Therefore, Celastrol is a promising candidate drug for T/E fusion expressing PCa. Our findings provide a novel strategy for the targeted therapy which may benefit the more than half of PCa patients who have T/E fusion expressing PCas.	[Shao, Longjiang; Cai, Yi; Castro, Patricia; Dakhov, Olga; Wang, Jianghua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Shao, Longjiang; Cai, Yi; Castro, Patricia; Dakhov, Olga; Wang, Jianghua] Michael E DeBakey Dept Vet Affairs Med Ctr, Houston, TX USA; [Zhou, Zhansong; Shi, Ping; Bai, Yaoxia; Ji, Huixiang; Shen, Wenhao] South West Hosp, Dept Urol, Chongqing, Peoples R China	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Army Medical University	Wang, JH (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	jwang1@bcm.edu	Castro, Patricia/AAN-3032-2021	Castro, Patricia/0000-0001-5286-8037	Department of Defense Prostate Cancer Research program [DOD W81XWH-08-1-0055]; NCI; Duncan Cancer Center Human Tissue and Pathology Core [NCI: P30CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	Department of Defense Prostate Cancer Research program(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Duncan Cancer Center Human Tissue and Pathology Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense Prostate Cancer Research program (DOD W81XWH-08-1-0055; JW) and the NCI to the Dan L. Duncan Cancer Center Human Tissue and Pathology Core (NCI: P30CA125123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Cai Y, 2009, CANCER RES, V69, P819, DOI 10.1158/0008-5472.CAN-08-2537; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Dai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014153; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Goldstein AS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002169; Guo HR, 2011, INTEGR CANCER THER, V10, P127, DOI 10.1177/1534735410387599; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hishikawa K, 2001, Nihon Yakurigaku Zasshi, V118, P197; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Huang YL, 2012, ANTI-CANCER DRUG, V23, P515, DOI 10.1097/CAD.0b013e3283514b68; Jeong SJ, 2005, J BIOL CHEM, V280, P10326, DOI 10.1074/jbc.M412643200; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Kannaiyan R, 2011, APOPTOSIS; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Kannaiyan R, 2011, CANCER LETT, V303, P9, DOI 10.1016/j.canlet.2010.10.025; Kim Y, 2011, CELL PHYSIOL BIOCHEM, V28, P175, DOI 10.1159/000331729; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Morita T, 2010, AM J HYPERTENS, V23, P821, DOI 10.1038/ajh.2010.87; Paimela T, 2011, PHARM RES; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Seo SI, 2009, APMIS, V117, P623, DOI 10.1111/j.1600-0463.2009.02506.x; Shirley RB, 2005, NEOPLASIA, V7, P1104, DOI 10.1593/neo.05520; Soller MJ, 2006, GENE CHROMOSOME CANC, V45, P717, DOI 10.1002/gcc.20329; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tamaki K, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/278958; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang J, 2010, CANC RES; Wang JH, 2004, CLIN CANCER RES, V10, P6169, DOI 10.1158/1078-0432.CCR-04-0408; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Wang WW, 2008, J CHROMATOGR B, V863, P163, DOI 10.1016/j.jchromb.2007.11.044; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang LY, 2009, AM J PATHOL, V175, P489, DOI 10.2353/ajpath.2009.080727; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhu H, 2010, CANCER LETT, V297, P155, DOI 10.1016/j.canlet.2010.04.030; Zhu H, 2010, J PHARMACOL EXP THER, V334, P489, DOI 10.1124/jpet.110.165654	50	38	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58391	10.1371/journal.pone.0058391	http://dx.doi.org/10.1371/journal.pone.0058391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23554889	Green Submitted, Green Published, gold			2022-12-25	WOS:000316936100115
J	Bortoluzzi, A; Muskett, FW; Waters, LC; Addis, PW; Rieck, B; Munder, T; Schleier, S; Forti, F; Ghisotti, D; Carr, MD; O'Hare, HM				Bortoluzzi, Alessio; Muskett, Frederick W.; Waters, Lorna C.; Addis, Philip W.; Rieck, Barbara; Munder, Thomas; Schleier, Susanne; Forti, Francesca; Ghisotti, Daniela; Carr, Mark D.; O'Hare, Helen M.			Mycobacterium tuberculosis RNA Polymerase-binding Protein A (RbpA) and Its Interactions with Sigma Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; TISSUE INHIBITOR; MATRIX-METALLOPROTEINASE; PHENOTYPIC TOLERANCE; STRUCTURE PREDICTION; ESCHERICHIA-COLI; LARGER PROTEINS; NMR; SEQUENCE; ASSIGNMENT	RNA polymerase-binding protein A (RbpA), encoded by Rv2050, is specific to the actinomycetes, where it is highly conserved. In the pathogen Mycobacterium tuberculosis, RbpA is essential for growth and survival. RbpA binds to the beta subunit of the RNA polymerase where it activates transcription by unknown mechanisms, and it may also influence the response of M. tuberculosis to the current frontline anti-tuberculosis drug rifampicin. Here we report the solution structure of RbpA and identify the principle sigma factor sigma(A) and the stress-induced sigma(B) as interaction partners. The protein has a central ordered domain with a conserved hydrophobic surface that may be a potential protein interaction site. The N and C termini are highly dynamic and are involved in the interaction with the sigma factors. RbpA forms a tight complex with the N-terminal domain of sigma(B) via its N- and C-terminal regions. The interaction with sigma factors may explain how RbpA stabilizes sigma subunit binding to the core RNA polymerase and thereby promotes initiation complex formation. RbpA could therefore influence the competition between principal and alternative sigma factors and hence the transcription profile of the cell.	[Bortoluzzi, Alessio; Muskett, Frederick W.; Waters, Lorna C.; Addis, Philip W.; Carr, Mark D.; O'Hare, Helen M.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Rieck, Barbara; O'Hare, Helen M.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England; [Munder, Thomas; Schleier, Susanne] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol eV, Dept Cell & Mol Biol, D-07745 Jena, Germany; [Forti, Francesca; Ghisotti, Daniela] Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy	University of Leicester; University of Leicester; Hans Knoll Institute (HKI); University of Milan	Carr, MD (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.	mdc12@le.ac.uk; hmo7@le.ac.uk	O'Hare, Helen/G-1528-2012; GHISOTTI, DANIELA ERICA/B-7732-2017	O'Hare, Helen/0000-0002-8666-7433; GHISOTTI, DANIELA ERICA/0000-0003-2924-5303; Addis, Philip/0000-0003-1185-651X; Carr, Mark/0000-0002-3939-0996	College of Medicine, Biological Sciences and Psychology, University of Leicester college studentship; Research Council UK fellowship; Biotechnology and Biological Sciences Research Council Grant [BB/H007865/1]; UCB; NM4TB EC_VI Framework [LSHP-CT-2005-018923]; BBSRC [BB/H007865/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H007865/1] Funding Source: researchfish	College of Medicine, Biological Sciences and Psychology, University of Leicester college studentship; Research Council UK fellowship; Biotechnology and Biological Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UCB(UCB Pharma SA); NM4TB EC_VI Framework; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a College of Medicine, Biological Sciences and Psychology, University of Leicester college studentship (to A. B.), a Research Council UK fellowship (to H. M. O.), Biotechnology and Biological Sciences Research Council Grant BB/H007865/1 (to H. M. O.), UCB support (to L. C. W. and P. W. A.), and NM4TB EC_VI Framework Contract LSHP-CT-2005-018923 (to D. G., F. F., and H. M. O.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bougdour A, 2004, J BIOL CHEM, V279, P19540, DOI 10.1074/jbc.M314145200; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crubezy E, 1998, CR ACAD SCI III-VIE, V321, P941, DOI 10.1016/S0764-4469(99)80009-2; Dey A, 2011, MICROBIOL-SGM, V157, P2056, DOI 10.1099/mic.0.047480-0; Dey A, 2010, MICROBIOL-SGM, V156, P873, DOI 10.1099/mic.0.033670-0; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; England P, 2008, J BIOL CHEM, V283, P33455, DOI 10.1074/jbc.M807380200; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Forti F, 2011, TUBERCULOSIS, V91, P569, DOI 10.1016/j.tube.2011.07.004; Gao G, 2000, J MOL BIOL, V301, P537, DOI 10.1006/jmbi.2000.3976; Gilmore JM, 2010, BIOCHEMISTRY-US, V49, P6143, DOI 10.1021/bi1002635; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu YB, 2012, NUCLEIC ACIDS RES, V40, P6547, DOI 10.1093/nar/gks346; KARUNAIRATNAM MC, 1958, BIOCHIM BIOPHYS ACTA, V29, P649, DOI 10.1016/0006-3002(58)90028-3; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KLEBE RJ, 1983, GENE, V25, P333, DOI 10.1016/0378-1119(83)90238-X; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; MACURA S, 1980, MOL PHYS, V41, P95, DOI 10.1080/00268978000102601; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Mihatsch K, 2009, CARDIOVASC RES, V81, P108, DOI 10.1093/cvr/cvn276; MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; Newell KV, 2006, MOL MICROBIOL, V60, P687, DOI 10.1111/j.1365-2958.2006.05116.x; O'Hare H, 2008, J MICROBIOL METH, V73, P79, DOI 10.1016/j.mimet.2008.02.008; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shepherd N, 2001, J BACTERIOL, V183, P2527, DOI 10.1128/JB.183.8.2527-2534.2001; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tafelmeyer P, 2004, CHEM BIOL, V11, P681, DOI 10.1016/j.chembiol.2004.02.026; Teutschbein J, 2009, MICROBIOL RES, V164, P253, DOI 10.1016/j.micres.2006.11.016; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Typas A, 2007, EMBO J, V26, P1569, DOI 10.1038/sj.emboj.7601629; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Williamson RA, 1999, J BIOL CHEM, V274, P37226, DOI 10.1074/jbc.274.52.37226	69	32	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14438	14450		10.1074/jbc.M113.459883	http://dx.doi.org/10.1074/jbc.M113.459883			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548911	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000319253500047
J	Quimbar, P; Malik, U; Sommerhoff, CP; Kaas, Q; Chan, LY; Huang, YH; Grundhuber, M; Dunse, K; Craik, DJ; Anderson, MA; Daly, NL				Quimbar, Pedro; Malik, Uru; Sommerhoff, Christian P.; Kaas, Quentin; Chan, Lai Y.; Huang, Yen-Hua; Grundhuber, Maresa; Dunse, Kerry; Craik, David J.; Anderson, Marilyn A.; Daly, Norelle L.			High-affinity Cyclic Peptide Matriptase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SERINE-PROTEASE; TRYPSIN-INHIBITOR; DISULFIDE BRIDGE; POTENT; DESIGN; SFTI-1; CYCLOTIDES; DYNAMICS; PROSTATE; COMPLEX	The type II transmembrane serine protease matriptase is a key activator of multiple signaling pathways associated with cell proliferation and modification of the extracellular matrix. Deregulated matriptase activity correlates with a number of diseases, including cancer and hence highly selective matriptase inhibitors may have therapeutic potential. The plant-derived cyclic peptide, sunflower trypsin inhibitor-1 (SFTI-1), is a promising drug scaffold with potent matriptase inhibitory activity. In the current study we have analyzed the structure-activity relationships of SFTI-1 and Momordica cochinchinensis trypsin inhibitor-II (MCoTI-II), a structurally divergent trypsin inhibitor from Momordica cochinchinensis that also contains a cyclic backbone. We show that MCoTI-II is a significantly more potent matriptase inhibitor than SFTI-1 and that all alanine mutants of both peptides, generated using positional scanning mutagenesis, have decreased trypsin affinity, whereas several mutations either maintain or result in enhanced matriptase inhibitory activity. These intriguing results were used to design one of the most potent matriptase inhibitors known to date with a 290 pM equilibrium dissociation constant, and provide the first indication on how to modulate affinity for matriptase over trypsin in cyclic peptides. This information might be useful for the design of more selective and therapeutically relevant inhibitors of matriptase.	[Dunse, Kerry; Anderson, Marilyn A.] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia; [Malik, Uru; Kaas, Quentin; Chan, Lai Y.; Huang, Yen-Hua; Craik, David J.; Daly, Norelle L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Sommerhoff, Christian P.; Grundhuber, Maresa] Univ Munich, Univ Hosp, Inst Lab Med, D-80336 Munich, Germany; [Daly, Norelle L.] James Cook Univ, Sch Pharm & Mol Sci, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld 4878, Australia	La Trobe University; University of Queensland; University of Munich; James Cook University	Daly, NL (corresponding author), James Cook Univ, Smithfield, Qld 4870, Australia.	norelle.daly@jcu.edu.au	Dunse, Kerry/A-8624-2012; Huang, Yen-Hua/J-9056-2014; Craik, David/B-1695-2010; Kaas, Quentin/J-8727-2014; Daly, Norelle/D-4302-2013; Anderson, Marilyn/A-4259-2012; CHAN, LAI YUE/C-6489-2014	Huang, Yen-Hua/0000-0001-6937-2660; Craik, David/0000-0003-0007-6796; Dunse, Kerry/0000-0003-1490-3465; Kaas, Quentin/0000-0001-9988-6152; Daly, Norelle/0000-0002-4697-6602; Anderson, Marilyn/0000-0002-8257-5128; CHAN, LAI YUE/0000-0002-9346-2487	Queensland Government Smart State Fellowship; Hexima Limited; Deutsche Forschungsgemeinschaft [SO 249/1-1]; Australian Postgraduate Award	Queensland Government Smart State Fellowship; Hexima Limited; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Australian Postgraduate Award(Australian Government)	This work was supported in part by a Queensland Government Smart State Fellowship (to N. L. D.), which was co-funded by Hexima Limited, and Project SO 249/1-1, priority program 1394 "Mast cells-promoters of health and modulator of diseases," of the Deutsche Forschungsgemeinschaft (to C. P. S.).; Supported by an Australian Postgraduate Award.	Avrutina O, 2005, BIOL CHEM, V386, P1301, DOI 10.1515/BC.2005.148; Avrutina O, 2012, ORG BIOMOL CHEM, V10, P7753, DOI 10.1039/c2ob26162f; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Bergum C, 2010, PROSTATE, V70, P1422, DOI 10.1002/pros.21177; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cerutti DS, 2009, J PHYS CHEM B, V113, P6971, DOI 10.1021/jp9010372; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Conlan BF, 2011, CURR PHARM DESIGN, V17, P4318; Craik DJ, 2012, EXPERT OPIN DRUG DIS, V7, P179, DOI 10.1517/17460441.2012.661554; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fittler H, 2013, ORG BIOMOL CHEM, V11, P1848, DOI 10.1039/c3ob27469a; Forbs D, 2005, INT J ONCOL, V27, P1061; Goddard T.D., SPARKY 3; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guo X, 2006, CHEM BIOL DRUG DES, V68, P341, DOI 10.1111/j.1747-0285.2006.00457.x; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Legowska A, 2010, BIOORGAN MED CHEM, V18, P8188, DOI 10.1016/j.bmc.2010.10.014; Legowska A, 2010, PROTEIN PEPTIDE LETT, V17, P1223, DOI 10.2174/092986610792231483; Li P, 2007, J MED CHEM, V50, P5976, DOI 10.1021/jm0704898; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Napp J, 2010, INT J CANCER, V127, P1958, DOI 10.1002/ijc.25405; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Rafal Lukajtis, 2011, J Pept Sci, V17, P281, DOI 10.1002/psc.1330; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders Andrew J, 2006, J Exp Ther Oncol, V6, P39; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Steinmetzer T, 2006, J MED CHEM, V49, P4116, DOI 10.1021/jm051272l; Swedberg JE, 2012, CHEMBIOCHEM, V13, P336, DOI 10.1002/cbic.201100673; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tam JP, 1998, PROTEIN SCI, V7, P1583, DOI 10.1002/pro.5560070712; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yuan C, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-30	49	106	112	0	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13885	13896		10.1074/jbc.M113.460030	http://dx.doi.org/10.1074/jbc.M113.460030			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23548907	Green Published, hybrid			2022-12-25	WOS:000318850300069
J	Morrison, SD; Rashidi, V; Banushi, VH; Barbhaiya, NJ; Gashi, VH; Sarnquist, C; Maldonado, Y; Harxhi, A				Morrison, Shane D.; Rashidi, Vania; Banushi, Vilson H.; Barbhaiya, Namrata J.; Gashi, Valbona H.; Sarnquist, Clea; Maldonado, Yvonne; Harxhi, Arjan			Cultural Adaptation of a Survey to Assess Medical Providers' Knowledge of and Attitudes towards HIV/AIDS in Albania	PLOS ONE			English	Article							HIV; KAPPA; CARE; PHYSICIANS; AGREEMENT; RISK	Though the HIV/AIDS epidemic in Southeastern Europe is one of low reported prevalence, numerous studies have described the pervasiveness of medical providers' lack of knowledge of HIV/AIDS in the Balkans. This study sought to culturally adapt an instrument to assess medical providers' knowledge of and attitudes towards HIV/AIDS in Albania. Cultural adaptation was completed through development of a survey from previously validated instruments, translation of the survey into Albanian, blinded back translation, expert committee review of the draft instrument, focus group pre-testing with community- and University Hospital Center of Tirana-based physicians and nurses, and test-retest reliability testing. Blinded back translation of the instrument supported the initial translation with slight changes to the idiomatic and conceptual equivalences. Focus group pre-testing generally supported the instrument, yet some experiential and idiomatic changes were implemented. Based on unweighted kappa and/or prevalence adjusted bias adjusted kappa (PABAK), 20 of the 43 questions were deemed statistically significant at kappa and/or PABAK >= 0.5, while 12 others did not cross zero on the 95% confidence interval for kappa, indicating their probable significance. Subsequently, an instrument to assess medical providers' knowledge of and attitudes toward HIV/AIDS for an Albanian population was developed which can be expanded within Albania and potentially to other countries within the Balkans, which have an Albanian-speaking population.	[Morrison, Shane D.; Sarnquist, Clea; Maldonado, Yvonne] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Rashidi, Vania; Barbhaiya, Namrata J.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Banushi, Vilson H.; Gashi, Valbona H.; Harxhi, Arjan] Univ Tirana, Fac Med, Dept Infect Dis, Tirana, Albania	Stanford University; Stanford University; University of Tirana (UT)	Morrison, SD (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	shanem@stanford.edu; bonniem@stanford.edu		Morrison, Shane/0000-0003-3868-3532; Harxhi, Arjan/0000-0001-8518-7377	Center for East Europe and Eurasia Studies at Stanford University Summer Research Fellowship; Infectious Diseases Society of America; Stanford University Goodrich Traveling Medical Scholars grant	Center for East Europe and Eurasia Studies at Stanford University Summer Research Fellowship; Infectious Diseases Society of America; Stanford University Goodrich Traveling Medical Scholars grant	Funding for this study was provided by the Center for East Europe and Eurasia Studies at Stanford University Summer Research Fellowship, Medical Scholars Grant from the Infectious Diseases Society of America, and the Stanford University Goodrich Traveling Medical Scholars grant to Shane D. Morrison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; [Anonymous], 2008, WORLD HLTH STAT 2008; [Anonymous], 2003, ADHERENCE LONG TERM; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bino S, 2006, ALBANIA BEHAV BIOL S; Boulle A, 2007, SEX TRANSM INFECT, V83, P503, DOI 10.1136/sti.2007.027748; Brachman P, 1996, ARCH INTERN MED, V156, P761, DOI 10.1001/archinte.156.7.761; Brusaferro S, 1997, Med Lav, V88, P495; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Ciccozzi M, 2005, J INFECT DIS, V192, P475, DOI 10.1086/431599; Devroey D, 2003, AIDS, V17, P641, DOI 10.1097/01.aids.0000050848.71999.52; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Grudens-Schuck N, 2004, FOCUS GROUP FUNDAMEN; GUILLEMIN F, 1995, SCAND J RHEUMATOL, V24, P61, DOI 10.3109/03009749509099285; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; HARXHI A, 2002, RAPID ASSESSMENT RES; International Organization for Migration, 2007, REP ALB MIGR PROF; Jovic-Vranes A, 2006, OCCUP MED-OXFORD, V56, P275, DOI 10.1093/occmed/kql019; Kocic Biljana, 2008, Central European Journal of Public Health, V16, P134; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lohrer H, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-134; MACLURE M, 1987, AM J EPIDEMIOL, V126, P161, DOI 10.1093/aje/126.2.161; Mann Jonathan M, 1994, Health Hum Rights, V1, P6; Ministry of Health Kenya, 2004, ADH ANT THER AD GUID; Ministry of Health (Republic of Albania), 2003, LETS KEEP ALB LOW HI; Ministry of Health (Republic of Albania), 2012, NAT STRAT P IN PRESS; Ministry of Health (Republic of Albania), 2007, ALB COUNTR PROGR REP; Morrison SD, 2011, CENT EUR J PUBL HEAL, V19, P91, DOI 10.21101/cejph.a3644; Quach L, 2005, AIDS PATIENT CARE ST, V19, P335, DOI 10.1089/apc.2005.19.335; Reis C, 2005, PLOS MED, V2, P743, DOI 10.1371/journal.pmed.0020246; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Stepanoya E, 2004, 15 INT C AIDS BANGK; Tesic V, 2006, COLLEGIUM ANTROPOL, V30, P89; The World Bank, 2008, ALB KEY IND; TIRELLI U, 1991, BRIT MED J, V303, P582, DOI 10.1136/bmj.303.6802.582; UNAIDS, 1999, UN AIDS EP UPD; UNAIDS, 2011, UNAIDS DAT TABL; UNAIDS, 2010, GLOB REP UNAIDS REP; *UNAIDS WHO, 2007, 2007 AIDS EP UPD; UNAIDS/World Health Organization, 2009, FACT SHEET GLOB HIV; UNAIDS/World Health Organization, 2007, FACT SHEET HIV AIDS; UNICEF, 2004, RAP ASS RESP TIR; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2008, EP HIV AIDS 2008 UPD	45	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59816	10.1371/journal.pone.0059816	http://dx.doi.org/10.1371/journal.pone.0059816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544101	Green Submitted, Green Published, gold			2022-12-25	WOS:000317480700061
J	Webb, H; Lanfear, R; Hamill, J; Foley, WJ; Kulheim, C				Webb, Hamish; Lanfear, Robert; Hamill, John; Foley, William J.; Kuelheim, Carsten			The Yield of Essential Oils in Melaleuca alternifolia (Myrtaceae) Is Regulated through Transcript Abundance of Genes in the MEP Pathway	PLOS ONE			English	Article							METHYLERYTHRITOL PHOSPHATE PATHWAYS; TEA TREE OIL; ISOPRENOID BIOSYNTHESIS; NONMEVALONATE PATHWAY; AUSTRALIAN MYRTACEAE; PLASTIDIAL PATHWAYS; EUCALYPTUS-GLOBULUS; HIGHER-PLANTS; ARABIDOPSIS; 1-DEOXY-D-XYLULOSE	Medicinal tea tree (Melaleuca alternifolia) leaves contain large amounts of an essential oil, dominated by monoterpenes. Several enzymes of the chloroplastic methylerythritol phosphate (MEP) pathway are hypothesised to act as bottlenecks to the production of monoterpenes. We investigated, whether transcript abundance of genes encoding for enzymes of the MEP pathway were correlated with foliar terpenes in M. alternifolia using a population of 48 individuals that ranged in their oil concentration from 39-122 mg.g DM-1. Our study shows that most genes in the MEP pathway are co-regulated and that the expression of multiple genes within the MEP pathway is correlated with oil yield. Using multiple regression analysis, variation in expression of MEP pathway genes explained 87% of variation in foliar monoterpene concentrations. The data also suggest that sesquiterpenes in M. alternifolia are syrithesised, at least in part, from isopentenyl pyrophosphate originating from the plastid via the MEP pathway.	[Webb, Hamish; Lanfear, Robert; Foley, William J.; Kuelheim, Carsten] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Webb, Hamish; Hamill, John] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia	Australian National University; Monash University	Kulheim, C (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	carsten.kulheim@anu.edu.au	Lanfear, Robert/A-2022-2010; Kulheim, Carsten/AAR-2734-2021; Foley, William J/C-8069-2009; Kulheim, Carsten/F-4720-2010	Lanfear, Robert/0000-0002-1140-2596; Foley, William J/0000-0001-8587-1814; Kulheim, Carsten/0000-0002-0798-3324	Australian Research Council [LP110100184]; Australian Tea Tree Industry Association (ATTIA); Rural Industries Research and Development Corporation	Australian Research Council(Australian Research Council); Australian Tea Tree Industry Association (ATTIA); Rural Industries Research and Development Corporation	The work was funded by an Australian Research Council Linkage grant to W.J.F. (LP110100184) with the active partnership of the Australian Tea Tree Industry Association (ATTIA) and a supplementary grant from the Rural Industries Research and Development Corporation. The funders had no role is study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; Battilana J, 2009, THEOR APPL GENET, V118, P653, DOI 10.1007/s00122-008-0927-8; Besser K, 2009, PLANT PHYSIOL, V149, P499, DOI 10.1104/pp.108.126276; Bick JA, 2003, ARCH BIOCHEM BIOPHYS, V415, P146, DOI 10.1016/S0003-9861(03)00233-9; Botella-Pavia P, 2004, PLANT J, V40, P188, DOI 10.1111/j.1365-313X.2004.02198.x; Butcher PA, 1996, NEW FOREST, V11, P31; BUTCHER PA, 1994, BIOCHEM SYST ECOL, V22, P419, DOI 10.1016/0305-1978(94)90033-7; Carretero-Paulet L, 2006, PLANT MOL BIOL, V62, P683, DOI 10.1007/s11103-006-9051-9; Carson CF, 2006, CLIN MICROBIOL REV, V19, P50, DOI 10.1128/CMR.19.1.50-62.2006; Chow KS, 2012, J EXP BOT, V63, P1863, DOI 10.1093/jxb/err363; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; Crawley MJ, 2005, STAT INTRO USING R; de Almeida MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-73; Doran JC, 2006, AUST J EXP AGR, V46, P1521, DOI 10.1071/Ea05205; Dudareva N, 2005, P NATL ACAD SCI USA, V102, P933, DOI 10.1073/pnas.0407360102; Enfissi EMA, 2005, PLANT BIOTECHNOL J, V3, P17, DOI 10.1111/j.1467-7652.2004.00091.x; Fernandez M, 2010, TREES-STRUCT FUNCT, V24, P1109, DOI 10.1007/s00468-010-0483-0; HANOVER JW, 1966, HEREDITY, V21, P73, DOI 10.1038/hdy.1966.5; Hart PH, 2000, INFLAMM RES, V49, P619, DOI 10.1007/s000110050639; Hemmerlin A, 2012, PROG LIPID RES, V51, P95, DOI 10.1016/j.plipres.2011.12.001; Homer LE, 2000, BIOCHEM SYST ECOL, V28, P367, DOI 10.1016/S0305-1978(99)00071-X; Hsieh MH, 2005, PLANT PHYSIOL, V138, P641, DOI 10.1104/pp.104.058735; Kasahara H, 2004, J BIOL CHEM, V279, P14049, DOI 10.1074/jbc.M314195200; Kasahara H, 2002, J BIOL CHEM, V277, P45188, DOI 10.1074/jbc.M208659200; Keszei A, 2008, AUST J BOT, V56, P197, DOI 10.1071/BT07146; Keszei A, 2010, PHYTOCHEMISTRY, V71, P844, DOI 10.1016/j.phytochem.2010.03.013; Kulheim C, 2011, NEW PHYTOL, V191, P1041, DOI 10.1111/j.1469-8137.2011.03769.x; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; List S, 1995, AUST J BOT, V43, P629, DOI 10.1071/BT9950629; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Phillips MA, 2007, PLANT MOL BIOL, V65, P243, DOI 10.1007/s11103-007-9212-5; R Development Core Team, 2009, R FDN STAT COMP; Russell MF, 2003, PHYTOCHEMISTRY, V62, P683, DOI 10.1016/S0031-9422(02)00607-6; Skorupinska-Tudek K, 2008, J BIOL CHEM, V283, P21024, DOI 10.1074/jbc.M706069200; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Stein M, 2002, NIST MASS SPECTRAL S; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wildung M, 2005, TRANSGENIC RES, V14, P365, DOI 10.1007/s11248-005-5475-2; Xie Z, 2008, PLANT J, V54, P349, DOI 10.1111/j.1365-313X.2008.03429.x; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/	42	28	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60631	10.1371/journal.pone.0060631	http://dx.doi.org/10.1371/journal.pone.0060631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544156	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700115
J	Lau, MT; So, WK; Leung, PCK				Lau, Man-Tat; So, Wai-Kin; Leung, Peter C. K.			Fibroblast Growth Factor 2 Induces E-Cadherin Down-Regulation via PI3K/Akt/mTOR and MAPK/ERK Signaling in Ovarian Cancer Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TRANSCRIPTION FACTOR SNAIL; REPRESSES E-CADHERIN; MESENCHYMAL TRANSFORMATION; TUMOR-CELLS; MAMMALIAN TARGET; GENE-EXPRESSION; CARCINOMA-CELLS; PATHWAY; PROGRESSION	Fibroblast growth factor 2 (FGF2) is produced by ovarian cancer cells and it has been suggested to play an important role in tumor progression. In this study, we report that FGF2 treatment down-regulated E-cadherin by up-regulating its transcriptional repressors, Slug and ZEB1, in human ovarian cancer cells. The pharmacological inhibition of phosphatidylinositol-3-kinase (PI3K), mammalian target of rapamycin (mTOR), and MEK suggests that both PI3K/Akt/mTOR and MAPK/ERK signaling are required for FGF2-induced E-cadherin down-regulation. Moreover, FGF2 up-regulated Slug and ZEB1 expression via the PI3K/Akt/mTOR and MAPK/ERK signaling pathways, respectively. Finally, FGF2-induced cell invasion was abolished by the inhibition of the PI3K/Akt/mTOR and MAPK/ERK pathways, and the forced expression of E-cadherin diminished the intrinsic invasiveness of ovarian cancer cells as well as the FGF2-induced cell invasion. This study demonstrates a novel mechanism in which FGF2 down-regulates E-cadherin expression through the activation of PI3K/Akt/mTOR and MAPK/ERK signaling, and the up-regulation of Slug and ZEB1 in human ovarian cancer cells.	[Lau, Man-Tat; So, Wai-Kin; Leung, Peter C. K.] Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia	Leung, PCK (corresponding author), Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada.	peter.leung@ubc.ca		Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research to PCKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton DPJ, 1997, CLIN CANCER RES, V3, P1579; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Billottet C, 2004, MOL BIOL CELL, V15, P4725, DOI 10.1091/mbc.E04-04-0336; Blair KJ, 2011, OTOL NEUROTOL, V32, P308, DOI 10.1097/MAO.0b013e318206fc3d; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chalkiadaki G, 2009, INT J BIOCHEM CELL B, V41, P1323, DOI 10.1016/j.biocel.2008.11.008; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; CRICKARD K, 1994, GYNECOL ONCOL, V55, P277, DOI 10.1006/gyno.1994.1290; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Darai E, 1997, HUM PATHOL, V28, P922, DOI 10.1016/S0046-8177(97)90007-1; Davidson B, 2002, MOL CELL ENDOCRINOL, V187, P39, DOI 10.1016/S0303-7207(01)00709-2; De Cecco L, 2004, ONCOGENE, V23, P8171, DOI 10.1038/sj.onc.1207979; DIBLASIO AM, 1993, AM J OBSTET GYNECOL, V169, P1517, DOI 10.1016/0002-9378(93)90428-L; Dirix LY, 1997, BRIT J CANCER, V76, P238, DOI 10.1038/bjc.1997.368; El-Hariry I, 2001, BRIT J CANCER, V84, P1656, DOI 10.1054/bjoc.2001.1813; Elloul S, 2006, VIRCHOWS ARCH, V449, P520, DOI 10.1007/s00428-006-0274-6; Elloul S, 2010, CLIN EXP METASTAS, V27, P161, DOI 10.1007/s10585-010-9315-2; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fujimoto J, 1997, EUR J GYNAECOL ONCOL, V18, P349; Giavazzi R, 2003, AM J PATHOL, V162, P1913, DOI 10.1016/S0002-9440(10)64325-8; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; GRAFF JR, 1995, CANCER RES, V55, P5195; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hajra KM, 2002, CANCER RES, V62, P1613; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Hatziapostolou M, 2006, J BIOL CHEM, V281, P32217, DOI 10.1074/jbc.M607104200; HENNIG G, 1995, ONCOGENE, V11, P475; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kamura S, 2010, BRIT J CANCER, V103, P370, DOI 10.1038/sj.bjc.6605775; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; Lau MT, 2011, ONCOGENE, V30, P2753, DOI 10.1038/onc.2011.6; Lau MT, 2012, CANCER LETT, V326, P191, DOI 10.1016/j.canlet.2012.08.016; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P2358, DOI 10.1167/iovs.05-1490; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li T, 2010, PHARM BIOL, V48, P161, DOI 10.3109/13880200903062630; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Liu H, 2009, DIABETES, V58, P663, DOI 10.2337/db07-1208; Luo J, 1999, CANCER RES, V59, P3552; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Nawrocki-Raby B, 2003, AM J PATHOL, V163, P653, DOI 10.1016/S0002-9440(10)63692-9; Nicosia SV, 2003, HEMATOL ONCOL CLIN N, V17, P927, DOI 10.1016/S0889-8588(03)00056-X; Nollet F, 1999, Mol Cell Biol Res Commun, V2, P77, DOI 10.1006/mcbr.1999.0155; Obermair A, 1998, CANCER LETT, V130, P69, DOI 10.1016/S0304-3835(98)00119-0; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Saegusa M, 2009, AM J PATHOL, V174, P2107, DOI 10.2353/ajpath.2009.081018; Sako A, 2003, J SURG RES, V115, P113, DOI 10.1016/S0022-4804(03)00307-X; Salgado R., 2004, Angiogenesis, V7, P29, DOI 10.1023/B:AGEN.0000037331.14489.0b; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Secord AA, 2007, GYNECOL ONCOL, V106, P221, DOI 10.1016/j.ygyno.2007.03.021; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Van der Poel HG, 2004, J UROLOGY, V172, P1333, DOI 10.1097/01.ju.0000138829.97838.19; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wesley UV, 2005, CANCER RES, V65, P1325, DOI 10.1158/0008-5472.CAN-04-1852; Wu C, 2008, DIFFERENTIATION, V76, P193, DOI 10.1111/j.1432-0436.2007.00193.x; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149; Wu JC, 2008, EXP CELL RES, V314, P421, DOI 10.1016/j.yexcr.2007.10.002; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774; Yu YC, 2006, CLIN EXP METASTAS, V23, P65, DOI 10.1007/s10585-006-9020-3	68	77	86	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59083	10.1371/journal.pone.0059083	http://dx.doi.org/10.1371/journal.pone.0059083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554977	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800057
J	Milan-Lobo, L; Enquist, J; van Rijn, RM; Whistler, JL				Milan-Lobo, Laura; Enquist, Johan; van Rijn, Richard M.; Whistler, Jennifer L.			Anti-Analgesic Effect of the Mu/Delta Opioid Receptor Heteromer Revealed by Ligand-Biased Antagonism	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MORPHINE-TOLERANCE; PHYSICAL-DEPENDENCE; REDUCES TOLERANCE; DELTA; MU; TRAFFICKING; ANALGESIA; OPIATE; PAIN	Delta (DOR) and mu opioid receptors (MOR) can complex as heteromers, conferring functional properties in agonist binding, signaling and trafficking that can differ markedly from their homomeric counterparts. Because of these differences, DOR/MOR heteromers may be a novel therapeutic target in the treatment of pain. However, there are currently no ligands selective for DOR/MOR heteromers, and, consequently, their role in nociception remains unknown. In this study, we used a pharmacological opioid cocktail that selectively activates and stabilizes the DOR/MOR heteromer at the cell surface by blocking its endocytosis to assess its role in antinociception. We found that mice treated chronically with this drug cocktail showed a significant right shift in the ED50 for opioid-mediated analgesia, while mice treated with a drug that promotes degradation of the heteromer did not. Furthermore, promoting degradation of the DOR/MOR heteromer after the right shift in the ED50 had occurred, or blocking signal transduction from the stabilized DOR/MOR heteromer, shifted the ED50 for analgesia back to the left. Taken together, these data suggest an anti-analgesic role for the DOR/MOR heteromer in pain. In conclusion, antagonists selective for DOR/MOR heteromer could provide an avenue for alleviating reduced analgesic response during chronic pain treatment.	[Milan-Lobo, Laura; Enquist, Johan; van Rijn, Richard M.; Whistler, Jennifer L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Whistler, Jennifer L.] Univ Calif San Francisco, Dept Neurol, Emeryville, CA USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	Whistler, JL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA.	jwhistler@gallo.ucsf.edu	van Rijn, Richard M./I-8790-2019	van Rijn, Richard M./0000-0002-9957-1633	Austrian Science Fund (FWF) [J2967-B09]; European Molecular Biology Organization (EMBO) [ALTF1229-2006]; Foundation for Alcohol Research-ABMRF (RMVR), National Institutes of Health (NIH) [DA015232, DA019958, AA020539]; State of California through the University of California San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K99AA020539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019958, R01DA015232] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Foundation for Alcohol Research-ABMRF (RMVR), National Institutes of Health (NIH); State of California through the University of California San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by a Schrodinger fellowship from the Austrian Science Fund (FWF) (J2967-B09 to LML), a European Molecular Biology Organization (EMBO) long term fellowship (ALTF1229-2006 to JE), Foundation for Alcohol Research-ABMRF (RMVR), National Institutes of Health (NIH) grants DA015232, DA019958 (both to JLW) and AA020539 (RMVR), and by funds provided by the State of California for medical research through the University of California San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHAMID EE, 1991, J PHARMACOL EXP THER, V258, P299; Abul-Husn NS, 2007, BRIT J PHARMACOL, V151, P877, DOI 10.1038/sj.bjp.0707277; Arttamangkul S, 2008, MOL PHARMACOL, V74, P972, DOI 10.1124/mol.108.048512; Bailey CP, 2005, CURR OPIN PHARMACOL, V5, P60, DOI 10.1016/j.coph.2004.08.012; Bie BH, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-37; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Daniels DJ, 2005, P NATL ACAD SCI USA, V102, P19208, DOI 10.1073/pnas.0506627102; Dykstra LA, 2002, PSYCHOPHARMACOLOGY, V163, P420, DOI 10.1007/s00213-002-1100-8; Fan T, 2005, J BIOL CHEM, V280, P38478, DOI 10.1074/jbc.M505644200; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; FUNDYTUS ME, 1995, EUR J PHARMACOL, V286, P105, DOI 10.1016/0014-2999(95)00554-X; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gomes I, 2011, MOL PHARMACOL, V79, P1044, DOI 10.1124/mol.110.070847; Gupta A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000807; Hasbi A, 2007, BIOCHEMISTRY-US, V46, P12997, DOI 10.1021/bi701436w; He L, 2005, CURR BIOL, V15, P1028, DOI 10.1016/j.cub.2005.04.052; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hepburn MJ, 1997, J PHARMACOL EXP THER, V281, P1350; Kabli N, 2010, BRIT J PHARMACOL, V161, P1122, DOI 10.1111/j.1476-5381.2010.00944.x; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kest B, 1996, BRAIN RES BULL, V39, P185, DOI 10.1016/0361-9230(95)02092-6; Kim JA, 2008, CURR BIOL, V18, P129, DOI 10.1016/j.cub.2007.12.057; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; McNaull B, 2007, EUR J PHARMACOL, V560, P132, DOI 10.1016/j.ejphar.2006.12.013; Mercadante S, 2001, J CLIN ONCOL, V19, P2898, DOI 10.1200/JCO.2001.19.11.2898; Mercadante S, 2009, J PAIN SYMPTOM MANAG, V37, P632, DOI 10.1016/j.jpainsymman.2007.12.024; Milan-Lobo L, 2011, J PHARMACOL EXP THER, V337, P868, DOI 10.1124/jpet.111.179093; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Stevenson GW, 2003, J PHARMACOL EXP THER, V307, P1054, DOI 10.1124/jpet.103.056515; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Wang HB, 2010, P NATL ACAD SCI USA, V107, P13117, DOI 10.1073/pnas.1008382107; Zhang Z, 2010, J NEUROSCI, V30, P4735, DOI 10.1523/JNEUROSCI.5968-09.2010; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3	40	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58362	10.1371/journal.pone.0058362	http://dx.doi.org/10.1371/journal.pone.0058362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554887	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800014
J	Monroy, PLC; Grefte, S; Kuijpers-Jagtman, AM; Helmich, MPAC; Ulrich, DJO; Von den Hoff, JW; Wagener, FADTG				Monroy, Paola L. Carvajal; Grefte, Sander; Kuijpers-Jagtman, Anne M.; Helmich, Maria P. A. C.; Ulrich, Dietmar J. O.; Von den Hoff, Johannes W.; Wagener, Frank A. D. T. G.			A Rat Model for Muscle Regeneration in the Soft Palate	PLOS ONE			English	Article							LEVATOR VELI-PALATINI; ADULT SKELETAL-MUSCLE; CLEFT-PALATE; SATELLITE CELLS; EUSTACHIAN-TUBE; VELOPHARYNGEAL INSUFFICIENCY; CHILDREN BORN; MICE LACKING; STEM-CELL; DIFFERENTIATION	Background: Children with a cleft in the soft palate have difficulties with speech, swallowing, and sucking. Despite successful surgical repositioning of the muscles, optimal function is often not achieved. Scar formation and defective regeneration may hamper the functional recovery of the muscles after cleft palate repair. Therefore, the aim of this study is to investigate the anatomy and histology of the soft palate in rats, and to establish an in vivo model for muscle regeneration after surgical injury. Methods: Fourteen adult male Sprague Dawley rats were divided into four groups. Groups 1 (n = 4) and 2 (n = 2) were used to investigate the anatomy and histology of the soft palate, respectively. Group 3 (n = 6) was used for surgical wounding of the soft palate, and group 4 (n = 2) was used as unwounded control group. The wounds (1 mm) were evaluated by (immuno) histochemistry (AZAN staining, Pax7, MyoD, MyoG, MyHC, and ASMA) after 7 days. Results: The present study shows that the anatomy and histology of the soft palate muscles of the rat is largely comparable with that in humans. All wounds showed clinical evidence of healing after 7 days. AZAN staining demonstrated extensive collagen deposition in the wound area, and initial regeneration of muscle fibers and salivary glands. Proliferating and differentiating satellite cells were identified in the wound area by antibody staining. Conclusions: This model is the first, suitable for studying muscle regeneration in the rat soft palate, and allows the development of novel adjuvant strategies to promote muscle regeneration after cleft palate surgery.	[Monroy, Paola L. Carvajal; Kuijpers-Jagtman, Anne M.; Von den Hoff, Johannes W.; Wagener, Frank A. D. T. G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands; [Grefte, Sander; Helmich, Maria P. A. C.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands; [Ulrich, Dietmar J. O.] Radboud Univ Nijmegen, Med Ctr, Dept Plast & Reconstruct Surg, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Von den Hoff, JW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.	h.vondenhoff@dent.umcn.nl	Ulrich, D.J.O./H-8099-2014; Wagener, Frank/O-6225-2014; Von den Hoff, Johannes W/L-8762-2015; Kuijpers-Jagtman, Anne Marie/A-9413-2008	Wagener, Frank/0000-0003-4837-1559; Kuijpers-Jagtman, Anne Marie/0000-0001-8172-0090	The Netherlands Organization for Scientific Research (NWO) [017.009.009]	The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was partly funded by a Mosaic grant (017.009.009) from The Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALBIIN N, 1983, ANAT REC, V207, P513, DOI 10.1002/ar.1092070313; Andersson EM, 2010, CLEFT PALATE-CRAN J, V47, P335, DOI 10.1597/07-230.1; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Bae YC, 2002, ANN PLAS SURG, V48, P359, DOI 10.1097/00000637-200204000-00004; BOORMAN JG, 1985, BRIT J PLAST SURG, V38, P333, DOI 10.1016/0007-1226(85)90237-1; Braithwaite F, 1968, Br J Plast Surg, V21, P60, DOI 10.1016/S0007-1226(68)80087-6; Calzolari E, 2007, AM J MED GENET A, V143A, P528, DOI 10.1002/ajmg.a.31447; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Danoviz ME, 2012, METHODS MOL BIOL, V798, P21, DOI 10.1007/978-1-61779-343-1_2; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; FARA M, 1970, PLAST RECONSTR SURG, V46, P488; Fukushima K, 2001, AM J SPORT MED, V29, P394, DOI 10.1177/03635465010290040201; FURUSAWA K, 1991, BRAIN RES BULL, V26, P599, DOI 10.1016/0361-9230(91)90101-O; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; Grefte S, 2010, REGEN MED, V5, P737, DOI 10.2217/RME.10.69; Grefte S, 2010, MED SCI SPORT EXER, V42, P813, DOI 10.1249/MSS.0b013e3181beeb52; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Huang MHS, 1997, PLAST RECONSTR SURG, V100, P833, DOI 10.1097/00006534-199709001-00003; Huang MHS, 1998, PLAST RECONSTR SURG, V101, P613, DOI 10.1097/00006534-199803000-00007; Hwang K, 2009, J CRANIOFAC SURG, V20, P1591, DOI 10.1097/SCS.0b013e3181b0dbb2; Inman DS, 2005, BRIT J PLAST SURG, V58, P1051, DOI 10.1016/j.bjps.2005.05.019; Jackson WM, 2010, EXPERT OPIN BIOL TH, V10, P505, DOI 10.1517/14712591003610606; Kelly RG, 2010, EXP CELL RES, V316, P3034, DOI 10.1016/j.yexcr.2010.04.029; Kirschner RE, 1999, PLAST RECONSTR SURG, V104, P1998, DOI 10.1097/00006534-199912000-00009; Koo SH, 2001, PLAST RECONSTR SURG, V108, P938, DOI 10.1097/00006534-200109150-00018; Kuehn DP, 2003, AM J SPEECH-LANG PAT, V12, P103, DOI 10.1044/1058-0360(2003/056); Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Marrinan EM, 1998, CLEFT PALATE-CRAN J, V35, P95, DOI 10.1597/1545-1569(1998)035<0095:VFINCP>2.3.CO;2; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Monroy PLC, 2012, TISSUE ENG PART B-RE, V18, P468, DOI [10.1089/ten.TEB.2012.0049, 10.1089/ten.teb.2012.0049]; Moon JB, 1998, CLEFT PALATE-CRAN J, V35, P419, DOI 10.1597/1545-1569(1998)035<0419:MFTDIT>2.3.CO;2; Morris H L, 1973, Cleft Palate J, V10, P62; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Mulder JJS, 1999, ANN OTO RHINOL LARYN, V108, P277, DOI 10.1177/000348949910800311; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nathan E, 2008, DEVELOPMENT, V135, P647, DOI 10.1242/dev.007989; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Pavlath GK, 1998, DEV DYNAM, V212, P495, DOI 10.1002/(SICI)1097-0177(199808)212:4<495::AID-AJA3>3.3.CO;2-I; Persson C, 2002, CLEFT PALATE-CRAN J, V39, P397, DOI 10.1597/1545-1569(2002)039<0397:SOIICP>2.0.CO;2; Phua YS, 2008, CLEFT PALATE-CRAN J, V45, P172, DOI 10.1597/06-205.1; RINTALA AE, 1995, BRIT J ORAL MAX SURG, V33, P295, DOI 10.1016/0266-4356(95)90040-3; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Stal PS, 2000, J ANAT, V197, P275, DOI 10.1017/S0021878299006627; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; Yablonka-Reuveni Z, 1999, DEV BIOL, V210, P440, DOI 10.1006/dbio.1999.9284; Yablonka-Reuveni Z, 2011, J HISTOCHEM CYTOCHEM, V59, P1041, DOI 10.1369/0022155411426780; YAMAOKA M, 1992, CLEFT PALATE-CRAN J, V29, P271, DOI 10.1597/1545-1569(1992)029<0271:MSDITL>2.3.CO;2; Yasuda K, 2003, BRAIN RES, V968, P80, DOI 10.1016/S0006-8993(02)04273-7; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	57	22	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59193	10.1371/journal.pone.0059193	http://dx.doi.org/10.1371/journal.pone.0059193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554995	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800069
J	Zhang, XJ; Hao, LL; Meng, LJ; Liu, ML; Zhao, LN; Hu, F; Ding, CB; Wang, Y; He, BL; Pan, YX; Fang, W; Chen, J; Hu, SN; Jia, MC				Zhang, Xiujun; Hao, Lili; Meng, Lijun; Liu, Meiling; Zhao, Lina; Hu, Fen; Ding, Cunbao; Wang, Yang; He, Baoling; Pan, Yuxin; Fang, Wei; Chen, Jing; Hu, Songnian; Jia, Mengchun			Digital Gene Expression Tag Profiling Analysis of the Gene Expression Patterns Regulating the Early Stage of Mouse Spermatogenesis	PLOS ONE			English	Article							CELL JUNCTION DYNAMICS; RHO GTPASES; SERTOLI; TESTIS; PATHWAY; AP-1; ACTIVATION; APOPTOSIS; ONTOLOGY; KINASE	Detailed characterization of the gene expression patterns in spermatogonia and primary spermatocytes is critical to understand the processes which occur prior to meiosis during normal spermatogenesis. The genome-wide expression profiles of mouse type B spermatogonia and primary spermatocytes were investigated using the Solexa/Illumina digital gene expression (DGE) system, a tag based high-throughput transcriptome sequencing method, and the developmental processes which occur during early spermatogenesis were systematically analyzed. Gene expression patterns vary significantly between mouse type B spermatogonia and primary spermatocytes. The functional analysis revealed that genes related to junction assembly, regulation of the actin cytoskeleton and pluripotency were most significantly differently expressed. Pathway analysis indicated that the Wnt non-canonical signaling pathway played a central role and interacted with the actin filament organization pathway during the development of spermatogonia. This study provides a foundation for further analysis of the gene expression patterns and signaling pathways which regulate the molecular mechanisms of early spermatogenesis.	[Zhang, Xiujun; Zhao, Lina; Hu, Fen; Ding, Cunbao; Wang, Yang; He, Baoling; Pan, Yuxin; Fang, Wei; Chen, Jing] Hebei United Univ, Coll Life Sci, Tangshan, Hebei, Peoples R China; [Zhang, Xiujun; Liu, Meiling; Jia, Mengchun] Natl Res Inst Family Planning, Dept Reprod Endocrinol, Beijing, Peoples R China; [Hao, Lili; Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Meng, Lijun] Tangshan Coll, Dept Environm & Chem Engn, Tangshan, Hebei, Peoples R China	North China University of Science & Technology; National Research Institute for Family Planning - China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Hu, SN (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	husn@big.ac.cn; mengchunjia@163.com	meng, li/GVT-2063-2022; Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	National Natural Science Foundation of China [81170616, 81072093, 30671092]; Natural Science Foundation of Hebei Province [C2009001260, C2012401039]; Scientific and Technical Supporting Programs of Hebei Province [10276109D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Scientific and Technical Supporting Programs of Hebei Province	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81170616; 81072093; 30671092), the Natural Science Foundation of Hebei Province (C2009001260; C2012401039) and the Scientific and Technical Supporting Programs of Hebei Province (No. 10276109D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; Anderson DH, 2006, PROG LIPID RES, V45, P102, DOI 10.1016/j.plipres.2005.12.003; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; BUSH J, 1993, GENE, V136, P61, DOI 10.1016/0378-1119(93)90448-C; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Chu DS, 2013, ADV EXP MED BIOL, V757, P171, DOI 10.1007/978-1-4614-4015-4_7; Cory AT, 2007, MOL REPROD DEV, V74, P1491, DOI 10.1002/mrd.20722; DYM M, 1994, ENDOCR REV, V15, P102, DOI 10.1210/er.15.1.102; Gad AKB, 2010, CELL SIGNAL, V22, P183, DOI 10.1016/j.cellsig.2009.10.001; Gauglhofer C, 2011, HEPATOLOGY, V53, P854, DOI 10.1002/hep.24099; Guttman JA, 2004, BIOL REPROD, V70, P805, DOI 10.1095/biolreprod.103.022723; Habas R, 2006, METHOD ENZYMOL, V406, P500, DOI 10.1016/S0076-6879(06)06038-1; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Ishida-Takagishi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1861; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Lee S. H., 2010, MOL CELLS, V29, P311, DOI DOI 10.1007/s10059-010-0053-8; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Li Michelle Wm, 2011, Spermatogenesis, V1, P123, DOI 10.4161/spmg.1.2.16393; Lie PPY, 2010, PHILOS T R SOC B, V365, P1581, DOI 10.1098/rstb.2009.0261; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Lui WY, 2009, J MOL ENDOCRINOL, V43, P43, DOI 10.1677/JME-08-0174; Lui WY, 2003, BBA-MOL CELL RES, V1593, P121, DOI 10.1016/S0167-4889(02)00348-8; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Mezzacappa Courtney, 2012, Methods Mol Biol, V839, P119, DOI 10.1007/978-1-61779-510-7_10; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rossi P, 2004, GENE EXPR PATTERNS, V4, P267, DOI 10.1016/j.modgep.2003.11.003; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Siu ER, 2009, P NATL ACAD SCI USA, V106, P9298, DOI 10.1073/pnas.0813113106; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Ward KK, 2012, CLIN EXP METASTASIS; Warr N, 2009, DEV BIOL, V326, P273, DOI 10.1016/j.ydbio.2008.11.023; Wong EW, 2012, FASEB J; Xiao X, 2013, HUM REPROD UPDATE; Xiao Y, 2007, CANCER BIOL THER, V6, P1044, DOI 10.4161/cbt.6.7.4317; Young J'nelle S, 2012, Spermatogenesis, V2, P63; Zhou X, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-246	46	19	20	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58680	10.1371/journal.pone.0058680	http://dx.doi.org/10.1371/journal.pone.0058680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554914	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800022
J	Vittori, M; Rozman, A; Grdadolnik, J; Novak, U; Strus, J				Vittori, Milos; Rozman, Alenka; Grdadolnik, Joze; Novak, Urban; Strus, Jasna			Mineral Deposition in Bacteria-Filled and Bacteria-Free Calcium Bodies in the Crustacean Hyloniscus riparius (Isopoda: Oniscidea)	PLOS ONE			English	Article							TITANETHES-ALBUS CRUSTACEA; PORCELLIO-SCABER; TERRESTRIAL ISOPODS; RAMAN-SPECTROSCOPY; CARBONATE; TRANSPORT; STORAGE; CUTICLE; ULTRASTRUCTURE; MORPHOLOGY	Crustacean calcium bodies are epithelial sacs which contain a mineralized matrix. The objectives of this study were to describe the microscopic anatomy of calcium bodies in the terrestrial isopod Hyloniscus riparius and to establish whether they undergo molt-related structural changes. We performed 3D reconstruction of the calcium bodies from paraffin sections and analyzed their structure with light and electron microscopy. In addition, we analyzed the chemical composition of their mineralized matrices with micro-Raman spectroscopy. Two pairs of these organs are present in H. riparius. One pair is filled with bacteria while the other pair is not. In non-molting animals, the bacteria-filled calcium bodies contain apatite crystals and the bacteria-free calcium bodies enclose CaCO3-containing concretions with little organic matrix. During preparation for molt, an additional matrix layer is deposited in both pairs of calcium bodies. In the bacteria-filled calcium bodies it contains a mixture of calcium carbonate and calcium phosphate, whereas only calcium carbonate is present in bacteria-free calcium bodies. After ecdysis, all mineral components in bacteria-free calcium bodies and the additional matrix layer in bacteria-filled calcium bodies are completely resorbed. During calcium resorption, the apical surface of the calcium body epithelium is deeply folded and electron dense granules are present in spaces between epithelial cells. Our results indicate that the presence of bacteria might be linked to calcium phosphate mineralization. Calcium bodies likely provide a source of calcium and potentially phosphate for the mineralization of the new cuticle after molt. Unlike other terrestrial isopods, H. riparius does not form sternal CaCO3 deposits and the bacteria-free calcium bodies might functionally replace them in this species.	[Vittori, Milos; Rozman, Alenka; Strus, Jasna] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia; [Grdadolnik, Joze; Novak, Urban] Natl Inst Chem, Ljubljana, Slovenia; [Grdadolnik, Joze] Ctr Excellence, EN FIST, Ljubljana, Slovenia	University of Ljubljana; National Institute of Chemistry - Slovenia	Vittori, M (corresponding author), Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia.	milos.vittori@gmail.com	Strus, Jasna/I-4376-2019	Grdadolnik, Joze/0000-0002-0312-168X	Slovenian Research Agency (ARRS) [1000-09-310037]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	This work was financed by the Slovenian Research Agency (ARRS), grant No 1000-09-310037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva-Tal A, 2011, P NATL ACAD SCI USA, V108, P14763, DOI 10.1073/pnas.1102608108; Rivadeneyra MA, 2010, ISME J, V4, P922, DOI 10.1038/ismej.2010.17; Awonusi A, 2007, CALCIFIED TISSUE INT, V81, P46, DOI 10.1007/s00223-007-9034-0; Becker A, 2003, DALTON T, P551, DOI 10.1039/b210529b; Bentov S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1839; Billen J, 2000, ARTHROPOD STRUCT DEV, V29, P259, DOI 10.1016/S1467-8039(00)00029-3; Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Frost RL, 2012, J RAMAN SPECTROSC, V43, P571, DOI 10.1002/jrs.3063; Gal JY, 1996, TALANTA, V43, P1497, DOI 10.1016/0039-9140(96)01925-X; Glotzner J, 2000, ARTHROPOD STRUCT DEV, V29, P241, DOI 10.1016/S1467-8039(00)00030-X; GRAF F, 1985, CELL TISSUE RES, V242, P83; GREENAWAY P, 1991, ACTA ZOOL-STOCKHOLM, V72, P29, DOI 10.1111/j.1463-6395.1991.tb00313.x; Hild S, 2008, J STRUCT BIOL, V163, P100, DOI 10.1016/j.jsb.2008.04.010; Hild S, 2009, J STRUCT BIOL, V168, P426, DOI 10.1016/j.jsb.2009.07.017; HIRSCHLER A, 1990, FEMS MICROBIOL ECOL, V73, P211, DOI 10.1016/0378-1097(90)90732-6; Kazanci M, 2006, CALCIFIED TISSUE INT, V79, P354, DOI 10.1007/s00223-006-0011-9; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; Luquet G, 2012, ZOOKEYS, P103, DOI 10.3897/zookeys.176.2318; MCFALLNGAI M, 1990, BIOL BULL, V179, P332, DOI 10.2307/1542325; Mehely LV, 1932, STUDIA ZOOL, V2, P103; Neues F, 2007, CRYSTENGCOMM, V9, P1245, DOI 10.1039/b710789g; Penel G, 1999, BONE, V25, p81S, DOI 10.1016/S8756-3282(99)00139-8; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; ROER R, 1984, AM ZOOL, V24, P893; Rosch P, 2005, APPL ENVIRON MICROB, V71, P1626, DOI 10.1128/AEM.71.3.1626-1637.2005; RUTT HN, 1974, J PHYS C SOLID STATE, V7, P4522, DOI 10.1088/0022-3719/7/24/015; Schmidt Christian, 2008, Arthropod Systematics & Phylogeny, V66, P191; Seidl B, 2011, J STRUCT BIOL, V174, P512, DOI 10.1016/j.jsb.2011.03.005; Simcic T, 2010, MAR FRESHW BEHAV PHY, V43, P149, DOI 10.1080/10236244.2010.483052; STEEL CGH, 1993, CAN J ZOOL, V71, P4, DOI 10.1139/z93-002; Strus J, 2001, CRUSTACEAN ISS, V13, P343; Tas AC, 2009, J AM CERAM SOC, V92, P2907, DOI 10.1111/j.1551-2916.2009.03351.x; Tlili MM, 2002, J RAMAN SPECTROSC, V33, P10, DOI 10.1002/jrs.806; VERHOEFF K. W., 1926, [MITTEIL BULGARISCHEN ENT GES], V3, P135; Vittori M, 2012, J STRUCT BIOL, V180, P216, DOI 10.1016/j.jsb.2012.05.014; Vittori M, 2012, ZOOKEYS, P23, DOI 10.3897/zookeys.176.2285; Wehrmeister U, 2010, J RAMAN SPECTROSC, V41, P193, DOI 10.1002/jrs.2438; Welch SA, 2002, GEOMICROBIOL J, V19, P343, DOI 10.1080/01490450290098414; Zidar P, 1998, CRUSTACEANA, V71, P646, DOI 10.1163/156854098X00644; Ziegler A, 2003, CRUSTACEANA MONOGR, V2, P299; Ziegler A, 2005, MICRON, V36, P137, DOI 10.1016/j.micron.2004.09.006; Ziegler A, 2002, CELL CALCIUM, V31, P307, DOI 10.1016/S0143-4160(02)00060-X; Ziegler A, 1997, ZOOMORPHOLOGY, V117, P181, DOI 10.1007/s004350050043; Ziegler A, 1996, CELL TISSUE RES, V284, P459, DOI 10.1007/s004410050606	47	6	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58968	10.1371/journal.pone.0058968	http://dx.doi.org/10.1371/journal.pone.0058968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554963	gold, Green Published, Green Submitted			2022-12-25	WOS:000316252500060
J	Wang, YP; Cheng, ML; Zhang, BF; Nie, F; Jiang, HM				Wang, Yuping; Cheng, Mingliang; Zhang, Baofang; Nie, Fei; Jiang, Hongmei			Dietary Supplementation of Blueberry Juice Enhances Hepatic Expression of Metallothionein and Attenuates Liver Fibrosis in Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; INDUCED DNA; INJURY; OXYGEN; MICE; PROANTHOCYANIDIN; STEATOSIS; PROTEIN; LEAVES; DAMAGE	Aim: To investigate the effect of blueberry juice intake on rat liver fibrosis and its influence on hepatic antioxidant defense. Methods: Rabbiteye blueberry was used to prepare fresh juice to feed rats by daily gastric gavage. Dan-shao-hua-xian capsule (DSHX) was used as a positive control for liver fibrosis protection. Liver fibrosis was induced in male Sprague-Dawley rats by subcutaneous injection of CCl4 and feeding a high-lipid/low-protein diet for 8 weeks. Hepatic fibrosis was evaluated by Masson staining. The expression of alpha-smooth muscle actin (alpha-SMA) and collagen III (Col III) were determined by immunohistochemical techniques. The activities of superoxide dismutase (SOD) and malondialdehyde (MDA) in liver homogenates were determined. Metallothionein (MT) expression was detected by real-time RT-PCR and immunohistochemical techniques. Results: Blueberry juice consumption significantly attenuates CCl4-induced rat hepatic fibrosis, which was associated with elevated expression of metallothionein (MT), increased SOD activity, reduced oxidative stress, and decreased levels of alpha-SMA and Col III in the liver. Conclusion: Our study suggests that dietary supplementation of blueberry juice can augment antioxidative capability of the liver presumably via stimulating MT expression and SOD activity, which in turn promotes HSC inactivation and thus decreases extracellular matrix collagen accumulation in the liver, and thereby alleviating hepatic fibrosis.	[Wang, Yuping; Jiang, Hongmei] Guiyang Med Coll, Dept Clin Microbiol & Immunol, Affiliated Hosp, Guiyang, Guizhou Provinc, Peoples R China; [Cheng, Mingliang; Zhang, Baofang] Guiyang Med Coll, Dept Infect Dis, Affiliated Hosp, Guiyang, Guizhou Provinc, Peoples R China; [Nie, Fei] Guizhou Acad Sci, Guiyang, Guizhou Provinc, Peoples R China	Guizhou Medical University; Guizhou Medical University	Cheng, ML (corresponding author), Guiyang Med Coll, Dept Infect Dis, Affiliated Hosp, Guiyang, Guizhou Provinc, Peoples R China.	chengml@21cn.com			Department of Science and Technology of Guizhou Province for Traditional Chinese Medicine Modernization [ZY[2012]3017]; Foundation of the Governor of Guizhou Province [[2012] 44]; National Foundation for Educational Teams of China [[2009]12]	Department of Science and Technology of Guizhou Province for Traditional Chinese Medicine Modernization; Foundation of the Governor of Guizhou Province; National Foundation for Educational Teams of China	This study was supported by a grant from the Department of Science and Technology of Guizhou Province for Traditional Chinese Medicine Modernization (Grant No. ZY[2012]3017), a grant from the Foundation of the Governor of Guizhou Province ([2012] 44), and a grant from the National Foundation for Educational Teams of China ([2009]12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai L, 2000, J BIOL CHEM, V275, P38957, DOI 10.1074/jbc.C000593200; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Carrera G, 2003, AM J GASTROENTEROL, V98, P1142; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Cherian MG, 2006, EXP BIOL MED, V231, P138; Chiaverini N, 2010, FREE RADICAL RES, V44, P605, DOI 10.3109/10715761003692511; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Eum WS, 2004, FREE RADICAL BIO MED, V37, P339, DOI 10.1016/j.freeradbiomed.2004.04.036; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Geng Xiao-Xia, 2004, Hepatobiliary Pancreat Dis Int, V3, P558; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jiang YC, 2004, MOL THER, V10, P1130, DOI 10.1016/j.ymthe.2004.08.011; Kang YJ, 2006, EXP BIOL MED, V231, P1459, DOI 10.1177/153537020623100903; Koh M, 2001, B KOREAN CHEM SOC, V22, P362; Lai MMC, 2002, GASTROENTEROLOGY, V122, P568, DOI 10.1053/gast.2002.31474; Ming LC, 2008, HEPATIC FIBROSIS, P3; Nachman-Clewner M, 2008, INVEST OPHTH VIS SCI, V49, P3207, DOI 10.1167/iovs.07-1039; Osman N, 2007, DIGEST LIVER DIS, V39, P849, DOI 10.1016/j.dld.2007.06.001; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Prior RL, 2000, J AOAC INT, V83, P950; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; Tahan G, 2007, DIGEST DIS SCI, V52, P3348, DOI 10.1007/s10620-006-9717-9; Tahan V, 2004, J PINEAL RES, V37, P78, DOI 10.1111/j.1600-079X.2004.00137.x; Takami Y, 2010, HEPATOL RES, V40, P337, DOI 10.1111/j.1872-034X.2009.00589.x; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; Wang YD, 2000, WORLD J GASTRONET S3, V6, P73; Wang YP, 2010, ZHONG HUA YI XUE ZA, V9, P2504; Wang YP, 2010, WORLD J GASTROENTERO, V16, P2657, DOI 10.3748/wjg.v16.i21.2657; Wang YP, 2010, HEPATOB PANCREAT DIS, V9, P164; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8418, DOI 10.1021/jf801381y; Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w; Yang Q, 2005, WORLD J GASTROENTERO, V11, P4953, DOI 10.3748/wjg.v11.i32.4953	35	26	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58659	10.1371/journal.pone.0058659	http://dx.doi.org/10.1371/journal.pone.0058659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554912	gold, Green Published, Green Submitted			2022-12-25	WOS:000316252500038
J	Yang, ZX; Han, ZB; Ji, YR; Wang, YW; Liang, L; Chi, Y; Yang, SG; Li, LN; Luo, WF; Li, JP; Chen, DD; Du, WJ; Cao, XC; Zhuo, GS; Wang, T; Han, ZC				Yang, Zhou Xin; Han, Zhi-Bo; Ji, Yue Ru; Wang, You Wei; Liang, Lu; Chi, Ying; Yang, Shao Guang; Li, Li Na; Luo, Wei Feng; Li, Jian Ping; Chen, Dan Dan; Du, Wen Jing; Cao, Xiao Cang; Zhuo, Guang Sheng; Wang, Tao; Han, Zhong Chao			CD106 Identifies a Subpopulation of Mesenchymal Stem Cells with Unique Immunomodulatory Properties	PLOS ONE			English	Article							HUMAN BONE-MARROW; STROMAL CELLS; UMBILICAL-CORD; HUMAN PLACENTA; IFN-GAMMA; ADHESION MOLECULE-1; ADIPOSE-TISSUE; TNF-ALPHA; EXPRESSION; TOLERANCE	Mesenchymal stem cells (MSCs) reside in almost all of the body tissues, where they undergo self-renewal and multi-lineage differentiation. MSCs derived from different tissues share many similarities but also show some differences in term of biological properties. We aim to search for significant differences among various sources of MSCs and to explore their implications in physiopathology and clinical translation. We compared the phenotype and biological properties among different MSCs isolated from human term placental chorionic villi (CV), umbilical cord (UC), adult bone marrow (BM) and adipose (AD). We found that CD106 (VCAM-1) was expressed highest on the CV-MSCs, moderately on BM-MSCs, lightly on UC-MSCs and absent on AD-MSCs. CV-MSCs also showed unique immune-associated gene expression and immunomodulation. We thus separated CD106(+) cells and CD106(-) cells from CV-MSCs and compared their biological activities. Both two subpopulations were capable of osteogenic and adipogenic differentiation while CD106(+) CV-MSCs were more effective to modulate T helper subsets but possessed decreased colony formation capacity. In addition, CD106(+) CV-MSCs expressed more cytokines than CD106(-) CV-MSCs. These data demonstrate that CD106 identifies a subpopulation of CV-MSCs with unique immunoregulatory activity and reveal a previously unrecognized mechanism underlying immunomodulation of MSCs.	[Yang, Zhou Xin; Han, Zhi-Bo; Ji, Yue Ru; Wang, You Wei; Chi, Ying; Yang, Shao Guang; Li, Jian Ping; Chen, Dan Dan; Du, Wen Jing; Han, Zhong Chao] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Yang, Zhou Xin; Han, Zhi-Bo; Ji, Yue Ru; Wang, You Wei; Chi, Ying; Yang, Shao Guang; Li, Jian Ping; Chen, Dan Dan; Du, Wen Jing; Han, Zhong Chao] Chinese Acad Med Sci, Hosp Blood Dis, Tianjin, Peoples R China; [Yang, Zhou Xin; Han, Zhi-Bo; Ji, Yue Ru; Wang, You Wei; Chi, Ying; Yang, Shao Guang; Li, Jian Ping; Chen, Dan Dan; Du, Wen Jing; Han, Zhong Chao] Peking Union Med Coll, Tianjin, Peoples R China; [Wang, You Wei; Liang, Lu; Han, Zhong Chao] Natl Engn Res Ctr Cell Prod, Tianjin, Peoples R China; [Han, Zhi-Bo; Liang, Lu; Zhuo, Guang Sheng; Wang, Tao] Beijing Inst Hlth & Stem Cells, Beijing, Peoples R China; [Li, Li Na; Luo, Wei Feng] Jinan Univ, Sch Med, Guangzhou, Guangdong, Peoples R China; [Cao, Xiao Cang] Tianjin Med Univ, Tianjin Med Univ Gen Hosp, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jinan University; Tianjin Medical University	Han, ZC (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China.	hanzhongchao@hotmail.com	Li, Jianping/Q-1618-2019; Wang, Youwei/M-4544-2019; Han, Zhong Chao/D-7157-2016; Chen, Dan/GRY-2691-2022; Li, Jianping/U-6806-2017; Du, Weiting/C-9971-2014	Han, Zhong Chao/0000-0002-2687-7682; Chen, Dan/0000-0002-1570-9034; cao, xiaocang/0000-0001-8376-3481	863 project [2011AA020118]; 973 program of China from the Ministry Science & Technology of China [2011 CB964800, 2011CB964802]	863 project(National High Technology Research and Development Program of China); 973 program of China from the Ministry Science & Technology of China	This study was supported by the 863 project (Grant no. 2011AA020118) and the 973 program of China 2011 CB964800 (Grant no. 2011CB964802) from the Ministry Science & Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Bernardo ME, 2007, CONNECT TISSUE RES, V48, P132, DOI 10.1080/03008200701228464; Bieback K, 2008, BIO-MED MATER ENG, V18, pS71; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Cesario A, 2011, CURR MED CHEM, V18, P2263, DOI 0929-8673/11 $58.00+.00; Chen K, 2010, CLIN IMMUNOL, V135, P448, DOI 10.1016/j.clim.2010.01.015; D'Addio F, 2011, J IMMUNOL, V187, P4530, DOI 10.4049/jimmunol.1002031; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Gieseke F, 2010, BLOOD, V116, P3770, DOI 10.1182/blood-2010-02-270777; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Hsieh JY, 2010, STEM CELLS DEV, V19, P1895, DOI 10.1089/scd.2009.0485; Hwang JH, 2009, J KOREAN MED SCI, V24, P547, DOI 10.3346/jkms.2009.24.4.547; Jansen BJH, 2010, STEM CELLS DEV, V19, P481, DOI 10.1089/scd.2009.0288; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; KWEE L, 1995, DEVELOPMENT, V121, P489; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Li G, 2009, PROTEOMICS, V9, P20, DOI 10.1002/pmic.200701195; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Liu M, 2010, PLATELETS, V21, P199, DOI 10.3109/09537101003602483; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; MATTSSON R, 1991, J REPROD IMMUNOL, V19, P115, DOI 10.1016/0165-0378(91)90012-F; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Paulesu L, 2008, EVOL DEV, V10, P778, DOI 10.1111/j.1525-142X.2008.00292.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Robin C, 2009, CELL STEM CELL, V5, P385, DOI 10.1016/j.stem.2009.08.020; Selmani Z, 2009, TRANSPLANTATION, V87, pS62, DOI 10.1097/TP.0b013e3181a2a4b3; SIMMONS PJ, 1992, BLOOD, V80, P388; Simon C, 1998, FERTIL STERIL, V70, P896, DOI 10.1016/S0015-0282(98)00275-1; Terness P, 2007, AM J REPROD IMMUNOL, V58, P238, DOI 10.1111/j.1600-0897.2007.00510.x; TERRANOVA PF, 1995, P SOC EXP BIOL MED, V209, P325; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Vacchio MS, 2005, J IMMUNOL, V174, P4657, DOI 10.4049/jimmunol.174.8.4657; Wang D, 2010, EXP CELL RES, V316, P2414, DOI 10.1016/j.yexcr.2010.04.018; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	49	100	109	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59354	10.1371/journal.pone.0059354	http://dx.doi.org/10.1371/journal.pone.0059354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555021	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500083
J	Lee, SH; Bae, SC; Kim, KW; Lee, YM				Lee, S. H.; Bae, S. C.; Kim, K. W.; Lee, Y. M.			RUNX3 inhibits hypoxia-inducible factor-1 alpha protein stability by interacting with prolyl hydroxylases in gastric cancer cells	ONCOGENE			English	Article						RUNX3; hypoxia; HIF-1 alpha; prolyl hydroxylase; angiogenesis	HIPPEL-LINDAU PROTEIN; TUMOR-SUPPRESSOR; FACTOR 1-ALPHA; KINASE PHOSPHORYLATES; GENE-EXPRESSION; GROWTH-FACTOR; ANGIOGENESIS; OXYGEN; METASTASIS; PATHWAY	RUNX3 is silenced by histone modification and hypoxia-inducible factor (HIF)-1 alpha is stabilized under hypoxia, but little is known of cross-talk between RUNX3 and HIF-1 alpha under hypoxia. In the present study, the authors investigated the effect of RUNX3 on HIF-1 alpha stability in gastric cancer cells. RUNX3 overexpression was found to downregulate HIF-1 alpha stability under normoxic and hypoxic conditions. Furthermore, the activity of a luciferase reporter containing five copies of vascular endothelial growth factor (VEGF) promoter hypoxia-responsive element (5 x HRE) and the amount of secreted VEGF, were diminished in RUNX3-expressing but increased in RUNX3-knockdown cells. When expression of RUNX3 was recovered using epigenetic reagents the expressions of HIF-1 alpha and VEGF were clearly suppressed under hypoxic conditions. RUNX3 also significantly attenuated the half-life of HIF-1 alpha protein, and induced the cytosolic localization and ubiquitination of HIF-1 alpha. In addition, RUNX3 directly interacted with the C-terminal activation domain of HIF-1 alpha and prolyl hydroxylase (PHD) 2 and enhanced the interaction between HIF-1 alpha and PHD2, which potentiated proline hydroxylation and promoted the degradation of HIF-1 alpha. Furthermore, RUNX3 overexpression significantly inhibited hypoxia-induced angiogenesis in vitro and in vivo. Taken together, these results suggest that RUNX3 destabilizes HIF-1 alpha protein by promoting the proline hydroxylation of HIF-1 alpha through binding to HIF-1 alpha/PHD2. RUNX3 appears to be a novel suppressor of HIF-1 alpha and of hypoxia-mediated angiogenesis in gastric cancer cells.	[Lee, S. H.] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Bae, S. C.] Chungbook Natl Univ, Sch Med, Chongju, South Korea; [Kim, K. W.] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Lee, S. H.; Lee, Y. M.] Kyungpook Natl Univ, Coll Pharm, Taegu 702701, South Korea; [Lee, S. H.; Lee, Y. M.] Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Taegu 702701, South Korea	Kyungpook National University; Seoul National University (SNU); Kyungpook National University; Kyungpook National University	Lee, YM (corresponding author), Kyungpook Natl Univ, Coll Pharm, Taegu 702701, South Korea.	lym@knu.ac.kr	Kim, Kyu Won/AAJ-7213-2020		National Research Foundation grant from the Basic Research Lab program [2012-028835]; National Research Foundation grant from Mid-career Researcher Program [2010-0026741]; Korean Ministry of Education, Science Technology (MEST)	National Research Foundation grant from the Basic Research Lab program; National Research Foundation grant from Mid-career Researcher Program; Korean Ministry of Education, Science Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a National Research Foundation grant from the Basic Research Lab program (2012-028835) and from Mid-career Researcher Program (2010-0026741) funded by the Korean Ministry of Education, Science Technology (MEST).	An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bae MK, 2005, CANCER RES, V65, P2520, DOI 10.1158/0008-5472.CAN-03-2735; Cao YH, 2007, ADV CANCER RES, V97, P203, DOI 10.1016/S0065-230X(06)97009-2; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chang CC, 2011, J ORAL PATHOL MED, V40, P567, DOI 10.1111/j.1600-0714.2011.01009.x; Chuang LSH, 2010, ONCOGENE, V29, P2605, DOI 10.1038/onc.2010.88; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Coulon C, 2010, ARTERIOSCL THROM VAS, V30, P2331, DOI 10.1161/ATVBAHA.110.214106; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Goh YM, 2010, J BIOL CHEM, V285, P10122, DOI 10.1074/jbc.M109.071381; Guo WH, 2002, ONCOGENE, V21, P8351, DOI 10.1038/sj.onc.1206037; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Isobe T, 2012, INT J CLIN ONCOL; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jeong CH, 2005, INT J ONCOL, V26, P211; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kim HR, 2008, J CELL BIOCHEM, V105, P1048, DOI 10.1002/jcb.21906; Kim JH, 2009, J CELL BIOCHEM, V107, P557, DOI 10.1002/jcb.22157; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee MN, 2010, J NATL CANCER I, V102, P426, DOI 10.1093/jnci/djq026; Lee SH, 2009, ONCOGENE, V28, P184, DOI 10.1038/onc.2008.377; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lund AH, 2002, CANCER CELL, V1, P213, DOI 10.1016/S1535-6108(02)00049-1; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Nakase Y, 2005, BRIT J CANCER, V92, P562, DOI 10.1038/sj.bjc.6602372; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Takeda K, 2009, ARTERIOSCL THROM VAS, V29, P2132, DOI 10.1161/ATVBAHA.109.196071; Wei DY, 2005, CANCER RES, V65, P4809, DOI 10.1158/0008-5472.CAN-04-3741; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Zhang YQ, 2007, MED SCI MONITOR, V13, pRA175; Zhong H, 2000, CANCER RES, V60, P1541	46	31	33	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2014	33	11					1458	1467		10.1038/onc.2013.76	http://dx.doi.org/10.1038/onc.2013.76			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD0SD	23542169				2022-12-25	WOS:000332943500013
J	Hickok, JR; Vasudevan, D; Antholine, WE; Thomas, DD				Hickok, Jason R.; Vasudevan, Divya; Antholine, William E.; Thomas, Douglas D.			Nitric Oxide Modifies Global Histone Methylation by Inhibiting Jumonji C Domain-containing Demethylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MOLECULAR-MECHANISMS; CELLULAR SENESCENCE; H3 LYSINE-9; IRON; G9A; METHYLTRANSFERASE; EXPRESSION; JMJD1A; REPRESSION	Methylation of lysine residues on histone tails is an important epigenetic modification that is dynamically regulated through the combined effects of methyltransferases and demethylases. The Jumonji C domain Fe(II) alpha-ketoglutarate family of proteins performs the majority of histone demethylation. We demonstrate that nitric oxide ((NO)-N-center dot) directly inhibits the activity of the demethylase KDM3A by forming a nitrosyliron complex in the catalytic pocket. Exposing cells to either chemical or cellular sources of (NO)-N-center dot resulted in a significant increase in dimethyl Lys-9 on histone 3 (H3K9me2), the preferred substrate for KDM3A. G9a, the primary methyltransferase acting on H3K9me2, was down-regulated in response to (NO)-N-center dot, and changes in methylation state could not be accounted for by methylation in general. Furthermore, cellular iron sequestration via dinitrosyliron complex formation correlated with increased methylation. The mRNA of several histone demethylases and methyltransferases was also differentially regulated in response to (NO)-N-center dot. Taken together, these data reveal three novel and distinct mechanisms whereby (NO)-N-center dot can affect histone methylation as follows: direct inhibition of Jumonji C demethylase activity, reduction in iron cofactor availability, and regulation of expression of methyl-modifying enzymes. This model of (NO)-N-center dot as an epigenetic modulator provides a novel explanation for nonclassical gene regulation by (NO)-N-center dot.	[Hickok, Jason R.; Vasudevan, Divya; Thomas, Douglas D.] Univ Illinois, Dept Med Chem, Chicago, IL 60612 USA; [Hickok, Jason R.; Vasudevan, Divya; Thomas, Douglas D.] Univ Illinois, Dept Pharmacognosy, Chicago, IL 60612 USA; [Antholine, William E.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical College of Wisconsin	Thomas, DD (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, 833 S Wood St MC 781, Chicago, IL 60612 USA.	ddthomas@uic.edu		Thomas, Douglas/0000-0003-1252-0786	National Institutes of Health from NIGMS [R01GM085232, 1S10RR027848-01A1]; University of Illinois at Chicago Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094175, R01GM085232] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Illinois at Chicago Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM085232 and 1S10RR027848-01A1 from NIGMS. This work was also supported by the University of Illinois at Chicago Cancer Center.	Beshiri ML, 2012, P NATL ACAD SCI USA, V109, P18499, DOI 10.1073/pnas.1216724109; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Cascella B, 2012, BIOCHEMISTRY-US, V51, P8699, DOI 10.1021/bi3012466; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chen HB, 2006, MOL CELL BIOL, V26, P3728, DOI 10.1128/MCB.26.10.3728-3737.2006; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Chen HB, 2010, J BIOL CHEM, V285, P7374, DOI 10.1074/jbc.M109.058503; Chen H, 2009, BIOMETALS, V22, P191, DOI 10.1007/s10534-008-9190-3; Chervona Y, 2012, FREE RADICAL BIO MED, V53, P1041, DOI 10.1016/j.freeradbiomed.2012.07.020; Cho HS, 2012, INT J CANCER, V131, pE179, DOI 10.1002/ijc.26501; Chowdhury R, 2011, J MOL BIOL, V410, P268, DOI 10.1016/j.jmb.2011.04.075; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Cyr AR, 2011, ANTIOXID REDOX SIGN, V15, P551, DOI 10.1089/ars.2010.3492; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Ene CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051407; Falandry C, 2010, J BIOL CHEM, V285, P20234, DOI 10.1074/jbc.M109.052399; Fandrey J, 2006, CARDIOVASC RES, V71, P642, DOI 10.1016/j.cardiores.2006.05.005; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Guo X, 2011, NEOPLASMA, V58, P153, DOI 10.4149/neo_2011_02_153; Hickok JR, 2012, ANTIOXID REDOX SIGN, V17, P962, DOI 10.1089/ars.2012.4543; Hickok JR, 2011, J BIOL CHEM, V286, P41413, DOI 10.1074/jbc.M111.287052; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Hickok JR, 2010, CURR PHARM DESIGN, V16, P381, DOI 10.2174/138161210790232149; Huang CY, 2010, CELL RES, V20, P154, DOI 10.1038/cr.2010.5; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Khan SN, 2010, CLIN CHIM ACTA, V411, P1401, DOI 10.1016/j.cca.2010.06.020; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Knowles HJ, 2006, CANCER RES, V66, P2600, DOI 10.1158/0008-5472.CAN-05-2351; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; LEE MH, 1994, BIOCHEMISTRY-US, V33, P3679, DOI 10.1021/bi00178a026; Li Q, 2009, CARCINOGENESIS, V30, P1243, DOI 10.1093/carcin/bgp088; Lim S, 2010, INT J CANCER, V127, P1991, DOI 10.1002/ijc.25538; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Lohse B, 2011, BIOORGAN MED CHEM, V19, P3625, DOI 10.1016/j.bmc.2011.01.046; MacArthur PH, 2007, J CHROMATOGR B, V851, P93, DOI 10.1016/j.jchromb.2006.12.012; Mallette FA, 2012, CELL REP, V2, P1233, DOI 10.1016/j.celrep.2012.09.033; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Minami T., 2013, CANC RES IN PRESS; Ohta K, 2013, INT J ONCOL, V42, P1212, DOI 10.3892/ijo.2013.1799; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pierce BS, 2007, BIOCHEMISTRY-US, V46, P8569, DOI 10.1021/bi700662d; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Ramadoss S, 2012, J BIOL CHEM, V287, P44508, DOI 10.1074/jbc.M112.424903; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Roberts NJ, 2012, SCI TRANSL MED, V4; Sanchez-Fernandez EM, 2013, BIOCHEM J, V449, P491, DOI 10.1042/BJ20121155; Sen N, 2011, P NATL ACAD SCI USA, V108, P20178, DOI 10.1073/pnas.1117820108; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tausendschon M, 2011, CYTOKINE, V53, P256, DOI 10.1016/j.cyto.2010.11.002; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzatsos A, 2013, J CLIN INVEST, V123, P727, DOI 10.1172/JCI64535; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Ye L, 2012, CELL STEM CELL, V11, P50, DOI 10.1016/j.stem.2012.04.009; Yoshimi A, 2011, J CELL BIOCHEM, V112, P415, DOI 10.1002/jcb.22972; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942; Zhu ZQ, 2010, CELL RES, V20, P794, DOI 10.1038/cr.2010.75	79	71	71	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16004	16015		10.1074/jbc.M112.432294	http://dx.doi.org/10.1074/jbc.M112.432294			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23546878	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000319822300052
J	Johnson, ES; Lindblom, KR; Robeson, A; Stevens, RD; Ilkayeva, OR; Newgard, CB; Kornbluth, S; Andersen, JL				Johnson, Erika Segear; Lindblom, Kelly R.; Robeson, Alexander; Stevens, Robert D.; Ilkayeva, Olga R.; Newgard, Christopher B.; Kornbluth, Sally; Andersen, Joshua L.			Metabolomic Profiling Reveals a Role for Caspase-2 in Lipoapoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE CELLS; SATURATED FATTY-ACIDS; NONALCOHOLIC STEATOHEPATITIS; INDUCED APOPTOSIS; AMINO-ACIDS; HEPATOCYTE LIPOAPOPTOSIS; CLINICAL-IMPLICATIONS; XENOPUS-LAEVIS; CYTOCHROME-C	The accumulation of long-chain fatty acids (LCFAs) in non-adipose tissues results in lipid-induced cytotoxicity (or lipoapoptosis). Lipoapoptosis has been proposed to play an important role in the pathogenesis of several metabolic diseases, including non-alcoholic fatty liver disease, diabetes mellitus, and cardiovascular disease. In this report, we demonstrate a novel role for caspase-2 as an initiator of lipoapoptosis. Using a metabolomics approach, we discovered that the activation of caspase-2, the initiator of apoptosis in Xenopus egg extracts, is associated with an accumulation of LCFA metabolites. Metabolic treatments that blocked the buildup of LCFAs potently inhibited caspase-2 activation, whereas adding back an LCFA in this scenario restored caspase activation. Extending these findings to mammalian cells, we show that caspase-2 was engaged and activated in response to treatment with the saturated LCFA palmitate. Down-regulation of caspase-2 significantly impaired cell death induced by saturated LCFAs, suggesting that caspase-2 plays a pivotal role in lipid-induced cytotoxicity. Together, these findings reveal a previously unknown role for caspase-2 as an initiator caspase in lipoapoptosis and suggest that caspase-2 may be an attractive therapeutic target for inhibiting pathological lipid-induced apoptosis.	[Johnson, Erika Segear; Lindblom, Kelly R.; Robeson, Alexander; Newgard, Christopher B.; Kornbluth, Sally] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Stevens, Robert D.; Andersen, Joshua L.] Duke Univ, Dept Med, Durham, NC 27710 USA; [Ilkayeva, Olga R.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA	Duke University; Duke University; Duke University	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, POB 3813,C370 LSRC Res Dr, Durham, NC 27710 USA.	kornb001@mc.duke.edu; jandersen@chem.byu.edu			National Institutes of Health [GM080333, 5F31CA165545-02]; Ruth L. Kirschstein National Research Service Award; NATIONAL CANCER INSTITUTE [F31CA165545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184, R01GM080333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM080333 (to S. K.) and 5F31CA165545-02, a Ruth L. Kirschstein National Research Service Award (to E. S. J).	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Andersen JL, 2011, MOL CELL, V43, P834, DOI 10.1016/j.molcel.2011.07.028; Arici M, 2003, J AM SOC NEPHROL, V14, P17, DOI 10.1097/01.ASN.0000042167.66685.EA; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Cazanave SC, 2010, CLIN LIPIDOL, V5, P71, DOI 10.2217/CLP.09.85; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; deVries JE, 1997, J LIPID RES, V38, P1384; DWORKIN MB, 1991, TRENDS BIOCHEM SCI, V16, P229, DOI 10.1016/0968-0004(91)90091-9; DWORKIN MB, 1990, DEV BIOL, V138, P177, DOI 10.1016/0012-1606(90)90187-N; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; FOLBERGR.J, 1974, BRAIN RES, V80, P265, DOI 10.1016/0006-8993(74)90690-8; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Furstova V, 2008, LIFE SCI, V82, P684, DOI 10.1016/j.lfs.2007.12.023; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; GOLDBERG ND, 1966, J BIOL CHEM, V241, P3997; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; HOCHACHKA PW, 1975, COMP BIOCHEM PHYSIOL, V50, P17, DOI 10.1016/0305-0491(75)90292-8; Hu W, 2011, J BIOL CHEM, V286, P16596, DOI 10.1074/jbc.M110.186916; Ibrahim SH, 2011, J PEDIATR GASTR NUTR, V53, P109, DOI 10.1097/MPG.0b013e31820e82a1; Imre G, 2012, EMBO J, V31, P2615, DOI 10.1038/emboj.2012.93; Kim JE, 2008, BONE, V43, P394, DOI 10.1016/j.bone.2008.03.021; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Kotarsky H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041156; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Listenberger LL, 2002, TRENDS CARDIOVAS MED, V12, P134, DOI 10.1016/S1050-1738(02)00152-4; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Mutomba MC, 2000, FEBS LETT, V478, P19, DOI 10.1016/S0014-5793(00)01817-2; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Ratziu V, 2012, HEPATOLOGY, V55, P419, DOI 10.1002/hep.24747; Sadagopan N, 2007, AM J HYPERTENS, V20, P1209, DOI 10.1016/j.amjhyper.2007.05.010; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; SHIOKAWA K, 1986, ZOOL SCI, V3, P793; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; Staiger K, 2006, DIABETES, V55, P3121, DOI 10.2337/db06-0188; TAEGTMEYER H, 1978, CIRC RES, V43, P808, DOI 10.1161/01.RES.43.5.808; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; Wieckowska A, 2005, CURR OPIN PEDIATR, V17, P636, DOI 10.1097/01.mop.0000172816.79637.c5; WIESNER RJ, 1989, J MOL CELL CARDIOL, V21, P49, DOI 10.1016/0022-2828(89)91492-2; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010	57	30	30	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14463	14475		10.1074/jbc.M112.437210	http://dx.doi.org/10.1074/jbc.M112.437210			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23553630	Green Published, hybrid			2022-12-25	WOS:000319253500049
J	Kasiviswanathan, R; Minko, IG; Lloyd, RS; Copeland, WC				Kasiviswanathan, Rajesh; Minko, Irina G.; Lloyd, R. Stephen; Copeland, William C.			Translesion Synthesis Past Acrolein-derived DNA Adducts by Human Mitochondrial DNA Polymerase gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE CROSS-LINKS; NUCLEOTIDE INCORPORATION; 1,N(2)-PROPANODEOXYGUANOSINE ADDUCTS; 1,N-2-PROPANODEOXYGUANOSINE ADDUCTS; 1,N-2-DEOXYGUANOSINE ADDUCTS; DEOXYGUANOSINE ADDUCT; REPLICATION BYPASS; SEQUENTIAL ACTION; ESCHERICHIA-COLI; OXIDATIVE STRESS	Acrolein, a mutagenic aldehyde, is produced endogenously by lipid peroxidation and exogenously by combustion of organic materials, including tobacco products. Acrolein reacts with DNA bases forming exocyclic DNA adducts, such as gamma-hydroxy-1,N-2-propano-2'-deoxyguanosine (gamma-HOPdG) and gamma-hydroxy-1,N-6-propano-2'-deoxyadenosine (gamma-HOPdA). The bulky gamma-HOPdG adduct blocks DNA synthesis by replicative polymerases but can be bypassed by translesion synthesis polymerases in the nucleus. Although acrolein-induced adducts are likely to be formed and persist in mitochondrial DNA, animal cell mitochondria lack specialized translesion DNA synthesis polymerases to tolerate these lesions. Thus, it is important to understand how pol gamma, the sole mitochondrial DNA polymerase in human cells, acts on acrolein-adducted DNA. To address this question, we investigated the ability of pol gamma to bypass the minor groove gamma-HOPdG and major groove gamma-HOPdA adducts using single nucleotide incorporation and primer extension analyses. The efficiency of pol gamma-catalyzed bypass of gamma-HOPdG was low, and surprisingly, pol gamma preferred to incorporate purine nucleotides opposite the adduct. Pol gamma also exhibited similar to 2-fold lower rates of excision of the misincorporated purine nucleotides opposite gamma-HOPdG compared with the corresponding nucleotides opposite dG. Extension of primers from the termini opposite gamma-HOPdG was accomplished only following error-prone purine nucleotide incorporation. However, pol gamma preferentially incorporated dT opposite the gamma-HOPdA adduct and efficiently extended primers from the correctly paired terminus, indicating that gamma-HOPdA is probably non-mutagenic. In summary, our data suggest that acrolein-induced exocyclic DNA lesions can be bypassed by mitochondrial DNA polymerase but, in the case of the minor groove gamma-HOPdG adduct, at the cost of unprecedented high mutation rates.	[Kasiviswanathan, Rajesh; Copeland, William C.] NIEHS, Mitochondrial DNA Replicat Grp, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Minko, Irina G.; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Oregon Health & Science University; Oregon Health & Science University	Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953; Lloyd, R. Stephen/0000-0001-7273-372X	National Institutes of Health Intramural Research Program; NIEHS [ES065078, ES065080, ES05355]; NCI [CA106858]; National Institute of Mental Health [R03 MH 094179]; NATIONAL CANCER INSTITUTE [R01CA106858, P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065080, ZIAES065078, P01ES005355, Z01ES065078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH094179] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, Grants ES065078 and ES065080 from NIEHS (to W. C. C.), Grant ES05355 from NIEHS (to R. S. L.), NCI Grant CA106858 (to R. S. L.), and National Institute of Mental Health Grant R03 MH 094179 (to R. S. L.).	Arumugam N, 1999, ARCH ENVIRON CON TOX, V36, P373, DOI 10.1007/PL00006608; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; CHI NW, 1994, J BIOL CHEM, V269, P29984; CHIT NW, 1994, J BIOL CHEM, V269, P29993; Chung FL, 1999, MUTAT RES-FUND MOL M, V424, P71, DOI 10.1016/S0027-5107(99)00009-3; Chung FL, 1999, IARC SCI PUBL, P45; CHUNG FL, 1984, CANCER RES, V44, P990; Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002; de los Santos C, 2001, J BIOL CHEM, V276, P9077, DOI 10.1074/jbc.M009028200; GALLIANI G, 1983, TETRAHEDRON LETT, V24, P4491, DOI 10.1016/S0040-4039(00)85935-3; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213; Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; Johnson AA, 2001, J BIOL CHEM, V276, P38090; Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Kasiviswanathan R, 2012, J BIOL CHEM, V287, P9222, DOI 10.1074/jbc.M111.306852; Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015; Kim HYH, 2002, J AM CHEM SOC, V124, P9324, DOI 10.1021/ja020333r; Kozekov ID, 2003, J AM CHEM SOC, V125, P50, DOI 10.1021/ja020778f; Kurtz AJ, 2003, J BIOL CHEM, V278, P5970, DOI 10.1074/jbc.M212012200; Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001; McCulloch SD, 2009, NUCLEIC ACIDS RES, V37, P2830, DOI 10.1093/nar/gkp103; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; Minko IG, 2003, J BIOL CHEM, V278, P784, DOI 10.1074/jbc.M207774200; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Minko IG, 2008, MUTAT RES-FUND MOL M, V637, P161, DOI 10.1016/j.mrfmmm.2007.08.001; Minko IG, 2009, CHEM RES TOXICOL, V22, P759, DOI 10.1021/tx9000489; NATH RG, 1994, P NATL ACAD SCI USA, V91, P7491, DOI 10.1073/pnas.91.16.7491; Nath RG, 1996, CANCER RES, V56, P452; Nechev LV, 2000, CHEM RES TOXICOL, V13, P421, DOI 10.1021/tx990167+; Pan J, 2002, CHEM RES TOXICOL, V15, P367, DOI 10.1021/tx010136q; Penn A, 2001, ENVIRON HEALTH PERSP, V109, P219, DOI 10.2307/3434688; PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202; SODUM RS, 1988, BIOORG CHEM, V16, P272, DOI 10.1016/0045-2068(88)90015-6; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Stone JE, 2011, DNA REPAIR, V10, P826, DOI 10.1016/j.dnarep.2011.04.032; Sun LJ, 2006, MITOCHONDRION, V6, P136, DOI 10.1016/j.mito.2006.04.003; Takata K, 2010, NUCLEIC ACIDS RES, V38, P3233, DOI 10.1093/nar/gkq048; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Vaisman A, 2000, J BIOL CHEM, V275, P13017, DOI 10.1074/jbc.275.17.13017; VanderVeen LA, 2001, J BIOL CHEM, V276, P9066, DOI 10.1074/jbc.M008900200; Washington MT, 2004, MOL CELL BIOL, V24, P6900, DOI 10.1128/MCB.24.16.6900-6906.2004; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Wolfle WT, 2005, MOL CELL BIOL, V25, P8748, DOI 10.1128/MCB.25.19.8748-8754.2005; Wu JY, 2011, MOL NUTR FOOD RES, V55, P1401, DOI 10.1002/mnfr.201100255; Yamanaka K, 2011, J BACTERIOL, V193, P3815, DOI 10.1128/JB.01550-10; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Yang IY, 2001, J BIOL CHEM, V276, P9071, DOI 10.1074/jbc.M008918200; Zang H, 2005, J BIOL CHEM, V280, P1165, DOI 10.1074/jbc.M405996200; Zhang HS, 2006, GENETICS, V172, P2683, DOI 10.1534/genetics.105.051029	59	18	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14247	14255		10.1074/jbc.M113.458802	http://dx.doi.org/10.1074/jbc.M113.458802			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543747	Green Published, hybrid			2022-12-25	WOS:000319253500029
J	Yumoto, K; Thomas, PS; Lane, J; Matsuzaki, K; Inagaki, M; Ninomiya-Tsuji, J; Scott, GJ; Ray, MK; Ishii, M; Maxson, R; Mishina, Y; Kaartinen, V				Yumoto, Kenji; Thomas, Penny S.; Lane, Jamie; Matsuzaki, Kouichi; Inagaki, Maiko; Ninomiya-Tsuji, Jun; Scott, Gregory J.; Ray, Manas K.; Ishii, Mamoru; Maxson, Robert; Mishina, Yuji; Kaartinen, Vesa			TGF-beta-activated Kinase 1 (Tak1) Mediates Agonist-induced Smad Activation and Linker Region Phosphorylation in Embryonic Craniofacial Neural Crest-derived Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CAUSES CLEFT-PALATE; SIGNAL-TRANSDUCTION; RECEPTOR KINASE; MICE; BMP; MOUSE; PATHWAYS; FUSION; FAMILY	Although the importance of TGF-beta superfamily signaling in craniofacial growth and patterning is well established, the precise details of its signaling mechanisms are still poorly understood. This is in part because of the concentration of studies on the role of the Smad-dependent (so-called "canonical") signaling pathways relative to the Smad-independent ones in many biological processes. Here, we have addressed the role of TGF-beta beta-activated kinase 1 (Tak1, Map3k7), one of the key mediators of Smad-independent (noncanonical) TGF-beta superfamily signaling in craniofacial development, by deleting Tak1 specifically in the neural crest lineage. Tak1-deficient mutants display a round skull, hypoplastic maxilla and mandible, and cleft palate resulting from a failure of palatal shelves to appropriately elevate and fuse. Our studies show that in neural crest-derived craniofacial ecto-mesenchymal cells, Tak1 is not only required for TGF-beta -and bone morphogenetic protein-induced p38 Mapk activation but also plays a role in agonist-induced C-terminal and linker region phosphorylation of the receptor-mediated R-Smads. Specifically, we demonstrate that the agonist-induced linker region phosphorylation of Smad2 at Thr-220, which has been shown to be critical for full transcriptional activity of Smad2, is dependent on Tak1 activity and that in palatal mesenchymal cells TGF beta RI and Tak1 kinases mediate both overlapping and distinct TGF-beta 2-induced transcriptional responses. To summarize, our results suggest that in neural crest-derived ecto-mesenchymal cells, Tak1 provides a critical point of intersection in a complex dialogue between the canonical and noncanonical arms of TGF-beta superfamily signaling required for normal craniofacial development.	[Yumoto, Kenji; Thomas, Penny S.; Lane, Jamie; Mishina, Yuji; Kaartinen, Vesa] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Matsuzaki, Kouichi] Kansai Med Univ, Dept Gastroenterol & Hepatol, Moriguchi, Osaka 5708506, Japan; [Inagaki, Maiko; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Scott, Gregory J.; Ray, Manas K.] NIEHS, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA; [Ishii, Mamoru; Maxson, Robert] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Michigan System; University of Michigan; Kansai Medical University; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Southern California	Kaartinen, V (corresponding author), Univ Michigan, Dept Biol & Mat Sci, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	vesak@umich.edu	Kaartinen, Vesa/AAU-5396-2021	Kaartinen, Vesa/0000-0002-9432-510X; Ninomiya-Tsuji, Jun/0000-0002-5584-0176	National Institutes of Health [R01DE020843, ES071003-11, RO1 DE013085, HL074862, S10RR026475-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE020843 and ES071003-11 (to Y. M.), RO1 DE013085 and HL074862 (to V. K.), and S10RR026475-01 (to the University of Michigan mu CT Core Facility).	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Baek JA, 2011, DEV BIOL, V350, P520, DOI 10.1016/j.ydbio.2010.12.028; Bellusci S, 1997, DEVELOPMENT, V124, P53; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cardoso S, 2012, J RECEPT SIG TRANSD, V32, P150, DOI 10.3109/10799893.2012.664553; Cohen-Solal KA, 2011, PIGM CELL MELANOMA R, V24, P512, DOI 10.1111/j.1755-148X.2011.00858.x; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Dudas M, 2004, DEV BIOL, V266, P96, DOI 10.1016/j.ydbio.2003.10.007; Dudas M, 2006, DEV BIOL, V296, P298, DOI 10.1016/j.ydbio.2006.05.030; Economou AD, 2012, NAT GENET, V44, P348, DOI 10.1038/ng.1090; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Han J, 2009, DEVELOPMENT, V136, P4225, DOI 10.1242/dev.036723; Harlow E., 1988, ANTIBODIES LAB MANUA, P481; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Hoffmann A, 2005, J BIOL CHEM, V280, P27271, DOI 10.1074/jbc.M503368200; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Liu WJ, 2008, DEVELOPMENT, V135, P3959, DOI 10.1242/dev.025304; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; Nagy A, 2003, MANIPULATING MOUSE E, P687; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Song ZC, 2013, J BIOL CHEM, V288, P10440, DOI 10.1074/jbc.M112.432286; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Thomas PS, 2010, DEV BIOL, V340, P613, DOI 10.1016/j.ydbio.2010.02.021; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; Wtighton KH, 2008, CELL SIGNAL, V20, P1579, DOI 10.1016/j.cellsig.2008.02.003; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	47	55	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13467	13480		10.1074/jbc.M112.431775	http://dx.doi.org/10.1074/jbc.M112.431775			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23546880	Green Published, hybrid			2022-12-25	WOS:000318850300031
J	Kuo, LC; Chen, SW; Lin, CJ; Lin, WJ; Lin, SC; Su, FC				Kuo, Li-Chieh; Chen, Shih-Wei; Lin, Chien-Ju; Lin, Wei-Jr; Lin, Sheng-Che; Su, Fong-Chin			The Force Synergy of Human Digits in Static and Dynamic Cylindrical Grasps	PLOS ONE			English	Article							MULTI-FINGER TASKS; QUANTITATIVE-ANALYSIS; MOTOR VARIABILITY; PRECISION GRIP; COORDINATION; OBJECT; HAND; MANIPULATION	This study explores the force synergy of human digits in both static and dynamic cylindrical grasping conditions. The patterns of digit force distribution, error compensation, and the relationships among digit forces are examined to quantify he synergetic patterns and coordination of multi-finger movements. This study recruited 24 healthy participants to perform cylindrical grasps using a glass simulator under normal grasping and one-finger restricted conditions. Parameters such as the grasping force, patterns of digit force distribution, and the force coefficient of variation are determined. Correlation coefficients and principal component analysis (PCA) are used to estimate the synergy strength under the dynamic grasping condition. Specific distribution patterns of digit forces are identified for various conditions. The compensation of adjacent fingers for the force in the normal direction of an absent finger agrees with the principle of error compensation. For digit forces in anti-gravity directions, the distribution patterns vary significantly by participant. The forces exerted by the thumb are closely related to those exerted by other fingers under all conditions. The index-middle and middle ring finger pairs demonstrate a significant relationship. The PCA results show that the normal forces of digits are highly coordinated. This study reveals that normal force synergy exists under both static and dynamic cylindrical grasping conditions.	[Kuo, Li-Chieh] Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan 70101, Taiwan; [Chen, Shih-Wei; Lin, Wei-Jr; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Lin, Chien-Ju; Lin, Wei-Jr; Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 70101, Taiwan; [Lin, Sheng-Che] Natl Cheng Kung Univ, Sect Plast Surg, Dept Surg, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Su, FC (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan.	fcsu@mail.ncku.edu.tw	SU, FONG-CHIN/C-8094-2011; Kuo, Li-Chieh/ABC-3826-2021; Lin, Chien-Ju/AAP-5725-2020	SU, FONG-CHIN/0000-0002-3870-4842; Kuo, Li-Chieh/0000-0001-7728-0096; Lin, Chien-Ju/0000-0001-9571-8610; Kuo, Li-Chieh/0000-0002-5644-655X	National Health Research Institute of Taiwan [NHRI-EX100-10040EI]	National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan)	This study was supported by the National Health Research Institute of Taiwan under grant NHRI-EX100-10040EI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbib M.A., 1985, EXP BRAIN RES S, V10, P111, DOI DOI 10.1007/978-3-642-70105-4_; Baud-Bovy G, 2001, J NEUROPHYSIOL, V86, P604, DOI 10.1152/jn.2001.86.2.604; Bernstein N.A., 1967, COORDINATION REGULAT; Braido P, 2004, HUM MOVEMENT SCI, V22, P661, DOI 10.1016/j.humov.2003.10.001; Burstedt MKO, 1999, J NEUROPHYSIOL, V82, P2393, DOI 10.1152/jn.1999.82.5.2393; de Freitas PB, 2008, J HUM KINET, V20, P37; de Freitas PB, 2008, NEUROSCI LETT, V434, P234; Gorniak S, 2009, EXP BRAIN RES, V194, P1, DOI 10.1007/s00221-008-1663-7; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Kim SW, 2008, HUM MOVEMENT SCI, V27, P408, DOI 10.1016/j.humov.2007.08.005; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Latash ML, 2001, EXP BRAIN RES, V141, P153, DOI 10.1007/s002210100861; Latash ML, 2008, SYNERGY; Li S, 2003, EXP BRAIN RES, V150, P230, DOI 10.1007/s00221-003-1449-x; Li ZM, 2002, ERGONOMICS, V45, P425, DOI 10.1080/00140130210129673; Li ZM, 2007, J BIOMECH, V40, P502, DOI 10.1016/j.jbiomech.2006.02.019; MacKenzie C. L., 1994, THE GRASPING HAND; MAH CD, 1994, J MOTOR BEHAV, V26, P83, DOI 10.1080/00222895.1994.9941664; MAIER MA, 1995, EXP BRAIN RES, V103, P123, DOI 10.1007/BF00241970; Martin JR, 2009, EXP BRAIN RES, V192, P293, DOI 10.1007/s00221-008-1615-2; Quaine F, 2011, INT J SPORTS MED, V32, P49, DOI 10.1055/s-0030-1267230; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; Scholz JP, 2002, BIOL CYBERN, V86, P29, DOI 10.1007/s004220100279; Sun Y, 2011, EXP BRAIN RES, V209, P571, DOI 10.1007/s00221-011-2590-6; Valero-Cuevas FJ, 2000, J NEUROPHYSIOL, V83, P1469, DOI 10.1152/jn.2000.83.3.1469; Weiss EJ, 2004, J NEUROPHYSIOL, V92, P523, DOI 10.1152/jn.01265.2003; Winges SA, 2004, J NEUROPHYSIOL, V92, P3210, DOI 10.1152/jn.00516.2004; Zatsiorsky VM, 2003, EXP BRAIN RES, V148, P77, DOI 10.1007/s00221-002-1278-3; Zatsiorsky VM, 1998, BIOL CYBERN, V79, P139, DOI 10.1007/s004220050466; Zatsiorsky VM, 2000, EXP BRAIN RES, V131, P187, DOI 10.1007/s002219900261; Zhang W, 2008, J NEUROPHYSIOL, V99, P500, DOI 10.1152/jn.01029.2007	31	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60509	10.1371/journal.pone.0060509	http://dx.doi.org/10.1371/journal.pone.0060509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544151	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700110
J	Morton, PK; Schemerhorn, BJ				Morton, Philip K.; Schemerhorn, Brandon J.			Population Structure and the Colonization Route of One of the Oldest North American Invasive Insects: Stories from the Worn Road of the Hessian Fly, Mayetiola destructor (Say)	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; GENE CONFERRING RESISTANCE; COMPUTER-PROGRAM; DIPTERA; WHEAT; CECIDOMYIIDAE; BOTTLENECK; VIRULENCE; VH13	An integral part to understanding the biology of an invasive species is determining its origin, particularly in pest species. As one of the oldest known invasive species, the goals of this study were to evaluate the evidence of a westward expansion of Hessian fly into North America, from a potential singular introduction event, and the population genetic structure of current populations. Levels of genetic diversity and population structure in the Hessian fly were compared across North America Europe, North Africa, Western Asia, and New Zealand. Furthermore, Old World populations were evaluated as possible sources of introduction. We tested diversity and population structure by examining 18 microsatellite loci with coverage across all four Hessian fly chromosomes. Neither genetic diversity nor population genetic structure provided evidence of a westward movement from a single introduction in North America. Introduced populations in North America did not show identity or assignment to any Old World population, likely indicating a multiple introduction scenario with subsequent gene flow between populations. Diversity and selection were assessed on a chromosomal level, with no differences in diversity or selection between chromosomes or between native and introduced populations.	[Morton, Philip K.; Schemerhorn, Brandon J.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Schemerhorn, Brandon J.] USDA ARS, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA)	Morton, PK (corresponding author), Univ Oklahoma, Biol Stn, Kingston, OK 73019 USA.	pmorton@ou.edu		Schemerhorn, Brandon/0000-0003-0247-478X	United States Department of Agriculture [USDA-ARS CRIS 3602-22000-14D]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture grant USDA-ARS CRIS 3602-22000-14D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; BLACK WC, 1990, J HERED, V81, P331, DOI 10.1093/oxfordjournals.jhered.a110998; Bray AM, 2011, BIOL INVASIONS, V13, P2869, DOI 10.1007/s10530-011-9970-5; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Coombs JA, 2007, CREATE 1 0 SOFTWARE; Cornuet JM, 1996, GENETICS, V144, P2001; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; El Bouhssini M, 2001, B ENTOMOL RES, V91, P327; Fitch A, 1847, AM Q J AGR SCI, V4, P244; Formusoh ES, 1996, ANN ENTOMOL SOC AM, V89, P428, DOI 10.1093/aesa/89.3.428; Foster JE, 1986, BULLETIN, V502; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; GALLUN RL, 1978, ANN ENTOMOL SOC AM, V71, P481, DOI 10.1093/aesa/71.4.481; GALLUN RL, 1977, ANN NY ACAD SCI, V287, P223, DOI 10.1111/j.1749-6632.1977.tb34241.x; GARNIERGERE P, 1992, J HERED, V83, P239, DOI 10.1093/oxfordjournals.jhered.a111204; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2001, FSTAT PROGRAM ESTIMA; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Harris MO, 2006, ANN ENTOMOL SOC AM, V99, P305, DOI 10.1603/0013-8746(2006)099[0305:VHFDCL]2.0.CO;2; HATCHETT JH, 1970, ANN ENTOMOL SOC AM, V63, P1400, DOI 10.1093/aesa/63.5.1400; Jakobsson M, 2007, CLUMPP CLUSTER MATCH; Johnson AJ, 2004, ANN ENTOMOL SOC AM, V97, P940, DOI 10.1603/0013-8746(2004)097[0940:AFAOMD]2.0.CO;2; Johnson AJ, 2012, B ENTOMOL RES; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Martin-Sanchez JA, 2003, THEOR APPL GENET, V106, P1248, DOI 10.1007/s00122-002-1182-z; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Morton PK, 2011, ENVIRON ENTOMOL, V40, P1303, DOI 10.1603/EN10244; Packard AS, 1880, B US ENTOMOLOGICAL C; Packard CM, 1928, USDA B, V81; Patterson F. L., 1973, Proceedings of the fourth international wheat genetics symposium. Pests., P445; Pauly P. J., 2002, ENV HIST, V7, P377; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Prestidge R.A., 1987, Proceedings of New Zealand Weed and Pest Control Conference, V40, P226; Pritchard JK, 2004, DOCUMENTATION STRUCT; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; Ratcliffe R.H., 1997, NEW DEV ENTOMOLOGY, P47; Rider SD, 2002, GENOME, V45, P812, DOI [10.1139/G02-047, 10.1139/g02-047]; Rosenberg N, 2004, MOL ECOL, V4, P127; Sardesai N, 2005, THEOR APPL GENET, V111, P1167, DOI 10.1007/s00122-005-0048-6; Schemerhorn BJ, 2009, J HERED, V100, P790, DOI 10.1093/jhered/esp045; Schulte SJ, 1999, GENOME, V42, P821, DOI 10.1139/gen-42-5-821; STUART JJ, 1988, J HERED, V79, P184, DOI 10.1093/oxfordjournals.jhered.a110490; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Williams CE, 2003, THEOR APPL GENET, V107, P1516, DOI 10.1007/s00122-003-1393-y; Withers TM, 1995, P NZ PLAN P, V48, P165, DOI 10.30843/nzpp.1995.48.11548; Work TT, 2005, BIOL INVASIONS, V7, P323, DOI 10.1007/s10530-004-1663-x; ZEISS MR, 1993, J AGR ENTOMOL, V10, P107	57	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59833	10.1371/journal.pone.0059833	http://dx.doi.org/10.1371/journal.pone.0059833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544103	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700063
J	Rao, T; Ruiz-Gomez, G; Hill, TA; Hoang, HN; Fairlie, DP; Mason, JM				Rao, Tara; Ruiz-Gomez, Gloria; Hill, Timothy A.; Hoang, Huy N.; Fairlie, David P.; Mason, Jody M.			Truncated and Helix-Constrained Peptides with High Affinity and Specificity for the cFos Coiled-Coil of AP-1	PLOS ONE			English	Article							HYDROGEN-BOND-SURROGATE; SHORT ALPHA-HELICES; TRANSCRIPTION FACTORS; LEUCINE-ZIPPER; STAPLED P53; DESIGN; INHIBITION; STABILITY; SELECTION; ENERGY	Protein-based therapeutics feature large interacting surfaces. Protein folding endows structural stability to localised surface epitopes, imparting high affinity and target specificity upon interactions with binding partners. However, short synthetic peptides with sequences corresponding to such protein epitopes are unstructured in water and promiscuously bind to proteins with low affinity and specificity. Here we combine structural stability and target specificity of proteins, with low cost and rapid synthesis of small molecules, towards meeting the significant challenge of binding coiled coil proteins in transcriptional regulation. By iteratively truncating a Jun-based peptide from 37 to 22 residues, strategically incorporating i -> i+4 helix-inducing constraints, and positioning unnatural amino acids, we have produced short, water-stable, a-helical peptides that bind cFos. A three-dimensional NMR-derived structure for one peptide (24) confirmed a highly stable alpha-helix which was resistant to proteolytic degradation in serum. These short structured peptides are entropically pre-organized for binding with high affinity and specificity to cFos, a key component of the oncogenic transcriptional regulator Activator Protein-1 (AP-1). They competitively antagonized the cJun-cFos coiled-coil interaction. Truncating a Jun-based peptide from 37 to 22 residues decreased the binding enthalpy for cJun by similar to 9 kcal/mol, but this was compensated by increased conformational entropy (T Delta S <= 7.5 kcal/mol). This study demonstrates that rational design of short peptides constrained by alpha-helical cyclic pentapeptide modules is able to retain parental high helicity, as well as high affinity and specificity for cFos. These are important steps towards small antagonists of the cJun-cFos interaction that mediates gene transcription in cancer and inflammatory diseases.	[Rao, Tara; Mason, Jody M.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Ruiz-Gomez, Gloria; Hill, Timothy A.; Hoang, Huy N.; Fairlie, David P.] Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, Brisbane, Qld, Australia	University of Essex; University of Queensland	Mason, JM (corresponding author), Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England.	jmason@essex.ac.uk	Mason, Jody/W-8204-2019; Mason, Jody/A-9329-2011; Hill, Timothy A/C-9670-2017; Fairlie, David P/F-8865-2014; Hoang, Huy N/I-6357-2015	Mason, Jody/0000-0002-4118-1958; Mason, Jody/0000-0002-4118-1958; Hill, Timothy A/0000-0001-9727-9930; Fairlie, David P/0000-0002-7856-8566; Hoang, Huy N/0000-0002-7124-6097	Wellcome Trust [WT090184MA]; Cancer Research UK [DBB3800]; Australian Research Council [FF668733, DP00770936]; National Health and Medical Research Council [511194, APP1028423, APP1027369]; ARC Federation; NHMRC; Cancer Research UK [11738] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Federation(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK)	JMM gratefully acknowledges support from the Wellcome Trust (WT090184MA) and Cancer Research UK for a career establishment award (DBB3800). DPF acknowledges the Australian Research Council (FF668733, DP00770936) and National Health and Medical Research Council (511194, APP1028423, APP1027369) for grant support and for ARC Federation and NHMRC Senior Principal Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appella DH, 1997, NATURE, V387, P381, DOI 10.1038/387381a0; Aud D, 2006, NAT CLIN PRACT RHEUM, V2, P434, DOI 10.1038/ncprheum0222; Baek S, 2012, J AM CHEM SOC, V134, P103, DOI 10.1021/ja2090367; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Bernal F, 2010, CANCER CELL, V18, P411, DOI 10.1016/j.ccr.2010.10.024; Bird GH, 2008, METHOD ENZYMOL, V446, P369, DOI 10.1016/S0076-6879(08)01622-4; Bird GH, 2010, P NATL ACAD SCI USA, V107, P14093, DOI 10.1073/pnas.1002713107; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bullock BN, 2011, J AM CHEM SOC, V133, P14220, DOI 10.1021/ja206074j; Chapman RN, 2004, J AM CHEM SOC, V126, P12252, DOI 10.1021/ja0466659; Chapman R, 2008, BIOCHEMISTRY-US, V47, P4189, DOI 10.1021/bi800136m; Crooks RO, 2011, J BIOL CHEM, V286, P29470, DOI 10.1074/jbc.M111.221267; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Dixon JM, 2005, PHOTOCHEM PHOTOBIOL, V81, P212, DOI 10.1562/2004-11-06-TSN-361.1; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fairlie DP, 1998, CURR MED CHEM, V5, P29; Fairlie DP, 2000, J MED CHEM, V43, P1271, DOI 10.1021/jm990315t; Fuchs SM, 2006, CELL MOL LIFE SCI, V63, P1819, DOI 10.1007/s00018-006-6170-z; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Guarracino DA, 2011, BIOPOLYMERS, V95, P1, DOI 10.1002/bip.21546; Harrison RS, 2010, P NATL ACAD SCI USA, V107, P11686, DOI 10.1073/pnas.1002498107; Henchey LK, 2010, J AM CHEM SOC, V132, P941, DOI 10.1021/ja9082864; Ibarra-Molero B, 2001, BIOCHEMISTRY-US, V40, P719, DOI 10.1021/bi001438e; Johnson LM, 2011, J AM CHEM SOC, V133, P10038, DOI 10.1021/ja203358t; Judice JK, 1997, P NATL ACAD SCI USA, V94, P13426, DOI 10.1073/pnas.94.25.13426; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; Kim YW, 2009, BIOORG MED CHEM LETT, V19, P2533, DOI 10.1016/j.bmcl.2009.03.022; Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762; Kutchukian PS, 2009, J AM CHEM SOC, V131, P4622, DOI 10.1021/ja805037p; Lavigne P, 1996, SCIENCE, V271, P1136, DOI 10.1126/science.271.5252.1136; Libermann TA, 2006, CURR GENE THER, V6, P17, DOI 10.2174/156652306775515501; Liu J, 2008, J AM CHEM SOC, V130, P4334, DOI 10.1021/ja077704u; Mason JM, 2007, BIOCHEMISTRY-US, V46, P4804, DOI 10.1021/bi602506p; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Mason JM, 2010, FUTURE MED CHEM, V2, P1813, DOI [10.4155/fmc.10.259, 10.4155/FMC.10.259]; Mason JM, 2009, BIOCHEMISTRY-US, V48, P10380, DOI 10.1021/bi901401e; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; PACE CN, 1988, J BIOL CHEM, V263, P11820; Patgiri A, 2008, ACCOUNTS CHEM RES, V41, P1289, DOI 10.1021/ar700264k; Seebach D, 2008, ACCOUNTS CHEM RES, V41, P1366, DOI 10.1021/ar700263g; Shepherd NE, 2005, J AM CHEM SOC, V127, P2974, DOI 10.1021/ja0456003; Shepherd NE, 2004, ANGEW CHEM INT EDIT, V43, P2687, DOI 10.1002/anie.200352659; Shepherd NE, 2006, J AM CHEM SOC, V128, P13284, DOI 10.1021/ja064058a; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang D, 2008, ANGEW CHEM INT EDIT, V47, P1879, DOI 10.1002/anie.200704227; Wang DY, 2006, ORG BIOMOL CHEM, V4, P4074, DOI 10.1039/b612891b; Wang D, 2006, J AM CHEM SOC, V128, P9248, DOI 10.1021/ja062710w; Wang DY, 2005, ANGEW CHEM INT EDIT, V44, P6525, DOI 10.1002/anie.200501603; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338	58	38	39	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59415	10.1371/journal.pone.0059415	http://dx.doi.org/10.1371/journal.pone.0059415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544065	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000317480700027
J	Rastrick, SPS; Whiteley, NM				Rastrick, Samuel P. S.; Whiteley, Nia M.			Influence of Natural Thermal Gradients on Whole Animal Rates of Protein Synthesis in Marine Gammarid Amphipods	PLOS ONE			English	Article							NORTHWESTERN ATLANTIC; SYNTHESIS CAPACITIES; METABOLIC COST; LIFE-HISTORY; TEMPERATURE; TURNOVER; GROWTH; LIMPET; ADAPTATION; CRUSTACEAN	Although temperature is known to have an important effect on protein synthesis rates and growth in aquatic ectotherms held in the laboratory, little is known about the effects of thermal gradients on natural populations in the field. To address this issue we determined whole-animal fractional rates of protein synthesis (k(s)) in four dominant species of gammarid amphipods with different distributions along the coasts of Western Europe from arctic to temperate latitudes. Up to three populations of each species were collected in the summer and k(s) measured within 48 h. Summer k(s) values were relatively high in the temperate species, Gammarus locusta, from Portugal (48 degrees N) and Wales (53 degrees N) and were maintained across latitudes by the conservation of translational efficiency. In sharp contrast, summer k(s). remained remarkably low in the boreal/temperate species G. duebeni from Wales, Scotland (58 degrees N) and Tromso (70 degrees N), probably as a temporary energy saving strategy to ensure survival in rapidly fluctuating environments of the high intertidal. Values for k(s) increased in acclimated G. duebeni from Scotland and Tromso showing a lack of compensation with latitude. In the subarctic/boreal species, G. oceanicus, summer k(s) remained unchanged in Scotland and Tromso but fell significantly in Svalbard (79 degrees N) at 5 degrees C, despite a slight increase in RNA content. At 79 degrees N, mean k(s) was 4.5 times higher in the circumpolar species G. setosus than in G. oceanicus due to a doubling in RNA content. The relationship between whole-animal protein synthesis rates and natural thermal gradients is complex, varies between species and appears to be associated with local temperatures and their variability, as well as changes in other environmental factors.	[Rastrick, Samuel P. S.; Whiteley, Nia M.] Bangor Univ, Sch Biol Sci, Coll Nat Sci, Bangor, Gwynedd, Wales	Bangor University	Whiteley, NM (corresponding author), Bangor Univ, Sch Biol Sci, Coll Nat Sci, Bangor, Gwynedd, Wales.	n.m.whiteley@bangor.ac.uk	Rastrick, Sam/C-3027-2013		NERC [NER/S/A/2005/13424]	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by a NERC studentship to SPS Rastrick (NER/S/A/2005/13424). http://www.nerc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHFORD AJ, 1986, J BIOL CHEM, V261, P4059; Bedulina DS, 2010, COMP BIOCHEM PHYS B, V155, P413, DOI 10.1016/j.cbpb.2010.01.004; BREY T, 1993, ANTARCT SCI, V5, P253, DOI 10.1017/S0954102093000343; Brooks SJ, 2003, COMP BIOCHEM PHYS A, V135, P527, DOI 10.1016/S1095-6433(03)00111-9; BULNHEIM HP, 1979, OECOLOGIA, V44, P80, DOI 10.1007/BF00346402; Conceicao LEC, 1997, FISH PHYSIOL BIOCHEM, V16, P291, DOI 10.1023/A:1007751130768; Costa FO, 2009, SYST BIODIVERS, V7, P365, DOI 10.1017/S1477200009990120; Costa F. O. C. M. H, 2000, POL ARCH HYDROBIOL, V47, P541; Costa FO, 2004, MAR ECOL PROG SER, V277, P197, DOI 10.3354/meps277197; DEFUR PL, 1983, BIOL BULL, V165, P582, DOI 10.2307/1541467; Duffy JE, 2000, ECOL MONOGR, V70, P237, DOI 10.1890/0012-9615(2000)070[0237:SIOGAO]2.0.CO;2; FENCHEL TM, 1979, OIKOS, V33, P316, DOI 10.2307/3544008; Fraser KPP, 2007, ADV MAR BIOL, V52, P267, DOI 10.1016/S0065-2881(06)52003-6; Fraser KPP, 2007, J EXP BIOL, V210, P2691, DOI 10.1242/jeb.003715; Fraser KPP, 2002, J EXP BIOL, V205, P3077; Garlick PJ, 1980, BIOCHEM J, V192, P47; Gaston KJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P179, DOI 10.1046/j.1466-822x.2001.00225.x; Hawkins AJS, 1987, FUNCT ECOL, V1, P339, DOI 10.2307/2389790; Hawkins AJS, 1999, AM ZOOL, V39, P401; HAWKINS AJS, 1989, PHYSIOL ZOOL, V62, P745, DOI 10.1086/physzool.62.3.30157925; HAWKINS AJS, 1991, FUNCT ECOL, V5, P222, DOI 10.2307/2389260; HOULIHAN DF, 1990, PHYSIOL ZOOL, V63, P735, DOI 10.1086/physzool.63.4.30158174; Ikko N V, 2010, Dokl Biol Sci, V431, P149; Intanai I, 2009, COMP BIOCHEM PHYS A, V152, P372, DOI 10.1016/j.cbpa.2008.11.006; Klekowski R.Z., 1990, ATLAS MARINE FAUNA 1, V2; LITTLE C, 1989, J MOLLUS STUD, V55, P273, DOI 10.1093/mollus/55.2.273; Marsh AG, 2001, SCIENCE, V291, P1950, DOI 10.1126/science.1056341; McCarthy Ian D., 1997, Society for Experimental Biology Seminar Series, V61, P51; MCCARTHY ID, 1994, P ROY SOC B-BIOL SCI, V257, P141, DOI 10.1098/rspb.1994.0107; McCleary SJ, 2006, THESIS BANGOR U; Mente E, 2002, J EXP BIOL, V205, P3107; Pantin CFA, 1934, J EXP BIOL, V11, P11; PARRY GD, 1978, J ANIM ECOL, V47, P351, DOI 10.2307/3788; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Place SP, 2004, AM J PHYSIOL-REG I, V287, pR429, DOI 10.1152/ajpregu.00223.2004; Portner HO, 2007, PHILOS T R SOC B, V362, P2233, DOI 10.1098/rstb.2006.1947; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2005, SCI MAR, V69, P271; PREEDY VR, 1988, BIOCHEM J, V250, P179, DOI 10.1042/bj2500179; Rastrick SPS, 2011, PHYSIOL BIOCHEM ZOOL, V84, P154, DOI 10.1086/658857; Robertson RF, 2001, J EXP MAR BIOL ECOL, V262, P113, DOI 10.1016/S0022-0981(01)00286-6; Robertson RF, 2001, POLAR BIOL, V24, P677; SAINTE-MARIE B, 1991, HYDROBIOLOGIA, V223, P189, DOI 10.1007/BF00047641; Shatilina ZM, 2011, J THERM BIOL, V36, P142, DOI 10.1016/j.jtherbio.2010.12.008; SKADSHEIM A, 1989, J EXP MAR BIOL ECOL, V127, P25, DOI 10.1016/0022-0981(89)90207-4; STEELE DH, 1974, CAN J ZOOL, V52, P1115, DOI 10.1139/z74-149; STEELE VJ, 1970, CAN J ZOOLOG, V48, P659, DOI 10.1139/z70-124; Storch D, 2005, J EXP BIOL, V208, P2409, DOI 10.1242/jeb.01632; Storch D, 2003, J COMP PHYSIOL B, V173, P611, DOI 10.1007/s00360-003-0371-7; Tomos A.D., 1994, PLANT CELL BIOL A PR, P297; Vader W, 1977, CRUSTACEANA S, V4, P192; WATERLOW JC, 1995, ANNU REV NUTR, V15, P57, DOI 10.1146/annurev.nu.15.070195.000421; Weslawski Jan Marcin, 2002, Polish Polar Research, V23, P253; Weslawski Jan Marcin, 2010, Marine Biodiversity, V40, P123, DOI 10.1007/s12526-010-0038-z; Whiteley N, 2005, PHYSIOL BIOCHEM ZOOL, V78, P227, DOI 10.1086/427054; Whiteley NM, 2011, J EXP MAR BIOL ECOL, V400, P70, DOI 10.1016/j.jembe.2011.02.027; Whiteley N.M., 2009, PROTEIN BIOSYNTHESIS, P249; Whiteley NM, 1996, AM J PHYSIOL-REG I, V271, pR1295, DOI 10.1152/ajpregu.1996.271.5.R1295; Wright, 1995, NITROGEN METABOLISM	59	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60050	10.1371/journal.pone.0060050	http://dx.doi.org/10.1371/journal.pone.0060050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544122	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700081
J	Firmino, J; Tinevez, JY; Knust, E				Firmino, Joao; Tinevez, Jean-Yves; Knust, Elisabeth			Crumbs Affects Protein Dynamics in Anterior Regions of the Developing Drosophila Embryo	PLOS ONE			English	Article							YELLOW FLUORESCENT PROTEIN; EPITHELIAL-CELLS; MITOTIC DOMAINS; APICAL MEMBRANE; GENE-EXPRESSION; POLARITY; INTERCALATION; MORPHOGENESIS; ELONGATION; MATURATION	Maintenance of apico-basal polarity is essential for epithelial integrity and requires particular reinforcement during tissue morphogenesis, when cells are reorganised, undergo shape changes and remodel their junctions. It is well established that epithelial integrity during morphogenetic processes depends on the dynamic exchange of adherens junction components, but our knowledge on the dynamics of other proteins and their dynamics during these processes is still limited. The early Drosophila embryo is an ideal system to study membrane dynamics during morphogenesis. Here, morphogenetic activities differ along the anterior-posterior axis, with the extending germband showing a high degree of epithelial remodelling. We developed a Fluorescence Recovery After Photobleaching (FRAP) assay with a higher temporal resolution, which allowed the distinction between a fast and a slow component of recovery of membrane proteins during the germband extension stage. We show for the first time that the recovery kinetics of a general membrane marker, SpiderGFP, differs in the anterior and posterior parts of the embryo, which correlates well with the different morphogenetic activities of the respective embryonic regions. Interestingly, absence of crumbs, a polarity regulator essential for epithelial integrity in the Drosophila embryo, decreases the fast component of SpiderGFP and of the apical marker Stranded at Second-Venus specifically in the anterior region. We suggest that the defects in kinetics observed in crumbs mutant embryos are the first signs of tissue instability in this region, explaining the earlier breakdown of the head epidermis in comparison to that of the trunk, and that diffusion in the plasma membrane is affected by the absence of Crumbs.	[Firmino, Joao; Tinevez, Jean-Yves; Knust, Elisabeth] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Knust, E (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	knust@mpi-cbg.de	Tinevez, Jean-Yves/E-8398-2012; Knust, Elisabeth/B-4338-2017; Tinevez, Jean-Yves/L-7581-2015; Tinevez, Jean-Yves/O-4551-2019	Tinevez, Jean-Yves/0000-0002-0998-4718; Tinevez, Jean-Yves/0000-0002-0998-4718; Tinevez, Jean-Yves/0000-0002-0998-4718	Max-Planck Society	Max-Planck Society(Max Planck Society)	Funding provided by the Max-Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Blanco MT, 2011, J CELL BIOL, V193, P455, DOI 10.1083/jcb.201011018; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Campbell K, 2009, J CELL SCI, V122, P2604, DOI 10.1242/jcs.047183; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Castanon I, 2011, CURR OPIN CELL BIOL, V23, P697, DOI 10.1016/j.ceb.2011.09.009; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Costa Michael, 1993, P425; da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; FOE VE, 1989, DEVELOPMENT, V107, P1; Gorfinkiel N, 2011, CURR OPIN CELL BIOL, V23, P531, DOI 10.1016/j.ceb.2011.06.002; Grawe F, 1996, DEVELOPMENT, V122, P951; HARTENSTEIN V, 1994, DEV BIOL, V165, P480, DOI 10.1006/dbio.1994.1269; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; Hildick KL, 2012, JOVE-J VIS EXP, DOI 10.3791/3747; Huang J, 2011, J CELL SCI, V124, P4001, DOI 10.1242/jcs.086694; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Llimargas M, 2004, DEVELOPMENT, V131, P181, DOI 10.1242/dev.00917; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Muschalik N, 2011, J CELL SCI, V124, P3715, DOI 10.1242/jcs.091223; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Oda H, 1999, DEV BIOL, V216, P406, DOI 10.1006/dbio.1999.9494; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Richard M, 2009, EUR J CELL BIOL, V88, P765, DOI 10.1016/j.ejcb.2009.07.006; Roberts DB, 1986, DROSOPHILA PRACTICAL, Vxix; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHONBAUM CP, 1992, DEV BIOL, V151, P431, DOI 10.1016/0012-1606(92)90183-H; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; St Johnston D, 2011, CURR OPIN CELL BIOL, V23, P540, DOI 10.1016/j.ceb.2011.07.005; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528; Vincent J P, 1997, Methods Mol Biol, V62, P385; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yin CY, 2009, CURR TOP DEV BIOL, V89, P163, DOI 10.1016/S0070-2153(09)89007-8; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zallen JA, 2008, SEMIN CELL DEV BIOL, V19, P263, DOI 10.1016/j.semcdb.2008.01.005	54	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58839	10.1371/journal.pone.0058839	http://dx.doi.org/10.1371/journal.pone.0058839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555600	Green Published, gold, Green Submitted			2022-12-25	WOS:000316546400012
J	Owada, S; Shimoda, Y; Tsuchihara, K; Esumi, H				Owada, Satoshi; Shimoda, Yuko; Tsuchihara, Katsuya; Esumi, Hiroyasu			Critical Role of H2O2 Generated by NOX4 during Cellular Response under Glucose Deprivation	PLOS ONE			English	Article							TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PYRVINIUM PAMOATE; INDUCED APOPTOSIS; ACTIVATION; PROTEIN; CELLS; AKT; INVOLVEMENT; PATHWAY	Glucose is the most efficient energy source, and various cancer cells depend on glycolysis for energy production. For maintenance of survival and proliferation, glucose sensing and adaptation to poor nutritional circumstances must be well organized in cancer cells. While the glucose sensing machinery has been well studied in yeasts, the molecular mechanism of glucose sensing in mammalian cells remains to be elucidated. We have reported glucose deprivation rapidly induces AKT phosphorylation through PI3K activation. We assumed that regulation of AKT is relevant to glucose sensing and further investigated the underlying mechanisms. In this study, AKT phosphorylation under glucose deprivation was inhibited by galactose and fructose, but induced by 2-deoxyglucose (2-DG). Both 2-DG treatment and glucose deprivation were found to induce AKT phosphorylation in HepG2 cells. These findings suggested that glucose transporter may not be involved in the sensing of glucose and induction of AKT phosphorylation, and that downstream metabolic events may have important roles. A variety of metabolic stresses reportedly induce the production of reactive oxygen species (ROS). In the present study, glucose deprivation was found to induce intracellular hydrogen peroxide (H2O2) production in HepG2 cells. N-acetylcysteine (NAC), an antioxidant reagent, reduced both the increase in cellular H2O2 levels and AKT phosphorylation induced by glucose deprivation. These results strongly suggest that the glucose deprivation-induced increase of H2O2 in the cells mediated the AKT phosphorylation. RNA interference of NOX4, but not of NOX5, completely suppressed the glucose deprivation-induced AKT phosphorylation as well as increase of the intracellular levels of ROS, whereas exogenous H2O2 could still induce AKT phosphorylation in the NOX4-knockdown cells. In this study, we demonstrated that the ROS generated by NOX4 are involved in the intracellular adaptive responses by recognizing metabolic flux.	[Owada, Satoshi; Shimoda, Yuko; Tsuchihara, Katsuya; Esumi, Hiroyasu] Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Owada, Satoshi; Shimoda, Yuko; Tsuchihara, Katsuya; Esumi, Hiroyasu] Natl Canc Ctr Hosp East, Canc Physiol Project, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan	University of Tokyo; National Cancer Center - Japan	Esumi, H (corresponding author), Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.	hesumi@ncc.go.jp			Ministry of Health, Labour and Welfare Japan [H22-3ji taigann-ippann-033]	Ministry of Health, Labour and Welfare Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare Japan [H22-3ji taigann-ippann-033 to HE] (http://www.mhlw.go.jp/english/). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggeli IKS, 2006, CELL SIGNAL, V18, P1801, DOI 10.1016/j.cellsig.2006.02.001; Alvarez-Tejado M, 2002, J BIOL CHEM, V277, P13508, DOI 10.1074/jbc.M200017200; Bang OS, 2000, BIOCHEM BIOPH RES CO, V278, P306, DOI 10.1006/bbrc.2000.3805; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Brown JM, 1998, CANCER RES, V58, P1408; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CRANE RK, 1954, J BIOL CHEM, V210, P597; Esposito F, 2003, J BIOL CHEM, V278, P20828, DOI 10.1074/jbc.M211841200; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Guo M, 2000, BIOCHEM PHARMACOL, V60, P635, DOI 10.1016/S0006-2952(00)00379-8; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Inazuka F, 2012, J BIOL CHEM, V287, P16379, DOI 10.1074/jbc.M111.302687; Izuishi K, 2000, CANCER RES, V60, P6201; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jiang ZJ, 2002, BIOCHEM BIOPH RES CO, V294, P726, DOI 10.1016/S0006-291X(02)00540-5; Kim HJ, 2011, FREE RADICAL BIO MED, V50, P1039, DOI 10.1016/j.freeradbiomed.2011.01.014; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Kim YK, 2006, CELL SIGNAL, V18, P236, DOI 10.1016/j.cellsig.2005.04.008; LESS JR, 1991, CANCER RES, V51, P265; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Nomura M, 2001, J BIOL CHEM, V276, P25558, DOI 10.1074/jbc.M101164200; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Tanaka M, 2009, MOL CELL BIOL, V29, P402, DOI 10.1128/MCB.01035-08; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Tomitsuka E, 2012, J BIOCHEM, V152, P171, DOI 10.1093/jb/mvs041; TOWER DB, 1958, J NEUROCHEM, V3, P185, DOI 10.1111/j.1471-4159.1958.tb12625.x; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990	37	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e56628	10.1371/journal.pone.0056628	http://dx.doi.org/10.1371/journal.pone.0056628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555559	Green Submitted, Green Published, gold			2022-12-25	WOS:000316546400003
J	Leman, SC; House, L; Maiti, D; Endert, A; North, C				Leman, Scotland C.; House, Leanna; Maiti, Dipayan; Endert, Alex; North, Chris			Visual to Parametric Interaction (V2PI)	PLOS ONE			English	Article								Typical data visualizations result from linear pipelines that start by characterizing data using a model or algorithm to reduce the dimension and summarize structure, and end by displaying the data in a reduced dimensional form. Sensemaking may take place at the end of the pipeline when users have an opportunity to observe, digest, and internalize any information displayed. However, some visualizations mask meaningful data structures when model or algorithm constraints (e. g., parameter specifications) contradict information in the data. Yet, due to the linearity of the pipeline, users do not have a natural means to adjust the displays. In this paper, we present a framework for creating dynamic data displays that rely on both mechanistic data summaries and expert judgement. The key is that we develop both the theory and methods of a new human-data interaction to which we refer as "Visual to Parametric Interaction" (V2PI). With V2PI, the pipeline becomes bidirectional in that users are embedded in the pipeline; users learn from visualizations and the visualizations adjust to expert judgement. We demonstrate the utility of V2PI and a bi-directional pipeline with two examples.	[Leman, Scotland C.; House, Leanna; Maiti, Dipayan] Virginia Tech, Dept Stat, Blacksburg, VA 24061 USA; [Endert, Alex; North, Chris] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	House, L (corresponding author), Virginia Tech, Dept Stat, Blacksburg, VA 24061 USA.	lhouse@vt.edu			National Science Foundation, Computer and Communications Foundations [0937071]; Direct For Computer & Info Scie & Enginr [0937071] Funding Source: National Science Foundation	National Science Foundation, Computer and Communications Foundations(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Science Foundation, Computer and Communications Foundations, #0937071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abowd G. D., 1991, People and Computers VI. Proceedings of the HCI '91 Conference, P73; Andrews N. O., 2007, TECHNICAL REPORT; Bishop CM, 1998, NEURAL COMPUT, V10, P215, DOI 10.1162/089976698300017953; Buja A, 1998, J COMPUTATIONAL GRAP, V5, P78; Card SK, 1999, INFORM VISUALIZATION; Carroll JD, 1970, PSYCHOMETRIKA, V35, P238, DOI DOI 10.1007/BF02310791; Endert A., 2011, 2011 IEEE Conference on Visual Analytics Science and Technology, P121, DOI 10.1109/VAST.2011.6102449; Hastie T., 2008, ELEMENTS STAT LEARNI; House L, 2012, TECHNICAL REPORT; Icke I., 2009, TECHNICAL REPORT; Jeong DH, 2009, COMPUT GRAPH FORUM, V28, P767, DOI 10.1111/j.1467-8659.2009.01475.x; JOLLIFFE I., 2005, PRINCIPAL COMPONENT; Keim D, 2008, VISUAL DATA MINING T, P767; Keim DA, 2002, IEEE T VIS COMPUT GR, V8, P1, DOI 10.1109/2945.981847; Koren Y, 2003, INFOVIS 2002: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2003, PROCEEDINGS, P121, DOI 10.1109/INFVIS.2003.1249017; Kruskal JB, 1978, SAGE U PAPER SERIES, V48, P07; Lederberg J, 1989, EXCITEMENT FASCINATI; Mordecai A., 1976, NONLINEAR PROGRAMMIN; Myers B., 2000, ACM Transactions on Computer-Human Interaction, V7, P3, DOI 10.1145/344949.344959; Norman D. A., 1990, DESIGN EVERYDAY THIN; Pak Chung W, 2004, P IEEE S INF VIS INF; Pike WA, 2009, INFORM VISUALIZATION, V5, P78; Pirolli P., 2005, P 2005 INT C INT AN; Schiffman SS, 1981, INTRO MULTIDIMENSION; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Thomas J. J., 2005, ILLUMINATING PATH; Tipping ME, 1999, NEURAL COMPUT, V11, P443, DOI 10.1162/089976699300016728; TORGERSON W, 1958, THEORY METHODS SCALI	28	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e50474	10.1371/journal.pone.0050474	http://dx.doi.org/10.1371/journal.pone.0050474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23555552	Green Submitted, gold, Green Published			2022-12-25	WOS:000317562600001
J	Yang, XH; Gong, Y; Tang, YF; Li, HF; He, Q; Gower, L; Liaw, L; Friesel, RE				Yang, Xuehui; Gong, Yan; Tang, Yuefeng; Li, Hongfang; He, Qing; Gower, Lindsey; Liaw, Lucy; Friesel, Robert E.			Spry1 and Spry4 Differentially Regulate Human Aortic Smooth Muscle Cell Phenotype via Akt/FoxO/Myocardin Signaling	PLOS ONE			English	Article							GENE-EXPRESSION; ENDOTHELIAL-CELLS; SPROUTY PROTEINS; ERK ACTIVATION; GROWTH; MYOCARDIN; PROLIFERATION; INHIBITION; PATHWAY; OVEREXPRESSION	Background: Changes in the vascular smooth muscle cell (VSMC) contractile phenotype occur in pathological states such as restenosis and atherosclerosis. Multiple cytokines, signaling through receptor tyrosine kinases (RTK) and PI3K/Akt and MAPK/ERK pathways, regulate these phenotypic transitions. The Spry proteins are feedback modulators of RTK signaling, but their specific roles in VSMC have not been established. Methodology/Principal Findings: Here, we report for the first time that Spry1, but not Spry4, is required for maintaining the differentiated state of human VSMC in vitro. While Spry1 is a known MAPK/ERK inhibitor in many cell types, we found that Spry1 has little effect on MAPK/ERK signaling but increases and maintains Akt activation in VSMC. Sustained Akt signaling is required for VSMC marker expression in vitro, while ERK signaling negatively modulates Akt activation and VSMC marker gene expression. Spry4, which antagonizes both MAPK/ERK and Akt signaling, suppresses VSMC differentiation marker gene expression. We show using siRNA knockdown and ChIP assays that FoxO3a, a downstream target of PI3K/Akt signaling, represses myocardin promoter activity, and that Spry1 increases, while Spry4 decreases myocardin mRNA levels. Conclusions: Together, these data indicate that Spry1 and Spry4 have opposing roles in VSMC phenotypic modulation, and Spry1 maintains the VSMC differentiation phenotype in vitro in part through an Akt/FoxO/myocardin pathway.	[Yang, Xuehui; Gong, Yan; Tang, Yuefeng; He, Qing; Gower, Lindsey; Liaw, Lucy; Friesel, Robert E.] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Gong, Yan; Tang, Yuefeng; He, Qing; Liaw, Lucy; Friesel, Robert E.] Univ Maine, Grad Sch Biomed Sci, Orono, ME USA; [Li, Hongfang] Lanzhou Univ, Coll Basic Med, Dept Physiol, Lanzhou 730000, Peoples R China	Maine Medical Center; University of Maine System; University of Maine Orono; Lanzhou University	Yang, XH (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA.	yangx@mmc.org; friesr@mmc.org		Gong, Yan/0000-0002-4805-0459	National Institutes of Health [R01 HL065301, P30RR030927/P30GM103392, R01 Hl070865, P20RR181789/P20GM103465]; Founders Affiliate of the American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR030927] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070865, R01HL109652, R01HL065301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103392, P20GM103465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Founders Affiliate of the American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 HL065301 and P30RR030927/P30GM103392 (confocal microscopy, DNA sequencing, and viral vector cores) RF, PI, R01 Hl070865 to LL, and P20RR181789/P20GM103465 (cell phenotyping core) to DM Wojchowski, PI, and institutional support from the Maine Medical Center. YG is the recipient of a predoctoral fellowship award from the Founders Affiliate of the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Brown DJ, 2005, J VASC SURG, V41, P509, DOI 10.1016/j.jvs.2004.12.024; Chen PY, 2009, J BIOL CHEM, V284, P15980, DOI 10.1074/jbc.M809399200; COOK CL, 1994, CIRC RES, V74, P189, DOI 10.1161/01.RES.74.2.189; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lito P, 2008, J BIOL CHEM, V283, P2002, DOI 10.1074/jbc.M709046200; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; OBRIEN ER, 1993, CIRC RES, V73, P223, DOI 10.1161/01.RES.73.2.223; Owens Gary K, 2007, Novartis Found Symp, V283, P174; OWENS GK, 1986, J BIOL CHEM, V261, P3373; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ozaki K, 2005, J CELL SCI, V118, P5861, DOI 10.1242/jcs.02711; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Sasaki A, 2003, CELL CYCLE, V2, P281, DOI 10.4161/cc.2.4.418; Sathyanarayana P, 2012, BLOOD, V119, P5522, DOI 10.1182/blood-2011-11-392571; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Tamama K, 2008, STEM CELLS DEV, V17, P897, DOI 10.1089/scd.2007.0155; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Thomas JA, 2009, AM J PHYSIOL-HEART C, V296, pH442, DOI 10.1152/ajpheart.00165.2008; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Yang XH, 2008, DEV BIOL, V321, P64, DOI 10.1016/j.ydbio.2008.05.555; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a	35	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58746	10.1371/journal.pone.0058746	http://dx.doi.org/10.1371/journal.pone.0058746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554919	gold, Green Submitted, Green Published			2022-12-25	WOS:000316409800025
J	Cullen, TM; Ryan, MJ; Schroder-Adams, C; Currie, PJ; Kobayashi, Y				Cullen, Thomas M.; Ryan, Michael J.; Schroeder-Adams, Claudia; Currie, Philip J.; Kobayashi, Yoshitsugu			An Ornithomimid (Dinosauria) Bonebed from the Late Cretaceous of Alberta, with Implications for the Behavior, Classification, and Stratigraphy of North American Ornithomimids	PLOS ONE			English	Article							HORSESHOE CANYON FORMATION; SOUTHERN ALBERTA; PARK FORMATION; SEDIMENTOLOGY; TAPHONOMY; CANADA	Bonebeds can provide a wealth of anatomical, taphonomic, and ontogenetic information about the specimens preserved within them, and can provide evidence for inferred behavior. The material described here represents the first known bonebed of ornithomimids in North America, and the fourth record of an ornithomimosaur bonebed in the world. Partial skeletons representing three individuals are preserved in this assemblage, each comprising primarily portions of the posterior postcrania (pelvis, hind limbs and tail). All three individuals are morphologically similar, although one is larger in overall size. Given the stratigraphic position of the site, and the morphology of the postcrania, the preserved material represents a taxon from the clade containing Ornithomimus and Struthiomimus. Pedal ungual morphology is examined and found to be too variable to be useful in distinguishing these species taxonomically. This site provides additional evidence of gregarious behavior in ornithomimids and the first probable record of that behavior in North American forms.	[Cullen, Thomas M.; Ryan, Michael J.; Schroeder-Adams, Claudia] Carleton Univ, Dept Earth Sci, Ottawa, ON K1S 5B6, Canada; [Ryan, Michael J.] Cleveland Museum Nat Hist, Dept Vertebrate Paleontol, Cleveland, OH USA; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Kobayashi, Yoshitsugu] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido, Japan	Carleton University; Cleveland Museum of Natural History; University of Alberta; Hokkaido University	Cullen, TM (corresponding author), Carleton Univ, Dept Earth Sci, Ottawa, ON K1S 5B6, Canada.	thomas_cullen@carleton.ca	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161; Cullen, Thomas/0000-0002-4261-1323; Schroder-Adams, Claudia/0000-0002-0245-2559				Allain R, 2011, J VERTEBRATE PALCONT, V2011, P46; Coria RA, 2006, GEODIVERSITAS, V28, P71; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; Currie PJ, 2010, CAN J EARTH SCI, V47, P1277, DOI 10.1139/E10-072; Currie PJ, 2005, LIFE O PAST, P313; CURRIE PJ, 1993, CRETACEOUS RES, V14, P127, DOI 10.1006/cres.1993.1011; DODSON P, 1971, PALAEOGEOGR PALAEOCL, V10, P21, DOI 10.1016/0031-0182(71)90044-7; Dodson P, 1978, SYST ZOOL, V24, P37; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Eberth DA, 2002, C CAN SOC PETR GEOL; Eberth DA, 2012, CAN J EARTH SCI, V49, P1053, DOI 10.1139/E2012-035; Eberth DA, 2010, CAN J EARTH SCI, V47, P1119, DOI 10.1139/E10-045; Eberth David A., 2007, P103; Fiorillo A.R., 1988, U WYOMING CONTRIBUTI, V26, P57; Goloboff P, 2008, CLADISTICS, V24, P91; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Ji Q, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)420<0001:AEODAI>2.0.CO;2; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; Kobayashi Y, 2006, J VERTEBR PALEONTOL, V26, p86A; Longrich N, 2008, PALAEONTOLOGY, V51, P983, DOI 10.1111/j.1475-4983.2008.00791.x; Makovicky P.J., 2009, P ROYAL SOC B, V277, P211; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; Mathews JC, 2009, J VERTEBR PALEONTOL, V29, P286, DOI 10.1080/02724634.2009.10010382; NICHOLLS EL, 1981, CAN J EARTH SCI, V18, P518, DOI 10.1139/e81-045; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Osborn HF, 1916, B AM MUS NAT HIST, V35, P733; Parks W. A., 1933, University of Toronto Studies Geological Series, VNo. 34, P3; RUSSELL DA, 1972, CAN J EARTH SCI, V9, P375, DOI 10.1139/e72-031; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Smith D., 1990, Journal of Vertebrate Paleontology, V10, P255; STERNBERG C. M., 1933, CANADIAN FIELD NATURALIST, V47, P79; Varricchio DJ, 2008, ACTA PALAEONTOL POL, V53, P567, DOI 10.4202/app.2008.0402; Xu L, 2011, CRETACEOUS RES, V32, P213, DOI 10.1016/j.cretres.2010.12.004	35	28	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58853	10.1371/journal.pone.0058853	http://dx.doi.org/10.1371/journal.pone.0058853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554938	gold, Green Published			2022-12-25	WOS:000316252500049
J	McCarthy, CB; Santini, MS; Pimenta, PFP; Diambra, LA				McCarthy, Christina B.; Soledad Santini, Maria; Pimenta, Paulo F. P.; Diambra, Luis A.			First Comparative Transcriptomic Analysis of Wild Adult Male and Female Lutzomyia longipalpis, Vector of Visceral Leishmaniasis	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; PERMETHRIN INDUCES OVEREXPRESSION; DROSOPHILA ACTIN GENES; PERITROPHIC MATRIX; CUTANEOUS LEISHMANIASIS; INSECTICIDE RESISTANCE; FUNCTIONAL GENOMICS; MOLECULAR-CLONING; RNA INTERFERENCE; MISMATCH REPAIR	Leishmaniasis is a vector-borne disease with a complex epidemiology and ecology. Visceral leishmaniasis (VL) is its most severe clinical form as it results in death if not treated. In Latin America VL is caused by the protist parasite Leishmania infantum (syn. chagasi) and transmitted by Lutzomyia longipalpis. This phlebotomine sand fly is only found in the New World, from Mexico to Argentina. However, due to deforestation, migration and urbanisation, among others, VL in Latin America is undergoing an evident geographic expansion as well as dramatic changes in its transmission patterns. In this context, the first VL outbreak was recently reported in Argentina, which has already caused 7 deaths and 83 reported cases. Insect vector transcriptomic analyses enable the identification of molecules involved in the insect's biology and vector-parasite interaction. Previous studies on laboratory reared Lu. longipalpis have provided a descriptive repertoire of gene expression in the whole insect, midgut, salivary gland and male reproductive organs. Nevertheless, the study of wild specimens would contribute a unique insight into the development of novel bioinsecticides. Given the recent VL outbreak in Argentina and the compelling need to develop appropriate control strategies, this study focused on wild male and female Lu. longipalpis from an Argentine endemic (Posadas, Misiones) and a Brazilian non-endemic (Lapinha Cave, Minas Gerais) VL location. In this study, total RNA was extracted from the sand flies, submitted to sequence independent amplification and high-throughput pyrosequencing. This is the first time an unbiased and comprehensive transcriptomic approach has been used to analyse an infectious disease vector in its natural environment. Transcripts identified in the sand flies showed characteristic profiles which correlated with the environment of origin and with taxa previously identified in these same specimens. Among these, various genes represented putative targets for vector control via RNA interference (RNAi).	[McCarthy, Christina B.; Diambra, Luis A.] Univ Nacl La Plata, Ctr Reg Estudios Genom, Fac Ciencias Exactas, Buenos Aires, DF, Argentina; [McCarthy, Christina B.] Univ Nacl Noroeste Prov Buenos Aires, Dept Informat & Tecnol, Buenos Aires, DF, Argentina; [Soledad Santini, Maria] Minist Salud, Ctr Nacl Diagnost & Invest Endemoepidemias, Adm Nacl Labs, Buenos Aires, DF, Argentina; [Soledad Santini, Maria] Minist Salud, Inst Salud, Buenos Aires, DF, Argentina; [Pimenta, Paulo F. P.] Fundacao Oswaldo Cruz FIOCRUZ, Lab Med Entomol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil	National University of La Plata; Universidad Nacional del Noroeste de la Provincia de Buenos Aires; Fundacao Oswaldo Cruz	McCarthy, CB (corresponding author), Univ Nacl La Plata, Ctr Reg Estudios Genom, Fac Ciencias Exactas, Buenos Aires, DF, Argentina.	mccarthychristina@gmail.com	Pimenta, Paulo/AAH-1502-2020; L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880; McCarthy, Christina Beryl/0000-0001-9725-5285	Fundacion Bunge y Born grant [FBBEI5/08]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT PRH 112]	Fundacion Bunge y Born grant; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This research was supported by a Fundacion Bunge y Born grant (FBBEI5/08) and an Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) grant (PICT PRH 112) to CBM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alemany C, 2000, BBA-MOL CELL RES, V1495, P319, DOI 10.1016/S0167-4889(99)00159-7; Alexander B, 2009, TROP MED INT HEALTH, V14, P1272, DOI 10.1111/j.1365-3156.2009.02371.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; [Anonymous], 2002, Wkly Epidemiol Rec, V77, P365; Aurade RM, 2010, BBA-BIOMEMBRANES, V1798, P1135, DOI 10.1016/j.bbamem.2010.02.019; Azevedo RVDM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034495; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; BERNSTEIN SI, 1993, INT REV CYTOL, V143, P63; BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Buss DS, 2002, MED VET ENTOMOL, V16, P218, DOI 10.1046/j.1365-2915.2002.00365.x; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105; Chou WC, 2004, P NATL ACAD SCI USA, V101, P4578, DOI 10.1073/pnas.0306687101; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coutinho-Abreu IV, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000901; Coy MR, 2012, J APPL ENTOMOL, DOI DOI 10.1111/J/1439-0418.2012.01713.X; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Craig NL., 2002, MOBILE DNA-UK; Cummins SF, 2009, INT J DEV BIOL, V53, P1081, DOI 10.1387/ijdb.082791sc; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Danielli A, 2003, J BIOL CHEM, V278, P4184, DOI 10.1074/jbc.M208187200; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Diaz-Albiter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017486; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; Dougherty M.J., 1991, Parassitologia (Rome), V33, P185; Eickbush T.H., 2002, MOBILE DNA-UK, V2, P1111, DOI [10.1128/9781555817954.ch49, DOI 10.1128/9781555817954.CH49]; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Filmore D., 2004, MOD DRUG DISCOV, V7, P24; Fisher R, 1970, STATISTICAL METHODS, P96; FREEMAN BA, 1982, LAB INVEST, V47, P412; FYRBERG EA, 1983, CELL, V33, P115, DOI 10.1016/0092-8674(83)90340-9; FYRBERG EA, 1980, CELL, V19, P365, DOI 10.1016/0092-8674(80)90511-5; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Ganko EW, 2003, MOL BIOL EVOL, V20, P1925, DOI 10.1093/molbev/msg200; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gochfeld M, 1997, ENVIRON HEALTH PERSP, V105, P817, DOI 10.1289/ehp.97105s4817; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Han SJ, 1998, J BIOL CHEM, V273, P369, DOI 10.1074/jbc.273.1.369; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; IARC, 1987, ARS ARS COMP GROUP 1; Iwanaga S, 1998, J BIOCHEM, V123, P1; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; Johnson JK, 2001, INSECT BIOCHEM MOLEC, V31, P1125, DOI 10.1016/S0965-1748(01)00072-8; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; Kang S, 2008, KOREAN J PARASITOL, V46, P1, DOI 10.3347/kjp.2008.46.1.1; Kanost MR, 2001, ADV EXP MED BIOL, V484, P319; KAUL S. M., 1978, Journal of Communicable Diseases, V10, P208; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Konstandi OA, 2005, INSECT BIOCHEM MOLEC, V35, P1043, DOI 10.1016/j.ibmb.2005.04.005; Konstandi OA, 2006, INT J DEV BIOL, V50, P543, DOI 10.1387/ijdb.052122ok; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lee SM, 2006, CHEMOSPHERE, V65, P1074, DOI 10.1016/j.chemosphere.2006.02.042; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2002, PROTEIN ENG, V15, P643, DOI 10.1093/protein/15.8.643; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lloyd AC, 2002, NAT CELL BIOL, V4, pE25, DOI 10.1038/ncb0202-e25; Magalhaes T, 2008, ARCH INSECT BIOCHEM, V68, P134, DOI 10.1002/arch.20238; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; McCarthy CB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001304; Meyer JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001478; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Morris RV, 2001, J IMMUNOL, V167, P5226, DOI 10.4049/jimmunol.167.9.5226; Mukhopadhyay A, 1992, SUSCEPTIBILITY PHLEB; Munks RJL, 2005, INSECT MOL BIOL, V14, P483, DOI 10.1111/j.1365-2583.2005.00579.x; Naidu R, 2006, MANAGING ARSENIC IN THE ENVIRONMENT: FROM SOIL TO HUMAN HEALTH, P331; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Oduol F, 2000, P NATL ACAD SCI USA, V97, P11397, DOI 10.1073/pnas.180060997; Orme S, 2012, PAN PESTICIDES DATAB; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Pereira C, 1998, PARASITOLOGY, V117, P63, DOI 10.1017/S003118209800273X; Pin OY, 1996, J CELL BIOL, V135, P1027, DOI 10.1083/jcb.135.4.1027; Pitaluga AN, 2009, MOL GENET GENOMICS, V282, P307, DOI 10.1007/s00438-009-0466-2; Porretta D, 2008, MED VET ENTOMOL, V22, P48, DOI 10.1111/j.1365-2915.2008.00712.x; PREDKI PF, 1994, ENVIRON HEALTH PERSP, V102, P195, DOI 10.2307/3431786; Pridgeon JW, 2008, J MED ENTOMOL, V45, P414, DOI 10.1603/0022-2585(2008)45[414:TAADRK]2.0.CO;2; Pridgeon JW, 2009, J MED ENTOMOL, V46, P810, DOI 10.1603/033.046.0411; Pridgeon JW, 2009, J MED ENTOMOL, V46, P580, DOI 10.1603/033.046.0324; Pridgeon JW, 2003, INSECT BIOCHEM MOLEC, V33, P1043, DOI 10.1016/S0965-1748(03)00120-6; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098; Ramalho-Ortigao JM, 2003, INSECT BIOCHEM MOLEC, V33, P279, DOI 10.1016/S0965-1748(02)00209-6; READY PD, 1979, J MED ENTOMOL, V16, P413, DOI 10.1093/jmedent/16.5.413; Reumer A, 2008, GEN COMP ENDOCR, V155, P22, DOI 10.1016/j.ygcen.2007.06.021; Rey Luís C., 2005, J. Pediatr. (Rio J.), V81, P73, DOI [10.1590/S0021-75572005000100014, 10.2223/JPED.1286]; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Riggio M, 2002, BBA-GENE STRUCT EXPR, V1576, P127, DOI 10.1016/S0167-4781(02)00337-8; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Ropert C, 2002, MICROBES INFECT, V4, P1015, DOI 10.1016/S1286-4579(02)01609-X; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P109, DOI 10.1590/S0074-02762008000100018; Salomon OD, 2001, MEDICINA-BUENOS AIRE, V61, P174; Salomon OD, 2010, MEM I OSWALDO CRUZ, V105, P928, DOI 10.1590/S0074-02762010000700016; Shirafuji N, 1997, BLOOD, V90, P4567, DOI 10.1182/blood.V90.11.4567.4567_4567_4577; Singh S, 2006, INDIAN J MED RES, V123, P311; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S; Santini MS, 2010, REV INST MED TROP SP, V52, P187, DOI 10.1590/S0036-46652010000400004; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; SUDIA WILLIAM D., 1962, MOSQUITO NEWS, V22, P126; Surendran SN, 2005, B ENTOMOL RES, V95, P371, DOI 10.1079/BER2005368; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; TOBIN SL, 1990, DEV GENET, V11, P15, DOI 10.1002/dvg.1020110104; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; WIKSTROM M, 1985, J INORG BIOCHEM, V23, P327, DOI 10.1016/0162-0134(85)85042-X; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x	147	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58645	10.1371/journal.pone.0058645	http://dx.doi.org/10.1371/journal.pone.0058645			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554910	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500036
J	Ng, S; Ip, DKM; Fang, VJ; Chan, KH; Chiu, SS; Leung, GM; Peiris, JSM; Cowling, BJ				Ng, Sophia; Ip, Dennis K. M.; Fang, Vicky J.; Chan, Kwok-Hung; Chiu, Susan S.; Leung, Gabriel M.; Peiris, J. S. Malik; Cowling, Benjamin J.			The Effect of Age and Recent Influenza Vaccination History on the Immunogenicity and Efficacy of 2009-10 Seasonal Trivalent Inactivated Influenza Vaccination in Children	PLOS ONE			English	Article							ANTIBODY-RESPONSES; PANDEMIC INFLUENZA; PROTECTIVE EFFICACY; ANNUAL IMMUNIZATION; CONSECUTIVE YEARS; IMMUNE-RESPONSE; HONG-KONG; VIRUS; VACCINES; STRAINS	Background: There is some evidence that annual vaccination of trivalent inactivated influenza vaccine (TIV) may lead to reduced vaccine immunogenicity but evidence is lacking on whether vaccine efficacy is affected by prior vaccination history. The efficacy of one dose of TIV in children 6-8 y of age against influenza B is uncertain. We examined whether immunogenicity and efficacy of influenza vaccination in school-age children varied by age and past vaccination history. Methods and Findings: We conducted a randomized controlled trial of 2009-10 TIV. Influenza vaccination history in the two preceding years was recorded. Immunogenicity was assessed by comparison of HI titers before and one month after receipt of TIV/placebo. Subjects were followed up for 11 months with symptom diaries, and respiratory specimens were collected during acute respiratory illnesses to permit confirmation of influenza virus infections. We found that previous vaccination was associated with reduced antibody responses to TIV against seasonal A(H1N1) and A(H3N2) particularly in children 9-17 y of age, but increased antibody responses to the same lineage of influenza B virus in children 6-8 y of age. Serological responses to the influenza A vaccine viruses were high regardless of vaccination history. One dose of TIV appeared to be efficacious against confirmed influenza B in children 6-8 y of age regardless of vaccination history. Conclusions: Prior vaccination was associated with lower antibody titer rises following vaccination against seasonal influenza A vaccine viruses, but higher responses to influenza B among individuals primed with viruses from the same lineage in preceding years. In a year in which influenza B virus predominated, no impact of prior vaccination history was observed on vaccine efficacy against influenza B. The strains that circulated in the year of study did not allow us to study the effect of prior vaccination on vaccine efficacy against influenza A.	[Ng, Sophia; Ip, Dennis K. M.; Fang, Vicky J.; Leung, Gabriel M.; Peiris, J. S. Malik; Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok-Hung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chiu, Susan S.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Li Ka Shing Fac Med, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009; Chan, Kwok Hung/ABD-5399-2021; Ng, Sophia/AAA-1461-2019; Chiu, Susan Shui Seng/C-4247-2009; Ip, Dennis Kai Ming/C-4283-2009	Cowling, Benjamin John/0000-0002-6297-7154; Ng, Sophia/0000-0001-7817-7744; Leung, Gabriel/0000-0002-2503-6283; Chiu, Susan Shui Seng/0000-0002-3908-1974; Ip, Dennis Kai Ming/0000-0003-3592-8709	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR [CHP-CE-03, PHE-2]; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Area of Excellence Scheme of the University Grants Committee of Hong Kong [AoE/M-12/06]; F. Hoffman-La Roche Ltd.; Crucell MV; MedImmune Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Area of Excellence Scheme of the University Grants Committee of Hong Kong; F. Hoffman-La Roche Ltd.; Crucell MV; MedImmune Inc.(AstraZenecaMedimmune); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR (grant nos. CHP-CE-03 and PHE-2), the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558), and the Area of Excellence Scheme of the University Grants Committee of Hong Kong (grant no. AoE/M-12/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. DKMI has received research funding from F. Hoffman-La Roche Ltd. JSMP receives research funding from Crucell MV and serves as an ad hoc consultant for GlaxoSmithKline and Sanofi. BJC has received research funding from MedImmune Inc., and consults for Crucell MV. BJC is an Academic Editor for PLOS ONE. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The authors report no other potential conflicts of interest.	Bernstein DI, 2003, PEDIATR INFECT DIS J, V22, P28, DOI 10.1097/00006454-200301000-00010; Beyer WEP, 1998, VACCINE, V16, P1929, DOI 10.1016/S0264-410X(98)00123-6; Beyer WEP, 1999, ARCH INTERN MED, V159, P182, DOI 10.1001/archinte.159.2.182; Beyer WEP, 1996, VACCINE, V14, P1331, DOI 10.1016/S0264-410X(96)00058-8; BLACK SC, 2011, AM POETRY REV, V40, P30; Bodewes R, 2009, LANCET INFECT DIS, V9, P784, DOI 10.1016/S1473-3099(09)70263-4; Brown F, 2003, P SCI WORKSH, pxi; Chiu SS, 2007, PEDIATRICS, V119, P1076, DOI 10.1542/peds.2006-3176; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Cowling BJ, 2012, CLIN INFECT DIS, V55, P695, DOI 10.1093/cid/cis518; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Cowling BJ, 2012, CLIN INFECT IN PRESS; de Bruijn IA, 1999, J INFECT DIS, V179, P31, DOI 10.1086/314540; de Groot JAH, 2008, STAT MED, V27, P5880, DOI 10.1002/sim.3410; deBruijn IA, 1997, VACCINE, V15, P1323, DOI 10.1016/S0264-410X(97)00019-4; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Gardner EM, 2001, VACCINE, V19, P4610, DOI 10.1016/S0264-410X(01)00246-8; Grohskopf Lisa, 2012, Morbidity and Mortality Weekly Report, V61, P613; Gross PA, 1999, VACCINE, V17, P2284, DOI 10.1016/S0264-410X(98)00478-2; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; HOWELLS CHL, 1975, LANCET, V1, P381; Huijskens E, 2011, CLIN VACCINE IMMUNOL, V18, P1401, DOI 10.1128/CVI.05046-11; Iorio AM, 2007, GERONTOLOGY, V53, P411, DOI 10.1159/000110579; Keitel WA, 1997, VACCINE, V15, P1114, DOI 10.1016/S0264-410X(97)00003-0; Keitel Wendy A, 2002, Semin Pediatr Infect Dis, V13, P112, DOI 10.1053/spid.2002.122998; Little R, 2004, STAT SINICA, V14, P949; Michiels B, 2006, VACCINE, V24, P3145, DOI 10.1016/j.vaccine.2006.01.040; Molenberghs G., 2007, MISSING DATA CLIN ST; Nabeshima S, 2007, J MED VIROL, V79, P320, DOI 10.1002/jmv.20801; Neuzil KM, 2006, J INFECT DIS, V194, P1032, DOI 10.1086/507309; Ng S, 2012, PEDIATR INFECT DIS J, V31, P964, DOI 10.1097/INF.0b013e318263280e; Ohmit SE, 2013, CLIN INFECT IN PRESS; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Seidman JC, 2012, INFLUENZA OTHER RESP, V6, P52, DOI 10.1111/j.1750-2659.2011.00268.x; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; WHO, 2009, REC COMP INFL VIR VA; WHO Influenza Centre, 2009, REP WHO INFL CTR; World Health Organization (WHO), 2008, REC COMP INFL VIR VA; World Health Organization (WHO), 2007, REC COMP INFL VIR VA; Wright PF, 2008, PEDIATR INFECT DIS J, V27, P1004, DOI 10.1097/INF.0b013e31817d53c5; Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b	44	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59077	10.1371/journal.pone.0059077	http://dx.doi.org/10.1371/journal.pone.0059077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554974	Green Submitted, gold, Green Published			2022-12-25	WOS:000316252500065
J	Ranzani, OT; Zampieri, FG; Forte, DN; Azevedo, LCP; Park, M				Ranzani, Otavio T.; Zampieri, Fernando Godinho; Forte, Daniel Neves; Pontes Azevedo, Luciano Cesar; Park, Marcelo			C-Reactive Protein/Albumin Ratio Predicts 90-Day Mortality of Septic Patients	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; IN-HOSPITAL MORTALITY; INTENSIVE-CARE; PROTEIN-CONCENTRATION; RISK PREDICTION; ICU DISCHARGE; SEPSIS; SURVIVAL; MARKER; READMISSION	Introduction: Residual inflammation at ICU discharge may have impact upon long-term mortality. However, the of ongoing inflammation on mortality after ICU discharge is poorly described. C-reactive protein (CRP) and albumin are measured frequently in the ICU and exhibit opposing patterns during inflammation. Since infection is a potent trigger of inflammation, we hypothesized that CRP levels at discharge would correlate with long-term mortality in septic patients and that the CRP/albumin ratio would be a better marker of prognosis than CRP alone. Methods: We evaluated 334 patients admitted to the ICU as a result of severe sepsis or septic shock who were discharged alive after a minimum of 72 hours in the ICU. We evaluated the performance of both CRP and CRP/albumin to predict mortality at 90 days after ICU discharge. Two multivariate logistic models were generated based on measurements at discharge: one model included CRP (Model-CRP), and the other included the CRP/albumin ratio (Model-CRP/albumin). Results: There were 229 (67%) and 111 (33%) patients with severe sepsis and septic shock, respectively. During the 90 days of follow-up, 73 (22%) patients died. CRP/albumin ratios at admission and at discharge were associated with a poor outcome and showed greater accuracy than CRP alone at these time points (p = 0.0455 and p = 0.0438, respectively). CRP levels and the CRP/albumin ratio were independent predictors of mortality at 90 days (Model-CRP: adjusted OR 2.34, 95% CI 1.14-4.83, p = 0.021; Model-CRP/albumin: adjusted OR 2.18, 95% CI 1.10-4.67, p = 0.035). Both models showed similar accuracy (p = 0.2483). However, Model-CRP was not calibrated. Conclusions: Residual inflammation at ICU discharge assessed using the CRP/albumin ratio is an independent risk factor for mortality at 90 days in septic patients. The use of the CRP/albumin ratio as a long-term marker of prognosis provides more consistent results than standard CRP values alone.	[Ranzani, Otavio T.; Zampieri, Fernando Godinho; Forte, Daniel Neves; Pontes Azevedo, Luciano Cesar; Park, Marcelo] Univ Sao Paulo, Hosp Clin, Emergency Med Discipline, Intens Care Unit, Sao Paulo, Brazil; [Zampieri, Fernando Godinho] Hosp Alemao Oswaldo Cruz, Intens Care Unit, Sao Paulo, Brazil; [Forte, Daniel Neves; Pontes Azevedo, Luciano Cesar; Park, Marcelo] Hosp Sirio Libanes, Res & Educ Inst, Sao Paulo, Brazil	Universidade de Sao Paulo; Hospital Sirio Libanes	Ranzani, OT (corresponding author), Univ Sao Paulo, Hosp Clin, Emergency Med Discipline, Intens Care Unit, Sao Paulo, Brazil.	otavioranzani@yahoo.com.br	Ranzani, Otavio T./K-1196-2012; Azevedo, Luciano CP/H-2652-2012; Zampieri, Fernando/K-3305-2014	Ranzani, Otavio T./0000-0002-4677-6862; Azevedo, Luciano CP/0000-0001-6759-3910; Zampieri, Fernando/0000-0001-9315-6386				Al-Subaie N, 2010, BRIT J ANAESTH, V105, P318, DOI 10.1093/bja/aeq171; Araujo I, 2012, BIOMARKERS, V17, P180, DOI 10.3109/1354750X.2012.654407; Artero A, 2010, J CRIT CARE, V25, P276, DOI 10.1016/j.jcrc.2009.12.004; Bortz WM, 2002, J GERONTOL A-BIOL, V57, pM283, DOI 10.1093/gerona/57.5.M283; Carriere I, 2008, J AM GERIATR SOC, V56, P840, DOI 10.1111/j.1532-5415.2008.01677.x; Casalino E, 1998, CHEST, V113, P421, DOI 10.1378/chest.113.2.421; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; DEVILLOTA ED, 1980, INTENS CARE MED, V7, P19, DOI 10.1007/BF01692917; Fairclough E, 2009, CLIN MED, V9, P30, DOI 10.7861/clinmedicine.9-1-30; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Grander W, 2010, CHEST, V138, P856, DOI 10.1378/chest.09-1677; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HEDLUND JU, 1993, THORAX, V48, P785, DOI 10.1136/thx.48.8.785; Ho KM, 2008, INTENS CARE MED, V34, P481, DOI 10.1007/s00134-007-0928-0; Ho KM, 2006, J CRIT CARE, V21, P259, DOI 10.1016/j.jcrc.2006.01.005; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kaben A, 2008, CRIT CARE, V12, DOI 10.1186/cc7023; Lee JH, 2011, J CRIT CARE, V26, P287, DOI 10.1016/j.jcrc.2010.10.007; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Pinilla JC, 1998, SURGERY, V124, P799, DOI 10.1067/msy.1998.91365; Povas P, 2005, CLIN INFECT DIS, V40, P1855, DOI 10.1086/430382; Povoa P, 2005, EUR RESPIR J, V25, P804, DOI 10.1183/09031936.05.00071704; Povoa P, 2002, INTENS CARE MED, V28, P235, DOI 10.1007/s00134-002-1209-6; Povoa P, 2006, CRIT CARE, V10, DOI 10.1186/cc4892; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Ranzani OT, 2011, BRAZ J MED BIOL RES, V44, P1184, DOI [10.1590/S0100-879X2011007500132, 10.1590/S0100-879X2011001100016]; Ranzani OT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.013; Rey C, 2007, INTENS CARE MED, V33, P477, DOI 10.1007/s00134-006-0509-7; Sakr Y, 2008, J CRIT CARE, V23, P475, DOI 10.1016/j.jcrc.2007.09.006; Silvestre J, 2010, BMC ANESTHESIOL, V10, DOI 10.1186/1471-2253-10-17; Taori G, 2009, CRIT CARE, V13, DOI 10.1186/cc7988; Van Hemelrijck M, 2012, INT J MOL EPIDEMIOL, V3, P66; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Xie QH, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-30; Yende S, 2006, THORAX, V61, P10, DOI 10.1136/thx.2004.034181; Yende S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022847	40	234	243	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59321	10.1371/journal.pone.0059321	http://dx.doi.org/10.1371/journal.pone.0059321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555017	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500080
J	Wolniczak, I; Caceres-DelAguila, JA; Palma-Ardiles, G; Arroyo, KJ; Solis-Visscher, R; Paredes-Yauri, S; Mego-Aquije, K; Bernabe-Ortiz, A				Wolniczak, Isabella; Alonso Caceres-DelAguila, Jose; Palma-Ardiles, Gabriela; Arroyo, Karen J.; Solis-Visscher, Rodrigo; Paredes-Yauri, Stephania; Mego-Aquije, Karina; Bernabe-Ortiz, Antonio			Association between Facebook Dependence and Poor Sleep Quality: A Study in a Sample of Undergraduate Students in Peru	PLOS ONE			English	Article							ONLINE SOCIAL NETWORKING; UNIVERSITY-STUDENTS; HIGH-SCHOOL; ADDICTION; ADOLESCENTS; COMPUTER; DEPRESSION; TIME	Objectives: Internet can accelerate information exchange. Social networks are the most accessed especially Facebook. This kind of networks might create dependency with several negative consequences in people's life. The aim of this study was to assess potential association between Facebook dependence and poor sleep quality. Methodology/Principal Findings: A cross sectional study was performed enrolling undergraduate students of the Universidad Peruana de Ciencias Aplicadas, Lima, Peru. The Internet Addiction Questionnaire, adapted to the Facebook case, and the Pittsburgh Sleep Quality Index, were used. A global score of 6 or greater was defined as the cutoff to determine poor sleep quality. Generalized linear model were used to determine prevalence ratios (PR) and 95% confidence intervals (95% CI). A total of 418 students were analyzed; of them, 322 (77.0%) were women, with a mean age of 20.1 (SD: 2.5) years. Facebook dependence was found in 8.6% (95% CI: 5.9%-11.3%), whereas poor sleep quality was present in 55.0% (95% CI: 50.2%-59.8%). A significant association between Facebook dependence and poor sleep quality mainly explained by daytime dysfunction was found (PR = 1.31; IC95%: 1.04-1.67) after adjusting for age, sex and years in the faculty. Conclusions: There is a relationship between Facebook dependence and poor quality of sleep. More than half of students reported poor sleep quality. Strategies to moderate the use of this social network and to improve sleep quality in this population are needed.	[Wolniczak, Isabella; Alonso Caceres-DelAguila, Jose; Palma-Ardiles, Gabriela; Arroyo, Karen J.; Solis-Visscher, Rodrigo; Paredes-Yauri, Stephania; Mego-Aquije, Karina; Bernabe-Ortiz, Antonio] Univ Peruana Ciencias Aplicadas UPC, Fac Hlth Sci, Sch Med, Lima, Peru	Universidad Peruana de Ciencias Aplicadas (UPC)	Caceres-DelAguila, JA (corresponding author), Univ Peruana Ciencias Aplicadas UPC, Fac Hlth Sci, Sch Med, Lima, Peru.	u711594@upc.edu.pe		Bernabe-Ortiz, Antonio/0000-0002-6834-1376; Caceres Del Aguila, Jose Alonso/0000-0001-7897-5033				Ajrouch KJ, 2005, J GERONTOL B-PSYCHOL, V60, pS311, DOI 10.1093/geronb/60.6.S311; Andreassen CS, 2012, PSYCHOL REP, V110, P501, DOI 10.2466/02.09.18.PR0.110.2.501-517; [Anonymous], 2013, FAC STAT KEY FACTS; Barion A, 2007, SLEEP MED, V8, P566, DOI 10.1016/j.sleep.2006.11.017; Buysse D J, 1989, Psychiatry Res, V28, P193; Cheng SH, 2012, PSYCHIAT RES; Cheung LM, 2011, J SLEEP RES, V20, P311, DOI 10.1111/j.1365-2869.2010.00883.x; Choi K, 2009, PSYCHIAT CLIN NEUROS, V63, P455, DOI 10.1111/j.1440-1819.2009.01925.x; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Echeburua E, 1999, ADICCIONES SIN DROGA; Echeburua E, 2010, ADICCIONES, V22, P91, DOI 10.20882/adicciones.196; Elphinston RA, 2011, CYBERPSYCH BEH SOC N, V14, P631, DOI 10.1089/cyber.2010.0318; Escobar-Cordoba F, 2005, REV NEUROLOGIA, V40, P150, DOI 10.33588/rn.4003.2004320; Gomes AA, 2011, CHRONOBIOL INT, V28, P786, DOI 10.3109/07420528.2011.606518; Griffiths MD, 2012, PSYCHOL REP, V110, P518, DOI 10.2466/01.07.18.PR0.110.2.518-520; Househ M, 2011, STUD HEALTH TECHNOL, V169, P616, DOI 10.3233/978-1-60750-806-9-616; Huang HY, 2009, CYBERPSYCHOL BEHAV, V12, P675, DOI 10.1089/cpb.2009.0060; Jimenez-Genchi A, 2008, GAC MED MEX, V144, P491; Luengo-Lopez A., 2004, REV PROFESIONAL ESPA, V2, P22; Mesquita G, 2007, ARQ NEURO-PSIQUIAT, V65, P428, DOI 10.1590/S0004-282X2007000300012; Mesquita G, 2010, ARQ NEURO-PSIQUIAT, V68, P720, DOI 10.1590/S0004-282X2010000500009; Moreno MA, 2012, ARCH PEDIAT ADOL MED, V166, P157, DOI 10.1001/archpediatrics.2011.180; Munezawa T, 2011, SLEEP, V34, P1013, DOI 10.5665/SLEEP.1152; Pantic I, 2012, PSYCHIAT DANUB, V24, P90; Rocha CRS, 2010, ARQ NEURO-PSIQUIAT, V68, P903, DOI 10.1590/S0004-282X2010000600014; Rosales Mayor Edmundo, 2008, Acta méd. peruana, V25, P199; Ruder TD, 2011, CRISIS, V32, P280, DOI 10.1027/0227-5910/a000086; Schmit S, 2011, ENCEPHALE, V37, P217, DOI 10.1016/j.encep.2010.06.006; Sierra JC, 2002, SALUD MENT, V25, P35; Socialbakers, 2013, FAC STAT COUNTR; Tsai HF, 2009, PSYCHIAT RES, V167, P294, DOI 10.1016/j.psychres.2008.01.015; Van den Bulck J, 2004, SLEEP, V27, P101, DOI 10.1093/sleep/27.1.101; Wilson K, 2010, CYBERPSYCH BEH SOC N, V13, P173, DOI 10.1089/cyber.2009.0094; Young K.S., 1999, INNOVATIONS CLIN PRA, V17, P351	34	114	122	1	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59087	10.1371/journal.pone.0059087	http://dx.doi.org/10.1371/journal.pone.0059087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WV	23554978	Green Submitted, Green Published, gold			2022-12-25	WOS:000316252500067
J	Zhu, LJ; Du, ML; Gu, DY; Ma, L; Chu, HY; Tong, N; Chen, JF; Zhang, ZD; Wang, ML				Zhu, Lingjun; Du, Mulong; Gu, Dongying; Ma, Lan; Chu, Haiyan; Tong, Na; Chen, Jinfei; Zhang, Zhengdong; Wang, Meilin			Genetic Variant rs7758229 in 6q26-q27 Is Not Associated with Colorectal Cancer Risk in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EPIDEMIOLOGY	Background: A recent genome-wide association study has identified a new genetic variant rs7758229 in SLC22A3 for colorectal cancer susceptibility in a Japanese population, but it is unknown whether this newly identified variant is associated with colorectal cancer in other populations, including the Chinese population. Methods: We examined the associations between rs7758229 and colorectal cancer risk among 1,147 cases and 1,203 controls matched by age and sex. Logistic regression model was used to assess the associations. Results: No significant association was found between rs7758229 and colorectal cancer risk (OR = 0.95, 95% CI = 0.84-1.09, P = 0.463). Similar results were observed in the stratification of tumor location (OR = 0.94, 95% CI = 0.80-1.11, P = 0.481 for colon cancer, and OR = 0.96, 95% CI = 0.82-1.13, P = 0.621 for rectum cancer). Conclusions: Our findings did not support an association between rs7758229 in 6q26-q27 and the risk of colorectal cancer in a Chinese population.	[Zhu, Lingjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Du, Mulong; Ma, Lan; Chu, Haiyan; Tong, Na; Zhang, Zhengdong; Wang, Meilin] Nanjing Med Univ, Sch Publ Hlth, Dept Genet Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Du, Mulong; Zhang, Zhengdong; Wang, Meilin] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers, Dept Environm Genom, Nanjing, Jiangsu, Peoples R China; [Gu, Dongying; Chen, Jinfei] Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, ML (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Genet Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China.	mwang@njmu.edu.cn	zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [81201570, 81102089, 81230068]; National Natural Science Foundation of Jiangsu Province [BK2010080, BK2011773]; Key Program for Basic Research of Jiangsu Provincial Department of Education [11KJB330002]; Qing Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Program for Basic Research of Jiangsu Provincial Department of Education; Qing Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This study was partly supported by National Natural Science Foundation of China (81201570, 81102089, and 81230068), National Natural Science Foundation of Jiangsu Province (BK2010080 and BK2011773), the Key Program for Basic Research of Jiangsu Provincial Department of Education (11KJB330002), the Qing Lan Project of Jiangsu Provincial Department of Education, and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colditz GA, 2006, NAT REV CANCER, V6, P75, DOI 10.1038/nrc1784; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Kapiteijn E, 2001, J PATHOL, V195, P171, DOI 10.1002/path.918; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lynch HT, 1999, CANCER, V86, P2457, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2457::AID-CNCR2>3.0.CO;2-I; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Thean LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042407; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; Zhu LJ, 2012, DNA CELL BIOL, V31, P349, DOI 10.1089/dna.2011.1348	12	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59256	10.1371/journal.pone.0059256	http://dx.doi.org/10.1371/journal.pone.0059256			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555006	Green Submitted, Green Published, gold			2022-12-25	WOS:000316252500077
J	Tang, XD; Xu, S; Wang, XW				Tang, Xiaoduan; Xu, Shen; Wang, Xinwei			Nanoscale Probing of Thermal, Stress, and Optical Fields under Near-Field Laser Heating	PLOS ONE			English	Article							HEMISPHERICAL CAVITY ARRAYS; RAMAN-SPECTROSCOPY; MICROSCOPY; RESOLUTION; SILICON; FABRICATION; SUPERLENS; LITHOGRAPHY; ENHANCEMENT; PARTICLES	Micro/nanoparticle induced near-field laser ultra-focusing and heating has been widely used in laser-assisted nanopatterning and nanolithography to pattern nanoscale features on a large-area substrate. Knowledge of the temperature and stress in the nanoscale near-field heating region is critical for process control and optimization. At present, probing of the nanoscale temperature, stress, and optical fields remains a great challenge since the heating area is very small (similar to 100 nm or less) and not immediately accessible for sensing. In this work, we report the first experimental study on nanoscale mapping of particle-induced thermal, stress, and optical fields by using a single laser for both near-field excitation and Raman probing. The mapping results based on Raman intensity variation, wavenumber shift, and linewidth broadening all give consistent conjugated thermal, stress, and near-field focusing effects at a 20 nm resolution (<lambda/26, lambda = 32 nm). Nanoscale mapping of near-field effects of particles from 1210 down to 160 nm demonstrates the strong capacity of such a technique. By developing a new strategy for physical analysis, we have de-conjugated the effects of temperature, stress, and near-field focusing from the Raman mapping. The temperature rise and stress in the nanoscale heating region is evaluated at different energy levels. High-fidelity electromagnetic and temperature field simulation is conducted to accurately interpret the experimental results.	[Tang, Xiaoduan; Xu, Shen; Wang, Xinwei] Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA; [Wang, Xinwei] Qingdao Technol Univ, Sch Environm & Municipal Engn, Qingdao, Shandong, Peoples R China	Iowa State University; Qingdao University of Technology	Wang, XW (corresponding author), Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA.	xwang3@iastate.edu	Xu, Shen/A-6921-2016; Tang, Xiaoduan/F-2525-2014; Wang, Xinwei/AAH-4694-2019	Xu, Shen/0000-0003-4973-3179; Tang, Xiaoduan/0000-0002-2880-134X; 	National Science Foundation [CMMI-0926704, CMMI-1200397, CBET-0932573]	National Science Foundation(National Science Foundation (NSF))	Financial support for this work was provided by the National Science Foundation (CMMI-0926704, CMMI-1200397, and CBET-0932573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2008, MICROELECTRON ENG, V85, P1443, DOI 10.1016/j.mee.2008.01.089; BEECHEM T, 2007, REV SCI INSTRUM, V78, DOI DOI 10.1063/1.2738946; Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85; DECKMAN HW, 1988, J VAC SCI TECHNOL B, V6, P333, DOI 10.1116/1.583991; Frey HG, 2002, APPL PHYS LETT, V81, P5030, DOI 10.1063/1.1530736; HART TR, 1970, PHYS REV B-SOLID ST, V1, P638, DOI 10.1103/PhysRevB.1.638; Huang SM, 2002, J APPL PHYS, V92, P2495, DOI 10.1063/1.1501768; HULTEEN JC, 1995, J VAC SCI TECHNOL A, V13, P1553, DOI 10.1116/1.579726; Kouteva-Arguirova S, 2003, J APPL PHYS, V94, P4946, DOI 10.1063/1.1611282; Lee JY, 2009, NATURE, V460, P498, DOI 10.1038/nature08173; Li LP, 2004, NANOTECHNOLOGY, V15, P1655, DOI 10.1088/0957-4484/15/11/049; Li LP, 2004, J APPL PHYS, V96, P5144, DOI 10.1063/1.1796515; Li LP, 2004, NANOTECHNOLOGY, V15, P333, DOI 10.1088/0957-4484/15/3/017; Liu ZW, 2007, NANO LETT, V7, P403, DOI 10.1021/nl062635n; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; McLeod E, 2008, NAT NANOTECHNOL, V3, P413, DOI 10.1038/nnano.2008.150; Munzer HJ, 2001, J MICROSC-OXFORD, V202, P129, DOI 10.1046/j.1365-2818.2001.00876.x; Ng V, 2002, NANOTECHNOLOGY, V13, P554, DOI 10.1088/0957-4484/13/5/302; Reserbat-Plantey A, 2012, NAT NANOTECHNOL, V7, P151, DOI [10.1038/nnano.2011.250, 10.1038/NNANO.2011.250]; Rho J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1148; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shi L, 2000, APPL PHYS LETT, V77, P4295, DOI 10.1063/1.1334658; Smolyaninov II, 2007, SCIENCE, V315, P1699, DOI 10.1126/science.1138746; Tang XD, 2012, OPT EXPRESS, V20, P14152, DOI 10.1364/OE.20.014152; Taubner T, 2006, SCIENCE, V313, P1595, DOI 10.1126/science.1131025; Wang ZB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1211; WISCHNATH UF, 2008, REV SCI INSTRUM, V79, DOI DOI 10.1063/1.2955764; Yue YN, 2011, SMALL, V7, P3324, DOI 10.1002/smll.201101598; Yue YA, 2011, ACS NANO, V5, P4466, DOI 10.1021/nn2011442; ZENHAUSERN F, 1995, SCIENCE, V269, P1083, DOI 10.1126/science.269.5227.1083	30	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58030	10.1371/journal.pone.0058030	http://dx.doi.org/10.1371/journal.pone.0058030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555566	Green Published, gold, Green Submitted			2022-12-25	WOS:000317262200003
J	Judson, RN; Gray, SR; Walker, C; Carroll, AM; Itzstein, C; Lionikas, A; Zammit, PS; De Bari, C; Wackerhage, H				Judson, Robert N.; Gray, Stuart R.; Walker, Claire; Carroll, Andrew M.; Itzstein, Cecile; Lionikas, Arimantas; Zammit, Peter S.; De Bari, Cosimo; Wackerhage, Henning			Constitutive Expression of Yes-Associated Protein (Yap) in Adult Skeletal Muscle Fibres Induces Muscle Atrophy and Myopathy	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; SLOW-TWITCH MUSCLE; CARDIOMYOCYTE PROLIFERATION; GENE-EXPRESSION; CENTRONUCLEAR MYOPATHIES; MYOTUBULAR MYOPATHY; CELL-PROLIFERATION; SELF-RENEWAL; SIZE-CONTROL; ORGAN SIZE	The aim of this study was to investigate the function of the Hippo pathway member Yes-associated protein (Yap, gene name Yap1) in skeletal muscle fibres in vivo. Specifically we bred an inducible, skeletal muscle fibre-specific knock-in mouse model (MCK-tTA-hYAP1 S127A) to test whether the over expression of constitutively active Yap (hYAP1 S127A) is sufficient to drive muscle hypertrophy or stimulate changes in fibre type composition. Unexpectedly, after 5-7 weeks of constitutive hYAP1 S127A over expression, mice suddenly and rapidly lost 20-25% body weight and suffered from gait impairments and kyphosis. Skeletal muscles atrophied by 34-40% and the muscle fibre cross sectional area decreased by approximate to 40% when compared to control mice. Histological analysis revealed evidence of skeletal muscle degeneration and regeneration, necrotic fibres and a NADH-TR staining resembling centronuclear myopathy. In agreement with the histology, mRNA expression of markers of regenerative myogenesis (embryonic myosin heavy chain, Myf5, myogenin, Pax7) and muscle protein degradation (atrogin-1, MuRF1) were significantly elevated in muscles from trarisgenic mice versus control. No significant changes in fibre type composition were detected using ATPase staining. The phenotype was largely reversible, as a cessation of hYAP1 S127A expression rescued body and muscle weight, restored muscle morphology and prevented further pathological progression. To conclude, high Yap activity in muscle fibres does not induce fibre hypertrophy nor fibre type changes but instead results in a reversible atrophy and deterioration.	[Gray, Stuart R.; Lionikas, Arimantas; Wackerhage, Henning] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland; [Judson, Robert N.; Walker, Claire; Carroll, Andrew M.; Itzstein, Cecile; De Bari, Cosimo] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Zammit, Peter S.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of Aberdeen; University of Aberdeen; University of London; King's College London	Wackerhage, H (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland.	h.wackerhage@abdn.ac.uk	Carroll, Andrew/G-7831-2017; Gray, Stuart R/L-2489-2017; Zammit, peter/GXV-7746-2022	Carroll, Andrew/0000-0001-9260-8352; Gray, Stuart R/0000-0001-8969-9636; zammit, peter/0000-0001-9562-3072	Oliver Bird PhD studentship for Robert Judson; Medical Research Council [99477]; NHS; Medical Research Council [G1100193] Funding Source: researchfish; MRC [G1100193] Funding Source: UKRI	Oliver Bird PhD studentship for Robert Judson; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by an Oliver Bird PhD studentship for Robert Judson, a NHS Grapian Endowment grant (Henning Wackerhage, Cosimo De Bad) and a Medical Research Council project grant (99477; Henning Wackerhage, Peter S. Zammit, Cosimo De Bari). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Carroll Andrew M., 2012, Frontiers in Genetics, V2, P99, DOI 10.3389/fgene.2011.00099; Carson JA, 1996, AM J PHYSIOL-CELL PH, V270, pC1624, DOI 10.1152/ajpcell.1996.270.6.C1624; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Eghtesad S, 2011, MOL MED, V17, P917, DOI 10.2119/molmed.2010.00256; Fujimura-Kiyono C, 2008, NEUROL INDIA, V56, P325; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; Grill MA, 2003, TRANSGENIC RES, V12, P33, DOI 10.1023/A:1022119005836; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Hardie DG, 2011, P NUTR SOC, V70, P92, DOI 10.1017/S0029665110003915; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; HERON MI, 1993, J MORPHOL, V216, P35, DOI 10.1002/jmor.1052160106; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Judson RN, 2012, J CELL SCI; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Mielcarek M, 2002, MECH DEVELOP, V119, pS269, DOI 10.1016/S0925-4773(03)00127-8; Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209; Nguyen QGV, 2003, TRANSGENIC RES, V12, P337, DOI 10.1023/A:1023369225799; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Philp A, 2011, J APPL PHYSIOL, V110, P561, DOI 10.1152/japplphysiol.00941.2010; Pobbati AV, 2012, STRUCTURE, V20, P1135, DOI 10.1016/j.str.2012.04.004; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Romero NB, 2011, SEMIN PEDIATR NEUROL, V18, P250, DOI 10.1016/j.spen.2011.10.006; Romero NB, 2010, NEUROMUSCULAR DISORD, V20, P223, DOI 10.1016/j.nmd.2010.01.014; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Scharner J, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-28; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; SIEGEL AJ, 1983, JAMA-J AM MED ASSOC, V250, P2835, DOI 10.1001/jama.250.20.2835; STUDITSKY AN, 1964, ANN NY ACAD SCI, V120, P789, DOI 10.1111/j.1749-6632.1964.tb34771.x; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Tiao G, 1997, AM J PHYSIOL-REG I, V272, pR849, DOI 10.1152/ajpregu.1997.272.3.R849; Tsika RW, 2008, J BIOL CHEM, V283, P36154, DOI 10.1074/jbc.M807461200; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vercherat C, 2009, HUM MOL GENET, V18, P4304, DOI 10.1093/hmg/ddp383; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Watt KI, 2010, BIOCHEM BIOPH RES CO, V393, P619, DOI 10.1016/j.bbrc.2010.02.034; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhi X, 2012, AM J PATHOL, V180, P2452, DOI 10.1016/j.ajpath.2012.02.025; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	64	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59622	10.1371/journal.pone.0059622	http://dx.doi.org/10.1371/journal.pone.0059622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544078	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000317480700038
J	Jurecka-Lubieniecka, B; Ploski, R; Kula, D; Krol, A; Bednarczuk, T; Kolosza, Z; Tukiendorf, A; Szpak-Ulczok, S; Stanjek-Cichoracka, A; Polanska, J; Jarzab, B				Jurecka-Lubieniecka, Beata; Ploski, Rafal; Kula, Dorota; Krol, Aleksandra; Bednarczuk, Tomasz; Kolosza, Zofia; Tukiendorf, Andrzej; Szpak-Ulczok, Sylwia; Stanjek-Cichoracka, Anita; Polanska, Joanna; Jarzab, Barbara			Association between Age at Diagnosis of Graves' Disease and Variants in Genes Involved in Immune Response	PLOS ONE			English	Article							AUTOIMMUNE THYROID-DISEASE; OPHTHALMOPATHY; SUSCEPTIBILITY; ANTICIPATION; HLA; POLYMORPHISM; CTLA-4; CHILDHOOD; PHENOTYPE; JAPANESE	Background: Graves disease (GD) is a complex disease in which genetic predisposition is modified by environmental factors. The aim of the study was to examine the association between genetic variants in genes encoding proteins involved in immune response and the age at diagnosis of GD. Methods: 735 GD patients and 1216 healthy controls from Poland were included into the study. Eight genetic variants in the HLA-DRB1, TNF, CTLA4, CD40, NFKb, PTPN22, IL4 and IL10 genes were genotyped. Patients were stratified by the age at diagnosis of GD and the association with genotype was analysed. Results: Polymorphism in the HLA-DRB1, TNF and CTLA4 genes were associated with GD. The carriers of the HLA DRB1*03 allele were more frequent in patients with age at GD diagnosis <= 30 years than in patients with older age at GD diagnosis. Conclusions: HLADRB1*03 allele is associated with young age at diagnosis of Graves' disease in polish population,	[Jurecka-Lubieniecka, Beata; Kula, Dorota; Krol, Aleksandra; Kolosza, Zofia; Tukiendorf, Andrzej; Szpak-Ulczok, Sylwia; Jarzab, Barbara] Ctr & Inst Oncol, Dept Nucl Med & Endocrine Oncol, Gliwice Branch, Maria Sklodowska Curie Mem Canc, Gliwice, Poland; [Ploski, Rafal; Bednarczuk, Tomasz] Med Univ Warsaw, Dept Forens Med, Warsaw, Poland; [Stanjek-Cichoracka, Anita] Med Univ Silesia, Dept Isotop Diagnost & Radiopharmaceut, Katowice, Poland; [Polanska, Joanna] Silesian Tech Univ, Inst Automat Control, Gliwice, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Medical University of Warsaw; Medical University Silesia; Silesian University of Technology	Jarzab, B (corresponding author), Ctr & Inst Oncol, Dept Nucl Med & Endocrine Oncol, Gliwice Branch, Maria Sklodowska Curie Mem Canc, Gliwice, Poland.	bjarzab@io.gliwice.pl	Jarząb, Barbara/AAI-7942-2020; Bednarczuk, Tomasz/AFQ-8418-2022; Barbara, Jarzab/I-4654-2019; Polanska, Joanna/H-4513-2013	Jarząb, Barbara/0000-0001-9811-9584; Polanska, Joanna/0000-0001-8004-9864; Kolosza, Zofia/0000-0002-6064-1243; Krol, Aleksandra/0000-0002-2084-5014; Szpak-Ulczok, Sylwia/0000-0002-1432-5848; Jurecka-Lubieniecka, Beata/0000-0001-6333-0451; Stanjek-Cichoracka, Anita/0000-0002-5503-0149; Ploski, Rafal/0000-0001-6286-5526; Kula, Dorota/0000-0002-0986-1929	Ministry of Science and Higher Education [N N519 579938]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Ministry of Science and Higher Education, Grant number N N519 579938. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahabadia A, 2001, LANCET, V358, P984, DOI 10.1016/S0140-6736(01)06125-6; [Anonymous], 2007, THYROID, V17, P1027, DOI 10.1089/thy.2007.1526; Ban Y, 2004, GENES IMMUN, V5, P203, DOI 10.1038/sj.gene.6364059; Bednarczuk T, 2004, HUM IMMUNOL, V65, P632, DOI 10.1016/j.humimm.2004.02.033; Bednarczuk T, 2003, EUR J ENDOCRINOL, V148, P13, DOI 10.1530/eje.0.1480013; Bednarczuk T, 2007, CLIN ENDOCRINOL, V67, P3, DOI 10.1111/j.1365-2265.2007.02854.x; Bossowski AT, 2007, J ENDOCRINOL INVEST, V30, P388, DOI 10.1007/BF03346315; Brix TH, 2003, THYROID, V13, P447, DOI 10.1089/105072503322021106; Chan W, 2002, BRIT J OPHTHALMOL, V86, P740, DOI 10.1136/bjo.86.7.740; Cocco E, 2004, NEUROLOGY, V62, P1794, DOI 10.1212/01.WNL.0000125194.27381.D4; FARID NR, 1980, CLIN ENDOCRINOL, V13, P535, DOI 10.1111/j.1365-2265.1980.tb03421.x; Farid NR, 1998, THYROID, V8, P407, DOI 10.1089/thy.1998.8.407; FRECKER M, 1986, CLIN ENDOCRINOL, V25, P479, DOI 10.1111/j.1365-2265.1986.tb03599.x; Godakos Al, 2010, PEDIAT ENDOCRINOL S2, V7, p[L234, 44]; Goldstein SM, 2008, THYROID, V18, P997, DOI 10.1089/thy.2008.0014; Hemminki M, 2010, J AUTOIMMUN, V34, pJ307, DOI 10.1016/j.jaut.2009.11.019; Heward JM, 2007, J CLIN ENDOCR METAB, V92, P685, DOI 10.1210/jc.2006-2064; Hunt PJ, 2001, CLIN ENDOCRINOL, V55, P491, DOI 10.1046/j.1365-2265.2001.01356.x; Kavvoura FK, 2007, J CLIN ENDOCR METAB, V92, P3162, DOI 10.1210/jc.2007-0147; Khalilzadeh O, 2010, CLIN EXP MED, V10, P123, DOI 10.1007/s10238-009-0078-5; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Krassas GE, 2005, EUR J ENDOCRINOL, V153, P515, DOI 10.1530/eje.1.01991; Kula D, 2006, THYROID, V16, P447, DOI 10.1089/thy.2006.16.447; Kurylowicz A, 2007, GENES IMMUN, V8, P532, DOI 10.1038/sj.gene.6364418; Kurylowicz A, 2005, THYROID, V15, P1119, DOI 10.1089/thy.2005.15.1119; Lavard L, 1997, TISSUE ANTIGENS, V50, P639, DOI 10.1111/j.1399-0039.1997.tb02922.x; Manji N, 2008, J CLIN ENDOCR METAB, V91, P4873; O'Sullivan B, 2007, EXPERT OPIN THER TAR, V11, P111, DOI 10.1517/14728222.11.2.111; ONUMA H, 1994, HUM IMMUNOL, V39, P195, DOI 10.1016/0198-8859(94)90260-7; Paterson AD, 1996, AM J HUM GENET, V59, P264; Perrild H, 1997, EXP CLIN ENDOCR DIAB, V105, P55, DOI 10.1055/s-0029-1211934; Prummel MF, 2004, EUR J ENDOCRINOL, V150, P605, DOI 10.1530/eje.0.1500605; Radstake TRDJ, 2001, J RHEUMATOL, V28, P962; Rioux JD, 2005, NATURE, V435, P584, DOI 10.1038/nature03723; Sawai Y, 2000, J CLIN ENDOCR METAB, V85, P1176, DOI 10.1210/jc.85.3.1176; Segni M, 2001, J Pediatr Endocrinol Metab, V14 Suppl 5, P1271; Segni M, 2001, J PEDIAT ENDOCRIN S5, V14, P1297; Simmonds MJ, 2004, GENES IMMUN, V5, P267, DOI 10.1038/sj.gene.6364066; Tomer Y, 2007, J AUTOIMMUN, V29, P69, DOI 10.1016/j.jaut.2007.05.006; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Tomer Y, 2009, J AUTOIMMUN, V32, P231, DOI 10.1016/j.jaut.2009.02.007; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Villanueva R, 2000, THYROID, V10, P791, DOI 10.1089/thy.2000.10.791; Vos XG, 2009, EUR J ENDOCRINOL, V161, P113, DOI 10.1530/EJE-08-0991; WEETMAN AP, 1988, CLIN ENDOCRINOL, V28, P619, DOI 10.1111/j.1365-2265.1988.tb00236.x; Wong GWK, 1999, CLIN ENDOCRINOL, V50, P493; Yin XM, 2012, THYROID, V22, P730, DOI 10.1089/thy.2012.0007; Zamani M, 2000, AM J MED GENET, V95, P432, DOI 10.1002/1096-8628(20001218)95:5<432::AID-AJMG5>3.0.CO;2-7; Zeitlin AA, 2008, CLIN ENDOCRINOL, V68, P671, DOI 10.1111/j.1365-2265.2007.03075.x	49	31	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59349	10.1371/journal.pone.0059349	http://dx.doi.org/10.1371/journal.pone.0059349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544060	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700022
J	Mossel, EC; Ledermann, JP; Phillips, AT; Borland, EM; Powers, AM; Olson, KE				Mossel, Eric C.; Ledermann, Jeremy P.; Phillips, Aaron T.; Borland, Erin M.; Powers, Ann M.; Olson, Ken E.			Molecular Determinants of Mouse Neurovirulence and Mosquito Infection for Western Equine Encephalitis Virus	PLOS ONE			English	Article							SINDBIS-VIRUS; ENCEPHALOMYELITIS VIRUS; GENETIC-DETERMINANTS; E2 GLYCOPROTEIN; AEDES-AEGYPTI; ALPHAVIRUS; VIRULENCE; CALIFORNIA; STRAINS	Western equine encephalitis virus (WEEV) is a naturally occurring recombinant virus derived from ancestral Sindbis and Eastern equine encephalitis viruses. We previously showed that infection by WEEV isolates McMillan (McM) and IMP-181 (IMP) results in high (similar to 90-100%) and low (0%) mortality, respectively, in outbred CD-1 mice when virus is delivered by either subcutaneous or aerosol routes. However, relatively little is known about specific virulence determinants of WEEV We previously observed that IMP infected Culex tarsalis mosquitoes at a high rate (app. 80%) following ingestion of an infected bloodmeal but these mosquitoes were infected by McM at a much lower rate (10%). To understand the viral role in these phenotypic differences, we characterized the pathogenic phenotypes of McM/IMP chimeras. Chimeras encoding the E2 of McM on an IMP backbone (or the reciprocal) had the most significant effect on infection phenotypes in mice or mosquitoes. Furthermore, exchanging the arginine, present on IMP E2 glycoprotein at position 214, for the glutamine present at the same position on McM, ablated mouse mortality. Curiously, the reciprocal exchange did not confer mouse virulence to the IMP virus. Mosquito infectivity was also determined and significantly, one of the important loci was the same as the mouse virulence determinant identified above. Replacing either IMP E2 amino acid 181 or 214 with the corresponding McM amino acid lowered mosquito infection rates to McM-like levels. As with the mouse neurovirulence, reciprocal exchange of amino acids did not confer mosquito infectivity. The identification of WEEV E2 amino acid 214 as necessary for both IMP mosquito infectivity and McM mouse virulence indicates that they are mutually exclusive phenotypes and suggests an explanation for the lack of human or equine WEE cases even in the presence of active transmission.	[Mossel, Eric C.; Phillips, Aaron T.; Olson, Ken E.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA; [Mossel, Eric C.; Ledermann, Jeremy P.; Borland, Erin M.; Powers, Ann M.] Ctr Dis Control, Div Vector Borne Infect Dis, Ft Collins, CO 80522 USA	Colorado State University	Olson, KE (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.	kolson@colostate.edu	Borland, Erin/K-6607-2019	Borland, Erin/0000-0001-8631-9466	NIH/NIAID [U54AI-065357, R01 AI46435]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046435, U54AI065357] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH/NIAID grant U54AI-065357 to the Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research (http://www.rmrce.colostate.edu/) and NIH/NIAID R01 AI46435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atasheva S, 2010, J VIROL; BIANCHI TI, 1993, AM J TROP MED HYG, V49, P322, DOI 10.4269/ajtmh.1993.49.322; Blakqori G, 2005, J VIROL, V79, P10420, DOI 10.1128/JVI.79.16.10420-10428.2005; Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101; Centers for Disease Control and Prevention website, 1964, CONF PROB W EQ ENC V; EMMONS R W, 1975, Proceedings and Papers of the Annual Conference of the California Mosquito Control Association, V43, P59; Forrester NL, 2008, VIROLOGY, V380, P170, DOI 10.1016/j.virol.2008.08.012; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1023; Hardy JL, 1997, AM J TROP MED HYG, V57, P240, DOI 10.4269/ajtmh.1997.57.240; Jupille HJ, 2011, VIROLOGY, V410, P216, DOI 10.1016/j.virol.2010.11.012; Lee PY, 2002, J VIROL, V76, P6302, DOI 10.1128/JVI.76.12.6302-631-.2002; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Logue CH, 2009, J GEN VIROL, V90, P1848, DOI 10.1099/vir.0.008656-0; LUSTIG S, 1988, J VIROL, V62, P2329, DOI 10.1128/JVI.62.7.2329-2336.1988; Meyer KF, 1931, SCIENCE, V74, P227, DOI 10.1126/science.74.1913.227; MEYER WJ, 1993, J VIROL, V67, P5117, DOI 10.1128/JVI.67.9.5117-5125.1993; Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025; Nagata LP, 2006, J GEN VIROL, V87, P2353, DOI 10.1099/vir.0.81815-0; Pierro DJ, 2008, J VIROL, V82, P2966, DOI 10.1128/JVI.02060-07; Pierro DJ, 2007, J GEN VIROL, V88, P1545, DOI 10.1099/vir.0.82577-0; Reisen WK, 2008, AM J TROP MED HYG, V78, P681, DOI 10.4269/ajtmh.2008.78.681; Reisen WK, 2001, J MED ENTOMOL, V38, P393, DOI 10.1603/0022-2585-38.3.393; Reisen WK, 1988, ARBOVIRUSES EPIDEMIO, VV, P89; Saxton-Shaw KD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001931; STRAUSS EG, 1991, J VIROL, V65, P4654, DOI 10.1128/JVI.65.9.4654-4664.1991; Tsetsarkin KA, 2009, PLOS ONE, V4, pe6835; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; WOODWARD TM, 1991, J GEN VIROL, V72, P2431, DOI 10.1099/0022-1317-72-10-2431; Zhang MT, 2011, VECTOR-BORNE ZOONOT, V11, P269, DOI 10.1089/vbz.2010.0078; Zhang R, 2011, EMBO J, V30, P3854, DOI 10.1038/emboj.2011.261	31	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60427	10.1371/journal.pone.0060427	http://dx.doi.org/10.1371/journal.pone.0060427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544138	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700097
J	Myeni, SK; Wang, L; Zhou, DG				Myeni, Sebenzile K.; Wang, Lu; Zhou, Daoguo			SipB-SipC Complex Is Essential for Translocon Formation	PLOS ONE			English	Article							CELL PLASMA-MEMBRANE; III SECRETION; SALMONELLA-TYPHIMURIUM; HOST-CELLS; EFFECTOR PROTEINS; ACTIN NUCLEATION; SHIGELLA; ENTRY; IPAC	The delivery of effector proteins by Salmonella across the host cell membrane requires a subset of effectors secreted by the type III secretion system (TTSS) known as translocators. SipC and SipB are translocator proteins that are inserted into host membranes and presumably form a channel that translocates type III effectors into the host cell. The molecular events of how these translocators insert into the host cell membrane remain unknown. We have previously shown that the SipC C-terminal amino acid region (321-409) is required for the translocation of effectors into host cells. In this study, we demonstrate that the ability to form SipC-SipB complex is essential for their insertion into the host membrane. The SipB-interacting domain of SipC is near its C-terminal amino acid region (340-409). In the absence of SipB, SipC was not detected in the membrane fraction. Furthermore, SipC mutants that no longer interact with SipB are defective in inserting into the host cell membrane. We propose a mechanism whereby SipC binds SipB through its C-terminal region to facilitate membrane-insertion and subsequent translocon formation in the host cell membrane.	[Myeni, Sebenzile K.; Wang, Lu; Zhou, Daoguo] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhou, DG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	zhoud@purdue.edu			 [NIAID-AI049978]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049978] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was funded by NIAID-AI049978. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Cain RJ, 2004, MOL MICROBIOL, V54, P887, DOI 10.1111/j.1365-2958.2004.04336.x; Chang JH, 2005, MOL MICROBIOL, V55, P1379, DOI 10.1111/j.1365-2958.2004.04480.x; Chang JH, 2007, MOL MICROBIOL, V66, P1548, DOI 10.1111/j.1365-2958.2007.06024.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 1998, P NATL ACAD SCI USA, V95, P14006, DOI 10.1073/pnas.95.24.14006; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; Hayward RD, 2000, MOL MICROBIOL, V37, P727, DOI 10.1046/j.1365-2958.2000.02027.x; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HUECK CJ, 1995, MOL MICROBIOL, V18, P479, DOI 10.1111/j.1365-2958.1995.mmi_18030479.x; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Miki T, 2004, MICROB PATHOGENESIS, V37, P65, DOI 10.1016/j.micpath.2004.04.006; Myeni SK, 2010, J BIOL CHEM, V285, P13357, DOI 10.1074/jbc.M109.094045; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Osiecki JC, 2001, MOL MICROBIOL, V42, P469, DOI 10.1046/j.1365-2958.2001.02654.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Scherer CA, 2000, MOL MICROBIOL, V37, P1133, DOI 10.1046/j.1365-2958.2000.02066.x; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Tucker SC, 2000, J BACTERIOL, V182, P2262, DOI 10.1128/JB.182.8.2262-2268.2000; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	34	27	32	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60499	10.1371/journal.pone.0060499	http://dx.doi.org/10.1371/journal.pone.0060499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544147	Green Submitted, Green Published, gold			2022-12-25	WOS:000317480700106
J	Shin, JH; Greer, B; Hakim, CH; Zhou, ZN; Chung, YC; Duan, Y; He, ZH; Duan, DS				Shin, Jin-Hong; Greer, Brian; Hakim, Chady H.; Zhou, Zhongna; Chung, Yu-chia; Duan, Ye; He, Zhihai; Duan, Dongsheng			Quantitative Phenotyping of Duchenne Muscular Dystrophy Dogs by Comprehensive Gait Analysis and Overnight Activity Monitoring	PLOS ONE			English	Article								The dystrophin-deficient dog is excellent large animal model for testing novel therapeutic modalities for Duchenne muscular dystrophy (DMD). Despite well-documented descriptions of dystrophic symptoms in these dogs, very few quantitative studies have been performed. Here, we developed a comprehensive set of non-invasive assays to quantify dog gait (stride length and speed), joint angle and limb mobility (for both forelimb and hind limb), and spontaneous activity at night To validate these assays, we examined three 8-m-old mix-breed dystrophic dogs. We also included three age-matched siblings as the normal control. High-resolution video recorders were used to digitize dog walking and spontaneous movement at night. Stride speed and length were significantly decreased in affected dogs. The mobility of the limb segments (forearm, front foot, lower thigh, rear foot) and the carpus and hock joints was significantly reduced in dystrophic dogs. There was also a significant reduction of the movement in affected dogs during overnight monitoring. In summary, we have established a comprehensive set of outcome measures for clinical phenotyping of DMD dogs. These non-invasive end points would be valuable in monitoring disease progression and therapeutic efficacy in translational studies in the DMD dog model.	[Shin, Jin-Hong; Greer, Brian; Hakim, Chady H.; Duan, Dongsheng] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; [Zhou, Zhongna; Chung, Yu-chia; He, Zhihai] Univ Missouri, Dept Elect & Comp Engn, Columbia, MO 65212 USA; [Duan, Ye] Univ Missouri, Dept Comp Sci, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Duan, DS (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA.	duand@missouri.edu	Shin, Jin-Hong/AAZ-8809-2020	Shin, Jin-Hong/0000-0002-5174-286X; Duan, Dongsheng/0000-0003-4109-1132	National Institutes of Health [AR-49419]; Muscular Dystrophy Association; National Science Foundation [CNS-0931607]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health AR-49419 (DD), the Muscular Dystrophy Association (DD) and National Science Foundation CNS-0931607 (ZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelemy I, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-75; Barthelemy I, 2009, NEUROMUSCULAR DISORD, V19, P788, DOI 10.1016/j.nmd.2009.07.014; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; D'Angelo MG, 2009, GAIT POSTURE, V29, P36, DOI 10.1016/j.gaitpost.2008.06.002; Duan D, 2011, RES REP BIOL, V2, P31, DOI 10.2147/RRB.S13463; Fine DM, 2011, NEUROMUSCULAR DISORD, V21, P453, DOI 10.1016/j.nmd.2011.03.010; Gaiad TP, 2011, RES VET SCI, V91, P188, DOI 10.1016/j.rvsc.2011.01.007; Ganea R, 2011, J CHILD NEUROL; KORNEGAY JN, 1988, MUSCLE NERVE, V11, P1056, DOI 10.1002/mus.880111008; Kunkel LM, 2005, AM J HUM GENET, V76, P205, DOI 10.1086/428143; Marsh AP, 2009, NEUROMUSCUL DISORD; MEIER H., 1958, CORNELL VET, V48, P313; Nakayama M, 2006, MOL THER, V13, pS53, DOI 10.1016/j.ymthe.2006.08.152; Shelton GD, 2005, NEUROMUSCULAR DISORD, V15, P127, DOI 10.1016/j.nmd.2004.10.019; Thomas SS, 2010, J CHILD NEUROL, V25, P1103, DOI 10.1177/0883073810371002; VALENTINE BA, 1986, ACTA NEUROPATHOL, V71, P301, DOI 10.1007/BF00688053; Yang HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044438; Yue YP, 2011, METHODS MOL BIOL, V709, P313, DOI 10.1007/978-1-61737-982-6_21	18	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59875	10.1371/journal.pone.0059875	http://dx.doi.org/10.1371/journal.pone.0059875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544107	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700067
J	Kuklinski, P; Taylor, PD; Denisenko, NV; Berning, B				Kuklinski, Piotr; Taylor, Paul D.; Denisenko, Nina V.; Berning, Bjoern			Atlantic Origin of the Arctic Biota? Evidence from Phylogenetic and Biogeographical Analysis of the Cheilostome Bryozoan Genus Pseudoflustra	PLOS ONE			English	Article							PHYLOGEOGRAPHY; BIODIVERSITY; PACIFIC; FAUNA; OCEAN; AGE	The intricate geological evolution of the Arctic Ocean is paralleled by complexities in the biogeographical and phylogenetical histories of the Arctic biota, including bryozoans. Here we present revised taxonomic descriptions for all known species of the bryozoan genus Pseudoflustra, and use the present-day distributions and phylogenetic relationships between these species to infer the historical biogeography of the genus. Nine species belonging to the genus Pseudoflustra are recognized in the Arctic and North Atlantic. One new species, previously identified as Ichthyaria aviculata, is described as Pseudoflustra radeki sp. nov. Another species, previously assigned to Smittoidea as S. perrieri, is transferred to Pseudoflustra. Biogeographical analysis of Pseudoflustra reveals that species distributions mostly match current patterns pertaining in the North Atlantic and Arctic Ocean. Distributions were probably shaped by recent geological history as present-day current directions in the Arctic Ocean are believed to have been similar for at least the last 120 000 years. Phylogenetic analysis of Pseudoflustra places the five Arctic-North Atlantic species in a clade crownward of a paraphyletic grouping of North Atlantic species. Given that the Arctic Ocean was fully glaciated until 18 000 years, the most likely explanation for this phylogeographical pattern is that species of Pseudoflustra colonized the Arctic relatively recently from North Atlantic sources. However, a fuller understanding of the origin of Pseudoflustra in the Arctic will require molecular and fossil data, neither of which are currently available.	[Kuklinski, Piotr] Polish Acad Sci, Inst Oceanol, Sopot, Poland; [Kuklinski, Piotr; Taylor, Paul D.] Nat Hist Museum, London SW7 5BD, England; [Denisenko, Nina V.] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Berning, Bjoern] Upper Austrian State Museum, Leonding, Austria	Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences; Natural History Museum London; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences	Kuklinski, P (corresponding author), Polish Acad Sci, Inst Oceanol, Sopot, Poland.	kuki@iopan.gda.pl	Denisenko, Nina/O-4087-2019	Kuklinski, Piotr/0000-0002-1507-215X; Taylor, Paul/0000-0002-3127-080X; Berning, Bjorn/0000-0002-0068-9739; Denisenko, Nina/0000-0003-0284-5026	Polish National Science Centre [E12AP004]; Russian Ministry of Education and Science; SYNTHESYS; European Community [FR-TAF-1902]; ArcOD mini grant	Polish National Science Centre; Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); SYNTHESYS; European Community(European Commission); ArcOD mini grant	This study has been completed thanks to an ArcOD mini grant and funds from the Polish National Science Centre (E12AP004). The study was also supported by the Russian Ministry of Education and Science. PK and BB received support from the SYNTHESYS Project (http://www.synthesys.info/), which is financed by European Community Research Infrastructure Action under the FP7 "Capacities" Program, and which allowed studying material at the MNHN (FR-TAF-1902) and at the NM (AT-TAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison JA, 2005, EVOLUTION, V59, P532, DOI 10.1111/j.0014-3820.2005.tb01013.x; Anderson LL, 2006, P NATL ACAD SCI USA, V103, P12447, DOI 10.1073/pnas.0605310103; Andersson KA., 1902, ZOOL JB ABT SYST GEO, V15, P537; Bidenkap O., 1897, ZOOLOGISCHE JB ABTEI, V10, P609; Bodil Bluhm A., 2011, Marine Biodiversity, V41, P87, DOI 10.1007/s12526-010-0078-4; Busk G, 1861, Q J MICROSC SCI, V1, P77, DOI DOI 10.1242/JCS.S2-1.1.77; Calvet Louis, 1906, Bulletin du Museum Paris, V12; Cheetham AH, 2006, J PALEONTOL, V80, P49, DOI 10.1666/0022-3360(2006)080[0049:MDOAAT]2.0.CO;2; COOK PL, 1981, CAH BIOL MAR, V22, P89; d'Hondt J.-L., 1973, Bulletin Mus Natn Hist Nat Paris (Zool), VNo. 92, P365; d'Hondt J.-L., 1975, B MUSEUM NATL HIST N, V299, P553; d'Hondt JL, 2004, CAH BIOL MAR, V45, P281; Darby DA, 2006, PROG OCEANOGR, V71, P129, DOI 10.1016/j.pocean.2006.09.009; Darling KF, 2007, P NATL ACAD SCI USA, V104, P5002, DOI 10.1073/pnas.0700520104; Denisenko NV, 1990, OCCURENCE ECOLOGY BR; Denisenko NV, 2010, EXPLORATIONS FAUNA S, V66, P89; dHondt J.-L., 2009, MEM SOC LINN BORDEAU, V11, P1; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; Golikov A.N., 1989, P257; Gontar V.I., 1989, P341; Gontar VI, 2010, TUMEN I NO DEV SIBER, V10, P139; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Grischenko Andrei V., 2002, P97; Hardy Sarah Mincks, 2011, Marine Biodiversity, V41, P195, DOI 10.1007/s12526-010-0056-x; HAYAMI T, 1975, Science Reports of the Tohoku University Second Series (Geology), V45, P83; Hayward P.J., 1999, SYNOPSES BRIT FAUNA, V14; HAYWARD PJ, 1978, J ZOOL, V184, P207; HAYWARD PJ, 1994, SARSIA, V79, P181, DOI 10.1080/00364827.1994.10413558; Hayward PJ, 1998, SYNOPSES BRIT FAUNA, V10; Hincks T., 1892, Annals of Natural History, Vix, P149; Hincks T, 1880, ANN MAGAZINE NATUR 5, V6, P277; Jones EP, 2001, POLAR RES, V20, P139, DOI 10.1111/j.1751-8369.2001.tb00049.x; Jullien J., 1883, B SOC ZOOLOGIQUE FRA, V7, P497, DOI DOI 10.5962/BHL.TITLE.4721; Jullien JL, 1903, RESULTATS CAMPAGNES, V23, P1; Kennett J., 1982, MARINE GEOLOGY; Kluge G.A., 1929, RABOTY MURMANSKOI BI, V3, P1; Kluge G.A., 1946, T DREIF EKSP GLAVS N, V3, P194; Kluge G.A., 1962, BRYOZOANS NO SEAS US; Kluge G.A., 1915, FAUNA KOLSKY GULF CO, V8, P376; Kluge GA., 1975, BRYOZOA NO SEAS USSR; Kuklinski P, 2005, J NAT HIST, V39, P539, DOI 10.1080/00222930400001350; Kuklinski P, 2006, POLAR BIOL, V29, P652, DOI 10.1007/s00300-005-0102-5; Lombardi C, 2010, ZOOL J LINN SOC-LOND, V160, P17, DOI 10.1111/j.1096-3642.2009.00594.x; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marcus E, 1919, NOTIZEN EINIGES MAT, P255; Marfenin NN, 1997, HYDROBIOLOGIA, V355, P153, DOI 10.1023/A:1003069831832; Mayer AG, 1918, BIOGR MEM NAT ACAD S, VVIII, P417; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; Nelson RJ, 2009, MAR ECOL PROG SER, V381, P129, DOI 10.3354/meps07940; Nesis K.N., 1984, SOVIET J MARINE BIOL, V9, P235; PALUMBI SR, 1991, EVOLUTION, V45, P1790, DOI 10.1111/j.1558-5646.1991.tb02688.x; POWELL NA, 1968, J FISH RES BOARD CAN, V25, P2269, DOI 10.1139/f68-202; RIDER J, 1977, LETHAIA, V10, P29; Ryland J.S., 1974, Thalassia Jugosl, V10, P239; Ryland JS., 1991, NOAA TECHNICAL REPOR, V99, P1; Sars M, 1863, BESKRIVELSE NOGLE NO; Smitt FA, 1868, OFVERSIGT VETENSKAP, V6, P443; Smitt FA, 1868, KRITISK FORTECKNIN 4, V1867, P3; Stimpson W, 1854, SMITHSONIAN CONTRIBU, V5, P17; Vainola R, 2003, MAR BIOL, V143, P935, DOI 10.1007/s00227-003-1137-1; VANOPPEN MJH, 1995, MAR BIOL, V123, P179, DOI 10.1007/BF00350338; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; Verrill AE, 1879, P US NAT MUS, V2, P188; VIGELIUS WJ, 1882, NIEDERL ARCH ZOOL S, V1, P1; Waeschenbach A, 2012, MOL PHYLOGENET EVOL, V62, P718, DOI 10.1016/j.ympev.2011.11.011; Wares JP, 2001, BIOL BULL-US, V201, P95, DOI 10.2307/1543530; Weider LJ, 2000, ANN ZOOL FENN, V37, P217	68	13	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59152	10.1371/journal.pone.0059152	http://dx.doi.org/10.1371/journal.pone.0059152			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536863	gold, Green Submitted, Green Published			2022-12-25	WOS:000317397200016
J	Chamling, X; Seo, SJ; Bugge, K; Searby, C; Guo, DF; Drack, AV; Rahmouni, K; Sheffield, VC				Chamling, Xitiz; Seo, Seongjin; Bugge, Kevin; Searby, Charles; Guo, Deng F.; Drack, Arlene V.; Rahmouni, Kamal; Sheffield, Val C.			Ectopic Expression of Human BBS4 Can Rescue Bardet-Biedl Syndrome Phenotypes in Bbs4 Null Mice	PLOS ONE			English	Article							SYNDROME PROTEINS; MOUSE MODELS; CILIOGENESIS; MUTATIONS; COMPLEX; OBESITY; CILIA	Bardet-Biedl syndrome (BBS) is a genetically heterogeneous autosomal recessive disorder characterized by obesity, retinal degeneration, polydactyly, hypogenitalism and renal defects. Recent findings have associated the etiology of the disease with cilia, and BBS proteins have been implicated in trafficking various ciliary cargo proteins. To date, 17 different genes have been reported for BBS among which BBS1 is the most common cause of the disease followed by BBS10, and BBS4. A murine model of Bbs4 is known to phenocopy most of the human BBS phenotypes, and it is being used as a BBS disease model. To better understand the in vivo localization, cellular function, and interaction of BBS4 with other proteins, we generated a transgenic BBS4 mouse expressing the human BBS4 gene under control of the beta actin promoter. The transgene is expressed in various tissues including brain, eye, testis, heart, kidney, and adipose tissue. These mice were further bred to express the transgene in Bbs4 null mice, and their phenotype was characterized. Here we report that despite tissue specific variable expression of the transgene, human BBS4 was able to complement the deficiency of Bbs4 and rescue all the BBS phenotypes in the Bbs4 null mice. These results provide an encouraging prospective for gene therapy for BBS related phenotypes and potentially for other ciliopathies.	[Chamling, Xitiz; Bugge, Kevin; Searby, Charles; Sheffield, Val C.] Univ Iowa, Dept Pediat, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Seo, Seongjin; Drack, Arlene V.; Sheffield, Val C.] Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Bugge, Kevin; Searby, Charles; Sheffield, Val C.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Guo, Deng F.; Rahmouni, Kamal] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Guo, Deng F.; Rahmouni, Kamal] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Interdisciplinary Program Genet, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu	Rahmouni, Kamal/Y-1788-2019	Drack, Arlene/0000-0002-8195-8426; Rahmouni, Kamal/0000-0001-5136-6748; Sheffield, Val/0000-0002-6282-0835; Seo, Seongjin/0000-0002-7908-3210; chamling, xitiz/0000-0001-6401-7715; Searby, Charles/0000-0002-8108-8782	National Institute of Health [R01EY022616, RO1EY017168, RO1EY110298]; NATIONAL EYE INSTITUTE [R01EY011298, R01EY017168, R01EY022616] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083543] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grants R01EY022616 (to S.S.), RO1EY017168 and RO1EY110298 (to V.C.S.). V.C.S. is a Howard Hughes Medical Institute investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billingsley G, 2011, OPHTHALMIC GENET, V32, P181, DOI 10.3109/13816810.2011.567319; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; Eichers ER, 2006, HUM GENET, V120, P211, DOI 10.1007/s00439-006-0197-y; Forsythe E, 2012, EUR J HUM GENET; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Ittner LM, 2007, NAT PROTOC, V2, P1206, DOI 10.1038/nprot.2007.145; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Jozefczuk J, 2012, JOVE-J VIS EXP, DOI 10.3791/3854; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Pereiro I, 2010, MOL VIS, V16, P137; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Simons DL, 2011, P NATL ACAD SCI USA, V108, P6276, DOI 10.1073/pnas.1019222108; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Zhang QH, 2012, HUM MOL GENET, V21, P1945, DOI 10.1093/hmg/dds004; Zhang QH, 2011, P NATL ACAD SCI USA, V108, P20678, DOI 10.1073/pnas.1113220108	24	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59101	10.1371/journal.pone.0059101	http://dx.doi.org/10.1371/journal.pone.0059101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554981	Green Submitted, Green Published, gold			2022-12-25	WOS:000316409800058
J	Hou, XD; Liu, QP; Smith, TJ; Li, N; Zong, MH				Hou, Xue-Dan; Liu, Qiu-Ping; Smith, Thomas J.; Li, Ning; Zong, Min-Hua			Evaluation of Toxicity and Biodegradability of Cholinium Amino Acids Ionic Liquids	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITIES; ACETYLCHOLINESTERASE; IMIDAZOLIUM; PYRIDINIUM; SACCHARINATE; PRETREATMENT; SOLVENTS; CHLORIDE; TARGETS; BIOMASS	Cholinium amino acid ionic liquids ([Ch][AA] ILs), which are wholly composed of renewable biomaterials, have recently been demonstrated to have very promising properties for applications in organic synthesis and biomass pretreatment. In this work, the toxicity of these ILs toward enzymes and bacteria was assessed, and the effect of the anion on these properties is discussed. The inhibitory potentials of this type of ILs to acetylcholinesterase were weaker approximately an order of magnitude than the traditional IL 1-butyl-3-methylimidazolium tetrafluoroborate. Additionally, the [Ch][AA] ILs displayed low toxicity toward the bacteria tested. Furthermore, the biodegradability of the [Ch][AA] ILs was evaluated via the closed bottle and CO2 headspace tests using wastewater microorganisms. All the ILs were classified as 'readily biodegradable' based on their high levels of mineralization (62-87%). The presence of extra carboxyl or amide groups on the amino acid side chain rendered the ILs significantly more susceptible to microbial breakdown. In addition, for most of the [Ch][AA] ILs, low toxicity correlated with good biodegradability. The low toxicity and high biodegradability of these novel [Ch][AA] make them promising candidates for use as environmentally friendly solvents in large-scale applications.	[Hou, Xue-Dan; Li, Ning; Zong, Min-Hua] S China Univ Technol, Coll Light Ind & Food Sci, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China; [Hou, Xue-Dan; Liu, Qiu-Ping] S China Univ Technol, Coll Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Smith, Thomas J.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England	South China University of Technology; South China University of Technology; Sheffield Hallam University	Li, N (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China.	lining@scut.edu.cn; btmhzong@scut.edu.cn	Li, Ning/I-3417-2012	Li, Ning/0000-0003-1684-4454; Smith, Thomas/0000-0002-4246-5020	National Natural Science Foundation of China [20906032, 21072065]; Research Fund for the Doctoral Program of Higher Education [20090172110019]; Fundamental Research Funds for the Central Universities, SCUT [2012ZP0009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Fundamental Research Funds for the Central Universities, SCUT(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (20906032 and 21072065), the Research Fund for the Doctoral Program of Higher Education (20090172110019), and the Fundamental Research Funds for the Central Universities, SCUT (2012ZP0009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arning J, 2008, GREEN CHEM, V10, P47, DOI 10.1039/b712109a; Boethling RS, 2007, CHEM REV, V107, P2207, DOI 10.1021/cr050952t; Coleman D, 2010, CHEM SOC REV, V39, P600, DOI 10.1039/b817717c; Docherty KM, 2007, BIODEGRADATION, V18, P481, DOI 10.1007/s10532-006-9081-7; Docherty KM, 2005, GREEN CHEM, V7, P185, DOI 10.1039/b419172b; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Ford L, 2010, GREEN CHEM, V12, P1783, DOI 10.1039/c0gc00082e; Fukumoto K, 2005, J AM CHEM SOC, V127, P2398, DOI 10.1021/ja043451i; Gathergood N, 2004, GREEN CHEM, V6, P166, DOI 10.1039/b315270g; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Hou XD, 2012, BIOTECHNOL BIOENG, V109, P2484, DOI 10.1002/bit.24522; Hu SQ, 2007, TETRAHEDRON LETT, V48, P5613, DOI 10.1016/j.tetlet.2007.06.051; Lee SH, 2006, BIOTECHNOL LETT, V28, P1335, DOI 10.1007/s10529-006-9095-6; Liu QP, 2012, GREEN CHEM, V14, P304, DOI 10.1039/c2gc16128a; Luo YR, 2009, CHEMOSPHERE, V77, P313, DOI 10.1016/j.chemosphere.2009.07.026; Machado MF, 2005, BIOTECHNOL LETT, V27, P1233, DOI 10.1007/s10529-005-0023-y; Maia A, 2011, MINI-REV ORG CHEM, V8, P178, DOI 10.2174/157019311795177826; Mora-Pale M, 2011, BIOTECHNOL BIOENG, V108, P1229, DOI 10.1002/bit.23108; Moriel P, 2010, TETRAHEDRON LETT, V51, P4877, DOI 10.1016/j.tetlet.2010.07.060; Nockemann P, 2007, J PHYS CHEM B, V111, P5254, DOI 10.1021/jp068446a; Pernak J, 2004, GREEN CHEM, V6, P323, DOI 10.1039/b404625k; Pernak J, 2001, EUR J MED CHEM, V36, P313, DOI 10.1016/S0223-5234(01)01226-0; Petkovic M, 2011, CHEM SOC REV, V40, P1383, DOI 10.1039/c004968a; Petkovic M, 2010, GREEN CHEM, V12, P643, DOI 10.1039/b922247b; Pinto PCAG, 2011, CHEMOSPHERE, V82, P1620, DOI 10.1016/j.chemosphere.2010.11.046; Plaquevent JC, 2008, CHEM REV, V108, P5035, DOI 10.1021/cr068218c; Plechkova NV, 2008, CHEM SOC REV, V37, P123, DOI 10.1039/b006677j; Rickwood CJ, 2004, AQUAT TOXICOL, V67, P45, DOI 10.1016/j.aquatox.2003.11.004; Romero A, 2008, J HAZARD MATER, V151, P268, DOI 10.1016/j.jhazmat.2007.10.079; Russell AD, 2003, J ANTIMICROB CHEMOTH, V52, P750, DOI 10.1093/jac/dkg422; Stasiewicz M, 2008, ECOTOX ENVIRON SAFE, V71, P157, DOI 10.1016/j.ecoenv.2007.08.011; Stock F, 2004, GREEN CHEM, V6, P286, DOI 10.1039/b402348j; Tao GH, 2006, GREEN CHEM, V8, P639, DOI 10.1039/b600813e; Thi PTP, 2010, WATER RES, V44, P352, DOI 10.1016/j.watres.2009.09.030; Turner MB, 2003, GREEN CHEM, V5, P443, DOI 10.1039/b302570e; Wang H, 2011, CHEMOSPHERE, V82, P1597, DOI 10.1016/j.chemosphere.2010.11.049; Weaver KD, 2010, GREEN CHEM, V12, P507, DOI 10.1039/b918726j; Yu YH, 2008, CHEM-EUR J, V14, P11174, DOI 10.1002/chem.200800620	38	243	255	4	216	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59145	10.1371/journal.pone.0059145	http://dx.doi.org/10.1371/journal.pone.0059145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554985	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800062
J	Jones, SI; Vodkin, LO				Jones, Sarah I.; Vodkin, Lila O.			Using RNA-Seq to Profile Soybean Seed Development from Fertilization to Maturity	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; CELL-WALL PROTEIN; EXPRESSION ANALYSIS; PATTERNS; IDENTIFICATION; ACCUMULATION; SEQUENCES; ELEMENTS; GENES; AUXIN	To understand gene expression networks leading to functional properties and compositional traits of the soybean seed, we have undertaken a detailed examination of soybean seed development from a few days post-fertilization to the mature seed using Illumina high-throughput transcriptome sequencing (RNA-Seq). RNA was sequenced from seven different stages of seed development, yielding between 12 million and 78 million sequenced transcripts. These have been aligned to the 79,000 gene models predicted from the soybean genome recently sequenced by the Department of Energy Joint Genome Institute. Over one hundred gene models were identified with high expression exclusively in young seed stages, starting at just four days after fertilization. These were annotated as being related to many basic components and processes such as histones and proline-rich proteins. Genes encoding storage proteins such as glycinin and beta-conglycinin had their highest expression levels at the stages of largest fresh weight, confirming previous knowledge that these storage products are being rapidly accumulated before the seed begins the desiccation process. Other gene models showed high expression in the dry, mature seeds, perhaps indicating the preparation of pathways needed later, in the early stages of imbibition. Many highly-expressed gene models at the dry seed stage are, as expected, annotated as hydrophilic proteins associated with low water conditions, such as late embryogenesis abundant (LEA) proteins and dehydrins, which help preserve the cellular structures and nutrients within the seed during desiccation. More significantly, the power of RNA-Seq to detect genes expressed at low levels revealed hundreds of transcription factors with notable expression in at least one stage of seed development. Results from a second biological replicate demonstrate high reproducibility of these data revealing a comprehensive view of the transciptome of seed development in the cultivar Williams, the reference cultivar for the first soybean genome sequence.	[Jones, Sarah I.; Vodkin, Lila O.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Vodkin, LO (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	l-vodkin@illinois.edu			Illinois Soybean Association; United Soybean Board; Illinois-Missouri Biotechnology Alliance	Illinois Soybean Association; United Soybean Board; Illinois-Missouri Biotechnology Alliance	This research was supported by grants from the Illinois Soybean Association, the United Soybean Board, and the Illinois-Missouri Biotechnology Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Appelhagen I, 2011, PLANT J, V67, P406, DOI 10.1111/j.1365-313X.2011.04603.x; Asakura T, 2012, PLANT PHYSIOL BIOCH, V52, P147, DOI 10.1016/j.plaphy.2011.12.007; BAULCOMBE DC, 1980, J BIOL CHEM, V255, P8907; Bewley JD, 2000, BIOCH MOL BIOL PLANT, P988; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Carlson JB, 2004, SOYBEANS IMPROVEMENT, V16, P59; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez DO, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-468; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; HONG JC, 1989, PLANT CELL, V1, P937, DOI 10.1105/tpc.1.9.937; Hunt M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-145; Islas-Flores I, 2002, BBA-GEN SUBJECTS, V1571, P64, DOI 10.1016/S0304-4165(02)00210-6; Jenik PD, 2005, DEVELOPMENT, V132, P3577, DOI 10.1242/dev.01952; Jones SI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-136; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le BH, 2007, PLANT PHYSIOL, V144, P562, DOI 10.1104/pp.107.100362; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; LINDSTROM JT, 1991, PLANT CELL, V3, P561, DOI 10.1105/tpc.3.6.561; MEINKE DW, 1981, PLANTA, V153, P130, DOI 10.1007/BF00384094; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; NIELSEN NC, 1989, PLANT CELL, V1, P313, DOI 10.1105/tpc.1.3.313; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Panavas T, 1999, PLANT MOL BIOL, V40, P237, DOI 10.1023/A:1006146230602; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; Ritchie S.W., 1996, 53 IOW STAT U SCI TE; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sha AH, 2012, MOL BIOL REP, V39, P2867, DOI 10.1007/s11033-011-1046-1; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; Skrzypczak-Jankun E, 2004, ACTA CRYSTALLOGR D, V60, P613, DOI 10.1107/S0907444904000861; Stephenson LC, 1998, PLANT PHYSIOL, V116, P923, DOI 10.1104/pp.116.3.923; Thibaud-Nissen FO, 2003, PLANT PHYSIOL, V132, P118, DOI 10.1104/pp.103.019968; Tuteja JH, 2009, PLANT CELL, V21, P3063, DOI 10.1105/tpc.109.069856; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x; Zabala G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-177	41	98	102	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59270	10.1371/journal.pone.0059270	http://dx.doi.org/10.1371/journal.pone.0059270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555009	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800078
J	Yang, LN; Gao, FL; Shang, LP; Zhan, JS; McDonald, BA				Yang, Lina; Gao, Fangluan; Shang, Liping; Zhan, Jiasui; McDonald, Bruce A.			Association between Virulence and Triazole Tolerance in the Phytopathogenic Fungus Mycosphaerella graminicola	PLOS ONE			English	Article							MULTIPLE MECHANISMS ACCOUNT; POPULATION DIFFERENTIATION; CRYPTOCOCCUS-NEOFORMANS; QUANTITATIVE TRAITS; SEPTORIA-TRITICI; LOCAL ADAPTATION; IN-VITRO; RESISTANCE; MELANIN; EVOLUTION	Host resistance and synthetic antimicrobials such as fungicides are two of the main approaches used to control plant diseases in conventional agriculture. Although pathogens often evolve to overcome host resistance and antimicrobials, the majority of reports have involved qualitative host - pathogen interactions or antimicrobials targeting a single pathogen protein or metabolic pathway. Studies that consider jointly the evolution of virulence, defined as the degree of damage caused to a host by parasite infection, and antimicrobial resistance are rare. Here we compared virulence and fungicide tolerance in the fungal pathogen Mycosphaerella graminicola sampled from wheat fields across three continents and found a positive correlation between virulence and tolerance to a triazole fungicide. We also found that quantitative host resistance selected for higher pathogen virulence. The possible mechanisms responsible for these observations and their consequences for sustainable disease management are discussed.	[Yang, Lina; Zhan, Jiasui] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Fujian, Peoples R China; [Yang, Lina; Gao, Fangluan; Shang, Liping; Zhan, Jiasui] Fujian Agr & Forestry Univ, Inst Plant Virol, Lab Plant Virol Fujian Prov, Fuzhou, Fujian, Peoples R China; [McDonald, Bruce A.] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zhan, JS (corresponding author), Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Fujian, Peoples R China.	Jiasui.zhan@fafu.edu.cn	McDonald, Bruce A/A-2748-2008	McDonald, Bruce A/0000-0002-5332-2172; Gao, Fangluan/0000-0001-9031-9944	Chinese National Science Foundation [31071655]; Swiss Federal Institute of Technology [TH-49a/02-1]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Swiss Federal Institute of Technology	The project was supported by Chinese National Science Foundation Grant no. 31071655 and Swiss Federal Institute of Technology Grant TH-49a/02-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; ANDERSSON S, 1993, BIOL J LINN SOC, V49, P185, DOI 10.1111/j.1095-8312.1993.tb00897.x; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Choi YE, 2011, APPL ENVIRON MICROB, V77, P942, DOI 10.1128/AEM.01830-10; CORDERO MJ, 1994, MOL PLANT MICROBE IN, V7, P23, DOI 10.1094/MPMI-7-0023; Cousin A, 2006, MOL PLANT PATHOL, V7, P269, DOI [10.1111/j.1364-3703.2006.00337.x, 10.1111/J.1364-3703.2006.00337.X]; Cowger C, 2002, PHYTOPATHOLOGY, V92, P624, DOI 10.1094/PHYTO.2002.92.6.624; DAHL C, 1987, P NATL ACAD SCI USA, V84, P4012, DOI 10.1073/pnas.84.12.4012; DWYER G, 1990, ECOL MONOGR, V60, P423, DOI 10.2307/1943014; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Gandon S, 2000, P ROY SOC B-BIOL SCI, V267, P985, DOI 10.1098/rspb.2000.1100; Gisi U, 1997, PESTIC SCI, V51, P290, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;290::AID-PS637&gt;3.0.CO;2-H; GOODNIGHT CJ, 1989, AM NAT, V133, P888, DOI 10.1086/284958; Gupta A, 2008, FEMS MICROBIOL LETT, V278, P22, DOI 10.1111/j.1574-6968.2007.00937.x; Ikeda R, 2003, MICROBIOL IMMUNOL, V47, P271, DOI 10.1111/j.1348-0421.2003.tb03395.x; Janzac B, 2010, MOL PLANT MICROBE IN, V23, P823, DOI 10.1094/MPMI-23-6-0823; Jiang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028291; Kelm C, 2012, MOL BREEDING, V29, P813, DOI 10.1007/s11032-011-9592-8; Kliebenstein DJ, 2012, ANNU REV PHYTOPATHOL, V50, P155, DOI 10.1146/annurev-phyto-081211-172950; KOJIMA KI, 1967, EVOLUTION, V21, P518, DOI [10.2307/2406613, 10.1111/j.1558-5646.1967.tb03408.x]; Kroner A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023331; Lamari L, 2002, ASSESS LIMAGE ANAL S; Lannou C, 2012, ANNU REV PHYTOPATHOL, V50, P319, DOI 10.1146/annurev-phyto-081211-173031; Leroux P, 2011, PEST MANAG SCI, V67, P44, DOI 10.1002/ps.2028; Liaw SJ, 2010, INT J ANTIMICROB AG, V35, P126, DOI 10.1016/j.ijantimicag.2009.09.015; Liu X, 2010, PLANT DIS, V94, P1137, DOI 10.1094/PDIS-94-9-1137; Lynch M, 1999, EVOLUTION, V53, P100, DOI 10.1111/j.1558-5646.1999.tb05336.x; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; Mehrabi R, 2006, MOL PLANT MICROBE IN, V19, P389, DOI 10.1094/MPMI-19-0389; Morris-Jones R, 2003, INFECT IMMUN, V71, P4026, DOI 10.1128/IAI.71.7.4026-4033.2003; Morrissey JP, 1999, MICROBIOL MOL BIOL R, V63, P708, DOI 10.1128/MMBR.63.3.708-724.1999; Ngamskulrungroj Popchai, 2009, Australasian Mycologist, V28, P9; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Nosanchuk JD, 2000, LANCET, V355, P2049, DOI 10.1016/S0140-6736(00)02356-4; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Orton ES, 2011, MOL PLANT PATHOL, V12, P413, DOI 10.1111/j.1364-3703.2010.00688.x; Ott R.L., 1992, INTRO STAT METHODS D; Palmer CL, 2002, MOL PLANT PATHOL, V3, P63, DOI 10.1046/j.1464-6722.2002.00100.x; Pariaud B, 2009, PHYTOPATHOLOGY, V99, P869, DOI 10.1094/PHYTO-99-7-0869; PINK DAC, 1992, EUPHYTICA, V63, P169, DOI 10.1007/BF00023921; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Risser P, 2011, PHYTOPATHOLOGY, V101, P1209, DOI 10.1094/PHYTO-08-10-0203; Roff DA, 2006, INTRODUCTION TO COMPUTER-INTENSIVE METHODS OF DATA ANALYSIS IN BIOLOGY, P1, DOI 10.2277/ 0521608651; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; *SAS I INC, 1990, SAS US GUID STAT VER; SHAW MW, 1989, PLANT PATHOL, V38, P35, DOI 10.1111/j.1365-3059.1989.tb01425.x; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; SPITZE K, 1993, GENETICS, V135, P367; Stergiopoulos I, 2003, PEST MANAG SCI, V59, P1333, DOI 10.1002/ps.766; Sun CB, 2006, PLANT CELL, V18, P3686, DOI 10.1105/tpc.105.037861; Taborda CP, 2008, MYCOPATHOLOGIA, V165, P331, DOI 10.1007/s11046-007-9061-4; Takuno S, 2007, GENETICS, V177, P949, DOI 10.1534/genetics.107.073825; Truong-Bolduc QC, 2005, J BACTERIOL, V187, P2395, DOI 10.1128/JB.187.7.2395-2405.2005; Urban M, 1999, EMBO J, V18, P512, DOI 10.1093/emboj/18.3.512; Van de Wouw AP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001180; Vergne E., 2010, BMC PLANT BIOL, V10, P206, DOI DOI 10.1186/1471-2229-10-206; Wheeler M, 2000, INFECT IMMUN, V68, P3696, DOI 10.1128/IAI.68.6.3696-3703.2000; WINK M, 1988, THEOR APPL GENET, V75, P225, DOI 10.1007/BF00303957; Youngchim S, 2004, J MED MICROBIOL, V53, P175, DOI 10.1099/jmm.0.05421-0; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhan J, 2007, INT J PARASITOL, V37, P861, DOI 10.1016/j.ijpara.2007.03.003; Zhan J, 2006, MOL PLANT PATHOL, V7, P259, DOI 10.1111/J.1364-3703.2006.00336.X; Zhan J, 2005, MOL ECOL, V14, P2683, DOI 10.1111/j.1365-294X.2005.02638.x; Zhan J, 2004, FUNGAL GENET BIOL, V41, P590, DOI 10.1016/j.fgb.2004.01.006; Zhan J, 1998, PHYTOPATHOLOGY, V88, P1330, DOI 10.1094/PHYTO.1998.88.12.1330; Zhan J, 2003, FUNGAL GENET BIOL, V38, P286, DOI 10.1016/S1087-1845(02)00538-8; Zhan J, 2002, J EVOLUTION BIOL, V15, P634, DOI 10.1046/j.1420-9101.2002.00428.x; Zhan J., 2009, POPULATION GENETICS, DOI [10.1002/9780470015902.a0021269, DOI 10.1002/9780470015902.A0021269]; Zhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038611; Zhan JS, 2011, MOL ECOL, V20, P1689, DOI 10.1111/j.1365-294X.2011.05023.x	74	21	23	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59568	10.1371/journal.pone.0059568	http://dx.doi.org/10.1371/journal.pone.0059568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555044	gold, Green Submitted, Green Published			2022-12-25	WOS:000316409800100
J	Anders, C; Ashton, N; Ranjzad, P; Dilworth, MR; Woolf, AS				Anders, Corina; Ashton, Nick; Ranjzad, Parisa; Dilworth, Mark R.; Woolf, Adrian S.			Ex Vivo Modeling of Chemical Synergy in Prenatal Kidney Cystogenesis	PLOS ONE			English	Article							APPARENT MINERALOCORTICOID EXCESS; STAGE RENAL-DISEASE; LOW-BIRTH-WEIGHT; AUTOSOMAL-DOMINANT; CORTISOL-LEVELS; BLOOD-PRESSURE; CYST FORMATION; ORGAN-CULTURE; MOUSE KIDNEY; IN-VITRO	Cyclic adenosine monophosphate (cAMP) drives genetic polycystic kidney disease (PKD) cystogenesis. Yet within certain PKD families, striking differences in disease severity exist between affected individuals, and genomic and/or environmental modifying factors have been evoked to explain these observations. We hypothesized that PKD cystogenesis is accentuated by an aberrant fetal milieu, specifically by glucocorticoids. The extent and nature of cystogenesis was assessed in explanted wild-type mouse embryonic metanephroi, using 8-Br-cAMP as a chemical to mimic genetic PKD and the glucocorticoid dexamethasone as the environmental modulator. Cysts and glomeruli were quantified by an observer blinded to culture conditions, and tubules were phenotyped using specific markers. Dexamethasone or 8-Br-cAMP applied on their own produced cysts predominantly arising in proximal tubules and descending limbs of loops of Henle. When applied together, however, dexamethasone over a wide concentration range synergized with 8-Br-cAMP to generate a more severe, glomerulocystic, phenotype; we note that prominent glomerular cysts have been reported in autosomal dominant PKD fetal kidneys. Our data support the idea that an adverse antenatal environment exacerbates renal cystogenesis.	[Anders, Corina; Ranjzad, Parisa; Dilworth, Mark R.; Woolf, Adrian S.] Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Anders, Corina; Ranjzad, Parisa; Dilworth, Mark R.; Woolf, Adrian S.] St Marys & Manchester Childrens Hosp, Manchester, Lancs, England; [Ashton, Nick] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester	Anders, C (corresponding author), Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	corina.anders@manchester.ac.uk	Woolf, Adrian S./AAZ-1075-2020; Dilworth, Mark/J-6395-2015	Woolf, Adrian S./0000-0001-5541-1358; Dilworth, Mark/0000-0002-7106-7451; Ranjzad, Parisa/0000-0001-7413-4157; Ashton, Nick/0000-0003-3366-1617	Manchester Biomedical Research Centre; Medical Research Council; Kids Kidney Research	Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kids Kidney Research(Kidney Research UK (KRUK))	ASW and CA acknowledge research funding support from the Manchester Biomedical Research Centre. MRD acknowledges research funding from the Medical Research Council. ASW and PR acknowledge research funding support from Kids Kidney Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalat S, 2009, J AM SOC NEPHROL, V20, P1123, DOI 10.1681/ASN.2008060633; Ahrabi AK, 2010, NEPHROL DIAL TRANSPL, V25, P1067, DOI 10.1093/ndt/gfp611; Alwasel SH, 2012, PEDIATR NEPHROL, V27, P285, DOI 10.1007/s00467-011-1976-9; Alwasel SH, 2009, CLIN SCI, V117, P75, DOI 10.1042/CS20080294; AVNER ED, 1985, KIDNEY INT, V28, P447, DOI 10.1038/ki.1985.151; AVNER ED, 1984, LAB INVEST, V50, P208; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bergmann C, 2011, J AM SOC NEPHROL, V22, P2047, DOI 10.1681/ASN.2010101080; Bingham C, 2001, AM J HUM GENET, V68, P219, DOI 10.1086/316945; Cale CM, 1998, INT J DEV BIOL, V42, P663; Celsi G, 1998, PEDIATR RES, V44, P317, DOI 10.1203/00006450-199809000-00009; Chan SK, 2010, AM J PHYSIOL-RENAL, V298, pF346, DOI 10.1152/ajprenal.00574.2009; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; Clark P, 2004, J AM SOC NEPHROL, V15, P299, DOI 10.1097/01.ASN.0000111248.23454.19; DAVIES J, 1994, DEV DYNAM, V199, P45, DOI 10.1002/aja.1001990105; DEGET F, 1995, CLIN GENET, V47, P248, DOI 10.1111/j.1399-0004.1995.tb04305.x; Dilworth MR, 2008, NEPHROL DIAL TRANSPL, V23, P871, DOI 10.1093/ndt/gfm671; Dotsch J, 2009, J MOL MED, V87, P841, DOI 10.1007/s00109-009-0507-7; Feather SA, 1997, NEPHROL DIAL TRANSPL, V12, P1354, DOI 10.1093/ndt/12.7.1354; Furu L, 2003, J AM SOC NEPHROL, V14, P2004, DOI 10.1097/01.ASN.0000078805.87038.05; Gascue C, 2011, PEDIATR NEPHROL, V26, P1181, DOI 10.1007/s00467-010-1697-5; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Goilav B, 2008, PEDIATR NEPHROL, V23, P1473, DOI 10.1007/s00467-008-0851-9; GRANTHAM JJ, 1987, KIDNEY INT, V31, P1145, DOI 10.1038/ki.1987.121; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Harris PC, 2009, J AM SOC NEPHROL, V20, P1188, DOI 10.1681/ASN.2009010014; HOYER JR, 1974, LAB INVEST, V30, P757; KAPLAN BS, 1988, AM J MED GENET, V29, P639, DOI 10.1002/ajmg.1320290323; Karihaloo A, 2011, J AM SOC NEPHROL, V22, P1809, DOI 10.1681/ASN.2011010084; Laitinen L, 1987, J HISTOCHEM CYTOCHEM, V35, P55, DOI 10.1177/35.1.3794309; LangleyEvans SC, 1996, PLACENTA, V17, P169, DOI 10.1016/S0143-4004(96)80010-5; Magenheimer BS, 2006, J AM SOC NEPHROL, V17, P3424, DOI 10.1681/ASN.2006030295; Manabe M, 2005, PEDIATR INT, V47, P60, DOI 10.1111/j.1442-200x.2004.02002.x; Marion V, 2011, KIDNEY INT, V79, P1013, DOI 10.1038/ki.2010.538; McArdle HJ, 2006, PLACENTA, V27, pS56, DOI 10.1016/j.placenta.2006.01.014; McMullen S, 2012, MED HYPOTHESES, V78, P88, DOI 10.1016/j.mehy.2011.09.047; Mears Katrina, 2004, J Obstet Gynaecol, V24, P129; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Morris RG, 2005, AM J PHYSIOL-RENAL, V289, pF194, DOI 10.1152/ajprenal.00121.2004; Moudgil A, 2000, PEDIATR NEPHROL, V15, P60, DOI 10.1007/s004670000377; Mrug M, 2008, KIDNEY INT, V73, P63, DOI 10.1038/sj.ki.5002627; Nakanishi K, 2000, J AM SOC NEPHROL, V11, P760, DOI 10.1681/ASN.V114760; Nussey S, 2001, ENDOCRINOLOGY INTEGR; Orskov B, 2012, KIDNEY INT, V81, P919, DOI 10.1038/ki.2011.459; Potter EL, 1972, NORMAL ABNORMAL DEV, P1; REEDERS ST, 1986, LANCET, V2, P6; Rossetti S, 2007, J AM SOC NEPHROL, V18, P1374, DOI 10.1681/ASN.2007010125; Sam S, 2004, CLIN ENDOCRINOL, V60, P29, DOI 10.1111/j.1365-2265.2004.01923.x; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; STEWART PM, 1988, J CLIN INVEST, V82, P340, DOI 10.1172/JCI113592; Tarantal AF, 2001, KIDNEY INT, V59, P446, DOI 10.1046/j.1523-1755.2001.059002446.x; Torra R, 1997, KIDNEY INT, V52, P33, DOI 10.1038/ki.1997.300; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; Vikse BE, 2008, J AM SOC NEPHROL, V19, P151, DOI 10.1681/ASN.2007020252; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Welham SJM, 2005, PHYSIOL GENOMICS, V22, P48, DOI 10.1152/physiolgenomics.00167.2004; Welham SJM, 2002, KIDNEY INT, V61, P1231, DOI 10.1046/j.1523-1755.2002.00264.x; Winyard PJD, 1996, KIDNEY INT, V49, P135, DOI 10.1038/ki.1996.18; Woolf Adrian S, 2011, Klin Padiatr, V223 Suppl 1, pS10, DOI 10.1055/s-0030-1255876; WOOLF AS, 2009, PEDIAT NEPHROLOGY, P3; Woolf AS, 2006, HEPTINSTALLS PATHOLO, P71; Yamaguchi T, 2010, AM J PHYSIOL-RENAL, V299, pF944, DOI 10.1152/ajprenal.00387.2010; Yang SP, 2001, AM J PATHOL, V159, P109, DOI 10.1016/S0002-9440(10)61678-1	65	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57797	10.1371/journal.pone.0057797	http://dx.doi.org/10.1371/journal.pone.0057797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554868	Green Submitted, Green Published, gold			2022-12-25	WOS:000316252500008
J	Chen, BZ; Gui, F; Xie, BG; Deng, YJ; Sun, XY; Lin, MY; Tao, YX; Li, SJ				Chen, Bingzhi; Gui, Fu; Xie, Baogui; Deng, Youjin; Sun, Xianyun; Lin, Mengying; Tao, Yongxin; Li, Shaojie			Composition and Expression of Genes Encoding Carbohydrate-Active Enzymes in the Straw-Degrading Mushroom Volvariella volvacea	PLOS ONE			English	Article							GENOME SEQUENCE; CLASSIFICATION; INSIGHTS; MECHANISMS	Volvariella volvacea is one of a few commercial cultivated mushrooms mainly using straw as carbon source. In this study, the genome of V. volcacea was sequenced and assembled. A total of 285 genes encoding carbohydrate-active enzymes (CAZymes) in V. volvacea were identified and annotated. Among 15 fungi with sequenced genomes, V. volvacea ranks seventh in the number of genes encoding CAZymes. In addition, the composition of glycoside hydrolases in V. volcacea is dramatically different from other basidiomycetes: it is particularly rich in members of the glycoside hydrolase families GH10 (hemicellulose degradation) and GH43 (hemicellulose and pectin degradation), and the lyase families PL1, PL3 and PL4 (pectin degradation) but lacks families GH5b, GH11, GH26, GH62, GH93, GH115, GH105, GH9, GH53, GH32, GH74 and CE12. Analysis of genome-wide gene expression profiles of 3 strains using 3'-tag digital gene expression (DGE) reveals that 239 CAZyme genes were expressed even in potato destrose broth medium. Our data also showed that the formation of a heterokaryotic strain could dramatically increase the expression of a number of genes which were poorly expressed in its parental homokaryotic strains.	[Chen, Bingzhi; Gui, Fu; Xie, Baogui; Deng, Youjin; Lin, Mengying; Tao, Yongxin] Fujian Agr & Forestry Univ, Mycol Res Ctr, Coll Life Sci, Fuzhou, Peoples R China; [Sun, Xianyun; Li, Shaojie] Chinese Acad Sci, State Key Lab Mycol, Inst Microbiol, Beijing, Peoples R China	Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Xie, BG (corresponding author), Fujian Agr & Forestry Univ, Mycol Res Ctr, Coll Life Sci, Fuzhou, Peoples R China.	mrcfafu@163.com; shaojieli@gmail.com	sun, xianyun/AEJ-8467-2022; Li, Shaojie/AAH-2077-2020; Gui, Fu/AAG-6197-2020	Gui, Fu/0000-0001-8329-7118	China Agriculture Research System [CARS24]; Chinese Academy of Sciences	China Agriculture Research System; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by China Agriculture Research System (No. CARS24) and the grant "100 Talent Program" from the Chinese Academy of Sciences (to Shaojie Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos CJ, 1996, INTRO MYCOLOGY, P23; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; CAI YJ, 1994, MYCOL RES, V98, P1019, DOI 10.1016/S0953-7562(09)80428-0; Cai YJ, 1998, ENZYME MICROB TECH, V22, P122, DOI 10.1016/S0141-0229(97)00151-8; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen R, 2003, FOOD TECHNOL BIOTECH, V41, P339; Chen SC, 2004, FEMS MICROBIOL LETT, V230, P171, DOI 10.1016/S0378-1097(03)00878-4; Cone WJ, 2010, ADV ANIMAL BIOSCIENC, V1, P271, DOI [10.1017/S2040470010004140, DOI 10.1017/S2040470010004140]; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kues U, 2010, CURRENT TRENDS BIOTE, V4, P834; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Wang J, 2008, BIORESOURCE TECHNOL, V99, P8524, DOI 10.1016/j.biortech.2008.03.007; Zhang JX, 2009, IND SCI DEV EDIBLE F, P40; Zhao FY, 2010, BIORESOURCE TECHNOL, V101, P6482, DOI 10.1016/j.biortech.2010.03.035; Zuccaro A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002290	39	30	31	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58780	10.1371/journal.pone.0058780	http://dx.doi.org/10.1371/journal.pone.0058780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554925	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500043
J	Hardison, DR; Sunda, WG; Shea, D; Litaker, RW				Hardison, Donnie Ransom; Sunda, William G.; Shea, Damian; Litaker, Richard Wayne			Increased Toxicity of Karenia brevis during Phosphate Limited Growth: Ecological and Evolutionary Implications	PLOS ONE			English	Article							FLORIDA RED TIDE; CHEMICAL-COMPOSITION; MISSISSIPPI RIVER; NORTH-ATLANTIC; MARINE-PHYTOPLANKTON; NITROGEN LIMITATION; SODIUM-CHANNELS; HUMAN EXPOSURE; CELL-DENSITY; BREVETOXINS	Karenia brevis is the dominant toxic red tide algal species in the Gulf of Mexico. It produces potent neurotoxins (brevetoxins [PbTxs]), which negatively impact human and animal health, local economies, and ecosystem function. Field measurements have shown that cellular brevetoxin contents vary from 1-68 pg/cell but the source of this variability is uncertain. Increases in cellular toxicity caused by nutrient-limitation and inter-strain differences have been observed in many algal species. This study examined the effect of P-limitation of growth rate on cellular toxin concentrations in five Karenia brevis strains from different geographic locations. Phosphorous was selected because of evidence for regional P-limitation of algal growth in the Gulf of Mexico. Depending on the isolate, P-limited cells had 2.3- to 7.3-fold higher PbTx per cell than P-replete cells. The percent of cellular carbon associated with brevetoxins (%C-PbTx) was similar to 0.7 to 2.1% in P-replete cells, but increased to 1.6-5% under P-limitation. Because PbTxs are potent anti-grazing compounds, this increased investment in PbTxs should enhance cellular survival during periods of nutrient-limited growth. The % C-PbTx was inversely related to the specific growth rate in both the nutrient-replete and P-limited cultures of all strains. This inverse relationship is consistent with an evolutionary tradeoff between carbon investment in PbTxs and other grazing defenses, and C investment in growth and reproduction. In aquatic environments where nutrient supply and grazing pressure often vary on different temporal and spatial scales, this tradeoff would be selectively advantageous as it would result in increased net population growth rates. The variation in PbTx/cell values observed in this study can account for the range of values observed in the field, including the highest values, which are not observed under N-limitation. These results suggest P-limitation is an important factor regulating cellular toxicity and adverse impacts during at least some K. brevis blooms.	[Hardison, Donnie Ransom; Sunda, William G.; Litaker, Richard Wayne] Ctr Coastal Fisheries & Habitat Res, Natl Ocean & Atmospher Adm, Natl Ocean Serv, Beaufort, NC 28516 USA; [Hardison, Donnie Ransom; Shea, Damian] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; University of North Carolina; North Carolina State University	Hardison, DR (corresponding author), Ctr Coastal Fisheries & Habitat Res, Natl Ocean & Atmospher Adm, Natl Ocean Serv, Beaufort, NC 28516 USA.	rance.hardison@noaa.gov	Litaker, Richard Wayne/AAH-2036-2021; Shea, Damian/K-1360-2014	Litaker, Richard Wayne/0000-0001-6293-8000; Shea, Damian/0000-0003-1348-6639	National Oceanic and Atmospheric Administration (NOAA)	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA)	This project was funded by National Oceanic and Atmospheric Administration (NOAA) program funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf JE, 2009, J PHYCOL, V45, P176, DOI 10.1111/j.1529-8817.2008.00641.x; ASAI S, 1984, J ALLERGY CLIN IMMUN, V73, P824, DOI 10.1016/0091-6749(84)90454-8; Backer LC, 2005, ENVIRON HEALTH PERSP, V113, P644, DOI 10.1289/ehp.7502; Backer LC, 2009, HARMFUL ALGAE, V8, P618, DOI 10.1016/j.hal.2008.11.008; Baden D.G., 2000, FOOD SCI TECHNOL N M, P505, DOI [10.1201/9780203909539.ch23, DOI 10.1201/9780203909539.CH23]; BADEN DG, 1988, TOXICON, V26, P961, DOI 10.1016/0041-0101(88)90261-9; Baker AR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018518; Bricelj VM, 2012, HARMFUL ALGAE, V16, P27, DOI 10.1016/j.hal.2012.01.001; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; BRYANT JP, 1985, ABSTR PAP AM CHEM S, V190, P91; Cheng YS, 2005, ENVIRON HEALTH PERSP, V113, P638, DOI 10.1289/ehp.7496; Cohen JH, 2007, J PLANKTON RES, V29, P301, DOI 10.1093/plankt/fbm016; DROOP MR, 1974, J MAR BIOL ASSOC UK, V54, P825, DOI 10.1017/S002531540005760X; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Echevarria M, 2012, AQUAT TOXICOL, V106, P85, DOI 10.1016/j.aquatox.2011.10.011; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; Fu FX, 2010, AQUAT MICROB ECOL, V59, P55, DOI 10.3354/ame01396; Graneli E, 2006, ECOL STU AN, V189, P229, DOI 10.1007/978-3-540-32210-8_18; Hardison DR, 2012, J PHYCOL, V48, P844, DOI 10.1111/j.1529-8817.2012.01186.x; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Heil CA, 2007, LIMNOL OCEANOGR, V52, P1067, DOI 10.4319/lo.2007.52.3.1067; Heil DC, 2009, HARMFUL ALGAE, V8, P608, DOI 10.1016/j.hal.2008.11.007; Hill BH, 2011, WATER AIR SOIL POLL, V216, P605, DOI 10.1007/s11270-010-0556-0; Hitchcock GL, 2012, HARMFUL ALGAE, V13, P89, DOI 10.1016/j.hal.2011.10.008; Hoagland P, 2006, ECOL STU AN, V189, P391, DOI 10.1007/978-3-540-32210-8_30; Hoagland P, 2009, ENVIRON HEALTH PERSP, V117, P1239, DOI 10.1289/ehp.0900645; Hong JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036845; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Ianora A, 2006, ESTUAR COAST, V29, P531, DOI 10.1007/BF02784281; Ianora A, 2011, MAR DRUGS, V9, P1625, DOI 10.3390/md9091625; Janowitz GS, 2008, CONT SHELF RES, V28, P177, DOI 10.1016/j.csr.2007.04.016; Janowitz GS, 2006, MAR ECOL PROG SER, V314, P49, DOI 10.3354/meps314049; Jickells T, 2006, BIOGEOSCI DISC, V3, P183, DOI DOI 10.5194/BGD-3-183-2006; Johansson N, 1999, MAR BIOL, V135, P209, DOI 10.1007/s002270050618; Johansson N, 1999, J EXP MAR BIOL ECOL, V239, P243, DOI 10.1016/S0022-0981(99)00048-9; KELLER MD, 1988, J EXP MAR BIOL ECOL, V117, P279, DOI 10.1016/0022-0981(88)90063-9; Kirkpatrick B, 2004, HARMFUL ALGAE, V3, P99, DOI 10.1016/j.hal.2003.08.005; Kirkpatrick B, 2006, HARMFUL ALGAE, V5, P526, DOI 10.1016/j.hal.2005.09.004; Kirkpatrick B, 2010, HARMFUL ALGAE, V9, P186, DOI 10.1016/j.hal.2009.09.003; Kubanek J, 2005, LIMNOL OCEANOGR, V50, P883, DOI 10.4319/lo.2005.50.3.0883; Lambers H, 2008, PLANT PHYSL ECOLOGY, P413; Landsberg JH, 2009, HARMFUL ALGAE, V8, P598, DOI 10.1016/j.hal.2008.11.010; Lekan DK, 2010, HARMFUL ALGAE, V9, P39, DOI 10.1016/j.hal.2009.07.004; Lenes JM, 2001, LIMNOL OCEANOGR, V46, P1261, DOI 10.4319/lo.2001.46.6.1261; Liu HB, 2001, J PHYCOL, V37, P500, DOI 10.1046/j.1529-8817.2001.037004500.x; Mahowald NM, 2009, ANNU REV MAR SCI, V1, P245, DOI 10.1146/annurev.marine.010908.163727; Mendoza WG, 2008, CHEMOSPHERE, V73, P1373, DOI 10.1016/j.chemosphere.2008.07.089; Mitra A, 2006, BIOL LETTERS, V2, P194, DOI 10.1098/rsbl.2006.0447; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Morgan KL, 2009, HARMFUL ALGAE, V8, P212, DOI 10.1016/j.hal.2008.05.002; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pan YL, 1996, J PHYCOL, V32, P371, DOI 10.1111/j.0022-3646.1996.00371.x; Pan Youlian, 1998, Natural Toxins, V6, P127, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<127::AID-NT9>3.3.CO;2-U; Pierce R, 2008, CONT SHELF RES, V28, P45, DOI 10.1016/j.csr.2007.04.012; Pierce RH, 2008, ECOTOXICOLOGY, V17, P623, DOI 10.1007/s10646-008-0241-x; Pierce RH, 2005, HARMFUL ALGAE, V4, P965, DOI 10.1016/j.hal.2004.11.004; Plakas SM, 2010, TOXICON, V56, P137, DOI 10.1016/j.toxicon.2009.11.007; POLI MA, 1986, MOL PHARMACOL, V30, P129; Purkerson SL, 1999, NEUROTOXICOLOGY, V20, P909; Rabalais NN, 1996, ESTUARIES, V19, P386, DOI 10.2307/1352458; REDFIELD AC, 1958, AM SCI, V46, P205; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; Rivera-Monroy VH, 2011, CRIT REV ENV SCI TEC, V41, P633, DOI 10.1080/10643389.2010.530907; SAKSHAUG E, 1989, LIMNOL OCEANOGR, V34, P198, DOI 10.4319/lo.1989.34.1.0198; Schaeffer BA, 2009, J PHYCOL, V45, P154, DOI 10.1111/j.1529-8817.2008.00627.x; SERRUYA C, 1975, J PHYCOL, V11, P155, DOI 10.1111/j.1529-8817.1975.tb02764.x; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; Simpson TW, 2008, J ENVIRON QUAL, V37, P318, DOI 10.2134/jeq2007.0599; Sohm JA, 2011, NAT REV MICROBIOL, V9, P499, DOI 10.1038/nrmicro2594; Sohm JA, 2008, LIMNOL OCEANOGR, V53, P2495, DOI 10.4319/lo.2008.53.6.2495; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; Stumpf RP, 2008, CONT SHELF RES, V28, P189, DOI 10.1016/j.csr.2007.04.017; Sunda WG, 2010, MAR ECOL PROG SER, V401, P63, DOI 10.3354/meps08390; Sunda W.G., 2005, ALGAE CULTURING TECH, V4, P35, DOI [10.1016/b978-012088426-1/50005-6, DOI 10.1016/B978-012088426-1/50005-6]; Sunda WG, 2007, AQUAT SCI, V69, P341, DOI 10.1007/s00027-007-0887-0; Sunda WG, 2006, J PHYCOL, V42, P963, DOI 10.1111/j.1529-8817.2006.00261.x; Sylvan JB, 2006, ENVIRON SCI TECHNOL, V40, P7548, DOI 10.1021/es061417t; Tester PA, 1997, LIMNOL OCEANOGR, V42, P1039, DOI 10.4319/lo.1997.42.5_part_2.1039; Tester PA, 2008, CONT SHELF RES, V28, P59, DOI 10.1016/j.csr.2007.04.007; TURNER RE, 1991, BIOSCIENCE, V41, P140, DOI 10.2307/1311453; Vargo GA, 2002, HARMFUL ALGAE; Vargo GA, 2008, CONT SHELF RES, V28, P73, DOI 10.1016/j.csr.2007.04.008; Waggett RJ, 2012, MAR ECOL PROG SER, V444, P15, DOI 10.3354/meps09401; Walker ND, 2005, J COASTAL RES, V21, P1228, DOI 10.2112/04-0347.1; Walsh JJ, 2001, J GEOPHYS RES-OCEANS, V106, P11597, DOI 10.1029/1999JC000123; Watkins SM, 2008, MAR DRUGS, V6, P431, DOI [10.3390/md20080021, 10.3390/md6030431]; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	89	58	60	7	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58545	10.1371/journal.pone.0058545	http://dx.doi.org/10.1371/journal.pone.0058545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554901	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500029
J	Singh, A; Rahman, T; Malik, M; Hickey, AJ; Leifer, CA; Hazlett, KRO; Sellati, TJ				Singh, Anju; Rahman, Tabassum; Malik, Meenakshi; Hickey, Anthony J.; Leifer, Cynthia A.; Hazlett, Karsten R. O.; Sellati, Timothy J.			Discordant Results Obtained with Francisella tularensis during In Vitro and In Vivo Immunological Studies Are Attributable to Compromised Bacterial Structural Integrity	PLOS ONE			English	Article							RECEPTOR 2; INFLAMMATORY RESPONSES; AIM2 INFLAMMASOME; VIRULENCE FACTORS; DENDRITIC CELLS; IMMUNE-RESPONSE; CUTTING EDGE; MACROPHAGES; ACTIVATION; DNA	Francisella tularensis (Ft) is a highly infectious intracellular pathogen and the causative agent of tularemia. Because Ft can be dispersed via small droplet-aerosols and has a very low infectious dose it is characterized as a category A Select Agent of biological warfare. Respiratory infection with the attenuated Live Vaccine Strain (LVS) and the highly virulent SchuS4 strain of Ft engenders intense peribronchiolar and perivascular inflammation, but fails to elicit select pro-inflammatory mediators (e. g., TNF, IL-1 beta, IL-6, IL-12, and IFN-gamma) within the first similar to 72 h. This in vivo finding is discordant with the principally T(H)1-oriented response to Ft frequently observed in cell-based studies wherein the aforementioned cytokines are produced. An often overlooked confounding factor in the interpretation of experimental results is the influence of environmental cues on the bacterium's capacity to elicit certain host responses. Herein, we reveal that adaptation of Ft to its mammalian host imparts an inability to elicit select pro-inflammatory mediators throughout the course of infection. Furthermore, in vitro findings that non-host adapted Ft elicits such a response from host cells reflect aberrant recognition of the DNA of structurally-compromised bacteria by AIM2-dependent and -independent host cell cytosolic DNA sensors. Growth of Ft in Muller-Hinton Broth or on Muller-Hinton-based chocolate agar plates or genetic mutation of Ft was found to compromise the structural integrity of the bacterium thus rendering it capable of aberrantly eliciting pro-inflammatory mediators (e. g., TNF, IL-1 beta, IL-6, IL-12, and IFN-gamma). Our studies highlight the profound impact of different growth conditions on host cell response to infection and demonstrate that not all in vitro-derived findings may be relevant to tularemia pathogenesis in the mammalian host. Rational development of a vaccine and immunotherapeutics can only proceed from a foundation of knowledge based upon in vitro findings that recapitulate those observed during natural infection.	[Singh, Anju; Rahman, Tabassum; Malik, Meenakshi; Hickey, Anthony J.; Hazlett, Karsten R. O.; Sellati, Timothy J.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Leifer, Cynthia A.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	Albany Medical College; Cornell University	Sellati, TJ (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	sellatt@mail.amc.edu	Malik, Meenakshi/F-1501-2015; Sellati, Timothy/ABE-8023-2021	Malik, Meenakshi/0000-0003-0051-4485; 	US Army Research Laboratory; US Army Research Office [W911NF-11-1-0274];  [PO1AI056320];  [RO1AI075193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320, R01AI075193] Funding Source: NIH RePORTER	US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This material is based upon work supported by, or in part by, the US Army Research Laboratory and the US Army Research Office under Contract/Grant Number W911NF-11-1-0274 and by PO1AI056320 (KROH), and PO1AI056320 and RO1AI075193 (TJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Carlson PE, 2007, MICROB PATHOGENESIS, V42, P204, DOI 10.1016/j.micpath.2007.02.001; Carlson PE, 2009, J BACTERIOL, V191, P6855, DOI 10.1128/JB.00995-09; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cowley SC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00026; Faith SA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00126; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; Bass JIF, 2010, J IMMUNOL, V184, P6386, DOI 10.4049/jimmunol.0901640; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; Hong KJ, 2007, INFECT IMMUN, V75, P5338, DOI 10.1128/IAI.00561-07; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Loegering DJ, 2006, MICROB PATHOGENESIS, V41, P218, DOI 10.1016/j.micpath.2006.07.007; Lu Z, 2007, IMMUNOL LETT, V112, P92, DOI 10.1016/j.imlet.2007.07.006; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Periasamy S, 2011, J LEUKOCYTE BIOL, V90, P493, DOI 10.1189/jlb.0411197; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Ulland TK, 2010, J IMMUNOL, V185, P2670, DOI 10.4049/jimmunol.1001610; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Zarrella TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022335; Zelphati O, 1996, PHARMACEUT RES, V13, P1367, DOI 10.1023/A:1016026101195	32	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58513	10.1371/journal.pone.0058513	http://dx.doi.org/10.1371/journal.pone.0058513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554897	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500027
J	Elphick, MR; Achhala, S; Martynyuk, N				Elphick, Maurice R.; Achhala, Sufyan; Martynyuk, Natalia			The Evolution and Diversity of SALMFamide Neuropeptides	PLOS ONE			English	Article							STARFISH ASTERIAS-RUBENS; CUCUMBER HOLOTHURIA-GLABERRIMA; POLYCLONAL ANTIBODIES; TISSUE DISTRIBUTION; ECHINODERM; DROSOPHILA; MUSCLE; RELAXATION; S1; S2	The SALMFamides are a family of neuropeptides that act as muscle relaxants in echinoderms. Two types of SALMFamides have been identified: L-type (e. g. the starfish neuropeptides S1 and S2) with the C-terminal motif LxFamide (x is variable) and F-type with the C-terminal motif FxFamide. In the sea urchin Strongylocentrotus purpuratus (class Echinoidea) there are two SALMFamide genes, one encoding L-type SALMFamides and a second encoding F-type SALMFamides, but hitherto it was not known if this applies to other echinoderms. Here we report the identification of SALMFamide genes in the sea cucumber Apostichopus japonicus (class Holothuroidea) and the starfish Patiria miniata (class Asteroidea). In both species there are two SALMFamide genes: one gene encoding L-type SALMFamides (e. g. S1 in P. miniata) and a second gene encoding F-type SALMFamides plus one or more L-type SALMFamides (e. g. S2-like peptide in P. miniata). Thus, the ancestry of the two SALMFamide gene types traces back to the common ancestor of echinoids, holothurians and asteroids, although it is not clear if the occurrence of L-type peptides in F-type SALMFamide precursors is an ancestral or derived character. The gene sequences also reveal a remarkable diversity of SALMFamide neuropeptides. Originally just two peptides (S1 and S2) were isolated from starfish but now we find that in P. miniata, for example, there are sixteen putative SALMFamide neuropeptides. Thus, the SALMFamides would be a good model system for experimental analysis of the physiological significance of neuropeptide "cocktails" derived from the same precursor protein.	[Elphick, Maurice R.; Achhala, Sufyan; Martynyuk, Natalia] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of London; Queen Mary University London	Elphick, MR (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	m.r.elphick@qmul.ac.uk		Elphick, Maurice/0000-0002-9169-0048				BRADBURY AF, 1982, NATURE, V298, P686, DOI 10.1038/298686a0; Burke RD, 2006, DEV BIOL, V300, P434, DOI 10.1016/j.ydbio.2006.08.007; Deber CM, 2001, PROLINE RESIDUES PRO; DIAZMIRANDA L, 1995, COMP BIOCHEM PHYS C, V110, P171, DOI 10.1016/0742-8413(94)00094-Q; DIAZMIRANDA L, 1992, BIOL BULL, V182, P241, DOI 10.2307/1542117; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Elphick MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044492; Elphick MR, 2005, J EXP BIOL, V208, P4273, DOI 10.1242/jeb.01910; Elphick MR, 2001, J EXP BIOL, V204, P875; ELPHICK MR, 1995, J EXP BIOL, V198, P2519; ELPHICK MR, 1991, P ROY SOC B-BIOL SCI, V243, P121, DOI 10.1098/rspb.1991.0020; ELPHICK MR, 1991, PEPTIDES, V12, P455, DOI 10.1016/0196-9781(91)90083-2; Grimmelikhuijzen CJP, 2012, REGUL PEPTIDES, V177, pS6, DOI 10.1016/j.regpep.2012.05.001; Hewes RS, 1998, J NEUROSCI, V18, P7138; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Melarange R, 2003, J EXP BIOL, V206, P893, DOI 10.1242/jeb.00197; Melarange R, 1999, P ROY SOC B-BIOL SCI, V266, P1785, DOI 10.1098/rspb.1999.0847; Mita M, 2004, ZOOL SCI, V21, P299, DOI 10.2108/zsj.21.299; NEWMAN SJ, 1995, P ROY SOC B-BIOL SCI, V261, P187, DOI 10.1098/rspb.1995.0135; NEWMAN SJ, 1995, P ROY SOC B-BIOL SCI, V261, P139, DOI 10.1098/rspb.1995.0128; Ohtani M, 1999, PEPTIDE SCIENCE - PRESENT AND FUTURE, P419; Pisani D, 2012, MOL PHYLOGENET EVOL, V62, P27, DOI 10.1016/j.ympev.2011.08.028; Priyam A., SEQUENCESERVER UNPUB; Rowe ML, 2012, GEN COMP ENDOCR, V179, P331, DOI 10.1016/j.ygcen.2012.09.009; Rowe ML, 2010, MAR GENOM, V3, P91, DOI 10.1016/j.margen.2010.08.003; Strand FL, 1999, NEUROPEPTIDES REGULA; Veenstra JA, 2011, GEN COMP ENDOCR, V171, P160, DOI 10.1016/j.ygcen.2011.01.005; Wegener C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r131; WEISS KR, 1993, J PHYSIOLOGY-PARIS, V87, P141, DOI 10.1016/0928-4257(93)90025-O; Yun SS, 2007, COMP BIOCHEM PHYS A, V147, P536, DOI 10.1016/j.cbpa.2007.02.002	30	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59076	10.1371/journal.pone.0059076	http://dx.doi.org/10.1371/journal.pone.0059076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536859	gold, Green Published, Green Submitted			2022-12-25	WOS:000316251100119
J	Lu, D; Han, C; Wu, T				Lu, D.; Han, C.; Wu, T.			15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE(2)/PPAR gamma-mediated activation of p21(WAF1/Cip1)	ONCOGENE			English	Article						hepatocellular carcinoma (HCC); 15-hydroxyprostaglandin dehydrogenase (15-PGDH); 15-keto-PGE(2); p21; PPAR gamma; liver	15-HYDROXYPROSTAGLANDIN DEHYDROGENASE EXPRESSION; PCNA BINDING DOMAINS; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; LUNG-CANCER; GASTRIC-CANCER; RENAL-FUNCTION; BETA-CATENIN; FATTY-ACIDS; PPAR-GAMMA	15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is a key enzyme in prostaglandin (PG) metabolism. This study provides important evidence for inhibition of hepatocellular carcinoma (HCC) growth by 15-PGDH through the 15-keto-prostaglandin E-2 (15-keto-PGE(2))/peroxisome proliferator-activated receptor-gamma (PPAR gamma)/p21(WAF1/Cip1) signaling pathway. Forced overexpression of 15-PGDH inhibited HCC cell growth in vitro, whereas knockdown of 15-PGDH enhanced tumor growth parameters. In a tumor xenograft model in severe combined immunodeficiency mice, inoculation of human HCC cells (Huh7) with overexpression of 15-PGDH led to significant inhibition of tumor growth, whereas knockdown of 15-PGDH enhanced tumor growth. In a separate tumor xenograft model in which mouse HCC cells (Hepa1-6) were inoculated into syngeneic C57BL/6 mice, intratumoral injection of adenovirus vector expressing 15-PGDH (pAd-15-PGDH) significantly inhibited xenograft tumor growth. The antitumor effect of 15-PGDH is mediated through its enzymatic product, 15-keto-PGE(2), which serves as an endogenous PPAR gamma ligand. Activation of PPAR gamma by 15-PGDH-derived 15-keto-PGE(2) enhanced the association of PPAR gamma with the p21(WAF1/Cip1) promoter and increased p21 expression and association with cyclin-dependent kinase 2 (CDK2), CDK4 and proliferating cell nuclear antigen. Depletion of p21 by short hairpin RNA reversed 15-PGDH-induced inhibition of HCC cell growth; overexpression of p21 prevented 15-PGDH knockdown-induced tumor cell growth. These results show a key 15-PGDH/15-keto-PGE(2)-mediated activation of PPAR gamma and p21WAF1/Cip1 signaling cascade that regulates hepatocarcinogenesis and tumor progression.	[Lu, D.; Han, C.; Wu, T.] Tulane Univ, Sch Med, Dept Pathol, New Orleans, LA 70112 USA; [Lu, D.; Han, C.; Wu, T.] Tulane Univ, Sch Med, Lab Med, New Orleans, LA 70112 USA; [Lu, D.] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tulane University; Tulane University; Tongji University	Wu, T (corresponding author), Tulane Univ, Sch Med, Dept Pathol, 1430 Tulane Ave,SL-79, New Orleans, LA 70112 USA.	twu@tulane.edu			National Institutes of Health [CA102325, CA106280, CA134568, DK077776]; NATIONAL CANCER INSTITUTE [R01CA134568, R01CA102325, R01CA106280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK077776, R01DK077776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Hsin-Hsiung Tai at the University of Kentucky for providing the 15-PGDH-adenoviral vector. This work was supported by National Institutes of Health grants CA102325, CA106280, CA134568 and DK077776.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Backlund MG, 2005, J BIOL CHEM, V280, P3217, DOI 10.1074/jbc.M411221200; Backlund MG, 2008, CANCER RES, V68, P9331, DOI 10.1158/0008-5472.CAN-08-2893; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Bosch-Marce M, 1999, GASTROENTEROLOGY, V116, P1167, DOI 10.1016/S0016-5085(99)70020-X; Breinig M, 2007, CURR PHARM DESIGN, V13, P3305, DOI 10.2174/138161207782360627; Cervello M, 2006, WORLD J GASTROENTERO, V12, P5113; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chou WL, 2007, J BIOL CHEM, V282, P18162, DOI 10.1074/jbc.M702289200; Claria J, 2005, HEPATOLOGY, V41, P579, DOI 10.1002/hep.20595; Couzin J, 2004, SCIENCE, V306, P1673, DOI 10.1126/science.306.5702.1673; Ding YF, 2005, CARCINOGENESIS, V26, P65, DOI 10.1093/carcin/bgh277; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Eruslanov E, 2009, J IMMUNOL, V182, P7548, DOI 10.4049/jimmunol.0802358; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Frank B, 2011, CARCINOGENESIS, V32, P190, DOI 10.1093/carcin/bgq231; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Huang GS, 2008, CANCER RES, V68, P5040, DOI 10.1158/0008-5472.CAN-07-6575; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kaliberova LN, 2009, MOL CANCER THER, V8, P3130, DOI 10.1158/1535-7163.MCT-09-0270; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Lim K, 2008, CANCER RES, V68, P553, DOI 10.1158/0008-5472.CAN-07-2295; Lim K, 2009, MOL CANCER THER, V8, P3046, DOI 10.1158/1535-7163.MCT-09-0551; Liu ZX, 2008, CARCINOGENESIS, V29, P1219, DOI 10.1093/carcin/bgm297; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; Moore AE, 2009, CARCINOGENESIS, P30; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Rousseau D, 1999, ONCOGENE, V18, P4313, DOI 10.1038/sj.onc.1202686; Starostina NG, 2012, TRENDS CELL BIOL, V22, P33, DOI 10.1016/j.tcb.2011.10.004; Tai HH, 2011, CANCER METAST REV, V30, P409, DOI 10.1007/s10555-011-9314-z; Tatsuwaki H, 2010, CANCER SCI, V101, P550, DOI 10.1111/j.1349-7006.2009.01390.x; Thiel A, 2009, CLIN CANCER RES, V15, P4572, DOI 10.1158/1078-0432.CCR-08-2518; Tong M, 2006, CARCINOGENESIS, V27, P2170, DOI 10.1093/carcin/bgl053; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tseng-Rogenski S, 2010, AM J PATHOL, V176, P1462, DOI 10.2353/ajpath.2010.090875; Vanchieri C, 2004, J NATL CANCER I, V96, P1734, DOI 10.1093/jnci/96.23.1734; Wakimoto N, 2008, CANCER RES, V68, P6978, DOI 10.1158/0008-5472.CAN-07-5675; Wolf I, 2006, CANCER RES, V66, P7818, DOI 10.1158/0008-5472.CAN-05-4368; Wu T, 2006, CANCER TREAT REV, V32, P28, DOI 10.1016/j.ctrv.2005.10.004; Yan M, 2009, P NATL ACAD SCI USA, V106, P9409, DOI 10.1073/pnas.0902367106; Yang L, 2007, CANCER RES, V67, P5587, DOI 10.1158/0008-5472.CAN-06-2287	44	32	33	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 27	2014	33	9					1101	1112		10.1038/onc.2013.69	http://dx.doi.org/10.1038/onc.2013.69			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XT	23542179	Green Accepted			2022-12-25	WOS:000331933800004
J	Li, B; Shi, YQ; Shu, JH; Gao, JL; Wu, P; Tang, SJ				Li, Bei; Shi, Yuqiang; Shu, Jianhong; Gao, Junling; Wu, Ping; Tang, Shao-Jun			Wingless-type Mammary Tumor Virus Integration Site Family, Member 5A (Wnt5a) Regulates Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Glycoprotein 120 (gp120)-induced Expression of Pro-Inflammatory Cytokines via the Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) and c-Jun N-terminal Kinase (JNK) Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; COAT PROTEIN; MECHANICAL ALLODYNIA; FRIZZLED HOMOLOGS; PROINFLAMMATORY CYTOKINES; PAIN FACILITATION; ARACHIDONIC-ACID; NMDA RECEPTORS; DORSAL-HORN; STEM-CELLS	Chronic expression of pro-inflammatory cytokines critically contributes to the pathogenesis of HIV-associated neurological disorders (HANDs), but the host mechanism that regulates the HIV-induced cytokine expression in the CNS remains elusive. Here, we present evidence for a crucial role of Wnt5a signaling in the expression of pro-inflammatory cytokines in the spinal cord induced by a major HIV-envelope protein, gp120. Wnt5a is mainly expressed in spinal neurons, and rapidly up-regulated by intrathecal injection (i.t.) of gp120. We show that inhibition of Wnt5a by specific antagonists blocks gp120-induced up-regulation of IL-1 beta, IL-6, and TNF-alpha in the spinal cord. Conversely, injection (i.t.) of purified recombinant Wnt5a stimulates the expression of these cytokines. To elucidate the role of the Wnt5a-regulated signaling pathways in gp120-induced cytokine expression, we have focused on CaMKII and JNKs, the well characterized down-stream targets of Wnt5a signaling. We find that Wnt5a is required for gp120 to activate CaMKII and JNK signaling. Furthermore, we demonstrate that the Wnt5a/CaM-KII pathway is critical for the gp120-induced expression of IL-1 beta, whereas the Wnt5a/JNK pathway is for TNF-alpha expression. Meanwhile, the expression of IL-6 is co-regulated by both pathways. These results collectively suggest that Wnt5a signaling cascades play a crucial role in the regulation of gp120-induced expression of pro-inflammatory cytokines in the CNS.	[Li, Bei; Shi, Yuqiang; Shu, Jianhong; Gao, Junling; Wu, Ping; Tang, Shao-Jun] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Li, Bei] Hainan Prov Inst Drug Control, Haikou 570216, Hainan, Peoples R China; [Shu, Jianhong] Zhejiang Sci Tech Univ, Inst Biochem, Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou 310018, Peoples R China	University of Texas System; University of Texas Medical Branch Galveston; Zhejiang Sci-Tech University	Tang, SJ (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	shtang@utmb.edu			National Institutes of Health [R01-NS079166]; University of Texas Medical Branch; Whitehall Foundation; John Dunn Foundation; TIRR Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Medical Branch; Whitehall Foundation; John Dunn Foundation; TIRR Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported, in whole or in part, by National Institutes of Health Grants R01-NS079166 (to S. J. T.), the University of Texas Medical Branch Start-up Funds, the Whitehall Foundation, and the John Dunn Foundation and TIRR Foundation (to P. W.).	ALOISI F, 1992, J IMMUNOL, V149, P2358; Barks JDE, 1997, NEUROSCIENCE, V76, P397, DOI 10.1016/S0306-4522(96)00373-9; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BERNARDO A, 1994, CELL MOL NEUROBIOL, V14, P159, DOI 10.1007/BF02090782; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cerpa W, 2011, J NEUROSCI, V31, P9466, DOI 10.1523/JNEUROSCI.6311-10.2011; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Dreyer EB, 1995, EUR J NEUROSCI, V7, P2502, DOI 10.1111/j.1460-9568.1995.tb01048.x; Endo M, 2012, J CELL SCI, V125, P2017, DOI 10.1242/jcs.097782; Gemignani A, 2000, EUR J NEUROSCI, V12, P2839, DOI 10.1046/j.1460-9568.2000.00172.x; George SJ, 2008, ARTERIOSCL THROM VAS, V28, P400, DOI 10.1161/ATVBAHA.107.160952; Giunta B, 2004, BRAIN RES BULL, V64, P165, DOI 10.1016/j.brainresbull.2004.06.008; Giunta B., 2008, HDB NEUROCHEMISTRY M, P407; Grovit-Ferbas K, 2010, IMMUNOL RES, V48, P40, DOI 10.1007/s12026-010-8166-x; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Holguin A, 2004, PAIN, V110, P517, DOI 10.1016/j.pain.2004.02.018; Hughes KR, 2011, INFLAMM BOWEL DIS, V17, P213, DOI 10.1002/ibd.21353; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Iskander S, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-7; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kraft-Terry SD, 2009, NEURON, V64, P133, DOI 10.1016/j.neuron.2009.09.042; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Lee I, 2007, PAIN, V133, P9, DOI 10.1016/j.pain.2007.01.035; Li B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022920; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu XH, 2008, DIGEST LIVER DIS, V40, P560, DOI 10.1016/j.dld.2007.12.011; Loram LC, 2010, BRAIN BEHAV IMMUN, V24, P959, DOI 10.1016/j.bbi.2010.03.008; Louboutin JP, 2011, EUR J NEUROSCI, V34, P2015, DOI 10.1111/j.1460-9568.2011.07908.x; Louboutin JP, 2010, EXP NEUROL, V221, P231, DOI 10.1016/j.expneurol.2009.11.004; MERRILL JE, 1991, FASEB J, V5, P2391, DOI 10.1096/fasebj.5.10.2065887; Milligan ED, 2001, J NEUROSCI, V21, P2808, DOI 10.1523/JNEUROSCI.21-08-02808.2001; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; PATRIZIO M, 1994, NEUROSCI LETT, V178, P184, DOI 10.1016/0304-3940(94)90755-2; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pugh CR, 2000, BRAIN RES, V861, P8, DOI 10.1016/S0006-8993(99)02445-2; Rao JS, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-101; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; SAWADA M, 1992, BRAIN RES, V583, P296, DOI 10.1016/S0006-8993(10)80037-X; Schoeniger-Skinner DK, 2007, BRAIN BEHAV IMMUN, V21, P660, DOI 10.1016/j.bbi.2006.10.010; Schwartz ES, 2009, J NEUROSCI, V29, P159, DOI 10.1523/JNEUROSCI.3792-08.2009; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2001, ARTHRITIS RHEUM, V44, P772, DOI 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.3.CO;2-C; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Shah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021261; Shah A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-96; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shi YQ, 2012, J NEUROSCI, V32, P10833, DOI 10.1523/JNEUROSCI.5628-11.2012; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wagner JA, 1996, J EXP MED, V183, P2417, DOI 10.1084/jem.183.6.2417; Wallace DR, 2006, SYNAPSE, V59, P51, DOI 10.1002/syn.20214; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Wu CY, 2009, GLIA, V57, P1775, DOI 10.1002/glia.20890; Xu HX, 2011, J NEUROSCI, V31, P17074, DOI 10.1523/JNEUROSCI.4072-11.2011; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004	68	42	48	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13610	13619		10.1074/jbc.M112.381046	http://dx.doi.org/10.1074/jbc.M112.381046			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539626	hybrid, Green Published			2022-12-25	WOS:000318850300043
J	Rodriguez, Y; Smerdon, MJ				Rodriguez, Yesenia; Smerdon, Michael J.			The Structural Location of DNA Lesions in Nucleosome Core Particles Determines Accessibility by Base Excision Repair Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; POLYMERASE-BETA; CROSS-LINKING; CATALYTIC MECHANISM; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURES; SEQUENCE CONTEXT; MAMMALIAN-CELLS; URACIL RESIDUES; GLYCOSYLASE	Packaging of DNA into chromatin affects accessibility of DNA regulatory factors involved in transcription, replication, and repair. Evidence suggests that even in the nucleosome core particle (NCP), accessibility to damaged DNA is hindered by the presence of the histone octamer. Base excision repair is the major pathway in mammalian cells responsible for correcting a large number of chemically modified bases. We have measured the repair of site-specific uracil and single nucleotide gaps along the surface of the NCP. Our results indicate that removal of DNA lesions is greatly dependent on their rotational and translational positioning in NCPs. Significantly, the rate of uracil removal with outwardly oriented DNA backbones is 2-10-fold higher than those with inwardly oriented backbones. In general, uracils with inwardly oriented backbones farther away from the dyad center of the NCP are more accessible than those near the dyad. The translational positioning of outwardly oriented gaps is the key factor driving gap filling activity. An outwardly oriented gap near the DNA ends exhibits a 3-fold increase in gap filling activity as compared with one near the dyad with the same rotational orientation. Near the dyad, uracil DNA glycosylase/APE1 removes an outwardly oriented uracil efficiently; however, polymerase beta activity is significantly inhibited at this site. These data suggest that the hindrance presented by the location of a DNA lesion is dependent on the structural requirements for enzyme catalysis. Therefore, remodeling at DNA damage sites in NCPs is critical for preventing accumulation of aborted intermediates and ensuring completion of base excision repair.	[Rodriguez, Yesenia] Washington State Univ, Sch Mol Biosci, Dept Pharmaceut Sci, Pullman, WA 99164 USA; [Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University; Washington State University	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	smerdon@wsu.edu			National Institutes of Health from the NIEHS [ES004106]; NIGMS [T32GM008336]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health from the NIEHS; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES004106 from the NIEHS (to M. J. S.) and Training Award T32GM008336 from NIGMS.	Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Baute J, 2008, CRIT REV BIOCHEM MOL, V43, P239, DOI 10.1080/10409230802309905 ; Beard BC, 2005, DNA REPAIR, V4, P203, DOI 10.1016/j.dnarep.2004.09.011; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Berquist BR, 2008, J MOL BIOL, V379, P17, DOI 10.1016/j.jmb.2008.03.053; Cai Y, 2010, BIOCHEMISTRY-US, V49, P9943, DOI 10.1021/bi101560y; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Cole HA, 2010, J BIOL CHEM, V285, P2876, DOI 10.1074/jbc.M109.073544; Dalal S, 2008, BIOCHEMISTRY-US, V47, P12118, DOI 10.1021/bi8011548; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Donigan KA, 2009, MOL CARCINOGEN, V48, P362, DOI 10.1002/mc.20497; Donny W, 2004, J BIOL CHEM, V279, P25268, DOI 10.1074/jbc.M400804200; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; EFTEDAL I, 1993, NUCLEIC ACIDS RES, V21, P2095, DOI 10.1093/nar/21.9.2095; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Friedberg EC, 2005, DNA REPAIR MUTAGENES, P169; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Gansen A, 2009, J PHYS CHEM B, V113, P2604, DOI 10.1021/jp7114737; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hinz JM, 2010, P NATL ACAD SCI USA, V107, P4646, DOI 10.1073/pnas.0914443107; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Huggins CF, 2002, MOL CELL, V10, P1201, DOI 10.1016/S1097-2765(02)00736-0; JACKSON V, 1978, CELL, V15, P945, DOI 10.1016/0092-8674(78)90278-7; Kosmoski JV, 1999, BIOCHEMISTRY-US, V38, P9485, DOI 10.1021/bi990297h; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Liu YA, 2007, J BIOL CHEM, V282, P13532, DOI 10.1074/jbc.M611295200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Menoni H, 2007, MOL CELL BIOL, V27, P5949, DOI 10.1128/MCB.00376-07; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; NILSEN H, 1995, FEBS LETT, V362, P205, DOI 10.1016/0014-5793(95)00244-4; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Prasad R, 2010, J BIOL CHEM, V285, P40479, DOI 10.1074/jbc.M110.155267; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Schroeder JC, 2003, CANCER RES, V63, P7530; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Tan S, 2011, CURR OPIN STRUC BIOL, V21, P128, DOI 10.1016/j.sbi.2010.11.006; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Tims HS, 2007, METHODS, V41, P296, DOI 10.1016/j.ymeth.2007.01.001; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; TULLIUS TD, 1991, FREE RADICAL RES COM, V12-3, P521; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Wei Q., 2007, DNA REPAIR GENETIC I, P376; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0; Ye Y, 2012, BIOCHEMISTRY-US, V51, P6028, DOI 10.1021/bi3006412; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	67	66	66	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13863	13875		10.1074/jbc.M112.441444	http://dx.doi.org/10.1074/jbc.M112.441444			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23543741	Green Published, hybrid			2022-12-25	WOS:000318850300067
J	Job, ER; Bottazzi, B; Gilbertson, B; Edenborough, KM; Brown, LE; Mantovani, A; Brooks, AG; Reading, PC				Job, Emma R.; Bottazzi, Barbara; Gilbertson, Brad; Edenborough, Kathryn M.; Brown, Lorena E.; Mantovani, Alberto; Brooks, Andrew G.; Reading, Patrick C.			Serum Amyloid P Is a Sialylated Glycoprotein Inhibitor of Influenza A Viruses	PLOS ONE			English	Article							SURFACTANT PROTEIN-D; MANNOSE-BINDING LECTIN; C-REACTIVE PROTEIN; CARBOHYDRATE-RECOGNITION DOMAIN; HEMAGGLUTININ RECEPTOR-BINDING; LONG PENTRAXIN PTX3; INNATE IMMUNITY; SIALIC ACIDS; IN-VITRO; ANTIVIRAL ACTIVITY	Members of the pentraxin family, including PTX3 and serum amyloid P component (SAP), have been reported to play a role in innate host defence against a range of microbial pathogens, yet little is known regarding their antiviral activities. In this study, we demonstrate that human SAP binds to human influenza A virus (IAV) strains and mediates a range of antiviral activities, including inhibition of IAV-induced hemagglutination (HA), neutralization of virus infectivity and inhibition of the enzymatic activity of the viral neuraminidase (NA). Characterization of the anti-IAV activity of SAP after periodate or bacterial sialidase treatment demonstrated that alpha(2,6)-linked sialic acid residues on the glycosidic moiety of SAP are critical for recognition by the HA of susceptible IAV strains. Other proteins of the innate immune system, namely human surfactant protein A and porcine surfactant protein D, have been reported to express sialylated glycans which facilitate inhibition of particular IAV strains, yet the specific viral determinants for recognition of these inhibitors have not been defined. Herein, we have selected virus mutants in the presence of human SAP and identified specific residues in the receptor-binding pocket of the viral HA which are critical for recognition and therefore susceptibility to the antiviral activities of SAP. Given the widespread expression of alpha(2,6)-linked sialic acid in the human respiratory tract, we propose that SAP may act as an effective receptor mimic to limit IAV infection of airway epithelial cells.	[Job, Emma R.; Gilbertson, Brad; Edenborough, Kathryn M.; Brown, Lorena E.; Brooks, Andrew G.; Reading, Patrick C.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Bottazzi, Barbara; Mantovani, Alberto] Humanitas Clin & Res Ctr, Lab Res Immunol & Inflammat, Milan, Italy; [Mantovani, Alberto] Univ Milan, Dept Translat Med, Milan, Italy; [Reading, Patrick C.] WHO Collaborating Ctr Reference & Res Influenza, North Melbourne, Vic, Australia	University of Melbourne; University of Milan; World Health Organization	Reading, PC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	preading@unimelb.edu.au	bottazzi, barbara/ABH-9274-2020; Mantovani, Alberto/HCI-7449-2022; Edenborough, Kathryn/K-2626-2019	bottazzi, barbara/0000-0002-1930-9257; Mantovani, Alberto/0000-0001-5578-236X; Edenborough, Kathryn/0000-0002-9598-5740; Brooks, Andrew/0000-0002-4085-9683; Brown, Lorena/0000-0001-9342-909X; Reading, Patrick/0000-0002-8860-5308; Gilbertson, Brad/0000-0001-7921-0032	National Health and Medical Research Council (NHMRC) of Australia [1032079]; Australian Government Department of Health and Ageing; European Research Council (ERC project HIIS); European Commission [FP7-HEALTH-2011-ADITEC-280873]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); European Research Council (ERC project HIIS); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Project Grant #1032079 from the National Health and Medical Research Council (NHMRC) of Australia. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The financial support of the European Research Council (ERC project HIIS) and of the European Commission (FP7-HEALTH-2011-ADITEC-280873) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS EM, 1994, J GEN VIROL, V75, P615, DOI 10.1099/0022-1317-75-3-615; ANDERS EM, 1986, J VIROL, V60, P476, DOI 10.1128/JVI.60.2.476-482.1986; Anders EM, 1990, PNAS, V87; Andersen O, 1997, SCAND J IMMUNOL, V46, P331, DOI 10.1046/j.1365-3083.1997.d01-147.x; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BALTZ ML, 1982, BIOCHIM BIOPHYS ACTA, V701, P229, DOI 10.1016/0167-4838(82)90118-2; BENNE CA, 1995, J INFECT DIS, V171, P335, DOI 10.1093/infdis/171.2.335; Bottazzi B, 2006, CURR OPIN IMMUNOL, V18, P10, DOI 10.1016/j.coi.2005.11.009; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; BROWN LE, 1982, MOL IMMUNOL, V19, P329, DOI 10.1016/0161-5890(82)90347-9; Chang WC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-64; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; CORFIELD AP, 1983, BIOCHIM BIOPHYS ACTA, V744, P121, DOI 10.1016/0167-4838(83)90080-8; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; Das T, 2004, GLYCOCONJUGATE J, V20, P537; Das T, 2003, BIOCHEM J, V373, P345, DOI 10.1042/BJ20021701; Dean MM, 2006, MOL IMMUNOL, V43, P950, DOI 10.1016/j.molimm.2005.06.023; Deban L, 2009, BIOFACTORS, V35, P138, DOI 10.1002/biof.21; DONG AC, 1994, J BIOL CHEM, V269, P6424; DWEK RA, 1993, ANNU REV BIOCHEM, V62, P65, DOI 10.1146/annurev.bi.62.070193.000433; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; Farberman MM, 2010, EUR RESPIR J, V35, P410, DOI 10.1183/09031936.00020809; Fidler KJ, 2009, THORAX, V64, P150, DOI 10.1136/thx.2008.100073; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gomi K, 2004, CHEST, V126, P95, DOI 10.1378/chest.126.1.95; Gottschalk A., 1972, GLYCOPROTEINS THEIR; Haagsman HP, 2008, NEONATOLOGY, V93, P288, DOI 10.1159/000121454; HANAOKA K, 1989, J BIOL CHEM, V264, P9842; HARTLEY CA, 1992, J VIROL, V66, P4358, DOI 10.1128/JVI.66.7.4358-4363.1992; Hartshorn KL, 2006, BIOCHEM J, V393, P545, DOI 10.1042/BJ20050695; Hartshorn KL, 2003, AM J PHYSIOL-LUNG C, V285, pL1066, DOI 10.1152/ajplung.00057.2003; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Hawgood S, 2004, J VIROL, V78, P8565, DOI 10.1128/JVI.78.16.8565-8572.2004; HAWKINS PN, 1991, CLIN EXP IMMUNOL, V84, P308; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Herbert J, 2002, MOL MED, V8, P9, DOI 10.1007/BF03401998; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Horvath A, 2001, ANTIVIR RES, V52, P43, DOI 10.1016/S0166-3542(01)00158-9; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Inforzato A, 2006, BIOCHEMISTRY-US, V45, P11540, DOI 10.1021/bi0607453; Jambo KC, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-42; Jayaraman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027517; Kase T, 1999, IMMUNOLOGY, V97, P385; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; KOTTGEN E, 1992, J IMMUNOL, V149, P445; Krizanova O, 1969, Curr Top Microbiol Immunol, V47, P125; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Manfredi AA, 2008, CURR OPIN IMMUNOL, V20, P538, DOI 10.1016/j.coi.2008.05.004; Mikerov AN, 2008, MED MICROBIOL IMMUN, V197, P9, DOI 10.1007/s00430-007-0051-4; Moreira AP, 2010, J ALLERGY CLIN IMMUN, V126, P712, DOI 10.1016/j.jaci.2010.06.010; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Ng WC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/732191; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; PEPYS MB, 1994, P NATL ACAD SCI USA, V91, P5602, DOI 10.1073/pnas.91.12.5602; PRITCHETT TJ, 1989, J BIOL CHEM, V264, P9850; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Ryan-Poirier K, 1998, VIRUS RES, V56, P169, DOI 10.1016/S0168-1702(98)00067-7; Schauer R, 2000, GLYCOCONJUGATE J, V17, P485, DOI 10.1023/A:1011062223612; SUZUKI Y, 1986, J BIOL CHEM, V261, P7057; SWEET C, 1980, MICROBIOL REV, V44, P303, DOI 10.1128/MMBR.44.2.303-330.1980; Tate MD, 2011, MICROBES INFECT, V13, P202, DOI 10.1016/j.micinf.2010.10.004; Tecle T, 2007, ARCH VIROL, V152, P1731, DOI 10.1007/s00705-007-0983-4; Tecle T, 2008, BIOCHEM J, V412, P323, DOI 10.1042/BJ20071663; TENNENT GA, 1994, BIOCHEM SOC T, V22, P74, DOI 10.1042/bst0220074; Thompson D, 2002, J MOL BIOL, V320, P1081, DOI 10.1016/S0022-2836(02)00514-4; van Eijk M, 2004, AM J RESP CELL MOL, V30, P871, DOI 10.1165/rcmb.2003-0355OC; van Eijk M, 2003, J IMMUNOL, V171, P1431, DOI 10.4049/jimmunol.171.3.1431; van Eijk M, 2002, AM J RESP CELL MOL, V26, P739, DOI 10.1165/ajrcmb.26.6.4520; Verma A, 2012, J IMMUNOL, V189, P2478, DOI 10.4049/jimmunol.1103786; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; White MR, 2004, AM J PHYSIOL-LUNG C, V288, P831; Wilks S, 2012, VACCINE, V30, P4369, DOI 10.1016/j.vaccine.2012.02.076	78	34	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59623	10.1371/journal.pone.0059623	http://dx.doi.org/10.1371/journal.pone.0059623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544079	Green Submitted, gold, Green Published			2022-12-25	WOS:000317480700039
J	Leff, JW; Fierer, N				Leff, Jonathan W.; Fierer, Noah			Bacterial Communities Associated with the Surfaces of Fresh Fruits and Vegetables	PLOS ONE			English	Article							MICROBIOLOGICAL QUALITY; DIVERSITY; SALMONELLA; MICROFLORA; ECOLOGY; UNIFRAC	Fresh fruits and vegetables can harbor large and diverse populations of bacteria. However, most of the work on produce-associated bacteria has focused on a relatively small number of pathogenic bacteria and, as a result, we know far less about the overall diversity and composition of those bacterial communities found on produce and how the structure of these communities varies across produce types. Moreover, we lack a comprehensive view of the potential effects of differing farming practices on the bacterial communities to which consumers are exposed. We addressed these knowledge gaps by assessing bacterial community structure on conventional and organic analogs of eleven store-bought produce types using a culture-independent approach, 16 S rRNA gene pyrosequencing. Our results demonstrated that the fruits and vegetables harbored diverse bacterial communities, and the communities on each produce type were significantly distinct from one another. However, certain produce types (i.e., sprouts, spinach, lettuce, tomatoes, peppers, and strawberries) tended to share more similar communities as they all had high relative abundances of taxa belonging to the family Enterobacteriaceae when compared to the other produce types (i.e., apples, peaches, grapes, and mushrooms) which were dominated by taxa belonging to the Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria phyla. Although potentially driven by factors other than farming practice, we also observed significant differences in community composition between conventional and organic analogs within produce types. These differences were often attributable to distinctions in the relative abundances of Enterobacteriaceae taxa, which were generally less abundant in organically-grown produce. Taken together, our results suggest that humans are exposed to substantially different bacteria depending on the types of fresh produce they consume with differences between conventionally and organically farmed varieties contributing to this variation.	[Leff, Jonathan W.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Fierer, N (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	Noah.Fierer@colorado.edu		FIERER, NOAH/0000-0002-6432-4261; Leff, Jonathan/0000-0003-3309-2709	Alfred P. Sloan Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was supported with funding from the Alfred P. Sloan Foundation's Microbiology of the Built Environment Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadias M, 2008, INT J FOOD MICROBIOL, V123, P121, DOI 10.1016/j.ijfoodmicro.2007.12.013; Badosa E, 2008, J SCI FOOD AGR, V88, P605, DOI 10.1002/jsfa.3124; Beuchat LR, 1996, J FOOD PROTECT, V59, P204, DOI 10.4315/0362-028X-59.2.204; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Coutinho TA, 2009, MOL PLANT PATHOL, V10, P325, DOI [10.1111/j.1364-3703.2009.00542.x, 10.1111/J.1364-3703.2009.00542.X]; Critzer FJ, 2010, CURR OPIN BIOTECH, V21, P125, DOI 10.1016/j.copbio.2010.01.006; Dastager SG, 2009, LETT APPL MICROBIOL, V49, P20, DOI 10.1111/j.1472-765X.2009.02616.x; Enya J, 2007, MICROB ECOL, V53, P524, DOI 10.1007/s00248-006-9085-1; Fatica MK, 2011, VIRULENCE, V2, P573, DOI 10.4161/viru.2.6.17880; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Flores GL, 2012, ENV MICROBI IN PRESS; Gitaitis RD, 1997, PLANT DIS, V81, P1096, DOI 10.1094/PDIS.1997.81.9.1096C; Gram L, 2002, INT J FOOD MICROBIOL, V78, P79, DOI 10.1016/S0168-1605(02)00233-7; Granado J, 2008, MICROB ECOL, V56, P720, DOI 10.1007/s00248-008-9391-x; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Harris L.J., 2003, COMPR REV FOOD SCI F, V2, P78, DOI [10.1111/j.1541-4337.2003.tb00031, DOI 10.1111/J.1541-4337.2003.TB00031]; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; Kim M, 2012, MICROB ECOL, V63, P674, DOI 10.1007/s00248-011-9953-1; KING AD, 1991, J FOOD SCI, V56, P459, DOI 10.1111/j.1365-2621.1991.tb05303.x; Kroupitski Y, 2011, FOOD MICROBIOL, V28, P990, DOI 10.1016/j.fm.2011.01.007; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Liao CS, 2001, J FOOD PROTECT, V64, P1110, DOI 10.4315/0362-028X-64.8.1110; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; NGUYENTHE C, 1994, CRIT REV FOOD SCI, V34, P371, DOI 10.1080/10408399409527668; Oliveira M, 2010, FOOD MICROBIOL, V27, P679, DOI 10.1016/j.fm.2010.03.008; Ottesen AR, 2009, J FOOD PROTECT, V72, P2321, DOI 10.4315/0362-028X-72.11.2321; Ponce AG, 2008, J FOOD SCI, V73, pM257, DOI 10.1111/j.1750-3841.2008.00789.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Rudi K, 2002, APPL ENVIRON MICROB, V68, P1146, DOI 10.1128/AEM.68.3.1146-1156.2002; Schmid F, 2011, APPL ENVIRON MICROB, V77, P2188, DOI 10.1128/AEM.02187-10; Shi X, 2009, J APPL MICROBIOL, V107, P329, DOI 10.1111/j.1365-2672.2009.04211.x; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Telias A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-81; Teplitski M, 2011, TRENDS MICROBIOL, V19, P121, DOI 10.1016/j.tim.2010.11.007; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WRIGHT C, 1976, APPL ENVIRON MICROB, V31, P453, DOI 10.1128/AEM.31.3.453-454.1976; Yashiro E, 2011, J APPL MICROBIOL, V110, P1284, DOI 10.1111/j.1365-2672.2011.04975.x; Zagory D, 1999, POSTHARVEST BIOL TEC, V15, P313, DOI 10.1016/S0925-5214(98)00093-3	45	244	255	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59310	10.1371/journal.pone.0059310	http://dx.doi.org/10.1371/journal.pone.0059310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544058	gold, Green Published			2022-12-25	WOS:000317480700020
J	Sauerland, U; Gotzner, N				Sauerland, Uli; Gotzner, Nicole			Familial Sinistrals Avoid Exact Numbers	PLOS ONE			English	Article							CEREBRAL-DOMINANCE; LEFT-HANDEDNESS; LATERALITY; LANGUAGE; HANDERS; MODEL; SIZE; SEX	We report data from an Internet questionnaire of sixty number trivia. Participants were asked for the number of cups in their house, the number of cities they know and 58 other quantities. We compare the answers of familial sinistrals - individuals who are left-handed themselves or have a left-handed close blood-relative with those of pure familial dextrals - right-handed individuals who reported only having right-handed close blood-relatives. We show that familial sinistrals use rounder numbers than pure familial dextrals in the survey responses. Round numbers in the decimal system are those that are multiples of powers of 10 or of half or a quarter of a power of 10. Roundness is a gradient concept, e.g. 100 is rounder than 50 or 200. We show that very round number like 100 and 1000 are used with 25% greater likelihood by familial sinistrals than by pure familial dextrals, while pure familial dextrals are more likely to use less round numbers such as 25, 60, and 200. We then use Sigurd's (1988, Language in Society) index of the roundness of a number and report that familial sinistrals responses are significantly rounder on average than those of pure familial dextrals. To explain the difference, we propose that the cognitive effort of using exact numbers is greater for the familial sinistral group because their language and number systems tend to be more distributed over both hemispheres of the brain. Our data support the view that exact and approximate quantities are processed by two separate cognitive systems. Specifically, our behavioral data corroborates he view that the evolutionarily older, approximate number system is present in both hemispheres of the brain, while the exact number system tends to be localized in only one hemisphere.	[Sauerland, Uli] Harvard Univ, Dept Linguist, Cambridge, MA 02138 USA; [Sauerland, Uli] Ctr Gen Linguist, Berlin, Germany; [Gotzner, Nicole] Humboldt Univ, Dept German Linguist, D-10099 Berlin, Germany	Harvard University; Leibniz Zentrum Allgemeine Sprachwissenschaft (ZAS); Humboldt University of Berlin	Sauerland, U (corresponding author), Harvard Univ, Dept Linguist, Cambridge, MA 02138 USA.	uli@alum.mit.edu		Gotzner, Nicole/0000-0002-9584-4518; Sauerland, Uli/0000-0003-2175-535X	German Science Foundation DFG [SA 925/1, SA 925/4]; Bundesministerium fur Bildung und Forschung (BMBF) [01UG0711]	German Science Foundation DFG(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors' research was primarily funded by the German Science Foundation DFG (http://www.dfg.de) grants SA 925/1 and SA 925/4, the latter within the ESF Eurocores LogiCCC (www.esf.org/index.php?id=3241) coordinated research project VAAG. Furthermore, this work was supported in part by Bundesministerium fur Bildung und Forschung (BMBF, www.bmbf.de) (Grant Nr. 01UG0711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RJ, 1977, NEUROPSYCHOLOGIA, V15, P769, DOI 10.1016/0028-3932(77)90007-0; ANNETT M, 1990, NEUROPSYCHOLOGIA, V28, P61, DOI 10.1016/0028-3932(90)90086-4; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Broca Paul P, 1865, B SOCIETE ANTHROPOLO, V6, P377; BRYDEN MP, 1994, BRAIN COGNITION, V26, P103, DOI 10.1006/brcg.1994.1045; BRYDEN MP, 1965, NEUROPSYCHOLOGIA, V3, P1, DOI 10.1016/0028-3932(65)90015-1; Comrie B., 2005, WORLD ATLAS LANGUAGE; COWART W, 1989, J PSYCHOLINGUIST RES, V18, P89, DOI 10.1007/BF01069049; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S., 1999, NUMBER SENSE MIND CR; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; HARDYCK C, 1977, PSYCHOL BULL, V84, P385, DOI 10.1037/0033-2909.84.3.385; HECAEN H, 1981, BRAIN LANG, V12, P261, DOI 10.1016/0093-934X(81)90018-3; Josse G, 2004, BRAIN RES REV, V44, P1, DOI 10.1016/j.brainresrev.2003.10.001; Krifka M., 2007, COGNITIVE FDN INTERP, P111; McKeever WF, 2000, LATERALITY, V5, P111, DOI 10.1080/713754367; Mckeever WF, 1995, NEUROPSYCHOLOGIA, V33, P1627, DOI 10.1016/0028-3932(95)00042-9; Nettle D, 2003, BRAIN COGNITION, V52, P390, DOI 10.1016/S0278-2626(03)00187-8; Papadatou-Pastou M, 2008, PSYCHOL BULL, V134, P677, DOI 10.1037/a0012814; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Piazza M, 2006, BRAIN RES, V1106, P177, DOI 10.1016/j.brainres.2006.05.104; Pinel P, 2010, J COGNITIVE NEUROSCI, V22, P48, DOI 10.1162/jocn.2009.21184; Sappington J, 2005, LATERALITY, V10, P369, DOI 10.1080/13576500442000157; SIGURD B, 1988, LANG SOC, V17, P243, DOI 10.1017/S0047404500012781; SUBIRANA A, 1958, BRAIN, V81, P415, DOI 10.1093/brain/81.3.415; Townsend DJ, 2001, BRAIN LANG, V78, P308, DOI 10.1006/brln.2001.2469; Tzourio-Mazoyer N, 2010, J NEUROSCI, V30, P13314, DOI 10.1523/JNEUROSCI.2593-10.2010; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; Zolfonoun Ehsan, 2015, CLIN CHEM LAB MED, V103, P835, DOI [10.1515/ract-2015-2466, DOI 10.1515/CCLM-2022-0965]; ZURIF EB, 1969, NEUROPSYCHOLOGIA, V7, P179, DOI 10.1016/0028-3932(69)90015-3	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59103	10.1371/journal.pone.0059103	http://dx.doi.org/10.1371/journal.pone.0059103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544052	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700014
J	Weidner, M; Huwel, S; Ebert, F; Schwerdtle, T; Galla, HJ; Humpf, HU				Weidner, Maria; Huewel, Sabine; Ebert, Franziska; Schwerdtle, Tanja; Galla, Hans-Joachim; Humpf, Hans-Ulrich			Influence of T-2 and HT-2 Toxin on the Blood-Brain Barrier In Vitro: New Experimental Hints for Neurotoxic Effects	PLOS ONE			English	Article							OXIDATIVE STRESS; FUSARIUM TOXINS; PERMEABILITY; METABOLITES; TRANSPORT; TOXICITY; CELLS; TRICHOTHECENES; MODEL	The trichothecene mycotoxin T-2 toxin is a common contaminant of food and feed and is also present in processed cereal derived products. Cytotoxic effects of T-2 toxin and its main metabolite HT-2 toxin are already well described with apoptosis being a major mechanism of action. However, effects on the central nervous system were until now only reported rarely. In this study we investigated the effects of T-2 and HT-2 toxin on the blood-brain barrier (BBB) in vitro. Besides strong cytotoxic effects on the BBB as determined by the CCK-8 assay, impairment of the barrier function starting at low nanomolar concentrations were observed for T-2 toxin. HT-2 toxin, however, caused barrier disruption at higher concentrations compared to T-2 toxin. Further, the influence on the tight junction protein occludin was studied and permeability of both toxins across the BBB was detected when applied from the apical (blood) or the basolateral (brain) side respectively These results clearly indicate the ability of both toxins to enter the brain via the BBB.	[Weidner, Maria; Ebert, Franziska; Schwerdtle, Tanja; Humpf, Hans-Ulrich] Univ Munster, Inst Food Chem, D-48149 Munster, Germany; [Huewel, Sabine; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster; University of Munster	Humpf, HU (corresponding author), Univ Munster, Inst Food Chem, D-48149 Munster, Germany.	humpf@wwu.de	Humpf, Hans-Ulrich/AAV-4845-2020	Humpf, Hans-Ulrich/0000-0003-3296-3058	German Research Foundation (DFG) [HU-730/7-2]; Brigitte and Wolfram Gedek-Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Brigitte and Wolfram Gedek-Foundation	German Research Foundation (DFG), Grant Number HU-730/7-2; Brigitte and Wolfram Gedek-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Beyer Marita, 2009, Mycotoxin Res, V25, P41, DOI 10.1007/s12550-009-0006-2; Bouaziz C, 2008, TOXICOLOGY, V254, P19, DOI 10.1016/j.tox.2008.08.020; Chaudhari M, 2009, TOXICOLOGY, V262, P153, DOI 10.1016/j.tox.2009.06.002; Chaudhary M, 2010, FOOD CHEM TOXICOL, V48, P3436, DOI 10.1016/j.fct.2010.09.018; CRONE C, 1982, BRAIN RES, V241, P49, DOI 10.1016/0006-8993(82)91227-6; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DESJARDINS AE, 1993, MICROBIOL REV, V57, P595, DOI 10.1128/MMBR.57.3.595-604.1993; Doi K, 2011, INT J MOL SCI, V12, P5213, DOI 10.3390/ijms12085213; Edwards SG, 2009, FOOD ADDIT CONTAM A, V26, P1063, DOI 10.1080/02652030902788953; EFSA, 2011, EFSA J, V12; FAIRHURST S, 1987, TOXICOLOGY, V43, P31, DOI 10.1016/0300-483X(87)90072-2; Foroud NA, 2009, INT J MOL SCI, V10, P147, DOI 10.3390/ijms10010147; Franke H, 1999, BRAIN RES, V818, P65, DOI 10.1016/S0006-8993(98)01282-7; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Hoheisel D, 1998, BIOCHEM BIOPH RES CO, V244, P312, DOI 10.1006/bbrc.1997.8051; Konigs M, 2009, TOXICOLOGY, V258, P106, DOI 10.1016/j.tox.2009.01.012; Kroll S, 2009, ANN NY ACAD SCI, V1165, P228, DOI 10.1111/j.1749-6632.2009.04040.x; Li MX, 2006, TOXICOL APPL PHARM, V214, P318, DOI 10.1016/j.taap.2006.01.007; Li YS, 2011, J AGR FOOD CHEM, V59, P3441, DOI 10.1021/jf200767q; Lischper M, 2010, BRAIN RES, V1326, P114, DOI 10.1016/j.brainres.2010.02.054; Lohmann C, 2002, J DRUG TARGET, V10, P263, DOI 10.1080/10611860290031903; Mulac D, 2012, MOL NUTR FOOD RES, V56, P475, DOI 10.1002/mnfr.201100431; OHTA M, 1977, J BIOCHEM-TOKYO, V82, P1591, DOI 10.1093/oxfordjournals.jbchem.a131854; Ravindran J, 2011, TOXICOLOGY, V280, P44, DOI 10.1016/j.tox.2010.11.006; Rempe R, 2011, BIOCHEM BIOPH RES CO, V406, P64, DOI 10.1016/j.bbrc.2011.01.110; Schollenberger M, 2006, MYCOPATHOLOGIA, V161, P43, DOI 10.1007/s11046-005-0199-7; Schothorst RC, 2004, TOXICOL LETT, V153, P133, DOI 10.1016/j.toxlet.2004.04.045; SIRKKA U, 1992, PHARMACOL TOXICOL, V70, P111, DOI 10.1111/j.1600-0773.1992.tb00438.x; Sudakin DL, 2003, TOXICOL LETT, V143, P97, DOI 10.1016/S0378-4274(03)00116-4; van der Fels-Klerx HJ, 2010, WORLD MYCOTOXIN J, V3, P349, DOI 10.3920/WMJ2010.1237; Wang J, 1998, FOOD CHEM TOXICOL, V36, P947, DOI 10.1016/S0278-6915(98)00078-7; Weidner M, 2013, CHEM RES TOXICOL, V26, P347, DOI 10.1021/tx3004664; Weidner M, 2012, J AGR FOOD CHEM, V60, P5676, DOI 10.1021/jf300634k; Wu Qinghua, 2012, Mycotoxin Res, V28, P191, DOI 10.1007/s12550-012-0134-y	36	58	59	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60484	10.1371/journal.pone.0060484	http://dx.doi.org/10.1371/journal.pone.0060484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544145	gold, Green Submitted, Green Published			2022-12-25	WOS:000317480700104
J	Yu, X; Driscoll, CT; Huang, JY; Holsen, TM; Blackwell, BD				Yu, Xue; Driscoll, Charles T.; Huang, Jiaoyan; Holsen, Thomas M.; Blackwell, Bradley D.			Modeling and Mapping of Atmospheric Mercury Deposition in Adirondack Park, New York	PLOS ONE			English	Article							DRY DEPOSITION; SCIENTIFIC UNCERTAINTIES; WET DEPOSITION; CMAQ MODEL; TRANSPORT; FOREST; PARTICLE; AIR; METHYLMERCURY; PRECIPITATION	The Adirondacks of New York State, USA is a region that is sensitive to atmospheric mercury (Hg) deposition. In this study, we estimated atmospheric Hg deposition to the Adirondacks using a new scheme that combined numerical modeling and limited experimental data. The majority of the land cover in the Adirondacks is forested with 47% of the total area deciduous, 20% coniferous and 10% mixed. We used litterfall plus throughfall deposition as the total atmospheric Hg deposition to coniferous and deciduous forests during the leaf-on period, and wet Hg deposition plus modeled atmospheric dry Hg deposition as the total Hg deposition to the deciduous forest during the leaf-off period and for the non-forested areas year-around. To estimate atmospheric dry Hg deposition we used the Big Leaf model. The average atmospheric Hg deposition to the Adirondacks was estimated as 17.4 mu g m(-2) yr(-1) with a range of -3.7-46.0 mu g m(-2) yr(-1). Atmospheric Hg dry deposition (370 kg yr(-1)) was found to be more important than wet deposition (210 kg yr(-1)) to the entire Adirondacks (2.4 million ha). The spatial pattern showed a large variation in atmospheric Hg deposition with scattered areas in the eastern Adirondacks having total Hg deposition greater than 30 mu g m(-2) yr(-1), while the southwestern and the northern areas received Hg deposition ranging from 25-30 mu g m(-2) yr(-1).	[Yu, Xue; Driscoll, Charles T.; Blackwell, Bradley D.] Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA; [Huang, Jiaoyan] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Holsen, Thomas M.] Clarkson Univ, Dept Civil & Environm Engn, Potsdam, NY USA	Syracuse University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Clarkson University	Yu, X (corresponding author), Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA.	xuyu@syr.edu	Driscoll, Charles/F-9832-2014	Driscoll, Charles/0000-0003-2692-2890; Huang, Jiaoyan/0000-0001-6148-238X; Holsen, Thomas/0000-0001-9599-6733	New York State Energy Research and Development Authority; U.S. Environmental Protection Agency	New York State Energy Research and Development Authority; U.S. Environmental Protection Agency(United States Environmental Protection Agency)	Support for this research was provided by New York State Energy Research and Development Authority and the U.S. Environmental Protection Agency. The website for New York State Energy Research and Development Authority is: http://www.nyserda.ny.gov/. The website for the U.S. Environmental Protection Agency is: http://www.epa.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop KH, 1998, BIOGEOCHEMISTRY, V40, P101, DOI 10.1023/A:1005983932240; Bullock OR, 2002, ATMOS ENVIRON, V36, P2135, DOI 10.1016/S1352-2310(02)00220-0; Bushey JT, 2008, ATMOS ENVIRON, V42, P6905, DOI 10.1016/j.atmosenv.2008.05.043; Choi HD, 2008, ENVIRON SCI TECHNOL, V42, P5644, DOI 10.1021/es7028137; Choi HD, 2008, ATMOS ENVIRON, V42, P1818, DOI 10.1016/j.atmosenv.2007.11.036; Cohen M, 2004, ENVIRON RES, V95, P247, DOI 10.1016/j.envres.2003.11.007; Daly C, 1997, 10TH CONFERENCE ON APPLIED CLIMATOLOGY, P10; Dastoor AP, 2004, ATMOS ENVIRON, V38, P147, DOI 10.1016/j.atmosenv.2003.08.037; Demers JD, 2007, ECOL APPL, V17, P1341, DOI 10.1890/06-1697.1; Denkenberger JS, 2012, ENVIRON POLLUT, V161, P291, DOI 10.1016/j.envpol.2011.06.007; Driscoll C.T., 1991, P133; Driscoll CT, 2007, BIOSCIENCE, V57, P17, DOI 10.1641/B570106; DRISCOLL CT, 1994, ENVIRON SCI TECHNOL, V28, pA136, DOI 10.1021/es00052a721; Ericksen JA, 2003, ATMOS ENVIRON, V37, P1613, DOI 10.1016/S1352-2310(03)00008-6; Esteban E, 2008, ENVIRON EXP BOT, V62, P316, DOI 10.1016/j.envexpbot.2007.10.006; Evers DC, 2007, BIOSCIENCE, V57, P29, DOI 10.1641/B570107; Fry J., 2009, TECHNICAL REPORT; Gardfeldt K, 2003, J PHYS CHEM A, V107, P4478, DOI 10.1021/jp0275342; Gbor PK, 2007, ATMOS ENVIRON, V41, P1135, DOI 10.1016/j.atmosenv.2006.10.005; Grigal D. F., 2002, Environmental Reviews, V10, P1, DOI 10.1139/a01-013; Gustin M, 2012, ENVIRON SCI TECHNOL, V44, P2222; Gustin MS, 2012, EXCHANGE MERCURY ATM; HICKS BB, 1987, WATER AIR SOIL POLL, V36, P311, DOI 10.1007/BF00229675; Holloway T, 2012, ATMOS CHEM PHYS, V12, P7117, DOI 10.5194/acp-12-7117-2012; Huang JY, 2012, J ENVIRON MONITOR, V14, P2976, DOI 10.1039/c2em30514c; Kolka RK, 1999, WATER AIR SOIL POLL, V113, P273, DOI 10.1023/A:1005020326683; Lawson ST, 2003, J ENVIRON MONITOR, V5, P578, DOI 10.1039/b210125d; Lee DS, 2001, ATMOS ENVIRON, V35, P5455, DOI 10.1016/S1352-2310(01)00284-9; Lin CJ, 2006, ATMOS ENVIRON, V40, P2911, DOI 10.1016/j.atmosenv.2006.01.009; Lin X, 2003, ATMOS CHEM PHYS, V3, P535, DOI 10.5194/acp-3-535-2003; Lindberg SE, 1998, ENVIRON SCI TECHNOL, V32, P49, DOI 10.1021/es970546u; Mao H, 2012, ATMOS CHEM PHYS, V12, P5099, DOI 10.5194/acp-12-5099-2012; Mao H., 2011, ATMOS CHEM PHYS DISC, V11, P28395, DOI [DOI 10.5194/ACPD-11-28395-2011, 10.5194/acpd-11-28395-2011]; Miller EK, 2005, ECOTOXICOLOGY, V14, P53, DOI 10.1007/s10646-004-6259-9; MILLER EK, 1993, ATMOS ENVIRON A-GEN, V27, P2121, DOI 10.1016/0960-1686(93)90042-W; MUNTHE J, 1995, WATER AIR SOIL POLL, V80, P363, DOI 10.1007/BF01189686; PETERSEN G, 1995, ATMOS ENVIRON, V29, P47, DOI 10.1016/1352-2310(94)00223-8; Pirrone N, 2010, ATMOS CHEM PHYS, V10, P5951, DOI 10.5194/acp-10-5951-2010; PLEIJEL K, 1995, ATMOS ENVIRON, V29, P1441; Pongprueksa P, 2008, ATMOS ENVIRON, V42, P1828, DOI 10.1016/j.atmosenv.2007.11.020; Prestbo EM, 2009, ATMOS ENVIRON, V43, P4223, DOI 10.1016/j.atmosenv.2009.05.028; Rea AW, 1996, ATMOS ENVIRON, V30, P3257, DOI 10.1016/1352-2310(96)00087-8; Rimmer CC, 2005, ECOTOXICOLOGY, V14, P223, DOI 10.1007/s10646-004-6270-1; Risch MR, 2012, ENVIRON POLLUT, V161, P284, DOI 10.1016/j.envpol.2011.06.005; Rutter AP, 2007, ATMOS ENVIRON, V41, P8647, DOI 10.1016/j.atmosenv.2007.07.024; Rutter AP, 2007, ENVIRON SCI TECHNOL, V41, P3934, DOI 10.1021/es062439i; Ryaboshapko A, 2002, ATMOS ENVIRON, V36, P3881, DOI 10.1016/S1352-2310(02)00351-5; Schmolke SR, 2003, ATMOS ENVIRON, V37, pS51, DOI 10.1016/S1352-2310(03)00250-4; Schroeder WH, 1998, ATMOS ENVIRON, V32, P809, DOI 10.1016/S1352-2310(97)00293-8; Seigneur C, 2004, FUEL PROCESS TECHNOL, V85, P441, DOI 10.1016/j.fuproc.2003.11.001; SHANNON JD, 1995, ATMOS ENVIRON, V29, P1649, DOI 10.1016/1352-2310(95)00075-A; Sheehan KD, 2006, WATER AIR SOIL POLL, V170, P249, DOI 10.1007/s11270-006-3034-y; Subir M, 2012, ATMOS ENVIRON, V46, P1, DOI 10.1016/j.atmosenv.2011.07.047; Subir M, 2011, ATMOS ENVIRON, V45, P5664, DOI 10.1016/j.atmosenv.2011.04.046; Swartzendruber PC, 2009, ENVIRON SCI TECHNOL, V43, P7484, DOI 10.1021/es901390t; Tipping E, 2011, ENVIRON POLLUT, V159, P3474, DOI 10.1016/j.envpol.2011.08.019; Townsend JM, 2012, ECOTOXICOLOGY; US EPA, 2012, DEP MAPP; Wesely ML, 2000, ATMOS ENVIRON, V34, P2261, DOI 10.1016/S1352-2310(99)00467-7; Witt EL, 2009, WATER AIR SOIL POLL, V199, P3, DOI 10.1007/s11270-008-9854-1; Xu XH, 1999, ATMOS ENVIRON, V33, P4345, DOI 10.1016/S1352-2310(99)00245-9; Yu X, 2011, ECOTOXICOLOGY, V20, P1543, DOI 10.1007/s10646-011-0717-y; Zhang L, 2012, ENVIRON POLLUT, V161, P272, DOI 10.1016/j.envpol.2011.06.003; Zhang L, 2003, ATMOS CHEM PHYS, V3, P2067, DOI 10.5194/acp-3-2067-2003; Zhang L., 2012, ATMOSPHERIC CHEM PHY, V12, P2783; Zhang LM, 2009, ATMOS ENVIRON, V43, P5853, DOI 10.1016/j.atmosenv.2009.08.019; Zhang LM, 2002, ATMOS ENVIRON, V36, P537, DOI 10.1016/S1352-2310(01)00447-2; Zhang LM, 2001, ATMOS ENVIRON, V35, P549, DOI 10.1016/S1352-2310(00)00326-5	68	19	19	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59322	10.1371/journal.pone.0059322	http://dx.doi.org/10.1371/journal.pone.0059322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536871	Green Submitted, Green Published, gold			2022-12-25	WOS:000317397200019
J	Braun, R; Finney, R; Yan, CH; Chen, QR; Hu, Y; Edmonson, M; Meerzaman, D; Buetow, K				Braun, Rosemary; Finney, Richard; Yan, Chunhua; Chen, Qing-Rong; Hu, Ying; Edmonson, Michael; Meerzaman, Daoud; Buetow, Kenneth			Discovery Analysis of TCGA Data Reveals Association between Germline Genotype and Survival in Ovarian Cancer Patients	PLOS ONE			English	Article							GENE-EXPRESSION; PLATINUM COMPLEXES; TUMOR RESPONSE; BREAST-CANCER; CHEMOTHERAPY; CARCINOMA; SUSCEPTIBILITY; VARIANTS; POLYMORPHISMS; PREDICTION	Background: Ovarian cancer remains a significant public health burden, with the highest mortality rate of all the gynecological cancers. This is attributable to the late stage at which the majority of ovarian cancers are diagnosed, coupled with the low and variable response of advanced tumors to standard chemotherapies. To date, clinically useful predictors of treatment response remain lacking. Identifying the genetic determinants of ovarian cancer survival and treatment response is crucial to the development of prognostic biomarkers and personalized therapies that may improve outcomes for the late-stage patients who comprise the majority of cases. Methods: To identify constitutional genetic variations contributing to ovarian cancer mortality, we systematically investigated associations between germline polymorphisms and ovarian cancer survival using data from The Cancer Genome Atlas Project (TCGA). Using stage-stratified Cox proportional hazards regression, we examined >650,000 SNP loci for association with survival. We additionally examined whether the association of significant SNPs with survival was modified by somatic alterations. Results: Germline polymorphisms at rs4934282 (AGAP11/C10orf116) and rs1857623 (DNAH14) were associated with stage-adjusted survival (p = 1.12e-07 and 1.80e-07, FDR q = 1.2e-04 and 2.4e-04, respectively). A third SNP, rs4869 (C10orf116), was additionally identified as significant in the exome sequencing data; it is in near-perfect LD with rs4934282. The associations with survival remained significant when somatic alterations. Conclusions: Discovery analysis of TCGA data reveals germline genetic variations that may play a role in ovarian cancer survival even among late-stage cases. The significant loci are located near genes previously reported as having a possible relationship to platinum and taxol response. Because the variant alleles at the significant loci are common (frequencies for rs4934282 A/C alleles = 0.54/0.46, respectively; rs1857623 A/G alleles = 0.55/0.45, respectively) and germline variants can be assayed noninvasively, our findings provide potential targets for further exploration as prognostic biomarkers and individualized therapies.	[Braun, Rosemary] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Braun, Rosemary; Finney, Richard; Yan, Chunhua; Chen, Qing-Rong; Hu, Ying; Edmonson, Michael; Meerzaman, Daoud; Buetow, Kenneth] NCI, Ctr Biomed Informat & Informat Technol, NIH, Bethesda, MD 20892 USA; [Buetow, Kenneth] Arizona State Univ, Computat Sci & Informat Program, Complex Adapt Syst Initiat, Phoenix, AZ USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Arizona State University; Arizona State University-Downtown Phoenix	Braun, R (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	rbraun@northwestern.edu	sun, lingdong/AAJ-8058-2020	sun, lingdong/0000-0002-4657-0346; Braun, Rosemary/0000-0001-9668-9866	National Cancer Institute, United States National Institutes of Health, Bethesda, MD; NATIONAL CANCER INSTITUTE [K22CA148779] Funding Source: NIH RePORTER	National Cancer Institute, United States National Institutes of Health, Bethesda, MD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are supported by the Intramural Research Program of the National Cancer Institute, United States National Institutes of Health, Bethesda, MD. There were no external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON K, 1991, NEUROLOGY, V41, P1800, DOI 10.1212/WNL.41.11.1800; Arslan AA, 2005, HUM REPROD, V20, P852, DOI 10.1093/humrep/deh698; Aulchenko YS, 2007, GENABEL R LIB GENOME; Bartel F, 2008, CLIN CANCER RES, V14, P89, DOI 10.1158/1078-0432.CCR-07-1192; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLACKLEDGE G, 1989, BRIT J CANCER, V59, P650, DOI 10.1038/bjc.1989.132; Bolton KL, 2012, J INTERN MED, V271, P366, DOI 10.1111/j.1365-2796.2011.02509.x; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Chang H, 2010, J CANCER RES CLIN, V136, P1901, DOI 10.1007/s00432-010-0849-0; Clifford RJ, 2004, BIOINFORMATICS, V20, P1006, DOI 10.1093/bioinformatics/bth029; Engler DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030996; Fasching PA, 2009, MOL ONCOL, V3, P171, DOI 10.1016/j.molonc.2009.01.008; Fernandez-Ramires R, 2009, BRIT J CANCER, V101, P1469, DOI 10.1038/sj.bjc.6605275; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Han CH, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-5; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Hernandez-Vargas H, 2007, BREAST CANCER RES TR, V102, P157, DOI 10.1007/s10549-006-9322-9; Howlader N, 2011, SEER CANC STAT REV 1; Huang R, 2011, CLIN CANC RES; Indermaur MD, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.003; Jakupec MA, 2003, REV PHYSIOL BIOCH P, V146, P1, DOI 10.1007/s10254-002-0001-x; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kang HC, 2004, CLIN CANCER RES, V10, P272, DOI 10.1158/1078-0432.CCR-1025-3; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marsh S, 2007, J CLIN ONCOL, V25, P4528, DOI 10.1200/JCO.2006.10.4752; Matsuo K, 2010, AM J CLIN ONCOL-CANC, V33, P358, DOI 10.1097/COC.0b013e3181af30d3; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Nikas JB, 2011, CANCER INFORM, V10, P233, DOI 10.4137/CIN.S8104; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; PRESTAYKO AW, 1979, CANCER TREAT REV, V6, P17, DOI 10.1016/S0305-7372(79)80057-2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rose PG, 2010, GYNECOL ONCOL, V117, P324, DOI 10.1016/j.ygyno.2010.01.040; Sano H, 2012, BREAST CANCER-TOKYO, V19, P37, DOI 10.1007/s12282-011-0263-8; Skubitz APN, 2006, TRANSL RES, V148, P223, DOI 10.1016/j.trsl.2006.06.001; TCGA, 2011, RES PUBL HER AR WHOL; Therneau T, 2011, SURVIVAL SURVIVAL AN; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang XY, 2010, ANTI-CANCER AGENT ME, V10, P396, DOI 10.2174/1871520611009050396; Zhang J, 2007, GENOME RES, V17, P1111, DOI 10.1101/gr.5963407; Ziliak D, 2012, MOL CANCER THER, V11, P2054, DOI 10.1158/1535-7163.MCT-12-0221	46	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e55037	10.1371/journal.pone.0055037	http://dx.doi.org/10.1371/journal.pone.0055037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555554	Green Published, Green Submitted, gold			2022-12-25	WOS:000316546400001
J	Iancu, OD; Oberbeck, D; Darakjian, P; Kawane, S; Erk, J; McWeeney, S; Hitzemann, R				Iancu, Ovidiu D.; Oberbeck, Denesa; Darakjian, Priscila; Kawane, Sunita; Erk, Jason; McWeeney, Shannon; Hitzemann, Robert			Differential Network Analysis Reveals Genetic Effects on Catalepsy Modules	PLOS ONE			English	Article							HALOPERIDOL-INDUCED CATALEPSY; QUANTITATIVE TRAIT LOCI; FALSE DISCOVERY RATE; COMBINATORIAL-CONTROL; MOUSE; EXPRESSION; MICE; TRANSCRIPTOME; DISEASE; IDENTIFICATION	We performed short-term bi-directional selective breeding for haloperidol-induced catalepsy, starting from three mouse populations of increasingly complex genetic structure: an F-2 intercross, a heterogeneous stock (HS) formed by crossing four inbred strains (HS4) and a heterogeneous stock (HS-CC) formed from the inbred strain founders of the Collaborative Cross (CC). All three selections were successful, with large differences in haloperidol response emerging within three generations. Using a custom differential network analysis procedure, we found that gene coexpression patterns changed significantly; importantly, a number of these changes were concordant across genetic backgrounds. In contrast, absolute geneexpression changes were modest and not concordant across genetic backgrounds, in spite of the large and similar phenotypic differences. By inferring strain contributions from the parental lines, we are able to identify significant differences in allelic content between the selected lines concurrent with large changes in transcript connectivity. Importantly, this observation implies that genetic polymorphisms can affect transcript and module connectivity without large changes in absolute expression levels. We conclude that, in this case, selective breeding acts at the subnetwork level, with the same modules but not the same transcripts affected across the three selections.	[Iancu, Ovidiu D.; Oberbeck, Denesa; Erk, Jason; Hitzemann, Robert] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Darakjian, Priscila; Kawane, Sunita; McWeeney, Shannon] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA; [McWeeney, Shannon] Oregon Hlth & Sci Univ, Div Biostat Publ Hlth & Preventat Med, Portland, OR 97201 USA; [Hitzemann, Robert] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Res Serv, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Iancu, OD (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	iancuo@ohsu.edu		McWeeney, Shannon/0000-0001-8333-6607	Veterans Affairs Research Service;  [MH 51372];  [DA 005228]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005228] Funding Source: NIH RePORTER	Veterans Affairs Research Service(US Department of Veterans Affairs); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by MH 51372, DA 005228, and the Veterans Affairs Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Bailly-Bechet M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-355; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Belknap JK, 1997, BEHAV GENET, V27, P55, DOI 10.1023/A:1025615409383; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjorklund A, 2010, PROG BRAIN RES, V184, P53, DOI 10.1016/S0079-6123(10)84004-X; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Delic S, 2008, GENES BRAIN BEHAV, V7, P821, DOI 10.1111/j.1601-183X.2008.00412.x; Desplats PA, 2008, NEUROBIOL DIS, V31, P298, DOI 10.1016/j.nbd.2008.05.005; Dorval Veronique, 2012, Front Neurol, V3, P12, DOI 10.3389/fneur.2012.00012; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EXCOFFIER L, 1992, GENETICS, V131, P479; Farber CR, 2010, J BONE MINER RES, V25, P2359, DOI 10.1002/jbmr.138; French CA, 2011, MOL PSYCHIAT; Hitzemann R, 1995, INT REV NEUROBIOL, V38, P43, DOI 10.1016/S0074-7742(08)60524-3; Hitzemann R, 2000, ALCOHOL RES HEALTH, V24, P149; Hofstetter JR, 2008, GENES BRAIN BEHAV, V7, P214, DOI 10.1111/j.1601-183X.2007.00340.x; Iancu OD, 2012, GENES BRAIN BEHAV, V11, P29, DOI 10.1111/j.1601-183X.2011.00736.x; Iancu OD, 2012, BIOINFORMATICS, V28, P1592, DOI 10.1093/bioinformatics/bts245; Iancu OD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-585; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Kanes S, 1996, J PHARMACOL EXP THER, V277, P1016; KANES SJ, 1993, J PHARMACOL EXP THER, V267, P538; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Keum JW, 2009, BIOTECHNOL BIOENG, V102, P577, DOI 10.1002/bit.22081; Kim S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.42; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Malmanger B, 2006, MAMM GENOME, V17, P1193, DOI 10.1007/s00335-006-0070-2; Moretti R, 2008, BIOCHIMIE, V90, P1015, DOI 10.1016/j.biochi.2008.02.014; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Mozhui K, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.24; Muers M, 2011, NAT REV GENET, V12, DOI [10.1038/nrg3059, 10.1038/nrg3058]; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; Nishi A, 2010, J PHARMACOL SCI, V114, P6, DOI 10.1254/jphs.10R01FM; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Patel NV, 1999, BEHAV GENET, V29, P303, DOI 10.1023/A:1021653732147; QIAN YF, 1993, J PHARMACOL EXP THER, V267, P1582; QIAN YF, 1992, J PHARMACOL EXP THER, V261, P341; Rasmussen E, 1999, J PHARMACOL EXP THER, V290, P1337; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Ronnegard L, 2011, GENETICS, V188, P435, DOI 10.1534/genetics.111.127068; Schwindinger WF, 2003, J BIOL CHEM, V278, P6575, DOI 10.1074/jbc.M211132200; Tang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023691; Vadasz C, 2007, NEUROSCIENCE, V149, P561, DOI 10.1016/j.neuroscience.2007.06.049; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	56	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58951	10.1371/journal.pone.0058951	http://dx.doi.org/10.1371/journal.pone.0058951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555609	Green Submitted, Green Published, gold			2022-12-25	WOS:000316546400016
J	Costessi, L; Porro, F; Iaconcig, A; Nedeljkovic, M; Muro, AF				Costessi, Luisa; Porro, Fabiola; Iaconcig, Alessandra; Nedeljkovic, Mirjana; Muro, Andres Fernando			Characterization of the Distal Polyadenylation Site of the beta-Adducin (Add2) Pre-mRNA	PLOS ONE			English	Article							UPSTREAM-SEQUENCE-ELEMENT; 3' UNTRANSLATED REGIONS; NUCLEAR FACTOR TDP-43; ALTERNATIVE POLYADENYLATION; EFFICIENT POLYADENYLATION; PROCESSING EFFICIENCY; SYNAPTIC PLASTICITY; FACTOR CSTF-64; FACTOR-I; PROTEIN	Most genes have multiple polyadenylation sites (PAS), which are often selected in a tissue-specific manner, altering protein products and affecting mRNA stability, subcellular localization and/or translability. Here we studied the polyadenylation mechanisms associated to the beta-adducin gene (Add2). We have previously shown that the Add2 gene has a very tight regulation of alternative polyadenylation, using proximal PAS in erythroid tissues, and a distal one in brain. Using chimeric minigenes and cell transfections we identified the core elements responsible for polyadenylation at the distal PAS. Deletion of either the hexanucleotide motif (Hm) or the downstream element (DSE) resulted in reduction of mature mRNA levels and activation of cryptic PAS, suggesting an important role for the DSE in polyadenylation of the distal Add2 PAS. Point mutation of the UG repeats present in the DSE, located immediately after the cleavage site, resulted in a reduction of processed mRNA and in the activation of the same cryptic site. RNA-EMSA showed that this region is active in forming RNA-protein complexes. Competition experiments showed that RNA lacking the DSE was not able to compete the RNA-protein complexes, supporting the hypothesis of an essential important role for the DSE. Next, using a RNA-pull down approach we identified some of the proteins bound to the DSE. Among these proteins we found PTB, TDP-43, FBP1 and FBP2, nucleolin, RNA helicase A and vigilin. All these proteins have a role in RNA metabolism, but only PTB has a reported function in polyadenylation. Additional experiments are needed to determine the precise functional role of these proteins in Add2 polyadenylation.	[Costessi, Luisa; Porro, Fabiola; Iaconcig, Alessandra; Nedeljkovic, Mirjana; Muro, Andres Fernando] ICGEB, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Muro, AF (corresponding author), ICGEB, Trieste, Italy.	muro@icgeb.org	Muro, Andrés F/K-3156-2016	Muro, Andrés F/0000-0002-9628-0494	ICGEB	ICGEB	This work was supported by ICGEB intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Arhin GK, 2002, NUCLEIC ACIDS RES, V30, P1842, DOI 10.1093/nar/30.8.1842; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Bednarek E, 2011, NEURON, V69, P1132, DOI 10.1016/j.neuron.2011.02.034; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Blechingberg J, 2007, NUCLEIC ACIDS RES, V35, P7636, DOI 10.1093/nar/gkm931; Briata P, 2011, FRONT BIOSCI-LANDMRK, V16, P1787, DOI 10.2741/3821; BROWN PH, 1991, J VIROL, V65, P3340, DOI 10.1128/JVI.65.6.3340-3343.1991; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; CARSWELL S, 1989, MOL CELL BIOL, V9, P4248, DOI 10.1128/MCB.9.10.4248; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chen F, 1998, NUCLEIC ACIDS RES, V26, P2891, DOI 10.1093/nar/26.12.2891; Costessi L, 2006, NUCLEIC ACIDS RES, V34, P243, DOI 10.1093/nar/gkj425; Cunningham KS, 2000, P NATL ACAD SCI USA, V97, P12498, DOI 10.1073/pnas.220425497; Danckwardt S, 2007, EMBO J, V26, P2658, DOI 10.1038/sj.emboj.7601699; Danckwardt S, 2011, MOL CELL, V41, P298, DOI 10.1016/j.molcel.2010.12.032; Darmon SK, 2012, RNA BIOL, V9, P1255, DOI 10.4161/rna.21957; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Gilligan DM, 1999, P NATL ACAD SCI USA, V96, P10717, DOI 10.1073/pnas.96.19.10717; Hall-Pogar T, 2005, NUCLEIC ACIDS RES, V33, P2565, DOI 10.1093/nar/gki544; Hall-Pogar T, 2007, RNA, V13, P1103, DOI 10.1261/rna.577707; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kruse C, 2000, BIOCHEM J, V346, P107, DOI 10.1042/0264-6021:3460107; Le Sommer C, 2005, MOL CELL BIOL, V25, P9595, DOI 10.1128/MCB.25.21.9595-9607.2005; Lou H, 1999, MOL CELL BIOL, V19, P78; Manojlovic Z, 2012, RNA, V18, P321, DOI 10.1261/rna.030288.111; MARDON HJ, 1987, NUCLEIC ACIDS RES, V15, P7725, DOI 10.1093/nar/15.19.7725; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Millevoi S, 2009, NUCLEIC ACIDS RES, V37, P4672, DOI 10.1093/nar/gkp470; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Moreira A, 1998, GENE DEV, V12, P2522, DOI 10.1101/gad.12.16.2522; Morgan M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-708; Muro AF, 2000, BLOOD, V95, P3978; Natalizio BJ, 2002, J BIOL CHEM, V277, P42733, DOI 10.1074/jbc.M208070200; Nunes NM, 2010, EMBO J, V29, P1523, DOI 10.1038/emboj.2010.42; Pagani F, 2003, J BIOL CHEM, V278, P1511, DOI 10.1074/jbc.M209676200; Pielage J, 2011, NEURON, V69, P1114, DOI 10.1016/j.neuron.2011.02.007; Porro F, 2010, GENES BRAIN BEHAV, V9, P84, DOI 10.1111/j.1601-183X.2009.00537.x; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; SEIDEL B, 1995, BRAIN RES, V700, P13, DOI 10.1016/0006-8993(95)00962-P; Shell SA, 2005, J BIOL CHEM, V280, P39950, DOI 10.1074/jbc.M508848200; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Sully G, 2004, BIOCHEM J, V377, P629, DOI 10.1042/BJ20031484; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; TRIPODI G, 1991, BIOCHEM BIOPH RES CO, V177, P939, DOI 10.1016/0006-291X(91)90629-L; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; VALSAMAKIS A, 1991, P NATL ACAD SCI USA, V88, P2108, DOI 10.1073/pnas.88.6.2108; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; VIBEPEDERSEN K, 1984, EMBO J, V3, P2511, DOI 10.1002/j.1460-2075.1984.tb02165.x; Woo HH, 2011, MOL CELL BIOL, V31, P215, DOI 10.1128/MCB.01031-10; Yao CG, 2012, P NATL ACAD SCI USA, V109, P18773, DOI 10.1073/pnas.1211101109	72	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58879	10.1371/journal.pone.0058879	http://dx.doi.org/10.1371/journal.pone.0058879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554949	Green Submitted, Green Published, gold			2022-12-25	WOS:000316409800043
J	De Meyer, T; Mampaey, E; Vlemmix, M; Denil, S; Trooskens, G; Renard, JP; De Keulenaer, S; Dehan, P; Menschaert, G; Van Criekinge, W				De Meyer, Tim; Mampaey, Evi; Vlemmix, Michael; Denil, Simon; Trooskens, Geert; Renard, Jean-Pierre; De Keulenaer, Sarah; Dehan, Pierre; Menschaert, Gerben; Van Criekinge, Wim			Quality Evaluation of Methyl Binding Domain Based Kits for Enrichment DNA-Methylation Sequencing	PLOS ONE			English	Article							HIGH-THROUGHPUT; GENOME; WIDE; EPIGENETICS; MICROARRAY; SITES	DNA-methylation is an important epigenetic feature in health and disease. Methylated sequence capturing by Methyl Binding Domain (MBD) based enrichment followed by second-generation sequencing provides the best combination of sensitivity and cost-efficiency for genome-wide DNA-methylation profiling. However, existing implementations are numerous, and quality control and optimization require expensive external validation. Therefore, this study has two aims: 1) to identify a best performing kit for MBD-based enrichment using independent validation data, and 2) to evaluate whether quality evaluation can also be performed solely based on the characteristics of the generated sequences. Five commercially available kits for MBD enrichment were combined with Illumina GAIIx sequencing for three cell lines (HCT15, DU145, PC3). Reduced representation bisulfite sequencing data (all three cell lines) and publicly available Illumina Infinium BeadChip data (DU145 and PC3) were used for benchmarking. Consistent large-scale differences in yield, sensitivity and specificity between the different kits could be identified, with Diagenode's MethylCap kit as overall best performing kit under the tested conditions. This kit could also be identified with the Fragment CpG-plot, which summarizes the CpG content of the captured fragments, implying that the latter can be used as a tool to monitor data quality. In conclusion, there are major quality differences between kits for MBD-based capturing of methylated DNA, with the MethylCap kit performing best under the used settings. The Fragment CpG-plot is able to monitor data quality based on inherent sequence data characteristics, and is therefore a cost-efficient tool for experimental optimization, but also to monitor quality throughout routine applications.	[De Meyer, Tim; Vlemmix, Michael; Denil, Simon; Trooskens, Geert; Renard, Jean-Pierre; De Keulenaer, Sarah; Menschaert, Gerben; Van Criekinge, Wim] Univ Ghent, Fac Biosci Engn, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium; [Mampaey, Evi] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium; [Renard, Jean-Pierre; Van Criekinge, Wim] MDX Hlth SA, Ghent, Belgium; [Dehan, Pierre] Univ Liege, Dept Expt Pathol, Liege, Belgium	Ghent University; Ghent University; University of Liege	De Meyer, T (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium.	Tim.DeMeyer@ugent.be	De Meyer, Tim/D-3892-2011	De Meyer, Tim/0000-0003-2994-9693; Menschaert, Gerben/0000-0002-7575-2085	MDX Health; N2N (Nucleotide 2 Networks) Multidisciplinary Research Partnership (Special Research Fund Ghent University)	MDX Health; N2N (Nucleotide 2 Networks) Multidisciplinary Research Partnership (Special Research Fund Ghent University)	MDX Health partially funded this study to improve their own experimental procedures with the generated knowledge. TDM wants to acknowledge and is funded on the N2N (Nucleotide 2 Networks) Multidisciplinary Research Partnership (Special Research Fund Ghent University). The study was designed in collaboration with MDX Health. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Burgoon LD, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni167; Chouliaras L, 2010, PROG NEUROBIOL, V90, P498, DOI 10.1016/j.pneurobio.2010.01.002; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim YJ, 2011, CLIN CANCER RES, V17, P4523, DOI 10.1158/1078-0432.CCR-10-2817; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kristensen LS, 2009, CLIN CHEM, V55, P1471, DOI 10.1373/clinchem.2008.121962; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Nair SS, 2011, EPIGENETICS-US, V6, P34, DOI 10.4161/epi.6.1.13313; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Vener T, 2008, CLIN CHEM, V54, P874, DOI 10.1373/clinchem.2007.094912; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-10	30	39	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59068	10.1371/journal.pone.0059068	http://dx.doi.org/10.1371/journal.pone.0059068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554971	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800053
J	He, HQ; Genovese, KJ; Swaggerty, CL; Nisbet, DJ; Kogut, MH				He, Haiqi; Genovese, Kenneth J.; Swaggerty, Christina L.; Nisbet, David J.; Kogut, Michael H.			Nitric Oxide as a Biomarker of Intracellular Salmonella Viability and Identification of the Bacteriostatic Activity of Protein Kinase A Inhibitor H-89	PLOS ONE			English	Article							PHOSPHOTHREONINE LYASE; PATHOGENICITY ISLAND-2; HOST; ENTERITIDIS; MACROPHAGES; ACTIVATION; RESPONSES; EFFECTOR; SURVIVAL; CHICKEN	Salmonella enterica serovar Enteritidis is one of the most prevalent Salmonella serovars in poultry and is often associated with human salmonellosis. S. Enteritidis is known to suppress nitric oxide (NO) production in infected chicken macrophage HD11 cells, while dead S. Enteritidis stimulates a high level of NO production, suggesting a bacterial inhibitory effect on NO production. Based on these observations, the present study was conducted to evaluate whether NO production in S. Enteritidis-infected HD11 cells can be used as a biomarker to identify molecules that kill intracellular Salmonella. Since Salmonella are known to manipulate the host cell kinase network to facilitate intracellular survival, we screened a group of pharmaceutical inhibitors of various kinases to test our hypothesis. A protein kinase A inhibitor, H-89, was found to reverse the suppression of NO production in S. Enteritidis-infected HD11 cells. Production of NO in S. Enteritidis-infected HD11 cells increased significantly following treatment with H-89 at or above 20 mu M. Inversely, the number of viable intracellular Salmonella decreased significantly in cells treated with H-89 at or above 30 mM. Furthermore, the growth rate of S. Enteritidis in culture was significantly inhibited by H-89 at concentrations from 20 to 100 mM. Our results demonstrate that NO-based screening using S. Enteritidis-infected HD11 cells is a viable tool to identify chemicals with anti-intracellular Salmonella activity. Using this method, we have shown H-89 has bacteriostatic activity against Salmonella, independent of host cell protein kinase A or Akt1 activity.	[He, Haiqi; Genovese, Kenneth J.; Swaggerty, Christina L.; Nisbet, David J.; Kogut, Michael H.] USDA ARS, Southern Plains Agr Res Ctr, College Stn, TX 77845 USA	United States Department of Agriculture (USDA)	He, HQ (corresponding author), USDA ARS, Southern Plains Agr Res Ctr, College Stn, TX 77845 USA.	haiqi.he@ars.usda.gov	Kogut, Michael H./Z-3119-2019	Kogut, Michael/0000-0001-5821-3728	USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported only by USDA-ARS intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbor TA, 2011, CELL MICROBIOL, V13, P1858, DOI 10.1111/j.1462-5822.2011.01701.x; Alam MS, 2008, MICROBIOL IMMUNOL, V52, P197, DOI 10.1111/j.1348-0421.2008.00030.x; Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; Alcaine SD, 2007, J FOOD PROTECT, V70, P780, DOI 10.4315/0362-028X-70.3.780; Babu US, 2006, DEV COMP IMMUNOL, V30, P942, DOI 10.1016/j.dci.2005.12.001; Bang IS, 2006, J BIOL CHEM, V281, P28039, DOI 10.1074/jbc.M605174200; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; *CDC, 2008, SALM SURV ANN SUMM 2; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Cooper KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022260; Das P, 2009, MICROBIOL-SGM, V155, P2476, DOI 10.1099/mic.0.029611-0; Du FY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000595; FDA, 2010, NAT ANT RES MON SYST; Foley S L, 2008, J Anim Sci, V86, pE173; Gantois I, 2008, AVIAN PATHOL, V37, P399, DOI 10.1080/03079450802216611; Gast PK, 2004, AVIAN DIS, V48, P863, DOI 10.1637/7204-05050R; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Haneda T, 2012, CELL MICROBIOL, V14, P485, DOI 10.1111/j.1462-5822.2011.01733.x; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; He HQ, 2012, FOODBORNE PATHOG DIS, V9, P1104, DOI 10.1089/fpd.2012.1233; He HQ, 2011, CYTOKINE, V53, P363, DOI 10.1016/j.cyto.2010.12.009; Henard CA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00084; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; KOGUT MH, 1995, J LEUKOCYTE BIOL, V57, P56, DOI 10.1002/jlb.57.1.56; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Lathers CM, 2001, J CLIN PHARMACOL, V41, P595, DOI 10.1177/00912700122010474; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Malik-Kale P, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00125; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Mijouin L, 2012, FASEB J, V26, P1569, DOI 10.1096/fj.11-189647; Mills PC, 2008, MICROBIOL-SGM, V154, P1218, DOI 10.1099/mic.0.2007/014290-0; Okamura M, 2005, VET IMMUNOL IMMUNOP, V107, P327, DOI 10.1016/j.vetimm.2005.05.009; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Rogers LD, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001668; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shames SR, 2009, INT J BIOCHEM CELL B, V41, P380, DOI 10.1016/j.biocel.2008.08.013; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Uchiya K, 2004, INFECT IMMUN, V72, P1964, DOI 10.1128/IAI.72.4.1964-1973.2004; Withanage GSK, 2005, BRIT POULTRY SCI, V46, P261, DOI 10.1080/00071660500098608; Wu HX, 2012, CELL MICROBIOL, V14, P28, DOI 10.1111/j.1462-5822.2011.01694.x	44	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58873	10.1371/journal.pone.0058873	http://dx.doi.org/10.1371/journal.pone.0058873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554945	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800041
J	Mallez, S; Castagnone, C; Espada, M; Vieira, P; Eisenback, JD; Mota, M; Guillemaud, T; Castagnone-Sereno, P				Mallez, Sophie; Castagnone, Chantal; Espada, Margarida; Vieira, Paulo; Eisenback, Jonathan D.; Mota, Manuel; Guillemaud, Thomas; Castagnone-Sereno, Philippe			First Insights into the Genetic Diversity of the Pinewood Nematode in Its Native Area Using New Polymorphic Microsatellite Loci	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS NEMATODA; APPROXIMATE BAYESIAN COMPUTATION; WILT DISEASE; POPULATION-STRUCTURE; WOOD NEMATODE; UNITED-STATES; DNA; COLEOPTERA; APHELENCHOIDIDAE; IDENTIFICATION	The pinewood nematode, Bursaphelenchus xylophilus, native to North America, is the causative agent of pine wilt disease and among the most important invasive forest pests in the East-Asian countries, such as Japan and China. Since 1999, it has been found in Europe in the Iberian Peninsula, where it also causes significant damage. In a previous study, 94 pairs of microsatellite primers have been identified in silico in the pinewood nematode genome. In the present study, specific PCR amplifications and polymorphism tests to validate these loci were performed and 17 microsatellite loci that were suitable for routine analysis of B. xylophilus genetic diversity were selected. The polymorphism of these markers was evaluated on nematodes from four field origins and one laboratory collection strain, all originate from the native area. The number of alleles and the expected heterozygosity varied between 2 and 11 and between 0.039 and 0.777, respectively. First insights into the population genetic structure of B. xylophilus were obtained using clustering and multivariate methods on the genotypes obtained from the field samples. The results showed that the pinewood nematode genetic diversity is spatially structured at the scale of the pine tree and probably at larger scales. The role of dispersal by the insect vector versus human activities in shaping this structure is discussed.	[Mallez, Sophie; Guillemaud, Thomas] INRA, UMR Inst Sophia Agrobiotech 1355, Equipe Biol Populat Introduites, Sophia Antipolis, France; [Mallez, Sophie; Castagnone, Chantal; Castagnone-Sereno, Philippe] INRA, UMR Inst Sophia Agrobiotech 1355, Equipe Interact Plantes Nematodes, Sophia Antipolis, France; [Mallez, Sophie; Castagnone, Chantal; Guillemaud, Thomas; Castagnone-Sereno, Philippe] Univ Nice Sophia Antipolis, UMR Inst Sophia Agrobiotech, Sophia Antipolis, France; [Mallez, Sophie; Castagnone, Chantal; Guillemaud, Thomas; Castagnone-Sereno, Philippe] CNRS, UMR 7254 Inst Sophia Agrobiotech, Sophia Antipolis, France; [Espada, Margarida; Vieira, Paulo; Mota, Manuel] Univ Evora Nucl Mitra, Inst Ciencias Agr & Ambientais Mediterra, NemaLab ICAAM, Evora, Portugal; [Eisenback, Jonathan D.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Evora; Virginia Polytechnic Institute & State University	Mallez, S (corresponding author), INRA, UMR Inst Sophia Agrobiotech 1355, Equipe Biol Populat Introduites, Sophia Antipolis, France.	sophie.mallez@sophia.inra.fr	Vieira, Paulo/I-7173-2019; Mota, Manuel/G-6031-2019; guillemaud, thomas/B-4899-2012	Vieira, Paulo/0000-0001-5627-2628; Mota, Manuel/0000-0002-4145-5031; guillemaud, thomas/0000-0003-0451-1644; Espada, Margarida/0000-0002-3826-711X	European Union [KBBE.2010.1.4-09 REPHRAME]	European Union(European Commission)	This work was supported by a grant from European Union (KBBE.2010.1.4-09 REPHRAME project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2011, PLANT DIS, V95, P776, DOI 10.1094/PDIS-12-10-0902; Beaumont MA, 2002, GENETICS, V162, P2025; Belkhir K, 1996, 5000 CNRS UMR U MONT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Castagnone C, 2005, EUR J PLANT PATHOL, V112, P191, DOI 10.1007/s10658-004-0580-2; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; Coe TS, 2009, ECOTOXICOLOGY, V18, P144, DOI 10.1007/s10646-008-0267-0; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DROPKIN VH, 1981, PLANT DIS, V65, P1022, DOI 10.1094/PD-65-1022; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans HF, 1996, OEPP EPPO B, V26, P199; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fonseca L, 2012, HELMINTHOLOGIA, V49, P96, DOI 10.2478/s11687-012-0020-3; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; He Y, 2003, NEMATOLOGY, V5, P809, DOI 10.1163/156854103773040718; Hunt D. J., 2007, Journal of Nematode Morphology and Systematics, V10, P99; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Jung J, 2010, ANIM CELLS SYST, V14, P31, DOI 10.1080/19768351003770889; Jung J, 2010, GENES GENOM, V32, P151, DOI 10.1007/s13258-009-0842-7; Karaiskou N, 2008, ANN ZOOL FENN, V45, P478, DOI 10.5735/086.045.0602; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kim KS, 2007, ENVIRON ENTOMOL, V36, P637, DOI 10.1603/0046-225X(2007)36[637:GDILCO]2.0.CO;2; Leach M, 2012, PLANT DIS, V96, P30, DOI 10.1094/PDIS-02-11-0132; LINIT MJ, 1988, J NEMATOL, V20, P227; Lombaert E, 2011, MOL ECOL, V20, P4654, DOI 10.1111/j.1365-294X.2011.05322.x; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Luikart G, 1999, TRENDS ECOL EVOL, V14, P253, DOI 10.1016/S0169-5347(99)01632-8; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; MAMIYA Y, 1976, JARQ, V10, P206; Mamiya Y., 1975, Japanese Journal of Nematology., V5, P16; MAMIYA Y, 1988, J NEMATOL, V20, P219; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; MAMIYA Y, 1972, Review of Plant Protection Research, V5, P46; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Metge K, 2008, PINE WILT DISEASE: A WORLDWIDE THREAT TO FOREST ECOSYSTEMS, P175, DOI 10.1007/978-1-4020-8455-3_15; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Mulet K, 2011, EUR J PLANT PATHOL, V129, P501, DOI 10.1007/s10658-010-9721-y; Naves PM, 2007, J APPL ENTOMOL, V131, P21, DOI 10.1111/j.1439-0418.2006.01111.x; Picard D, 2004, MOL ECOL, V13, P2899, DOI 10.1111/j.1365-294X.2004.02275.x; Plantard O, 2004, MOL ECOL, V13, P33, DOI 10.1046/j.1365-294X.2003.02023.x; Plantard O, 2003, MOL ECOL NOTES, V3, P139, DOI 10.1046/j.1471-8286.2003.00383.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2012, R LANG ENV STAT COMP; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Robertson L, 2011, NEMATOLOGY, V13, P755, DOI 10.1163/138855411X578888; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; SHIBATA E, 1986, APPL ENTOMOL ZOOL, V21, P184, DOI 10.1303/aez.21.184; Soliman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045505; Sousa E, 2001, NEMATOLOGY, V3, P89, DOI 10.1163/156854101300106937; Suzuki K., 2002, Dendrobiology, V48, P71; TARES S, 1992, HEREDITY, V68, P157, DOI 10.1038/hdy.1992.24; Thiery M, 2000, GENOME, V43, P160, DOI 10.1139/gen-43-1-160; Valadas V, 2013, J HELMINTHOL, V87, P457, DOI 10.1017/S0022149X12000673; Valadas V, 2012, NEMATOLOGY, P1; Vieira P, 2007, J NEMATOL, V39, P118; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WINGFIELD MJ, 1982, CAN J FOREST RES, V12, P71, DOI 10.1139/x82-010; Yoder M, 2006, NEMATOLOGY, V8, P367, DOI 10.1163/156854106778493448; Zhou ZH, 2007, PHYTOPATHOLOGY, V97, P304, DOI 10.1094/PHYTO-97-3-0304; [No title captured]	71	21	23	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59165	10.1371/journal.pone.0059165	http://dx.doi.org/10.1371/journal.pone.0059165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554990	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800065
J	Pavan, A; Contillo, A; Mather, G				Pavan, Andrea; Contillo, Adriano; Mather, George			Modelling Adaptation to Directional Motion Using the Adelson-Bergen Energy Sensor	PLOS ONE			English	Article							CAT STRIATE CORTEX; VISUAL-CORTEX; COMPLEX CELLS; TRANSPARENT MOTION; APPARENT MOTION; SINGLE CELLS; RESPONSES; DISCRIMINATION; NORMALIZATION; PERCEPTION	The motion energy sensor has been shown to account for a wide range of physiological and psychophysical results in motion detection and discrimination studies. It has become established as the standard computational model for retinal movement sensing in the human visual system. Adaptation effects have been extensively studied in the psychophysical literature on motion perception, and play a crucial role in theoretical debates, but the current implementation of the energy sensor does not provide directly for modelling adaptation-induced changes in output. We describe an extension of the model to incorporate changes in output due to adaptation. The extended model first computes a space-time representation of the output to a given stimulus, and then a RC gain-control circuit ("leaky integrator") is applied to the time-dependent output. The output of the extended model shows effects which mirror those observed in psychophysical studies of motion adaptation: a decline in sensor output during stimulation, and changes in the relative of outputs of different sensors following this adaptation.	[Pavan, Andrea; Contillo, Adriano] SISSA, I-34014 Trieste, Italy; [Pavan, Andrea] Univ Regensburg, Inst Psychol, D-93053 Regensburg, Germany; [Contillo, Adriano] Johannes Gutenberg Univ Mainz, PRISMA Cluster Excellence & Inst Phys THEP, D-55122 Mainz, Germany; [Mather, George] Lincoln Univ, Sch Psychol, Lincoln, England	International School for Advanced Studies (SISSA); University of Regensburg; Johannes Gutenberg University of Mainz; University of Lincoln	Pavan, A (corresponding author), SISSA, I-34014 Trieste, Italy.	andrea.pavan@psychologie.uni-regensburg.de	; Pavan, Andrea/Y-5507-2018	Mather, George/0000-0002-3102-4828; Pavan, Andrea/0000-0002-7697-6320; Pavan, Andrea/0000-0002-8257-8206	SISSA (International School for Advanced Studies); Alexander von Humboldt Foundation; University of Mainz; University of Lincoln; Wellcome Trust; Deutsche Forschungsgemeinschaft (DFG) within the Emmy-Noether program [SA/1975 1-1]	SISSA (International School for Advanced Studies); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); University of Mainz; University of Lincoln; Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft (DFG) within the Emmy-Noether program(German Research Foundation (DFG))	This research was supported by SISSA (International School for Advanced Studies), the Alexander von Humboldt Foundation, The University of Mainz, the University of Lincoln, and the Wellcome Trust. AC was also supported by the Deutsche Forschungsgemeinschaft (DFG) within the Emmy-Noether program (Grant SA/1975 1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; BERGEN JR, 1985, VISION RES, V25, P577, DOI 10.1016/0042-6989(85)90163-4; Challinor KL, 2010, VISION RES, V50, P1109, DOI 10.1016/j.visres.2010.04.002; de Grind WAV, 2003, VISION RES, V43, P117, DOI 10.1016/S0042-6989(02)00495-9; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; FUORTES MGF, 1964, J PHYSIOL-LONDON, V172, P239, DOI 10.1113/jphysiol.1964.sp007415; Garcia JO, 2009, EUR J NEUROSCI, V30, P1172, DOI 10.1111/j.1460-9568.2009.06893.x; Georgeson MA, 1999, VISION RES, V39, P4393, DOI 10.1016/S0042-6989(99)00147-9; GIASCHI D, 1993, J NEUROPHYSIOL, V70, P2024, DOI 10.1152/jn.1993.70.5.2024; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Heeger DJ, 1999, VISUAL NEUROSCI, V9, P181; HERSHENSON M, 1993, VISION RES, V33, P1913, DOI 10.1016/0042-6989(93)90018-R; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Mather G, 1998, MOTION AFTEREFFECT, P157; QIAN N, 1994, J NEUROSCI, V14, P7367; Rainville SJM, 2005, VISION RES, V45, P1115, DOI 10.1016/j.visres.2004.10.018; Rainville SJM, 2002, VISION RES, V42, P1727, DOI 10.1016/S0042-6989(02)00108-6; Rushton W. A. H., 1962, P ROY SOC LOND B BIO, V986, P20; STROUT JJ, 1994, VISION RES, V34, P3223, DOI 10.1016/0042-6989(94)90086-8; Takeuchi T, 1997, VISION RES, V37, P745, DOI 10.1016/S0042-6989(96)00207-6; TAYLOR MM, 1963, PERCEPT MOTOR SKILL, V16, P119, DOI 10.2466/pms.1963.16.1.119; van de Grind WA, 2004, VISION RES, V44, P2269, DOI 10.1016/j.visres.2004.04.012; vanWezel RJA, 1996, VISION RES, V36, P2805, DOI 10.1016/0042-6989(95)00324-X; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051	26	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59298	10.1371/journal.pone.0059298	http://dx.doi.org/10.1371/journal.pone.0059298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555013	Green Accepted, Green Published, gold			2022-12-25	WOS:000316409800081
J	Barca, L; Pezzulo, G; Castrataro, M; Rinaldi, P; Caselli, MC				Barca, Laura; Pezzulo, Giovanni; Castrataro, Marianna; Rinaldi, Pasquale; Caselli, Maria Cristina			Visual Word Recognition in Deaf Readers: Lexicality Is Modulated by Communication Mode	PLOS ONE			English	Article							ROUTE CASCADED MODEL; LANGUAGE; CHILDREN; COCHLEAR; ORGANIZATION; ACTIVATION; DYSLEXIA; IMPLANT; HEARING; AGE	Evidence indicates that adequate phonological abilities are necessary to develop proficient reading skills and that later in life phonology also has a role in the covert visual word recognition of expert readers. Impairments of acoustic perception, such as deafness, can lead to atypical phonological representations of written words and letters, which in turn can affect reading proficiency. Here, we report an experiment in which young adults with different levels of acoustic perception (i.e., hearing and deaf individuals) and different modes of communication (i.e., hearing individuals using spoken language, deaf individuals with a preference for sign language, and deaf individuals using the oral modality with less or no competence in sign language) performed a visual lexical decision task, which consisted of categorizing real words and consonant strings. The lexicality effect was restricted to deaf signers who responded faster to real words than consonant strings, showing over-reliance on whole word lexical processing of stimuli. No effect of stimulus type was found in deaf individuals using the oral modality or in hearing individuals. Thus, mode of communication modulates the lexicality effect. This suggests that learning a sign language during development shapes visuo-motor representations of words, which are tuned to the actions used to express them (phono-articulatory movements vs. hand movements) and to associated perceptions. As these visuo-motor representations are elicited during on-line linguistic processing and can overlap with the perceptual-motor processes required to execute the task, they can potentially produce interference or facilitation effects.	[Barca, Laura; Pezzulo, Giovanni; Castrataro, Marianna; Rinaldi, Pasquale; Caselli, Maria Cristina] Natl Res Council ISTC CNR, Inst Cognit Sci & Technol, Rome, Italy; [Pezzulo, Giovanni] Natl Res Council ILC CNR, Ist Linguist Computaz Antonio Zampolli, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Linguistica Computazionale "A. Zampolli" (ILC-CNR)	Barca, L (corresponding author), Natl Res Council ISTC CNR, Inst Cognit Sci & Technol, Rome, Italy.	laura.barca@istc.cnr.it	Barca, Laura/J-8274-2018; Pezzulo, Giovanni/F-6854-2014; Caselli, Maria Cristina/O-1373-2015; Pezzulo, Giovanni/AAY-3586-2020; Rinaldi, Pasquale/I-5907-2012	Barca, Laura/0000-0002-8553-7717; Pezzulo, Giovanni/0000-0001-6813-8282; Caselli, Maria Cristina/0000-0003-3460-0170; Pezzulo, Giovanni/0000-0001-6813-8282; Rinaldi, Pasquale/0000-0002-6544-7941	European's Community Seventh Framework Programme [PERG02-GA-2007-224919, FP7-270108]	European's Community Seventh Framework Programme	The research leading to these results was funded by the European's Community Seventh Framework Programme (FP7/2007-2013) under the grant agreement number PERG02-GA-2007-224919 (WoRHD) to Laura Barca; and number FP7-270108 (Goal-Leaders) to Giovanni Pezzulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Barca L, 2007, READ WRIT, V20, P495, DOI 10.1007/s11145-006-9040-z; Barca L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035932; Barca L, 2011, BRAIN LANG, V118, P53, DOI 10.1016/j.bandl.2010.09.003; Barca L, 2010, READ WRIT, V23, P569, DOI 10.1007/s11145-009-9192-8; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Beech J. R., 1997, J RES READ, V20, P105, DOI DOI 10.1111/1467-9817.00024; Bottari D, 2012, COGN NEUROSCI-UK, V3, P8, DOI 10.1080/17588928.2011.578209; Burani C, 2007, EUR J COGN PSYCHOL, V19, P828, DOI 10.1080/09541440600847946; CAMPBELL R, 1988, Q J EXP PSYCHOL-A, V40, P771, DOI 10.1080/14640748808402298; Caselli MC, 2012, J SPEECH LANG HEAR R, V55, P382, DOI 10.1044/1092-4388(2011/10-0248); Castles A, 1996, COGN NEUROPSYCHOL, V13, P25, DOI 10.1080/026432996382051; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Connor CM, 2006, EAR HEARING, V27, P628, DOI 10.1097/01.aud.0000240640.59205.42; Corina D, 2007, BRAIN RES, V1152, P111, DOI 10.1016/j.brainres.2007.03.054; Cornelissen PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005359; Cornoldi C., 1998, PROVE LETTURA MT; D'Ausillo A, 2009, CURR BIOL, V19, P381, DOI 10.1016/j.cub.2009.01.017; Elliott EA, 2012, J DEAF STUD DEAF EDU, V17, P227, DOI 10.1093/deafed/enr047; Filik R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025782; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Goswami U, 2008, ANN NY ACAD SCI, V1145, P1, DOI 10.1196/annals.1416.018; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Leybaert J, 2006, MARDAGA BELGIQUE, P223; Lopez-Crespo G, 2012, RES DEV DISABIL, V33, P362, DOI 10.1016/j.ridd.2011.10.022; Mazzotta S, 2005, PSICOLOGICA CLIN SVI, V2, P247; Miller P, 2006, J DEAF STUD DEAF EDU, V11, P21, DOI 10.1093/deafed/enj001; Miller Paul, 2002, J Deaf Stud Deaf Educ, V7, P312, DOI 10.1093/deafed/7.4.312; Morford JP, 2011, COGNITION, V118, P286, DOI 10.1016/j.cognition.2010.11.006; Neville HJ, 1998, P NATL ACAD SCI USA, V95, P922, DOI 10.1073/pnas.95.3.922; Nicholas JG, 2008, AM J SPEECH-LANG PAT, V17, P121, DOI 10.1044/1058-0360(2008/013); OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ormel E, 2010, J SPEECH LANG HEAR R, V53, P801, DOI 10.1044/1092-4388(2010/08-0033); Orsolini M, 2006, LANG COGNITIVE PROC, V21, P576, DOI 10.1080/01690960500139355; Pagliuca G, 2008, LANG COGNITIVE PROC, V23, P422, DOI 10.1080/01690960701626036; Pammer K, 2004, NEUROIMAGE, V22, P1819, DOI 10.1016/j.neuroimage.2004.05.004; Perfetti C A, 2000, J Deaf Stud Deaf Educ, V5, P32, DOI 10.1093/deafed/5.1.32; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; Pobric G, 2010, CURR BIOL, V20, P964, DOI 10.1016/j.cub.2010.03.070; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Raven J.C., 1998, ADV PROGR MATRICES; Rinaldi P, 2009, J DEAF STUD DEAF EDU, V14, P63, DOI 10.1093/deafed/enn019; Steinbrink C, 2012, BRAIN LANG, V121, P1, DOI 10.1016/j.bandl.2011.12.003; Transler C, 2005, BRIT J DEV PSYCHOL, V23, P525, DOI 10.1348/026151005X26796; Waters GF, READING ITS DEV COMP, P323; Wheat KL, 2010, J NEUROSCI, V30, P5229, DOI 10.1523/JNEUROSCI.4448-09.2010; Willems RM, 2007, BRAIN LANG, V101, P278, DOI 10.1016/j.bandl.2007.03.004; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Wilson T, 2005, EXP BRAIN RES, V162, P1, DOI 10.1007/s00221-004-2099-3; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	54	10	10	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59080	10.1371/journal.pone.0059080	http://dx.doi.org/10.1371/journal.pone.0059080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WV	23554976	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500066
J	Forrester, HB; Temple-Smith, P; Ham, S; de Kretser, D; Southwick, G; Sprung, CN				Forrester, Helen B.; Temple-Smith, Peter; Ham, Seungmin; de Kretser, David; Southwick, Graeme; Sprung, Carl N.			Genome-Wide Analysis Using Exon Arrays Demonstrates an Important Role for Expression of Extra-Cellular Matrix, Fibrotic Control and Tissue Remodelling Genes in Dupuytren's Disease	PLOS ONE			English	Article							COLLAGENASE CLOSTRIDIUM-HISTOLYTICUM; PERCUTANEOUS NEEDLE FASCIOTOMY; SMOOTH MUSCLE ACTIN; TGF-BETA; GROWTH-FACTOR; CONNECTIVE-TISSUE; ETIOLOGY; PROTEIN; EPIDEMIOLOGY; CONTRACTURE	Dupuytren's disease (DD) is a classic example of pathological fibrosis which results in a debilitating disorder affecting a large sector of the human population. It is characterized by excessive local proliferation of fibroblasts and over-production of collagen and other components of extracellular matrix (ECM) in the palmar fascia. The fibrosis progressively results in contracture of elements between the palmar fascia and skin causing flexion deformity or clawing of the fingers and a severe reduction in hand function. While much is known about the pathogenesis and surgical treatment of DD, little is known about the factors that cause its onset and progression, despite many years of research. Gene expression patterns in DD patients now offers the potential to identify genes that direct the pathogenesis of DD. In this study we used primary cultures of fibroblasts derived from excisional biopsies of fibrotic tissue from DD patients to compare the gene expression profiles on a genome-wide basis with normal control fibroblasts. Our investigations have identified genes that may be involved with DD pathogenesis including some which are directly relevant to fibrosis. In particular, these include significantly reduced expression levels of three matrix metallopeptidases (MMP1, MMP3, MMP16), follistatin, and STAT1, and significantly increased expression levels of fibroblast growth factors (FGF9, FGF11), a number of collagen genes and other ECM genes in DD patient samples. Many of these gene products are known to be involved in fibrosis, tumour formation and in the normal processes of tissue remodelling. In addition, alternative splicing was identified in some DD associated genes. These highly sensitive genomic investigations provide new insight into the molecular mechanisms that may underpin the development and progression of DD.	[Forrester, Helen B.; Sprung, Carl N.] Monash Univ, Monash Inst Med Res, Ctr Innate Immunol & Infect Dis, Clayton, Vic, Australia; [Temple-Smith, Peter; Ham, Seungmin] Monash Univ, Dept Obstet & Gynaecol, Southern Clin Sch, Monash Med Ctr, Clayton, Vic 3168, Australia; [Temple-Smith, Peter; Ham, Seungmin] Prince Henrys Inst, Clayton, Vic, Australia; [de Kretser, David] Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [de Kretser, David; Southwick, Graeme] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Temple-Smith, Peter; Southwick, Graeme] Melbourne Inst Plast Surg, Malvern, Vic, Australia	Monash University; Monash University; Prince Henry's Institute of Medical Research; Monash University; Monash University	Sprung, CN (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immunol & Infect Dis, Clayton, Vic, Australia.	carl.sprung@monash.edu	Ham, Seungmin/AAK-5928-2021	Ham, Seungmin/0000-0002-3548-3431; Southwick, Graeme/0000-0002-1207-5638; , Peter/0000-0002-4754-369X	round of the Priority-driven Collaborative Cancer Research Scheme [1002743]; Australian Government Department of Health and Ageing; Australian National Health and Medical Research Council [145780, 288713]; Australian National Breast Cancer Foundation [PG-08-06]; National Institute of Health [5U19AI067773-07]; Advanced Plastic Surgery Education Foundation; Victorian Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	round of the Priority-driven Collaborative Cancer Research Scheme; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Breast Cancer Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advanced Plastic Surgery Education Foundation; Victorian Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported through the 2010 round of the Priority-driven Collaborative Cancer Research Scheme (grant 1002743) and funded by the Australian Government Department of Health and Ageing with the assistance of Cancer Australia. Also, this work was supported by the Australian National Health and Medical Research Council (grant numbers 145780, 288713; http://www.nhmrc.gov.au/); the Australian National Breast Cancer Foundation (grant PG-08-06; http://www.nbcf.org.au/); and the National Institute of Health (grant 5U19AI067773-07) and a grant from the Advanced Plastic Surgery Education Foundation. Support was also provided by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama S K, 1996, Hum Cell, V9, P181; Al-Qattan MM, 2006, J HAND SURG-AM, V31A, P1527, DOI 10.1016/j.jhsa.2006.08.012; Anthony Shawn G, 2008, Hand (N Y), V3, P87, DOI 10.1007/s11552-007-9076-9; Antsiferova M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1585; Aoki F, 2005, AM J RESP CRIT CARE, V172, P713, DOI 10.1164/rccm.200412-1620OC; Augoff K, 2005, PLAST RECONSTR SURG, V115, P128, DOI 10.1097/01.PRS.0000146038.61595.4A; BADALAMENTE MA, 1992, J HAND SURG-AM, V17A, P317, DOI 10.1016/0363-5023(92)90414-K; Bainbridge C, 2012, J PLAST SURG HAND SU; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; BAZIN S, 1980, EUR J CLIN INVEST, V10, P9, DOI 10.1111/j.1365-2362.1980.tb00317.x; Bengtsson H, 2006, AROMA AFFYMETRIS GEN, P745; Bisson MA, 2003, J HAND SURG-BRIT EUR, V28B, P351, DOI 10.1016/S0266-7681(03)00135-9; BOCANEGRA TS, 1981, J RHEUMATOL, V8, P1026; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Burge P, 1999, HAND CLIN, V15, P63; CHAMMAS M, 1995, J HAND SURG-AM, V20A, P109, DOI 10.1016/S0363-5023(05)80068-1; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Coleman S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-61; Desai SS, 2011, J HAND SURG-AM, V36A, P936, DOI 10.1016/j.jhsa.2011.03.002; Desai SS, 2010, EXPERT OPIN BIOL TH, V10, P1395, DOI 10.1517/14712598.2010.510509; Dolmans GH, 2011, NEW ENGL J MED, V365, P307, DOI 10.1056/NEJMoa1101029; Forrester HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053358; Forsman M, 2008, J SURG RES, V146, P271, DOI 10.1016/j.jss.2007.06.022; Gilpin D, 2010, J HAND SURG-AM, V35A, P2027, DOI 10.1016/j.jhsa.2010.08.007; Grootaert C, 2012, EXPERT REV PROTEOMIC, V9, P181, DOI [10.1586/epr.12.12, 10.1586/EPR.12.12]; Gudmundsson KG, 2000, J CLIN EPIDEMIOL, V53, P291, DOI 10.1016/S0895-4356(99)00145-6; Hindocha Sandip, 2009, Hand (N Y), V4, P256, DOI 10.1007/s11552-008-9160-9; Hueston JT, 1963, DUPUYTRENS CONTNRACT; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Johnston P, 2008, J HAND SURG-AM, V33A, P1160, DOI 10.1016/j.jhsa.2008.04.002; Johnston P, 2007, J HAND SURG-AM, V32A, P343, DOI 10.1016/j.jhsa.2006.12.010; Krause C, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-14; LAWLER J, 1995, J BIOL CHEM, V270, P2809, DOI 10.1074/jbc.270.6.2809; Lee LC, 2006, J HAND SURG-AM, V31A, P211, DOI 10.1016/j.jhsa.2005.09.007; LING RSM, 1963, J BONE JOINT SURG BR, V45, P709, DOI 10.1302/0301-620X.45B4.709; Ludlow H, 2009, CLIN ENDOCRINOL, V71, P867, DOI 10.1111/j.1365-2265.2009.03567.x; MURPHY G, 1987, BIOCHEM J, V248, P265, DOI 10.1042/bj2480265; MURRELL GAC, 1987, BMJ-BRIT MED J, V295, P1373, DOI 10.1136/bmj.295.6610.1373; MURRELL GAC, 1990, AUST NZ J SURG, V60, P247, DOI 10.1111/j.1445-2197.1990.tb07362.x; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; NOBLE J, 1984, J BONE JOINT SURG BR, V66, P322, DOI 10.1302/0301-620X.66B3.6725338; O'Gorman DB, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-13; Pan D, 2003, ANN PLAS SURG, V50, P618, DOI 10.1097/01.SAP.0000069066.35253.B3; Patella S, 2006, AM J PHYSIOL-GASTR L, V290, pG137, DOI 10.1152/ajpgi.00080.2005; Pegorier S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-85; Qian A, 2004, UROLOGY, V64, P399, DOI 10.1016/j.urology.2004.04.006; Ratkaj I, 2012, CELL PHYSIOL BIOCHEM, V30, P927, DOI 10.1159/000341470; Rayan Ghazi M, 2007, J Bone Joint Surg Am, V89, P189; Rayan GM, 1999, HAND CLIN, V15, P87; Rehman S, 2012, MOL BIOSYST; Rehman S, 2008, J HAND SURG-AM, V33A, P359, DOI 10.1016/j.jhsa.2007.11.010; Ross DC, 1999, HAND CLIN, V15, P53; Rozen WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043406; Satish L, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-113; Satish L, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-10; Sgonc R, 2008, RHEUMATOLOGY, V47, pV5, DOI 10.1093/rheumatology/ken275; Shih B, 2012, ANN RHEUM DIS; Shih B, 2009, J HAND SURG-AM, V34A, P124, DOI 10.1016/j.jhsa.2008.09.017; Slattery D, 2010, ANZ J SURG, V80, P495, DOI 10.1111/j.1445-2197.2010.05364.x; Sprung CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025758; Sprung CN, 2005, CLIN CANCER RES, V11, P6352, DOI 10.1158/1078-0432.CCR-04-1931; Thurston AJ, 2003, J BONE JOINT SURG BR, V85B, P469, DOI 10.1302/0301-620X.85B4.14215; Townley WA, 2006, BRIT MED J, V332, P397, DOI 10.1136/bmj.332.7538.397; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Van Rijssen AL, 2006, J HAND SURG-BRIT EUR, V31B, P498, DOI 10.1016/j.jhsb.2006.03.174; van Rijssen AL, 2006, J HAND SURG-AM, V31A, P717, DOI 10.1016/j.jhsa.2006.02.021; Yi IS, 1999, HAND CLIN, V15, P43; Zhang AY, 2008, J HAND SURG-EUR VOL, V33E, P783, DOI 10.1177/1753193408091352	70	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59056	10.1371/journal.pone.0059056	http://dx.doi.org/10.1371/journal.pone.0059056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554969	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500063
J	Herath, TDK; Darveau, RP; Seneviratne, CJ; Wang, CY; Wang, Y; Jin, LJ				Herath, Thanuja D. K.; Darveau, Richard P.; Seneviratne, Chaminda J.; Wang, Cun-Yu; Wang, Yu; Jin, Lijian			Tetra- and Penta-Acylated Lipid A Structures of Porphyromonas gingivalis LPS Differentially Activate TLR4-Mediated NF-kappa B Signal Transduction Cascade and Immuno-Inflammatory Response in Human Gingival Fibroblasts	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; LIPOPOLYSACCHARIDE-BINDING PROTEIN; GRAM-NEGATIVE BACTERIA; INNATE HOST-DEFENSE; ESCHERICHIA-COLI; GENE-EXPRESSION; PERIODONTAL-DISEASE; HETEROGENEOUS EXPRESSION; INTERLEUKIN-8 SECRETION; CELL ACTIVATION	Background: Porphyromonas gingivalis is a major pathogen of periodontal disease that affects a majority of adults worldwide. Increasing evidence shows that periodontal disease is linked to various systemic diseases like diabetes and cardiovascular disease, by contributing to increased systemic levels of inflammation. Lipopolysaccharides (LPS), as a key virulent attribute of P. gingivalis, possesses significant amount of lipid A heterogeneity containing tetra- (LPS1435/1449) and penta-acylated (LPS1690) structures. Hitherto, the exact molecular mechanism of P. gingivalis LPS involved in periodontal pathogenesis remains unclear, due to limited understanding of the specific receptors and signaling pathways involved in LPS-host cell interactions. Methodology/Principal Findings: This study systematically investigated the effects of P. gingivalis LPS1435/1449 and LPS1690 on the expression of TLR2 and TLR4 signal transduction and the activation of pro-inflammatory cytokines IL-6 and IL-8 in human gingival fibroblasts (HGFs). We found that LPS1435/1449 and LPS1690 differentially modulated TLR2 and TLR4 expression. NF-kappa B pathway was significantly activated by LPS1690 but not by LPS1435/1449. In addition, LPS1690 induced significant expression of NF-kappa B and p38 MPAK pathways-related genes, such as NFKBIA, NFKB1, IKBKB, MAP2K4 and MAPK8. Notably, the pro-inflammatory genes including GM-CSF, CXCL10, G-CSF, IL-6, IL-8 and CCL2 were significantly upregulated by LPS1690 while down-regulated by LPS1435/1449. Blocking assays confirmed that TLR4-mediated NF-kappa B signaling was vital in LPS1690-induced expression of IL-6 and IL-8 in HGFs. Conclusions/Significance: The present study suggests that the tetra-and penta-acylated lipid A structures of P. gingivalis LPS differentially activate TLR4-mediated NF-kappa B signaling pathway, and significantly modulate the expression of IL-6 and IL-8 in HGFs. The ability to alter the lipid A structure of LPS could be one of the strategies carried-out by P. gingivalis to evade innate host defense in gingival tissues, thereby contributing to periodontal pathogenesis.	[Herath, Thanuja D. K.; Seneviratne, Chaminda J.; Jin, Lijian] Univ Hong Kong, Fac Dent, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Darveau, Richard P.] Univ Washington, Sch Dent, Seattle, WA 98195 USA; [Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Wang, Yu] Univ Hong Kong, Dept Pharmacol & Pharm, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of Hong Kong	Jin, LJ (corresponding author), Univ Hong Kong, Fac Dent, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	ljjin@hkucc.hku.hk		wang, yu/0000-0001-8697-2940; /0000-0003-0816-538X	Hong Kong Research Grants Council [HKU766909M, HKU768411M, HKU767512M]; Modern Dental Laboratory/HKU Endowment Fund; Southeast Asian Division of the International Association for Dental Research (IADR-SEA) Unilever/Hatton Divisional Award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012768] Funding Source: NIH RePORTER	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Modern Dental Laboratory/HKU Endowment Fund; Southeast Asian Division of the International Association for Dental Research (IADR-SEA) Unilever/Hatton Divisional Award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Hong Kong Research Grants Council (HKU766909M, HKU768411M and HKU767512M to LJJ) (http://www.ugc.edu.hk/eng/rgc/index.htm) and the Modern Dental Laboratory/HKU Endowment Fund to LJJ. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors would like to thank Mr. Raymond Tong and Mr. Alan Wong from the Faculty of Dentistry, The University of Hong Kong, for their technical assistance. We are grateful to Dr. David Green for proofreading the manuscript. This study received the Southeast Asian Division of the International Association for Dental Research (IADR-SEA) Unilever/Hatton Divisional Award in 2011.	Al-Qutub MN, 2006, INFECT IMMUN, V74, P4474, DOI 10.1128/IAI.01924-05; Ara T, 2009, J PERIODONTAL RES, V44, P21, DOI 10.1111/j.1600-0765.2007.01041.x; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Bainbridge BW, 2006, CELL MICROBIOL, V8, P120, DOI 10.1111/j.1462-5822.2005.00605.x; Bainbridge BW, 2001, ACTA ODONTOL SCAND, V59, P131, DOI 10.1080/000163501750266710; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Baluchamy S, 2010, IN VITRO CELL DEV-AN, V46, P718, DOI 10.1007/s11626-010-9330-2; Berezow AB, 2009, MICROB PATHOGENESIS, V47, P68, DOI 10.1016/j.micpath.2009.04.015; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Burns E, 2010, J IMMUNOL, V184, P1455, DOI 10.4049/jimmunol.0900378; CAROFF M, 1988, CARBOHYD RES, V175, P273, DOI 10.1016/0008-6215(88)84149-1; Chen C, 2007, CELL MICROBIOL, V9, P1028, DOI 10.1111/j.1462-5822.2006.00849.x; Coats SR, 2003, INFECT IMMUN, V71, P6799, DOI 10.1128/IAI.71.12.6799-6807.2003; Coats SR, 2011, INFECT IMMUN, V79, P203, DOI 10.1128/IAI.00937-10; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Curtis MA, 2011, CELL HOST MICROBE, V10, P302, DOI 10.1016/j.chom.2011.09.008; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Darveau RP, 2002, INFECT IMMUN, V70, P1867, DOI 10.1128/IAI.70.4.1867-1873.2002; Di Domenico G, 2003, Minerva Stomatol, V52, P81; Di Domenico G, 2003, MINERVA STOMATOL, V52, P87; Dixon DR, 2005, J DENT RES, V84, P584, DOI 10.1177/154405910508400702; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Erridge C, 2007, CARDIOVASC RES, V73, P181, DOI 10.1016/j.cardiores.2006.11.004; Faria Morandini AC, 2012, J PERIODONTOL; Gibson FC, 2007, CURR PHARM DESIGN, V13, P3665, DOI 10.2174/138161207783018554; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; Hajishengallis G, 2002, INFECT IMMUN, V70, P6658, DOI 10.1128/IAI.70.12.6658-6664.2002; Hajishengallis G, 2011, J ORAL BIOSCI, V53, P233, DOI 10.2330/joralbiosci.53.233; Hajishengallis G, 2009, MICROBES INFECT, V11, P637, DOI 10.1016/j.micinf.2009.03.009; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hatakeyama J, 2003, ORAL MICROBIOL IMMUN, V18, P14, DOI 10.1034/j.1399-302X.2003.180103.x; Hayashi J, 1996, INFECT IMMUN, V64, P4946, DOI 10.1128/IAI.64.12.4946-4951.1996; Herath TDK, 2011, J CLIN PERIODONTOL, V38, P694, DOI 10.1111/j.1600-051X.2011.01741.x; Heumann D, 2002, CLIN CHIM ACTA, V323, P59, DOI 10.1016/S0009-8981(02)00180-8; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002; Kocgozlu L, 2009, J DENT RES, V88, P741, DOI 10.1177/0022034509341166; Kumada H, 2008, ORAL MICROBIOL IMMUN, V23, P60, DOI 10.1111/j.1399-302X.2007.00392.x; KUMADA H, 1995, J BACTERIOL, V177, P2098, DOI 10.1128/jb.177.8.2098-2106.1995; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Liu RK, 2008, J PERIODONTOL, V79, P1241, DOI [10.1902/jop.2008.070575, 10.1902/jop.2008.070575 ]; Lu Q, 2009, INNATE IMMUN-LONDON, V15, P325, DOI 10.1177/1753425909104899; Mahanonda R, 2007, J IMMUNOL, V178, P1151, DOI 10.4049/jimmunol.178.2.1151; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Nemoto E, 2006, J DENT RES, V85, P733, DOI 10.1177/154405910608500809; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Ogawa T, 2002, INT IMMUNOL, V14, P1325, DOI 10.1093/intimm/dxf097; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; Reife RA, 2006, CELL MICROBIOL, V8, P857, DOI 10.1111/j.1462-5822.2005.00672.x; REIFE RA, 1995, INFECT IMMUN, V63, P4686, DOI 10.1128/IAI.63.12.4686-4694.1995; Ren L, 2005, J PERIODONTAL RES, V40, P407, DOI 10.1111/j.1600-0765.2005.00822.x; Ren L, 2009, J CLIN PERIODONTOL, V36, P619, DOI 10.1111/j.1600-051X.2009.01436.x; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; RIETSCHEL ET, 1992, SCI AM, V267, P54, DOI 10.1038/scientificamerican0892-54; Sawada N, 2007, CLIN EXP IMMUNOL, V148, P529, DOI 10.1111/j.1365-2249.2007.03346.x; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; SCHWARTZ J, 1972, J PERIODONTOL, V43, P270, DOI 10.1902/jop.1972.43.5.270; Seydel U, 2000, CHEM IMMUNOL, V74, P5; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Sugawara S, 1998, INFECT IMMUN, V66, P3043, DOI 10.1128/IAI.66.7.3043-3049.1998; Tabeta K, 2000, INFECT IMMUN, V68, P3731, DOI 10.1128/IAI.68.6.3731-3735.2000; TAMURA M, 1992, INFECT IMMUN, V60, P4932, DOI 10.1128/IAI.60.11.4932-4937.1992; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Uehara A, 2007, J DENT RES, V86, P249, DOI 10.1177/154405910708600310; Wang PL, 2001, BIOCHEM BIOPH RES CO, V288, P863, DOI 10.1006/bbrc.2001.5842; Wang PL, 2002, CRIT REV ORAL BIOL M, V13, P132, DOI 10.1177/154411130201300204; Wang PL, 2000, BIOCHEM BIOPH RES CO, V273, P1161, DOI 10.1006/bbrc.2000.3060; Yamagishi VTK, 2011, J ENDODONT, V37, P812, DOI 10.1016/j.joen.2011.03.013; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i; Zhang D, 2008, INNATE IMMUN-LONDON, V14, P99, DOI 10.1177/1753425907088244; Zhang YH, 2008, ORG BIOMOL CHEM, V6, P3371, DOI 10.1039/b809090d	79	111	113	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58496	10.1371/journal.pone.0058496	http://dx.doi.org/10.1371/journal.pone.0058496			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554896	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500026
J	Naidoo, K; Steenkamp, ET; Coetzee, MPA; Wingfield, MJ; Wingfield, BD				Naidoo, Kershney; Steenkamp, Emma T.; Coetzee, Martin P. A.; Wingfield, Michael J.; Wingfield, Brenda D.			Concerted Evolution in the Ribosomal RNA Cistron	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACERS; GENE CONVERSION; DEATH EVOLUTION; BIRTH; DNA; MECHANISM; FAMILY; RDNA; POLYMORPHISM; CHROMOSOMES	Background: Gene conversion is the mechanism proposed to be responsible for the homogenization of multigene families such as the nuclear ribosomal gene clusters. This concerted evolutionary process prevents individual genes in gene clusters from accumulating mutations. The mechanism responsible for concerted evolution is not well understood but recombination during meiosis has been hypothesized to play a significant role in this homogenization. In this study we tested the hypothesis of unequal crossing over playing a significant role in gene conversion events within the ribosomal RNA cistron during meiosis, mitosis or both life stages in the fungal tree pathogen Ceratocystis manginecans. Methods: Ceratocystis manginecans, a haploid ascomycete, reproduces homothallically and was found to have two distinct sequences within the internally transcribed spacer (ITS) region of the ribosomal RNA cistron. The different ITS types were scored using PCR-RFLP assays and chi-square analyses to determine the level of significance of the changes in the ratios of the ITS types. Results: The relative ratios of the two ITS sequence types changed when the fungal isolates were cultured vegetatively or allowed to produced sexual structures and spores. These active changes were shown to occur more frequently during meiosis than mitosis. Conclusion: The evidence presented provides concrete support for homogenization in the rRNA gene clusters found in this fungus and that the most reasonable explanation for this process is unequal crossing over.	[Naidoo, Kershney; Coetzee, Martin P. A.; Wingfield, Michael J.; Wingfield, Brenda D.] Univ Pretoria, Fac Nat & Agr Sci, Dept Genet, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa; [Steenkamp, Emma T.] Univ Pretoria, Dept Microbiol & Plant Pathol, Fac Nat & Agr Sci, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	Wingfield, BD (corresponding author), Univ Pretoria, Fac Nat & Agr Sci, Dept Genet, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa.	brenda.wingfield@fabi.up.ac.za	Naidoo, Kershney/P-8002-2016; Wingfield, Brenda D./B-1376-2008; Wingfield, Michael J/A-9473-2008; Steenkamp, Emma T/B-7958-2009; Coetzee, Martin P.A./B-1732-2008	Naidoo, Kershney/0000-0002-2668-5592; Wingfield, Brenda D./0000-0002-6189-1519; Steenkamp, Emma T/0000-0003-0217-8219; Coetzee, Martin P.A./0000-0001-7848-4111	Department of Science and Technology (DST)/National Research Foundation (NRF); Centre of Excellene in Tree Health Biotechnology (CTHB); Improving Academic Qualifications (IAQ) NRF grant	Department of Science and Technology (DST)/National Research Foundation (NRF); Centre of Excellene in Tree Health Biotechnology (CTHB); Improving Academic Qualifications (IAQ) NRF grant	This work was supported by members of the Tree Protection Co-operation Programme (TPCP), the Department of Science and Technology (DST)/National Research Foundation (NRF), the Centre of Excellene in Tree Health Biotechnology (CTHB) and the Improving Academic Qualifications (IAQ) NRF grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2001, MYCOL RES, V105, P284, DOI 10.1017/S0953756201003628; ARNHEIM N, 1980, P NATL ACAD SCI-BIOL, V77, P7323, DOI 10.1073/pnas.77.12.7323; BROWN DD, 1972, J MOL BIOL, V63, P57, DOI 10.1016/0022-2836(72)90521-9; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Cronn RC, 1996, J MOL EVOL, V42, P685, DOI 10.1007/BF02338802; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; Ganley ARD, 2011, MOL BIOL EVOL, V28, P2883, DOI 10.1093/molbev/msr117; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Innan H, 2011, GENES-BASEL, V2, P394, DOI 10.3390/genes2020394; LaFave M, 2009, PLOS GENET, V5, P1; Lange C, 2011, MOL MICROBIOL, V80, P666, DOI 10.1111/j.1365-2958.2011.07600.x; Liao D, 2003, NATURE ENCY HUMAN GE, P938; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Lichten M, 2001, CURR BIOL, V11, pR253, DOI 10.1016/S0960-9822(01)00131-2; LINDEGREN CC, 1953, J GENET, V51, P625, DOI 10.1007/BF02982949; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nei M, 2000, P NATL ACAD SCI USA, V97, P10866, DOI 10.1073/pnas.97.20.10866; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Odorico DM, 1997, MOL BIOL EVOL, V14, P465, DOI 10.1093/oxfordjournals.molbev.a025783; Pinhal D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-151; Queiroz CD, 2011, MOL PHYLOGENET EVOL, V59, P293, DOI 10.1016/j.ympev.2011.01.013; *R DEV COR TEAM, 2007, LANG ENV STAT COMP; RITOSSA FM, 1968, P NATL ACAD SCI USA, V60, P509, DOI 10.1073/pnas.60.2.509; Rooney AP, 2005, P NATL ACAD SCI USA, V102, P5084, DOI 10.1073/pnas.0409689102; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sokal R. R., 2012, BIOMETRY; SZOSTAK JW, 1980, NATURE, V284, P426, DOI 10.1038/284426a0; TARTOF KD, 1974, P NATL ACAD SCI USA, V71, P1272, DOI 10.1073/pnas.71.4.1272; TARTOF KD, 1988, GENETICS, V120, P1; van Wyk M, 2006, FUNGAL DIVERS, V21, P181; van Wyk M, 2007, FUNGAL DIVERS, V27, P213; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Witthuhn RC, 2000, CURR GENET, V38, P48, DOI 10.1007/s002940000131; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	42	50	53	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59355	10.1371/journal.pone.0059355	http://dx.doi.org/10.1371/journal.pone.0059355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555022	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500084
J	Vigueira, CC; Rauh, B; Mitchell-Olds, T; Lawton-Rauh, AL				Vigueira, Cynthia C.; Rauh, Brad; Mitchell-Olds, Thomas; Lawton-Rauh, Amy L.			Signatures of Demography and Recombination at Coding Genes in Naturally-Distributed Populations of Arabidopsis Lyrata Subsp Petraea	PLOS ONE			English	Article							GENOME-WIDE DEPARTURE; NUCLEOTIDE POLYMORPHISM; LINKAGE DISEQUILIBRIUM; STATISTICAL PROPERTIES; HELIANTHUS-ANNUUS; REGULATORY GENES; NEUTRAL MODEL; PATTERNS; DNA; DIVERSITY	Demography impacts the observed standing level of genetic diversity present in populations. Distinguishing the relative impacts of demography from selection requires a baseline of expressed gene variation in naturally occurring populations. Six nuclear genes were sequenced to estimate the patterns and levels of genetic diversity in natural Arabidopsis lyrata subsp. petraea populations that differ in demographic histories since the Pleistocene. As expected, northern European populations have genetic signatures of a strong population bottleneck likely due to glaciation during the Pleistocene. Levels of diversity in the northern populations are about half of that in central European populations. Bayesian estimates of historical population size changes indicate that central European populations also have signatures of population size change since the last glacial maxima, suggesting that these populations are not as stable as previously thought. Time since divergence amongst northern European populations is higher than amongst central European populations, suggesting that the northern European populations were established before the Pleistocene and survived glaciation in small separated refugia. Estimates of demography based on expressed genes are complementary to estimates based on microsatellites and transposable elements, elucidating temporal shifts in population dynamics and confirming the importance of marker selection for tests of demography.	[Vigueira, Cynthia C.; Rauh, Brad; Lawton-Rauh, Amy L.] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; [Vigueira, Cynthia C.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Rauh, Brad] Clemson Univ, Dept Hort, Clemson, SC 29634 USA; [Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Durham, NC USA	Clemson University; Washington University (WUSTL); Clemson University; Duke University	Lawton-Rauh, AL (corresponding author), Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA.	amylr@clemson.edu	; Mitchell-Olds, Thomas/K-8121-2012	Lawton-Rauh, Amy/0000-0003-4610-7367; Mitchell-Olds, Thomas/0000-0003-3439-9921	Clemson University; Calhoun Honors College Departmental Honors Research program; HHMI/SCLife program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086496] Funding Source: NIH RePORTER	Clemson University; Calhoun Honors College Departmental Honors Research program; HHMI/SCLife program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank the following people for generously providing seeds from collected A. l. petraea populations: Maria J. Clauss (also provided seeds from the trio families used in this study), Marcus Koch, Sebastian Ramos-Onsins, and Outi Savolainen. We would also like to thank all undergraduate researchers who helped contribute to the data collection for this project: Peter Wehner (University of Jena, Germany) and at Clemson University: Sarah Walker, Margaret Beaudrot, and Kyle Gettler. The Clemson University undergraduates on this project were supported by internal internship grants from Clemson University, including the Calhoun Honors College Departmental Honors Research program, and the HHMI/SCLife program.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Andolfatto P, 2000, GENETICS, V156, P257; Ansell SW, 2010, HEREDITY, V105, P543, DOI 10.1038/hdy.2010.10; Arunyawat U, 2007, MOL BIOL EVOL, V24, P2310, DOI 10.1093/molbev/msm162; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Bomblies K, 2007, CURR OPIN GENET DEV, V17, P500, DOI 10.1016/j.gde.2007.09.006; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heidel AJ, 2010, MOL ECOL, V19, P3364, DOI 10.1111/j.1365-294X.2010.04761.x; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 1997, GENETICS, V145, P833; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; Ikeda H, 2009, MOL BIOL EVOL, V26, P2207, DOI 10.1093/molbev/msp128; Ingvarsson PK, 2008, GENETICS, V180, P329, DOI 10.1534/genetics.108.090431; JUKES T H, 1969, P21; Keller SR, 2010, MOL ECOL, V19, P1212, DOI 10.1111/j.1365-294X.2010.04546.x; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Koch MA, 2007, P NATL ACAD SCI USA, V104, P6272, DOI 10.1073/pnas.0701338104; Lawton-Rauh A, 2007, MOL ECOL, V16, P3995, DOI 10.1111/j.1365-294X.2007.03445.x; Lawton-Rauh A, 2003, MOL ECOL, V12, P1301, DOI 10.1046/j.1365-294X.2003.01814.x; Lawton-Rauh A, 2008, CURR OPIN PLANT BIOL, V11, P103, DOI 10.1016/j.pbi.2008.02.009; Leinonen PH, 2009, AM J BOT, V96, P1129, DOI 10.3732/ajb.0800080; Lockton S, 2008, P NATL ACAD SCI USA, V105, P13965, DOI 10.1073/pnas.0804671105; Mable BK, 2007, MOL ECOL, V16, P3565, DOI 10.1111/j.1365-294X.2007.03416.x; Mitchell-Olds T, 2001, TRENDS ECOL EVOL, V16, P693, DOI 10.1016/S0169-5347(01)02291-1; Muller MH, 2008, HEREDITY, V100, P47, DOI 10.1038/sj.hdy.6801057; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ross-Ibarra J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002411; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Scascitelli M, 2010, MOL ECOL, V19, P521, DOI 10.1111/j.1365-294X.2009.04504.x; Schmid K, 2006, THEOR APPL GENET, V112, P1104, DOI 10.1007/s00122-006-0212-7; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Shimizu KK, 2002, POPUL ECOL, V44, P221, DOI 10.1007/s101440200025; Stadler T, 2008, GENETICS, V178, P339, DOI 10.1534/genetics.107.081810; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strasburg JL, 2008, EVOLUTION, V62, P1936, DOI 10.1111/j.1558-5646.2008.00415.x; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Strasburg JL, 2010, MOL BIOL EVOL, V27, P297, DOI 10.1093/molbev/msp233; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Wang WK, 2010, NEW PHYTOL, V188, P488, DOI 10.1111/j.1469-8137.2010.03383.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wright SI, 2005, MOL BIOL EVOL, V22, P506, DOI 10.1093/molbev/msi035	60	6	7	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58916	10.1371/journal.pone.0058916	http://dx.doi.org/10.1371/journal.pone.0058916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554957	Green Submitted, gold, Green Published			2022-12-25	WOS:000316252500056
J	Breig, O; Baklouti, F				Breig, Osman; Baklouti, Faouzi			Proteasome-Mediated Proteolysis of SRSF5 Splicing Factor Intriguingly Co-occurs with SRSF5 mRNA Upregulation during Late Erythroid Differentiation	PLOS ONE			English	Article							MURINE ERYTHROLEUKEMIA-CELLS; SR PROTEIN FAMILY; GENE-EXPRESSION; ISOFORM EXPRESSION; FACTOR SRP40; BETA-II; ENHANCER; NUCLEAR; PHOSPHORYLATION; IDENTIFICATION	SR proteins exhibit diverse functions ranging from their role in constitutive and alternative splicing, to virtually all aspects of mRNA metabolism. These findings have attracted growing interest in deciphering the regulatory mechanisms that control the tissue-specific expression of these SR proteins. In this study, we show that SRSF5 protein decreases drastically during erythroid cell differentiation, contrasting with a concomitant upregulation of SRSF5 mRNA level. Proteasome chemical inhibition provided strong evidence that endogenous SRSF5 protein, as well as protein deriving from stably transfected SRSF5 cDNA, are both targeted to proteolysis as the cells undergo terminal differentiation. Consistently, functional experiments show that overexpression of SRSF5 enhances a specific endogenous pre-mRNA splicing event in proliferating cells, but not in differentiating cells, due to proteasome-mediated targeting of both endogenous and transfection-derived SRSF5. Further investigation of the relationship between SRSF5 structure and its post-translation regulation and function, suggested that the RNA recognition motifs of SRSF5 are sufficient to activate pre-mRNA splicing, whereas proteasome-mediated proteolysis of SRSF5 requires the presence of the C-terminal RS domain of the protein. Phosphorylation of SR proteins is a key post-translation regulation that promotes their activity and subcellular availability. We here show that inhibition of the CDC2-like kinase (CLK) family and mutation of the AKT phosphorylation site Ser86 on SRSF5, have no effect on SRSF5 stability. We reasoned that at least AKT and CLK signaling pathways are not involved in proteasome-induced turnover of SRSF5 during late erythroid development.	[Breig, Osman; Baklouti, Faouzi] Univ Lyon 1, CNRS, UMR, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Baklouti, F (corresponding author), Univ Lyon 1, CNRS, UMR, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France.	faouzi.baklouti@univ-lyon1.fr	BAKLOUTI, Faouzi/E-7670-2013	BAKLOUTI, Faouzi/0000-0002-2830-292X	Ligue Nationale Contre le Cancer, Comite de la Loire; INSERM	Ligue Nationale Contre le Cancer, Comite de la Loire; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from the Ligue Nationale Contre le Cancer, Comite de la Loire. OB and FB were supported by the Ligue Nationale Contre le Cancer, Comite de la Loire and the INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baklouti F, 1996, BLOOD, V87, P3934, DOI 10.1182/blood.V87.9.3934.bloodjournal8793934; Baldin V, 2008, MOL BIOL CELL, V19, P1706, DOI 10.1091/mbc.E07-07-0637; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Blaustein M, 2007, INT J BIOCHEM CELL B, V39, P2031, DOI 10.1016/j.biocel.2007.04.004; Blaybel R, 2008, CELL RES, V18, P834, DOI 10.1038/cr.2008.68; Bourgeois CF, 1999, MOL CELL BIOL, V19, P7347; Breig O, 2010, ONCOGENE, V29, P2807, DOI 10.1038/onc.2010.29; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; Caputi M, 2004, J VIROL, V78, P6517, DOI 10.1128/JVI.78.12.6517-6526.2004; Chandler SD, 1997, P NATL ACAD SCI USA, V94, P3596, DOI 10.1073/pnas.94.8.3596; de Thonel A, 2010, BLOOD, V116, P85, DOI 10.1182/blood-2009-09-241778; Deguillien M, 2001, BLOOD, V98, P3809, DOI 10.1182/blood.V98.13.3809; DIAMOND RH, 1993, J BIOL CHEM, V268, P15185; Du KY, 1997, GENE, V204, P243, DOI 10.1016/S0378-1119(97)00552-0; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; England SJ, 2011, BLOOD, V117, P2708, DOI 10.1182/blood-2010-07-299743; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Hallay H, 2006, J BIOL CHEM, V281, P37159, DOI 10.1074/jbc.M603864200; Han F, 2007, EXP CELL RES, V313, P1518, DOI 10.1016/j.yexcr.2007.01.028; Huang SC, 2012, MOL CELL BIOL, V32, P513, DOI 10.1128/MCB.06423-11; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Khandros E, 2012, BLOOD, V119, P5265, DOI 10.1182/blood-2011-12-397729; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; Kloc M, 2011, BIOCHIMIE, V93, P1955, DOI 10.1016/j.biochi.2011.07.008; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Lee TL, 2010, P NATL ACAD SCI USA, V107, P52, DOI 10.1073/pnas.0909153107; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Lin SR, 2005, MOL CELL, V20, P413, DOI 10.1016/j.molcel.2005.09.015; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; McFarlane M, 2010, BIOCHEM SOC T, V38, P1116, DOI 10.1042/BST0381116; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Moran-Crusio K, 2012, TRENDS IMMUNOL, V33, P357, DOI 10.1016/j.it.2012.01.009; Moriniere M, 2010, BLOOD CELL MOL DIS, V45, P284, DOI 10.1016/j.bcmd.2010.08.011; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Palusa SG, 2010, NEW PHYTOL, V185, P83, DOI 10.1111/j.1469-8137.2009.03065.x; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Patel NA, 2001, J BIOL CHEM, V276, P22648, DOI 10.1074/jbc.M101260200; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; Schwarz K, 2000, J IMMUNOL, V164, P6147, DOI 10.4049/jimmunol.164.12.6147; SCREATON GR, 1995, EMBO J, V14, P4336, DOI 10.1002/j.1460-2075.1995.tb00108.x; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Snow BE, 1997, GENOMICS, V43, P165, DOI 10.1006/geno.1997.4794; Soret J, 2006, PROG MOLEC, V44, P65; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Swanson CM, 2010, J VIROL, V84, P6748, DOI 10.1128/JVI.02526-09; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Theoleyre O, 2004, ONCOGENE, V23, P920, DOI 10.1038/sj.onc.1207206; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; Wu J Y, 2003, Prog Mol Subcell Biol, V31, P153; Yang G, 2005, BLOOD, V105, P2146, DOI 10.1182/blood-2004-05-1757; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhang SJ, 2012, BLOOD, V119, P4480, DOI 10.1182/blood-2011-11-390252; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	67	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59137	10.1371/journal.pone.0059137	http://dx.doi.org/10.1371/journal.pone.0059137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536862	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100122
J	Domenech, A; Ardanuy, C; Pallares, R; Grau, I; Santos, S; De la Campa, AG; Linares, J				Domenech, Arnau; Ardanuy, Carmen; Pallares, Roman; Grau, Immaculada; Santos, Salud; De la Campa, Adela G.; Linares, Josefina			Some Pneumococcal Serotypes Are More Frequently Associated with Relapses of Acute Exacerbations in COPD Patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; STREPTOCOCCUS-PNEUMONIAE; INVASIVE-DISEASE; STRAINS	Objectives: To analyze the role of the capsular type in pneumococci causing relapse and reinfection episodes of acute exacerbation in COPD patients. Methods: A total of 79 patients with 116 recurrent episodes of acute exacerbations caused by S. pneumoniae were included into this study (1995-2010). A relapse episode was considered when two consecutive episodes were caused by the same strain (identical serotype and genotype); otherwise it was considered reinfection. Antimicrobial susceptibility testing (microdilution), serotyping (PCR, Quellung) and molecular typing (PFGE/MLST) were performed. Results: Among 116 recurrent episodes, 81 (69.8%) were reinfections, caused by the acquisition of a new pneumococcus, and 35 (30.2%) were relapses, caused by a pre-existing strain. Four serotypes (9V, 19F, 15A and 11A) caused the majority (60.0%) of relapses. When serotypes causing relapses and reinfection were compared, only two serotypes were associated with relapses: 9V (OR 8.0; 95% CI, 1.34-85.59) and 19F (OR 16.1; 95% CI, 1.84-767.20). Pneumococci isolated from relapses were more resistant to antimicrobials than those isolated from the reinfection episodes: penicillin (74.3% vs. 34.6%, p < 0.001), ciprofloxacin (25.7% vs. 9.9%, p < 0.027), levofloxacin (22.9% vs. 7.4%, p = 0.029), and co-trimoxazole (54.3% vs. 25.9%, p < 0.001). Conclusions: Although the acquisition of a new S. pneumoniae strain was the most frequent cause of recurrences, a third of the recurrent episodes were caused by a pre-existing strain. These relapse episodes were mainly caused by serotypes 9V and 19F, suggesting an important role for capsular type.	[Domenech, Arnau; Ardanuy, Carmen; Linares, Josefina] Univ Barcelona, IDIBELL, Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain; [Domenech, Arnau; Ardanuy, Carmen; Pallares, Roman; Grau, Immaculada; De la Campa, Adela G.; Linares, Josefina] ISCIII, CIBERES Ciber Enfermedades Resp, Madrid, Spain; [Grau, Immaculada] Univ Barcelona, IDIBELL, Hosp Univ Bellvitge, Dept Infect Dis, Barcelona, Spain; [De la Campa, Adela G.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [De la Campa, Adela G.] CSIC, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Consejo Superior de Investigaciones Cientificas (CSIC)	Ardanuy, C (corresponding author), Univ Barcelona, IDIBELL, Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain.	c.ardanuy@bellvitgehospital.cat	PALLARES, Roman/B-5710-2008; de la Campa, Adela G/K-1654-2014; Ardanuy, Carmen/C-4463-2015; Liñares, Josefina/N-9450-2014	PALLARES, Roman/0000-0003-3262-8508; de la Campa, Adela G/0000-0002-3598-2548; Santos, Salud/0000-0002-5835-1028; Grau, Imma/0000-0002-3040-8184; Ardanuy, Carmen/0000-0003-0225-607X; Domenech, Arnau/0000-0002-0829-511X	Fondo de Investigaciones Sanitarias de la Seguridad Social [PI 0901904]; Plan Nacional de I+D+I of Ministerio de Ciencia e Innovacion [BIO2008-02154, BIO2011-25343]; CIBER de Enfermedades Respiratorias, CIBERES; Instituto de Salud Carlos III (ISCIII), Madrid, Spain [CB06/06/0037]; Formacion de Profesorado Universitario (FPU; Ministerio de Educacion, Spain); Wellcome Trust	Fondo de Investigaciones Sanitarias de la Seguridad Social(Instituto de Salud Carlos III); Plan Nacional de I+D+I of Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBER de Enfermedades Respiratorias, CIBERES; Instituto de Salud Carlos III (ISCIII), Madrid, Spain(Instituto de Salud Carlos III); Formacion de Profesorado Universitario (FPU; Ministerio de Educacion, Spain)(Spanish Government); Wellcome Trust(Wellcome Trust)	This work was supported by grants from the Fondo de Investigaciones Sanitarias de la Seguridad Social [PI 0901904], by grants [BIO2008-02154 and BIO2011-25343] from Plan Nacional de I+D+I of Ministerio de Ciencia e Innovacion, and by CIBER de Enfermedades Respiratorias, CIBERES; [CB06/06/0037], run by the Instituto de Salud Carlos III (ISCIII), Madrid, Spain. A. D. was supported by a grant from Formacion de Profesorado Universitario (FPU; Ministerio de Educacion, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the use of the Streptococcus pneumoniae MLST web site at Imperial College London, funded by the Wellcome Trust. We wish to thank all the staff of Microbiology Laboratory of Hospital Universitari de Bellvitge who contributed to this project on a daily basis.	Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Centers for Disease Control and Prevention, 2012, PCR DED PNEUM SER; Clinical Laboratory Standard Institute, 2011, M100S21 CLSINCCLS, V31; Davidson R, 2002, NEW ENGL J MED, V346, P747, DOI 10.1056/NEJMoa012122; de la Campa AG, 2003, ANTIMICROB AGENTS CH, V47, P1419, DOI 10.1128/AAC.47.4.1419-1422.2003; Domenech A, 2012, J CLIN MICROBIOL, V50, P4047, DOI 10.1128/JCM.02056-12; Domenech A, 2011, J ANTIMICROB CHEMOTH, V66, P487, DOI 10.1093/jac/dkq480; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Schenkein JG, 2008, CHEST, V133, P767, DOI 10.1378/chest.07-0996; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; World Health Organization, 2012, CHRON OBSTR PULM DIS	14	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59027	10.1371/journal.pone.0059027	http://dx.doi.org/10.1371/journal.pone.0059027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536850	gold, Green Submitted, Green Published			2022-12-25	WOS:000316251100112
J	Klosen, P; Sebert, ME; Rasri, K; Laran-Chich, MP; Simonneaux, V				Klosen, Paul; Sebert, Marie-Emilie; Rasri, Kamontip; Laran-Chich, Marie-Pierre; Simonneaux, Valerie			TSH restores a summer phenotype in photoinhibited mammals via the RF-amides RFRP3 and kisspeptin	FASEB JOURNAL			English	Article						seasonal rhythms; reproduction; body weight; melatonin; tancyte; deiodinase 2; somatostatin	RFAMIDE-RELATED PEPTIDE-3; MT1 MELATONIN RECEPTOR; SEASONAL BODY-WEIGHT; PARS TUBERALIS; DJUNGARIAN HAMSTER; GENE-EXPRESSION; PHOTOPERIODIC REGULATION; PHODOPUS-SUNGORUS; BINDING SITES; FOOD-INTAKE	In mammals, melatonin is the pivotal messenger synchronizing biological functions, notably reproductive activity, with annual daylength changes. Recently, two major findings clarified melatonin's mode of action. First, melatonin controls the production of thyroid stimulating hormone (TSH) by the pars tuberalis of the adenohypophysis. This TSH regulates local thyroid hormone availability in the mediobasal hypothalamus. Second, the RF-amides kisspeptin and RFRP-3, recently discovered regulators of the gonadotropic axis, are involved in the melatonin control of reproduction. This study aims to establish a mechanistic link between the melatonin-driven TSH and the RF-amide control of reproduction. We treated short-day-adapted male Djungarian and Syrian hamsters with a chronic central infusion of TSH. In both hamster species, the central administration of 5 mIU/d TSH for 4 to 6 wk restored the summer phenotype of both testicular activity and kisspeptin and RFRP expression. Vehicle treated hamsters remain sexually inactive. Furthermore, the TSH treatment increased the body weight of lean short-day-adapted Djungarian hamsters and reduced hypothalamic somatostatin expression to the summer phenotype. In summary, our study demonstrates the pivotal role of melatonin-driven TSH for the seasonal regulation of reproduction and body weight, and uncovers the neuropeptides relaying this signal within the hypothalamus.Klosen, P., Sebert, M.-E., Rasri, K., Laran-Chich, M.-P., Simonneaux, V. TSH restores a summer phenotype in photoinhibited mammals via the RF-amides RFRP3 and kisspeptin.	[Klosen, Paul; Sebert, Marie-Emilie; Laran-Chich, Marie-Pierre; Simonneaux, Valerie] Univ Strasbourg, CNRS, Unite Propres Rech UPR 3212, Dept Neurobiol Rythmes,Inst Neurosci Cellulaires, F-67084 Strasbourg, France; [Rasri, Kamontip] Thammasat Univ, Dept Preclin Sci, Fac Med, Rangsit, Thailand	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Thammasat University	Simonneaux, V (corresponding author), Univ Strasbourg, CNRS, Inst Neurosci Cellulaires & Integrat, UPR3212, 5 Rue Blaise Pascal, F-67084 Strasbourg, France.	simonneaux@inci-cnrs.unistra.fr		Klosen, Paul/0000-0001-9724-5044	Agence Nationale de la Recherche (ANR) FrenchKiss [BLAN-07-0056]; Centre National de la Recherche Scientifique	Agence Nationale de la Recherche (ANR) FrenchKiss(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	The authors thank Dr. Jens Mikkelsen (Neurobiology Research Unit, Copenhagen University Hospital, Copenhagen, Denmark) for plasma testosterone assay; Prof. Veerle Darras (Laboratory of Comparative Endocrinology, Leuven, Belgium) for tissue T3 assay; and Dr. Dominique Ciocca for animal care and technical assistance. Animal study was conducted at the Animal Resource and Experimentation Platform/Chronobiotron (TGIR, UMS 3415 Unistra/CNRS). This work was supported in part by the Agence Nationale de la Recherche (ANR) FrenchKiss (BLAN-07-0056) and the Centre National de la Recherche Scientifique.	Ancel C, 2012, ENDOCRINOLOGY, V153, P1352, DOI 10.1210/en.2011-1622; Ansel L, 2010, J BIOL RHYTHM, V25, P81, DOI 10.1177/0748730410361918; Baker JR, 1932, P R SOC LOND B-CONTA, V110, P313, DOI 10.1098/rspb.1932.0027; Barrett P, 2005, ENDOCRINOLOGY, V146, P1930, DOI 10.1210/en.2004-1452; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Barrett P, 2012, J PINEAL RES, V52, P376, DOI 10.1111/j.1600-079X.2011.00963.x; Bentley GE, 2010, BRAIN RES, V1364, P62, DOI 10.1016/j.brainres.2010.10.001; BITTMAN EL, 1983, ENDOCRINOLOGY, V113, P2276, DOI 10.1210/endo-113-6-2276; BOCKERS TM, 1995, J NEUROENDOCRINOL, V7, P607, DOI 10.1111/j.1365-2826.1995.tb00798.x; Clarke IJ, 2008, ENDOCRINOLOGY, V149, P5811, DOI 10.1210/en.2008-0575; Clarke IJ, 2009, PEPTIDES, V30, P154, DOI 10.1016/j.peptides.2008.08.022; COOK CB, 1992, ENDOCRINOLOGY, V130, P1077, DOI 10.1210/en.130.2.1077; Dardente H, 2008, J NEUROENDOCRINOL, V20, P1252, DOI 10.1111/j.1365-2826.2008.01784.x; Dardente H, 2003, J NEUROENDOCRINOL, V15, P778, DOI 10.1046/j.1365-2826.2003.01060.x; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; Ebling FJP, 2008, J NEUROENDOCRINOL, V20, P827, DOI 10.1111/j.1365-2826.2008.01721.x; FIGALA J, 1973, OECOLOGIA, V12, P89, DOI 10.1007/BF00345511; Gofflot F, 2007, CELL, V131, P405, DOI 10.1016/j.cell.2007.09.012; Greives TJ, 2008, J NEUROENDOCRINOL, V20, P1339, DOI 10.1111/j.1365-2826.2008.01790.x; Greives TJ, 2007, ENDOCRINOLOGY, V148, P1158, DOI 10.1210/en.2006-1249; Hanon EA, 2010, J NEUROENDOCRINOL, V22, P51, DOI 10.1111/j.1365-2826.2009.01937.x; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Herwig A, 2012, J NEUROENDOCRINOL, V24, P991, DOI 10.1111/j.1365-2826.2012.02324.x; HOFFMAN RA, 1965, SCIENCE, V148, P1609, DOI 10.1126/science.148.3677.1609; Janati A, 2013, J NEUROENDOCRINOL, V25, P402, DOI 10.1111/jne.12015; Jethwa PH, 2007, ENDOCRINOLOGY, V148, P4044, DOI 10.1210/en.2007-0038; Klosen P, 2002, J HISTOCHEM CYTOCHEM, V50, P1647, DOI 10.1177/002215540205001209; KLOSEN P, 1993, J HISTOCHEM CYTOCHEM, V41, P455, DOI 10.1177/41.3.8429209; Kriegsfeld LJ, 2006, P NATL ACAD SCI USA, V103, P2410, DOI 10.1073/pnas.0511003103; LECHAN RM, 1993, ENDOCRINOLOGY, V132, P2461, DOI 10.1210/en.132.6.2461; LERCHL A, 1995, GEN COMP ENDOCR, V98, P129, DOI 10.1006/gcen.1995.1053; MASSONPEVET M, 1994, CELL TISSUE RES, V278, P97, DOI 10.1007/s004410050196; MAYWOOD ES, 1995, ENDOCRINOLOGY, V136, P144, DOI 10.1210/en.136.1.144; Mikkelsen JD, 2009, REGUL PEPTIDES, V152, P95, DOI 10.1016/j.regpep.2008.10.001; Mikkelsen JD, 2009, PEPTIDES, V30, P26, DOI 10.1016/j.peptides.2008.09.004; MORGAN PJ, 1994, NEUROCHEM INT, V24, P101, DOI 10.1016/0197-0186(94)90100-7; Murphy M, 2012, ENDOCRINOLOGY, V153, P101, DOI 10.1210/en.2011-1249; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Rasri K, 2008, NEUROSCIENCE, V157, P174, DOI 10.1016/j.neuroscience.2008.08.058; Revel FG, 2008, ENDOCRINOLOGY, V149, P902, DOI 10.1210/en.2007-0848; Revel FG, 2006, CURR BIOL, V16, P1730, DOI 10.1016/j.cub.2006.07.025; Reyns GE, 2003, GEN COMP ENDOCR, V134, P80, DOI 10.1016/S0016-6480(03)00220-X; Rizwan MZ, 2012, ENDOCRINOLOGY, V153, P3770, DOI 10.1210/en.2012-1133; Ross AW, 2004, ENDOCRINOLOGY, V145, P13, DOI 10.1210/en.2003-0838; Simonneaux Valerie, 2012, Front Endocrinol (Lausanne), V3, P168, DOI 10.3389/fendo.2012.00168; Simonneaux V, 2009, PEPTIDES, V30, P146, DOI 10.1016/j.peptides.2008.06.006; Tsutsui K, 2012, GEN COMP ENDOCR, V177, P305, DOI 10.1016/j.ygcen.2012.02.013; Ubuka T, 2012, ENDOCRINOLOGY, V153, P373, DOI 10.1210/en.2011-1110; VANECEK J, 1987, BRAIN RES, V435, P359, DOI 10.1016/0006-8993(87)91625-8; Wallis K, 2010, MOL ENDOCRINOL, V24, P1904, DOI 10.1210/me.2010-0175; WEAVER DR, 1989, J NEUROSCI, V9, P2581; WITTKOWSKI W, 1988, CELL TISSUE RES, V251, P183, DOI 10.1007/BF00215463; Yasuo S, 2007, ENDOCRINOLOGY, V148, P4385, DOI 10.1210/en.2007-0497	54	77	82	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2677	2686		10.1096/fj.13-229559	http://dx.doi.org/10.1096/fj.13-229559			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23538709				2022-12-25	WOS:000328841000017
J	Clark, KD; Strand, MR				Clark, Kevin D.; Strand, Michael R.			Hemolymph Melanization in the Silkmoth Bombyx mori Involves Formation of a High Molecular Mass Complex That Metabolizes Tyrosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,3-GLUCAN RECOGNITION PROTEIN; TENEBRIO-MOLITOR LARVAE; PRO-PHENOL OXIDASE; MANDUCA-SEXTA L; PROPHENOLOXIDASE ACTIVATION; IMMUNE-RESPONSES; TOBACCO HORNWORM; PSEUDOPLUSIA-INCLUDENS; PHENOLOXIDASE ACTIVITY; LEPIDOPTERAN INSECT	The phenoloxidase (PO) cascade regulates the melanization of blood (hemolymph) in insects and other arthropods. Most studies indicate that microbial elicitors activate the PO cascade, which results in processing of the zymogen PPO to PO. PO is then thought to oxidize tyrosine and o-diphenols to quinones, which leads to melanin. However, different lines of investigation raise questions as to whether these views are fully correct. Here we report that hemolymph from the silkmoth, Bombyx mori, rapidly melanizes after collection from a wound site. Prior studies indicated that in vitro activated PPO hydroxylates Tyr inefficiently. Measurement of in vivo substrate titers, however, suggested that Tyr was the only PO substrate initially present in B. mori plasma and that it is rapidly metabolized by PO. Fractionation of plasma by gel filtration chromatography followed by bioassays indicated that melanization activity was primarily associated with a high mass complex (similar to 670 kDa) that contained PO. The prophenoloxidase-activating protease inhibitor Egf1.0 blocked formation of this complex and Tyr metabolism, but the addition of phenylthiourea to plasma before fractionation enhanced complex formation and Tyr metabolism. Mass spectrometry analysis indicated that the complex contained PO plus other proteins. Taken together, our results indicate that wounding alone activates the PO cascade in B. mori. They also suggest that complex formation is required for efficient use of Tyr as a substrate.	[Clark, Kevin D.; Strand, Michael R.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Clark, KD (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	kclark@uga.edu; mrstrand@uga.edu	Clark, Kevin/GQA-9811-2022		National Science Foundation Grant [IOS-1121006]; United States Department of Agriculture Grant [2008-35320-18756]; Georgia Agricultural Experiment Station; Direct For Biological Sciences [1121006] Funding Source: National Science Foundation	National Science Foundation Grant(National Science Foundation (NSF)); United States Department of Agriculture Grant; Georgia Agricultural Experiment Station; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant IOS-1121006, United States Department of Agriculture Grant 2008-35320-18756, and the Georgia Agricultural Experiment Station.	Asada N, 1999, BIOCHEM GENET, V37, P149, DOI 10.1023/A:1018730404305; ASHIDA M, 1980, INSECT BIOCHEM, V10, P37, DOI 10.1016/0020-1790(80)90036-0; ASHIDA M, 1988, TISSUE CELL, V20, P599, DOI 10.1016/0040-8166(88)90061-4; ASHIDA M, 1981, INSECT BIOCHEM, V11, P57, DOI 10.1016/0020-1790(81)90041-X; ASHIDA M, 1988, INSECT BIOCHEM, V18, P11, DOI 10.1016/0020-1790(88)90031-5; ASO Y, 1985, INSECT BIOCHEM, V15, P9, DOI 10.1016/0020-1790(85)90038-1; Beck G, 1996, J BIOL CHEM, V271, P11035, DOI 10.1074/jbc.271.19.11035; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Chase MR, 2000, INSECT BIOCHEM MOLEC, V30, P953, DOI 10.1016/S0965-1748(00)00068-0; Christen JM, 2012, INSECT BIOCHEM MOLEC, V42, P946, DOI 10.1016/j.ibmb.2012.09.008; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Clark KD, 2010, INSECT BIOCHEM MOLEC, V40, P460, DOI 10.1016/j.ibmb.2010.04.005; Dionex Corp, 2003, 150 DION CORP, P4; DOHKE K, 1973, ARCH BIOCHEM BIOPHYS, V157, P203, DOI 10.1016/0003-9861(73)90406-2; Gorman MJ, 2007, INSECT BIOCHEM MOLEC, V37, P1327, DOI 10.1016/j.ibmb.2007.08.006; HALL M, 1995, P NATL ACAD SCI USA, V92, P7764, DOI 10.1073/pnas.92.17.7764; Hopkins TL, 1998, ARCH INSECT BIOCHEM, V38, P193, DOI 10.1002/(SICI)1520-6327(1998)38:4&lt;193::AID-ARCH5&gt;3.0.CO;2-S; HOPKINS TL, 1984, INSECT BIOCHEM, V14, P533, DOI 10.1016/0020-1790(84)90008-8; Jaenicke E, 2003, BIOCHEM J, V371, P515, DOI 10.1042/BJ20021058; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; KAWABATA T, 1995, P NATL ACAD SCI USA, V92, P7774, DOI 10.1073/pnas.92.17.7774; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kim MH, 2000, EUR J BIOCHEM, V267, P2599, DOI 10.1046/j.1432-1327.2000.01271.x; Kwon TH, 2000, EUR J BIOCHEM, V267, P6188, DOI 10.1046/j.1432-1327.2000.01695.x; Lee MH, 2004, J BIOL CHEM, V279, P3218, DOI 10.1074/jbc.M309821200; Lee SY, 2000, J BIOL CHEM, V275, P1337, DOI 10.1074/jbc.275.2.1337; Li YC, 2009, P NATL ACAD SCI USA, V106, P17002, DOI 10.1073/pnas.0906095106; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; MUNKIRS DD, 1990, J INVERTEBR PATHOL, V56, P267, DOI 10.1016/0022-2011(90)90110-R; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Nyholm SV, 2012, NAT REV MICROBIOL, V10, P815, DOI 10.1038/nrmicro2894; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Sakamoto M, 2011, DEV COMP IMMUNOL, V35, P611, DOI 10.1016/j.dci.2011.01.003; Strand MR, 2010, INSECT VIROLOGY, P171; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sugumaran M, 2000, ARCH BIOCHEM BIOPHYS, V379, P252, DOI 10.1006/abbi.2000.1884; Tsuchiya M, 1996, FEMS IMMUNOL MED MIC, V15, P129, DOI 10.1016/0928-8244(96)00053-3; Vavricka CJ, 2010, PROTEIN CELL, V1, P830, DOI 10.1007/s13238-010-0109-8; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P731, DOI 10.1016/j.ibmb.2004.03.008; YASUHARA Y, 1995, ARCH BIOCHEM BIOPHYS, V320, P14, DOI 10.1006/abbi.1995.1337; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200; Zhu Y, 2003, INSECT BIOCHEM MOLEC, V33, P541, DOI 10.1016/S0965-1748(03)00028-6	56	49	52	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14476	14487		10.1074/jbc.M113.459222	http://dx.doi.org/10.1074/jbc.M113.459222			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23553628	Green Published, hybrid			2022-12-25	WOS:000319253500050
J	Xue, XY; Raynard, S; Busygina, V; Singh, AK; Sung, P				Xue, Xiaoyu; Raynard, Steven; Busygina, Valeria; Singh, Akhilesh K.; Sung, Patrick			Role of Replication Protein A in Double Holliday Junction Dissolution Mediated by the BLM-Topo III alpha-RMI1-RMI2 Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-III-ALPHA; DOUBLE-STRAND BREAKS; DNA END-RESECTION; BLOOMS-SYNDROME HELICASE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; GENOME STABILITY; ESSENTIAL COMPONENT; CROSSING-OVER; REPAIR	The conserved BTR complex, composed of the Bloom's syndrome helicase (BLM), topoisomerase III alpha, RMI1, and RMI2, regulates homologous recombination in favor of non-crossover formation via the dissolution of the double Holliday Junction (dHJ). Here we show enhancement of the BTR-mediated dHJ dissolution reaction by the heterotrimeric single-stranded DNA binding protein replication protein A (RPA). Our results suggest that RPA acts by sequestering a single-stranded DNA intermediate during dHJ dissolution. We provide evidence that RPA physically interacts with RMI1. The RPA interaction domain in RMI1 has been mapped, and RMI1 mutants impaired for RPA interaction have been generated. Examination of these mutants ascertains the significance of the RMI1-RPA interaction in dHJ dissolution. Our results thus implicate RPA as a cofactor of the BTR complex in dHJ dissolution.	[Xue, Xiaoyu; Raynard, Steven; Busygina, Valeria; Singh, Akhilesh K.; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Sung, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, C130 Sterling Hall Med,333 Cedar St, New Haven, CT 06520 USA.	patrick.sung@yale.edu			National Institutes of Health [RO1 ES015632, RO1 ES07061, RO1 GM57814]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015632, R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 ES015632, RO1 ES07061, and RO1 GM57814.	Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Chen SH, 2012, J BIOL CHEM, V287, P19346, DOI 10.1074/jbc.M112.363044; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FU TJ, 1994, J MOL BIOL, V236, P91, DOI 10.1006/jmbi.1994.1121; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; KUHN EM, 1986, CANCER GENET CYTOGEN, V22, P1, DOI 10.1016/0165-4608(86)90132-9; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; Raynard S, 2008, J BIOL CHEM, V283, P15701, DOI 10.1074/jbc.M802127200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Van Komen S, 2006, METHOD ENZYMOL, V408, P445, DOI 10.1016/S0076-6879(06)08028-1; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	35	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14221	14227		10.1074/jbc.M113.465609	http://dx.doi.org/10.1074/jbc.M113.465609			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543748	hybrid, Green Published			2022-12-25	WOS:000319253500026
J	Testa, ND; Ghosh, SM; Shingleton, AW				Testa, Nicholas D.; Ghosh, Shampa M.; Shingleton, Alexander W.			Sex-Specific Weight Loss Mediates Sexual Size Dimorphism in Drosophila melanogaster	PLOS ONE			English	Article							BODY-SIZE; STATIC ALLOMETRY; GROWTH; EVOLUTION; CELL; METAMORPHOSIS; PERSPECTIVE; GENETICS; INSECTS	The selective pressures leading to the evolution of Sexual Size Dimorphism (SSD) have been well studied in many organisms, yet, the underlying developmental mechanisms are poorly understood. By generating a complete growth profile by sex in Drosophila melanogaster, we describe the sex-specific pattern of growth responsible for SSD. Growth rate and critical size for pupariation significantly contributed to adult SSD, whereas duration of growth did not. Surprisingly, SSD at peak larval mass was twice that of the uneclosed adult SSD with weight loss between peak larval mass and pupariation playing an important role in generating the final SSD. Our finding that weight loss is an important regulator of SSD adds additional complexity to our understanding of how body size is regulated in different sexes. Collectively, these data allow for the elucidation of the molecular-genetic mechanisms that generate SSD, an important component of understanding how SSD evolves.	[Testa, Nicholas D.; Ghosh, Shampa M.; Shingleton, Alexander W.] Michigan State Univ, Dept Zool & Ecol & Evolutionary Biol & Behav, E Lansing, MI 48824 USA	Michigan State University	Testa, ND (corresponding author), Michigan State Univ, Dept Zool & Ecol & Evolutionary Biol & Behav, E Lansing, MI 48824 USA.	testanick@gmail.com		Shingleton, Alexander/0000-0001-9862-9947	National Science Foundation [IOS-0919855, IOS-0845847]; Michigan State University	National Science Foundation(National Science Foundation (NSF)); Michigan State University	This research was supported by National Science Foundation grants IOS-0919855 and IOS-0845847 to AWS, and fellowship support from Michigan State University to NDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Bininda-Emonds ORP, 2000, EVOLUTION, V54, P1011; Blanckenhorn WU, 2007, AM NAT, V169, P245, DOI 10.1086/510597; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Caldwell PE, 2005, CURR BIOL, V15, P2175, DOI 10.1016/j.cub.2005.11.041; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; D'Amico LJ, 2001, P ROY SOC B-BIOL SCI, V268, P1589, DOI 10.1098/rspb.2001.1698; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; De Jong G, 2003, J GENET, V82, P207, DOI 10.1007/BF02715819; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Esperk T, 2007, ECOL ENTOMOL, V32, P243, DOI 10.1111/j.1365-2311.2007.00872.x; Fabian DK, 2012, MOL ECOL, V21, P4748, DOI 10.1111/j.1365-294X.2012.05731.x; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fischer K, 2001, ENTOMOL EXP APPL, V100, P325, DOI 10.1023/A:1019297222922; Freeman M, 1997, DEVELOPMENT, V124, P261; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Molleman F, 2011, J INSECT PHYSIOL, V57, P712, DOI 10.1016/j.jinsphys.2011.02.009; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Nijhout H F, 2006, J Biol, V5, P16, DOI 10.1186/jbiol43; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; NIJHOUT HF, 1981, AM ZOOL, V21, P631; Norman MD, 2002, NEW ZEAL J MAR FRESH, V36, P733, DOI 10.1080/00288330.2002.9517126; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Shingleton AW, 2005, CURR BIOL, V15, pR825, DOI 10.1016/j.cub.2005.10.006; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556; Stillwell RC, 2010, P ROY SOC B-BIOL SCI, V277, P2069, DOI 10.1098/rspb.2009.2277; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	41	54	56	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58936	10.1371/journal.pone.0058936	http://dx.doi.org/10.1371/journal.pone.0058936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555608	gold, Green Submitted, Green Published			2022-12-25	WOS:000317262200008
J	Bergstrom, J; Cederlund, K; Dahlen, B; Lantz, AS; Skedinger, M; Palmberg, L; Sundblad, BM; Larsson, K				Bergstrom, Jan; Cederlund, Kerstin; Dahlen, Barbro; Lantz, Ann-Sofie; Skedinger, Maria; Palmberg, Lena; Sundblad, Britt-Marie; Larsson, Kjell			Dental Health in Smokers with and without COPD	PLOS ONE			English	Article							LUNG-FUNCTION TESTS; REGRESSION EQUATIONS; PERIODONTAL-DISEASE; REFERENCE VALUES; SMOKING; ASSOCIATION; QUALITY	The association between chronic obstructive pulmonary disease (COPD) and periodontal disease is sparsely studied The aim was to describe the co-variation of periodontitis and lung function impairment in smokers. The hypothesis was that the destructive processes in the mouth and the lungs are interdependent due to a general individual susceptibility to detrimental effects of tobacco smoke. Smokers with COPD (n=28) stage II and III according to GOLD guidelines and smokers without COPD (n=29) and healthy non-smokers (n=23) participated in the study. The groups of smokers were matched for cumulative exposure to tobacco smoke. Radiographic, general and dental clinical examination, lung function measurements and quality of life (SF-36) assessment were conducted. The relationship between respiratory and dental outcomes was analyzed. Dental health, assessed by plaque, gingival bleeding, periodontal pocket depth and loss of teeth was impaired in the smokers compared with non-smokers with no major differences between smokers with and without COPD. There was, however, a weak correlation between periodontitis and emphysema/impaired diffusion capacity. Impaired quality of life was associated with smoking and impaired lung function but not influenced by dental status. In conclusion periodontitis was strongly associated with smoking, weakly associated with lung tissue destruction and very weakly or even not at all associated with chronic airflow limitation. The results indicate that, although there was a co-variation between periodontitis and pathologic lung processes in smokers, the risk of developing COPD, as defined by spirometric outcomes, is not associated with the risk of impaired dental health in smokers,	[Bergstrom, Jan] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Cederlund, Kerstin] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Med Imaging & Technol, Stockholm, Sweden; [Dahlen, Barbro; Lantz, Ann-Sofie; Skedinger, Maria] Karolinska Univ, Huddinge Hosp, Stockholm, Sweden; [Palmberg, Lena; Sundblad, Britt-Marie; Larsson, Kjell] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Larsson, K (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	kjell.larsson@ki.se		Sundblad, Britt-Marie/0000-0002-9939-418X	Swedish Heart and Lung Foundation; Karolinska Institutet; King Gustaf V's and Queen Victoria's Foundation; Stockholm County Council	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institutet(Karolinska Institutet); King Gustaf V's and Queen Victoria's Foundation; Stockholm County Council(Stockholm County Council)	This study was supported by grants from the Swedish Heart and Lung Foundation, Karolinska Institutet, King Gustaf V's and Queen Victoria's Foundation and Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P2104; [Anonymous], 2009, GLOB STRAT DIAGN MAN; Azarpazhooh A, 2006, J PERIODONTOL, V77, P1465, DOI 10.1902/jop.2006.060010; Hayes C, 1998, Ann Periodontol, V3, P257, DOI 10.1902/annals.1998.3.1.257; HEDENSTROM H, 1986, UPSALA J MED SCI, V91, P299, DOI 10.3109/03009738609178670; HEDENSTROM H, 1985, B EUR PHYSIOPATH RES, V21, P551; Hyman JJ, 2004, J PERIODONTOL, V75, P9, DOI 10.1902/jop.2004.75.1.9; Jones PW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-71; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Katancik JA, 2005, J PERIODONTOL, V76, P2161, DOI 10.1902/jop.2005.76.11-S.2161; Leuckfeld I, 2008, RESP MED, V102, P488, DOI 10.1016/j.rmed.2007.12.001; Pickard AS, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-26; Scannapieco F A, 1998, Ann Periodontol, V3, P251, DOI 10.1902/annals.1998.3.1.251; Scannapieco FA, 2001, J PERIODONTOL, V72, P50, DOI 10.1902/jop.2001.72.1.50; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Wang ZM, 2009, J CLIN PERIODONTOL, V36, P750, DOI 10.1111/j.1600-051X.2009.01448.x	19	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59492	10.1371/journal.pone.0059492	http://dx.doi.org/10.1371/journal.pone.0059492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544074	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700034
J	Koprulu, AD; Kastner, R; Wienerroither, S; Lassnig, C; Putz, EM; Majer, O; Reutterer, B; Sexl, V; Kuchler, K; Muller, M; Decker, T; Ellmeier, W				Koepruelue, Afitap Derya; Kastner, Renate; Wienerroither, Sebastian; Lassnig, Caroline; Putz, Eva Maria; Majer, Olivia; Reutterer, Benjamin; Sexl, Veronika; Kuchler, Karl; Mueller, Mathias; Decker, Thomas; Ellmeier, Wilfried			The Tyrosine Kinase Btk Regulates the Macrophage Response to Listeria monocytogenes Infection	PLOS ONE			English	Article							X-LINKED AGAMMAGLOBULINEMIA; INTERFERON-GAMMA PRODUCTION; NATURAL-KILLER-CELLS; TOLL-LIKE RECEPTORS; KAPPA-B ACTIVATION; TEC FAMILY KINASES; PATTERN-RECOGNITION; REACTIVE OXYGEN; INNATE IMMUNITY; DOMAIN	In this study we investigated the role of Bruton's tyrosine kinase (Btk) in the immune response to the Gram-positive intracellular bacterium Listeria monocytogenes (Lm). In response to Lm infection, Btk was activated in bone marrow-derived macrophages (BMMs) and Btk(-/-) BMMs showed enhanced TNF-alpha, IL-6 and IL-12p40 secretion, while type I interferons were produced at levels similar to wild-type (wt) BMMs. Although Btk-deficient BMMs displayed reduced phagocytosis of E. coli fragments, there was no difference between wt and Btk(-/-) BMMs in the uptake of Lm upon infection. Moreover, there was no difference in the response to heat-killed Lm between wt and Btk(-/)- BMMs, suggesting a role for Btk in signaling pathways that are induced by intracellular Lm. Finally Btk(-/-) mice displayed enhanced resistance and an increased mean. survival time upon Lm infection in comparison to wt mice. This correlated with elevated IFN-gamma and IL-12p70 serum levels in Btk(-/-) mice at day 1 after infection. Taken together, our data suggest an important regulatory role for Btk in macrophages during Lm infection.	[Koepruelue, Afitap Derya; Ellmeier, Wilfried] Med Univ Vienna, Div Immunobiol, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Vienna, Austria; [Kastner, Renate; Wienerroither, Sebastian; Reutterer, Benjamin; Decker, Thomas] Univ Vienna, Dept Microbiol & Immunobiol, Max F Perutz Labs, Vienna, Austria; [Lassnig, Caroline; Mueller, Mathias] Univ Vet Med, Inst Anim Breeding & Genet & Biomodels Austria, Vienna, Austria; [Putz, Eva Maria; Sexl, Veronika] Univ Vet Med, Inst Pharmacol & Toxicol, Vienna, Austria; [Majer, Olivia; Kuchler, Karl] Med Univ Vienna, Dept Mol Genet, Max F Perutz Labs, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Ellmeier, W (corresponding author), Med Univ Vienna, Div Immunobiol, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Vienna, Austria.	wilfried.ellmeier@meduniwien.ac.at	kuchler, karl/AAL-6937-2020; König, Eva Maria/AAF-4041-2019; Sexl, Veronika/B-8657-2016	kuchler, karl/0000-0003-2719-5955; König, Eva Maria/0000-0002-9990-4477; Putz, Eva Maria/0000-0002-5309-4114; Ellmeier, Wilfried/0000-0001-8192-8481; Muller, Mathias/0000-0002-7879-3552; LASSNIG, Caroline/0000-0001-7905-3620; Sexl, Veronika/0000-0001-9363-0412	Austrian Science Fund (FWF)/Medical University of Vienna [DK W1212]; Austrian Science Fund [P19930]; Medical University of Vienna; University of Vienna; Austrian Science Fund (FWF) [SFB F28]; Austrian Science Fund (FWF) [P 23641] Funding Source: researchfish	Austrian Science Fund (FWF)/Medical University of Vienna(Austrian Science Fund (FWF)); Austrian Science Fund(Austrian Science Fund (FWF)); Medical University of Vienna; University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work in the laboratory of W.E. was supported by the Austrian Science Fund (FWF)/Medical University of Vienna doctoral program (DK W1212) "Inflammation and Immunity", by the Austrian Science Fund (P19930), and by the Medical University of Vienna and University of Vienna cluster collaboration grant "Microbial Infections & Host Immune Response" to K.K., W.E. and T.D. M.M., V.S. and T.D were also supported by the Austrian Science Fund (FWF) project SFB F28. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoras ALB, 2003, J INVEST ALLERG CLIN, V13, P181; BACCARINI M, 1985, J IMMUNOL, V134, P2658; Bao Y, 2012, J BIOL CHEM; Bao Y, 2011, EUR J IMMUNOL, V41, P657, DOI 10.1002/eji.201040840; BURGESS AW, 1985, J BIOL CHEM, V260, P6004; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; de Diego RP, 2006, J ALLERGY CLIN IMMUN, V117, P1462, DOI 10.1016/j.jaci.2006.01.037; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Gonzalez-Serrano ME, 2012, J CLIN IMMUNOL, V32, P967, DOI 10.1007/s10875-012-9706-z; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Jongstra-Bilen J, 2008, J IMMUNOL, V181, P288, DOI 10.4049/jimmunol.181.1.288; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Koprulu AD, 2009, CRIT REV IMMUNOL, V29, P317, DOI 10.1615/CritRevImmunol.v29.i4.30; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; Marron TU, 2012, J ALLERGY CLIN IMMUN, V129, P184, DOI 10.1016/j.jaci.2011.10.009; Melcher M, 2008, J IMMUNOL, V180, P8048, DOI 10.4049/jimmunol.180.12.8048; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Mukhopadhyay S, 2002, J IMMUNOL, V168, P2914, DOI 10.4049/jimmunol.168.6.2914; Mukhopadhyay S, 1999, J IMMUNOL, V163, P1786; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Ohteki T, 1999, J EXP MED, V189, P1981, DOI 10.1084/jem.189.12.1981; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Reutterer B, 2008, CELL MICROBIOL, V10, P1116, DOI 10.1111/j.1462-5822.2007.01114.x; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Vijayan V, 2011, J IMMUNOL, V187, P817, DOI 10.4049/jimmunol.1003631; Williams MA, 2012, TRENDS IMMUNOL, V33, P488, DOI 10.1016/j.it.2012.04.007; Witte CE, 2012, ADV IMMUNOL, V113, P135, DOI 10.1016/B978-0-12-394590-7.00002-6; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yin JY, 2009, J IMMUNOL, V182, P7069, DOI 10.4049/jimmunol.0802410	41	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60476	10.1371/journal.pone.0060476	http://dx.doi.org/10.1371/journal.pone.0060476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544144	gold, Green Submitted, Green Published			2022-12-25	WOS:000317480700103
J	Liu, L; Wei, JR; Zhang, HS; Xin, JH; Huang, JP				Liu, Lu; Wei, Jianrong; Zhang, Huishu; Xin, Jianhong; Huang, Jiping			A Statistical Physics View of Pitch Fluctuations in the Classical Music from Bach to Chopin: Evidence for Scaling	PLOS ONE			English	Article							POWER-LAW; CLASSIFICATION; BEHAVIOR	Because classical music has greatly affected our life and culture in its long history, it has attracted extensive attention from researchers to understand laws behind it. Based on statistical physics, here we use a different method to investigate classical music, namely, by analyzing cumulative distribution functions (CDFs) and autocorrelation functions of pitch fluctuations in compositions. We analyze 1,876 compositions of five representative classical music composers across 164 years from Bach, to Mozart, to Beethoven, to Mendelsohn, and to Chopin. We report that the biggest pitch fluctuations of a composer gradually increase as time evolves from Bach time to Mendelsohn/Chopin time. In particular, for the compositions of a composer, the positive and negative tails of a CDF of pitch fluctuations are distributed not only in power laws (with the scale-free property), but also in symmetry (namely, the probability of a treble following a bass and that of a bass following a treble are basically the same for each composer). The power-law exponent decreases as time elapses. Further, we also calculate the autocorrelation function of the pitch fluctuation. The autocorrelation function shows a power-law distribution for each composer. Especially, the power law exponents vary with the composers, indicating their different levels of long-range correlation of notes. This work not only suggests a way understand and develop music from a viewpoint of statistical physics, but also enriches the realm of traditional statistical physics by analyzing music.	[Huang, Jiping] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Surface Phys, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Huang, JP (corresponding author), Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China.	jphuang@fudan.edu.cn			National Natural Science Foundation of China [11075035, 11222544]; Program for New Century Excellent Talents in University; Fok Ying Tung Education Foundation [131008]; Shanghai Rising-Star Program [12QA1400200]; CNKBRSF [2011CB922004]; National Fund for Talent Training in Basic Science [J1103204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Shanghai Rising-Star Program; CNKBRSF(National Basic Research Program of China); National Fund for Talent Training in Basic Science	The authors acknowledge the financial support by the National Natural Science Foundation of China under Grant Nos. 11075035 and 11222544, by the Program for New Century Excellent Talents in University, by Fok Ying Tung Education Foundation under Grant No. 131008, by Shanghai Rising-Star Program (No. 12QA1400200), by CNKBRSF under Grant No. 2011CB922004, and by National Fund for Talent Training in Basic Science (No. J1103204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, RANDOM DATA ANAL MEA; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Box GE., 2011, TIME SERIES ANAL FOR, V734; Cavanagh Lynn, 2009, WAM WEBZINE AUDIO MU; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Johnson J., 2002, WHO NEEDS CLASSICAL; Kennedy M, 2006, OXFORD DICT MUSIC AN, P1008; King A, 1973, P ROYAL MUSICAL ASS, V100, P1; Levitin DJ, 2012, P NATL ACAD SCI USA, V109, P3716, DOI 10.1073/pnas.1113828109; Liu XF, 2010, PHYSICA A, V389, P126, DOI 10.1016/j.physa.2009.08.035; Manaris B, 2005, COMPUT MUSIC J, V29, P55, DOI 10.1162/comj.2005.29.1.55; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Perreault J, 2004, THEMATIC CATALOGUE M; Petersen A, 2012, SCI REPORTS; Song KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033588; Taruskin R, 2009, OXFORD HIST W MUSIC, V3; Tzanetakis G, 2002, IEEE T SPEECH AUDI P, V10, P293, DOI 10.1109/TSA.2002.800560; VOSS RF, 1989, PHYSICA D, V38, P362, DOI 10.1016/0167-2789(89)90220-0; Young RW, 1939, J ACOUST SOC AM, V11, P134, DOI 10.1121/1.1916017; Zhao L, 2011, P NATL ACAD SCI USA, V108, P15058, DOI 10.1073/pnas.1105239108; Zhou WC, 2009, PHYSICA A, V388, P891, DOI 10.1016/j.physa.2008.11.028; Zwillinger D., 2000, CRC STANDARD PROBABI	22	19	19	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58710	10.1371/journal.pone.0058710	http://dx.doi.org/10.1371/journal.pone.0058710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	124QO	23544047	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700010
J	Vinceti, B; Loo, J; Gaisberger, H; van Zonneveld, MJ; Schueler, S; Konrad, H; Kadu, CAC; Geburek, T				Vinceti, Barbara; Loo, Judy; Gaisberger, Hannes; van Zonneveld, Maarten J.; Schueler, Silvio; Konrad, Heino; Kadu, Caroline A. C.; Geburek, Thomas			Conservation Priorities for Prunus africana Defined with the Aid of Spatial Analysis of Genetic Data and Climatic Variables	PLOS ONE			English	Article							TROPICAL TREES; DIVERSITY; BIODIVERSITY; POPULATIONS; FOREST; STRATEGIES; MITOCHONDRIAL; PREDICTION; PROTECTION; MANAGEMENT	Conservation priorities for Prunus africana, a tree species found across Afromontane regions, which is of great commercial interest internationally and of local value for rural communities, were defined with the aid of spatial analyses applied to a set of georeferenced molecular marker data (chloroplast and nuclear microsatellites) from 32 populations in 9 African countries. Two approaches for the selection of priority populations for conservation were used differing in the way they optimize representation of intra-specific diversity of P. africana across a minimum number of populations. The first method (Si) was aimed at maximizing genetic diversity of the conservation units and their distinctiveness with regard to climatic conditions, the second method (S2) at optimizing representativeness of the genetic diversity found throughout the species' range. Populations in East African countries (especially Kenya and Tanzania) were found to be of great conservation value, as suggested by previous findings. These populations are complemented by those in Madagascar and Cameroon. The combination of the two methods for prioritization led to the identification of a set of 6 priority populations. The potential distribution of P. africana was then modeled based on a dataset of 1,500 georeferenced observations. This enabled an assessment of whether the priority populations identified are exposed to threats from agricultural expansion and climate change, and whether they are located within the boundaries of protected areas. The range of the species has been affected by past climate change and the modeled distribution of P. africana indicates that the species is likely to be negatively affected in future, with an expected decrease in distribution by 2050. Based on these insights, further research at the regional and national scale is recommended, in order to strengthen P. africana conservation efforts.	[Vinceti, Barbara; Loo, Judy; Gaisberger, Hannes] Biovers Int, Headquarters, Rome, Italy; [van Zonneveld, Maarten J.] Biovers Int, Reg Off Amer, Cali, Colombia; [Schueler, Silvio; Konrad, Heino; Geburek, Thomas] Fed Res & Training Ctr Forests Nat Hazards & Land, Dept Genet, Vienna, Austria; [Kadu, Caroline A. C.] Kenyatta Univ, Dept Biochem & Biotechnol, Sch Pure & Appl Sci, Nairobi, Kenya; [van Zonneveld, Maarten J.] Univ Ghent, Fac Biosci Engn, B-9000 Ghent, Belgium	Alliance; Bioversity International; Alliance; Bioversity International; Kenyatta University; Ghent University	Vinceti, B (corresponding author), Biovers Int, Headquarters, Rome, Italy.	b.vinceti@cgiar.org	Konrad, Heino/ABH-1018-2021; Schueler, Silvio/V-2612-2019	Schueler, Silvio/0000-0003-0155-5692; Gaisberger, Hannes/0000-0002-6023-1236; Konrad, Heino/0000-0003-1820-9550	Austrian Development Agency	Austrian Development Agency	This research was funded by the Austrian Development Agency. It is the result of a collaboration between Bioversity International and the Federal Research and Training Centre for Forests, Natural Hazards and Landscape in Austria, and of a partnership with research institutions in African countries: Kenyatta University, Nairobi, Kenya; University of the Witwatersrand, Johannesburg, South Africa; Silo National des Graines Forestieres, Madagascar; Tanzania Forestry Research Institute, Tanzania; Institute of Agricultural Research for Development (IRAD), Cameroon; Faculty of Agriculture and Environmental Science, Bindura University of Science Education, Zimbabwe; National Forestry Resources Research Institute, Uganda; Coordinador Nacional de la COMIFAC Ministerio de Agricultura y Bosques, Equatorial Guinea within the framework of the project 'Development of strategies for the conservation and sustainable use of Prunus africana to improve the livelihood of small-scale farmers'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD DAT PROT AR; [Anonymous], DOWNSC GCM DAT PORT; Avana T, 2004, BOIS FOR TROP, V28, P41; Ayele TB, 2011, J NAT CONSERV, V19, P8, DOI 10.1016/j.jnc.2010.03.001; Barker N, 1994, STRELITZIA, V1, P221; Booy G, 2000, PLANT BIOLOGY, V2, P379, DOI 10.1055/s-2000-5958; Boshier D. H., 2000, ECOLOGICAL CONSEQUEN, P267; BUTYNSKI TM, 1994, BIODIVERS CONSERV, V3, P893, DOI 10.1007/BF00129665; Cavers S, 2009, SILVAE GENET, V58, P276, DOI 10.1515/sg-2009-0035; Chan LM, 2011, MOL PHYLOGENET EVOL, V59, P523, DOI 10.1016/j.ympev.2011.01.020; Chapman AD., 2005, PRINCIPLES METHODS D; Cunningham A. B., 2002, People and Plants Working Paper, UNESCO; Cunningham A.B, 2005, 16 M PLANTS COMM LIM, P3; Cunningham AB, 2006, ETUDE CITES COMMERCE, P57; Dawson IK, 2009, BIODIVERS CONSERV, V18, P969, DOI 10.1007/s10531-008-9516-z; Dawson IK, 1999, MOL ECOL, V8, P151, DOI 10.1046/j.1365-294X.1999.00518.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; European Commission Joint Research Center Global Environment Monitoring Unit, 2000, GLOB LAND COV MAP; Faith DP, 1996, CONSERV BIOL, V10, P1286, DOI 10.1046/j.1523-1739.1996.10041286.x; FAO, 2010, FOR RES ASS FRA; Farwig N, 2006, OECOLOGIA, V147, P238, DOI 10.1007/s00442-005-0288-9; Farwig N, 2008, CONSERV GENET, V9, P317, DOI 10.1007/s10592-007-9343-x; Fashing PJ, 2004, BIOL CONSERV, V120, P449, DOI 10.1016/j.biocon.2004.03.018; Diniz JAF, 2006, GENET MOL BIOL, V29, P207, DOI 10.1590/S1415-47572006000200004; Diniz JAF, 2012, CONSERV GENET, V13, P1085, DOI 10.1007/s10592-012-0356-8; Ford-Lloyd B., 2008, P110; Frankel OH, 1995, CONSERVATION PLANT B, P91; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Franzel S, 2009, ADV EC BOT, V17, P408; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Gamache I, 2003, MOL ECOL, V12, P891, DOI 10.1046/j.1365-294X.2003.01800.x; GBIF data portal, US NAT PLANT GERMPL; Geldenhuys C. J., 1981, South African Forestry Journal, P61; GRAUDAL L, 1995, FOREST ECOL MANAG, V73, P117, DOI 10.1016/0378-1127(94)03497-K; Graudal L, 2004, FOREST GENETIC RESOU, V1, P25; Guarino L., 2002, P387, DOI 10.1079/9780851995229.0387; GURIES RP, 1982, EVOLUTION, V36, P387, DOI 10.2307/2408058; Gyau A, 2012, INT FOREST REV, V14, P265, DOI 10.1505/146554812802646620; Hall JB, 2000, SCH AGR FOREST SCI P, V18, P104; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; Hijmans RJ, 2000, CONSERV BIOL, V14, P1755, DOI [10.1046/j.1523-1739.2000.98543.x, 10.1111/j.1523-1739.2000.98543.x]; Hijmans RJ, 2005, DIVA GIS 2005 MANUAL; Hollingsworth PM, 2005, MOL ECOL, V14, P497, DOI 10.1111/j.1365-294X.2005.02431.x; Ingram V, 2009, NATL PRUNUS AFRICANA, P156; Ingram V., 2007, NATURE FAUNE, V22, P29; Jamnadass R., 2009, Tropical Plant Biology, V2, P1, DOI 10.1007/s12042-008-9027-9; Jimu L., 2011, Journal of Ecology and the Natural Environment, V3, P118; Jimu L, 2013, AFR J ECOL, V51, P102, DOI 10.1111/aje.12011; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kadu CAC, 2011, MOL ECOL, V20, P165, DOI 10.1111/j.1365-294X.2010.04931.x; Kadu CAC, 2012, ANN BOT IN PRESS; Kadu CAC, 2012, PHYTOCHEMISTRY, V83, P70, DOI 10.1016/j.phytochem.2012.06.001; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Laikre L, 2010, CONSERV BIOL, V24, P86, DOI 10.1111/j.1523-1739.2009.01425.x; LEDIG FT, 1986, FOREST ECOL MANAG, V14, P77, DOI 10.1016/0378-1127(86)90093-9; Lee SL, 2006, BIOL CONSERV, V131, P72, DOI 10.1016/j.biocon.2006.02.005; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loyola RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006807; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Marshall D. R., 1975, Crop genetic resources for today and tomorrow. Genetic variation in plant populations., P53; Maxted N, 2008, CONSERVING PLANT GENETIC DIVERSITY IN PROTECTED AREAS: POPULATION MANAGEMENT OF CROP WILD RELATIVES, P65, DOI 10.1079/9781845932824.0065; Maxted N, 2008, DIVERS DISTRIB, V14, P1018, DOI 10.1111/j.1472-4642.2008.00512.x; Mbatudde M, 2011, AFR J ECOL, DOI [10.1111/j.1365-2028.2012.01327.x, DOI 10.1111/41365-2028.2012.01327.X]; Metrick A, 1998, J ECON PERSPECT, V12, P21, DOI 10.1257/jep.12.3.21; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Muchugi A, 2006, S AFR J BOT, V72, P498, DOI 10.1016/j.sajb.2006.01.003; Muir G, 2004, ANN BOT-LONDON, V93, P691, DOI 10.1093/aob/mch096; Muona O, 1990, SCAND J FOREST RES, V5, P97, DOI 10.1080/02827589009382596; Navarro-Cerrillo RM, 2008, AFR J ECOL, V46, P620, DOI 10.1111/j.1365-2028.2008.00944.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1974, GENETICS, V76, P379; Nichols KM, 2010, MOLECULAR APPROACHES IN NATURAL RESOURCE CONSERVATION AND MANAGEMENT, P123; Njoroge, 2012, ETHNOBOTANY RES APPL, V10, P329, DOI DOI 10.17348/ERA.10.0.329-338; Orwa C., 2009, AGROFORESTREE DATABA; Pandey M, 2010, CONSERV GENET, V11, P977, DOI 10.1007/s10592-009-9940-y; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Philips J, 2009, BRIEF TUTORIAL MAXEN; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; R Core Team, 2016, R FDN STAT COMP; Rajora OP, 2002, CAN J BOT, V80, P1173, DOI [10.1139/b02-105, 10.1139/B02-105]; REBELO AG, 1992, CONSERV BIOL, V6, P243, DOI 10.1046/j.1523-1739.1992.620243.x; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Saenz-Romero C, 2006, FOREST ECOL MANAG, V229, P340, DOI 10.1016/j.foreco.2006.04.014; Scheldeman X., 2010, TRAINING MANUAL SPAT; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Smith T.B., 1993, Biodiversity Letters, V1, P164, DOI 10.2307/2999740; Sneath PHA, 1973, NUMERICAL TAXONOMY P, P278; SOLOW A, 1993, J ENVIRON ECON MANAG, V24, P60, DOI 10.1006/jeem.1993.1004; St Clair JB, 2011, TURK J BOT, V35, P403, DOI 10.3906/bot-1012-98; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V7; Stewart KM, 2003, J ETHNOPHARMACOL, V89, P3, DOI 10.1016/j.jep.2003.08.002; Summers DM, 2012, GLOBAL CHANGE BIOL, V18, P3268, DOI 10.1111/j.1365-2486.2012.02771.x; Sunderland TCH, 1999, EXPLOITATION P UNPUB; Taberlet P, 2012, ECOL LETT, V15, P1439, DOI 10.1111/ele.12004; Theilade I., 2001, CONSERVATION PLAN GE; Thomas E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047676; Thomassen HA, 2011, EVOL APPL, V4, P397, DOI 10.1111/j.1752-4571.2010.00172.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tucker CM, 2012, CONSERV BIOL, V26, P593, DOI 10.1111/j.1523-1739.2012.01845.x; Tymchuk WV, 2010, MOL ECOL, V19, P1842, DOI 10.1111/j.1365-294X.2010.04596.x; UNEP WCMC, 2009, CITES TRAD DAT; van Breugel P, 2011, POTENTIAL NATURAL VE; van der Heide CM, 2005, ECOL ECON, V55, P218, DOI 10.1016/j.ecolecon.2004.12.018; van Zonneveld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029845; van Zonneveld M, 2009, FOREST ECOL MANAG, V257, P1566, DOI 10.1016/j.foreco.2008.12.027; Vandergast AG, 2008, BIOL CONSERV, V141, P1648, DOI 10.1016/j.biocon.2008.04.009; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; Weitzman ML, 1998, ECONOMETRICA, V66, P1279, DOI 10.2307/2999617; Were J, 2004, COMP STORAGE BIOL TR, P67; White F., 1983, SONDERBD NATURWISS V, V7, P87; Williams PH, 2002, J BIOSCIENCES, V27, P327, DOI 10.1007/BF02704963	120	45	45	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59987	10.1371/journal.pone.0059987	http://dx.doi.org/10.1371/journal.pone.0059987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544118	Green Published, gold			2022-12-25	WOS:000317480700077
J	Tobar-Tosse, F; Rodriguez, AC; Velez, PE; Zambrano, MM; Moreno, PA				Tobar-Tosse, Fabian; Rodriguez, Adrian C.; Velez, Patricia E.; Zambrano, Maria M.; Moreno, Pedro A.			Exploration of Noncoding Sequences in Metagenomes	PLOS ONE			English	Article							CLASSIFICATION; PREDICTION; DNA; IDENTIFICATION; ADAPTATION; EVOLUTION; SELECTION; RNAS	Environment-dependent genomic features have been defined for different metagenomes, whose genes and their associated processes are related to specific environments. Identification of ORFs and their functional categories are the most common methods for association between functional and environmental features. However, this analysis based on finding ORFs misses noncoding sequences and, therefore, some metagenome regulatory or structural information could be discarded. In this work we analyzed 23 whole metagenomes, including coding and noncoding sequences using the following sequence patterns: (G+C) content, Codon Usage (Cd), Trinucleotide Usage (Tn), and functional assignments for ORF prediction. Herein, we present evidence of a high proportion of noncoding sequences discarded in common similarity-based methods in metagenomics, and the kind of relevant information present in those. We found a high density of trinucleotide repeat sequences (TRS) in noncoding sequences, with a regulatory and adaptive function for metagenome communities. We present associations between trinucleotide values and gene function, where metagenome clustering correlate with microorganism adaptations and kinds of metagenomes. We propose here that noncoding sequences have relevant information to describe metagenomes that could be considered in a whole metagenome analysis in order to improve their organization, classification protocols, and their relation with the environment.	[Tobar-Tosse, Fabian; Rodriguez, Adrian C.; Velez, Patricia E.; Zambrano, Maria M.; Moreno, Pedro A.] Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, Colombia; [Velez, Patricia E.] FACNED Univ Cauca, Dept Biol, Popayan, Colombia; [Zambrano, Maria M.] Corp CorpoGen, Bogota, Colombia; [Moreno, Pedro A.] Univ Valle, Sch Comp & Syst Engn, Cali, Colombia; [Tobar-Tosse, Fabian; Zambrano, Maria M.; Moreno, Pedro A.] PanAmer Bioinformat Inst, Santa Marta, Magdalena, Colombia	Universidad del Cauca; Universidad del Valle	Moreno, PA (corresponding author), Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, Colombia.	pedro.moreno@correounivalle.edu.co	Zambrano, Maria Mercedes/AAD-2805-2019; Tobar-Tosse, Fabian/P-1710-2014	Zambrano, Maria Mercedes/0000-0002-0796-4473; Tobar-Tosse, Fabian/0000-0001-5334-4286; Moreno Tovar, Pedro Antonio/0000-0001-9154-7009; VELEZ VARELA, PATRICIA EUGENIA/0000-0003-3470-8704	Departamento Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS from the Republic of COLOMBIA [6570-392-19990]; MAVDT [15]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS from the Republic of COLOMBIA; MAVDT; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	The authors' study was supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS from the Republic of COLOMBIA, Project No 6570-392-19990 for GeBix (Colombian Center for Genomics and Bioinformatics of Extreme Environments). Fabian Tobar was also the recipient of a student fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was carried out under MAVDT contract no. 15, 2008 for access to genetic resources and UAESPNN Research permit no. DTNO-N-20/2007.; JGI Publication Policy: "The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231."	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bohlin J, 2011, THESCIENTIFICWORLDJO, V11, P715, DOI 10.1100/tsw.2011.70; Caro-Quintero A, 2012, ENVIRON MICROBIOL, V14, P347, DOI 10.1111/j.1462-2920.2011.02668.x; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Flores M, 2000, P NATL ACAD SCI USA, V97, P9138, DOI 10.1073/pnas.97.16.9138; Frank AC, 2002, GENETICA, V115, P1; Groussin M, 2011, MOL BIOL EVOL, V28, P2661, DOI 10.1093/molbev/msr098; Grzymski JJ, 2008, P NATL ACAD SCI USA, V105, P17516, DOI 10.1073/pnas.0802782105; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Ivanova N, 2010, ENVIRON MICROBIOL, V12, P1803, DOI 10.1111/j.1462-2920.2010.02270.x; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Kelley DR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1067; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Li WZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003375; Marchais A, 2009, GENOME RES, V19, P1084, DOI 10.1101/gr.089714.108; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P8472, DOI 10.1073/pnas.0702412104; Otsuka Y, 2004, J CLIN MICROBIOL, V42, P3538, DOI 10.1128/JCM.42.8.3538-3548.2004; Park SH, 2007, BIOCHEM BIOPH RES CO, V356, P961, DOI 10.1016/j.bbrc.2007.03.090; Porceddu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022855; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Rogozin IB, 2002, NUCLEIC ACIDS RES, V30, P4264, DOI 10.1093/nar/gkf549; Seo J, 2002, COMPUTER, V35, P80; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Weinberg Z, 2009, NATURE, V462, P656, DOI 10.1038/nature08586; Yang B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S2-S5; Yok NG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-20; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	35	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59488	10.1371/journal.pone.0059488	http://dx.doi.org/10.1371/journal.pone.0059488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536879	Green Submitted, Green Published, gold			2022-12-25	WOS:000317397200027
J	Yang, ZH; Grinchuk, V; Urban, JF; Bohl, J; Sun, R; Notari, L; Yan, S; Ramalingam, T; Keegan, AD; Wynn, TA; Shea-Donohue, T; Zhao, AP				Yang, Zhonghan; Grinchuk, Viktoriya; Urban, Joseph F., Jr.; Bohl, Jennifer; Sun, Rex; Notari, Luigi; Yan, Shu; Ramalingam, Thirumalai; Keegan, Achsah D.; Wynn, Thomas A.; Shea-Donohue, Terez; Zhao, Aiping			Macrophages as IL-25/IL-33-Responsive Cells Play an Important Role in the Induction of Type 2 Immunity	PLOS ONE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; SMALL-INTESTINE; CYTOKINE; EXPRESSION; RECEPTOR; IL-33; IL-25; IL-13; INFECTION; STAT6	Type 2 immunity is essential for host protection against nematode infection but is detrimental in allergic inflammation or asthma. There is a major research focus on the effector molecules and specific cell types involved in the initiation of type 2 immunity. Recent work has implicated an important role of epithelial-derived cytokines, IL-25 and IL-33, acting on innate immune cells that are believed to be the initial sources of type 2 cytokines IL-4/IL-5/IL-13. The identities of the cell types that mediate the effects of IL-25/IL-33, however, remain to be fully elucidated. In the present study, we demonstrate that macrophages as IL-25/IL-33-responsive cells play an important role in inducing type 2 immunity using both in vitro and in vivo approaches. Macrophages produced type 2 cytokines IL-5 and IL-13 in response to the stimulation of IL-25/IL-33 in vitro, or were the IL-13-producing cells in mice administrated with exogenous IL-33 or infected with Heligmosomoides bakeri. In addition, IL-33 induced alternative activation of macrophages primarily through autocrine IL-13 activating the IL-4R alpha-STAT6 pathway. Moreover, depletion of macrophages attenuated the IL-25/IL-33-induced type 2 immunity in mice, while adoptive transfer of IL-33-activated macrophages into mice with a chronic Heligmosomoides bakeri infection induced worm expulsion accompanied by a potent type 2 protective immune response. Thus, macrophages represent a unique population of the innate immune cells pivotal to type 2 immunity and a potential therapeutic target in controlling type 2 immunity-mediated inflammatory pathologies.	[Yang, Zhonghan; Grinchuk, Viktoriya; Bohl, Jennifer; Sun, Rex; Notari, Luigi; Yan, Shu; Shea-Donohue, Terez; Zhao, Aiping] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Yang, Zhonghan; Grinchuk, Viktoriya; Bohl, Jennifer; Sun, Rex; Notari, Luigi; Yan, Shu; Shea-Donohue, Terez; Zhao, Aiping] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Yang, Zhonghan] Sun Yat Sen Univ, Dept Biochem, Zhongshan Med Sch, Guangzhou 510275, Guangdong, Peoples R China; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD USA; [Keegan, Achsah D.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Ramalingam, Thirumalai; Wynn, Thomas A.] NIAID, Div Parasitol, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Sun Yat Sen University; United States Department of Agriculture (USDA); University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhao, AP (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	azhao@mbrc.umaryland.edu	Wynn, Thomas A/AAO-3523-2021	Wynn, Thomas A/0000-0002-7244-8731; Urban, Joseph/0000-0002-1590-8869	NIH [R01-DK083418, R01-AI/DK49316, R01-AI038985]; USDA CRIS [1235-51000-055]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000829, R01AI049316, R01AI038985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083418, T32DK067872] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA CRIS(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01-DK083418 (AZ), R01-AI/DK49316 (T. S-D), R01-AI038985 (ADK), and USDA CRIS project #1235-51000-055 (JFU). The opinions and assertions in this article are those of the authors and do not necessarily represent those of the U. S. Department of Agriculture or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Caruso R, 2009, GASTROENTEROLOGY, V136, P2270, DOI 10.1053/j.gastro.2009.02.049; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; El Asmar R, 2002, GASTROENTEROLOGY, V123, P1607, DOI 10.1053/gast.2002.36578; Espinassous Q, 2009, J IMMUNOL, V183, P1446, DOI 10.4049/jimmunol.0803067; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Joshi AD, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-52; Kang ZZ, 2012, IMMUNITY, V36, P821, DOI 10.1016/j.immuni.2012.03.021; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Madden KB, 2004, J IMMUNOL, V172, P5616, DOI 10.4049/jimmunol.172.9.5616; Madden KB, 2002, J IMMUNOL, V169, P4417, DOI 10.4049/jimmunol.169.8.4417; Morimoto M, 2009, J IMMUNOL, V183, P1934, DOI 10.4049/jimmunol.0804299; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Platt AM, 2008, IMMUNOL LETT, V119, P22, DOI 10.1016/j.imlet.2008.05.009; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rizzo A, 2012, INFLAMM BOWEL DIS, V18, P449, DOI 10.1002/ibd.21799; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shea-Donohue T, 2001, J IMMUNOL, V167, P2234, DOI 10.4049/jimmunol.167.4.2234; Shea-Donohue T, 2010, GUT MICROBES, V1, P316, DOI 10.4161/gmic.1.5.13329; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; Siracusa MC, 2011, ANN NY ACAD SCI, V1217, P166, DOI 10.1111/j.1749-6632.2010.05918.x; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zhang X, 2001, ISOLATION CHARACTERI, V14, P14; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2006, GASTROENTEROLOGY, V131, P568, DOI 10.1053/j.gastro.2006.05.013; Zhao AP, 2010, J IMMUNOL, V185, P6921, DOI 10.4049/jimmunol.1000450; Zhao AP, 2005, J IMMUNOL, V175, P2563, DOI 10.4049/jimmunol.175.4.2563; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948; Zhao AP, 2001, J PHARMACOL EXP THER, V299, P768	44	61	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59441	10.1371/journal.pone.0059441	http://dx.doi.org/10.1371/journal.pone.0059441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536877	gold, Green Submitted, Green Published			2022-12-25	WOS:000317397200025
J	Chen, SC; Kim, DK; Chase, MW; Kim, JH				Chen, Shichao; Kim, Dong-Kap; Chase, Mark W.; Kim, Joo-Hwan			Networks in a Large-Scale Phylogenetic Analysis: Reconstructing Evolutionary History of Asparagales (Lilianae) Based on Four Plastid Genes	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; CHLOROPLAST DNA; 18S RDNA; RBCL; CLASSIFICATION; MITOCHONDRIAL; INFERENCE; ACCURACY; MATK; AGE	Phylogenetic analysis aims to produce a bifurcating tree, which disregards conflicting signals and displays only those that are present in a large proportion of the data. However, any character (or tree) conflict in a dataset allows the exploration of support for various evolutionary hypotheses. Although data-display network approaches exist, biologists cannot easily and routinely use them to compute rooted phylogenetic networks on real datasets containing hundreds of taxa. Here, we constructed an original neighbour-net for a large dataset of Asparagales to highlight the aspects of the resulting network that will be important for interpreting phylogeny. The analyses were largely conducted with new data collected for the same loci as in previous studies, but from different species accessions and greater sampling in many cases than in published analyses. The network tree summarised the majority data pattern in the characters of plastid sequences before tree building, which largely confirmed the currently recognised phylogenetic relationships. Most conflicting signals are at the base of each group along the Asparagales backbone, which helps us to establish the expectancy and advance our understanding of some difficult taxa relationships and their phylogeny. The network method should play a greater role in phylogenetic analyses than it has in the past. To advance the understanding of evolutionary history of the largest order of monocots Asparagales, absolute diversification times were estimated for family-level clades using relaxed molecular clock analyses.	[Chen, Shichao] Tongji Univ, Coll Life Sci & Technol, Shanghai 200092, Peoples R China; [Kim, Dong-Kap] Korea Natl Arboretum, Div Forest Resource Conservat, Pochon, Gyeonggi Do, South Korea; [Chase, Mark W.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Kim, Joo-Hwan] Gachon Univ, Dept Life Sci, Songnam 200092, Gyeonggi Do, South Korea	Tongji University; Korea National Arboretum; Royal Botanic Gardens, Kew; Gachon University	Kim, JH (corresponding author), Gachon Univ, Dept Life Sci, Songnam 200092, Gyeonggi Do, South Korea.	kimjh2009@gachon.ac.kr	Chase, Mark W/A-6642-2011		Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2010-0029131, 2008-0060631]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2010-0029131, 2008-0060631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDELT HJ, 1992, ADV MATH, V92, P47, DOI 10.1016/0001-8708(92)90061-O; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bremer K, 1998, ANN MO BOT GARD, V85, P531, DOI 10.2307/2992015; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Chase M.W., 1995, MONOCOTYLEDONS SYSTE, P685; Chase M.W., 1995, MONOCOTYLEDONS SYSTE, P109, DOI DOI 10.1016/0378-8741(87)90103-6; Chase Mark W., 2006, Aliso, V22, P63; Chase MW, 2009, BOT J LINN SOC, V161, P132, DOI 10.1111/j.1095-8339.2009.00999.x; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Chase MW, 2000, ANN BOT-LONDON, V86, P935, DOI 10.1006/anbo.2000.1262; Conran JG, 2009, AM J BOT, V96, P466, DOI 10.3732/ajb.0800269; Dahlgren R., 1985, FAMILIES MONOCOTYLED; Darwin C., 1877, DIFFERENT FORMS FLOW; Dohm JC, 2006, J MOL EVOL, V63, P437, DOI 10.1007/s00239-005-0094-3; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Dressler R.L., 1990, ORCHIDS NATURAL HIST; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emadzade K, 2010, TAXON, V59, P809, DOI 10.1002/tax.593011; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; Fay MF, 1996, TAXON, V45, P441, DOI 10.2307/1224136; Fay MF., 2000, MONOCOTS SYSTEMATICS, P360; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J, 2004, INFERRING PHYTOGENIE; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Friis E., 1988, TERTIARY RES, V9, P7; Friis EM, 2004, P NATL ACAD SCI USA, V101, P16565, DOI 10.1073/pnas.0407174101; Goldblatt P, 2008, SYST BOT, V33, P495, DOI 10.1600/036364408785679806; Graham Sean W., 2006, Aliso, V22, P3; Gray RD, 2010, PHILOS T R SOC B, V365, P3923, DOI 10.1098/rstb.2010.0162; Grimm GW, 2006, EVOL BIOINFORM, V2, P7; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Herendeen P.S., 1995, MONOCOTYLEDONS SYSTE, P1; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Holland BR, 2004, MOL BIOL EVOL, V21, P1459, DOI 10.1093/molbev/msh145; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Huson DH, 2009, BIOINFORMATICS, V25, pI85, DOI 10.1093/bioinformatics/btp217; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; JOHNSON LA, 1995, ANN MO BOT GARD, V82, P149, DOI 10.2307/2399875; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Kim DK, 2012, J PLANT BIOL, V55, P325, DOI 10.1007/s12374-011-0016-4; Kim JH, 2010, ANN BOT-LONDON, V106, P775, DOI 10.1093/aob/mcq167; Kocyan A, 2011, MOL PHYLOGENET EVOL, V60, P122, DOI 10.1016/j.ympev.2011.02.021; Kuhl JC, 2005, GENOME, V48, P1052, DOI 10.1139/G05-073; Li XX, 2007, ACTA PHYTOTAXON SIN, V45, P113, DOI 10.1360/aps06148; LOCKHART PJ, 1992, J MOL EVOL, V34, P153; Maddison WP., 2000, MACCLADE ANAL PHYLOG; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; McPherson M, 2001, INFERENCE ASPARAGALE; Morrison D. A, 2000, MONOCOTS SYSTEMATICS, P3; Morrison DA, 2010, MOL BIOL EVOL, V27, P1044, DOI 10.1093/molbev/msp309; Nakhleh L, 2011, PROBLEM SOLVING HANDBOOK IN COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, P125, DOI 10.1007/978-0-387-09760-2_7; NICKRENT DL, 1995, ANN MO BOT GARD, V82, P208, DOI 10.2307/2399878; Nylander J, 2004, MRMODELTEST V2 EVOLU; O'Hara RJ, 1997, ZOOL SCR, V26, P323, DOI 10.1111/j.1463-6409.1997.tb00422.x; OLMSTEAD RG, 1994, SYST BIOL, V43, P467, DOI 10.2307/2413546; OLMSTEAD RG, 1992, ANN MO BOT GARD, V79, P249, DOI 10.2307/2399768; Pires J. Chris, 2006, Aliso, V22, P287; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; Rambaut A., 2007, TRACER V1 4; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3; Rudall P, 2002, INT J PLANT SCI, V163, P261, DOI 10.1086/338323; Rudall PJ, 1998, BOT J LINN SOC, V127, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seberg O, 2012, AM J BOT, V99, P875, DOI 10.3732/ajb.1100468; Shepherd LD, 2008, MOL PHYLOGENET EVOL, V48, P176, DOI 10.1016/j.ympev.2008.02.023; SHINWARI ZK, 1994, PLANT SYST EVOL, V192, P263, DOI 10.1007/BF00986256; Soltis PS, 1998, MOL SYSTEMATICS PLAN, P188, DOI DOI 10.1007/978-1-4615-5419-6_7; Steele PR, 2012, AM J BOT, V99, P330, DOI 10.3732/ajb.1100491; Stevenson D. W., 1995, MONOCOTYLEDONS SYSTE, P543; Swofford DL, 2007, PAUP PHYLOGENETIC AN; Terry RG, 1997, SYST BOT, V22, P333, DOI 10.2307/2419461; van der Mark, 2005, MRBAYES 3 1 MANUAL, P1; Vogl C, 2003, J MOL EVOL, V56, P330, DOI 10.1007/s00239-002-2404-3; Wagele JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-147; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wolfe AD, 2004, SYST BOT, V29, P1011, DOI 10.1600/0363644042451008; Woolfit M, 2007, EUKARYOT CELL, V6, P721, DOI 10.1128/EC.00338-06; Wu Q, 2008, FEMS YEAST RES, V8, P641, DOI 10.1111/j.1567-1364.2008.00362.x; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	91	54	59	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59472	10.1371/journal.pone.0059472	http://dx.doi.org/10.1371/journal.pone.0059472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23544071	Green Published, gold, Green Submitted			2022-12-25	WOS:000316411600059
J	Hane, F; Tran, G; Attwood, SJ; Leonenko, Z				Hane, Francis; Tran, Gary; Attwood, Simon J.; Leonenko, Zoya			Cu2+ Affects Amyloid-beta (1-42) Aggregation by Increasing Peptide-Peptide Binding Forces	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; ALZHEIMERS-DISEASE; MOLECULAR-DYNAMICS; OXIDATIVE STRESS; FIBRIL FORMATION; METAL-IONS; PROTEIN; COPPER; IRON; COMPLEXES	The link between metals, Alzheimer's disease (AD) and its implicated protein, amyloid-beta (A beta), is complex and highly studied. AD is believed to occur as a result of the misfolding and aggregation of A beta. The dyshomeostasis of metal ions and their propensity to interact with A beta has also been implicated in AD. In this work, we use single molecule atomic force spectroscopy to measure the rupture force required to dissociate two A beta (1-42) peptides in the presence of copper ions, Cu2+. In addition, we use atomic force microscopy to resolve the aggregation of A beta formed. Previous research has shown that metal ions decrease the lag time associated with A beta aggregation. We show that with the addition of copper ions the unbinding force increases notably. This suggests that the reduction of lag time associated with A beta aggregation occurs on a single molecule level as a result of an increase in binding forces during the very initial interactions between two A beta peptides. We attribute these results to copper ions acting as a bridge between the two peptide molecules, increasing the stability of the peptide-peptide complex.	[Hane, Francis; Tran, Gary; Leonenko, Zoya] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Attwood, Simon J.; Leonenko, Zoya] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Leonenko, Z (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	zleonenk@uwaterloo.ca	attwood, simon J/N-7237-2014	attwood, simon J/0000-0002-2973-2059; Hane, Francis/0000-0002-2738-584X	Canadian Foundation of Innovation; Ontario Research Fund; Natural Science and Engineering Council of Canada	Canadian Foundation of Innovation(Canada Foundation for Innovation); Ontario Research Fund; Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by Canadian Foundation of Innovation), Ontario Research Fund and Natural Science and Engineering Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Allison DP, 2002, CURR OPIN BIOTECH, V13, P47, DOI 10.1016/S0958-1669(02)00283-5; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7; Azimi S, 2011, INT J ALZHEIMERS DIS, P1; Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2; Barz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034345; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Cote S, 2012, J PHYS CHEM B, V116, P4043, DOI 10.1021/jp2126366; Curtain CC, 2003, J BIOL CHEM, V278, P2977, DOI 10.1074/jbc.M205455200; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; Han DX, 2008, BIOMETALS, V21, P189, DOI 10.1007/s10534-007-9107-6; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; He XL, 2010, J MOL BIOL, V395, P134, DOI 10.1016/j.jmb.2009.10.019; Hewitt N, 2009, J PHYS CHEM B, V113, P1202, DOI 10.1021/jp807327a; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Huang XD, 2004, J BIOL INORG CHEM, V9, P954, DOI 10.1007/s00775-004-0602-8; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Hung YH, 2010, J BIOL INORG CHEM, V15, P61, DOI 10.1007/s00775-009-0600-y; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Innocenti M, 2010, J ALZHEIMERS DIS, V19, P1323, DOI 10.3233/JAD-2010-1338; Jiang DL, 2009, BIOCHEMISTRY-US, V48, P7939, DOI 10.1021/bi900907a; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Karacsony O, 2011, LANGMUIR, V27, P11287, DOI 10.1021/la202530j; Kim BH, 2011, BIOCHEMISTRY-US, V50, P5154, DOI 10.1021/bi200147a; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Liu W, 2000, J CELL SCI, V113, P635; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lynch T, 2000, EXP GERONTOL, V35, P445, DOI 10.1016/S0531-5565(00)00112-1; Lyubchenko YL, 2010, WIRES NANOMED NANOBI, V2, P526, DOI 10.1002/wnan.102; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; McAllister C, 2005, J MOL BIOL, V354, P1028, DOI 10.1016/j.jmb.2005.10.012; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Mothana B, 2009, ARKIVOC, P116, DOI 10.3998/ark.5550190.0010.511; Nair NG, 2010, J ALZHEIMERS DIS, V20, P57, DOI 10.3233/JAD-2010-1346; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Pedersen JT, 2011, J BIOL CHEM, V286, P26952, DOI 10.1074/jbc.M111.220863; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Raffa DF, 2007, J PHYS CHEM B, V111, P3789, DOI 10.1021/jp0689621; Rauk A, 2009, CHEM SOC REV, V38, P2698, DOI 10.1039/b807980n; Roy S, 2005, MED HYPOTHESES, V65, P123, DOI 10.1016/j.mehy.2004.08.031; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sayre LM, 2000, J NEUROCHEM, V74, P270, DOI 10.1046/j.1471-4159.2000.0740270.x; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Suwalsky M, 2009, J ALZHEIMERS DIS, V17, P81, DOI 10.3233/JAD-2009-1032; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1997, J BIOL CHEM, V272, P12601, DOI 10.1074/jbc.272.19.12601; Yamaguchi T, 2010, BIOCHEMISTRY-US, V49, P7100, DOI 10.1021/bi100583x; Yu JP, 2008, J MOL BIOL, V384, P992, DOI 10.1016/j.jmb.2008.10.006	55	88	88	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59005	10.1371/journal.pone.0059005	http://dx.doi.org/10.1371/journal.pone.0059005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536847	Green Published, gold			2022-12-25	WOS:000316251100109
J	Choudhary, S; Kalita, M; Fang, L; Patel, KV; Tian, B; Zhao, YX; Edeh, CB; Brasier, AR				Choudhary, Sanjeev; Kalita, Mridul; Fang, Ling; Patel, Kershaw V.; Tian, Bing; Zhao, Yingxin; Edeh, Chukwudi B.; Brasier, Allan R.			Inducible Tumor Necrosis Factor (TNF) Receptor-associated Factor-1 Expression Couples the Canonical to the Non-canonical NF-kappa B Pathway in TNF Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; COMPLEX-FORMATION; KINASE-ALPHA; ACTIVATION; TRAF2; PHOSPHORYLATION; IDENTIFICATION; LYMPHOTOXIN; PROTEIN; CIAP2	The NF-kappa B transcription factor mediates the inflammatory response through distinct (canonical and non-canonical) signaling pathways. The mechanisms controlling utilization of either of these pathways are largely unknown. Here we observe that TNF stimulation induces delayed NF-kappa B2/p100 processing and investigate the coupling mechanism. TNF stimulation induces TNF-associated factor-1 (TRAF-1) that directly binds NF-kappa B-inducing kinase (NIK) and stabilizes it from degradation by disrupting its interaction with TRAF2.cIAP2 ubiquitin ligase complex. We show that TRAF1 depletion prevents TNF-induced NIK stabilization and reduces p52 production. To further examine the interactions of TRAF1 and NIK with NF-kappa B2/p100 processing, we mathematically modeled TRAF1.NIK as a coupling signaling complex and validated computational inference by siRNA knockdown to show non-canonical pathway activation is dependent not only on TRAF1 induction but also NIK stabilization by forming TRAF1.NIK complex. Thus, these integrated computational-experimental studies of TNF-induced TRAF1 expression identified TRAF1.NIK as a central complex linking canonical and non-canonical pathways by disrupting the TRAF2-cIAP2 ubiquitin ligase complex. This feed-forward kinase pathway is essential for the activation of non-canonical pathway.	[Choudhary, Sanjeev; Kalita, Mridul; Fang, Ling; Patel, Kershaw V.; Tian, Bing; Zhao, Yingxin; Edeh, Chukwudi B.; Brasier, Allan R.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Choudhary, Sanjeev; Zhao, Yingxin; Brasier, Allan R.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Zhao, Yingxin; Brasier, Allan R.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Choudhary, S (corresponding author), Univ Texas Med Branch, MRB 8-138,301 Univ Blvd, Galveston, TX 77555 USA.	sachoudh@utmb.edu		Brasier, Allan/0000-0002-5012-4090; Choudhary, Sanjeev/0000-0001-8290-7420; , Kershaw/0000-0003-2002-4096	National Institutes of Health [AI062885]; National Institutes of Health (NHLBI) [HHSN268201000037C]; (National Institutes of Health) University of Texas Medical Branch Clinical and Translational Science Award [1U54RR02614]; National Institute of Diabetes and Digestive and Kidney Diseases [DK079053]; American Heart Association [0630100N]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); (National Institutes of Health) University of Texas Medical Branch Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI062885 (to A. R. B.), HHSN268201000037C (NHLBI; to A. R. B.), 1U54RR02614 (University of Texas Medical Branch Clinical and Translational Science Award; to A. R. B.), and National Institute of Diabetes and Digestive and Kidney Diseases DK079053 (to S. C.). This work was also supported by American Heart Association Grant 0630100N (to S. C.).	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brasier AR, 2011, J VIROL, V85, P11752, DOI 10.1128/JVI.05360-11; Choudhary S, 2005, J VIROL, V79, P8948, DOI 10.1128/JVI.79.14.8948-8959.2005; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He LS, 2004, J BIOL CHEM, V279, P55855, DOI 10.1074/jbc.M407284200; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Keshishian H, 2009, MOL CELL PROTEOMICS, V8, P2339, DOI 10.1074/mcp.M900140-MCP200; Kim JY, 2011, J CELL SCI, V124, P647, DOI 10.1242/jcs.075770; Lavorgna A, 2009, MOL IMMUNOL, V46, P3278, DOI 10.1016/j.molimm.2009.07.029; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Liu P, 2008, J BIOL CHEM, V283, P23169, DOI 10.1074/jbc.M802729200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luftig MA, 2001, J BIOL CHEM, V276, P14602, DOI 10.1074/jbc.C100103200; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Qing GL, 2005, J BIOL CHEM, V280, P9765, DOI 10.1074/jbc.C400502200; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Starkey JM, 2006, DIABETES, V55, P1252, DOI 10.2337/db05-1554; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhao Y., 2011, MOL CELL PROTEOMICS, V10; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	34	32	35	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14612	14623		10.1074/jbc.M113.464081	http://dx.doi.org/10.1074/jbc.M113.464081			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543740	hybrid, Green Published			2022-12-25	WOS:000319253500061
J	Fanjul-Fernandez, M; Folgueras, AR; Fueyo, A; Balbin, M; Suarez, MF; Fernandez-Garcia, MS; Shapiro, SD; Freije, JMP; Lopez-Otin, C				Fanjul-Fernandez, Miriam; Folgueras, Alicia R.; Fueyo, Antonio; Balbin, Milagros; Suarez, Maria F.; Soledad Fernandez-Garcia, M.; Shapiro, Steven D.; Freije, Jose M. P.; Lopez-Otin, Carlos			Matrix Metalloproteinase Mmp-1a Is Dispensable for Normal Growth and Fertility in Mice and Promotes Lung Cancer Progression by Modulating Inflammatory Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTIVE ROLE; TUMOR-GROWTH; FACTOR-BETA; METASTASIS; EXPRESSION; IDENTIFICATION; COLLAGENASE; INVASION; RECEPTOR; CELLS	Human MMP-1 is a matrix metalloproteinase repeatedly associated with many pathological conditions, including cancer. Thus, MMP1 overexpression is a poor prognosis marker in a variety of advanced cancers, including colorectal, breast, and lung carcinomas. Moreover, MMP-1 plays a key role in the metastatic behavior of melanoma, breast, and prostate cancer cells. However, functional and mechanistic studies on the relevance of MMP-1 in cancer have been hampered by the absence of an in vivo model. In this work, we have generated mice deficient in Mmp1a, the murine ortholog of human MMP1. Mmp1a(-/-) mice are viable and fertile and do not exhibit obvious abnormalities, which has facilitated studies of cancer susceptibility. These studies have shown a decreased susceptibility to develop lung carcinomas induced by chemical carcinogens in Mmp1a(-/-) mice. Histopathological analysis indicated that tumors generated in Mmp1a(-/-) mice are smaller than those of wild-type mice, consistently with the idea that the absence of Mmp-1a hampers tumor progression. Proteomic analysis revealed decreased levels of chitinase-3-like 3 and accumulation of the receptor for advanced glycation end-products and its ligand S100A8 in lung samples from Mmp1a(-/-) mice compared with those from wild-type. These findings suggest that Mmp-1a could play a role in tumor progression by modulating the polarization of a Th1/Th2 inflammatory response to chemical carcinogens. On the basis of these results, we propose that Mmp1a knock-out mice provide an excellent in vivo model for the functional analysis of human MMP-1 in both physiological and pathological conditions.	[Fanjul-Fernandez, Miriam; Folgueras, Alicia R.; Suarez, Maria F.; Freije, Jose M. P.; Lopez-Otin, Carlos] Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, Inst Univ Oncol, E-33006 Oviedo, Spain; [Fueyo, Antonio] Univ Oviedo, Fac Med, Dept Biol Func, Inst Univ Oncol, E-33006 Oviedo, Spain; [Balbin, Milagros] Hosp Univ Cent Asturias, Med Oncol Serv, Oviedo 33006, Spain; [Soledad Fernandez-Garcia, M.] Hosp Univ Cent Asturias, Oviedo 33006, Spain; [Shapiro, Steven D.] Univ Pittsburgh, Dept Med, Sch Med, Pittsburgh, PA 15261 USA	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Central University Hospital Asturias; Central University Hospital Asturias; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lopez-Otin, C (corresponding author), Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	clo@uniovi.es	Folgueras, Alicia/B-3281-2017; Balbín, Milagros/I-4206-2015; Freije, José M.P./A-6535-2008; López-Otín, Carlos/AAB-2106-2020; Suárez, María Fernanda Valencia/F-8200-2019; Fueyo, Antonio/ABH-3243-2020	Folgueras, Alicia/0000-0003-3426-9502; Balbín, Milagros/0000-0001-5325-0407; Freije, José M.P./0000-0002-4688-8266; López-Otín, Carlos/0000-0001-6964-1904; Suárez, María Fernanda Valencia/0000-0001-8987-8431; Fueyo, Antonio/0000-0002-7121-9398; Miriam, Fanjul Fernandez/0000-0002-0074-2325	Ministerio de Economia y Competitividad-Spain; Fundacion Botin; Obra Social Cajastur-Asturias, Spain	Ministerio de Economia y Competitividad-Spain; Fundacion Botin; Obra Social Cajastur-Asturias, Spain	This work was supported by grants from Ministerio de Economia y Competitividad-Spain and Fundacion Botin. The Instituto Universitario de Oncologia is supported by Obra Social Cajastur-Asturias, Spain.	Agarwal A, 2010, CANCER RES, V70, P5880, DOI 10.1158/0008-5472.CAN-09-4341; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Balbin M, 1998, J BIOL CHEM, V273, P23959, DOI 10.1074/jbc.273.37.23959; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Cai YP, 2009, J IMMUNOL, V182, P5393, DOI 10.4049/jimmunol.0803874; Chen YL, 2008, J IMMUNOL, V181, P4272, DOI 10.4049/jimmunol.181.6.4272; Chizzolini C, 2000, J IMMUNOL, V164, P5952, DOI 10.4049/jimmunol.164.11.5952; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Foley CJ, 2012, J BIOL CHEM, V287, P24330, DOI 10.1074/jbc.M112.356303; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Garg P, 2010, CANCER RES, V70, P792, DOI 10.1158/0008-5472.CAN-09-3166; Godefroy E, 2011, CANCER CELL, V19, P333, DOI 10.1016/j.ccr.2011.01.037; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; Greenlee KJ, 2006, J IMMUNOL, V177, P7312, DOI 10.4049/jimmunol.177.10.7312; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Iida J, 2007, MELANOMA RES, V17, P205, DOI 10.1097/CMR.0b013e3282a660ad; Im YH, 2001, CANCER RES, V61, P6665; Jawad MU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014250; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Korpi JT, 2008, BRIT J CANCER, V98, P766, DOI 10.1038/sj.bjc.6604239; LIOTTA LA, 1990, CANCER METAST REV, V9, P285, DOI 10.1007/BF00049519; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Marshall NA, 2012, CANCER RES, V72, P581, DOI 10.1158/0008-5472.CAN-11-0307; Masset A, 2011, INT J CANCER, V128, P283, DOI 10.1002/ijc.25326; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Nabeshima Y, 2006, BIOCHEM BIOPH RES CO, V346, P658, DOI 10.1016/j.bbrc.2006.05.183; Nielsen BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002959; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Poola I, 2005, NAT MED, V11, P481, DOI 10.1038/nm1243; Pulukuri SMK, 2008, INT J ONCOL, V32, P757; RudolphOwen LA, 1997, ENDOCRINOLOGY, V138, P4902, DOI 10.1210/en.138.11.4902; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Sauter W, 2008, CANCER EPIDEM BIOMAR, V17, P1127, DOI 10.1158/1055-9965.EPI-07-2840; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Wang HW, 2010, CELL CYCLE, V9, P4824, DOI 10.4161/cc.9.24.14322; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446; Yu Q, 2000, GENE DEV, V14, P163	50	39	39	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14647	14656		10.1074/jbc.M112.439893	http://dx.doi.org/10.1074/jbc.M112.439893			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548910	hybrid, Green Published			2022-12-25	WOS:000319253500064
J	Balasubramaniyan, N; Luo, YH; Sun, AQ; Suchy, FJ				Balasubramaniyan, Natarajan; Luo, Yuhuan; Sun, An-Qiang; Suchy, Frederick J.			SUMOylation of the Farnesoid X Receptor (FXR) Regulates the Expression of FXR Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO-INTERACTING MOTIF; BILE-ACID TRANSPORTER; CHROMATIN IMMUNOPRECIPITATION; MECHANISMS; ACTIVATION; ALPHA; BETA; TRANSCRIPTION; METHYLATION; CHOLESTASIS	The farnesoid X receptor (FXR) belongs to a family of ligand-activated transcription factors that regulate many aspects of metabolism including bile acid homeostasis. Here we show that FXR is covalently modified by the small ubiquitin-like modifier (Sumo1), an important regulator of cell signaling and transcription. Well conserved consensus sites at lysine 122 and 275 in the AF-1 and ligand binding domains, respectively, of FXR were subject to SUMOylation in vitro and in vivo. Chromatin immunoprecipitation (ChIP) analysis showed that Sumo1 was recruited to the bile salt export pump (BSEP), the small heterodimer partner (SHP), and the OST alpha-OST beta organic solute transporter loci in a ligand-dependent fashion. Sequential chromatin immunoprecipitation (ChIP-ReChIP) verified the concurrent binding of FXR and Sumo1 to the BSEP and SHP promoters. Overexpression of Sumo1 markedly decreased binding and/or recruitment of FXR to the BSEP and SHP promoters on ChIP-ReChIP. SUMOylation did not have an apparent effect on nuclear localization of FXR. Expression of Sumo1 markedly inhibited the ligand-dependent, transactivation of BSEP and SHP promoters by FXR/retinoid X receptor alpha (RXR alpha) in HepG2 cells. In contrast, mutations that abolished SUMOylation of FXR or siRNA knockdown of Sumo1 expression augmented the transactivation of BSEP and SHP promoters by FXR. Pathways for SUMOylation were significantly altered during obstructive cholestasis with differential Sumo1 recruitment to the promoters of FXR target genes. In conclusion, FXR is subject to SUMOylation that regulates its capacity to transactivate its target genes in normal liver and during obstructive cholestasis.	Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; Univ Colorado, Sch Med, Childrens Hosp, Colorado Res Inst, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Suchy, FJ (corresponding author), 13123 E 16th Ave,B065, Aurora, CO 80045 USA.	frederick.suchy@childrenscolorado.org			National Institutes of Health from the NIDDK [DK-084434]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084434] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-084434 from the NIDDK (to F. J. S.).	Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Ananthanarayanan M, 2004, J BIOL CHEM, V279, P54348, DOI 10.1074/jbc.M410021200; Ananthanarayanan M, 2011, AM J PHYSIOL-GASTR L, V300, pG771, DOI 10.1152/ajpgi.00499.2010; Andreou Artemisia M., 2009, Biotechnology Journal, V4, P1740, DOI 10.1002/biot.200900219; Balasubramaniyan N, 2012, AM J PHYSIOL-GASTR L, V302, pG937, DOI 10.1152/ajpgi.00441.2011; Chaya D, 2004, METHOD ENZYMOL, V376, P361; Choi SJ, 2006, J BIOL CHEM, V281, P30669, DOI 10.1074/jbc.M604033200; Das PM, 2004, BIOTECHNIQUES, V37, P961, DOI 10.2144/04376RV01; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geier A, 2006, NAT CLIN PRACT GASTR, V3, P574, DOI 10.1038/ncpgasthep0602; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kolesar P, 2012, NUCLEIC ACIDS RES, V40, P7831, DOI 10.1093/nar/gks484; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Paddibhatla I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001234; Picard N, 2012, MOL CELL BIOL, V32, P2709, DOI 10.1128/MCB.06624-11; Pichler Andrea, 2008, V446, P131, DOI 10.1007/978-1-60327-084-7_9; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rosonina E, 2010, GENE DEV, V24, P1242, DOI 10.1101/gad.1917910; Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943; Schwartz D, 2012, ESSAYS BIOCHEM, V52, P165, DOI [10.1042/bse0520165, 10.1042/BSE0520165]; Soroka CJ, 2010, SEMIN LIVER DIS, V30, P178, DOI 10.1055/s-0030-1253226; Sun AQ, 2004, J BIOL CHEM, V279, P16295, DOI 10.1074/jbc.M312838200; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Teng SL, 2012, AMINO ACIDS, V43, P447, DOI 10.1007/s00726-011-1100-2; Treuter E, 2011, BBA-MOL BASIS DIS, V1812, P909, DOI 10.1016/j.bbadis.2010.12.008; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Winter S, 2010, ESSAYS BIOCHEM, V48, P45, DOI [10.1042/bse0480045, 10.1042/BSE0480045]; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhou WL, 2012, J CELL SCI, V125, P3630, DOI 10.1242/jcs.102889; Zollner G, 2006, MOL PHARMACEUT, V3, P231, DOI 10.1021/mp060010s; Zollner G, 2008, CLIN LIVER DIS, V12, P1, DOI 10.1016/j.cld.2007.11.010	38	42	45	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13850	13862		10.1074/jbc.M112.443937	http://dx.doi.org/10.1074/jbc.M112.443937			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23546875	Green Published, hybrid			2022-12-25	WOS:000318850300066
J	Krishnapuram, R; Dhurandhar, EJ; Dubuisson, O; Hegde, V; Dhurandhar, NV				Krishnapuram, Rashmi; Dhurandhar, Emily J.; Dubuisson, Olga; Hegde, Vijay; Dhurandhar, Nikhil V.			Doxycycline-Regulated 3T3-L1 Preadipocyte Cell Line with Inducible, Stable Expression of Adenoviral E4orf1 Gene: A Cell Model to Study Insulin-Independent Glucose Disposal	PLOS ONE			English	Article							MAMMALIAN-CELLS; MESSENGER-RNA; RESISTANCE; ADIPOSITY; SYSTEM; AD-36	Impaired glycemic control and excessive adiposity are major risk factors for Type 2 Diabetes mellitus. In rodent models Ad36, a human adenovirus, improves glycemic control, independent of dietary fat intake or adiposity. It is impractical to use Ad36 for therapeutic action. Instead, we identified that E4orf1 protein of Ad36, mediates its anti-hyperglycemic action independent of insulin signaling. To further evaluate the therapeutic potential of E4orf1 to improve glycemic control, we established a stable 3T3-L1 cell system in which E4orf1 expression can be regulated. The development and characterization of this cell line is described here. Full-length adenoviral-36 E4orf1 cDNA obtained by PCR was cloned into a tetracycline responsive element containing vector (pTRE-Tight-E4orf1). Upon screening dozens of pTRE-Tight-E4orf1 clones, we identified the one with the highest expression of E4orf1 in response to doxycycline treatment. Furthermore, using this inducible system we characterized the ability of E4orf1 to improve glucose disposal in a time dependent manner. This stable cell line offers a valuable resource to carefully study the novel signaling pathways E4orf1 uses to enhance cellular glucose disposal independent of insulin.	[Krishnapuram, Rashmi; Dhurandhar, Emily J.; Dubuisson, Olga; Hegde, Vijay; Dhurandhar, Nikhil V.] Pennington Biomed Res Ctr, Infect & Obes Lab, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Dhurandhar, NV (corresponding author), Pennington Biomed Res Ctr, Infect & Obes Lab, Baton Rouge, LA USA.	Nikhil.Dhurandhar@PBRC.EDU			Vital Health Interventions, LLC; COBRE [NIH 8 P20- GM103528, NIH 8 P20 GM103528]; NORC center from the National Institutes of Health [NIH 2P30-DK072476, NIH 2P30DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528] Funding Source: NIH RePORTER	Vital Health Interventions, LLC; COBRE; NORC center from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was funded in part by Vital Health Interventions, LLC, awarded to NVD. In addition, this work utilized the facilities of the Cell Biology and Bioimaging Core of the Pennington Biomedical Research Center, that are supported in part by COBRE (NIH 8 P20- GM103528) and NORC (NIH 2P30-DK072476) center grants from the National Institutes of Health. Also, this work used Genomics core facilities of the Pennington Biomedical Research Center, that are supported in part by COBRE (NIH 8 P20 GM103528) and NORC (NIH 2P30DK072476) center grants from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dhurandhar EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047813; Dhurandhar EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023394; Dhurandhar N, 2012, J DIABETES IN PRESS; Ewald D, 1996, SCIENCE, V273, P1384, DOI 10.1126/science.273.5280.1384; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; Frese KK, 2003, ONCOGENE, V22, P710, DOI 10.1038/sj.onc.1206151; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Iida A, 1996, J VIROL, V70, P6054, DOI 10.1128/JVI.70.9.6054-6059.1996; JAVIER R, 1992, SCIENCE, V257, P1267, DOI 10.1126/science.1519063; Krishnapuram R, 2011, AM J PHYSIOL-ENDOC M, V300, pE779, DOI 10.1152/ajpendo.00703.2010; Krishnapuram R, 2012, INT J OBESI IN PRESS; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; Pasarica M, 2006, OBESITY, V14, P1905, DOI 10.1038/oby.2006.222; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Rathod M, 2007, INT J OBESITY, V31, P78, DOI 10.1038/sj.ijo.0803358; Rogers PM, 2008, INT J OBESITY, V32, P397, DOI 10.1038/sj.ijo.0803748; Rogers PM, 2008, DIABETES, V57, P2321, DOI 10.2337/db07-1311; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Yarranton Geoffrey T., 1992, Current Opinion in Biotechnology, V3, P506, DOI 10.1016/0958-1669(92)90078-W	24	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60651	10.1371/journal.pone.0060651	http://dx.doi.org/10.1371/journal.pone.0060651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544159	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700118
J	Liu, YL; Barua, D; Liu, P; Wilson, BS; Oliver, JM; Hlavacek, WS; Singh, AK				Liu, Yanli; Barua, Dipak; Liu, Peng; Wilson, Bridget S.; Oliver, Janet M.; Hlavacek, William S.; Singh, Anup K.			Single-Cell Measurements of IgE-Mediated Fc epsilon RI Signaling Using an Integrated Microfluidic Platform	PLOS ONE			English	Article							MAST-CELLS; TYROSINE PHOSPHORYLATION; FLOW-CYTOMETRY; EARLY EVENTS; DYNAMICS; LYN; RECEPTOR; PATHWAYS; BINDING; ACTIVATION	Heterogeneity in responses of cells to a stimulus, such as a pathogen or allergen, can potentially play an important role in deciding the fate of the responding cell population and the overall systemic response. Measuring heterogeneous responses requires tools capable of interrogating individual cells. Cell signaling studies commonly do not have single-cell resolution because of the limitations of techniques used such as Westerns, ELISAs, mass spectrometry, and DNA microarrays. Microfluidics devices are increasingly being used to overcome these limitations. Here, we report on a microfluidic platform for cell signaling analysis that combines two orthogonal single-cell measurement technologies: on-chip flow cytometry and optical imaging. The device seamlessly integrates cell culture, stimulation, and preparation with downstream measurements permitting hands-free, automated analysis to minimize experimental variability. The platform was used to interrogate IgE receptor (Fc epsilon RI) signaling, which is responsible for triggering allergic reactions, in RBL-2H3 cells. Following on-chip crosslinking of IgE-Fc epsilon RI complexes by multivalent antigen, we monitored signaling events including protein phosphorylation, calcium mobilization and the release of inflammatory mediators. The results demonstrate the ability of our platform to produce quantitative measurements on a cell-by-cell basis from just a few hundred cells. Model-based analysis of the Syk phosphorylation data suggests that heterogeneity in Syk phosphorylation can be attributed to protein copy number variations, with the level of Syk phosphorylation being particularly sensitive to the copy number of Lyn.	[Liu, Yanli; Liu, Peng; Singh, Anup K.] Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA USA; [Barua, Dipak; Hlavacek, William S.] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Div Theoret, Los Alamos, NM USA; [Barua, Dipak; Hlavacek, William S.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Wilson, Bridget S.; Oliver, Janet M.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Wilson, Bridget S.; Oliver, Janet M.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of New Mexico; University of New Mexico	Singh, AK (corresponding author), Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA USA.	aksingh@sandia.gov		Barua, Dipak/0000-0001-8394-1233; Hlavacek, William/0000-0003-4383-8711	U.S. Department of Energy [DE-AC04-94AL85000]; Los Alamos National Laboratory [DE-AC52-06NA25396]; National Institutes of Health/National Institute of General Medical Sciences [P50GM085273]; United States Department of Energy [DE-AC04-94AL85000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Amanda Carroll-Portillo and Anna Holmes of University of New Mexico, and Thomas Perroud, Nimisha Srivastava, Ronald F. Renzi, Jim Van De Vreugde and Jim He of Sandia National Laboratories for providing materials and assistance with instrumentation. Sandia is a multiprogram laboratory operated by Sandia Corp., a Lockheed Martin Co., for the U.S. Department of Energy under Contract DE-AC04-94AL85000. Los Alamos National Laboratory is operated under Contract DE-AC52-06NA25396.; This work was supported by National Institutes of Health/National Institute of General Medical Sciences grant P50GM085273. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Yanli Liu, Peng Liu, and K. Singh are employed by Sandia National Laboratories. The authors thank Sandia National Laboratories for providing materials and assistance with instrumentation. Sandia is a multiprogram laboratory operated by Sandia Corp., a Lockheed Martin Co., for the United States Department of Energy under Contract DE-AC04-94AL85000. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anand RK, 2012, CURR OPIN CHEM BIOL, V16, P391, DOI 10.1016/j.cbpa.2012.05.187; Andrews NL, 2009, IMMUNITY, V31, P469, DOI 10.1016/j.immuni.2009.06.026; Barua D, 2012, J IMMUNOL, V189, P646, DOI 10.4049/jimmunol.1102003; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; BENHAMOU M, 1992, IMMUNOL TODAY, V13, P195, DOI 10.1016/0167-5699(92)90152-W; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Blinov ML, 2004, BIOINFORMATICS, V20, P3289, DOI 10.1093/bioinformatics/bth378; Carroll-Portillo A, 2010, J IMMUNOL, V184, P1328, DOI 10.4049/jimmunol.0903071; Casale TB, 1996, AM J RESP CELL MOL, V15, P35, DOI 10.1165/ajrcmb.15.1.8679220; Cheung LSL, 2010, J MICROELECTROMECH S, V19, P752, DOI 10.1109/JMEMS.2010.2052021; Cohen S. D., 1996, Computers in Physics, V10, P138; Couzon C, 2009, EUR BIOPHYS J BIOPHY, V38, P1035, DOI 10.1007/s00249-009-0506-1; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEMBO M, 1978, J IMMUNOL, V121, P345; Di Carlo D, 2006, ANAL CHEM, V78, P7918; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Faeder JR, 2003, J IMMUNOL, V170, P3769, DOI 10.4049/jimmunol.170.7.3769; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; GALLI SJ, 1991, CURR OPIN IMMUNOL, V3, P865, DOI 10.1016/S0952-7915(05)80005-6; Gaudet S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002482; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hernandez-Hansen V, 2005, J IMMUNOL, V175, P7880, DOI 10.4049/jimmunol.175.12.7880; Hilfinger A, 2011, P NATL ACAD SCI USA, V108, P12167, DOI 10.1073/pnas.1018832108; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; Lee PJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1938253; LEE RJ, 1995, MOL BIOL CELL, V6, P825, DOI 10.1091/mbc.6.7.825; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; LIU FT, 1980, J IMMUNOL, V124, P2728; Liu P, 2011, LAB CHIP, V11, P2673, DOI 10.1039/c1lc20151d; Liu YL, 2009, LAB CHIP, V9, P1033, DOI 10.1039/b820985e; MILLARD PJ, 1988, P NATL ACAD SCI USA, V85, P1854, DOI 10.1073/pnas.85.6.1854; Naal RMZG, 2004, BIOSENS BIOELECTRON, V20, P791, DOI 10.1016/j.bios.2004.03.017; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; O'Neill SK, 2011, IMMUNITY, V35, P746, DOI 10.1016/j.immuni.2011.10.011; Perroud TD, 2008, ANAL CHEM, V80, P6365, DOI 10.1021/ac8007779; Perroud TD, 2009, LAB CHIP, V9, P507, DOI 10.1039/b817285d; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Sanderson MP, 2010, MOL IMMUNOL, V48, P171, DOI 10.1016/j.molimm.2010.08.012; Srivastava N, 2009, ANAL CHEM, V81, P3261, DOI 10.1021/ac8024224; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Torigoe C, 1997, P NATL ACAD SCI USA, V94, P1372, DOI 10.1073/pnas.94.4.1372; Wang JP, 2011, P NATL ACAD SCI USA, V108, P6909, DOI 10.1073/pnas.1014753108; Wilson BS, 2011, ADV EXP MED BIOL, V716, P91, DOI 10.1007/978-1-4419-9533-9_6; WILSON BS, 1991, J CELL PHYSIOL, V149, P403, DOI 10.1002/jcp.1041490307; Wofsy C, 1997, J IMMUNOL, V159, P5984; Wu MY, 2012, LAB CHIP, V12, P2823, DOI 10.1039/c2lc40344g; Wu MY, 2012, CURR OPIN BIOTECH, V23, P83, DOI 10.1016/j.copbio.2011.11.023; Xiao WB, 2005, J IMMUNOL, V175, P6885, DOI 10.4049/jimmunol.175.10.6885; Xu KL, 1998, J IMMUNOL, V160, P3225	60	22	23	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60159	10.1371/journal.pone.0060159	http://dx.doi.org/10.1371/journal.pone.0060159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544131	Green Submitted, gold, Green Published			2022-12-25	WOS:000317480700090
J	Maruthupandian, J; Marimuthu, G				Maruthupandian, Jayabalan; Marimuthu, Ganapathy			Cunnilingus Apparently Increases Duration of Copulation in the Indian Flying Fox, Pteropus giganteus	PLOS ONE			English	Article							SPERM COMPETITION; MATING SYSTEM; BEHAVIOR; BAT	We observed a total of 57 incidences of copulation in a colony of the Indian flying fox, Pteropus giganteus, over 13 months under natural conditions. The colony consisted of about 420 individuals, roosting in a Ficus religiosa tree. Copulations occurred between 07.00 h and 09.30 h from July to January, with more occurring in October and November. Initially males groomed their penis before approaching a nearby female. Females typically moved away and males followed. When the female stopped moving, the male started licking her vagina (cunnilingus). Typically each bout of cunnilingus lasted for about 50 s. In 57 out of 69 observations, the male mounted the female and copulated. The duration of copulation varied from 10 to 20 sec. After completion of copulation, the male continued cunnilingus for 94 to 188 sec. The duration of precopulatory cunnilingus and copulation was positively correlated whereas, the duration of pre- and post-copulatory cunnilingus was negatively correlated. Apart from humans, oral sex as foreplay prior to copulation is uncommon in mammals. Another pteropodid bat, Cynopterus sphinx exhibits fellatio with females licking the penis of males during copulation. It appears that bats, especially pteropodids perform oral sex, either cunnilingus or fellatio, possibly for achieving longer copulation.	[Maruthupandian, Jayabalan; Marimuthu, Ganapathy] Madurai Kamaraj Univ, Sch Biol Sci, Dept Anim Behav & Physiol, Madurai 625021, Tamil Nadu, India	Madurai Kamaraj University	Marimuthu, G (corresponding author), Madurai Kamaraj Univ, Sch Biol Sci, Dept Anim Behav & Physiol, Madurai 625021, Tamil Nadu, India.	emailboxgm@gmail.com	Marimuthu, Ganapathy/I-7689-2013	Marimuthu, Ganapathy/0000-0001-7874-645X	University Grants Commission, New Delhi; UGC-CAS HI	University Grants Commission, New Delhi(University Grants Commission, India); UGC-CAS HI	The study was supported by the University Grants Commission, New Delhi with a Major Research Project to GM. Additional support was provided by UGC-CAS HI to the School of Biological Sciences, Madurai Kamaraj University. In both cases UGC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADBURY JW, 1977, Z TIERPSYCHOL, V45, P225; DAVIES NB, 1983, NATURE, V302, P334, DOI 10.1038/302334a0; Hosken DJ, 1998, BEHAV ECOL SOCIOBIOL, V44, P169, DOI 10.1007/s002650050529; Keeley ATH, 2004, J MAMMAL, V85, P113, DOI 10.1644/BME-004; Koilraj BJ, 2001, CURR SCI INDIA, V80, P15; Markus N, 2002, ACTA CHIROPTEROL, V4, P153, DOI 10.3161/001.004.0204; Mathur Virendra, 2012, Journal of Threatened Taxa, V4, P2699; NELSON J. E., 1965, AUSTRALIAN J ZOOL, V13, P53, DOI 10.1071/ZO9650053; NEUWEILER G, 1969, Zeitschrift fuer Tierpsychologie, V26, P166; Tan M, 2009, PLOS ONE, V4, P1; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P123	12	7	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59743	10.1371/journal.pone.0059743	http://dx.doi.org/10.1371/journal.pone.0059743			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544092	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700052
J	Vanhauteghem, D; Janssens, GPJ; Lauwaerts, A; Sys, S; Boyen, F; Cox, E; Meyer, E				Vanhauteghem, Donna; Janssens, Geert Paul Jules; Lauwaerts, Angelo; Sys, Stanislas; Boyen, Filip; Cox, Eric; Meyer, Evelyne			Exposure to the Proton Scavenger Glycine under Alkaline Conditions Induces Escherichia coli Viability Loss	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; ATP SYNTHESIS; INORGANIC POLYPHOSPHATE; ANTIMICROBIAL ACTIVITY; PH HOMEOSTASIS; FLOW-CYTOMETRY; CYTOPLASMIC PH; BACTERIA; STRESS; INDUCTION	Our previous work described a clear loss of Escherichia coli (E coli) membrane integrity after incubation with glycine or its N-methylated derivatives N-methylglycine (sarcosine) and N,N-dimethylglycine (DMG), but not N,,N,N-trimethylglycine (betaine), under alkaline stress conditions. The. current study offers a thorough viability analysis, based on a combination of real-time physiological techniques, of E. colt exposed to glycine and its N-methylated derivatives at alkaline pH. Flow cytometry was applied to assess various physiological parameters such as membrane permeability, esterase activity, respiratory activity and membrane potential. ATP and inorganic phosphate concentrations were also determined. Membrane damage was confirmed through the measurement of nucleic acid leakage. Results further showed no loss of esterase or respiratory activity, while an instant and significant decrease in the ATP concentration occurred upon exposure to either glycine, sarcosine or DMG, but not betaine; There was a clear membrane hyperpolarization as well as a significant increase in cellular inorganic phosphate concentration Based on these results, we suggest that the inability to sustain an adequate level of ATP combined with a decrease in membrane functionality leads to the loss of bacterial viability when exposed to the proton scavengers glycine, sarcosine and DMG at alkaline pH.	[Vanhauteghem, Donna; Janssens, Geert Paul Jules] Univ Ghent, Dept Nutr Genet & Ethol, Fac Vet Med, Merelbeke, Belgium; [Vanhauteghem, Donna; Meyer, Evelyne] Univ Ghent, Dept Pharmacol Toxicol & Biochem, Fac Vet Med, Merelbeke, Belgium; [Lauwaerts, Angelo] Taminco, Ghent, Belgium; [Sys, Stanislas] Univ Ghent, Dept Internal Med & Clin Biol Large Anim, Fac Vet Med, Merelbeke, Belgium; [Boyen, Filip] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Merelbeke, Belgium; [Cox, Eric] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University	Vanhauteghem, D (corresponding author), Univ Ghent, Dept Nutr Genet & Ethol, Fac Vet Med, Merelbeke, Belgium.	Donna.Vanhauteghem@Ugent.be	Janssens, Geert/C-2264-2008; Lauwaerts, Angelo/AAG-7259-2021; Boyen, Filip/AAF-6109-2020	Boyen, Filip/0000-0002-4777-6880; Cox, Eric/0000-0003-4281-2990	IWT (Agency for Innovation through Science and Technology in Flanders); Taminco Ltd. (Ghent, Belgium); Taminco Ltd.	IWT (Agency for Innovation through Science and Technology in Flanders); Taminco Ltd. (Ghent, Belgium); Taminco Ltd.	A PhD scholarship funded this research through a R&D project granted by IWT (Agency for Innovation through Science and Technology in Flanders; www.iwt.be) in cooperation with Taminco Ltd. (Ghent, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A PhD scholarship funded this research through a R&D project granted by IWT (Agency for Innovation through Science and Technology in Flanders; www.iwt.be) in cooperation with Taminco Ltd. Even though one of the authors has an affiliation to Taminco Ltd., this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ades SE, 2003, J BACTERIOL, V185, P2512, DOI 10.1128/JB.185.8.2512-2519.2003; Aoki SK, 2009, J BACTERIOL, V191, P1777, DOI 10.1128/JB.01437-08; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Baatout S, 2005, ANN MICROBIOL, V55, P73; Baatout S, 2007, ACTA ASTRONAUT, V60, P451, DOI 10.1016/j.actaastro.2006.09.012; Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Berney M, 2006, MICROBIOL-SGM, V152, P1719, DOI 10.1099/mic.0.28617-0; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Bot CT, 2010, BIOPHYS CHEM, V146, P133, DOI 10.1016/j.bpc.2009.11.005; Breeuwer P, 2000, INT J FOOD MICROBIOL, V55, P193, DOI 10.1016/S0168-1605(00)00163-X; Breeuwer P, 2004, MOL MICROBIAL ECOLOG, P1563, DOI DOI 10.1007/978-1-4020-2177-0_; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Capaldi RA, 2000, J EXP BIOL, V203, P29; Castaneda-Garcia A, 2011, J ANTIMICROB CHEMOTH, V66, P1489, DOI 10.1093/jac/dkr165; Creach V, 2003, J MICROBIOL METH, V52, P19, DOI 10.1016/S0167-7012(02)00128-8; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; Dimroth P, 2000, J EXP BIOL, V203, P51; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Grillo-Puertas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050368; Hammes F, 2011, ADV BIOCHEM ENG BIOT, V124, P123, DOI 10.1007/10_2010_95; Hoefel D, 2003, J MICROBIOL METH, V52, P379, DOI 10.1016/S0167-7012(02)00207-5; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kaim G, 1998, FEBS LETT, V434, P57, DOI 10.1016/S0014-5793(98)00969-7; KINOSHITA N, 1984, J BACTERIOL, V160, P1074, DOI 10.1128/JB.160.3.1074-1077.1984; KOBAYASHI H, 1985, J BIOL CHEM, V260, P72; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Nebe-von-Caron G, 2000, J MICROBIOL METH, V42, P97, DOI 10.1016/S0167-7012(00)00181-0; Nobmann P, 2010, J APPL MICROBIOL, V108, P2152, DOI 10.1111/j.1365-2672.2009.04622.x; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Sanchez E, 2010, APPL ENVIRON MICROB, V76, P6888, DOI 10.1128/AEM.03052-09; Sanchez L, 2007, AMINO ACIDS, V32, P133, DOI 10.1007/s00726-006-0318-x; Sanchez L, 2006, TOXICOL LETT, V161, P53, DOI 10.1016/j.toxlet.2005.07.015; SCHULDINER S, 1986, J BACTERIOL, V168, P936, DOI 10.1128/jb.168.2.936-939.1986; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; Strauber H, 2010, CYTOM PART A, V77A, P623, DOI 10.1002/cyto.a.20920; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; TAGLICHT D, 1987, J BACTERIOL, V169, P885, DOI 10.1128/jb.169.2.885-887.1987; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Van den Broeck W, 1999, INFECT IMMUN, V67, P520, DOI 10.1128/IAI.67.2.520-526.1999; Vanhauteghem D, 2012, AMINO ACIDS, V43, P245, DOI 10.1007/s00726-011-1068-y; Vives-Rego J, 2000, FEMS MICROBIOL REV, V24, P429, DOI 10.1111/j.1574-6976.2000.tb00549.x; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Yohannes E, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-59; Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404	49	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60328	10.1371/journal.pone.0060328	http://dx.doi.org/10.1371/journal.pone.0060328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544135	Green Published, gold			2022-12-25	WOS:000317480700094
J	Michelan, TS; Thomaz, SM; Bini, LM				Michelan, Thaisa S.; Thomaz, Sidinei M.; Bini, Luis M.			Native Macrophyte Density and Richness Affect the Invasiveness of a Tropical Poaceae Species	PLOS ONE			English	Article							INVASION-RESISTANCE; PLANT DIVERSITY; BIODIVERSITY; INVASIBILITY; COMPETITION; ECOSYSTEM; PATTERNS; SIGNALGRASS; ROOT	The role of the native species richness and density in ecosystem invasibility is a matter of concern for both ecologists and managers. We tested the hypothesis that the invasiveness of Urochloa arrecta (non-native in the Neotropics) is negatively affected by the species richness and abundance of native aquatic macrophytes in freshwater ecosystems. We first created four levels of macrophyte richness in a greenhouse (richness experiment), and we then manipulated the densities of the same native species in a second experiment (density experiment). When the native macrophytes were adults, fragments of U. arrecta were added, and their growth was assessed. Our results from the richness experiment corroborated the hypothesis of a negative relationship between the native species richness and the growth of U. arrecta, as measured by sprout length and root biomass. However, the resistance to invasion was not attributed to the presence of a particular native species with a greater competitive ability. In the density experiment, U. arrecta growth decreased significantly with an increased density of all five of the native species. Density strongly affected the performance of the Poaceae in a negative manner, suggesting that patches that are densely colonized by native macrophytes and less subject to disturbances will be more resistant to invasion than those that are poorly colonized and more commonly subjected to disturbances. Our density experiment also showed that some species exhibit a higher competitive ability than others (sampling effect). Although native richness and abundance clearly limit the colonization and establishment of U. arrecta, these factors cannot completely prevent the invasion of aquatic ecosystems by this Poaceae species.	[Michelan, Thaisa S.; Thomaz, Sidinei M.] Univ Estadual Maringa, Dept Biol, Maringa, Parana, Brazil; [Bini, Luis M.] Univ Fed Goias, Dept Ecol, ICB, Goiania, Go, Brazil	Universidade Estadual de Maringa; Universidade Federal de Goias	Michelan, TS (corresponding author), Univ Estadual Maringa, Dept Biol, Maringa, Parana, Brazil.	thaisamichelan@gmail.com	Bini, Luis Mauricio/D-5865-2013; Michelan, Thaisa Sala/HGV-0299-2022; Thomaz, Sidinei Magela/A-7331-2013; Michelan, Thaisa S/I-5255-2012	Bini, Luis Mauricio/0000-0003-3398-9399; Michelan, Thaisa Sala/0000-0001-9416-0758; Michelan, Thaisa S/0000-0001-9416-0758	Brazilian Council of Research (CNPq); CNPq	Brazilian Council of Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	TS Michelan acknowledges the Brazilian Council of Research (CNPq) for providing a scholarship, and SM Thomaz and LM Bini are especially thankful to the CNPq for continuous funding through a Research Productivity Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Brown RL, 2003, OIKOS, V102, P15, DOI 10.1034/j.1600-0706.2003.12191.x; Paciullo DSC, 2011, REV BRAS ZOOTECN, V40, P270, DOI 10.1590/S1516-35982011000200006; Capers RS, 2007, ECOLOGY, V88, P3135, DOI 10.1890/06-1911.1; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Casatti L, 2009, HYDROBIOLOGIA, V632, P273, DOI 10.1007/s10750-009-9849-y; Catford JA, 2011, J APPL ECOL, V48, P432, DOI 10.1111/j.1365-2664.2010.01945.x; Clark GF, 2011, ECOL LETT, V14, P52, DOI 10.1111/j.1461-0248.2010.01550.x; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Crawley MJ, 1999, ECOL LETT, V2, P140; Darwin C., 1859, ORIGIN SPECIES MEANS; Elton C. S., 1958, ECOLOGY INVASIONS AN; Goldberg D, 1993, DESIGN ANAL ECOLOGIC, P77; GOLDSBOROUGH WJ, 1988, ECOLOGY, V69, P1775, DOI 10.2307/1941156; Havel JE, 2005, BIOSCIENCE, V55, P518, DOI 10.1641/0006-3568(2005)055[0518:DRFIIL]2.0.CO;2; Hector A, 2001, ECOL RES, V16, P819, DOI 10.1046/j.1440-1703.2001.00443.x; Heino J, 2008, LIMNOL OCEANOGR, V53, P1446, DOI 10.4319/lo.2008.53.4.1446; Hershner C, 2008, CONSERV BIOL, V22, P544, DOI 10.1111/j.1523-1739.2008.00957.x; Jiang L, 2009, J ECOL, V97, P603, DOI 10.1111/j.1365-2745.2009.01503.x; Lanta V, 2008, PLANT ECOL, V198, P253, DOI 10.1007/s11258-008-9401-6; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Levine JM, 2008, CURR BIOL, V18, pR57, DOI 10.1016/j.cub.2007.11.030; Li F, 2011, AQUAT ECOL, V45, P89, DOI 10.1007/s10452-010-9334-8; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Lortie CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004823; MacArthur R.H., 1972, pvii; Michelan TS, 2010, NAT CONSERVACAO, V8, P133, DOI 10.4322/natcon.00802005; Michelan TS, 2010, FRESHWATER BIOL, V55, P1315, DOI 10.1111/j.1365-2427.2009.02355.x; Naeem S, 2000, OIKOS, V91, P97, DOI 10.1034/j.1600-0706.2000.910108.x; Palma-Silva C, 2000, PLANT ECOL, V148, P157, DOI 10.1023/A:1009823014111; Pott VJ, 2011, BRAZ J BIOL, V71, P255, DOI 10.1590/S1519-69842011000200004; R Development Core Team, 2012, R LANG ENV STAT COMP; Richardson DM, 2008, DIVERS DISTRIB, V14, P161, DOI 10.1111/j.1472-4642.2007.00464.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schiffers K, 2011, ECOLOGY, V92, P610, DOI 10.1890/10-1086.1; Smith MD, 2004, OIKOS, V106, P253, DOI 10.1111/j.0030-1299.2004.13057.x; Song MH, 2006, ACTA OECOL, V29, P214, DOI 10.1016/j.actao.2005.10.005; Teuton TC, 2004, WEED SCI, V52, P376, DOI 10.1614/WS-03-121R1; Thomaz SM, 2009, ACTA OECOL, V35, P614, DOI 10.1016/j.actao.2009.05.008; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Van der Valk A. G., 2006, BIOL FRESHWATER WETL; Vila M, 2004, BIOL INVASIONS, V6, P59, DOI 10.1023/B:BINV.0000010122.77024.8a	45	27	38	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60004	10.1371/journal.pone.0060004	http://dx.doi.org/10.1371/journal.pone.0060004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536902	Green Published, Green Submitted, gold			2022-12-25	WOS:000317397200050
J	Singh, R; Kone, BC; Gounni, AS; Uzonna, JE				Singh, Rani; Kone, Bruce C.; Gounni, Abdelilah S.; Uzonna, Jude E.			Molecular Regulation of Trypanosoma congolense-Induced Nitric Oxide Production in Macrophages	PLOS ONE			English	Article							INTERFERON-GAMMA; GENE-EXPRESSION; AFRICAN TRYPANOSOMIASIS; SURFACE GLYCOPROTEIN; JAK/STAT PATHWAY; ALPHA GENE; RESISTANCE; INFECTION; BRUCEI; INNATE	BALB/c mice are highly susceptible while C57BL/6 mice are relatively resistant to experimental Trypanosoma congolense infection. Several reports show that an early interferon-gamma (IFN-gamma) response in infected mice is critically important for resistance via the activation of macrophages and production of nitric oxide (NO). NO is a pivotal effector molecule and possesses both cytostatic and cytolytic properties for the parasite. However, the molecular mechanisms leading to T. congolense (TC)-induced NO release from macrophages are not known. In this study, we investigated the signaling pathways induced by trypanosomes in immortalized macrophage cell lines from the highly susceptible BALB/c (BALB. BM) and relatively resistant C57Bl/6 (ANA-1) mice. We found that T. congolense whole cell extract (TC-WCE) induces significantly higher levels of NO production in IFN-gamma-primed ANA-1 than BALB. BM cells, which was further confirmed in primary bone marrow-derived macrophage (BMDM) cultures. NO production was dependent on mitogen-activated protein kinase (MAPK, including p38, Erk1/2, and JNK) phosphorylation and was significantly inhibited by specific MAPK inhibitors in BALB. BM, but not in ANA-1 cells. In addition, T. congolense-and IFN-gamma-induced NO production in ANA-1 and BALB. BM cells was dependent on STAT1 phosphorylation and was totally suppressed by the use of fludarabine (a specific STAT1 inhibitor). We further show that T. congolense induces differential iNOS transcriptional promoter activation in IFN-gamma-primed cells, which is dependent on the activation of both GAS1 and GAS2 transcription factors in BALB. BM but only on GAS1 in ANA-1 cells. Taken together, our findings show the existence of differential signalling events that lead to NO production in macrophages from the highly susceptible and relatively resistant mice following treatment with IFN-gamma and T. congolense. Understanding these pathways may help identify immunomodulatory mechanisms that regulate the outcome of infection during Trypanosome infections.	[Singh, Rani; Gounni, Abdelilah S.; Uzonna, Jude E.] Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada; [Kone, Bruce C.] Univ Texas Med Sch, Houston, TX USA	University of Manitoba; University of Texas System; University of Texas Health Science Center Houston	Uzonna, JE (corresponding author), Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada.	uzonna@cc.umanitoba.ca	Gounni, Abdelilah Soussi/AAH-3456-2020	Soussi Gounni, Abdelilah/0000-0002-7282-0388; Gounni, Abdelilah/0000-0003-1265-6560	Natural Sciences and Engineering Council (NSERC); Manitoba Health Research Research Council (MHRC) Research Chairs program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075065] Funding Source: NIH RePORTER	Natural Sciences and Engineering Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Health Research Research Council (MHRC) Research Chairs program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Natural Sciences and Engineering Council (NSERC) and Manitoba Health Research Research Council (MHRC) Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron M, 2006, J IMMUNOL, V177, P6271, DOI 10.4049/jimmunol.177.9.6271; Bhat NR, 1998, J NEUROSCI, V18, P1633; BIRAGYN A, 1995, J IMMUNOL, V155, P674; Blanchette J, 2003, IMMUNOLOGY, V108, P513, DOI 10.1046/j.1365-2567.2003.01620.x; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Coller SP, 2003, J IMMUNOL, V171, P1466, DOI 10.4049/jimmunol.171.3.1466; COX GW, 1989, J NATL CANCER I, V81, P1492, DOI 10.1093/jnci/81.19.1492; DESCOTEAUX A, 1990, J IMMUNOL, V145, P846; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; FORTIER AH, 2001, CURRENT PROTOCOLS IM; Galdiero M, 2006, CYTOKINE, V36, P218, DOI 10.1016/j.cyto.2006.12.003; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Kaushik RS, 1999, EXP PARASITOL, V92, P131, DOI 10.1006/expr.1999.4408; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Lopez R, 2008, J IMMUNOL, V181, P4908, DOI 10.4049/jimmunol.181.7.4908; Lu W., 2011, J PARASITOL RES, V2011, DOI DOI 10.1155/2011/316067; MABBOTT NA, 1994, PARASITOL RES, V80, P687, DOI 10.1007/BF00932954; Magez S, 2006, J INFECT DIS, V193, P1575, DOI 10.1086/503808; Magez S, 1998, J IMMUNOL, V160, P1949; Magez S, 2009, FUTURE MICROBIOL, V4, P1075, DOI 10.2217/FMB.09.65; Mansfield J. M., 1995, Molecular approaches to parasitology., P477; Marrero MB, 1998, BIOCHEM BIOPH RES CO, V252, P508, DOI 10.1006/bbrc.1998.9678; MATHIAS S, 1990, J IMMUNOL, V145, P3450; Meli R, 1996, IMMUNOPHARMACOLOGY, V34, P1, DOI 10.1016/0162-3109(95)00052-6; Mou ZR, 2010, INFECT IMMUN, V78, P5271, DOI 10.1128/IAI.00168-10; Naessens J, 2006, INT J PARASITOL, V36, P521, DOI 10.1016/j.ijpara.2006.02.012; Ogunremi O, 1995, J PARASITOL, V81, P876, DOI 10.2307/3284033; Paulnock DM, 2010, PARASITOLOGY, V137, P2051, DOI 10.1017/S0031182010001460; Schofield CJ, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-24; Shan LY, 2010, J IMMUNOL, V184, P7134, DOI 10.4049/jimmunol.0902515; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; TABEL H, 1982, PARASITE IMMUNOL, V4, P329, DOI 10.1111/j.1365-3024.1982.tb00444.x; VINCENDEAU P, 1992, EXP PARASITOL, V75, P353, DOI 10.1016/0014-4894(92)90220-5; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59631	10.1371/journal.pone.0059631	http://dx.doi.org/10.1371/journal.pone.0059631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536884	Green Submitted, Green Published, gold			2022-12-25	WOS:000317397200032
J	Xu, N; Jia, DS; Chen, WF; Wang, H; Liu, FL; Ge, HY; Zhu, XD; Song, YL; Zhang, X; Zhang, D; Ge, D; Bai, CX				Xu, Nuo; Jia, Deshui; Chen, Wenfeng; Wang, Hao; Liu, Fanglei; Ge, Haiyan; Zhu, Xiaodan; Song, Yuanlin; Zhang, Xin; Zhang, David; Ge, Di; Bai, Chunxue			FoxM1 Is Associated with Poor Prognosis of Non-Small Cell Lung Cancer Patients through Promoting Tumor Metastasis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GLIOMA-CELLS; EXPRESSION; TRANSCRIPTION; CARCINOMA; PROGRESSION; ACTIVATION; SURVIVAL; GROWTH; MMP-9	Background: FoxM1 has been reported to be important in initiation and progression of various tumors. However, whether FoxM1 has any indication for prognosis in non-small cell lung cancer patients remains unclear. Methodology/Principal Findings: In this study, FoxM1 expression in tumor cells was examined first by immunohistochemistry in 175 NSCLC specimens, the result of which showed that FoxM1 overexpression was significantly associated with positive smoking status (P = 0.001), poorer tissue differentiation (P = 0.0052), higher TNM stage (P<0.0001), lymph node metastasis (P<0.0001), advanced tumor stage (P<0.0001), and poorer prognosis (P<0.0001). Multivariable analysis showed that FoxM1 expression increased the hazard of death (hazard ratio, 1.899; 95% CI, 1.016-3.551). Furthermore, by various in vitro and in vivo experiments, we showed that targeted knockdown of FoxM1 expression could inhibit the migratory and invasive abilities of NSCLC cells, whereas enforced expression of FoxM1 could increased the invasion and migration of NSCLC cells. Finally, we found that one of the cellular mechanisms by which FoxM1 promotes tumor metastasis is through inducing epithelial-mesenchymal transition (EMT) program. Conclusions: These results suggested that FoxM1 overexpression in tumor tissues is significantly associated with the poor prognosis of NSCLC patients through promoting tumor metastasis.	[Xu, Nuo; Liu, Fanglei; Ge, Haiyan; Zhu, Xiaodan; Song, Yuanlin; Zhang, Xin; Bai, Chunxue] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Jia, Deshui] Fudan Univ, Shanghai Med Sch, Shanghai 200433, Peoples R China; [Chen, Wenfeng] Fudan Univ, Sch Publ Hlth, Dept Biostat, Shanghai 200433, Peoples R China; [Wang, Hao; Ge, Di] Fudan Univ, Dept Thoracol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Zhang, David] Mt Sinai Sch Med, Dept Pathol, Mol Pathol Div, New York, NY USA	Fudan University; Fudan University; Fudan University; Fudan University; Icahn School of Medicine at Mount Sinai	Ge, D (corresponding author), Fudan Univ, Dept Thoracol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	Ge.di@zs-hospital.sh.cn; bai.chunxue@zs-hospital.sh.cn	Jia, Deshui/U-9732-2019	Bai, Chunxue/0000-0001-5798-3130	Shanghai Leading Academic Discipline Project [B115]; China National "985" project	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); China National "985" project	This work was supported by Shanghai Leading Academic Discipline Project, project number B115 and China National "985" project (phase III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2007, CANCER EPIDEM BIOMAR, V16, P1845, DOI 10.1158/1055-9965.EPI-07-0146; Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Balli D, 2011, CANCER RES, V71, P40, DOI 10.1158/0008-5472.CAN-10-2004; Calvisi DF, 2009, GUT, V58, P679, DOI 10.1136/gut.2008.152652; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Elzagallaai AA, 2011, J POPUL THER CLIN PH, V18, pE1; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Gibbons DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005401; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Liu Yi-qian, 2011, Zhonghua Zhong Liu Za Zhi, V33, P426; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Patel BP, 2007, HEAD NECK-J SCI SPEC, V29, P564, DOI 10.1002/hed.20561; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Ruokolainen H, 2004, CLIN CANCER RES, V10, P3110, DOI 10.1158/1078-0432.CCR-03-0530; Saji H, 2011, J THORAC ONCOL, V6, P1865, DOI 10.1097/JTO.0b013e31822a35c3; Sobin LH., 2009, TNM CLASSIFICATION M, V7th ed, P136; Sun HC, 2011, CANCER LETT, V306, P214, DOI 10.1016/j.canlet.2011.03.009; Travis K, 2004, J NATL CANCER I, V96, P900, DOI 10.1093/jnci/96.12.900; Wu D, 2005, J AM SOC NEPHROL, V16, P646, DOI 10.1681/ASN.2004060445; Xia JT, 2012, PANCREAS, V41, P629, DOI 10.1097/MPA.0b013e31823bcef2; Yang DK, 2009, HUM PATHOL, V40, P464, DOI 10.1016/j.humpath.2008.10.001; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Yu JS, 2011, CLIN CANCER RES, V17, P1924, DOI 10.1158/1078-0432.CCR-10-1551; Zhou Lei, 2009, Zhonghua Yi Xue Za Zhi, V89, P2424	39	63	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59412	10.1371/journal.pone.0059412	http://dx.doi.org/10.1371/journal.pone.0059412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536876	Green Published, gold, Green Submitted			2022-12-25	WOS:000317397200024
J	Fernandez-Real, JM; Puig, J; Serrano, M; Sabater, M; Rubio, A; Moreno-Navarrete, JM; Fontan, M; Casamitjana, R; Xifra, G; Ortega, FJ; Salvador, J; Fruhbeck, G; Ricart, W				Manuel Fernandez-Real, Jose; Puig, Josep; Serrano, Marta; Sabater, Monica; Rubio, Antoni; Maria Moreno-Navarrete, Jose; Fontan, Marina; Casamitjana, Roser; Xifra, Gemma; Jose Ortega, Francisco; Salvador, Javier; Fruehbeck, Gema; Ricart, Wifredo			Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations	PLOS ONE			English	Article							DOMINANT HYPOPHOSPHATEMIC RICKETS; LEFT-VENTRICULAR HYPERTROPHY; FGF23; MORTALITY; FGF-23; BONE; FIBROBLAST-GROWTH-FACTOR-23; OSTEOMALACIA; SENSITIVITY; PHOSPHATE	Fibroblast growth factor 23 (FGF-23) is known to be produced by the bone and linked to metabolic risk. We aimed to explore circulating FGF-23 in association with fatness and insulin sensitivity, atherosclerosis and bone mineral density (BMD). Circulating intact FGF-23 (iFGF-23) and C-terminal (CtFGF-23) concentrations (ELISA) were measured in 133 middle aged men from the general population in association with insulin sensitivity (Cohort 1); and in association with fat mass and bone mineral density (DEXA) and atherosclerosis (intima media thickness, IMT) in 78 subjects (52 women) with a wide range of adiposity (Cohort 2). Circulating iFGF-23 was also measured before and after weight loss. In all subjects as a whole, serum intact and C-terminal concentrations were linearly and positively associated with BMI. In cohort 1, both serum iFGF-23 and CtFGF-23 concentrations increased with insulin resistance. Serum creatinine contributed to iFGF-23 variance, while serum ferritin and insulin sensitivity (but not BMI, age or serum creatinine) contributed to 17% of CtFGF-23 variance. In cohort 2, CtFGF-23 levels were higher in women vs. men, and increased with BMI, fat mass, fasting and post-load serum glucose, insulin, HOMA-IR and PTH, being negatively associated with circulating vitamin D and ferritin levels. The associations of CtFGF-23 with bone density in the radius, lumbar spine and carotid IMT were no longer significant after controlling for BMI. Weight loss led to decreased iFGF-23 concentrations. In summary, the associations of circulating FGF-23 concentration with parameters of glucose metabolism, bone density and atherosclerosis are dependent on iron and obesity status-associated insulin resistance.	[Manuel Fernandez-Real, Jose; Serrano, Marta; Sabater, Monica; Maria Moreno-Navarrete, Jose; Xifra, Gemma; Jose Ortega, Francisco; Ricart, Wifredo] CIBERobn Fisiopatol Obesidad & Nutr CB06 03 010, Dept Diabet Endocrinol & Nutr, Inst Invest Biomed Girona, Girona, Spain; [Puig, Josep] CIBERobn Fisiopatol Obesidad & Nutr CB06 03 010, Dept Radiol, Inst Invest Biomed Girona, Girona, Spain; [Rubio, Antoni] CIBERobn Fisiopatol Obesidad & Nutr CB06 03 010, Dept Nucl Med, Inst Invest Biomed Girona, Girona, Spain; [Fontan, Marina] CIBERobn Fisiopatol Obesidad & Nutr CB06 03 010, Dept Biochem, Inst Invest Biomed Girona, Girona, Spain; [Casamitjana, Roser] CIBERdem, Hormonal Lab, Barcelona, Spain; [Salvador, Javier; Fruehbeck, Gema] CIBERobn Fisiopatol Obesidad & Nutr, Dept Endocrinol & Nutr, Clin Univ Navarra, Pamplona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Navarra	Fernandez-Real, JM (corresponding author), CIBERobn Fisiopatol Obesidad & Nutr CB06 03 010, Dept Diabet Endocrinol & Nutr, Inst Invest Biomed Girona, Girona, Spain.	jmfreal@idibgi.org	Ortega, Francisco José J/F-3883-2016; Moreno-Navarrete, José María/ABG-5548-2021; Moreno-Navarrete, José María/H-9772-2015; Sabater-Masdeu, Mònica/G-1168-2016; Fernández-Real, Jose Manuel/AGH-3599-2022	Ortega, Francisco José J/0000-0003-2111-769X; Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Sabater-Masdeu, Mònica/0000-0001-9636-0921; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Ricart, Wifredo/0000-0002-3452-9098	Ministerio de Educacion y Ciencia [SAF2005-02073]; Generalitat de Catalunya [2005SGR00947, 2005SGR00467]	Ministerio de Educacion y Ciencia(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by research grants from the Ministerio de Educacion y Ciencia (SAF2005-02073), and Generalitat de Catalunya (2005SGR00947 and 2005SGR00467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; Durham BH, 2007, ANN CLIN BIOCHEM, V44, P463, DOI 10.1258/000456307781646102; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Grethen E, 2012, J CLIN ENDOCR METAB, V97, P1655, DOI 10.1210/jc.2011-2280; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2011, CLIN J AM SOC NEPHRO, V6, P2871, DOI 10.2215/CJN.02740311; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Holecki M, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/707126; Hsu HJ, 2009, AM J MED SCI, V337, P116, DOI 10.1097/MAJ.0b013e3181815498; Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Marsell R, 2009, OSTEOPOROSIS INT, V20, P1167, DOI 10.1007/s00198-008-0780-2; Mirza MAI, 2011, ARTERIOSCL THROM VAS, V31, P219, DOI 10.1161/ATVBAHA.110.214619; Mirza MAI, 2009, ATHEROSCLEROSIS, V207, P546, DOI 10.1016/j.atherosclerosis.2009.05.013; Mirza MAI, 2009, NEPHROL DIAL TRANSPL, V24, P3125, DOI 10.1093/ndt/gfp205; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Riminucci M, 2003, J CLIN INVEST, V112, P683, DOI 10.1172/JC120031899; Sabater M, 2010, J CLIN ENDOCR METAB, V95, P4720, DOI 10.1210/jc.2010-0630; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; Tsuji K, 2010, J BONE MINER RES, V25, P1711, DOI 10.1002/jbmr.65; Winther K, 2012, SCAND J CLIN LAB INV, V72, P108, DOI 10.3109/00365513.2011.640407; Wojcik M, 2012, CLIN ENDOCRINOL, V77, P537, DOI 10.1111/j.1365-2265.2011.04299.x; World Health Organization Study Group on Assessment of Fracture Risk and Its Application to Screening and Postmenopausal Osteoporosis, 1994, WHO TECHN REP SER, V84; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105	33	31	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58961	10.1371/journal.pone.0058961	http://dx.doi.org/10.1371/journal.pone.0058961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555610	Green Published, Green Submitted, gold			2022-12-25	WOS:000316546400017
J	Chen, CH; Chen, W; Chen, CS; Moyzis, R; He, QH; Lei, XM; Li, J; Wang, YX; Liu, B; Xiu, DM; Zhu, B; Dong, Q				Chen, Chunhui; Chen, Wen; Chen, Chuansheng; Moyzis, Robert; He, Qinghua; Lei, Xuemei; Li, Jin; Wang, Yunxin; Liu, Bin; Xiu, Daiming; Zhu, Bi; Dong, Qi			Genetic Variations in the Serotoninergic System Contribute to Body-Mass Index in Chinese Adolescents	PLOS ONE			English	Article							INDUCED WEIGHT-GAIN; RECEPTOR GENE; PROMOTER POLYMORPHISM; ANOREXIA-NERVOSA; FUNCTIONAL POLYMORPHISM; ENVIRONMENTAL-FACTORS; OBESITY RISK; FOOD-INTAKE; ASSOCIATION; TRANSPORTER	Objective: Obesity has become a worldwide health problem in the past decades. Human and animal studies have implicated serotonin in appetite regulation, and behavior genetic studies have shown that body mass index (BMI) has a strong genetic component. However, the roles of genes related to the serotoninergic (5-hydroxytryptamine, 5-HT) system in obesity/BMI are not well understood, especially in Chinese subjects. Subjects and Design: With a sample of 478 healthy Chinese volunteers, this study investigated the relation between BMI and genetic variations of the serotoninergic system as characterized by 136 representative polymorphisms. We used a system-level approach to identify SNPs associated with BMI, then estimated their overall contribution to BMI by multiple regression and verified it by permutation. Results: We identified 12 SNPs that made statistically significant contributions to BMI. After controlling for gender and age, four of these SNPs accounted for 7.7% additional variance of BMI. Permutation analysis showed that the probability of obtaining these findings by chance was low (p = 0.015, permuted for 1000 times). Conclusion: These results showed that genetic variations in the serotoninergic system made a moderate contribution to individual differences in BMI among a healthy Chinese sample, suggesting that a similar approach can be used to study obesity.	[Chen, Chunhui; Chen, Wen; Lei, Xuemei; Li, Jin; Wang, Yunxin; Liu, Bin; Xiu, Daiming; Zhu, Bi; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [Moyzis, Robert] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Moyzis, Robert] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA USA; [He, Qinghua] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	Beijing Normal University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Southern California	Dong, Q (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	dongqi@bnu.edu.cn	He, Qinghua/B-2573-2008	He, Qinghua/0000-0001-6396-6273; Chen, Chuansheng/0000-0002-8224-1005; Chen, Wen/0000-0001-7563-4495	111 Project of the Ministry of Education of China [B07008]; National Natural Science Foundation of China [31100807]; Research Fund for the Dectoral Program of Higher Education [20110003120001]	111 Project of the Ministry of Education of China(Ministry of Education, China - 111 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Dectoral Program of Higher Education	This study was supported by the 111 Project (B07008) of the Ministry of Education of China, National Natural Science Foundation of China (31100807), and The Research Fund for the Dectoral Program of Higher Education (20110003120001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agil A, 2011, J PINEAL RES, V50, P207, DOI 10.1111/j.1600-079X.2010.00830.x; Albay Ricardo III, 2009, BMC Physiology, V9, P4, DOI 10.1186/1472-6793-9-4; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Austin MA, 1997, OBES RES, V5, P326, DOI 10.1002/j.1550-8528.1997.tb00559.x; Bah J, 2010, METABOLISM, V59, P1156, DOI 10.1016/j.metabol.2009.11.007; Bickerdike MJ, 1999, DIABETES OBES METAB, V1, P207, DOI 10.1046/j.1463-1326.1999.00037.x; Bloom SR, 2008, MOL INTERV, V8, P82, DOI 10.1124/mi.8.2.6; Calati R, 2011, INT J EAT DISORDER, V44, P191, DOI 10.1002/eat.20811; Chen CY, 2009, PHARMACOL REV, V61, P430, DOI 10.1124/pr.109.001958; Chen CH, 2012, ADDICT BIOL, V17, P479, DOI 10.1111/j.1369-1600.2011.00348.x; Chen CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021636; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Collier DA, 1997, LANCET, V350, P412, DOI 10.1016/S0140-6736(05)64135-9; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cowen PJ, 1996, PSYCHOL MED, V26, P1155, DOI 10.1017/S003329170003587X; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; De Luca V, 2007, INT J NEUROPSYCHOPH, V10, P697, DOI 10.1017/S1461145707007547; Deary IJ, 2012, NATURE, V482, P212, DOI 10.1038/nature10781; Edwards TL, 2012, AM J EPIDEMIOL, V175, P11, DOI 10.1093/aje/kwr272; Enoch MA, 1998, LANCET, V351, P1785, DOI 10.1016/S0140-6736(05)78746-8; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; FABSITZ RR, 1994, AM J EPIDEMIOL, V140, P711, DOI 10.1093/oxfordjournals.aje.a117319; Farber L, 2004, SCAND J RHEUMATOL, V33, P2, DOI 10.1080/03009740410006943; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fox CS, 2005, J CLIN ENDOCR METAB, V90, P3197, DOI 10.1210/jc.2004-1752; Fuemmeler BF, 2008, OBESITY, V16, P348, DOI 10.1038/oby.2007.65; Furnes MW, 2009, J PHYSIOL PHARMACOL, V60, P25; Ge KeYou, 1997, Asia Pacific Journal of Clinical Nutrition, V6, P175; Godlewska BR, 2009, PHARMACOGENOMICS J, V9, P234, DOI 10.1038/tpj.2009.18; Goodman E, 2000, PEDIATRICS, V106, P52, DOI 10.1542/peds.106.1.52; Guan L, 2009, MOL PSYCHIATR, V14, P546, DOI 10.1038/sj.mp.4002139; Gunes A, 2009, J CLIN PSYCHOPHARM, V29, P65, DOI 10.1097/JCP.0b013e31819302c3; Halder Indrani, 2007, Metabolic Syndrome and Related Disorders, V5, P323, DOI 10.1089/met.2007.0008; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Hayashi M, 1999, J NEUROCHEM, V73, P2538, DOI 10.1046/j.1471-4159.1999.0732538.x; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hinney A., 1997, Life Sciences, V61, pPL295, DOI 10.1016/S0024-3205(97)00888-6; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Hoekstra PJ, 2010, J CHILD ADOL PSYCHOP, V20, P473, DOI 10.1089/cap.2009.0071; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Jorm AF, 2003, AUST NZ J PUBL HEAL, V27, P434, DOI 10.1111/j.1467-842X.2003.tb00423.x; Kato M, 2006, WOODHEAD MATERIALS, P3, DOI 10.1533/9781845691127.1.3; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Lan MY, 2009, J ENDOCRINOL INVEST, V32, P119, DOI 10.1007/BF03345699; Lei SF, 2006, EUR J CLIN NUTR, V60, P511, DOI 10.1038/sj.ejcn.1602345; Lemmens VEPP, 2008, OBES REV, V9, P446, DOI 10.1111/j.1467-789X.2008.00468.x; Levitan RD, 2001, BIOL PSYCHIAT, V50, P640, DOI 10.1016/S0006-3223(01)01201-X; Lim JS, 2011, INT J OBESITY, V35, P744, DOI 10.1038/ijo.2010.188; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Lohoff' FW, 2008, NEUROSCI LETT, V434, P41, DOI 10.1016/j.neulet.2008.01.024; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; MAHATA SK, 1993, NEUROSCI LETT, V156, P70, DOI 10.1016/0304-3940(93)90442-N; Mekhmoukh A, 2012, APPETITE, V59, P90, DOI 10.1016/j.appet.2012.03.021; Mergen H, 2007, ENDOCR J, V54, P89, DOI 10.1507/endocrj.K06-023; Monteleone P, 2006, PSYCHOSOM MED, V68, P99, DOI 10.1097/01.psy.0000195746.52074.63; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Nakamura T, 1999, MOL PSYCHIATR, V4, P85, DOI 10.1038/sj.mp.4000474; Need AC, 2006, ANN HUM GENET, V70, P293, DOI 10.1111/j.1469-1809.2005.00228.x; Park YM, 2008, J CLIN PHARM THER, V33, P55, DOI 10.1111/j.1365-2710.2008.00872.x; PETER D, 1995, J NEUROSCI, V15, P6179; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian QJ, 2003, AM J MED GENET B, V118B, P103, DOI 10.1002/ajmg.b.10064; Reynolds Gavin P, 2006, J Psychopharmacol, V20, P15, DOI 10.1177/1359786806066040; Ricca V, 2004, NEUROSCI LETT, V365, P92, DOI 10.1016/j.neulet.2004.04.057; Rosmond R, 2002, OBES RES, V10, P585, DOI 10.1038/oby.2002.79; Rybakowski F, 2006, NEUROPSYCHOBIOLOGY, V53, P33, DOI 10.1159/000090701; Ryu S, 2007, PROG NEURO-PSYCHOPH, V31, P673, DOI 10.1016/j.pnpbp.2006.12.021; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Saelens BE, 2012, AM J PREV MED, V42, pE57, DOI 10.1016/j.amepre.2012.02.008; Sakamaki R, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-4; Sargent BJ, 2009, BRIT J CLIN PHARMACO, V68, P852, DOI 10.1111/j.1365-2125.2009.03550.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shinozaki G, 2012, PSYCHIAT GENET; Sookoian S, 2008, OBESITY, V16, P488, DOI 10.1038/oby.2007.64; Sorli JV, 2008, APPETITE, V50, P260, DOI 10.1016/j.appet.2007.07.011; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Story M, 2009, J ADOLESCENT HEALTH, V45, pS1, DOI 10.1016/j.jadohealth.2009.06.022; Strauss RS, 1999, INT J OBESITY, V23, P904, DOI 10.1038/sj.ijo.0800971; Strine TW, 2008, GEN HOSP PSYCHIAT, V30, P127, DOI 10.1016/j.genhosppsych.2007.12.008; Sugai T, 2006, PHARMACOGENOMICS J, V6, P351, DOI 10.1038/sj.tpj.6500382; Tan DX, 2011, OBES REV, V12, P167, DOI 10.1111/j.1467-789X.2010.00756.x; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; van Strien T, 2010, J PSYCHIATR RES, V44, P1035, DOI 10.1016/j.jpsychires.2010.03.012; Vimaleswaran KS, 2010, INT J OBESITY, V34, P1028, DOI 10.1038/ijo.2009.292; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; WHO (World Health Organization), 2009, GLOB DAT BOD MASS IN; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wolden-Hanson T, 2000, ENDOCRINOLOGY, V141, P487, DOI 10.1210/en.141.2.487; World Health Organization, 2000, WHO TECHN REP SER, V894; Yamada K, 2006, BIOL PSYCHIAT, V60, P192, DOI 10.1016/j.biopsych.2005.11.008; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhao CM, 2008, CELL TISSUE RES, V331, P575, DOI 10.1007/s00441-007-0514-3; Zhao G, 2009, INT J OBESITY, V33, P257, DOI 10.1038/ijo.2008.268; Zhu B, 2012, NEUROPSYCHOBIOLOGY, V65, P83, DOI 10.1159/000329555	99	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58717	10.1371/journal.pone.0058717	http://dx.doi.org/10.1371/journal.pone.0058717			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554917	gold, Green Published			2022-12-25	WOS:000316409800023
J	Gu, LJ; Xiong, XX; Wei, DT; Gao, XW; Krams, S; Zhao, H				Gu, Lijuan; Xiong, Xiaoxing; Wei, Dingtai; Gao, Xuwen; Krams, Sheri; Zhao, Heng			T Cells Contribute to Stroke-Induced Lymphopenia in Rats	PLOS ONE			English	Article							ISCHEMIC-STROKE; CEREBRAL-ISCHEMIA; FOCAL ISCHEMIA; ACUTE-PHASE; REG CELLS; IN-VITRO; IMMUNODEPRESSION; BRAIN; HMGB1; IMMUNOSUPPRESSION	Stroke-induced immunodepression (SIID) results when T cell and non-T immune cells, such as B cells, NK cells and monocytes, are reduced in the peripheral blood and spleen after stroke. We investigated the hypothesis that T cells are required for the reductions in non-T cell subsets observed in SIID, and further examined a potential correlation between lymphopenia and High-mobility group protein B1 (HMGB1) release, a protein that regulates inflammation and immunodepression. Our results showed that focal ischemia resulted in similar cortical infarct sizes in both wild type (WT) Sprague Dawley (SD) rats and nude rats with a SD genetic background, which excludes the possibility of different infarct sizes affecting SIID. In addition, the numbers of CD68-positive macrophages in the ischemic brain did not differ between WT and nude rats. Numbers of total peripheral blood mononuclear cells (PBMCs) or splenocytes and lymphocyte subsets, including T cells, CD4(+) or CD8(+) T cells, B cells and monocytes in the blood and spleen, were decreased after stroke in WT rats. In nude rats, however, the total number of PBMCs and absolute numbers of NK cells, B cells and monocytes were increased in the peripheral blood after stroke; nude rats are athymic therefore they have few T cells present. Adoptive transfer of WT splenocytes into nude rats before stroke resulted in lymphopenia after stroke similar to WT rats. Moreover, in vitro T cell proliferation stimulated by Concanavalin A was significantly inhibited in WT rats as well as in nude rats receiving WT splenocyte adoptive transfer, suggesting that T cell function is indeed inhibited after stroke. Lastly, we demonstrated that stroke-induced lymphopenia is associated with a reduction in HMGB1 release in the peripheral blood. In conclusion, T cells are required for stroke-induced reductions in non-T immune cells and they are the most crucial lymphocytes for SIID.	[Gu, Lijuan] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Gu, Lijuan; Xiong, Xiaoxing; Wei, Dingtai; Gao, Xuwen; Zhao, Heng] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Krams, Sheri] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA	Zhejiang University; Stanford University; Stanford University	Zhao, H (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.	hzhao@stanford.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Krams, Sheri/0000-0002-6049-5119; Xiong, Xiaoxing/0000-0001-6983-8547	NIH [R01 NS27292-03]; AHA;  [1R01NS064136-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064136, R01NS027292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH R01 NS27292-03 (GKS/HZ), AHA grant in aid and 1R01NS064136-01 (HZ). The funders had no role in study design data collection and analysis decision to publish or preparation of the manuscript.	Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; BROWN M, 1973, JAMA-J AM MED ASSOC, V224, P1493, DOI 10.1001/jama.224.11.1493; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; CZLONKOWSKA A, 1979, J NEUROL SCI, V43, P455, DOI 10.1016/0022-510X(79)90024-8; Emsley Hedley C. A., 2010, Infectious Disorders - Drug Targets, V10, P91; Gao XW, 2010, TRANSL STROKE RES, V1, P202, DOI 10.1007/s12975-010-0017-5; Gu LJ, 2012, STROKE, V43, P1941, DOI 10.1161/STROKEAHA.112.656611; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Hedrick SM, 2002, IMMUNITY, V16, P619, DOI 10.1016/S1074-7613(02)00316-3; Hirasawa T, 1998, EXP ANIM TOKYO, V47, P63, DOI 10.1538/expanim.47.63; Huang LF, 2009, SHOCK, V31, P322, DOI 10.1097/SHK.0b013e3181834070; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Inatsu A, 2011, J IMMUNOL, V187, P2155, DOI 10.4049/jimmunol.1003235; Juneja S, 1995, CLIN LAB HAEMATOL, V17, P335; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; KOSTIC V, 1988, EUR NEUROL, V28, P331, DOI 10.1159/000116296; Kurabayashi H, 1996, J MED, V27, P171; Lee MK, 2006, TRANSPLANTATION, V81, P1063, DOI 10.1097/01.tp.0000168365.80771.5a; Liesz A, 2009, STROKE, V40, P2849, DOI 10.1161/STROKEAHA.109.549618; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; Lommatzsch M, 2005, AM J RESP CRIT CARE, V171, P115, DOI 10.1164/rccm.200406-758OC; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meisel C, 2004, STROKE, V35, P2, DOI 10.1161/01.STR.0000109041.89959.4C; Millicevic NM, 2001, BLOOD, V98, P3035, DOI 10.1182/blood.V98.10.3035; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523; Peterfalvi A, 2009, CEREBROVASC DIS, V28, P490, DOI 10.1159/000236527; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Sakamoto R, 2001, BIOL PHARM BULL, V24, P906, DOI 10.1248/bpb.24.906; Sarrafzadeh A, 2011, STROKE, V42, P53, DOI 10.1161/STROKEAHA.110.594705; Schulte-Herbruggen O, 2009, NEUROIMMUNOMODULAT, V16, P213, DOI 10.1159/000205514; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Tarkowski E, 1991, J Clin Lab Immunol, V35, P171; Theodorou GL, 2008, CLIN EXP IMMUNOL, V152, P456, DOI 10.1111/j.1365-2249.2008.03650.x; Urra X, 2009, NEUROSCIENCE, V158, P1174, DOI 10.1016/j.neuroscience.2008.06.014; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Vogelgesang A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008718; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wei DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030892; Wild CA, 2012, INT IMMUNOL, V24, P485, DOI 10.1093/intimm/dxs051; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Yan J, 2009, J NEUROIMMUNOL, V206, P112, DOI 10.1016/j.jneuroim.2008.11.001; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhu XM, 2011, CYTOKINE, V54, P296, DOI 10.1016/j.cyto.2011.02.017	52	20	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59602	10.1371/journal.pone.0059602	http://dx.doi.org/10.1371/journal.pone.0059602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555048	gold, Green Submitted, Green Published			2022-12-25	WOS:000316409800104
J	Bieringer, M; Han, JW; Kendl, S; Khosravi, M; Plattet, P; Schneider-Schaulies, J				Bieringer, Maria; Han, Jung Woo; Kendl, Sabine; Khosravi, Mojtaba; Plattet, Philippe; Schneider-Schaulies, Juergen			Experimental Adaptation of Wild-Type Canine Distemper Virus (CDV) to the Human Entry Receptor CD150	PLOS ONE			English	Article							MEASLES-VIRUS; CELLULAR RECEPTOR; SLAM CD150; NATURAL INFECTION; RHESUS-MONKEYS; HEMAGGLUTININ; PROTEIN; MORBILLIVIRUSES; NECTIN4; CDW150	Canine distemper virus (CDV), a close relative of measles virus (MV), is widespread and well known for its broad host range. When the goal of measles eradication may be achieved, and when measles vaccination will be stopped, CDV might eventually cross the species barrier to humans and emerge as a new human pathogen. In order to get an impression how fast such alterations may occur, we characterized required adaptive mutations to the human entry receptors CD150 (SLAM) and nectin-4 as first step to infect human target cells. Recombinant wild-type CDV-A75/17(red) adapted quickly to growth in human H358 epithelial cells expressing human nectin-4. Sequencing of the viral attachment proteins (hemagglutinin, H, and fusion protein, F) genes revealed that no adaptive alteration was required to utilize human nectin-4. In contrast, the virus replicated only to low titres (10(2) pfu/ml) in Vero cells expressing human CD150 (Vero-hSLAM). After three passages using these cells virus was adapted to human CD150 and replicated to high titres (10(5) pfu/ml). Sequence analyses revealed that only one amino acid exchange in the H-protein at position 540 Asp -> Gly (D540G) was required for functional adaptation to human CD150. Structural modelling suggests that the adaptive mutation D540G in H reflects the sequence alteration from canine to human CD150 at position 70 and 71 from Pro to Leu (P70L) and Gly to Glu (G71E), and compensates for the gain of a negative charge in the human CD150 molecule. Using this model system our data indicate that only a minimal alteration, in this case one adaptive mutation, is required for adaptation of CDV to the human entry receptors, and help to understand the molecular basis why this adaptive mutation occurs.	[Bieringer, Maria; Han, Jung Woo; Kendl, Sabine; Schneider-Schaulies, Juergen] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Khosravi, Mojtaba; Plattet, Philippe] Univ Bern, Dept Clin Vet Med, Vetsuisse Fac, Bern, Switzerland	University of Wurzburg; University of Bern	Schneider-Schaulies, J (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, Wurzburg, Germany.	jss@vim.uni-wuerzburg.de	khosravi, mojtaba/AAV-5148-2021	Schneider-Schaulies, Jurgen/0000-0001-7713-5518	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	The work was supported by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL MJG, 1984, ARCH VIROL, V82, P73, DOI 10.1007/BF01309369; Baron MD, 2005, J GEN VIROL, V86, P1753, DOI 10.1099/vir.0.80836-0; Beineke A, 2009, VET IMMUNOL IMMUNOP, V127, P1, DOI 10.1016/j.vetimm.2008.09.023; de Vries RD, 2010, J VIROL, V84, P4714, DOI 10.1128/JVI.02633-09; Erlenhoefer C, 2001, J VIROL, V75, P4499, DOI 10.1128/JVI.75.10.4499-4505.2001; Harder TC, 1997, TRENDS MICROBIOL, V5, P120, DOI 10.1016/S0966-842X(97)01010-X; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Hsu EC, 2001, VIROLOGY, V279, P9, DOI 10.1006/viro.2000.0711; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Muhlebach MD, 2011, NATURE; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; OSTERHAUS ADME, 1989, VET REC, V125, P647; Otsuki N, 2013, VIROLOGY, V435, P485, DOI 10.1016/j.virol.2012.10.033; Pratakpiriya W, 2012, J VIROL, V86, P10207, DOI 10.1128/JVI.00824-12; Qiu W, 2011, EMERG INFECT DIS, V17, P1541, DOI 10.3201/eid1708.101153; Rivals JP, 2007, VIROLOGY, V359, P6, DOI 10.1016/j.virol.2006.07.054; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Rothlisberger A, 2010, J VIROL, V84, P6328, DOI 10.1128/JVI.01878-09; ROHOWSKYKOCHAN C, 1995, NEUROLOGY, V45, P1554, DOI 10.1212/WNL.45.8.1554; Sakai K, 2012, J VIROL; Sawatsky B, 2012, J VIROL, V86, P3658, DOI 10.1128/JVI.06414-11; Seki F, 2003, J VIROL, V77, P9943, DOI 10.1128/JVI.77.18.9943-9950.2003; Strebel PM, 2011, J INFECT DIS, V204, pS1, DOI 10.1093/infdis/jir111; Sun ZZ, 2010, VET MICROBIOL, V141, P374, DOI 10.1016/j.vetmic.2009.09.024; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tatsuo H, 2002, MICROBIOL IMMUNOL, V46, P135, DOI 10.1111/j.1348-0421.2002.tb02678.x; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wiener D, 2010, VIRUS RES, V153, P234, DOI 10.1016/j.virusres.2010.08.007; YOSHIKAWA Y, 1989, VET MICROBIOL, V20, P193, DOI 10.1016/0378-1135(89)90043-6; Zipperle L, 2010, J VIROL, V84, P9618, DOI 10.1128/JVI.01077-10	33	55	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57488	10.1371/journal.pone.0057488	http://dx.doi.org/10.1371/journal.pone.0057488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554862	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500004
J	Chen, L; Wei, TY; Si, XX; Wang, QQ; Li, Y; Leng, Y; Deng, AM; Chen, J; Wang, GY; Zhu, SC; Kang, JH				Chen, Long; Wei, Tingyi; Si, Xiaoxing; Wang, Qianqian; Li, Yan; Leng, Ye; Deng, Anmei; Chen, Jie; Wang, Guiying; Zhu, Songcheng; Kang, Jiuhong			Lysine Acetyltransferase GCN5 Potentiates the Growth of Non-small Cell Lung Cancer via Promotion of E2F1, Cyclin D1, and Cyclin E1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; SMALL-MOLECULE INHIBITORS; P53-MDM2 INTERACTION; MESANGIAL CELLS; COLON-CANCER; GENE; TRANSCRIPTION; ACETYLATION; PROTEIN; PCAF	The lysine acetyltransferases play crucial but complex roles in cancer development. GCN5 is a lysine acetyltransferase that generally regulates gene expression, but its role in cancer development remains largely unknown. In this study, we report that GCN5 is highly expressed in non-small cell lung cancer tissues and that its expression correlates with tumor size. We found that the expression of GCN5 promotes cell growth and the G(1)/S phase transition in multiple lung cancer cell lines. Further study revealed that GCN5 regulates the expression of E2F1, cyclin D1, and cyclin E1. Our reporter assays indicated that the expression of GCN5 enhances the activities of the E2F1, cyclin D1, and cyclin E1 promoters. ChIP experiments suggested that GCN5 binds directly to these promoters and increases the extent of histone acetylation within these regions. Mechanistic studies suggested that GCN5 interacts with E2F1 and is recruited by E2F1 to the E2F1, cyclin D1, and cyclin E1 promoters. The function of GCN5 in lung cancer cells is abrogated by the knockdown of E2F1. Finally, we confirmed that GCN5 regulates the expression of E2F1, cyclin D1, and cyclin E1 and potentiates lung cancer cell growth in a mouse tumor model. Taken together, our results demonstrate that GCN5 specifically potentiates lung cancer growth by directly promoting the expression of E2F1, cyclin D1, and cyclin E1 in an E2F1-dependent manner. Our study identifies a specific and novel function of GCN5 in lung cancer development and suggests that the GCN5-E2F1 interaction represents a potential target for lung cancer treatment.	[Chen, Long; Wei, Tingyi; Si, Xiaoxing; Li, Yan; Leng, Ye; Wang, Guiying; Zhu, Songcheng; Kang, Jiuhong] Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res, Sch Life Sci & Technol,Clin & Translat Res Ctr, Shanghai 200092, Peoples R China; [Wang, Qianqian; Deng, Anmei; Chen, Jie] Second Mil Med Univ, Changhai Hosp, Dept Hematol & Lab Med, Shanghai 200433, Peoples R China	Tongji University; Naval Medical University	Zhu, SC (corresponding author), Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res, Sch Life Sci & Technol,Clin & Translat Res Ctr, 1239 Si Ping Rd, Shanghai 200092, Peoples R China.	zhusongcheng@tongji.edu.cn; jhkang@tongji.edu.cn			Ministry of Science and Technology [2011CB965100, 2010CB944902, 2011CBA01106, 2011DFA30480, 2010CB945000, 2012CB966603]; National Natural Science Foundation of China [91219305, 31171432, 31101061, 31210103905, 30971451, 31071306, 31000378, 81170499]; Science and Technology Commission of Shanghai Municipality Grant [11ZR1438500, 11XD1405300]; Ministry of Education from "Chen Guang" Project from Shanghai Municipal Education Commission [IRT1168, 20110072110039]; Shanghai Education Development Foundation Grant [12CG19]; Fundamental Research Funds for the Central Universities	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education from "Chen Guang" Project from Shanghai Municipal Education Commission; Shanghai Education Development Foundation Grant; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Ministry of Science and Technology Grants 2011CB965100, 2010CB944902, 2011CBA01106, 2011DFA30480, 2010CB945000, and 2012CB966603; National Natural Science Foundation of China Grants 91219305, 31171432, 31101061, 31210103905, 30971451, 31071306, 31000378, and 81170499; Science and Technology Commission of Shanghai Municipality Grant 11ZR1438500 and 11XD1405300; Ministry of Education Grants IRT1168 and 20110072110039 from "Chen Guang" Project from Shanghai Municipal Education Commission; Shanghai Education Development Foundation Grant 12CG19, and the Fundamental Research Funds for the Central Universities.	Ahmad M, 2012, DNA CELL BIOL, V31, pS62, DOI 10.1089/dna.2011.1575; Akil A, 2012, CANCER EPIDEMIOL, V36, pE300, DOI 10.1016/j.canep.2012.05.011; Al Dayel Fouad, 2012, J Infect Public Health, V5 Suppl 1, pS31, DOI 10.1016/j.jiph.2012.09.008; Alla V, 2010, JNCI-J NATL CANCER I, V102, P127, DOI 10.1093/jnci/djp458; Armas-Pineda C, 2007, J EXP CLIN CANC RES, V26, P269; Banerjee D, 2000, CANCER RES, V60, P2365; Cagle PT, 2012, ARCH PATHOL LAB MED, V136, P1482, DOI 10.5858/arpa.2012-0508-RA; Cartier J, 2011, J BIOL CHEM, V286, P26406, DOI 10.1074/jbc.M110.191239; Chen JK, 2010, MOL CELL BIOL, V30, P5621, DOI 10.1128/MCB.00465-10; Coffey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045539; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Fantin VR, 2007, CLIN CANCER RES, V13, P7237, DOI 10.1158/1078-0432.CCR-07-2114; Geng Y, 1996, ONCOGENE, V12, P1173; Germaniuk-Kurowska A, 2007, CANCER RES, V67, P11789, DOI 10.1158/0008-5472.CAN-07-2721; Giannini G, 2012, FUTURE MED CHEM, V4, P1439, DOI [10.4155/FMC.12.80, 10.4155/fmc.12.80]; Guo RF, 2011, NUCLEIC ACIDS RES, V39, P1390, DOI 10.1093/nar/gkq983; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Icardi L, 2012, CYTOKINE GROWTH F R, V23, P283, DOI 10.1016/j.cytogfr.2012.08.002; Inoshita S, 1999, KIDNEY INT, V56, P1238, DOI 10.1046/j.1523-1755.1999.00705.x; Iwamoto M, 2004, CANCER BIOL THER, V3, P395, DOI 10.4161/cbt.3.4.733; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kishimoto M, 2005, CLIN CANCER RES, V11, P512; Komatsu N, 2006, ONCOL REP, V15, P187; Lee JH, 2012, ADV CANCER RES, V116, P39, DOI 10.1016/B978-0-12-394387-3.00002-1; Li J, 2011, J BIOMOL SCREEN, V16, P450, DOI 10.1177/1087057111399191; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Liu Y, 2013, CANCER RES, V73, P1308, DOI 10.1158/0008-5472.CAN-12-2489; Ma JA, 2010, CARCINOGENESIS, V31, P1552, DOI 10.1093/carcin/bgq140; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Park WJ, 2012, MOLECULES, V17, P13116, DOI 10.3390/molecules171113116; Ramsey MR, 2011, CANCER RES, V71, P4373, DOI 10.1158/0008-5472.CAN-11-0046; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Shiota M, 2010, CANCER SCI, V101, P1797, DOI 10.1111/j.1349-7006.2010.01598.x; Son JW, 2012, TUBERC RESPIR DIS, V73, P137, DOI 10.4046/trd.2012.73.3.137; Suzuki J, 2009, CLIN CANCER RES, V15, P3163, DOI 10.1158/1078-0432.CCR-08-2319; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Udayakumar T, 2010, SEMIN RADIAT ONCOL, V20, P258, DOI 10.1016/j.semradonc.2010.05.007; Vu BT, 2011, CURR TOP MICROBIOL, V348, P151, DOI 10.1007/82_2010_110; Wang F., 2013, CELL MOL LI IN PRESS; Watanabe N, 2012, CURR DRUG TARGETS, V13, P1654, DOI 10.2174/138945012803530035; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yan HL, 2012, CELL SIGNAL, V24, P961, DOI 10.1016/j.cellsig.2011.12.019; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200	50	100	104	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14510	14521		10.1074/jbc.M113.458737	http://dx.doi.org/10.1074/jbc.M113.458737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543735	hybrid, Green Published			2022-12-25	WOS:000319253500053
J	Heim, KP; Crowley, PJ; Brady, LJ				Heim, Kyle P.; Crowley, Paula J.; Brady, L. Jeannine			An Intramolecular Interaction Involving the N Terminus of a Streptococcal Adhesin Affects Its Conformation and Adhesive Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEIN ANTIGEN; CIRCULAR-DICHROISM SPECTRA; SALIVARY AGGLUTININ; BACTERIA-BINDING; MUTANS P1; MONOCLONAL-ANTIBODIES; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; ISOPEPTIDE BONDS; ADHERENCE	The adhesin P1 is localized on the surface of the oral pathogen Streptococcus mutans and facilitates an interaction with the glycoprotein complex salivary agglutinin that is comprised primarily of the scavenger receptor gp340. Recent crystal structures of P1 display an unusual structure in which the protein folds back upon itself to form an elongated hybrid helical stalk with a globular head at the apex and a globular C-terminal region at the base. The N terminus of P1 has not yet been characterized. In this report we describe the contribution of an interaction between the N-terminal and C-terminal portions of the protein that is required for proper function of P1 on the surface of S. mutans. Utilizing recombinant N-terminal and C-terminal fragments, we employed isothermal titration calorimetry and native gel electrophoresis to demonstrate that these fragments form a high affinity and stable complex in solution. Furthermore, circular dichroism and surface plasmon resonance measurements indicated that the N-terminal fragment contributes to the folding and increases the functionality of the C-terminal fragment in trans. Finally, we utilized circular dichroism, surface plasmon resonance, and differential scanning calorimetry to show that an N-terminal 106-amino acid segment within P1 contributes to the proper folding and function of the full-length recombinant molecule and increases the stability of its elongated hybrid helical stalk.	[Heim, Kyle P.; Crowley, Paula J.; Brady, L. Jeannine] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Brady, LJ (corresponding author), Univ Florida, Dept Oral Biol, 1395 Ctr Dr,D4-22, Gainesville, FL 32610 USA.	jbrady@dental.ufl.edu	Brady, L. Jeannine/P-5059-2019		National Institutes of Health [R01DE08007, R01DE21789]; University of Florida Alumni Fellowship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE008007, R01DE021789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Alumni Fellowship(University of Florida); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE08007 and R01DE21789 (NIDCR). This work was also supported by a University of Florida Alumni Fellowship.	AYAKAWA GY, 1987, INFECT IMMUN, V55, P2759, DOI 10.1128/IAI.55.11.2759-2767.1987; Balakrishnan M, 2000, AUST DENT J, V45, P235, DOI 10.1111/j.1834-7819.2000.tb00257.x; Bikker FJ, 2004, J BIOL CHEM, V279, P47699, DOI 10.1074/jbc.M406095200; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; BLEIWEIS AS, 1992, ADV EXP MED BIOL, V327, P229; BLEIWEIS AS, 1990, ARCH ORAL BIOL, V35, pS15, DOI 10.1016/0003-9969(90)90126-U; BOWEN WH, 1991, INFECT IMMUN, V59, P4606, DOI 10.1128/IAI.59.12.4606-4609.1991; BRADY LJ, 1992, INFECT IMMUN, V60, P1008, DOI 10.1128/IAI.60.3.1008-1017.1992; Brady LJ, 1998, INFECT IMMUN, V66, P4274; BRADY LJ, 1991, INFECT IMMUN, V59, P1803, DOI 10.1128/IAI.59.5.1803-1810.1991; BRADY LJ, 1991, INFECT IMMUN, V59, P4425, DOI 10.1128/IAI.59.12.4425-4435.1991; BUCKLEY ND, 1995, J BACTERIOL, V177, P5028, DOI 10.1128/jb.177.17.5028-5034.1995; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Crowley PJ, 2008, INFECT IMMUN, V76, P2456, DOI 10.1128/IAI.01315-07; CROWLEY PJ, 1993, INFECT IMMUN, V61, P1547, DOI 10.1128/IAI.61.4.1547-1552.1993; Crowley PJ, 1999, INFECT IMMUN, V67, P1201, DOI 10.1128/IAI.67.3.1201-1206.1999; ERICSON T, 1983, EUR J BIOCHEM, V133, P255, DOI 10.1111/j.1432-1033.1983.tb07456.x; Forsgren N, 2010, J MOL BIOL, V397, P740, DOI 10.1016/j.jmb.2010.01.065; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; GOMEZ J, 1995, J MOL BIOL, V252, P337, DOI 10.1006/jmbi.1995.0501; Guzman-Armstrong Sandra, 2005, J Sch Nurs, V21, P272; HAJISHENGALLIS G, 1992, INFECT IMMUN, V60, P5057, DOI 10.1128/IAI.60.12.5057-5064.1992; HAJISHENGALLIS G, 1994, J DENT RES, V73, P1493, DOI 10.1177/00220345940730090301; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; Holdgate G, 2010, METHODS MOL BIOL, V572, P101, DOI 10.1007/978-1-60761-244-5_7; Hu XQ, 2011, J AM CHEM SOC, V133, P478, DOI 10.1021/ja107513t; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; KELLY C, 1990, ARCH ORAL BIOL, V35, pS33, DOI 10.1016/0003-9969(90)90128-W; KISHIMOTO E, 1989, INFECT IMMUN, V57, P3702, DOI 10.1128/IAI.57.12.3702-3707.1989; KOGA T, 1986, J GEN MICROBIOL, V132, P2873; KOGA T, 1990, INFECT IMMUN, V58, P289, DOI 10.1128/IAI.58.2.289-296.1990; Larson MR, 2011, J BIOL CHEM, V286, P21657, DOI 10.1074/jbc.M111.231100; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; Lee SF, 2003, INFECT IMMUN, V71, P676, DOI 10.1128/IAI.71.2.676-681.2003; LEE SF, 1989, INFECT IMMUN, V57, P3306, DOI 10.1128/IAI.57.11.3306-3313.1989; Leito JTD, 2008, BIOL CHEM, V389, P1193, DOI 10.1515/BC.2008.135; Lewis Edwin A., 2005, V305, P1; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Lopez Maria M, 2002, Methods Mol Biol, V173, P121; Ma BY, 2000, PROTEIN ENG, V13, P617, DOI 10.1093/protein/13.9.617; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; McArthur WP, 2007, FEMS IMMUNOL MED MIC, V50, P342, DOI 10.1111/j.1574-695X.2007.00260.x; Mosci F, 1990, Minerva Stomatol, V39, P413; MUNRO GH, 1993, INFECT IMMUN, V61, P4590, DOI 10.1128/IAI.61.11.4590-4598.1993; MURPHY KP, 1992, J MOL BIOL, V227, P293, DOI 10.1016/0022-2836(92)90699-K; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Nylander A, 2011, ACTA CRYSTALLOGR F, V67, P23, DOI 10.1107/S174430911004443X; Oho T, 1998, INFECT IMMUN, V66, P115, DOI 10.1128/IAI.66.1.115-121.1998; Oli MW, 2012, MICROBIOL-SGM, V158, P2903, DOI 10.1099/mic.0.060855-0; Oli MW, 2006, J MICROBIOL METH, V65, P503, DOI 10.1016/j.mimet.2005.09.011; PERRY D, 1989, INFECT IMMUN, V57, P805, DOI 10.1128/IAI.57.3.805-809.1989; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Rhodin NR, 2004, INFECT IMMUN, V72, P4680, DOI 10.1128/IAI.72.8.4680-4688.2004; Rhodin NR, 2004, INFECT IMMUN, V72, P13, DOI 10.1128/IAI.72.1.13-21.2004; Robinette RA, 2009, J IMMUNOL, V183, P4628, DOI 10.4049/jimmunol.0803300; RUSSELL MW, 1980, INFECT IMMUN, V28, P486; RUSSELL MW, 1989, ORAL MICROBIOL IMMUN, V4, P106, DOI 10.1111/j.1399-302X.1989.tb00107.x; RUSSELL RRB, 1979, J GEN MICROBIOL, V114, P109, DOI 10.1099/00221287-114-1-109; Seifert TB, 2004, INFECT IMMUN, V72, P4699, DOI 10.1128/IAI.72.8.4699-4706.2004; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Tsai CJ, 2001, CRIT REV BIOCHEM MOL, V36, P399, DOI 10.1080/20014091074228; van Dolleweerd CJ, 2004, J BIOL CHEM, V279, P22198, DOI 10.1074/jbc.M400820200; Velazquez-Campoy Adrian, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1708s23; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zucca M, 1990, G Batteriol Virol Immunol, V83, P108	74	9	9	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13762	13774		10.1074/jbc.M113.459974	http://dx.doi.org/10.1074/jbc.M113.459974			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539625	Green Published, hybrid			2022-12-25	WOS:000318850300058
J	Kerzerho, J; Schneider, A; Favry, E; Castelli, FA; Maillere, B				Kerzerho, Jerome; Schneider, Aurelie; Favry, Emmanuel; Castelli, Florence Anne; Maillere, Bernard			The Signal Peptide of the Tumor-shared Antigen Midkine Hosts CD4(+) T Cell Epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING GROWTH-FACTOR; CATHEPSIN-D; REPERTOIRE; CANCER; EXPRESSION; MICE; SPECIFICITY; GENERATION; CARCINOMAS; FREQUENCY	Because of the key role of CD4 T cell response in immunity to tumors, we investigated the CD4(+) T cell response to the recently identified tumor antigen Midkine (MDK). By weekly stimulations of T lymphocytes harvested from seven HLA-DR-typed healthy donors, we derived CD4(+) T cell lines specific for eight MDK peptides. Most of the T cell lines reacted with the peptides 9-23 and 14-28, located in and overlapping the MDK signal peptide, respectively. Accordingly, the MDK signal peptide appeared to be rich in good binders to common HLA-DR molecules. The peptide 9-23-specific T cell lines were specifically stimulated by autologous dendritic cells loaded with lysates of MDK-transfected cells or with lysates of tumor cells naturally expressing the MDK protein. One T cell line was stimulated by HLA-compatible MDK-transfected tumor cells. By contrast, the peptide 14-28-specific T cell lines were not stimulated in any of these conditions. Our data demonstrate that CD4(+) T cell epitopes present in the signal peptide can be accessible to recognition by CD4(+) T cells and may therefore contribute to tumor immunity, whereas a peptide overlapping the junction between the signal peptide and the mature protein is not.	[Kerzerho, Jerome; Schneider, Aurelie; Favry, Emmanuel; Castelli, Florence Anne; Maillere, Bernard] CEA, IBiTecS, Serv Ingn Mol Prot SIMOPRO, Labex LERMIT,Labex VRI, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Maillere, B (corresponding author), CEA, IBiTecS, Serv Ingn Mol Prot SIMOPRO, F-91191 Gif Sur Yvette, France.	bernard.maillere@cea.fr			Commissariat a l'Energie Atomique	Commissariat a l'Energie Atomique(French Atomic Energy Commission)	This work was supported by the Commissariat a l'Energie Atomique.	Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Assudani DP, 2007, CANCER IMMUNOL IMMUN, V56, P70, DOI 10.1007/s00262-006-0154-6; Borbosa MDF, 2007, DRUG DISCOV TODAY, V12, P674, DOI 10.1016/j.drudis.2007.06.005; Castelli FA, 2002, J IMMUNOL, V169, P6928, DOI 10.4049/jimmunol.169.12.6928; Castelli FA, 2008, EUR J IMMUNOL, V38, P2821, DOI 10.1002/eji.200738072; Castelli FA, 2007, EUR J IMMUNOL, V37, P1513, DOI 10.1002/eji.200636783; Choudhuri R, 1997, CANCER RES, V57, P1814; Delluc S, 2011, FASEB J, V25, P2040, DOI 10.1096/fj.10-173872; Delluc S, 2010, BLOOD, V116, P4542, DOI 10.1182/blood-2010-04-280875; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Egilmez NK, 2002, CANCER RES, V62, P2611; El Hage F, 2008, P NATL ACAD SCI USA, V105, P10119, DOI 10.1073/pnas.0802753105; Haynes L, 2001, Prog Brain Res, V132, P313; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hewitt EW, 1997, J IMMUNOL, V159, P4693; Hobo A, 2009, J CLIN INVEST, V119, P1616, DOI 10.1172/JCI37249; Horiba M, 2006, CIRCULATION, V114, P1713, DOI 10.1161/CIRCULATIONAHA.106.632273; Ikematsu S, 2000, BRIT J CANCER, V83, P701, DOI 10.1054/bjoc.2000.1339; Ikematsu S, 2008, CANCER SCI, V99, P2070, DOI 10.1111/j.1349-7006.2008.00957.x; Ishiguro H, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00027; Kerzerho J, 2010, J IMMUNOL, V185, P418, DOI 10.4049/jimmunol.0901014; Koide N, 1999, HEPATO-GASTROENTEROL, V46, P3189; Kovjazin R, 2011, VACCINE, V29, P4676, DOI 10.1016/j.vaccine.2011.04.103; Kwok WW, 2012, J IMMUNOL, V188, P2537, DOI 10.4049/jimmunol.1102190; Maeda S, 2007, BRIT J CANCER, V97, P405, DOI 10.1038/sj.bjc.6603879; Martoglio B, 2003, BIOCHEM SOC T, V31, P1243; Maruyama K, 2004, ARTHRITIS RHEUM-US, V50, P1420, DOI 10.1002/art.20175; Mitchell MS, 2007, CANCER IMMUNOL IMMUN, V56, P287, DOI 10.1007/s00262-006-0191-1; MIZUOCHI T, 1994, IMMUNOL LETT, V43, P189, DOI 10.1016/0165-2478(94)90221-6; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; MURAMATSU H, 1991, BIOCHEM BIOPH RES CO, V177, P652, DOI 10.1016/0006-291X(91)91838-4; Muramatsu T, 2011, CURR PHARM DESIGN, V17, P410, DOI 10.2174/138161211795164167; Musson JA, 2010, INFECT IMMUN, V78, P4356, DOI 10.1128/IAI.00195-10; OBrien T, 1996, CANCER RES, V56, P2515; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Sato W, 2001, J IMMUNOL, V167, P3463, DOI 10.4049/jimmunol.167.6.3463; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Takei Y, 2001, CANCER RES, V61, P8486; Takenaka H, 2009, AM J PHYSIOL-HEART C, V296, pH462, DOI 10.1152/ajpheart.00733.2008; Texier C, 2000, J IMMUNOL, V164, P3177, DOI 10.4049/jimmunol.164.6.3177; Texier C, 2001, EUR J IMMUNOL, V31, P1837, DOI 10.1002/1521-4141(200106)31:6&lt;1837::AID-IMMU1837&gt;3.0.CO;2-H; Thomas WD, 1998, INT J CANCER, V75, P384; Wang QL, 2007, J BIOMED SCI, V14, P783, DOI 10.1007/s11373-007-9192-0; Wang XF, 2008, J IMMUNOL, V181, P431, DOI 10.4049/jimmunol.181.1.431; Wang XF, 2007, CANCER IMMUNOL IMMUN, V56, P807, DOI 10.1007/s00262-006-0230-y; Wolfel C, 2000, INT J CANCER, V88, P432; Ye C, 1999, BRIT J CANCER, V79, P179, DOI 10.1038/sj.bjc.6690030; Zarour HM, 2002, CANCER RES, V62, P213; Zhang Y, 2005, J IMMUNOL, V174, P2404, DOI 10.4049/jimmunol.174.4.2404	49	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13370	13377		10.1074/jbc.M112.427302	http://dx.doi.org/10.1074/jbc.M112.427302			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23553629	Green Published, hybrid			2022-12-25	WOS:000318850300022
J	Minor, EA; Court, BL; Young, JI; Wang, GF				Minor, Emily A.; Court, Brenda L.; Young, Juan I.; Wang, Gaofeng			Ascorbate Induces Ten-Eleven Translocation (Tet) Methylcytosine Dioxygenase-mediated Generation of 5-Hydroxymethylcytosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; VITAMIN-C; DNA DEMETHYLATION; 5-METHYLCYTOSINE; BRAIN; SPECIFICATION; HYDROXYLATION; CONVERSION; TRANSPORT; PROTEINS	Ascorbate (vitamin C) is best known for its role in scurvy, in which the hydroxylation of collagen catalyzed by dioxygenases is incomplete due to ascorbate deficiency. Here, we report a novel function of ascorbate in the hydroxylation of 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC) in DNA catalyzed by Tet (ten-eleven translocation) methylcytosine dioxygenase. The content of 5-hmC is extremely low in mouse embryonic fibroblasts cultured in ascorbate-free medium. Additions of ascorbate dose-and time-dependently enhance the generation of 5-hmC, without any effects on the expression of Tet genes. Treatment with another reducer glutathione (GSH) does not change the level of 5-hmC. Further, blocking ascorbate entry into cells by phloretin and knocking down Tet (Tet1, Tet2, and Tet3) expression by short interference RNAs (siRNA) significantly inhibit the effect of ascorbate on 5-hmC. These results suggest that ascorbate enhances 5-hmC generation, most likely by acting as a co-factor for Tet methylcytosine dioxygenase to hydroxylate 5-mC. Thus, we have uncovered a novel role for ascorbate in modulating the epigenetic control of genome activity.	[Minor, Emily A.; Court, Brenda L.; Young, Juan I.; Wang, Gaofeng] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn,John P Hussman Inst Human, Miami, FL 33136 USA	University of Miami	Wang, GF (corresponding author), Univ Miami, Miller Sch Med, Biomed Res Bldg,Rm 525,1501 NW 10th Ave, Miami, FL 33136 USA.	gwang@med.miami.edu			James and Esther King Biomedical Research Program award [3KN08]; BrightFocus Foundation [M2012048]	James and Esther King Biomedical Research Program award; BrightFocus Foundation(BrightFocus Foundation)	This research was supported, in part, by a James and Esther King Biomedical Research Program award (3KN08) and a BrightFocus Foundation grant (M2012048) (to G. W.)	Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Khare T, 2012, NAT STRUCT MOL BIOL, V19, P1037, DOI 10.1038/nsmb.2372; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; May JM, 2005, ARCH BIOCHEM BIOPHYS, V434, P178, DOI 10.1016/j.abb.2004.10.023; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tsao C. S., 1997, J NUTR, V117, P291; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wilson JX, 2005, ANNU REV NUTR, V25, P105, DOI 10.1146/annurev.nutr.25.050304.092647; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	22	274	284	7	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13669	13674		10.1074/jbc.C113.464800	http://dx.doi.org/10.1074/jbc.C113.464800			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23548903	hybrid, Green Published			2022-12-25	WOS:000318850300050
J	Pan, WW; Zhou, JJ; Liu, XM; Xu, Y; Guo, LJ; Yu, C; Shi, QH; Fan, HY				Pan, Wei-Wei; Zhou, Jian-Jie; Liu, Xiao-Man; Xu, Ying; Guo, Lian-Jun; Yu, Chao; Shi, Qing-Hua; Fan, Heng-Yu			Death Domain-associated Protein DAXX Promotes Ovarian Cancer Development and Chemoresistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PML NUCLEAR-BODIES; SURFACE EPITHELIAL-CELLS; INHIBITORY PROTEIN; APOPTOSIS; REPRESSION; CHK2; UBIQUITINATION; EXPRESSION; BINDING; ATR	Understanding the genes involved in apoptosis and DNA damage responses may improve therapeutic strategies for ovarian cancer. The death domain-associated protein DAXX can be either a pro-apoptotic or an anti-apoptotic factor, depending on the cell type and context. In this study, we found that DAXX was highly expressed in human ovarian surface epithelial tumors but not in granulosa cell tumors. In cultured ovarian cancer cells, DAXX interacted with promyelocytic leukemia protein (PML) and localized to subnuclear domains (so-called PML nuclear bodies). A role for DAXX in ovarian cancer cell proliferation, metastasis, and radio/chemoresistance was examined. Overexpression of DAXX enhanced multiple ovarian cancer cell lines' proliferation, colony formation, and migration, whereas Daxx depletion by RNA interference had the opposite effects. When transplanted into nude mice, ovarian cancer cells that overexpressed DAXX displayed enhanced tumorigenesis capability in vivo, whereas Daxx depletion inhibited tumor development. Importantly, Daxx induced tumorigenic transformation of normal ovarian surface epithelial cells. Daxx also protected ovarian cancer cells against x-irradiation-and chemotherapy-induced DNA damage by interacting with PML. Taken together, our results suggest that DAXX is a novel ovarian cancer oncogene that promotes ovarian cancer cell proliferation and chemoresistance in ovarian cancer cells. Thus, modulating DAXX-PML nuclear body activity may be an effective strategy for preventing the recurrence and chemoresistance of ovarian cancers.	[Pan, Wei-Wei; Zhou, Jian-Jie; Liu, Xiao-Man; Guo, Lian-Jun; Yu, Chao; Fan, Heng-Yu] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Pan, Wei-Wei; Xu, Ying] Jiaxing Univ, Sch Med, Jiaxing 314001, Peoples R China; [Shi, Qing-Hua] Univ Sci & Technol China, Sch Life Sci, Hefei 230022, Peoples R China	Zhejiang University; Jiaxing University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Fan, HY (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	hyfan@zju.edu.cn	Xu, Ying/A-3009-2013; Xu, Ying/AAF-3081-2019; Shi, Qinghua/N-2950-2013	Xu, Ying/0000-0002-6689-7768; Xu, Ying/0000-0002-6689-7768; 	National Natural Science Foundation of China [81172473]; National Basic Research Program of China [2011CB944504, 2012CB944403]; Natural Science Foundation of Zhejiang Province [R2100145, Y2110873]; Science and Technology Bureau Project of Jiaxing [2011AY1048-6]; Zhejiang University [2011QN81001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Science and Technology Bureau Project of Jiaxing; Zhejiang University	This work was supported by National Natural Science Foundation of China Grant 81172473, National Basic Research Program of China Grants 2011CB944504 and 2012CB944403, Natural Science Foundation of Zhejiang Province Grants R2100145 and Y2110873, Science and Technology Bureau Project of Jiaxing Grant 2011AY1048-6, and Basic Scientific Research Funding of Zhejiang University Grant 2011QN81001.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Block GJ, 2006, MOL CELL BIOL, V26, P8814, DOI 10.1128/MCB.00636-06; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Dellaire G, 2006, J CELL SCI, V119, P1026, DOI 10.1242/jcs.02816; Dellaire G, 2006, J CELL BIOL, V175, P55, DOI 10.1083/jcb.200604009; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Huang YS, 2012, CELL CYCLE, V11, P99, DOI 10.4161/cc.11.1.18430; Joe YS, 2006, J BIOL CHEM, V281, P28764, DOI 10.1074/jbc.M604392200; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin DY, 2003, J BIOL CHEM, V278, P15958, DOI 10.1074/jbc.M300387200; Lindsay CR, 2008, FRONT BIOSCI-LANDMRK, V13, P7132, DOI 10.2741/3216; Lv L, 2012, CELL CYCLE, V11, P2864, DOI 10.4161/cc.21196; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Morozov VM, 2008, ONCOGENE, V27, P2177, DOI 10.1038/sj.onc.1210865; Mullany LK, 2011, ONCOGENE, V30, P3522, DOI 10.1038/onc.2011.70; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Takahashi Y, 2004, ONCOGENE, V23, P2819, DOI 10.1038/sj.onc.1207533; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; TVEIT KM, 1989, ANTICANCER RES, V9, P1577; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Wethkamp N, 2009, J BIOL CHEM, V284, P28783, DOI 10.1074/jbc.M109.041186; Yang ST, 2006, J BIOL CHEM, V281, P26645, DOI 10.1074/jbc.M604391200; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yeurl PL, 2008, J CELL BIOCHEM, V103, P456, DOI 10.1002/jcb.21408	34	39	41	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13620	13630		10.1074/jbc.M112.446369	http://dx.doi.org/10.1074/jbc.M112.446369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539629	Green Published, hybrid			2022-12-25	WOS:000318850300044
J	Demircik, F; Buch, T; Waisman, A				Demircik, Filiz; Buch, Thorsten; Waisman, Ari			Efficient B Cell Depletion via Diphtheria Toxin in CD19-Cre/iDTR Mice	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; AUTOIMMUNE-DISEASES; IN-VIVO; RITUXIMAB; LYMPHOMA; LYMPHOCYTES	B cells were first discovered as antibody producing cell as B-1 B cells and finally as effector cells. In recent years their capacity to serve as antigen presenting cells is Increasingly appreciated, and better tools are needed to study their function. We have previously described a new mouse model, the IDTR mice, that allow for the Cre-mediated expression of the diphtheria toxin receptor, thus rendering cells that express the Cre-recombinase sensitivity to diphtheria toxin. Herein describe a new mouse line, the B-DTR mice, where the CD19-Cre was crossed to the iDTR mice. B-DTR allows for the efficient and cost-effective depletion of different B cell subpopulations, but only partially plasma cells. These mice can therefore be used to study the importance of B cells versus plasma cells in different immune responses and autoimmune diseases.	[Demircik, Filiz; Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany; [Buch, Thorsten] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany	Johannes Gutenberg University of Mainz; Technical University of Munich	Waisman, A (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany.	waisman@uni-mainz.de	Buch, Thorsten/P-1659-2019; Waisman, Ari/C-7383-2015	Buch, Thorsten/0000-0002-2236-9074; Waisman, Ari/0000-0003-4304-8234	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) graduate school [GRK 1043]; DFG [WA 1600/3-1, SFB/TR 52, FOR1336]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) graduate school(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This study was supported by funds via the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) graduate school GRK 1043 to AW and by the DFG grants WA 1600/3-1, SFB/TR 52 and the DFG research group FOR1336 to AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barun B, 2011, CLIN IMMUNOL; Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; CERNY A, 1989, CLIN EXP IMMUNOL, V77, P124; CERNY A, 1987, J IMMUNOL, V138, P4222; Cooper N, 2010, BRIT J HAEMATOL, V149, P3, DOI 10.1111/j.1365-2141.2010.08076.x; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Dorner T, 2009, AUTOIMMUN REV, V9, P82, DOI 10.1016/j.autrev.2009.08.007; Ezconycji AN, 2011, RHEUMATOLOGY; Hagemeister F, 2010, DRUGS, V70, P261, DOI 10.2165/11532180-000000000-00000; Hagenbeek A, 2008, BLOOD, V111, P5486, DOI 10.1182/blood-2007-10-117671; Hasegawa M, 2006, AM J PATHOL, V169, P954, DOI 10.2353/ajpath.2006.060205; Hauser Stephen L, 2008, N Engl J Med, V358, P676, DOI 10.1056/NEJMoa0706383; Kessel A, 2008, CLIN REV ALLERG IMMU, V34, P74, DOI 10.1007/s12016-008-8074-1; Lehmann-Horn K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-146; Liu Q, 2007, J IMMUNOL, V179, P3821, DOI 10.4049/jimmunol.179.6.3821; Martinez-Gamboa L, 2006, AUTOIMMUN REV, V5, P437, DOI 10.1016/j.autrev.2006.02.004; RAYFIELD LS, 1989, IMMUNOL LETT, V20, P21, DOI 10.1016/0165-2478(89)90063-1; Reff M E, 1994, Blood, V83, P435; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rubtsov AV, 2011, BLOOD; SCHEUERMANN RH, 1995, LEUKEMIA LYMPHOMA, V18, P385, DOI 10.3109/10428199509059636; SLAPERCORTENBACH ICM, 1990, EXP HEMATOL, V18, P49; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; Waisman A, 2008, MED MICROBIOL IMMUN, V197, P145, DOI 10.1007/s00430-008-0088-z; WALDOR MK, 1984, P NATL ACAD SCI-BIOL, V81, P2855, DOI 10.1073/pnas.81.9.2855; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; WINTER JN, 1987, INT J CANCER, V39, P670, DOI 10.1002/ijc.2910390603; Zocher M, 2003, INT IMMUNOL, V15, P789, DOI 10.1093/intimm/dxg076	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60643	10.1371/journal.pone.0060643	http://dx.doi.org/10.1371/journal.pone.0060643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544158	gold, Green Submitted, Green Published			2022-12-25	WOS:000317480700117
J	Gotz, A; Jessberger, R				Goetz, Anne; Jessberger, Rolf			Dendritic Cell Podosome Dynamics Does Not Depend on the F-actin Regulator SWAP-70	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; OSTEOCLASTS; ADHESION; ZONE	In addition to classical adhesion structures like filopodia or focal adhesions, dendritic cells similar to macrophages osteoclasts assemble highly dynamic F-actin structures called podosomes. They are involved in cellular processes such as extracellular matrix degradation, bone resorption by osteoclasts, and trans-cellular diapedesis of lymphocytes. Besides adhesion and migration, podosomes enable dendritic cells to degrade connective tissue by matrix metalloproteinases. SWAP-70 interacts with RhoGTPases and F-actin and regulates migration of dendritic cells. SWAP-70 deficient osteoclasts are impaired in F-actin-ring formation and bone resorption. In the present study, we demonstrate that SWAP-70 is not required for podosome formation and F-actin turnover in dendritic cells. Furthermore, we found that toll like receptor 4 ligand induced podosome disassembly and podosome-mediated matrix degradation is not affected by SWAP-70 in dendritic cells. Thus, podosome formation and function in dendritic cells is independent SWAP-70.	[Goetz, Anne; Jessberger, Rolf] Tech Univ Dresden, Inst Physiol Chem, Fac Med Carl Gustav Carus, Dresden, Germany	Technische Universitat Dresden	Jessberger, R (corresponding author), Tech Univ Dresden, Inst Physiol Chem, Fac Med Carl Gustav Carus, Dresden, Germany.	rolf.jessberger@tu-dresden.de	Goetz, Anton/M-7208-2017	Goetz, Anton/0000-0002-3847-6376	DFG (German Research Foundation) [JE 150/10-1]	DFG (German Research Foundation)(German Research Foundation (DFG))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grant number JE 150/10-1 from the DFG (German Research Foundation); http://www.dfg.de.	Altman A, 2009, IMMUNITY, V31, P1, DOI 10.1016/j.immuni.2009.06.013; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Chacon Martinez CA, 2011, REGULATION ACTIN DYN; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chopin M, 2011, EUR J IMMUNOL, V41, P3063, DOI 10.1002/eji.201141742; Chopin M, 2010, EUR J IMMUNOL, V40, P3544, DOI 10.1002/eji.201040556; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Garbe AI, 2012, J BONE MINER RES, V27, P2085, DOI 10.1002/jbmr.1670; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Hammarfjord O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021615; Hilpela P, 2003, MOL BIOL CELL, V14, P3242, DOI 10.1091/mbc.e03-01-0043; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Ihara S, 2006, J CELL SCI, V119, P500, DOI 10.1242/jcs.02767; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Masat L, 2000, P NATL ACAD SCI USA, V97, P2180, DOI 10.1073/pnas.040374497; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Oberbanscheidt P, 2007, EUR J CELL BIOL, V86, P13, DOI 10.1016/j.ejcb.2006.08.005; Ocana-Morgner C, 2011, J IMMUNOL, V186, P5345, DOI 10.4049/jimmunol.1003461; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Pearce G, 2011, BLOOD, V117, P1574, DOI 10.1182/blood-2010-07-295659; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Ripich T, 2011, HAEMATOL-HEMATOL J, V96, P1743, DOI 10.3324/haematol.2011.050468; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Sivalenka RR, 2004, MOL CELL BIOL, V24, P10277, DOI 10.1128/MCB.24.23.10277-10288.2004; Wakamatsu I, 2006, MOL CELL BIOCHEM, V293, P137, DOI 10.1007/s11010-006-9236-1; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; West MA, 2008, J CELL BIOL, V182, P993, DOI 10.1083/jcb.200801022	35	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60642	10.1371/journal.pone.0060642	http://dx.doi.org/10.1371/journal.pone.0060642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544157	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700116
J	Li, R; Wang, YM; Liu, YJ; Chen, QJ; Fu, WC; Wang, H; Cai, H; Peng, W; Zhang, XM				Li, Rui; Wang, Yunman; Liu, Yujun; Chen, Qijing; Fu, Wencheng; Wang, Hao; Cai, Hui; Peng, Wen; Zhang, Xuemei			Curcumin Inhibits Transforming Growth Factor-beta 1-Induced EMT via PPAR gamma Pathway, Not Smad Pathway in Renal Tubular Epithelial Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; TGF-BETA; MESENCHYMAL TRANSITION; SIGNALING PATHWAYS; GENE-EXPRESSION; MULTIPLE SITES; FIBROSIS; RATS; MECHANISMS; PHOSPHORYLATION	Tubulointerstitial fibrosis (TIF) is the final common pathway in the end-stage renal disease. Epithelial-to-mesenchymal transition (EMT) is considered a major contributor to the TIF by increasing the number of myofibroblasts. Curcumin, a polyphenolic compound derived from rhizomes of Curcuma, has been shown to possess potent anti-fibrotic properties but the mechanism remains elusive. We found that curcumin inhibited the EMT as assessed by reduced expression of alpha-SMA and PAI-1, and increased E-cadherin in TGF-beta 1 treated proximal tubular epithelial cell HK-2 cells. Both of the conventional TGF-beta 1/Smad pathway and non-Smad pathway were investigated. Curcumin reduced TGF-beta receptor type I (T beta R-I) and TGF-beta receptor type II (T beta R II), but had no effect on phosphorylation of Smad2 and Smad3. On the other hand, in non-Smad pathway curcumin reduced TGF-beta 1-induced ERK phosphorylation and PPAR gamma phosphorylation, and promoted nuclear translocation of PPAR gamma. Further, the effect of curcumin on alpha-SMA, PAI-1, E-cadherin, T beta R I and T beta R II were reversed by ERK inhibitor U0126 or PPAR gamma inhibitor BADGE, or PPAR gamma shRNA. Blocking PPAR gamma signaling pathway by inhibitor BADGE or shRNA had no effect on the phosphorylation of ERK whereas the suppression of ERK signaling pathway inhibited the phosphorylation of PPAR gamma. We conclude that curcumin counteracted TGF-beta 1-induced EMT in renal tubular epithelial cells via ERK-dependent and then PPAR gamma-dependent pathway.	[Li, Rui; Chen, Qijing; Zhang, Xuemei] Fudan Univ, Dept Pharmacol, Sch Pharm, Shanghai 200433, Peoples R China; [Wang, Yunman; Liu, Yujun; Fu, Wencheng; Wang, Hao; Peng, Wen] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Nephrol, Shanghai, Peoples R China; [Cai, Hui] Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA USA; [Cai, Hui] Atlanta Vet Adm Med Ctr, Renal Sect, Decatur, GA USA	Fudan University; Shanghai University of Traditional Chinese Medicine; Emory University	Peng, W (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Nephrol, Shanghai, Peoples R China.	wenpeng@shutcm.edu.cn; xuemzhang@fudan.edu.cn			Natural Science Foundation of Shanghai [11ZR1433200]; Science Foundation of Shanghai Education Commission [2010JW61]; Science and Technology of Putuo District, Shanghai [2008PTKW010]; College of the Shanghai Municipal Education Commission, China	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Science Foundation of Shanghai Education Commission; Science and Technology of Putuo District, Shanghai; College of the Shanghai Municipal Education Commission, China	This research was supported by Natural Science Foundation of Shanghai (NO.11ZR1433200), Science Foundation of Shanghai Education Commission (NO.2010JW61), Science and Technology of Putuo District, Shanghai (NO.2008PTKW010) and the Innovation Team of the College of the Shanghai Municipal Education Commission, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 2009, REPROD TOXICOL, V27, P246, DOI 10.1016/j.reprotox.2008.10.001; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Burgermeister E, 2008, PPAR RES, V2008, DOI 10.1155/2008/309469; Chen A, 2008, BRIT J PHARMACOL, V153, P557, DOI 10.1038/sj.bjp.0707542; Chen AP, 2005, AM J PHYSIOL-GASTR L, V288, pG447, DOI 10.1152/ajpgi.00209.2004; Chung BH, 2005, NEPHROLOGY, V10, pS40, DOI 10.1111/j.1440-1797.2005.00456.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Diradourian C, 2005, BIOCHIMIE, V87, P33, DOI 10.1016/j.biochi.2004.11.010; Gaedeke J, 2004, KIDNEY INT, V66, P112, DOI 10.1111/j.1523-1755.2004.00713.x; Gao JS, 2011, EUR J PHARMACOL, V654, P92, DOI 10.1016/j.ejphar.2010.12.008; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008; Han JY, 2010, J KOREAN MED SCI, V25, P35, DOI 10.3346/jkms.2010.25.1.35; Hu Y, 2010, AM J NEPHROL, V31, P332, DOI 10.1159/000287230; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Kiss-Toth E, 2008, PPAR RES, V2008, DOI 10.1155/2008/183108; Ko GJ, 2008, NEPHROL DIAL TRANSPL, V23, P2750, DOI 10.1093/ndt/gfn157; Kuwabara N, 2006, UROLOGY, V67, P440, DOI 10.1016/j.urology.2005.09.028; Li Yu, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P1224; Lipecka J, 2006, J PHARMACOL EXP THER, V317, P500, DOI 10.1124/jpet.105.097667; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Ma LJ, 2001, KIDNEY INT, V59, P1899, DOI 10.1046/j.1523-1755.2001.0590051899.x; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Narala VR, 2009, GENE THER MOL BIOL, V13, P20; Panchapakesan U, 2005, AM J PHYSIOL-RENAL, V289, pF1153, DOI 10.1152/ajprenal.00097.2005; Punithavathi D, 2000, BRIT J PHARMACOL, V131, P169, DOI 10.1038/sj.bjp.0703578; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Rojas A, 2009, BBA-MOL CELL RES, V1793, P1165, DOI 10.1016/j.bbamcr.2009.02.001; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yang JC, 2009, CLIN SCI, V116, P17, DOI 10.1042/CS20070462; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yao QY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-156; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	42	58	62	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58848	10.1371/journal.pone.0058848	http://dx.doi.org/10.1371/journal.pone.0058848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544048	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700011
J	Shao, L; Xu, L; You, QS; Wang, YX; Chen, CX; Yang, H; Zhou, JQ; Jonas, JB; Wei, WB				Shao, Lei; Xu, Liang; You, Qi Sheng; Wang, Ya Xing; Chen, Chang Xi; Yang, Hua; Zhou, Jin Qiong; Jonas, Jost B.; Wei, Wen Bin			Prevalence and Associations of Incomplete Posterior Vitreous Detachment in Adult Chinese: The Beijing Eye Study	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; VITREOMACULAR TRACTION; MACULAR THICKNESS; POPULATION	Purpose: To determine prevalence and associations of incomplete posterior vitreous detachment (PVD). Methods: The population-based cross-sectional Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6 +/- 9.8 years (range: 50-93 years). A detailed ophthalmic examination was performed including spectral-domain optical coherence tomography (SD-OCT). Incomplete PVD was differentiated into type 1 (shallow PVD with circular perifoveal vitreous attachment), type 2 (PVD reaching fovea but not foveola), type 3 (shallow PVD with pinpoint vitreous attachment at the foveola), and type 4 (PVD completely detached from the macula, attached to the optic disc). Results: An incomplete PVD was detected in 3948 eyes (prevalence: 60.5 +/- 0.6%; 95% Confidence Interval (CD: 59.3%,61.7%) of 2198 subjects (67.1 +/- 0.8%;95%CI: 65.6%,68.7%). Type 1 PVD was seen in 3090 (78.3%) eyes, type 2 PVD in 504 (12.8%) eyes, type 3 PVD in 70 (1.8%) eyes, and type 4 PVD in 284 (7.2%) eyes. Prevalence of incomplete PVD was associated with younger age (P<0.001;OR:0.91), male gender (P<0.001;OR:0.64), rural region of habitation (P<0.001;OR:0.49), larger corneal diameter (P=0.04;OR:0.91), better best corrected visual acuity (P=0.02;OR:0.41), and hyperopic refractive error (P<0.001;OR:1.15). The type of incomplete PVD was associated with higher age (P<0.001), urban region of habitation (P<0.001), myopic refractive error (P=0.001), thinner cornea (P=0.005), and better best corrected visual acuity (P=0.056). Conclusions: In adult Chinese in Greater Beijing, prevalence of an incomplete PVD (detected in 67.1% subjects) was associated with younger age, male gender, rural region of habitation, larger corneal diameter, better best corrected visual acuity and hyperopic refractive error.	[Shao, Lei; Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Xu, Liang; You, Qi Sheng; Wang, Ya Xing; Chen, Chang Xi; Yang, Hua; Zhou, Jin Qiong; Jonas, Jost B.] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Wei, WB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	wenbing_wei@yahoo.com.cn	You, Qisheng/AAG-7153-2020; wei, wei/HHR-8613-2022; wang, YA XING/K-9671-2016; You, Qisheng/A-3619-2014	You, Qisheng/0000-0003-0743-7320; wang, YA XING/0000-0003-2749-7793; You, Qisheng/0000-0003-0743-7320	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government	This work was supported by State Natural Sciences Fund (grant #81041018) and Natural Sciences Fund of Beijing government (grant #7092021, 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung CM, 2013, AM J OPHTHA IN PRESS; Chuo JY, 2006, AM J OPHTHALMOL, V142, P931, DOI 10.1016/j.ajo.2006.08.002; Duan XR, 2010, OPHTHALMOLOGY, V117, P1585, DOI 10.1016/j.ophtha.2009.12.036; Eriksson U, 2009, ACTA OPHTHALMOL, V87, P741, DOI 10.1111/j.1755-3768.2008.01357.x; Gallemore RP, 2000, RETINA-J RET VIT DIS, V20, P115, DOI 10.1097/00006982-200002000-00002; Hayreh SS, 2004, OPHTHALMOLOGICA, V218, P333, DOI 10.1159/000079476; HEE MR, 1995, OPHTHALMOLOGY, V102, P748, DOI 10.1016/S0161-6420(95)30959-1; Huynh SC, 2006, INVEST OPHTH VIS SCI, V47, P2351, DOI 10.1167/iovs.05-1396; Johnson MW, 2005, AM J OPHTHALMOL, V140, P184, DOI 10.1016/j.ajo.2005.01.033; Jonas JB, 2012, ACTA OPHTHALMOL, V90, pe185, DOI 10.1111/j.1755-3768.2011.02316.x; Koh VT, 2012, INVEST OPHTH VIS SCI, V53, P5853, DOI 10.1167/iovs.12-10414; Koizumi H, 2008, AM J OPHTHALMOL, V145, P509, DOI 10.1016/j.ajo.2007.10.014; Krebs I, 2007, AM J OPHTHALMOL, V144, P741, DOI 10.1016/j.ajo.2007.07.024; Mirza RG, 2007, SURV OPHTHALMOL, V52, P397, DOI 10.1016/j.survophthal.2007.04.007; Panozzo G, 2007, ARCH OPHTHALMOL-CHIC, V125, P767, DOI 10.1001/archopht.125.6.767; Schwab C, 2012, ACTA OPHTHALMOL, V90, pe179, DOI 10.1111/j.1755-3768.2011.02310.x; Sebag J, 1989, VITREOUS STRUCTURE F, P80; Shui YB, 2009, ARCH OPHTHALMOL-CHIC, V127, P475, DOI 10.1001/archophthalmol.2008.621; Stalmans P, 2012, NEW ENGL J MED, V367, P606, DOI 10.1056/NEJMoa1110823; Uchino E, 2001, ARCH OPHTHALMOL-CHIC, V119, P1475; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004	22	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58498	10.1371/journal.pone.0058498	http://dx.doi.org/10.1371/journal.pone.0058498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544043	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700006
J	Oh, H; Quan, SA; Jeong, JY; Jang, SN; Lee, JE; Kim, DH				Oh, Hyunju; Quan, Shan Ai; Jeong, Jin-Young; Jang, Soong-Nang; Lee, Jung Eun; Kim, Dong-Hyun			Waist Circumference, Not Body Mass Index, Is Associated with Renal Function Decline in Korean Population: Hallym Aging Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; QUALITY-OF-LIFE; METABOLIC SYNDROME; RISK-FACTORS; FAT DISTRIBUTION; OBESITY; PREVALENCE; ADIPOSITY; INFLAMMATION	Background: Prospective investigation of obesity and renal function decline in Asia is sparse. We examined the associations of body mass index (BMI) and waist circumference (WC) with renal function decline in a prospective study of Korean population. Methods: A total of 454 participants who had baseline estimated glomerular filtration rate (eGFR) levels of more than 60 mL/min/1.73 m(2) in Hallym Aging Study (HAS) were included and followed for 6 years. Renal function decline was defined as follows: (1) an eGFR decline >= 3 mL/min/1.73 m(2)/year (n = 82 cases); (2) an eGFR decrease of 20% or greater (n = 87 cases) at follow-up; (3) an eGFR decrease of 20% greater at follow-up or eGFR decline >= 3 mL/min/1.73 m(2)/year (n = 91 cases); and (4) an eGFR <60 mL/min/1.73 m(2) at follow-up (n = 54 cases). eGFR was determined based on the Modification of Diet in Renal Disease (MDRD) Study equation. Multivariate logistic regression model was used to determine the association between obesity and renal function decline. Results: We found that central obesity was associated with faster renal function decline. Comparing WC of >95 cm in men or >90 cm in women with <= 90 cm in men or <= 85 cm in women, ORs (95% CIs) ranged from 2.31 (1.14-4.69) to 2.78 (1.19-6.50) for the 4 definitions of renal function decline (all p-values for trend <0.05). Waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) also was associated with renal function decline. There was no significant association of BMI with renal function decline. Conclusions: Central obesity, but not BMI, is associated with faster renal function decline in Korean population. Our results provide important evidence that simple measurement of central fat deposition rather than BMI could predict decline in renal function in Korean population.	[Oh, Hyunju; Lee, Jung Eun] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Quan, Shan Ai; Kim, Dong-Hyun] Hallym Univ, Dept Social & Prevent Med, Chunchon, South Korea; [Jeong, Jin-Young] Korea Hlth Promot Fdn, Seoul, South Korea; [Jang, Soong-Nang] Chung Ang Univ, Dept Nursing, Seoul 156756, South Korea; [Kim, Dong-Hyun] Hallym Res Inst Clin Epidemiol, Chunchon, South Korea	Sookmyung Women's University; Hallym University; Chung Ang University	Lee, JE (corresponding author), Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea.	junglee@sm.ac.kr; dhkims@hallym.ac.kr	Lee, Jung Eun/AAC-5634-2020; Jang, Soong-nang/AAC-1322-2020	Lee, Jung Eun/0000-0003-1141-878X; Jang, Soong-nang/0000-0003-2621-945X	Hallym University [HRF-S-2012-5]	Hallym University	This study was supported by Hallym University Research Fund, 2012 (HRF-S-2012-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bash LD, 2009, AM J EPIDEMIOL, V170, P414, DOI 10.1093/aje/kwp151; Bavbek N, 2008, J NEPHROL, V21, P761; Burton JO, 2012, NEPHROL DIAL TRANSPL, V27, P1860, DOI 10.1093/ndt/gfr574; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Chang SH, 2012, MATURITAS; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Curhan GC, 2004, ARCH INTERN MED, V164, P1519, DOI 10.1001/archinte.164.14.1519; de Boer IH, 2009, AM J KIDNEY DIS, V54, P1043, DOI 10.1053/j.ajkd.2009.07.018; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P29, DOI 10.1053/j.ajkd.2008.02.363; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Foster MC, 2011, HYPERTENSION, V58, P784, DOI 10.1161/HYPERTENSIONAHA.111.175315; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Furukawa Y, 2010, STROKE, V41, P550, DOI 10.1161/STROKEAHA.109.569145; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Han SS, 2010, AM J NEPHROL, V31, P83, DOI 10.1159/000258660; Hsu CY, 2000, AM J KIDNEY DIS, V36, P272, DOI 10.1053/ajkd.2000.8971; Hu DS, 2000, OBES RES, V8, P411, DOI 10.1038/oby.2000.51; Huang B, 1997, INT J OBESITY, V21, P340, DOI 10.1038/sj.ijo.0800410; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Kim I, 2010, J KOREAN MED SCI, V25, P293, DOI 10.3346/jkms.2010.25.2.293; 윤중, 2011, Journal of Obesity & Metabolic Syndrome, V20, P202; Kim Sejoong, 2008, Kidney Research and Clinical Practice, V27, P20; Kitiyakara C, 2007, KIDNEY INT, V71, P693, DOI 10.1038/sj.ki.5002128; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Lee HaeJeung, 2002, Korean Journal of Community Nutrition, V7, P277; 최소연, 2007, Kidney Research and Clinical Practice, V26, P420; Lee JE, 2007, AM J HYPERTENS, V20, P1189, DOI 10.1016/j.amjhyper.2007.04.020; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lew SQ, 2005, SEMIN DIALYSIS, V18, P119, DOI 10.1111/j.1525-139X.2005.18215.x; Lin JL, 2011, AM J KIDNEY DIS, V57, P245, DOI 10.1053/j.ajkd.2010.09.027; Luk AOY, 2008, DIABETES CARE, V31, P2357, DOI 10.2337/dc08-0971; MacGregor MS, 2007, NEPHROL DIAL TRANSPL, V22, P8, DOI 10.1093/ndt/gfm444; Miyatake N, 2011, ACTA MED OKAYAMA, V65, P363; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Park HC, 2010, CLIN NEPHROL, V73, P374; Ramos LF, 2008, J AM SOC NEPHROL, V19, P593, DOI 10.1681/ASN.2007030355; Rifkin DE, 2008, ARCH INTERN MED, V168, P2212, DOI 10.1001/archinte.168.20.2212; Ryu S, 2008, J AM SOC NEPHROL, V19, P1798, DOI 10.1681/ASN.2007121286; 정주석, 2004, [The Korean Journal of Medicine, 대한내과학회지], V67, P266; Singh NP, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-4; Sun F, 2010, NEPHROLOGY, V15, P84, DOI 10.1111/j.1440-1797.2009.01150.x; Tesauro M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/653182; The International Association for the Study of Obesity and the International Obesity Task Force, 2000, AS PAC PERSP RED OB; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Trirogoff ML, 2007, AM J CLIN NUTR, V86, P1642, DOI 10.1093/ajcn/86.5.1642; Watanabe H, 2010, DIABETES-METAB RES, V26, P26, DOI 10.1002/dmrr.1058; Wells JCK, 2012, INT J OBESITY, V36, P148, DOI 10.1038/ijo.2011.51; Yoshida T, 2008, INTERNAL MED, V47, P1859, DOI 10.2169/internalmedicine.47.1171	54	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59071	10.1371/journal.pone.0059071	http://dx.doi.org/10.1371/journal.pone.0059071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536858	Green Published, Green Submitted, gold			2022-12-25	WOS:000317397200015
J	Sanquer, S; Amrein, C; Grenet, D; Guillemain, R; Philippe, B; Boussaud, V; Herry, L; Lena, C; Diouf, A; Paunet, M; Billaud, EM; Loriaux, F; Jais, JP; Barouki, R; Stern, M				Sanquer, Sylvia; Amrein, Catherine; Grenet, Dominique; Guillemain, Romain; Philippe, Bruno; Boussaud, Veronique; Herry, Laurence; Lena, Celine; Diouf, Alphonsine; Paunet, Michelle; Billaud, Eliane M.; Loriaux, Francoise; Jais, Jean-Philippe; Barouki, Robert; Stern, Marc			Expression of Calcineurin Activity after Lung Transplantation: A 2-Year Follow-Up	PLOS ONE			English	Article							BRONCHIOLITIS-OBLITERANS-SYNDROME; ALLOGRAFT-REJECTION; BLOOD-CONCENTRATION; RISK-FACTORS; RECIPIENTS; CYCLOSPORINE; IMMUNOSUPPRESSION; CA2+/CALCINEURIN; ACTIVATION; TACROLIMUS	The objective of this pharmacodynamic study was to longitudinally assess the activity of calcineurin during the first 2 years after lung transplantation. From March 2004 to October 2008, 107 patients were prospectively enrolled and their follow-up was performed until 2009. Calcineurin activity was measured in peripheral blood mononuclear cells. We report that calcineurin activity was linked to both acute and chronic rejection. An optimal activity for calcineurin with two thresholds was defined, and we found that the risk of rejection was higher when the enzyme activity was above the upper threshold of 102 pmol/mg/min or below the lower threshold of 12 pmol/mg/min. In addition, we report that the occurrence of malignancies and viral infections was significantly higher in patients displaying very low levels of calcineurin activity. Taken together, these findings suggest that the measurement of calcineurin activity may provide useful information for the management of the prevention therapy of patients receiving lung transplantation.	[Sanquer, Sylvia; Herry, Laurence; Lena, Celine; Diouf, Alphonsine; Barouki, Robert] Hop Univ Necker Enfants Malad, AP HP, Serv Biochim Metabol & Prote, Paris, France; [Sanquer, Sylvia; Herry, Laurence; Lena, Celine; Diouf, Alphonsine; Barouki, Robert] INSERM, UMR S 747, Paris, France; [Sanquer, Sylvia; Herry, Laurence; Lena, Celine; Diouf, Alphonsine; Barouki, Robert] Univ Paris 05, Ctr Univ St Peres, Paris, France; [Amrein, Catherine; Guillemain, Romain; Boussaud, Veronique] Hop Europeen Georges Pompidou, AP HP, Serv Chirurg Cardiovasc, Paris, France; [Grenet, Dominique; Philippe, Bruno; Stern, Marc] Hop Foch, Serv Pneumol, Paris, France; [Paunet, Michelle] Hop Foch, Biol Lab, Suresnes, France; [Billaud, Eliane M.] Hop Europeen Georges Pompidou, AP HP, Serv Pharmacol, Paris, France; [Billaud, Eliane M.; Jais, Jean-Philippe] Univ Paris 05, Paris, France; [Loriaux, Francoise] Hop Europeen Georges Pompidou, AP HP, Serv Biochim, Paris, France; [Jais, Jean-Philippe] Hop Necker Enfants Malad, AP HP, Serv Biostat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Sanquer, S (corresponding author), Hop Univ Necker Enfants Malad, AP HP, Serv Biochim Metabol & Prote, Paris, France.	sylvia.sanquer@gmail.com		STERN, Marc/0000-0001-5275-6959	French association Vaincre la Mucoviscidose	French association Vaincre la Mucoviscidose	Funding for this study was provided by the French association Vaincre la Mucoviscidose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Githmi I, 2006, EUR J CARDIO-THORAC, V30, P846, DOI 10.1016/j.ejcts.2006.09.027; Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Aris R, 1998, AM J RESP CRIT CARE, V158, P335; BANDO K, 1995, J THORAC CARDIOV SUR, V110, P4, DOI 10.1016/S0022-5223(05)80003-0; Batiuk TD, 1997, J CLIN INVEST, V100, P1894, DOI 10.1172/JCI119719; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Caruso R, 2001, CLIN CHEM, V47, P1679; Copeland CAF, 2010, AM J RESP CRIT CARE, V182, P784, DOI 10.1164/rccm.201002-0211OC; Crim C, 1996, AM J RESP CRIT CARE, V153, P1041, DOI 10.1164/ajrccm.153.3.8630543; Estenne M, 2002, AM J RESP CRIT CARE, V166, P440, DOI 10.1164/rccm.200201-003PP; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fukudo M, 2005, CLIN PHARMACOL THER, V78, P168, DOI 10.1016/j.clpt.2005.04.008; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Gregson AL, 2008, TRANSPLANTATION, V85, P1056, DOI 10.1097/TP.0b013e318169bd85; Halloran PF, 1999, TRANSPLANTATION, V68, P1356, DOI 10.1097/00007890-199911150-00023; Hodge G, 2012, J HEART LUNG TRANSPL, V31, P538, DOI 10.1016/j.healun.2012.02.004; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Lin HM, 1998, JAMA-J AM MED ASSOC, V280, P1153, DOI 10.1001/jama.280.13.1153; Martinu Tereza, 2009, Proc Am Thorac Soc, V6, P54, DOI 10.1513/pats.200808-080GO; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; Sanquer S, 2004, TRANSPLANTATION, V77, P854, DOI 10.1097/01.TP.0000114612.55925.22; Schowengerdt KO, 2000, TRANSPLANTATION, V69, P2102, DOI 10.1097/00007890-200005270-00023; Sharples LD, 1996, TRANSPLANTATION, V61, P560, DOI 10.1097/00007890-199602270-00008; Sharples LD, 2002, J HEART LUNG TRANSPL, V21, P271, DOI 10.1016/S1053-2498(01)00360-6; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TRULOCK EP, 1993, CHEST, V103, P1566, DOI 10.1378/chest.103.5.1566; Yano I, 2012, EUR J CLIN PHARMACOL, V68, P259, DOI 10.1007/s00228-011-1129-x; Yano I, 2008, DRUG METAB PHARMACOK, V23, P150, DOI 10.2133/dmpk.23.150; YOUSEM SA, 1992, AM J SURG PATHOL, V16, P877, DOI 10.1097/00000478-199209000-00006; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1; YOUSEM SA, 1993, AM J SURG PATHOL, V17, P491, DOI 10.1097/00000478-199305000-00008	36	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59634	10.1371/journal.pone.0059634	http://dx.doi.org/10.1371/journal.pone.0059634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536885	gold, Green Published, Green Submitted			2022-12-25	WOS:000317397200033
J	Li, FJ; Wu, NQ; Lu, HY; Zhang, JP; Wang, WL; Ma, MZ; Zhang, XH; Yang, XY				Li, Fengjiang; Wu, Naiqin; Lu, Houyuan; Zhang, Jianping; Wang, Weilin; Ma, Mingzhi; Zhang, Xiaohu; Yang, Xiaoyan			Mid-Neolithic Exploitation of Mollusks in the Guanzhong Basin of Northwestern China: Preliminary Results	PLOS ONE			English	Article							LUOCHUAN LOESS SEQUENCE; RADIOCARBON TIME SCALE; ISOTOPE RATIOS; TERRESTRIAL MOLLUSKS; MONSOON VARIABILITY; RECORD; PLATEAU; ASSEMBLAGES; SHELLS; RECONSTRUCTION	Mollusk remains are abundant in archaeological sites in the Guanzhong Basin of Northwestern China, providing good opportunities for investigations into the use of mollusks by prehistoric humans. Here we report on freshwater gastropod and bivalve mollusks covering the time interval from about 5600 to 4500 cal. yrs BP from sites of Mid-Late Neolithic age. They are identified as Cipangopaludina chinensis and Unio douglasiae, both of which are currently food for humans. The shells are well preserved and have no signs of abrasion. They are all freshwater gastropods and bivalves found in pits without water-reworked deposits and have modern representatives which can be observed in rivers, reservoirs, and paddy fields in the studied region. Mollusk shells were frequently recovered in association with mammal bones, lithic artifacts, and pottery. These lines of evidence indicate that the mollusks are the remains of prehistoric meals. The mollusk shells were likely discarded into the pits by prehistoric humans after the flesh was eaten. However, these mollusk remains may not have been staple food since they are not found in large quantities. Mollusk shell tools and ornaments are also observed. Shell tools include shell knives, shell reaphooks and arrowheads, whereas shell ornaments are composed of pendants and loops. All the shell tools and ornaments are made of bivalve mollusks and do not occur in large numbers. The finding of these freshwater mollusk remains supports the view that the middle Holocene climate in the Guanzhong Basin may have been warm and moist, which was probably favorable to freshwater mollusks growing and developing in the region.	[Li, Fengjiang; Wu, Naiqin; Lu, Houyuan; Zhang, Jianping] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China; [Wang, Weilin; Ma, Mingzhi] Shaanxi Prov Inst Archaeol, Xian, Peoples R China; [Zhang, Xiaohu] Inst Cultural Rel Henan Prov, Zhengzhou, Peoples R China; [Yang, Xiaoyan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Li, FJ (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China.	fengjiangli@mail.iggcas.ac.cn	Lu, houyuan/L-8661-2019; Lu, houyuan/AAD-3100-2019; Zhang, Jianping/A-8167-2014; Liu, Kam-Biu/B-4966-2012	Lu, houyuan/0000-0001-5721-6679; Zhang, Jianping/0000-0003-0815-009X; Liu, Kam-Biu/0000-0002-0038-2198; Li, Fengjiang/0000-0003-3748-8305	Chinese Academy of Sciences [KZCX2-EW-QN107]; National Basic Research Program of China [2010CB950204]; Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues [XDA05130604]; National Natural Science Foundation of China [41230104, 41072130, 41272205]; National Social Science Foundation of China [ZD183]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China	This study is supported by the Chinese Academy of Sciences (KZCX2-EW-QN107), the National Basic Research Program of China (No. 2010CB950204), the Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues (XDA05130604), the National Natural Science Foundation of China (Projects 41230104, 41072130, and 41272205), the National Social Science Foundation of China (11&ZD183) and the president excellent prize of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELL PI, 1985, CHEM GEOL, V58, P183, DOI 10.1016/0168-9622(85)90037-5; [Anonymous], 2001, BIOL TERRESTRIAL MOL; Bahn P, 1983, PYRENEAN PREHISTORY; Barandiaran I, 1989, TRABAJOS ARQUEOLOGIA, P275; Braun A, 1847, GEOGN GEOLOGY PETERF, V1, P49; CASS (Institute of Archaeology at the Chinese Acadeny of Social Sciences), 1983, BAOJ BEISH; Chenorkian R, 1989, MOLLUSQUES TESTACES; Crawford GW, 2003, ANTIQUITY, V77, P87, DOI 10.1017/S0003598X00061378; FARRAND W.R., 2000, DEPOSITIONAL HIST FR; Fernandez-Armesto F, 2002, NEAR 1000S TABLES HI; GIROD A., 2003, HOLOCENE MOLLUSCS ED, V13, P35; GOODFRIEND GA, 1992, QUATERNARY SCI REV, V11, P665, DOI 10.1016/0277-3791(92)90076-K; GOODFRIEND GA, 1987, EARTH PLANET SC LETT, V86, P377, DOI 10.1016/0012-821X(87)90234-2; GOODFRIEND GA, 1988, NATURE, V333, P757, DOI 10.1038/333757a0; [顾海滨 Gu Haibin], 2006, [第四纪研究, Quaternary Sciences], V26, P562; Gutierrez Zugasti FI, 2009, MESOLITHIC HORIZONS, P161; Hu SM, 2001, ARCHAEOLOGY CULTURAL, V22, P53; Hu SM, 2011, ARCHAEOL CULT REL, V32, P97; [胡松梅 HU Songmei], 2007, [西北大学学报. 自然科学版, Journal of Northwest University. Natural Science Edition], V37, P115; Keen DH, 1995, QUATERNARY SCI REV, V14, P699, DOI 10.1016/0277-3791(95)00087-9; Kuhn SL, 2001, P NATL ACAD SCI USA, V98, P7641, DOI 10.1073/pnas.121590798; Li FJ, 2006, SCI CHINA SER D, V49, P724, DOI 10.1007/s11430-006-0724-7; Li FJ, 2010, GLOBAL PLANET CHANGE, V72, P73, DOI 10.1016/j.gloplacha.2010.04.006; Li FJ, 2008, EARTH PLANET SC LETT, V274, P439, DOI 10.1016/j.epsl.2008.07.038; Li FJ, 2006, GEOLOGY, V34, P405, DOI 10.1130/G22232.1; Li XQ, 2007, SCI CHINA SER D, V50, P1707, DOI 10.1007/s11430-007-0066-0; Li XQ, 2009, HOLOCENE, V19, P1213, DOI 10.1177/0959683609345083; Li YM, 1979, J ZHENGZHOU U PHILOS, V4, P97; Liu TS., 1985, LOESS ENV; Liu YY, 1979, EC FAUNA SINICA CHIN; Lu HY, 2005, NATURE, V437, P967, DOI 10.1038/437967a; LUBELL D, 1976, SCIENCE, V191, P910, DOI 10.1126/science.191.4230.910; Lubell D., 2004, DOCUMENTA PRAEHISTOR, V31, P1; Lubell D., 2004, PETITS ANIMAUX SOC H, P77; Luo X, 1994, WORLD ANTIQUITY, P67; MAGARITZ M, 1983, ISOT GEOSCI, V1, P243; MAGARITZ M, 1981, EARTH PLANET SC LETT, V52, P101, DOI 10.1016/0012-821X(81)90212-0; Mienis Henk K., 2004, Archaeomalacology Group Newsletter, V6, P3; Mienis Henk K., 2012, Archaeomalacology Group Newsletter, V21, P9; Mienis HK, 2012, ARCHAEOMALACOGY GROU, V21, P8; Miracle P., 2001, DOCUMENTA PRAEHISTOR, V26, P177, DOI DOI 10.4312/DP.28.10; Moine O, 2002, QUATERNARY RES, V57, P162, DOI 10.1006/qres.2001.2286; Pearson GW, 1993, RADIOCARBON, V35, P193; Rizner M, 2009, MESOLITHIC HORIZONS, P527; Rousseau DD, 2009, CLIM PAST, V5, P157, DOI 10.5194/cp-5-157-2009; Rousseau DD, 1997, GEOLOGY, V25, P275, DOI 10.1130/0091-7613(1997)025<0275:ANMROT>2.3.CO;2; Rousseau DD, 1999, QUATERNARY RES, V52, P286, DOI 10.1006/qres.1999.2078; ROUSSEAU DD, 1991, QUATERNARY RES, V36, P195, DOI 10.1016/0033-5894(91)90025-Z; Rousseau DD, 2000, GLOBAL PLANET CHANGE, V26, P199, DOI 10.1016/S0921-8181(00)00086-2; School of Archaeology and Museology of Northwest University, 2000, EXC REP ANB ARCH SIT; Shaanxi Provincial Institute of Archaeology Archaeology Team of Baoji City, 2007, GUANT ARCH SIT BAOJ; Shang X, 2010, REV PALAEOBOT PALYNO, V160, P46, DOI 10.1016/j.revpalbo.2010.01.004; SONG YQ, 2002, CONSIDERATION RELATI; State Administration of Cultural Heritage, 1998, ATL CHIN REL; Straus LG, 1992, IBERIA IBERIANS STON, P194; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; The Archaeology Department of Peking University The Institute of Archaeology Chinese Academy of Social Sciences, 2003, 6 PEK U ARCH DEP PEK; The Institute of Archaeology Chinese Academy of Social Sciences, 1994, BAIJ ARCH SIT LINT C; The Institute of Archaeology Chinese Academy of Social Sciences, 1988, EXC REP WUG COUNT HU; Waselkov GA, 1987, ADV ARCHAEOL METH TH, V10, P93, DOI DOI 10.1016/B978-0-12-003110-8.50006-2; Wei S, 1999, RELICS MUSEOLGY, P5; Wu NQ, 2007, QUATERNARY SCI REV, V26, P1884, DOI 10.1016/j.quascirev.2007.04.006; Wu NQ, 1996, SCI CHINA SER D, V39, P494; Wu NQ, 2000, CHINESE SCI BULL, V45, P1617, DOI 10.1007/BF02886225; Wu NQ, 2006, PALAEOGEOGR PALAEOCL, V233, P287, DOI 10.1016/j.palaeo.2005.10.006; Wu NQ, 2002, BOREAS, V31, P20, DOI 10.1080/03009480210648; Wu NQ, 2001, J GEOPHYS RES-ATMOS, V106, P20045, DOI 10.1029/2001JD900224; Xi'an Banpo Musem Shaanxi Provincial Institute of Archaeology Lintong County Musem, 1988, JIANGZH EXC REP NEOL; Zhang HY., 2007, ACTA ARCHAEOL SIN, V2, P153; Zhang JP, 2010, BOREAS, V39, P592, DOI 10.1111/j.1502-3885.2010.00145.x; ZHANG ZP, 2003, QUANHU VILLAGE HUA C; Zheng J, 1996, CULTURAL RELICS CENT, P11; Zugasti FIG, 2011, ENVIRON ARCHAEOL, V16, P36, DOI 10.1179/146141010X12640787648306	74	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58999	10.1371/journal.pone.0058999	http://dx.doi.org/10.1371/journal.pone.0058999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23544050	Green Submitted, Green Published, gold			2022-12-25	WOS:000316411600023
J	Lee, JY; Stearns, T				Lee, Joanna Y.; Stearns, Tim			FOP Is a Centriolar Satellite Protein Involved in Ciliogenesis	PLOS ONE			English	Article							PRIMARY CILIUM; MYELOPROLIFERATIVE DISORDERS; MOLECULAR CHARACTERIZATION; CENTROSOMAL PROTEINS; BBS PROTEINS; CEP290; GENE; INTERACTS; LEUKEMIA; COMPLEX	Centriolar satellites are proteinaceous granules that are often clustered around the centrosome. Although centriolar satellites have been implicated in protein trafficking in relation to the centrosome and cilium, the details of their function and composition remain unknown. FOP (FGFR1 Oncogene Partner) is a known centrosome protein with homology to the centriolar satellite proteins FOR20 and OFD1. We find that FOP partially co-localizes with the satellite component PCM1 in a cell cycle-dependent manner, similarly to the satellite and cilium component BBS4. As for BBS4, FOP localization to satellites is cell cycle dependent, with few satellites labeled in G(1), when FOP protein levels are lowest, and most labeled in G(2). FOP-FGFR1, an oncogenic fusion that causes a form of leukemia called myeloproliferative neoplasm, also localizes to centriolar satellites where it increases tyrosine phosphorylation. Depletion of FOP strongly inhibits primary cilium formation in human RPE-1 cells. These results suggest that FOP is a centriolar satellite cargo protein and, as for several other satellite-associated proteins, is involved in ciliogenesis. Localization of the FOP-FGFR1 fusion kinase to centriolar satellites may be relevant to myeloproliferative neoplasm disease progression.	[Lee, Joanna Y.; Stearns, Tim] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Stearns, Tim] Stanford Sch Med, Dept Genet, Stanford, CA USA	Stanford University; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	stearns@stanford.edu		Stearns, Tim/0000-0002-0671-6582	NIH Cell and Molecular Biology Training Grant; ARCS Foundation; NIH [GM52022]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER	NIH Cell and Molecular Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH Cell and Molecular Biology Training Grant to J.Y.L. (http://www.nigms.nih.gov/Training/InstPredoc/PredocTrainingDescription.htm), an ARCS Foundation Award to J.Y.L. (https://www.arcsfoundation.org), and NIH Grant GM52022 to T. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva C, 2009, CELL CYCLE, V8, P1217, DOI 10.4161/cc.8.8.8248; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Aubusson-Fleury A, 2012, J CELL SCI; Barenz F, 2011, EUR J CELL BIOL, V90, P983, DOI 10.1016/j.ejcb.2011.07.007; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; BALCZON R, 1994, J CELL BIOL, V124, P783, DOI 10.1083/jcb.124.5.783; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Delaval B, 2005, LEUKEMIA, V19, P1739, DOI 10.1038/sj.leu.2403926; Delaval B, 2005, CANCER RES, V65, P7231, DOI 10.1158/0008-5472.CAN-04-4167; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kubo A, 2003, J CELL SCI, V116, P919, DOI 10.1242/jcs.00282; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Mahjoub MR, 2010, J CELL BIOL, V191, P331, DOI 10.1083/jcb.201003009; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Mikolajka A, 2006, J MOL BIOL, V359, P863, DOI 10.1016/j.jmb.2006.03.070; Murati A, 2005, LEUKEMIA, V19, P1692, DOI 10.1038/sj.leu.2403879; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Popovici C, 1999, BLOOD, V93, P1381, DOI 10.1182/blood.V93.4.1381.404k30_1381_1389; Reiter A, 2005, CANCER RES, V65, P2662, DOI 10.1158/0008-5472.CAN-04-4263; Rosnet O, 2007, HAEMATOLOGICA, V92, P728, DOI 10.3324/haematol.11387; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Sedjai F, 2010, J CELL SCI, V123, P2391, DOI 10.1242/jcs.065045; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	37	31	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58589	10.1371/journal.pone.0058589	http://dx.doi.org/10.1371/journal.pone.0058589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554904	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500032
J	Naithani, KJ; Baldwin, DC; Gaines, KP; Lin, H; Eissenstat, DM				Naithani, Kusum J.; Baldwin, Doug C.; Gaines, Katie P.; Lin, Henry; Eissenstat, David M.			Spatial Distribution of Tree Species Governs the Spatio-Temporal Interaction of Leaf Area Index and Soil Moisture across a Forested Landscape	PLOS ONE			English	Article							SHALE HILLS CATCHMENT; TROPICAL DRY FOREST; WATER AVAILABILITY; TEMPORAL DYNAMICS; WOODY-PLANTS; PHENOLOGY; VEGETATION; MODEL; VARIABILITY; RESPONSES	Quantifying coupled spatio-temporal dynamics of phenology and hydrology and understanding underlying processes is a fundamental challenge in ecohydrology. While variation in phenology and factors influencing it have attracted the attention of ecologists for a long time, the influence of biodiversity on coupled dynamics of phenology and hydrology across a landscape is largely untested. We measured leaf area index (L) and volumetric soil water content (theta) on a co-located spatial grid to characterize forest phenology and hydrology across a forested catchment in central Pennsylvania during 2010. We used hierarchical Bayesian modeling to quantify spatio-temporal patterns of L and theta. Our results suggest that the spatial distribution of tree species across the landscape created unique spatio-temporal patterns of L, which created patterns of water demand reflected in variable soil moisture across space and time. We found a lag of about 11 days between increase in L and decline in theta. Vegetation and soil moisture become increasingly homogenized and coupled from leaf-onset to maturity but heterogeneous and uncoupled from leaf maturity to senescence. Our results provide insight into spatio-temporal coupling between biodiversity and soil hydrology that is useful to enhance ecohydrological modeling in humid temperate forests.	[Naithani, Kusum J.; Baldwin, Doug C.] Penn State Univ, Dept Geog, University Pk, PA 16802 USA; [Naithani, Kusum J.; Gaines, Katie P.; Eissenstat, David M.] Penn State Univ, Intercoll Grad Degree Program Ecol, University Pk, PA 16802 USA; [Gaines, Katie P.; Lin, Henry; Eissenstat, David M.] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Naithani, KJ (corresponding author), Penn State Univ, Dept Geog, University Pk, PA 16802 USA.	naithani@psu.edu	Eissenstat, David/AAE-2793-2020; Naithani, Kusum/A-5441-2009; Lin, Henry/E-8234-2011	Naithani, Kusum/0000-0003-2503-113X; 	U.S. National Science Foundation through the Susquehanna Shale Hills Critical Zone Observatory [EAR 0725019]; Directorate For Geosciences [1239285] Funding Source: National Science Foundation; Division Of Earth Sciences [0725019] Funding Source: National Science Foundation	U.S. National Science Foundation through the Susquehanna Shale Hills Critical Zone Observatory; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was funded by the U.S. National Science Foundation through the Susquehanna Shale Hills Critical Zone Observatory (EAR 0725019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Asbjornsen H, 2004, FOREST ECOL MANAG, V192, P313, DOI 10.1016/j.foreco.2004.01.035; Asbjornsen H, 2011, J PLANT ECOL, V4, P3, DOI 10.1093/jpe/rtr005; Booth MS, 2003, J ECOL, V91, P36, DOI 10.1046/j.1365-2745.2003.00739.x; BORCHERT R, 1994, TREES-STRUCT FUNCT, V8, P198, DOI 10.1007/BF00196847; BORCHERT R, 1994, ECOLOGY, V75, P1437, DOI 10.2307/1937467; Breshears DD, 2009, ECOHYDROLOGY, V2, P503, DOI 10.1002/eco.75; Breshears DD, 1999, LANDSCAPE ECOL, V14, P465, DOI 10.1023/A:1008040327508; Brooks JR, 2006, PLANT CELL ENVIRON, V29, P138, DOI 10.1111/j.1365-3040.2005.01409.x; CHEN JM, 1992, PLANT CELL ENVIRON, V15, P421, DOI 10.1111/j.1365-3040.1992.tb00992.x; Choler P, 2010, BIOGEOSCIENCES, V7, P907, DOI 10.5194/bg-7-907-2010; Crockford RH, 2000, HYDROL PROCESS, V14, P2903, DOI [10.1002/1099-1085(200011/12)14:16/17<2903::AID-HYP126>3.0.CO;2-6, 10.1002/1099-1085(200011/12)14:16/17&lt;2903::AID-HYP126&gt;3.0.CO;2-6]; Diggle P.J., 2002, GEOGR ENV MODEL, V6, P129, DOI [DOI 10.1080/1361593022000029467, 10.1080/1361593022000029467]; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Duniway MC, 2010, ECOHYDROLOGY, V3, P55, DOI 10.1002/eco.94; Estrella N, 2009, CLIM RES, V39, P235, DOI 10.3354/cr00818; Guo QH, 2010, PHOTOGRAMM ENG REM S, V76, P701, DOI 10.14358/PERS.76.6.701; Guo X, 2008, INT ARCH PHOTOGRAM B, VXXXVII; Jin M, 2002, METEOROL ATMOS PHYS, V80, P117, DOI 10.1007/s007030200019; KIKUZAWA K, 1995, CAN J BOT, V73, P158, DOI 10.1139/b95-019; KIKUZAWA K, 1983, CAN J BOT, V61, P2133, DOI 10.1139/b83-230; Kikuzawa K., 1988, PLANT SPEC BIOL, V3, P67, DOI DOI 10.1111/j.1442-1984.1988.tb00172.x; Lin H, 2006, VADOSE ZONE J, V5, P317, DOI 10.2136/vzj2005.0058; Lin H, 2005, ADV AGRON, V85, P1, DOI 10.1016/S0065-2113(04)85001-6; Naithani KJ, 2012, J HYDROL, V464, P176, DOI 10.1016/j.jhydrol.2012.07.008; NEMANI R, 1993, INT J REMOTE SENS, V14, P2519, DOI 10.1080/01431169308904290; Okin GS, 2001, REMOTE SENS ENVIRON, V77, P212, DOI 10.1016/S0034-4257(01)00207-3; Oren R, 1998, ECOL APPL, V8, P990, DOI 10.1890/1051-0761(1998)008[0990:WBDTSL]2.0.CO;2; Pielke RA, 1998, GLOBAL CHANGE BIOL, V4, P461, DOI 10.1046/j.1365-2486.1998.t01-1-00176.x; Potts DL, 2010, ECOHYDROLOGY, V3, P20, DOI 10.1002/eco.91; Reich PB, 2004, ECOL MONOGR, V74, P3, DOI 10.1890/02-4047; Ribeiro Jr P. J., 2001, R NEWS, V1, P14; RICHARDS JH, 1987, OECOLOGIA, V73, P486, DOI 10.1007/BF00379405; Richardson JJ, 2009, AGR FOREST METEOROL, V149, P1152, DOI 10.1016/j.agrformet.2009.02.007; Seiwa K, 1999, ANN BOT-LONDON, V83, P355, DOI 10.1006/anbo.1998.0831; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; Sigurdsson BD, 2001, TREES-STRUCT FUNCT, V15, P403, DOI 10.1007/s004680100121; Sprintsin M, 2007, REMOTE SENS ENVIRON, V109, P416, DOI 10.1016/j.rse.2007.01.020; Stogsdill Jr W, 1989, FOREST ECOL MANAG, V29, P105; Tabacchi E, 2000, HYDROL PROCESS, V14, P2959, DOI [10.1002/1099-1085(200011/12)14:16/17<2959::AID-HYP129>3.0.CO;2-B, 10.1002/1099-1085(200011/12)14:16/17&lt;2959::AID-HYP129&gt;3.0.CO;2-B]; Takagi K, 2012, GEODERMA, V173, P289, DOI 10.1016/j.geoderma.2011.11.003; Takagi K, 2011, VADOSE ZONE J, V10, P832, DOI 10.2136/vzj2010.0134; Tarboton DG, 1997, WATER RESOUR RES, V33, P309, DOI 10.1029/96WR03137; TISSUE DT, 1995, FUNCT ECOL, V9, P518, DOI 10.2307/2390018; Vitasse Y, 2009, AGR FOREST METEOROL, V149, P735, DOI 10.1016/j.agrformet.2008.10.019; Vivoni ER, 2012, J HYDROMETEOROL, V13, P1631, DOI 10.1175/JHM-D-11-0131.1; Vivoni ER, 2012, ECOHYDROLOGY, V5, P235, DOI 10.1002/eco.1248; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; Williams RJ, 1997, ECOLOGY, V78, P2542, DOI 10.1890/0012-9658(1997)078[2542:LPOWSI]2.0.CO;2; Zhu Q, 2010, SOIL SCI SOC AM J, V74, P1750, DOI 10.2136/sssaj2010.0055	50	34	36	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58704	10.1371/journal.pone.0058704	http://dx.doi.org/10.1371/journal.pone.0058704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554915	Green Published, Green Submitted, gold			2022-12-25	WOS:000316252500039
J	Terao, C; Hashimoto, M; Yamamoto, K; Murakami, K; Ohmura, K; Nakashima, R; Yamakawa, N; Yoshifuji, H; Yukawa, N; Kawabata, D; Usui, T; Yoshitomi, H; Furu, M; Yamada, R; Matsuda, F; Ito, H; Fujii, T; Mimori, T				Terao, Chikashi; Hashimoto, Motomu; Yamamoto, Keiichi; Murakami, Kosaku; Ohmura, Koichiro; Nakashima, Ran; Yamakawa, Noriyuki; Yoshifuji, Hajime; Yukawa, Naoichiro; Kawabata, Daisuke; Usui, Takashi; Yoshitomi, Hiroyuki; Furu, Moritoshi; Yamada, Ryo; Matsuda, Fumihiko; Ito, Hiromu; Fujii, Takao; Mimori, Tsuneyo			Three Groups in the 28 Joints for Rheumatoid Arthritis Synovitis - Analysis Using More than 17,000 Assessments in the KURAMA Database	PLOS ONE			English	Article							DISEASE-ACTIVITY INDEX; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; CLASSIFICATION CRITERIA; CLINICAL-PRACTICE; ACTIVITY SCORE; VALIDITY; SYSTEM; DAMAGE; TRIAL	Rheumatoid arthritis (RA) is a joint-destructive autoimmune disease. Three composite indices evaluating the same 28 joints are commonly used for the evaluation of RA activity. However, the relationship between, and the frequency of, the joint involvements are still not fully understood. Here, we obtained and analyzed 17,311 assessments for 28 joints in 1,314 patients with RA from 2005 to 2011 from electronic clinical chart templates stored in the KURAMA (Kyoto University Rheumatoid Arthritis Management Alliance) database. Affected rates for swelling and tenderness were assessed for each of the 28 joints and compared between two different sets of RA patients. Correlations of joint symptoms were analyzed for swellings and tenderness using kappa coefficient and eigen vectors by principal component analysis. As a result, we found that joint affected rates greatly varied from joint to joint both for tenderness and swelling for the two sets. Right wrist joint is the most affected joint of the 28 joints. Tenderness and swellings are well correlated in the same joints except for the shoulder joints. Patients with RA tended to demonstrate right-dominant joint involvement and joint destruction. We also found that RA synovitis could be classified into three categories of joints in the correlation analyses: large joints with wrist joints, PIP joints, and MCP joints. Clustering analysis based on distribution of synovitis revealed that patients with RA could be classified into six subgroups. We confirmed the symmetric joint involvement in RA. Our results suggested that RA synovitis can be classified into subgroups and that several different mechanisms may underlie the pathophysiology in RA synovitis.	[Terao, Chikashi; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Terao, Chikashi; Hashimoto, Motomu; Murakami, Kosaku; Ohmura, Koichiro; Nakashima, Ran; Yamakawa, Noriyuki; Yoshifuji, Hajime; Yukawa, Naoichiro; Kawabata, Daisuke; Usui, Takashi; Fujii, Takao; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Yamamoto, Keiichi] Kyoto Univ, Translat Res Ctr, Dept Clin Trial Design & Management, Kyoto, Japan; [Yoshitomi, Hiroyuki; Furu, Moritoshi; Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Yamada, Ryo] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Unit Stat Genet, Kyoto, Japan; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, INSERM, Unite U852, Kyoto, Japan; [Matsuda, Fumihiko] Japan Sci & Technol Agcy, CREST Program, Kawaguchi, Saitama, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University; Japan Science & Technology Agency (JST)	Terao, C (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	a0001101@kuhp.kyoto-u.ac.jp	Kosaku, Murakami/T-8806-2019; Yamamoto, Keiichi/AFQ-9006-2022; Yoshifuji, Hajime/AAZ-1657-2020	Yamamoto, Keiichi/0000-0003-3278-5001; , Hiroyuki/0000-0001-7339-9030; Yamada, Ryo/0000-0002-1587-630X	Mitsubishi Tanabe Pharma Corporation; Eisai Co., Ltd.; Abbott Japan Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Pfizer Japan Inc.; Bristol-Myyers K.K.; Bristol-Myyers; Grants-in-Aid for Scientific Research [23791112, 24659274] Funding Source: KAKEN	Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Eisai Co., Ltd.(Eisai Co Ltd); Abbott Japan Co., Ltd.(Abbott Laboratories); Chugai Pharmaceutical Co., Ltd.; Pfizer Japan Inc.(Pfizer); Bristol-Myyers K.K.; Bristol-Myyers; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research grants from Mitsubishi Tanabe Pharma Corporation (http://www.mt-pharma.co.jp/e/), Eisai Co., Ltd. (http://www.eisai.co.jp/index.html), Abbott Japan Co., Ltd. (http://www.abbott.co.jp/), Chugai Pharmaceutical Co., Ltd. (http://www.chugai-pharm.co.jp/hc/ss/english/index.html), Pfizer Japan Inc. (http://www.pfizer.co.jp/pfizer/english/company/), and Bristol-Myyers K.K. (http://www.bms.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; The KURAMA database was supported by funding from Mitsubishi Tanabe Pharma Corporation, Eisai Co., Ltd., Abbott Japan Co., Ltd., Chugai Pharmaceutical Co., Ltd., Pfizer Japan Inc. and Bristol-Myyers. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aletaha D, 2007, BEST PRACT RES CL RH, V21, P663, DOI 10.1016/j.berh.2007.02.004; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Backhaus M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1194, DOI 10.1002/art.24646; Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Machold KP, 2002, J RHEUMATOL, V29, P2278; Salaffi F, 2009, CLIN EXP RHEUMATOL, V27, P552; Scheel AK, 2005, ARTHRITIS RHEUM-US, V52, P733, DOI 10.1002/art.20939; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Smolen JS, 2006, ARTHRITIS RHEUM-US, V54, P702, DOI 10.1002/art.21678; van der Heijde D, 2000, J RHEUMATOL, V27, P261; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; VANDERHEIJDE DMFM, 1992, ANN RHEUM DIS, V51, P177, DOI 10.1136/ard.51.2.177; Yamamoto K, 2012, CLIN TRIALS, V9, P408, DOI 10.1177/1740774512445912	17	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59341	10.1371/journal.pone.0059341	http://dx.doi.org/10.1371/journal.pone.0059341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555018	Green Submitted, gold, Green Published			2022-12-25	WOS:000316252500081
J	Mamtani, M; Kulkarni, H; Dyer, TD; Almasy, L; Mahaney, MC; Duggirala, R; Comuzzie, AG; Blangero, J; Curran, JE				Mamtani, Manju; Kulkarni, Hemant; Dyer, Thomas D.; Almasy, Laura; Mahaney, Michael C.; Duggirala, Ravindranath; Comuzzie, Anthony G.; Blangero, John; Curran, Joanne E.			Waist Circumference Independently Associates with the Risk of Insulin Resistance and Type 2 Diabetes in Mexican American Families	PLOS ONE			English	Article							BODY-MASS INDEX; ABDOMINAL OBESITY; METABOLIC SYNDROME; PREDICTOR; GENETICS; RATIO	Objective: In spite of the growing recognition of the specific association of waist circumference (WC) with type 2 diabetes (T2D) and insulin resistance (IR), current guidelines still use body mass index (BMI) as a tool of choice. Our objective was to determine whether WC is a better T2D predictor than BMI in family-based settings. Research Design and Methods: Using prospectively collected data on 808 individuals from 42 extended Mexican American families representing 7617.92 person-years follow-up, we examined the performance of WC and BMI as predictors of cumulative and incident risk of T2D. We used robust statistical methods that accounted for the kinships and included polygenic models, discrete trait modeling, Akaike information criterion, odds ratio (OR), relative risk (RR) and Kullback-Leibler R-2. SOLAR software was used to conduct all the data analyses. Results: We found that in multivariate polygenic models, WC was an independent predictor of cumulative (OR = 2.76, p = 0.0002) and future risk of T2D (RR = 2.15, p = 3.56x10(-9)) and outperformed BMI when compared in a head-to-head fashion. High WC (>= 94.65 cm after adjusting for age and sex) was also associated with high fasting glucose, insulin and triglyceride levels and low high-density lipoprotein levels indicating a potential association with IR. Moreover, WC was specifically and significantly associated with insulin resistant T2D (OR = 4.83, p = 1.01x10(-13)). Conclusions: Our results demonstrate the value of using WC as a screening tool of choice for future risk of T2D in Mexican American families. Also, WC is specifically associated with insulin resistant T2D.				mmamtani@txbiomedgenetics.org	Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021; Kulkarni, Hemant/AEM-5750-2022	Curran, Joanne/0000-0002-6898-155X	National Institutes of Health (NIH) [R01 DK082610, R01 DK079169]; NIH [R01 HL045522, R37 MH059450]; National Center for Research Resources [S10 RR029392]; National Center for Research Resources of the National Institutes of Health [C06 RR013556, C06 RR017515]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017515, C06RR013556, S10RR029392] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082610, R01DK079169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH059450, R44MH059450] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health (NIH) grants R01 DK082610 and R01 DK079169. Data collection for the San Antonio Family Heart Study was supported by NIH grant R01 HL045522. The development of the analytical methods and software used in this study was supported by NIH grant R37 MH059450. The AT&T Genomics Computing Center supercomputing facilities used for this work were supported in part by a gift from the AT&T Foundation and with support from the National Center for Research Resources Grant Number S10 RR029392. This investigation was conducted in facilities constructed with support from Research Facilities Improvement Program grants C06 RR013556 and C06 RR017515 from the National Center for Research Resources of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Appel Susan J, 2004, J Am Acad Nurse Pract, V16, P335, DOI 10.1111/j.1745-7599.2004.tb00456.x; Bardini G, 2011, DIABETIC MED, V28, P1229, DOI 10.1111/j.1464-5491.2011.03332.x; Bastarrachea RA, 2007, MED CLIN-BARCELONA, V129, P11, DOI 10.1157/13106675; Bayoumi RA, 2007, OBESITY, V15, P551, DOI 10.1038/oby.2007.555; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Feller S, 2010, DTSCH ARZTEBL INT, V107, P470, DOI 10.3238/arztebl.2010.0470; Feng RN, 2012, J EPIDEMIOL, V22, P317, DOI 10.2188/jea.JE20110120; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Gao Jian-Bo, 2011, Zhonghua Nei Ke Za Zhi, V50, P474, DOI 10.3760/cma.j.issn.0578-1426.2011.06.007; Garber AJ, 2012, DIABETES OBES METAB, V14, P399, DOI 10.1111/j.1463-1326.2011.01536.x; Gavin JR, 1999, DIABETES CARE, V22, pS5; Ginter E, 2010, BRATISL MED J, V111, P134; Gonzalez-Chavez Antonio, 2011, Cir Cir, V79, P126; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; He YN, 2009, PUBLIC HEALTH NUTR, V12, P1078, DOI 10.1017/S1368980008003856; Keller U, 2006, INT J VITAM NUTR RES, V76, P172, DOI 10.1024/0300-9831.76.4.172; Kim MK, 2011, DIABETES RES CLIN PR, V93, P174, DOI 10.1016/j.diabres.2011.04.009; Korsic Mirko, 2011, Lijec Vjesn, V133, P284; Lam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a; MacCluer JW, 1999, NUTR REV, V57, pS59, DOI 10.1111/j.1753-4887.1999.tb01790.x; Mamtani MR, 2005, ARCH MED RES, V36, P581, DOI 10.1016/j.arcmed.2005.03.049; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Naser KA, 2006, INT J CLIN PRACT, V60, P1093, DOI 10.1111/j.1742-1241.2006.01003.x; Osei Kwame, 2003, Ethnicity & Disease, V13; Pancoska P, 2009, CTS-CLIN TRANSL SCI, V2, P413, DOI 10.1111/j.1752-8062.2009.00162.x; Qiao Q, 2010, EUR J CLIN NUTR, V64, P30, DOI 10.1038/ejcn.2009.93; Qu HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021041; Schulze MB, 2012, DIABETOLOGIA, V55, P1660, DOI 10.1007/s00125-012-2499-z; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Tabata S, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-1; Voruganti VS, 2008, J MOL MED, V86, P303, DOI 10.1007/s00109-007-0273-3; Wahrenberg H, 2005, BRIT MED J, V330, P1363, DOI 10.1136/bmj.38429.473310.AE; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Warren TY, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110170; Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x	38	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59153	10.1371/journal.pone.0059153	http://dx.doi.org/10.1371/journal.pone.0059153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536864	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100123
J	Gyoneva, S; Traynelis, SF				Gyoneva, Stefka; Traynelis, Stephen F.			Norepinephrine Modulates the Motility of Resting and Activated Microglia via Different Adrenergic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-COERULEUS; BETA(2)-ADRENERGIC RECEPTOR; GENE-EXPRESSION; SENILE DEMENTIA; G-PROTEINS; NORADRENALINE; CELLS; BRAIN; NEURONS; PHOSPHORYLATION	Microglia, the resident immune cells of the central nervous system (CNS), monitor the brain for disturbances of tissue homeostasis by constantly moving their fine processes. Microglia respond to tissue damage through activation of ATP/ADP receptors followed by directional process extension to the damaged area. A common feature of several neurodegenerative diseases is the loss of norepinephrine, which might contribute to the associated neuroinflammation. We carried out a high resolution analysis of the effects of norepinephrine (NE) on microglial process dynamics in acute brain slices from mice that exhibit microglia-specific enhanced green fluorescent protein expression. Bath application of NE to the slices resulted in significant process retraction in microglia. Analysis of adrenergic receptor expression with quantitative PCR indicated that resting microglia primarily express beta(2) receptors but switch expression to alpha(2A) receptors under proinflammatory conditions modeled by LPS treatment. Despite the differential receptor expression, NE caused process retraction in both resting and LPS-activated microglia cultured in the gelatinous substrate Matrigel in vitro. The use of subtype-selective receptor agonists and antagonists confirmed the involvement of beta(2) receptors in mediating microglial process dynamics in resting cells and alpha(2A) receptors in activated cells. Co-application of NE with ATP to resting microglia blocked the ATP-induced process extension and migration in isolated microglia, and beta(2) receptor antagonists prolonged ATP effects in brain slice tissues, suggesting the presence of cross-talk between adrenergic and purinergic signaling in microglia. These data show that the neurotransmitter NE can modulate microglial motility, which could affect microglial functions in pathogenic situations of either elevated or reduced NE levels.	[Gyoneva, Stefka; Traynelis, Stephen F.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Gyoneva, S (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr, Dept Pharmacol, Rm 5062,1510 Clifton Rd NE, Atlanta, GA 30322 USA.	stefka.gyoneva@gmail.com			National Institutes of Health [1F31NS076215]; NINDS [5T32ES12870]; NIEHS [T32GM008602]; Udall Parkinson's Disease Research Center at Emory University;  [P50-NS071669]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076215, P50NS071669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Udall Parkinson's Disease Research Center at Emory University; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1F31NS076215, a NINDS National Research Service Award (to S. G.); 5T32ES12870, an NIEHS toxicology institutional training grant (to S. G.); T32GM008602, a pharmacological sciences institutional training grant (to S. G.); and P50-NS071669, a NINDS internal pilot grant from the Udall Parkinson's Disease Research Center at Emory University (to S. F. T).	ATKINSON BN, 1991, J NEUROCHEM, V56, P587, DOI 10.1111/j.1471-4159.1991.tb08190.x; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bianco F, 2005, BRAIN RES REV, V48, P144, DOI 10.1016/j.brainresrev.2004.12.004; Bohm SK, 1997, BIOCHEM J, V322, P1; CHANPALAY V, 1989, J COMP NEUROL, V287, P373, DOI 10.1002/cne.902870308; Colton CA, 1996, NEUROCHEM INT, V29, P43, DOI 10.1016/0197-0186(95)00139-5; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; EASON MG, 1992, J BIOL CHEM, V267, P15795; Farber K, 2005, MOL CELL NEUROSCI, V29, P128, DOI 10.1016/j.mcn.2005.01.003; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Feinstein DL, 2002, NEUROCHEM INT, V41, P357, DOI 10.1016/S0197-0186(02)00049-9; Fornai F, 1997, J PHARMACOL EXP THER, V283, P100; Fujita H, 1998, NEUROSCI LETT, V242, P37, DOI 10.1016/S0304-3940(98)00003-2; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gyoneva S, 2009, PARKINSONISM RELAT D, V15, pS195, DOI 10.1016/S1353-8020(09)70813-2; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Heneka MT, 2002, J NEUROSCI, V22, P2434, DOI 10.1523/JNEUROSCI.22-07-02434.2002; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; IVERSEN LL, 1983, NEUROSCI LETT, V39, P95, DOI 10.1016/0304-3940(83)90171-4; Jardanhazi-Kurutz D, 2011, NEUROSCIENCE, V176, P396, DOI 10.1016/j.neuroscience.2010.11.052; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KALARIA RN, 1989, NEUROSCI LETT, V97, P203, DOI 10.1016/0304-3940(89)90164-X; Kandasamy K, 2005, J BIOL CHEM, V280, P1931, DOI 10.1074/jbc.M405937200; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kong Y, 2010, J NEUROSCI, V30, P11848, DOI 10.1523/JNEUROSCI.2985-10.2010; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee SH, 2012, GLIA, V60, P1366, DOI 10.1002/glia.22355; Leverenz JB, 2001, NEUROBIOL AGING, V22, P555, DOI 10.1016/S0197-4580(01)00221-4; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; LOUGHLIN AJ, 1993, IMMUNOLOGY, V79, P125; MANN DMA, 1980, BRIT J PSYCHIAT, V136, P533, DOI 10.1192/bjp.136.6.533; Mori K, 2002, NEUROPHARMACOLOGY, V43, P1026, DOI 10.1016/S0028-3908(02)00211-3; Morioka N, 2009, NEUROCHEM INT, V55, P226, DOI 10.1016/j.neuint.2009.03.004; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Paspalas CD, 1998, BRAIN RES BULL, V45, P247, DOI 10.1016/S0361-9230(97)00327-4; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pocock JM, 2007, TRENDS NEUROSCI, V30, P527, DOI 10.1016/j.tins.2007.07.007; Prinz M, 2001, BRAIN RES, V899, P264, DOI 10.1016/S0006-8993(01)02174-6; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Rommelfanger KS, 2007, BIOCHEM PHARMACOL, V74, P177, DOI 10.1016/j.bcp.2007.01.036; Rommelfanger KS, 2004, J NEUROCHEM, V91, P1116, DOI 10.1111/j.1471-4159.2004.02785.x; Scheffel J, 2012, GLIA, V60, P1930, DOI 10.1002/glia.22409; Schutsky K, 2011, J NEUROSCI, V31, P14172, DOI 10.1523/JNEUROSCI.2122-11.2011; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Sperlagh B, 2007, PURINERG SIGNAL, V3, P117, DOI 10.1007/s11302-006-9043-x; Stanford SC, 1995, PHARMACOL THERAPEUT, V68, P297, DOI 10.1016/0163-7258(95)02010-1; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Tanaka KF, 2002, J NEUROSCI RES, V70, P232, DOI 10.1002/jnr.10399; Tha KK, 2000, BRAIN RES, V885, P25, DOI 10.1016/S0006-8993(00)02883-3; Tholanikunnel BG, 2010, J BIOL CHEM, V285, P33816, DOI 10.1074/jbc.M110.168229; Vazquez-Prado J, 2003, CELL SIGNAL, V15, P549, DOI 10.1016/S0898-6568(02)00151-1; Zhang WP, 2004, NEUROPHARMACOLOGY, V47, P438, DOI 10.1016/j.neuropharm.2004.04.017	64	115	115	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15291	15302		10.1074/jbc.M113.458901	http://dx.doi.org/10.1074/jbc.M113.458901			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23548902	Green Published, hybrid			2022-12-25	WOS:000319452100055
J	Xin, H; Lu, RZ; Lee, H; Zhang, W; Zhang, CY; Deng, JH; Liu, Y; Shen, SD; Wagner, KU; Forman, S; Jove, R; Yu, H				Xin, Hong; Lu, Rongze; Lee, Heehyoung; Zhang, Wang; Zhang, Chunyan; Deng, Jiehui; Liu, Yong; Shen, Shudan; Wagner, Kay-Uwe; Forman, Stephen; Jove, Richard; Yu, Hua			G-protein-coupled Receptor Agonist BV8/Prokineticin-2 and STAT3 Protein Form a Feed-forward Loop in Both Normal and Malignant Myeloid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR ANGIOGENESIS; BV8; IDENTIFICATION; ACTIVATION; EXPRESSION; HOMOLOG; CROSSTALK; APOPTOSIS; SYSTEM; CANCER	An important role of BV8 in mobilization of myeloid cells and myeloid cell-dependent angiogenesis has been established. Recently, it has also been shown that granulocyte colony-stimulating factor (G-CSF)-induced BV8 expression is STAT3 dependent in CD11b(+)Gr1(+) myeloid cells. However, the BV8 downstream signaling pathway(s) intrinsic to myeloid cells crucial for angiogenesis, and potentially also for development of cancers of myeloid origin, remains largely unknown. Here we show that BV8 activates STAT3, which is critical for regulating genes important for both tumor cell proliferation/survival and tumor angiogenesis, in both normal and malignant myeloid cells. Further, BV8-induced STAT3 activation requires Janus-activated kinase 2 (JAK2) activity as shown by both genetic and pharmacologic inhibition. Knocking down BV8 in human myeloid leukemia cells inhibits STAT3 activity and expression of STAT3 downstream angiogenic and pro-proliferation/survival genes, leading to a decrease in tumor cell viability. BV8 shRNA expressing leukemia cells exhibit reduced STAT3 activity and tumor growth in vivo. Taken together, we have delineated a signaling pathway downstream of BV8 that plays critical roles in both the tumor microenvironment and malignant myeloid cells for angiogenesis and tumor cell proliferation/survival.	[Xin, Hong; Lee, Heehyoung; Zhang, Wang; Zhang, Chunyan; Deng, Jiehui; Liu, Yong; Shen, Shudan; Yu, Hua] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA; [Lu, Rongze] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA; [Jove, Richard] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Forman, Stephen] City Hope Natl Med Ctr, Dept Hematol Hematopoiet Cell Transplantat, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Nebraska System; University of Nebraska Medical Center; City of Hope	Yu, H (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	hyu@coh.org	Lu, Rongze/R-2149-2016	Deng, Jiehui/0000-0001-7986-8643; Wagner, Kay-Uwe/0000-0002-5081-0226; YU, Hua/0000-0003-0931-1000	Tim Nesvig Fund at the City of Hope Comprehensive Cancer Center; National Institutes of Health [R01 CA122976, U54 CA163117, P50 CA107399, R01CA146092, P30 CA033572]; V Foundation Translational Research Grant; HEADstrong Foundation	Tim Nesvig Fund at the City of Hope Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation Translational Research Grant; HEADstrong Foundation	This study was supported by the Tim Nesvig Fund at the City of Hope Comprehensive Cancer Center, the National Institutes of Health (Grants R01 CA122976, U54 CA163117, P50 CA107399, and R01CA146092 to H. Y. and P30 CA033572 to the City of Hope Cancer Center, the V Foundation Translational Research Grant, and the HEADstrong Foundation, in memory of Nicholas E. Colleluori.	Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; De Toni F, 2006, ONCOGENE, V25, P3113, DOI 10.1038/sj.onc.1209346; Giannini E, 2009, P NATL ACAD SCI USA, V106, P14646, DOI 10.1073/pnas.0903720106; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Krempler A, 2004, GENESIS, V40, P52, DOI 10.1002/gene.20063; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Lu RZ, 2012, CANCER RES, V72, P2239, DOI 10.1158/0008-5472.CAN-11-3016; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Melchiorri D, 2001, EUR J NEUROSCI, V13, P1694, DOI 10.1046/j.1460-9568.2001.01549.x; Mollay C, 1999, EUR J PHARMACOL, V374, P189, DOI 10.1016/S0014-2999(99)00229-0; Qu XP, 2012, J BIOL CHEM, V287, P19574, DOI 10.1074/jbc.M111.326801; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Tamburini J, 2007, BLOOD, V110, P1025, DOI 10.1182/blood-2006-12-061283; Wu JH, 2004, CANCER RES, V64, P6461, DOI 10.1158/0008-5472.CAN-04-0866; Xin H, 2011, CANCER RES, V71, P6601, DOI 10.1158/0008-5472.CAN-11-1217; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yang F, 2012, CANCER BIOL THER, V13, P534, DOI 10.4161/cbt.19603; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	31	48	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13842	13849		10.1074/jbc.M113.450049	http://dx.doi.org/10.1074/jbc.M113.450049			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23548897	hybrid, Green Published			2022-12-25	WOS:000318850300065
J	Dodla, R; Wilson, CJ				Dodla, Ramana; Wilson, Charles J.			Effect of Sharp Jumps at the Edges of Phase Response Curves on Synchronization of Electrically Coupled Neuronal Oscillators	PLOS ONE			English	Article							RESETTING CURVES; SPIKING NEURONS; STABILITY; NETWORKS; DYNAMICS; SYNAPSES; LOCKING	We study synchronization phenomenon of coupled neuronal oscillators using the theory of weakly coupled oscillators. The role of sudden jumps in the phase response curve profiles found in some experimental recordings and models on the ability of coupled neurons to exhibit synchronous and antisynchronous behavior is investigated, when the coupling between the neurons is electrical. The level of jumps in the phase response curve at either end, spike width and frequency of voltage time course of the coupled neurons are parameterized using piecewise linear functional forms, and the conditions for stable synchrony and stable antisynchrony in terms of those parameters are computed analytically. The role of the peak position of the phase response curve on phase-locking is also investigated.	[Dodla, Ramana; Wilson, Charles J.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA	University of Texas System; University of Texas at San Antonio (UTSA)	Dodla, R (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	ramana.dodla@utsa.edu	Wilson, Charles/D-2529-2011; Dodla, Ramana/B-3608-2008	Wilson, Charles/0000-0002-9004-2145; Dodla, Ramana/0000-0002-8057-9571	National Institutes of Health [NS047085]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS047085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grant NS047085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achuthan S, 2009, J NEUROSCI, V29, P5218, DOI 10.1523/JNEUROSCI.0426-09.2009; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brown E, 2004, NEURAL COMPUT, V16, P673, DOI 10.1162/089976604322860668; Chow CC, 2000, NEURAL COMPUT, V12, P1643, DOI 10.1162/089976600300015295; Dodla R, 2012, NEUR M PLANN; Dror R, 1999, BIOL CYBERN, V80, P11, DOI 10.1007/s004220050501; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Ermentrout B, 2001, NEURAL COMPUT, V13, P1285, DOI 10.1162/08997660152002861; Ermentrout G. B., 2002, SIMULATING ANAL ANIM; ERMENTROUT GB, 1991, J MATH BIOL, V29, P195, DOI 10.1007/BF00160535; ERMENTROUT GB, 1986, SIAM J APPL MATH, V46, P233, DOI 10.1137/0146017; Farries MA, 2012, J NEUROPHYSIOL, V108, P1838, DOI 10.1152/jn.00054.2012; Goel P, 2002, PHYSICA D, V163, P191, DOI 10.1016/S0167-2789(01)00374-8; Gouwens NW, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000951; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; HOPPENSTEADT F, 1997, WEAKLY CONNECTED NEU; Jeong HY, 2007, NEURAL COMPUT, V19, P706, DOI 10.1162/neco.2007.19.3.706; KAWAHARA K, 1988, BIOL CYBERN, V58, P235, DOI 10.1007/BF00364129; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Ladenbauer J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002478; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; Maran SK, 2008, J COMPUT NEUROSCI, V24, P37, DOI 10.1007/s10827-007-0040-z; Neltner L, 2001, NEURAL COMPUT, V13, P765, DOI 10.1162/089976601300014330; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; NEU JC, 1979, SIAM J APPL MATH, V37, P307, DOI 10.1137/0137022; NEU JC, 1979, SIAM J APPL MATH, V36, P509, DOI 10.1137/0136038; Pfeuty B, 2005, NEURAL COMPUT, V17, P633, DOI 10.1162/0899766053019917; Pfeuty B, 2003, J NEUROSCI, V23, P6280; Pravlidis P, 1973, BIOL OSCILLATORS THE; Smeal RM, 2010, PHILOS T R SOC B, V365, P2407, DOI 10.1098/rstb.2009.0292; Tuckwell HC, 1998, INTRO THEORETICAL NE, V1; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; Wang XJ, 1996, J NEUROSCI, V16, P6402; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e58922	10.1371/journal.pone.0058922	http://dx.doi.org/10.1371/journal.pone.0058922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555607	Green Published, gold, Green Submitted			2022-12-25	WOS:000317263900008
J	Duan, JL; Shao, F; Shao, YG; Li, JY; Ling, Y; Teng, KD; Li, HW; Wu, CX				Duan, Jinlin; Shao, Fan; Shao, Yonggang; Li, Junying; Ling, Yao; Teng, Kedao; Li, Hongwei; Wu, Changxin			Androgen Inhibits Abdominal Fat Accumulation and Negatively Regulates the PCK1 Gene in Male Chickens	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; STAT SIGNALING PATHWAY; TESTOSTERONE REPLACEMENT; INSULIN SENSITIVITY; EXPRESSION PATTERNS; CYTOSOLIC FORM; OBESITY; MEN; CAPONIZATION; MASS	Capons are male chickens whose testes have been surgically incised. Capons show a significant increase in fat accumulation compared to intact male chickens. However, while caponization leads to a significant reduction in androgen levels in roosters, little is known about the molecular mechanisms through which androgen status affects lipogenesis in avian species. Therefore, investigation of the influence of androgens on fat accumulation in the chicken will provide insights into this process. In this study, Affymetrix microarray technology was used to analyze the gene expression profiles of livers from capons and intact male chickens because the liver is the major site of lipogenesis in avian species. Through gene ontology, we found that genes involved in hepatic lipogenic biosynthesis were the most highly enriched. Interestingly, among the upregulated genes, the cytosolic form of the phosphoenolpyruvate carboxykinase (PCK1) gene showed the greatest fold change. Additionally, in conjunction with quantitative real-time PCR data, our results suggested that androgen status negatively regulated the PCK1 gene in male chickens.	[Duan, Jinlin; Shao, Fan; Li, Junying; Ling, Yao; Li, Hongwei; Wu, Changxin] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Shao, Yonggang] Xinjiang Agr Univ, Coll Anim Sci, Urumqi, Xinjiang, Peoples R China; [Teng, Kedao; Li, Hongwei] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China	China Agricultural University; Xinjiang Agricultural University; China Agricultural University	Li, HW (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	lhwcau@163.com						ANDREONE TL, 1982, J BIOL CHEM, V257, P35; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Bhasin S, 2001, J ENDOCRINOL, V170, P27, DOI 10.1677/joe.0.1700027; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P407, DOI 10.1210/jc.82.2.407; Blouin K, 2010, CLIN ENDOCRINOL, V72, P176, DOI 10.1111/j.1365-2265.2009.03645.x; Brodsky IG, 1996, J CLIN ENDOCR METAB, V81, P3469, DOI 10.1210/jc.81.10.3469; Cao HN, 2004, J CLIN ENDOCR METAB, V89, P898, DOI 10.1210/jc.2003-031361; CHAPMAN MJ, 1980, J LIPID RES, V21, P789; Charles C, 2000, J CLIN ENDOCR METAB, V85, P1026; Chen KL, 2007, POULTRY SCI, V86, P1754, DOI 10.1093/ps/86.8.1754; Chen KL, 2006, ASIAN AUSTRAL J ANIM, V19, P438, DOI 10.5713/ajas.2006.438; Chen KL, 2005, POULTRY SCI, V84, P547, DOI 10.1093/ps/84.4.547; Chen KL, 2010, POULTRY SCI, V88, P887; Chen KL, 2000, J AGR ASSOC CHINA, V1, P54; Chen KuoLung, 2000, Journal of the Chinese Society of Animal Science, V29, P77; COOK JS, 1986, P NATL ACAD SCI USA, V83, P7583, DOI 10.1073/pnas.83.20.7583; DeRisi J, 1996, NAT GENET, V14, P457; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Eklund AC, 2006, NAT BIOTECHNOL, V24, P1071, DOI 10.1038/nbt0906-1071; FENNELL MJ, 1992, POULTRY SCI, V71, P357, DOI 10.3382/ps.0710357; Fennell MJ, 1990, GEN COMP ENDOCR, V77, P763; FIELD RA, 1971, J ANIM SCI, V32, P849; Gapstur SM, 2002, CANCER EPIDEM BIOMAR, V11, P1041; Garcia E, 1999, J ENDOCRINOL, V161, P89, DOI 10.1677/joe.0.1610089; Gomez-Valades AG, 2006, MOL THER, V13, P401, DOI 10.1016/j.ymthe.2005.08.026; Gomez-Valades AG, 2008, DIABETES, V57, P2199, DOI 10.2337/db07-1087; Gondret F, 2001, J LIPID RES, V42, P106; GUNN JM, 1975, BIOCHEM J, V150, P195, DOI 10.1042/bj1500195; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Hsieh CW, 2011, J LIPID RES, V52, P1352, DOI 10.1194/jlr.M012666; Hsieh CW, 2009, J NUTR, V139, P2257, DOI 10.3945/jn.109.113092; Hsieh CY, 2001, J CHIN SOC ANIM SCI, V30, P229; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Katznelson L, 1996, J CLIN ENDOCR METAB, V81, P4358, DOI 10.1210/jc.81.12.4358; Khaw K T, 1992, Ann Epidemiol, V2, P675, DOI 10.1016/1047-2797(92)90012-F; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LACASA D, 1995, ENDOCRINE, V3, P789, DOI 10.1007/BF02935682; Lacasa D, 1997, ENDOCRINOLOGY, V138, P3181, DOI 10.1210/en.138.8.3181; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MARIN P, 1995, J CLIN ENDOCR METAB, V80, P239, DOI 10.1210/jc.80.1.239; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363; MULLER MJ, 1982, ENDOCRINOLOGY, V111, P1469; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; PASQUALI R, 1991, METABOLISM, V40, P101, DOI 10.1016/0026-0495(91)90199-7; Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054; Rajan S, 2003, ENDOCRINOLOGY, V144, P5081; Rees SD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-83; Rosalim SY, 1976, METHODS RADIOIMMUNOA; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; SHRAGO E, 1971, METABOLISM, V20, P54, DOI 10.1016/0026-0495(71)90059-X; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun Y, 2002, J BIOL CHEM, V277, P23301, DOI 10.1074/jbc.M200964200; TILGHMAN S M, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1304, DOI 10.1073/pnas.71.4.1304; Tilghman SM, 1976, GLUCONEOGENESIS ITS, P47; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; WATFORD M, 1981, J BIOL CHEM, V256, P23; WICKS WD, 1972, BIOCHIM BIOPHYS ACTA, V264, P177, DOI 10.1016/0304-4165(72)90129-8; WILSON JD, 1988, ENDOCR REV, V9, P181, DOI 10.1210/edrv-9-2-181; Zhang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	70	14	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59636	10.1371/journal.pone.0059636	http://dx.doi.org/10.1371/journal.pone.0059636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544081	gold, Green Submitted, Green Published			2022-12-25	WOS:000317480700041
J	Horn, N; Wegmann, U; Dertlit, E; Mulholland, F; Conine, SRA; Waldront, KW; Bongaerts, RJ; Mayer, MJ; Narbad, A				Horn, Nikki; Wegmann, Udo; Dertlit, Enes; Mulholland, Francis; Conine, Samuel R. A.; Waldront, Keith W.; Bongaerts, Roy J.; Mayer, Melinda J.; Narbad, Arjan			Spontaneous Mutation Reveals Influence of Exopolysaccharide on Lactobacillus johnsonii Surface Characteristics	PLOS ONE			English	Article							LACTIC-ACID BACTERIA/; STREPTOCOCCUS-PNEUMONIAE; GASTROINTESTINAL-TRACT; COMPETITIVE-EXCLUSION; FUNCTIONAL-ANALYSIS; LACTOCOCCUS-LACTIS; GENOME SEQUENCE; GENE CLUSTERS; IN-VITRO; BIOSYNTHESIS	As a competitive exclusion agent, Lactobacillus johnsonii FI9785 has been shown to prevent the colonization of selected pathogenic bacteria from the chicken gastrointestinal tract. During growth of the bacterium a rare but consistent emergence of an altered phenotype was noted, generating smooth colonies in contrast to the wild type rough form. A smooth colony variant was isolated and two-dimensional gel analysis of both strains revealed a protein spot with different migration properties in the two phenotypes. The spot in both gels was identified as a putative tyrosine kinase (EpsC), associated with a predicted exopolysaccharide gene cluster. Sequencing of the epsC gene from the smooth mutant revealed a single substitution (G to A) in the coding strand, resulting in the amino acid change D88N in the corresponding gene product. A native plasmid of L. johnsonii was engineered to produce a novel vector for constitutive expression and this was used to demonstrate that expression of the wild type epsC gene in the smooth mutant produced a reversion to the rough colony phenotype. Both the mutant and epsC complemented strains had increased levels of exopolysaccharides compared to the wild type strain, indicating that the rough phenotype is not solely associated with the quantity of exopolysaccharide. Another gene in the cluster, epsE, that encoded a putative undecaprenyl-phosphate galactosephosphotransferase, was deleted in order to investigate its role in exopolysaccharide biosynthesis. The Delta epsE strain exhibited a large increase in cell aggregation and a reduction in exopolysaccharide content, while plasmid complementation of epsE restored the wild type phenotype. Flow cytometry showed that the wild type and derivative strains exhibited clear differences in their adhesive ability to HT29 monolayers in tissue culture, demonstrating an impact of EPS on surface properties and bacteria-host interactions.	[Horn, Nikki; Wegmann, Udo; Dertlit, Enes; Mayer, Melinda J.; Narbad, Arjan] Inst Food Res, Dept Gut Hlth & Food Safety, Norwich, Norfolk, England; [Dertlit, Enes] Bayburt Univ, Dept Food Engn, Bayburt, Turkey; [Mulholland, Francis] Inst Food Res, Prote Unit, Norwich, Norfolk, England; [Conine, Samuel R. A.; Waldront, Keith W.] Inst Food Res, Dept Food & Hlth, Norwich, Norfolk, England; [Bongaerts, Roy J.] Inst Food Res, Analyt Sci Unit, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Bayburt University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Mayer, MJ (corresponding author), Inst Food Res, Dept Gut Hlth & Food Safety, Norwich, Norfolk, England.	Melinda.Mayer@IFR.ac.uk		Wegmann, Udo/0000-0003-1690-3688	Biotechnology and Biological Science Research Council [IFR/08/1, BB/J004529/1, BB/J004545/1]; Turkish Ministry of Education; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044476, BBS/E/F/00042291, BBS/E/F/00044453] Funding Source: researchfish; BBSRC [BBS/E/F/00044476, BBS/E/F/00044453] Funding Source: UKRI	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Turkish Ministry of Education(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by strategic core grants (IFR/08/1, BB/J004529/1 and BB/J004545/1) from the Biotechnology and Biological Science Research Council. ED is grateful to the Turkish Ministry of Education for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Badel S, 2011, BIOTECHNOL ADV, V29, P54, DOI 10.1016/j.biotechadv.2010.08.011; Bender MH, 2001, J BIOL CHEM, V276, P47966, DOI 10.1074/jbc.M105448200; BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; Broadbent JR, 2003, J DAIRY SCI, V86, P407, DOI 10.3168/jds.S0022-0302(03)73619-4; Cesena C, 2001, J DAIRY SCI, V84, P1001, DOI 10.3168/jds.S0022-0302(01)74559-6; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Cozzone AJ, 2004, ARCH MICROBIOL, V181, P171, DOI 10.1007/s00203-003-0640-6; De Vuyst L, 2001, INT DAIRY J, V11, P687, DOI 10.1016/S0958-6946(01)00114-5; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Granato D, 1999, APPL ENVIRON MICROB, V65, P1071; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; Horn N, 2005, PLASMID, V54, P176, DOI 10.1016/j.plasmid.2005.01.005; Ibnou-Zekri N, 2003, INFECT IMMUN, V71, P428, DOI 10.1128/IAI.71.1.428-436.2003; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Jolly L, 2001, INT DAIRY J, V11, P733, DOI 10.1016/S0958-6946(01)00117-0; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; La Ragione RM, 2004, LETT APPL MICROBIOL, V38, P197, DOI 10.1111/j.1472-765X.2004.01474.x; Lamothe GT, 2002, ARCH MICROBIOL, V178, P218, DOI 10.1007/s00203-002-0447-x; Larsen N, 2007, INT J FOOD MICROBIOL, V114, P113, DOI 10.1016/j.ijfoodmicro.2006.10.033; Lebeer S, 2011, LETT APPL MICROBIOL, V52, P220, DOI 10.1111/j.1472-765X.2010.02994.x; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lee JH, 2011, J BACTERIOL, V193, P5030, DOI 10.1128/JB.05640-11; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Minic Z, 2007, J BACTERIOL, V189, P1351, DOI 10.1128/JB.01122-06; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; Morona JK, 2003, J BACTERIOL, V185, P3009, DOI 10.1128/JB.185.10.3009-3019.2003; Neeser JR, 2000, GLYCOBIOLOGY, V10, P1193, DOI 10.1093/glycob/10.11.1193; Peant B, 2005, MICROBIOL-SGM, V151, P1839, DOI 10.1099/mic.0.27852-0; Pinto MGV, 2007, J FOOD PROTECT, V70, P125, DOI 10.4315/0362-028X-70.1.125; Pitino I, 2012, FOOD MICROBIOL, V31, P57, DOI 10.1016/j.fm.2012.02.013; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Stingele F, 1999, J BACTERIOL, V181, P6354, DOI 10.1128/JB.181.20.6354-6360.1999; Tallon R, 2003, RES MICROBIOL, V154, P705, DOI 10.1016/j.resmic.2003.09.006; Timbermont L, 2011, AVIAN PATHOL, V40, P341, DOI 10.1080/03079457.2011.590967; vanKranenburg R, 1997, MOL MICROBIOL, V24, P387, DOI 10.1046/j.1365-2958.1997.3521720.x; Ventura M, 2002, APPL ENVIRON MICROB, V68, P6172, DOI 10.1128/AEM.68.12.6172-6181.2002; Walter J, 2008, MICROBIOL-SGM, V154, P72, DOI 10.1099/mic.0.2007/010637-0; Wang YP, 2008, INT J BIOL MACROMOL, V43, P283, DOI 10.1016/j.ijbiomac.2008.06.011; Wegmann U, 1999, APPL ENVIRON MICROB, V65, P4729; Wegmann U, 2009, J BACTERIOL, V191, P7142, DOI 10.1128/JB.01182-09; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; Zhou TQ, 2000, EMBO J, V19, P4838, DOI 10.1093/emboj/19.17.4838	47	52	55	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59957	10.1371/journal.pone.0059957	http://dx.doi.org/10.1371/journal.pone.0059957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544114	Green Submitted, gold, Green Published			2022-12-25	WOS:000317480700073
J	Kawamoto, Y; Takemoto, H; Higuchi, S; Sakamaki, T; Hart, JA; Hart, TB; Tokuyama, N; Reinartz, GE; Guislain, P; Dupain, J; Cobden, AK; Mulavwa, MN; Yangozene, K; Darroze, S; Devos, C; Furuichi, T				Kawamoto, Yoshi; Takemoto, Hiroyuki; Higuchi, Shoko; Sakamaki, Tetsuya; Hart, John A.; Hart, Terese B.; Tokuyama, Nahoko; Reinartz, Gay E.; Guislain, Patrick; Dupain, Jef; Cobden, Amy K.; Mulavwa, Mbangi N.; Yangozene, Kumugo; Darroze, Serge; Devos, Celine; Furuichi, Takeshi			Genetic Structure of Wild Bonobo Populations: Diversity of Mitochondrial DNA and Geographical Distribution	PLOS ONE			English	Article							PAN-PANISCUS; PLEISTOCENE REFUGIA; CENTRAL-AFRICA; RIVERS; FOREST; DISPERSAL; REGION; CONGO	Bonobos (Pan paniscus) inhabit regions south of the Congo River including all areas between its southerly tributaries. To investigate the genetic diversity and evolutionary relationship among bonobo populations, we sequenced mitochondrial DNA from 376 fecal samples collected in seven study populations located within the eastern and western limits of the species' range. In 136 effective samples from different individuals (range: 7-37 per population), we distinguished 54 haplotypes in six clades (A1, A2, B1, B2, C, D), which included a newly identified clade (D). MtDNA haplotypes were regionally clustered; 83 percent of haplotypes were locality-specific. The distribution of haplotypes across populations and the genetic diversity within populations thus showed highly geographical patterns. Using population distance measures, seven populations were categorized in three clusters: the east, central, and west cohorts. Although further elucidation of historical changes in the geological setting is required, the geographical patterns of genetic diversity seem to be shaped by paleoenvironmental changes during the Pleistocene. The present day riverine barriers appeared to have a weak effect on gene flow among populations, except for the Lomami River, which separates the TL2 population from the others. The central cohort preserves a high genetic diversity, and two unique clades of haplotypes were found in the Wamba/Iyondji populations in the central cohort and in the TL2 population in the eastern cohort respectively. This knowledge may contribute to the planning of bonobo conservation.	[Kawamoto, Yoshi; Takemoto, Hiroyuki; Higuchi, Shoko; Sakamaki, Tetsuya; Tokuyama, Nahoko; Furuichi, Takeshi] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Hart, John A.; Hart, Terese B.] Lukuru Wildlife Res Fdn, Kinshasa, DEM REP CONGO; [Reinartz, Gay E.; Guislain, Patrick] Zool Soc Milwaukee, Bonobo & Congo Biodivers Initiat, Milwaukee, WI USA; [Dupain, Jef; Cobden, Amy K.] African Wildlife Fdn, Kinshasa, DEM REP CONGO; [Mulavwa, Mbangi N.; Yangozene, Kumugo] Minist High Educ & Sci Res, Res Ctr Ecol & Forestry, Mabali, DEM REP CONGO; [Darroze, Serge; Devos, Celine] World Wide Fund Nat, Kinshasa, DEM REP CONGO; [Cobden, Amy K.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA	Kyoto University; World Wildlife Fund; Emory University	Furuichi, T (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	furuichi@pri.kyoto-u.ac.jp	Tokuyama, Nahoko/AAB-4866-2021	DARROZE, SERGE/0000-0002-6092-004X	Environment Research and Technology Development Fund [D-1007]; Global Environment Research Fund of the Ministry of the Environment, Japan [F-061]; Japan Society for the Promotion of Science (JSPS) [17255005, 22255007]; JSPS Asia-Africa Science Platform Program; JSPS Primate Origins of Human Evolution (HOPE) Project [AS-22-027, ITP-23-006]; US Fish and Wildlife; Arcus Foundation; Wood Tiger Foundation; Full Circle Foundation; US Fish and Wildlife Service Assistance Award [96200-0-G017]; Columbus Zoo and Aquarium; Barron Wall; L.L. Leakey Foundation; Congo Basin Forest Partnership/USAID-WWF [623-A-00-06-00072-00]; Susan McConnell; Wildlife Conservation Network; AZA Ape TAG Conservation Initiative; WWF Belgium; WWF Netherlands; Belgian Cooperation; CARPE program (USAID); Grants-in-Aid for Scientific Research [25257407, 22570089] Funding Source: KAKEN	Environment Research and Technology Development Fund; Global Environment Research Fund of the Ministry of the Environment, Japan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Asia-Africa Science Platform Program; JSPS Primate Origins of Human Evolution (HOPE) Project; US Fish and Wildlife(US Fish & Wildlife Service); Arcus Foundation; Wood Tiger Foundation; Full Circle Foundation; US Fish and Wildlife Service Assistance Award; Columbus Zoo and Aquarium; Barron Wall; L.L. Leakey Foundation; Congo Basin Forest Partnership/USAID-WWF(United States Agency for International Development (USAID)); Susan McConnell; Wildlife Conservation Network; AZA Ape TAG Conservation Initiative; WWF Belgium; WWF Netherlands; Belgian Cooperation; CARPE program (USAID)(United States Agency for International Development (USAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Environment Research and Technology Development Fund (D-1007) (to TF); the Global Environment Research Fund (F-061) of the Ministry of the Environment, Japan (to Nishida); Japan Society for the Promotion of Science (JSPS) Grants-in-aid for Scientific Research (17255005 and 22255007, to TF); the JSPS Asia-Africa Science Platform Program (2009-2011, 2012-2014 to TF); the JSPS Primate Origins of Human Evolution (HOPE) Project (AS-22-027 and ITP-23-006, to TS); US Fish and Wildlife (2007-2009, 2010-2011, to Lukuru Wildlife Research Foundation); Arcus Foundation (2007-2008, 2010, 2012, to Lukuru Wildlife Research Foundation); Wood Tiger Foundation (2010, 2012, to Lukuru Wildlife Research Foundation); Full Circle Foundation (2011, to Lukuru Wildlife Research Foundation); the US Fish and Wildlife Service Assistance Award (96200-0-G017, to African Wildlife Foundation); Arcus Foundation, the Columbus Zoo and Aquarium, and Barron Wall (to AWF); the L.L. Leakey Foundation (to AKC); the Congo Basin Forest Partnership/USAID-WWF (623-A-00-06-00072-00, to ZSM); Susan McConnell and Richard Scheller (Wildlife Conservation Network) (to ZSM); the AZA Ape TAG Conservation Initiative (to ZSM); WWF Belgium, WWF Netherlands, Belgian Cooperation funding for co-financing, and CARPE program (USAID) for program coordination, for WWF bonobo project in the Lac Tumba Landscape. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anhuf D, 2006, PALAEOGEOGR PALAEOCL, V239, P510, DOI 10.1016/j.palaeo.2006.01.017; Anthony NM, 2007, P NATL ACAD SCI USA, V104, P20432, DOI 10.1073/pnas.0704816105; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; COLYN M, 1991, J BIOGEOGR, V18, P403, DOI 10.2307/2845482; Deinard AS, 2000, AM J PHYS ANTHROPOL, V111, P25, DOI 10.1002/(SICI)1096-8644(200001)111:1<25::AID-AJPA3>3.0.CO;2-R; Dupain J, 2000, BIOL CONSERV, V94, P265, DOI 10.1016/S0006-3207(00)00004-5; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Furuichi Takeshi, 2012, P413; Gerloff U, 1999, P ROY SOC B-BIOL SCI, V266, P1189, DOI 10.1098/rspb.1999.0762; Grubb Peter, 2001, P88; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Hashimoto C, 1996, PRIMATES, V37, P305, DOI 10.1007/BF02381862; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Idani G, 2008, BONOBOS BEHAV ECOLOG, P291; Inogwabini BI, 2007, ORYX, V41, P532, DOI 10.1017/S0030605307414120; Kano T., 1992, LAST APE PYGMY CHIMP; KINGDON J S, 1980, Transactions of the Zoological Society of London, V35, P425; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Maley J., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P68; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Nei M., 1987, MOL EVOLUTIONARY GEN; Nicolas V, 2011, J BIOGEOGR, V38, P191, DOI 10.1111/j.1365-2699.2010.02399.x; Reinartz GE, 2006, INT J PRIMATOL, V27, P603, DOI 10.1007/s10764-006-9020-9; Rommerskirchen F, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001223; Schneider S., 2000, ARLEQUIN VER 2 000 S; Stankiewicz J, 2006, J AFR EARTH SCI, V44, P75, DOI 10.1016/j.jafrearsci.2005.11.008; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tosi AJ, 2008, ZOOL J LINN SOC-LOND, V154, P408, DOI 10.1111/j.1096-3642.2008.00419.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; White P. Scott, 1992, P29; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Zhang BW, 2006, BIOCHEM GENET, V44, P503, DOI 10.1007/s10528-006-9050-1; Zsurka G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-270	41	48	49	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59660	10.1371/journal.pone.0059660	http://dx.doi.org/10.1371/journal.pone.0059660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544084	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700044
J	Li, XH; Chen, JX; Yue, GX; Liu, YY; Zhao, X; Guo, XL; Liu, Q; Jiang, YM; Bai, MH				Li, Xiao-Hong; Chen, Jia-Xu; Yue, Guang-Xin; Liu, Yue-Yun; Zhao, Xin; Guo, Xiao-Ling; Liu, Qun; Jiang, You-Ming; Bai, Ming-Hua			Gene Expression Profile of the Hippocampus of Rats Subjected to Chronic Immobilization Stress	PLOS ONE			English	Article							C-REACTIVE PROTEIN; T-CELL DEVELOPMENT; GLUCOCORTICOID-RECEPTOR; DENDRITIC CELLS; HORMONE RECEPTOR-2; IMMUNE-RESPONSE; HUMAN MONOCYTES; DOWN-REGULATION; NERVOUS-SYSTEM; MESSENGER-RNA	Objective: This study systematically investigated the effect of chronic stress on the hippocampus and its damage mechanism at the whole genome level. Methods: The rat whole genome expression chips (Illumina) were used to detect gene expression differences in the hippocampus of rats subjected to chronic immobilization stress (daily immobilization stress for 3 h, for 7 or 21 days). The hippocampus gene expression profile was studied through gene ontology and signal pathway analyses using bioinformatics. A differentially expressed transcription regulation network was also established. Real-time quantitative polymerase chain reaction (RT-PCR) was used to verify the microarray results and determine expression of the Gabra1, Fadd, Crhr2, and Cdk6 genes in the hippocampal tissues. Results: Compared to the control group, 602 differentially expressed genes were detected in the hippocampus of rats subjected to stress for 7 days, while 566 differentially expressed genes were expressed in the animals experiencing stress for 21 days. The stress significantly inhibited the primary immune system functions of the hippocampus in animals subjected to stress for both 7 and 21 days. Immobilization activated the extracellular matrix receptor interaction pathway after 7 day exposure to stress and the cytokine-cytokine receptor interaction pathway. The enhanced collagen synthesis capacity of the hippocampal tissue was the core molecular event of the stress regulation network in the 7-day group, while the inhibition of hippocampal cell growth was the core molecular event in the 21-day group. For the Gabra1, Fadd, Crhr2, and Cdk6 genes, RT-PCR results were nearly in line with gene chip assay results. Conclusion: During the 7-day and 21-day stress processes, the combined action of polygenic, multilevel, and multi-signal pathways leads to the disorder of the immunologic functions of the hippocampus, hippocampal apoptosis, and proliferation disequilibrium.	[Li, Xiao-Hong; Chen, Jia-Xu; Liu, Yue-Yun; Zhao, Xin; Guo, Xiao-Ling; Liu, Qun; Jiang, You-Ming; Bai, Ming-Hua] Beijing Univ Chinese Med, Sch Preclin Med, Beijing, Peoples R China; [Li, Xiao-Hong] Guangxi Univ Chinese Med, Sch Preclin Med, Nanning, Peoples R China; [Yue, Guang-Xin] Chinese Acad Med Sci, Inst Basic Theory TCM, Beijing, Peoples R China	Beijing University of Chinese Medicine; Guangxi University of Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Theory for Chinese Medicine, CACMS	Chen, JX (corresponding author), Beijing Univ Chinese Med, Sch Preclin Med, Beijing, Peoples R China.	chenjx@bucm.edu.cn	Bai, Minghua/ABB-2223-2020		National Natural Science Foundation of China [30672578, 81072756]; China National Funds for Distinguished Young Scientists [30825046]; Program for Innovative Research Team in Beijing University of Chinese Medicine [2011CXTD-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in Beijing University of Chinese Medicine	This research is supported by National Natural Science Foundation of China (No. 30672578, 81072756: http://www.nsfc.gov.cn/), China National Funds for Distinguished Young Scientists (No. 30825046: http://www.nsfc.gov.cn/), and Program for Innovative Research Team in Beijing University of Chinese Medicine (2011CXTD-07: http://www.bucm.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Balasubramanian S, 1999, ONCOGENE, V18, P1297, DOI 10.1038/sj.onc.1202417; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bamberger CM, 1997, MOL CELL ENDOCRINOL, V131, P233, DOI 10.1016/S0303-7207(97)00115-9; Bartolomucci A, 2003, J NEUROIMMUNOL, V141, P58, DOI 10.1016/S0165-5728(03)00220-0; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; BLALOCK JE, 1994, IMMUNOL TODAY, V15, P504, DOI 10.1016/0167-5699(94)90205-4; Blotta MH, 1997, J IMMUNOL, V158, P5589; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Brin S., 1998, COMPUT NETW ISDN SYS, V30, P107, DOI [DOI 10.1016/S0169-7552(98)00110-X, 10.1016/s0169-7552(98)00110-x]; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chao HM, 1998, ENDOCRINOLOGY, V139, P1810, DOI 10.1210/en.139.4.1810; Chen JX, 2008, CELL MOL NEUROBIOL, V28, P745, DOI 10.1007/s10571-007-9169-6; Chen JX, 2008, CELL MOL NEUROBIOL, V28, P237, DOI 10.1007/s10571-007-9170-0; Chen Jia-Xu, 2004, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V20, P71; [陈家旭 CHEN Jiaxu], 2007, [中国病理生理杂志, Chinese Journal of Pathophysiology], V23, P1296; Chen JX, 2004, CHINA J TRADITIONAL, V19, P83; Chen JX, 2006, CHINESE REMEDIES CLI, V3, P223; Chiaretti S, 2006, BLOOD, V107, P197, DOI 10.1182/blood-2005-04-1755; Chiu BC, 2002, MECH AGEING DEV, V123, P313, DOI 10.1016/S0047-6374(01)00372-4; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Dodd JS, 2009, J IMMUNOL, V183, P7006, DOI 10.4049/jimmunol.0900085; Dong C, 2008, J IMMUNOTOXICOL, V5, P43, DOI 10.1080/15476910801897953; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Dozmorov IM, 1998, J IMMUNOL, V160, P2700; Du Clos TW, 2004, IMMUNOL RES, V30, P261, DOI 10.1385/IR:30:3:261; Duits LA, 2002, IMMUNOLOGY, V106, P517, DOI 10.1046/j.1365-2567.2002.01430.x; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; FALCONER MA, 1964, ARCH NEUROL-CHICAGO, V10, P233, DOI 10.1001/archneur.1964.00460150003001; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Franchimont D, 2000, J IMMUNOL, V164, P1768, DOI 10.4049/jimmunol.164.4.1768; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997; Herman JP, 1998, J NEUROSCI, V18, P7462; Herman JP, 1999, ENDOCRINOLOGY, V140, P3981, DOI 10.1210/en.140.9.3981; Hornberger LK, 2000, CIRC RES, V87, P508; Huaux F, 2003, J IMMUNOL, V171, P5470, DOI 10.4049/jimmunol.171.10.5470; Kagami S, 2000, BLOOD, V95, P1370, DOI 10.1182/blood.V95.4.1370.004k29_1370_1377; Karlsson L, 2005, CURR OPIN IMMUNOL, V17, P65, DOI 10.1016/j.coi.2004.11.003; Kempermann G, 2003, BIOL PSYCHIAT, V54, P499, DOI 10.1016/S0006-3223(03)00319-6; Kondo S, 1998, FASEB J, V12, P801, DOI 10.1096/fasebj.12.10.801; Lawrence DA, 2000, TOXICOLOGY, V142, P189, DOI 10.1016/S0300-483X(99)00144-4; Lemons ML, 2006, EXP NEUROL, V202, P324, DOI 10.1016/j.expneurol.2006.06.008; Lemons ML, 2008, EXP NEUROL, V209, P343, DOI 10.1016/j.expneurol.2007.05.027; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Lubberts E, 2005, ARTHRITIS RES THER, V7, P29, DOI 10.1186/ar1478; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Malissen B, 2005, ADV IMMUNOL, V87, P1, DOI 10.1016/S0065-2776(05)87001-4; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Matsuda S, 2004, EMBO J, V23, P2577, DOI 10.1038/sj.emboj.7600268; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nakanishi T, 1997, J BIOCHEM-TOKYO, V121, P197; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146; Osborne John D, 2007, Methods Mol Biol, V377, P223; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pan JP, 2001, IMMUNOL LETT, V76, P153, DOI 10.1016/S0165-2478(01)00183-3; Parnet P, 2002, J NEUROIMMUNOL, V125, P5, DOI 10.1016/S0165-5728(02)00022-X; RINEHART JJ, 1974, J CLIN INVEST, V54, P1337, DOI 10.1172/JCI107880; Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567; Ryu J, 2007, CARDIOVASC RES, V75, P555, DOI 10.1016/j.cardiores.2007.04.027; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V5, P925; Savoysky E, 1996, BIOCHEM BIOPH RES CO, V226, P329, DOI 10.1006/bbrc.1996.1356; SCHEDLOWSKI M, 1993, NEUROPSYCHOBIOLOGY, V28, P87, DOI 10.1159/000119006; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheela DR, 1993, NEUROIMMUNOL, V42, P193; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Skjoaas KA, 2000, VET IMMUNOL IMMUNOP, V87, P79; Starkie RL, 2005, BRAIN BEHAV IMMUN, V19, P404, DOI 10.1016/j.bbi.2005.03.005; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; [唐已婷 Tang Yiting], 2002, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V25, P23; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Wang AJ, 1996, ACTA PHYSL SIN, V48, P348; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Woiciechowsky C, 1999, J MOL MED-JMM, V77, P769, DOI 10.1007/s001099900051; YOUNG W, 1992, J NEUROTRAUMA S1, V9, P9; Zhao X, 2003, LAB ANIMAIL SCI MANA, V20, P6	91	27	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e57621	10.1371/journal.pone.0057621	http://dx.doi.org/10.1371/journal.pone.0057621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544040	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700003
J	Meineke, EK; Dunn, RR; Sexton, JO; Frank, SD				Meineke, Emily K.; Dunn, Robert R.; Sexton, Joseph O.; Frank, Steven D.			Urban Warming Drives Insect Pest Abundance on Street Trees	PLOS ONE			English	Article							NATURAL ENEMIES; LAND-USE; TEMPERATURE; WATER; HOMOPTERA; PLANT; SIZE; URBANIZATION; CONSEQUENCES; RESPONSES	Cities profoundly alter biological communities, favoring some species over others, though the mechanisms that govern these changes are largely unknown. Herbivorous arthropod Pests are often more abundant in urban than in rural areas,. and urban outbreaks have been attributed to reduced control by predators and parasitoids and to increased susceptibility of stressed urban plants. These hypotheses, however, leave many outbreaks unexplained and fail to predict variation in pest abundance within cities. Here we show that the abundance of a common insect pest is positively related to temperature even when controlling for other habitat characteristics The scale insect Parthenolecanium quercifex was 13 times more abundant on willow oak trees in the hottest parts of Raleigh, NC, in the southeastern United States, than in cooler areas, though parasitism rates were similar. We further separated the effects of heat from those of natural enemies and plant quality in a greenhouse reciprocal transplant experiment. P. quercifex collected from hot urban trees became more abundant in hot greenhouses than in cool greenhouses, whereas the abundance of P. quercifex collected from cooler urban trees remained low in hot and cool greenhouses. Parthenolecanium quercifex living in urban hot spots succeed with warming, and they do so because some demes have either acclimatized or adapted to high temperatures. Our results provide the first evidence that heat can be a key driver of insect pest outbreaks on urban trees. Since urban warming is similar in magnitude to global warming predicted in the next 50 years, pest abundance on city trees may foreshadow widespread outbreaks as natural forests also grow warmer.	[Meineke, Emily K.; Frank, Steven D.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Dunn, Robert R.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Sexton, Joseph O.] Univ Maryland, Dept Geog, College Pk, MD 20742 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University System of Maryland; University of Maryland College Park	Meineke, EK (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	ekmeinek@ncsu.edu		Dunn, Robert/0000-0002-6030-4837	USGS Southeast Regional Climate Science Center; NASA [ROSES-NNX09AK22G]; NSF [0953390]; USDA Southern Region IPM [2010-02678]; North Carolina Nursery and Landscape Association; Horticultural Research Institute; USDA; NCSU Department of Entomology; EPA STAR Fellowship	USGS Southeast Regional Climate Science Center; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); USDA Southern Region IPM; North Carolina Nursery and Landscape Association; Horticultural Research Institute; USDA(United States Department of Agriculture (USDA)); NCSU Department of Entomology; EPA STAR Fellowship(United States Environmental Protection Agency)	This work was supported by a grant from the USGS Southeast Regional Climate Science Center to RRD and SDF. RRD was also supported by NASA Biodiversity Grant (ROSES-NNX09AK22G) and an NSF Career grant (0953390). SDF was also supported by grants from USDA Southern Region IPM (2010-02678), North Carolina Nursery and Landscape Association, the Horticultural Research Institute, and the USDA IR-4 Project. EKM was also funded by the NCSU Department of Entomology and an EPA STAR Fellowship. (URLs: http://www.epa.gov/ncer/fellow/; http://ir4.rutgers.edu; http://www.doi.gov/csc/southeast/index.cfm; http://cce.nasa.gov/cce/biodiversity.htm; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 503214; http://www.cals.ncsu.edu/entomology/; http://www.csrees.usda.gov/funding/rfas/ipm_southern.html; http://www.hriresearch.org; http://www.ncnla.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTAD DN, 1990, EVOL ECOL, V4, P43, DOI 10.1007/BF02270714; Angilletta MJ, 2009, BIO HABIT, P35; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Ben-Dov Y, 1997, SOFT SCALE INSECTS T; Bennett AB, 2012, LANDSCAPE URBAN PLAN, V104, P26, DOI 10.1016/j.landurbplan.2011.09.007; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; EDMUNDS GF, 1978, SCIENCE, V199, P941, DOI 10.1126/science.199.4332.941; Ernsting G, 2000, AM NAT, V155, P804, DOI 10.1086/303361; Fluckiger W, 1999, ACTA HORTIC, P325; Gibbs M, 2010, J INSECT PHYSIOL, V56, P1275, DOI 10.1016/j.jinsphys.2010.04.009; Gomes V, 2011, BIODIVERS CONSERV, V20, P3577, DOI 10.1007/s10531-011-0149-2; Green DM, 2009, POPUL ECOL, V51, P253, DOI 10.1007/s10144-008-0131-3; Gregg BM, 2001, J ARBORICULT, V27, P8; Gullan PJ, 1997, ANN REV ENTOMOLOGY, V42; HANKS LM, 1993, ECOLOGY, V74, P1081, DOI 10.2307/1940478; HANKS LM, 1994, ECOLOGY, V75, P2301, DOI 10.2307/1940885; Hart M, 2009, THEOR APPL CLIMATOL, V95, P397, DOI 10.1007/s00704-008-0017-5; Hodkinson ID, 2006, GLOBAL CHANGE BIOL, V12, P1308, DOI 10.1111/j.1365-2486.2006.01155.x; Howard L, 1833, CLIMATE LONDON DEDUC; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Jenerette GD, 2011, ECOL APPL, V21, P2637, DOI 10.1890/10-1493.1; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Koricheva J, 1998, ANNU REV ENTOMOL, V43, P195, DOI 10.1146/annurev.ento.43.1.195; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Macfadyen S, 2009, AGR ECOSYST ENVIRON, V133, P14, DOI 10.1016/j.agee.2009.04.012; Mattson W.J., 1987, P365; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; OKE TR, 1973, ATMOS ENVIRON, V7, P769, DOI 10.1016/0004-6981(73)90140-6; Preisser EL, 2008, ECOL ENTOMOL, V33, P709, DOI 10.1111/j.1365-2311.2008.01021.x; Putnam J., 1880, P DAVENPORT ACAD SCI, V2, P293; Rank NE, 2002, EVOLUTION, V56, P2278, DOI 10.1111/j.0014-3820.2002.tb00151.x; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; San Martin y Gomez G, 2012, OECOLOGIA, V169; Schnitzler FR, 2011, ECOL ENTOMOL, V36, P241, DOI 10.1111/j.1365-2311.2011.01266.x; SCHULTZ PB, 1984, ENVIRON ENTOMOL, V13, P1515, DOI 10.1093/ee/13.6.1515; Speight MR, 1998, ECOLOGY, V79, P1503, DOI 10.1890/0012-9658(1998)079[1503:HCSPRH]2.0.CO;2; Steigenga MJ, 2007, ENTOMOL EXP APPL, V125, P195, DOI 10.1111/j.1570-7458.2007.00610.x; WIERSUM LK, 1983, PLANT SOIL, V75, P443, DOI 10.1007/BF02369978	40	132	143	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59687	10.1371/journal.pone.0059687	http://dx.doi.org/10.1371/journal.pone.0059687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544087	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700047
J	Pincheira-Donoso, D; Bauer, AM; Meiri, S; Uetz, P				Pincheira-Donoso, Daniel; Bauer, Aaron M.; Meiri, Shai; Uetz, Peter			Global Taxonomic Diversity of Living Reptiles	PLOS ONE			English	Article							LIZARD GENUS LIOLAEMUS; BODY-SIZE; PHYLOGENETIC-RELATIONSHIPS; ECOLOGICAL OPPORTUNITY; MITOCHONDRIAL GENOMES; DIVERSIFICATION; EVOLUTION; EXTINCTION; SPECIATION; RADIATION	Reptiles are one of the most ecologically and evolutionarily remarkable groups of living organisms, having successfully colonized most of the planet, including the oceans and some of the harshest and more environmentally unstable ecosystems on earth. Here, based on a complete dataset of all the world's diversity of living reptiles, we analyse lineage taxonomic richness both within and among clades, at different levels of the phylogenetic hierarchy. We also analyse the historical tendencies in the descriptions of new reptile species from Linnaeus to March 2012. Although (non-avian) reptiles are the second most species-rich group of amniotes after birds, most of their diversity (96.3%) is concentrated in squamates (59% lizards, 35% snakes, and 2% amphisbaenians). In strong contrast, turtles (3.4%), crocodilians (0.3%), and tuataras (0.01%) are far less diverse. In terms of species discoveries, most turtles and crocodilians were described early, while descriptions of lizards, snakes and amphisbaenians are multimodal with respect to time. Lizard descriptions, in particular, have reached unprecedented levels during the last decade. Finally, despite such remarkably asymmetric distributions of reptile taxonomic diversity among groups, we found that the distributions of lineage richness are consistently right-skewed, with most clades (monophyletic families and genera) containing few lineages (monophyletic genera and species, respectively), while only a few have radiated greatly (notably the families Colubridae and Scincidae, and the lizard genera Anolis and Liolaemus). Therefore, such consistency in the frequency distribution of richness among clades and among phylogenetic levels suggests that the nature of reptile biodiversity is fundamentally fractal (i.e., it is scale invariant). We then compared current reptile diversity with the global reptile diversity and taxonomy known in 1980. Despite substantial differences in the taxonomies (relative to 2012), the patterns of lineage richness remain qualitatively identical, hence reinforcing our conclusions about the fractal nature of reptile biodiversity.	[Pincheira-Donoso, Daniel] Lincoln Univ, Sch Life Sci, Lab Evolutionary Ecol Adaptat, Lincoln, England; [Bauer, Aaron M.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Meiri, Shai] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Uetz, Peter] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	University of Lincoln; Villanova University; Tel Aviv University; Virginia Commonwealth University	Pincheira-Donoso, D (corresponding author), Lincoln Univ, Sch Life Sci, Lab Evolutionary Ecol Adaptat, Riseholme Pk, Lincoln, England.	DPincheiraDonoso@lincoln.ac.uk	Uetz, Peter/A-7119-2012; Meiri, Shai/D-2403-2010	Uetz, Peter/0000-0001-6194-4927; Pincheira-Donoso, Daniel/0000-0002-0050-6410; Meiri, Shai/0000-0003-3839-6330				Albino AM, 2008, AMEGHINIANA, V45, P775; Arnold EN, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1430.1.1; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Barraclough TG, 1998, EVOL ECOL, V12, P751; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; BirdLife-International, 2011, BIRDLIFE CHECKL BIRD; Burbrink FT, 2010, EVOLUTION, V64, P934, DOI 10.1111/j.1558-5646.2009.00888.x; Cei JM, 1986, REPTILES CENTRO CENT; Cei Jose M., 1993, Museo Regionale di Scienze Naturali Monografie (Turin), V14, P1; Collen B, 2004, GLOBAL ECOL BIOGEOGR, V13, P459, DOI 10.1111/j.1466-822X.2004.00121.x; Coyne JA, 2004, SPECIATION, V37; Darwin C. S., 1859, ORIGIN SPECIES MEANS; DEQUEIROZ K, 1994, TRENDS ECOL EVOL, V9, P27, DOI 10.1016/0169-5347(94)90231-3; Espinoza RE, 2004, P NATL ACAD SCI USA, V101, P16819, DOI 10.1073/pnas.0401226101; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Fontanella FM, 2012, ZOOL J LINN SOC-LOND, V164, P825, DOI 10.1111/j.1096-3642.2011.00786.x; Fritz SA, 2012, J BIOGEOGR, V39, P1373, DOI 10.1111/j.1365-2699.2012.02757.x; Frost DR, 2011, AMPHIBIAN SPECIES WO; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Galis F, 2001, CHARACTER CONCEPT EV, P583; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Hay JM, 2010, CONSERV GENET, V11, P1063, DOI 10.1007/s10592-009-9952-7; Hedges S.B., 2012, Zootaxa, V3288, P1; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Hubbell Stephen P., 2001, V32, pi; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Ihlow F, 2012, GLOBAL CHANGE BIOL, V18, P1520, DOI 10.1111/j.1365-2486.2011.02623.x; King G.M., 1996, REPTILES HERBIVORY; Kumazawa Y, 2007, GENE, V388, P19, DOI 10.1016/j.gene.2006.09.026; Labra A, 2009, AM NAT, V174, P204, DOI 10.1086/600088; Linnaeus C., 1758, SYSTEMA NATURAE REGN, V1, DOI 10.5962/bhl.title.542; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Lourenco JM, 2012, MOL PHYLOGENET EVOL, V62, P496, DOI 10.1016/j.ympev.2011.10.022; Mayr E., 1963, ANIMAL SPECIES EVOLU; Meiri S, 2008, GLOBAL ECOL BIOGEOGR, V17, P724, DOI 10.1111/j.1466-8238.2008.00414.x; Nicholson KE, 2012, ZOOTAXA, P1; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nunn C. L., 2011, COMP APPROACH EVOLUT; Okajima Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-141; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; Pincheira-Donoso D., 2005, PUBLICACION OCASIONA, V59, P1; Pincheira-Donoso Daniel, 2008, Zootaxa, V1800, P1; Pincheira-Donoso D, 2013, GLOBAL ECOL BIOGEOGR, V22, P857, DOI 10.1111/geb.12052; Pincheira-Donoso D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028942; Pincheira-Donoso D, 2011, EVOL BIOL, V38, P197, DOI 10.1007/s11692-011-9118-7; Pincheira-Donoso D, 2009, ECOL RES, V24, P1223, DOI 10.1007/s11284-009-0607-4; Pincheira-Donoso D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-68; Pough FH, 2004, HERPETOLOGY; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Rasmussen AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027373; Reed RN, 2002, GLOBAL ECOL BIOGEOGR, V11, P41, DOI 10.1046/j.1466-822X.2002.00260.x; Reeder DeeAnn M., 2007, Occasional Papers Museum of Texas Tech University, V269, P1; Reisz RR, 1997, TRENDS ECOL EVOL, V12, P218, DOI 10.1016/S0169-5347(97)01060-4; Ribas CC, 2007, P ROY SOC B-BIOL SCI, V274, P2399, DOI 10.1098/rspb.2007.0613; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; ROSS CA, 1990, P BIOL SOC WASH, V103, P955; SAVAGE J M, 1989, Amphibia-Reptilia, V10, P105, DOI 10.1163/156853889X00142; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schmitz A, 2003, CR PALEVOL, V2, P703, DOI 10.1016/j.crpv.2003.07.002; Schulte JA, 2000, BIOL J LINN SOC, V69, P75, DOI 10.1006/bijl.1999.0346; Schulte JA, 2004, J EVOLUTION BIOL, V17, P408, DOI 10.1046/j.1420-9101.2003.00659.x; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Shine R, 1988, BIOL REPTILIA, V16, P276; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Sumida S. S., 1997, AMNIOTE ORIGINS COMP; Thomas GH, 2008, GLOBAL ECOL BIOGEOGR, V17, P340, DOI 10.1111/j.1466-8238.2008.00384.x; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Townsend TM, 2011, MOL PHYLOGENET EVOL, V61, P363, DOI 10.1016/j.ympev.2011.07.008; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Uetz P., 2012, REPTILE DATABASE; Uetz P, 2010, ZOOTAXA, P59, DOI 10.11646/zootaxa.2334.1.3; Uetz Peter, 2000, Herpetological Review, V31, P13; Vitt LJ, 2009, HERPETOLOGY; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; Wilson DE, 1993, MAMMAL SPECIES WORLD; Wood PL, 2012, MOL PHYLOGENET EVOL, V65, P992, DOI 10.1016/j.ympev.2012.08.025; Zhang M, 2011, MOL PHYLOGENET EVOL, V60, P62, DOI 10.1016/j.ympev.2011.03.029	82	95	106	3	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59741	10.1371/journal.pone.0059741	http://dx.doi.org/10.1371/journal.pone.0059741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544091	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700051
J	Sato, T; Arai, E; Kohno, T; Tsuta, K; Watanabe, S; Soejima, K; Betsuyaku, T; Kanai, Y				Sato, Takashi; Arai, Eri; Kohno, Takashi; Tsuta, Koji; Watanabe, Shun-ichi; Soejima, Kenzo; Betsuyaku, Tomoko; Kanai, Yae			DNA Methylation Profiles at Precancerous Stages Associated with Recurrence of Lung Adenocarcinoma	PLOS ONE			English	Article							CANCER; HYPERMETHYLATION; IDENTIFICATION; DISRUPTION; CARCINOMAS; MUTATIONS; APOPTOSIS; GENES	The aim of this study was to clarify the significance of DNA methylation alterations at precancerous stages of lung adenocarcinoma. Using single-CpG resolution lnfinium array, genome-wide DNA methylation analysis was performed in 36 samples of normal lung tissue obtained from patients without any primary lung tumor, 145 samples of non-cancerous lung tissue (N) obtained from patients with lung adenocarcinomas, and 145 samples of tumorous tissue (T). Stepwise progression of DNA methylation alterations from normal lung tissue to non-cancerous lung tissue obtained from patients with lung adenocarcinomas, and then tumorous tissue samples, was observed at 3,270 CpG sites, suggesting that non-cancerous lung tissue obtained from patients with lung adenocarcinomas was at precancerous stages with DNA methylation alterations. At CpG sites of 2,083 genes, DNA methylation status in samples of non-cancerous lung tissue obtained from patients with lung adenocarcinomas was significantly correlated with recurrence after establishment of lung adenocarcinomas. Among such recurrence-related genes, 28 genes are normally unmethylated (average beta-values based on lnfinium assay in normal lung tissue samples was less than 0.2) and their DNA hypermethylation at precancerous stages was strengthened during progression to lung adenocarcinomas (Delta beta(T-N)>0.1). Among these 28 genes, we focused on 6 for which implications in transcription regulation, apoptosis or cell adhesion had been reported. DNA hypermethylation of the ADCY5, EVX1, GFRA1, PDE9A, and TBX20 genes resulted in reduced mRNA expression in tumorous tissue samples. 5-Aza-2'-deoxycytidine treatment of lung cancer cell lines restored the mRNA expression levels of these 5 genes. Reduced mRNA expression in tumorous tissue samples was significantly correlated with tumor aggressiveness. These data suggest that DNA methylation alterations at precancerous stages determine tumor aggressiveness and outcome through silencing of specific genes.	[Sato, Takashi; Arai, Eri; Kanai, Yae] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan; [Sato, Takashi; Soejima, Kenzo; Betsuyaku, Tomoko] Keio Univ, Sch Med, Dept Med, Div Pulm Med, Tokyo 160, Japan; [Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan; [Tsuta, Koji] Natl Canc Ctr, Dept Pathol & Clin Labs, Div Pathol, Tokyo, Japan; [Watanabe, Shun-ichi] Natl Canc Ctr, Thorac Surg Div, Dept Thorac Oncol, Tokyo, Japan	National Cancer Center - Japan; Keio University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Arai, E (corresponding author), Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan.	earai@ncc.go.jp	Kanai, Yae/AAE-6987-2019; Soejima, Kenzo/T-9878-2019	Soejima, Kenzo/0000-0001-9749-995X; Sato, Takashi/0000-0002-2338-1665	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio) [10-42]; Ministry of Health, Labor and Welfare of Japan; National Cancer Center Research and Development Fund [23-A-11]; Japan Society for the Promotion of Science (JSPS) [233900 90, 23790456]; National Cancer Center Research and Development Fund, Japan [23-A-1]; Foundation for Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research [23390096, 23790456] Funding Source: KAKEN	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Center Research and Development Fund, Japan; Foundation for Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio, 10-42, http://www.nibio.go.jp/part/promote/fundamental/doc/index.html) and partially supported by a Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan (2, http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin-koubo14/09.html), National Cancer Center Research and Development Fund (23-A-11, http://www.ncc.go.jp/jp/about/rinri/kaihatsu/files/h24_ncc_research_list.pdf), and Grants-in-Aid for Scientific Research (B, 233900 90, http://www.jsps.go.jp/j-grantsinaid/) and for Young Scientists (B, 23790456, http://www.jsps.go.jp/j-grantsinaid/) from the Japan Society for the Promotion of Science (JSPS). National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund (23-A-1, http://www.ncc.go.jp/jp/about/rinri/kaihatsu/files/h24_ncc_research_list.pdf), Japan. T. Sato is an awardee of a research resident fellowship from the Foundation for Promotion of Cancer Research in Japan (http://www.fpcr.or.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai E, 2006, INT J CANCER, V119, P288, DOI 10.1002/ijc.21807; Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Arai E, 2009, CARCINOGENESIS, V30, P214, DOI 10.1093/carcin/bgn268; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bralten LBC, 2010, ONCOGENE, V29, P6138, DOI 10.1038/onc.2010.342; BRIATA P, 1995, J BIOL CHEM, V270, P27695, DOI 10.1074/jbc.270.46.27695; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Carvalho RH, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-9; Chakraborty S, 2012, DEV BIOL, V363, P234, DOI 10.1016/j.ydbio.2011.12.034; de Fraipont F, 2012, CLIN CANCER RES, V18, P2976, DOI 10.1158/1078-0432.CCR-11-2797; Dietrich D, 2012, DIAGN MOL PATHOL, V21, P93, DOI 10.1097/PDM.0b013e318240503b; Eguchi K, 1997, CANCER RES, V57, P4913; Fisher DA, 1998, J BIOL CHEM, V273, P15559, DOI 10.1074/jbc.273.25.15559; Greulich Heidi, 2010, Genes Cancer, V1, P1200, DOI 10.1177/1947601911407324; Hamilton JP, 2011, DIGEST DIS, V29, P130, DOI 10.1159/000323874; Heller G, 2010, CANCER METAST REV, V29, P95, DOI 10.1007/s10555-010-9203-x; Kadara H, 2012, RESPIROLOGY, V17, P50, DOI 10.1111/j.1440-1843.2011.02095.x; Kanai Y, 2008, PATHOL INT, V58, P544, DOI 10.1111/j.1440-1827.2008.02270.x; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; Kanai Y, 2010, CANCER SCI, V101, P36, DOI 10.1111/j.1349-7006.2009.01383.x; Kuang SQ, 2008, LEUKEMIA, V22, P1529, DOI 10.1038/leu.2008.130; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; Lockwood WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037775; Moran A, 2012, INT J ONCOL, V40, P739, DOI 10.3892/ijo.2011.1253; NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Okumura S, 2007, CIRCULATION, V116, P1776, DOI 10.1161/CIRCULATIONAHA.107.698662; Omura Noriyuki, 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P7; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Sambrook J, 1989, MOL CLONING LAB MANU, pE3; Saravani R, 2012, CELL PROLIFERAT, V45, P199, DOI 10.1111/j.1365-2184.2012.00819.x; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Sinclair PB, 2011, HUM MOL GENET, V20, P2591, DOI 10.1093/hmg/ddr159; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Travis WD, 2004, WHO CLASSIFICATION T, P35; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Truong M, 2012, BRIT J CANCER, V107, P100, DOI 10.1038/bjc.2012.216; Verri C, 2009, AM J RESP CRIT CARE, V179, P396, DOI 10.1164/rccm.200807-1153OC; Wu DG, 2012, LUNG CANCER, V76, P106, DOI 10.1016/j.lungcan.2011.09.005; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Zochbauer-Muller S, 2003, INT J CANCER, V107, P612, DOI 10.1002/ijc.11458	43	41	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59444	10.1371/journal.pone.0059444	http://dx.doi.org/10.1371/journal.pone.0059444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544068	gold, Green Published, Green Submitted			2022-12-25	WOS:000317480700029
J	Vidal-Dupiol, J; Zoccola, D; Tambutte, E; Grunau, C; Cosseau, C; Smith, KM; Freitag, M; Dheilly, NM; Allemand, D; Tambutte, S				Vidal-Dupiol, Jeremie; Zoccola, Didier; Tambutte, Eric; Grunau, Christoph; Cosseau, Celine; Smith, Kristina M.; Freitag, Michael; Dheilly, Nolwenn M.; Allemand, Denis; Tambutte, Sylvie			Genes Related to Ion-Transport and Energy Production Are Upregulated in Response to CO2-Driven pH Decrease in Corals: New Insights from Transcriptome Analysis	PLOS ONE			English	Article							OCEAN ACIDIFICATION; SEAWATER ACIDIFICATION; SCLERACTINIAN CORALS; EXPRESSION PATTERNS; MOLECULAR-CLONING; CARBONIC-ACID; SEA-ANEMONE; CALCIFICATION; STRESS; LOCALIZATION	Since the preindustrial era, the average surface ocean pH has declined by 0.1 pH units and is predicted to decline by an additional 0.3 units by the year 2100. Although subtle, this decreasing pH has profound effects on the seawater saturation state of carbonate minerals and is thus predicted to impact on calcifying organisms. Among these are the scleractinian corals, which are the main builders of tropical coral reefs. Several recent studies have evaluated the physiological impact of low pH, particularly in relation to coral growth and calcification. However, very few studies have focused on the impact of low pH at the global molecular level. In this context we investigated global transcriptomic modifications in a scleractinian coral (Pocillopora damicornis) exposed to pH 7.4 compared to pH 8.1 during a 3-week period. The RNAseq approach shows that 16% of our transcriptome was affected by the treatment with 6% of upregulations and 10% of downregulations. A more detailed analysis suggests that the downregulations are less coordinated than the upregulations and allowed the identification of several biological functions of interest. In order to better understand the links between these functions and the pH, transcript abundance of 48 candidate genes was quantified by q-RT-PCR (corals exposed at pH 7.2 and 7.8 for 3 weeks). The combined results of these two approaches suggest that pH >= 7.4 induces an upregulation of genes coding for proteins involved in calcium and carbonate transport, conversion of CO2 into HCO3- and organic matrix that may sustain calcification. Concomitantly, genes coding for heterotrophic and autotrophic related proteins are upregulated. This can reflect that low pH may increase the coral energy requirements, leading to an increase of energetic metabolism with the mobilization of energy reserves. In addition, the uncoordinated downregulations measured can reflect a general trade-off mechanism that may enable energy reallocation.	[Vidal-Dupiol, Jeremie; Zoccola, Didier; Tambutte, Eric; Allemand, Denis; Tambutte, Sylvie] Ctr Sci Monaco, Monaco, Monaco; [Grunau, Christoph; Cosseau, Celine; Dheilly, Nolwenn M.] Univ Perpignan Via Domitia, Ecol & Evolut Interact UMR 5244, Perpignan, France; [Grunau, Christoph; Cosseau, Celine; Dheilly, Nolwenn M.] CNRS, Ecol & Evolut Interact UMR 5244, Perpignan, France; [Smith, Kristina M.; Freitag, Michael] Oregon State Univ, Dept Biochem & Biophys, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Oregon State University	Vidal-Dupiol, J (corresponding author), Ctr Sci Monaco, Monaco, Monaco.	jeremie.vidal-dupiol@univ-perp.fr	Dheilly, Nolwenn/AAU-9185-2020; Cosseau, Celine/G-8240-2011; Vidal-Dupiol, Jérémie/B-3165-2010; Zoccola, Didier/A-5997-2009; Dheilly, Nolwenn Marie M/A-7213-2011; Vidal-Dupiol, Jeremie/ABG-8874-2020; Grunau, Christoph/A-6989-2010	Dheilly, Nolwenn/0000-0002-3675-5013; Zoccola, Didier/0000-0002-1524-8098; Dheilly, Nolwenn Marie M/0000-0002-3675-5013; Vidal-Dupiol, Jeremie/0000-0002-0577-2953; Grunau, Christoph/0000-0002-2161-412X	American Cancer Society [RSG-08-030-01-CCG]; OSU Computational and Genome Biology Initiative; Centre Scientifique de Monaco (CSM)	American Cancer Society(American Cancer Society); OSU Computational and Genome Biology Initiative; Centre Scientifique de Monaco (CSM)	This work was supported by funds from the American Cancer Society (RSG-08-030-01-CCG) and start-up funds from the OSU Computational and Genome Biology Initiative. JV-D's postdoctoral fellowship was supported by the Centre Scientifique de Monaco (CSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Bertucci A, 2011, MAR BIOTECHNOL, V13, P992, DOI 10.1007/s10126-011-9363-x; Bluthgen N, 2004, GENE ONTOLOGY; Brulle F, 2007, COMP BIOCHEM PHYS C, V144, P334, DOI 10.1016/j.cbpc.2006.10.007; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Dickinson GH, 2012, J EXP BIOL, V215, P29, DOI 10.1242/jeb.061481; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dupont S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029568; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Fox S, 2010, PLANT SYSTEMS BIOL, P79; Franssen SU, 2011, P NATL ACAD SCI USA, V108, P19276, DOI 10.1073/pnas.1107680108; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Gagliano M, 2010, MAR BIOL, V157, P1849, DOI 10.1007/s00227-010-1456-y; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hashimoto K, 2004, CORAL REEFS, V23, P485, DOI 10.1007/s00338-004-0410-1; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Houlbreque F, 2012, CORAL REEFS, V31, P101, DOI 10.1007/s00338-011-0819-2; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Huning A, 2013, MAR BIOL, V160, P1845, DOI 10.1007/s00227-012-1930-9; Iguchi A, 2012, MAR ENVIRON RES, V73, P32, DOI 10.1016/j.marenvres.2011.10.008; Inoue M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047786; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Leclercq N, 2002, LIMNOL OCEANOGR, V47, P558, DOI 10.4319/lo.2002.47.2.0558; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033679; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; McCulloch M, 2012, NAT CLIM CHANG; McCulloch M, 2012, GEOCHIM COSMOCHIM AC, V87, P21, DOI 10.1016/j.gca.2012.03.027; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Moya A, 2008, J BIOL CHEM, V283, P25475, DOI 10.1074/jbc.M804726200; Moya A, 2008, COMP BIOCHEM PHYS A, V151, P29, DOI 10.1016/j.cbpa.2008.05.009; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Pati A, 2011, STAND GENOMIC SCI, V5, P248, DOI 10.4056/sigs.2075298; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Pomraning KR, 2012, FUNGAL SECONDARY MET; Pomraning KR, 2009, METHODS, V47, P142, DOI 10.1016/j.ymeth.2008.09.022; Reyes-Bermudez A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-178; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Robinson JL, 2011, PHYSIOL BIOCHEM ZOOL, V84, P363, DOI 10.1086/660162; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Romano SL, 2000, B MAR SCI, V67, P1043; Runcie DE, 2012, MOL ECOL, V21, P4547, DOI 10.1111/j.1365-294X.2012.05717.x; Sabourault C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-333; Santos IR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046053; Schulz M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-18; Seo J, 2004, J BIOCHEM MOL BIOL, V37, P35; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P320, DOI 10.1016/j.cbpa.2011.06.023; Su JG, 2009, FISH SHELLFISH IMMUN, V27, P33, DOI 10.1016/j.fsi.2009.02.016; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Towanda T, 2012, BIOL OPEN, V1, P615, DOI 10.1242/bio.2012521; Traylor-Knowles N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-585; van Heuven S., 2009, MATLAB PROGRAM DEV C; Venn A, P NATL ACAD IN PRESS; Venn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020013; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vidal-Dupiol J, 2011, J EXP BIOL, V214, P1533, DOI 10.1242/jeb.053165; Wang B, 2006, MAR BIOTECHNOL, V8, P491, DOI 10.1007/s10126-005-6136-4; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-453; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wilkinson C., 2008, STATUS CORAL REEFS W; Wong KKW, 2011, COMP BIOCHEM PHYS D, V6, P310, DOI 10.1016/j.cbd.2011.07.001; Zerbino D, 2010, USING VELVET DE NOVO, P1; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zippay ML, 2010, J SHELLFISH RES, V29, P429, DOI 10.2983/035.029.0220; Zoccola D, 2004, BBA-BIOMEMBRANES, V1663, P117, DOI 10.1016/j.bbamem.2004.02.010; Zoccola D, 2009, MAR BIOTECHNOL, V11, P260, DOI 10.1007/s10126-008-9141-6	96	106	108	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58652	10.1371/journal.pone.0058652	http://dx.doi.org/10.1371/journal.pone.0058652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544045	Green Published, gold, Green Submitted			2022-12-25	WOS:000317480700008
J	Bandyopadhyay, K; Li, PC; Gjerset, RA				Bandyopadhyay, Keya; Li, Pingchuan; Gjerset, Ruth A.			The p14ARF Alternate Reading Frame Protein Enhances DNA Binding of Topoisomerase I by Interacting with the Serine 506-Phosphorylated Core Domain	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR P53; KINASE CK2 ACTIVITY; ILLEGITIMATE RECOMBINATION; P53-DEPENDENT APOPTOSIS; P14(ARF) EXPRESSION; RELAXATION ACTIVITY; CASEIN KINASE-2; COLON-CANCER; PHOSPHORYLATION	In addition to its well-characterized function as a tumor suppressor, p14ARF (ARF) is a positive regulator of topoisomerase I (topo I), a central enzyme in DNA metabolism and a target for cancer therapy. We previously showed that topo I hyperphosphorylation, a cancer-associated event mediated by elevated levels of the protein kinase CK2, increases topo I activity and the cellular sensitivity to topo I-targeted drugs. Topo I hyperphosphorylation also increases its interaction with ARF. Because the ARF-topo I interaction could be highly relevant to DNA metabolism and cancer treatment, we identified the regions of topo I involved in ARF binding and characterized the effects of ARF binding on topo I function. Using a series of topo I deletion constructs, we found that ARF interacted with the topo I core domain, which encompasses most of the catalytic and DNA-interacting residues. ARF binding increased the DNA relaxation activity of hyperphosphorylated topo I by enhancing its association with DNA, but did not affect the topo I catalytic rate. In cells, ARF promoted the chromatin association of hyperphosphorylated, but not basal phosphorylated, topo I, and increased topo I-mediated DNA nicking under conditions of oxidative stress. The aberrant nicking was found to correlate with increased formation of DNA double-strand breaks, which are precursors of many genome destabilizing events. The results suggest that the convergent actions of oxidative stress and elevated CK2 and ARF levels, which are common features of cancer cells, lead to a dysregulation of topo I that may contribute both to the cellular response to topo I-targeted drugs and to genome instability.	[Bandyopadhyay, Keya; Li, Pingchuan; Gjerset, Ruth A.] Torrey Pines Inst Mol Studies San Diego, San Diego, CA 92121 USA		Gjerset, RA (corresponding author), Torrey Pines Inst Mol Studies San Diego, San Diego, CA 92121 USA.	rgjerset@tpims.org			United States National Institutes of Health/National Cancer Institute [CA111868, CA135369]; NATIONAL CANCER INSTITUTE [R01CA135369, R01CA111868] Funding Source: NIH RePORTER	United States National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the United States National Institutes of Health/National Cancer Institute (CA111868 and CA135369); http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RD, 1994, MUTAT RES-FUND MOL M, V309, P109, DOI 10.1016/0027-5107(94)90048-5; Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Arlt MF, 2010, DNA REPAIR, V9, P678, DOI 10.1016/j.dnarep.2010.03.005; Ayrault O, 2006, ONCOGENE, V25, P7577, DOI 10.1038/sj.onc.1209743; Bandyopadhyay K, 2007, BIOCHEMISTRY-US, V46, P14325, DOI 10.1021/bi7013618; Bandyopadhyay K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050427; Bandyopadhyay K, 2011, BIOCHEMISTRY-US, V50, P704, DOI 10.1021/bi101110e; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Burri N, 2001, LAB INVEST, V81, P217, DOI 10.1038/labinvest.3780230; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chowdhury AR, 2002, BIOCHEM J, V366, P653, DOI 10.1042/BJ20020098; CODERONI S, 1990, MOL BIOL REP, V14, P35, DOI 10.1007/BF00422713; DAYAMAKIN M, 1994, CANCER RES, V54, P2262; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Faust RA, 1999, INT J BIOCHEM CELL B, V31, P941, DOI 10.1016/S1357-2725(99)00050-3; Faust RA, 1996, CANCER LETT, V101, P31, DOI 10.1016/0304-3835(96)04110-9; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Hackbarth JS, 2008, J BIOL CHEM, V283, P16711, DOI 10.1074/jbc.M802246200; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; KAISERMAN HB, 1988, BIOCHEMISTRY-US, V27, P3216, DOI 10.1021/bi00409a014; Karayan L, 2001, ONCOGENE, V20, P836, DOI 10.1038/sj.onc.1204170; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Larsen A K, 1999, Pathol Oncol Res, V5, P171, DOI 10.1053/paor.1999.0209; Lee M, 2006, PATHOL RES PRACT, V202, P415, DOI 10.1016/j.prp.2005.11.011; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; LIU LF, 1983, J BIOL CHEM, V258, P5365; Martinez EJ, 1999, P NATL ACAD SCI USA, V96, P3496, DOI 10.1073/pnas.96.7.3496; MCCONAUGHY BL, 1981, BIOCHIM BIOPHYS ACTA, V655, P1, DOI 10.1016/0005-2787(81)90059-9; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Mounawar M, 2007, CANCER RES, V67, P5667, DOI 10.1158/0008-5472.CAN-06-4229; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Olivier A, 2003, ONCOGENE, V22, P1945, DOI 10.1038/sj.onc.1206214; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; POMMIER Y, 1990, J BIOL CHEM, V265, P9418; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Rada B, 2011, MUCOSAL IMMUNOL, V4, P158, DOI 10.1038/mi.2010.62; Radfar A, 1998, P NATL ACAD SCI USA, V95, P13194, DOI 10.1073/pnas.95.22.13194; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Redinbo MR, 2000, BIOCHEMISTRY-US, V39, P6832, DOI 10.1021/bi992690t; Reikhardt B A, 2003, Neurosci Behav Physiol, V33, P799, DOI 10.1023/A:1025101516128; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; SAMUELS DS, 1989, FEBS LETT, V259, P57, DOI 10.1016/0014-5793(89)81493-0; Sanchez-Aguilera A, 2002, BLOOD, V99, P1411, DOI 10.1182/blood.V99.4.1411; Sano T, 2000, PATHOL INT, V50, P709, DOI 10.1046/j.1440-1827.2000.01109.x; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; SHUMAN S, 1989, P NATL ACAD SCI USA, V86, P3489, DOI 10.1073/pnas.86.10.3489; Soe K, 2001, NUCLEIC ACIDS RES, V29, P3195, DOI 10.1093/nar/29.15.3195; STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; TSAO YP, 1993, CANCER RES, V53, P5908; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vestey SB, 2004, BREAST CANCER RES, V6, pR571, DOI 10.1186/bcr912; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; YENICE S, 1994, PROSTATE, V24, P11, DOI 10.1002/pros.2990240105; Zhu J, 1996, MOL CELL BIOL, V16, P1805; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100	64	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58835	10.1371/journal.pone.0058835	http://dx.doi.org/10.1371/journal.pone.0058835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555599	gold, Green Submitted, Green Published			2022-12-25	WOS:000317418500017
J	Proverbio, AM; Vanutelli, ME; Adorni, R				Proverbio, Alice Mado; Vanutelli, Maria Elide; Adorni, Roberta			Can You Catch a Liar? How Negative Emotions Affect Brain Responses when Lying or Telling the Truth	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; DECEPTIVE RESPONSES; EXECUTIVE PROCESSES; WORKING-MEMORY; REACTION-TIME; CONFLICT; ACTIVATION; ATTENTION; PAIN	The capacity to deceive others is a complex mental skill that requires the ability to suppress truthful information. The polygraph is widely used in countries such as the USA to detect deception. However, little is known about the effects of emotional processes (such as the fear of being found guilty despite being innocent) on the physiological responses that are used to detect lies. The aim of this study was to investigate the time course and neural correlates of untruthful behavior by analyzing electrocortical indexes in response to visually presented neutral and affective questions. Affective questions included sexual, shameful or disgusting topics. A total of 296 questions that were inherently true or false were presented to 25 subjects while ERPs were recorded from 128 scalp sites. Subjects were asked to lie on half of the questions and to answer truthfully on the remaining half. Behavioral and ERP responses indicated an increased need for executive control functions, namely working memory, inhibition and task switching processes, during deceptive responses. Deceptive responses also elicited a more negative N400 over the prefrontal areas and a smaller late positivity (LP 550-750 ms) over the prefrontal and frontal areas. However, a reduction in LP amplitude was also elicited by truthful affective responses. The failure to observe a difference in LP responses across conditions likely results from emotional interference. A swLORETA inverse solution was computed on the N400 amplitude (300-400 ms) for the dishonest - honest contrast. These results showed the activation of the superior, medial, middle and inferior frontal gyri (BA9, 11, 47) and the anterior cingulate cortex during deceptive responses. Our results conclude that the N400 amplitude is a reliable neural marker of deception.	[Proverbio, Alice Mado; Vanutelli, Maria Elide; Adorni, Roberta] Univ Milano Bicocca, Dept Psychol, Milan, Italy	University of Milano-Bicocca	Proverbio, AM (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	mado.proverbio@unimib.it	Adorni, Roberta/GMW-9037-2022	Adorni, Roberta/0000-0002-2851-8376; Proverbio, Alice Mado/0000-0002-5138-1523; Vanutelli, Maria Elide/0000-0001-9349-1707	University of Milano-Bicocca; "Dote ricercatori": FSE,Fondo Sociale Europeo (European Social Fund), Regione Lombardia	University of Milano-Bicocca; "Dote ricercatori": FSE,Fondo Sociale Europeo (European Social Fund), Regione Lombardia	This research was supported by a FAR2011 grant from the University of Milano-Bicocca to AMP. AR was supported in part by "Dote ricercatori": FSE,Fondo Sociale Europeo (European Social Fund), Regione Lombardia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2007, J COGNITIVE NEUROSCI, V19, P287, DOI 10.1162/jocn.2007.19.2.287; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Christ SE, 2009, CEREB CORTEX, V19, P1557, DOI 10.1093/cercor/bhn189; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Ding XP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048639; Dong GH, 2010, NEUROSCI LETT, V479, P1, DOI 10.1016/j.neulet.2010.05.014; Doucet C, 1999, PSYCHOPHYSIOLOGY, V36, P351, DOI 10.1017/S0048577299980563; Egner T., 2011, FRONT PSYCHOL, V2, P1; EKMAN P, 1991, AM PSYCHOL, V46, P913, DOI 10.1037/0003-066X.46.9.913; Foland LC, 2008, PSYCHIAT RES-NEUROIM, V162, P27, DOI 10.1016/j.pscychresns.2007.04.007; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Harnsberger JD, 2009, J FORENSIC SCI, V54, P642, DOI 10.1111/j.1556-4029.2009.01026.x; Hu XQ, 2011, BRAIN RES, V1369, P149, DOI 10.1016/j.brainres.2010.10.106; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Johnson R, 2004, NEUROPSYCHOLOGIA, V42, P878, DOI 10.1016/j.neuropsychologia.2003.12.005; Johnson R, 2003, BIOL PSYCHOL, V64, P217, DOI 10.1016/j.biopsycho.2003.07.006; Johnson R, 2008, NEUROIMAGE, V39, P469, DOI 10.1016/j.neuroimage.2007.08.032; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lamm C, 2010, J COGNITIVE NEUROSCI, V22, P362, DOI 10.1162/jocn.2009.21186; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Langleben DD, 2005, HUM BRAIN MAPP, V26, P262, DOI 10.1002/hbm.20191; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee TMC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012291; Lee TMC, 2009, BRAIN COGNITION, V69, P406, DOI 10.1016/j.bandc.2008.09.002; Liu X, 2008, J COGNITIVE NEUROSCI, V20, P1711, DOI 10.1162/jocn.2008.20116; Luu P, 2000, J NEUROSCI, V20, P464, DOI 10.1523/JNEUROSCI.20-01-00464.2000; Mak AKY, 2009, NEUROSCI LETT, V457, P101, DOI 10.1016/j.neulet.2009.03.094; Malcolm SR, 2005, LATERALITY, V10, P103, DOI 10.1080/13576500442000274; Marshall L, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-23; Meijer EH, 2009, APPL PSYCHOPHYS BIOF, V34, P221, DOI 10.1007/s10484-009-9099-9; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Notebaert L, 2011, EMOTION, V11, P81, DOI 10.1037/a0021286; Nunez JM, 2005, NEUROIMAGE, V25, P267, DOI 10.1016/j.neuroimage.2004.10.041; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Priori A, 2008, CEREB CORTEX, V18, P451, DOI 10.1093/cercor/bhm088; Proverbio AM, 2009, NEUROPSYCHOLOGIA, V47, P2374, DOI 10.1016/j.neuropsychologia.2008.10.030; Rosenfeld JP, 1999, INT J PSYCHOPHYSIOL, V33, P3, DOI 10.1016/S0167-8760(99)00021-5; Ruff CC, 2001, NEUROIMAGE, V14, P1150, DOI 10.1006/nimg.2001.0893; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Spence SA, 2004, PHILOS T R SOC B, V359, P1755, DOI 10.1098/rstb.2004.1555; Tu S, 2009, BRAIN RES, V1247, P142, DOI 10.1016/j.brainres.2008.09.090; van Veen V, 2006, CURR DIR PSYCHOL SCI, V15, P237, DOI 10.1111/j.1467-8721.2006.00443.x; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2	52	12	13	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e59383	10.1371/journal.pone.0059383	http://dx.doi.org/10.1371/journal.pone.0059383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123NP	23536874	gold, Green Published, Green Submitted			2022-12-25	WOS:000317397200022
J	Genchev, GZ; Kobayashi, T; Lu, H				Genchev, Georgi Z.; Kobayashi, Tomoyoshi; Lu, Hui			Calcium Induced Regulation of Skeletal Troponin - Computational Insights from Molecular Dynamics Simulations	PLOS ONE			English	Article							THIN-FILAMENTS; CA2+ BINDING; ANGSTROM RESOLUTION; MUSCLE-CONTRACTION; STRUCTURAL BASIS; ACTIN-FILAMENTS; TERMINAL DOMAIN; N-DOMAIN; CALMODULIN; PROTEINS	The interaction between calcium and the regulatory site(s) of striated muscle regulatory protein troponin switches on and off muscle contraction. In skeletal troponin binding of calcium to sites I and II of the TnC subunit results in a set of structural changes in the troponin complex, displaces tropomyosin along the actin filament and allows myosin-actin interaction to produce mechanical force. In this study, we used molecular dynamics simulations to characterize the calcium dependent dynamics of the fast skeletal troponin molecule and its TnC subunit in the calcium saturated and depleted states. We focused on the N-lobe and on describing the atomic level events that take place subsequent to removal of the calcium ion from the regulatory sites I and II. A main structural event - a closure of the A/B helix hydrophobic pocket results from the integrated effect of the following conformational changes: the breakage of H-bond interactions between the backbone nitrogen atoms of the residues at positions 2, 9 and sidechain oxygen atoms of the residue at position 12 (N-2-OE12/N-9-OE12) in sites I and II; expansion of sites I and II and increased site II N-terminal end-segment flexibility; strengthening of the beta-sheet scaffold; and the subsequent re-packing of the N-lobe hydrophobic residues. Additionally, the calcium release allows the N-lobe to rotate relative to the rest of the Tn molecule. Based on the findings presented herein we propose a novel model of skeletal thin filament regulation.	[Genchev, Georgi Z.; Lu, Hui] Univ Illinois, Dept Bioengn, Bioinformat Program, Chicago, IL 60680 USA; [Kobayashi, Tomoyoshi] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Kobayashi, Tomoyoshi] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60680 USA; [Lu, Hui] Shanghai Childrens Hosp, Shanghai Inst Med Genet, Shanghai 200040, Peoples R China; [Lu, Hui] Minist Hlth, Key Lab Embryo Mol Biol, Shanghai, Peoples R China; [Lu, Hui] Shanghai Lab Embryo & Reprod Engn, Shanghai, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Shanghai Jiao Tong University	Kobayashi, T (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA.	tkoba@uic.edu; huilu@uic.edu	Lu, Hui/K-3264-2019	Lu, Hui/0000-0001-8347-0830	National Science Foundation [TG-MCB090005]; National Institutes of Health U.S.A. [R01HL082923, T32HL007692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082923, T32HL007692] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health U.S.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the National Science Foundation through XSEDE resources provided by TACC-Lonestar (TG-MCB090005), and R01HL082923 and T32HL007692 from the National Institutes of Health U.S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga GM, 2002, ANN MED, V34, P248, DOI 10.1080/078538902320322510; Barkema GT, 1996, PHYS REV LETT, V77, P4358, DOI 10.1103/PhysRevLett.77.4358; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216; CHANDRA M, 1994, J BIOL CHEM, V269, P14988; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Deriu MA, 2012, PROTEINS, V80, P1598, DOI 10.1002/prot.24053; Deriu MA, 2011, J BIOMECH, V44, P630, DOI 10.1016/j.jbiomech.2010.11.014; Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n; Dupuis L, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3671986; Endoh M, 2008, CIRC J, V72, P1915, DOI 10.1253/circj.CJ-08-0838; Ertz-Berger BR, 2005, P NATL ACAD SCI USA, V102, P18219, DOI 10.1073/pnas.0509181102; Evenas J, 1998, BIOCHEMISTRY-US, V37, P13744, DOI 10.1021/bi9806448; Evenas J, 1997, BIOCHEMISTRY-US, V36, P3448, DOI 10.1021/bi9628275; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Fan J, 2012, BIOPHYS J, V103, P1334, DOI 10.1016/j.bpj.2012.08.029; FLICKER PF, 1982, J MOL BIOL, V162, P495, DOI 10.1016/0022-2836(82)90540-X; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Gagne SM, 1997, BIOCHEMISTRY-US, V36, P4386, DOI 10.1021/bi963076+; Grabarek Z, 2005, J MOL BIOL, V346, P1351, DOI 10.1016/j.jmb.2005.01.004; GRABAREK Z, 1990, NATURE, V345, P132, DOI 10.1038/345132a0; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Knowles AC, 2012, J MOL BIOL, V421, P125, DOI 10.1016/j.jmb.2012.05.005; Kobayashi C, 2006, BIOPHYS J, V90, P3043, DOI 10.1529/biophysj.105.078071; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kobayashi T, 2008, PFLUG ARCH EUR J PHY, V457, P37, DOI 10.1007/s00424-008-0511-8; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Li Y, 2000, P NATL ACAD SCI USA, V97, P5140, DOI 10.1073/pnas.090098997; Lindert S, 2012, J PHYS CHEM B, V116, P8449, DOI 10.1021/jp212173f; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Paakkonen K, 1998, J BIOL CHEM, V273, P15633, DOI 10.1074/jbc.273.25.15633; Paul DM, 2009, J BIOL CHEM, V284, P15007, DOI 10.1074/jbc.M808615200; Pearlstone JR, 2000, J BIOL CHEM, V275, P35106, DOI 10.1074/jbc.M001000200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; Project E, 2006, BIOPHYS J, V90, P3842, DOI 10.1529/biophysj.105.077792; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Strynadka NCJ, 1997, J MOL BIOL, V273, P238, DOI 10.1006/jmbi.1997.1257; Varughese JF, 2011, J BIOMOL STRUCT DYN, V29, P123, DOI 10.1080/07391102.2011.10507378; Varughese JF, 2010, J BIOMOL STRUCT DYN, V28, P159, DOI 10.1080/07391102.2010.10507350; Vigil D, 2001, BIOPHYS J, V80, P2082, DOI 10.1016/S0006-3495(01)76182-6; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102	55	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58313	10.1371/journal.pone.0058313	http://dx.doi.org/10.1371/journal.pone.0058313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554884	gold, Green Published, Green Submitted			2022-12-25	WOS:000316409800012
J	Tanaka, H; Tanabe, N; Kawato, T; Nakai, K; Kariya, T; Matsumoto, S; Zhao, N; Motohashi, M; Maeno, M				Tanaka, Hideki; Tanabe, Natsuko; Kawato, Takayuki; Nakai, Kumiko; Kariya, Taro; Matsumoto, Sakurako; Zhao, Ning; Motohashi, Masafumi; Maeno, Masao			Nicotine Affects Bone Resorption and Suppresses the Expression of Cathepsin K, MMP-9 and Vacuolar-Type H+-ATPase d2 and Actin Organization in Osteoclasts	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-II; NF-KAPPA-B; CIGARETTE-SMOKING; PERIODONTAL-DISEASE; MATRIX METALLOPROTEINASES; GINGIVAL FIBROBLASTS; GENE-EXPRESSION; RISK-FACTORS; CELLS; SUBUNIT	Tobacco smoking is an important risk factor for the development of several cancers, osteoporosis, and inflammatory diseases such as periodontitis. Nicotine is one of the major components of tobacco. In previous study, we showed that nicotine inhibits mineralized nodule formation by osteoblasts, and the culture medium from osteoblasts containing nicotine and lipopolysaccharide increases osteoclast differentiation. However, the direct effect of nicotine on the differentiation and function of osteoclasts is poorly understood. Thus, we examined the direct effects of nicotine on the expression of nicotine receptors and bone resorption-related enzymes, mineral resorption, actin organization, and bone resorption using RAW264.7 cells and bone marrow cells as osteoclast precursors. Cells were cultured with 10(-5), 10(-4), or 10(-3) M nicotine and/or 50 mu M alpha-bungarotoxin (btx), an 7 nicotine receptor antagonist, in differentiation medium containing the soluble RANKL for up 7 days. 1-5, 7, 9, and 10 nicotine receptors were expressed on RAW264.7 cells. The expression of 7 nicotine receptor was increased by the addition of nicotine. Nicotine suppressed the number of tartrate-resistant acid phosphatase positive multinuclear osteoclasts with large nuclei(>= 10 nuclei), and decreased the planar area of each cell. Nicotine decreased expression of cathepsin K, MMP-9, and V-ATPase d2. Btx inhibited nicotine effects. Nicotine increased CA II expression although decreased the expression of V-ATPase d2 and the distribution of F-actin. Nicotine suppressed the planar area of resorption pit by osteoclasts, but did not affect mineral resorption. These results suggest that nicotine increased the number of osteoclasts with small nuclei, but suppressed the number of osteoclasts with large nuclei. Moreover, nicotine reduced the planar area of resorption pit by suppressing the number of osteoclasts with large nuclei, V-ATPase d2, cathepsin K and MMP-9 expression and actin organization.	[Tanaka, Hideki; Kawato, Takayuki; Motohashi, Masafumi; Maeno, Masao] Nihon Univ, Sch Dent, Dept Oral Hlth Sci, Tokyo 101, Japan; [Tanabe, Natsuko; Zhao, Ning] Nihon Univ, Sch Dent, Dept Biochem, Tokyo 101, Japan; [Tanabe, Natsuko; Kawato, Takayuki; Motohashi, Masafumi; Maeno, Masao] Nihon Univ, Sch Dent, Dent Res Ctr, Div Funct Morphol, Tokyo 101, Japan; [Nakai, Kumiko; Kariya, Taro; Matsumoto, Sakurako] Nihon Univ, Grad Sch Dent, Tokyo, Japan; [Zhao, Ning] Shandong Univ, Sch Dent, Dept Endodont, Jinan 250100, Shandong Provin, Peoples R China	Nihon University; Nihon University; Nihon University; Nihon University; Shandong University	Tanabe, N (corresponding author), Nihon Univ, Sch Dent, Dept Biochem, Tokyo 101, Japan.	tanabe.natsuko@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Japanese Society for the Promotion of Science [21592401]; Strategic Research Base Development Program for Private Universities; MEXT [S1001024]; Promotion and Mutual Aid Corporation for Private Schools of Japan; Sato Fund, Nihon University School of Dentistry	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Base Development Program for Private Universities; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Sato Fund, Nihon University School of Dentistry	The present study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan, to promote multidisciplinary research projects; a Grant-in-Aid for Scientific Research (C) from the Japanese Society for the Promotion of Science (number 21592401); the Strategic Research Base Development Program for Private Universities, subsidized by MEXT, 2010 (S1001024); and the Promotion and Mutual Aid Corporation for Private Schools of Japan. The present study was also supported by the Sato Fund, Nihon University School of Dentistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2000, J PERIODONTOL, V71, P1874, DOI 10.1902/jop.2000.71.12.1874; ALOIA JF, 1985, AM J MED, V78, P95, DOI 10.1016/0002-9343(85)90468-1; Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019; Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; BENOWITZ NL, 1989, ANN INTERN MED, V111, P112, DOI 10.7326/0003-4819-111-2-112; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Chung CH, 2011, LAB INVEST, V91, P732, DOI 10.1038/labinvest.2011.8; CLARKE NG, 1984, ARCH ORAL BIOL, V29, P789, DOI 10.1016/0003-9969(84)90008-6; CLARKE NG, 1981, ORAL SURG ORAL MED O, V52, P577, DOI 10.1016/0030-4220(81)90071-2; DANIELL HW, 1976, ARCH INTERN MED, V136, P298, DOI 10.1001/archinte.136.3.298; David JP, 2001, J CELL PHYSIOL, V188, P89, DOI 10.1002/jcp.1099; Denlinger LC, 1996, J BIOL CHEM, V271, P337, DOI 10.1074/jbc.271.1.337; Fujisaki K, 2007, LIFE SCI, V80, P1311, DOI 10.1016/j.lfs.2006.12.037; Giannopoulou C, 2001, J CLIN PERIODONTOL, V28, P769, DOI 10.1034/j.1600-051X.2001.280808.x; Hapidin H, 2007, J BONE MINER METAB, V25, P93, DOI 10.1007/s00774-006-0733-9; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Johnson GK, 2004, J PERIODONTOL, V75, P196, DOI 10.1902/jop.2004.75.2.196; Katono T, 2006, ACTA BIOCH BIOPH SIN, V38, P874, DOI 10.1111/j.1745-7270.2006.00240.x; Kuwabara A, 2011, J HARD TISSUE BIOL, V20, P247, DOI 10.2485/jhtb.20.247; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li Q, 2011, LIFE SCI, V89, P395, DOI 10.1016/j.lfs.2011.07.008; Liu B, 2003, J ORAL PATHOL MED, V32, P367, DOI 10.1034/j.1600-0714.2003.00126.x; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Margolis DS, 2008, CALCIFIED TISSUE INT, V82, P66, DOI 10.1007/s00223-007-9098-x; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; MERLETTI F, 1989, CANCER RES, V49, P4919; NEHER GH, 1974, TOXICOL APPL PHARM, V27, P253, DOI 10.1016/0041-008X(74)90196-3; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; PAGE RC, 1976, LAB INVEST, V34, P235; Pennypacker B, 2009, BONE, V44, P199, DOI 10.1016/j.bone.2008.08.130; PERKINS KA, 1986, PSYCHOPHARMACOLOGY, V90, P373; Ryder MI, 1998, J PERIODONTAL RES, V33, P359, DOI 10.1111/j.1600-0765.1998.tb02211.x; Schoonderwoert VTG, 2002, MOL MEMBR BIOL, V19, P67, DOI 10.1080/09687680110112910; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Takahashi N, 2003, METH MOLEC MED, V80, P129; Tanaka H, 2006, LIFE SCI, V78, P1733, DOI 10.1016/j.lfs.2005.08.017; Tanaka H, 2005, LIFE SCI, V77, P2273, DOI 10.1016/j.lfs.2005.02.022; Tanigawa S, 2011, J HARD TISSUE BIOL, V20, P195, DOI 10.2485/jhtb.20.195; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tipton DA, 1995, J PERIODONTOL, V66, P1056, DOI 10.1902/jop.1995.66.12.1056; Torrungruang K, 2005, J PERIODONTOL, V76, P566, DOI 10.1902/jop.2005.76.4.566; van der Zanden EP, 2012, NEUROIMMUNOMODULAT, V19, P255, DOI 10.1159/000335185; Voronov I, 2008, BIOCHEM PHARMACOL, V75, P2034, DOI 10.1016/j.bcp.2008.02.025; Voronov I, 2005, BIOCHEM PHARMACOL, V70, P300, DOI 10.1016/j.bcp.2005.04.028; WARR GA, 1973, AM REV RESPIR DIS, V108, P371; Yang DQ, 2012, J BONE MINER RES, V27, P1695, DOI 10.1002/jbmr.1623	49	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59402	10.1371/journal.pone.0059402	http://dx.doi.org/10.1371/journal.pone.0059402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555029	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800087
J	Xanthopoulos, K; Lagoudaki, R; Kontana, A; Kyratsous, C; Panagiotidis, C; Grigoriadis, N; Yiangou, M; Sklaviadis, T				Xanthopoulos, Konstantinos; Lagoudaki, Rosa; Kontana, Anastasia; Kyratsous, Christos; Panagiotidis, Christos; Grigoriadis, Nikolaos; Yiangou, Minas; Sklaviadis, Theodoros			Immunization with Recombinant Prion Protein Leads to Partial Protection in a Murine Model of TSEs through a Novel Mechanism	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; HEAT-SHOCK PROTEINS; MONOCLONAL-ANTIBODIES; LYMPHOTOXIN PATHWAY; MICE; SCRAPIE; DISEASE; DELAYS; REPLICATION	Transmissible spongiform encephalopathies are neurodegenerative diseases, which despite fervent research remain incurable. Immunization approaches have shown great potential at providing protection, however tolerance effects hamper active immunization protocols. In this study we evaluated the antigenic potential of various forms of recombinant murine prion protein and estimated their protective efficacy in a mouse model of prion diseases. One of the forms tested provided a significant elongation of survival interval. The elongation was mediated via an acute depletion of mature follicular dendritic cells, which are associated with propagation of the prion infectious agent in the periphery and in part to the development of humoral immunity against prion protein. This unprecedented result could offer new strategies for protection against transmissible encephalopathies as well as other diseases associated with follicular dendritic cells.	[Xanthopoulos, Konstantinos; Sklaviadis, Theodoros] Aristotle Univ Thessaloniki, Sch Pharm, Pharmacol Lab, GR-54006 Thessaloniki, Greece; [Lagoudaki, Rosa; Grigoriadis, Nikolaos] AHEPA Univ Hosp, Dept Neurol, Lab Expt Neurol & Neuroimmunol, Thessaloniki, Greece; [Kontana, Anastasia; Yiangou, Minas] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece; [Kyratsous, Christos; Panagiotidis, Christos] Aristotle Univ Thessaloniki, Sch Pharm, Cell Biol Lab, GR-54006 Thessaloniki, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Ahepa University Hospital; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Sklaviadis, T (corresponding author), Aristotle Univ Thessaloniki, Sch Pharm, Pharmacol Lab, GR-54006 Thessaloniki, Greece.	sklaviad@pharm.auth.gr	Sklaviadis, Theoodoros/AGK-6763-2022; Dafou, Dimitra/N-6094-2015	Dafou, Dimitra/0000-0003-4170-0612; Panagiotidis, Christos/0000-0001-9683-7320; Sklaviadis, Theodoros/0000-0002-0246-3100	Alexander S. Onassis Public Benefit Foundation; research committee of Aristotle University of Thessaloniki	Alexander S. Onassis Public Benefit Foundation; research committee of Aristotle University of Thessaloniki	This work was partially supported by Alexander S. Onassis Public Benefit Foundation and the research committee of Aristotle University of Thessaloniki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2004, NAT REV IMMUNOL, V4, P725, DOI 10.1038/nri1437; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Beekes M, 2007, FEBS J, V274, P588, DOI 10.1111/j.1742-4658.2007.05631.x; Bremer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007160; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Canello T, 2008, BIOCHEMISTRY-US, V47, P8866, DOI 10.1021/bi800801f; Castro-Seoane R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002538; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DINTZIS RZ, 1983, J IMMUNOL, V131, P2196; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Falara V, 2008, PLANT MOL BIOL, V68, P633, DOI 10.1007/s11103-008-9399-0; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Goni F, 2008, NEUROSCIENCE, V153, P679, DOI 10.1016/j.neuroscience.2008.02.051; Goni F, 2005, NEUROSCIENCE, V133, P413, DOI 10.1016/j.neuroscience.2005.02.031; Gonzalez SF, 2009, CURR OPIN IMMUNOL, V21, P251, DOI 10.1016/j.coi.2009.05.013; Heikenwalder M, 2008, IMMUNITY, V29, P998, DOI 10.1016/j.immuni.2008.10.014; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Ishibashi D, 2007, VACCINE, V25, P985, DOI 10.1016/j.vaccine.2006.09.078; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Koller MF, 2002, J NEUROIMMUNOL, V132, P113, DOI 10.1016/S0165-5728(02)00316-8; Kyratsous CA, 2009, GENE, V440, P9, DOI 10.1016/j.gene.2009.03.011; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2003, J VIROL, V77, P6845, DOI 10.1128/JVI.77.12.6845-6854.2003; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Mabbott NA, 2002, J VIROL, V76, P5131, DOI 10.1128/JVI.76.10.5131-5139.2002; Magri G, 2005, VACCINE, V23, P2862, DOI 10.1016/j.vaccine.2004.11.067; Mok SWF, 2012, J IMMUNOL, V188, P5032, DOI 10.4049/jimmunol.1200349; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; O'Connor T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002867; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Polymenidou M, 2004, P NATL ACAD SCI USA, V101, P14670, DOI 10.1073/pnas.0404772101; Polymenidou M, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-23; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sachsamanoglou M, 2004, J NEUROIMMUNOL, V146, P22, DOI 10.1016/j.jneuroim.2003.09.018; Sambrook J., 2002, MOL CLONING LAB MANU; Sigurdsson EM, 2003, NEUROSCI LETT, V336, P185, DOI 10.1016/S0304-3940(02)01192-8; Sigurdsson EM, 2002, AM J PATHOL, V161, P13, DOI 10.1016/S0002-9440(10)64151-X; Song CH, 2008, J GEN VIROL, V89, P1533, DOI 10.1099/vir.0.83578-0; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Srivastava PK, 2001, VACCINE, V19, P2590, DOI 10.1016/S0264-410X(00)00492-8; van Nierop K, 2002, SEMIN IMMUNOL, V14, P251, DOI 10.1016/S1044-5323(02)00057-X; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; YIANGOU M, 1989, INT ARCH ALLER A IMM, V89, P217, DOI 10.1159/000234949	46	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59143	10.1371/journal.pone.0059143	http://dx.doi.org/10.1371/journal.pone.0059143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554984	Green Published, Green Submitted, gold			2022-12-25	WOS:000316409800061
J	Chiyomaru, T; Yamamura, S; Fukuhara, S; Hidaka, H; Majid, S; Saini, S; Arora, S; Deng, GR; Shahryari, V; Chang, I; Tanaka, Y; Tabatabai, ZL; Enokida, H; Seki, N; Nakagawa, M; Dahiya, R				Chiyomaru, Takeshi; Yamamura, Soichiro; Fukuhara, Shinichiro; Hidaka, Hideo; Majid, Shahana; Saini, Sharanjot; Arora, Sumit; Deng, Guoren; Shahryari, Varahram; Chang, Inik; Tanaka, Yuichiro; Tabatabai, Z. Laura; Enokida, Hideki; Seki, Naohiko; Nakagawa, Masayuki; Dahiya, Rajvir			Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MATRIX-METALLOPROTEINASE TYPE-2; INHIBITS CELL-PROLIFERATION; ENRICHMENT ANALYSIS; INDUCED APOPTOSIS; GENE-EXPRESSION; TARGETING EGFR; INVASION; PROGRESSION; METASTASIS	Genistein has been shown to inhibit cancers both in vitro and in vivo, by altering the expression of several microRNAs (miRNAs). In this study, we focused on tumor suppressor miRNAs regulated by genistein and investigated their function in prostate cancer (PCa) and target pathways. Using miRNA microarray analysis and real-time RT-PCR we observed that miR-574-3p was significantly up-regulated in PCa cells treated with genistein compared with vehicle control. The expression of miR-574-3p was significantly lower in PCa cell lines and clinical PCa tissues compared with normal prostate cells (RWPE-1) and adjacent normal tissues. Low expression level of miR-574-3p was correlated with advanced tumor stage and higher Gleason score in PCa specimens. Re-expression of miR-574-3p in PCa cells significantly inhibited cell proliferation, migration and invasion in vitro and in vivo. miR-574-3p restoration induced apoptosis through reducing Bcl-xL and activating caspase-9 and caspase-3. Using GeneCodis software analysis, several pathways affected by miR-574-3p were identified, such as 'Pathways in cancer', 'Jak-STAT signaling pathway', and 'Wnt signaling pathway'. Luciferase reporter assays demonstrated that miR-574-3p directly binds to the 39 UTR of several target genes (such as RAC1, EGFR and EP300) that are components of 'Pathways in cancer'. Quantitative real-time PCR and Western analysis showed that the mRNA and protein expression levels of the three target genes in PCa cells were markedly down-regulated with miR-574-3p. Loss-of-function studies demonstrated that the three target genes significantly affect cell proliferation, migration and invasion in PCa cell lines. Our results show that genistein up-regulates tumor suppressor miR-574-3p expression targeting several cell signaling pathways. These findings enhance understanding of how genistein regulates with miRNA in PCa.	[Chiyomaru, Takeshi; Yamamura, Soichiro; Fukuhara, Shinichiro; Majid, Shahana; Saini, Sharanjot; Arora, Sumit; Deng, Guoren; Shahryari, Varahram; Chang, Inik; Tanaka, Yuichiro; Dahiya, Rajvir] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA; [Chiyomaru, Takeshi; Yamamura, Soichiro; Fukuhara, Shinichiro; Majid, Shahana; Saini, Sharanjot; Arora, Sumit; Deng, Guoren; Shahryari, Varahram; Chang, Inik; Tanaka, Yuichiro; Tabatabai, Z. Laura; Dahiya, Rajvir] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hidaka, Hideo; Enokida, Hideki; Nakagawa, Masayuki] Kagoshima Univ, Dept Urol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Tabatabai, Z. Laura] San Francisco VA Med Ctr, Dept Pathol, San Francisco, CA USA; [Seki, Naohiko] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Kagoshima University; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Chiba University	Dahiya, R (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA.	rdahiya@urology.ucsf.edu			National Center for Research Resources of the National Institutes of Health [R01CA160079, R01CA138642, T32DK007790]; VA Merit Review; VA Program Project; NATIONAL CANCER INSTITUTE [R01CA138642, R01CA160079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007790] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review(US Department of Veterans Affairs); VA Program Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Center for Research Resources of the National Institutes of Health through Grant Numbers R01CA160079, R01CA138642, T32DK007790 and VA Merit Review and VA Program Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attar RM, 2009, CLIN CANCER RES, V15, P3251, DOI 10.1158/1078-0432.CCR-08-1171; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chan LWC, 2012, CURR TOP MED CHEM, V12, P920; Chen Y, 2011, CANCER PREV RES, V4, P76, DOI 10.1158/1940-6207.CAPR-10-0167; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Chiyomaru T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043812; Cho WCS, 2011, RNA BIOL, V8, P125, DOI 10.4161/rna.8.1.14259; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; de Souza PL, 2010, NUTR REV, V68, P542, DOI 10.1111/j.1753-4887.2010.00314.x; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fuse M, 2012, J HUM GENET IN PRESS; Giles KM, 2011, METHODS MOL BIOL, V676, P147, DOI 10.1007/978-1-60761-863-8_11; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guo YP, 2007, J NUTR BIOCHEM, V18, P408, DOI 10.1016/j.jnutbio.2006.08.006; Huang XK, 2005, CANCER RES, V65, P3470, DOI 10.1158/0008-5472.CAN-04-2807; Katakowski M, 2010, CANCER INVEST, V28, P1024, DOI 10.3109/07357907.2010.512596; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Khan N, 2010, ENDOCR-RELAT CANCER, V17, pR39, DOI 10.1677/ERC-09-0262; Kim YS, 2012, J NUTR BIOCHEM, V23, P691, DOI 10.1016/j.jnutbio.2012.03.002; Kumi-Diaka J, 2000, BIOL CELL, V92, P595, DOI 10.1016/S0248-4900(00)01109-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Li XY, 2001, CANCER RES, V61, P1699; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Li YW, 2004, NEOPLASIA, V6, P354, DOI 10.1593/neo.03478; Li YW, 2002, J NUTR, V132, P3623, DOI 10.1093/jn/132.12.3623; Li YW, 2002, CLIN CANCER RES, V8, P2369; Luedde Tom, 2010, Hepatology, V52, P1164, DOI 10.1002/hep.23854; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nelson CJ, 2008, CANCER, V113, P1097, DOI 10.1002/cncr.23658; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Saramaki OR, 2006, INT J CANCER, V119, P1322, DOI 10.1002/ijc.21976; Shah RB, 2006, PROSTATE, V66, P1437, DOI 10.1002/pros.20460; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Su YY, 2012, INT IMMUNOPHARMACOL, V13, P468, DOI 10.1016/j.intimp.2012.05.016; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tao J, 2012, ONCOL REP, V27, P1967, DOI 10.3892/or.2012.1711; Tatarano S, 2012, INT J ONCOL, V40, P951, DOI 10.3892/ijo.2011.1294; Tatarano S, 2011, INT J ONCOL, V39, P13, DOI 10.3892/ijo.2011.1012; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; Vader P, 2011, ANGIOGENESIS, V14, P457, DOI 10.1007/s10456-011-9229-x; Wang H.X., 2012, TOXICOL IND HEALTH, V1, P1; Xu B, 2012, PROSTATE, V72, P1171, DOI 10.1002/pros.22466; Xu L, 2006, MOL PHARMACOL, V70, P869, DOI 10.1124/mol.106.023861; Yamaguchi G, 2012, BIOCHEM BIOPH RES CO, V420, P411, DOI 10.1016/j.bbrc.2012.03.008; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang YK, 2011, EXP BIOL MED, V236, P714, DOI 10.1258/ebm.2011.010347	55	118	122	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58929	10.1371/journal.pone.0058929	http://dx.doi.org/10.1371/journal.pone.0058929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554959	Green Submitted, Green Published, gold			2022-12-25	WOS:000316252500058
J	Herlihy, SE; Tang, YT; Gomer, RH				Herlihy, Sarah E.; Tang, Yitai; Gomer, Richard H.			A Dictyostelium Secreted Factor Requires a PTEN-Like Phosphatase to Slow Proliferation and Induce Chemorepulsion	PLOS ONE			English	Article							REPRESSES CELL-PROLIFERATION; PROTEIN-KINASE B; PHOSPHATIDYLINOSITOL 3-KINASE; TUMOR-SUPPRESSOR; LEADING-EDGE; CHEMOTAXIS; DISCOIDEUM; SIZE; ACTIVATION; GRADIENTS	In Dictyostelium discoideum, AprA and CfaD are secreted proteins that inhibit cell proliferation. We found that the proliferation of cells lacking CnrN, a phosphatase and tensin homolog (PTEN)-like phosphatase, is not inhibited by exogenous AprA and is increased by exogenous CfaD. The expression of CnrN in cnr (N) over bar cells partially rescues these altered sensitivities, suggesting that CnrN is necessary for the ability of AprA and CfaD to inhibit proliferation. Cells lacking CnrN accumulate normal levels of AprA and CfaD. Like cells lacking AprA and CfaD, cnr (N) over bar cells proliferate faster and reach a higher maximum cell density than wild type cells, tend to be multinucleate, accumulate normal levels of mass and protein per nucleus, and form less viable spores. When cnr (N) over bar cells expressing myc-tagged CnrN are stimulated with a mixture of rAprA and rCfaD, levels of membrane-associated myc-CnrN increase. AprA also causes chemorepulsion of Dictyostelium cells, and CnrN is required for this process. Combined, these results suggest that CnrN functions in a signal transduction pathway downstream of AprA and CfaD mediating some, but not all, of the effects of AprA and CfaD.	[Herlihy, Sarah E.; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Tang, Yitai] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Texas A&M University System; Texas A&M University College Station; Stanford University	Gomer, RH (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	rgomer@tamu.edu		Gomer, Richard/0000-0003-2361-4307; Herlihy, Sarah/0000-0002-1457-211X	National Institutes of Health GM grant [GM074990]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074990] Funding Source: NIH RePORTER	National Institutes of Health GM grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM grant GM074990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bakthavatsalam D, 2008, J CELL SCI, V121, P2473, DOI 10.1242/jcs.026682; Bakthavatsalam D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-44; Bowman RL, 2011, EUKARYOT CELL, V10, P494, DOI 10.1128/EC.00270-10; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; Brock DA, 1999, GENE DEV, V13, P1960, DOI 10.1101/gad.13.15.1960; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Choe JM, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-4; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Furnari FB, 1998, CANCER RES, V58, P5002; Gamer LW, 2003, DEV CELL, V4, P143, DOI 10.1016/S1534-5807(03)00027-3; Gomer R, 2002, J MUSCLE RES CELL M, V23, P809, DOI 10.1023/A:1024487930787; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Huang YE, 2003, MOL BIOL CELL, V14, P1913, DOI 10.1091/mbc.E02-10-0703; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; Muinonen-Martin AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015309; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Novak KD, 1997, J CELL BIOL, V136, P633, DOI 10.1083/jcb.136.3.633; Paramio JM, 1999, ONCOGENE, V18, P7462, DOI 10.1038/sj.onc.1203151; Phillips JE, 2012, P NATL ACAD SCI USA, V109, P10990, DOI 10.1073/pnas.1206350109; Phillips JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021765; Phillips JE, 2010, EUKARYOT CELL, V9, P1557, DOI 10.1128/EC.00121-10; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sen P, 2003, MOL CELL BIOCHEM, V253, P241, DOI 10.1023/A:1026020101379; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Tang YT, 2008, EUKARYOT CELL, V7, P1758, DOI 10.1128/EC.00210-08; Tang Yitai, 2008, Communicative & Integrative Biology, V1, P185; Weng LP, 1999, CANCER RES, V59, P5808; Wessels D, 2007, J CELL SCI, V120, P2517, DOI 10.1242/jcs.010876	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59365	10.1371/journal.pone.0059365	http://dx.doi.org/10.1371/journal.pone.0059365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555023	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500085
J	Gama, JA; Reis, AM; Domingues, I; Mendes-Soares, H; Matos, AM; Dionisio, F				Gama, Joao Alves; Reis, Ana Maria; Domingues, Iolanda; Mendes-Soares, Helena; Matos, Ana Margarida; Dionisio, Francisco			Temperate Bacterial Viruses as Double-Edged Swords in Bacterial Warfare	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; REPRODUCTIVE FITNESS; RIBOSOMAL-PROTEIN; SPITEFUL BEHAVIOR; COMPETITION; EVOLUTION; LYSOGENIZATION; POPULATION; MUTATIONS	It has been argued that bacterial cells may use their temperate viruses as biological weapons. For instance, a few bacterial cells among a population of lysogenic cells could release the virus and kill susceptible non-lysogenic competitors, while their clone mates would be immune. Because viruses replicate inside their victims upon infection, this process would amplify their number in the arena. Sometimes, however, temperate viruses spare recipient cells from death by establishing themselves in a dormant state inside cells. This phenomenon is called lysogenization and, for some viruses such as the lambda virus, the probability of lysogenization increases with the multiplicity of infection. Therefore, the amplification of viruses leads to conflicting predictions about the efficacy of temperate viruses as biological weapons: amplification can increase the relative advantage of clone mates of lysogens but also the likelihood of saving susceptible cells from death, because the probability of lysogenization is higher. To test the usefulness of viruses as biological weapons, we performed competition experiments between lysogenic Escherichia coli cells carrying the lambda virus and susceptible lambda-free E. coli cells, either in a structured or unstructured habitat. In structured and sometimes in unstructured habitats, the lambda virus qualitatively behaved as a "replicating toxin". However, such toxic effect of lambda viruses ceased after a few days of competition. This was due to the fact that many of initially susceptible cells became lysogenic. Massive lysogenization of susceptible cells occurred precisely under the conditions where the amplification of the virus was substantial. From then on, these cells and their descendants became immune to the lambda virus. In conclusion, if at short term bacterial cells may use temperate viruses as biological weapons, after a few days only the classical view of temperate bacterial viruses as parasitic agents prevails.	[Gama, Joao Alves; Domingues, Iolanda; Dionisio, Francisco] Gulbenkian Inst Sci, Oeiras, Portugal; [Gama, Joao Alves; Domingues, Iolanda; Dionisio, Francisco] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1200 Lisbon, Portugal; [Reis, Ana Maria; Dionisio, Francisco] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, P-1200 Lisbon, Portugal; [Reis, Ana Maria; Dionisio, Francisco] Univ Lisbon, Fac Ciencias, Ctr Biodivers Funct & Integrat Genom, P-1200 Lisbon, Portugal; [Mendes-Soares, Helena] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Mendes-Soares, Helena] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Idaho; University of Idaho; Idaho; University of Idaho	Dionisio, F (corresponding author), Gulbenkian Inst Sci, Oeiras, Portugal.	francisco.dionisio@gmail.com	Gama, Joao/T-2905-2019; Dionisio, Francisco/A-2129-2009; Matos, Ana MFP/U-5810-2017; Reis, Ana Maria/P-6419-2015	Gama, Joao/0000-0003-0967-6616; Dionisio, Francisco/0000-0002-3653-1511; Matos, Ana MFP/0000-0002-0160-256X; Reis, Ana Maria/0000-0003-3363-5953; Mendes Soares, Helena/0000-0002-6727-4327	Fundacao para a Ciencia e Tecnologia [SFRH/BD/82375/2011, EXPL/BIA-EVF/1281/2012, PTDC/BIA-BDE/66180/2006, TECH/2007/0001]; TECT-European Science Foundation program	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); TECT-European Science Foundation program	This work was supported by Fundacao para a Ciencia e Tecnologia (http://alfa.fct.mctes.pt/): a Ph.D. fellowship to ILD (SFRH/BD/82375/2011) and projects EXPL/BIA-EVF/1281/2012, PTDC/BIA-BDE/66180/2006 and TECH/2007/0001, as well to the TECT-European Science Foundation program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 1998, TRENDS MICROBIOL, V6, P66, DOI 10.1016/S0966-842X(97)01196-7; Bossi L, 2003, J BACTERIOL, V185, P6467, DOI 10.1128/JB.185.21.6467-6471.2003; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Brown SP, 2006, CURR BIOL, V16, P2048, DOI 10.1016/j.cub.2006.08.089; Brown SP, 2009, PHILOS T R SOC B, V364, P3157, DOI 10.1098/rstb.2009.0055; Brown SP, 2009, EVOL APPL, V2, P32, DOI 10.1111/j.1752-4571.2008.00059.x; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Campbell A. M., 1996, ESCHERICHIA COLI SAL; Casas V, 2011, FUTURE MICROBIOL, V6, P1461, DOI [10.2217/fmb.11.124, 10.2217/FMB.11.124]; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Chumpolkulwong N, 2004, EUR J BIOCHEM, V271, P1127, DOI 10.1111/j.1432-1033.2004.04016.x; d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373; DEATH A, 1993, J BACTERIOL, V175, P1475, DOI 10.1128/JB.175.5.1475-1483.1993; Dionisio F, 2002, GENETICS, V162, P1525; Dionisio F, 2007, EVOL ECOL RES, V9, P1199; DUCKWORTH DH, 1976, BACTERIOL REV, V40, P793, DOI 10.1128/MMBR.40.4.793-802.1976; EDLIN G, 1975, NATURE, V255, P735, DOI 10.1038/255735a0; EDLIN G, 1977, J VIROL, V21, P560, DOI 10.1128/JVI.21.2.560-564.1977; Erickson M, 2009, FEMS MICROBIOL LETT, V294, P37, DOI 10.1111/j.1574-6968.2009.01554.x; Foster KR, 2000, TRENDS ECOL EVOL, V15, P469, DOI 10.1016/S0169-5347(00)01978-9; FRANK SA, 1994, EVOL ECOL, V8, P369, DOI 10.1007/BF01238189; FRIEDMAN DI, 1984, MICROBIOL REV, V48, P299, DOI 10.1128/MMBR.48.4.299-325.1984; Gallet R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-241; Gardner A, 2004, J EVOLUTION BIOL, V17, P1195, DOI 10.1111/j.1420-9101.2004.00775.x; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; GORDON DM, 1992, J GEN MICROBIOL, V138, P17, DOI 10.1099/00221287-138-1-17; Grafen A., 1985, Oxford Surveys in Evolutionary Biology, V2, P28; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HENDRIX RW, 1992, SCIENCE, V258, P1145, DOI 10.1126/science.1439823; Iwasa Y, 1998, EVOL ECOL, V12, P785, DOI 10.1023/A:1006590431483; JIN DJ, 1989, J BACTERIOL, V171, P5229, DOI 10.1128/jb.171.9.5229-5231.1989; Joo J, 2006, P ROY SOC B-BIOL SCI, V273, P1843, DOI 10.1098/rspb.2006.3512; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; KOURILSKY P, 1974, BIOCHIMIE, V56, P1517; LECOCQ JP, 1976, MOL GEN GENET, V145, P53, DOI 10.1007/BF00331557; Li MY, 1998, SCI CHINA SER C, V41, P29, DOI 10.1007/BF02882703; LIN L, 1977, J VIROL, V21, P554, DOI 10.1128/JVI.21.2.554-559.1977; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Pelosi L, 2006, GENETICS, V173, P1851, DOI 10.1534/genetics.105.049619; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Riley MA, 2003, J EVOLUTION BIOL, V16, P690, DOI 10.1046/j.1420-9101.2003.00575.x; Rozsa L, 1999, J PARASITOL, V85, P1032, DOI 10.2307/3285664; Rozsa L, 2000, OIKOS, V91, P396, DOI 10.1034/j.1600-0706.2000.910220.x; Silva RF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002181; SUMMERS WC, 2006, BACTERIOPHAGES, P3; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; Twort FW, 1915, LANCET, V2, P1241, DOI 10.1016/s0140-6736(01)20383-3; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Wiener P, 2000, ECOL LETT, V3, P122, DOI 10.1046/j.1461-0248.2000.00129.x; YATES JL, 1977, P NATL ACAD SCI USA, V74, P689, DOI 10.1073/pnas.74.2.689; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034	55	42	42	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59043	10.1371/journal.pone.0059043	http://dx.doi.org/10.1371/journal.pone.0059043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536852	Green Submitted, Green Published, gold			2022-12-25	WOS:000316251100114
J	Wei, ZF; Tong, B; Xia, YF; Lu, Q; Chou, GX; Wang, ZT; Dai, Y				Wei, Zhi-feng; Tong, Bei; Xia, Yu-feng; Lu, Qian; Chou, Gui-xin; Wang, Zheng-tao; Dai, Yue			Norisoboldine Suppresses Osteoclast Differentiation through Preventing the Accumulation of TRAF6-TAK1 Complexes and Activation of MAPKs/NF-kappa B/c-Fos/NFATc1 Pathways	PLOS ONE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; RECEPTOR ACTIVATOR; BONE-RESORPTION; RADIX LINDERAE; RANKL; MAPK; MACROPHAGES; EXPRESSION; PROTEIN	Norisoboldine (NOR) is the main alkaloid constituent in the dry root of Lindera aggregata (Sims) Kosterm. (L. strychnifolia Vill.). As reported previously, orally administered NOR displayed a robust inhibition of joint bone destruction present in both mouse collagen-induced arthritis and rat adjuvant-induced arthritis with lower efficacious doses than that required for ameliorating systemic inflammation. This attracted us to assess the effects of NOR on differentiation and function of osteoclasts, primary effector cells for inflammatory bone destruction, to get insight into its anti-rheumatoid arthritis mechanisms. Both RAW264.7 cells and mouse bone marrow-derived macrophages (BMMs) were stimulated with RANKL (100 ng/mL) to establish osteoclast differentiation models. ELISA, RT-PCR, gelatin zymography, western blotting, immunoprecipitation and EMSA were used to reveal related signalling pathways. NOR (10 and 30 mu M), without significant cytotoxicity, showed significant reduction of the number of osteoclasts and the resorption pit areas, and it targeted osteoclast differentiation at the early stage. In conjunction with the anti-resorption effect of NOR, mRNA levels of cathepsin K and MMP-9 were decreased, and the activity of MMP-9 was attenuated. Furthermore, our mechanistic studies indicated that NOR obviously suppressed the ubiquitination of TRAF6, the accumulation of TRAF6-TAK1 complexes and the activation of ERK and p38 MAPK, and reduced the nuclear translocation of NF-kappa B-p65 and DNA-binding activity of NF-kappa B. However, NOR had little effect on expressions of TRAF6 or the phosphorylation and degradation of I kappa B alpha. Moreover, NOR markedly inhibited expressions of transcription factor NFATc1, but not c-Fos. Intriguingly, the subsequent nuclear translocations of c-Fos and NFATc1 were substantially down-regulated. Hence, we demonstrated for the first time that preventing the differentiation and function of osteoclasts at the early stage was an important anti-bone destruction mechanism of NOR, which might be attributed to inhibition of ubiquitination of TRAF6, the accumulation of TRAF6-TAK1 complexes and the activation of MAPKs/NF-kappa B/c-Fos/NFATc1 pathways.	[Wei, Zhi-feng; Tong, Bei; Xia, Yu-feng; Lu, Qian; Dai, Yue] China Pharmaceut Univ, State Key Lab Nat Med, Dept Pharmacol Chinese Mat Med, Nanjing, Jiangsu, Peoples R China; [Chou, Gui-xin; Wang, Zheng-tao] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China	China Pharmaceutical University; Shanghai University of Traditional Chinese Medicine	Dai, Y (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Dept Pharmacol Chinese Mat Med, Nanjing, Jiangsu, Peoples R China.	yuedaicpu@hotmail.com	Tong, Bei/HGE-8171-2022; Wang, Zhengtao/AAH-7360-2019	Wang, Zhengtao/0000-0003-2797-4625	Specialized Research Fund for the Doctoral Program of Higher Education [20090096110007]; Innovative Training Plan for Graduate Students of Jiangsu Province [CXLX12_0326]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University [IRT1193]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Innovative Training Plan for Graduate Students of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by Specialized Research Fund for the Doctoral Program of Higher Education (NO. 20090096110007), Innovative Training Plan for Graduate Students of Jiangsu Province (CXLX12_0326) and the Priority Academic Program Development of Jiangsu Higher Education Institutions, and was partially funded by Program for Changjiang Scholars and Innovative Research Team in University (IRT1193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Berthelot JM, 2010, JOINT BONE SPINE, V77, P537, DOI 10.1016/j.jbspin.2010.04.015; Blair HC, 2006, REV ENDOCR METAB DIS, V7, P23, DOI 10.1007/s11154-006-9010-4; Blair JM, 2007, INT J BIOCHEM CELL B, V39, P1077, DOI 10.1016/j.biocel.2006.11.008; Braun T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3380; Broadhead ML, 2011, EXPERT OPIN THER TAR, V15, P169, DOI 10.1517/14728222.2011.546351; Cheng BB, 2012, FOOD CHEM TOXICOL, V50, P1610, DOI 10.1016/j.fct.2012.02.019; Chou Gui-Xin, 2005, Chinese Journal of Natural Medicines, V3, P272; Chou Guixin, 1999, Journal of Plant Resources and Environment, V8, P1; Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; Ishii J, 2008, J CELL BIOCHEM, V105, P896, DOI 10.1002/jcb.21886; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Krens SFG, 2006, FEBS LETT, V580, P4984, DOI 10.1016/j.febslet.2006.08.025; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Lee MS, 2009, J IMMUNOL, V183, P3390, DOI 10.4049/jimmunol.0804314; Lewiecki E Michael, 2009, Curr Rheumatol Rep, V11, P196; Logar DB, 2007, J BONE MINER METAB, V25, P219, DOI 10.1007/s00774-007-0753-0; Luo Y, 2010, PHYTOMEDICINE, V17, P726, DOI 10.1016/j.phymed.2010.01.013; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Ngian GS, 2010, AUST FAM PHYSICIAN, V39, P626; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Okamoto K, 2011, INT IMMUNOPHARMACOL, V11, P543, DOI 10.1016/j.intimp.2010.11.010; Pettit AR, 2006, RHEUMATOLOGY, V45, P1068, DOI 10.1093/rheumatology/kel045; Schett G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2166; Schett G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2110; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Sharp JT, 2010, ARTHRIT CARE RES, V62, P537, DOI 10.1002/acr.20172; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Szekanecz Z, 2007, CURR OPIN RHEUMATOL, V19, P289, DOI 10.1097/BOR.0b013e32805e87ae; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang C, 2007, J ETHNOPHARMACOL, V111, P322, DOI 10.1016/j.jep.2006.11.031; Wei ZF, 2012, J CELL BIOCHEM, V113, P2785, DOI 10.1002/jcb.24156; Wilson TJ, 2008, CANCER RES, V68, P5803, DOI 10.1158/0008-5472.CAN-07-5889; Xu S, 2011, RHEUMATOL INT; Zhao QX, 2010, INT J BIOCHEM CELL B, V42, P576, DOI 10.1016/j.biocel.2009.12.018; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	41	41	46	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59171	10.1371/journal.pone.0059171	http://dx.doi.org/10.1371/journal.pone.0059171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536866	Green Published, gold, Green Submitted			2022-12-25	WOS:000316251100126
J	Whitehorn, J; Chau, TNB; Nguyet, NM; Kien, DTH; Quyen, NTH; Trung, DT; Pang, JX; Wills, B; Chau, NVV; Farrar, J; Hibberd, ML; Khor, CC; Simmons, CP				Whitehorn, James; Tran Nguyen Bich Chau; Nguyen Minh Nguyet; Duong Thi Hue Kien; Nguyen Than Ha Quyen; Dinh The Trung; Pang, Junxiong; Wills, Bridget; Nguyen Van Vinh Chau; Farrar, Jeremy; Hibberd, Martin L.; Khor, Chiea Chuen; Simmons, Cameron P.			Genetic Variants of MICB and PLCE1 and Associations with Non-Severe Dengue	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SHOCK SYNDROME; SUSCEPTIBILITY; INFECTION; FEVER; LOCUS	Background: A recent genome-wide association study (GWAS) identified susceptibility loci for dengue shock syndrome (DSS) at MICB rs3132468 and PLCE1 rs3740360. The aim of this study was to define the extent to which MICB (rs3132468) and PLCE1 (rs3740360) were associated with less severe clinical phenotypes of pediatric and adult dengue. Methods: 3961 laboratory-confirmed dengue cases and 5968 controls were genotyped at MICB rs3132468 and PLCE1 rs3740360. Per-allele odds ratios (OR) with 95% confidence intervals (CI) were calculated for each patient cohort. Pooled analyses were performed for adults and paediatrics respectively using a fixed effects model. Results: Pooled analysis of the paediatric and adult cohorts indicated a significant association between MICB rs3132468 and dengue cases without shock (OR = 1.15; 95% CI: 1.07 -1.24; P = 0.0012). Similarly, pooled analysis of pediatric and adult cohorts indicated a significant association between dengue cases without shock and PLCE1 rs3740360 (OR = 0.92; 95% CI: 0.85 -0.99; P = 0.018). We also note significant association between both SNPs (OR = 1.48; P = 0.0075 for MICB rs3132468 and OR = 0.75, P = 0.041 for PLCE1 rs3740360) and dengue in infants. Discussion: This study confirms that the MICB rs3132468 and PLCE1 rs3740360 risk genotypes are not only associated with DSS, but are also associated with less severe clinical phenotypes of dengue, as well as with dengue in infants. These findings have implications for our understanding of dengue pathogenesis.	[Whitehorn, James] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Whitehorn, James; Tran Nguyen Bich Chau; Nguyen Minh Nguyet; Duong Thi Hue Kien; Nguyen Than Ha Quyen; Dinh The Trung; Wills, Bridget; Farrar, Jeremy; Simmons, Cameron P.] Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam; [Pang, Junxiong; Hibberd, Martin L.; Khor, Chiea Chuen] Genome Inst Singapore, Singapore, Singapore; [Pang, Junxiong; Hibberd, Martin L.; Khor, Chiea Chuen] Natl Univ Singapore, Sch Publ Hlth, Singapore 117548, Singapore; [Wills, Bridget; Farrar, Jeremy; Simmons, Cameron P.] Univ Oxford, Ctr Trop Med, Oxford, England; [Nguyen Van Vinh Chau] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Khor, Chiea Chuen] Natl Univ Singapore, Dept Paediat, Singapore 117548, Singapore; [Khor, Chiea Chuen] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore	University of London; London School of Hygiene & Tropical Medicine; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; University of Oxford; National University of Singapore; National University of Singapore	Whitehorn, J (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1E 7HT, England.	james.whitehorn@lshtm.ac.uk	Simmons, Cameron P/ABA-3896-2021; Pang, Junxiong/AAI-5115-2021; Farrar, Jeremy J./HGA-7610-2022	Simmons, Cameron P/0000-0002-9039-7392; Hibberd, Martin/0000-0001-8587-1849; Farrar, Jeremy/0000-0002-2700-623X; Pang, Junxiong, Vincent/0000-0002-9788-701X; Nguyen, Nguyet/0000-0002-5960-7849; Khor, Chiea Chuen/0000-0002-1128-4729; Whitehorn, James/0000-0003-0789-5954; Wills, Bridget/0000-0001-9086-8804	Wellcome Trust of Great Britain; Genome Institute of Singapore	Wellcome Trust of Great Britain(Wellcome Trust); Genome Institute of Singapore	This work was supported by the Wellcome Trust of Great Britain (www.wellcome.ac.uk) and the Genome Institute of Singapore intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476; Colbert JA, 2007, PEDIATR INFECT DIS J, V26, P850, DOI 10.1097/INF.0b013e3180619692; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Khor CC, 2011, NAT GENET; Khor CC, 2011, HUM MOL GENET, V20, P1864, DOI 10.1093/hmg/ddr060; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Lye DC, 2010, INT J INFECT DIS, V14, pE410, DOI 10.1016/j.ijid.2009.06.026; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Tran NBC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000657; Trung DT, 2010, CURR TOP MICROBIOL, V338, P57, DOI 10.1007/978-3-642-02215-9_5; Vasanwala FF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-212; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; World Health Organization, 2009, DENGUE GUIDELINES DI; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	21	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59067	10.1371/journal.pone.0059067	http://dx.doi.org/10.1371/journal.pone.0059067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536857	Green Published, Green Accepted, gold			2022-12-25	WOS:000316251100118
J	Zhao, QB; Zhou, ZJ; Xu, HB; Chen, S; Xu, F; Fan, WL; Han, L				Zhao, Qingbai; Zhou, Zhijin; Xu, Haibo; Chen, Shi; Xu, Fang; Fan, Wenliang; Han, Lei			Dynamic Neural Network of Insight: A Functional Magnetic Resonance Imaging Study on Solving Chinese 'Chengyu' Riddles	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DEFAULT MODE; AMYGDALA; BRAIN; AHA; CONFLICT; ACTIVATION; SYSTEM; TASK; EEG	The key components of insight include breaking mental sets and forming the novel, task-related associations. The majority of researchers have agreed that the anterior cingulate cortex may mediate processes of breaking ones mental set, while the exact neural correlates of forming novel associations are still debatable. In the present study, we used a paradigm of answer selection to explore brain activations of insight by using event-related functional magnetic resonance imaging during solving Chinese chengyu (in Chinese pinyin) riddles. Based on the participants choice, the trials were classified into the insight and non-insight conditions. Both stimulus-locked and response-locked analyses are conducted to detect the neural activity corresponding to the early and late periods of insight solution, respectively. Our data indicate that the early period of insight solution shows more activation in the middle temporal gyrus, the middle frontal gyrus and the anterior cingulate cortex. These activities might be associated to the extensive semantic processing, as well as detecting and resolving cognitive conflicts. In contrast, the late period of insight solution produced increased activities in the hippocampus and the amygdala, possibly reflecting the forming of novel association and the concomitant Aha feeling. Our study supports the key role of hippocampus in forming novel associations, and indicates a dynamic neural network during insight solution.	[Zhao, Qingbai; Zhou, Zhijin; Chen, Shi; Xu, Fang] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China; [Zhao, Qingbai; Zhou, Zhijin; Chen, Shi; Xu, Fang] Cent China Normal Univ, Sch Psychol, Key Lab Human Dev & Mental Hlth Hubei Prov, Wuhan, Peoples R China; [Xu, Haibo; Fan, Wenliang] Huazhong Univ Sci & Technol, MRI Ctr Union Hosp, Wuhan 430074, Peoples R China; [Han, Lei] Shandong Normal Univ, Sch Psychol, Jinan, Peoples R China	Central China Normal University; Huazhong University of Science & Technology; Shandong Normal University	Zhou, ZJ (corresponding author), Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China.	zhouzj@mail.ccnu.edu.cn; xuhaibo1120@hotmail.com		Fan, Wenliang/0000-0001-8949-6775	National Natural Science Foundation of China [81171386, 30770623]; Social Science and Humanitites Research Youth Foundation Project of the Educational Ministry of china [10YJCXLX065]; Social Science Foundation of Hubei Province; Fundamental Research Funds for Central Universities [CCNU11C01005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Science and Humanitites Research Youth Foundation Project of the Educational Ministry of china; Social Science Foundation of Hubei Province; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (grant 81171386 and 30770623), the Social Science and Humanitites Research Youth Foundation Project of the Educational Ministry of china (grant 10YJCXLX065), and the "Twelfth Five" Plan Project from Social Science Foundation of Hubei Province, as well as by the Fundamental Research Funds for Central Universities (grant CCNU11C01005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2007, BRAIN LANG, V100, P163, DOI 10.1016/j.bandl.2005.10.004; Aziz-Zadeh L, 2009, HUM BRAIN MAPP, V30, P908, DOI 10.1002/hbm.20554; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Barch DM, 2000, J COGNITIVE NEUROSCI, V12, P298, DOI 10.1162/089892900562110; Bink M.L., 2000, REV GEN PSYCHOL, V4, P59, DOI DOI 10.1037/1089-2680.4.1.59; Bowden EM, 2007, METHODS, V42, P87, DOI 10.1016/j.ymeth.2006.11.007; Bowden EM, 2003, PSYCHON B REV, V10, P730, DOI 10.3758/BF03196539; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Cranford EA, 2012, J PROBL SOLVING, V4, P128, DOI 10.7771/1932-6246.1129; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Giora R, 1997, COGN LINGUIST, V8, P183, DOI 10.1515/cogl.1997.8.3.183; Goel V, 2005, CEREB CORTEX, V15, P1170, DOI 10.1093/cercor/bhh217; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Huang FR, 2013, ACTA PSYCHOL SINICA, V45, P36; Jamal NI, 2012, HUM BRAIN MAPP, V33, P235, DOI 10.1002/hbm.21208; Johnson JD, 2008, HIPPOCAMPUS, V18, P975, DOI 10.1002/hipo.20456; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Kershaw TC, 2004, J EXP PSYCHOL LEARN, V30, P3, DOI 10.1037/0278-7393.30.1.3; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Knoblich G, 2001, MEM COGNITION, V29, P1000, DOI 10.3758/BF03195762; Kohler W., 1925, MENTALITY APES; Kounios J, 2008, NEUROPSYCHOLOGIA, V46, P281, DOI 10.1016/j.neuropsychologia.2007.07.013; Kounios J, 2006, PSYCHOL SCI, V17, P882, DOI 10.1111/j.1467-9280.2006.01798.x; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; Luo J, 2004, NEUROREPORT, V15, P2013, DOI 10.1097/00001756-200409150-00004; Luo J, 2003, HIPPOCAMPUS, V13, P316, DOI 10.1002/hipo.10069; Luo J, 2002, HIPPOCAMPUS, V12, P487, DOI 10.1002/hipo.10027; Luo J, 2006, BRAIN RES BULL, V70, P430, DOI 10.1016/j.brainresbull.2006.07.005; [罗劲 Luo Jing], 2004, [心理学报, Acta Psychologica Sinica], V36, P219; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mai XQ, 2004, HUM BRAIN MAPP, V22, P261, DOI 10.1002/hbm.20030; Mashal N, 2008, CORTEX, V44, P848, DOI 10.1016/j.cortex.2007.04.004; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Qiu J, 2008, BRAIN COGNITION, V68, P100, DOI 10.1016/j.bandc.2008.03.004; Qiu J, 2008, EXP BRAIN RES, V186, P629, DOI 10.1007/s00221-008-1270-7; Qiu J, 2006, NEUROREPORT, V17, P679, DOI 10.1097/00001756-200604240-00025; Qiu J, 2010, CORTEX, V46, P397, DOI 10.1016/j.cortex.2009.06.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Redish AD, 2001, BEHAV BRAIN RES, V127, P81, DOI 10.1016/S0166-4328(01)00356-4; Sandkuhler S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001459; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Weisberg RW, 1996, NATURE INSIGHT; Zhang M, 2011, BRAIN RES BULL, V84, P210, DOI 10.1016/j.brainresbull.2011.01.001	47	11	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59351	10.1371/journal.pone.0059351	http://dx.doi.org/10.1371/journal.pone.0059351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	24282623	Green Submitted, gold, Green Published			2022-12-25	WOS:000316409800084
J	Hoffer, ME; Balaban, C; Slade, MD; Tsao, JW; Hoffer, B				Hoffer, Michael E.; Balaban, Carey; Slade, Martin D.; Tsao, Jack W.; Hoffer, Barry			Amelioration of Acute Sequelae of Blast Induced Mild Traumatic Brain Injury by N-Acetyl Cysteine: A Double-Blind, Placebo Controlled Study	PLOS ONE			English	Article							TYMPANIC MEMBRANE; RAT MODEL; NOISE; ACETYLCYSTEINE; RELIABILITY; MECHANISMS; INDUCTION; PRESSURE; PROTECTS; EXPOSURE	Background: Mild traumatic brain injury (mTBI) secondary to blast exposure is the most common battlefield injury in Southwest Asia. There has been little prospective work in the combat setting to test the efficacy of new countermeasures. The goal of this study was to compare the efficacy of N-acetyl cysteine (NAC) versus placebo on the symptoms associated with blast exposure mTBI in a combat setting. Methods: This study was a randomized double blind, placebo-controlled study that was conducted on active duty service members at a forward deployed field hospital in Iraq. All symptomatic U. S. service members who were exposed to significant ordnance blast and who met the criteria for mTBI were offered participation in the study and 81 individuals agreed to participate. Individuals underwent a baseline evaluation and then were randomly assigned to receive either N-acetyl cysteine (NAC) or placebo for seven days. Each subject was re-evaluated at 3 and 7 days. Outcome measures were the presence of the following sequelae of mTBI: dizziness, hearing loss, headache, memory loss, sleep disturbances, and neurocognitive dysfunction. The resolution of these symptoms seven days after the blast exposure was the main outcome measure in this study. Logistic regression on the outcome of 'no day 7 symptoms' indicated that NAC treatment was significantly better than placebo (OR = 3.6, p = 0.006). Secondary analysis revealed subjects receiving NAC within 24 hours of blast had an 86% chance of symptom resolution with no reported side effects versus 42% for those seen early who received placebo. Conclusion: This study, conducted in an active theatre of war, demonstrates that NAC, a safe pharmaceutical countermeasure, has beneficial effects on the severity and resolution of sequelae of blast induced mTBI. This is the first demonstration of an effective short term countermeasure for mTBI. Further work on long term outcomes and the potential use of NAC in civilian mTBI is warranted.	[Hoffer, Michael E.] USN, Med Ctr, Dept Otolaryngol, Spatial Orientat Ctr, San Diego, CA 92152 USA; [Balaban, Carey] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Balaban, Carey] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Balaban, Carey] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA USA; [Balaban, Carey] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Balaban, Carey; Slade, Martin D.] Yale Univ, Dept Internal Med, New Haven, CT USA; [Tsao, Jack W.] USN, Bur Med & Surg, Wounded Ill & Injured Directorate M9, Washington, DC USA; [Hoffer, Barry] Case Western Reserve Univ, Dept Neurosurg, Cleveland, OH 44106 USA	United States Department of Defense; United States Navy; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; United States Department of Defense; United States Navy; Case Western Reserve University	Hoffer, ME (corresponding author), USN, Med Ctr, Dept Otolaryngol, Spatial Orientat Ctr, San Diego, CA 92152 USA.	Michael.hoffer@med.navy.mil	Balaban, Carey/O-6586-2019; Balaban, Carey/I-3467-2017	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844	Department of Defense	Department of Defense(United States Department of Defense)	Supported by the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2011, OTOL NEUROTOL, V32, P1309, DOI 10.1097/MAO.0b013e31822e5bee; Balaban CD, 2012, BRAIN INJUR IN PRESS; Bielefeld EC, 2007, ACTA OTO-LARYNGOL, V127, P914, DOI 10.1080/00016480601110188; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Cuzzocrea S, 2000, BRIT J PHARMACOL, V130, P1219, DOI 10.1038/sj.bjp.0703421; De Vries H, 1996, PHARMACOL REV, V49, P143; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; French L., 2009, CARE COMBAT AMPUTEE, P399; Gabaix X., 2008, FDN POSITIVE NORMATI, P292, DOI [10.1093/acprof:oso/9780195328318.003.0012, DOI 10.1093/ACPROF:OSO/9780195328318.003.0012]; GARTH RJN, 1994, J LARYNGOL OTOL, V108, P925, DOI 10.1017/S0022215100128555; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Hart AM, 2004, NEUROSCIENCE, V125, P91, DOI 10.1016/j.neuroscience.2003.12.040; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; James DJ, 1982, 0482 ARM WEAP RES ES; JENSEN JH, 1993, ACTA OTO-LARYNGOL, V113, P62, DOI 10.3109/00016489309135768; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kopke RD, 2007, HEARING RES, V226, P114, DOI 10.1016/j.heares.2006.10.008; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Marchetti GF, 2008, PHYS THER, V88, P640, DOI 10.2522/ptj.20070130; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Pahan K, 1998, FREE RADICAL BIO MED, V24, P39, DOI 10.1016/S0891-5849(97)00137-8; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Pocock S.J., 2013, CLIN TRIALS PRACTICA; Reitan RM, 1992, TRAIL MAKIGN TEST MA; Ritenour AE, 2008, J TRAUMA, V64, pS174, DOI 10.1097/TA.0b013e318160773e; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Saljo A, 2003, J NEUROTRAUM, V20, P787, DOI 10.1089/089771503767870014; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Santangelo F, 2003, CURR MED CHEM, V10, P2599, DOI 10.2174/0929867033456567; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Stranahan AM, 2009, CURR MED CHEM, V16, P4668, DOI 10.2174/092986709789878292; Strauss E., 1998, COMPENDIUM NEUROPSYC, P447; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tombaugh TN, 1998, COMPENDIUM NEUROPSYC, P481; Tsai SY, 2009, P NATL ACAD SCI USA, V106, P22468, DOI 10.1073/pnas.0909089106; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Wagner S, 2011, ARCH CLIN NEUROPSYCH, V26, P314, DOI 10.1093/arclin/acr024	46	158	162	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54163	10.1371/journal.pone.0054163	http://dx.doi.org/10.1371/journal.pone.0054163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23544123	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500034
J	Park, M; Wetzler, M; Jardetzky, TS; Barron, AE				Park, Minyoung; Wetzler, Modi; Jardetzky, Theodore S.; Barron, Annelise E.			A Readily Applicable Strategy to Convert Peptides to Peptoid-based Therapeutics	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; SIDE-CHAIN; ANTIMICROBIAL PEPTIDES; SCANNING MUTAGENESIS; HIV-1 ENTRY; PROLINE; DESIGN; PROTEIN; RESIDUES; ANALOGS	Incorporation of unnatural amino acids and peptidomimetic residues into therapeutic peptides is highly efficacious and commonly employed, but generally requires laborious trial-and-error approaches. Previously, we demonstrated that C-20 peptide has the potential to be a potential antiviral agent. Herein we report our attempt to improve the biological properties of this peptide by introducing peptidomimetics. Through combined alanine, proline, and sarcosine scans coupled with a competitive fluorescence polarization assay developed for identifying antiviral peptides, we enabled to pinpoint peptoid-tolerant peptide residues within C-20 peptide. The synergistic benefits of combining these (and other) commonly employed methods could lead to a easily applicable strategy for designing and refining therapeutically-attractive peptidomimetics.	[Park, Minyoung] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Wetzler, Modi; Barron, Annelise E.] Stanford Univ, Dept Bioengn, Sch Engn, Stanford, CA 94305 USA; [Wetzler, Modi; Barron, Annelise E.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Jardetzky, Theodore S.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Barron, AE (corresponding author), Stanford Univ, Dept Bioengn, Sch Engn, Stanford, CA 94305 USA.	aebarron@stanford.edu	; Viner, Russell/A-1441-2009; Sovio, Ulla/H-8532-2019	Barron, Annelise/0000-0002-0735-6873; Viner, Russell/0000-0003-3047-2247; Sovio, Ulla/0000-0002-0799-1105; Park, Min Hae/0000-0002-2563-4910	National Institutes of Health [R01-GM61050, R01-AI072666]; Stanford University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University(Stanford University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants (R01-GM61050 to TSJ and R01-AI072666 to AEB) and the Bio-X Interdisciplinary Initiatives Program at Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antosova Z, 2009, TRENDS BIOTECHNOL, V27, P628, DOI 10.1016/j.tibtech.2009.07.009; Armand P, 1998, P NATL ACAD SCI USA, V95, P4309, DOI 10.1073/pnas.95.8.4309; Cantel S, 2008, J ORG CHEM, V73, P5663, DOI 10.1021/jo800142s; Caporale A, 2010, J PEPT SCI, V16, P480, DOI 10.1002/psc.1265; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Culf AS, 2010, MOLECULES, V15, P5282, DOI 10.3390/molecules15085282; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dohm MT, 2011, CURR PHARM DESIGN, V17, P2732; Eggenberger K, 2009, CHEMBIOCHEM, V10, P2504, DOI 10.1002/cbic.200900331; Eyles SJ, 2001, NAT STRUCT BIOL, V8, P380, DOI 10.1038/87524; Hoffmann B, 2006, PROTEIN PEPTIDE LETT, V13, P829, DOI 10.2174/092986606777841299; Isaad AL, 2009, J PEPT SCI, V15, P451, DOI 10.1002/psc.1141; Jagasia R, 2009, J ORG CHEM, V74, P2964, DOI 10.1021/jo802097m; Kodadek T, 2010, NAT CHEM BIOL, V6, P162, DOI 10.1038/nchembio.303; Kondo T, 2011, PLANT CELL PHYSIOL, V52, P30, DOI 10.1093/pcp/pcq146; Lee BC, 2011, ACS CHEM BIOL, V6, P1367, DOI 10.1021/cb200300w; Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n; Nguyen JT, 2000, CHEM BIOL, V7, P463, DOI 10.1016/S1074-5521(00)00130-7; Ni L, 2005, ANTIVIR THER, V10, P833; Otvos Laszlo Jr., 2008, V494, P1, DOI 10.1007/978-1-59745-419-3_1; Park M, 2011, ANAL BIOCHEM, V409, P195, DOI 10.1016/j.ab.2010.10.020; Parthasarathy R, 1995, PROG BIOPHYS MOL BIO, V64, P1, DOI 10.1016/0079-6107(95)00009-7; Punna S, 2004, SYNLETT, P99, DOI 10.1055/s-2003-43375; Reddy MM, 2011, CELL, V144, P132, DOI 10.1016/j.cell.2010.11.054; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Ruijtenbeek R, 2001, CHEMBIOCHEM, V2, P171, DOI 10.1002/1439-7633(20010302)2:3<171::AID-CBIC171>3.0.CO;2-B; Sato AK, 2006, CURR OPIN BIOTECH, V17, P638, DOI 10.1016/j.copbio.2006.10.002; Schulman BA, 1996, NAT STRUCT BIOL, V3, P682, DOI 10.1038/nsb0896-682; Sia SK, 2002, P NATL ACAD SCI USA, V99, P14664, DOI 10.1073/pnas.232566599; Uchida M, 2009, P NATL ACAD SCI USA, V106, P19375, DOI 10.1073/pnas.0906145106; Udugamasooriya DG, 2008, BIOORG MED CHEM LETT, V18, P5892, DOI 10.1016/j.bmcl.2008.07.023; Unciti-Broceta A, 2009, BIOORGAN MED CHEM, V17, P959, DOI 10.1016/j.bmc.2008.02.068; Vagner J, 2008, CURR OPIN CHEM BIOL, V12, P292, DOI 10.1016/j.cbpa.2008.03.009; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang EX, 2003, BIOCHEM BIOPH RES CO, V302, P469, DOI 10.1016/S0006-291X(03)00197-9; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572; Zhu WL, 2007, J PEPT SCI, V13, P529, DOI 10.1002/psc.882; Zhu WL, 2006, BIOCHEMISTRY-US, V45, P13007, DOI 10.1021/bi060487+; Zimmermann J, 2003, J BIOL CHEM, V278, P36810, DOI 10.1074/jbc.M305934200; ZUCKERMANN RN, 1992, J AM CHEM SOC, V114, P10646, DOI 10.1021/ja00052a076; Zuckermann RN, 2009, CURR OPIN MOL THER, V11, P299	44	42	48	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58874	10.1371/journal.pone.0058874	http://dx.doi.org/10.1371/journal.pone.0058874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555603	Green Published, gold, Green Submitted			2022-12-25	WOS:000316546400014
J	Regier, JC; Mitter, C; Zwick, A; Bazinet, AL; Cummings, MP; Kawahara, AY; Sohn, JC; Zwickl, DJ; Cho, S; Davis, DR; Baixeras, J; Brown, J; Parr, C; Weller, S; Lees, DC; Mitter, KT				Regier, Jerome C.; Mitter, Charles; Zwick, Andreas; Bazinet, Adam L.; Cummings, Michael P.; Kawahara, Akito Y.; Sohn, Jae-Cheon; Zwickl, Derrick J.; Cho, Soowon; Davis, Donald R.; Baixeras, Joaquin; Brown, John; Parr, Cynthia; Weller, Susan; Lees, David C.; Mitter, Kim T.			A Large-Scale, Higher-Level, Molecular Phylogenetic Study of the Insect Order Lepidoptera (Moths and Butterflies)	PLOS ONE			English	Article							EVOLUTION; GENE; BOOTSTRAP; TREE; CLASSIFICATION; HOMOLOGIES; SUPPORT	Background: Higher-level relationships within the Lepidoptera, and particularly within the species-rich subclade Ditrysia, are generally not well understood, although recent studies have yielded progress. We present the most comprehensive molecular analysis of lepidopteran phylogeny to date, focusing on relationships among superfamilies. Methodology / Principal Findings: 483 taxa spanning 115 of 124 families were sampled for 19 protein-coding nuclear genes, from which maximum likelihood tree estimates and bootstrap percentages were obtained using GARLI. Assessment of heuristic search effectiveness showed that better trees and higher bootstrap percentages probably remain to be discovered even after 1000 or more search replicates, but further search proved impractical even with grid computing. Other analyses explored the effects of sampling nonsynonymous change only versus partitioned and unpartitioned total nucleotide change; deletion of rogue taxa; and compositional heterogeneity. Relationships among the non-ditrysian lineages previously inferred from morphology were largely confirmed, plus some new ones, with strong support. Robust support was also found for divergences among non-apoditrysian lineages of Ditrysia, but only rarely so within Apoditrysia. Paraphyly for Tineoidea is strongly supported by analysis of nonsynonymous-only signal; conflicting, strong support for tineoid monophyly when synonymous signal was added back is shown to result from compositional heterogeneity. Conclusions / Significance: Support for among-superfamily relationships outside the Apoditrysia is now generally strong. Comparable support is mostly lacking within Apoditrysia, but dramatically increased bootstrap percentages for some nodes after rogue taxon removal, and concordance with other evidence, strongly suggest that our picture of apoditrysian phylogeny is approximately correct. This study highlights the challenge of finding optimal topologies when analyzing hundreds of taxa. It also shows that some nodes get strong support only when analysis is restricted to nonsynonymous change, while total change is necessary for strong support of others. Thus, multiple types of analyses will be necessary to fully resolve lepidopteran phylogeny.	[Regier, Jerome C.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Regier, Jerome C.; Mitter, Charles; Sohn, Jae-Cheon; Mitter, Kim T.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Zwick, Andreas] State Museum Nat Hist, Stuttgart, Germany; [Bazinet, Adam L.; Cummings, Michael P.] Univ Maryland, Lab Mol Evolut, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Kawahara, Akito Y.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Zwickl, Derrick J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Cho, Soowon] Chungbuk Natl Univ, Dept Plant Med, Chonju, South Korea; [Davis, Donald R.] Smithsonian Inst, Dept Entomol, Washington, DC 20560 USA; [Baixeras, Joaquin] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Brown, John] ARS, Systemat Entomol Lab, USDA, Beltsville, MD USA; [Parr, Cynthia] Smithsonian Inst, Encyclopedia Life, Washington, DC 20560 USA; [Weller, Susan] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Lees, David C.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; State University System of Florida; University of Florida; University of Arizona; Chungbuk National University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Valencia; Smithsonian Institution; United States Department of Agriculture (USDA); Smithsonian Institution; University of Minnesota System; University of Minnesota Twin Cities; Natural History Museum London	Regier, JC (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA.	regier@umd.edu; cmitter@umd.edu	Pedraza-Diaz, Susana/HGB-3199-2022; Zwick, Andreas/A-5735-2015; Cho, Soowon/AAF-7890-2019; Bazinet, Adam/H-3182-2019; Lees, David/AAD-7382-2021; Yakovlev, Roman/J-7243-2013; Almela, Joaquin Baixeras/L-1734-2014; Ortega-Mora, Luis-Miguel/F-1470-2016; Pedraza-Diaz, Susana/F-3988-2018	Zwick, Andreas/0000-0002-7532-1752; Almela, Joaquin Baixeras/0000-0002-6092-0496; Regidor Cerrillo, Javier/0000-0001-5831-6970; Katzer, Frank/0000-0001-5902-4136; GARCIA-CULEBRAS, ALICIA/0000-0003-2362-0117; Mezo, Mercedes/0000-0001-8819-453X; Ortega-Mora, Luis-Miguel/0000-0002-4986-6783; Diez-Fuertes, Francisco/0000-0003-2413-9229; Pedraza-Diaz, Susana/0000-0001-9401-6473; Schares, Gereon R. M./0000-0002-3217-289X; Gonzalez-Warleta, Marta/0000-0003-3315-5757; Moore, Dadin/0000-0001-6735-3810	U. S. National Science Foundation's Assembling the Tree of Life program [1042845, 0531626, 0531769]; Division Of Environmental Biology [1042845] Funding Source: National Science Foundation	U. S. National Science Foundation's Assembling the Tree of Life program; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by the U. S. National Science Foundation's Assembling the Tree of Life program, award numbers 1042845, 0531626, and 0531769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Aberer AJ, 2011, IEEE INT C BIOINFORM, P118, DOI 10.1109/BIBM.2011.70; Bazinet A, 2008, DISTRIBUTED GRID COM, P2; Bazinet A. L., 2011, 2011 IEEE International Symposium on Parallel & Distributed Processing, Workshops and Phd Forum, P1896, DOI 10.1109/IPDPS.2011.344; Bazinet AL, 2009, THESIS U MARYLAND US; Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; Cummings MP, 2003, SYST BIOL, V52, P477, DOI 10.1080/10635150390218213; Davi D. R., 1998, SMITHSONIAN CONTRIBU, V597, P1; de Jong Rienk, 2007, Tijdschrift voor Entomologie, V150, P319; DeBry RW, 2000, SYST BIOL, V49, P171; Drummond A. J., 2011, GENEIOUS VERSION 5 4; Epstein Marc E., 2003, Zootaxa, V247, P1; HEDGES SB, 1992, MOL BIOL EVOL, V9, P366; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; Hennig W., 1953, Beitraege zur Entomologie Berlin, V3, P1; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Kaila L, 2011, MOL PHYLOGENET EVOL, V61, P801, DOI 10.1016/j.ympev.2011.08.016; Kawahara AY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005719; Kawahara AY, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-182; KRISTENSEN N P, 1984, Steenstrupia, V10, P141; Kristensen N.P., 1998, HDB ZOOLOGY, V4, P7, DOI 10.1515/9783110804744.7; Kristensen NP, 2012, SYST ENTOMOL, V37, P237, DOI 10.1111/j.1365-3113.2012.00619.x; KRISTENSEN NP, 2003, HDB ZOOLOGY 36, V4; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; MILLER JS, 1991, B AM MUS NAT HIST, V204, P1; MINET J, 1991, ENTOMOL SCAND, V22, P69; MINET J, 1994, ENTOMOL SCAND, V25, P63, DOI 10.1163/187631294X00045; MINET J, 1986, Alexanor, V14, P291; MINET J, 1983, ANN SOC ENTOMOL FR, V19, P175; Mitchell A, 2006, SYST ENTOMOL, V31, P21, DOI 10.1111/j.1365-3113.2005.00306.x; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Myers DS, 2008, GRID COMPUTING FOR BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P71; Powell Jerry A., 1999, Handbuch der Zoologie (Berlin), V4, P403; Rammert U, 1993, THESIS U BIELEFELD G; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Regier JC, 2005, BIOTECHNIQUES, V38, P34, DOI 10.2144/05381BM02; Regier JC, 2008, SYST ENTOMOL, V33, P219, DOI 10.1111/j.1365-3113.2007.00416.x; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Regier JC, 2012, SYST ENTOMOL, V37, P635, DOI 10.1111/j.1365-3113.2012.00641.x; Regier JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035574; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Ripplinger J, 2010, MOL PHYLOGENET EVOL, V56, P642, DOI 10.1016/j.ympev.2010.04.035; Robinson GS, 1993, MONOGRAPHS AUSTR S2; Roe AD, 2009, GENETICS MOL BIOL LE, P1, DOI [10.1201/9781420060201-c1, DOI 10.1201/9781420060201-C1]; Rota J, 2011, SYST ENTOMOL, V36, P317, DOI 10.1111/j.1365-3113.2010.00563.x; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Scoble MJ, 1992, LEPIDOPTERA FORM FUN; Sihvonen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020356; Sohn J-C, 2013, PLOS ONE IN PRESS; Sohn JC, 2012, ZOOTAXA, P1; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Wagner David L., 2001, P249; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; WILKINSON M, 1994, SYST BIOL, V43, P343, DOI 10.2307/2413673; Yamamoto S, 2007, MOL PHYLOGENET EVOL, V44, P711, DOI 10.1016/j.ympev.2006.12.027; Young CJ, 2006, ZOOTAXA, P1; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zwick A., 2006, THESIS AUSTR NATL U; Zwick A, 2008, SYST ENTOMOL, V33, P190, DOI 10.1111/j.1365-3113.2007.00410.x; Zwick A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047450; Zwickl D., 2006, GARLI GENETIC ALGORI	67	222	233	3	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58568	10.1371/journal.pone.0058568	http://dx.doi.org/10.1371/journal.pone.0058568			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23940816	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500031
J	Chakraborty, P; Roy, SK				Chakraborty, Prabuddha; Roy, Shyamal K.			Expression of Estrogen Receptor alpha 36 (ESR36) in the Hamster Ovary throughout the Estrous Cycle: Effects of Gonadotropins	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ER-ALPHA; DIFFERENTIAL REGULATION; TARGETED DISRUPTION; LUTEINIZING-HORMONE; DOWN-REGULATION; MEMBRANE; BETA; VARIANT; MOUSE	Estradiol-17 beta (E) plays an important role in ovarian follicular development. Evidence indicates that some of the effect of E is mediated by the transmembrane estrogen receptor. In this study, we examined the spatio-temporal expression of recently discovered ER alpha 36 (ESR36), a splice variant of Esr1 and a receptor for non-genomic E signaling, in the hamster ovary during the estrous cycle and the role of gonadotropins and ovarian steroid hormones in ESR36 expression. ESR36 expression was high on estrus (D1:0900 h) and declined precipitously by proestrus (D4:0900 h) and remained low up to D4:1600 h. Immunofluorescence findings corroborated immunoblot findings and revealed that ESR36 was expressed only in the cell membrane of both follicular and non-follicular cells, except the oocytes. Ovarian ESR36 was capable of binding to the E-affinity matrix, and have different molecular weight than that of the ESR1 or GPER. Hypophysectomy (Hx) resulted in a marked decline in ESR36 protein levels. FSH and LH, alone or combined, markedly upregulated ESR36 protein in Hx hamsters to the levels observed in D1 hamsters, but neither E nor P had any effect. Inhibition of the gonadotropin surge by phenobarbital treatment on D4:1100 h attenuated ESR36 expression in D1:0900 h ovaries, but the decline was restored by either FSH or LH replacement on D4 afternoon. This is the first report to show that ESR36, which is distinct from ESR1 or GPER is expressed in the plasma membrane of ovarian follicular and non-follicular cells, binds to E and its expression is regulated directly by the gonadotropins. In light of our previous findings, the results suggest that ovarian cells contain at least two distinct membrane estrogen receptors, such as GPER and ESR36, and strongly suggest for a non-genomic action of E regulating ovarian follicular functions.	[Chakraborty, Prabuddha; Roy, Shyamal K.] Univ Nebraska Med Ctr, Dept Cellular Physiol, Omaha, NE USA; [Chakraborty, Prabuddha; Roy, Shyamal K.] Univ Nebraska Med Ctr, Dept Integrat Physiol, Omaha, NE USA; [Roy, Shyamal K.] Univ Nebraska Med Ctr, Dept Obstet & Gynecol, Omaha, NE USA; [Roy, Shyamal K.] Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Roy, SK (corresponding author), Univ Nebraska Med Ctr, Dept Cellular Physiol, Omaha, NE USA.	skroy@unmc.edu			National Institutes of Child Health and Human Development [RO1-HD38468]; Olson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038468] Funding Source: NIH RePORTER	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Olson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was supported by a grant (RO1-HD38468) from the National Institutes of Child Health and Human Development and by the Olson Foundation to S.K.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; BAST JD, 1974, ENDOCRINOLOGY, V94, P1295, DOI 10.1210/endo-94-5-1295; Braun AM, 2004, BIOL REPROD, V71, P146, DOI 10.1095/biolreprod.103.025825; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Drummond AE, 1999, MOL CELL ENDOCRINOL, V151, P57, DOI 10.1016/S0303-7207(99)00038-6; Dupont S, 2000, DEVELOPMENT, V127, P4277; Falkenstein E, 2000, PHARMACOL REV, V52, P513; GREENWALD GS, 1974, ENDOCRINOLOGY, V95, P1282, DOI 10.1210/endo-95-5-1282; GREENWALD GS, 1994, PHYSL REPRODUCTION, V2, P629, DOI DOI 10.1039/C7RA00224F; Ho KJ, 2002, ARTERIOSCL THROM VAS, V22, P1952, DOI 10.1161/01.ATV.0000041200.85946.4A; Kang LG, 2010, J CELL MOL MED, V14, P1485, DOI 10.1111/j.1582-4934.2009.00877.x; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Le Mellay V, 1999, J CELL BIOCHEM, V75, P138, DOI 10.1002/(SICI)1097-4644(19991001)75:1<138::AID-JCB14>3.0.CO;2-I; Levin ER, 2001, J APPL PHYSIOL, V91, P1860, DOI 10.1152/jappl.2001.91.4.1860; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Marquez DC, 2001, ONCOGENE, V20, P5420, DOI 10.1038/sj.onc.1204729; MERK FB, 1972, ENDOCRINOLOGY, V90, P992, DOI 10.1210/endo-90-4-992; MOORE PJ, 1974, AM J ANAT, V139, P37, DOI 10.1002/aja.1001390103; Palter SF, 2001, ENDOCR REV, V22, P389, DOI 10.1210/er.22.3.389; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RICHARDS JS, 1980, PHYSIOL REV, V60, P51, DOI 10.1152/physrev.1980.60.1.51; ROY SK, 1986, J REPROD FERTIL, V78, P201, DOI 10.1530/jrf.0.0780201; ROY SK, 1987, BIOL REPROD, V37, P39, DOI 10.1095/biolreprod37.1.39; ROY SK, 1995, ENDOCRINOLOGY, V136, P4610, DOI 10.1210/en.136.10.4610; Roy SK, 2000, BIOL REPROD, V62, P1858, DOI 10.1095/biolreprod62.6.1858; ROY SK, 1994, MICROSC RES TECHNIQ, V27, P83, DOI 10.1002/jemt.1070270203; Roy SK., 1999, COMP ENDOCRINOLOGY R, P315; Schomberg DW, 1999, ENDOCRINOLOGY, V140, P2733, DOI 10.1210/en.140.6.2733; TESARIK J, 1995, J CLIN ENDOCR METAB, V80, P1438, DOI 10.1210/jc.80.4.1438; Tu BB, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.015; Wang C, 2008, ENDOCRINOLOGY, V149, P4452, DOI 10.1210/en.2008-0441; Wang C, 2007, ENDOCRINOLOGY, V148, P4853, DOI 10.1210/en.2007-0727; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Xu BZ, 2009, HISTOCHEM CELL BIOL, V131, P347, DOI 10.1007/s00418-008-0526-4; Yang PX, 2002, ENDOCRINOLOGY, V143, P2385, DOI 10.1210/en.143.6.2385; Zhang YM, 2004, BIOL REPROD, V70, P1580, DOI 10.1095/biolreprod.103.026898	41	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e58291	10.1371/journal.pone.0058291	http://dx.doi.org/10.1371/journal.pone.0058291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23894315	Green Published, Green Submitted, gold			2022-12-25	WOS:000317263900005
J	Cheng, YC; Hsieh, FY; Chiang, MC; Scotting, PJ; Shih, HY; Lin, SJ; Wu, HL; Lee, HT				Cheng, Yi-Chuan; Hsieh, Fu-Yu; Chiang, Ming-Chang; Scotting, Paul J.; Shih, Hung-Yu; Lin, Sheng-Jia; Wu, Hui-Lan; Lee, Han-Ting			Akt1 Mediates Neuronal Differentiation in Zebrafish via a Reciprocal Interaction with Notch Signaling	PLOS ONE			English	Article							THREONINE PROTEIN-KINASE; IN-VITRO; NERVOUS-SYSTEM; MOLECULAR-CLONING; CELLS; NEUROGENESIS; ACTIVATION; MICE; TRANSCRIPTION; LEUKEMIA	Akt1 is well known for its role in regulating cell proliferation, differentiation, and apoptosis and is implicated in tumors and several neurological disorders. However, the role of Akt1 in neural development has not been well defined. We have isolated zebrafish akt1 and shown that this gene is primarily transcribed in the developing nervous system, and its spatiotemporal expression pattern suggests a role in neural differentiation. Injection of akt1 morpholinos resulted in loss of neuronal precursors with a concomitant increase in post-mitotic neurons, indicating that knockdown of Akt1 is sufficient to cause premature differentiation of neurons. A similar phenotype was observed in embryos deficient for Notch signaling. Both the ligand (deltaA) and the downstream target of Notch (her8a) were downregulated in akt1 morphants, indicating that Akt1 is required for Delta-Notch signaling. Furthermore, akt1 expression was downregulated in Delta-Notch signaling-deficient embryos and could be induced by constitutive activation of Notch signaling. In addition, knockdown of Akt1 was able to nullify the inhibition of neuronal differentiation caused by constitutive activation of Notch signaling. Taken together, these results provide in vivo evidence that Akt1 interacts with Notch signaling reciprocally and provide an explanation of why Akt1 is essential for the inhibition of neuronal differentiation.	[Cheng, Yi-Chuan; Hsieh, Fu-Yu; Shih, Hung-Yu; Lin, Sheng-Jia; Wu, Hui-Lan; Lee, Han-Ting] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Chiang, Ming-Chang] Fu Jen Catholic Univ, Dept Life Sci, New Taipei City, Taiwan; [Scotting, Paul J.] Univ Nottingham, Ctr Genet & Genom, Childrens Brain Tumour Res Ctr, Queens Med Ctr, Nottingham NG7 2RD, England	Chang Gung University; Fu Jen Catholic University; University of Nottingham	Cheng, YC (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	yccheng@mail.cgu.edu.tw	Lin, Sheng-Jia/AGC-3315-2022	Lin, Sheng-Jia/0000-0002-7559-6529; ozturk, nail can/0000-0001-9459-2120; Shih, Hung-Yu/0000-0002-3490-1750	Chang Gung Memorial Hospital [CMRPD170513]; National Science Council of Taiwan [96-2745-B-182-003-URD]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Chang Gung Memorial Hospital (CMRPD170513) and the National Science Council of Taiwan (96-2745-B-182-003-URD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bang OS, 2001, J CELL SCI, V114, P81; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Burke RE, 2007, PHARMACOL THERAPEUT, V114, P261, DOI 10.1016/j.pharmthera.2007.02.002; Calzavara E, 2008, J CELL BIOCHEM, V103, P1405, DOI 10.1002/jcb.21527; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cheng YC, 2000, DEV BRAIN RES, V121, P233, DOI 10.1016/S0165-3806(00)00049-3; Cheng YC, 2004, DEV CELL, V6, P539, DOI 10.1016/S1534-5807(04)00097-8; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Chung PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019394; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; Dottori M, 2008, STEM CELLS, V26, P1146, DOI 10.1634/stemcells.2007-1118; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Jo HS, 2012, EMBO J, V31, P817, DOI 10.1038/emboj.2011.443; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Lai WS, 2006, P NATL ACAD SCI USA, V103, P16906, DOI 10.1073/pnas.0604994103; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Mckenzie G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-10; Namikawa K, 2000, J NEUROSCI, V20, P2875; Oishi K, 2009, P NATL ACAD SCI USA, V106, P13064, DOI 10.1073/pnas.0808400106; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Peng Y, 2004, J BIOL CHEM, V279, P28509, DOI 10.1074/jbc.M402294200; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saji M, 2011, ONCOGENE, V30, P4307, DOI 10.1038/onc.2011.136; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Song J, 2008, FEBS LETT, V582, P1693, DOI 10.1016/j.febslet.2008.04.024; STAAL SP, 1977, P NATL ACAD SCI USA, V74, P3065, DOI 10.1073/pnas.74.7.3065; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Takamiya M, 2006, DEV DYNAM, V235, P978, DOI 10.1002/dvdy.20720; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Xu QL, 1995, DEVELOPMENT, V121, P4005; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhao NJ, 2010, ONCOL REP, V23, P1443, DOI 10.3892/or_00000782; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882	59	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54262	10.1371/journal.pone.0054262	http://dx.doi.org/10.1371/journal.pone.0054262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23544149	Green Published, gold, Green Submitted			2022-12-25	WOS:000314759400138
J	Zhao, Q; Wang, LX; Tao, T; Xu, B				Zhao, Qi; Wang, Lixia; Tao, Tao; Xu, Biao			Impacts of the "transport subsidy initiative on poor TB patients" in Rural China: A Patient-Cohort Based Longitudinal Study in Rural China	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; INCENTIVES; SERVICES; BARRIERS; ACCESS	Objective: To describe the financial burden on TB patients for transportation during treatment, and to evaluate the impacts of the "transportation subsidy initiative on poor TB patients" in rural China for improving poor patients' access to TB treatment. Methods: A Case-cohort of 429 TB patients was investigated through questionnaire interviews in four counties of two provinces in China. Information on the financial burden for transportation during TB diagnosis and treatment was collected. Qualitative in-depth interviews with 26 TB patients were carried out to understand their perceptions of transportation subsidy initiative. Results: The mean transportation cost of TB medical care was 97 CNY (70 CNY in median), varying from 0 to 700 CNY. About 51% of the patients spent more than 10 CNY per round trip to the TB dispensary. Of the 429 TB patients investigated, 139 had received transportation subsidies after getting TB diagnosis; 15/139 (10.9%) showed dissatisfaction, mainly because the subsidy amount being insufficient. The income of patients receiving transportation subsidies was significantly lower than those not receiving the subsidies (p<0.05). The impression that an appropriate transportation subsidy enables patients to complete the required visits during their TB treatment was obtained after observation of over 80% of the patients. Conclusion: The transportation subsidy plays an important role in reducing financial burden on poor TB patients for the completion of treatment. However, the coverage was limited and the amount of subsidy was not enough under the present policy. Considering the poverty of rural TB patients, a universal coverage and a rational amount of transportation subsidy should be proposed.	[Zhao, Qi; Tao, Tao; Xu, Biao] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Wang, Lixia] Natl Ctr TB Prevent & Control, Beijing, Peoples R China	Fudan University	Xu, B (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China.	bxu@shmu.edu.cn		Fan, Wenliang/0000-0001-8949-6775	WHO/CHN China [CHN/09/STB/000539, CHN/09/STB/000540]; Shanghai Leading Academic Discipline Project [12GWZX0101]; Distinguished Professorship Award by China Medical Board [G16916403]; Swedish International Development Cooperation Agency [EPI-4]	WHO/CHN China; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Distinguished Professorship Award by China Medical Board; Swedish International Development Cooperation Agency	This investigation received financial support from WHO/CHN China granted project (Grant No. CHN/09/STB/000539 & CHN/09/STB/000540). It also has been supported by the Shanghai Leading Academic Discipline Project (Project Number: 12GWZX0101), the Distinguished Professorship Award to the corresponding author granted by China Medical Board (No. G16916403), and the Swedish International Development Cooperation Agency granted project "Evidence for Policy and Implementation (EPI-4) Intensifying efforts to achieve the health-related MDGs in four countries with developing economies". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beith A, 2007, PERFORMANCE BASED IN; Bowong S, 2010, COMMUN NONLINEAR SCI, V15, P3621, DOI 10.1016/j.cnsns.2010.01.007; Chen C, 2007, CHINESE J ANTITUBERC, V29, P293; Davidson H, 2000, INT J TUBERC LUNG D, V4, P860; Godfrey-Faussett R, 2002, INT J TUBERC LUNG D, V6, P796; Hu D, 2008, CHINESE J HLTH ED, V24, P436; Lienhardt C, 2001, INT J TUBERC LUNG D, V5, P233; Liu XY, 2007, TROP MED INT HEALTH, V12, P1464, DOI 10.1111/j.1365-3156.2007.01953.x; Lonnroth K, 2001, SOC SCI MED, V52, P935, DOI 10.1016/S0277-9536(00)00195-7; MOH, 2002, CHIN TUB PREV CONTR; MOH, 2008, GUID PROV TRANSP SUB; Mookherj S, 2005, FOOD SUPPORT TUBERCU; Mookherji S, 2005, SUMMARY CURRENT EVID; National Technic Steering Group Of The Epidemiological Sampling Survey For Tuberculosis, 2002, Zhonghua Jie He He Hu Xi Za Zhi, V25, P3; Needham DM, 1998, INT J TUBERC LUNG D, V2, P811; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Squire SB, 2006, LANCET, V367, P955, DOI 10.1016/S0140-6736(06)68393-1; Wang Y, 2011, 5 NATL EPIDEMIOLOGY; Wares DF, 2001, INT J TUBERC LUNG D, V5, P732; Wei X, 2008, INT J TUBERC LUNG D, V12, P538; Weil D, 2004, MAPPING MOTIVATIONS; World Health Organization, 2006, STOP TB STRATEGY BUI; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization (WHO), 2005, ADDR POV TB CONTR; Xu B, 2006, HEALTH POLICY PLANN, V21, P365, DOI 10.1093/heapol/czl019; Yao H, 2008, INT J TUBERC LUNG D, V12, P1166; Zhang TH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-19; Zhao J, 2008, CHINESE J ANTITUBERC, V30, P452	28	11	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e82503	10.1371/journal.pone.0082503	http://dx.doi.org/10.1371/journal.pone.0082503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282623	gold, Green Submitted, Green Published			2022-12-25	WOS:000327543500127
J	Haupt, VJ; Daminelli, S; Schroeder, M				Haupt, V. Joachim; Daminelli, Simone; Schroeder, Michael			Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key	PLOS ONE			English	Article							MOLECULAR COMPLEXITY; DATABASE; PHARMACOLOGY; ALGORITHM; MECHANISM; BIOLOGY; UPDATE; ALIGN	Drug repositioning applies established drugs to new disease indications with increasing success. A pre-requisite for drug repurposing is drug promiscuity (polypharmacology) - a drug's ability to bind to several targets. There is a long standing debate on the reasons for drug promiscuity. Based on large compound screens, hydrophobicity and molecular weight have been suggested as key reasons. However, the results are sometimes contradictory and leave space for further analysis. Protein structures offer a structural dimension to explain promiscuity: Can a drug bind multiple targets because the drug is flexible or because the targets are structurally similar or even share similar binding sites? We present a systematic study of drug promiscuity based on structural data of PDB target proteins with a set of 164 promiscuous drugs. We show that there is no correlation between the degree of promiscuity and ligand properties such as hydrophobicity or molecular weight but a weak correlation to conformational flexibility. However, we do find a correlation between promiscuity and structural similarity as well as binding site similarity of protein targets. In particular, 71% of the drugs have at least two targets with similar binding sites. In order to overcome issues in detection of remotely similar binding sites, we employed a score for binding site similarity: LigandRMSD measures the similarity of the aligned ligands and uncovers remote local similarities in proteins. It can be applied to arbitrary structural binding site alignments. Three representative examples, namely the anticancer drug methotrexate, the natural product quercetin and the anti-diabetic drug acarbose are discussed in detail. Our findings suggest that global structural and binding site similarity play a more important role to explain the observed drug promiscuity in the PDB than physicochemical drug properties like hydrophobicity or molecular weight. Additionally, we find ligand flexibility to have a minor influence.	[Haupt, V. Joachim; Daminelli, Simone; Schroeder, Michael] Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Germany	Technische Universitat Dresden	Schroeder, M (corresponding author), Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Germany.	michael.schroeder@biotec.tu-dresden.de	Schroeder, Michael/A-3040-2010	Weller, Aron/0000-0002-0663-4384; Schroeder, Mariana/0000-0002-9517-4243	EU project "Ponte"; German Federal Ministry of Economics and Technology project "GeneCloud"	EU project "Ponte"; German Federal Ministry of Economics and Technology project "GeneCloud"	Funding by the EU project "Ponte" (http://www.ponte-project.eu) and the German Federal Ministry of Economics and Technology project "GeneCloud" (http://transinsight.com/genecloud) is kindly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzaoui K, 2007, CHEMMEDCHEM, V2, P874, DOI 10.1002/cmdc.200700036; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boly R, 2011, INT J ONCOL, V38, P833, DOI 10.3892/ijo.2010.890; Bottegoni G, 2006, BIOINFORMATICS, V22, pE58, DOI 10.1093/bioinformatics/btl212; Brandt W, 2010, CURR TOP MED CHEM, V10, P1361, DOI 10.2174/156802610792232060; Daminelli S, 2012, INTEGR BIOL-UK, V4, P778, DOI 10.1039/c2ib00154c; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Gunther S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-293; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; Haupt VJ, 2011, BRIEF BIOINFORM, V12, P312, DOI 10.1093/bib/bbr011; Heinrich JC, 2011, J CANCER RES CLIN, V137, P1349, DOI 10.1007/s00432-011-1005-1; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Kalinina OV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002043; Kellenberger E, 2006, J CHEM INF MODEL, V46, P717, DOI 10.1021/ci050372x; Kellenberger E, 2008, CURR COMPUT-AID DRUG, V4, P209, DOI 10.2174/157340908785747401; Kinnings SL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000976; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Konc J, 2012, J CHEM INF MODEL, V52, P604, DOI 10.1021/ci2005687; Kroeze W. K., 2012, POLYPHARMACOLOGY DRU, P133, DOI [10.1002/9781118098141.ch7, DOI 10.1002/9781118098141.CH7]; Leach AR, 2011, CURR OPIN CHEM BIOL, V15, P489, DOI 10.1016/j.cbpa.2011.05.008; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Li QL, 2010, DRUG DISCOV TODAY, V15, P1052, DOI 10.1016/j.drudis.2010.10.003; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Liu TY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002326; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Mestres J, 2009, MOL BIOSYST, V5, P1051, DOI 10.1039/b905821b; Morphy R, 2007, DRUG DISCOV TODAY, V12, P156, DOI 10.1016/j.drudis.2006.12.006; Najmanovich R, 2008, BIOINFORMATICS, V24, pI105, DOI 10.1093/bioinformatics/btn263; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-5; O'Connor KA, 2005, NAT REV DRUG DISCOV, V4, P1005, DOI 10.1038/nrd1900; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Painter J, 2004, J APPL CRYSTALLOGR, V37, P174, DOI 10.1107/S0021889803025639; Peters JU, 2009, CHEMMEDCHEM, V4, P680, DOI 10.1002/cmdc.200800411; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Rahman SA, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-12; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Schalon C, 2008, PROTEINS, V71, P1755, DOI 10.1002/prot.21858; van Dijk ADJ, 2005, FEBS J, V272, P293, DOI 10.1111/j.1742-4658.2004.04473.x; Xie L, 2007, PLOS COMPUT BIOL, V3, P2324, DOI 10.1371/journal.pcbi.0030217; Xie L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S9; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Xie L, 2012, ANNU REV PHARMACOL, V52, P361, DOI 10.1146/annurev-pharmtox-010611-134630; Xie L, 2009, BIOINFORMATICS, V25, pI305, DOI 10.1093/bioinformatics/btp220; Xie L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002037; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou X, 2008, BIOPHYS J, V95, P3366, DOI 10.1529/biophysj.107.117747; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014; [No title captured]	64	109	109	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65894	10.1371/journal.pone.0065894	http://dx.doi.org/10.1371/journal.pone.0065894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805191	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500019
J	Shen, LJ; Chen, FY; Zhang, Y; Cao, LF; Kuang, Y; Zhong, M; Wang, T; Zhong, H				Shen, Li-Jing; Chen, Fang-Yuan; Zhang, Yong; Cao, Lan-Fang; Kuang, Ying; Zhong, Min; Wang, Ting; Zhong, Hua			MYCN Transgenic Zebrafish Model with the Characterization of Acute Myeloid Leukemia and Altered Hematopoiesis	PLOS ONE			English	Article							GENE-EXPRESSION; DNA-DAMAGE; STEM-CELLS; TGF-BETA; C-MYC; DIFFERENTIATION; SCL; PROLIFERATION; ARREST; GROWTH	Background: Amplification of MYCN (N-Myc) oncogene has been reported as a frequent event and a poor prognostic marker in human acute myeloid leukemia (AML). The molecular mechanisms and transcriptional networks by which MYCN exerts its influence in AML are largely unknown. Methodology/Principal Findings: We introduced murine MYCN gene into embryonic zebrafish through a heat-shock promoter and established the stable germline Tg(MYCN: HSE:EGFP) zebrafish. N-Myc downstream regulated gene 1 (NDRG1), negatively controlled by MYCN in human and functionally involved in neutrophil maturation, was significantly under-expressed in this model. Using peripheral blood smear detection, histological section and flow cytometric analysis of single cell suspension from kidney and spleen, we found that MYCN overexpression promoted cell proliferation, enhanced the repopulating activity of myeloid cells and the accumulation of immature hematopoietic blast cells. MYCN enhanced primitive hematopoiesis by upregulating sc1 and Imo2 expression and promoted myelopoiesis by inhibiting gata1 expression and inducing pu.1, mpo expression. Microarray analysis identified that cell cycle, glycolysis/gluconeogenesis, MAPK/Ras, and p53-mediated apoptosis pathways were upregulated. In addition, mismatch repair, transforming and growth factor beta(TGF beta) were downregulated in MYCN-overexpressing blood cells (p<0.01). All of these signaling pathways are critical in the proliferation and malignant transformation of blood cells. Conclusion/Significance: The above results induced by overexpression of MYCN closely resemble the main aspects of human AML, suggesting that MYCN plays a role in the etiology of AML. MYCN reprograms hematopoietic cell fate by regulating NDRG1 and several lineage-specific hematopoietic transcription factors. Therefore, this MYCN transgenic zebrafish model facilitates dissection of MYCN-mediated signaling in vivo, and enables high-throughput scale screens to identify the potential therapeutic targets.	[Shen, Li-Jing; Chen, Fang-Yuan; Zhang, Yong; Zhong, Min; Wang, Ting; Zhong, Hua] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Hematol, Shanghai 200030, Peoples R China; [Cao, Lan-Fang] Shanghai Jiao Tong Univ, Sch Med, Dept Pediat, Renji Hosp, Shanghai 200030, Peoples R China; [Kuang, Ying] Shanghai Res Ctr Biomodel Organisms, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, FY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Hematol, Shanghai 200030, Peoples R China.	chenfangyuan62@163.com	; Rehman, Jalees/J-8258-2012	Marsboom, Glenn/0000-0001-6309-7557; Rehman, Jalees/0000-0002-2787-9292; Zhou, Yongqiang/0000-0003-1402-345X; Toth, Peter/0000-0003-2168-0124; Osburn, Christopher/0000-0002-9334-4202	National Natural Science Foundation of China [30900636]; Science and Technology Commission of Shanghai Municipality Grant [08JCI414900]; Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine [09XJ21066]; Science and Technology Commission of Shanghai Fund Project of TCM guide project [12401906700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine; Science and Technology Commission of Shanghai Fund Project of TCM guide project	This work was supported in part by National Natural Science Foundation of China Grant (30900636), Science and Technology Commission of Shanghai Municipality Grant (08JCI414900), Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine (09XJ21066), Science and Technology Commission of Shanghai Fund Project of TCM guide project (12401906700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Akers LJ, 2011, LEUKEMIA RES, V35, P814, DOI 10.1016/j.leukres.2010.12.028; Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; BECKMANN RP, 1992, J CELL BIOL, V117, P1137, DOI 10.1083/jcb.117.6.1137; Bell E, 2007, CELL CYCLE, V6, P1249, DOI 10.4161/cc.6.10.4222; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Chen J, 2007, LEUKEMIA, V21, P462, DOI 10.1038/sj.leu.2404546; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; CUNNIFF NFA, 1993, J BIOL CHEM, V268, P8317; de Boer J, 2011, LEUKEMIA, V25, P321, DOI 10.1038/leu.2010.253; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Fujimori H, 2008, J HEPATOL, V48, P962, DOI 10.1016/j.jhep.2008.01.031; Gupta Tripti, 2010, J Vis Exp, DOI 10.3791/1717; Halloran MC, 2000, DEVELOPMENT, V127, P1953; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Kawagoe H, 2007, CANCER RES, V67, P10677, DOI 10.1158/0008-5472.CAN-07-1118; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Le HY, 2008, J BIOL CHEM, V283, P17652, DOI 10.1074/jbc.M710517200; Levantini E, 2011, EMBO J, V30, P4059, DOI 10.1038/emboj.2011.285; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Ng KP, 2011, LEUKEMIA, V25, P1739, DOI 10.1038/leu.2011.159; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rinaldi A, 2011, BRIT J HAEMATOL, V154, P590, DOI 10.1111/j.1365-2141.2011.08789.x; Rowley AF, 1997, THROMB HAEMOSTASIS, V77, P227; Scandurra M, 2010, HEMATOL ONCOL, V28, P62, DOI 10.1002/hon.932; Shafizadeh E, 2004, CURR OPIN HEMATOL, V11, P255, DOI 10.1097/01.moh.0000138686.15806.71; Sheppard RD, 1998, ONCOGENE, V17, P2073, DOI 10.1038/sj.onc.1202125; Sugihara E, 2006, CANCER RES, V66, P4020, DOI 10.1158/0008-5472.CAN-05-3250; Sun W, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-22; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tschan MP, 2010, LEUKEMIA RES, V34, P393, DOI 10.1016/j.leukres.2009.08.037; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P11; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wu H, 2012, ONCOL LETT, V3, P1119, DOI 10.3892/ol.2012.614; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904	47	209	220	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59070	10.1371/journal.pone.0059070	http://dx.doi.org/10.1371/journal.pone.0059070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	24204740	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800054
J	Zhang, C; Zhou, YH; Xu, CL; Chi, FL; Ju, HN				Zhang, Chi; Zhou, Yu-Hao; Xu, Chun-Li; Chi, Feng-Ling; Ju, Hai-Ning			Efficacy of Intensive Control of Glucose in Stroke Prevention: A Meta-Analysis of Data from 59197 Participants in 9 Randomized Controlled Trials	PLOS ONE			English	Article							RISK	Background: The efficacy of treatments that lower glucose in reducing the risk of incident stroke remains unclear. We therefore did a systematic review and meta-analysis to evaluate the efficacy of intensive control of glucose in the prevention of stroke. Methodology/Principal Findings: We systematically searched Medline, EmBase, and the Cochrane Library for trials published between 1950 and June, 2012. We included randomized controlled trials that reported on the effects of intensive control of glucose on incident stroke compared with standard care. Summary estimates of relative risk (RR) reductions were calculated with a random effects model, and the analysis was further stratified by factors that could affect the treatment effects. Of 649 identified studies, we included nine relevant trials, which provided data for 59197 patients and 2037 events of stroke. Overall, intensive control of glucose as compared to standard care had no effect on incident stroke (RR, 0.96; 95% CI 0.88-1.06; P = 0.445). In the stratified analyses, a beneficial effect was seen in those trials when body mass index (BMI) more than 30 (RR, 0.86; 95% CI: 0.75-0.99; P = 0.041). No other significant differences were detected between the effect of intensive control of glucose and standard care when based on other subset factors. Conclusions/Significance: Our study indicated intensive control of glucose can effectively reduce the risk of incident stroke when patients with BMI more than 30.	[Zhang, Chi; Chi, Feng-Ling] Shanghai Seventh Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zhou, Yu-Hao] Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China; [Xu, Chun-Li] Shanghai Seventh Peoples Hosp, Dept Neurol, Shanghai, Peoples R China; [Ju, Hai-Ning] Shanghai Seventh Peoples Hosp, Dept Cardiol, Shanghai, Peoples R China		Zhou, YH (corresponding author), Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China.	yuhao860407@yahoo.com.cn	; Pearce, Joshua/C-9240-2013	Chen, Maogen/0000-0001-9319-5334; Pearce, Joshua/0000-0001-9802-3056				Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Goff DC, 2007, AM J CARDIOL, V99, p4I, DOI 10.1016/j.amjcard.2007.03.002; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Malmberg K, 1996, EUR HEART J, V17, P1337; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1186/2046-4053-4-1, 10.1136/bmj.i4086, 10.1136/bmj.b2535]; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Wilcox R, 2007, STROKE, V38, P865, DOI 10.1161/01.STR.0000257974.06317.49; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	30	109	113	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54465	10.1371/journal.pone.0054465	http://dx.doi.org/10.1371/journal.pone.0054465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23544104	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500075
J	Li, M; Zhang, YM; Zhang, ZY; Ji, XH; Zhang, R; Liu, DL; Gao, LP; Zhang, J; Wang, BA; Wu, YS; Wu, SJ; Chen, XL; Feng, SQ; Chen, XS				Li, Min; Zhang, Yanmin; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wang, Biao; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen			Hypersensitive Ethylene Signaling and ZMdPG1 Expression Lead to Fruit Softening and Dehiscence	PLOS ONE			English	Article							DNA-BINDING PROTEINS; GOLDEN-DELICIOUS APPLES; GCC-BOX; TOMATO FRUIT; ARABIDOPSIS-THALIANA; RESPONSIVE ELEMENT; PLANT DEVELOPMENT; GENE-EXPRESSION; MESSENGER-RNA; CIS-ELEMENTS	Taishanzaoxia' fruit rapid softening and dehiscence during ripening stage and this process is very sensitive to endogenous ethylene. In this study, we cloned five ethylene signal transcription factors (ZMdEIL1, ZMdEIL2, ZMdEIL3, ZMdERF1 and ZMdERF2) and one functional gene, ZMdPG1, encoding polygalacturonase that could loose the cell connection which associated with fruit firmness decrease and fruit dehiscence to illustrate the reasons for this specific fruit phenotypic and physiological changes. Expression analysis showed that ZMdERF1 and ZMdEIL2 transcription were more abundant in 'Taishanzaoxia' softening fruit and dehiscent fruit and their expression was inhibited by an ethylene inhibitor 1-methylcyclopropene. Therefore, ZMdERF1 and ZMdEIL2 expression were responses to endogenous ethylene and associated with fruit softening and dehiscence. ZMdPG1 expression was induced when fruit softening and dehiscence but this induction can be blocked by 1-MCP, indicating that ZMdPG1 was essential for fruit softening and dehiscence and its expression was mediated by the endogenously occurred ethylene. ZMdPG1 overexpression in Arabidopsis led to silique early dehiscence while suppressing ZMdPG1 expression by antisense ZMdPG1 prevented silique naturally opening. The result also suggested that ZMdPG1 related with the connection between cells that contributed to fruit softening and dehiscence. ZMdERF1 was more closely related with ethylene signaling but it was not directly regulated the ZMdPG1, which might be regulated by the synergic pattern of ethylene transcription factors because of both the ZMdERF1 and ZMdERF2 could interact with ZMdEIL2.	[Li, Min; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Yanmin] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Wang, Biao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Key Basic Research Program of China [2011CB100606]; National Natural Science Foundation of China [31171932, 31272132]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (2011CB100606 and the National Natural Science Foundation of China (31171932 and 31272132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Atkinson R.G., 2008, New Zealand Patent, Patent No. [NZ570886, 570886]; ATKINSON RG, 1994, PLANT PHYSIOL, V105, P1437, DOI 10.1104/pp.105.4.1437; Atkinson RG, 2002, PLANT PHYSIOL, V129, P122, DOI 10.1104/pp.010986; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Camps C, 2005, J TEXTURE STUD, V36, P387, DOI 10.1111/j.1745-4603.2005.00023.x; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DELLAPENNA D, 1986, P NATL ACAD SCI USA, V83, P6420, DOI 10.1073/pnas.83.17.6420; DELLAPENNA D, 1989, PLANT PHYSIOL, V90, P1372, DOI 10.1104/pp.90.4.1372; Hiwasa K, 2004, J EXP BOT, V55, P2281, DOI 10.1093/jxb/erh250; Huang SZ, 2010, PLANT SCI, V178, P251, DOI 10.1016/j.plantsci.2010.01.005; Jiang CZ, 2008, J EXP BOT, V59, P973, DOI 10.1093/jxb/ern023; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Li YC, 2007, PLANT CELL REP, V26, P1999, DOI 10.1007/s00299-007-0394-8; Liu ChaoChao, 2011, Acta Horticulturae Sinica, V38, P133; Liu MeiYan, 2012, Acta Horticulturae Sinica, V39, P845; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Mir NA, 2001, J AM SOC HORTIC SCI, V126, P618, DOI 10.21273/JASHS.126.5.618; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Peace CP, 2005, MOL BREEDING, V16, P21, DOI 10.1007/s11032-005-0828-3; Pirrello J, 2006, PLANT CELL PHYSIOL, V47, P1195, DOI 10.1093/pcp/pcj084; Rieu I, 2003, J EXP BOT, V54, P2239, DOI 10.1093/jxb/erg240; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Saftner RA, 2003, J AM SOC HORTIC SCI, V128, P120, DOI 10.21273/JASHS.128.1.0120; Sawada K, 2000, J NEUROCHEM, V74, P1731, DOI 10.1046/j.1471-4159.2000.0741731.x; Schupp JR, 2004, HORTSCIENCE, V39, P1030, DOI 10.21273/HORTSCI.39.5.1030; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; SPEIRS J, 1990, J PLANT PHYSIOL, V135, P576, DOI 10.1016/S0176-1617(11)80639-5; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Tieman DM, 2001, PLANT J, V26, P47, DOI 10.1046/j.1365-313x.2001.01006.x; TIEMAN DM, 1994, PLANT PHYSIOL, V106, P429, DOI 10.1104/pp.106.2.429; Toivonen PMA, 2005, J HORTIC SCI BIOTECH, V80, P439, DOI 10.1080/14620316.2005.11511957; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Wakasa Y, 2006, POSTHARVEST BIOL TEC, V39, P193, DOI 10.1016/j.postharvbio.2005.10.005; Wang AD, 2009, POSTHARVEST BIOL TEC, V52, P38, DOI 10.1016/j.postharvbio.2008.09.001; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Wang ZY, 2000, PLANT MOL BIOL, V42, P317, DOI 10.1023/A:1006309529922; Wei JM, 2010, POSTHARVEST BIOL TEC, V56, P147, DOI 10.1016/j.postharvbio.2009.12.003; Weinthal D, 2009, TRENDS PLANT SCI, V14, P59, DOI 10.1016/j.tplants.2008.11.002; Yin XR, 2008, J EXP BOT, V59, P2097, DOI 10.1093/jxb/ern067; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yin XueRen, 2009, Acta Horticulturae Sinica, V36, P133; Yokotani N, 2003, J EXP BOT, V54, P2775, DOI 10.1093/jxb/erg308; Yuan RC, 2007, HORTSCIENCE, V42, P101, DOI 10.21273/HORTSCI.42.1.101	57	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58745	10.1371/journal.pone.0058745	http://dx.doi.org/10.1371/journal.pone.0058745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527016	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600038
J	Li, M; Zhang, QP; Liu, LN; Lu, WP; Wei, H; Li, RW; Lu, S				Li, Mei; Zhang, Qiuping; Liu, Lina; Lu, Weipeng; Wei, Hong; Li, Rachel W.; Lu, Shen			Expression of the Mismatch Repair Gene hMLH1 Is Enhanced in Non-Small Cell Lung Cancer with EGFR Mutations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; CLINICAL-SIGNIFICANCE; ACQUIRED-RESISTANCE; SOMATIC MUTATIONS; SIGNALING PATHWAY; KRAS MUTATIONS; CARCINOMAS; PROTEINS; HMSH2	Mismatch repair (MMR) plays a pivotal role in keeping the genome stable. MMR dysfunction can lead to carcinogenesis by gene mutation accumulation. HMSH2 and hMLH1 are two key components of MMR. High or low expression of them often mark the status of MMR function. Mutations (EGFR, KRAS, etc) are common in non-small cell lung cancer (NSCLC). However, it is not clear what role MMR plays in NSCLC gene mutations. The expression of MMR proteins hMSH2 and hMLH1, and the proliferation markers PCNA and Ki67 were measured by immunohistochemistry in 181 NSCLCs. EGFR and KRAS mutations were identified by high resolution melting analysis. Stronger hMLH1 expression correlated to a higher frequency of EGFR mutations in exon 19 and 21 (p<0.0005). Overexpression of hMLH1 and the adenocarcinoma subtype were both independent factors that related to EGFR mutations in NSCLCs (p=0.013 and p<0.0005). The expression of hMLH1, hMSH2 and PCNA increased, while Ki67 expression significantly decreased (p=0.030) in NSCLCs with EGFR mutations. Overexpression of hMLH1 could be a new molecular marker to predict the response to EGFR-TKIs in NSCLCs. Furthermore, EGFR mutations might be an early event of NSCLC that occur before MMR dysfunction.	[Li, Mei; Lu, Weipeng; Wei, Hong; Lu, Shen] Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China; [Zhang, Qiuping] Dalian Med Univ, Hosp 1, Dept Pathol, Dalian, Peoples R China; [Liu, Lina] Dalian Med Univ, Hosp 1, Dept Internal Med, Dalian, Peoples R China; [Li, Rachel W.] Australian Med Univ, Sch Med, Canberra, ACT, Australia	Dalian Medical University; Dalian Medical University; Dalian Medical University	Lu, S (corresponding author), Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China.	lvshen1956@126.com	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Nature Science Funds in China [81071805]; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	National Nature Science Funds in China; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	This work was supported by the National Nature Science Funds in China (Fund No. 81071805; URL: http://isisn.nsfc.gov.cn/egrantweb/), and Dalian Merricon Gene Diagnosis Technology Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Betz BL, 2011, AM J CLIN PATHOL, V136, P564, DOI 10.1309/AJCP84TUTQOSUONG; Bischoff J, 2012, CLIN EXP METASTAS, V29, P889, DOI 10.1007/s10585-012-9478-0; Chung H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003463; Donehower LA, 2013, J PATHOL, V229, P99, DOI 10.1002/path.4087; Kawaguchi M, 2009, INT J ONCOL, V34, P1541, DOI 10.3892/ijo_00000283; Kouso H, 2008, J SURG ONCOL, V98, P377, DOI 10.1002/jso.21108; Lee SY, 2010, J THORAC ONCOL, V5, P1734, DOI 10.1097/JTO.0b013e3181f0beca; Li M, 2011, NEOPLASMA, V58, P74, DOI 10.4149/neo_2011_01_74; Li M, 2008, ONCOL REP, V19, P401; Li M, 2009, ONCOL REP, V22, P1013, DOI 10.3892/or_00000529; Lo FY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-235; Luchtenborg M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-160; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008; Romeo F, 2011, INT J BIOCHEM CELL B, V43, P1754, DOI 10.1016/j.biocel.2011.08.011; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Saletta F, 2007, CANCER RES, V67, P7088, DOI 10.1158/0008-5472.CAN-06-4420; Sasaki H, 2006, LUNG CANCER, V54, P103, DOI 10.1016/j.lungcan.2006.06.003; Scartozzi M, 2006, LUNG CANCER, V53, P103, DOI 10.1016/j.lungcan.2006.03.008; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shih CM, 2010, INT J MOL MED, V25, P165, DOI 10.3892/ijmm_00000327; Sholl LM, 2010, AM J CLIN PATHOL, V133, P922, DOI 10.1309/AJCPST1CTHZS3PSZ; Stoehr C, 2012, PATHOBIOLOGY, V79, P162, DOI 10.1159/000335642; Stubbert LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-207; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Vageli D, 2009, LUNG CANCER, V64, P282, DOI 10.1016/j.lungcan.2008.09.018; Vageli DP, 2012, INT J BIOL MARKER, V27, pE400, DOI 10.5301/JBM.2012.9420; van Puijenbroek M, 2008, FAM CANCER, V7, P319, DOI 10.1007/s10689-008-9194-8; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wang Y, 2000, GENE DEV, V14, P927; Wang YC, 2003, J CLIN INVEST, V111, P887, DOI 10.1172/JCI200315475; Wu CC, 2008, CANCER, V113, P3199, DOI 10.1002/cncr.23925; Xinarianos G, 2000, CANCER RES, V60, P4216; Yamaguchi F, 2012, LUNG CANCER, V78, P201, DOI 10.1016/j.lungcan.2012.08.014	47	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78500	10.1371/journal.pone.0078500	http://dx.doi.org/10.1371/journal.pone.0078500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	23527016	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300065
J	Zhang, GL; Huang, SQ; Duan, QH; Shu, W; Hou, YC; Zhu, SY; Miao, XP; Nie, SF; Wei, S; Guo, N; Shan, H; Xu, YH				Zhang, Guoliang; Huang, Shuqiong; Duan, Qionghong; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Guo, Nan; Shan, Hua; Xu, Yihua			Application of a Hybrid Model for Predicting the Incidence of Tuberculosis in Hubei, China	PLOS ONE			English	Article							TIME-SERIES; HEALTH SYSTEM; SEASONALITY; TRANSMISSION	Background: A prediction model for tuberculosis incidence is needed in China which may be used as a decision-supportive tool for planning health interventions and allocating health resources. Methods: The autoregressive integrated moving average (ARIMA) model was first constructed with the data of tuberculosis report rate in Hubei Province from Jan 2004 to Dec 2011. The data from Jan 2012 to Jun 2012 were used to validate the model. Then the generalized regression neural network (GRNN)-ARIMA combination model was established based on the constructed ARIMA model. Finally, the fitting and prediction accuracy of the two models was evaluated. Results: A total of 465,960 cases were reported between Jan 2004 and Dec 2011 in Hubei Province. The report rate of tuberculosis was highest in 2005 (119.932 per 100,000 population) and lowest in 2010 (84.724 per 100,000 population). The time series of tuberculosis report rate show a gradual secular decline and a striking seasonal variation. The ARIMA (2, 1, 0) x (0, 1, 1) 12 model was selected from several plausible ARIMA models. The residual mean square error of the GRNN-ARIMA model and ARIMA model were 0.4467 and 0.6521 in training part, and 0.0958 and 0.1133 in validation part, respectively. The mean absolute error and mean absolute percentage error of the hybrid model were also less than the ARIMA model. Discussion and Conclusions: The gradual decline in tuberculosis report rate may be attributed to the effect of intensive measures on tuberculosis. The striking seasonal variation may have resulted from several factors. We suppose that a delay in the surveillance system may also have contributed to the variation. According to the fitting and prediction accuracy, the hybrid model outperforms the traditional ARIMA model, which may facilitate the allocation of health resources in China.	[Zhang, Guoliang; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Xu, Yihua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Huang, Shuqiong] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Duan, Qionghong] TB Inst TB Control & Prevent Wuhan City, Wuhan, Peoples R China; [Guo, Nan] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Shan, Hua] Johns Hopkins Med Inst, Dept Pathol, Div Blood Transfus, Baltimore, MD 21205 USA	Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Xu, YH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	xuyihua_6@hotmail.com	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wenzel, Sally/0000-0002-4242-0164; Dow, Max/0000-0001-8245-2294; Zhang, An/0000-0002-9338-6250; Wang, Jinfeng/0000-0002-6687-9420	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BuHamra S, 2003, APPL MATH MODEL, V27, P805, DOI 10.1016/S0307-904X(03)00079-9; Cao SY, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-56; Chen XY, 2004, LANCET, V364, P417; Cheng G, 2005, T ROY SOC TROP MED H, V99, P355, DOI 10.1016/j.trstmh.2004.07.005; Debanne SM, 2000, EMERG INFECT DIS, V6, P148, DOI 10.3201/eid0602.000207; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Hu WB, 2004, AM J TROP MED HYG, V71, P129, DOI 10.4269/ajtmh.2004.71.129; Jain A, 2007, APPL SOFT COMPUT, V7, P585, DOI 10.1016/j.asoc.2006.03.002; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057752; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Leung MT, 2000, COMPUT OPER RES, V27, P1093, DOI 10.1016/S0305-0548(99)00144-6; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Li WM, 2008, NEURAL COMPUT APPL, V17, P441, DOI 10.1007/s00521-007-0131-9; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; Medeiros MC, 2000, IEEE T NEURAL NETWOR, V11, P1402, DOI 10.1109/72.883463; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; Ozyildirim BM, 2013, NEURAL NETWORKS, V39, P18, DOI 10.1016/j.neunet.2012.12.001; Parrinello CM, 2012, INT J TUBERC LUNG D, V16, P32, DOI 10.5588/ijtld.11.0145; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076	31	271	318	9	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80969	10.1371/journal.pone.0080969	http://dx.doi.org/10.1371/journal.pone.0080969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	23658832	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200125
J	Zhang, A; Qi, QW; Jiang, LL; Zhou, F; Wang, JF				Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng			Population Exposure to PM2.5 in the Urban Area of Beijing	PLOS ONE			English	Article							COARSE PARTICLES; FINE PARTICLES; AIR-QUALITY	The air quality in Beijing, especially its PM2.5 level, has become of increasing public concern because of its importance and sensitivity related to health risks. A set of monitored PM2.5 data from 31 stations, released for the first time by the Beijing Environmental Protection Bureau, covering 37 days during autumn 2012, was processed using spatial interpolation and overlay analysis. Following analyses of these data, a distribution map of cumulative exceedance days of PM2.5 and a temporal variation map of PM2.5 for Beijing have been drawn. Computational and analytical results show periodic and directional trends of PM2.5 spreading and congregating in space, which reveals the regulation of PM2.5 overexposure on a discontinuous medium-term scale. With regard to the cumulative effect of PM2.5 on the human body, the harm from lower intensity overexposure in the medium term, and higher overexposure in the short term, are both obvious. Therefore, data of population distribution were integrated into the aforementioned PM2.5 spatial spectrum map. A spatial statistical analysis revealed the patterns of PM2.5 gross exposure and exposure probability of residents in the Beijing urban area. The methods and conclusions of this research reveal relationships between long-term overexposure to PM2.5 and people living in high-exposure areas of Beijing, during the autumn of 2012.	[Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Qi, QW (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	qiqw@igsnrr.ac.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wenzel, Sally/0000-0002-4242-0164; Dow, Max/0000-0001-8245-2294; Zhang, An/0000-0002-9338-6250; Wang, Jinfeng/0000-0002-6687-9420	National Natural Science Foundation of China [41201412]; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Natural Science Foundation of China (41201412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayraktar H, 2005, STOCH ENV RES RISK A, V19, P301, DOI 10.1007/s00477-005-0234-8; Bureau BCA Mapping BIoSa, 2005, BEIJ ADM DISTR ATL; Bureau BCA Mapping BIoSa, 2007, BEIJ ADM DISTR TUZH; China's Ministry of Environmental Protection, 2012, AMB AIR QUAL STAND; Du XA, 2010, J ENVIRON SCI-CHINA, V22, P1757, DOI 10.1016/S1001-0742(09)60316-8; Fann N, 2011, RISK ANAL, DOI DOI 10.1111/J.1539-6924.2011.01630.X; Gavett SH, 2001, INT ARCH ALLERGY IMM, V124, P109, DOI 10.1159/000053685; Haley VB, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-42; Hao YP, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-3; Jorgensen NW, 2012, J AM COLL CARDIOL, V60; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Kunii O, 2002, ARCH ENVIRON HEALTH, V57, P16, DOI 10.1080/00039890209602912; Li P, 2012, PLOS ONE; Lippmann M, 1998, ISSUES ENV SCI TECHN, V10, P75; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; Municipality OftSPCoB Statistics BMBo Beijing SOotNBoSi, 2012, TAB 2010 POP CENS BE; Pang W, 2010, ENVIRONMETRICS, V21, P305, DOI 10.1002/env.1007; Qiu F, 2012, GISCI REMOTE SENS, V49, P644, DOI 10.2747/1548-1603.49.5.644; Schwartz J, 2000, EPIDEMIOLOGY, V11, P6, DOI 10.1097/00001648-200001000-00004; Sun YL, 2006, ENVIRON SCI TECHNOL, V40, P3148, DOI 10.1021/es051533g; Urbat M, 2004, ATMOS ENVIRON, V38, P3781, DOI 10.1016/j.atmosenv.2004.03.061; Vallejo M, 2006, J EXPO SCI ENV EPID, V16, P125, DOI 10.1038/sj.jea.7500447; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; [袁杨森 YUAN Yangsen], 2007, [生态环境, Ecology and Environment], V16, P18; Zhao W, 2012, GEOGRAPHICAL RES, V417-428	25	271	318	9	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63486	10.1371/journal.pone.0063486	http://dx.doi.org/10.1371/journal.pone.0063486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658832	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500073
J	Zhang, YB; Wei, C; Jiang, WD; Wang, L; Li, CR; Wang, YY; Dow, JM; Sun, WX				Zhang, Yuanbao; Wei, Chao; Jiang, Wendi; Wang, Lei; Li, Churui; Wang, Yunyue; Dow, John Maxwell; Sun, Wenxian			The HD-GYP Domain Protein RpfG of Xanthomonas oryzae pv. oryzicola Regulates Synthesis of Extracellular Polysaccharides that Contribute to Biofilm Formation and Virulence on Rice	PLOS ONE			English	Article							DIFFUSIBLE SIGNAL FACTOR; 2-COMPONENT SYSTEM; GENE-EXPRESSION; CAMPESTRIS; VESICATORIA; PHOSPHODIESTERASE; SEQUENCES; ACTIVATOR; BACTERIA; CLUSTER	Bacterial leaf streak caused by Xanthomonas oryzae pv. oryzicola (Xoc) is one of the most important diseases in rice. However, little is known about the pathogenicity mechanisms of Xoc. Here we have investigated the function of three HD-GYP domain regulatory proteins in biofilm formation, the synthesis of virulence factors and virulence of Xoc. Deletion of rpfG resulted in altered production of extracellular polysaccharides (EPS), abolished virulence on rice and enhanced biofilm formation, but had little effect on the secretion of proteases and motility. In contrast, mutational analysis showed that the other two HD-GYP domain proteins had no effect on virulence factor synthesis and tested phenotypes. Mutation of rpfG led to up-regulation of the type III secretion system and altered expression of three putative glycosyltransferase genes gumD, pgaC and xagB, which are part of operons directing the synthesis of different extracellular polysaccharides. The pgaABCD and xagABCD operons were greatly up-regulated in the Xoc Delta rpfG mutant, whereas the expression of the gum genes was unaltered or slightly enhanced. The elevated biofilm formation of the Xoc Delta rpfG mutant was dramatically reduced upon deletion of gumD, xagA and xagB, but not when pgaA and pgaC were deleted. Interestingly, only the Delta gumD mutant, among these single gene mutants, exhibits multiple phenotype alterations including reduced biofilm and EPS production and attenuated virulence on rice. These data indicate that RpfG is a global regulator that controls biofilm formation, EPS production and bacterial virulence in Xoc and that both gumD- and xagB-dependent EPS contribute to biofilm formation under different conditions.	[Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China; [Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China; [Wei, Chao; Wang, Yunyue] Yunnan Agr Univ, Minist Educ, Key Lab Agr Biodivers & Plant Dis Management, Kunming, Peoples R China; [Dow, John Maxwell] Univ Coll Cork, Biosci Inst, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Yunnan Agricultural University; University College Cork	Zhang, YB (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China.	wxs@cau.edu.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wenzel, Sally/0000-0002-4242-0164; Dow, Max/0000-0001-8245-2294; Zhang, An/0000-0002-9338-6250; Wang, Jinfeng/0000-0002-6687-9420	973 program [2011CB100700]; National Natural Science Foundation of China (NSFC) [31272007]; PCSIRT Program [IRT1042, NCET-09-0736]; Ph.D. Programs Foundation of Ministry of Education of China; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	973 program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); PCSIRT Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the 973 program 2011CB100700, National Natural Science Foundation of China (NSFC) grant 31272007, PCSIRT Program IRT1042, NCET-09-0736 and Ph.D. Programs Foundation of Ministry of Education of China to WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P911, DOI 10.1094/MPMI.2000.13.9.911; AWODERU VA, 1991, TROP PEST MANAGE, V37, P356, DOI 10.1080/09670879109371614; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; BOYER MH, 1984, J BIOTECHNOL, V1, P241, DOI 10.1016/0168-1656(84)90009-9; CANNON FC, 1979, MOL GEN GENET, V174, P59, DOI 10.1007/BF00433306; Castaneda A, 2005, MOL PLANT MICROBE IN, V18, P1306, DOI 10.1094/MPMI-18-1306; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; DiLuzio WR, 2005, NATURE, V435, P1271, DOI 10.1038/nature03660; Dow J M, 1994, Curr Top Microbiol Immunol, V192, P29; Dow JM, 2006, MOL PLANT MICROBE IN, V19, P1378, DOI 10.1094/MPMI-19-1378; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dow M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe23; Feng JX, 2009, MICROBIOL-SGM, V155, P3033, DOI 10.1099/mic.0.028910-0; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Guo YP, 2012, MOL PLANT MICROBE IN, V25, P165, DOI 10.1094/MPMI-07-11-0184; Han SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029192; HARDING NE, 1987, J BACTERIOL, V169, P2854, DOI 10.1128/jb.169.6.2854-2861.1987; He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Huang DL, 2008, NUCLEIC ACIDS RES, V36, P4295, DOI 10.1093/nar/gkn328; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JIANG J, 2009, ACTA MICROBIOL SIN, V49, P1018; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Lee SW, 2008, J BACTERIOL, V190, P2183, DOI 10.1128/JB.01406-07; Li YR, 2011, APPL ENVIRON MICROB, V77, P3809, DOI 10.1128/AEM.02849-10; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Meng FH, 2011, J BACTERIOL, V193, P2477, DOI 10.1128/JB.01360-10; MOFFETT ML, 1983, PLANT BACTERIAL DIS, P393; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; OU SH, 1985, ROCE DIS; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Rai R, 2012, MOL PLANT MICROBE IN, V25, P789, DOI 10.1094/MPMI-11-11-0285-R; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Souza LCA, 2006, FEMS MICROBIOL LETT, V257, P236, DOI 10.1111/j.1574-6968.2006.00176.x; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Sultan SZ, 2010, FEMS MICROBIOL LETT, V302, P22, DOI 10.1111/j.1574-6968.2009.01837.x; Sun WX, 2011, MOL PLANT PATHOL, V12, P731, DOI [10.1111/j.1364-3703.2011.00707.x, 10.1111/J.1364-3703.2011.00707.X]; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Swift S, 1999, INFECT IMMUN, V67, P5192, DOI 10.1128/IAI.67.10.5192-5199.1999; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Yang FH, 2012, MOL PLANT MICROBE IN, V25, P1361, DOI 10.1094/MPMI-01-12-0014-R; Yi XA, 2010, MOL MICROBIOL, V77, P787, DOI 10.1111/j.1365-2958.2010.07246.x; Zou HS, 2011, CURR MICROBIOL, V62, P908, DOI 10.1007/s00284-010-9804-1	73	271	318	9	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59428	10.1371/journal.pone.0059428	http://dx.doi.org/10.1371/journal.pone.0059428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23658832	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700121
J	Lin, YL; Tsai, YJ; Liu, YF; Cheng, YC; Hung, CM; Lee, YJ; Pan, HC; Li, C				Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Cheng, Yi-Chuan; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan			The Critical Role of Protein Arginine Methyltransferase prmt8 in Zebrafish Embryonic and Neural Development Is Non-Redundant with Its Paralogue prmt1	PLOS ONE			English	Article							METHYLATION; PROTEIN-ARGININE-METHYLTRANSFERASE-8; IDENTIFICATION; BINDING; FAMILY; DOMAIN; GENES; BRAIN; REST	Protein arginine methyltransferase (PRMT) 1 is the most conserved and widely distributed PRMT in eukaryotes. PRMT8 is a vertebrate-restricted paralogue of PRMT1 with an extra N-terminal sequence and brain-specific expression. We use zebrafish (Danio rerio) as a vertebrate model to study PRMT8 function and putative redundancy with PRMT1. The transcripts of zebrafish prmt8 were specifically expressed in adult zebrafish brain and ubiquitously expressed from zygotic to early segmentation stage before the neuronal development. Whole-mount in situ hybridization revealed ubiquitous prmt8 expression pattern during early embryonic stages, similar to that of prmt1. Knockdown of prmt8 with antisense morpholino oligonucleotide phenocopied prmt1-knockdown, with convergence/extension defects at gastrulation. Other abnormalities observed later include short body axis, curled tails, small and malformed brain and eyes. Catalytically inactive prmt8 failed to complement the morphants, indicating the importance of methyltransferase activity. Full-length prmt8 but not prmt1 cRNA can rescue the phenotypic changes. Nevertheless, cRNA encoding Prmt1 fused with the N-terminus of Prmt8 can rescue the prmt8 morphants. In contrast, N-terminus-deleted but not full-length prmt8 cRNA can rescue the prmt1 morphants as efficiently as prmt1 cRNA. Abnormal brain morphologies illustrated with brain markers and loss of fluorescent neurons in a transgenic fish upon prmt8 knockdown confirm the critical roles of prmt8 in neural development. In summery, our study is the first report showing the expression and function of prmt8 in early zebrafish embryogenesis. Our results indicate that prmt8 may play important roles non-overlapping with prmt1 in embryonic and neural development depending on its specific N-terminus.	[Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Liu, Yu-Fang; Pan, Huichin; Li, Chuan] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Cheng, Yi-Chuan] Chang Gung Univ, Dept Biochem & Mol Biol, Tao Yuan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chang Gung University	Li, C (corresponding author), Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan.	cli@csmu.edu.tw	Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/Q-6444-2017; Liu, Ying/GLN-6419-2022; van den Berg, Anke/H-1718-2011; Wu, Ping-Hsun/S-8746-2017; Chang, Chin-Kuo/E-4991-2010	Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Ying/0000-0001-5753-4247; van den Berg, Anke/0000-0002-8894-2638; Chen, Fanjun/0000-0001-8105-1683; Lin, Ming-Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; Liu, Yang/0000-0002-2362-9501; Chang, Chin-Kuo/0000-0002-8338-7196	National Science Council [95-2320-B-040-042, 96-2320-B-040-022-MY2, 98-2320-B-040-011-MY3]; Chung Shan Medical University [CSMU 94-OM-A-023, 97-OM-A-136, 98OM-A-060]	National Science Council(Ministry of Science and Technology, Taiwan); Chung Shan Medical University	The project was supported by 95-2320-B-040-042, 96-2320-B-040-022-MY2 and 98-2320-B-040-011-MY3 from National Science Council and CSMU 94-OM-A-023, 97-OM-A-136 and 98OM-A-060 from Chung Shan Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Batut J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025427; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Gates KP, 2010, DEV BIOL, V340, P293, DOI 10.1016/j.ydbio.2010.01.029; Hung CJ, 2007, J BIOCHEM MOL BIOL, V40, P617; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kousaka A, 2009, NEUROSCIENCE, V163, P1146, DOI 10.1016/j.neuroscience.2009.06.061; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lin CH, 2002, J PROTEIN CHEM, V21, P447, DOI 10.1023/A:1021394903025; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lu JG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-246; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Pahlich S, 2008, PROTEINS, V72, P1125, DOI 10.1002/prot.22004; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Tsai YJ, 2011, FEBS J, V278, P905, DOI 10.1111/j.1742-4658.2011.08006.x; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	29	266	277	14	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e55221	10.1371/journal.pone.0055221	http://dx.doi.org/10.1371/journal.pone.0055221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	24244618	gold, Green Submitted, Green Published			2022-12-25	WOS:000316252500001
J	Liu, Y; Zhang, AQ; Cao, L; Xia, HT; Ma, JJ				Liu, Yong; Zhang, An-Qiang; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie			Taurolidine Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							HOME PARENTERAL-NUTRITION; CENTRAL VENOUS CATHETERS; TARGETED USE; HEMODIALYSIS; BACTEREMIA; CITRATE; HEPARIN; SEPSIS; CANCER; TAUROLOCK(R)	Background: Catheter-related bloodstream infections (CRBSIs) are a significant cause of morbidity and mortality in critically ill patients, contributing to prolonged hospital stays and increased costs. Whether taurolidine lock solutions (TLS) are beneficial for the prevention of CRBSIs remains controversial. In this meta-analysis, we aim to assess the efficacy of TLS for preventing CRBSIs. Methods: We conducted a systematic search of PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. Eligible studies included randomized controlled trials that reported on the effects of TLS for preventing CRBSIs. The primary outcome in these studies was catheter-related bloodstream infections, with microbial distribution of CRBSI and catheter-associated thrombosis as secondary outcomes. Data were combined using random-effects models owing to significant clinical heterogeneity. Results: Six randomized controlled trials (RCTs) conducted from 2004 through 2013 involving 431 patients and 86,078 catheter-days were included in the review. TLS were significantly associated with a lower incidence of CRBSIs when compared to heparin lock solutions (Risk Ratio [RR], 0.34; 95% Confidence Interval [CI], 0.21-0.55). Use of TLS significantly decreased the incidence of CRBSIs from gram-negative (G-) bacteria (P = 0.004; RR, 0.27; CI, 0.11-0.65), and was associated with a non-significant decrease in gram-positive (G+) bacterial infections (P = 0.07; RR, 0.41; CI, 0.15-1.09). No significant association was observed with TLS and catheter-associated thrombosis (RR, 1.99; CI, 0.75-5.28). Conclusions: The use of TLS reduced the incidence of CRBSIs without obvious adverse effects or bacterial resistance. However, the susceptibility of G+ and G- bacteria to taurolidine and the risk for catheter-associated thrombosis of TLS are indeterminate due to limited data. The results should be treated with caution due to the limited sample sizes and methodological deficiencies of included studies. Therefore, additional well-designed and adequately powered RCTs are needed to confirm these findings.	[Liu, Yong; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie] Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China; [Zhang, An-Qiang] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University	Liu, Y (corresponding author), Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China.	616756156@qq.com	Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/Q-6444-2017; Liu, Ying/GLN-6419-2022; van den Berg, Anke/H-1718-2011; Wu, Ping-Hsun/S-8746-2017; Chang, Chin-Kuo/E-4991-2010	Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Ying/0000-0001-5753-4247; van den Berg, Anke/0000-0002-8894-2638; Chen, Fanjun/0000-0001-8105-1683; Lin, Ming-Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; Liu, Yang/0000-0002-2362-9501; Chang, Chin-Kuo/0000-0002-8338-7196				Akyuz C, 2010, PEDIATR BLOOD CANCER, V55, P949; Al-Amin A, 2012, BRIT J SURG, V99, P158; Allon M, 2003, CLIN INFECT DIS, V36, P1539, DOI 10.1086/375234; Betjes MGH, 2004, NEPHROL DIAL TRANSPL, V19, P1546, DOI 10.1093/ndt/gfh014; Bisseling TM, 2010, CLIN NUTR, V29, P464, DOI 10.1016/j.clnu.2009.12.005; Bradshaw JH, 2008, J PEDIATR GASTR NUTR, V47, P179, DOI 10.1097/MPG.0b013e318162c428; Branger B, 2008, ARTIF ORGANS, V32, P918, DOI 10.1111/j.1525-1594.2008.00684.x; Braumann C, 2005, J SURG RES, V129, P129, DOI 10.1016/j.jss.2005.03.012; Chu HP, 2012, J PEDIATR GASTR NUTR, V55, P403, DOI 10.1097/MPG.0b013e31825bb0ae; Dumichen MJ, 2012, J HOSP INFECT, V80, P304, DOI 10.1016/j.jhin.2012.01.003; Filiopoulos V, 2011, AM J NEPHROL, V33, P260, DOI 10.1159/000324685; Geron R, 2006, HAREFUAH, V145, P943; Geron Ronit, 2006, Harefuah, V145, P881; GORMAN SP, 1987, J APPL BACTERIOL, V62, P315, DOI 10.1111/j.1365-2672.1987.tb04926.x; Haag GM, 2011, J VASC ACCESS, V12, P244, DOI 10.5301/JVA.2011.6265; Handrup MM, 2012, APMIS, V120, P794, DOI 10.1111/j.1600-0463.2012.02910.x; Handrup MM, 2013, PEDIAT BLOOD CANC; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill SM, 2011, J PEDIAT GASTROEN S1, V52, pE64; Jonkers C., 2012, CLIN NUTR S, V7, P203; Jurewitsch B, 2005, CLIN NUTR, V24, P462, DOI 10.1016/j.clnu.2005.02.001; Jurewitsch B, 1998, JPEN-PARENTER ENTER, V22, P242, DOI 10.1177/0148607198022004242; Labriola L, 2008, NEPHROL DIAL TRANSPL, V23, P1666, DOI 10.1093/ndt/gfm847; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020; Moher David, 2009, BMJ, V339, pb2535, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Novikov A, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-40; O'Grady NP, 2011, CLIN INFECT DIS, V52, P1087, DOI 10.1093/cid/cir138; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Horo JC, 2011, AM J NEPHROL, V34, P415, DOI 10.1159/000331262; Oliveira C, 2012, PEDIATRICS, V129, P318, DOI 10.1542/peds.2011-1602; Olthof ED, 2012, CLIN NUTR; Olthof ED, 2012, CLIN NUTR S7, V7, P149; Rafferty GP, 2010, GUT, V59, pA35, DOI 10.1136/gut.2009.208991f; Rommes JH, 2001, CURR ANAESTH CRIT CA, V12, P25; Schiavone PA, 2010, PRACT GASTROENTEROL, V34, P22; Schiffer CA, 2013, J CLIN ONCOL; Shah CB, 2002, ANTIMICROB AGENTS CH, V46, P1674, DOI 10.1128/AAC.46.6.1674-1679.2002; Simon A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-102; Solomon LR, 2012, SEMIN DIALYSIS, V25, P233, DOI 10.1111/j.1525-139X.2011.00951.x; Solomon LR, 2010, AM J KIDNEY DIS, V55, P1060, DOI 10.1053/j.ajkd.2009.11.025; Sweet S, 2009, AM J KIDNEY DIS, V53, pA74; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; Taylor C, 2008, J REN CARE, V34, P116, DOI 10.1111/j.1755-6686.2008.00027.x; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Torres-Viera C, 2000, ANTIMICROB AGENTS CH, V44, P1720, DOI 10.1128/AAC.44.6.1720-1724.2000; Toure A, 2012, CLIN NUTR, V31, P567, DOI 10.1016/j.clnu.2012.01.001; van de Wetering MD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003295.pub2; Vernon MA, 2006, SCOT MED J, V51, P54; Weber M, 2009, ZBL CHIR, V134, P350, DOI 10.1055/s-0028-1098929; Yahav D, 2008, CLIN INFECT DIS, V47, P83, DOI 10.1086/588667; Zwiech R, 2013, AM J THER	53	266	277	14	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79417	10.1371/journal.pone.0079417	http://dx.doi.org/10.1371/journal.pone.0079417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24244618	Green Published, Green Submitted, gold			2022-12-25	WOS:000327539800007
J	Liu, Y; Lai, NW; Gao, K; Chen, FJ; Yuan, LX; Mi, GH				Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua			Ammonium Inhibits Primary Root Growth by Reducing the Length of Meristem and Elongation Zone and Decreasing Elemental Expansion Rate in the Root Apex in Arabidopsis thaliana	PLOS ONE			English	Article							AUXIN TRANSPORT; GRAVITROPISM; STRESS; EFFLUX; NH4+; ORGANIZATION; SENSITIVITY; MUTATIONS; TOXICITY; NITROGEN	The inhibitory effect of ammonium on primary root growth has been well documented; however the underlying physiological and molecular mechanisms are still controversial. To avoid ammonium toxicity to shoot growth, we used a vertical two-layer split plate system, in which the upper layer contained nitrate and the lower layer contained ammonium. In this way, nitrogen status was maintained and only the apical part of the root system was exposed to ammonium. Using a kinematic approach, we show here that 1 mM ammonium reduces primary root growth, decreasing both elemental expansion and cell production. Ammonium inhibits the length of elongation zone and the maximum elemental expansion rate. Ammonium also decreases the apparent length of the meristem as well as the number of dividing cells without affecting cell division rate. Moreover, ammonium reduces the number of root cap cells but appears to affect neither the status of root stem cell niche nor the distal auxin maximum at the quiescent center. Ammonium also inhibits root gravitropism and concomitantly down-regulates the expression of two pivotal auxin transporters, AUX1 and PIN2. Insofar as ammonium inhibits root growth rate in AUX1 and PIN2 loss-of-function mutants almost as strongly as in wild type, we conclude that ammonium inhibits root growth and gravitropism by largely distinct pathways.	[Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China	China Agricultural University	Mi, GH (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	miguohua@cau.edu.cn	Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/Q-6444-2017; Liu, Ying/GLN-6419-2022; van den Berg, Anke/H-1718-2011; Wu, Ping-Hsun/S-8746-2017; Chang, Chin-Kuo/E-4991-2010	Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Ying/0000-0001-5753-4247; van den Berg, Anke/0000-0002-8894-2638; Chen, Fanjun/0000-0001-8105-1683; Lin, Ming-Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; Liu, Yang/0000-0002-2362-9501; Chang, Chin-Kuo/0000-0002-8338-7196	NSFC [30771289, 31121062]	NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by NSFC (No.30771289), the innovative group grant of NSFC (No.31121062) [http://isisn.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, SOIL SOLUTION CHEM A; Baskin TI, 2013, WIRES DEV BIOL, V2, P65, DOI 10.1002/wdev.94; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; CAO YW, 1993, PLANT PHYSIOL, V102, P983, DOI 10.1104/pp.102.3.983; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Gazzarrini S, 1999, PLANT CELL, V11, P937, DOI 10.1105/tpc.11.5.937; Geisler M, 2002, PLANT PHYSIOL, V130, P1747, DOI 10.1104/pp.011197; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Jiang K, 2005, ANNU REV CELL DEV BI, V21, P485, DOI 10.1146/annurev.cellbio.21.122303.114753; Kudoyarova GR, 1997, PLANT GROWTH REGUL, V23, P207, DOI 10.1023/A:1005990725068; Lewis DR, 2007, PLANT CELL, V19, P1838, DOI 10.1105/tpc.107.051599; Li Q, 2010, PLANT CELL ENVIRON, V33, P1529, DOI 10.1111/j.1365-3040.2010.02162.x; Ma Z, 2003, PLANT PHYSIOL, V131, P1381, DOI 10.1104/pp.012161; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; MORRIS AK, 1992, B MATH BIOL, V54, P1069, DOI 10.1007/BF02460667; Mosier AR, 2004, AGR NITROGEN CYCLE A; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; PICKETT FB, 1990, PLANT PHYSIOL, V94, P1462, DOI 10.1104/pp.94.3.1462; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Rogato A, 2010, PLANT PHYSIOL, V154, P784, DOI 10.1104/pp.110.160309; ROMAN G, 1995, GENETICS, V139, P1393; SHARP RE, 1988, PLANT PHYSIOL, V87, P50, DOI 10.1104/pp.87.1.50; SILK WK, 1992, INT J PLANT SCI, V153, pS49, DOI 10.1086/297063; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Walch-Liu P, 2000, J EXP BOT, V51, P227, DOI 10.1093/jexbot/51.343.227; West G, 2004, PLANT PHYSIOL, V135, P1050, DOI 10.1104/pp.104.040022; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P223, DOI 10.1111/j.1365-3040.2009.02073.x; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zou N, 2012, J EXP BOT, V63, P3777, DOI 10.1093/jxb/ers068	44	266	277	14	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61031	10.1371/journal.pone.0061031	http://dx.doi.org/10.1371/journal.pone.0061031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	24244618	gold, Green Published, Green Submitted			2022-12-25	WOS:000317898000091
J	Liu, YX; van den Berg, A; Veenstra, R; Rutgers, B; Nolte, I; van Imhoff, G; Visser, L; Diepstra, A				Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Nolte, Ilja; van Imhoff, Gustaaf; Visser, Lydia; Diepstra, Arjan			PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV plus Hodgkin Lymphoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; REED-STERNBERG CELLS; ARCHITECTURE; RESPONSES; CHROMATIN	Tumor cells of classical Hodgkin lymphoma (cHL) are characterized by a general loss of B cell phenotype, whereas antigen presenting properties are commonly retained. HLA class I is expressed in most EBV+ cHL cases, with an even enhanced expression in a proportion of the cases. Promyelocytic leukemia protein (PML) and special AT-rich region binding protein 1 (SATB1) are two global chromatin organizing proteins that have been shown to regulate HLA class I expression in Jurkat cells. We analyzed HLA class I, number of PML nuclear bodies (NBs) and SATB1 expression in tumor cells of 54 EBV+ cHL cases and used 27 EBV- cHL cases as controls. There was a significant difference in presence of HLA class I staining between EBV+ and EBV2 cases (p < 0.0001). We observed normal HLA class I expression in 35% of the EBV+ and in 19% of the EBV- cases. A stronger than normal HLA class I expression was observed in approximately 40% of EBV+ cHL and not in EBV- cHL cases. 36 EBV+ cHL cases contained less than 10 PML-NBs per tumor cell, whereas 16 cases contained more than 10 PMLNBs. The number of PML-NBs was positively correlated to the level of HLA class I expression (p < 0.01). The percentage of SATB1 positive cells varied between 0% to 100% in tumor cells and was inversely correlated with the level of HLA class I expression, but only between normal and strong expression (p < 0.05). Multivariable analysis indicated that the number of PML-NBs and the percentage of SATB1+ tumor cells are independent factors affecting HLA class I expression in EBV+ cHL. In conclusion, both PML and SATB1 are correlated to HLA class I expression levels in EBV+ cHL.	[Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Visser, Lydia; Diepstra, Arjan] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Nolte, Ilja] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Imhoff, Gustaaf] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Diepstra, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.diepstra@umcg.nl	Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/Q-6444-2017; Liu, Ying/GLN-6419-2022; van den Berg, Anke/H-1718-2011; Wu, Ping-Hsun/S-8746-2017; Chang, Chin-Kuo/E-4991-2010	Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Ying/0000-0001-5753-4247; van den Berg, Anke/0000-0002-8894-2638; Chen, Fanjun/0000-0001-8105-1683; Lin, Ming-Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; Liu, Yang/0000-0002-2362-9501; Chang, Chin-Kuo/0000-0002-8338-7196	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF) [RUG 2009-4313]	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	This work was supported by grants from Abel Tasman Talent Program (ATTP), University Medical Center Groningen and the Dutch Cancer Society (KWF: RUG 2009-4313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chang SK, 2002, MOL CELLS, V14, P130; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; DELABIE J, 1995, LEUKEMIA LYMPHOMA, V18, P35, DOI 10.3109/10428199509064920; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Diepstra A, 2008, TISSUE ANTIGENS, V71, P219, DOI 10.1111/j.1399-0039.2008.01005.x; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; Diepstra A, 2009, J CLIN ONCOL, V27, P3815, DOI 10.1200/JCO.2008.20.5138; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Huang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010865; Jarrett RF, 2002, ANN ONCOL, V13, P23, DOI 10.1093/annonc/13.S1.23; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kuppers R, 2006, TRENDS IMMUNOL, V27, P203, DOI 10.1016/j.it.2006.03.001; Lallemand-Breitenbach V, COLD SPRING HARB PER, V2; Lee SP, 1997, J IMMUNOL, V158, P3325; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; ROWE M, 1995, EUR J IMMUNOL, V25, P1374, DOI 10.1002/eji.1830250536; Shiels C, 2001, J CELL SCI, V114, P3705; Sides MD, 2011, VIROLOGY, V416, P86, DOI 10.1016/j.virol.2011.04.005; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Stein H, 2008, WHO CLASSIFICATION T, V2, P321; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Woodberry T, 2005, J INFECT DIS, V192, P1513, DOI 10.1086/491741; Zuo J, 2008, J VIROL, V82, P2385, DOI 10.1128/JVI.01946-07; Zuo JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000255	29	266	277	14	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72930	10.1371/journal.pone.0072930	http://dx.doi.org/10.1371/journal.pone.0072930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24244618	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600043
